PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Semigran, HL; Mehrotra, A; Hwang, A				Semigran, Hannah L.; Mehrotra, Ateev; Hwang, Ann			Drowning in a Sea of Paperwork: Toward a More Patient-Centered Billing System in the United States	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; Ctr Consumer Engagement Hlth Innovat, Community Catalyst, Boston, MA USA; [Semigran, Hannah L.; Mehrotra, Ateev; Hwang, Ann] Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.		Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				English A, 2012, CONFIDENTIALITY INDI; LeCuyer Nick A., 2007, MCKINSEY Q; McCormack L, 2009, J CONSUM AFF, V43, P223, DOI 10.1111/j.1745-6606.2009.01138.x; Pollitz Karen, 2014, MED DEBT PEOPLE HLTH; Schoen C, 2013, HEALTH AFFAIR, V32, P2205, DOI 10.1377/hlthaff.2013.0879; Sparrow M., 2000, LICENSE STEAL FRAUD; Wikler Elizabeth, 2012, PAPER CUTS REDUCING	7	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					611	+		10.7326/M15-2283	http://dx.doi.org/10.7326/M15-2283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26830362				2022-12-28	WOS:000375744000020
J	Schoffski, P; Chawla, S; Maki, RG; Italiano, A; Gelderblom, H; Choy, E; Grignani, G; Camargo, V; Bauer, S; Rha, SY; Blay, JY; Hohenberger, P; D'Adamo, D; Guo, M; Chmielowski, B; Le Cesne, A; Demetri, GD; Patel, SR				Schoffski, Patrick; Chawla, Sant; Maki, Robert G.; Italiano, Antoine; Gelderblom, Hans; Choy, Edwin; Grignani, Giovanni; Camargo, Veridiana; Bauer, Sebastian; Rha, Sun Young; Blay, Jean-Yves; Hohenberger, Peter; D'Adamo, David; Guo, Matthew; Chmielowski, Bartosz; Le Cesne, Axel; Demetri, George D.; Patel, Shreyaskumar R.			Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial	LANCET			English	Article							SOFT-TISSUE SARCOMA; DOUBLE-BLIND; MESYLATE; GEMCITABINE; ANTHRACYCLINE; CHEMOTHERAPY; IFOSFAMIDE; DOCETAXEL; PAZOPANIB	Background A non-randomised, phase 2 study showed activity and tolerability of eribulin in advanced or metastatic soft-tissue sarcoma. In this phase 3 study, we aimed to compare overall survival in patients with advanced or metastatic soft-tissue sarcoma who received eribulin with that in patients who received dacarbazine (an active control). Methods We did this randomised, open-label, phase 3 study across 110 study sites in 22 countries. We enrolled patients aged 18 years or older with intermediate-grade or high-grade advanced liposarcoma or leiomyosarcoma who had received at least two previous systemic regimens for advanced disease (including an anthracycline). Using an interactive voice and web response system, an independent statistician randomly assigned (1:1) patients to receive eribulin mesilate (1.4 mg/m(2) intravenously on days 1 and 8) or dacarbazine (850 mg/m(2), 1000 mg/m(2), or 1200 mg/m(2) [dose dependent on centre and clinician] intravenously on day 1) every 21 days until disease progression. Randomisation was stratified by disease type, geographical region, and number of previous regimens for advanced soft-tissue sarcoma and in blocks of six. Patients and investigators were not masked to treatment assignment. The primary endpoint was overall survival in the intention-to-treat population. The study is registered with ClinicalTrials.gov, number NCT01327885, and is closed to recruitment, but treatment and follow-up continue. Findings Between March 10, 2011 and May 22, 2013, we randomly assigned patients to eribulin (n=228) or dacarbazine (n=224). Overall survival was significantly improved in patients assigned to eribulin compared with those assigned to dacarbazine (median 13.5 months [95% CI 10.9-15.6] vs 11.5 months [9.6-13.0]; hazard ratio 0.77 [95% CI 0.62-0.95]; p=0.0169). Treatment-emergent adverse events occurred in 224 (99%) of 226 patients who received eribulin and 218 (97%) of 224 who received dacarbazine. Grade 3 or higher adverse events were more common in patients who received eribulin (152 [67%]) than in those who received dacarbazine (126 [56%]), as were deaths (10 [4%] vs 3 [1%]); one death (in the eribulin group) was considered treatment-related by the investigators. Interpretation Overall survival was improved in patients assigned to eribulin compared with those assigned to an active control, suggesting that eribulin could be a treatment option for advanced soft-tissue sarcoma.	[Schoffski, Patrick] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, B-3000 Leuven, Belgium; [Chawla, Sant] Sarcoma Oncol Ctr, Santa Monica, CA USA; [Maki, Robert G.] Mt Sinai Med Ctr, Tisch Canc Inst, New York, NY 10029 USA; [Italiano, Antoine] Inst Bergonie, Dept Oncol, Bordeaux, France; [Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands; [Choy, Edwin] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Grignani, Giovanni] Fdn Piemonte Oncol IRCCS, Dept Med Oncol, Candiolo, Italy; [Camargo, Veridiana] Hosp Sirio Libanes, Dept Med Oncol, Sao Paulo, Brazil; [Camargo, Veridiana] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Bauer, Sebastian] Univ Duisburg Essen, West German Canc Ctr, Essen, Germany; [Rha, Sun Young] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Blay, Jean-Yves] Univ Lyon 1, LYRIC INCa DGOS 4664, F-69365 Lyon, France; [Blay, Jean-Yves] Ctr Leon Berard, F-69373 Lyon, France; [Hohenberger, Peter] Univ Mannheim, Med Ctr, Dept Surg, Div Surg Oncol & Thorac Surg, D-68131 Mannheim, Germany; [D'Adamo, David] Eisai & Co Ltd, Woodcliff Lake, NJ USA; [Chmielowski, Bartosz] Univ Calif Los Angeles, Jonsson Comprehens Canc, Dept Hematol, Los Angeles, CA USA; [Le Cesne, Axel] Gustave Roussy, Villejuif, France; [Demetri, George D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Sarcoma Ctr, 44 Binney St, Boston, MA 02115 USA; [Demetri, George D.] Harvard Univ, Sch Med, Ludwig Ctr, Boston, MA USA; [Patel, Shreyaskumar R.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA	KU Leuven; University Hospital Leuven; Icahn School of Medicine at Mount Sinai; UNICANCER; Institut Bergonie; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Massachusetts General Hospital; IRCCS Fondazione del Piemonte per l'Oncologia; Hospital Sirio Libanes; University of Duisburg Essen; Yonsei University; Yonsei University Health System; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; University of Mannheim; Eisai Co Ltd; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UNICANCER; Gustave Roussy; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	Schoffski, P (corresponding author), Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, B-3000 Leuven, Belgium.	patrick.schoffski@uzleuven.be	Bauer, Sebastian/HHR-9319-2022; Blay, Jean-Yves/N-3966-2016; Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019; Bauer, Sebastian/D-8120-2012; Grignani, Giovanni/AAB-5913-2022	Blay, Jean-Yves/0000-0001-7190-120X; Maki, Robert G/0000-0002-9853-2528; Bauer, Sebastian/0000-0001-5949-8120; GRIGNANI, GIOVANNI/0000-0001-5515-569X; Gelderblom, Hans/0000-0001-9270-8636; Rha, Sun Young/0000-0002-2512-4531	Eisai; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Eisai(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Eisai.	[Anonymous], E7389 ADM 4 BOL INF; Blay JY, 2015, LANCET ONCOL, V16, P531, DOI 10.1016/S1470-2045(15)70102-6; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Dickson Mark A., 2015, Sarcoma, V2015, P532478, DOI 10.1155/2015/532478; Dybdal-Hargreaves NF, 2015, CLIN CANCER RES, V21, P2445, DOI 10.1158/1078-0432.CCR-14-3252; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Funahashi Y, 2014, CANCER SCI, V105, P1334, DOI 10.1111/cas.12488; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Kaufman PA, 2015, J CLIN ONCOL, V33, P594, DOI 10.1200/JCO.2013.52.4892; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; Mastrangelo G, 2012, CANCER-AM CANCER SOC, V118, P5339, DOI 10.1002/cncr.27555; Munhoz RR, 2015, ONCOLOGIST, V20, P1245, DOI 10.1634/theoncologist.2015-0245; Nedea EA, 2006, HEMATOL ONCOL CLIN N, V20, P401, DOI 10.1016/j.hoc.2006.01.017; Paz-Ares L, 2012, INVEST NEW DRUG, V30, P729, DOI 10.1007/s10637-010-9561-9; Schoffski Patrick, 2014, Oncol Res Treat, V37, P355, DOI 10.1159/000362631; Schoffski P, 2011, LANCET ONCOL, V12, P1045, DOI 10.1016/S1470-2045(11)70230-3; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; Stiller CA, 2013, EUR J CANCER, V49, P684, DOI 10.1016/j.ejca.2012.09.011; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80	25	446	462	1	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1629	1637		10.1016/S0140-6736(15)01283-0	http://dx.doi.org/10.1016/S0140-6736(15)01283-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26874885	Green Accepted			2022-12-28	WOS:000374145100030
J	Gyamfi-Bannerman, C; Thom, EA; Blackwell, SC; Tita, ATN; Reddy, UM; Saade, GR; Rouse, DJ; McKenna, DS; Clark, EAS; Thorp, JM; Chien, EK; Peaceman, AM; Gibbs, RS; Swamy, GK; Norton, ME; Casey, BM; Caritis, SN; Tolosa, JE; Sorokin, Y; VanDorsten, JP; Jain, L				Gyamfi-Bannerman, C.; Thom, E. A.; Blackwell, S. C.; Tita, A. T. N.; Reddy, U. M.; Saade, G. R.; Rouse, D. J.; McKenna, D. S.; Clark, E. A. S.; Thorp, J. M., Jr.; Chien, E. K.; Peaceman, A. M.; Gibbs, R. S.; Swamy, G. K.; Norton, M. E.; Casey, B. M.; Caritis, S. N.; Tolosa, J. E.; Sorokin, Y.; VanDorsten, J. P.; Jain, L.		NICHD Maternal-Fetal Med Units Net	Antenatal Betamethasone for Women at Risk for Late Preterm Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL LUNG MATURATION; RESPIRATORY-DISTRESS; INFANTS; CORTICOSTEROIDS; MORBIDITY; BIRTH	BACKGROUND Infants who are born at 34 to 36 weeks of gestation (late preterm) are at greater risk for adverse respiratory and other outcomes than those born at 37 weeks of gestation or later. It is not known whether betamethasone administered to women at risk for late preterm delivery decreases the risks of neonatal morbidities. METHODS We conducted a multicenter, randomized trial involving women with a singleton pregnancy at 34 weeks 0 days to 36 weeks 5 days of gestation who were at high risk for delivery during the late preterm period (up to 36 weeks 6 days). The participants were assigned to receive two injections of betamethasone or matching placebo 24 hours apart. The primary outcome was a neonatal composite of treatment in the first 72 hours (the use of continuous positive airway pressure or high-flow nasal cannula for at least 2 hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 hours, extracorporeal membrane oxygenation, or mechanical ventilation) or stillbirth or neonatal death within 72 hours after delivery. RESULTS The primary outcome occurred in 165 of 1427 infants (11.6%) in the betamethasone group and 202 of 1400 (14.4%) in the placebo group (relative risk in the betamethasone group, 0.80; 95% confidence interval [CI], 0.66 to 0.97; P = 0.02). Severe respiratory complications, transient tachypnea of the newborn, surfactant use, and bronchopulmonary dysplasia also occurred significantly less frequently in the betamethasone group. There were no significant between-group differences in the incidence of chorioamnionitis or neonatal sepsis. Neonatal hypoglycemia was more common in the betamethasone group than in the placebo group (24.0% vs. 15.0%; relative risk, 1.60; 95% CI, 1.37 to 1.87; P<0.001). CONCLUSIONS Administration of betamethasone to women at risk for late preterm delivery significantly reduced the rate of neonatal respiratory complications.(Funded by the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT01222247.)	[Gyamfi-Bannerman, C.] Columbia Univ, 622 W 168th St,PH-16, New York, NY 10032 USA; [Thom, E. A.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Blackwell, S. C.] 3niv Texas Hlth Sci Ctr Houston, Childrens Mem Hermann Hosp, Houston, TX 77030 USA; [Saade, G. R.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Casey, B. M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Tita, A. T. N.] Univ Alabama Birmingham, Birmingham, AL USA; [Reddy, U. M.] Kennedy Shriver Natl Inst Child Hlth & Human Dev, Bethesda, MD USA; [Rouse, D. J.] Brown Univ, Providence, RI 02912 USA; [McKenna, D. S.] Ohio State Univ, Columbus, OH 43210 USA; [Chien, E. K.] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Clark, E. A. S.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Thorp, J. M., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Swamy, G. K.] Duke Univ, Durham, NC USA; [Peaceman, A. M.] Northwestern Univ, Chicago, IL USA; [Gibbs, R. S.] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Norton, M. E.] Stanford Univ, Stanford, CA 94305 USA; [Caritis, S. N.] Univ Pittsburgh, Pittsburgh, PA USA; [Tolosa, J. E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Sorokin, Y.] Wayne State Univ, Detroit, MI USA; [VanDorsten, J. P.] Med Univ S Carolina, Charleston, SC USA; [Jain, L.] Emory Univ, Atlanta, GA 30322 USA	Columbia University; George Washington University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brown University; University System of Ohio; Ohio State University; Case Western Reserve University; MetroHealth System; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Northwestern University; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Wayne State University; Medical University of South Carolina; Emory University	Gyamfi-Bannerman, C (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, 622 W 168th St,PH-16, New York, NY 10032 USA.	cg2231@cumc.columbia.edu		Tita, Alan/0000-0002-7244-9056; Wapner, Ronald/0000-0003-0727-1244; Chien, Edward/0000-0003-3268-0111	NHLBI [HL098554, HL098354]; NICHD [HD21410, HD27915, HD27917, HD27869, HD34116, HD34208, HD40485, HD40500, HD40512, HD40544, HD40545, HD40560, HD53097, HD53118, HD68268, HD68258, HD68282, HD36801]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD068258, UG1HD040545, U10HD034116, U10HD068268, U10HD036801, U10HD040512, UG1HD034208, U10HD040500, U10HD068258, U10HD040560, U10HD027917, U10HD053097, UG1HD040544, UG1HD034116, U10HD021410, U10HD027915, UG1HD040512, UG1HD027915, UG1HD040560, U10HD068282, U10HD040544, U10HD040545, UG1HD027869, U10HD034208, UG1HD068268, UG1HD068282, U10HD040485, UG1HD053097, U10HD027869, UG1HD040500, UG1HD040485, U10HD053118] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD034136, U01HD021410, U01HD036801] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098554, R01HL098554, R01HL098354, U01HL098354] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (HL098554 and HL098354) from the NHLBI, by grants (HD21410, HD27915, HD27917, HD27869, HD34116, HD34208, HD40485, HD40500, HD40512, HD40544, HD40545, HD40560, HD53097, HD53118, HD68268, HD68258, HD68282, and HD36801) from the NICHD, and by a grant (UL1 TR000040) from the National Center for Advancing Translational Sciences, National Institutes of Health.	[Anonymous], 1994, NIH Consens Statement, V12, P1; [Anonymous], 1995, INT J GYNECOL OBSTET, V50, P303; Balci O, 2010, GYNECOL OBSTET INVES, V70, P95, DOI 10.1159/000295898; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Porto AMF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1696; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rosenberger WF, 2002, RANDOMIZATION CLIN T; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Yoder BA, 2008, OBSTET GYNECOL, V111, P814, DOI 10.1097/AOG.0b013e31816499f4	20	353	374	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1311	1320		10.1056/NEJMoa1516783	http://dx.doi.org/10.1056/NEJMoa1516783			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3UW	26842679	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000373425000005
J	Patel, MS; Asch, DA; Rosin, R; Small, DS; Bellamy, SL; Heuer, J; Sproat, S; Hyson, C; Haff, N; Lee, SM; Wesby, L; Hoffer, K; Shuttleworth, D; Taylor, DH; Hilbert, V; Zhu, JS; Yang, L; Wang, XM; Volpp, KG				Patel, Mitesh S.; Asch, David A.; Rosin, Roy; Small, Dylan S.; Bellamy, Scarlett L.; Heuer, Jack; Sproat, Susan; Hyson, Chris; Haff, Nancy; Lee, Samantha M.; Wesby, Lisa; Hoffer, Karen; Shuttleworth, David; Taylor, Devon H.; Hilbert, Victoria; Zhu, Jingsan; Yang, Lin; Wang, Xingmei; Volpp, Kevin G.			Framing Financial Incentives to Increase Physical Activity Among Overweight and Obese Adults A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							WEARABLE DEVICES; HEALTH BEHAVIOR; IMPROVE HEALTH; HEART-DISEASE; INACTIVITY; ECONOMICS; EXERCISE; LESSONS; REGRET; LIFE	Background: Financial incentive designs to increase physical activity have not been well-examined. Objective: To test the effectiveness of 3 methods to frame financial incentives to increase physical activity among overweight and obese adults. Design: Randomized, controlled trial. (ClinicalTrials.gov: NCT 02030119) Setting: University of Pennsylvania. Participants: 281 adult employees (body mass index >= 27 kg/m(2)). Intervention: 13-week intervention. Participants had a goal of 7000 steps per day and were randomly assigned to a control group with daily feedback or 1 of 3 financial incentive programs with daily feedback: a gain incentive ($1.40 given each day the goal was achieved), lottery incentive (daily eligibility [expected value approximately $1.40] if goal was achieved), or loss incentive ($ 42 allocated monthly upfront and $1.40 removed each day the goal was not achieved). Participants were followed for another 13 weeks with daily performance feedback but no incentives. Measurements: Primary outcome was the mean proportion of participant-days that the 7000-step goal was achieved during the intervention. Secondary outcomes included the mean proportion of participant-days achieving the goal during follow-up and the mean daily steps during intervention and follow-up. Results: The mean proportion of participant-days achieving the goal was 0.30 (95% CI, 0.22 to 0.37) in the control group, 0.35 (CI, 0.28 to 0.42) in the gain-incentive group, 0.36 (CI, 0.29 to 0.43) in the lottery-incentive group, and 0.45 (CI, 0.38 to 0.52) in the loss-incentive group. In adjusted analyses, only the lossincentive group had a significantly greater mean proportion of participant-days achieving the goal than control (adjusted difference, 0.16 [CI, 0.06 to 0.26]; P = 0.001), but the adjusted difference in mean daily steps was not significant (861 [CI, 24 to 1746]; P = 0.056). During follow-up, daily steps decreased for all incentive groups and were not different from control. Limitation: Single employer. Conclusion: Financial incentives framed as a loss were most effective for achieving physical activity goals.	Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Penn Med Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Columbia Univ, Med Ctr, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Harvard University; Massachusetts General Hospital; Columbia University	Patel, MS (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, 423 Guardian Dr,13th Floor Blockley Hall, Philadelphia, PA 19104 USA.	mpatel@upenn.edu		Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599; Bellamy, Scarlett/0000-0002-2906-4046	National Institute on Aging; NATIONAL INSTITUTE ON AGING [P30AG034546, RC4AG039114] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging.	[Anonymous], 2014, US DIG CONS REP; Asch David A, 2012, LDI Issue Brief, V17, P1; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; BIJNEN FCH, 1994, B WORLD HEALTH ORGAN, V72, P1; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; California Department of Public Health, 2015, WORKS PROGR CAL FIT; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Centers for Disease Control and Prevention, FACTS PHYS ACT; Centers for Disease Control and Prevention, 2015, STEPS TO WELLNESS A; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Conn VS, 2009, AM J PREV MED, V37, P330, DOI 10.1016/j.amepre.2009.06.008; Connolly T, 2006, J BEHAV DECIS MAKING, V19, P139, DOI 10.1002/bdm.510; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.2307/1271471]; Dishman RK, 1998, AM J PREV MED, V15, P344, DOI 10.1016/S0749-3797(98)00077-4; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; [Fidelity Investments National Business Group on Health], 2016, TAK ACT IMPR EMPL HL; File Thom, 2013, COMPUTER INTERNET US; Finkelstein EA, 2008, PREV MED, V47, P182, DOI 10.1016/j.ypmed.2008.05.002; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Horwitz JR, 2013, HEALTH AFFAIR, V32, P468, DOI 10.1377/hlthaff.2012.0683; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kaiser Family Foundation, 2014, 2014 EMPLOYER HEALTH; Kang MS, 2005, MEAS PHYS EDUC EXERC, V9, P233, DOI 10.1207/s15327841mpee0904_3; Kullgren JT, 2014, HEALTH EDUC BEHAV, V41, p43S, DOI 10.1177/1090198114540464; Kullgren JT, 2013, ANN INTERN MED, V158, P505, DOI 10.7326/0003-4819-158-7-201304020-00002; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Mitchell MS, 2013, AM J PREV MED, V45, P658, DOI 10.1016/j.amepre.2013.06.017; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; O'Donoghue T, 2000, J BEHAV DECIS MAKING, V13, P233, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<233::AID-BDM325>3.0.CO;2-U; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Pan JX, 2003, COMPUTATION STAT, V18, P57, DOI 10.1007/s001800300132; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; SAS Institute, 2013, SAS VERS 9 4 HELP DO; Schabenberger O, 1996, J STAT COMPUT SIM, V54, P231, DOI 10.1080/00949659608811730; Sen AP, 2014, J GEN INTERN MED, V29, P770, DOI 10.1007/s11606-014-2778-0; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Sisson SB, 2012, AM J HEALTH PROMOT, V26, P152, DOI 10.4278/ajhp.100326-QUAN-95; Texas Department of State Health Services, 2015, WORKS WELLN RES; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; U. S. Department of Health and Human Services, 2008, 2008 PHYSICAL ACTIVI; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Watson Towers, 2015, FULL REP TOW WATS NB; Wisconsin Department of Health Services, 2015, NUTR PHYS ACT RES; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zeelenberg M, 2004, ORGAN BEHAV HUM DEC, V93, P155, DOI 10.1016/j.obhdp.2003.10.001	54	157	158	0	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					385	+		10.7326/M15-1635	http://dx.doi.org/10.7326/M15-1635			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG6PG	26881417	Green Accepted			2022-12-28	WOS:000372207200012
J	Segal, BM; Stuve, O				Segal, Benjamin M.; Stueve, Olaf			Primary progressive multiple sclerosis-why we are failing	LANCET			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; ORAL FINGOLIMOD; DOUBLE-BLIND; PATHOLOGY; IMMUNE; MS		[Segal, Benjamin M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Segal, Benjamin M.] VA Ann Arbor Hlth Care Syst, Neurol Sect, Ann Arbor, MI USA; [Stueve, Olaf] VA Med Ctr, Neurol Sect, VA North Texas Hlth Care Syst, Med Serv Dallas, Dallas, TX 75216 USA; [Stueve, Olaf] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Stueve, Olaf] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technical University of Munich	Stuve, O (corresponding author), VA Med Ctr, Neurol Sect, VA North Texas Hlth Care Syst, Med Serv Dallas, Dallas, TX 75216 USA.; Stuve, O (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Stuve, O (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.	olaf.stuve@utsouthwestern.edu		Segal, Benjamin/0000-0002-0906-6319				Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kowarik MC, 2011, NEUROLOGY, V76, P1214, DOI 10.1212/WNL.0b013e3182143564; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; Lublin F, 2016, LANCET; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Montalban X, 2015, EFFICACY SAFETY OCRE; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313	14	9	9	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1032	1034		10.1016/S0140-6736(16)00158-6	http://dx.doi.org/10.1016/S0140-6736(16)00158-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26827076				2022-12-28	WOS:000371775000006
J	Kondrat, SA; Smith, PJ; Wells, PP; Chater, PA; Carter, JH; Morgan, DJ; Fiordaliso, EM; Wagner, JB; Davies, TE; Lu, L; Bartley, JK; Taylor, SH; Spencer, MS; Kiely, CJ; Kelly, GJ; Park, CW; Rosseinsky, MJ; Hutchings, GJ				Kondrat, Simon A.; Smith, Paul J.; Wells, Peter P.; Chater, Philip A.; Carter, James H.; Morgan, David J.; Fiordaliso, Elisabetta M.; Wagner, Jakob B.; Davies, Thomas E.; Lu, Li; Bartley, Jonathan K.; Taylor, Stuart H.; Spencer, Michael S.; Kiely, Christopher J.; Kelly, Gordon J.; Park, Colin W.; Rosseinsky, Matthew J.; Hutchings, Graham J.			Stable amorphous georgeite as a precursor to a high-activity catalyst	NATURE			English	Article							PAIR DISTRIBUTION FUNCTION; SUPERCRITICAL ANTISOLVENT PRECIPITATION; METHANOL SYNTHESIS CATALYSTS; GAS SHIFT REACTION; ZINC-OXIDE; COPPER; PERFORMANCE; IFEFFIT; AZURITE; SURFACE	Copper and zinc form an important group of hydroxycarbonate minerals that include zincian malachite, aurichalcite, rosasite and the exceptionally rare and unstable- and hence little known and largely ignored(1)-georgeite. The first three of these minerals are widely used as catalyst precursors(2-4) for the industrially important methanol-synthesis and low-temperature water-gas shift (LTS) reactions(5-7), with the choice of precursor phase strongly influencing the activity of the final catalyst. The preferred phase(2,3,8-10) is usually zincian malachite. This is prepared by a co-precipitation method that involves the transient formation of georgeite(11); with few exceptions(12) it uses sodium carbonate as the carbonate source, but this also introduces sodium ions-a potential catalyst poison. Here we show that supercritical antisolvent (SAS) precipitation using carbon dioxide (refs 13, 14), a process that exploits the high diffusion rates and solvation power of supercritical carbon dioxide to rapidly expand and supersaturate solutions, can be used to prepare copper/zinc hydroxycarbonate precursors with low sodium content. These include stable georgeite, which we find to be a precursor to highly active methanol-synthesis and superior LTS catalysts. Our findings highlight the value of advanced synthesis methods in accessing unusual mineral phases, and show that there is room for exploring improvements to established industrial catalysts.	[Kondrat, Simon A.; Smith, Paul J.; Carter, James H.; Morgan, David J.; Davies, Thomas E.; Bartley, Jonathan K.; Taylor, Stuart H.; Spencer, Michael S.; Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales; [Wells, Peter P.] UK Catalysis Hub, Res Complex Harwell, Harwell OX11 0FA, Oxon, England; [Wells, Peter P.] UCL, Dept Chem, Kathleen Lonsdale Bldg,Gordon St, London WC1H 0AJ, England; [Chater, Philip A.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Chater, Philip A.; Davies, Thomas E.; Rosseinsky, Matthew J.] Univ Liverpool, Dept Chem, Crown St, Liverpool L69 7ZD, Merseyside, England; [Fiordaliso, Elisabetta M.; Wagner, Jakob B.] Tech Univ Denmark, Ctr Electron Nanoscopy, Fysikvej 307, DK-2800 Lyngby, Denmark; [Lu, Li; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, 5 E Packer Ave, Bethlehem, PA 18015 USA; [Kelly, Gordon J.; Park, Colin W.] Johnson Matthey, POB 1,Belasis Ave, Billingham TS23 1LB, Cleveland, England	Cardiff University; University of London; University College London; Diamond Light Source; University of Liverpool; Technical University of Denmark; Lehigh University	Kondrat, SA; Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	KondratSA@cardiff.ac.uk; Hutch@cardiff.ac.uk	Wagner, Jakob Birkedal/M-5371-2019; Bartley, Jonathan Keith/AAE-3706-2022; Fiordaliso, Elisabetta Maria/O-1026-2017; Morgan, David John/F-6285-2010; Wells, Peter P/L-6933-2016; Taylor, Stuart/A-3125-2011; Kondrat, Simon A/U-4775-2017; Davies, Thomas E./AAL-1917-2021; Lu, Li/H-3078-2016; Chater, Philip/AAF-8956-2019; Wagner, Jakob B./H-5392-2011	Wagner, Jakob Birkedal/0000-0002-2945-0190; Bartley, Jonathan Keith/0000-0003-4640-541X; Fiordaliso, Elisabetta Maria/0000-0002-1221-2604; Morgan, David John/0000-0002-6571-5731; Wells, Peter P/0000-0002-0859-9172; Taylor, Stuart/0000-0002-1933-4874; Kondrat, Simon A/0000-0003-4972-693X; Davies, Thomas E./0000-0002-8930-5067; Lu, Li/0000-0001-9636-3014; Chater, Philip/0000-0002-5513-9400; Wagner, Jakob B./0000-0002-2945-0190; Kiely, Christopher/0000-0001-5412-0970; Carter, James/0000-0001-6647-811X	Johnson Matthey; Engineering and Physical Sciences Research Council (EPSRC); UK Technology Strategy Board; EPSRC; UK Catalysis Hub [EP/K014714/1, EP/K014668/1, EP/K014706/1, EP/H000925/1, EP/I019693/1]; DOE Office of Science [DE-AC02-06CH11357]; National Science Foundation [MRI/DMR-1040229]; EPSRC [EP/K014668/1, EP/H000925/1, EP/K014706/2, EP/K014714/1, EP/K014706/1, EP/K014854/1, EP/I019693/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H000925/1, EP/I019693/1, EP/K014714/1, EP/K014706/1, EP/K014854/1, EP/K014668/1, EP/K014706/2] Funding Source: researchfish	Johnson Matthey; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Technology Strategy Board; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Catalysis Hub; DOE Office of Science(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Brookes, L. Van de Water, H. Stanness and C. Ramson for technical assistance. We thank Johnson Matthey and the Engineering and Physical Sciences Research Council (EPSRC) for funding though a CASE award, and acknowledge funding from the UK Technology Strategy Board and the EPSRC and UK Catalysis Hub (grants EP/K014714/1, EP/K014714/1, EP/K014668/1, EP/K014706/1, EP/H000925/1 and EP/I019693/1). We used the B18 beamline at the Diamond Light Source (allocation number SP8071) with the help of D. Gianolio and G. Cibin; and we used the I15 beamline, which contributed to the PDF results. This research used the resources of the Advanced Photon Source (APS)-a US Department of Energy (DOE) Office of Science User Facility, operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357; we thank K. Chapman for collecting PDF data at beamline 11-ID-B, APS. C.J.K acknowledges funding from the National Science Foundation Major Research Instrumentation program (GR#MRI/DMR-1040229). M.J.R. is a Royal Society Research Professor. We thank the A.P. Moller and Chastine Mc-Kinney Moller Foundation for contributing to the establishment of the Center for Electron Nanoscopy in the Technical University of Denmark. Source data for Figs 1-3 are available at http://dx.doi.org/10.17035/d.2015.0008102108.	Baltes C, 2008, J CATAL, V258, P334, DOI 10.1016/j.jcat.2008.07.004; Balzar D, 2004, J APPL CRYSTALLOGR, V37, P911, DOI 10.1107/S0021889804022551; Behrens M, 2013, J AM CHEM SOC, V135, P6061, DOI 10.1021/ja310456f; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Behrens M, 2010, CHEMCATCHEM, V2, P816, DOI 10.1002/cctc.201000017; Behrens M, 2010, Z ANORG ALLG CHEM, V636, P919, DOI 10.1002/zaac.201000028; Behrens M, 2009, J CATAL, V267, P24, DOI 10.1016/j.jcat.2009.07.009; Belin S, 2013, CATAL SCI TECHNOL, V3, P2944, DOI 10.1039/c3cy00254c; Belokoneva EL, 2001, PHYS CHEM MINER, V28, P498, DOI 10.1007/s002690100176; Bems B, 2003, CHEM-EUR J, V9, P2039, DOI 10.1002/chem.200204122; BRIDGE PJ, 1979, MINERAL MAG, V43, P97, DOI 10.1180/minmag.1979.043.325.04; CAMPBELL JS, 1970, IND ENG CHEM PROC DD, V9, P588, DOI 10.1021/i260036a016; CHINCHEN GC, 1988, APPL CATAL, V36, P1, DOI 10.1016/S0166-9834(00)80103-7; CHINCHEN GC, 1986, APPL CATAL, V25, P101, DOI 10.1016/S0166-9834(00)81226-9; Chupas PJ, 2003, J APPL CRYSTALLOGR, V36, P1342, DOI 10.1107/S0021889803017564; Coelho A. A., 2010, TOPAS ACAD GEN PROFI; Fichtl M. B., 2001, J APPL CRYSTALLOGR, V34, P172; Fujitani T, 1998, CATAL LETT, V56, P119, DOI 10.1023/A:1019000927366; Hansen TW, 2010, MATER SCI TECH-LOND, V26, P1338, DOI 10.1179/026708310X12756557336355; HARDING MM, 1994, ACTA CRYSTALLOGR B, V50, P673, DOI 10.1107/S0108768194007470; Keen D. A., 2014, ANGEW CHEM INT EDIT, V53, P7043; Klokishner S, 2011, J PHYS CHEM A, V115, P9954, DOI 10.1021/jp205848s; Kuld S, 2014, ANGEW CHEM INT EDIT, V53, P5941, DOI 10.1002/anie.201311073; Michel FM, 2005, CHEM MATER, V17, P6246, DOI 10.1021/cm050886b; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Perchiazzi N, 2006, EUR J MINERAL, V18, P787, DOI 10.1127/0935-1221/2006/0018-0787; POLLARD AM, 1991, MINERAL MAG, V55, P163, DOI 10.1180/minmag.1991.055.379.03; POLLARD AM, 1992, APPL CATAL A-GEN, V85, P1, DOI 10.1016/0926-860X(92)80125-V; Prieto G, 2013, CATAL TODAY, V215, P142, DOI 10.1016/j.cattod.2013.03.033; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Reverchon E, 1999, J SUPERCRIT FLUID, V15, P1, DOI 10.1016/S0896-8446(98)00129-6; RHODES C, 1995, CATAL TODAY, V23, P43, DOI 10.1016/0920-5861(94)00135-O; Rogers AF, 1917, J GEOL, V25, P515, DOI 10.1086/622518; Rothe J, 1998, J AM CHEM SOC, V120, P6019, DOI 10.1021/ja972748w; Schur M, 2003, ANGEW CHEM INT EDIT, V42, P3815, DOI 10.1002/anie.200250709; Short G. D., 1988, US patent, Patent No. [4,788,175, 4788175]; Soper AK, 2011, J APPL CRYSTALLOGR, V44, P714, DOI 10.1107/S0021889811021455; Spencer MS, 1999, TOP CATAL, V8, P259, DOI 10.1023/A:1019181715731; Tang ZR, 2009, CHEMCATCHEM, V1, P247, DOI 10.1002/cctc.200900195	39	106	109	9	315	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					83	+		10.1038/nature16935	http://dx.doi.org/10.1038/nature16935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26878237	Green Submitted, Green Accepted			2022-12-28	WOS:000371211900044
J	Hirano, H; Gootenberg, JS; Horii, T; Abudayyeh, OO; Kimura, M; Hsu, PD; Nakane, T; Ishitani, R; Hatada, I; Zhang, F; Nishimasu, H; Nureki, O				Hirano, Hisato; Gootenberg, Jonathan S.; Horii, Takuro; Abudayyeh, Omar O.; Kimura, Mika; Hsu, Patrick D.; Nakane, Takanori; Ishitani, Ryuichiro; Hatada, Izuho; Zhang, Feng; Nishimasu, Hiroshi; Nureki, Osamu			Structure and Engineering of Francisella novicida Cas9	CELL			English	Article							CRYSTAL-STRUCTURE; GUIDE RNA; DUAL-RNA; DNA; CRISPR-CAS9; COMPLEX; SYSTEM; ENDONUCLEASE; CLEAVAGE; IMMUNITY	The RNA-guided endonuclease Cas9 cleaves doublestranded DNA targets complementary to the guide RNA and has been applied to programmable genome editing. Cas9-mediated cleavage requires a protospacer adjacent motif (PAM) juxtaposed with the DNA target sequence, thus constricting the range of targetable sites. Here, we report the 1.7 angstrom resolution crystal structures of Cas9 from Francisella novicida (FnCas9), one of the largest Cas9 orthologs, in complex with a guide RNA and its PAM-containing DNA targets. A structural comparison of FnCas9 with other Cas9 orthologs revealed striking conserved and divergent features among distantly related CRISPR-Cas9 systems. We found that FnCas9 recognizes the 5'-NGG-3' PAM, and used the structural information to create a variant that can recognize themore relaxed 5'-YG-3' PAM. Furthermore, wedemonstrated that the FnCas9-ribonucleoprotein complex can be microinjected into mouse zygotes to edit endogenous sites with the 5'-YG-3' PAM, thus expanding the target space of the CRISPR-Cas9 toolbox.	[Hirano, Hisato; Nakane, Takanori; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Hsu, Patrick D.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Hsu, Patrick D.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Hsu, Patrick D.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Hsu, Patrick D.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan	University of Tokyo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Gunma University; Japan Science & Technology Agency (JST)	Nishimasu, H; Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Nishimasu, H (corresponding author), JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Hsu, Patrick/ABD-5749-2021; Macrae, Rhiannon/AAX-1536-2020; Abudayyeh, Omar/ABF-1746-2020; Gootenberg, Jonathan/AAY-8174-2021	Abudayyeh, Omar/0000-0002-7979-3220; Gootenberg, Jonathan/0000-0003-2757-2175; Hsu, Patrick/0000-0002-9380-2648; Nakane, Takanori/0000-0003-2697-2767	D.O.E. Computational Science Graduate Fellowship; Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED); NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NIH through NIDDK [5R01DK097768-03]; New York Stem Cell Foundation; Vallee Foundation; Simons, Paul G. Allen Family Foundation; JST; PRESTO; JSPS KAKENHI [26291010, 15H01463]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	D.O.E. Computational Science Graduate Fellowship(United States Department of Energy (DOE)); Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH through NIDDK; New York Stem Cell Foundation; Vallee Foundation; Simons, Paul G. Allen Family Foundation; JST(Japan Science & Technology Agency (JST)); PRESTO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Kaoru Kumazaki for assistance with model building and Arisa Kurabayashi for assistance with vector construction. We thank the beamline scientists at PXI at the Swiss Light Source and BL41XU at SPring-8 for assistance with data collection. J.S.G. is supported by a D.O.E. Computational Science Graduate Fellowship. I.H. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049) and NIDDK (5R01DK097768-03), the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator, a founder of Editas Medicine, and a scientific advisor for Editas Medicine and Horizon Discovery. H.N. is supported by JST, PRESTO, JSPS KAKENHI Grant Numbers 26291010 and 15H01463, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development (AMED), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	34	210	226	6	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					950	961		10.1016/j.cell.2016.01.039	http://dx.doi.org/10.1016/j.cell.2016.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26875867	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000370867300018
J	Johnson, DDP				Johnson, Dominic D. P.			ANTHROPOLOGY Hand of the gods in human civilization	NATURE			English	Editorial Material							SUPERNATURAL PUNISHMENT		[Johnson, Dominic D. P.] Univ Oxford, Dept Polit & Int Relat, Oxford OX1 3UQ, England	University of Oxford	Johnson, DDP (corresponding author), Univ Oxford, Dept Polit & Int Relat, Oxford OX1 3UQ, England.	dominic.johnson@politics.oxford.ac.uk	Johnson, Dominic/GXH-1117-2022					[Anonymous], 2016, ULTRASOCIETY 10000 Y; Johnson Dominic, 2016, GOD IS WATCHING YOU; Norenzayan A, 2013, BIG GODS RELIG TRANS; Purzycki BG, 2016, NATURE, V530, P327, DOI 10.1038/nature16980; Schloss JP, 2011, RELIG BRAIN BEHAV, V1, P46, DOI 10.1080/2153599X.2011.558707; Sosis R, 2009, J COGN CULT, V9, P315, DOI 10.1163/156770909X12518536414411; Watts J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2556; Whitehouse H, 2014, CURR ANTHROPOL, V55, P674, DOI 10.1086/678698; Wilson D., 2002, DARWINS CATHEDRAL EV; [No title captured]	10	3	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					285	287		10.1038/nature16879	http://dx.doi.org/10.1038/nature16879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DE0PP	26863194				2022-12-28	WOS:000370327100023
J	Bloodgood, JC				Bloodgood, Joseph C.			Cancer of the Breast Figures Which Show That Education Can Increase the Number of Cures (Reprinted from JAMA, vol 66, pg 552, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Bloodgood JC, 1916, J AMER MED ASSOC, V66, P552	1	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					709	709		10.1001/jama.2015.17074	http://dx.doi.org/10.1001/jama.2015.17074			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881384				2022-12-28	WOS:000370171500026
J	Beardsley, J; Wolbers, M; Kibengo, FM; Ggayi, ABM; Kamali, A; Cuc, NTK; Binh, TQ; Chau, NVV; Farrar, J; Merson, L; Phuong, L; Thwaites, G; Van Kinh, N; Thuy, PT; Chierakul, W; Siriboon, S; Thiansukhon, E; Onsanit, S; Supphamongkholchaikul, W; Chan, AK; Heyderman, R; Mwinjiwa, E; van Oosterhout, JJ; Imran, D; Basri, H; Mayxay, M; Dance, D; Phimmasone, P; Rattanavong, S; Lalloo, DG; Day, JN				Beardsley, J.; Wolbers, M.; Kibengo, F. M.; Ggayi, A. -B. M.; Kamali, A.; Cuc, N. T. K.; Binh, T. Q.; Chau, N. V. V.; Farrar, J.; Merson, L.; Phuong, L.; Thwaites, G.; Van Kinh, N.; Thuy, P. T.; Chierakul, W.; Siriboon, S.; Thiansukhon, E.; Onsanit, S.; Supphamongkholchaikul, W.; Chan, A. K.; Heyderman, R.; Mwinjiwa, E.; van Oosterhout, J. J.; Imran, D.; Basri, H.; Mayxay, M.; Dance, D.; Phimmasone, P.; Rattanavong, S.; Lalloo, D. G.; Day, J. N.		CryptoDex Investigators	Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; RANDOMIZED CONTROLLED-TRIAL; TUBERCULOUS MENINGITIS; ANTIRETROVIRAL THERAPY; BACTERIAL-MENINGITIS; ANTIFUNGAL; ADULTS; COMBINATION; CORTICOSTEROIDS; PROTOCOL	BACKGROUND Cryptococcal meningitis associated with human immunodeficiency virus (HIV) infection causes more than 600,000 deaths each year worldwide. Treatment has changed little in 20 years, and there are no imminent new anticryptococcal agents. The use of adjuvant glucocorticoids reduces mortality among patients with other forms of meningitis in some populations, but their use is untested in patients with cryptococcal meningitis. METHODS In this double-blind, randomized, placebo-controlled trial, we recruited adult patients with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All the patients received either dexamethasone or placebo for 6 weeks, along with combination antifungal therapy with amphotericin B and fluconazole. RESULTS The trial was stopped for safety reasons after the enrollment of 451 patients. Mortality was 47% in the dexamethasone group and 41% in the placebo group by 10 weeks (hazard ratio in the dexamethasone group, 1.11; 95% confidence interval [CI], 0.84 to 1.47; P = 0.45) and 57% and 49%, respectively, by 6 months (hazard ratio, 1.18; 95% CI, 0.91 to 1.53; P = 0.20). The percentage of patients with disability at 10 weeks was higher in the dexamethasone group than in the placebo group, with 13% versus 25% having a prespecified good outcome (odds ratio, 0.42; 95% CI, 0.25 to 0.69; P< 0.001). Clinical adverse events were more common in the dexamethasone group than in the placebo group (667 vs. 494 events, P = 0.01), with more patients in the dexamethasone group having grade 3 or 4 infection (48 vs. 25 patients, P = 0.003), renal events (22 vs. 7, P = 0.004), and cardiac events (8 vs. 0, P = 0.004). Fungal clearance in cerebrospinal fluid was slower in the dexamethasone group. Results were consistent across Asian and African sites. CONCLUSIONS Dexamethasone did not reduce mortality among patients with HIV-associated cryptococcal meningitis and was associated with more adverse events and disability than was placebo. (Funded by the United Kingdom Department for International Development and others through the Joint Global Health Trials program; Current Controlled Trials number, ISRCTN59144167.)	[Beardsley, J.; Wolbers, M.; Farrar, J.; Merson, L.; Thwaites, G.; Day, J. N.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam; [Cuc, N. T. K.; Chau, N. V. V.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Binh, T. Q.; Phuong, L.] Cho Ray Hosp, Ho Chi Minh City, Vietnam; [Van Kinh, N.] Natl Hosp Trop Dis, Hanoi, Vietnam; [Thuy, P. T.] Bach Mai Hosp, Hanoi, Vietnam; [Beardsley, J.; Wolbers, M.; Farrar, J.; Merson, L.; Thwaites, G.; Mayxay, M.; Dance, D.; Day, J. N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Heyderman, R.] UCL, London, England; [Lalloo, D. G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kibengo, F. M.; Ggayi, A. -B. M.; Kamali, A.] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Chierakul, W.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Siriboon, S.; Supphamongkholchaikul, W.] Ubon Sappasithiprasong Hosp, Ubon Ratchathani, Thailand; [Thiansukhon, E.; Onsanit, S.] Udon Thani Hosp, Udon Thani, Thailand; [Chan, A. K.; Mwinjiwa, E.; van Oosterhout, J. J.] Dignitas Int, Zomba, Malawi; [Heyderman, R.; Lalloo, D. G.] Clin Res Programme, Malawi Liverpool Wellcome Trust, Blantyre, Malawi; [Heyderman, R.; van Oosterhout, J. J.] Univ Malawi, Coll Med, Blantyre, Malawi; [Chan, A. K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Imran, D.] Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Basri, H.] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Mayxay, M.; Dance, D.; Phimmasone, P.; Rattanavong, S.] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Mayxay, M.] Univ Hlth Sci, Viangchan, Laos	University of Oxford; National Hospital of Tropical Diseases; University of Oxford; University of London; University College London; Liverpool School of Tropical Medicine; University of Liverpool; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Malawi; University of Malawi; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Indonesia; Eijkman Institute	Day, JN (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam.	jday@oucru.org	Thwaites, Guy E/R-4993-2019; Farrar, Jeremy J./HGA-7610-2022; Chierakul, Wirongrong/AAC-3226-2020	Thwaites, Guy E/0000-0002-2858-2087; Chierakul, Wirongrong/0000-0003-2103-9425; Dance, David/0000-0001-9189-7244; Heyderman, Robert/0000-0003-4573-449X; Lalloo, David/0000-0001-7680-2200; Ruzagira, Eugene/0000-0002-7291-1693; /0000-0002-1075-4135; Imran, Darma/0000-0002-4109-4192; Newton, Paul/0000-0002-4608-6431; Merson, Laura/0000-0002-4168-1960	United Kingdom Department for International Development; Joint Global Health Trials program; Medical Research Council [G1100684, G1100682] Funding Source: researchfish; MRC [G1100682, G1100684] Funding Source: UKRI	United Kingdom Department for International Development; Joint Global Health Trials program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the United Kingdom Department for International Development and others through the Joint Global Health Trials program; Current Controlled Trials number, ISRCTN59144167.	[Anonymous], 2014, R LANG ENV STAT COMP; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Day J, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-441; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Heemskerk D, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-25; Jarvis JN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004754; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 1999, J ANTIMICROB CHEMOTH, V43, P817, DOI 10.1093/jac/43.6.817; Loyse A, 2013, J ANTIMICROB CHEMOTH, V68, P2435, DOI 10.1093/jac/dkt221; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; *MEDDRA, INT C HARM TECHN REQ; OstroskyZeichner L, 1996, ANTIMICROB AGENTS CH, V40, P1194, DOI 10.1128/AAC.40.5.1194; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P50, DOI 10.1016/S0035-9203(97)90393-X; Simmons CP, 2005, J IMMUNOL, V175, P579, DOI 10.4049/jimmunol.175.1.579; Sungkanuparph S, 2009, CLIN INFECT DIS, V49, P931, DOI 10.1086/605497; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103	29	173	184	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					542	554		10.1056/NEJMoa1509024	http://dx.doi.org/10.1056/NEJMoa1509024			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863355	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000369755800007
J	Iredell, J; Brown, J; Tagg, K				Iredell, Jon; Brown, Jeremy; Tagg, Kaitlin			Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPECTRUM-BETA-LACTAMASE; GRAM-NEGATIVE BACILLI; IN-VITRO SUSCEPTIBILITIES; INTRAABDOMINAL INFECTIONS WORLDWIDE; INTENSIVE-CARE UNITS; ASIA-PACIFIC REGION; ANTIMICROBIAL DRUG SUSCEPTIBILITY; CLOSTRIDIUM-DIFFICILE INFECTION; DOUBLE-CARBAPENEM REGIMEN; URINARY-TRACT-INFECTIONS	Resistance of the Enterobacteriaceae to antibiotics, especially of the beta lactam type, is increasingly dominated by the mobilization of continuously expressed single genes that encode efficient drug modifying enzymes. Strong and ubiquitous selection pressure has seemingly been accompanied by a shift from "natural" resistance, such as inducible chromosomal enzymes, membrane impermeability, and drug efflux, to the modern paradigm of mobile gene pools that largely determine the epidemiology of modern antibiotic resistance. In this way, antibiotic resistance is more available than ever before to organisms such as Escherichia coli and Klebsiella pneumoniae that are important causes of major sepsis. Modulation of the phenotype by host bacteria makes gene transmission less obvious and may in part explain why tracking and control of carbapenem resistance has been particularly problematic in the Enterobacteriaceae. This review discusses the underlying principles and clinical implications of the mobility and fixation of resistance genes and the exploitable opportunities and potential threats arising from apparent limitations on diversity in these mobile gene pools. It also provides some illustrative paradoxes and clinical corollaries, as well as a summary of future options.	[Iredell, Jon; Tagg, Kaitlin] Univ Sydney, Westmead Inst Med Res, Sydney, NSW 2006, Australia; [Iredell, Jon; Tagg, Kaitlin] Marie Bashir Inst, Sydney, NSW, Australia; [Brown, Jeremy] Inst Clin Pathol & Med Res, Dept Microbiol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research	Iredell, J (corresponding author), Univ Sydney, Westmead Inst Med Res, Sydney, NSW 2006, Australia.; Iredell, J (corresponding author), Marie Bashir Inst, Sydney, NSW, Australia.	jonathan.iredell@sydney.edu.au						Adler A, 2011, J ANTIMICROB CHEMOTH, V66, P2763, DOI 10.1093/jac/dkr382; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; [Anonymous], 2013, INFECT DRUG RESIST, DOI DOI 10.2147/IDR.S43868; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arnoldini M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001928; Baquero F, 2003, ASM NEWS, V69, P547; Baquero F, 2004, NAT REV MICROBIOL, V2, P510, DOI 10.1038/nrmicro909; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Baquero F, 2009, SURG INFECT, V10, P99, DOI 10.1089/sur.2008.0020; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bartlett JG, 2011, CLIN INFECT DIS, V53, pS4, DOI 10.1093/cid/cir362; Beardmore RE, 2011, NATURE, V472, P342, DOI 10.1038/nature09905; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Boyd EF, 1996, GENETICS, V143, P1091; Bragg R, 2014, ADV EXP MED BIOL, V807, P97, DOI 10.1007/978-81-322-1777-0_7; Brener SJ, 2011, AM J CARDIOL, V108, P918, DOI 10.1016/j.amjcard.2011.05.022; Brink AJ, 2012, SURG INFECT, V13, P43, DOI 10.1089/sur.2011.074; Bulik CC, 2011, ANTIMICROB AGENTS CH, V55, P3002, DOI 10.1128/AAC.01420-10; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Canica MMM, 1997, J MOL EVOL, V44, P57, DOI 10.1007/PL00006121; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Castanheira M, 2013, ANTIMICROB AGENTS CH, V57, P3012, DOI 10.1128/AAC.02252-12; Centers for Disease Control and Prevention, 2012, CRE TOOLK; Chen B, 2011, APPL ENVIRON MICROB, V77, P148, DOI 10.1128/AEM.01676-10; Choi SH, 2008, ANTIMICROB AGENTS CH, V52, P995, DOI 10.1128/AAC.01083-07; Chow Joseph W, 2005, Surg Infect (Larchmt), V6, P439, DOI 10.1089/sur.2005.6.439; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Clewell DB, 1993, BACTERIAL CONJUGATIO, P75; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC; Coleman BL, 2013, WATER RES, V47, P3026, DOI 10.1016/j.watres.2013.03.008; Cuthbertson BH, 2013, CRIT CARE, V17, DOI 10.1186/cc13096; Dahlberg C, 2003, GENETICS, V165, P1641; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; de Smet AMGA, 2011, LANCET INFECT DIS, V11, P372, DOI 10.1016/S1473-3099(11)70035-4; Denisuik AJ, 2013, J ANTIMICROB CHEMOTH, V68, pi57, DOI 10.1093/jac/dkt027; Desroy N, 2013, J MED CHEM, V56, P1418, DOI 10.1021/jm301499r; Devasahayam G, 2010, EXPERT OPIN INV DRUG, V19, P215, DOI 10.1517/13543780903505092; Dhanji H, J ANTIMICROB CHEMOTH; Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Drawz SM, 2014, ANTIMICROB AGENTS CH, V58, P1835, DOI 10.1128/AAC.00826-13; Enne VI, 2005, J ANTIMICROB CHEMOTH, V56, P544, DOI 10.1093/jac/dki255; Espedido B, 2005, J CLIN MICROBIOL, V43, P4918, DOI 10.1128/JCM.43.9.4918-4919.2005; Falagas ME, 2014, ANTIMICROB AGENTS CH, V58, P654, DOI 10.1128/AAC.01222-13; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Feng Q, 2015, EUR J CLIN MICROBIOL, V34, P197, DOI 10.1007/s10096-014-2219-3; Ferenci T, 2015, BIOESSAYS, V37, P123, DOI 10.1002/bies.201400153; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Filice G, 2013, ANTIMICROBIAL STEWAR; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Galani I, 2012, J CHEMOTHERAPY, V24, P191, DOI 10.1179/1973947812Y.0000000015; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Geser N, 2012, ANTIMICROB AGENTS CH, V56, P1609, DOI 10.1128/AAC.05539-11; Giamarellou H, 2013, ANTIMICROB AGENTS CH, V57, P2388, DOI 10.1128/AAC.02399-12; Gillings MR, 2015, GENES-BASEL, V6, P841, DOI 10.3390/genes6030841; Ginn AN, 2014, INT J ANTIMICROB AG, V43, P563, DOI 10.1016/j.ijantimicag.2014.02.010; Ginn AN, 2013, INT J ANTIMICROB AG, V42, P19, DOI 10.1016/j.ijantimicag.2013.03.003; Ginn AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038719; Giske CG, 2013, EUCAST GUIDELINES DE; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hasan B, 2014, MICROB DRUG RESIST, V30, P30; Hasan B, 2012, EMERG INFECT DIS, V18, P2055, DOI 10.3201/eid1812.120513; Hawkey PM, 2001, FEMS MICROBIOL LETT, V194, P53, DOI 10.1016/S0378-1097(00)00506-1; Hawser S, 2011, EUR J CLIN MICROBIOL, V30, P173, DOI 10.1007/s10096-010-1066-0; Hawser SP, 2012, CLIN MICROBIOL INFEC, V18, P253, DOI 10.1111/j.1469-0691.2011.03550.x; Hawser SP, 2012, INT J ANTIMICROB AG, V39, P490, DOI 10.1016/j.ijantimicag.2012.02.018; Hawser SP, 2010, SURG INFECT, V11, P371, DOI 10.1089/sur.2009.057; Hawser SP, 2009, INT J ANTIMICROB AG, V34, P585, DOI 10.1016/j.ijantimicag.2009.07.013; HEIDT PJ, 1983, PROG FOOD NUTR SCI, V7, P53; Herelle F, 1917, CR ACAD SCI D NAT, P373; Hernandez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076150; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Hirai I, 2013, INT J ANTIMICROB AG, V42, P500, DOI 10.1016/j.ijantimicag.2013.08.005; Ho VP, 2011, SURG INFECT, V12, P255, DOI 10.1089/sur.2010.073; Hoban DJ, 2012, DIAGN MICR INFEC DIS, V74, P62, DOI 10.1016/j.diagmicrobio.2012.05.024; Hoban DJ, 2010, ANTIMICROB AGENTS CH, V54, P3031, DOI 10.1128/AAC.01808-09; Hooper DC, 2015, ANN NY ACAD SCI, V1354, P12, DOI 10.1111/nyas.12830; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; Hsueh PR, 2006, INT J ANTIMICROB AG, V28, P238, DOI 10.1016/j.ijantimicag.2006.04.010; Hughes D, 2015, NAT REV GENET, V16, P459, DOI 10.1038/nrg3922; Humeniuk C, 2002, ANTIMICROB AGENTS CH, V46, P3045, DOI 10.1128/AAC.46.9.3045-3049.2002; Hunter PA, 2010, J ANTIMICROB CHEMOTH, V65, pI3, DOI 10.1093/jac/dkp433; Iredell J, 2007, J ANTIMICROB CHEMOTH, V59, P816, DOI 10.1093/jac/dkm002; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jain A, 2013, FEMS MICROBIOL LETT, V348, P87, DOI 10.1111/1574-6968.12241; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kachrimanidou M, 2011, CRIT REV MICROBIOL, V37, P178, DOI 10.3109/1040841X.2011.556598; Kaiser RM, 2013, DIAGN MICR INFEC DIS, V76, P356, DOI 10.1016/j.diagmicrobio.2013.03.032; Kamruzzaman M, 2013, DIAGN MICR INFEC DIS, V76, P222, DOI 10.1016/j.diagmicrobio.2013.02.016; Kamruzzaman M, 2015, ANTIMICROB AGENTS CH, V59, P5088, DOI 10.1128/AAC.00420-15; Karageorgopoulos DE, 2012, J ANTIMICROB CHEMOTH, V67, P2777, DOI 10.1093/jac/dks270; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Kern WV, 2006, J ANTIMICROB CHEMOTH, V57, P339, DOI 10.1093/jac/dki445; Kester JC, 2014, CRIT REV BIOCHEM MOL, V49, P91, DOI 10.3109/10409238.2013.869543; Khawaldeh A, 2011, J MED MICROBIOL, V60, P1697, DOI 10.1099/jmm.0.029744-0; Kitchel B, 2010, ANTIMICROB AGENTS CH, V54, P4201, DOI 10.1128/AAC.00008-10; Ko WC, 2009, J INFECTION, V59, P95, DOI 10.1016/j.jinf.2009.06.003; Koppolu V, 2013, INFECT IMMUN, V81, P4220, DOI 10.1128/IAI.00919-13; Kotte O, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135022; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Lagace-Wiens P, 2014, CORE EVID, V9, P13, DOI 10.2147/CE.S40698; Lagace-Wiens PRS, 2013, J ANTIMICROB CHEMOTH, V68, pi23, DOI 10.1093/jac/dkt023; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leitner I, 2011, J ANTIMICROB CHEMOTH, V66, P834, DOI 10.1093/jac/dkq526; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Ley RE, 2014, NAT MED, V20, P248, DOI 10.1038/nm.3494; Li WY, 2014, AMINO ACIDS, V46, P2287, DOI 10.1007/s00726-014-1820-1; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu Y. P., 2015, J ADV CLIN PHARM, V1, P1, DOI DOI 10.1109/TCYB.2015.2388582; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Livermore DM, 2012, J ANTIMICROB CHEMOTH, V67, P1569, DOI 10.1093/jac/dks088; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Lohiya Ayush, 2015, J Clin Diagn Res, V9, pLC15, DOI 10.7860/JCDR/2015/14230.6254; Lonchel CM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-53; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Martinez JL, 2014, UPSALA J MED SCI, V119, P68, DOI 10.3109/03009734.2014.901444; Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Mandal SM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00105; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Martinez JL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00265; Martinez-Martinez L, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01860.x; Mathers AJ, 2015, ANTIMICROB AGENTS CH, V59, P1661, DOI 10.1128/AAC.04292-14; Maurer FP, 2015, J CLIN MICROBIOL, V53, P95, DOI 10.1128/JCM.01692-14; Mendes RE, 2013, ANTIMICROB AGENTS CH, V57, P5721, DOI 10.1128/AAC.01121-13; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Mouton JW, 2012, CLIN MICROBIOL INFEC, V18, pE37, DOI 10.1111/j.1469-0691.2011.03752.x; Muniesa M, 2013, FUTURE MICROBIOL, V8, P739, DOI 10.2217/fmb.13.32; Nation RL, 2009, CURR OPIN INFECT DIS, V22, P535, DOI 10.1097/QCO.0b013e328332e672; [National Health and Medical Research Council Australian Government], 2010, AUSTRALIAN GUIDELINE; Navon-Venezia S, 2009, ANTIMICROB AGENTS CH, V53, P818, DOI 10.1128/AAC.00987-08; Neonakis IK, 2010, CHEMOTHERAPY, V56, P448, DOI 10.1159/000320943; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nordmann P, 2013, J ANTIMICROB CHEMOTH, V68, P487, DOI 10.1093/jac/dks426; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; O'Fallon E, 2010, INFECT CONT HOSP EP, V31, P1148, DOI 10.1086/656590; Oliva A, 2014, J ANTIMICROB CHEMOTH, V69, P1718, DOI 10.1093/jac/dku027; Oteo J, 2006, J CLIN MICROBIOL, V44, P2359, DOI 10.1128/JCM.00447-06; Partridge SR, 2015, INT J ANTIMICROB AG, V45, P130, DOI 10.1016/j.ijantimicag.2014.10.006; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Paterson DL, 2005, J ANTIMICROB CHEMOTH, V55, P965, DOI 10.1093/jac/dki117; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pecor ND, 2015, MBIO, V6, DOI 10.1128/mBio.01030-15; Peleg AY, 2005, CLIN INFECT DIS, V41, P1549, DOI 10.1086/497831; Petschow B, 2013, ANN NY ACAD SCI, V1306, P1, DOI 10.1111/nyas.12303; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Garcillan-Barcia MP, 2015, PLASMID, V77, P17, DOI 10.1016/j.plasmid.2014.11.003; Garcillan-Barcia MP, 2011, FEMS MICROBIOL REV, V35, P936, DOI 10.1111/j.1574-6976.2011.00291.x; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P1730, DOI 10.1093/jac/dkr174; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Pontikis K, 2014, INT J ANTIMICROB AG, V43, P52, DOI 10.1016/j.ijantimicag.2013.09.010; Pournaras S, 2009, J ANTIMICROB CHEMOTH, V64, P348, DOI 10.1093/jac/dkp207; Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; Pucci MJ, 2013, CLIN MICROBIOL REV, V26, P792, DOI 10.1128/CMR.00033-13; Quale J, 2012, MICROB DRUG RESIST, V18, P132, DOI 10.1089/mdr.2011.0163; Rahme C, 2014, DIAGN MICR INFEC DIS, V80, P239, DOI 10.1016/j.diagmicrobio.2014.07.007; Rao GG, 2014, ANTIMICROB AGENTS CH, V58, P1381, DOI 10.1128/AAC.00327-13; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Rodriguez MM, 2004, ANTIMICROB AGENTS CH, V48, P4895, DOI 10.1128/AAC.48.12.4895-4897.2004; Rodriguez-Lazaro D, 2015, INT J FOOD MICROBIOL, V209, P20, DOI 10.1016/j.ijfoodmicro.2014.10.016; Rogers BA, 2012, EUR J CLIN MICROBIOL, V31, P2413, DOI 10.1007/s10096-012-1584-z; Rogers BA, 2011, CLIN INFECT DIS, V53, P49, DOI 10.1093/cid/cir273; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Rossi F, 2006, J ANTIMICROB CHEMOTH, V58, P205, DOI 10.1093/jac/dkl199; Sahoo KC, 2012, INT J ENV RES PUB HE, V9, P746, DOI 10.3390/ijerph9030746; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321, DOI 10.1128/AAC.41.11.2321; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; San Millan A, 2014, ISME J, V8, P601, DOI 10.1038/ismej.2013.182; SATO K, 1991, J ANTIMICROB CHEMOTH, V28, P35, DOI 10.1093/jac/28.1.35; Sbrana F, 2013, CLIN INFECT DIS, V56, P697, DOI 10.1093/cid/cis969; Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13; Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sherley M, 2003, PLASMID, V49, P79, DOI 10.1016/S0147-619X(02)00107-5; Shitrit P, 2013, J HOSP INFECT, V85, P230, DOI 10.1016/j.jhin.2013.07.014; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; Solomkin JS, 2014, ANTIMICROB AGENTS CH, V58, P1847, DOI 10.1128/AAC.01614-13; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stecher B, NAT REV MICROBIOL; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Sutcliffe JA, 2013, ANTIMICROB AGENTS CH, V57, P5548, DOI 10.1128/AAC.01288-13; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Tagg KA, 2015, DIAGN MICR INFEC DIS, V83, P56, DOI 10.1016/j.diagmicrobio.2015.06.001; Tagg KA, 2014, ANTIMICROB AGENTS CH, V58, P4949, DOI 10.1128/AAC.02773-14; Takiff HE, 2015, LANCET INFECT DIS, V15, P1077, DOI 10.1016/S1473-3099(15)00071-7; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Timofte D, 2011, J CLIN MICROBIOL, V49, P3411, DOI 10.1128/JCM.01045-11; Titelman E, 2014, CLIN MICROBIOL INFEC, V20, pO508, DOI 10.1111/1469-0691.12559; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; Turnidge JD, 2014, COMMUN DIS INTELL, V38, pE54; Turnidge JD, 2013, COMMUN DIS INTELL, V37, pE219; TVEDE M, 1989, LANCET, V1, P1156; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; Twort FW, 1921, LANCET, V2, P204; Tzouvelekis LS, 2014, CLIN MICROBIOL INFEC, V20, P862, DOI 10.1111/1469-0691.12697; Vaara M, 2013, J ANTIMICROB CHEMOTH, V68, P1213, DOI 10.1093/jac/dkt039; van Hal SJ, 2009, J CLIN MICROBIOL, V47, P2325, DOI 10.1128/JCM.02141-08; VANDERWAAIJ D, 1974, J HYG-CAMBRIDGE, V72, P379, DOI 10.1017/S0022172400023615; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Vento TJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-68; Villegas MV, 2011, BRAZ J INFECT DIS, V15, P34, DOI 10.1590/S1413-86702011000100007; von Wintersdorff CJH, 2014, EMERG INFECT DIS, V20, P649, DOI [10.3201/eid2004.131718, 10.3201/eid.2004.131718]; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Walsh TR, 2006, CURR OPIN MICROBIOL, V9, P476, DOI 10.1016/j.mib.2006.08.009; Wang XJ, 2014, ANTIMICROB AGENTS CH, V58, P1774, DOI 10.1128/AAC.02123-13; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wendt C, 2010, EUR J CLIN MICROBIOL, V29, P563, DOI 10.1007/s10096-010-0896-0; WILSON KH, 1981, INFECT IMMUN, V34, P626, DOI 10.1128/IAI.34.2.626-628.1981; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yang J, 2013, J BIOL CHEM, V288, P31115, DOI 10.1074/jbc.M113.503912; Yang QW, 2013, J MED MICROBIOL, V62, P1343, DOI 10.1099/jmm.0.059816-0; Yang QW, 2010, INT J ANTIMICROB AG, V36, P507, DOI 10.1016/j.ijantimicag.2010.09.001; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Yurist-Doutsch S, 2014, ANNU REV GENET, V10, P10; Zhang H, 2014, CHINESE MED J-PEKING, V127, P2429, DOI 10.3760/cma.j.issn.0366-6999.20131538	260	153	162	1	120	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2016	352								h6420	10.1136/bmj.h6420	http://dx.doi.org/10.1136/bmj.h6420			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IH	26858245				2022-12-28	WOS:000370380000001
J	Shakir, R				Shakir, Raad			Brain health: widening the scope of NCDs	LANCET			English	Editorial Material							RISK		[Shakir, Raad] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London W6 8RF, England	Imperial College London	Shakir, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Charing Cross Hosp Campus, London W6 8RF, England.	r.shakir@imperial.ac.uk						[Anonymous], 2015, LANCET NEUROL, V14, P1, DOI 10.1016/S1474-4422(14)70312-6; Bloom DE, 2011, GLOBAL EC BURDEN NON; Gardener H, 2015, NAT REV NEUROL, V11, P651, DOI 10.1038/nrneurol.2015.195; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Patel V, 2015, LANCET; Pearce N, 2015, LANCET, V386, P2235; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shakir R, 2015, J NEUROL SCI, V356, P1, DOI 10.1016/j.jns.2015.07.005; Silberberg D, 2015, NATURE, V527, pS151, DOI 10.1038/nature16028; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	12	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					518	519		10.1016/S0140-6736(16)00100-8	http://dx.doi.org/10.1016/S0140-6736(16)00100-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26867432				2022-12-28	WOS:000369835800013
J	Christensen, KD; Roberts, JS; Whitehouse, PJ; Royal, CDM; Obisesan, TO; Cupples, LA; Vernarelli, JA; Bhatt, DL; Linnenbringer, E; Butson, MB; Fasaye, GA; Uhlmann, WR; Hiraki, S; Wang, N; Cook-Deegan, R; Green, RC				Christensen, Kurt D.; Roberts, J. Scott; Whitehouse, Peter J.; Royal, Charmaine D. M.; Obisesan, Thomas O.; Cupples, L. Adrienne; Vernarelli, Jacqueline A.; Bhatt, Deepak L.; Linnenbringer, Erin; Butson, Melissa B.; Fasaye, Grace-Ann; Uhlmann, Wendy R.; Hiraki, Susan; Wang, Na; Cook-Deegan, Robert; Green, Robert C.		REVEAL Study Grp	Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GENOMIC INCIDENTAL FINDINGS; APOLIPOPROTEIN-E GENOTYPES; APOE GENOTYPE; REVEAL; EXOME; TESTS; RECOMMENDATIONS; EDUCATION; SERVICES; RETURN	Background: Increasing use of genetic testing raises questions about disclosing secondary findings, including pleiotropic information. Objective: To determine the safety and behavioral effect of disclosing modest associations between apolipoprotein E (APOE) genotype and coronary artery disease (CAD) risk during APOE-based genetic risk assessments for Alzheimer disease (AD). Design: Randomized, multicenter equivalence clinical trial. (ClinicalTrials.gov:NCT00462917) Setting: 4 teaching hospitals. Participants: 257 asymptomatic adults were enrolled, 69% of whom had 1 AD-affected first-degree relative. Intervention: Disclosure of genetic risk information about AD and CAD (AD+CAD) or AD only (AD-only). Measurements: Primary outcomes were Beck Anxiety Inventory (BAI) and Center for Epidemiologic Studies Depression Scale (CES-D) scores at 12 months. Secondary outcomes were all measures at 6 weeks and 6 months and test-related distress and health behavior changes at 12 months. Results: At 12 months, mean BAI scores were 3.5 in both the AD-only and AD+CAD groups (difference, 0.0 [95% CI, -1.0 to 1.0]), and mean CES-D scores were 6.4 and 7.1 in the AD-only and AD+CAD groups, respectively (difference, 0.7 [CI, -1.0 to 2.4]). Both confidence bounds fell within the equivalence margin of +/- 5 points. Among carriers of the APOE epsilon 4 allele, distress was lower in the AD+CAD groups (difference, -4.8 [CI, -8.6 to -1.0]) (P = 0.031 for the interaction between group and APOE genotype). Participants in the AD+CAD groups also reported more health behavior changes, regardless of APOE genotype. Limitations: Outcomes were self-reported by volunteers without severe anxiety, severe depression, or cognitive problems. Analyses omitted 33 randomly assigned participants. Conclusion: Disclosure of pleiotropic information did not increase anxiety or depression and may have decreased distress among persons at increased risk for 2 conditions. Providing risk modification information about CAD improved health behaviors. Findings highlight the potential benefits of disclosure of secondary genetic findings when options exist for decreasing risk.	[Christensen, Kurt D.; Green, Robert C.] Brigham & Womens Hosp, EC Alumnae Bldg,Suite 301,41 Ave Louis Pasteur, Boston, MA 02115 USA; [Roberts, J. Scott] Univ Michigan, Sch Publ Hlth, 3854 SPH 1,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Whitehouse, Peter J.; Butson, Melissa B.] Case Western Reserve Univ, Univ Foley Elderhealth Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA; [Royal, Charmaine D. M.] Duke Univ, Off Undergrad Scholars & Fellows, Smith Warehouse,Room B209,114 South Buchanan St, Durham, NC 27701 USA; [Obisesan, Thomas O.] Howard Univ Hosp, 2041 Georgia Ave NW,Towers Bldg 5000, Washington, DC 20060 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA; [Vernarelli, Jacqueline A.] Fairfield Univ, 1073 North Benson Rd, Fairfield, CT 06824 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Linnenbringer, Erin] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 South Euclid Ave,Campus Box 8100, St Louis, MO 63110 USA; [Fasaye, Grace-Ann] Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Uhlmann, Wendy R.] Univ Michigan, Sch Med, Dept Human Genet, 300 North Ingalls Bldg,NI3 A03,SPC 5419, Ann Arbor, MI 48109 USA; [Hiraki, Susan] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Wang, Na] Boston Univ, Sch Publ Hlth, 801 Massachusetts Ave,CT340C, Boston, MA 02118 USA; [Cook-Deegan, Robert] Sanford Sch Publ Policy, Duke Box 90239, Durham, NC 27708 USA	Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Case Western Reserve University; Duke University; Howard University; Boston University; Fairfield University; Harvard University; Brigham & Women's Hospital; Washington University (WUSTL); Walter Reed National Military Medical Center; University of Michigan System; University of Michigan; Boston University	Green, RC (corresponding author), Brigham & Womens Hosp, EC Alumnae Bldg,Suite 301,41 Ave Louis Pasteur, Boston, MA 02115 USA.; Green, RC (corresponding author), Harvard Univ, Sch Med, Partners Personalized Med, EC Alumnae Bldg,Suite 301,41 Ave Louis Pasteur, Boston, MA 02115 USA.	rcgreen@genetics.med.harvard.edu	Linnenbringer, Erin/AAF-1996-2020	Linnenbringer, Erin/0000-0002-3883-0013; Cupples, L. Adrienne/0000-0003-0273-7965; Obisesan, Thomas Olabode/0000-0002-0291-512X; Christensen, Kurt/0000-0003-4068-776X; Uhlmann, Wendy R./0000-0002-4243-438X; Cook-Deegan, Robert/0000-0002-8251-4237; Royal, Charmaine/0000-0003-3593-851X	National Institutes of Health [HG002213, HG006500, HD077671, HG006993, AG013846, RR000533, RR010284, TR001102]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409, UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284, M01RR000533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006500, F32HG006993, R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grants HG002213, HG006500, HD077671, HG006993, AG013846, RR000533, RR010284, and TR001102 from the National Institutes of Health.	[Anonymous], 2015, ONLINE MENDELIAN INH; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Christensen KD, 2008, GENET MED, V10, P207, DOI 10.1097/GIM.0b013e318164e4cf; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Cupples LA, 2004, GENET MED, V6, P192, DOI 10.1097/01.GIM.0000132679.92238.58; Green RC, 2015, ALZHEIMERS DEMENT, V11, P1222, DOI 10.1016/j.jalz.2014.10.014; Green RC, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P102, DOI 10.1016/B978-0-12-382227-7.00009-4; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Henrikson NB, 2008, PHARMACOGENOMICS J, V8, P85, DOI 10.1038/sj.tpj.6500457; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jackson L, 2012, AM J MED GENET A, V158A, P3159, DOI 10.1002/ajmg.a.35615; Janssens ACJW, 2015, GENET MED, V17, P621, DOI 10.1038/gim.2014.169; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kocarnik JM, 2014, JAMA-J AM MED ASSOC, V311, P795, DOI 10.1001/jama.2014.369; Korf BR, 2013, DISCOV MED, V16, P241; Lee JW, 2014, CLIN GENET, V86, P21, DOI 10.1111/cge.12392; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; Morris JC, 2005, ALZ DIS ASSOC DIS, V19, P100, DOI 10.1097/01.wad.0000167923.56275.d8; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Payne K, 2008, VALUE HEALTH, V11, P497, DOI 10.1111/j.1524-4733.2007.00259.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roberts JS, 2012, GENET MED, V14, P742, DOI 10.1038/gim.2012.37; Roberts JS, 2005, J GERIATR PSYCH NEUR, V18, P250, DOI 10.1177/0891988705281883; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; Vernarelli JA, 2010, AM J CLIN NUTR, V91, P1402, DOI 10.3945/ajcn.2009.28981; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Watson MS, 2015, GENET MED, V17, DOI [10.1038/gim.2015.94, 10.1038/gim.2014.151]; Weiner C, 2014, AM J EPIDEMIOL, V180, P562, DOI 10.1093/aje/kwu217; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004	44	30	30	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					155	U148		10.7326/M15-0187	http://dx.doi.org/10.7326/M15-0187			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26810768	Green Accepted			2022-12-28	WOS:000369169400004
J	Morris, MC; Brockman, J; Schneider, JA; Wang, YM; Bennett, DA; Tangney, CC; van de Rest, O				Morris, Martha Clare; Brockman, John; Schneider, Julie A.; Wang, Yamin; Bennett, David A.; Tangney, Christy C.; van de Rest, Ondine			Association of Seafood Consumption, Brain Mercury Level, and APOE epsilon 4 Status With Brain Neuropathology in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-E GENOTYPE; N-3 FATTY-ACIDS; FOOD FREQUENCY QUESTIONNAIRE; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; DOCOSAHEXAENOIC ACID; FISH-OIL; CONTROLLED-TRIAL; DEMENTIA RISK; IMPAIRMENT	IMPORTANCE Seafood consumption is promoted for its many health benefits even though its contamination by mercury, a known neurotoxin, is a growing concern. OBJECTIVE To determine whether seafood consumption is correlated with increased brain mercury levels and also whether seafood consumption or brain mercury levels are correlated with brain neuropathologies. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analyses of deceased participants in the Memory and Aging Project clinical neuropathological cohort study, 2004-2013. Participants resided in Chicago retirement communities and subsidized housing. The study included 286 autopsied brains of 554 deceased participants (51.6%). The mean (SD) age at death was 89.9 (6.1) years, 67%(193) were women, and the mean (SD) educational attainment was 14.6 (2.7) years. EXPOSURES Seafood intake was first measured by a food frequency questionnaire at a mean of 4.5 years before death. MAIN OUTCOMES AND MEASURES Dementia-related pathologies assessed were Alzheimer disease, Lewy bodies, and the number of macroinfarcts and microinfarcts. Dietary consumption of seafood and n-3 fatty acids was annually assessed by a food frequency questionnaire in the years before death. Tissue concentrations of mercury and selenium were measured using instrumental neutron activation analyses. RESULTS Among the 286 autopsied brains of 544 participants, brain mercury levels were positively correlated with the number of seafood meals consumed per week (p = 0.16; P = .02). In models adjusted for age, sex, education, and total energy intake, seafood consumption (>= 1 meal[s]/week) was significantly correlated with less Alzheimer disease pathology including lower density of neuritic plaques (beta = -0.69 score units [95% CI, -1.34 to -0.04]), less severe and widespread neurofibrillary tangles (beta = -0.77 score units [95% CI, -1.52 to -0.02]), and lower neuropathologically defined Alzheimer disease (beta = -0.53 score units [95% CI, -0.96 to -0.10]) but only among apolipoprotein E (APOE epsilon 4) carriers. Higher intake levels of a-linolenic acid (18: 3 n-3) were correlated with lower odds of cerebral macroinfarctions (odds ratio for tertiles 3 vs 1, 0.51 [95% CI, 0.27 to 0.94]). Fish oil supplementation had no statistically significant correlation with any neuropathologic marker. Higher brain concentrations of mercury were not significantly correlated with increased levels of brain neuropathology. CONCLUSIONS AND RELEVANCE In cross-sectional analyses, moderate seafood consumption was correlated with lesser Alzheimer disease neuropathology. Although seafood consumption was also correlated with higher brain levels of mercury, these levels were not correlated with brain neuropathology.	[Morris, Martha Clare; Wang, Yamin] Rush Univ, Med Ctr, Dept Internal Med, Sect Nutr & Nutr Epidemiol, 1645 W Jackson,Ste 675, Chicago, IL 60612 USA; [Brockman, John] Missouri Univ Res Reactor, Columbia, MO USA; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimer Dis Ctr, Chicago, IL 60612 USA; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Tangney, Christy C.] Rush Univ, Med Ctr, Dept Clin Nutr, Chicago, IL 60612 USA; [van de Rest, Ondine] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Rush University; University of Missouri System; University of Missouri Columbia; Rush University; Rush University; Rush University; Rush University; Wageningen University & Research	Morris, MC (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Sect Nutr & Nutr Epidemiol, 1645 W Jackson,Ste 675, Chicago, IL 60612 USA.	martha_c_morris@rush.edu		Brockman, John/0000-0001-7419-5558	National Institutes of Health [R01AG031553, R21ES021290, R01AG17917]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031553, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants (R01AG031553, R21ES021290 and R01AG17917).	[Anonymous], 1997, Neurobiol Aging, V18, pS1; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barberger-Gateau P, 2011, CURR ALZHEIMER RES, V8, P479, DOI 10.2174/156720511796391926; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Berry MJ, 2008, ECOHEALTH, V5, P456, DOI 10.1007/s10393-008-0204-y; Beydoun MA, 2007, AM J CLIN NUTR, V85, P1103; Bjorklund G, 2015, BIOMETALS, V28, P605, DOI 10.1007/s10534-015-9857-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cole GM, 2010, NUTR REV, V68, pS102, DOI 10.1111/j.1753-4887.2010.00345.x; Daiello LA, 2015, ALZHEIMERS DEMENT, V11, P226, DOI 10.1016/j.jalz.2014.02.005; de Goede J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017967; de Souza AS, 2011, NUTR REV, V69, P132, DOI 10.1111/j.1753-4887.2011.00374.x; Dietrich M, 2005, LIPIDS, V40, P329, DOI 10.1007/s11745-006-1390-4; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; FUNG YK, 1995, J TOXICOL-CLIN TOXIC, V33, P243, DOI 10.3109/15563659509017991; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803; Huang TL, 2010, J ALZHEIMERS DIS, V21, P673, DOI 10.3233/JAD-2010-090934; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kariv-Inbal Z, 2012, J ALZHEIMERS DIS, V28, P667, DOI 10.3233/JAD-2011-111265; Kroger E, 2009, AM J CLIN NUTR, V90, P184, DOI 10.3945/ajcn.2008.26987; Larrieu S, 2004, J Nutr Health Aging, V8, P150; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Morris MC, 2003, AM J EPIDEMIOL, V158, P1213, DOI 10.1093/aje/kwg290; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Park JH, 2014, AM J ALZHEIMERS DIS, V29, P76, DOI 10.1177/1533317513506778; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Ronnemaa E, 2012, EUR J CLIN NUTR, V66, P885, DOI 10.1038/ejcn.2012.63; Rusina R, 2011, NEUROTOX RES, V20, P329, DOI 10.1007/s12640-011-9246-y; Samieri C, 2008, AM J CLIN NUTR, V88, P714, DOI 10.1093/ajcn/88.3.714; Samieri C, 2013, J LIPID RES, V54, P2559, DOI 10.1194/jlr.P036475; Samieri C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.020; SAMUDRALWAR DL, 1995, J NEUROL SCI, V130, P139, DOI 10.1016/0022-510X(95)00018-W; Saxe SR, 1999, J AM DENT ASSOC, V130, P191, DOI 10.14219/jada.archive.1999.0168; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Stonehouse W, 2013, AM J CLIN NUTR, V97, P1134, DOI 10.3945/ajcn.112.053371; Tangney CC, 2004, J NUTR, V134, P927, DOI 10.1093/jn/134.4.927; Tangney CC, 2014, ALZHEIMERS DEMENT, V10, P280, DOI [10.1016/j.jalz.2014.07.151, DOI 10.1016/J.JALZ.2014.07.151]; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Weil M, 2005, JAMA-J AM MED ASSOC, V293, P1875, DOI 10.1001/jama.293.15.1875; Whalley LJ, 2008, AM J CLIN NUTR, V87, P449, DOI 10.1093/ajcn/87.2.449; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	52	75	79	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					489	497		10.1001/jama.2015.19451	http://dx.doi.org/10.1001/jama.2015.19451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836731	Green Accepted, Bronze			2022-12-28	WOS:000369049500018
J	Checchi, F; Waldman, RJ; Roberts, LF; Ager, A; Asgary, R; Benner, MT; Blanchet, K; Burnham, G; d'Harcourt, E; Leaning, J; Massaquoi, MBF; Mills, EJ; Moresky, RT; Patel, P; Roberts, B; Toole, MJ; Woodruff, B; Zwi, AB				Checchi, Francesco; Waldman, Ronald J.; Roberts, Leslie F.; Ager, Alastair; Asgary, Ramin; Benner, Marie T.; Blanchet, Karl; Burnham, Gilbert; d'Harcourt, Emmanuel; Leaning, Jennifer; Massaquoi, Moses B. F.; Mills, Edward J.; Moresky, Rachel T.; Patel, Preeti; Roberts, Bayard; Toole, Michael J.; Woodruff, Bradley; Zwi, Anthony B.			World Health Organization and emergency health: if not now, when?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL HEALTH; LESSONS; POLIO		[Checchi, Francesco] Save Children, Humanitarian Tech Unit, London, England; [Checchi, Francesco; Blanchet, Karl] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Waldman, Ronald J.] Doctors World USA, New York, NY USA; [Waldman, Ronald J.] George Washington Univ, Milken Inst Sch Publ Hlth, Global Hlth Dept, Washington, DC USA; [Roberts, Leslie F.; Ager, Alastair; Moresky, Rachel T.; Woodruff, Bradley] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA; [Ager, Alastair] Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Asgary, Ramin] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Benner, Marie T.] Malteser Int, Cologne, Germany; [Burnham, Gilbert] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [d'Harcourt, Emmanuel] Int Rescue Comm, New York, NY USA; [Leaning, Jennifer] Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, 665 Huntington Ave, Boston, MA 02115 USA; [Massaquoi, Moses B. F.] Minist Hlth & Social Welf, Monrovia, Liberia; [Mills, Edward J.] Global Evaluat Sci, Vancouver, BC, Canada; [Moresky, Rachel T.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Patel, Preeti] Kings Coll London, Dept War Studies, London WC2R 2LS, England; [Roberts, Bayard] London Sch Hyg & Trop Med, ECOHOST Ctr Hlth & Social Change, London WC1, England; [Toole, Michael J.] Burnet Inst, Melbourne, Vic, Australia; [Toole, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Woodruff, Bradley] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Zwi, Anthony B.] Univ New S Wales, Sch Social Sci, Hlth Rights & Dev HEARD UNSW, Sydney, NSW, Australia	Save the Children; University of London; London School of Hygiene & Tropical Medicine; George Washington University; Columbia University; Queen Margaret University; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; Burnet Institute; Monash University; Emory University; Rollins School Public Health; University of New South Wales Sydney	Checchi, F (corresponding author), Save Children, Humanitarian Tech Unit, London, England.	F.Checchi@savethechildren.org.uk	Zwi, Anthony/AAP-8731-2020; Zwi, Anthony/AAP-7026-2021	Zwi, Anthony/0000-0001-6902-6602; Roberts, Bayard/0000-0003-4482-5859; Patel, Preeti/0000-0003-3875-453X; Checchi, Francesco/0000-0001-9030-5382; Ager, Alastair/0000-0002-9474-3563				Action Aid, 2005, IN DEPTH STUD IMP OP; [Anonymous], 1995, Lancet, V345, P339; [Anonymous], 2004, LANCET, V364, P475; [Anonymous], 2015, 1 ADV GROUP REF WHOS; Asgary R, 2015, AM J TROP MED HYG, V92, P678, DOI 10.4269/ajtmh.14-0364; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Boseley S., 2015, GUARDIAN; Boseley S, 2014, GUARDIAN; Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; Bruckner Catherine, 2011, Confl Health, V5, P13, DOI 10.1186/1752-1505-5-13; Calain P, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0058-1; Centre for Research on the Epidemiology of Disasters, 2013, PEOPL AFF CONFL 2013; Centre for Research on the Epidemiology of Disasters, 2015, HUM COST NAT DIS 201; Checchi F, 2006, HUMANITARIAN EXCHANG, V36, P7; Cheng M, 2015, ASS PRESS; Clift C, 2015, WHO EBOLA REPORT IS; Clift C, 2014, CHATHAM HOUSE REPORT; DuBois M., 2015, EBOLA RESPONSE W AFR; Ebola Interim Assessment Panel, 2015, REP EB INT ASS PAN; Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0; Fink-Hooijer F, 2015, HUMANITARIAN EXCHANG, V64, P3; Godlee F, 1997, BRIT MED J, V314, P1359; GODLEE F, 1994, BRIT MED J, V309, P1566, DOI 10.1136/bmj.309.6968.1566; Gostin LO, 2015, PUBLIC HEALTH, V129, P854, DOI 10.1016/j.puhe.2015.05.002; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; Hanrieder T, 2015, EUR J INT RELAT, V21, P215, DOI 10.1177/1354066114530011; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Horton R, 2015, LANCET, V386, P1024, DOI 10.1016/S0140-6736(15)00152-X; Independent Monitoring Board of the Global Polio Eradication Initiative, 2013, 8 IND MON BOARD GLOB; Lee K, 2014, PUBLIC HEALTH, V128, P119, DOI 10.1016/j.puhe.2013.08.002; MoH, 2005, SURVEY REPORT; Moon S, 2015, LANCET; Mullan Z, 2015, LANCET GLOB HEALTH, V3, pE423, DOI 10.1016/S2214-109X(15)00092-3; Office of the United Nations Special Envoy on Ebola, 2015, RES RES; PLoS Medicine Editors, 2007, PLoS Med, V4, pe197; Rutter PD, 2014, J INFECT DIS, V210, pS16, DOI 10.1093/infdis/jiu181; Sahloul Z, 2014, LANCET, V383, P407, DOI 10.1016/S0140-6736(13)62558-1; Salignon P, 2009, HUMANITARIAN PR 1029; Sphere Project, 2011, SPHER HDB; Spiegel Paul B, 2007, Confl Health, V1, P2, DOI 10.1186/1752-1505-1-2; Sridhar D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3841; Tan YSA, 2015, PREHOSP DISASTER MED, V30, P264, DOI 10.1017/S1049023X15000254; Vasagar J, 2005, GUARDIAN; WHO, 2015, EB SIT REP; World Health Organization, 2015, GOV BOD DOC OFF REC; World Health Organization, 2009, REP REV COMM FUNCT I; World Health Organization, 2015, ADV GROUP REF WHOS W; World Health Organization (WHO), 2013, EM RESP FRAM; Yamey G, 2002, BMJ-BRIT MED J, V325, P1170, DOI 10.1136/bmj.325.7373.1170	49	22	22	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2016	352								i469	10.1136/bmj.i469	http://dx.doi.org/10.1136/bmj.i469			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC6EX	26821569	Bronze, Green Published			2022-12-28	WOS:000369313700013
J	Liu, B; Zheng, YG; Yin, F; Yu, JZ; Silverman, N; Pan, DJ				Liu, Bo; Zheng, Yonggang; Yin, Feng; Yu, Jianzhong; Silverman, Neal; Pan, Duojia			Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila	CELL			English	Article							TUMOR-SUPPRESSOR; CELL-PROLIFERATION; KAPPA-B; TEAD/TEF FAMILY; YAP ONCOPROTEIN; PROTEIN-KINASE; GROWTH-CONTROL; TISSUE-GROWTH; GENE ENCODES; SIZE-CONTROL	The Hippo signaling pathway functions through Yorkie to control tissue growth and homeostasis. How this pathway regulates non-developmental processes remains largely unexplored. Here, we report an essential role for Hippo signaling in innate immunity whereby Yorkie directly regulates the transcription of the Drosophila IkB homolog, Cactus, in Toll receptor-mediated antimicrobial response. Loss of Hippo pathway tumor suppressors or activation of Yorkie in fat bodies, the Drosophila immune organ, leads to elevated cactus mRNA levels, decreased expression of antimicrobial peptides, and vulnerability to infection by Gram-positive bacteria. Furthermore, Grampositive bacteria acutely activate Hippo-Yorkie signaling in fat bodies via the Toll-Myd88-Pelle cascade through Pelle-mediated phosphorylation and degradation of the Cka subunit of the Hippoinhibitory STRIPAK PP2A complex. Our studies elucidate a Toll-mediated Hippo signaling pathway in antimicrobial response, highlight the importance of regulating IkB/Cactus transcription in innate immunity, and identify Gram-positive bacteria as extracellular stimuli of Hippo signaling under physiological settings.	[Liu, Bo; Zheng, Yonggang; Yin, Feng; Yu, Jianzhong; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu	YIN, FENG/AAM-3823-2020; Liu, Bo/K-1268-2016	YIN, FENG/0000-0002-8444-1123; Silverman, Neal/0000-0002-4259-456X	NIH [EY015708, AI060025]; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, R56AI060025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. Louisa Wu (University of Maryland) for Drs-GFP and Dpt-GFP reporter lines and Dr. Steven X. Hou (National Cancer Institute) for Cka antibody. We thank Bloomington Drosophila Stock Center, Kyoto Drosophila Genetic Resource Center, Vienna Drosophila Resource Center, Drosophila Genomics Resource Center, and Developmental Studies Hybridoma Bank for fly strains and reagents. This study was supported in part by grants from the NIH (EY015708 to D.P. and AI060025 to N.S.). D.P. is an investigator of the Howard Hughes Medical Institute.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Daigneault J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075150; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Marcinkevicius E, 2013, DEVELOPMENT, V140, P433, DOI 10.1242/dev.083949; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	58	161	173	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					406	419		10.1016/j.cell.2015.12.029	http://dx.doi.org/10.1016/j.cell.2015.12.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824654	Green Accepted, Bronze			2022-12-28	WOS:000368906800012
J	Vincenti, F; Rostaing, L; Grinyo, J; Rice, K; Steinberg, S; Gaite, L; Moal, MC; Mondragon-Ramirez, GA; Kothari, J; Polinsky, MS; Meier-Kriesche, HU; Munier, S; Larsen, CP				Vincenti, Flavio; Rostaing, Lionel; Grinyo, Joseph; Rice, Kim; Steinberg, Steven; Gaite, Luis; Moal, Marie-Christine; Mondragon-Ramirez, Guillermo A.; Kothari, Jatin; Polinsky, Martin S.; Meier-Kriesche, Herwig-Ulf; Munier, Stephane; Larsen, Christian P.			Belatacept and Long-Term Outcomes in Kidney Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; CADAVERIC RENAL-TRANSPLANTATION; CRITERIA DONOR KIDNEYS; PHASE-III; MYCOPHENOLATE-MOFETIL; IMMUNOSUPPRESSIVE REGIMENS; GRAFT-SURVIVAL; UNITED-STATES; BENEFIT-EXT; RISK-FACTOR	BACKGROUND In previous analyses of BENEFIT, a phase 3 study, belatacept-based immunosuppression, as compared with cyclosporine-based immunosuppression, was associated with similar patient and graft survival and significantly improved renal function in kidney-transplant recipients. Here we present the final results from this study. METHODS We randomly assigned kidney-transplant recipients to a more-intensive belatacept regimen, a less-intensive belatacept regimen, or a cyclosporine regimen. Efficacy and safety outcomes for all patients who underwent randomization and transplantation were analyzed at year 7 (month 84). RESULTS A total of 666 participants were randomly assigned to a study group and underwent transplantation. Of the 660 patients who were treated, 153 of the 219 patients treated with the more-intensive belatacept regimen, 163 of the 226 treated with the less-intensive belatacept regimen, and 131 of the 215 treated with the cyclosporine regimen were followed for the full 84-month period; all available data were used in the analysis. A 43% reduction in the risk of death or graft loss was observed for both the more-intensive and the less-intensive belatacept regimens as compared with the cyclosporine regimen (hazard ratio with the more-intensive regimen, 0.57; 95% confidence interval [CI], 0.35 to 0.95; P = 0.02; hazard ratio with the less-intensive regimen, 0.57; 95% CI, 0.35 to 0.94; P = 0.02), with equal contributions from the lower rates of death and graft loss. The mean estimated glomerular filtration rate (eGFR) increased over the 7-year period with both belatacept regimens but declined with the cyclosporine regimen. The cumulative frequencies of serious adverse events at month 84 were similar across treatment groups. CONCLUSIONS Seven years after transplantation, patient and graft survival and the mean eGFR were significantly higher with belatacept (both the more-intensive regimen and the less-intensive regimen) than with cyclosporine.	[Vincenti, Flavio] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Steinberg, Steven] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA; [Rostaing, Lionel] Univ Hosp, Toulouse, France; [Rostaing, Lionel] INSERM, IFR BMT, U563, Toulouse, France; [Moal, Marie-Christine] Hop La Cavale Blanche, Brest, France; [Grinyo, Joseph] Univ Hosp Bellvitge, Barcelona, Spain; [Rice, Kim] Baylor Univ, Med Ctr, Dallas, TX USA; [Gaite, Luis] Clin Nefrol, Santa Fe, Argentina; [Mondragon-Ramirez, Guillermo A.] Inst Mexicano Trasplantes, Cuernavaca, Morelos, Mexico; [Kothari, Jatin] Hinduja Hlth Care, Hinduja Hosp, Mumbai, Maharashtra, India; [Kothari, Jatin] Apex Kidney Fdn, Mumbai, Maharashtra, India; [Polinsky, Martin S.; Meier-Kriesche, Herwig-Ulf] Bristol Myers Squibb Co, Princeton, NJ USA; [Munier, Stephane] Bristol Myers Squibb Co, Braine Lalleud, Belgium; [Larsen, Christian P.] Emory Univ, Transplant Ctr, Atlanta, GA 30322 USA	University of California System; University of California San Francisco; Sharp Memorial Hospital Rehabilitation & Physical Therapy; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest; Universite de Bretagne Occidentale; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Baylor University; Baylor University Medical Center; Bristol-Myers Squibb; Bristol-Myers Squibb; Emory University	Vincenti, F (corresponding author), Univ Calif San Francisco, Transplant Ctr, 505 Parnassus Ave, San Francisco, CA 94143 USA.	flavio.vincenti@ucsf.edu			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00256750.	Archdeacon P, 2012, AM J TRANSPLANT, V12, P554, DOI 10.1111/j.1600-6143.2011.03976.x; Behrend M, 1999, TRANSPLANTATION, V68, P391; Bestard O, 2012, NEFROLOGIA, V32, P374, DOI 10.3265/Nefrologia.pre2012.Jan.11176; Caillard S, 2005, TRANSPLANTATION, V80, P1233, DOI 10.1097/01.tp.0000179639.98338.39; Charpentier B, 2013, AM J TRANSPLANT, V13, P2884, DOI 10.1111/ajt.12459; Durrbach A, 2010, AM J TRANSPLANT, V10, P547, DOI 10.1111/j.1600-6143.2010.03016.x; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; European Medicines Agency, NUL EUR PUBL ASS REP; Everly MJ, 2013, TRANSPLANTATION, V95, P410, DOI 10.1097/TP.0b013e31827d62e3; Fellstrom B, 2005, TRANSPLANTATION, V79, P1160, DOI 10.1097/01.TP.0000160764.35083.B8; Florman SM, 2015, AM J TRANSPLANT S3, V15; Gaston RS, 2009, CLIN J AM SOC NEPHRO, V4, P2029, DOI 10.2215/CJN.03820609; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Kahan BD, 2003, TRANSPLANT P, V35, p37S, DOI 10.1016/S0041-1345(03)00353-1; Kaplan B, 2003, J AM SOC NEPHROL, V14, P2980, DOI 10.1097/01.ASN.0000095250.92361.D5; Kim EJ, 2014, AM J TRANSPLANT, V14, P59, DOI 10.1111/ajt.12526; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorber MI, 2005, TRANSPLANTATION, V80, P244, DOI 10.1097/01.TP.0000164352.65613.24; Masson P, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010699.pub2; Mathew TH, 1998, TRANSPLANTATION, V65, P1450, DOI 10.1097/00007890-199806150-00007; Meier-Kriesche HU, 2003, TRANSPLANTATION, V75, P1291, DOI 10.1097/01.TP.0000061602.03327.E2; Miller J, 1997, TRANSPL P, V29, P304, DOI 10.1016/S0041-1345(96)00270-9; Mohan S, 2012, J AM SOC NEPHROL, V23, P2061, DOI 10.1681/ASN.2012070664; Nair R, 2009, TRANSPL P, V41, P4150, DOI 10.1016/j.transproceed.2009.09.074; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Opelz G, 2009, TRANSPLANTATION, V87, P795, DOI 10.1097/TP.0b013e318199c1c7; Pestana JOM, 2012, AM J TRANSPLANT, V12, P630, DOI 10.1111/j.1600-6143.2011.03914.x; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Sampaio MS, 2012, TRANSPLANTATION, V93, P73, DOI 10.1097/TP.0b013e31823ae7db; Shapiro R, 1999, TRANSPLANTATION, V68, P1851, DOI 10.1097/00007890-199912270-00006; Silva HT, 2014, TRANSPLANTATION, V97, P636, DOI 10.1097/01.TP.0000437669.93963.8E; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vitko S, 2005, AM J TRANSPLANT, V5, P2521, DOI 10.1111/j.1600-6143.2005.01063.x	39	407	415	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					333	343		10.1056/NEJMoa1506027	http://dx.doi.org/10.1056/NEJMoa1506027			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816011	Green Published			2022-12-28	WOS:000368760100007
J	Dyer, O				Dyer, Owen			Sixty seconds on . . . Zika virus	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500	1	4	4	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2016	352								i467	10.1136/bmj.i467	http://dx.doi.org/10.1136/bmj.i467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EQ	26812929	Bronze, Green Published			2022-12-28	WOS:000369313000011
J	Vallentin, D; Kosche, G; Lipkind, D; Long, MA				Vallentin, Daniela; Kosche, Georg; Lipkind, Dina; Long, Michael A.			Inhibition protects acquired song segments during vocal learning in zebra finches	SCIENCE			English	Article							SYNAPTIC BASIS; MOTOR; SYSTEM; INTERNEURONS; SELECTIVITY; IMITATION; PATHWAYS; DYNAMICS; NUCLEUS; NEURONS	Vocal imitation involves incorporating instructive auditory information into relevant motor circuits through processes that are poorly understood. In zebra finches, we found that exposure to a tutor's song drives spiking activity within premotor neurons in the juvenile, whereas inhibition suppresses such responses upon learning in adulthood. We measured inhibitory currents evoked by the tutor song throughout development while simultaneously quantifying each bird's learning trajectory. Surprisingly, we found that the maturation of synaptic inhibition onto premotor neurons is correlated with learning but not age. We used synthetic tutoring to demonstrate that inhibition is selective for specific song elements that have already been learned and not those still in refinement. Our results suggest that structured inhibition plays a crucial role during song acquisition, enabling a piece-by-piece mastery of complex tasks.	[Vallentin, Daniela; Kosche, Georg; Long, Michael A.] NYU, Langone Med Ctr, NYU Neurosci Inst, New York, NY 10016 USA; [Vallentin, Daniela; Kosche, Georg; Long, Michael A.] NYU, Langone Med Ctr, Dept Otolaryngol, New York, NY 10016 USA; [Vallentin, Daniela; Kosche, Georg; Long, Michael A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Lipkind, Dina] Hunter Coll, Dept Psychol, Lab Vocal Learning, New York, NY 10065 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; City University of New York (CUNY) System; Hunter College (CUNY)	Long, MA (corresponding author), NYU, Langone Med Ctr, NYU Neurosci Inst, 550 1St Ave, New York, NY 10016 USA.	mlong@med.nyu.edu			NIH [R01NS075044]; New York Stem Cell Foundation; Deutsche Forschungsgemeinschaft [VA 742/1-2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH grant R01NS075044, the New York Stem Cell Foundation, and Deutsche Forschungsgemeinschaft grant VA 742/1-2. We thank R. Froemke, J. Goldberg, G. Maimon, D. Okobi, B. Olveczky, and R. Tsien for comments on earlier versions of this manuscript; K. Katlowitz, K. Kuchibhotla, and J. Merel for assistance with statistics and analysis; and O. Tchernichovski for valuable discussions and for providing the birds used in this study. Supplement contains additional data. The authors declare no competing financial interests. Author contributions: D.V., G.K., and M.A.L. designed the research; D.V., G.K., and D.L. performed the research; D.V., G.K., D.L., and M.A.L. analyzed the data; D.L. contributed reagents and analytic tools; and D.V., G.K., and M.A.L. wrote the paper.	Accorsi-Mendonca D, 2007, AM J PHYSIOL-REG I, V292, pR396, DOI 10.1152/ajpregu.00776.2005; Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Blandin Y, 1999, Q J EXP PSYCHOL-A, V52, P957, DOI 10.1080/027249899390882; FIORITO G, 1992, SCIENCE, V256, P545, DOI 10.1126/science.256.5056.545; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Immelmann K., 1969, P61; Kenward B, 2006, ANIM BEHAV, V72, P1329, DOI 10.1016/j.anbehav.2006.04.007; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Li YT, 2012, J NEUROSCI, V32, P3981, DOI 10.1523/JNEUROSCI.5514-11.2012; Lipkind D, 2011, P NATL ACAD SCI USA, V108, P15572, DOI 10.1073/pnas.1012941108; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Morales B, 2002, J NEUROSCI, V22, P8084; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Pecka M, 2014, NEURON, V84, P457, DOI 10.1016/j.neuron.2014.09.010; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Raksin JN, 2012, J NEUROPHYSIOL, V107, P2185, DOI 10.1152/jn.01003.2009; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; Ravbar P, 2012, J NEUROSCI, V32, P3422, DOI 10.1523/JNEUROSCI.3740-11.2012; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Scotto-Lomassese S, 2007, EUR J NEUROSCI, V25, P1663, DOI 10.1111/j.1460-9568.2007.05418.x; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; VU ET, 1994, J NEUROSCI, V14, P6924; Whiten A, 1998, J COMP PSYCHOL, V112, P270, DOI 10.1037/0735-7036.112.3.270	33	68	68	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					267	271		10.1126/science.aad3023	http://dx.doi.org/10.1126/science.aad3023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816377	Green Accepted			2022-12-28	WOS:000368098600039
J	Moher, D; Moher, E				Moher, David; Moher, Ester			Stop Predatory Publishers Now: Act Collaboratively	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Moher, David] Ottawa Gen Hosp, Res Inst, Clin Epidemiol Program, Gen Campus,501 Smyth Rd,Room L1288, Ottawa, ON K1H 8L6, Canada; [Moher, Ester] Privacy Analyt, 251 Laurier Ave West,Suite 200, Ottawa, ON K1P 5J6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Moher, D (corresponding author), Ottawa Gen Hosp, Res Inst, Clin Epidemiol Program, Gen Campus,501 Smyth Rd,Room L1288, Ottawa, ON K1H 8L6, Canada.	dmoher@ohri.ca	Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206				Akhawe D, 2013, 22 USENIX SEC S WASH; Behavioural Insights Team, 2015, UPD REP 2013 2015; Lariviere V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127502; Moher D, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0423-3; Shen CY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0469-2; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	6	45	45	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					616	+		10.7326/M15-3015	http://dx.doi.org/10.7326/M15-3015			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26830517				2022-12-28	WOS:000375744000022
J	Gao, KM; Calabrese, JR				Gao, Keming; Calabrese, Joseph R.			Pharmacogenetics of lithium response: close to clinical practice?	LANCET			English	Editorial Material							DISEASE; CANCER		[Gao, Keming; Calabrese, Joseph R.] Case Western Reserve Univ, Sch Med, Dept Psychiat, Mood Disorders Program,Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital	Gao, KM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Psychiat, Mood Disorders Program,Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	keming.gao@uhhospitals.org	Gao, Keming/W-6017-2019					Canestaro WJ, 2012, J PERS MED, V2, P158, DOI 10.3390/jpm2040158; Chen CH, 2014, NEW ENGL J MED, V370, P119, DOI 10.1056/NEJMoa1212444; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P443, DOI 10.1021/cn5000309; Harrison PJ, 2016, CURR OPIN NEUROBIOL, V36, P1, DOI 10.1016/j.conb.2015.07.002; Hou L., 2016, LANCET; Mertens J, 2016, NATURE, V530, DOI 10.1038/nature16182; Rybakowski JK, 2013, CNS DRUGS, V27, P165, DOI 10.1007/s40263-013-0040-7; Sayols-Baixeras S, 2014, APPL CLIN GENET, V7, P15, DOI 10.2147/TACG.S35301; Shen T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00215; Song J, 2016, MOL PSYCHIATR, V21, P1290, DOI 10.1038/mp.2015.165; Szczepankiewicz A, 2013, NEUROPSYCH DIS TREAT, V9, P1573, DOI 10.2147/NDT.S28117; Tighe SK, 2011, THER ADV CHRONIC DIS, V2, P209, DOI 10.1177/2040622311399173; Vockley JG, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1832	13	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1034	1036		10.1016/S0140-6736(16)00147-1	http://dx.doi.org/10.1016/S0140-6736(16)00147-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26806517				2022-12-28	WOS:000371775000007
J	Dominissini, D; Nachtergaele, S; Moshitch-Moshkovitz, S; Peer, E; Kol, N; Ben-Haim, MS; Dai, Q; Di Segni, A; Salmon-Divon, M; Clark, WC; Zheng, GQ; Pan, T; Solomon, O; Eyal, E; Hershkovitz, V; Han, D; Dore, LC; Amariglio, N; Rechavi, G; He, C				Dominissini, Dan; Nachtergaele, Sigrid; Moshitch-Moshkovitz, Sharon; Peer, Eyal; Kol, Nitzan; Ben-Haim, Moshe Shay; Dai, Qing; Di Segni, Ayelet; Salmon-Divon, Mali; Clark, Wesley C.; Zheng, Guanqun; Pan, Tao; Solomon, Oz; Eyal, Eran; Hershkovitz, Vera; Han, Dali; Dore, Louis C.; Amariglio, Ninette; Rechavi, Gideon; He, Chuan			The dynamic N-1-methyladenosine methylome in eukaryotic messenger RNA	NATURE			English	Article							TRANSLATION INITIATION SITES; SINGLE-NUCLEOTIDE-RESOLUTION; EMBRYONIC STEM-CELLS; 25S RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; BASE MODIFICATION; M(1)A58 METHYLTRANSFERASE; RIBONUCLEIC-ACID; MAPPING REVEALS; METHYLATION	Gene expression can be regulated post-transcriptionally through dynamic and reversible RNA modifications. A recent noteworthy example is N-6-methyladenosine (m6A), which affects messenger RNA (mRNA) localization, stability, translation and splicing. Here we report on a new mRNA modification, N-1-methyladenosine (m(1)A), that occurs on thousands of different gene transcripts in eukaryotic cells, from yeast to mammals, at an estimated average transcript stoichiometry of 20% in humans. Employing newly developed sequencing approaches, we show that m(1)A is enriched around the start codon upstream of the first splice site: it preferentially decorates more structured regions around canonical and alternative translation initiation sites, is dynamic in response to physiological conditions, and correlates positively with protein production. These unique features are highly conserved in mouse and human cells, strongly indicating a functional role for m(1)A in promoting translation of methylated mRNA.	[Dominissini, Dan; Nachtergaele, Sigrid; Dai, Qing; Han, Dali; Dore, Louis C.; He, Chuan] Univ Chicago, Dept Chem, 929 East 57th St,Chicago, Chicago, IL 60637 USA; [Dominissini, Dan; Nachtergaele, Sigrid; Dai, Qing; Han, Dali; Dore, Louis C.; He, Chuan] Univ Chicago, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA; [Dominissini, Dan; Nachtergaele, Sigrid; Dai, Qing; Han, Dali; Dore, Louis C.; He, Chuan] Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA; [Moshitch-Moshkovitz, Sharon; Peer, Eyal; Kol, Nitzan; Ben-Haim, Moshe Shay; Di Segni, Ayelet; Salmon-Divon, Mali; Solomon, Oz; Eyal, Eran; Hershkovitz, Vera; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Peer, Eyal; Ben-Haim, Moshe Shay; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Solomon, Oz; Amariglio, Ninette] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Clark, Wesley C.; Zheng, Guanqun; Pan, Tao; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; University of Chicago	Dominissini, D; He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St,Chicago, Chicago, IL 60637 USA.; Dominissini, D; He, C (corresponding author), Univ Chicago, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.; Dominissini, D; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA.; Rechavi, G (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.; Rechavi, G (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.	dandominissini@gmail.com; gidi.rechavi@sheba.health.gov.il; chuanhe@uchicago.edu	Han, Dali/I-4145-2016; Salmon-Divon, Mali/AAG-4479-2019; Dore, Louis/A-5689-2009; Dai, Qing/ABD-8444-2021	Salmon-Divon, Mali/0000-0002-7272-0846; Dore, Louis/0000-0002-7837-5887; Dominissini, Dan/0000-0003-1121-5130; Ben-Haim, Moshe Shay/0000-0003-4737-9102	National Institutes of Health [HG008688, GM71440, GM113194, HG006699]; Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation (ISF) [1667/12]; Israeli Centers of Excellence (I-CORE) Program (ISF grants) [41/11, 1796/12]; Ernest and Bonnie Beutler Research Program; Kahn Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Human Frontier Science Program (HFSP) long-term fellowship; Yen post-doctoral fellowship in interdisciplinary research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699, R01HG008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, R01GM113194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation (ISF)(Israel Science Foundation); Israeli Centers of Excellence (I-CORE) Program (ISF grants); Ernest and Bonnie Beutler Research Program; Kahn Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Human Frontier Science Program (HFSP) long-term fellowship; Yen post-doctoral fellowship in interdisciplinary research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institutes of Health HG008688 and GM71440 grants to C. H., GM113194 grant to T. P. and C. H. and grants from the Flight Attendant Medical Research Institute (FAMRI), Israel Science Foundation (ISF grant no. 1667/12), Israeli Centers of Excellence (I-CORE) Program (ISF grants no. 41/11 and no. 1796/12), Ernest and Bonnie Beutler Research Program and Kahn Family Foundation to G. R. A part of this work was funded by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust (to D. D. and C. H.). C. H. is an investigator of the Howard Hughes Medical Institute (HHMI). G. R. is a member of the Sagol Neuroscience Network and holds the Djerassi Chair for Oncology at the Sackler Faculty of Medicine, Tel-Aviv University, Israel. D. D. is supported by a Human Frontier Science Program (HFSP) long-term fellowship. S. N. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2215-15), previously supported by a Yen post-doctoral fellowship in interdisciplinary research. Q. D. is supported by the National Institutes of Health grant HG006699. We wish to thank S. Farage-Barhom, K. Cesarkas and E. Glick-Saar for help with deep sequencing.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson JT, 2005, TOP CURR GENET, V12, P121, DOI 10.1007/b106364; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUNN DB, 1961, BIOCHIM BIOPHYS ACTA, V46, P198, DOI 10.1016/0006-3002(61)90668-0; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; GEIGER T, 2012, MOL CELL PROTEOMICS, V11, DOI [DOI 10.1074/mcp.M111.014050, DOI 10.1074/MCP.M111.014050]; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; HALL RH, 1963, BIOCHIM BIOPHYS ACTA, V68, P278; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; Hauenschild R, 2015, NUCLEIC ACIDS RES, V43, P9950, DOI 10.1093/nar/gkv895; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Hienzsch A, 2013, CHEM-EUR J, V19, P4244, DOI 10.1002/chem.201204209; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hobartner C, 2003, MONATSH CHEM, V134, P851, DOI 10.1007/s00706-003-0592-1; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; JONES JW, 1963, J AM CHEM SOC, V85, P193, DOI 10.1021/ja00885a019; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Li X., 2016, NAT CHEM BIOL; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/nchembio.1836, 10.1038/NCHEMBIO.1836]; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MACON JB, 1968, BIOCHEMISTRY-US, V7, P3453, DOI 10.1021/bi00850a021; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Noderer WL, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145136; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pearson D, 2011, CHEM COMMUN, V47, P5196, DOI 10.1039/c1cc11011j; Peifer C, 2013, NUCLEIC ACIDS RES, V41, P1151, DOI 10.1093/nar/gks1102; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P5428, DOI 10.1093/nar/gkt195; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Takuma H, 2015, J BIOL CHEM, V290, P5912, DOI 10.1074/jbc.M114.606038; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trotta E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113380; Wan Y, 2013, NAT PROTOC, V8, P849, DOI 10.1038/nprot.2013.045; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	77	514	540	13	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					441	+		10.1038/nature16998	http://dx.doi.org/10.1038/nature16998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26863196	Green Accepted			2022-12-28	WOS:000370690800027
J	Purzycki, BG; Apicella, C; Atkinson, QD; Cohen, E; McNamara, RA; Willard, AK; Xygalatas, D; Norenzayan, A; Henrich, J				Purzycki, Benjamin Grant; Apicella, Caren; Atkinson, Quentin D.; Cohen, Emma; McNamara, Rita Anne; Willard, Aiyana K.; Xygalatas, Dimitris; Norenzayan, Ara; Henrich, Joseph			Moralistic gods, supernatural punishment and the expansion of human sociality	NATURE			English	Article							COOPERATION; EVOLUTION; RELIGION; BELIEF	Since the origins of agriculture, the scale of human cooperation and societal complexity has dramatically expanded(1,2). This fact challenges standard evolutionary explanations of prosociality because well-studied mechanisms of cooperation based on genetic relatedness, reciprocity and partner choice falter as people increasingly engage in fleeting transactions with genetically unrelated strangers in large anonymous groups. To explain this rapid expansion of prosociality, researchers have proposed several mechanisms(3,4). Here we focus on one key hypothesis: cognitive representations of gods as increasingly knowledgeable and punitive, and who sanction violators of interpersonal social norms, foster and sustain the expansion of cooperation, trust and fairness towards co-religionist strangers(5-8). We tested this hypothesis using extensive ethnographic interviews and two behavioural games designed to measure impartial rule-following among people (n = 591, observations = 35,400) from eight diverse communities from around the world: (1) inland Tanna, Vanuatu; (2) coastal Tanna, Vanuatu; (3) Yasawa, Fiji; (4) Lovu, Fiji; (5) Pesqueiro, Brazil; (6) Pointe aux Piments, Mauritius; (7) the Tyva Republic (Siberia), Russia; and (8) Hadzaland, Tanzania. Participants reported adherence to a wide array of world religious traditions including Christianity, Hinduism and Buddhism, as well as notably diverse local traditions, including animism and ancestor worship. Holding a range of relevant variables constant, the higher participants rated their moralistic gods as punitive and knowledgeable about human thoughts and actions, the more coins they allocated to geographically distant co-religionist strangers relative to both themselves and local co-religionists. Our results support the hypothesis that beliefs in moralistic, punitive and knowing gods increase impartial behaviour towards distant co-religionists, and therefore can contribute to the expansion of prosociality.	[Purzycki, Benjamin Grant] Univ British Columbia, Ctr Human Evolut Cognit & Culture, 1871 West Mall, Vancouver, BC V6T 1Z2, Canada; [Apicella, Caren] Univ Penn, Dept Psychol, Solomon Labs, 3720 Walnut St, Philadelphia, PA 19104 USA; [Atkinson, Quentin D.] Univ Auckland, Dept Psychol, Human Sci Bldg,10 Symonds St, Auckland 1010, New Zealand; [Atkinson, Quentin D.] Max Planck Inst Sci Human Hist, Kahla Str 10, D-07745 Jena, Germany; [Cohen, Emma] Univ Oxford, Inst Cognit & Evolutionary Anthropol, 64 Banbury Rd, Oxford OX2 6PN, England; [Cohen, Emma] Univ Oxford Wadham Coll, Oxford OX1 3PN, England; [McNamara, Rita Anne; Norenzayan, Ara; Henrich, Joseph] Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada; [Willard, Aiyana K.] Univ Texas Austin, Dept Psychol, Culture & Dev Lab, 1 Univ Stn A8000, Austin, TX 78712 USA; [Xygalatas, Dimitris] Univ Connecticut, Dept Anthropol, 354 Mansfield Rd,Unit 1176, Storrs, CT 06029 USA; [Xygalatas, Dimitris] Aarhus Univ, Interacting Minds Ctr, Jens Chr Skous Vej 4,Bldg 1483, DK-8000 Aarhus, Denmark; [Xygalatas, Dimitris] Masaryk Univ, LEVYNA, Brno 60200, Czech Republic; [Henrich, Joseph] Univ British Columbia, Dept Econ, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada; [Henrich, Joseph] Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA	University of British Columbia; University of Pennsylvania; University of Auckland; University of Oxford; University of Oxford; University of British Columbia; University of Texas System; University of Texas Austin; University of Connecticut; Aarhus University; Masaryk University Brno; University of British Columbia; Harvard University	Purzycki, BG (corresponding author), Univ British Columbia, Ctr Human Evolut Cognit & Culture, 1871 West Mall, Vancouver, BC V6T 1Z2, Canada.; Henrich, J (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.; Henrich, J (corresponding author), Univ British Columbia, Dept Econ, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.; Henrich, J (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	bgpurzycki@alumni.ubc.ca; henrich@psych.ubc.ca	Xygalatas, Dimitris/P-3376-2019; Rita Anne McNamara, Rita A. McNamara/I-3185-2019	Xygalatas, Dimitris/0000-0003-1561-9327; Rita Anne McNamara, Rita A. McNamara/0000-0002-8530-768X; Atkinson, Quentin/0000-0002-8499-7535; Willard, Aiyana/0000-0001-9224-7534				Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Bering JM, 2005, HUM NATURE-INT BIOS, V16, P360, DOI 10.1007/s12110-005-1015-2; Botero CA, 2014, P NATL ACAD SCI USA, V111, P16784, DOI 10.1073/pnas.1408701111; Chuah SH, 2014, J ECON PSYCHOL, V45, P33, DOI 10.1016/j.joep.2014.07.002; Cohn A, 2014, NATURE, V516, P86, DOI 10.1038/nature13977; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Haidt J., 2010, HDB SOCIAL PSYCHOL, V2, P797, DOI 10.1002/9780470561119.socpsy002022; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hruschka D, 2014, HUM NATURE-INT BIOS, V25, P567, DOI 10.1007/s12110-014-9217-0; Johnson DDP, 2005, HUM NATURE-INT BIOS, V16, P410, DOI 10.1007/s12110-005-1017-0; McNamara RA, 2016, RELIG BRAIN BEHAV, V6, P34, DOI 10.1080/2153599X.2014.921235; Norenzayan A, 2013, BIG GODS RELIG TRANS; Norenzayan A., 2015, BEHAV BRAIN SCI; Pew Research Center, 2015, FUT WORLD REL POP GR; Piazza J, 2011, J EXP CHILD PSYCHOL, V109, P311, DOI 10.1016/j.jecp.2011.02.003; Purzycki BG, 2012, COGNITIVE SCI, V36, P846, DOI 10.1111/j.1551-6709.2012.01242.x; Purzycki BG, 2013, COGNITION, V129, P163, DOI 10.1016/j.cognition.2013.06.010; Purzycki BG, 2011, RELIG BRAIN BEHAV, V1, P31, DOI 10.1080/2153599X.2010.550723; Richerson PJ, 1999, HUM NATURE-INT BIOS, V10, P253, DOI 10.1007/s12110-999-1004-y; Rossano MJ, 2007, HUM NATURE-INT BIOS, V18, P272, DOI 10.1007/s12110-007-9002-4; Schloss JP, 2011, RELIG BRAIN BEHAV, V1, P46, DOI 10.1080/2153599X.2011.558707; Shariff AF, 2016, PERS SOC PSYCHOL REV, V20, P27, DOI 10.1177/1088868314568811; Shariff AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039048; Sosis R, 2003, CURR ANTHROPOL, V44, P713, DOI 10.1086/379260; Sosis R, 2003, CROSS-CULT RES, V37, P211, DOI 10.1177/1069397103037002003; Turchin P, 2013, STRUNGMANN FORUM REP, P61; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; Watts J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2556; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910	31	215	217	6	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					327	+		10.1038/nature16980	http://dx.doi.org/10.1038/nature16980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DE0PP	26863190	Green Published			2022-12-28	WOS:000370327100035
J	Winstein, CJ; Wolf, SL; Dromerick, AW; Lane, CJ; Nelsen, MA; Lewthwaite, R; Cen, SY; Azen, SP				Winstein, Carolee J.; Wolf, Steven L.; Dromerick, Alexander W.; Lane, Christianne J.; Nelsen, Monica A.; Lewthwaite, Rebecca; Cen, Steven Yong; Azen, Stanley P.		ICARE Investigative Team	Effect of a Task-Oriented Rehabilitation Program on Upper Extremity Recovery Following Motor Stroke The ICARE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSTRAINT-INDUCED MOVEMENT; THERAPY; IMPROVEMENT; IMPAIRMENT; EXERCISE; TIME	IMPORTANCE Clinical trials suggest that higher doses of task-oriented training are superior to current clinical practice for patients with stroke with upper extremity motor deficits. OBJECTIVE To compare the efficacy of a structured, task-oriented motor training program vs usual and customary occupational therapy (UCC) during stroke rehabilitation. DESIGN, SETTING, AND PARTICIPANTS Phase 3, pragmatic, single-blind randomized trial among 361 participants with moderate motor impairment recruited from 7 US hospitals over 44 months, treated in the outpatient setting from June 2009 to March 2014. INTERVENTIONS Structured, task-oriented upper extremity training (Accelerated Skill Acquisition Program[ASAP]; n = 119); dose-equivalent occupational therapy (DEUCC; n = 120); or monitoring-only occupational therapy (UCC; n = 122). The DEUCC group was prescribed 30 one hour sessions over 10 weeks; the UCC group was only monitored, without specification of dose. MAIN OUTCOMES AND MEASURES The primary outcome was 12-month change in log-transformed Wolf Motor Function Test time score (WMFT, consisting of a mean of 15 timed arm movements and hand dexterity tasks). Secondary outcomes were change in WMFT time score (minimal clinically important difference [MCID] = 19 seconds) and proportion of patients improving >= 25 points on the Stroke Impact Scale (SIS) hand function score (MCID = 17.8 points). RESULTS Among the 361 randomized patients (mean age, 60.7 years; 56% men; 42% African American; mean time since stroke onset, 46 days), 304 (84%) completed the 12-month primary outcome assessment; in intention-to-treat analysis, mean group change scores (log WMFT, baseline to 12 months) were, for the ASAP group, 2.2 to 1.4 (difference, 0.82); DEUCC group, 2.0 to 1.2 (difference, 0.84); and UCC group, 2.1 to 1.4 (difference, 0.75), with no significant between group differences (ASAP vs DEUCC: 0.14; 95% CI, -0.05 to 0.33; P = .16; ASAP vs UCC: -0.01; 95% CI, -0.22 to 0.21; P = .94; and DEUCC vs UCC: -0.14; 95% CI, -0.32 to 0.05; P = .15). Secondary outcomes for the ASAP group were WMFT change score, -8.8 seconds, and improved SIS, 73%; DEUCC group, WMFT, -8.1 seconds, and SIS, 72%; and UCC group, WMFT, -7.2 seconds, and SIS, 69%, with no significant pairwise between-group differences (ASAP vs DEUCC: WMFT, 1.8 seconds; 95% CI, -0.8 to 4.5 seconds; P = .18; improved SIS, 1%; 95% CI, -12% to 13%; P = .54; ASAP vs UCC: WMFT, -0.6 seconds, 95% CI, -3.8 to 2.6 seconds; P = .72; improved SIS, 4%; 95% CI,-9% to 16%; P = .48; and DEUCC vs UCC: WMFT, -2.1 seconds; 95% CI, -4.5 to 0.3 seconds; P = .08; improved SIS, 3%; 95% CI, -9% to 15%; P = .22). A total of 168 serious adverse events occurred in 109 participants, resulting in 8 patients withdrawing from the study. CONCLUSIONS AND RELEVANCE Among patients with motor stroke and primarily moderate upper extremity impairment, use of a structured, task-oriented rehabilitation program did not significantly improve motor function or recovery beyond either an equivalent or a lower dose of UCC upper extremity rehabilitation. These findings do not support superiority of this program among patients with motor stroke and primarily moderate upper extremity impairment.	[Winstein, Carolee J.; Lane, Christianne J.; Nelsen, Monica A.; Lewthwaite, Rebecca; Cen, Steven Yong; Azen, Stanley P.] Univ So Calif, 1540 Alcazar St,CHP 155, Los Angeles, CA 90033 USA; [Wolf, Steven L.] Emory Univ, Atlanta, GA 30322 USA; [Dromerick, Alexander W.] MedStar Natl Rehabil Hosp, Washington, DC USA	University of Southern California; Emory University	Winstein, CJ (corresponding author), Univ So Calif, 1540 Alcazar St,CHP 155, Los Angeles, CA 90033 USA.	winstein@usc.edu	Wolf, Steve/F-6588-2010; Benham, Sara/N-2627-2018	Wolf, Steve/0000-0002-9446-8995; Benham, Sara/0000-0002-2102-6678; Winstein, Carolee/0000-0001-9789-4626; Mohapatra, Sambit/0000-0001-7714-5281	National Institutes of Health, the National Institute of Neurological Disorders and Stroke; National Center for Medical Rehabilitation Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01NS056256]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058755, U01NS056256] Funding Source: NIH RePORTER	National Institutes of Health, the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Medical Rehabilitation Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The ICARE trial was funded jointly by the National Institutes of Health, the National Institute of Neurological Disorders and Stroke (primary), and the National Center for Medical Rehabilitation Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant U01NS056256). Each author received support from this grant during the conduct of the study.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ang JHY, 2006, INT J REHABIL RES, V29, P357; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bravi L, 2007, TOP STROKE REHABIL, V14, P68, DOI 10.1310/tsr1406-68; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/00131640121971374; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Institute of Medicine, 2001, CROSSING QUALITY CHA; James GA, 2009, TOP STROKE REHABIL, V16, P270, DOI 10.1310/tsr1604-270; Kaplan RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132382; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P3; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P486, DOI 10.1177/1545968309356295; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lum PS, 2009, TOP STROKE REHABIL, V16, P237, DOI 10.1310/tsr1604-237; Minelli C, 2009, NEUROL INT, V1, P10, DOI 10.4081/ni.2009.e4; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Page SJ, 2002, NEUROREHAB NEURAL RE, V16, P290, DOI 10.1177/154596802401105225; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Platz T, 2004, RESTOR NEUROL NEUROS, V22, P301; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Rosenbaum L, 2013, NEW ENGL J MED, V368, P959, DOI 10.1056/NEJMms1301576; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Tretriluxana J, 2013, TOP STROKE REHABIL, V20, P151, DOI 10.1310/tsr2002-151; Winstein C, 2014, J NEUROL PHYS THER, V38, P190, DOI 10.1097/NPT.0000000000000046; Winstein CJ, 2015, PROG BRAIN RES, V218, P331, DOI 10.1016/bs.pbr.2015.01.004; Winstein CJ, 2015, STROKE RECOVERY AND REHABILITATION, SECOND EDITION, P320; Winstein CJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-5; Wolf SL, 2006, ARCH PHYS MED REHAB, V87, P443, DOI 10.1016/j.apmr.2005.10.006; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2007, RESTOR NEUROL NEUROS, V25, P549; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	41	176	183	3	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					571	581		10.1001/jama.2016.0276	http://dx.doi.org/10.1001/jama.2016.0276			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864411	Green Accepted, Bronze			2022-12-28	WOS:000369635200016
J	Puylaert, CAJ; van Thiel, PP				Puylaert, Carl A. J.; van Thiel, Pieter-Paul			Katayama Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Puylaert, Carl A. J.; van Thiel, Pieter-Paul] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam	van Thiel, PP (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.p.vanthiel@amc.uva.nl							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					469	469		10.1056/NEJMicm1504536	http://dx.doi.org/10.1056/NEJMicm1504536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840136				2022-12-28	WOS:000369319100009
J	Kmietowicz, Z				Kmietowicz, Zosia			Questions your patients may have about Zika virus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Centers for Disease Control and Prevention, 2016, INT GUID PREGN WOM Z; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595; Public Health England National Travel Health Network and Centre, 2016, ZIK VIR TRAV ADV PRE; Royal College of Obstetricians and Gynaecologists, 2016, INT ALG ASS PREGN WO; Travel Health Pro, 2016, ZIK VIR UPD ADV TRAV	5	1	1	0	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								i649	10.1136/bmj.i649	http://dx.doi.org/10.1136/bmj.i649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QK	26839177	Green Published, Bronze			2022-12-28	WOS:000369767100017
J	Magurran, AE				Magurran, Anne E.			How ecosystems change	SCIENCE			English	Editorial Material							BIODIVERSITY; TIME		[Magurran, Anne E.] Univ St Andrews, Sch Biol, Ctr Biol Div, St Andrews, Fife, Scotland	University of St Andrews	Magurran, AE (corresponding author), Univ St Andrews, Sch Biol, Ctr Biol Div, St Andrews, Fife, Scotland.	aem1@st-andrews.ac.uk		Magurran, Anne/0000-0002-0036-2795				[Anonymous], 1861, ORIGIN SPECIES MEANS; Barcelo C, 2016, GLOBAL CHANGE BIOL, V22, P1155, DOI 10.1111/gcb.13047; Ceausu S, 2015, CONSERV BIOL, V29, P1017, DOI 10.1111/cobi.12533; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Ernest SKM, 2008, AM NAT, V172, pE257, DOI 10.1086/592402; Magurran AE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9405; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Pandolfi JM, 2014, SCIENCE, V344, P266, DOI 10.1126/science.1252963; Phillip DAT, 2013, ZOOTAXA, V3711, P1; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Stuart-Smith RD, 2015, NATURE, V528, P88, DOI 10.1038/nature16144; Supp SR, 2014, ECOLOGY, V95, P1717, DOI 10.1890/13-2250.1; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110	15	42	42	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					448	449		10.1126/science.aad6758	http://dx.doi.org/10.1126/science.aad6758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823412				2022-12-28	WOS:000368858200018
J	Young, ED; Kohl, IE; Warren, PH; Rubie, DC; Jacobson, SA; Morbidelli, A				Young, Edward D.; Kohl, Issaku E.; Warren, Paul H.; Rubie, David C.; Jacobson, Seth A.; Morbidelli, Alessandro			Oxygen isotopic evidence for vigorous mixing during the Moon-forming giant impact	SCIENCE			English	Article							TERRESTRIAL PLANETS; LATE ACCRETION; EARTH; MASS; FRACTIONATION; ORIGIN; DIFFERENTIATION; BODIES	Earth and the Moon are shown here to have indistinguishable oxygen isotope ratios, with a difference in Delta'O-17 of -1 +/- 5 parts per million (2 standard error). On the basis of these data and our new planet formation simulations that include a realistic model for primordial oxygen isotopic reservoirs, our results favor vigorous mixing during the giant impact and therefore a high-energy, high-angular-momentum impact. The results indicate that the late veneer impactors had an average Delta'O-17 within approximately 1 per mil of the terrestrial value, limiting possible sources for this late addition of mass to the Earth-Moon system.	[Young, Edward D.; Kohl, Issaku E.; Warren, Paul H.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA USA; [Rubie, David C.; Jacobson, Seth A.] Univ Bayreuth, Bayer Geoinst, D-95490 Bayreuth, Germany; [Jacobson, Seth A.; Morbidelli, Alessandro] Univ Nice Sophia Antipolis, Observ Cote Azur, CNRS, Lab Lagrange, F-06304 Nice, France	University of California System; University of California Los Angeles; University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Young, ED; Kohl, IE (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA USA.	eyoung@epss.ucla.edu; ikohl@epss.ucla.edu	Jacobson, Seth/I-7029-2015	Jacobson, Seth/0000-0002-4952-9007; Young, Edward/0000-0002-1299-0801	NASA Emerging Worlds program [NNX15AH43G]; European Research Council Advanced Grant "ACCRETE" [290568]	NASA Emerging Worlds program; European Research Council Advanced Grant "ACCRETE"(European Research Council (ERC))	We are grateful to NASA Johnson Space Center for approving use of the Apollo samples for this study. E.D.Y. acknowledges support from a grant from the NASA Emerging Worlds program (NNX15AH43G). D.C.R., S.A.J., and A.M. acknowledge support from the European Research Council Advanced Grant "ACCRETE" (contract 290568). Development of the Panorama instrument was supported by the Deep Carbon Observatory (Sloan Foundation), NSF, U.S. Department of Energy, Shell, the Carnegie Institution of Washington, and the University of California, Los Angeles. The complete data table for this study can be found in the supplementary materials.	Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Cao XB, 2011, GEOCHIM COSMOCHIM AC, V75, P7435, DOI 10.1016/j.gca.2011.09.048; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLAYTON RN, 1976, EARTH PLANET SC LETT, V30, P10, DOI 10.1016/0012-821X(76)90003-0; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Hallis LJ, 2010, GEOCHIM COSMOCHIM AC, V74, P6885, DOI 10.1016/j.gca.2010.09.023; Herwartz D, 2014, SCIENCE, V344, P1146, DOI 10.1126/science.1251117; Jacobsen S. B., 2012, AM GEOPH UN FALL M S; Jacobson SA, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0174; Jacobson SA, 2014, NATURE, V508, P84, DOI 10.1038/nature13172; Kaib NA, 2015, ICARUS, V252, P161, DOI 10.1016/j.icarus.2015.01.013; Kruijer TS, 2015, NATURE, V520, P534, DOI 10.1038/nature14360; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; MCKINNEY CR, 1950, REV SCI INSTRUM, V21, P724, DOI 10.1063/1.1745698; Newton J, 2000, METEORIT PLANET SCI, V35, P689, DOI 10.1111/j.1945-5100.2000.tb01452.x; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Nuth JA, 2004, METEORIT PLANET SCI, V39, P1957, DOI 10.1111/j.1945-5100.2004.tb00089.x; Pahlevan K, 2005, EARTH PLANET SC LETT, V262, P438; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; SAFRONOV VS, 1966, SOV ASTRON, V9, P987; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; Schlichting HE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/8; SHARP ZD, 1990, GEOCHIM COSMOCHIM AC, V54, P1353, DOI 10.1016/0016-7037(90)90160-M; Spicuzza MJ, 2007, EARTH PLANET SC LETT, V253, P254, DOI 10.1016/j.epsl.2006.10.030; Walker RJ, 2015, CHEM GEOL, V411, P125, DOI 10.1016/j.chemgeo.2015.06.028; WEISBERG MK, 1991, GEOCHIM COSMOCHIM AC, V55, P2657, DOI 10.1016/0016-7037(91)90380-N; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Young ED, 1998, GEOCHIM COSMOCHIM AC, V62, P3109, DOI 10.1016/S0016-7037(98)00213-0; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P1095, DOI 10.1016/S0016-7037(01)00832-8	40	135	140	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					493	496		10.1126/science.aad0525	http://dx.doi.org/10.1126/science.aad0525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823426	Green Submitted			2022-12-28	WOS:000368858200034
J	Syeda, R; Qiu, ZZ; Dubin, AE; Murthy, SE; Florendo, MN; Mason, DE; Mathur, J; Cahalan, SM; Peters, EC; Montal, M; Patapoutian, A				Syeda, Ruhma; Qiu, Zhaozhu; Dubin, Adrienne E.; Murthy, Swetha E.; Florendo, Maria N.; Mason, Daniel E.; Mathur, Jayanti; Cahalan, Stuart M.; Peters, Eric C.; Montal, Mauricio; Patapoutian, Ardem			LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength	CELL			English	Article							LEUCINE-RICH REPEAT; EPITHELIAL-CELLS; CL-CHANNELS; ESSENTIAL COMPONENT; ENDOTHELIAL-CELLS; CONDUCTANCE; MEMBRANE; VRAC; IDENTIFICATION; SPECIFICITY	The volume-regulated anion channel (VRAC) is activated when a cell swells, and it plays a central role in maintaining cell volume in response to osmotic challenges. SWELL1 (LRRC8A) was recently identified as an essential component of VRAC. However, the identity of the pore-forming subunits of VRAC and how the channel is gated by cell swelling are unknown. Here, we show that SWELL1 and up to four other LRRC8 subunits assemble into heterogeneous complexes of similar to 800 kDa. When reconstituted into bilayers, LRRC8 complexes are sufficient to form anion channels activated by osmolality gradients. In bilayers, as well as in cells, the single-channel conductance of the complexes depends on the LRRC8 composition. Finally, low ionic strength (Gamma) in the absence of an osmotic gradient activates the complexes in bilayers. These data demonstrate that LRRC8 proteins together constitute the VRAC pore and that hypotonic stress can activate VRAC through a decrease in cytoplasmic Gamma.	[Syeda, Ruhma; Qiu, Zhaozhu; Dubin, Adrienne E.; Murthy, Swetha E.; Florendo, Maria N.; Cahalan, Stuart M.; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Qiu, Zhaozhu; Mason, Daniel E.; Mathur, Jayanti; Peters, Eric C.] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA; [Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Scripps Research Institute; Novartis; University of California System; University of California San Diego	Dubin, AE; Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	adubin@scripps.edu; ardem@scripps.edu	Peters, Eric/W-2739-2019	Murthy, Swetha/0000-0001-9580-3380	NIH [NS083174];  [GM49711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jose Santos for helpful discussions on biochemistry and protein reconstitution; Shuying Sun for help in generating stable Flp-In cell lines; and Michael Bandell, David Jones, and Jie Xu for technical assistance in biochemistry. R.S. thanks Syed Asleh Al-Husaini for encouragement and support. This work was partly supported by grants from NIH awarded to A.P. (NS083174) and M.M. (GM49711). A.P. is an Investigator of the Howard Hughes Medical Institute.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Akita T, 2014, NEUROSCIENCE, V275, P211, DOI 10.1016/j.neuroscience.2014.06.015; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Cannon CL, 1998, AM J PHYSIOL-CELL PH, V275, pC416, DOI 10.1152/ajpcell.1998.275.2.C416; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Green T, 2015, J PHYSIOL-LONDON, V593, P73, DOI 10.1113/jphysiol.2014.273409; Hayashi T, 2011, BIOL PHARM BULL, V34, P1257, DOI 10.1248/bpb.34.1257; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; JACKSON PS, 1995, J GEN PHYSIOL, V105, P661, DOI 10.1085/jgp.105.5.661; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; Kunzelmann K, 2015, TRENDS BIOCHEM SCI, V40, P535, DOI 10.1016/j.tibs.2015.07.005; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Nilius B, 1998, J PHYSIOL-LONDON, V506, P353, DOI 10.1111/j.1469-7793.1998.353bw.x; Nilius B, 1996, GEN PHARMACOL-VASC S, V27, P1131, DOI 10.1016/S0306-3623(96)00061-4; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Pedersen SF, 2015, ACTA PHYSIOL, V213, P868, DOI 10.1111/apha.12450; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sabirov RZ, 2000, PFLUG ARCH EUR J PHY, V439, P315, DOI 10.1007/s004240050945; SOLC CK, 1991, AM J PHYSIOL, V261, pC658, DOI 10.1152/ajpcell.1991.261.4.C658; Syeda R, 2008, J AM CHEM SOC, V130, P15543, DOI 10.1021/ja804968g; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x; Tsumura T, 1996, AM J PHYSIOL-CELL PH, V271, pC1872, DOI 10.1152/ajpcell.1996.271.6.C1872; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; WEISS H, 1992, J MEMBRANE BIOL, V126, P109; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	38	146	154	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					499	511		10.1016/j.cell.2015.12.031	http://dx.doi.org/10.1016/j.cell.2015.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824658	Green Accepted, Bronze			2022-12-28	WOS:000368906800019
J	Rudd, S; Hodge, J; Finley, R; Lewis, P; Wang, M				Rudd, Shaun; Hodge, James; Finley, Rachael; Lewis, Peter; Wang, Michael			Should we ban boxing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEAD-INJURY; EXPOSURE; RISK		[Rudd, Shaun] Australian Med Assoc Queensland, Brisbane, Qld, Australia; [Hodge, James; Finley, Rachael] AMA Queensland, Brisbane, Qld, Australia; [Lewis, Peter] Australasian Ringside Med Assoc, Melbourne, Vic, Australia; [Wang, Michael] Monash Univ, Clayton, Vic 3800, Australia	Monash University	Finley, R (corresponding author), AMA Queensland, Brisbane, Qld, Australia.; Lewis, P (corresponding author), Australasian Ringside Med Assoc, Melbourne, Vic, Australia.	r.finley@amaq.com.au; peterlewis3143@hotmail.com						[Anonymous], 2015, ECONOMIST; Baird LC, 2010, NEUROSURGERY, V67, pE519, DOI 10.1227/01.NEU.0000373207.04297.13; Bloom GA, 1996, SOCIOL SPORT J, V13, P65, DOI 10.1123/ssj.13.1.65; Buchanan DR, 2008, AM J PUBLIC HEALTH, V98, P15, DOI 10.2105/AJPH.2007.110361; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Constantoyannis C, 2004, BRIT J SPORT MED, V38, P78, DOI 10.1136/bjsm.2002.001123; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Fortune N., 1999, DEFINITION INCIDENCE; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jenkins H, ITS NOT JUST GAME CO; Jones M, 2014, NORWAY BOXING BAN MA; Jones R. L., 1997, Journal of Sport and Social Issues, V21, P37, DOI 10.1177/019372397021001003; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Jordan BD, 1993, MED ASPECTS BOXING, P17; Karpman S, 2015, CLIN J SPORT MED; Kravitz L, 2003, J STRENGTH COND RES, V17, P104; Kreisfeld R, 2014, AUSTR SPORTS INJURY; Krystal A, 2014, BOXINGS LEGAL STATUS; Lane AM, 2008, ATHLETIC INSIGHT, V10; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lewis P, 1997, WORLD BOX MED C AR; Micheli LJ, 2011, ENCY SPORTS MED, V4, P196; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Roberts AH., 1969, BRAIN DAMAGE BOXERS; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svinth JR, 2007, J COMBAT SPORT; Weinberg SK, 1952, AM J SOCIOL, V57, P460, DOI 10.1086/221014; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	29	5	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2016	352								i389	10.1136/bmj.i389	http://dx.doi.org/10.1136/bmj.i389			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC6ET	26818415				2022-12-28	WOS:000369313300002
J	Gianatassio, R; Lopchuk, JM; Wang, J; Pan, CM; Malins, LR; Prieto, L; Brandt, TA; Collins, MR; Gallego, GM; Sach, NW; Spangler, JE; Zhu, HC; Zhu, JJ; Baran, PS				Gianatassio, Ryan; Lopchuk, Justin M.; Wang, Jie; Pan, Chung-Mao; Malins, Lara R.; Prieto, Liher; Brandt, Thomas A.; Collins, Michael R.; Gallego, Gary M.; Sach, Neal W.; Spangler, Jillian E.; Zhu, Huichin; Zhu, Jinjiang; Baran, Phil S.			Strain-release amination	SCIENCE			English	Article							ORGANIC-CHEMISTRY; CLICK CHEMISTRY; DERIVATIVES; BIOCONJUGATION; POTENT; FUNCTIONALIZATION; MACROCYCLIZATION; HETEROCYCLES; BRIDGEHEAD; DESIGN	To optimize drug candidates, modern medicinal chemists are increasingly turning to an unconventional structural motif: small, strained ring systems. However, the difficulty of introducing substituents such as bicyclo[1.1.1]pentanes, azetidines, or cyclobutanes often outweighs the challenge of synthesizing the parent scaffold itself. Thus, there is an urgent need for general methods to rapidly and directly append such groups onto core scaffolds. Here we report a general strategy to harness the embedded potential energy of effectively spring-loaded C-C and C-N bonds with the most oft-encountered nucleophiles in pharmaceutical chemistry, amines. Strain-release amination can diversify a range of substrates with a multitude of desirable bioisosteres at both the early and late stages of a synthesis. The technique has also been applied to peptide labeling and bioconjugation.	[Gianatassio, Ryan; Lopchuk, Justin M.; Wang, Jie; Pan, Chung-Mao; Malins, Lara R.; Prieto, Liher; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Brandt, Thomas A.] Pfizer Worldwide Res & Dev, Chem Res & Dev, Groton, CT 06340 USA; [Collins, Michael R.; Gallego, Gary M.; Sach, Neal W.; Spangler, Jillian E.; Zhu, Huichin; Zhu, Jinjiang] Pfizer Inc, La Jolla Labs, Dept Chem, San Diego, CA 92121 USA	Scripps Research Institute; Pfizer; Pfizer	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Malins, Lara R/U-3851-2018; Prieto, Liher/L-1494-2017	Malins, Lara R/0000-0002-7691-6432; Prieto, Liher/0000-0001-7965-7168	Pfizer, Inc.; National Institutes of Health [GM106210]; Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; University of the Basque Country; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176, R01GM106210, F32GM113385] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; University of the Basque Country; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by Pfizer, Inc., and the National Institutes of Health (GM106210). The National Institutes of Health provided a postdoctoral fellowship to J.M.L.; the Shanghai Institute of Organic Chemistry, Zhejiang Medicine Co., and Pharmaron provided a postdoctoral fellowship to J.W.; and the University of the Basque Country provided a predoctoral fellowship to L.P. We thank Y. Ishihara for assistance with the initial preparation of the manuscript. We are grateful to D.-H. Huang and L. Pasternack (The Scripps Research Institute) for assistance with nuclear magnetic resonance (NMR) spectroscopy and A. L. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis. Crystallographic data for compounds 9, 12, 53, C1, and S23 are available free of charge from the Cambridge Crystallographic Data Centre under accession numbers CCDC 1431179, 1438966, 1431180, 1431182, and 1431183, respectively.	Bennett B. L., 2012, Preparation of substituted diaminocarboxamide and diaminocarbonitrile pyrimidines as JNK pathway inhibitors, Patent No. [WO 2012145569, 2012145569]; Boutureira O, 2015, CHEM REV, V115, P2174, DOI 10.1021/cr500399p; Brandi A, 2008, CHEM REV, V108, P3988, DOI 10.1021/cr800325e; Brown SP, 2015, J AM CHEM SOC, V137, P4034, DOI 10.1021/ja512880g; Bunker KD, 2011, ORG LETT, V13, P4746, DOI 10.1021/ol201883z; Davies SG, 2012, TETRAHEDRON-ASYMMETR, V23, P1111, DOI 10.1016/j.tetasy.2012.08.009; DELLA EW, 1990, TETRAHEDRON LETT, V31, P5219, DOI 10.1016/S0040-4039(00)97847-X; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; GAONI Y, 1988, TETRAHEDRON LETT, V29, P1591, DOI 10.1016/S0040-4039(00)80361-5; GAONI Y, 1995, ORG PREP PROCED INT, V27, P185, DOI 10.1080/00304949509458453; Hayashi, 2013, (Nissan Chemical Industries, Ltd.), Patent No. [WO2013024895, 2013024895, WO 2013024895]; Ikee Y, 2008, CHEM PHARM BULL, V56, P346, DOI 10.1248/cpb.56.346; Jeffery S. M., 1993, J CHEM SOC P2, V2, P1617; Kalia J, 2010, CURR ORG CHEM, V14, P138, DOI 10.2174/138527210790069839; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lampman G. M., 1971, ORG SYNTH, V51, P55; Lau YH, 2015, CHEM SOC REV, V44, P91, DOI 10.1039/c4cs00246f; Levin MD, 2000, CHEM REV, V100, P169, DOI 10.1021/cr990094z; McKay CS, 2014, CHEM BIOL, V21, P1075, DOI 10.1016/j.chembiol.2014.09.002; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Messner M, 2000, EUR J ORG CHEM, V2000, P1137; Michaudel Q, 2015, ACCOUNTS CHEM RES, V48, P712, DOI 10.1021/ar500424a; Ni CF, 2015, CHEM REV, V115, P765, DOI 10.1021/cr5002386; Rohbogner CJ, 2008, ANGEW CHEM INT EDIT, V47, P1503, DOI 10.1002/anie.200703382; Spokoyny AM, 2013, J AM CHEM SOC, V135, P5946, DOI 10.1021/ja400119t; Stepan AF, 2012, J MED CHEM, V55, P3414, DOI 10.1021/jm300094u; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; Walczak MAA, 2015, ACCOUNTS CHEM RES, V48, P1149, DOI 10.1021/ar500437h; Wang YX, 2015, ANGEW CHEM INT EDIT, V54, P10931, DOI 10.1002/anie.201503975; Westphal MV, 2015, CHEMMEDCHEM, V10, P461, DOI 10.1002/cmdc.201402502; Wiberg K. B., 1968, ADV ALICYCL CHEM, V2, P185; WIBERG KB, 1982, J AM CHEM SOC, V104, P5239, DOI 10.1021/ja00383a046; WIBERG KB, 1989, CHEM REV, V89, P975, DOI 10.1021/cr00095a001; WIBERG KB, 1986, ANGEW CHEM INT EDIT, V25, P312, DOI 10.1002/anie.198603121; WIBERG KB, 1959, J AM CHEM SOC, V81, P5261, DOI 10.1021/ja01528a060; WIBERG KB, 1970, J ORG CHEM, V35, P369, DOI 10.1021/jo00827a018; Wrobleski ML, 2006, BIOORG MED CHEM LETT, V16, P3859, DOI 10.1016/j.bmcl.2006.04.031; Zehnder L, 2011, J MED CHEM, V54, P3368, DOI 10.1021/jm200128m	38	200	209	17	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					241	246		10.1126/science.aad6252	http://dx.doi.org/10.1126/science.aad6252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816372	Green Accepted			2022-12-28	WOS:000368098600032
J	Honigsbaum, M				Honigsbaum, Mark			The art of medicine Antibiotic antagonist: the curious career of Rene Dubos	LANCET			English	Editorial Material									[Honigsbaum, Mark] Queen Mary Univ London, London, England	University of London; Queen Mary University London	Honigsbaum, M (corresponding author), Queen Mary Univ London, London, England.	mark.honigsbaum@qmul.ac.uk		honigsbaum, mark/0000-0002-1891-8763	Wellcome Trust [103159] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cohn ZA., 1990, LAUNCHING ANTIBIOTIC; Dubos Rene, 1959, MIRAGE OF HLTH; Moberg CarolL., 2005, R DUBOS FRIEND GOOD; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					118	119		10.1016/S0140-6736(15)00840-5	http://dx.doi.org/10.1016/S0140-6736(15)00840-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26841989	Bronze, Green Published			2022-12-28	WOS:000368055500017
J	Kapur, N; Webb, R				Kapur, Nav; Webb, Roger			Suicide risk in people with chronic fatigue syndrome	LANCET			English	Editorial Material							DISORDERS; BEHAVIOR		[Kapur, Nav; Webb, Roger] Univ Manchester, Inst Brain Behav & Mental Hlth, Ctr Mental Hlth & Safety, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England	University of Manchester	Kapur, N (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Ctr Mental Hlth & Safety, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England.	nav.kapur@manchester.ac.uk		Kapur, Nav/0000-0002-3100-3234; Webb, Roger/0000-0001-8532-2647				Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Gunnell D, 2013, PSYCHOL MED, V43, P1415, DOI 10.1017/S0033291712002401; Isometsa E, 2014, CAN J PSYCHIAT, V59, P120, DOI 10.1177/070674371405900303; Niedzwiedz C, 2014, SUICIDE LIFE-THREAT, V44, P569, DOI 10.1111/sltb.12091; Office for National Statistics, 2013, SUIC UK 2013 REG; Roberts E, 2016, LANCET; Smith WR, 2006, PSYCHOL MED, V36, P1301, DOI 10.1017/S0033291706007975; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561	9	15	17	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1596	1597	1638	10.1016/S0140-6736(16)00270-1	http://dx.doi.org/10.1016/S0140-6736(16)00270-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ3ZL	26873809	hybrid			2022-12-28	WOS:000374145100006
J	Furman, J; Fiedler, M				Furman, Jason; Fiedler, Matthew			The Cadillac Tax - A Crucial Tool for Delivery-System Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Furman, Jason; Fiedler, Matthew] Council Econ Advisers, Execut Off President, Washington, DC USA									Baker LC, 2015, 21513 NBER; Clemens J, 2013, 19503 NBER; Gravelle Jane G., 2015, EXCISE TAX HIGH COST; Hatch Orrin G., 2015, COMMUNICATION; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1008	1009		10.1056/NEJMp1514970	http://dx.doi.org/10.1056/NEJMp1514970			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4TR	26840061				2022-12-28	WOS:000372066100004
J	Siu, AL				Siu, Albert L.		US Preventive Serv Task Force	Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; PRIMARY-CARE; TADS; ESCITALOPRAM; VALIDATION; INSTRUMENT; DISORDERS	Description: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents. Methods: The USPSTF reviewed the evidence on the benefits and harms of screening; the accuracy of primary care-feasible screening tests; and the benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years. Population: This recommendation applies to children and adolescents aged 18 years or younger who do not have a diagnosis of MDD. Recommendation: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation) T he USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger. (I statement)	[Siu, Albert L.] US Prevent Serv Task Force, Rockville, MD USA		Siu, AL (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.		Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997; Davidson, Karina/0000-0002-9162-477X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Canals J, 2001, EUR J PSYCHOL ASSESS, V17, P63, DOI 10.1027//1015-5759.17.1.63; Clarke GN, 1999, J AM ACAD CHILD PSY, V38, P272, DOI 10.1097/00004583-199903000-00014; Emslie GJ, 2009, J AM ACAD CHILD PSY, V48, P721, DOI 10.1097/CHI.0b013e3181a2b304; Forman-Hoffman V, 2016, ANN INTERN MED, V164, P342, DOI 10.7326/M15-2259; Forman-Hoffman VL, 2016, STRATEGIES IMPROVE M; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Hagan JF, 2008, BRIGHT FUTURES GUIDE, P19; Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0; Kennard B, 2006, J AM ACAD CHILD PSY, V45, P1404, DOI 10.1097/01.chi.0000242228.75516.21; Kramer T, 2012, CLIN CHILD PSYCHOL P, V17, P482, DOI 10.1177/1359104512442639; MacMillan HL, 2004, SCREENING DEPRESSION; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Patton GC, 1999, SOC PSYCH PSYCH EPID, V34, P166, DOI 10.1007/s001270050129; Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; U. S. Food & Drug Administration, 2007, ANT US CHILDR AD AD; Vitiello B, 2006, J AM ACAD CHILD PSY, V45, P1419, DOI 10.1097/01.chi.0000242229.52646.6e; Wagner KD, 2006, J AM ACAD CHILD PSY, V45, P280, DOI 10.1097/01.chi.0000192250.38400.9e; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079	19	104	106	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					360	U113		10.7326/M15-2957	http://dx.doi.org/10.7326/M15-2957			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF3CC	26858097				2022-12-28	WOS:000371220300007
J	Loayza-Puch, F; Rooijers, K; Buil, LCM; Zijlstra, J; Vrielink, JFO; Lopes, R; Ugalde, AP; van Breugel, P; Hofland, I; Wesseling, J; van Tellingen, O; Bex, A; Agami, R				Loayza-Puch, Fabricio; Rooijers, Koos; Buil, Levi C. M.; Zijlstra, Jelle; Vrielink, Joachim F. Oude; Lopes, Rui; Ugalde, Alejandro Pineiro; van Breugel, Pieter; Hofland, Ingrid; Wesseling, Jelle; van Tellingen, Olaf; Bex, Axel; Agami, Reuven			Tumour-specific proline vulnerability uncovered by differential ribosome codon reading	NATURE			English	Article							GENOME-WIDE ANALYSIS; REVEALS; TRANSLATION; DEPRIVATION; ALIGNMENT	Tumour growth and metabolic adaptation may restrict the availability of certain amino acids for protein synthesis. It has recently been shown that certain types of cancer cells depend on glycine, glutamine, leucine and serine metabolism to proliferate and survive(1-4). In addition, successful therapies using L-asparaginase-induced asparagine deprivation have been developed for acute lymphoblastic leukaemia(5). However, a tailored detection system for measuring restrictive amino acids in each tumour is currently not available. Here we harness ribosome profiling(6) for sensing restrictive amino acids, and develop diricore, a procedure for differential ribosome measurements of codon reading. We first demonstrate the functionality and constraints of diricore using metabolic inhibitors and nutrient deprivation assays. Notably, treatment with L-asparaginase elicited both specific diricore signals at asparagine codons and high levels of asparagine synthetase (ASNS). We then applied diricore to kidney cancer and discover signals indicating restrictive proline. As for asparagine, this observation was linked to high levels of PYCR1, a key enzyme in proline production(7), suggesting a compensatory mechanism allowing tumour expansion. Indeed, PYCR1 is induced by shortage of proline precursors, and its suppression attenuated kidney cancer cell proliferation when proline was limiting. High PYCR1 is frequently observed in invasive breast carcinoma. In an in vivo model system of this tumour, we also uncover signals indicating restrictive proline. We further show that CRISPR-mediated knockout of PYCR1 impedes tumorigenic growth in this system. Thus, diricore has the potential to reveal unknown amino acid deficiencies, vulnerabilities that can be used to target key metabolic pathways for cancer treatment.	[Loayza-Puch, Fabricio; Rooijers, Koos; Zijlstra, Jelle; Vrielink, Joachim F. Oude; Lopes, Rui; Ugalde, Alejandro Pineiro; van Breugel, Pieter; Agami, Reuven] Netherlands Canc Inst, Div Biol Stress Response, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Buil, Levi C. M.; van Tellingen, Olaf] Netherlands Canc Inst, Mouse Canc Clin, Dept Biopharmacol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Hofland, Ingrid] Netherlands Canc Inst, Core Facil Mol Pathol & Biobanking, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Wesseling, Jelle] Netherlands Canc Inst, Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Bex, Axel] Netherlands Canc Inst, Dept Urol, Div Surg Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Agami, Reuven] Erasmus Univ, Med Ctr, Dept Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Agami, R (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Agami, R (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022; Pineiro-Ugalde, Alejandro/AAB-5229-2020; Van Tellingen, Olaf/A-1344-2014	Pineiro-Ugalde, Alejandro/0000-0003-2522-0627; Van Tellingen, Olaf/0000-0002-1037-6269; Loayza-Puch, Fabricio/0000-0002-2999-8594; Agami, Reuven/0000-0002-2848-2473; Wesseling, Jelle/0000-0002-8940-2676; Rooijers, Koos/0000-0002-0412-468X	Human Frontier Science Program [LT000640/2013]; European Research Council [ERC-PoC EEG-CEC / EU665317]; Netherlands Organization for Scientific Research [NWO-VICI 918.11.601]; Dutch Cancer Society [KWF NKI-2013-5814]	Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	We thank R. Kerkhoven, R. Kluin and M. Nieuwland from the NKI-AVL Genomics Core Facility for assistance with deep-sequencing experiments, P. Snaebjornsson for valuable help with the pathology studies, and K. Verhoef for advice. We acknowledge the assistance of the NKI-AVL core facilities of Radionuclides Centre, Flow Cytometry, Molecular Pathology, and Biobanking (CFMPB). We thank R. Elkon for technical assistance, and all the members of the Agami group for valuable discussions. This work was supported by funds from the Human Frontier Science Program (LT000640/2013) to A.P.U, and the European Research Council (ERC-PoC EEG-CEC / EU665317), the Netherlands Organization for Scientific Research (NWO-VICI 918.11.601), and the Dutch Cancer Society (KWF NKI-2013-5814) to R.A.	Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; FRESNO M, 1976, EUR J BIOCHEM, V68, P355, DOI 10.1111/j.1432-1033.1976.tb10822.x; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Loayza-Puch F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r32; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Sabi R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S5; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	30	137	144	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					490	+		10.1038/nature16982	http://dx.doi.org/10.1038/nature16982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26878238				2022-12-28	WOS:000370690800038
J	Heymann, DL; Hodgson, A; Sall, AA; Freedman, DO; Staples, JE; Althabe, F; Baruah, K; Mahmud, G; Kandun, N; Vasconcelos, PFC; Bino, S; Menon, KU				Heymann, David L.; Hodgson, Abraham; Sall, Amadou Alpha; Freedman, David O.; Staples, J. Erin; Althabe, Fernando; Baruah, Kalpana; Mahmud, Ghazala; Kandun, Nyoman; Vasconcelos, Pedro F. C.; Bino, Silvia; Menon, K. U.			Zika virus and microcephaly: why is this situation a PHEIC?	LANCET			English	Editorial Material									[Heymann, David L.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Hodgson, Abraham] Senegal Inst Pasteur Dakar, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dakar, Senegal; [Freedman, David O.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Althabe, Fernando] Inst Clin Effectiveness & Hlth Policy, Dept Maternal & Child Hlth Res, Buenos Aires, DF, Argentina; [Baruah, Kalpana] Govt India, Minist Hlth & Family Welf, Natl Vector Borne Dis Control Programme, New Delhi, India; [Mahmud, Ghazala] Quaid I Azam Univ, Quaid I Azam Post Grad Med Coll, Fac Med, Pakistan Inst Med Sci, Islamabad, Pakistan; [Kandun, Nyoman] Minist Hlth, Field Epidemiol Training Program, Jakarta, Indonesia; [Vasconcelos, Pedro F. C.] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil; [Bino, Silvia] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania; [Menon, K. U.] Minist Commun & Informat, Singapore, Singapore	University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); Pakistan Institute of Medical Sciences; Quaid I Azam University; Ministry of Health - Indonesia; Instituto Evandro Chagas	Heymann, DL (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.; Heymann, DL (corresponding author), Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.	david.heymann@phe.gov.uk	Freedman, David O./AAV-2999-2020; Vasconcelos, Pedro/AAH-3142-2019	Freedman, David O./0000-0002-5642-5257; 				Brender N, 2014, GLOBAL RISK GOVERNANCE IN HEALTH, P26; *CDCP, 2016, SURV CONTR AED AEG A; Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN; Centers for Disease Control and Prevention, 2015, CONG RUB SYNDR RUB E; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pan American Health Organization, 2015, EP UPD ZIK VIR INF; Pan American Health Organization (PAHO); World Health Organization, 2016, EPIDEMIOLOGICAL UPDA; Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; The PLoS Med Editors, 2016, PLOS MED, V13; Weinhold B, 2009, ENVIRON HEALTH PERSP, V117, pA440, DOI 10.1289/ehp.117-a440; Whitty CJM, 2015, LANCET, V386, P1797, DOI 10.1016/S0140-6736(15)00758-8; WHO, 2016, CONGENIT ANOM; WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG; World Health Organization, 2016, ZIK VIR	17	255	275	2	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					719	721		10.1016/S0140-6736(16)00320-2	http://dx.doi.org/10.1016/S0140-6736(16)00320-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26876373	Green Published, Bronze			2022-12-28	WOS:000370418000004
J	De Strooper, B; Karran, E				De Strooper, Bart; Karran, Eric			The Cellular Phase of Alzheimer's Disease	CELL			English	Review							HUMAN GAMMA-SECRETASE; A-BETA; AMYLOID-BETA; MOUSE MODEL; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY CHANGES; COGNITIVE IMPAIRMENT; NEURONAL DYSFUNCTION; MICROGLIAL RESPONSE; DIAGNOSTIC-CRITERIA	The amyloid hypothesis for Alzheimer's disease (AD) posits a neuron-centric, linear cascade initiated by Ab and leading to dementia. This direct causality is incompatible with clinical observations. We review evidence supporting a long, complex cellular phase consisting of feedback and feedforward responses of astrocytes, microglia, and vasculature. The field must incorporate this holistic view and take advantage of advances in single-cell approaches to resolve the critical junctures at which perturbations initially amenable to compensatory feedback transform into irreversible, progressive neurodegeneration.	[De Strooper, Bart] VIB Leuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [De Strooper, Bart; Karran, Eric] Univ Ziekenhuizen, Ctr Human Genet, B-3000 Leuven, Belgium; [De Strooper, Bart; Karran, Eric] Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium; [De Strooper, Bart; Karran, Eric] UCL, Inst Neurol, London WC1N 3BG, England; [Karran, Eric] Alzheimer Res UK, Cambridge CB21 6AD, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London	De Strooper, B (corresponding author), VIB Leuven, VIB Ctr Biol Dis, B-3000 Leuven, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019		Janssen Pharmaceutics	Janssen Pharmaceutics	B.D.S. is a consultant for Janssen Pharmaceutics and receives research funding from this company. E.K. is an employee of ABBVIE.	Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Beauquis J, 2014, HIPPOCAMPUS, V24, P257, DOI 10.1002/hipo.22219; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bennett DA, 2014, BIOCHEM PHARMACOL, V88, P617, DOI 10.1016/j.bcp.2014.01.037; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Carrillo MC, 2013, ALZHEIMERS DEMENT, V9, P594, DOI 10.1016/j.jalz.2013.05.1762; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cheng JH, 2013, ELIFE, V2, DOI 10.7554/eLife.00647; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crawford AH, 2014, EXP NEUROL, V260, P50, DOI 10.1016/j.expneurol.2014.04.027; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Desai MK, 2010, AM J PATHOL, V177, P1422, DOI 10.2353/ajpath.2010.100087; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Ettle B., 2015, MOL NEUROBIOL; Gittis AH, 2015, SCIENCE, V349, P690, DOI 10.1126/science.aad0678; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; McGeer P L, 1988, Ann N Y Acad Sci, V540, P319, DOI 10.1111/j.1749-6632.1988.tb27086.x; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mufson EJ, 2015, NEUROSCIENCE, V309, P51, DOI 10.1016/j.neuroscience.2015.03.006; Nilsson P, 2014, ACS CHEM NEUROSCI, V5, P499, DOI 10.1021/cn500105p; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Pelvig DP, 2003, DEMENT GERIATR COGN, V16, P212, DOI 10.1159/000072805; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Santiago JA, 2014, TRENDS MOL MED, V20, P694, DOI 10.1016/j.molmed.2014.10.002; SCHELTENS P, 1992, BRAIN, V115, P735, DOI 10.1093/brain/115.3.735; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	97	888	894	12	318	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					603	615		10.1016/j.cell.2015.12.056	http://dx.doi.org/10.1016/j.cell.2015.12.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871627	Bronze			2022-12-28	WOS:000369998300008
J	Boyce, N				Boyce, Niall			The art of medicine Strangers when we meet: David Bowie, mortality, and metamorphosis	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					528	529		10.1016/S0140-6736(16)00226-9	http://dx.doi.org/10.1016/S0140-6736(16)00226-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26867436				2022-12-28	WOS:000369835800018
J	Cannon, JT; Vellutini, BC; Smith, J; Onquist, FR; Jondelius, U; Hejnol, A				Cannon, Johanna Taylor; Vellutini, Bruno Cossermelli; Smith, Julian, III; Onquist, Fredrik R.; Jondelius, Ulf; Hejnol, Andreas			Xenacoelomorpha is the sister group to Nephrozoa	NATURE			English	Article							MITOCHONDRIAL GENOME; XENOTURBELLA-BOCKI; PHYLOGENETIC POSITION; EVOLUTION; SELECTION; TREE; RESOLUTION; FLATWORMS; SOFTWARE; SUPPORTS	The position of Xenacoelomorpha in the tree of life remains a major unresolved question in the study of deep animal relationships(1). Xenacoelomorpha, comprising Acoela, Nemertodermatida, and Xenoturbella, are bilaterally symmetrical marine worms that lack several features common to most other bilaterians, for example an anus, nephridia, and a circulatory system. Two conflicting hypotheses are under debate: Xenacoelomorpha is the sister group to all remaining Bilateria (= Nephrozoa, namely protostomes and deuterostomes)(2,3) or is a clade inside Deuterostomia(4). Thus, determining the phylogenetic position of this clade is pivotal for understanding the early evolution of bilaterian features, or as a case of drastic secondary loss of complexity. Here we show robust phylogenomic support for Xenacoelomorpha as the sister taxon of Nephrozoa. Our phylogenetic analyses, based on 11 novel xenacoelomorph transcriptomes and using different models of evolution under maximum likelihood and Bayesian inference analyses, strongly corroborate this result. Rigorous testing of 25 experimental data sets designed to exclude data partitions and taxa potentially prone to reconstruction biases indicates that long-branch attraction, saturation, and missing data do not influence these results. The sister group relationship between Nephrozoa and Xenacoelomorpha supported by our phylogenomic analyses implies that the last common ancestor of bilaterians was probably a benthic, ciliated acoelomate worm with a single opening into an epithelial gut, and that excretory organs, coelomic cavities, and nerve cords evolved after xenacoelomorphs separated from the stem lineage of Nephrozoa.	[Cannon, Johanna Taylor; Onquist, Fredrik R.; Jondelius, Ulf] Nat Hist Riksmuseet, POB 50007, SE-10405 Stockholm, Sweden; [Vellutini, Bruno Cossermelli; Hejnol, Andreas] Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway; [Smith, Julian, III] Winthrop Univ, Dept Biol, 701 Oakland Ave, Rock Hill, SC 29733 USA	University of Bergen	Cannon, JT (corresponding author), Nat Hist Riksmuseet, POB 50007, SE-10405 Stockholm, Sweden.; Hejnol, A (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	joie.cannon@gmail.com; andreas.hejnol@uib.no	Hejnol, Andreas/C-5577-2012; Vellutini, Bruno C./H-3831-2019; Cannon, Johanna/V-3842-2019; Jondelius, Ulf/AAF-7943-2020	Hejnol, Andreas/0000-0003-2196-8507; Vellutini, Bruno C./0000-0002-0000-9465; Cannon, Johanna/0000-0002-3920-7741; Jondelius, Ulf/0000-0003-2847-2192	Swedish Research Council [2012-3913, 2014-5901]; Sars Core budget; Marie Curie Innovative Training Networks 'NEPTUNE' [FP7-PEOPLE-2012-ITN 317172, FP7-PEOPLE-2009-RG 256450]; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2013077];  [snic2014-1-323]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sars Core budget; Marie Curie Innovative Training Networks 'NEPTUNE'; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Swedish Research Council provided funding for U.J. and J.T.C. (grant 2012-3913) and F.R. (grant 2014-5901). A.H. received support from the Sars Core budget and Marie Curie Innovative Training Networks 'NEPTUNE' (FP7-PEOPLE-2012-ITN 317172) and FP7-PEOPLE-2009-RG 256450. We thank N. Lartillot and K. Kocot for discussions. Hejnol laboratory members K. Pang and A. Borve assisted with RNA extraction; A. Boddington, J. Bengtsen and A. Elde assisted with culture for Isodiametra pulchra and Convolutriloba macropyga. Thanks to W. Sterrer for collection of Sterreria sp. and Ascoparia sp., and to R. Janssen for finding X. bocki. The Sven Loven Centre of Marine Sciences Kristineberg, University of Gothenburg, and the Interuniversity Institute of Marine Sciences in Eilat provided logistical support for field collection. S. Baldauf assisted with laboratory space and resources for complementary DNA synthesis. We thank K. Larsson for the original illustrations. Computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC). Transcriptome assembly, data set construction, RAxML and PhyloBayes analyses were performed using resources provided through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project b2013077, and MrBayes analyses were run under project snic2014-1-323.	Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Ehlers U, 1997, ZOOMORPHOLOGY, V117, P71; Ehlers U, 1985, PHYLOGENETISCHE SYST; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Jondelius U, 2002, ZOOL SCR, V31, P201, DOI 10.1046/j.1463-6409.2002.00090.x; Jondelius U, 2011, SYST BIOL, V60, P845, DOI 10.1093/sysbio/syr073; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kocot KM, 2013, EVOL BIOINFORM, V9, P429, DOI 10.4137/EBO.S12813; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Le SQ, 2012, MOL BIOL EVOL, V29, P2921, DOI 10.1093/molbev/mss112; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Mwinyi A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-309; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Noren M, 1997, NATURE, V390, P31, DOI 10.1038/36242; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; SMITH JPS, 1986, HYDROBIOLOGIA, V132, P13, DOI 10.1007/BF00046223; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEINBOCK OTTO, 1930, VIDENSK MEDDEL DANSK NATURHIST FOR KOBENHAVN, V90, P47; Struck TH, 2014, EVOL BIOINFORM, V10, P51, DOI 10.4137/EBO.S14239; Thomson RC, 2014, P NATL ACAD SCI USA, V111, pE3659, DOI 10.1073/pnas.1407207111; Westblad E., 1949, ARK ZOOL, V1, P3; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112	45	182	186	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					89	+		10.1038/nature16520	http://dx.doi.org/10.1038/nature16520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842059	Green Submitted			2022-12-28	WOS:000369304500038
J	Faisy, C; Meziani, F; Planquette, B; Clavel, M; Gacouin, A; Bornstain, C; Schneider, F; Duguet, A; Gibot, S; Lerolle, N; Ricard, JD; Sanchez, O; Djibre, M; Ricome, JL; Rabbat, A; Heming, N; Urien, S; Esvan, M; Katsahian, S				Faisy, Christophe; Meziani, Ferhat; Planquette, Benjamin; Clavel, Marc; Gacouin, Arnaud; Bornstain, Caroline; Schneider, Francis; Duguet, Alexandre; Gibot, Sebastien; Lerolle, Nicolas; Ricard, Jean-Damien; Sanchez, Olivier; Djibre, Michel; Ricome, Jean-Louis; Rabbat, Antoine; Heming, Nicholas; Urien, Saik; Esvan, Maxime; Katsahian, Sandrine		DIABOLO Investigators	Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-FAILURE; THERAPEUTIC APPLICATIONS; CARBONIC-ANHYDRASES; METABOLIC ALKALOSIS; ACUTE EXACERBATIONS; BICARBONATE; INHIBITORS	IMPORTANCE Acetazolamide has been used for decades as a respiratory stimulant for patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, but no large randomized placebo-controlled trial is available to confirm this approach. OBJECTIVE To determine whether acetazolamide reduces mechanical ventilation duration in critically ill patients with COPD and metabolic alkalosis. DESIGN, SETTING, AND PARTICIPANTS The DIABOLO study, a randomized, double-blind, multicenter trial, was conducted from October 2011 through July 2014 in 15 intensive care units (ICUs) in France. A total of 382 patients with COPD who were expected to receive mechanical ventilation for more 24 hours were randomized to the acetazolamide or placebo group and 380 were included in an intention-to treat analysis. INTERVENTIONS Acetazolamide (500-1000 mg, twice daily) vs placebo administered intravenously in cases of pure or mixed metabolic alkalosis, initiated within 48 hours of ICU admission and continued during the ICU stay for a maximum of 28 days. MAIN OUTCOMES AND MEASURES The primary outcome was the duration of invasive mechanical ventilation via endotracheal intubation or tracheotomy. Secondary outcomes included changes in arterial blood gas and respiratory parameters, weaning duration, adverse events, use of noninvasive ventilation after extubation, successful weaning, the duration of ICU stay, and in-ICU mortality. RESULTS Among 382 randomized patients, 380 (mean age, 69 years; 272 men[71.6%]; 379 [99.7%] with endotracheal intubation) completed the study. For the acetazolamide group (n = 187), compared with the placebo group (n = 193), no significant between-group differences were found for median duration of mechanical ventilation (-16.0 hours; 95% CI, -36.5 to 4.0 hours; P = .17), duration of weaning off mechanical ventilation (-0.9 hours; 95% CI, -4.3 to 1.3 hours; P = .36), daily changes of minute-ventilation (-0.0L/min; 95% CI, -0.2 to 0.2 L/min; P = .72), or partial carbon-dioxide pressure in arterial blood (-0.3 mm Hg; 95% CI, -0.8 to 0.2 mm Hg; P = .25), although daily changes of serum bicarbonate (between-group difference, -0.8 mEq/L; 95% CI, -1.2 to -0.5 mEq/L; P < .001) and number of days with metabolic alkalosis (between-group difference, -1; 95% CI, -2 to -1 days; P < .001) decreased significantly more in the acetazolamide group. Other secondary outcomes also did not differ significantly between groups. CONCLUSIONS AND RELEVANCE Among patients with COPD receiving invasive mechanical ventilation, the use of acetazolamide, compared with placebo, did not result in a statistically significant reduction in the duration of invasive mechanical ventilation. However, the magnitude of the difference was clinically important, and it is possible that the study was underpowered to establish statistical significance.	[Faisy, Christophe; Sanchez, Olivier; Heming, Nicholas; Esvan, Maxime; Katsahian, Sandrine] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France; [Meziani, Ferhat] Hop Univ Strasbourg, Med Intens Care Unit, Nouvel Hop Civil, Strasbourg, France; [Meziani, Ferhat] Strasbourg Univ, Federat Med Translat Strasbourg, EA 7293, Strasbourg, France; [Planquette, Benjamin] Andre Mignot Hosp, Medicosurg Intens Care Unit, Le Chesnay, France; [Clavel, Marc] Limoges Univ Hosp, Med Intens Care Unit, Limoges, France; [Gacouin, Arnaud] Rennes Univ Hosp, Med Intens Care Unit, Rennes, France; [Bornstain, Caroline] Le Raincy Montfermeil Hosp, Med Intens Care Unit, Montfermeil, France; [Schneider, Francis] Hautepierre Hosp, Strasbourg Med Intens Care Unit, Strasbourg, France; [Duguet, Alexandre] Hop La Pitie Salpetriere, Dept Resp & Intens Care Med, Paris, France; [Gibot, Sebastien] Nancy Univ Hosp, Med Intens Care Unit, Nancy, France; [Lerolle, Nicolas] Angers Univ Hosp, Med Intens Care Unit, Angers, France; [Ricard, Jean-Damien] Hop Louis Mourier, Medicosurg Intens Care Unit, F-92701 Colombes, France; [Djibre, Michel] Tenon Hosp, Medicosurg Intens Care Unit, Paris, France; [Ricome, Jean-Louis] Poissy St Germain Hosp, Med Intens Care Unit, Poissy, France; [Rabbat, Antoine; Urien, Saik] Cochin Hosp, Med Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre Hospitalier de Versailles; CHU Limoges; CHU Rennes; Universite de Rennes; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Nancy; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Faisy, C (corresponding author), Hop Europeen Georges Pompidou, Med Intens Care Unit, 20 Rue Leblanc, F-75015 Paris, France.	christophe.faisy@egp.aphp.fr	DUFOUR, Nicolas N/U-4634-2018; François, Bruno/O-8404-2016; Legriel, Stephane/J-1307-2017; PLANQUETTE, Benjamin/AAL-7166-2021; Urien, Saïk/G-3240-2013	DUFOUR, Nicolas N/0000-0002-1359-6689; François, Bruno/0000-0002-2531-1652; Legriel, Stephane/0000-0003-4782-6734; Urien, Saïk/0000-0002-1065-0600; /0000-0002-4171-1672; SANCHEZ, Olivier/0000-0003-1633-8391; Troche, Gilles/0000-0002-8150-6630; KATSAHIAN, Sandrine/0000-0002-7261-0671; herbrecht, jean-etienne/0000-0002-6415-5330; Helms, Julie/0000-0003-0895-6800	French Ministry of Health; sanofi-aventis France	French Ministry of Health; sanofi-aventis France(Sanofi-Aventis)	The work was supported by the French Ministry of Health and sanofi-aventis France.	Bahloul Mabrouk, 2015, Int J Crit Illn Inj Sci, V5, P3, DOI 10.4103/2229-5151.152296; BERTHELSEN P, 1982, INTENS CARE MED, V8, P269, DOI 10.1007/BF01716736; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Breen D, 2002, THORAX, V57, P29, DOI 10.1136/thorax.57.1.29; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Faisy C, 2010, INTENS CARE MED, V36, P859, DOI 10.1007/s00134-010-1795-7; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gursel G, 2005, RESPIRATION, V72, P61, DOI 10.1159/000083402; Heming N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100443, 10.1371/journal.pone.0086313]; Heming N, 2012, CRIT CARE, V16, DOI 10.1186/cc11323; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc10448; HODGKIN JE, 1980, CRIT CARE MED, V8, P725, DOI 10.1097/00003246-198012000-00005; Holland AE, 2003, CHEST, V124, P490, DOI 10.1378/chest.124.2.490; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Kassamali R, 2011, CARDIOL REV, V19, P276, DOI 10.1097/CRD.0b013e31822b4939; KRINTEL JJ, 1983, ACTA ANAESTH SCAND, V27, P252, DOI 10.1111/j.1399-6576.1983.tb01946.x; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Liborio AB, 2015, INTENS CARE MED, V41, P479, DOI 10.1007/s00134-015-3649-9; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; Pastorekova S, 2004, J ENZYM INHIB MED CH, V19, P199, DOI 10.1080/14756360410001689540; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286; Zilberberg MD, 2009, CHEST, V135, P1157, DOI 10.1378/chest.08-1928	29	37	39	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					480	488		10.1001/jama.2016.0019	http://dx.doi.org/10.1001/jama.2016.0019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836730	Bronze			2022-12-28	WOS:000369049500017
J	Starck, SR; Tsai, JC; Chen, KL; Shodiya, M; Wang, L; Yahiro, K; Martins-Green, M; Shastri, N; Walter, P				Starck, Shelley R.; Tsai, Jordan C.; Chen, Keling; Shodiya, Michael; Wang, Lei; Yahiro, Kinnosuke; Martins-Green, Manuela; Shastri, Nilabh; Walter, Peter			Translation from the 5 ' untranslated region shapes the integrated stress response	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; OPEN READING FRAMES; FAMILIAL ESSENTIAL THROMBOCYTHEMIA; INITIATION-FACTOR 2; MESSENGER-RNA; PROTEIN-SYNTHESIS; BASE DELETION; KINASE PKR; EXPRESSION; CELLS	Translated regions distinct from annotated coding sequences have emerged as essential elements of the proteome. This includes upstream open reading frames (uORFs) present in mRNAs controlled by the integrated stress response (ISR) that show "privileged" translation despite inhibited eukaryotic initiation factor 2-guanosine triphosphate-initiator methionyl transfer RNA (eIF2.GTP.Met-tRNA(i)(Met)). We developed tracing translation by T cells to directly measure the translation products of uORFs during the ISR. We identified signature translation events from uORFs in the 5' untranslated region of binding immunoglobulin protein (BiP) mRNA (also called heat shock 70-kilodalton protein 5 mRNA) that were not initiated at the start codon AUG. BiP expression during the ISR required both the alternative initiation factor eIF2A and non-AUG-initiated uORFs. We propose that persistent uORF translation, for a variety of chaperones, shelters select mRNAs from the ISR, while simultaneously generating peptides that could serve as major histocompatibility complex class I ligands, marking cells for recognition by the adaptive immune system.	[Starck, Shelley R.; Tsai, Jordan C.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Starck, Shelley R.; Chen, Keling; Shodiya, Michael; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA; [Wang, Lei; Martins-Green, Manuela] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Yahiro, Kinnosuke] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Riverside; Chiba University	Starck, SR; Walter, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Starck, SR; Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	shelley@walterlab.ucsf.edu; nshastri@berkeley.edu; peter@walterlab.ucsf.edu		Yahiro, Kinnosuke/0000-0002-9813-0780; Tsai, Jordan/0000-0001-5202-722X	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24390104] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful for technical help from K. Banta and S. J. Yang (University of California, Berkeley) and K. Crotty (University of California, San Francisco). We thank M. Elvekrog, E. Costa, M. Lam, and W. Merrick for critical reading of the manuscript and C. Sidrauski, S. Ramundo, H. Tran, N. Ingolia, and J. Weissman for helpful discussions and advice. The human retinal pigment epithelial cell line (RPE-19) was a gift from X. Gong (School of Optometry, University of California, Berkeley). This research was supported by grants from the NIH to N. S. and P.W. P.W. is an Investigator of the Howard Hughes Medical Institute.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Booth L, 2015, J CELL PHYSIOL, V230, P1661, DOI 10.1002/jcp.24919; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; Engelhard VH, 2007, INT J MASS SPECTROM, V259, P32, DOI 10.1016/j.ijms.2006.08.009; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; GALABRU J, 1989, EUR J BIOCHEM, V178, P581, DOI 10.1111/j.1432-1033.1989.tb14485.x; Ghilardi N, 1999, BLOOD, V94, P1480, DOI 10.1182/blood.V94.4.1480.416a37c_1480_1482; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Gorbatyuk M.S., 2013, J GENET SYNDR GENE T, V4, DOI [10.4172/2157-7412.1000128, DOI 10.4172/2157-7412.1000128]; Gulow K, 2002, J CELL SCI, V115, P2443; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JOSLIN G, 1991, J IMMUNOL, V147, P1614; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Kondo T, 1998, BLOOD, V92, P1091, DOI 10.1182/blood.V92.4.1091.416a36_1091_1096; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Law GL, 2001, J BIOL CHEM, V276, P38036; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mielnicki LM, 1996, BIOCHEM BIOPH RES CO, V228, P586, DOI 10.1006/bbrc.1996.1702; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Olexiouk V, 2016, NUCLEIC ACIDS RES, V44, pD324, DOI 10.1093/nar/gkv1175; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhang XQ, 2015, NAT STRUCT MOL BIOL, V22, P404, DOI 10.1038/nsmb.3010; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200	85	203	206	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272							aad3867	10.1126/science.aad3867	http://dx.doi.org/10.1126/science.aad3867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823435	Green Accepted, Green Submitted			2022-12-28	WOS:000368858200027
J	Silver, D; Huang, A; Maddison, CJ; Guez, A; Sifre, L; van den Driessche, G; Schrittwieser, J; Antonoglou, I; Panneershelvam, V; Lanctot, M; Dieleman, S; Grewe, D; Nham, J; Kalchbrenner, N; Sutskever, I; Lillicrap, T; Leach, M; Kavukcuoglu, K; Graepel, T; Hassabis, D				Silver, David; Huang, Aja; Maddison, Chris J.; Guez, Arthur; Sifre, Laurent; van den Driessche, George; Schrittwieser, Julian; Antonoglou, Ioannis; Panneershelvam, Veda; Lanctot, Marc; Dieleman, Sander; Grewe, Dominik; Nham, John; Kalchbrenner, Nal; Sutskever, Ilya; Lillicrap, Timothy; Leach, Madeleine; Kavukcuoglu, Koray; Graepel, Thore; Hassabis, Demis			Mastering the game of Go with deep neural networks and tree search	NATURE			English	Article							COMPUTER; CHESS	The game of Go has long been viewed as the most challenging of classic games for artificial intelligence owing to its enormous search space and the difficulty of evaluating board positions and moves. Here we introduce a new approach to computer Go that uses 'value networks' to evaluate board positions and 'policy networks' to select moves. These deep neural networks are trained by a novel combination of supervised learning from human expert games, and reinforcement learning from games of self-play. Without any lookahead search, the neural networks play Go at the level of state-of-the-art Monte Carlo tree search programs that simulate thousands of random games of self-play. We also introduce a new search algorithm that combines Monte Carlo simulation with value and policy networks. Using this search algorithm, our program AlphaGo achieved a 99.8% winning rate against other Go programs, and defeated the human European Go champion by 5 games to 0. This is the first time that a computer program has defeated a human professional player in the full-sized game of Go, a feat previously thought to be at least a decade away.	[Silver, David; Huang, Aja; Maddison, Chris J.; Guez, Arthur; Sifre, Laurent; van den Driessche, George; Schrittwieser, Julian; Antonoglou, Ioannis; Panneershelvam, Veda; Lanctot, Marc; Dieleman, Sander; Grewe, Dominik; Kalchbrenner, Nal; Lillicrap, Timothy; Leach, Madeleine; Kavukcuoglu, Koray; Graepel, Thore; Hassabis, Demis] Google DeepMind, 5 New St Sq, London EC4A 3TW, England; [Nham, John; Sutskever, Ilya] Google, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA	Google Incorporated; Google Incorporated	Silver, D; Hassabis, D (corresponding author), Google DeepMind, 5 New St Sq, London EC4A 3TW, England.	davidsilver@google.com; demishassabis@google.com	Jeong, Yongwook/N-7413-2016					Allis L., 1994, THESIS; [Anonymous], 2006, INT C MACH LEARN, DOI DOI 10.1145/1143844.1143954; Baier H., 2011, P 23 BEN C ART INT B, P3; Baier H, 2010, IEEE T COMP INTEL AI, V2, P303, DOI 10.1109/TCIAIG.2010.2100396; Baudis Petr, 2012, Advances in Computer Games. 13th International Conference, ACG 2011. Revised Selected Papers, P24, DOI 10.1007/978-3-642-31866-5_3; Baudis P, 2011, ICGA J, V34, P131, DOI 10.3233/ICG-2011-34302; Baxter J, 2000, MACH LEARN, V40, P243, DOI 10.1023/A:1007634325138; BERLINER HJ, 1978, ARTIF INTELL, V10, P201, DOI 10.1016/S0004-3702(78)80012-5; Bouzy B., 2003, ADV COMPUTER GAMES M, P159; Browne CB, 2012, IEEE T COMP INTEL AI, V4, P1, DOI 10.1109/TCIAIG.2012.2186810; Buro M, 1999, LECT NOTES COMPUT SC, V1558, P126; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Clark C, 2015, PR MACH LEARN RES, V37, P1766; Coulom R, 2007, ICGA J, V30, P198; Coulom R, 2008, LECT NOTES COMPUT SC, V5131, P113, DOI 10.1007/978-3-540-87608-3_11; Dahl F. Honte, 1999, MACHINES LEARN PLAY, P205; Dean J., 2012, ADV NEURAL INFORM PR, P1223, DOI DOI 10.5555/2999134.2999271; Enzenberger M, 2004, INT FED INFO PROC, V135, P97; Enzenberger M, 2010, IEEE T COMP INTEL AI, V2, P259, DOI 10.1109/TCIAIG.2010.2083662; Enzenberger M, 2010, LECT NOTES COMPUT SC, V6048, P14; Gelly S., 2006, 6062 INRIA; Gelly S., 2007, P 24 INT C MACH LEAR, P273; Huang S., 2013, 8 INT C COMP GAM, P39; Huang SC, 2011, LECT NOTES COMPUT SC, V6515, P81, DOI 10.1007/978-3-642-17928-0_8; Huang SC, 2010, CONF TECHNOL APPL, P462, DOI 10.1109/TAAI.2010.78; KGS, RAT SYST MATH; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lanctot M, 2014, IEEE CONF COMPU INTE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Levinovitz A., 2014, WIRED MAGAZINE; Littman M.L., 1994, P 11 INT C INT C MAC, P157; Maddison C. J., 2015, 3 INT C LEARN REPR; Mandziuk J, 2007, STUD COMPUT INTELL, V63, P407; Mechner DA, 1998, SCIENCES, V38, P32, DOI 10.1002/j.2326-1951.1998.tb03356.x; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Muller M, 2002, ARTIF INTELL, V134, P145, DOI 10.1016/S0004-3702(01)00121-7; Rosin C, 2011, ANN MATH ARTIF INTEL, V61, P203, DOI 10.1007/s10472-011-9258-6; SAMUEL AL, 1967, IBM J RES DEV, V11, P601, DOI 10.1147/rd.116.0601; Schaeffer J, 2000, ADV COMPUT, V52, P189; Schaeffer J., 2001, P 17 INT JOINT C ART, P529; Schraudolph N.N., 1994, ADV NEURAL INFORMATI, V6, P817; Segal RB, 2011, LECT NOTES COMPUT SC, V6515, P36, DOI 10.1007/978-3-642-17928-0_4; Sheppard B, 2002, ARTIF INTELL, V134, P241, DOI 10.1016/S0004-3702(01)00166-7; Silver D., 2009, 26 INT C MACH LEARN, P119; Silver D, 2012, MACH LEARN, V87, P183, DOI 10.1007/s10994-012-5280-0; Sutskever I, 2008, LECT NOTES COMPUT SC, V5164, P101, DOI 10.1007/978-3-540-87559-8_11; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Sutton RS, 2000, ADV NEUR IN, V12, P1057; Tesauro G, 1997, ADV NEUR IN, V9, P1068; van den Herik HJ, 2002, ARTIF INTELL, V134, P277, DOI 10.1016/S0004-3702(01)00152-7; Veness J., 2009, ADV NEURAL INFORM PR; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696	61	6623	7079	267	4065	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					484	+		10.1038/nature16961	http://dx.doi.org/10.1038/nature16961			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819042				2022-12-28	WOS:000368673800028
J	[Anonymous]				[Anonymous]			A Cell-ebration of Induced Pluripotency	CELL			English	Editorial Material																			0	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					331	331		10.1016/j.cell.2016.01.017	http://dx.doi.org/10.1016/j.cell.2016.01.017			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824645	Bronze			2022-12-28	WOS:000368906800001
J	Zhang, FL; Hong, K; Li, TJ; Park, H; Yu, JQ				Zhang, Fang-Lin; Hong, Kai; Li, Tuan-Jie; Park, Hojoon; Yu, Jin-Quan			Functionalization of C(sp(3))-H bonds using a transient directing group	SCIENCE			English	Article							C-H BONDS; DIRECT BETA-ARYLATION; ASYMMETRIC-SYNTHESIS; AMINO-ACIDS; ACTIVATION; OLEFINATION; SELECTIVITY; INDOLINES; LIGANDS; KETONES	Proximity-driven metalation has been extensively exploited to achieve reactivity and selectivity in carbon-hydrogen (C-H) bond activation. Despite the substantial improvement in developing more efficient and practical directing groups, their stoichiometric installation and removal limit efficiency and, often, applicability as well. Here we report the development of an amino acid reagent that reversibly reacts with aldehydes and ketones in situ via imine formation to serve as a transient directing group for activation of inert C-H bonds. Arylation of a wide range of aldehydes and ketones at the beta or gamma positions proceeds in the presence of a palladium catalyst and a catalytic amount of amino acid. The feasibility of achieving enantioselective C-H activation reactions using a chiral amino acid as the transient directing group is also demonstrated.	[Zhang, Fang-Lin; Hong, Kai; Li, Tuan-Jie; Park, Hojoon; Yu, Jin-Quan] Scripps Res Inst, Comm Vasc Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Comm Vasc Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Hong, Kai/L-6118-2018; Zhang, Fang/HHN-2153-2022	Hong, Kai/0000-0001-7341-4931; 	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [2R01GM084019]; Wuhan University of Technology; Jiangsu Normal University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wuhan University of Technology; Jiangsu Normal University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute and the NIH (National Institute of General Medical Sciences grant 2R01GM084019) for financial support. F.-L.Z. thanks Wuhan University of Technology and T.-J.L. thanks Jiangsu Normal University for financial support. J.-Q.Y. and F.-L.Z. conceived the experimental concept; F.-L.Z. performed the arylation of primary C-H bonds; K.H. developed the enantioselective C-H arylation; T.-J.L. developed conditions for the beta-arylation of ketones; and H.P. performed enantioselective C-H arylation. Metrical parameters for the structure of compound S2 (see supplementary materials) are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 1434263.	Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Anas S, 2011, CHEM COMMUN, V47, P11483, DOI 10.1039/c1cc14292e; Bedford RB, 2003, ANGEW CHEM INT EDIT, V42, P112, DOI 10.1002/anie.200390037; BROWN JM, 1993, CHEM SOC REV, V22, P25, DOI 10.1039/cs9932200025; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Gao P, 2015, J AM CHEM SOC, V137, P12231, DOI 10.1021/jacs.5b06758; Gong W, 2014, J AM CHEM SOC, V136, P16940, DOI 10.1021/ja510233h; Gruenanger CU, 2008, ANGEW CHEM INT EDIT, V47, P7346, DOI 10.1002/anie.200802296; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Huang ZX, 2013, J AM CHEM SOC, V135, P17747, DOI 10.1021/ja410389a; Johnson R. A., 2005, CATALYTIC ASYMMETRIC, P231; Jun CH, 1997, J ORG CHEM, V62, P1200, DOI 10.1021/jo961887d; Kang T, 2014, J AM CHEM SOC, V136, P4141, DOI 10.1021/ja501014b; Larock R. C, 1999, COMPREHENSIVE ORGANI, P1197; Li Z, 2013, ACCOUNTS CHEM RES, V46, P506, DOI 10.1021/ar300216r; Lightburn TE, 2008, J AM CHEM SOC, V130, P9210, DOI 10.1021/ja803011d; MCINTIRE FC, 1947, J AM CHEM SOC, V69, P1377, DOI 10.1021/ja01198a040; Mo FY, 2014, SCIENCE, V345, P68, DOI 10.1126/science.1254465; Nakanishi M, 2011, ANGEW CHEM INT EDIT, V50, P7438, DOI 10.1002/anie.201102639; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Saget T, 2012, ANGEW CHEM INT EDIT, V51, P2238, DOI 10.1002/anie.201108511; Shi BF, 2008, ANGEW CHEM INT EDIT, V47, P4882, DOI 10.1002/anie.200801030; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a	30	453	453	23	362	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					252	256		10.1126/science.aad7893	http://dx.doi.org/10.1126/science.aad7893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816374	Green Accepted			2022-12-28	WOS:000368098600035
J	Potter, C				Potter, Christopher			The art of medicine All or nothing?	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					E34	E35		10.1016/S0140-6736(15)00773-4	http://dx.doi.org/10.1016/S0140-6736(15)00773-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26843315				2022-12-28	WOS:000364194700004
J	Roop, JI; Chang, KC; Brem, RB				Roop, Jeremy I.; Chang, Kyu Chul; Brem, Rachel B.			Polygenic evolution of a sugar specialization trade-off in yeast	NATURE			English	Article							SACCHAROMYCES; ADAPTATION; DROSOPHILA; GENETICS; GENOMICS; SYSTEM; DNA	The evolution of novel traits can involve many mutations scattered throughout the genome(1,2). Detecting and validating such a suite of alleles, particularly if they arose long ago, remains a key challenge in evolutionary genetics(1-3). Here we dissect an evolutionary trade-off of unprecedented genetic complexity between long-diverged species. When cultured in 1% glucose medium supplemented with galactose, Saccharomyces cerevisiae, but not S. bayanus or other Saccharomyces species, delayed commitment to galactose metabolism until glucose was exhausted. Promoters of seven galactose (GAL) metabolic genes from S. cerevisiae, when introduced together into S. bayanus, largely recapitulated the delay phenotype in 1% glucose-galactose medium, and most had partial effects when tested in isolation. Variation in GAL coding regions also contributed to the delay when tested individually in 1% glucose-galactose medium. When combined, S. cerevisiae GAL coding regions gave rise to profound growth defects in the S. bayanus background. In medium containing 2.5% glucose supplemented with galactose, wild-type S. cerevisiae repressed GAL gene expression and had a robust growth advantage relative to S. bayanus; transgenesis of S. cerevisiae GAL promoter alleles or GAL coding regions was sufficient for partial reconstruction of these phenotypes. S. cerevisiae GAL genes thus encode a regulatory program of slow induction and avid repression, and a fitness detriment during the glucose-galactose transition but a benefit when glucose is in excess. Together, these results make clear that genetic mapping of complex phenotypes is within reach, even in deeply diverged species.	[Roop, Jeremy I.; Brem, Rachel B.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chang, Kyu Chul] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chang, Kyu Chul; Brem, Rachel B.] Buck Inst Res Aging, Novato, CA 94945 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Buck Institute for Research on Aging	Brem, RB (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Brem, RB (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	rbrem@buckinstitute.org			NIGMS NIH HHS [GM087432, R01 GM087432] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087432] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bullard JH, 2010, P NATL ACAD SCI USA, V107, P5058, DOI 10.1073/pnas.0912959107; Caudy AA, 2013, GENETICS, V195, P275, DOI 10.1534/genetics.113.152918; Charlesworth J, 2008, MOL BIOL EVOL, V25, P1007, DOI 10.1093/molbev/msn005; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nair NU, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn943; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; New AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001764; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Peng WL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7226; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schraiber JG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003255; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Venturelli OS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002042; Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111	26	39	39	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					336	+		10.1038/nature16938	http://dx.doi.org/10.1038/nature16938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26863195	Green Accepted			2022-12-28	WOS:000370327100037
J	Elachola, H; Gozzer, E; Zhuo, JT; Memish, ZA				Elachola, Habida; Gozzer, Ernesto; Zhuo, Jiatong; Memish, Ziad A.			A crucial time for public health preparedness: Zika virus and the 2016 Olympics, Umrah, and Hajj	LANCET			English	Editorial Material							PANDEMIC H1N1; TRANSMISSION		[Gozzer, Ernesto] Inst Nacl Salud, Lima, Peru; [Zhuo, Jiatong] Guangxi Ctr Dis Control & Prevent, Guangxi, Peoples R China; [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia	Instituto Nacional de Salud - Peru; Ministry of Health - Saudi Arabia	Memish, ZA (corresponding author), Minist Hlth, Riyadh, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714; Gozzer, Ernesto/0000-0002-5597-8669				Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001; Alhaeli A, 2016, J INFECT PUBLIC HEAL, V9, P117, DOI 10.1016/j.jiph.2015.05.006; Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1; Bitar D, 2009, EUROSURVEILLANCE, V14; Brazil Ministry of Health, 2016, B EP, V47; Centers for Disease Control and Prevention, 2016, ZIK VIR; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Fantz A, 2016, OLYMPICS WILL INSPEC; Memish ZA, 2010, J ROY SOC MED, V103, P386, DOI 10.1258/jrsm.2010.100263; Ministry of Health Kingdom of Saudi Arabia, 2016, HAJJ 1436 HLTH REG; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; World Health Organization, 2016, WHO DIR GEN BRIEFS E; World Health Organization (WHO), 2016, WHO STAT 1 M INT HLT	15	31	33	0	79	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					630	632		10.1016/S0140-6736(16)00274-9	http://dx.doi.org/10.1016/S0140-6736(16)00274-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3QH	26864962	Green Published, Bronze			2022-12-28	WOS:000369837100009
J	Domack, E				Domack, Eugene			CLIMATE SCIENCE A great Arctic ice shelf	NATURE			English	Editorial Material							GLACIATION; MARGIN; OCEAN		[Domack, Eugene] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	Domack, E (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	edomack@usf.edu						Andreev AA, 2004, BOREAS, V33, P319, DOI 10.1080/03009480410001974; Basilyan A., 2008, IPY NEWS, V12, P7; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Dowdeswell JA, 2010, QUATERNARY SCI REV, V29, P3518, DOI 10.1016/j.quascirev.2010.06.002; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Engels JL, 2008, EARTH SURF PROC LAND, V33, P1047, DOI 10.1002/esp.1601; Jakobsson M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10365; JOHNSON RG, 1979, QUATERNARY RES, V12, P119, DOI 10.1016/0033-5894(79)90093-0; Kristoffersen Y, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000985; Niessen F, 2013, NAT GEOSCI, V6, P842, DOI [10.1038/NGEO1904, 10.1038/ngeo1904]; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Polyak L, 2001, NATURE, V410, P453, DOI 10.1038/35068536	12	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					163	164		10.1038/nature16878	http://dx.doi.org/10.1038/nature16878			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD4TX	26840488				2022-12-28	WOS:000369916700023
J	Matthews, GA; Nieh, EH; Vander Weele, CM; Halbert, SA; Pradhan, RV; Yosafat, AS; Glober, GF; Izadmehr, EM; Thomas, RE; Lacy, GD; Wildes, CP; Ungless, MA; Tye, KM				Matthews, Gillian A.; Nieh, Edward H.; Vander Weele, Caitlin M.; Halbert, Sarah A.; Pradhan, Roma V.; Yosafat, Ariella S.; Glober, Gordon F.; Izadmehr, Ehsan M.; Thomas, Rain E.; Lacy, Gabrielle D.; Wildes, Craig P.; Ungless, Mark A.; Tye, Kay M.			Dorsal Raphe Dopamine Neurons Represent the Experience of Social Isolation	CELL			English	Review							AMPA RECEPTORS; TYROSINE-HYDROXYLASE; EXTENDED AMYGDALA; INBRED STRAINS; RAT-BRAIN; IN-VIVO; LONELINESS; NUCLEUS; BELONG; REWARD	The motivation to seek social contact may arise from either positive or negative emotional states, as social interaction can be rewarding and social isolation can be aversive. While ventral tegmental area (VTA) dopamine (DA) neurons may mediate social reward, a cellular substrate for the negative affective state of loneliness has remained elusive. Here, we identify a functional role for DA neurons in the dorsal raphe nucleus (DRN), in which we observe synaptic changes following acute social isolation. DRN DA neurons show increased activity upon social contact following isolation, revealed by in vivo calcium imaging. Optogenetic activation of DRN DA neurons increases social preference but causes place avoidance. Furthermore, these neurons are necessary for promoting rebound sociability following an acute period of isolation. Finally, the degree to which these neurons modulate behavior is predicted by social rank, together supporting a role for DRN dopamine neurons in mediating a loneliness-like state.	[Matthews, Gillian A.; Nieh, Edward H.; Vander Weele, Caitlin M.; Halbert, Sarah A.; Pradhan, Roma V.; Yosafat, Ariella S.; Glober, Gordon F.; Izadmehr, Ehsan M.; Thomas, Rain E.; Lacy, Gabrielle D.; Wildes, Craig P.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Matthews, Gillian A.; Ungless, Mark A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England	Massachusetts Institute of Technology (MIT); Northwell Health; Imperial College London	Tye, KM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, Du Cane Rd, London W12 0NN, England.	mark.ungless@imperial.ac.uk; kaytye@mit.edu		Ungless, Mark/0000-0002-1730-3353; Pradhan, Roma/0000-0001-5397-4982; /0000-0001-6754-0333; /0000-0003-2154-6224	JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation; NARSAD Young Investigator Award; Alfred P Sloan Foundation; New York Stem Cell Foundation; McKnight Foundation; Whitehead Career Development Chair; NIH Director's New Innovator Award [DP2-DK-102256-01]; U.K. Medical Research Council [MC-A654-5QB70]; University Research Fellowship from The Royal Society; Simons Center for the Social Brain at MIT; NSF Graduate Research Program Fellowship; Integrative Neuronal Systems Fellowship; Training Program in the Neurobiology of Learning and Memory; Integrative Neuronal Systems Training Grant [NIGMS T32 GM007484]; Undergraduate Research Opportunities Program at MIT; MIT Summer Research Program; Northeastern Cooperative Education Program; NIMH [R01-MH102441-01]; NIA [RF1-AG047661-01]; Medical Research Council [MC_U120085816] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG047661] Funding Source: NIH RePORTER; MRC [MC_U120085816] Funding Source: UKRI	JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NARSAD Young Investigator Award(NARSAD); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); New York Stem Cell Foundation; McKnight Foundation; Whitehead Career Development Chair; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University Research Fellowship from The Royal Society(Royal Society of London); Simons Center for the Social Brain at MIT; NSF Graduate Research Program Fellowship; Integrative Neuronal Systems Fellowship; Training Program in the Neurobiology of Learning and Memory; Integrative Neuronal Systems Training Grant; Undergraduate Research Opportunities Program at MIT; MIT Summer Research Program; Northeastern Cooperative Education Program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to acknowledge M. Warden and C. Seo for advice regarding photometry, S.A. Hires and the entire Tye and Ungless Laboratories for helpful discussion, and A. Beyeler, R. Wichmann, P. Namburi, M. Bishop, and F. Brischoux for technical assistance. K.M.T. is a New York Stem Cell Foundation - Robertson Investigator and McKnight Scholar. This work was supported by funding from the JPB Foundation, PIIF, PNDRF, JFDP, Whitehall Foundation, Klingenstein Foundation, NARSAD Young Investigator Award, Alfred P Sloan Foundation, New York Stem Cell Foundation, McKnight Foundation, Whitehead Career Development Chair, R01-MH102441-01 (NIMH), RF1-AG047661-01 (NIA), and NIH Director's New Innovator Award DP2-DK-102256-01 (NIDDK). M.A.U. is supported by grant MC-A654-5QB70 from the U.K. Medical Research Council and a University Research Fellowship from The Royal Society. G.A.M. was supported by a Postdoctoral Fellowship from the Simons Center for the Social Brain at MIT. E.H.N. was supported by the NSF Graduate Research Program Fellowship, the Integrative Neuronal Systems Fellowship, and the Training Program in the Neurobiology of Learning and Memory. C.M.V.W. was supported by the Integrative Neuronal Systems Training Grant (NIGMS T32 GM007484) and an NSF Graduate Research Program Fellowship. A.S.Y. and R.V.P. were funded by the Undergraduate Research Opportunities Program at MIT. G.D.L. was supported by the MIT Summer Research Program and R.E.T. by the Northeastern Cooperative Education Program.	Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Browne Angela, 2011, FEDERAL SENTENCING R, V24, P46, DOI DOI 10.1525/FSR.2011.24.1.46; BUSS DM, 1990, J SOC CLIN PSYCHOL, V9, P196, DOI 10.1521/jscp.1990.9.2.196; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cacioppo S, 2014, PSYCHOL BULL, V140, P1464, DOI 10.1037/a0037618; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Conrad KL, 2011, PHYSIOL BEHAV, V104, P248, DOI 10.1016/j.physbeh.2011.03.001; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Dougalis AG, 2012, EUR J NEUROSCI, V36, P3322, DOI 10.1111/j.1460-9568.2012.08255.x; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Gardner WL, 2005, PERS SOC PSYCHOL B, V31, P1549, DOI 10.1177/0146167205277208; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hawkley LC, 2006, PSYCHOL AGING, V21, P152, DOI 10.1037/0882-7974.21.1.152; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375, DOI 10.1093/geronb/63.6.S375; HOKFELT T, 1976, MED BIOL, V54, P427; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kash TL, 2008, J NEUROSCI, V28, P13856, DOI 10.1523/JNEUROSCI.4715-08.2008; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; Meloni EG, 2006, J NEUROSCI, V26, P3855, DOI 10.1523/JNEUROSCI.4957-05.2006; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; NAGATSU I, 1979, ACTA HISTOCHEM CYTOC, V12, P20, DOI 10.1267/ahc.12.20; NIESINK RJM, 1982, PHYSIOL BEHAV, V29, P819, DOI 10.1016/0031-9384(82)90331-6; Peplau L.A., 1978, LONELINESS BIBLIO RE; de la Mora MP, 2010, PROG NEUROBIOL, V90, P198, DOI 10.1016/j.pneurobio.2009.10.010; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Robinson DL, 2002, J NEUROSCI, V22, P10477; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uhrich J, 1938, J COMP PSYCHOL, V25, P373, DOI 10.1037/h0056350; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Walker J, 2014, ACTA PSYCHIAT SCAND, V129, P427, DOI 10.1111/acps.12221; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025; Williams KD, 1997, PERS SOC PSYCHOL B, V23, P693, DOI 10.1177/0146167297237003; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; YOSHIDA M, 1989, BRAIN RES, V496, P373, DOI 10.1016/0006-8993(89)91091-3	69	184	188	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					617	631		10.1016/j.cell.2015.12.040	http://dx.doi.org/10.1016/j.cell.2015.12.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871628	Green Published, hybrid			2022-12-28	WOS:000369998300009
J	Poorter, L; Bongers, F; Aide, TM; Almeyda Zambrano, AM; Balvanera, P; Becknell, JM; Boukili, V; Brancalion, PHS; Broadbent, EN; Chazdon, RL; Craven, D; de Almeida-Cortez, JS; Cabral, GAL; de Jong, BHJ; Denslow, JS; Dent, DH; DeWalt, SJ; Dupuy, JM; Duran, SM; Espirito-Santo, MM; Fandino, MC; Cesar, RG; Hall, JS; Hernandez-Stefanoni, JL; Jakovac, CC; Junqueira, AB; Kennard, D; Letcher, SG; Licona, JC; Lohbeck, M; Marin-Spiotta, E; Martinez-Ramos, M; Massoca, P; Meave, JA; Mesquita, R; Mora, F; Munoz, R; Muscarella, R; Nunes, YRF; Ochoa-Gaona, S; de Oliveira, AA; Orihuela-Belmonte, E; Pena-Claros, M; Perez-Garcia, EA; Piotto, D; Powers, JS; Rodriguez-Velazquez, J; Romero-Perez, IE; Ruiz, J; Saldarriaga, JG; Sanchez-Azofeifa, A; Schwartz, NB; Steininger, MK; Swenson, NG; Toledo, M; Uriarte, M; van Breugel, M; van der Wal, H; Veloso, MDM; Vester, HFM; Vicentini, A; Vieira, ICG; Bentos, TV; Williamson, GB; Rozendaal, DMA				Poorter, Lourens; Bongers, Frans; Aide, T. Mitchell; Almeyda Zambrano, Angelica M.; Balvanera, Patricia; Becknell, Justin M.; Boukili, Vanessa; Brancalion, Pedro H. S.; Broadbent, Eben N.; Chazdon, Robin L.; Craven, Dylan; de Almeida-Cortez, Jarcilene S.; Cabral, George A. L.; de Jong, Ben H. J.; Denslow, Julie S.; Dent, Daisy H.; DeWalt, Saara J.; Dupuy, Juan M.; Duran, Sandra M.; Espirito-Santo, Mario M.; Fandino, Maria C.; Cesar, Ricardo G.; Hall, Jefferson S.; Hernandez-Stefanoni, Jose Luis; Jakovac, Catarina C.; Junqueira, Andre B.; Kennard, Deborah; Letcher, Susan G.; Licona, Juan-Carlos; Lohbeck, Madelon; Marin-Spiotta, Erika; Martinez-Ramos, Miguel; Massoca, Paulo; Meave, Jorge A.; Mesquita, Rita; Mora, Francisco; Munoz, Rodrigo; Muscarella, Robert; Nunes, Yule R. F.; Ochoa-Gaona, Susana; de Oliveira, Alexandre A. .; Orihuela-Belmonte, Edith; Pena-Claros, Marielos; Perez-Garcia, Eduardo A. .; Piotto, Daniel; Powers, Jennifer S.; Rodriguez-Velazquez, Jorge; Romero-Perez, I. Eunice; Ruiz, Jorge; Saldarriaga, Juan G.; Sanchez-Azofeifa, Arturo; Schwartz, Naomi B.; Steininger, Marc K.; Swenson, Nathan G.; Toledo, Marisol; Uriarte, Maria; van Breugel, Michiel; van der Wal, Hans; Veloso, Maria D. M.; Vester, Hans F. M.; Vicentini, Alberto; Vieira, Ima C. G.; Bentos, Tony Vizcarra; Williamson, G. Bruce; Rozendaal, Danae M. A.			Biomass resilience of Neotropical secondary forests	NATURE			English	Article							TROPICAL DRY FOREST; ABOVEGROUND BIOMASS; CARBON STOCKS; SPECIES COMPOSITION; STAND AGE; LAND-USE; TREE; CHRONOSEQUENCE; SUCCESSION; PATTERNS	Land-use change occurs nowhere more rapidly than in the tropics, where the imbalance between deforestation and forest regrowth has large consequences for the global carbon cycle(1). However, considerable uncertainty remains about the rate of biomass recovery in secondary forests, and how these rates are influenced by climate, landscape, and prior land use(2-4). Here we analyse aboveground biomass recovery during secondary succession in 45 forest sites and about 1,500 forest plots covering the major environmental gradients in the Neotropics. The studied secondary forests are highly productive and resilient. Aboveground biomass recovery after 20 years was on average 122 megagrams per hectare (Mg ha(-1)), corresponding to a net carbon uptake of 3.05 Mg C ha(-1) yr(-1), 11 times the uptake rate of old-growth forests. Aboveground biomass stocks took a median time of 66 years to recover to 90% of old-growth values. Aboveground biomass recovery after 20 years varied 11.3-fold ( from 20 to 225 Mg ha(-1)) across sites, and this recovery increased with water availability (higher local rainfall and lower climatic water deficit). We present a biomass recovery map of Latin America, which illustrates geographical and climatic variation in carbon sequestration potential during forest regrowth. The map will support policies to minimize forest loss in areas where biomass resilience is naturally low (such as seasonally dry forest regions) and promote forest regeneration and restoration in humid tropical lowland areas with high biomass resilience.	[Poorter, Lourens; Bongers, Frans; Jakovac, Catarina C.; Lohbeck, Madelon; Pena-Claros, Marielos] Wageningen Univ, Forest Ecol & Forest Management Grp, POB 47, NL-6700 AA Wageningen, Netherlands; [Aide, T. Mitchell] Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA; [Almeyda Zambrano, Angelica M.; Broadbent, Eben N.] Univ Alabama, Dept Geog, Spatial Ecol & Conservat Lab, Tuscaloosa, AL 35487 USA; [Balvanera, Patricia; Martinez-Ramos, Miguel; Mora, Francisco; Rodriguez-Velazquez, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Becknell, Justin M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Boukili, Vanessa; Chazdon, Robin L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Brancalion, Pedro H. S.; Cesar, Ricardo G.] Univ Sao Paulo, Luiz Queiroz Coll Agr, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil; [Craven, Dylan; Hall, Jefferson S.; van Breugel, Michiel] Smithsonian Trop Res Inst, SI ForestGEO, Balboa, Panama; [Craven, Dylan] German Ctr Integrat Biodiversity Res iDiv Halle J, D-04103 Leipzig, Germany; [Craven, Dylan] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany; [de Almeida-Cortez, Jarcilene S.; Cabral, George A. L.] Univ Fed Pernambuco, Dept Bot, BR-50670901 Recife, PE, Brazil; [de Jong, Ben H. J.; Ochoa-Gaona, Susana; Orihuela-Belmonte, Edith] El Colegio Frontera Sur, Unidad Campeche, Dept Sustainabil Sci, Campeche, Mexico; [Denslow, Julie S.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70130 USA; [Dent, Daisy H.] Smithsonian Trop Res Inst, Balboa, Panama; [Dent, Daisy H.] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [DeWalt, Saara J.; Rozendaal, Danae M. A.] Clemson Univ, Dept Sci Biol, Clemson, SC 29634 USA; [Dupuy, Juan M.; Hernandez-Stefanoni, Jose Luis] Ctr Invest Cient Yucatan, Unidad Recursos Nat, Merida, Yucatan, Mexico; [Duran, Sandra M.; Sanchez-Azofeifa, Arturo] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Espirito-Santo, Mario M.; Nunes, Yule R. F.; Veloso, Maria D. M.] Univ Estadual Montes Claros, Dept Biol Geral, BR-39401089 Montes Claros, MG, Brazil; [Fandino, Maria C.] Fondo Patrimonio Nat Biodiversidad & Areas Proteg, Bogota, Colombia; [Jakovac, Catarina C.; Massoca, Paulo; Mesquita, Rita; Vicentini, Alberto; Bentos, Tony Vizcarra; Williamson, G. Bruce] Inst Nacl de Pesquisas da Amazonia, Environm Dynam Res Coordinat, Biol Dynam Forest Fragments Project, BR-69067375 Manaus, Amazonas, Brazil; [Junqueira, Andre B.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AK Wageningen, Netherlands; [Junqueira, Andre B.] Wageningen Univ, Knowledge Technol & Innovat Grp, NL-6700 EW Wageningen, Netherlands; [Junqueira, Andre B.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Tecnol & Inovacao, BR-69060001 Manaus, Amazonas, Brazil; [Kennard, Deborah] Colorado Mesa Univ, Dept Physiol & Environm Sci, Grand Junction, CO 81501 USA; [Letcher, Susan G.] SUNY Coll Purchase, Dept Environm Studies, Purchase, NY 10577 USA; [Licona, Juan-Carlos; Toledo, Marisol] FCA UAGRM, IBIF, Santa Cruz, Bolivia; [Lohbeck, Madelon] World Agroforestry Ctr ICRAF, Nairobi 00100, Kenya; [Marin-Spiotta, Erika] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Meave, Jorge A.; Mora, Francisco; Munoz, Rodrigo; Perez-Garcia, Eduardo A. .; Romero-Perez, I. Eunice] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico; [Muscarella, Robert; Schwartz, Naomi B.; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Muscarella, Robert] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, DK-8000 Aarhus, Denmark; [de Oliveira, Alexandre A. .] Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508090 Sao Paulo, Brazil; [Piotto, Daniel] Univ Fed Sul Bahia, Ctr Formacao Ciencias Agroflorestais, BR-45613204 Itabuna, BA, Brazil; [Powers, Jennifer S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Powers, Jennifer S.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Ruiz, Jorge] UPTC, Sch Social Sci, Geog Area, Tunja, Colombia; [Ruiz, Jorge] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Saldarriaga, Juan G.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Steininger, Marc K.] Yale NUS Coll, Singapore 138610, Singapore; [Swenson, Nathan G.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [van Breugel, Michiel] El Colegio Frontera Unidad Villahermosa, Dept Agr Sociedad & Ambiente, Centro 86280, Tabasco, Mexico; [van Breugel, Michiel] Univ Amsterdam, IBED, NL-1090 GE Amsterdam, Netherlands; [van der Wal, Hans] Bonhoeffer Coll, NL-7545 AX Enschede, Netherlands; [Vester, Hans F. M.] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [Vester, Hans F. M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Vieira, Ima C. G.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	Wageningen University & Research; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Alabama System; University of Alabama Tuscaloosa; Universidad Nacional Autonoma de Mexico; Brown University; University of Connecticut; Universidade de Sao Paulo; Smithsonian Institution; Smithsonian Tropical Research Institute; Leipzig University; Universidade Federal de Pernambuco; El Colegio de la Frontera Sur (ECOSUR); Tulane University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Stirling; Clemson University; Centro de Investigacion Cientifica de Yucatan; University of Alberta; Universidade Estadual de Montes Claros; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Wageningen University & Research; Institute Nacional de Pesquisas da Amazonia; State University of New York (SUNY) System; CGIAR; World Agroforestry (ICRAF); University of Wisconsin System; University of Wisconsin Madison; Universidad Nacional Autonoma de Mexico; Columbia University; Aarhus University; Universidade de Sao Paulo; Universidade Federal do Sul da Bahia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidad Pedagogica y Tecnologica de Colombia (UPTC); University of California System; University of California Santa Barbara; University System of Maryland; University of Maryland College Park; Yale NUS College; National University of Singapore; University of Amsterdam; Museu Paraense Emilio Goeldi; Louisiana State University System; Louisiana State University; University of Regina	Poorter, L (corresponding author), Wageningen Univ, Forest Ecol & Forest Management Grp, POB 47, NL-6700 AA Wageningen, Netherlands.	lourens.poorter@wur.nl	Espirito-Santo, Mario/O-4813-2014; Dent, Daisy/L-3549-2016; Massoca, Paulo/A-4325-2015; Nunes, Yule Roberta Ferreira/AAA-9395-2019; Becknell, Justin/D-4577-2016; Mora, Francisco/AAN-2403-2021; César, Ricardo/I-3168-2014; Martínez-Ramos, Miguel/G-8451-2019; Almeida, Jarcilene/AAU-4072-2020; Sánchez, Arturo/L-3622-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Oliveira, Alexandre/ABH-1255-2020; Brancalion, Pedro/D-6995-2012; Muñoz, Rodrigo/L-5384-2019; Cabral, George/AAV-5224-2020; de lima cabral, george andré/C-9675-2015; Junqueira, Andre Braga/M-1142-2016; Jakovac, Catarina/P-7599-2018; Zambrano, Angelica Almeyda/Q-4758-2017; Poorter, Lourens/AAL-1709-2021; Vicentini, Alberto/F-7479-2012; van der Wal, Hans/B-5621-2015; Vieira, Ima C.G./H-6897-2012; Romero, Eunice/AAF-3924-2021; Meave, Jorge/B-3673-2008; Craven, Dylan/K-2717-2012; Almeida-Cortez, Jarcilene S./G-2935-2012; de Oliveira, Alexandre Adalardo/G-8830-2012; Piotto, Daniel/V-1232-2019; de Jong, Ben HJ/GYV-3632-2022; Lohbeck, Madelon/M-6390-2014; Chazdon, Robin/O-9766-2018; Saldarriaga, Juan G./R-3070-2016; Broadbent, Eben/H-2965-2013; Sanchez-Azofeifa, Arturo/F-4700-2014	Espirito-Santo, Mario/0000-0001-8274-3075; Dent, Daisy/0000-0002-1219-7344; Massoca, Paulo/0000-0001-6396-8244; Mora, Francisco/0000-0003-0390-0189; Martínez-Ramos, Miguel/0000-0002-7785-1917; Almeida, Jarcilene/0000-0002-7118-7090; Sánchez, Arturo/0000-0002-4946-1559; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Oliveira, Alexandre/0000-0001-5526-8109; Brancalion, Pedro/0000-0001-8245-4062; Muñoz, Rodrigo/0000-0001-9434-0126; Cabral, George/0000-0002-9804-7231; de lima cabral, george andré/0000-0002-9804-7231; Junqueira, Andre Braga/0000-0003-3681-1705; Jakovac, Catarina/0000-0002-8130-852X; Zambrano, Angelica Almeyda/0000-0001-5081-9936; Vicentini, Alberto/0000-0002-5906-9358; van der Wal, Hans/0000-0002-2765-8596; Vieira, Ima C.G./0000-0003-1233-318X; Romero, Eunice/0000-0002-8282-3005; Meave, Jorge/0000-0002-6241-8803; Craven, Dylan/0000-0003-3940-833X; Almeida-Cortez, Jarcilene S./0000-0002-7118-7090; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Piotto, Daniel/0000-0002-6505-0098; Ruiz, Jorge/0000-0003-0376-8608; Lohbeck, Madelon/0000-0002-3959-1800; Chazdon, Robin/0000-0002-7349-5687; NUNES, YULE/0000-0003-3328-7506; Saldarriaga, Juan G./0000-0003-1265-2949; Broadbent, Eben/0000-0002-4488-4237; Boukili, Vanessa/0000-0002-5950-2123; Pena-Claros, Marielos/0000-0001-9134-6733; Poorter, Lourens/0000-0003-1391-4875; Magalhaes Veloso, Maria das Dores/0000-0002-2692-0249; Vizcarra Bentos, Tony/0000-0002-4673-956X; Perez-Garcia, Eduardo A./0000-0002-4136-4500; Marin-Spiotta, Erika/0000-0001-7343-9354; Dupuy, Juan Manuel/0000-0001-7491-6837; Mesquita, Rita/0000-0003-1746-3215; Duran, Sandra M/0000-0003-2044-8139; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600; Cesar, Ricardo/0000-0002-3392-8089; Letcher, Susan/0000-0002-9475-7674	Australian Department of Foreign Affairs and Trade-DFAT; CGIAR-FTA; CIFOR; Colciencias grant [243-13-16640]; Consejo Nacional de Ciencia y Tecnologia [SEP-CONACYT 2009-129740, CONACYT 33851-B]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [563304/2010-3, 562955/2010-0, 574008/2008-0, PQ 307422/2012-7]; FOMIX-Yucatan [YUC-2008-C06-108863]; ForestGEO; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG CRA) [APQ-00001-11]; Fundacion Ecologica de Cuixmala, Heising-Simons Foundation; HSBC; ICETEX; Instituto Internacional de Educacao do Brasil-IEB; Instituto Nacional de Servicos Ambientais da Amazonia-Servamb-INPA; Inter-American Institute for Global Change (Tropi-Dr Network) via a grant from the US National Science Foundation [CRN3-025, GEO-1128040]; Motta Family Foundation; NASA; National Science Foundation (NSF-CNH-RCN) [1313788]; NSF [DEB-0129104, BCS-1349952, DEB-1053237, DEB 1050957, 0639393, 1147429, 0639114, 1147434]; NUFFIC; USAID (BOLFOR); Science without Borders Program (CAPES/CNPq) [88881.064976/2014-01]; Sao Paulo Research Foundation (FAPESP) [2011/06782-5, 2014/14503-7]; Silicon Valley Foundation; Stichting Het Kronendak; Tropenbos Foundation; University of Connecticut Research Foundation; Wageningen University; European Union [283093]; Direct For Biological Sciences [1546686, 1053237] Funding Source: National Science Foundation; Directorate For Geosciences [1128040] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1349952] Funding Source: National Science Foundation	Australian Department of Foreign Affairs and Trade-DFAT(Australian Government); CGIAR-FTA(CGIAR); CIFOR(CGIAR); Colciencias grant(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FOMIX-Yucatan; ForestGEO(Smithsonian InstitutionSmithsonian Tropical Research Institute); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG CRA); Fundacion Ecologica de Cuixmala, Heising-Simons Foundation; HSBC; ICETEX; Instituto Internacional de Educacao do Brasil-IEB; Instituto Nacional de Servicos Ambientais da Amazonia-Servamb-INPA; Inter-American Institute for Global Change (Tropi-Dr Network) via a grant from the US National Science Foundation; Motta Family Foundation; NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF-CNH-RCN)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NUFFIC; USAID (BOLFOR)(United States Agency for International Development (USAID)); Science without Borders Program (CAPES/CNPq); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Silicon Valley Foundation; Stichting Het Kronendak; Tropenbos Foundation; University of Connecticut Research Foundation; Wageningen University(European Commission); European Union(European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This paper is a product of the 2ndFOR collaborative research network on secondary forests. We thank the owners of the secondary forest sites for access to their forests, all the people who have established and measured the plots, and the institutions and funding agencies that supported them. We thank J. Zimmerman for the use of plot data, and the following agencies for financial support: Australian Department of Foreign Affairs and Trade-DFAT, CGIAR-FTA, CIFOR, Colciencias grant 1243-13-16640, Consejo Nacional de Ciencia y Tecnologia (SEP-CONACYT 2009-129740 for ReSerBos, CONACYT 33851-B), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 563304/2010-3, 562955/2010-0, 574008/2008-0 and PQ 307422/2012-7), FOMIX-Yucatan (YUC-2008-C06-108863), ForestGEO, Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG CRA APQ-00001-11), Fundacion Ecologica de Cuixmala, Heising-Simons Foundation, HSBC, ICETEX, Instituto Internacional de Educacao do Brasil-IEB, Instituto Nacional de Servicos Ambientais da Amazonia-Servamb-INPA, Inter-American Institute for Global Change (Tropi-Dr Network CRN3-025) via a grant from the US National Science Foundation (grant GEO-1128040), Motta Family Foundation, NASA Terrestrial Ecology Program, National Science Foundation (NSF-CNH-RCN grant 1313788 for Tropical Reforestation Network: Building a Socioecological Understanding of Tropical Reforestation (PARTNERS), NSF DEB-0129104, NSF BCS-1349952, NSF Career Grant DEB-1053237, NSF DEB 1050957, 0639393, 1147429, 0639114, and 1147434), NUFFIC, USAID (BOLFOR), Science without Borders Program (CAPES/CNPq) grant number 88881.064976/2014-01, The Sao Paulo Research Foundation (FAPESP) grant 2011/06782-5 and 2014/14503-7, Silicon Valley Foundation, Stichting Het Kronendak, Tropenbos Foundation, University of Connecticut Research Foundation, Wageningen University (INREF Terra Preta programme and FOREFRONT programme). This is publication number 683 in the Technical Series of the Biological Dynamics of Forest Fragments Project BDFFP-INPA-SI. This study was partly funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 283093; Role Of Biodiversity In climate change mitigatioN (ROBIN).	Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; [Anonymous], 2014, R LANG ENV STAT COMP; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Becknell JM, 2014, CAN J FOREST RES, V44, P604, DOI 10.1139/cjfr-2013-0331; Becknell JM, 2012, FOREST ECOL MANAG, V276, P88, DOI 10.1016/j.foreco.2012.03.033; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Bongers F, 2015, SCIENCE, V348, P642, DOI 10.1126/science.348.6235.642-c; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Broadbent EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086042; Williamson GB, 2014, PLANT ECOL DIVERS, V7, P341, DOI 10.1080/17550874.2012.735714; Cabral G.A.L., 2013, REV BRAS GEOG FISH, V06, P566, DOI DOI 10.5935/1984-2295.20130057; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon R. L., 2014, 2 GROWTH PROMISE TRO; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Denslow JS, 2000, J VEG SCI, V11, P201, DOI 10.2307/3236800; Fischer R, 2014, ENVIRON MODELL SOFTW, V52, P200, DOI 10.1016/j.envsoft.2013.10.026; Food and Agriculture Organization of the United Nations, 2010, 163 FAO; Grace J, 2014, GLOBAL CHANGE BIOL, V20, P3238, DOI 10.1111/gcb.12600; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; IPCC, 2014, CONTRIBUTION WORKING; IPCC, 2006, AGR OTH LAND US; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; Kennard DK, 2002, J TROP ECOL, V18, P53, DOI 10.1017/S0266467402002031; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lohbeck M, 2015, ECOLOGY, V96, P1242, DOI 10.1890/14-0472.1; Madeira B, 2009, PLANT ECOL, V201, P291, DOI [10.1007/978-90-481-2795-5_22, 10.1007/s11258-009-9580-9]; Dupuy JM, 2012, BIOTROPICA, V44, P151, DOI 10.1111/j.1744-7429.2011.00783.x; Marin-Spiotta E, 2007, ECOL APPL, V17, P828, DOI 10.1890/06-1268; Marin-Spiotta Erika, 2008, P22, DOI 10.1007/978-0-387-33642-8_2; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Mascaro J, 2012, FOREST ECOL MANAG, V276, P62, DOI 10.1016/j.foreco.2012.03.032; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Mora F, 2015, BIOTROPICA, V47, P38, DOI 10.1111/btp.12187; Nachtergaele F., 2012, HARMONIZED WORLD SOI; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orihuela-Belmonte DE, 2013, AGR ECOSYST ENVIRON, V171, P72, DOI 10.1016/j.agee.2013.03.012; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pearson R., 2005, SOURCE BOOK LAND USE; Pena-Claros M, 2003, BIOTROPICA, V35, P450, DOI 10.1111/j.1744-7429.2003.tb00602.x; Piotto D., 2011, THESIS; Poorter H, 2015, NEW PHYTOL, V208, P736, DOI 10.1111/nph.13571; Poorter L, 2015, GLOBAL ECOL BIOGEOGR, V24, P1314, DOI 10.1111/geb.12364; Powers JS, 2009, FOREST ECOL MANAG, V258, P959, DOI 10.1016/j.foreco.2008.10.036; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Rozendaal DMA, 2015, ECOL APPL, V25, P506, DOI 10.1890/14-0054.1; Ruiz J, 2005, BIOTROPICA, V37, P520, DOI 10.1111/j.1744-7429.2005.00070.x; Rutishauser E, 2015, CURR BIOL, V25, pR787, DOI 10.1016/j.cub.2015.07.034; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Steininger MK, 2000, J TROP ECOL, V16, P689, DOI 10.1017/S0266467400001656; Toledo M, 2006, BIOTROPICA, V38, P161, DOI 10.1111/j.1744-7429.2006.00120.x; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; van Breugel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082433; Vester HFM, 1998, FLORA, V193, P75, DOI 10.1016/S0367-2530(17)30816-2; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; Zanne A. E., 2009, DATA WORLDWIDE WOOD; Zarin DJ, 2005, FRONT ECOL ENVIRON, V3, P365, DOI 10.2307/3868585	69	586	601	36	595	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					211	+		10.1038/nature16512	http://dx.doi.org/10.1038/nature16512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840632				2022-12-28	WOS:000369916700037
J	Naaktgeboren, CA; de Groot, JAH; Rutjes, AWS; Bossuyt, PMM; Reitsma, JB; Moons, KGM				Naaktgeboren, Christiana A.; de Groot, Joris A. H.; Rutjes, Anne W. S.; Bossuyt, Patrick M. M.; Reitsma, Johannes B.; Moons, Karel G. M.			Anticipating missing reference standard data when planning diagnostic accuracy studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARTIAL VERIFICATION BIAS; SENSITIVITY; TESTS; SPECIFICITY; IMPUTATION; CORRECT	Results obtained using a reference standard may be missing for some participants in diagnostic accuracy studies. This paper looks at methods for dealing with such missing data when designing or conducting a prospective diagnostic accuracy study	[Naaktgeboren, Christiana A.; de Groot, Joris A. H.; Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Rutjes, Anne W. S.] Univ Bern, Dept Clin Res, CTU Bern, CH-3012 Bern, Switzerland; [Rutjes, Anne W. S.] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Bossuyt, Patrick M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Bern; University of Bern; University of Amsterdam	Reitsma, JB (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands.	j.b.reitsma-2@umcutrecht.nl	Rutjes, Anne/L-8750-2017; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021	Rutjes, Anne/0000-0001-9782-779X; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; de Groot, Joris/0000-0002-4846-5697; Reitsma, Johannes/0000-0003-4026-4345				Ahmed R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0943-5; Alonzo TA, 2014, REVSTAT-STAT J, V12, P67; Alonzo TA, 2011, STAT MED, V30, P1852, DOI 10.1002/sim.4232; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Biesheuvel CJ, 2006, ANN EPIDEMIOL, V16, P540, DOI 10.1016/j.annepidem.2005.10.004; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; CHOI BCK, 1992, J CLIN EPIDEMIOL, V45, P581, DOI 10.1016/0895-4356(92)90129-B; Cronin AM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-75; de Groot JAH, 2008, STAT MED, V27, P5880, DOI 10.1002/sim.3410; de Groot JAH, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4770; de Groot JAH, 2011, EPIDEMIOLOGY, V22, P234, DOI 10.1097/EDE.0b013e318207fc5c; de Groot JAH, 2011, ANN EPIDEMIOL, V21, P139, DOI 10.1016/j.annepidem.2010.10.004; DIAMOND GA, 1992, MED DECIS MAKING, V12, P22, DOI 10.1177/0272989X9201200105; Gaffikin L, 1999, LANCET, V353, P869; Glasziou P, 2008, ANN INTERN MED, V149, P816, DOI 10.7326/0003-4819-149-11-200812020-00009; Groenwold RHH, 2014, CAN MED ASSOC J, V186, P1153, DOI 10.1503/cmaj.131353; Hoes AW, 2009, CLIN EPIDEMIOLOGY; Holtman GA, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-179; Katki HA, 2012, STAT MED, V31, P436, DOI 10.1002/sim.4422; Knottnerus JA, 2002, EVIDENCE BASE CLIN D, P1; Kosinski AS, 2003, STAT MED, V22, P2711, DOI 10.1002/sim.1517; Lehman CD, 2012, AM J ROENTGENOL, V199, P1169, DOI 10.2214/AJR.12.8842; Lijmer JG, 2009, PROPOSALS PHASED EVA; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd Edn, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2002, J EPIDEMIOL COMMUN H, V56, P337, DOI 10.1136/jech.56.5.337; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Ransohoff D F, 1982, Med Decis Making, V2, P139, DOI 10.1177/0272989X8200200205; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutjes AW, 2005, SOURCES BIAS VARIATI; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Rutjes AWS., 2007, HEALTH TECHNOL ASSES, V11, P1; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010	40	22	22	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2016	352								i402	10.1136/bmj.i402	http://dx.doi.org/10.1136/bmj.i402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IR	26861453	Green Published, hybrid			2022-12-28	WOS:000370381000001
J	O'Keeffe, DT; Maraka, S; Rizza, RA				O'Keeffe, Derek T.; Maraka, Spyridoula; Rizza, Robert A.			HbA(1c) in the Evaluation of Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[O'Keeffe, Derek T.; Maraka, Spyridoula; Rizza, Robert A.] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55095 USA; [O'Keeffe, Derek T.] Natl Univ Ireland, Dept Med, Div Endocrinol, Galway, Ireland; [Maraka, Spyridoula] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Knowledge & Evaluat Res Unit, Rochester, MN 55095 USA	Mayo Clinic; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Rizza, RA (corresponding author), Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, 200 First St SW, Rochester, MN 55095 USA.	rizza.robert@mayo.edu		O'Keeffe, Derek/0000-0001-8501-2382; Maraka, Spyridoula/0000-0001-7259-132X				[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Rave K, 2006, NEPHROL DIAL TRANSPL, V21, P2166, DOI 10.1093/ndt/gfl175; Rodriguez-Segade S, 2011, CLIN CHEM, V57, P264, DOI 10.1373/clinchem.2010.144949	8	16	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					605	606		10.1001/jama.2015.16561	http://dx.doi.org/10.1001/jama.2015.16561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864415				2022-12-28	WOS:000369635200020
J	Danowski, TS				Danowski, T. S.			Narration: Timelessness (Reprinted from JAMA, vol 195, pg 291, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		DANOWSKI TS, 1966, JAMA-J AM MED ASSOC, V195, P291	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					520	520		10.1001/jama.2015.17068	http://dx.doi.org/10.1001/jama.2015.17068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836745				2022-12-28	WOS:000369049500031
J	Rollins, NC; Bhandari, N; Hajeebhoy, N; Horton, S; Lutter, CK; Martines, JC; Piwoz, EG; Richter, LM; Victora, CG				Rollins, Nigel C.; Bhandari, Nita; Hajeebhoy, Nemat; Horton, Susan; Lutter, Chessa K.; Martines, Jose C.; Piwoz, Ellen G.; Richter, Linda M.; Victora, Cesar G.		Lancet Breastfeeding Series Grp	Why invest, and what it will take to improve breastfeeding practices?	LANCET			English	Article							INFANT FORMULA; MATERNAL EMPLOYMENT; UNITED-STATES; DURATION; MOTHERS; IMPACT; MILK; PROMOTION; INTERVENTIONS; INITIATION	Despite its established benefits, breastfeeding is no longer a norm in many communities. Multifactorial determinants of breastfeeding need supportive measures at many levels, from legal and policy directives to social attitudes and values, women's work and employment conditions, and health-care services to enable women to breastfeed. When relevant interventions are delivered adequately, breastfeeding practices are responsive and can improve rapidly. The best outcomes are achieved when interventions are implemented concurrently through several channels. The marketing of breastmilk substitutes negatively affects breastfeeding: global sales in 2014 of US$44.8billion show the industry's large, competitive claim on infant feeding. Not breastfeeding is associated with lower intelligence and economic losses of about $302 billion annually or 0.49% of world gross national income. Breastfeeding provides short-term and long-term health and economic and environmental advantages to children, women, and society. To realise these gains, political support and financial investment are needed to protect, promote, and support breastfeeding.	[Rollins, Nigel C.] WHO, Dept Maternal Newborn Child & Adolescent Hlth MCA, CH-1211 Geneva, Switzerland; [Lutter, Chessa K.] WHO, Dept Noncommunicable Dis & Mental Hlth, CH-1211 Geneva, Switzerland; [Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Hajeebhoy, Nemat] FHI 360, Hanoi, Vietnam; [Horton, Susan] Univ Waterloo, Dept Econ, Waterloo, ON N2L 3G1, Canada; [Martines, Jose C.] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Ctr Int Hlth, N-5020 Bergen, Norway; [Piwoz, Ellen G.] Bill & Melinda Gates Fdn, Global Dev Program, Washington, DC USA; [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa; [Victora, Cesar G.] Univ Fed Pelotas, Int Ctr Equ Hlth, Postgrad Programme Epidemiol, Pelotas, Brazil	World Health Organization; World Health Organization; University of Waterloo; University of Bergen; Bill & Melinda Gates Foundation; University of Witwatersrand; Universidade Federal de Pelotas	Rollins, NC (corresponding author), WHO, Dept Maternal Newborn Child & Adolescent Hlth MCA, CH-1211 Geneva, Switzerland.	rollinsn@who.int	Barros, Aluisio JD/A-7417-2008; Martines, Jose Carlos/ABE-4082-2020; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; de França, Giovanny Vinícius Araújo/L-7385-2018	Barros, Aluisio JD/0000-0002-2022-8729; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Lutter, Chessa/0000-0003-1601-4645; Horton, Susan/0000-0002-9243-4767	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	NCR reports that WHO received funds from the Bill & Melinda Gates Foundation for commissioning systematic reviews and specific analyses in preparation for this paper. NB, NH, SH, CKL, JCM, EGP, LMR, and CGV declare no competing interests.	Abrahams SW, 2012, J HUM LACT, V28, P400, DOI 10.1177/0890334412447080; Acker M, 2009, SEX ROLES, V61, P476, DOI 10.1007/s11199-009-9655-z; ADAIR LS, 1993, DEMOGRAPHY, V30, P63, DOI 10.2307/2061863; Adair LS, 1996, J NUTR, V126, P103, DOI 10.1093/jn/126.1.103; AlFaleh KM, 2014, J TAIBAH UNIV MED SC, V9, P139, DOI 10.1016/j.jtumed.2013.11.003; Allers KS, 2015, DOES A A P LOGO BELO; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Avery A, 2009, BIRTH-ISS PERINAT C, V36, P141, DOI 10.1111/j.1523-536X.2009.00312.x; Baker J, 2013, FOOD NUTR BULL, V34, pS146, DOI 10.1177/15648265130343S202; Bandyopadhyay M, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-2; Bar-Yam N B, 1997, J Hum Lact, V13, P45, DOI 10.1177/089033449701300116; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Brown CRL, 2014, CAN J PUBLIC HEALTH, V105, pE179, DOI 10.17269/cjph.105.4244; Carbonell-Estrany Xavier, 2004, Pediatr Infect Dis J, V23, pS193, DOI 10.1097/01.inf.0000144664.31888.53; Cattaneo A, 2012, BREASTFEED MED, V7, P3, DOI 10.1089/bfm.2012.9999; Christina MGD, 2007, J MARRIAGE FAM, V69, P1107, DOI 10.1111/j.1741-3737.2007.00435.x; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Correa W, 2014, BREASTFEEDING ENV; Coutsoudis A, 2008, B WORLD HEALTH ORGAN, V86, P210, DOI 10.2471/BLT.07.041673; Dabritz HA, 2009, J HUM LACT, V25, P182, DOI 10.1177/0890334408328222; DAVANZO J, 1990, SOC BIOL, V37, P223, DOI 10.1080/19485565.1990.9988762; Dearden Kirk A, 2002, Food Nutr Bull, V23, P101; Dennis CL, 2007, ACTA PAEDIATR, V96, P590, DOI 10.1111/j.1651-2227.2007.00184.x; DiGirolamo A, 2005, HEALTH EDUC BEHAV, V32, P208, DOI 10.1177/1090198104271971; Dornelles CTL, 2007, J HEALTH POPUL NUTR, V25, P336; Feldman-Winter L, 2012, J HUM LACT, V28, P380, DOI 10.1177/0890334412444350; Francis S, 2002, MILK HUMAN KINDNESS; Fuller JJ, 1998, J AM DENT ASSOC S, V98, pA61, DOI DOI 10.1016/S0002-8223(98)00521-5; GrummerStrawn LM, 1996, INT J EPIDEMIOL, V25, P94, DOI 10.1093/ije/25.1.94; Guendelman S, 2009, PEDIATRICS, V123, pE38, DOI 10.1542/peds.2008-2244; Hannan A, 2005, J HUM LACT, V21, P284, DOI 10.1177/0890334405278490; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hawkins SS, 2007, PUBLIC HEALTH NUTR, V10, P891, DOI 10.1017/S1368980007226096; Heymann J, 2013, B WORLD HEALTH ORGAN, V91, P398, DOI 10.2471/BLT.12.109363; Holla-Bhar R, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0032-y; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Howard CR, 2006, BREASTFEED MED, V1, P146, DOI 10.1089/bfm.2006.1.146; *INT LAB ORG, 2014, MAT PAT WORK LAW PRA; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; Kelly YJ, 2005, PUBLIC HEALTH NUTR, V8, P417, DOI 10.1079/PHN2004702; Kervin BE, 2010, J PAEDIATR CHILD H, V46, P85, DOI 10.1111/j.1440-1754.2009.01643.x; Kiernan K, 2006, SOC SCI MED, V63, P335, DOI 10.1016/j.socscimed.2006.01.006; Kozhimanni KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104820; Labbok M., 2008, ACHIEVING EXCLUSIVE; Lawton R, 2012, BRIT J HEALTH PSYCH, V17, P854, DOI 10.1111/j.2044-8287.2012.02083.x; Leung GM, 2002, PAEDIATR PERINAT EP, V16, P236, DOI 10.1046/j.1365-3016.2002.00426.x; Leviniene G, 2009, MEDICINA-LITHUANIA, V45, P238, DOI 10.3390/medicina45030031; Linnecar A, 2014, FORMULA DISASTER WEI; Liu JH, 2006, AM J PUBLIC HEALTH, V96, P309, DOI 10.2105/AJPH.2004.060798; Lutter CK, 2013, ADV NUTR, V4, P213, DOI 10.3945/an.112.003111; Lutter CK, 2011, AM J PUBLIC HEALTH, V101, P2130, DOI 10.2105/AJPH.2011.300244; McAllister Helen, 2009, Breastfeed Rev, V17, P11; McCann MF, 2006, J BIOSOC SCI, V38, P341, DOI 10.1017/S0021932005007170; MELDRUM B, 1982, B BRIT PSYCHOL SOC, V35, P229; Meyerink Rachael O, 2002, J Hum Lact, V18, P38, DOI 10.1177/089033440201800106; Mirkovic KR, 2014, J HUM LACT, V30, P292, DOI 10.1177/0890334414535665; Muller Mike, 1974, THE BABY KILLER; Odom EC, 2013, PEDIATRICS, V131, pE726, DOI 10.1542/peds.2012-1295; Ogbuanu C, 2011, PEDIATRICS, V127, pE1414, DOI 10.1542/peds.2010-0459; Ojofeitimi E. O., 1999, Nutrition and Health (Bicester), V13, P11; Ong G, 2005, EUR J PUBLIC HEALTH, V15, P424, DOI 10.1093/eurpub/cki030; Parry K, 2013, BIRTH-ISS PERINAT C, V40, P115, DOI 10.1111/birt.12044; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Phoutthakeo P, 2014, J PAEDIATR CHILD H, V50, P51, DOI 10.1111/jpc.12391; Piwoz EG, 2015, FOOD NUTR BULL, V36, P373, DOI 10.1177/0379572115602174; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Roe B, 1999, DEMOGRAPHY, V36, P157, DOI 10.2307/2648105; Rollins N, 2013, CURR OPIN HIV AIDS, V8, P467, DOI 10.1097/COH.0b013e3283632ba2; Rosenberg KD, 2008, AM J PUBLIC HEALTH, V98, P290, DOI 10.2105/AJPH.2006.103218; Save the Children Pakistan Programme and Gallup Pakistan, 2013, BREASTF ROAD MAP PRO; Save the Children UK, 2015, SUP BAB; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sheehan D, 1999, CAN J PUBLIC HEALTH, V90, P408, DOI 10.1007/BF03404147; Simmons D, 2005, DIABETIC MED, V22, P177, DOI 10.1111/j.1464-5491.2004.01379.x; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Stein A., 1987, J REPROD INFANT PSYC, V5, P165; Suleiman A, 2001, Med J Malaysia, V56, P319; THIRY L, 1985, LANCET, V2, P891; Thurston A, 2013, J PERINAT NEONAT NUR, V27, P353, DOI 10.1097/JPN.0b013e3182a99e7a; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACTION; *UNICEF, STAT WORLDS CHILDR 2; UNICEF, PREV DIS SAV RES POT; UNICEF, 1990, INN DECL PROT PROM S; United Nations Office of the High Commissioner on the Rights of the Child, 1989, CONV RIGHTS CHILD; US Department of Agriculture Food and Nutrition Service Office of Policy Support, 2013, WIC FOOD COST REP; US Department of Health and Human Services, 2015, EX SUMM SURG GEN CAL; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Visness CM, 1997, AM J PUBLIC HEALTH, V87, P945, DOI 10.2105/AJPH.87.6.945; Wasser H, 2011, PEDIATRICS, V127, P229, DOI 10.1542/peds.2010-0166; WHO, 2010, PRINC REC INF FEED C; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; World Bank, 2020, WORLD DEV IND 2020; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization, 2009, ACC MED REAS US BREA; World Health Organization, 2015, ANT DRUGS TREAT PREG; World Health Organization, 1981, CONT PATT BREAST FEE; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN; Yee ChyeFook, 2007, International Journal of Consumer Studies, V31, P363, DOI 10.1111/j.1470-6431.2006.00564.x	105	988	1036	7	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					491	504		10.1016/S0140-6736(15)01044-2	http://dx.doi.org/10.1016/S0140-6736(15)01044-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26869576				2022-12-28	WOS:000368986800037
J	Devkota, S				Devkota, Suzanne			Prescription drugs obscure microbiome analyses	SCIENCE			English	Editorial Material									[Devkota, Suzanne] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Devkota, S (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA.	suzanne.devkota@cshs.org	Devkota, Suzanne/AAG-1958-2021	Devkota, Suzanne/0000-0001-5575-9362				Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Zhao YY, 2013, J AM CHEM SOC, V135, P12940, DOI 10.1021/ja4058635	9	25	25	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					452	453		10.1126/science.aaf1353	http://dx.doi.org/10.1126/science.aaf1353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823414				2022-12-28	WOS:000368858200020
J	Alford, DP				Alford, Daniel P.			Opioid Prescribing for Chronic Pain - Achieving the Right Balance through Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MANAGEMENT		[Alford, Daniel P.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Alford, Daniel P.] Boston Med Ctr, Boston, MA USA	Boston University; Boston Medical Center	Alford, DP (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Alford, DP (corresponding author), Boston Med Ctr, Boston, MA USA.							Alford DP, 2015, PAIN MED; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Fishman SM, 2013, PAIN MED, V14, P971, DOI 10.1111/pme.12107; Nicolaidis C, 2011, PAIN MED, V12, P890, DOI 10.1111/j.1526-4637.2011.01117.x	5	63	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					301	303		10.1056/NEJMp1512932	http://dx.doi.org/10.1056/NEJMp1512932			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB8IJ	26816007	Bronze			2022-12-28	WOS:000368760100001
J	Farmer, CG				Farmer, Colleen G.			A lizard that generates heat	NATURE			English	Editorial Material							ENDOTHERMY; THERMOREGULATION; PYTHONS		[Farmer, Colleen G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Farmer, CG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	cg.frmr@gmail.com						Farmer CG, 2000, AM NAT, V155, P326, DOI 10.1086/303323; Farmer CG, 2003, AM NAT, V162, P826, DOI 10.1086/380922; Fitzgerald L.A., 1991, P303; HUTCHISON VH, 1966, SCIENCE, V151, P694, DOI 10.1126/science.151.3711.694; Lopes HR, 1999, MANEJO CONSERVACION, P259; Manes M. E., 2003, Revista Argentina de Produccion Animal, V23, P119; Manes Mario E., 2007, Cuadernos de Herpetologia, V21, P21; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 1997, ECOLOGY, V78, P1713; SLIP DJ, 1988, J ZOOL, V216, P367; Tattersall GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500951; Winck GR, 2008, J NAT HIST, V42, P239, DOI 10.1080/00222930701828667	12	3	4	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					470	472		10.1038/529470a	http://dx.doi.org/10.1038/529470a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819039				2022-12-28	WOS:000368673800022
J	Greene, JA				Greene, Jeremy A.			Do-It-Yourself Medical Devices - Technology and Empowerment in American Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA.; Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA.							[Anonymous], 1879, BMJ, V2, P897; Blake CJ, 1880, BOSTON MED SURG J, V103, P486; FREDERIC.C, 1965, NEW ENGL J MED, V273, P1076; Zaleski A., 2015, POPULAR SCI	4	19	19	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					305	308		10.1056/NEJMp1511363	http://dx.doi.org/10.1056/NEJMp1511363			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB8IJ	26816009				2022-12-28	WOS:000368760100003
J	Li, CY; de Grijs, R; Deng, LC; Geller, AM; Xin, Y; Hu, Y; Faucher-Giguere, CA				Li, Chengyuan; de Grijs, Richard; Deng, Licai; Geller, Aaron M.; Xin, Yu; Hu, Yi; Faucher-Giguere, Claude-Andre			Formation of new stellar populations from gas accreted by massive young star clusters	NATURE			English	Article							SMALL-MAGELLANIC-CLOUD; MAIN-SEQUENCE TURNOFFS; SUB-GIANT BRANCH; GLOBULAR-CLUSTERS; MULTIPLE POPULATIONS; MILKY-WAY; EVOLUTION; GALAXIES; ENRICHMENT; ORIGIN	Stars in clusters are thought to form in a single burst from a common progenitor cloud of molecular gas. However, massive, old 'globular' clusters-those with ages greater than ten billion years and masses several hundred thousand times that of the Sun-often harbour multiple stellar populations(1-4), indicating that more than one star-forming event occurred during their lifetimes. Colliding stellar winds from late-stage, asymptotic-giant-branch stars(5-7) are often suggested to be triggers of second-generation star formation. For this to occur(8), the initial cluster masses need to be greater than a few million solar masses. Here we report observations of three massive relatively young star clusters (1-2 billion years old) in the Magellanic Clouds that show clear evidence of burst-like star formation that occurred a few hundred million years after their initial formation era. We show that such clusters could have accreted sufficient gas to form new stars if they had orbited in their host galaxies' gaseous disks throughout the period between their initial formation and the more recent bursts of star formation. This process may eventually give rise to the ubiquitous multiple stellar populations in globular clusters.	[Li, Chengyuan; de Grijs, Richard] Peking Univ, Kavli Inst Astron & Astrophys, Yi He Yuan Lu 5, Beijing 100871, Peoples R China; [Li, Chengyuan; de Grijs, Richard] Peking Univ, Dept Astron, Yi He Yuan Lu 5, Beijing 100871, Peoples R China; [Li, Chengyuan; Deng, Licai; Xin, Yu; Hu, Yi] Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, 20A Datun Rd, Beijing 100012, Peoples R China; [Li, Chengyuan] Chinese Acad Sci, Purple Mt Observ, 2 West Beijing Rd, Nanjing 210008, Jiangsu, Peoples R China; [de Grijs, Richard] Int Space Sci Inst Beijing, 1 Nanertiao, Beijing 100190, Peoples R China; [Geller, Aaron M.; Faucher-Giguere, Claude-Andre] Northwestern Univ, CIERA, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Geller, Aaron M.; Faucher-Giguere, Claude-Andre] Northwestern Univ, Dept Phys & Astron, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Geller, Aaron M.] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA	Peking University; Peking University; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Northwestern University; Northwestern University; University of Chicago	Li, CY (corresponding author), Peking Univ, Kavli Inst Astron & Astrophys, Yi He Yuan Lu 5, Beijing 100871, Peoples R China.; Li, CY (corresponding author), Peking Univ, Dept Astron, Yi He Yuan Lu 5, Beijing 100871, Peoples R China.; Li, CY (corresponding author), Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, 20A Datun Rd, Beijing 100012, Peoples R China.; Li, CY (corresponding author), Chinese Acad Sci, Purple Mt Observ, 2 West Beijing Rd, Nanjing 210008, Jiangsu, Peoples R China.	joshuali@pku.edu.cn	Deng, Licai/AAG-8082-2021; Faucher-Giguere, Claude-Andre/AAC-5298-2019; de Grijs, Richard/AAI-5255-2020	Deng, Licai/0000-0001-9073-9914; de Grijs, Richard/0000-0002-7203-5996; Li, Chengyuan/0000-0002-3084-5157; hu, yi/0000-0003-3317-4771	National Natural Science Foundation of China [11073001, 11373010, 11473037]; Chinese Academy of Sciences [XDB09000000]; 973 Program [2014CBB45700]; National Science Foundation Astronomy and Astrophysics Postdoctoral Fellowship [AST-1302765]; National Science Foundation [AST-1412836]; Division Of Astronomical Sciences [1302765] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); National Science Foundation Astronomy and Astrophysics Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank F. Ferraro, P. Kroupa and X. K. Liu for discussions. Partial financial support for this work was provided by the National Natural Science Foundation of China through grants 11073001, 11373010 and 11473037. C.L. was also partially supported by the Chinese Academy of Sciences (grant XDB09000000) and the 973 Program (grant 2014CBB45700). A.M.G. was funded by a National Science Foundation Astronomy and Astrophysics Postdoctoral Fellowship under award no. AST-1302765. C.-A. F.-G was supported by a National Science Foundation grant AST-1412836.	Ashman K. M., 1998, CAMBRIDGE ASTROPHYS, V30; Bastian N, 2015, MON NOT R ASTRON SOC, V448, P1863, DOI 10.1093/mnras/stv116; Bastian N, 2013, MON NOT R ASTRON SOC, V436, P2852, DOI 10.1093/mnras/stt1779; Bastian N, 2015, MON NOT R ASTRON SOC, V453, P357, DOI 10.1093/mnras/stv1661; Bedin LR, 2004, ASTROPHYS J, V605, pL125, DOI 10.1086/420847; Bekki K, 2011, MON NOT R ASTRON SOC, V412, P2241, DOI 10.1111/j.1365-2966.2010.18047.x; Binney J., 1998, GALACTIC DYNAMICS; Conroy C, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/36; D'Ercole A, 2008, MON NOT R ASTRON SOC, V391, P825, DOI 10.1111/j.1365-2966.2008.13915.x; Davis L. E., 1994, REFERENCE GUIDE IRAF; de Grijs R, 2007, CHINESE J ASTRON AST, V7, P155, DOI 10.1088/1009-9271/7/2/01; de Grijs R, 2010, PHILOS T R SOC A, V368, P693, DOI 10.1098/rsta.2009.0253; Dolphin A., 2013, DOLPHOT USERS GUIDE; Dolphin A, 2011, DOLPHOT ACS USERS GU; Dolphin A, 2011, DOLPHOT WFC3 USERS G; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Fukui Y, 2010, ANNU REV ASTRON ASTR, V48, P547, DOI 10.1146/annurev-astro-081309-130854; Girardi L, 2013, MON NOT R ASTRON SOC, V431, P3501, DOI 10.1093/mnras/stt433; Glatt K, 2008, ASTRON J, V136, P1703, DOI 10.1088/0004-6256/136/4/1703; Goudfrooij P, 2015, MON NOT R ASTRON SOC, V450, P1693, DOI 10.1093/mnras/stv700; Goudfrooij P, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/35; Gratton RG, 2012, ASTRON ASTROPHYS REV, V20, P1, DOI 10.1007/s00159-012-0050-3; Hills J.G., 1976, ASTROPHYS J, V17, pL87; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3488, DOI 10.1111/j.1365-2966.2012.20578.x; Hunter DA, 2003, ASTRON J, V126, P1836, DOI 10.1086/378056; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Li CY, 2014, NATURE, V516, P367, DOI 10.1038/nature13969; Li CY, 2013, MON NOT R ASTRON SOC, V436, P1497, DOI 10.1093/mnras/stt1669; Lu P, 2010, MON NOT R ASTRON SOC, V409, P1013, DOI 10.1111/j.1365-2966.2010.17356.x; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; McLaughlin DE, 2005, ASTROPHYS J SUPPL S, V161, P304, DOI 10.1086/497429; Milone AP, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/58; Milone AP, 2009, ASTRON ASTROPHYS, V497, P755, DOI 10.1051/0004-6361/200810870; Naiman JP, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/25; Niederhofer F., 2015, ASTRON ASTR IN PRESS; Pflamm-Altenburg J, 2009, MON NOT R ASTRON SOC, V397, P488, DOI 10.1111/j.1365-2966.2009.14954.x; Piotto G, 2007, ASTROPHYS J, V661, pL53, DOI 10.1086/518503; Rafelski M, 2005, ASTRON J, V129, P2701, DOI 10.1086/424938; Recchi S, 2005, ASTRON ASTROPHYS, V436, P145, DOI 10.1051/0004-6361:20042275; Renzini A, 2008, MON NOT R ASTRON SOC, V391, P354, DOI 10.1111/j.1365-2966.2008.13892.x; Rich RM, 2001, ASTRON J, V122, P842, DOI 10.1086/321164; Shustov BM, 2000, MON NOT R ASTRON SOC, V319, P1047, DOI 10.1046/j.1365-8711.2000.03852.x; Werchan F, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/48	44	22	22	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					502	+		10.1038/nature16493	http://dx.doi.org/10.1038/nature16493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819043	Green Submitted			2022-12-28	WOS:000368673800031
J	Barker, AL; Morello, RT; Wolfe, R; Brand, CA; Haines, TP; Hill, KD; Brauer, SG; Botti, M; Cumming, RG; Livingston, PM; Sherrington, C; Zavarsek, S; Lindley, RI; Kamar, J				Barker, Anna L.; Morello, Renata T.; Wolfe, Rory; Brand, Caroline A.; Haines, Terry P.; Hill, Keith D.; Brauer, Sandra G.; Botti, Mari; Cumming, Robert G.; Livingston, Patricia M.; Sherrington, Catherine; Zavarsek, Silva; Lindley, Richard I.; Kamar, Jeannette			6-PACK programme to decrease fall injuries in acute hospitals: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-LOW BEDS; ACUTE-CARE; PREVENT FALLS; MULTIFACTORIAL INTERVENTION; PATIENT; RISK; COST; MULTIDISCIPLINARY; NONPAYMENT; INPATIENTS	OBJECTIVE To evaluate the effect of the 6-PACK programme on falls and fall injuries in acute wards. DESIGN Cluster randomised controlled trial. SETTING Six Australian hospitals. PARTICIPANTS All patients admitted to 24 acute wards during the trial period. INTERVENTIONS Participating wards were randomly assigned to receive either the nurse led 6-PACK programme or usual care over 12 months. The 6-PACK programme included a fall risk tool and individualised use of one or more of six interventions: "falls alert" sign, supervision of patients in the bathroom, ensuring patients' walking aids are within reach, a toileting regimen, use of a low-low bed, and use of a bed/chair alarm. MAIN OUTCOME MEASURES The co-primary outcomes were falls and fall injuries per 1000 occupied bed days. RESULTS During the trial, 46 245 admissions to 16 medical and eight surgical wards occurred. As many people were admitted more than once, this represented 31 411 individual patients. Patients' characteristics and length of stay were similar for intervention and control wards. Use of 6-PACK programme components was higher on intervention wards than on control wards (incidence rate ratio 3.05, 95% confidence interval 2.14 to 4.34; P<0.001). In all, 1831 falls and 613 fall injuries occurred, and the rates of falls (incidence rate ratio 1.04, 0.78 to 1.37; P=0.796) and fall injuries (0.96, 0.72 to 1.27; P=0.766) were similar in intervention and control wards. CONCLUSIONS Positive changes in falls prevention practice occurred following the introduction of the 6-PACK programme. However, no difference was seen in falls or fall injuries between groups. High quality evidence showing the effectiveness of falls prevention interventions in acute wards remains absent. Novel solutions to the problem of in-hospital falls are urgently needed.	[Barker, Anna L.; Morello, Renata T.; Wolfe, Rory; Brand, Caroline A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Haines, Terry P.] Monash Univ, Monash Hlth, Kingston Ctr, Physiotherapy Dept,Allied Hlth Res Unit, Cheltenham, Vic 3195, Australia; [Hill, Keith D.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6102, Australia; [Brauer, Sandra G.] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia; [Botti, Mari; Livingston, Patricia M.] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic 3125, Australia; [Cumming, Robert G.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Sherrington, Catherine; Lindley, Richard I.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Zavarsek, Silva] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Clayton, Vic 3800, Australia; [Kamar, Jeannette] Northern Hlth, Northern Hosp, Epping, Vic 3076, Australia	Monash University; Monash University; Curtin University; University of Queensland; Deakin University; University of Sydney; George Institute for Global Health; University of Sydney; Monash University	Barker, AL (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	anna.barker@monash.edu	Cumming, Robert G/R-1548-2016; Hill, Keith D/L-6398-2017; Brauer, Sandra G/D-4519-2011; Lindley, Richard/B-8148-2013; Sherrington, Catherine/S-9196-2019; Haines, Terrence/E-9372-2015; Morello, Renata/AAC-6300-2019	Cumming, Robert G/0000-0002-0261-6103; Hill, Keith D/0000-0002-2191-0308; Brauer, Sandra G/0000-0001-9961-4739; Lindley, Richard/0000-0002-0104-5679; Sherrington, Catherine/0000-0001-8934-4368; Haines, Terrence/0000-0003-3150-6154; Wolfe, Rory/0000-0002-2126-1045; Barker, Anna/0000-0001-6607-975X; Zavarsek, Silva/0000-0002-7898-1406	National Health and Medical Research Council (NHMRC), Australia [APP1007627, APP1067236, APP1055604, APP1069758, APP632929]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council (NHMRC), Australia (APP1007627). ALB's salary was funded by a career development fellowship from the NHMRC (APP1067236). RTM's salary was supported by a postgraduate scholarship from the NHMRC (APP1055604). TPH's salary was funded by a career development fellowship from the NHMRC (APP1069758). CS's salary was funded by a career development fellowship from the NHMRC (APP632929). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. ALB, RTM, and RW had full access to all the data in the study, and the corresponding author had final responsibility for the decision to submit for publication.	American Geriatrics Society British Geriatrics Society, 2010, AGS BGS CLIN PRACT G; Ang E, 2011, J ADV NURS, V67, P1984, DOI 10.1111/j.1365-2648.2011.05646.x; Australian Commission on Safety and Quality in Healthcare, 2009, PREV FALLS HARM FAIL; Australian Council on Healthcare Standards, 2012, NAT SAF QUAL HLTH SE; Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT 2011; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P467, DOI 10.1136/qshc.2007.025676; Barker A., 2012, EVALUATION PREVENTIN; Barker A, 2013, J ADV NURS, V69, P112, DOI 10.1111/j.1365-2648.2012.05997.x; Barker A, 2011, INJURY PREV, V17, P1, DOI 10.1136/injuryprev-2011-040074; Barker A, 2011, J ADV NURS, V67, P450, DOI 10.1111/j.1365-2648.2010.05503.x; Brand CA, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038273; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Center for Performance Sciences, 2006, AC CAR IMPL MAN INT; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; Cummings E, 2011, HEALTH INF MANAG J, V40, P5, DOI 10.1177/183335831104000301; DiBardino D, 2012, J HOSP MED, V7, P497, DOI 10.1002/jhm.1917; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Dykes PC, 2010, JAMA-J AM MED ASSOC, V304, P1912, DOI 10.1001/jama.2010.1567; Evans D, 2001, Int J Nurs Pract, V7, P38; Haines TP, 2011, ARCH INTERN MED, V171, P516, DOI 10.1001/archinternmed.2010.444; Haines TP, 2010, J AM GERIATR SOC, V58, P435, DOI 10.1111/j.1532-5415.2010.02735.x; Haines TP, 2004, BMJ-BRIT MED J, V328, P676, DOI 10.1136/bmj.328.7441.676; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Healey F, 2004, AGE AGEING, V33, P390, DOI 10.1093/ageing/afh130; Healey F, 2014, AGE AGEING, V43, P484, DOI 10.1093/ageing/aft190; Hempel S, 2013, J AM GERIATR SOC, V61, P483, DOI 10.1111/jgs.12169; Hill AM, 2015, LANCET, V385, P2592, DOI 10.1016/S0140-6736(14)61945-0; Hill AM, 2010, J AM GERIATR SOC, V58, P1347, DOI 10.1111/j.1532-5415.2010.02856.x; Hitcho EB, 2004, J GEN INTERN MED, V19, P732, DOI 10.1111/j.1525-1497.2004.30387.x; Jorgensen TSH, 2015, INT J CLIN PRACT, V69, P703, DOI 10.1111/ijcp.12624; Koh SLS, 2009, SINGAP MED J, V50, P425; Mador JE, 2004, INT J GERIATR PSYCH, V19, P858, DOI 10.1002/gps.1165; MARTIN DC, 1993, STAT MED, V12, P329, DOI 10.1002/sim.4780120315; Morello RT, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja15.00296; National Institute for Health and Care Excellence, 2013, FALLS ASS PREV FALLS; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Power Maxine, 2012, Clin Risk, V18, P163; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ranasinghe DC, 2014, GAIT POSTURE, V39, P118, DOI 10.1016/j.gaitpost.2013.06.009; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Royal College of Physicians, 2012, REP 2011 INP FALLS P; Ryan P., 2011, RALLOC STATA MODULE; Sahota O, 2014, AGE AGEING, V43, P247, DOI 10.1093/ageing/aft155; Schwendimann R, 2008, GERONTOLOGY, V54, P342, DOI 10.1159/000129954; Shorr RI, 2012, ANN INTERN MED, V157, P692, DOI 10.7326/0003-4819-157-10-201211200-00005; Stenvall M, 2007, OSTEOPOROSIS INT, V18, P167, DOI 10.1007/s00198-006-0226-7; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; TIDEIKSAAR R, 1993, MT SINAI J MED, V60, P522; Umscheid CA, 2015, JAMA INTERN MED, V175, P354, DOI 10.1001/jamainternmed.2014.5293; van Gaal BGI, 2011, INT J NURS STUD, V48, P1040, DOI 10.1016/j.ijnurstu.2011.02.017; Wald HL, 2011, J HOSP MED, V6, P313, DOI 10.1002/jhm.906; Waters TM, 2015, JAMA INTERN MED, V175, P347, DOI 10.1001/jamainternmed.2014.5486; Wong CA, 2011, JT COMM J QUAL PATIE, V37, P81, DOI 10.1016/S1553-7250(11)37010-9	53	74	74	3	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2016	352								h6781	10.1136/bmj.h6781	http://dx.doi.org/10.1136/bmj.h6781			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EQ	26813674	Green Published, hybrid			2022-12-28	WOS:000369313000002
J	Detry, MA; Ma, Y				Detry, Michelle A.; Ma, Yan			Analyzing Repeated Measurements Using Mixed Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detry, Michelle A.] Berry Consultants LLC, 4301Westbank Dr,Bldg B,Ste 140, Austin, TX 78746 USA; [Ma, Yan] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Epidemiol & Biostat, Washington, DC USA	George Washington University	Detry, MA (corresponding author), Berry Consultants LLC, 4301Westbank Dr,Bldg B,Ste 140, Austin, TX 78746 USA.	michelle@berryconsultants.com						Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Moseley AM, 2015, JAMA-J AM MED ASSOC, V314, P1376, DOI 10.1001/jama.2015.12180; Newgard CD, 2015, JAMA-J AM MED ASSOC, V314, P940, DOI 10.1001/jama.2015.10516	5	159	162	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					407	408		10.1001/jama.2015.19394	http://dx.doi.org/10.1001/jama.2015.19394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813213				2022-12-28	WOS:000368589500018
J	Lublin, F; Miller, DH; Freedman, MS; Cree, BAC; Wolinsky, JS; Weiner, H; Lubetzki, C; Hartung, HP; Montalban, X; Uitdehaag, BMJ; Merschhemke, M; Li, BB; Putzki, N; Liu, FC; Haring, DA; Kappos, L				Lublin, Fred; Miller, David H.; Freedman, Mark S.; Cree, Bruce A. C.; Wolinsky, Jerry S.; Weiner, Howard; Lubetzki, Catherine; Hartung, Hans-Peter; Montalban, Xavier; Uitdehaag, Bernard M. J.; Merschhemke, Martin; Li, Bingbing; Putzki, Norman; Liu, Fonda C.; Haering, Dieter A.; Kappos, Ludwig		INFORMS Study Investigators	Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							BRAIN VOLUME LOSS; NATURAL-HISTORY; FTY720; DISABILITY; MS; MULTICENTER; INTERFERON; REVISIONS; EFFICACY; MODEL	Background No treatments have been approved for primary progressive multiple sclerosis. Fingolimod, an oral sphingosine 1-phosphate receptor modulator, is effective in relapse-onset multiple sclerosis, but has not been assessed in primary progressive multiple sclerosis. We assessed the safety and efficacy of fingolimod in patients with primary progressive multiple sclerosis. Methods In INFORMS, a multicentre, double-blind, placebo-controlled parallel-group study, patients with primary progressive multiple sclerosis recruited across 148 centres in 18 countries were randomly allocated (1: 1) with computer-generated blocks to receive oral fingolimod or placebo for at least 36 months and a maximum of 5 years. Patients were initially assigned to fingolimod 1.25 mg per day or placebo (cohort 1); however, after a protocol amendment on Nov 19, 2009, patients were switched in a masked manner to fingolimod 0.5 mg, whereas those on placebo continued on matching placebo. From then onwards, patients were assigned to receive fingolimod 0.5 mg/day or placebo (cohort 2). Key inclusion criteria were age 25-65 years, clinical diagnosis of primary progressive multiple sclerosis, 1 year or more of disease progression, and two of the following criteria: positive brain MRI; positive spinal cord MRI; or positive cerebrospinal fluid. Additional eligibility criteria included disease duration of 2-10 years and objective evidence of disability progression in the previous 2 years. Patients and study investigators were masked to group assignment. We used a novel primary composite endpoint based on change from baseline in Expanded Disability Status Scale (EDSS), 25' Timed-Walk Test, or Nine-Hole Peg Test to assess time to 3-month confirmed disability progression in study participants treated for at least 3 years. All randomised patients took at least one dose of study drug. The primary efficacy analysis included all patients in cohort 2 and those assigned to placebo in cohort 1. The safety analysis included all patients in cohorts 1 and 2. This study is registered with ClinicalTrials.gov, number NCT00731692. The study is now closed. Findings 970 patients were randomly assigned between Sept 3, 2008, and Aug 30, 2011 (147 to fingolimod 1.25 mg and 133 to placebo in cohort 1; 336 to fingolimod 0.5 mg and 354 to placebo in cohort 2). The efficacy analysis set (n= 823) consisted of 336 patients randomly allocated to fingolimod 0.5 mg and 487 to placebo. Baseline characteristics were similar across groups and representative of a primary progressive multiple sclerosis population (48% women, mean age 48.5 years [SD 8.4], mean EDSS 4.67 [SD 1.03], 87% free of gadolinium-enhancing lesions). By end of study, 3-month confirmed disability progression had occurred in 232 and 338 patients in the fingolimod and placebo groups, respectively, resulting in Kaplan-Meier estimates of 77.2% (95% CI 71.87-82.51) of patients in the fingolimod group versus 80.3% (73.31-87.25) of patients in the placebo group (risk reduction 5.05%; hazard ratio 0.95, 95% CI 0.80-1.12; p= 0.544). Safety results were generally consistent with those of studies of fingolimod in patients with relapse-onset multiple sclerosis. Lymphopenia occurred in 19 (6%) patients in the fingolimod group versus none in the placebo group, bradycardia in five (1%) versus one (<1%), and first-degree atrioventricular block in three (1%) versus six (1%). Serious adverse events occurred in 84 (25%) patients in the fingolimod group and 117 (24%) in the placebo group, including macular oedema in six (2%) versus six (1%), and basal-cell carcinoma in 14 (4%) versus nine (2%). Interpretation The anti-inflammatory effects of fingolimod did not slow disease progression in primary progressive multiple sclerosis. Therapeutic strategies for primary progressive multiple sclerosis might need different approaches to those used for relapse-onset multiple sclerosis.	[Lublin, Fred] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA; [Miller, David H.] UCL Inst Neurol, Queen Sq MS Ctr, London, England; [Freedman, Mark S.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Cree, Bruce A. C.] Univ Calif San Francisco, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA; [Wolinsky, Jerry S.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Weiner, Howard] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Lubetzki, Catherine] Univ Paris 06, Salpetriere Hosp, AP HP, Ctr Clin Invest, Paris, France; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Montalban, Xavier] Hosp Univ Vall dHebron, Barcelona, Spain; [Uitdehaag, Bernard M. J.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Merschhemke, Martin; Putzki, Norman; Haering, Dieter A.] Novartis Pharma AG, Basel, Switzerland; [Li, Bingbing; Liu, Fonda C.] Novartis Pharmaceut, E Hanover, NJ USA; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Med, CH-4003 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Clin Res, CH-4003 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Biomed, CH-4003 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Biomed Engn, CH-4003 Basel, Switzerland	Icahn School of Medicine at Mount Sinai; University of London; University College London; University of Ottawa; Ottawa Hospital Research Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf; Hospital Universitari Vall d'Hebron; Vrije Universiteit Amsterdam; Novartis; Novartis; University of Basel; University of Basel; University of Basel; University of Basel	Lublin, F (corresponding author), Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA.	fred.lublin@mssm.edu	Bertolotto, Antonio/K-8346-2015; Ruiz, Luis Brieva/C-3812-2011; Montalban, Xavier/J-5938-2016; Lublin, Fred/L-8405-2017; De Seze, Jerome/M-8316-2016; Cree, Bruce C/AAV-6109-2020	Bertolotto, Antonio/0000-0002-7052-1907; Ruiz, Luis Brieva/0000-0002-5871-6189; Montalban, Xavier/0000-0002-0098-9918; De Seze, Jerome/0000-0002-7197-7578; Cree, Bruce C/0000-0001-7689-2533; frederiksen, jette/0000-0003-1661-7438; Uitdehaag, Bernard/0000-0002-9226-7364; D'hooghe, Marie/0000-0002-0917-4176; Petersen, Thor/0000-0001-5633-2600; Butzkueven, Helmut/0000-0003-3940-8727; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040	Novartis Pharma AG; Novartis Pharma AG (Basel, Switzerland); UK MS Society; UCL-UCLH joint Biomedical Research Centre; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	Novartis Pharma AG; Novartis Pharma AG (Basel, Switzerland); UK MS Society; UCL-UCLH joint Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	Novartis Pharma AG.; Novartis Pharma AG (Basel, Switzerland) supported this study. Central MRI analysis was done at the Queen Square MS Centre, UCL Institute of Neurology (London, UK). Members of the central MRI analysis team were: David G MacManus, Tarek A Yousry, Claudia A M Wheeler-Kingshott, Ozgur Yaldizli, Jon Stutters, Catherine M Dalton, Virginia Santana, Almudena Garcia-Gomez, Carolina Crespo, David H Miller. The Queen Square MS Centre is supported by the UK MS Society and the UCL-UCLH joint Biomedical Research Centre. We thank the patients who participated in the study; the study-site personnel; Ana de Vera, Goeril Karlsson and the Novartis clinical team; and Katy Demery (Novartis) and Paul Coyle (Western Edge Medical Communications Ltd) for editorial assistance.	Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Barkhof F, 2014, MULT SCLER J, V20, P1704, DOI 10.1177/1352458514532317; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Hartung HP, 2009, ANN NEUROL, V66, P429, DOI 10.1002/ana.21880; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Jacobsen C, 2014, J NEUROL NEUROSUR PS, V85, P1109, DOI 10.1136/jnnp-2013-306906; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Koch M, 2009, NEUROLOGY, V73, P1996, DOI 10.1212/WNL.0b013e3181c5b47f; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Radue EW, 2015, NEUROLOGY, V84, P784, DOI 10.1212/WNL.0000000000001281; Schwid SR, 2002, NEUROLOGY, V58, P1294, DOI 10.1212/WNL.58.8.1294; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sormani MP, 2015, MULT SCLER J, V21, P916, DOI 10.1177/1352458515569099; Tremlett H, 2005, NEUROLOGY, V65, P1919, DOI 10.1212/01.wnl.0000188880.17038.1d; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; World Medical Association, DECL HELS ETH PRINC	29	258	265	0	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1075	1084		10.1016/S0140-6736(15)01314-8	http://dx.doi.org/10.1016/S0140-6736(15)01314-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26827074	Green Submitted			2022-12-28	WOS:000371775000027
J	Bienfait, A; Pla, JJ; Kubo, Y; Zhou, X; Stern, M; Lo, CC; Weis, CD; Schenkel, T; Vion, D; Esteve, D; Morton, JJL; Bertet, P				Bienfait, A.; Pla, J. J.; Kubo, Y.; Zhou, X.; Stern, M.; Lo, C. C.; Weis, C. D.; Schenkel, T.; Vion, D.; Esteve, D.; Morton, J. J. L.; Bertet, P.			Controlling spin relaxation with a cavity	NATURE			English	Article							SPONTANEOUS EMISSION; RESONANCE EXPERIMENTS; SILICON; POLARIZATION; MICROCAVITY; DONORS	Spontaneous emission of radiation is one of the fundamental mechanisms by which an excited quantum system returns to equilibrium. For spins, however, spontaneous emission is generally negligible compared to other non-radiative relaxation processes because of the weak coupling between the magnetic dipole and the electromagnetic field. In 1946, Purcell realized(1) that the rate of spontaneous emission can be greatly enhanced by placing the quantum system in a resonant cavity. This effect has since been used extensively to control the lifetime of atoms and semiconducting heterostructures coupled to microwave(2) or optical(3,4) cavities, and is essential for the realization of high-efficiency single-photon sources(5). Here we report the application of this idea to spins in solids. By coupling donor spins in silicon to a superconducting microwave cavity with a high quality factor and a small mode volume, we reach the regime in which spontaneous emission constitutes the dominant mechanism of spin relaxation. The relaxation rate is increased by three orders of magnitude as the spins are tuned to the cavity resonance, demonstrating that energy relaxation can be controlled on demand. Our results provide a general way to initialize spin systems into their ground state and therefore have applications in magnetic resonance and quantum information processing(6). They also demonstrate that the coupling between the magnetic dipole of a spin and the electromagnetic field can be enhanced up to the point at which quantum fluctuations have a marked effect on the spin dynamics; as such, they represent an important step towards the coherent magnetic coupling of individual spins to microwave photons.	[Bienfait, A.; Kubo, Y.; Zhou, X.; Stern, M.; Vion, D.; Esteve, D.; Bertet, P.] Univ Paris Saclay, CEA Saclay, CNRS, Quantron Grp,SPEC,CEA, F-91191 Gif Sur Yvette, France; [Pla, J. J.; Lo, C. C.; Morton, J. J. L.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Zhou, X.] CNRS, UMR 8520, ISEN Dept, Inst Elect Microelect & Nanotechnol, Ave Poincare,CS 60069, F-59652 Villeneuve Dascq, France; [Stern, M.] Bar Ilan Univ, BINA, Quantum Nanoelect Lab, Ramat Gan, Israel; [Weis, C. D.; Schenkel, T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Accelerator Technol & Appl Phys Div, Berkeley, CA 94720 USA; [Pla, J. J.] Univ New S Wales, Sch Elect Engn & Telecommun, Sydney, NSW 2052, Australia; [Kubo, Y.] Okinawa Inst Sci & Technol, Grad Univ, Onna, Okinawa 9040495, Japan	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lille - ISITE; Universite de Lille; Universite Polytechnique Hauts-de-France; Bar Ilan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of New South Wales Sydney; Okinawa Institute of Science & Technology Graduate University	Bertet, P (corresponding author), Univ Paris Saclay, CEA Saclay, CNRS, Quantron Grp,SPEC,CEA, F-91191 Gif Sur Yvette, France.	patrice.bertet@cea.fr	Pla, Jarryd J/J-4987-2015; Bienfait, Audrey/Y-6465-2018; Kubo, Yuimaru/I-6546-2013; Morton, John/I-3515-2013	Pla, Jarryd J/0000-0002-7152-3453; Bienfait, Audrey/0000-0002-2927-1037; Kubo, Yuimaru/0000-0001-5803-4287; ZHOU, Xin/0000-0002-8516-2142	European Research Council under the European Community [615767, 279781, 630070]; C'Nano IdF project QUANTROCRYO; Royal Society; Royal Commission; US Department of Energy [DE-AC02-05CH11231]; Engineering and Physical Sciences Research Council [EP/I035536/2, EP/H025952/2, EP/K025945/1] Funding Source: researchfish; EPSRC [EP/H025952/2, EP/K025945/1, EP/I035536/2] Funding Source: UKRI	European Research Council under the European Community(European Research Council (ERC)); C'Nano IdF project QUANTROCRYO; Royal Society(Royal Society of London); Royal Commission; US Department of Energy(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge technical support from P. Senat, D. Duet, J.-C. Tack, P. Pari and P. Forget, as well as discussions within the Quantronics group. We acknowledge support of the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) through grant agreements No. 615767 (CIRQUSS), 279781 (ASCENT) and 630070 (quRAM), and of the C'Nano IdF project QUANTROCRYO. J.J.L.M. is supported by the Royal Society. C.C.L. is supported by the Royal Commission for the Exhibition of 1851. T.S. and C.D.W. were supported by the US Department of Energy under contract DE-AC02-05CH11231.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Abragam A., 1983, PRINCIPLES NUCL MAGN, VIX; Bienfait A., 2015, NATURE NANOTECHNOL; BLOEMBERGEN N, 1959, PHYS REV, V114, P445, DOI 10.1103/PhysRev.114.445; BLOEMBERGEN N, 1954, PHYS REV, V95, P8, DOI 10.1103/PhysRev.95.8; BLOEMBERGEN N, 1949, PHYSICA, V15, P386, DOI 10.1016/0031-8914(49)90114-7; Butler MC, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063407; Can TV, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891866; CARVER TR, 1953, PHYS REV, V92, P212, DOI 10.1103/PhysRev.92.212.2; de Graaf SE, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863681; FEHER G, 1958, PHYS REV, V109, P221, DOI 10.1103/PhysRev.109.221; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; FEHER G, 1959, PHYS REV, V114, P1219, DOI 10.1103/PhysRev.114.1219; George RE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067601; Gerard JM, 1998, PHYS REV LETT, V81, P1110, DOI 10.1103/PhysRevLett.81.1110; GOY P, 1983, PHYS REV LETT, V50, P1903, DOI 10.1103/PhysRevLett.50.1903; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; HEINZEN DJ, 1987, PHYS REV LETT, V58, P1320, DOI 10.1103/PhysRevLett.58.1320; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Levitt M. H., 2013, SPIN DYNAMICS BASICS; Mentink-Vigier F, 2013, J MAGN RESON, V236, P117, DOI 10.1016/j.jmr.2013.08.012; Morley GW, 2010, NAT MATER, V9, P725, DOI [10.1038/nmat2828, 10.1038/NMAT2828]; Palacios-Laloy A., 2010, THESIS U PIERRE M CU; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; PURCELL EM, 1946, PHYS REV, V69, P681; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Samkharadze N., 2015, PREPRINT; Schweiger A., 2001, PRINCIPLES PULSE ELE, V225; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Sinova J, 2012, NAT MATER, V11, P368, DOI 10.1038/nmat3304; SLEATOR T, 1985, PHYS REV LETT, V55, P1742, DOI 10.1103/PhysRevLett.55.1742; Temnov VV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.243602; Van Duzer T., 1999, PRINCIPLES SUPERCOND; Wisby I, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894455; Wolfowicz G, 2013, NAT NANOTECHNOL, V8, P561, DOI [10.1038/NNANO.2013.117, 10.1038/nnano.2013.117]; Wolfowicz G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245301; Wood C. J., 2015, PREPRINT; Wood CJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.050501; YAMAMOTO Y, 1991, OPT COMMUN, V80, P337, DOI 10.1016/0030-4018(91)90419-E; Zhou X, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.214517	40	109	112	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					74	+		10.1038/nature16944	http://dx.doi.org/10.1038/nature16944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26878235	Green Submitted			2022-12-28	WOS:000371211900042
J	Fattahi, F; Steinbeck, JA; Kriks, S; Tchieu, J; Zimmer, B; Kishinevsky, S; Zeltner, N; Mica, Y; El-Nachef, W; Zhao, HY; de Stanchina, E; Gershon, MD; Grikscheit, TC; Chen, SB; Studer, L				Fattahi, Faranak; Steinbeck, Julius A.; Kriks, Sonja; Tchieu, Jason; Zimmer, Bastian; Kishinevsky, Sarah; Zeltner, Nadja; Mica, Yvonne; El-Nachef, Wael; Zhao, Huiyong; de Stanchina, Elisa; Gershon, Michael D.; Grikscheit, Tracy C.; Chen, Shuibing; Studer, Lorenz			Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease	NATURE			English	Article							EMBRYONIC STEM-CELLS; NEURAL CREST; MIGRATION; GUT; DIFFERENTIATION; MEGACOLON; MOTILITY; NEURONS; GENE	The enteric nervous system (ENS) is the largest component of the autonomic nervous system, with neuron numbers surpassing those present in the spinal cord(1). The ENS has been called the ` second brain'(1) given its autonomy, remarkable neurotransmitter diversity and complex cytoarchitecture. Defects in ENS development are responsible for many human disorders including Hirschsprung disease (HSCR). HSCR is caused by the developmental failure of ENS progenitors to migrate into the gastrointestinal tract, particularly the distal colon(2). Human ENS development remains poorly understood owing to the lack of an easily accessible model system. Here we demonstrate the efficient derivation and isolation of ENS progenitors from human pluripotent stem (PS) cells, and their further differentiation into functional enteric neurons. ENS precursors derived in vitro are capable of targeted migration in the developing chick embryo and extensive colonization of the adult mouse colon. The in vivo engraftment and migration of human PS-cell-derived ENS precursors rescue disease-related mortality in HSCR mice (Ednrb(s-l/s-l)), although the mechanism of action remains unclear. Finally, EDNRB-null mutant ENS precursors enable modelling of HSCR-related migration defects, and the identification of pepstatin A as a candidate therapeutic target. Our study establishes the first, to our knowledge, human PS-cell-based platform for the study of human ENS development, and presents cell-and drug-based strategies for the treatment of HSCR.	[Fattahi, Faranak; Steinbeck, Julius A.; Kriks, Sonja; Tchieu, Jason; Zimmer, Bastian; Kishinevsky, Sarah; Zeltner, Nadja; Mica, Yvonne; Studer, Lorenz] Ctr Stem Cell Biol, New York, NY 10065 USA; [Fattahi, Faranak; Steinbeck, Julius A.; Kriks, Sonja; Tchieu, Jason; Zimmer, Bastian; Kishinevsky, Sarah; Zeltner, Nadja; Mica, Yvonne; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA; [Fattahi, Faranak; Kishinevsky, Sarah] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [El-Nachef, Wael; Zhao, Huiyong; de Stanchina, Elisa] Mol Pharmacol Program, New York, NY 10065 USA; [Gershon, Michael D.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Pediat Surg, Los Angeles, CA 90027 USA; [Chen, Shuibing] Cornell Univ, Dept Surg, Weill Med Coll, New York, NY 10065 USA; [Mica, Yvonne] Thermo Fisher Sci, Waltham, MA 02451 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Columbia University; Children's Hospital Los Angeles; Cornell University; Thermo Fisher Scientific	Studer, L (corresponding author), Ctr Stem Cell Biol, New York, NY 10065 USA.; Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY 10065 USA.	studerl@mskcc.org	Tchieu, Jason/AAG-1551-2020; Studer, Lorenz/ABH-1491-2021	Tchieu, Jason/0000-0002-9793-9836; Studer, Lorenz/0000-0003-0741-7987; Zimmer, Bastian/0000-0003-0004-4890	Starr Foundation; NYSTEM [C026446]; NINDS [NS15547]; California Institute for Regenerative Medicine (CIRM) [RN200946-1, RN3-06425]; New York Stem Cell Foundation [R-103]; NIDDK [DP2 DK098093-01]; DFG;  [P30 CA008748];  [TRI-SCI 2014-030]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098093, DP3DK111907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015547] Funding Source: NIH RePORTER	Starr Foundation; NYSTEM; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); New York Stem Cell Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DFG(German Research Foundation (DFG)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Manova, M. Tomishima and A. Viale for technical assistance and G. Lee for human ES-cell-based PHOX2B-GFP reporter line. We are grateful for technical support provided by H. S. Ralph, K. Brodie and the MSKCC Flow Cytometry Core. We would also like to thank J.-F. Brunet for providing us with the PHOX2A antibody and P. Frykman for sharing their EDNRB<SUP>tm1Ywa</SUP>/FrykJ HSCR mouse strain. The work was supported by the Starr Foundation and by NYSTEM contract C026446 to L.S. and by P30 CA008748; by grant NS15547 from the NINDS to M.D.G. and by grants RN200946-1 and RN3-06425 from the California Institute for Regenerative Medicine (CIRM) to T.C.G; by TRI-SCI 2014-030 to L.S. and S.C., and by the New York Stem Cell Foundation (R-103) and NIDDK (DP2 DK098093-01) to S. C. S. C. is a New York Stem Cell Foundation - Robertson Investigator. J.A.S. was supported by a DFG fellowship. We would like to thank M. Tomishima and V. Tabar for comments on the manuscript.	Barthel ER, 2012, JOVE-J VIS EXP, DOI 10.3791/4279; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Chakravarti A, 1996, HUM MOL GENET, V5, P303; CHALAZONITIS A, 1994, J NEUROSCI, V14, P6571; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan KK, 2005, DEV DYNAM, V233, P473, DOI 10.1002/dvdy.20347; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Lorenzo C, 2000, AM J GASTROENTEROL, V95, P1759, DOI 10.1016/S0002-9270(00)00975-8; Dreser N, 2015, NEUROTOXICOLOGY, V50, P56, DOI 10.1016/j.neuro.2015.07.008; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gershon M, 1999, 2 BRAIN GROUNDBREAKI; Haas HA, 2002, J PERS SOC PSYCHOL, V82, P594, DOI 10.1037//0022-3514.82.4.594; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x; Steinbeck JA, 2016, CELL STEM CELL, V18, P134, DOI 10.1016/j.stem.2015.10.002; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Torii T, 2014, BIOCHEM BIOPH RES CO, V452, P782, DOI 10.1016/j.bbrc.2014.08.156; Wakatsuki S, 2014, GENES CELLS, V19, P66, DOI 10.1111/gtc.12108; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yoshida H, 2006, J BIOCHEM, V139, P583, DOI 10.1093/jb/mvj066; Zeltner N, 2014, JOVE-J VIS EXP, DOI 10.3791/51609; Zhang Y, 2012, GENE DEV, V26, P69, DOI 10.1101/gad.179283.111	31	178	190	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					105	+		10.1038/nature16951	http://dx.doi.org/10.1038/nature16951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26863197	Green Accepted			2022-12-28	WOS:000371211900049
J	Satizabal, CL; Beiser, AS; Chouraki, V; Chene, G; Dufouil, C; Seshadri, S				Satizabal, Claudia L.; Beiser, Alexa S.; Chouraki, Vincent; Chene, Genevieve; Dufouil, Carole; Seshadri, Sudha			Incidence of Dementia over Three Decades in the Framingham Heart Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POPULATION-BASED SURVEY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; GLOBAL PREVALENCE; LIFETIME RISK; UNITED-STATES; PEOPLE; TRENDS; PERFORMANCE	BACKGROUND The prevalence of dementia is expected to soar as the average life expectancy increases, but recent estimates suggest that the age-specific incidence of dementia is declining in high-income countries. Temporal trends are best derived through continuous monitoring of a population over a long period with the use of consistent diagnostic criteria. We describe temporal trends in the incidence of dementia over three decades among participants in the Framingham Heart Study. METHODS Participants in the Framingham Heart Study have been under surveillance for incident dementia since 1975. In this analysis, which included 5205 persons 60 years of age or older, we used Cox proportional-hazards models adjusted for age and sex to determine the 5-year incidence of dementia during each of four epochs. We also explored the interactions between epoch and age, sex, apolipoprotein E epsilon 4 status, and educational level, and we examined the effects of these interactions, as well as the effects of vascular risk factors and cardiovascular disease, on temporal trends. RESULTS The 5-year age-and sex-adjusted cumulative hazard rates for dementia were 3.6 per 100 persons during the first epoch (late 1970s and early 1980s), 2.8 per 100 persons during the second epoch (late 1980s and early 1990s), 2.2 per 100 persons during the third epoch (late 1990s and early 2000s), and 2.0 per 100 persons during the fourth epoch (late 2000s and early 2010s). Relative to the incidence during the first epoch, the incidence declined by 22%, 38%, and 44% during the second, third, and fourth epochs, respectively. This risk reduction was observed only among persons who had at least a high school diploma (hazard ratio, 0.77; 95% confidence interval, 0.67 to 0.88). The prevalence of most vascular risk factors (except obesity and diabetes) and the risk of dementia associated with stroke, atrial fibrillation, or heart failure have decreased over time, but none of these trends completely explain the decrease in the incidence of dementia. CONCLUSIONS Among participants in the Framingham Heart Study, the incidence of dementia has declined over the course of three decades. The factors contributing to this decline have not been completely identified. (Funded by the National Institutes of Health.)	[Satizabal, Claudia L.; Beiser, Alexa S.; Chouraki, Vincent; Seshadri, Sudha] Boston Univ, Sch Med, Boston, MA 02215 USA; [Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Satizabal, Claudia L.; Beiser, Alexa S.; Chouraki, Vincent; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Chene, Genevieve; Dufouil, Carole] INSERM, U1219 & CIC EC Clin Epidemiol 1401, Bordeaux, France; [Chene, Genevieve; Dufouil, Carole] Univ Bordeaux, ISPED Bordeaux Sch Publ Health, Bordeaux, France	Boston University; Boston University; Framingham Heart Study; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,B602, Boston, MA 02118 USA.	suseshad@bu.edu	chene, genevieve/H-8665-2014; Dufouil, Carole/J-4968-2012; Dufouil, Carole/F-5751-2014	chene, genevieve/0000-0002-8368-6460; Dufouil, Carole/0000-0003-2442-4476; Chouraki, Vincent/0000-0002-4698-1794; Satizabal, Claudia L/0000-0002-1115-4430; Beiser, Alexa/0000-0001-8551-7778; Seshadri, Sudha/0000-0001-6135-2622	National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505, R01AG049607, R01AG008122, R01AG033193, R01AG054076, R01AG033040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Au R, 2004, EXP AGING RES, V30, P333, DOI 10.1080/03610730490484380; Au R, 2012, CURR ALZHEIMER RES, V9, P673; BACHMAN DL, 1992, NEUROLOGY, V42, P115, DOI 10.1212/WNL.42.1.115; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; FARMER ME, 1987, PSYCHOL REP, V60, P1023, DOI 10.2466/pr0.1987.60.3c.1023; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harwood RH, 2004, B WORLD HEALTH ORGAN, V82, P251; Hebert LE, 2010, NEUROLOGY, V75, P786, DOI 10.1212/WNL.0b013e3181f0754f; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Kovari E, 2014, NEUROLOGY, V82, P326, DOI 10.1212/WNL.0000000000000069; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Manton K C, 2005, Adv Gerontol, V16, P30; Mathillas J, 2011, AGE AGEING, V40, P243, DOI 10.1093/ageing/afq173; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Seshadri S, 2011, ALZHEIMERS DEMENT, V7, P35, DOI 10.1016/j.jalz.2010.12.002; Sousa RM, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-53; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7; Wu YT, 2015, INT J GERIATR PSYCH, V30, P793, DOI 10.1002/gps.4297	37	558	571	6	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					523	532		10.1056/NEJMoa1504327	http://dx.doi.org/10.1056/NEJMoa1504327			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863354	Bronze, Green Accepted			2022-12-28	WOS:000369755800005
J	Milam, EC; Meehan, SA; Ramachandran, S				Milam, Emily C.; Meehan, Shane A.; Ramachandran, Sarika			Well-Demarcated, Scaly Plaques	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TINEA-CORPORIS; MANAGEMENT; INFECTIONS; DIAGNOSIS; CRURIS; SKIN		[Milam, Emily C.; Meehan, Shane A.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA; [Ramachandran, Sarika] Yale Univ, Sch Med, Dept Dermatol, 333 Cedar St,LCI 501,POB 208059, New Haven, CT 06520 USA	New York University; Yale University	Ramachandran, S (corresponding author), Yale Univ, Sch Med, Dept Dermatol, 333 Cedar St,LCI 501,POB 208059, New Haven, CT 06520 USA.	sarika.ramachandran@yale.edu		Milam, Emily C/0000-0002-8930-6561; Meehan, Shane/0000-0001-9055-5576				Carter RL, 1992, DICT DERMATOLOGIC TE, P260; Drake LA, 1996, J AM ACAD DERMATOL, V34, P282, DOI 10.1016/S0190-9622(96)80135-6; El-Gohary M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009992.pub2; Gupta AK, 2004, AM J CLIN DERMATOL, V5, P225, DOI 10.2165/00128071-200405040-00003; Gupta AK, 2004, CUTIS, V74, P5; Gupta AK, 2003, DERMATOL CLIN, V21, P395, DOI 10.1016/S0733-8635(03)00031-7; Habif TP, 2010, CLIN DERMATOLOGY COL, P491; IVE FA, 1968, BRIT MED J, V3, P149, DOI 10.1136/bmj.3.5611.149; Noble SL, 1998, AM FAM PHYSICIAN, V58, P163; Panasiti V, 2006, MYCOSES, V49, P26, DOI 10.1111/j.1439-0507.2005.01185.x	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					508	509		10.1001/jama.2015.16068	http://dx.doi.org/10.1001/jama.2015.16068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836734				2022-12-28	WOS:000369049500021
J	Lockwood, DNJ; Lambert, SM; Walker, SL				Lockwood, Diana N. J.; Lambert, Saba M.; Walker, Stephen L.			Cutaneous nodules with positive autoantibodies: diagnostic pitfalls	LANCET			English	Editorial Material							LEPROSY		[Lockwood, Diana N. J.; Lambert, Saba M.; Walker, Stephen L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Lambert, Saba M.] ALERT Ctr, Addis Ababa, Ethiopia	University of London; London School of Hygiene & Tropical Medicine	Lockwood, DNJ (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	diana.lockwood@lshtm.ac.uk	Lambert, Saba/AAJ-5570-2021	Lambert, Saba Maria/0000-0003-4376-5495				[Anonymous], 2015, Wkly Epidemiol Rec, V90, P461; FURUKAWA F, 1986, ARCH DERMATOL RES, V278, P317, DOI 10.1007/BF00407745; Lockwood DNJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1136; World Health Organization, DIAGN OF LEPR; Zhang GY, 2015, LANCET, V386, P1915, DOI 10.1016/S0140-6736(15)00678-9	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1916	1916		10.1016/S0140-6736(15)00679-0	http://dx.doi.org/10.1016/S0140-6736(15)00679-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26843314				2022-12-28	WOS:000364194700039
J	Howitt, MR; Lavoie, S; Michaud, M; Blum, AM; Tran, SV; Weinstock, JV; Gallini, CA; Redding, K; Margolskee, RF; Osborne, LC; Artis, D; Garrett, WS				Howitt, Michael R.; Lavoie, Sydney; Michaud, Monia; Blum, Arthur M.; Tran, Sara V.; Weinstock, Joel V.; Gallini, Carey Ann; Redding, Kevin; Margolskee, Robert F.; Osborne, Lisa C.; Artis, David; Garrett, Wendy S.			Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut	SCIENCE			English	Article							INTESTINAL EPITHELIAL-CELLS; CHAIN FATTY-ACIDS; BRUSH CELLS; SWEET TASTE; STEM-CELLS; IN-VITRO; INNATE; BITTER; MICROBIOTA; POPULATION	The intestinal epithelium forms an essential barrier between a host and its microbiota. Protozoa and helminths are members of the gut microbiota of mammals, including humans, yet the many ways that gut epithelial cells orchestrate responses to these eukaryotes remain unclear. Here we show that tuft cells, which are taste-chemosensory epithelial cells, accumulate during parasite colonization and infection. Disruption of chemosensory signaling through the loss of TRMP5 abrogates the expansion of tuft cells, goblet cells, eosinophils, and type 2 innate lymphoid cells during parasite colonization. Tuft cells are the primary source of the parasite-induced cytokine interleukin-25, which indirectly induces tuft cell expansion by promoting interleukin-13 production by innate lymphoid cells. Our results identify intestinal tuft cells as critical sentinels in the gut epithelium that promote type 2 immunity in response to intestinal parasites.	[Howitt, Michael R.; Lavoie, Sydney; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Howitt, Michael R.; Lavoie, Sydney; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Blum, Arthur M.; Weinstock, Joel V.] Tufts Med Ctr, Div Gastroenterol, Boston, MA 02111 USA; [Tran, Sara V.; Redding, Kevin; Margolskee, Robert F.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Osborne, Lisa C.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med Coll, New York, NY 10021 USA; [Garrett, Wendy S.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Osborne, Lisa C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Tufts Medical Center; Monell Chemical Senses Center; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of British Columbia	Garrett, WS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Garrett, WS (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.; Garrett, WS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	wgarrett@hsph.harvard.edu	Osborne, Lisa/K-3027-2015	Osborne, Lisa/0000-0002-7170-3235; Margolskee, Robert/0000-0002-9572-2887; Artis, David/0000-0002-1753-4100; Redding, Kevin/0000-0003-2300-4613; Garrett, Wendy/0000-0002-5092-0150	NUN National Research Service Award (NRSA) [F32DK098826]; NIH NRSA [F31DK105653]; NIH [R01 CA154426, R01 GM099531]; Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; NATIONAL CANCER INSTITUTE [R01CA154426, R01CA202704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105653, F32DK098826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014105, R01DC003055] Funding Source: NIH RePORTER	NUN National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank members of the Garret Lab for helpful discussion, T. Stappenbeck for supplying L-WRN cells, R. Montgomery for help with organoid imaging, and W. Fowle for help with SEM. The data from this study are tabulated in the main paper and in the supplementary materials. Trpm5<SUP>eGFP</SUP>), Trpm<SUP>5-/-</SUP> and gustducin<SUP>-/-</SUP> mice are available from Monell Chemical Senses Center under a material transfer agreement. This work was supported by NUN National Research Service Award (NRSA) F32DK098826 to M.R.H.; NIH NRSA F31DK105653 to S.L.; and NIH grants R01 CA154426 and R01 GM099531, a Burroughs Wellcome Career in Medical Sciences Award, and a Searle Scholars Award to W.S.G. The authors declare no competing financial interests.	Baker D. G., 2007, Flynn's parasites of laboratory animals, P303, DOI 10.1002/9780470344552.ch11; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Helmby H, 2003, EUR J IMMUNOL, V33, P2974, DOI 10.1002/eji.200324264; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Knan W. I., 2001, PARASITE IMMUNOL, V23, P39; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kusumakshi S, 2015, CHEM SENSES, V40, P413, DOI 10.1093/chemse/bjv023; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Parfrey LW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00298; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reynolds LA, 2014, J IMMUNOL, V193, P2984, DOI 10.4049/jimmunol.1401056; SAEKI H, 1983, JPN J VET SCI, V45, P151; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schutz B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00087; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	47	474	487	7	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1329	1333		10.1126/science.aaf1648	http://dx.doi.org/10.1126/science.aaf1648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26847546	Green Accepted			2022-12-28	WOS:000372397700045
J	Ho, P				Ho, Paul			ASTROPHYSICS Exoplanets hidden in the gaps	NATURE			English	Editorial Material									[Ho, Paul] Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan	Academia Sinica - Taiwan	Ho, P (corresponding author), Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan.	pho@asiaa.sinica.edu.tw	Ho, Paul/AAZ-5108-2020	Ho, Paul/0000-0002-3412-4306				Brogan CL, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/1/L3; van der Marel N, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201526988; Williams JP, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/59	5	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					169	170		10.1038/530169a	http://dx.doi.org/10.1038/530169a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863979				2022-12-28	WOS:000369916700028
J	Theillet, FX; Binolfi, A; Bekei, B; Martorana, A; Rose, HM; Stuiver, M; Verzini, S; Lorenz, D; van Rossum, M; Goldfarb, D; Selenko, P				Theillet, Francois-Xavier; Binolfi, Andres; Bekei, Beata; Martorana, Andrea; Rose, Honor May; Stuiver, Marchel; Verzini, Silvia; Lorenz, Dorothea; van Rossum, Marleen; Goldfarb, Daniella; Selenko, Philipp			Structural disorder of monomeric alpha-synuclein persists in mammalian cells	NATURE			English	Article							N-TERMINAL ACETYLATION; PROTEIN; AGGREGATION; NMR; REVEALS; FORMS; DYNAMICS	Intracellular aggregation of the human amyloid protein alpha-synuclein is causally linked to Parkinson's disease. While the isolated protein is intrinsically disordered, its native structure in mammalian cells is not known. Here we use nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectroscopy to derive atomic-resolution insights into the structure and dynamics of alpha-synuclein in different mammalian cell types. We show that the disordered nature of monomeric alpha-synuclein is stably preserved in non-neuronal and neuronal cells. Under physiological cell conditions, alpha-synuclein is amino-terminally acetylated and adopts conformations that are more compact than when in buffer, with residues of the aggregation-prone non-amyloid-beta component (NAC) region shielded from exposure to the cytoplasm, which presumably counteracts spontaneous aggregation. These results establish that different types of crowded intracellular environments do not inherently promote alpha-synuclein oligomerization and, more generally, that intrinsic structural disorder is sustainable in mammalian cells.	[Theillet, Francois-Xavier; Binolfi, Andres; Bekei, Beata; Rose, Honor May; Stuiver, Marchel; Verzini, Silvia; van Rossum, Marleen; Selenko, Philipp] Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Robert Rossle Str 10, D-13125 Berlin, Germany; [Martorana, Andrea; Goldfarb, Daniella] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Lorenz, Dorothea] Leibniz Inst Mol Pharmacol FMP Berlin, Dept Mol Physiol & Cell Biol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Theillet, Francois-Xavier] CEA Saclay, Dept Biochem Biophys & Struct Biol, Inst Integrat Biol Cell I2BC, CNRS,UMR 198, Bat 144, F-91191 Gif Sur Yvette, France; [Binolfi, Andres] Max Planck Lab Struct Biol Chem & Mol Biophys Ros, 27 Febrero 210 Bis,S2002LRK, Rosario, Santa Fe, Argentina; [Binolfi, Andres] Inst Invest Descubrimiento Farmacos Rosario IIDEF, 27 Febrero 210 Bis,S2002LRK, Rosario, Santa Fe, Argentina	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Weizmann Institute of Science; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Selenko, P (corresponding author), Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Robert Rossle Str 10, D-13125 Berlin, Germany.	selenko@fmp-berlin.de	Theillet, François-Xavier/AAZ-9137-2021	Theillet, François-Xavier/0000-0002-3264-210X; Binolfi, Andres/0000-0003-2374-0864; Stuiver, Marchel/0000-0003-3437-4468	Association pour la Recherche sur le Cancer (ARC); Israel Science Foundation (ISF) [1114/12]; Deutsche Forschungsgemeinschaft (DFG) [SE1794/1-1]; European Research Council (ERC) [647474]	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Israel Science Foundation (ISF)(Israel Science Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC))	We thank J. Burre, T. Sudhof, D. Jovin, D. Mulvihill, P. Caviedes and T. Maritzen for plasmids and reagents, and for critical discussions. V. Subramanian, D. Eliezer, J. Clark and J. Dyson for carefully reading the manuscript and helpful comments. M. Herzig for essential input in the development of the electroporation protocol and M. Beerbaum and P. Schmieder for maintenance of the NMR infrastructure. RCSN-3 cells are made available by P. Caviedes upon request (pcaviede@med.uchile.cl). F.-X. T. acknowledges funding from the Association pour la Recherche sur le Cancer (ARC). D.G. acknowledges support by the Israel Science Foundation (ISF) F.I.R.S.T. program (grant 1114/12). P.S. was funded by the Deutsche Forschungsgemeinschaft (DFG) via an Emmy Noether Project Grant (SE1794/1-1). This work is supported by the European Research Council (ERC) Consolidator Grant (CoG) 'NeuroInCellNMR' (647474) awarded to P.S.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dettmer U, 2016, CURR OPIN NEUROBIOL, V36, P15, DOI 10.1016/j.conb.2015.07.007; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Luth ES, 2015, BIOCHEMISTRY-US, V54, P279, DOI 10.1021/bi501188a; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Martorana A, 2014, J AM CHEM SOC, V136, P13458, DOI 10.1021/ja5079392; Monteith WB, 2015, P NATL ACAD SCI USA, V112, P1739, DOI 10.1073/pnas.1417415112; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paris I, 2008, NEUROTOX RES, V13, P221, DOI 10.1007/BF03033505; Selkoe D, 2014, NEURODEGENER DIS, V13, P114, DOI 10.1159/000355516; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Theillet FX, 2014, CHEM REV, V114, P6661, DOI 10.1021/cr400695p; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wu KP, 2010, J AM CHEM SOC, V132, P5546, DOI 10.1021/ja9105495	36	540	542	6	316	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					45	+		10.1038/nature16531	http://dx.doi.org/10.1038/nature16531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26808899	Green Accepted			2022-12-28	WOS:000369304500029
J	Dalgaard, K; Landgraf, K; Heyne, S; Lempradl, A; Longinotto, J; Gossens, K; Ruf, M; Orthofer, M; Strogantsev, R; Selvaraj, M; Lu, TTH; Casas, E; Teperino, R; Surani, MA; Zvetkova, I; Rimmington, D; Tung, YCL; Lam, B; Larder, R; Yeo, GSH; O'Rahilly, S; Vavouri, T; Whitelaw, E; Penninger, JM; Jenuwein, T; Cheung, CL; Ferguson-Smith, AC; Coll, AP; Korner, A; Pospisilik, JA				Dalgaard, Kevin; Landgraf, Kathrin; Heyne, Steffen; Lempradl, Adelheid; Longinotto, John; Gossens, Klaus; Ruf, Marius; Orthofer, Michael; Strogantsev, Ruslan; Selvaraj, Madhan; Lu, Tess Tsai-Hsiu; Casas, Eduard; Teperino, Raffaele; Surani, M. Azim; Zvetkova, Ilona; Rimmington, Debra; Tung, Y. C. Loraine; Lam, Brian; Larder, Rachel; Yeo, Giles S. H.; O'Rahilly, Stephen; Vavouri, Tanya; Whitelaw, Emma; Penninger, Josef M.; Jenuwein, Thomas; Cheung, Ching-Lung; Ferguson-Smith, Anne C.; Coll, Anthony P.; Koerner, Antje; Pospisilik, J. Andrew			Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity	CELL			English	Article							POSITION-EFFECT VARIEGATION; IMPRINTED GENE; TRANSGENERATIONAL INHERITANCE; INSULIN-RESISTANCE; EXPRESSION; MICE; PIRNAS; SCREEN; MOUSE; INFLAMMATION	More than one-half billion people are obese, and despite progress in genetic research, much of the heritability of obesity remains enigmatic. Here, we identify a Trim28-dependent network capable of triggering obesity in a non-Mendelian, "on/off" manner. Trim28(+/D9) mutant mice exhibit a bi-modal body-weight distribution, with isogenic animals randomly emerging as either normal or obese and few intermediates. We find that the obese-"on" state is characterized by reduced expression of an imprinted gene network including Nnat, Peg3, Cdkn1c, and Plagl1 and that independent targeting of these alleles recapitulates the stochastic bi-stable disease phenotype. Adipose tissue transcriptome analyses in children indicate that humans too cluster into distinct sub-populations, stratifying according to Trim28 expression, transcriptome organization, and obesity-associated imprinted gene dysregulation. These data provide evidence of discrete polyphenism in mouse and man and thus carry important implications for complex trait genetics, evolution, and medicine.	[Dalgaard, Kevin; Heyne, Steffen; Lempradl, Adelheid; Longinotto, John; Gossens, Klaus; Ruf, Marius; Selvaraj, Madhan; Lu, Tess Tsai-Hsiu; Teperino, Raffaele; Jenuwein, Thomas; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, Stubeweg 51, D-79108 Freiburg, Germany; [Landgraf, Kathrin; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Dept Womens & Child Hlth, D-04103 Leipzig, Germany; [Landgraf, Kathrin; Koerner, Antje] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04103 Leipzig, Germany; [Orthofer, Michael; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Strogantsev, Ruslan; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Casas, Eduard; Vavouri, Tanya] Inst Predict & Personalized Med Canc IMPPC, Can Ruti Campus,Ctra Can Ruti,Cami de les Ecoles, Barcelona 08916, Spain; [Casas, Eduard; Vavouri, Tanya] Josep Carreras Leukaemia Res Inst, Can Ruti Campus,Ctra Can Ruti,Cami de les Ecoles, Barcelona 08916, Spain; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Surani, M. Azim] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Tennis Court Rd, Cambridge CB2 3EG, England; [Zvetkova, Ilona; Rimmington, Debra; Tung, Y. C. Loraine; Lam, Brian; Larder, Rachel; Yeo, Giles S. H.; O'Rahilly, Stephen; Coll, Anthony P.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Zvetkova, Ilona; Rimmington, Debra; Tung, Y. C. Loraine; Lam, Brian; Larder, Rachel; Yeo, Giles S. H.; O'Rahilly, Stephen; Coll, Anthony P.] Addenbrookes Hosp, Welcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Cambridge CB2 0QQ, England; [Whitelaw, Emma] La Trobe Univ, La Trobe Inst Mol Sci, Dept Genet, Melbourne, Vic 3086, Australia; [Cheung, Ching-Lung] Univ Hong Kong, Ctr Genom Sci, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Dalgaard, Kevin] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Teperino, Raffaele] Helmholtz Zentrum Muenchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [Teperino, Raffaele] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany	Max Planck Society; Leipzig University; Leipzig University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Cambridge; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; La Trobe University; University of Hong Kong; Novo Nordisk; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de	Cheung, Ching-Lung/C-2529-2012; Lam, Brian YH/AAH-5749-2021; O'Rahilly, Stephen/ABF-6509-2020; Penninger, Josef M/I-6860-2013; Lempradl, Adelheid/AAJ-2529-2021; Landgraf, Kathrin/J-4937-2016; Vavouri, Tanya/I-6124-2019; Körner, Antje/B-3988-2015	Cheung, Ching-Lung/0000-0002-6233-9144; Lam, Brian YH/0000-0002-3638-9025; O'Rahilly, Stephen/0000-0003-2199-4449; Penninger, Josef M/0000-0002-8194-3777; Landgraf, Kathrin/0000-0002-6878-6033; Vavouri, Tanya/0000-0003-2352-9049; Körner, Antje/0000-0001-6001-0356; Yeo, Giles See How/0000-0001-8823-3615; Heyne, Steffen/0000-0002-9497-7538; Coll, Anthony Patrick/0000-0003-2594-7463; Ferguson-Smith, Anne/0000-0002-7608-5894; Teperino, Raffaele/0000-0001-8815-1409; Larder, Rachel/0000-0003-1697-9455	Max-Planck Society, ERC [ERC-StG-281641]; DFG [SFB992, SFB 1052]; EU_FP7 [279153]; BMBF (DEEP); MRC [MRC_MC_UU_12012/1]; Wellcome Trust [095515/Z/11/Z]; German Research Council (DFG) [CRC1052/1 C05]; Federal Ministry of Education and Research, Germany, FKZ [01EO1001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_12009, G0900554, MR/J001597/1, MC_UU_12012/1, MR/L00027X/1, MC_UU_12012/5, G0600717B, MC_UU_12012/5/B, G0600717] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10380] Funding Source: researchfish; Wellcome Trust [095606/Z/11/Z] Funding Source: researchfish; MRC [MC_UU_12012/5, MR/J001597/1, MR/L00027X/1, MC_UU_12012/1, G0900554, G0600717] Funding Source: UKRI	Max-Planck Society, ERC; DFG(German Research Foundation (DFG)); EU_FP7(European Commission); BMBF (DEEP)(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); German Research Council (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research, Germany, FKZ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	W. Reik, H. Esterbauer, F. Cammas, C. Imbusch, J.P. Curley, B. Kaverne, S. Smallwood, K. Nordstrom, K. Pietilainen, T. Manke, and L. Ancic for theoretical discussions, technical and analytical help and advice, and graphical inputs. This work was supported by funding from the Max-Planck Society, ERC (ERC-StG-281641), DFG (SFB992 "MedEp"; SFB 1052 "ObesityMechanisms"), EU_FP7 (NoE "Epigenesys"; "Beta-JUDO" no 279153), BMBF (DEEP), MRC (Metabolic Disease Unit - APC, SOR, GSHY, MRC_MC_UU_12012/1), Wellcome Trust (SOR, 095515/Z/11/Z), and the German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and the Federal Ministry of Education and Research, Germany, FKZ, 01EO1001 (Integrated Research and Treatment Center [IFB] Adiposity Diseases).	Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111; Brideau CM, 2010, MOL CELL BIOL, V30, P3357, DOI 10.1128/MCB.01355-09; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Center for Disease Control and Prevention (CDC), 2012, CONT NHANES DAT 1999; Center for Disease Control and Prevention (CDC), 1994, CONT NHANES DAT 1963; Cleaton MAM, 2014, ANNU REV GENOM HUM G, V15, P93, DOI 10.1146/annurev-genom-091212-153441; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Daxinger L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r96; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Gregor MF, 2013, CELL REP, V3, P1430, DOI 10.1016/j.celrep.2013.03.042; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hollick JB, 2001, GENETICS, V157, P369; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085477; Naumova N, 2010, J CELL SCI, V123, P1979, DOI 10.1242/jcs.051631; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patti ME, 2013, CELL MOL LIFE SCI, V70, P1597, DOI 10.1007/s00018-013-1298-0; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	58	112	112	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					353	364		10.1016/j.cell.2015.12.025	http://dx.doi.org/10.1016/j.cell.2015.12.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824653	Green Published, hybrid			2022-12-28	WOS:000368906800008
J	Raaschou, P; Simard, JF; Hagelberg, CA; Askling, J				Raaschou, Pauline; Simard, Julia F.; Hagelberg, Charlotte Asker; Askling, Johan		ARTIS Study Grp	Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORGAN TRANSPLANT RECIPIENTS; FACTOR INHIBITORS; THERAPY; REGISTER	OBJECTIVE To investigate the risk of squamous cell and basal cell skin cancer in patients with rheumatoid arthritis naive to biologic drugs, in patients starting tumour necrosis factor (TNF) inhibitor treatment, and in the general population. DESIGN Population based cohort study. SETTING Nationwide data from Sweden. PARTICIPANTS Cohort of patients with rheumatoid arthritis naive to biologics (n=46 409), cohort of patients with rheumatoid arthritis starting TNF inhibitor treatment as first biologic in 1998-2012 (n=12 558), and matched general population comparator cohort, identified through national quality of care and health registers. MAIN OUTCOME MEASURE Hazard ratio of first in situ or invasive squamous cell skin cancer (1998-2012) and first basal cell cancer (2004-12). RESULTS For basal cell cancer, the hazard ratio was 1.22 (95% confidence interval 1.07 to 1.41) comparing biologics-naive rheumatoid arthritis patients with the general population and 1.14 (0.98 to 1.33; 236 v 1587 events) comparing TNF inhibitor treated patients with biologics-naive patients. For squamous cell cancer, the hazard ratio was 1.88 (1.74 to 2.03) comparing biologics-naive rheumatoid arthritis patients with the general population and 1.30 (1.10 to 1.55; 191 v 847 events) comparing TNF inhibitors with biologics-naive patients; the latter translated to an annual number needed to harm in the order of 1600. Among people with a history of squamous cell or basal cell cancer, TNF inhibitors did not further increase risks. CONCLUSION A small to moderately increased risk of basal cell cancer was seen in biologics-naive rheumatoid arthritis patients, with no further effect of TNF inhibitors. For squamous cell cancer, the risk was nearly doubled in biologics-naive patients, with a further 30% increase in risk among patients treated with TNF inhibitors; this translates to one additional case for every 1600 years of treatment experience, assuming that this association reflected causality. Vigilance regarding skin malignancies may be advisable in rheumatoid arthritis, irrespective of TNF inhibitor treatment. Most of the increase in risk for non-melanoma skin cancer in patients with rheumatoid arthritis treated with TNF inhibitors originates from factors other than that treatment.	[Raaschou, Pauline; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; [Simard, Julia F.] Stanford Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Simard, Julia F.] Stanford Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA USA; [Hagelberg, Charlotte Asker] Karolinska Inst, Dept Med Solna, Clin Pharmacol Unit, S-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, S-17176 Stockholm, Sweden	Karolinska Institutet; Stanford University; Stanford University; Karolinska Institutet; Karolinska Institutet	Raaschou, P (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, S-17176 Stockholm, Sweden.	Pauline.raaschou@karolinska.se		Gomez-Reino, Juan/0000-0001-5229-6294; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Simard, Julia/0000-0001-5735-9856	ALF (agreement concerning medical education and research in health and medical care in Stockholm County Council); BTCure; Swedish Cancer Society (Cancerfonden); Swedish Foundation for Strategic Research (SSF); Swedish Program on Chronic Inflammation (COMBINE); Swedish Research Council (Vetenskapsradet); Merck; BMS; Pfizer; Abbott Laboratories; SOBI; UCB; Roche	ALF (agreement concerning medical education and research in health and medical care in Stockholm County Council); BTCure; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Program on Chronic Inflammation (COMBINE); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Merck(Merck & Company); BMS(Bristol-Myers Squibb); Pfizer(Pfizer); Abbott Laboratories(Abbott Laboratories); SOBI; UCB(UCB Pharma SA); Roche(Roche Holding)	This research was funded by ALF (the agreement concerning medical education and research in health and medical care in Stockholm County Council), BTCure, the Swedish Cancer Society (Cancerfonden), Swedish Foundation for Strategic Research (SSF), Swedish Program on Chronic Inflammation (COMBINE), and the Swedish Research Council (Vetenskapsradet). The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The ARTIS Study Group conducts scientific analyses using data from the Swedish Biologics Register ARTIS run by the Swedish Society for Rheumatology. For these analyses, the Swedish Society for Rheumatology has received funding from Merck, BMS, Pfizer, Abbott Laboratories, SOBI, UCB, and Roche. These entities had no influence on the data collection, statistical analyses, manuscript preparation, or the decision to submit. They were allowed to comment on the findings before submission, although all final decisions resided with the investigators.	Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Amari W, 2011, RHEUMATOLOGY, V50, P1431, DOI 10.1093/rheumatology/ker113; Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Chakravarty EF, 2005, J RHEUMATOL, V32, P2130; Di Lernia V, 2011, J DERMATOL TREAT, V22, P229, DOI 10.3109/09546631003681086; Dreyer L, 2013, ANN RHEUM DIS, V72, P79, DOI 10.1136/annrheumdis-2012-201969; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Heller RF, 2002, J EPIDEMIOL COMMUN H, V56, P606, DOI 10.1136/jech.56.8.606; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Leonardi-Bee J, 2012, ARCH DERMATOL, V148, P939, DOI 10.1001/archdermatol.2012.1374; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mercer LK, 2013, RHEUMATOLOGY, V52, P91, DOI 10.1093/rheumatology/kes350; Mercer LK, 2012, ANN RHEUM DIS, V71, P869, DOI 10.1136/annrheumdis-2011-200622; Neovius M, 2011, ANN RHEUM DIS, V70, P516, DOI 10.1136/ard.2010.130914; Saevarsdottir S, 2011, ARTHRITIS RHEUM-US, V63, P26, DOI 10.1002/art.27758; Smith KJ, 2001, J AM ACAD DERMATOL, V45, P953, DOI 10.1067/mjd.2001.117725; Socialstyrelsen, CANC INC SWED 2013; Socialstyrelsen, 2013, OPPN JAMF; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Wheless L, 2014, J AM ACAD DERMATOL, V71, P359, DOI 10.1016/j.jaad.2014.02.039; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062	30	76	78	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2016	352								i262	10.1136/bmj.i262	http://dx.doi.org/10.1136/bmj.i262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EX	26823527	hybrid, Green Published			2022-12-28	WOS:000369313700004
J	Schon, MP; Bertsch, HP				Schoen, Michael P.; Bertsch, Hans P.			Primary and Secondary Syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schoen, Michael P.; Bertsch, Hans P.] Univ Med Ctr Gottingen, Gottingen, Germany	University of Gottingen	Schon, MP (corresponding author), Univ Med Ctr Gottingen, Gottingen, Germany.	michael.schoen@med.uni-goettingen.de							0	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					372	372		10.1056/NEJMicm1502476	http://dx.doi.org/10.1056/NEJMicm1502476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816014				2022-12-28	WOS:000368760100011
J	George, DR; Edris, W; Hanson, R; Gilman, F				George, Daniel R.; Edris, Wade; Hanson, Ryan; Gilman, Falisha			The art of medicine Medicinal plants-the next generation	LANCET			English	Editorial Material									[George, Daniel R.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Humanities, Hershey, PA 17033 USA; [Edris, Wade; Hanson, Ryan; Gilman, Falisha] Penn State Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	George, DR (corresponding author), Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Humanities, Hershey, PA 17033 USA.	dgeorge1@hmc.psu.edu	Edris, Wade/AAL-9216-2021	Hanson, Ryan/0000-0002-2564-3710					0	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					220	221		10.1016/S0140-6736(16)00052-0	http://dx.doi.org/10.1016/S0140-6736(16)00052-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26842289				2022-12-28	WOS:000368130700018
J	Dong, SB; Shappee, BJ; Prieto, JL; Jha, SW; Stanek, KZ; Holoien, TWS; Kochanek, CS; Thompson, TA; Morrell, N; Thompson, IB; Basu, U; Beacom, JF; Bersier, D; Brimacombe, J; Brown, JS; Bufano, F; Chen, P; Conseil, E; Danilet, AB; Falco, E; Grupe, D; Kiyota, S; Masi, G; Nicholls, B; Olivares, EF; Pignata, G; Pojmanski, G; Simonian, GV; Szczygiel, DM; Wozniak, PR				Dong, Subo; Shappee, B. J.; Prieto, J. L.; Jha, S. W.; Stanek, K. Z.; Holoien, T. W. -S.; Kochanek, C. S.; Thompson, T. A.; Morrell, N.; Thompson, I. B.; Basu, U.; Beacom, J. F.; Bersier, D.; Brimacombe, J.; Brown, J. S.; Bufano, F.; Chen, Ping; Conseil, E.; Danilet, A. B.; Falco, E.; Grupe, D.; Kiyota, S.; Masi, G.; Nicholls, B.; Olivares, F. E.; Pignata, G.; Pojmanski, G.; Simonian, G. V.; Szczygiel, D. M.; Wozniak, P. R.			ASASSN-15lh: A highly super-luminous supernova	SCIENCE			English	Article							GAMMA-RAY BURSTS; SUPERLUMINOUS SUPERNOVAE; IC SUPERNOVAE; LIGHT CURVES; GALAXY; REDSHIFT; MAGNETAR	We report the discovery of ASASSN-15lh (SN 2015L), which we interpret as the most luminous supernova yet found. At redshift z = 0.2326, ASASSN-15lh reached an absolute magnitude of M-u,M-AB = -23.5 +/- 0.1 and bolometric luminosity L-bol = (2.2 +/- 0.2) x 10(45) ergs s(-1), which is more than twice as luminous as any previously known supernova. It has several major features characteristic of the hydrogen-poor super-luminous supernovae (SLSNe-I), whose energy sources and progenitors are currently poorly understood. In contrast to most previously known SLSNe-I that reside in star-forming dwarf galaxies, ASASSN-15lh appears to be hosted by a luminous galaxy (M-K approximate to -25.5) with little star formation. In the 4 months since first detection, ASASSN-15lh radiated (1.1 +/- 0.2) x 10(52) ergs, challenging the magnetar model for its engine.	[Dong, Subo] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Shappee, B. J.; Thompson, I. B.] Carnegie Observ, Pasadena, CA 91101 USA; [Prieto, J. L.] Univ Diego Portales, Nucleo Astron, Fac Ingn, Santiago, Chile; [Prieto, J. L.; Olivares, F. E.; Pignata, G.] Millennium Inst Astrophys, Santiago, Chile; [Jha, S. W.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Stanek, K. Z.; Holoien, T. W. -S.; Kochanek, C. S.; Thompson, T. A.; Basu, U.; Beacom, J. F.; Brown, J. S.; Danilet, A. B.; Simonian, G. V.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Stanek, K. Z.; Holoien, T. W. -S.; Kochanek, C. S.; Thompson, T. A.; Beacom, J. F.] Ohio State Univ, Ctr Cosmol & AstroParticle Phys CCAPP, Columbus, OH 43210 USA; [Morrell, N.] Carnegie Observ, Las Campanas Observ, La Serena, Chile; [Beacom, J. F.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Bersier, D.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Brimacombe, J.] Coral Towers Observ, Cairns, Qld 4870, Australia; [Bufano, F.] INAF Osservatorio Astrofis Catania, I-95123 Catania, Italy; [Chen, Ping] Peking Univ, Dept Astron, Beijing 100871, Peoples R China; [Conseil, E.] Observ Strasbourg, AFOEV, F-67000 Strasbourg, France; [Falco, E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Grupe, D.] Morehead State Univ, Dept Earth & Space Sci, Morehead, KY 40351 USA; [Kiyota, S.] Variable Star Observers League Japan VSOLJ, Chiba 2730126, Japan; [Masi, G.] Virtual Telescope Project, I-03023 Ceccano, Italy; [Nicholls, B.] Mt Vernon Observ, Nelson, New Zealand; [Olivares, F. E.; Pignata, G.] Univ Andres Bello, Dept Ciencias Fis, Santiago, Chile; [Pojmanski, G.; Szczygiel, D. M.] Warsaw Univ, Astron Observ, PL-00478 Warsaw, Poland; [Wozniak, P. R.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Peking University; Carnegie Institution for Science; University Diego Portales; Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Carnegie Institution for Science; University System of Ohio; Ohio State University; Liverpool John Moores University; Istituto Nazionale Astrofisica (INAF); Peking University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Morehead State University; Universidad Andres Bello; University of Warsaw; United States Department of Energy (DOE); Los Alamos National Laboratory	Dong, SB (corresponding author), Peking Univ, Kavli Inst Astron & Astrophys, Yi He Yuan Rd 5, Beijing 100871, Peoples R China.	dongsubo@pku.edu.cn	Skowron, Dorota M/AAL-8373-2020; Dong, Subo/AIB-2671-2022	Skowron, Dorota M/0000-0001-9439-604X; Dong, Subo/0000-0002-1027-0990; Grzegorz, Pojmanski/0000-0002-6495-0676; Beacom, John/0000-0002-0005-2631; Chen, Ping/0000-0003-0853-6427; Olivares E., Felipe/0000-0002-5115-6377; Shappee, Benjamin/0000-0003-4631-1149; Wozniak, Przemyslaw/0000-0002-9919-3310; Jha, Saurabh/0000-0001-8738-6011; Holoien, Thomas/0000-0001-9206-3460; BUFANO, Filomena/0000-0002-3429-2481; Prieto, Jose/0000-0003-1072-2712	CAS [XDB09000000]; NASA; FONDECYT [1151445, 3140326]; MAS project [IC120009]; NSF CAREER award [AST-0847157]; Direct For Mathematical & Physical Scien [1404311, 1515927] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/M000966/1] Funding Source: researchfish	CAS(Chinese Academy of Sciences); NASA(National Aeronautics & Space Administration (NASA)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MAS project; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge B. Zhang, L. Ho, A. Gal-Yam, and B. Katz for comments; NSF AST-1515927, OSU CCAPP, Mt. Cuba Astronomical Foundation, TAP, SAO, CAS grant XDB09000000 (S.D.); NASA Hubble Fellowship (B.J.S.); FONDECYT grant 1151445, MAS project IC120009 (J.L.P.); NSF CAREER award AST-0847157 (S.W.J.); U.S. Department of Energy (DOE) DE-FG02-97ER25308 (T.W.-S.H.); NSF PHY-1404311 (J.F.B.); D. Victor for donating equipment (BN); FONDECYT postdoctoral fellowship 3140326 (F.O.E.), and Los Alamos National Laboratory Laboratory Directed Research and Development program (P.R.W). B.J.S. is a Hubble and Carnegie-Princeton Fellow. All data used in this paper are made public, including the photometric data (tables S1 to S6) and spectroscopic data at public repository WISeREP (26) (http://wiserep.weizmann.ac.il).	BODENHEIMER P, 1974, ASTROPHYS J, V191, P465, DOI 10.1086/152985; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Hogg D. W., 2012, EPRINTSASTROPH021039; Inserra C, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/87; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Lunnan R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/138; MADDOX SJ, 1990, MON NOT R ASTRON SOC, V243, P692; Metzger BD, 2011, MON NOT R ASTRON SOC, V413, P2031, DOI 10.1111/j.1365-2966.2011.18280.x; Neill JD, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/15; Nicholl M, 2015, MON NOT R ASTRON SOC, V452, P3869, DOI 10.1093/mnras/stv1522; Nicholls B., 2015, ASTRONOMERS TELEGRAM, V7642, P1; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Quimby R. M., 2014, IAU S, P68; Quimby RM, 2013, MON NOT R ASTRON SOC, V431, P912, DOI 10.1093/mnras/stt213; Savaglio S, 2009, ASTROPHYS J, V691, P182, DOI 10.1088/0004-637X/691/1/182; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Shappee BJ, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/48; Stoll R, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/34; Vreeswijk PM, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/24; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656	25	149	151	0	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					257	260		10.1126/science.aac9613	http://dx.doi.org/10.1126/science.aac9613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816375	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000368098600036
J	Jayson, GC; Kerbel, R; Ellis, LM; Harris, AL				Jayson, Gordon C.; Kerbel, Robert; Ellis, Lee M.; Harris, Adrian L.			Antiangiogenic therapy in oncology: current status and future directions	LANCET			English	Review							PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; RENAL-CELL CARCINOMA; ADVANCED HEPATOCELLULAR-CARCINOMA; RECURRENT OVARIAN-CANCER; PANCREATIC NEUROENDOCRINE TUMORS; RESISTANT PROSTATE-CANCER; TYROSINE KINASE INHIBITOR; ANTI-ANGIOGENIC THERAPY; BREAST-CANCER	Angiogenesis, the formation of new blood vessels from pre-existing vessels, has been validated as a target in several tumour types through randomised trials, incorporating vascular endothelial growth factor (VEGF) pathway inhibitors into the therapeutic armoury. Although some tumours such as renal cell carcinoma, ovarian and cervical cancers, and pancreatic neuroendocrine tumours are sensitive to these drugs, others such as prostate cancer, pancreatic adenocarcinoma, and melanoma are resistant. Even when drugs have yielded significant results, improvements in progression-free survival, and, in some cases, overall survival, are modest. Thus, a crucial issue in development of these drugs is the search for predictive biomarkers-tests that predict which patients will, and will not, benefit before initiation of therapy. Development of biomarkers is important because of the need to balance efficacy, toxicity, and cost. Novel combinations of these drugs with other antiangiogenics or other classes of drugs are being developed, and the appreciation that these drugs have immunomodulatory and other modes of action will lead to combination regimens that capitalise on these newly understood mechanisms.	[Jayson, Gordon C.] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Jayson, Gordon C.] Univ Manchester, Christie Hosp, Manchester, Lancs, England; [Kerbel, Robert] Univ Toronto, Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Harris, Adrian L.] Univ Oxford, Churchill Hosp, Dept Med Oncol, Oxford, England	University of Manchester; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oxford	Jayson, GC (corresponding author), Christie Hosp, Manchester M20 4BX, Lancs, England.	gordon.jayson@ics.manchester.ac.uk	Harris, Adrian L/ABA-3343-2020; Jayson, Gordon/O-8224-2015	Harris, Adrian L/0000-0003-1376-8409; Jayson, Gordon/0000-0002-8515-8944	Genentech; Roche; Cerulean; Hoffman La Roche; AstraZeneca; Eli Lilly; Cerulean Pharma; Angiocrine Biosciences; Triphase Accelerator; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; Cancer Research UK [16466, 11359, 18974] Funding Source: researchfish; Medical Research Council [G0300648] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; Wellbeing of Women [RG1705] Funding Source: researchfish	Genentech(Roche HoldingGenentech); Roche(Roche Holding); Cerulean; Hoffman La Roche; AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Cerulean Pharma; Angiocrine Biosciences; Triphase Accelerator; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW))	LME reports personal fees from Genentech, Roche, and Cerulean. GCJ reports research grants from Hoffman La Roche and AstraZeneca and consultation fees from AstraZeneca. RK declares consulting fees from Eli Lilly, Cerulean Pharma, Angiocrine Biosciences, and Triphase Accelerator, and honoraria from Boehringer-Ingelheim and Regeneron. ALH declares no competing interests.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Backen A, 2014, CLIN CANCER RES, V20, P4549, DOI 10.1158/1078-0432.CCR-13-3248; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Bridges EM, 2011, BIOCHEM PHARMACOL, V81, P1183, DOI 10.1016/j.bcp.2011.02.016; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Collinson F, 2013, CLIN CANCER RES, V19, P5227, DOI 10.1158/1078-0432.CCR-13-0489; Corrie PG, 2014, LANCET ONCOL, V15, P620, DOI 10.1016/S1470-2045(14)70110-X; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Escudier B, 2012, NAT REV CLIN ONCOL, V9, P327, DOI 10.1038/nrclinonc.2012.59; Fakhrejahani E, 2014, JPN J CLIN ONCOL, V44, P197, DOI 10.1093/jjco/hyt201; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Gerber B, 2013, ANN ONCOL, V24, P2978, DOI 10.1093/annonc/mdt361; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Grothey A, 2013, LANCET ONCOL, V14, P2, DOI 10.1016/S1470-2045(12)70516-8; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Hasan J, 2002, BRIT J CANCER, V86, P1566, DOI 10.1038/sj.bjc.6600315; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Herbst RS, 2002, J CLIN ONCOL, V20, P3792, DOI 10.1200/JCO.2002.11.061; Hodi FS, 2014, CANCER IMMUNOL RES, V2, P632, DOI 10.1158/2326-6066.CIR-14-0053; Hoff PM, 2012, J CLIN ONCOL, V30, P3596, DOI 10.1200/JCO.2012.42.6031; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kangsamaksin T, 2015, CANCER DISCOV, V5, P182, DOI 10.1158/2159-8290.CD-14-0650; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Kung AL, 2007, ADV CANCER RES, V96, P191, DOI 10.1016/S0065-230X(06)96007-2; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Ledermann JA, 2013, EUR J CANCER, V49, pS5; Liang WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109757; Liu JF, 2014, LANCET ONCOL, V15, P1207, DOI 10.1016/S1470-2045(14)70391-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Michaelson MD, 2014, J CLIN ONCOL, V32, P76, DOI 10.1200/JCO.2012.48.5268; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; O'Connor JPB, 2012, CLIN CANCER RES, V18, P6588, DOI 10.1158/1078-0432.CCR-12-1501; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pezzella F, 1996, EUR J CANCER, V32A, P2494, DOI 10.1016/S0959-8049(96)00377-2; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Rapisarda A, 2009, MOL CANCER THER, V8, P1867, DOI 10.1158/1535-7163.MCT-09-0274; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Rini BI, 2014, J CLIN ONCOL, V32, P752, DOI 10.1200/JCO.2013.50.5305; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schmidinger M, 2010, CANCER TREAT REV, V36, P416, DOI 10.1016/j.ctrv.2010.01.003; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Simpkins F, 2007, GYNECOL ONCOL, V107, P118, DOI 10.1016/j.ygyno.2007.06.004; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Sitohy B, 2011, CANCER RES, V71, P7021, DOI 10.1158/0008-5472.CAN-11-1693; Smith DC, 2014, CLIN CANCER RES, V20, P6295, DOI 10.1158/1078-0432.CCR-14-1373; Subbiah V, 2012, J CLIN ONCOL, V30, pE64, DOI 10.1200/JCO.2011.38.2614; Sun M, 2014, INT J NEPHROL RENOV, V7, P401, DOI 10.2147/IJNRD.S48496; Szabo V, 2015, J PATHOL, V235, P384, DOI 10.1002/path.4464; Tang TC, 2010, NEOPLASIA, V12, P928, DOI 10.1593/neo.10804; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; vFerrara N., 2002, NAT REV CANCER, V2, P795; von Minckwitz G, 2014, LANCET ONCOL, V15, P1269, DOI 10.1016/S1470-2045(14)70439-5; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	113	504	534	11	214	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					518	529		10.1016/S0140-6736(15)01088-0	http://dx.doi.org/10.1016/S0140-6736(15)01088-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	26853587				2022-12-28	WOS:000380559400032
J	Berterame, S; Erthal, J; Thomas, J; Fellner, S; Vosse, B; Clare, P; Hao, W; Johnson, DT; Mohar, A; Pavadia, J; Samak, AKE; Sipp, W; Sumyai, V; Suryawati, S; Toufiq, J; Yans, R; Mattick, RP				Berterame, Stefano; Erthal, Juliana; Thomas, Johny; Fellner, Sarah; Vosse, Benjamin; Clare, Philip; Hao, Wei; Johnson, David T.; Mohar, Alejandro; Pavadia, Jagjit; Samak, Ahmed Kamal Eldin; Sipp, Werner; Sumyai, Viroj; Suryawati, Sri; Toufiq, Jallal; Yans, Raymond; Mattick, Richard P.			Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study	LANCET			English	Article							PALLIATIVE CARE; EUROPEAN COUNTRIES; INCOME COUNTRIES; PAIN RELIEF; MEDICINES; AVAILABILITY; CONSUMPTION; POLICY; CANCER; ACCESSIBILITY	Background Despite opioid analgesics being essential for pain relief, use has been inadequate in many countries. We aim to provide up-to-date worldwide, regional, and national data for changes in opioid analgesic use, and to analyse the relation of impediments to use of these medicines. Methods We calculated defined daily doses for statistical purposes (S-DDD) per million inhabitants per day of opioid analgesics worldwide and for regions and countries from 2001 to 2013, and we used generalised estimating equation analysis to assess longitudinal change in use. We compared use data against the prevalence of some health disorders needing opioid use. We surveyed 214 countries or territories about impediments to availability of these medicines, and used regression analyses to establish the strength of associations between impediments and use. Findings The S-DDD of opioid analgesic use more than doubled worldwide between 2001-03 and 2011-13, from 1417 S-DDD (95% CI -732 to 3565; totalling about 3.01 billion defined daily doses per annum) to 3027 S-DDD (-1162 to 7215; totalling about 7.35 billion defined daily doses per annum). Substantial increases occurred in North America (16 046 S-DDD [95% CI 4032-28 061] to 31 453 S-DDD [8121-54 785]), western and central Europe (3079 S-DDD [1274-4883] to 9320 S-DDD [3969-14 672]), and Oceania (2275 S-DDD [763-3787] to 9136 S-DDD [2508-15 765]). Countries in other regions have shown no substantial increase in use. Impediments to use included an absence of training and awareness in medical professionals, fear of dependence, restricted financial resources, issues in sourcing, cultural attitudes, fear of diversion, international trade controls, and onerous regulation. Higher number of impediments reported was significantly associated with lower use (unadjusted incidence rate ratio 0.39 [95% CI 0.29-0.52]; p<0.0001), but not when adjusted for gross domestic product and human development index (0.91 [0.73-1.14]; p=0.4271). Interpretation Use of opioid analgesics has increased, but remains low in Africa, Asia, Central America, the Caribbean, South America, and eastern and southeastern Europe. Identified impediments to use urgently need to be addressed by governments and international agencies.	[Berterame, Stefano; Erthal, Juliana; Thomas, Johny; Fellner, Sarah; Vosse, Benjamin] Vienna Int Ctr, Secretariat Int Narcot Control Board, Vienna, Austria; [Hao, Wei; Johnson, David T.; Mohar, Alejandro; Pavadia, Jagjit; Samak, Ahmed Kamal Eldin; Sipp, Werner; Sumyai, Viroj; Suryawati, Sri; Toufiq, Jallal; Yans, Raymond; Mattick, Richard P.] Vienna Int Ctr, Int Narcot Control Board, Vienna, Austria; [Clare, Philip; Mattick, Richard P.] Univ New S Wales, Fac Med, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Hao, Wei] Cent S Univ, Mental Hlth Inst, Psychiat, Changsha, Hunan, Peoples R China; [Mohar, Alejandro] Univ Nacl Autonoma Mexico, Inst Biomed, Inst Nacl Cancerol, Unidad Epidemiol, Tlalpan, DF, Mexico; [Sumyai, Viroj] Mahidol Univ, Assoc Southeast Asian Nations, Inst Hlth Dev, Salaya, Nakhonphathom, Thailand; [Suryawati, Sri] GadjahMada Univ, Fac Med, Dept Pharmacol & Therapeut, Div Med Policy & Management, Yogyakarta, Indonesia; [Toufiq, Jallal] Univ Mohammed 5, Fac Med, Rabat, Morocco; [Toufiq, Jallal] Hop Univ Psychiat Arrazi, Sale, Morocco	University of New South Wales Sydney; Central South University; Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Mahidol University; Gadjah Mada University; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Berterame, S (corresponding author), Vienna Int Ctr, Int Narcot Control Board, A-1400 Vienna, Austria.	stefano.berterame@incb.org	Clare, Philip J/N-7884-2015; Suryawati, Sri/AEV-8357-2022	Clare, Philip J/0000-0002-2009-7386; Suryawati, Sri/0000-0002-3127-2493; Erthal-Williamson, Juliana/0000-0001-7564-0529	International Narcotics Control Board, UN	International Narcotics Control Board, UN	International Narcotics Control Board, UN.	Anand S, 1994, HUMAN DEV INDEX METH; [Anonymous], [No title captured]; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Cherny NI, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt498; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Clark F, 2015, LANCET, V386, P231, DOI 10.1016/S0140-6736(15)61264-8; Cleary J, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt500; De Lima L, 2014, J PAIN SYMPTOM MANAG, V48, P649, DOI 10.1016/j.jpainsymman.2013.12.237; Duthey B, 2014, J PAIN SYMPTOM MANAG, V47, P283, DOI 10.1016/j.jpainsymman.2013.03.015; Ferlay J, GLOBOCAN 2012 V1 0; Hastie Barbara A, 2014, J Pain Palliat Care Pharmacother, V28, P259, DOI 10.3109/15360288.2014.941132; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; *INT NARC CONTR BO, 1989, DEM SUPPL OP MED SCI; *INT NARC CONTR BO, 1996, AV OP MED NEEDS; International Narcotics Control Board, 2014, NARC DRUGS EST WORLD; International Narcotics Control Board, 2011, AV INT CONTR DRUGS E; International Narcotics Control Board, 2015, REP 2014; International Narcotics Control Board, 2015, NARC DRUGS EST WORLD; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Kim YC, 2015, CANCER MED-US, V4, P1196, DOI 10.1002/cam4.471; Knaul FM, 2015, LANCET GLOB HEALTH, V3, P35; Knaul FM, 2015, LANCET, V386, P722, DOI 10.1016/S0140-6736(15)60289-6; Krakauer EL, 2015, J PAIN SYMPTOM MANAG, V49, P916, DOI 10.1016/j.jpainsymman.2014.10.012; Liberman J, 2011, PUBLIC HEALTH, V125, P840, DOI 10.1016/j.puhe.2011.09.032; Linge-Dahl L, 2015, J PALLIAT MED, V18, P1033, DOI 10.1089/jpm.2015.0051; Lohman D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-8; Meghani SH, 2012, PAIN MED, V13, P5, DOI 10.1111/j.1526-4637.2011.01289.x; Nickerson JW, 2014, LANCET, V383, P1802, DOI 10.1016/S0140-6736(14)60874-6; Paudel BD, 2015, J PAIN SYMPTOM MANAG, V49, P111, DOI 10.1016/j.jpainsymman.2014.02.011; Seya Marie-Josephine, 2011, J Pain Palliat Care Pharmacother, V25, P6, DOI 10.3109/15360288.2010.536307; Silbermann M, 2015, LANCET, V385, P1620, DOI 10.1016/S0140-6736(15)60791-7; Steedman MR, 2014, HEALTH AFFAIR, V33, P1612, DOI 10.1377/hlthaff.2014.0379; Svendsen K, 2011, PALLIATIVE MED, V25, P725, DOI 10.1177/0269216311398300; The Lancet, 2015, LANCET, V386, P2445; UNDP, HUM DEV IND ITS COMP; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; United Nations Office on Drugs and Crime, 2009, INT DRUG CONTR CONV; Vranken MJM, 2014, J PAIN SYMPTOM MANAG, V48, P1135, DOI 10.1016/j.jpainsymman.2014.02.013; World Bank, GDP PER CAP CURR US; World Health Organization, GLOB HLTH OBS DAT RE	40	327	332	2	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1644	1656		10.1016/S0140-6736(16)00161-6	http://dx.doi.org/10.1016/S0140-6736(16)00161-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26852264				2022-12-28	WOS:000374145100032
J	Meissner, HC				Meissner, H. Cody			Immunization Policy and the Importance of Sustainable Vaccine Pricing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meissner, H. Cody] Tufts Univ, Sch Med, 800 Washington St, Boston, MA 02111 USA	Tufts University	Meissner, HC (corresponding author), Tufts Univ, Sch Med, 800 Washington St, Boston, MA 02111 USA.	cmeissner@tuftsmedicalcenter.org						Centers for Disease Control and prevention, CDC VACC PRIC LIST; Centers for Disease Control and Prevention, 2015, MMWR MORB MORTAL WKL, V65; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Ubel PA, 2014, NEW ENGL J MED, V370, P1280, DOI 10.1056/NEJMp1401335; Zhou FJ, 2014, PEDIATRICS, V133, P577, DOI 10.1542/peds.2013-0698	7	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					981	982		10.1001/jama.2016.0469	http://dx.doi.org/10.1001/jama.2016.0469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26857277				2022-12-28	WOS:000371540200007
J	Isogai, S; Deupi, X; Opitz, C; Heydenreich, FM; Tsai, CJ; Rueckner, FB; Schertler, GFX; Veprintsev, DB; Grzesiek, S				Isogai, Shin; Deupi, Xavier; Opitz, Christian; Heydenreich, Franziska M.; Tsai, Ching-Ju; Rueckner, Florian B.; Schertler, Gebhard F. X.; Veprintsev, Dmitry B.; Grzesiek, Stephan			Backbone NMR reveals allosteric signal transduction networks in the beta(1)-adrenergic receptor	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; DYNAMIC PROCESS; ACTIVE STATE; PROTEIN; ACTIVATION; AGONIST	G protein-coupled receptors (GPCRs) are physiologically important transmembrane signalling proteins that trigger intracellular responses upon binding of extracellular ligands. Despite recent breakthroughs in GPCR crystallography(1-3), the details of ligand-induced signal transduction are not well understood owing to missing dynamical information. In principle, such information can be provided by NMR4, but so far only limited data of functional relevance on few side-chain sites of eukaryotic GPCRs have been obtained(5-9). Here we show that receptor motions can be followed at virtually any backbone site in a thermostabilized mutant of the turkey beta(1)-adrenergic receptor (beta(1)AR)(10-12). Labelling with [N-15] valine in a eukaryotic expression system provides over twenty resolved resonances that report on structure and dynamics in six ligand complexes and the apo form. The response to the various ligands is heterogeneous in the vicinity of the binding pocket, but gets transformed into a homogeneous readout at the intracellular side of helix 5 (TM5), which correlates linearly with ligand efficacy for the G protein pathway. The effect of several pertinent, thermostabilizing point mutations was assessed by reverting them to the native sequence. Whereas the response to ligands remains largely unchanged, binding of the G protein mimetic nanobody NB80 and G protein activation are only observed when two conserved tyrosines (Y227 and Y343) are restored. Binding of NB80 leads to very strong spectral changes throughout the receptor, including the extracellular ligand entrance pocket. This indicates that even the fully thermostabilized receptor undergoes activating motions in TM5, but that the fully active state is only reached in presence of Y227 and Y343 by stabilization with a G protein-like partner. The combined analysis of chemical shift changes from the point mutations and ligand responses identifies crucial connections in the allosteric activation pathway, and presents a general experimental method to delineate signal transmission networks at high resolution in GPCRs.	[Isogai, Shin; Opitz, Christian; Grzesiek, Stephan] Univ Basel, Focal Area Struct Biol & Biophys, Biozentrum, CH-4056 Basel, Switzerland; [Deupi, Xavier; Heydenreich, Franziska M.; Tsai, Ching-Ju; Rueckner, Florian B.; Schertler, Gebhard F. X.; Veprintsev, Dmitry B.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Schertler, Gebhard F. X.; Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Grzesiek, S (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	gebhard.schertler@psi.ch; dmitry.veprintsev@psi.ch; stephan.grzesiek@unibas.ch	Deupi, Xavier/B-2424-2009; Veprintsev, Dmitry B/H-2228-2012; Heydenreich, Franziska M/N-6314-2015	Deupi, Xavier/0000-0003-4572-9316; Veprintsev, Dmitry B/0000-0002-3583-5409; Heydenreich, Franziska M/0000-0002-8049-4383; Tsai, Ching-Ju/0000-0001-8320-5009; Grzesiek, Stephan/0000-0003-1998-4225; Schertler, Gebhard F.X./0000-0002-5846-6810	Marie Curie postdoctoral fellowship; EMBO postdoctoral fellowship; Swiss National Science Foundation [31-132857]; Sinergia [141898, 31-135754, 31-153145, 31-146520]; European Union [242135]; COST Action [CM1207]	Marie Curie postdoctoral fellowship(European Commission); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; European Union(European Commission); COST Action(European Cooperation in Science and Technology (COST))	We acknowledge T. Sharpe for expert help with biophysical assays. We thank J. Steyaert for providing the NB80 plasmid and M. Rogowski for preparing wild-type beta<INF>1</INF>AR baculovirus. F.B. was supported by Marie Curie and EMBO postdoctoral fellowships. This work was supported by Swiss National Science Foundation grants 31-132857 (S.G.), Sinergia 141898 (S.G., D.B.V., G.F.X.S.), 31-135754 (D.B.V.), 31-153145 (G.F.X.S.), 31-146520 (X.D.), European Union FP7 grant 242135 (S.G.), and COST Action CM1207 (GLISTEN) (X.D. and G.F.X.S.).	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baker JG, 2011, N-S ARCH PHARMACOL, V384, P71, DOI 10.1007/s00210-011-0648-4; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brueckner F, 2013, METHOD ENZYMOL, V520, P117, DOI 10.1016/B978-0-12-391861-1.00006-X; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; Ghosh E, 2015, NAT REV MOL CELL BIO, V16, P69, DOI 10.1038/nrm3933; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001; Grzesiek S, 2009, CURR OPIN STRUC BIOL, V19, P585, DOI 10.1016/j.sbi.2009.07.015; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Miller JL, 2011, J MOL BIOL, V413, P628, DOI 10.1016/j.jmb.2011.08.057; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Vajpai N, 2008, BIOMOL NMR ASSIGM, V2, P41, DOI 10.1007/s12104-008-9079-7; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746	31	114	114	1	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					237	+		10.1038/nature16577	http://dx.doi.org/10.1038/nature16577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840483	Green Accepted			2022-12-28	WOS:000369916700043
J	Jaccard, SL; Galbraith, ED; Martinez-Garcia, A; Anderson, RF				Jaccard, Samuel L.; Galbraith, Eric D.; Martinez-Garcia, Alfredo; Anderson, Robert F.			Covariation of deep Southern Ocean oxygenation and atmospheric CO2 through the last ice age	NATURE			English	Article							GLACIAL-INTERGLACIAL CHANGES; AUTHIGENIC URANIUM; LATE-QUATERNARY; SCALE CHANGES; SEA SEDIMENT; 2 MODES; PRODUCTIVITY; VARIABILITY; SECTOR; TH-230	No single mechanism can account for the full amplitude of past atmospheric carbon dioxide (CO2) concentration variability over glacial-interglacial cycles(1). A build-up of carbon in the deep ocean has been shown to have occurred during the Last Glacial Maximum(2,3). However, the mechanisms responsible for the release of the deeply sequestered carbon to the atmosphere at deglaciation, and the relative importance of deep ocean sequestration in regulating millennial-timescale variations in atmospheric CO2 concentration before the Last Glacial Maximum, have remained unclear. Here we present sedimentary redox-sensitive trace-metal records from the Antarctic Zone of the Southern Ocean that provide a reconstruction of transient changes in deep ocean oxygenation and, by inference, respired carbon storage throughout the last glacial cycle. Our data suggest that respired carbon was removed from the abyssal Southern Ocean during the Northern Hemisphere cold phases of the deglaciation, when atmospheric CO2 concentration increased rapidly, reflecting-at least in part-a combination of dwindling iron fertilization by dust and enhanced deep ocean ventilation. Furthermore, our records show that the observed covariation between atmospheric CO2 concentration and abyssal Southern Ocean oxygenation was maintained throughout most of the past 80,000 years. This suggests that on millennial timescales deep ocean circulation and iron fertilization in the Southern Ocean played a consistent role in modifying atmospheric CO2 concentration.	[Jaccard, Samuel L.] Univ Bern, Inst Geol Sci, Bern, Switzerland; [Jaccard, Samuel L.] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Galbraith, Eric D.] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Galbraith, Eric D.] ICREA, Barcelona, Spain; [Galbraith, Eric D.] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Galbraith, Eric D.] Univ Autonoma Barcelona, Dept Math, E-08193 Barcelona, Spain; [Martinez-Garcia, Alfredo] Swiss Fed Inst Technol, Inst Geol, Zurich, Switzerland; [Martinez-Garcia, Alfredo] Max Planck Inst Chem, Climate Geochem Dept, Mainz, Germany; [Anderson, Robert F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Bern; University of Bern; McGill University; ICREA; Autonomous University of Barcelona; Autonomous University of Barcelona; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Columbia University	Jaccard, SL (corresponding author), Univ Bern, Inst Geol Sci, Bern, Switzerland.	samuel.jaccard@geo.unibe.ch	Martínez-García, Alfredo/A-6244-2010; Jaccard, Samuel/G-3447-2014; Galbraith, Eric/F-9469-2014	Martínez-García, Alfredo/0000-0002-7206-5079; Jaccard, Samuel/0000-0002-5793-0896; Galbraith, Eric/0000-0003-4476-4232; Anderson, Robert/0000-0002-8472-2494	Swiss National Science Foundation [PP00P2-144811, PZ00P2_142424]; NSERC; US NSF; ICREA Funding Source: Custom	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); US NSF(National Science Foundation (NSF)); ICREA(ICREA)	S.L.J. and A. M.-G. were funded by the Swiss National Science Foundation (grants PP00P2-144811 and PZ00P2_142424, respectively), E.D.G. by NSERC, and R.F.A. by the US NSF. Sediment samples were provided by the core repository at the Lamont-Doherty Earth Observatory. Computational resources were provided to E.D.G. by Compute Canada and the Canadian Foundation for Innovation. We thank C. Buizert, H. Fischer, F. Herman and T. Pedersen for discussions.	Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Anderson RF, 1998, J MARINE SYST, V17, P497, DOI 10.1016/S0924-7963(98)00060-8; Anderson RF, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0054; Baranova O. K., 2010, DISSOLVED OXYGEN APP, V3; Bareille G, 1998, J MARINE SYST, V17, P527, DOI 10.1016/S0924-7963(98)00062-1; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; Boex J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02118; Brovkin V, 2012, CLIM PAST, V8, P251, DOI 10.5194/cp-8-251-2012; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Calvert SE, 1996, ECON GEOL BULL SOC, V91, P36, DOI 10.2113/gsecongeo.91.1.36; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; Chase Z, 2001, PALEOCEANOGRAPHY, V16, P468, DOI 10.1029/2000PA000542; Chiang JCH, 2014, EARTH PLANET SC LETT, V406, P233, DOI 10.1016/j.epsl.2014.09.012; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Dezileau L, 2002, CR GEOSCI, V334, P1039, DOI 10.1016/S1631-0713(02)01826-6; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Fleisher MQ, 2003, DEEP-SEA RES PT II, V50, P693, DOI 10.1016/S0967-0645(02)00591-X; FRANCOIS R, 1993, PALEOCEANOGRAPHY, V8, P611, DOI 10.1029/93PA00784; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Frank M, 2000, PALEOCEANOGRAPHY, V15, P642, DOI 10.1029/2000PA000497; Galbraith ED, 2010, BIOGEOSCIENCES, V7, P1043, DOI 10.5194/bg-7-1043-2010; Galbraith ED, 2015, GLOBAL BIOGEOCHEM CY, V29, P307, DOI 10.1002/2014GB004929; Galbraith ED, 2015, QUATERNARY SCI REV, V109, P38, DOI 10.1016/j.quascirev.2014.11.012; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Herman F, 2013, NATURE, V504, P423, DOI 10.1038/nature12877; Hoogakker BAA, 2015, NAT GEOSCI, V8, P40, DOI [10.1038/ngeo2317, 10.1038/NGEO2317]; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Lambert F, 2012, CLIM PAST, V8, P609, DOI 10.5194/cp-8-609-2012; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Morford JL, 1999, GEOCHIM COSMOCHIM AC, V63, P1735, DOI 10.1016/S0016-7037(99)00126-X; Nielsen SHH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001618; ROSENTHAL Y, 1995, PALEOCEANOGRAPHY, V10, P395, DOI 10.1029/95PA00310; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmittner A., 2007, GEOPHYS MONOGR SER, V173, P392; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2014, P NATL ACAD SCI USA, V111, P5480, DOI 10.1073/pnas.1400668111; Sugden DE, 2009, NAT GEOSCI, V2, P281, DOI 10.1038/NGEO474; Taylor S.R., 1985, CONTINENTAL CRUST IT; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Wagner M., 2015, CLIM PAST DISCUSS, V11, P637, DOI DOI 10.5194/CPD-11-637-2015; Yu JM, 2014, QUATERNARY SCI REV, V90, P80, DOI 10.1016/j.quascirev.2014.02.018; Ziegler M, 2013, NAT GEOSCI, V6, P457, DOI [10.1038/NGEO1782, 10.1038/ngeo1782]	56	141	145	10	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					207	+		10.1038/nature16514	http://dx.doi.org/10.1038/nature16514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840491				2022-12-28	WOS:000369916700036
J	Simms, RJ				Simms, Roslyn J.			Autosomal dominant polycystic kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LEFT-VENTRICULAR MASS; DIGITAL SYNDROME TYPE-1; RENAL-DISEASE; HYPERTENSION; DIAGNOSIS; CYSTS; MANAGEMENT; GENE; MICROALBUMINURIA; CLASSIFICATION		[Simms, Roslyn J.] Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit,Nephrol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Simms, RJ (corresponding author), Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit,Nephrol, Sheffield S10 2JF, S Yorkshire, England.	r.simms@sheffield.ac.uk			National Institute for Health Research (NIHR) UK; Academy of Medical Sciences (AMS) [AMS-SGCL12-Simms] Funding Source: researchfish; National Institute for Health Research [CL-2014-04-502] Funding Source: researchfish	National Institute for Health Research (NIHR) UK(National Institute for Health Research (NIHR)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	I am supported through a clinical lectureship from the National Institute for Health Research (NIHR) UK.	ALPERN MB, 1991, RADIOLOGY, V180, P79, DOI 10.1148/radiology.180.1.2052727; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Bailey MA, 2013, ANN VASC SURG, V27, P123, DOI 10.1016/j.avsg.2012.05.013; Barua M, 2009, J AM SOC NEPHROL, V20, P1833, DOI 10.1681/ASN.2009020162; Bolignano D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010294.pub2; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Cadnapaphornchai MA, 2008, KIDNEY INT, V74, P1192, DOI 10.1038/ki.2008.397; Cadnapaphornchai MA, 2014, CLIN J AM SOC NEPHRO, V9, P889, DOI 10.2215/CJN.08350813; Chang MY, 2013, BRIT J CLIN PHARMACO, V76, P524, DOI 10.1111/bcp.12136; Chapman AB, 1997, J AM SOC NEPHROL, V8, P1292; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; CHAPMAN AB, 1991, SEMIN NEPHROL, V11, P653; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chapman AB, 2010, ADV CHRONIC KIDNEY D, V17, P153, DOI 10.1053/j.ackd.2010.01.001; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; CHAPMAN JR, 1980, LANCET, V1, P646; Chebib FT, 2015, AM J KIDNEY DIS; Cornec-Le Gall E, 2015, J AM SOC NEPHROL; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; DALGAARD O. Z., 1957, ACTA MED SCAND SUPPL, V158, P1; DAVIES F, 1991, Q J MED, V79, P477; de Almeida EAF, 2006, AM J KIDNEY DIS, V47, P587, DOI 10.1053/j.ajkd.2005.12.023; Di Salvo DN, 2012, J ULTRAS MED, V31, P637, DOI 10.7863/jum.2012.31.4.637; Ecder T, 2001, J AM SOC NEPHROL, V12, P194, DOI 10.1681/ASN.V121194; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; GABOW PA, 1990, KIDNEY INT, V38, P1177, DOI 10.1038/ki.1990.330; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Gansevoort RT, 2016, NEPHROL DIAL TRANSPL, V31, P1887, DOI 10.1093/ndt/gfv422; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Hogan MC, 2015, CLIN GASTROENTEROL H, V13, P155, DOI 10.1016/j.cgh.2014.07.051; HOSSACK KF, 1988, NEW ENGL J MED, V319, P907, DOI 10.1056/NEJM198810063191404; Irazabal MV, 2015, J AM SOC NEPHROL, V26, P160, DOI 10.1681/ASN.2013101138; Irazabal MV, 2011, CLIN J AM SOC NEPHRO, V6, P1274, DOI 10.2215/CJN.09731110; Lantinga MA, 2015, NEPHROL DIAL TRANSPL, V30, P744, DOI 10.1093/ndt/gfu227; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luciano RL, 2014, NEPHROL DIAL TRANSPL, V29, P247, DOI 10.1093/ndt/gft437; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MorrisStiff G, 1997, BRIT J SURG, V84, P615, DOI 10.1046/j.1365-2168.1997.02616.x; Moua T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093674; Nahm AM, 2001, NEPHROL DIAL TRANSPL, V16, P1506, DOI 10.1093/ndt/16.7.1506; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Perrone RD, 2011, CLIN J AM SOC NEPHRO, V6, P2508, DOI 10.2215/CJN.04610511; Persu A, 2004, KIDNEY INT, V66, P2132, DOI 10.1111/j.1523-1755.2004.66003.x; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Qian Q, 2007, CLIN J AM SOC NEPHRO, V2, P1223, DOI 10.2215/CJN.01920507; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SCHIEVINK WI, 1995, J NEUROSURG, V83, P1004, DOI 10.3171/jns.1995.83.6.1004; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2006, NEPHROLOGY, V11, P124, DOI 10.1111/j.1440-1797.2006.00535.x; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Sharp CK, 1999, AM J KIDNEY DIS, V34, P863, DOI 10.1016/S0272-6386(99)70043-0; Shaw C, 2014, NEPHROL DIAL TRANSPL, V29, P1910, DOI 10.1093/ndt/gfu087; Sherstha R, 1997, HEPATOLOGY, V26, P1282; Simms RJ, 2016, NEPHROL DIAL TRANSPL, V31, P1130, DOI 10.1093/ndt/gfv299; Simms RJ, 2015, TRANSPLANTATION, V99, P1023, DOI 10.1097/TP.0000000000000466; Simms RJ, 2014, NEPHROL DIAL TRANSPL, V29, P106, DOI 10.1093/ndt/gfu106; Simon P, 1996, NEPHROLOGIE, V17, P123; Suwabe T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-179; Sweeney WE, 2011, PEDIATR NEPHROL, V26, P675, DOI 10.1007/s00467-010-1656-1; Thauvin-Robinet C, 2006, J MED GENET, V43, P54, DOI 10.1136/jmg.2004.027672; Thong KM, 2013, QJM-INT J MED, V106, P639, DOI 10.1093/qjmed/hct082; Tong A, 2015, NEPHROL DIAL TRANSPL, V30, P790, DOI 10.1093/ndt/gfv010; TORRES VE, 1994, J AM SOC NEPHROL, V5, P1186; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; WARD CJ, 1994, CELL, V77, P881; Xu HW, 2011, STROKE, V42, P204, DOI 10.1161/STROKEAHA.110.578740	75	23	24	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2016	352								i679	10.1136/bmj.i679	http://dx.doi.org/10.1136/bmj.i679			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JT	26868522				2022-12-28	WOS:000370383900005
J	Alderson, TR; Bax, A				Alderson, T. Reid; Bax, Ad			PARKINSON'S DISEASE Disorder in the court	NATURE			English	Editorial Material							ALPHA-SYNUCLEIN; CELL NMR; MULTIMERS		[Alderson, T. Reid; Bax, Ad] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Alderson, T. Reid] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oxford	Alderson, TR; Bax, A (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	reid.alderson@nih.gov; bax@nih.gov	Alderson, T. Reid/G-2995-2016	Alderson, T. Reid/0000-0001-5163-2276	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alderson T Reid, 2013, Intrinsically Disord Proteins, V1, P18, DOI 10.4161/idp.26255; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Binolfi A., 2016, NATURE COMMUN; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Freedberg DI, 2014, ANNU REV BIOPHYS, V43, P171, DOI 10.1146/annurev-biophys-051013-023136; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Luth ES, 2015, BIOCHEMISTRY-US, V54, P279, DOI 10.1021/bi501188a; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531	12	9	9	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					38	39		10.1038/nature16871	http://dx.doi.org/10.1038/nature16871			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26808901				2022-12-28	WOS:000369304500025
J	Houston, BA; Miller, PE; Rooper, LM; Scheel, PJ; Gelber, AC				Houston, Brian A.; Miller, P. Elliott; Rooper, Lisa M.; Scheel, Paul J., Jr.; Gelber, Allan C.			From Dancing to Debilitated	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERDHEIM-CHESTER-DISEASE; IMAGING FINDINGS; CARDIAC INVOLVEMENT; VEMURAFENIB; MUTATIONS; EFFICACY; ANAKINRA	A 69-year-old man sought care from his primary care physician for fatigue and an unintentional weight loss of 14 kg over the preceding year. He had a history of hypertension, hyperlipidemia, gastroesophageal reflux, and adult-onset diabetes mellitus. Medications included atorvastatin, glipizide, omeprazole, lisinopril, hydrochlorothiazide, and amlodipine. He was a retired nuclear engineer whose hobbies included dancing with his wife. He had a history of heavy tobacco use, but he had quit smoking 30 years earlier. Review of systems showed the absence of fevers, nausea, orthopnea, edema, or paroxysms of nocturnal dyspnea. Fatigue is a common symptom that can herald the onset of many disease processes. The presence of unintentional weight loss raises concern for a systemic process, including a neoplastic, endocrinologic, rheumatologic, or infectious disorder. The history of heavy tobacco use increases concern for cancer. The physical examination was notable for a systolic murmur. Laboratory studies revealed a blood urea nitrogen level of 70 mg per deciliter (25 mmol per liter), a creatinine level of 2.7 mg per deciliter (240 mu mol per liter), and a hemoglobin level of 9.9 g per deciliter; 1 month earlier, the creatinine level had been 1.1 mg per deciliter (100 mu mol per liter), and the hemoglobin level 10.6 g per deciliter. Transthoracic echocardiography revealed aortic sclerosis without stenosis, normal left ventricular size and function, and a moderate-sized pericardial effusion without chamber impingement or clinically significant respiratory variation in transmitral flow velocities as assessed by Doppler imaging. The patient was admitted to the hospital for further evaluation.	[Houston, Brian A.; Miller, P. Elliott; Scheel, Paul J., Jr.; Gelber, Allan C.] Johns Hopkins Univ Hosp, Thayer Firm, Osler Med Serv, Baltimore, MD 21287 USA; [Houston, Brian A.; Miller, P. Elliott; Scheel, Paul J., Jr.; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Dept Med, 5200 Eastern Ave,Mason F Lord Bldg,Ctr Tower, Baltimore, MD 21224 USA; [Rooper, Lisa M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Gelber, AC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 5200 Eastern Ave,Mason F Lord Bldg,Ctr Tower, Baltimore, MD 21224 USA.	agelber@jhmi.edu	Miller, Elliott/AAM-5774-2021	Rooper, Lisa/0000-0001-5636-9753				Aouba A, 2010, BLOOD, V116, P4070, DOI 10.1182/blood-2010-04-279240; Arnaud L, 2011, BLOOD, V117, P2778, DOI 10.1182/blood-2010-06-294108; Aubert O, 2013, JOINT BONE SPINE, V80, P206, DOI 10.1016/j.jbspin.2012.07.005; Diamond EL, 2014, BLOOD, V124, P483, DOI 10.1182/blood-2014-03-561381; Dion E, 2006, RADIOLOGY, V238, P632, DOI 10.1148/radiol.2382041525; Drier A, 2010, RADIOLOGY, V255, P586, DOI 10.1148/radiol.10090320; Haroche J, 2004, MEDICINE, V83, P371, DOI 10.1097/01.md.0000145368.17934.91; Haroche J, 2006, ARTHRITIS RHEUM, V54, P3330, DOI 10.1002/art.22165; Haroche J, 2013, RHEUM DIS CLIN N AM, V39, P299, DOI 10.1016/j.rdc.2013.02.011; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Haroche J, 2009, CIRCULATION, V119, pE597, DOI 10.1161/CIRCULATIONAHA.108.825075; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Killu AM, 2013, INT J CARDIOL, V167, pE115, DOI 10.1016/j.ijcard.2013.04.057; Lachenal F, 2006, J NEUROL, V253, P1267, DOI 10.1007/s00415-006-0160-9; Surabhi VR, 2008, RADIOGRAPHICS, V28, P1005, DOI 10.1148/rg.284075157; VeyssierBelot C, 1996, MEDICINE, V75, P157, DOI 10.1097/00005792-199605000-00005	17	4	4	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					470	477		10.1056/NEJMcps1311794	http://dx.doi.org/10.1056/NEJMcps1311794			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840137				2022-12-28	WOS:000369319100011
J	Mitra, A; Behar, N				Mitra, Anuja; Behar, Nebil			SPOT DIAGNOSIS Abdominal pain in a 31 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mitra, Anuja] Chelsea & Westminster Hosp, London Deanery, London SW10 9NH, England; [Behar, Nebil] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London; Imperial College London	Mitra, A (corresponding author), Chelsea & Westminster Hosp, London Deanery, London SW10 9NH, England.	anuja.mitra@doctors.org.uk						Appaji AC, 2013, J CLIN DIAGN RES, V7, P2575, DOI [10.7860/JCDR/2013/6177.3616, 10.7860/JCDR/2013/6117.3615]; Masselli G, 2012, RADIOLOGY, V264, P333, DOI 10.1148/radiol.12111658; Matzke GM, 2003, J LAPAROENDOSC ADV A, V13, P327, DOI 10.1089/109264203769681736	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								i524	10.1136/bmj.i524	http://dx.doi.org/10.1136/bmj.i524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QK	26838545	Green Submitted			2022-12-28	WOS:000369767100006
J	Aagaard, EM; Abaza, M				Aagaard, Eva M.; Abaza, Mona			The Residency Application Process - Burden and Consequences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aagaard, Eva M.] Univ Colorado, Sch Med, Dept Med, Div Gen Internal Med, Aurora, CO USA; [Abaza, Mona] Univ Colorado, Sch Med, Dept Otolaryngol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Aagaard, EM (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Gen Internal Med, Aurora, CO USA.							Abramson SB, 2013, NEW ENGL J MED, V369, P1085, DOI 10.1056/NEJMp1304681; Benson NM, 2015, ACAD MED, V90, P1386, DOI 10.1097/ACM.0000000000000802; Langdale LA, 2003, ACAD MED, V78, P39, DOI 10.1097/00001888-200301000-00009; Wolf SJ, 2014, ACAD MED, V89, P602, DOI 10.1097/ACM.0000000000000183	4	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					303	305		10.1056/NEJMp1510394	http://dx.doi.org/10.1056/NEJMp1510394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB8IJ	26816008				2022-12-28	WOS:000368760100002
J	Ng, CT; Mendoza, JL; Garcia, KC; Oldstone, MBA				Ng, Cherie T.; Mendoza, Juan L.; Garcia, K. Christopher; Oldstone, Michael B. A.			Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes	CELL			English	Review							PERSISTENT VIRAL-INFECTION; I INTERFERON; LISTERIA-MONOCYTOGENES; ANTIVIRAL RESPONSE; RHESUS MACAQUES; LCMV INFECTION; SIV INFECTION; VIRUS; RECEPTOR; CELLS	Type I interferon (IFN-I) elicits a complex cascade of events in response to microbial infection. Here, we review recent developments illuminating the large number of IFN-I species and describing their unique biologic functions.	[Ng, Cherie T.; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Mendoza, Juan L.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Mendoza, Juan L.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Biol Struct, 279 Campus Dr, Stanford, CA 94305 USA	Scripps Research Institute; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	mbaobo@scripps.edu		Mendoza, Juan/0000-0001-6972-7476	NIH [AI009484, AI099699, 1U19AI109662, K01CA175127]; NATIONAL CANCER INSTITUTE [K01CA175127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009484, R37AI009484, U19AI109662, R01AI099699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This is Publication Number 29072 from the Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, CA. This work is supported by NIH grants AI009484 and AI099699 (M.B.A.O.) and 1U19AI109662 (K.C.G.). J.L.M. is supported by NIH K01CA175127. K.C.G. is an investigator of the Howard Hughes Medical Institute.	Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baccala R, 2014, P NATL ACAD SCI USA, V111, P8925, DOI 10.1073/pnas.1408148111; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; KAZAR J, 1971, INFECT IMMUN, V3, P825, DOI 10.1128/IAI.3.6.825-832.1971; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Ng CT, 2011, CURR OPIN VIROL, V1, P160, DOI 10.1016/j.coviro.2011.05.006; Ng CT, 2012, P NATL ACAD SCI USA, V109, P7823, DOI 10.1073/pnas.1205850109; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Schnell FJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003073; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sullivan BM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004588; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	31	89	93	6	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					349	352		10.1016/j.cell.2015.12.027	http://dx.doi.org/10.1016/j.cell.2015.12.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824652	Green Accepted, Bronze			2022-12-28	WOS:000368906800007
J	Urnov, F				Urnov, Fyodor			The domestication of Cas9	NATURE			English	Editorial Material							GENOME; NUCLEASES		[Urnov, Fyodor] Sangamo BioSci, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Urnov, F (corresponding author), Sangamo BioSci, Richmond, CA 94804 USA.	furnov@sangamo.com						Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	12	11	12	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					468	469		10.1038/529468a	http://dx.doi.org/10.1038/529468a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819037				2022-12-28	WOS:000368673800020
J	Woolston, C				Woolston, Chris			Faking it	NATURE			English	Editorial Material																			0	8	8	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					555	557		10.1038/nj7587-555a	http://dx.doi.org/10.1038/nj7587-555a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26824109	Bronze			2022-12-28	WOS:000368673800043
J	Payre, F; Desplan, C				Payre, Francois; Desplan, Claude			Small peptides control heart activity	SCIENCE			English	Editorial Material							CALCIUM-PUMP; SARCOLIPIN; PHOSPHOLAMBAN		[Payre, Francois] Univ Toulouse 3, CNRS UMR5547, Ctr Biol Dev, F-31062 Toulouse, France; [Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; New York University	Payre, F (corresponding author), Univ Toulouse 3, CNRS UMR5547, Ctr Biol Dev, F-31062 Toulouse, France.	claude.desplan@nyu.edu		PAYRE, Francois/0000-0002-8144-6711; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY017916] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017916] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; TADA M, 1975, J BIOL CHEM, V250, P2640; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Zanet J, 2015, SCIENCE, V349, P1356, DOI 10.1126/science.aac5677	11	22	22	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					226	227		10.1126/science.aad9873	http://dx.doi.org/10.1126/science.aad9873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816363	Green Accepted			2022-12-28	WOS:000368098600019
J	Toyama, EQ; Herzig, S; Courchet, J; Lewis, TL; Loson, OC; Hellberg, K; Young, NP; Chen, H; Polleux, F; Chan, DC; Shaw, RJ				Toyama, Erin Quan; Herzig, Sebastien; Courchet, Julien; Lewis, Tommy L., Jr.; Loson, Oliver C.; Hellberg, Kristina; Young, Nathan P.; Chen, Hsiuchen; Polleux, Franck; Chan, David C.; Shaw, Reuben J.			AMP-activated protein kinase mediates mitochondrial fission in response to energy stress	SCIENCE			English	Article							MAMMALIAN-CELLS; PROTEOLYTIC CLEAVAGE; STRUCTURAL BASIS; PHOSPHORYLATION; AUTOPHAGY; FUSION; DRP1; OPA1; APOPTOSIS; DYNAMICS	Mitochondria undergo fragmentation in response to electron transport chain (ETC) poisons and mitochondrial DNA-linked disease mutations, yet how these stimuli mechanistically connect to the mitochondrial fission and fusion machinery is poorly understood. We found that the energy-sensing adenosine monophosphate (AMP)-activated protein kinase (AMPK) is genetically required for cells to undergo rapid mitochondrial fragmentation after treatment with ETC inhibitors. Moreover, direct pharmacological activation of AMPK was sufficient to rapidly promote mitochondrial fragmentation even in the absence of mitochondrial stress. A screen for substrates of AMPK identified mitochondrial fission factor (MFF), a mitochondrial outer-membrane receptor for DRP1, the cytoplasmic guanosine triphosphatase that catalyzes mitochondrial fission. Nonphosphorylatable and phosphomimetic alleles of the AMPK sites in MFF revealed that it is a key effector of AMPK-mediated mitochondrial fission.	[Toyama, Erin Quan; Herzig, Sebastien; Hellberg, Kristina; Young, Nathan P.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Toyama, Erin Quan; Herzig, Sebastien; Hellberg, Kristina; Young, Nathan P.; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Courchet, Julien; Lewis, Tommy L., Jr.; Polleux, Franck] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY 10032 USA; [Courchet, Julien; Lewis, Tommy L., Jr.; Polleux, Franck] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Loson, Oliver C.; Chen, Hsiuchen; Chan, David C.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Columbia University; Columbia University; California Institute of Technology	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	COURCHET, JULIEN/E-9645-2016; Herzig, Sebastien/AAA-8853-2019	COURCHET, JULIEN/0000-0002-1199-9329; Herzig, Sebastien/0000-0002-9329-2860; Lewis, Tommy/0000-0001-7033-7010; Polleux, Franck/0000-0003-4313-0481	NIH [R01DK080425, R01CA172229, P01 CA120964, R01GM062967, R01GM110039, R01NS089456, K99NS091526]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; American Cancer Society [122123-PF-12-029-01-TBE, 123016-PF-PF-12-191-01-TBE]; European Molecular Biology Organization (EMBO) [ALTF 1101-2013]; George E. Hewitt Foundation; American Physiological Society; Salk Institute [CCSG P30 CA014195]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195, R01CA172229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110039, R01GM062967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089456, K99NS091526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; American Cancer Society(American Cancer Society); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); George E. Hewitt Foundation; American Physiological Society; Salk Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants R01DK080425, R01CA172229, and P01 CA120964 to R.J.S; R01GM062967 and R01GM110039 to D.C.C; R01NS089456 to F.P.; and K99NS091526 to T.L.L. Work in the laboratory of R.J.S. was also supported in part by the Leona M. and Harry B. Helmsley Charitable Trust (grant 2012-PG-MED002). E.Q.T. and N.P.Y. were supported by American Cancer Society fellowships (122123-PF-12-029-01-TBE and 123016-PF-PF-12-191-01-TBE, respectively). S.H. was supported by a European Molecular Biology Organization (EMBO) Long Term Fellowship (ALTF 1101-2013). K.H. was funded by a George E. Hewitt Foundation for Medical Research fellowship. O.C.L. was supported by an American Physiological Society William Townsend Porter predoctoral fellowship. R.J.S. is the William R. Brody Chair at the Salk Institute and a Howard Hughes Medical Institute Early Career Scientist. We thank A. Singh and G. Kasof at Cell Signaling Technology for developing the antibody to MFF P-Ser172 in conjunction with E.Q.T. and R.J.S. We thank the Waitt Biophotonics Core and Flow Cytometry Core at the Salk Institute for use of their instruments, which are supported by the Salk Institute (grant CCSG P30 CA014195). We thank C. Merkwirth and M. Adams for helpful discussions and M. Chun for critical reading of the manuscript.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734	39	603	613	8	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					275	281		10.1126/science.aab4138	http://dx.doi.org/10.1126/science.aab4138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816379	Green Accepted			2022-12-28	WOS:000368098600041
J	Gross, P				Gross, Philip			The art of medicine Words on the borders of the body	LANCET			English	Editorial Material									Univ South Wales, Fac Business & Soc, Creat Writing, Cardiff CF37 1DL, S Glam, Wales	University of South Wales	Gross, P (corresponding author), Univ South Wales, Fac Business & Soc, Creat Writing, Cardiff CF37 1DL, S Glam, Wales.	philip.gross@southwales.ac.uk							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1816	1817		10.1016/S0140-6736(15)00771-0	http://dx.doi.org/10.1016/S0140-6736(15)00771-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26843301				2022-12-28	WOS:000364194700020
J	Blacher, J; Levy, B; Mourad, JJ; Safar, ME; Bakris, G				Blacher, Jacques; Levy, Bernard; Mourad, Jean-Jacques; Safar, Michel E.; Bakris, George			From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century	LANCET			English	Editorial Material							PULSE PRESSURE; BLOOD-PRESSURE; RISK; DISEASE; ADULTS; HEART		[Blacher, Jacques; Safar, Michel E.] Paris Descartes Univ, Hotel Dieu Univ Hosp, AP HP, Diag & Therapeut Ctr, F-75004 Paris, France; [Levy, Bernard] Lariboisiere Univ Hosp, Vessels & Blood Inst, Paris, France; [Levy, Bernard] INSERM, U970, Paris Cardiovasc Res Ctr, Paris, France; [Mourad, Jean-Jacques] Univ Paris 13, Avicenne Univ Hosp, AP HP, Dept Internal Med, Bobigny, France; [Bakris, George] Univ Chicago, Amer Soc Hypertens Comprehens Hypertens Ctr, Dept Med, Medicine, IL USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Blacher, J (corresponding author), Paris Descartes Univ, Hotel Dieu Univ Hosp, AP HP, Diag & Therapeut Ctr, F-75004 Paris, France.	jacques.blacher@aphp.fr	Blacher, Jacques/F-2685-2017	Blacher, Jacques/0000-0003-4860-4279; Mourad, Jean-Jacques/0000-0003-0877-8311				Aouba A, 2011, BEH, V22, P249; Bakris GL, 2005, AM J HYPERTENS, V18, p112S, DOI 10.1016/j.amjhyper.2004.11.046; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Benjamin EJ, JAMA, V271, P840; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Blacher J, 2004, J HYPERTENS, V22, P415, DOI 10.1097/00004872-200402000-00028; Blacher J, 2014, FUND CLIN PHARMACOL, V28, P1, DOI 10.1111/fcp.12044; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gasecki D, 2013, CURR HYPERTENS REP, V15, P547, DOI 10.1007/s11906-013-0398-4; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Marott SCW, 2014, EUR HEART J, V35, P1205, DOI 10.1093/eurheartj/eht507; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Omran A. R., 1998, World Health Statistics Quarterly, V51, P99; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Verger A, 2015, J HYPERTENS, V33, P1378, DOI 10.1097/HJH.0000000000000566; WEIDMANN P, 1975, KIDNEY INT, V8, P325, DOI 10.1038/ki.1975.120; Zhang Y, 2013, INT J CARDIOL, V168, P2714, DOI 10.1016/j.ijcard.2013.03.021	20	48	51	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					530	532		10.1016/S0140-6736(16)00002-7	http://dx.doi.org/10.1016/S0140-6736(16)00002-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	26856636				2022-12-28	WOS:000380559400033
J	Chen, LH; Hamer, DH				Chen, Lin H.; Hamer, Davidson H.			Zika Virus: Rapid Spread in the Western Hemisphere	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MICRONESIA		[Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis, 330 Mt Auburn St,South 2, Cambridge, MA 02138 USA; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, 801 Massachusetts Ave,Crosstown Third Floor, Boston, MA 02118 USA	Harvard University; Mount Auburn Hospital; Boston University	Chen, LH (corresponding author), Mt Auburn Hosp, 330 Mt Auburn St, Cambridge, MA 02138 USA.	lchen@hms.harvard.edu	Chen, Lin/ADS-6751-2022; Hamer, Davidson Howes/J-2020-2019	Hamer, Davidson Howes/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436				Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958; Hennessey M, 2015, ZIK VIR SPREADS NEW; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Pan American Health Organisation/World Health Organisation, ZIK VIR INF	10	76	79	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					613	+		10.7326/M16-0150	http://dx.doi.org/10.7326/M16-0150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26832396				2022-12-28	WOS:000375744000021
J	Donahue, JK				Donahue, J. Kevin			Cardiac gene therapy: a call for basic methods development	LANCET			English	Editorial Material							ADENOASSOCIATED VIRAL VECTORS; STABLE ANGINA; DELIVERY; ADENOVIRUS; PERFUSION; TRIAL		[Donahue, J. Kevin] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Donahue, JK (corresponding author), Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01655 USA.	donahuelab@gmail.com						Bridges CR, 2005, J THORAC CARDIOV SUR, V130, P1364, DOI 10.1016/j.jtcvs.2005.07.035; Brunner M, 2003, AM J PHYSIOL-HEART C, V285, pH194, DOI 10.1152/ajpheart.00971.2002; Donahue JK, 1997, P NATL ACAD SCI USA, V94, P4664, DOI 10.1073/pnas.94.9.4664; Donahue JK, 1998, GENE THER, V5, P630, DOI 10.1038/sj.gt.3300649; Emani SM, 2003, MOL THER, V8, P306, DOI 10.1016/S1525-0016(03)00149-7; FRENCH BA, 1994, CIRCULATION, V90, P2414, DOI 10.1161/01.CIR.90.5.2414; Greenberg B, 2016, LANCET, V387, P1178, DOI 10.1016/S0140-6736(16)00082-9; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Grines CL, 2003, J AM COLL CARDIOL, V42, P1339, DOI 10.1016/S0735-1097(03)00988-4; Grines CL, 2002, CIRCULATION, V105, P1291, DOI 10.1161/hc1102.105595; Kikuchi K, 2005, CIRCULATION, V111, P264, DOI 10.1161/01.CIR.0000153338.47507.83; Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468; Roth DM, 2004, HUM GENE THER, V15, P989, DOI 10.1089/hum.2004.15.989; Sasano T, 2007, J MOL CELL CARDIOL, V42, P954, DOI 10.1016/j.yjmcc.2007.02.004; Wang D, 2014, EXPERT OPIN DRUG DEL, V11, P345, DOI 10.1517/17425247.2014.871258; Wolfram JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000119	16	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1137	1139		10.1016/S0140-6736(16)00149-5	http://dx.doi.org/10.1016/S0140-6736(16)00149-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	26806516				2022-12-28	WOS:000372412000005
J	Lucey, DR; Gostin, LO				Lucey, Daniel R.; Gostin, Lawrence O.			The Emerging Zika Pandemic Enhancing Preparedness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EBOLA		[Lucey, Daniel R.] Georgetown Univ, Sch Med, Washington, DC 20001 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Centers for Disease Control and Prevention, ZIK VIR; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Gostin L, 2015, JAMA FORUM CRITICAL; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; PanAmerican Health Organization (PAHO)/World Health Organization, 2015, EP AL INCR MICR NE B; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; WHO, 2015, REP EB INT ASS PAN	9	72	73	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					865	866		10.1001/jama.2016.0904	http://dx.doi.org/10.1001/jama.2016.0904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26818622				2022-12-28	WOS:000371077500012
J	Elachola, H; Memish, ZA				Elachola, Habida; Memish, Ziad A.			Oil prices, climate change-health challenges in Saudi Arabia	LANCET			English	Editorial Material							DISEASE; KINGDOM		[Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia	Ministry of Health - Saudi Arabia	Memish, ZA (corresponding author), Minist Hlth, Riyadh, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Bcheraoui C El, 2013, INT J HYPERTENS, V2014, P2014; Bezruchka S, 2009, CAN MED ASSOC J, V181, P281, DOI 10.1503/cmaj.090553; De Bel-Air F., 2014, 12014 GULF LAB MARK; El Bcheraoui Charbel, 2015, J Family Med Prim Care, V4, P342, DOI 10.4103/2249-4863.161313; El Bcheraoui C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119051; El Bcheraoui C, 2014, INT J PUBLIC HEALTH, V59, P1011, DOI 10.1007/s00038-014-0612-4; Karamanoli E, 2015, LANCET, V386, P2239, DOI 10.1016/S0140-6736(15)01163-0; Kerr S., 2016, FINANC TIMES; Khatteeb AL- L., 2015, SAUDI ARABIAS EC TIM; Memish ZA, 2014, PREV CHRONIC DIS, V11; Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0; Memish ZA, 2011, ANN SAUDI MED, V31, P229, DOI 10.4103/0256-4947.81527; Mokdad AH, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000575; Pal JS, 2015, NAT CLIM CHANGE, DOI [10.1038/NCLIMATE2833, DOI 10.1038/NCLIMATE2833]; Tuffaha M, 2015, N AM J MED SCI, V7, P467, DOI 10.4103/1947-2714.168675	15	10	11	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					827	829		10.1016/S0140-6736(16)00203-8	http://dx.doi.org/10.1016/S0140-6736(16)00203-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE9RA	26827075	Green Published, Bronze			2022-12-28	WOS:000370974400008
J	Tarnow-Mordi, W; Stenson, B; Kirby, A; Juszczak, E; Donoghoe, M; Deshpande, S; Morley, C; King, A; Doyle, LW; Fleck, BW; Davis, PG; Halliday, HL; Hague, W; Cairns, P; Darlow, BA; Fielder, AR; Gebski, V; Marlow, N; Simmer, K; Tin, W; Ghadge, A; Williams, C; Keech, A; Wardle, SP; Kecskes, Z; Kluckow, M; Gole, G; Evans, N; Malcolm, G; Luig, M; Wright, I; Stack, J; Tan, K; Pritchard, M; Gray, PH; Morris, S; Headley, B; Dargaville, P; Simes, RJ; Brocklehurst, P				Tarnow-Mordi, William; Stenson, Ben; Kirby, Adrienne; Juszczak, Edmund; Donoghoe, Mark; Deshpande, Sanjeev; Morley, Colin; King, Andrew; Doyle, Lex W.; Fleck, Brian W.; Davis, Peter G.; Halliday, Henry L.; Hague, Wendy; Cairns, Pamela; Darlow, Brian A.; Fielder, Alistair R.; Gebski, Val; Marlow, Neil; Simmer, Karen; Tin, Win; Ghadge, Alpana; Williams, Cathy; Keech, Anthony; Wardle, Stephen P.; Kecskes, Zsuzsoka; Kluckow, Martin; Gole, Glen; Evans, Nicholas; Malcolm, Girvan; Luig, Melissa; Wright, Ian; Stack, Jacqueline; Tan, Kenneth; Pritchard, Margo; Gray, Peter H.; Morris, Scott; Headley, Bevan; Dargaville, Peter; Simes, R. John; Brocklehurst, Peter			Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PULSE OXIMETRY; METAANALYSIS; VALIDATION; GESTATION; THERAPY	BACKGROUND The safest ranges of oxygen saturation in preterm infants have been the subject of debate. METHODS In two trials, conducted in Australia and the United Kingdom, infants born before 28 weeks' gestation were randomly assigned to either a lower (85 to 89%) or a higher (91 to 95%) oxygen-saturation range. During enrollment, the oximeters were revised to correct a calibration-algorithm artifact. The primary outcome was death or disability at a corrected gestational age of 2 years; this outcome was evaluated among infants whose oxygen saturation was measured with any study oximeter in the Australian trial and those whose oxygen saturation was measured with a revised oximeter in the U.K. trial. RESULTS After 1135 infants in Australia and 973 infants in the United Kingdom had been enrolled in the trial, an interim analysis showed increased mortality at a corrected gestational age of 36 weeks, and enrollment was stopped. Death or disability in the Australian trial (with all oximeters included) occurred in 247 of 549 infants (45.0%) in the lower-target group versus 217 of 545 infants (39.8%) in the higher-target group (adjusted relative risk, 1.12; 95% confidence interval [CI], 0.98 to 1.27; P=0.10); death or disability in the U.K. trial (with only revised oximeters included) occurred in 185 of 366 infants (50.5%) in the lower-target group versus 164 of 357 infants (45.9%) in the higher-target group (adjusted relative risk, 1.10; 95% CI, 0.97 to 1.24; P=0.15). In post hoc combined, unadjusted analyses that included all oximeters, death or disability occurred in 492 of 1022 infants (48.1%) in the lower-target group versus 437 of 1013 infants (43.1%) in the higher-target group (relative risk, 1.11; 95% CI, 1.01 to 1.23; P=0.02), and death occurred in 222 of 1045 infants (21.2%) in the lower-target group versus 185 of 1045 infants (17.7%) in the higher-target group (relative risk, 1.20; 95% CI, 1.01 to 1.43; P=0.04). In the group in which revised oximeters were used, death or disability occurred in 287 of 580 infants (49.5%) in the lower-target group versus 248 of 563 infants (44.0%) in the higher-target group (relative risk, 1.12; 95% CI, 0.99 to 1.27; P=0.07), and death occurred in 144 of 587 infants (24.5%) versus 99 of 586 infants (16.9%) (relative risk, 1.45; 95% CI, 1.16 to 1.82; P=0.001). CONCLUSIONS Use of an oxygen-saturation target range of 85 to 89% versus 91 to 95% resulted in nonsignificantly higher rates of death or disability at 2 years in each trial but in significantly increased risks of this combined outcome and of death alone in post hoc combined analyses. (Funded by the Australian National Health and Medical Research Council and others; BOOST-II Current Controlled Trials number, ISRCTN00842661, and Australian New Zealand Clinical Trials Registry number, ACTRN12605000055606.)	[Tarnow-Mordi, William] Univ Sydney, WINNER Ctr, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Kirby, Adrienne; Donoghoe, Mark; Hague, Wendy; Gebski, Val; Ghadge, Alpana; Keech, Anthony; Simes, R. John] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Evans, Nicholas; Malcolm, Girvan] Royal Prince Alfred Hosp, Dept Neonatol, Sydney, NSW, Australia; [Luig, Melissa] Westmead Hosp, Dept Neonatol, Sydney, NSW, Australia; [Stack, Jacqueline] Liverpool Hosp, Rainbow Clin, Neonatal Intens Care Unit, Sydney, NSW, Australia; [Morley, Colin] Royal Womens Hosp, Dept Neonatal Res, Melbourne, Vic, Australia; [Doyle, Lex W.; Davis, Peter G.] Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Tan, Kenneth] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Simmer, Karen] King Edward Mem Hosp, Ctr Neonatal Res & Educ, Perth, WA, Australia; [Simmer, Karen] Univ Western Australia, Perth, WA 6009, Australia; [Kecskes, Zsuzsoka] Canberra Hosp, Neonatal Intens Care Unit, Canberra, ACT, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatol, St Leonards, NSW 2065, Australia; [Gole, Glen] Univ Queensland, Dept Ophthalmol, Brisbane, Qld, Australia; [Pritchard, Margo] Australian Catholic Univ, Royal Brisbane & Womens Hosp, Dept Womens & Newborn Serv, Brisbane, Qld, Australia; [Gray, Peter H.] Mater Mothers Hosp, Dept Neonatol, Brisbane, Qld, Australia; [Wright, Ian] Univ Wollongong, Paediat & Child Hlth Res, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Morris, Scott] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [Headley, Bevan] Adelaide Womens & Childrens Hosp, Dept Neonatol, Adelaide, SA, Australia; [Dargaville, Peter] Royal Hobart Hosp, Dept Neonatol, Hobart, Tas, Australia; [Stenson, Ben] Royal Infirm Edinburgh NHS Trust, Dept Reprod Med, Neonatal Unit, Edinburgh, Midlothian, Scotland; [Fleck, Brian W.] Princess Alexandra Eye Pavil, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Juszczak, Edmund; King, Andrew] Univ Oxford, Natl Perinatal Epidemiol Unit, Clin Trials Unit, S Parks Rd, Oxford, England; [Deshpande, Sanjeev] Royal Shrewsbury Hosp, Dept Paediat, Shrewsbury, Salop, England; [Halliday, Henry L.] Royal Matern Hosp, Belfast, Antrim, North Ireland; [Cairns, Pamela] St Michaels Hosp, Dept Neonatol, Bristol, Avon, England; [Williams, Cathy] Univ Bristol, Ctr Child & Adolescent Hlth, Sch Social & Community Med, Bristol, Avon, England; [Fielder, Alistair R.] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England; [Marlow, Neil; Brocklehurst, Peter] City Univ London, Inst Womens Hlth, London EC1V 0HB, England; [Tin, Win] James Cook Univ, Dept Neonatal Med, Middlesbrough, Cleveland, England; [Wardle, Stephen P.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Darlow, Brian A.] Univ Otago, Christchurch Sch Med, Dept Paediat, Christchurch, New Zealand	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Liverpool Hospital; Monash University; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; Australian National University; Canberra Hospital; Royal North Shore Hospital; University of Queensland; Australian Catholic University; Royal Brisbane & Women's Hospital; University of Wollongong; Flinders University South Australia; Womens & Childrens Hospital Australia; Royal Hobart Hospital; Royal Infirmary of Edinburgh; University of Edinburgh; University of Oxford; University of Bristol; City University London; City University London; University of London; University College London; Nottingham University Hospital NHS Trust; University of Otago	Tarnow-Mordi, W (corresponding author), Univ Sydney, WINNER Ctr, NHMRC Clin Trials Ctr, Locked Bag 77, Camperdown, NSW 1450, Australia.; Stenson, B (corresponding author), Royal Infirmary Edinburgh, Neonatal Unit, Edinburgh EH16 4SA, Midlothian, Scotland.	williamtm@med.usyd.edu.au; ben.stenson@nhslothian.scot.nhs.uk	Gray, Peter H/A-1425-2008; Gole, Glen A/F-4219-2010; Simes, Robert John/P-1497-2014; Doyle, Lex/AAJ-5205-2021; Marlow, Neil/D-2918-2009; Williams, Cathy/K-4919-2015; Pritchard, Margo/G-5188-2010	Gray, Peter H/0000-0002-2725-7709; Gole, Glen A/0000-0001-7285-2702; Doyle, Lex/0000-0002-7667-7312; Marlow, Neil/0000-0001-5890-2953; Williams, Cathy/0000-0002-9133-2021; Tan, Kenneth/0000-0002-1931-0549; Kluckow, Martin/0000-0003-1875-7530; Kecskes, Zsuzsoka/0000-0002-9722-1509; Dargaville, Peter/0000-0002-4142-477X; Gebski, Val/0000-0001-8748-1844; Simmer, Karen/0000-0003-4777-9069; Wright, Ian/0000-0001-5337-0134; Pritchard, Margo/0000-0002-1058-9117	Australian National Health and Medical Research Council; Medical Research Council [G0400415] Funding Source: researchfish; National Institute for Health Research [SRF-2015-08-005] Funding Source: researchfish; MRC [G0400415] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Australian National Health and Medical Research Council and others; BOOST-II Current Controlled Trials number, ISRCTN00842661, and Australian New Zealand Clinical Trials Registry number, ACTRN12605000055606.	Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Askie LM, 2014, COCHRANE DB SYST REV; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cole CH, 2003, PEDIATRICS, V112, P1415, DOI 10.1542/peds.112.6.1415; Darlow BA, 2014, J PEDIATR-US, V165, P30, DOI 10.1016/j.jpeds.2014.01.017; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Field D, 2008, ARCH DIS CHILD-FETAL, V93, pF212, DOI 10.1136/adc.2007.119271; Johnson S, 2004, DEV MED CHILD NEUROL, V46, P389, DOI 10.1017/S0012162204000635; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; Johnston ED, 2011, ARCH DIS CHILD-FETAL, V96, pF429, DOI 10.1136/adc.2010.206011; Jones JG, 2015, ARCH DIS CHILD FETAL; Lakshminrusimha S, 2015, J PERINATOL, V35, P8, DOI 10.1038/jp.2014.199; Manja V, 2015, JAMA PEDIATR, V169, P332, DOI 10.1001/jamapediatrics.2014.3307; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Quine D, 2009, ARCH DIS CHILD-FETAL, V94, pF51, DOI 10.1136/adc.2007.135285; Rosychuk RJ, 2012, NEONATOLOGY, V101, P14, DOI 10.1159/000326797; Saugstad OD, 2014, NEONATOLOGY, V105, P55, DOI 10.1159/000356561; Schmidt B, 2014, J PEDIATR-US, V165, P666, DOI 10.1016/j.jpeds.2014.05.028; Schmidt B, 2014, J PEDIATR-US, V165, P6, DOI 10.1016/j.jpeds.2014.03.004; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Schou IM, 2013, STAT MED, V32, P4859, DOI 10.1002/sim.5893; Silverman WA, 2004, PEDIATRICS, V113, P394, DOI 10.1542/peds.113.2.394; Sola A, 2014, ACTA PAEDIATR, V103, P1009, DOI 10.1111/apa.12692; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Tarnow-Mordi W, 2015, SEMIN FETAL NEONAT M, V20, P389, DOI 10.1016/j.siny.2015.10.001; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506	29	124	127	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					749	760		10.1056/NEJMoa1514212	http://dx.doi.org/10.1056/NEJMoa1514212			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26863265	Green Published, Bronze			2022-12-28	WOS:000370716600008
J	Nguyen, THD; Galej, WP; Bai, XC; Oubridge, C; Newman, AJ; Scheres, SHW; Nagai, K				Thi Hoang Duong Nguyen; Galej, Wojciech P.; Bai, Xiao-chen; Oubridge, Chris; Newman, Andrew J.; Scheres, Sjors H. W.; Nagai, Kiyoshi			Cryo-EM structure of the yeast U4/U6.U5 tri-snRNP at 3.7 angstrom resolution	NATURE			English	Article							PRE-MESSENGER-RNA; GROUP-II INTRON; U5 SNRNP; SPLICING FACTOR; SACCHAROMYCES-CEREVISIAE; SPLICEOSOME ACTIVATION; CRYSTAL-STRUCTURE; ACTIVE-SITE; ELECTRON CRYOMICROSCOPY; CONFORMATIONAL-CHANGES	U4/U6.U5 tri-snRNP represents a substantial part of the spliceosome before activation. A cryo-electron microscopy structure of Saccharomyces cerevisiae U4/U6.U5 tri-snRNP at 3.7 angstrom resolution led to an essentially complete atomic model comprising 30 proteins plus U4/U6 and U5 small nuclear RNAs (snRNAs). The structure reveals striking interweaving interactions of the protein and RNA components, including extended polypeptides penetrating into subunit interfaces. The invariant ACAGAGA sequence of U6 snRNA, which base-pairs with the 5'-splice site during catalytic activation, forms a hairpin stabilized by Dib1 and Prp8 while the adjacent nucleotides interact with the exon binding loop 1 of U5 snRNA. Snu114 harbours GTP, but its putative catalytic histidine is held away from the gamma-phosphate by hydrogen bonding to a tyrosine in the amino-terminal domain of Prp8. Mutation of this histidine to alanine has no detectable effect on yeast growth. The structure provides important new insights into the spliceosome activation process leading to the formation of the catalytic centre.	[Thi Hoang Duong Nguyen; Galej, Wojciech P.; Bai, Xiao-chen; Oubridge, Chris; Newman, Andrew J.; Scheres, Sjors H. W.; Nagai, Kiyoshi] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Nguyen, THD; Galej, WP; Nagai, K (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	knguyen@mrc-lmb.cam.ac.uk; wgalej@mrc-lmb.cam.ac.uk; kn@mrc-lmb.cam.ac.uk	Bai, Xiao-chen/HGV-1244-2022; Scheres, Sjors H.W./AAY-2265-2021	Bai, Xiao-chen/0000-0002-4234-5686; Scheres, Sjors H.W./0000-0002-0462-6540; Oubridge, Chris/0000-0001-8492-8305; Nguyen, Thi Hoang Duong/0000-0002-2180-3430; Galej, Wojciech/0000-0001-8859-5229	Medical Research Council [MC_U105184330, MC_UP_A025_1013] Funding Source: Medline; MRC [MC_U105184330, MC_UP_A025_1013] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ayadi L, 1998, J MOL BIOL, V284, P673, DOI 10.1006/jmbi.1998.2183; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bartels C, 2003, J BIOL CHEM, V278, P28324, DOI 10.1074/jbc.M303043200; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Brenner TJ, 2006, RNA, V12, P862, DOI 10.1261/rna.2319806; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Frazer LN, 2009, GENETICS, V183, P497, DOI 10.1534/genetics.109.107243; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; GALISSON F, 1993, NUCLEIC ACIDS RES, V21, P1555, DOI 10.1093/nar/21.7.1555; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gottschalk A, 1999, EMBO J, V18, P4535, DOI 10.1093/emboj/18.16.4535; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhn AN, 2000, GENETICS, V155, P1667; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li ZR, 1996, RNA, V2, P879; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; MADHANI HD, 1994, ANNU REV GENET, V28, P1; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Maracci C, 2014, P NATL ACAD SCI USA, V111, P14418, DOI 10.1073/pnas.1412676111; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Stevens SW, 2001, RNA, V7, P1543; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Turner IA, 2006, RNA, V12, P375, DOI 10.1261/rna.2229706; van Nues RW, 2001, GENETICS, V157, P1451; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629	66	152	153	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					298	+		10.1038/nature16940	http://dx.doi.org/10.1038/nature16940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26829225	Green Accepted			2022-12-28	WOS:000370327100029
J	Sabbatini, AK; Kocher, KE; Basu, A; Hsia, RY				Sabbatini, Amber K.; Kocher, Keith E.; Basu, Anirban; Hsia, Renee Y.			In-Hospital Outcomes and Costs Among Patients Hospitalized During a Return Visit to the Emergency Department	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMISSION RATES; ADMINISTRATIVE DATA; DISCHARGE; QUALITY; CARE; INDICATORS; PERFORMANCE; PREDICTORS; CONSENSUS; SAVINGS	IMPORTANCE Unscheduled short-term return visits to the emergency department (ED) are increasingly monitored as a hospital performance measure and have been proposed as a measure of the quality of emergency care. OBJECTIVE To examine in-hospital clinical outcomes and resource use among patients who are hospitalized during an unscheduled return visit to the ED. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of adult ED visits to acute care hospitals in Florida and New York in 2013 using data from the Healthcare Cost and Utilization Project. Patients with index ED visits were identified and followed up for return visits to the ED within 7, 14, and 30 days. EXPOSURES Hospital admissions occurring during an initial visit to the ED vs during a return visit to the ED. MAIN OUTCOMES AND MEASURES In-hospital mortality, intensive care unit (ICU) admission, length of stay, and inpatient costs. RESULTS Among the 9 036 483 index ED visits to 424 hospitals in the study sample, 1758 359 patients were admitted to the hospital during the index ED visit. Of these patients, 149 214 (8.5%) had a return visit to the ED within 7 days of the index ED visit, 228 370 (13.0%) within 14 days, and 349 335 (19.9%) within 30 days, and 76 151(51.0%), 122 040 (53.4%), and 190 768 (54.6%), respectively, were readmitted to the hospital. Among the 7 278 124 patients who were discharged during the index ED visit, 598 404 (8.2%) had a return visit to the ED within 7 days, 839 386 (11.5%) within 14 days, and 1205 865 (16.6%) within 30 days. Of these patients, 86 012 (14.4%) were admitted to the hospital within 7 days, 121587 (14.5%) within 14 days, and 173 279 (14.4%) within 30 days. The 86 012 patients discharged from the ED and admitted to the hospital during a return ED visit within 7 days had significantly lower rates of in-hospital mortality (1.85%) compared with the 1 609 145 patients who were admitted during the index ED visit without a return ED visit (2.48%) (odds ratio, 0.73 [95% CI, 0.69-0.78]), lower rates of ICU admission (23.3% vs 29.0%, respectively; odds ratio, 0.73 [95% CI, 0.71-0.761), lower mean costs 510169 vs $10 799; difference, $629 [95% CI, $47947811), and longer lengths of stay (5]6 days vs 4.97 days; IRR, 1.04 [95% CI,1.03-1.05]). Similar outcomes were observed for patients returning to the ED within 14 and 30 days of the index ED visit. In contrast, patients who returned to the ED after hospital discharge and were readmitted had higher rates of in-hospital mortality and ICU admission, longer lengths of stay, and higher costs during the repeat hospital admission compared with those admitted to the hospital during the index ED visit without a return ED visit. CONCLUSIONS AND RELEVANCE Compared with adult patients who were hospitalized during the index ED visit and did not have a return visit to the ED, patients who were initially discharged during an ED visit and admitted during a return visit to the ED had lower in-hospital mortality, ICU admission rates, and in-hospital costs and longer lengths of stay. These findings suggest that hospital admissions associated with return visits to the ED may not adequately capture deficits in the quality of care delivered during an ED visit.	[Sabbatini, Amber K.] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA; [Kocher, Keith E.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Kocher, Keith E.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Basu, Anirban] Univ Washington, Dept Hlth Serv & Econ, Seattle, WA 98195 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sabbatini, AK (corresponding author), Harborview Med Ctr, Div Emergency Med, 325 Ninth Ave,POB 359702, Seattle, WA 98104 USA.	asabbati@uw.edu		Kocher, Keith/0000-0001-7256-8859	AHRQ HHS [K08 HS024160, K12 HS022982, K12 HS022982-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024160, K12HS022982] Funding Source: NIH RePORTER; AHRQ [5K12HS022982-03] Funding Source: Federal RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Abualenain J, 2013, J EMERG MED, V45, P281, DOI 10.1016/j.jemermed.2012.11.012; Abualenain J, 2013, ANN EMERG MED, V61, P638, DOI 10.1016/j.annemergmed.2013.01.016; American College of Emergency Physicians, APP B ACEP CEDR QCDR; [Anonymous], 2010, ADVERSE EVENTS HOSP; Capp R, 2014, AM J EMERG MED, V32, P837, DOI 10.1016/j.ajem.2014.03.033; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Cubanksi J, 2014, MUCH IS ENOUGH OUT O; Easter JS, 2013, J EMERG MED, V44, P682, DOI 10.1016/j.jemermed.2012.05.011; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, CLIN CLASSIFICATIONS; Gabayan GZ, 2015, J AM GERIATR SOC, V63, P39, DOI 10.1111/jgs.13185; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Gabayan GZ, 2011, ANN EMERG MED, V58, P551, DOI 10.1016/j.annemergmed.2011.07.001; Griffey RT, 2015, ACAD EMERG MED, V22, P497, DOI 10.1111/acem.12666; Griffey RT, 2014, ACAD EMERG MED, V21, P1109, DOI 10.1111/acem.12476; Guttmann A, 2006, PEDIATRICS, V118, P114, DOI 10.1542/peds.2005-3029; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Hines AL, CONDITIONS LARGEST N; Hung GR, 2008, PEDIATR EMERG CARE, V24, P9, DOI 10.1097/pec.0b013e31815f39a5; Katz DA, 2013, J EMERG MED, V45, P947, DOI 10.1016/j.jemermed.2013.05.029; Levit KR, 2013, HEALTH SERV RES, V48, P1779, DOI 10.1111/1475-6773.12065; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1197/aemj.9.11.1131; Martin-Gill C, 2004, AM J EMERG MED, V22, P448, DOI 10.1016/j.ajem.2004.07.023; Nunez S, 2006, QUAL SAF HEALTH CARE, V15, P102, DOI 10.1136/qshc.2005.016618; Pham JC, 2011, ACAD EMERG MED, V18, P390, DOI 10.1111/j.1553-2712.2011.01042.x; PIERCE JM, 1990, ANN EMERG MED, V19, P752, DOI 10.1016/S0196-0644(05)81698-1; Rising KL, 2014, ACAD EMERG MED, V21, P864, DOI 10.1111/acem.12442; Rising KL, 2013, ANN EMERG MED, V62, P145, DOI 10.1016/j.annemergmed.2013.01.024; Ross MA, 2013, HEALTH AFFAIR, V32, P2149, DOI 10.1377/hlthaff.2013.0662; Sabbatini AK, 2014, HEALTH AFFAIR, V33, P1655, DOI 10.1377/hlthaff.2013.1318; Sauvin G, 2013, ACAD EMERG MED, V20, P33, DOI 10.1111/acem.12052; Schull MJ, 2011, CAN J EMERG MED, V13, P300, DOI 10.2310/8000.2011.110334; Schull MJ, 2011, CJEM, V13, pE28; Sklar DP, 2007, ANN EMERG MED, V49, P735, DOI 10.1016/j.annemergmed.2006.11.018; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; US Centers for Medicare & Medicaid Services, READM RED PROGR; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Venkatesh AK, 2015, MED CARE, V53, P237, DOI 10.1097/MLR.0000000000000261	38	72	72	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					663	671		10.1001/jama.2016.0649	http://dx.doi.org/10.1001/jama.2016.0649			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD8JB	26881369	Bronze, Green Accepted			2022-12-28	WOS:000370171500012
J	Jiang, WY; Samai, P; Marraffini, LA				Jiang, Wenyan; Samai, Poulami; Marraffini, Luciano A.			Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity	CELL			English	Article							ADAPTIVE BACTERIAL IMMUNITY; TARGET RECOGNITION; SPACER ACQUISITION; ANTIVIRAL DEFENSE; DUAL-RNA; COMPLEX; DNA; SYSTEM; CLEAVAGE; ELEMENTS	Type III-A CRISPR-Cas systems defend prokaryotes against viral infection using CRISPR RNA (crRNA)-guided nucleases that perform co-transcriptional cleavage of the viral target DNA and its transcripts. Whereas DNA cleavage is essential for immunity, the function of RNA targeting is unknown. Here, we show that transcription-dependent targeting results in a sharp increase of viral genomes in the host cell when the target is located in a late-expressed phage gene. In this targeting condition, mutations in the active sites of the type III-A RNases Csm3 and Csm6 lead to the accumulation of the target phage mRNA and abrogate immunity. Csm6 is also required to provide defense in the presence of mutated phage targets, when DNA cleavage efficiency is reduced. Our results show that the degradation of phage transcripts by CRISPR-associated RNases ensures robust immunity in situations that lead to a slow clearance of the target DNA.	[Jiang, Wenyan; Samai, Poulami; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Rita Allen Scholars Program; NIH Director's New Innovator Award [1DP2AI104556-01]; Sinsheimer Foundation Award; Irma T. Hirschl Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Rita Allen Scholars Program; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sinsheimer Foundation Award; Irma T. Hirschl Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Andrew Varble, Gregory Goldberg, and Nora Pyenson for critical reading of the manuscript. We are grateful to Gregory Goldberg for initial demonstrations of the csm6-independent chromosomal targeting. We thank the Rockefeller University Genomics Resource Center for performing the RNA-seq experiments. We are grateful to the Tavazoie lab for help with qRT-PCR. P.S. is supported by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University. L.A.M. is supported by the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ramia NF, 2014, CELL REP, V9, P1610, DOI 10.1016/j.celrep.2014.11.007; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Theis T, 2007, J MICROBIOL METH, V70, P355, DOI 10.1016/j.mimet.2007.05.011; Weinberger AD, 2015, CELL, V161, P964, DOI 10.1016/j.cell.2015.05.003; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	48	132	136	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					710	721		10.1016/j.cell.2015.12.053	http://dx.doi.org/10.1016/j.cell.2015.12.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26853474	Bronze, Green Accepted			2022-12-28	WOS:000369998300016
J	Menager, MM; Littman, DR				Menager, Mickael M.; Littman, Dan R.			Actin Dynamics Regulates Dendritic Cell-Mediated Transfer of HIV-1 to T Cells	CELL			English	Article							ARP2/3 COMPLEX; DC-SIGN; INFECTION; PROTEIN; SENSOR; TETRASPANINS; ENHANCEMENT; INHIBITION; PATHWAY; SYNAPSE	Whereas human dendritic cells (DCs) are largely resistant to productive infection with HIV-1, they have a unique ability to take up the virus and transmit it efficiently to T lymphocytes through a process of trans-infection or trans-enhancement. To elucidate the molecular and cell biological mechanism for trans-enhancement, we performed an shRNA screen of several hundred genes involved in organelle and membrane trafficking in immature human monocyte-derived dendritic cells (MDDCs). We identified TSPAN7 and DNM2, which control actin nucleation and stabilization, as having important and distinct roles in limiting HIV-1 endocytosis and in maintaining virus particles on dendrites, which is required for efficient transfer to T lymphocytes. Further characterization of this process may provide insights not only into the role of DCs in transmission and dissemination of HIV-1 but also more broadly into mechanisms controlling capture and internalization of pathogens.	[Menager, Mickael M.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	New York University; Howard Hughes Medical Institute	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA.	mickael.menager@med.nyu.edu; dan.littman@med.nyu.edu	Ménager, Mickaël M/L-2334-2017	Menager, Mickael/0000-0002-6838-2389	EMBO; Cancer Research Institute; Philippe Foundation; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health [R21AI084633]; NCRR [S10 RR023704-01A1]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084633] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Cancer Research Institute; Philippe Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Nir Hacohen, David Root, and Derya Unutmaz for help with the shRNA screen library design and generation; Alice F. Liang and the NYULMC OCS Microscopy Core for the service provided for light and electron microscopy; the New York Structural Biology Center; Wendy Lin for technical help; and Jarrod Johnson, Nicolas Manel, Sebastian Amigorena, and Philippe Benaroche for their critical advice. This work was supported by fellowships from EMBO, the Cancer Research Institute, and the Philippe Foundation (M.M.M.); by the Howard Hughes Medical Institute (D.R.L.) and Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.); and by grants from the National Institutes of Health (R21AI084633) (D.R.L.) and NCRR (S10 RR023704-01A1).	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Casalou C, 2014, J CELL SCI, V127, P2709, DOI 10.1242/jcs.143446; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Kaur S, 2014, ELIFE, V3, DOI 10.7554/eLife.00829; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Menon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094330; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sewald X, 2015, SCIENCE, V350, P563, DOI 10.1126/science.aab2749; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Do T, 2014, J VIROL, V88, P10327, DOI 10.1128/JVI.00788-14; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	52	61	62	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					695	709		10.1016/j.cell.2015.12.036	http://dx.doi.org/10.1016/j.cell.2015.12.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26830877	Green Accepted, Bronze			2022-12-28	WOS:000369998300015
J	Turner, M				Turner, Marian			Sequencing on the ground	NATURE			English	Editorial Material																		Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					167	167		10.1038/530167a	http://dx.doi.org/10.1038/530167a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI4ZL	26863977	Bronze			2022-12-28	WOS:000491113000001
J	Meeker, D; Linder, JA; Fox, CR; Friedberg, MW; Persell, SD; Goldstein, NJ; Knight, TK; Hay, JW; Doctor, JN				Meeker, Daniella; Linder, Jeffrey A.; Fox, Craig R.; Friedberg, Mark W.; Persell, Stephen D.; Goldstein, Noah J.; Knight, Tara K.; Hay, Joel W.; Doctor, Jason N.			Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-TRACT INFECTIONS; ACUTE BRONCHITIS; SOCIAL NORMS; ADULTS; PRINCIPLES; CLUSTER; RATES; ACCOUNTABILITY	IMPORTANCE Interventions based on behavioral science might reduce inappropriate antibiotic prescribing. OBJECTIVE To assess effects of behavioral interventions and rates of inappropriate (not guideline-concordant) antibiotic prescribing during ambulatory visits for acute respiratory tract infections. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized clinical trial conducted among 47 primary care practices in Boston and Los Angeles. Participants were 248 enrolled clinicians randomized to receive 0, 1, 2, or 3 interventions for 18 months. All clinicians received education on antibiotic prescribing guidelines on enrollment. Interventions began between November 1, 2011, and October 1, 2012. Follow-up for the latest-starting sites ended on April 1, 2014. Adult patients with comorbidities and concomitant infections were excluded. INTERVENTIONS Three behavioral interventions, implemented alone or in combination: suggested alternatives presented electronic order sets suggesting nonantibiotic treatments; accountable justification prompted clinicians to enter free-text justifications for prescribing antibiotics into patients' electronic health records; peer comparison sent emails to clinicians that compared their antibiotic prescribing rates with those of "top performers" (those with the lowest inappropriate prescribing rates). MAIN OUTCOMES AND MEASURES Antibiotic prescribing rates for visits with antibiotic-inappropriate diagnoses (nonspecific upper respiratory tract infections, acute bronchitis, and influenza) from 18 months preintervention to 18 months afterward, adjusting each intervention's effects for co-occurring interventions and preintervention trends, with random effects for practices and clinicians. RESULTS There were 14 753 visits (mean patient age, 47 years; 69% women) for antibiotic-inappropriate acute respiratory tract infections during the baseline period and 16 959 visits (mean patient age, 48 years; 67% women) during the intervention period. Mean antibiotic prescribing rates decreased from 24.1% at intervention start to 13.1% at intervention month 18 (absolute difference, -11.0%) for control practices; from 22.1% to 6.1% (absolute difference, -16.0%) for suggested alternatives (difference in differences, -5.0%[95% CI, -7.8% to 0.1%]; P = .66 for differences in trajectories); from 23.2% to 5.2%(absolute difference, -18.1%) for accountable justification (difference in differences, -7.0%[95% CI, -9.1% to -2.9%]; P < .001); and from 19.9% to 3.7%(absolute difference, -16.3%) for peer comparison (difference in differences, -5.2%[95% CI, -6.9% to -1.6%]; P < .001). There were no statistically significant interactions (neither synergy nor interference) between interventions. CONCLUSIONS AND RELEVANCE Among primary care practices, the use of accountable justification and peer comparison as behavioral interventions resulted in lower rates of inappropriate antibiotic prescribing for acute respiratory tract infections.	[Meeker, Daniella; Knight, Tara K.; Hay, Joel W.; Doctor, Jason N.] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90089 USA; [Meeker, Daniella] RAND Corp, Santa Monica, CA USA; [Linder, Jeffrey A.; Friedberg, Mark W.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Linder, Jeffrey A.; Friedberg, Mark W.] Harvard Univ, Sch Med, Boston, MA USA; [Fox, Craig R.; Goldstein, Noah J.] Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA USA; [Fox, Craig R.; Goldstein, Noah J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; [Friedberg, Mark W.] RAND Corp, Boston, MA USA; [Persell, Stephen D.] Northwestern Univ, Chicago, IL 60611 USA	University of Southern California; RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; Northwestern University	Doctor, JN (corresponding author), Univ So Calif, Sch Pharm, Leonard D Schaeffer Ctr Hlth Policy & Econ, Verna & Peter Dauterive Hall VPD,635 Downey Way, Los Angeles, CA 90089 USA.	jdoctor@usc.edu	Friedberg, Mark William/Y-2607-2019; Meeker, Daniella/AAV-5953-2020; Linder, Jeffrey/AAF-3424-2021	Friedberg, Mark William/0000-0002-7907-8358; Meeker, Daniella/0000-0002-1034-7628; Linder, Jeffrey/0000-0003-2217-184X	American Recovery & Reinvestment Act from the National Institutes of Health/National Institute on Aging and Agency for Healthcare Research and Quality [RC4 AG039115]; Agency for Healthcare Research and Quality through the American Recovery & Reinvestment Act [R01 HS19913-01]; Patient-Centered Outcomes Research Institute (PCORI) [CDRN-1306-04819]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039115] Funding Source: NIH RePORTER	American Recovery & Reinvestment Act from the National Institutes of Health/National Institute on Aging and Agency for Healthcare Research and Quality; Agency for Healthcare Research and Quality through the American Recovery & Reinvestment Act; Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the American Recovery & Reinvestment Act of 2009 (RC4 AG039115) from the National Institutes of Health/National Institute on Aging and Agency for Healthcare Research and Quality (Dr Doctor, University of Southern California). The project also benefited from technology funded by the Agency for Healthcare Research and Quality through the American Recovery & Reinvestment Act of 2009 (R01 HS19913-01) (Dr Ohno-Machado, University of California, San Diego). Data for the project were collected by the University of Southern California's Medical Information Network for Experimental Research (Med-INFER) which participates in the Patient Scalable National Network for Effectiveness Research (pSCANNER) supported by the Patient-Centered Outcomes Research Institute (PCORI), Contract CDRN-1306-04819 (Dr Ohno-Machado).	Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Baumeister Roy F, 1987, THEORIES GROUP BEHAV, P71, DOI [10.1007/978-1-4612-4634-3_4, DOI 10.1007/978-1-4612-4634-3_4]; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; De Cremer D, 2003, CURR PSYCHOL, V22, P155, DOI 10.1007/s12144-003-1006-6; Embi PJ, 2012, J AM MED INFORM ASSN, V19, pE145, DOI 10.1136/amiajnl-2011-000743; Fairlie T, 2012, ARCH INTERN MED, V172, P1513, DOI 10.1001/archinternmed.2012.4089; Gail MH, 1984, BIOMETRIKA, V71, P432; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Gonzales R, 2013, JAMA INTERN MED, V173, P267, DOI 10.1001/jamainternmed.2013.1589; Grice H., 1978, SOME FURTHER NOTES L; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Gunst RF, 2009, WIRES COMPUT STAT, V1, P234, DOI 10.1002/wics.27; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; JAMTVEDT G, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000259.PUB2; JERDEE TH, 1974, J APPL PSYCHOL, V59, P712, DOI 10.1037/h0037450; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Jones BE, 2015, ANN INTERN MED, V163, P73, DOI 10.7326/M14-1933; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Linder JA, 2006, J AM MED INFORM ASSN, V13, P61, DOI 10.1197/jamia.M1780; Linder JA, 2013, JAMA INTERN MED, V173, P273, DOI 10.1001/jamainternmed.2013.1984; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Metlay JP, 2007, ANN EMERG MED, V50, P221, DOI 10.1016/j.annemergmed.2007.03.022; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; O'Connor SD, 2014, AM J ROENTGENOL, V203, pW482, DOI 10.2214/AJR.14.13017; Observational Medical Outcomes Partnership, 2010, OMOP SPEC IMPL STAND; Office of the Press Secretary The White House, 2014, COMB ANT RES BACT; Office of the Press Secretary The White House, 2015, OFF PRESS SECR WHIT; Procop GW, 2015, AM J CLIN PATHOL, V143, P623, DOI 10.1309/AJCPJOJ3HKEBD3TU; Review on Antimicrobial Resistance, 2014, REV ANTIMICROBIAL RE; Robinson LD, 1991, INT STAT REV, V58, P227; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Steinman MAS, 2006, TECHNICAL REV, V4; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256	40	497	498	4	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					562	570		10.1001/jama.2016.0275	http://dx.doi.org/10.1001/jama.2016.0275			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD0UJ	26864410	Bronze, Green Accepted			2022-12-28	WOS:000369635200015
J	Goldacre, B				Goldacre, Ben			Make journals report clinical trials properly	NATURE			English	Editorial Material									[Goldacre, Ben] Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	ben.goldacre@phc.ox.ac.uk		Goldacre, Ben/0000-0002-5127-4728					0	20	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					7	7		10.1038/530007a	http://dx.doi.org/10.1038/530007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC6BK	26842021	Bronze			2022-12-28	WOS:000369304500004
J	Kim, DK; Bridges, CB; Harriman, KH				Kim, David K.; Bridges, Carolyn B.; Harriman, Kathleen H.		Advisory Comm Immunization Practic	Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2016	ANNALS OF INTERNAL MEDICINE			English	Article							MENINGOCOCCAL DISEASE RECOMMENDATIONS; VACCINES RECOMMENDATIONS; INFLUENZA VACCINATION; PREVENTION; RISK		[Kim, David K.; Bridges, Carolyn B.] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-19, Atlanta, GA 30333 USA; [Harriman, Kathleen H.] Calif Dept Publ Hlth, 850 Marina Bay Pkwy,Bldg P,Second Floor, Richmond, CA 94804 USA	Centers for Disease Control & Prevention - USA; California Department of Public Health	Kim, DK (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop A-19, Atlanta, GA 30333 USA.	dkim@cdc.gov						American College of Obstetricians and Gynecologists, 2015, ACOG APP IMM; American College of Physicians, 2012, ACP IMM ADV APP; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Barnes M, 2015, HEART, V101, P1738, DOI 10.1136/heartjnl-2015-307691; Centers for Disease Control and Prevention, VACC SCHED APP CLIN; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Guide to Community Preventive Services, INCR APPR VACC; Hurley LP, 2014, ANN INTERN MED, V160, P161, DOI 10.7326/M13-2332; Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P944, DOI 10.15585/mmwr.mm6434a4; Lu P, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.031; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Miller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Williams WW, 2014, MMWR-MORBID MORTAL W, V63, P95	20	29	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					184	U174		10.7326/M15-3005	http://dx.doi.org/10.7326/M15-3005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26829913				2022-12-28	WOS:000369169400007
J	Wilmshurst, P				Wilmshurst, Peter			Poor governance in the award of honours and degrees in British medicine: an extreme example of a systemic problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wilmshurst, Peter] Royal Stoke Univ Hosp, Stoke On Trent ST4 6QG, Staffs, England	Royal Stoke University Hospital	Wilmshurst, P (corresponding author), Royal Stoke Univ Hosp, Stoke On Trent ST4 6QG, Staffs, England.	peter.wilmshurst@tiscali.co.uk						[Anonymous], 2014, LONDON GAZETTE   AUG; [Anonymous], DOCTOR HIST; [Anonymous], 2014, BEDFORD NEWS    0627; BANERJEE AK, 1990, GUT, V31, P1358, DOI 10.1136/gut.31.12.1358; Farthing MJG, 2001, GUT, V48, P285, DOI 10.1136/gut.48.3.285; Wilmshurst P, 2002, BRIT MED J, V325, P1232, DOI 10.1136/bmj.325.7374.1232	6	1	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								h6952	10.1136/bmj.h6952	http://dx.doi.org/10.1136/bmj.h6952			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QK	26838121				2022-12-28	WOS:000369767100001
J	Mishanina, TV; Yu, LP; Karunaratne, K; Mondal, D; Corcoran, JM; Choi, MA; Kohen, A				Mishanina, Tatiana V.; Yu, Liping; Karunaratne, Kalani; Mondal, Dibyendu; Corcoran, John M.; Choi, Michael A.; Kohen, Amnon			An unprecedented mechanism of nucleotide methylation in organisms containing thyX	SCIENCE			English	Article							DEPENDENT THYMIDYLATE SYNTHASE; FLAVIN; ACTIVATION; SUBSTRATE	In several human pathogens, thyX-encoded flavin-dependent thymidylate synthase (FDTS) catalyzes the last step in the biosynthesis of thymidylate, one of the four DNA nucleotides. ThyX is absent in humans, rendering FDTS an attractive antibiotic target; however, the lack of mechanistic understanding prohibits mechanism-based drug design. Here, we report trapping and characterization of two consecutive intermediates, which together with previous crystal structures indicate that the enzyme's reduced flavin relays a methylene from the folate carrier to the nucleotide acceptor. Furthermore, these results corroborate an unprecedented activation of the nucleotide that involves no covalent modification but only electrostatic polarization by the enzyme's active site. These findings indicate a mechanism that is very different from thymidylate biosynthesis in humans, underscoring the promise of FDTS as an antibiotic target.	[Mishanina, Tatiana V.; Karunaratne, Kalani; Mondal, Dibyendu; Corcoran, John M.; Choi, Michael A.; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Carver Coll Med, NMR Core Facil, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Mishanina, Tatiana V.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Iowa; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu	mondal, dibyendu/AAT-8203-2021	mondal, dibyendu/0000-0003-0255-5029; Mishanina, Tatiana/0000-0001-7400-3501; Yu, Liping/0000-0003-3536-6427	NIH [R01 GM110775]; Iowa Center of Biocatalysis and Bioprocessing (NIH) [T32 GM008365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, T32GM007337, R01GM110775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa Center of Biocatalysis and Bioprocessing (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Roston for assistance with kinetic data fitting, and M. S. Hossain and F. W. Foss Jr. for assistance with preparation of 5-deaza-riboflavin. This work was funded by NIH R01 GM110775 to A.K. and a fellowship from the Iowa Center of Biocatalysis and Bioprocessing (NIH T32 GM008365) to T.V.M. and K.K.	CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Conrad JA, 2014, BIOCHEMISTRY-US, V53, P5199, DOI 10.1021/bi500648n; Hamdane D, 2012, J AM CHEM SOC, V134, P19739, DOI 10.1021/ja308145p; Koehn EM, 2012, P NATL ACAD SCI USA, V109, P15722, DOI 10.1073/pnas.1206077109; Koehn EM, 2009, NATURE, V458, P919, DOI 10.1038/nature07973; Leduc D, 2004, BIOCHEM SOC T, V32, P231, DOI 10.1042/BST0320231; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; Mishanina TV, 2015, J LABELLED COMPD RAD, V58, P370, DOI 10.1002/jlcr.3313; Mishanina TV, 2014, J AM CHEM SOC, V136, P10597, DOI 10.1021/ja506108b; Mishanina TV, 2012, J AM CHEM SOC, V134, P4442, DOI 10.1021/ja2120822; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113	12	33	33	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					507	510		10.1126/science.aad0300	http://dx.doi.org/10.1126/science.aad0300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823429	Green Accepted			2022-12-28	WOS:000368858200037
J	Poliak, S; Norovich, AL; Yamagata, M; Sanes, JR; Jessell, TM				Poliak, Sebastian; Norovich, Amy L.; Yamagata, Masahito; Sanes, Joshua R.; Jessell, Thomas M.			Muscle-type Identity of Proprioceptors Specified by Spatially Restricted Signals from Limb Mesenchyme	CELL			English	Article							NEURONS; CONNECTIVITY; CELLS; SPECIFICATION; EXPRESSION; LMX1B; MOTONEURONS; GENERATION; AFFERENTS; PATTERN	The selectivity with which proprioceptive sensory neurons innervate their central and peripheral targets implies that they exhibit distinctions in muscle-type identity. The molecular correlates of proprioceptor identity and its origins remain largely unknown, however. In screens to define muscle-type proprioceptor character, we find all-or-none differences in gene expression for proprioceptors that control antagonistic muscles at a single hindlimb joint. Analysis of three of these genes, cadherin13 (cdh13), semaphorin5a (sema5a), and cartilage-acidic protein-1 (crtac1), reveals expression in proprioceptor subsets that supply muscle groups located at restricted dorsoventral and proximodistal domains of the limb. Genetically altering the dorsoventral character of the limb mesenchyme elicits a change in the profile of proprioceptor cdh13, sema5a, and crtac1 expression. These findings indicate that proprioceptors acquire aspects of their muscle-type identity in response to mesenchymal signals expressed in restricted proximodistal and dorsoventral domains of the developing limb.	[Poliak, Sebastian; Jessell, Thomas M.] Columbia Univ, Dept Neurosci Biochem & Mol Biophys, New York, NY 10032 USA; [Norovich, Amy L.] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Jessell, Thomas M.] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, New York, NY 10032 USA; [Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Harvard University; Harvard University	Jessell, TM (corresponding author), Columbia Univ, Dept Neurosci Biochem & Mol Biophys, New York, NY 10032 USA.; Jessell, TM (corresponding author), Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, New York, NY 10032 USA.	tmj1@columbia.edu	Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931	Helen Hay Whitney Foundation fellowship; NIH; NINDS; Leila and Harold Mathers Foundation; ProjectALS; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R01NS080932] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Leila and Harold Mathers Foundation; ProjectALS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Qiaolian Liu for assistance, Gulsen Surmeli for help with muscle injections and DRG dissections, Sean O'Keeffe for RNA-seq data analysis, Irina de la Huerta for initial characterization of Cdh13-CreER<SUP>T2</SUP> mice, and Randy Johnson and Rajeshwar Awatramani for Rosa26::lox-STOP- lox::Lmx1b mice. We thank Nikolaos Balaskas, Joriene de Nooij, Andrew Murray, and David Ng for critical comments on the manuscript; Kathy McArthur for secretarial assistance; and Ira Schieren for graphics. Erica Famojure, Barbara Han, Susan Brenner-Morton, Monica Mendelsohn, and Nataliya Zabello provided lab support. S.P. was supported by a Helen Hay Whitney Foundation fellowship. J.R.S. was supported by grants from NIH. T.M.J. is an HHMI investigator and is supported by grants from NINDS, The Leila and Harold Mathers Foundation, and ProjectALS.	Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen HH, 2002, DEVELOPMENT, V129, P4879; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Feenstra JM, 2012, DEV GROWTH DIFFER, V54, P451, DOI 10.1111/j.1440-169X.2012.01331.x; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Fukuhara K, 2013, CELL REP, V5, P748, DOI 10.1016/j.celrep.2013.10.005; Gross MK, 2000, DEVELOPMENT, V127, P413; Haddick PCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084823; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Honig MG, 1998, DEVELOPMENT, V125, P995; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; Hunt C. C., 1974, HDB SENSORY PHYSL, VII, P2; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li Y, 2010, DEVELOPMENT, V137, P1181, DOI 10.1242/dev.045237; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mears SC, 1997, J NEUROSCI, V17, P3128; Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045; MENDELSON B, 1991, J NEUROSCI, V11, P1390; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; NICHOLS TR, 1994, ACTA ANAT, V151, P1; PHELAN KA, 1990, J NEUROSCI, V10, P2699; Poliak S, 2015, ELIFE, V4, DOI 10.7554/eLife.10841; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwabe T, 2013, CELL, V154, P351, DOI 10.1016/j.cell.2013.06.011; Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; Wenner P, 1995, J NEUROSCI, V15, P8191; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; Zhao J, 2006, GENESIS, V44, P364, DOI 10.1002/dvg.20224	48	26	26	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					512	525		10.1016/j.cell.2015.12.049	http://dx.doi.org/10.1016/j.cell.2015.12.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824659	Bronze, Green Accepted			2022-12-28	WOS:000368906800020
J	Baker, TB; Piper, ME; Stein, JH; Smith, SS; Bolt, DM; Fraser, DL; Fiore, MC				Baker, Timothy B.; Piper, Megan E.; Stein, James H.; Smith, Stevens S.; Bolt, Daniel M.; Fraser, David L.; Fiore, Michael C.			Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; UNITED-STATES; PLACEBO; ADHERENCE; CIGARETTE; PHARMACOTHERAPIES; OUTCOMES	IMPORTANCE Smoking cessation medications are routinely used in health care; it is vital to identify medications that most effectively treat this leading cause of preventable mortality. OBJECTIVE To compare the efficacies of varenicline, combination nicotine replacement therapy (C-NRT), and the nicotine patch for 26-week quit rates. DESIGN, SETTING, AND PARTICIPANTS Three-group randomized intention-to-treat clinical trial occurring from May 2012 to November 2015 among smokers recruited in the Madison, Wisconsin, and Milwaukee, Wisconsin, communities; 65.5% of smokers offered the study (2687/4102) refused participation prior to randomization. INTERVENTIONS Participants were randomized to one of three 12-week open-label smoking cessation pharmacotherapy groups: (1) nicotine patch only (n = 241); (2) varenicline only (including 1 prequit week; n = 424); and (3) C-NRT (nicotine patch + nicotine lozenge; n = 421). Six counseling sessions were offered. MAIN OUTCOMES AND MEASURES The primary outcome was carbon monoxide-confirmed self-reported 7-day point-prevalence abstinence at 26 weeks. Secondary outcomes were carbon monoxide-confirmed self-reported initial abstinence, prolonged abstinence at 26 weeks, and point-prevalence abstinence at weeks 4, 12, and 52. RESULTS Among 1086 smokers randomized (52% women; 67% white; mean age, 48 years; mean of 17 cigarettes smoked per day), 917 (84%) provided 12-month follow-up data. Treatments did not differ on any abstinence outcome measure at 26 or 52 weeks, including point-prevalence abstinence at 26 weeks (nicotine patch, 22.8%[55/241]; varenicline, 23.6% [100/424]; and C-NRT, 26.8%[113/421]) or at 52 weeks (nicotine patch, 20.8%[50/241]; varenicline, 19.1% [81/424]; and C-NRT, 20.2%[85/421]). At 26 weeks, the risk differences for abstinence were, for patch vs varenicline, -0.76%(95% CI, -7.4% to 5.9%); for patch vs C-NRT, -4.0%(95% CI, -10.8% to 2.8%); and for varenicline vs C-NRT, -3.3%(95% CI, -9.1% to 2.6%). All medications were well tolerated, but varenicline produced more frequent adverse events than did the nicotine patch for vivid dreams, insomnia, nausea, constipation, sleepiness, and indigestion. CONCLUSIONS AND RELEVANCE Among adults motivated to quit smoking, 12 weeks of open-label treatment with nicotine patch, varenicline, or C-NRT produced no significant differences in biochemically confirmed rates of smoking abstinence at 26 weeks. The results raise questions about the relative effectiveness of intense smoking pharmacotherapies.	[Baker, Timothy B.; Piper, Megan E.; Smith, Stevens S.; Fraser, David L.; Fiore, Michael C.] Univ Wisconsin, Sch Med & Publ Hlth, Ctr Tobacco Res & Intervent, 1930 Monroe St,Ste 200, Madison, WI 53711 USA; [Baker, Timothy B.; Piper, Megan E.; Smith, Stevens S.; Fiore, Michael C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 1930 Monroe St,Ste 200, Madison, WI 53711 USA; [Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Cardiovasc Med, 1930 Monroe St,Ste 200, Madison, WI 53711 USA; [Bolt, Daniel M.] Univ Wisconsin, Dept Educ Psychol, 1930 Monroe St,Ste 200, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Baker, TB (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Ctr Tobacco Res & Intervent, 1930 Monroe St,Ste 200, Madison, WI 53711 USA.	tbb@ctri.wisc.edu		Smith, Stevens/0000-0002-6824-2829; Stein, James/0000-0002-2770-8223	National Heart, Lung, and Blood Institute [5R01HL109031]; National Cancer Institute [K05CA139871]; NATIONAL CANCER INSTITUTE [K05CA139871, P01CA180945, R35CA197573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109031] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant 5R01HL109031 from the National Heart, Lung, and Blood Institute and grant K05CA139871 from the National Cancer Institute to the University of Wisconsin Center for Tobacco Research and Intervention.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Ahmed AIA, 2013, J CLIN PSYCHOPHARM, V33, P55, DOI 10.1097/JCP.0b013e31827c0117; Asthana A, 2012, AM HEART J, V163, P81, DOI 10.1016/j.ahj.2011.06.023; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Catz SL, 2011, NICOTINE TOB RES, V13, P361, DOI 10.1093/ntr/ntr003; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; Cooper TV, 2004, ADDICT BEHAV, V29, P1565, DOI 10.1016/j.addbeh.2004.02.033; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Fix BV, 2011, INT J ENV RES PUB HE, V8, P222, DOI 10.3390/ijerph8010222; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hedeker D, 2007, ADDICTION, V102, P1564, DOI 10.1111/j.1360-0443.2007.01946.x; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hsueh KC, 2014, PSYCHOPHARMACOLOGY, V231, P2819, DOI 10.1007/s00213-014-3482-9; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Liberman JN, 2013, J MANAGE CARE PHARM, V19, P125, DOI 10.18553/jmcp.2013.19.2.125; Marrone GF, 2011, ADDICTION, V106, P1325, DOI 10.1111/j.1360-0443.2011.03441.x; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Nides M, 2008, AM J HEALTH BEHAV, V32, P664, DOI 10.5555/ajhb.2008.32.6.664; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426; Stein JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098278; Swan GE, 2010, AM J PREV MED, V38, P482, DOI 10.1016/j.amepre.2010.01.024; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; Zhu SH, 2016, TOB CONTROL, V25, P464, DOI 10.1136/tobaccocontrol-2015-052332	30	117	119	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					371	379		10.1001/jama.2015.19284	http://dx.doi.org/10.1001/jama.2015.19284			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813210	Green Accepted, hybrid			2022-12-28	WOS:000368589500015
J	Bauchner, H; Fontanarosa, PB; Golub, RM				Bauchner, Howard; Fontanarosa, Phil B.; Golub, Robert M.			JAMA Welcomes the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												howard.bauchner@jamanetwork.org						Agency for Healthcare Research and Quality, 2014, GUID CLIN PREV SERV; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Mayberg HS, 2016, JAMA NEUROL, V73, P270, DOI 10.1001/jamaneurol.2015.5048; O'Connor E, 2016, AHRQ PUBLICATION; O'Connor E, 2016, JAMA-J AM MED ASSOC, V315, P388, DOI 10.1001/jama.2015.18948; O'Malley M S, 1987, JAMA, V257, P2196, DOI 10.1001/jama.257.16.2196; Reynolds CF, 2016, JAMA PSYCHIAT, V73, P189, DOI 10.1001/jamapsychiatry.2015.3281; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Siu AL, 2015, JAMA-J AM MED ASSOC, V314, P2021, DOI 10.1001/jama.2015.13154; Thase ME, 2016, JAMA-J AM MED ASSOC, V315, P349, DOI 10.1001/jama.2015.18406; Whooley MA, 2016, JAMA INTERN MED, V176, P436, DOI 10.1001/jamainternmed.2015.8493; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P1899, DOI 10.1001/jama.2013.3448	12	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					351	352		10.1001/jama.2015.18448	http://dx.doi.org/10.1001/jama.2015.18448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813207				2022-12-28	WOS:000368589500012
J	Oliver, D				Oliver, David			David Oliver: Keeping care home residents out of hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], GOOD PRACT; Badger B, 2007, EUR J PALLIAT CARE, V14, P238; British Geriatrics Society, 2013, COMM GUID HIGH QUAL; British Geriatrics Society, 2011, QUEST QUAL INQ QUAL; Connolly W, 2015, BRIT GER SOC SCI M M, P53; Dwyer R, 2014, AGE AGEING, V43, P759, DOI 10.1093/ageing/afu117; Gordon AL, 2015, J ROY COLL PHYS EDIN, V45, P148, DOI 10.4997/JRCPE.2015.213; Lisk R, 2015, BRIT GERIATRICS 0313; National Institute for Health and Care Excellence, 2015, OLD PEOPL SOC CAR NE; O'Keefe J, 2015, BRIT GER SOC SCI M M, P56; Oliver D, 2015, ENHANCING HEALTHCARE; Roberts S, 2015, BRIT GERIATRICS 0729; Smith P, 2015, QUALITYWATCH FOCUS A	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2016	352								i458	10.1136/bmj.i458	http://dx.doi.org/10.1136/bmj.i458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EQ	26813928	Bronze, Green Published			2022-12-28	WOS:000369313000009
J	Nielsen, M; Qaseem, A				Nielsen, Matthew; Qaseem, Amir		Amer Coll Phys	Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ASYMPTOMATIC MICROSCOPIC HEMATURIA; COST-EFFECTIVENESS ANALYSIS; BLADDER-CANCER; FLEXIBLE CYSTOSCOPY; FOLLOW-UP; PROPHYLACTIC ANTIBIOTICS; UROLOGICAL-ASSOCIATION; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; DIPSTICK HEMATURIA	Background: The presence of blood in the urine, or hematuria, is a common finding in clinical practice and can sometimes be a sign of occult cancer. This article describes the clinical epidemiology of hematuria and the current state of practice and science in this context and provides suggestions for clinicians evaluating patients with hematuria. Methods: A narrative review of available clinical guidelines and other relevant studies on the evaluation of hematuria was conducted, with particular emphasis on considerations for urologic referral. High-Value Care Advice 1: Clinicians should include gross hematuria in their routine review of systems and specifically ask all patients with microscopic hematuria about any history of gross hematuria. High-Value Care Advice 2: Clinicians should not use screening urinalysis for cancer detection in asymptomatic adults. High-Value Care Advice 3: Clinicians should confirm heme-positive results of dipstick testing with microscopic urinalysis that demonstrates 3 or more erythrocytes per high-powered field before initiating further evaluation in all asymptomatic adults. High-Value Care Advice 4: Clinicians should refer for further urologic evaluation in all adults with gross hematuria, even if self-limited. High-Value Care Advice 5: Clinicians should consider urology referral for cystoscopy and imaging in adults with microscopically confirmed hematuria in the absence of some demonstrable benign cause. High-Value Care Advice 6: Clinicians should pursue evaluation of hematuria even if the patient is receiving antiplatelet or anticoagulant therapy. High-Value Care Advice 7: Clinicians should not obtain urinary cytology or other urine-based molecular markers for bladder cancer detection in the initial evaluation of hematuria.	[Nielsen, Matthew] Univ N Carolina, Lineberger Comprehens Canc Ctr, 2107 Phys Off Bldg,Campus Box 7235, Chapel Hill, NC 27599 USA; [Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	University of North Carolina; University of North Carolina Chapel Hill; American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			American College of Physicians; American Cancer Society [MRSG-13-154-01-CPPB]; Urology Care Foundation/Astellas (Rising Stars in Urology Research Award)	American College of Physicians; American Cancer Society(American Cancer Society); Urology Care Foundation/Astellas (Rising Stars in Urology Research Award)	Financial support for the development of this article comes exclusively from the American College of Physicians operating budget. Dr. Nielsen is supported by the American Cancer Society (grant MRSG-13-154-01-CPPB) and the Urology Care Foundation/Astellas (Rising Stars in Urology Research Award).	American Urological Association, 2015, CHOOS WIS 10 THINGS; Bassett JC, 2015, J GEN INTERN MED, V30, P440, DOI 10.1007/s11606-014-3116-2; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Berland Lincoln L, 2009, J Am Coll Radiol, V6, P14, DOI 10.1016/j.jacr.2008.06.018; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; BRITTON JP, 1992, J UROLOGY, V148, P788, DOI 10.1016/S0022-5347(17)36720-4; BRITTON JP, 1989, BRIT MED J, V299, P1010, DOI 10.1136/bmj.299.6706.1010; Buteau A, 2014, UROL ONCOL-SEMIN ORI, V32, P128, DOI 10.1016/j.urolonc.2012.07.001; Centers for Medicare and Medicaid Services, 2015, PHYS FEE SCHED SEARC; Centers for Medicare & Medicaid Services, 2015, HOSP OUTP PPS; Centers for Medicare & Medicaid Services, 2015, CLIN LAB FEE SCHED B; Chacko KM, 2007, AM J PREV MED, V32, P59, DOI 10.1016/j.amepre.2006.09.002; Chou R, 2015, ANN INTERN MED, V163, P922, DOI 10.7326/M15-0997; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Cohn JA, 2014, CANCER-AM CANCER SOC, V120, P555, DOI 10.1002/cncr.28416; CORWIN HL, 1988, CLIN LAB MED, V8, P601, DOI 10.1016/S0272-2712(18)30678-4; CULCLASURE TF, 1994, ARCH INTERN MED, V154, P649, DOI 10.1001/archinte.154.6.649; Cumberbatch MGK, 2015, JAMA ONCOL, V1, P1282, DOI 10.1001/jamaoncol.2015.3209; Davis R, 2012, J UROLOGY, V188, P2473, DOI 10.1016/j.juro.2012.09.078; Edwards TJ, 2006, BJU INT, V97, P301, DOI 10.1111/j.1464-410X.2006.05976.x; Elias K, 2010, CANCER-AM CANCER SOC, V116, P2954, DOI 10.1002/cncr.25048; Fawcett D, 2008, JOINT CONSENSUS STAT; Friderichsen B, 1997, J PUBLIC HEALTH MED, V19, P55, DOI 10.1093/oxfordjournals.pubmed.a024588; Friedlander DF, 2014, AM J MED, V127, P633, DOI 10.1016/j.amjmed.2014.01.010; Golshahi Jafar, 2014, J Nephropathol, V3, P51, DOI 10.12860/jnp.2014.12; Grossfeld GD, 2001, UROLOGY, V57, P604, DOI 10.1016/S0090-4295(01)00920-7; Grossfeld GD, 2001, UROLOGY, V57, P599, DOI 10.1016/S0090-4295(01)00919-0; HealthPocket, 2015, BRONZ PLAN AFF CAR A; Herr HW, 2015, J UROLOGY, V193, P548, DOI 10.1016/j.juro.2014.07.015; HIATT RA, 1994, CANCER EPIDEM BIOMAR, V3, P439; Hole B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6768; Hollenbeck BK, 2010, CANCER-AM CANCER SOC, V116, P5235, DOI 10.1002/cncr.25310; Hurlen M, 2006, THROMB RES, V118, P433, DOI 10.1016/j.thromres.2005.07.023; Johnson EK, 2008, UROLOGY, V72, P498, DOI 10.1016/j.urology.2008.01.086; Johnson MI, 2007, BJU INT, V100, P826, DOI 10.1111/j.1464-410X.2007.07093.x; Jung H, 2011, J UROLOGY, V185, P1698, DOI 10.1016/j.juro.2010.12.093; Kaiser Family Foundation, 2014, EMPL HLTH BEN 2014 A; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Liu WC, 2005, AM J ROENTGENOL, V185, P1051, DOI 10.2214/AJR.04.0218; Logsetty S, 1994, CANADIAN GUIDE CLIN, P826; Loo Ronald, 2009, Perm J, V13, P37; Loo RK, 2013, MAYO CLIN PROC, V88, P129, DOI 10.1016/j.mayocp.2012.10.004; MARIANI AJ, 1989, J UROLOGY, V141, P350, DOI 10.1016/S0022-5347(17)40763-4; McBride JF, 2012, CLIN IMAG, V36, P455, DOI 10.1016/j.clinimag.2012.01.001; MESSING EM, 1992, J UROLOGY, V148, P289, DOI 10.1016/S0022-5347(17)36575-8; MESSING EM, 1995, J UROLOGY, V154, P57, DOI 10.1016/S0022-5347(01)67224-0; MESSING EM, 1989, CANCER, V64, P2361, DOI 10.1002/1097-0142(19891201)64:11<2361::AID-CNCR2820641128>3.0.CO;2-4; MESSING EM, 1987, J UROLOGY, V137, P919, DOI 10.1016/S0022-5347(17)44294-7; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Mishriki SF, 2008, UROLOGY, V71, P13, DOI 10.1016/j.urology.2007.08.031; MOHR DN, 1986, JAMA-J AM MED ASSOC, V256, P224, DOI 10.1001/jama.256.2.224; Moyer VA, 2011, ANN INTERN MED, V155, P246, DOI 10.7326/0003-4819-155-4-201108160-00008; Mungan NA, 2000, UROLOGY, V55, P368, DOI 10.1016/S0090-4295(99)00481-1; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF NI; Nieder AM, 2010, UROL ONCOL-SEMIN ORI, V28, P500, DOI 10.1016/j.urolonc.2008.10.018; Prochazka AV, 2005, ARCH INTERN MED, V165, P1347, DOI 10.1001/archinte.165.12.1347; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; R Davis, 2012, DIAGNOSIS EVALUATION; Rane A, 2001, EUR UROL, V39, P212, DOI 10.1159/000052438; Rao PK, 2010, J UROLOGY, V183, P560, DOI 10.1016/j.juro.2009.10.049; Rodgers M, 2006, HEALTH TECHNOL ASSES, V10, pIII; Shen L, 2014, ACR APPROPRIATENESS; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Tsili AC, 2007, EUR RADIOL, V17, P1046, DOI 10.1007/s00330-006-0383-2; Ubel PA, 2015, NEW ENGL J MED, V372, P2475, DOI 10.1056/NEJMp1504245; van der Molen AJ, 2012, AM J ROENTGENOL, V198, P1256, DOI 10.2214/AJR.11.8255; VANSAVAGE JG, 1995, J UROLOGY, V153, P1594, DOI 10.1016/S0022-5347(01)67469-X; Vrtiska TJ, 2009, AM J ROENTGENOL, V192, P941, DOI 10.2214/AJR.07.2679; Wilson L, 2005, J ENDOUROL, V19, P1006, DOI 10.1089/end.2005.19.1006; Wollin T, 2009, CUAJ-CAN UROL ASSOC, V3, P77; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214	75	48	50	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					488	+		10.7326/M15-1496	http://dx.doi.org/10.7326/M15-1496			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26810935	Green Published			2022-12-28	WOS:000373625300011
J	Bidinosti, M; Botta, P; Kruttner, S; Proenca, CC; Stoehr, N; Bernhard, M; Fruh, I; Mueller, M; Bonenfant, D; Voshol, H; Carbone, W; Neal, SJ; McTighe, SM; Roma, G; Dolmetsch, RE; Porter, JA; Caroni, P; Bouwmeester, T; Luthi, A; Galimberti, I				Bidinosti, Michael; Botta, Paolo; Kruttner, Sebastian; Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Fruh, Isabelle; Mueller, Matthias; Bonenfant, Debora; Voshol, Hans; Carbone, Walter; Neal, Sarah J.; McTighe, Stephanie M.; Roma, Guglielmo; Dolmetsch, Ricardo E.; Porter, Jeffrey A.; Caroni, Pico; Bouwmeester, Tewis; Luthi, Andreas; Galimberti, Ivan			CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency	SCIENCE			English	Article							SCAFFOLDING PROTEIN SHANK3; GROWTH-FACTOR-I; MUTATIONS; MICE; EXPRESSION; BEHAVIORS; ISOFORMS; FAMILY	SH3 and multiple ankyrin repeat domains 3 (SHANK3) haploinsufficiency is causative for the neurological features of Phelan-McDermid syndrome (PMDS), including a high risk of autism spectrum disorder (ASD). We used unbiased, quantitative proteomics to identify changes in the phosphoproteome of Shank3-deficient neurons. Down-regulation of protein kinase B (PKB/Akt)-mammalian target of rapamycin complex 1 (mTORC1) signaling resulted from enhanced phosphorylation and activation of serine/threonine protein phosphatase 2A (PP2A) regulatory subunit, B56b, due to increased steady-state levels of its kinase, Cdc2-like kinase 2 (CLK2). Pharmacological and genetic activation of Akt or inhibition of CLK2 relieved synaptic deficits in Shank3-deficient and PMDS patient-derived neurons. CLK2 inhibition also restored normal sociability in a Shank3-deficient mouse model. Our study thereby provides a novel mechanistic and potentially therapeutic understanding of deregulated signaling downstream of Shank3 deficiency.	[Bidinosti, Michael; Proenca, Catia C.; Stoehr, Natacha; Bernhard, Mario; Fruh, Isabelle; Mueller, Matthias; Carbone, Walter; Roma, Guglielmo; Porter, Jeffrey A.; Bouwmeester, Tewis; Galimberti, Ivan] Novartis Inst Biomed Res, Dev Mol Pathways, Basel, Switzerland; [Bonenfant, Debora; Voshol, Hans] Novartis Inst Biomed Res, Analyt Sci & Imaging, Basel, Switzerland; [Botta, Paolo; Kruttner, Sebastian; Caroni, Pico; Luthi, Andreas] Friedrich Miescher Inst, Basel, Switzerland; [Neal, Sarah J.; McTighe, Stephanie M.; Dolmetsch, Ricardo E.] Novartis Inst Biomed Res, Neurosci, Cambridge, MA USA	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research; Novartis	Galimberti, I (corresponding author), Novartis Inst Biomed Res, Dev Mol Pathways, Basel, Switzerland.	ivan.galimberti@novartis.com		Botta, Paolo/0000-0003-0570-5774; Carbone, Walter/0000-0001-6150-8295				Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Duffney LJ, 2015, CELL REP, V11, P1400, DOI 10.1016/j.celrep.2015.04.064; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Gower CM, 2016, ACS CHEM BIOL, V11, P121, DOI 10.1021/acschembio.5b00847; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Kolevzon A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-54; Kouser M, 2013, J NEUROSCI, V33, P18448, DOI 10.1523/JNEUROSCI.3017-13.2013; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; SMALLEY SL, 1992, J AUTISM DEV DISORD, V22, P339, DOI 10.1007/BF01048239; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012	27	95	99	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1199	1203		10.1126/science.aad5487	http://dx.doi.org/10.1126/science.aad5487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26847545				2022-12-28	WOS:000386158400046
J	Freund, T; Peters-Klimm, F; Boyd, CM; Mahler, C; Gensichen, J; Erler, A; Beyer, M; Gondan, M; Rochon, J; Gerlach, FM; Szecsenyi, J				Freund, Tobias; Peters-Klimm, Frank; Boyd, Cynthia M.; Mahler, Cornelia; Gensichen, Jochen; Erler, Antje; Beyer, Martin; Gondan, Matthias; Rochon, Justine; Gerlach, Ferdinand M.; Szecsenyi, Joachim			Medical Assistant-Based Care Management for High-Risk Patients in Small Primary Care Practices A Cluster Randomized Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; INTERVENTIONS; READMISSIONS; DEPRESSION; WORKFORCE; PROGRAM; ACCESS; US	Background: Patients with multiple chronic conditions are at high risk for potentially avoidable hospitalizations, which may be reduced by care coordination and self-management support. Medical assistants are an increasingly available resource for patient care in primary care practices. Objective: To determine whether protocol-based care management delivered by medical assistants improves care in patients at high risk for future hospitalization in primary care. Design: Two-year cluster randomized clinical trial. (Current Controlled Trials: ISRCTN56104508) Setting: 115 primary care practices in Germany. Patients: 2076 patients with type 2 diabetes, chronic obstructive pulmonary disease, or chronic heart failure and a likelihood of hospitalization in the upper quartile of the population, as predicted by an analysis of insurance data. Intervention: Protocol-based care management, including structured assessment, action planning, and monitoring delivered by medical assistants, compared with usual care. Measurements: All-cause hospitalizations at 12 months (primary outcome) and quality-of-life scores (12-Item Short Form Health Survey [SF-12] and EuroQol instrument [EQ-5D]). Results: Included patients had an average of 4 co-occurring chronic conditions. All-cause hospitalizations did not differ between groups at 12 months (risk ratio [RR], 1.01 [95% CI, 0.87 to 1.18]) and 24 months (RR, 0.98 [CI, 0.85 to 1.12]). Quality of life (differences, 1.16 [CI, 0.24 to 2.08] on SF-12 physical component and 1.68 [CI, 0.60 to 2.77] on SF-12 mental component) and general health (difference on EQ-5D, 0.03 [CI, 0.00 to 0.05]) improved significantly at 24 months. Intervention costs totaled $10 per patient per month. Limitation: Small number of primary care practices and low intensity of intervention. Conclusion: This low-intensity intervention did not reduce all-cause hospitalizations but showed positive effects on quality of life at reasonable costs in high-risk multimorbid patients. Primary Funding Source: AOK Baden-Wurttemberg and AOK Bundesverband.	Univ Heidelberg Hosp, Heidelberg, Germany; Heidelberg Univ, Heidelberg, Germany; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Friedrich Schiller Univ Hosp, Jena, Germany; Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; Univ Copenhagen, Copenhagen, Denmark; [Freund, Tobias; Peters-Klimm, Frank; Mahler, Cornelia; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Vosstr 2, D-69115 Heidelberg, Germany; [Boyd, Cynthia M.] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Mason F Lord Bldg,Ctr Tower,5200 Eastern Ave, Baltimore, MD 21224 USA; [Gensichen, Jochen] Friedrich Schiller Univ Hosp Jena, Inst Gen Practice, Bachstr 18, D-07743 Jena, Germany; [Erler, Antje; Beyer, Martin; Gerlach, Ferdinand M.] Goethe Univ Frankfurt, Inst Gen Practice, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Gondan, Matthias] Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; [Rochon, Justine] Heidelberg Univ, Inst Biometry & Med Informat, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johns Hopkins University; Friedrich Schiller University of Jena; Goethe University Frankfurt; University of Copenhagen; Ruprecht Karls University Heidelberg; Johns Hopkins University; Friedrich Schiller University of Jena; Goethe University Frankfurt; University of Copenhagen; Ruprecht Karls University Heidelberg	Freund, T (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Vosstr 2, D-69115 Heidelberg, Germany.	tobias.freund@med.uni-heidelberg.de		Gondan, Matthias/0000-0001-9974-0057	AOK Baden-Wurttemberg; AOK Bundesverband	AOK Baden-Wurttemberg; AOK Bundesverband	AOK Baden-Wurttemberg and AOK Bundesverband.	Ansari Z, 2003, SOZ PRAVENTIV MED, V48, P33, DOI 10.1007/s000380300004; Bodenheimer T, 2009, PATIENT EDUC COUNS, V76, P174, DOI 10.1016/j.pec.2009.06.001; Boult C, 2013, J GEN INTERN MED, V28, P612, DOI 10.1007/s11606-012-2287-y; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x; Egginton JS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-72; Ferrer RL, 2009, ANN FAM MED, V7, P504, DOI 10.1370/afm.1059; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Freund T, 2015, INT J NURS STUD, V52, P727, DOI 10.1016/j.ijnurstu.2014.11.014; Freund T, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-157; Freund T, 2013, ANN FAM MED, V11, P363, DOI 10.1370/afm.1498; Freund T, 2011, Z EVIDENZ FORTBILD Q, V105, P434, DOI 10.1016/j.zefq.2010.06.027; Freund T, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-163; Freund T, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-70; Gensichen Jochen, 2006, Z Arztl Fortbild Qualitatssich, V100, P375; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Gerlach FM, 2013, EVALUATION FAMILY DO; Ghorob A, 2012, NEW ENGL J MED, V366, P1955, DOI 10.1056/NEJMp1202775; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Haupt C., 2013, MONITOR VERSORGUNGSF, V1, P36; Jaarsma T, 2008, ARCH INTERN MED, V168, P316, DOI 10.1001/archinternmed.2007.83; Jerant A, 2008, QUAL LIFE RES, V17, P1195, DOI 10.1007/s11136-008-9401-y; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kultusministerkonferenz, 2005, RAHM MED FACH MED FA; Lemmens KMM, 2009, RESP MED, V103, P670, DOI 10.1016/j.rmed.2008.11.017; Ose D, 2010, J EVAL CLIN PRACT, V16, P1289, DOI 10.1111/j.1365-2753.2009.01330.x; Parker SL, 2013, J NEUROSURG-SPINE, V18, P154, DOI 10.3171/2012.10.SPINE12312; Peters-Klimm F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-56; Purdy S.J.W., 2010, AVOIDING HOSP ADMISS, P7; Rosemann T, 2007, ARTHRIT RHEUM-ARTHR, V57, P1390, DOI 10.1002/art.23080; Schwartz MD, 2012, JAMA-J AM MED ASSOC, V308, P2252, DOI 10.1001/jama.2012.77034; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Therneau T, 2012, COXME MIXED EFFECTS; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	41	43	43	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					323	+		10.7326/M14-2403	http://dx.doi.org/10.7326/M14-2403			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26833209				2022-12-28	WOS:000371220300003
J	Halter, DP; Heinemann, FW; Bachmann, J; Meyer, K				Halter, Dominik P.; Heinemann, Frank W.; Bachmann, Julien; Meyer, Karsten			Uranium-mediated electrocatalytic dihydrogen production from water	NATURE			English	Article							RAY CRYSTAL-STRUCTURE; HYDROGEN GENERATION; MONOARENE COMPLEX; REDUCTION; ACTIVATION; H-2; COORDINATION; DINITROGEN; CHEMISTRY; MECHANISM	Depleted uranium is a mildly radioactive waste product that is stockpiled worldwide. The chemical reactivity of uranium complexes is well documented, including the stoichiometric activation of small molecules of biological and industrial interest such as H2O, CO2, CO, or N-2 (refs 1-11), but catalytic transformations with actinides remain underexplored in comparison to transition-metal catalysis(12-14). For reduction of water to H-2, complexes of low-valent uranium show the highest potential, but are known to react violently and uncontrollably forming stable bridging oxo or uranyl species(15). As a result, only a few oxidations of uranium with water have been reported so far; all stoichiometric(2,3,16,17). Catalytic H-2 production, however, requires the reductive recovery of the catalyst via a challenging cleavage of the uranium-bound oxygen-containing ligand. Here we report the electrocatalytic water reduction observed with a trisaryloxide U(iii) complex [(((ArO)-Ar-Ad,Me)(3)mes)U] (refs 18 and 19)-the first homogeneous uranium catalyst for H-2 production from H2O. The catalytic cycle involves rare terminal U(iv)-OH and U(v)= O complexes, which have been isolated, characterized, and proven to be integral parts of the catalytic mechanism. The recognition of uranium compounds as potentially useful catalysts suggests new applications for such light actinides. The development of uranium-based catalysts provides new perspectives on nuclear waste management strategies, by suggesting that mildly radioactive depleted uranium-an abundant waste product of the nuclear power industry-could be a valuable resource.	[Halter, Dominik P.; Heinemann, Frank W.; Bachmann, Julien; Meyer, Karsten] Univ Erlangen Nurnberg, Dept Chem & Pharm, Inorgan Chem, Egerlandstr 1, D-91053 Erlangen, Germany	University of Erlangen Nuremberg	Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Inorgan Chem, Egerlandstr 1, D-91053 Erlangen, Germany.	karsten.meyer@fau.de	Heinemann, Frank Wilhelm/AAC-3062-2022; Bachmann, Julien/G-4381-2011; Meyer, Karsten/G-2570-2012	Heinemann, Frank Wilhelm/0000-0002-9007-8404; Bachmann, Julien/0000-0001-6480-6212; Meyer, Karsten/0000-0002-7844-2998; Halter, Dominik/0000-0003-0733-8955				Ariyaratne KANS, 2004, J ORGANOMET CHEM, V689, P2029, DOI 10.1016/j.jorganchem.2004.03.029; ARNEY DSJ, 1993, J AM CHEM SOC, V115, P9840, DOI 10.1021/ja00074a077; Bain GA, 2008, J CHEM EDUC, V85, P532, DOI 10.1021/ed085p532; Cavell AC, 2015, INORG CHEM, V54, P3325, DOI 10.1021/ic5030394; Cobo S, 2012, NAT MATER, V11, P802, DOI [10.1038/NMAT3385, 10.1038/nmat3385]; Cooper O, 2014, J AM CHEM SOC, V136, P6716, DOI 10.1021/ja5017624; Das A, 2015, ACS CATAL, V5, P1397, DOI 10.1021/acscatal.5b00045; Evans WJ, 2003, J AM CHEM SOC, V125, P14264, DOI 10.1021/ja037647e; FELTHAM AM, 1971, CHEM REV, V71, P177, DOI 10.1021/cr60270a002; Fox AR, 2008, NATURE, V455, P341, DOI 10.1038/nature07372; Franke SM, 2013, INORG CHEM, V52, P10552, DOI 10.1021/ic401532j; Frey ASP, 2011, ANGEW CHEM INT EDIT, V50, P6881, DOI 10.1002/anie.201101509; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; Haber F., 1911, US patent, Patent No. [999,025, 999025]; Halter DP, 2014, INORG CHEM, V53, P8418, DOI 10.1021/ic501011p; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; John GH, 2005, INORG CHEM, V44, P7606, DOI 10.1021/ic0507971; Karunadasa HI, 2010, NATURE, V464, P1329, DOI 10.1038/nature08969; Korobkov I, 2005, PROG INORG CHEM, V54, P321, DOI 10.1002/0471725560.ch4; La Pierre HS, 2014, PROG INORG CHEM, V58, P303; La Pierre HS, 2014, ANGEW CHEM INT EDIT, V53, P7158, DOI 10.1002/anie.201402050; La Pierre HS, 2014, ANGEW CHEM INT EDIT, V53, P7154, DOI 10.1002/anie.201402048; Letko CS, 2014, J AM CHEM SOC, V136, P9364, DOI 10.1021/ja5019755; Liddle ST, 2015, ANGEW CHEM INT EDIT, V54, P8604, DOI 10.1002/anie.201412168; Lukens WW, 1996, J AM CHEM SOC, V118, P901, DOI 10.1021/ja9531283; Natrajan L, 2005, INORG CHEM, V44, P6115, DOI 10.1021/ic0505652; Neese F., 1993, THESIS U KONSTANZ; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; Roberts JAS, 2013, INORG CHEM, V52, P3823, DOI 10.1021/ic302461q; Schmidt AC, 2014, J AM CHEM SOC, V136, P11980, DOI 10.1021/ja504528n; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stubbert BD, 2011, J AM CHEM SOC, V133, P18070, DOI 10.1021/ja2078015; Summerscales OT, 2006, J AM CHEM SOC, V128, P9602, DOI 10.1021/ja063222r; Sundstrom EJ, 2012, J AM CHEM SOC, V134, P5233, DOI 10.1021/ja210949r; Thoi VS, 2013, CHEM SOC REV, V42, P2388, DOI 10.1039/c2cs35272a; Tway C. L., 2005, US patent, Patent No. [6,916,763, 6916763]; Wolf A., 2009, US patent application, Patent No. [13/122,490, 13122490]	37	120	123	21	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					317	+		10.1038/nature16530	http://dx.doi.org/10.1038/nature16530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26808900				2022-12-28	WOS:000370327100033
J	Bae, E; Cohen, JM; Grudberg, SC				Bae, Edward; Cohen, Jeffrey M.; Grudberg, Sarah C.			Hyperpigmented Reticulated Patch in an Older Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ERYTHEMA-AB-IGNE; ABIGNE		[Bae, Edward] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cohen, Jeffrey M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Cohen, Jeffrey M.; Grudberg, Sarah C.] Harvard Univ, Sch Med, Boston, MA USA; [Grudberg, Sarah C.] Boston VA HealthCare Syst, Dept Med, 1400 Vet Foreign Wars Pkwy, Boston, MA 02132 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Grudberg, SC (corresponding author), Boston VA HealthCare Syst, Dept Med, 1400 Vet Foreign Wars Pkwy, Boston, MA 02132 USA.	sarah.grudberg@va.gov						Adamson H G, 1911, Proc R Soc Med, V4, P46; Alguire PC, 1998, J GEN INTERN MED, V13, P46, DOI 10.1046/j.1525-1497.1998.00009.x; Botten D, 2010, CAN MED ASSOC J, V182, pE857, DOI 10.1503/cmaj.091868; Bunick CG, 2014, INT J DERMATOL, V53, pe353, DOI 10.1111/ijd.12329; HEWITT JB, 1993, BRIT J DERMATOL, V128, P591, DOI 10.1111/j.1365-2133.1993.tb00247.x; Miller Kristen, 2011, Dermatol Online J, V17, P28; PETERKIN GAG, 1955, BMJ-BRIT MED J, V2, P1599, DOI 10.1136/bmj.2.4956.1599; Riahi RR, 2014, INT J DERMATOL, V53, pE395, DOI 10.1111/ijd.12407; SAHL WJ, 1992, J AM ACAD DERMATOL, V27, P109, DOI 10.1016/S0190-9622(08)80818-3; Siragusa M, 1999, INT J DERMATOL, V38, P361, DOI 10.1046/j.1365-4362.1999.00720.x	10	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					699	700		10.1001/jama.2015.17693	http://dx.doi.org/10.1001/jama.2015.17693			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881374				2022-12-28	WOS:000370171500017
J	Hipgrave, DB; Chang, SY; Li, XW; Wu, YN				Hipgrave, David B.; Chang, Suying; Li, Xiaowei; Wu, Yongning			Salt and Sodium Intake in China	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hipgrave, David B.] UNICEF Headquarters, New York, NY USA; [Chang, Suying] UNICEF, Beijing, Peoples R China; [Li, Xiaowei; Wu, Yongning] China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Bldg 2,37 Guangqu Rd, Beijing 100022, Peoples R China	UNICEF	Wu, YN (corresponding author), China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Bldg 2,37 Guangqu Rd, Beijing 100022, Peoples R China.	wuyongning@cfsa.ne.cn	Wu, Yongning/F-5818-2019	Wu, Yongning/0000-0001-6430-1302				Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Liang YJ, 2014, INT J CARDIOL, V175, P96, DOI 10.1016/j.ijcard.2014.04.258; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization Food and Agriculture Organization of the United Nations European Food Safety Authority, HARM TOT DIET STUD A; Zhai F, 2006, REP NAT NUTR HLTH 2	6	65	75	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					703	705		10.1001/jama.2015.15816	http://dx.doi.org/10.1001/jama.2015.15816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881375	Bronze			2022-12-28	WOS:000370171500018
J	Cros, B				Cros, Brigitte			PLASMA PHYSICS Compact coupling for a two-stage accelerator	NATURE			English	Editorial Material									[Cros, Brigitte] Univ Paris Saclay, Univ Paris 11, CNRS, Phys Gaz & Plasmas Lab, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cros, B (corresponding author), Univ Paris Saclay, Univ Paris 11, CNRS, Phys Gaz & Plasmas Lab, F-91405 Orsay, France.	brigitte.cros@u-psud.fr						Leemans WP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.245002; Pukhov A, 2002, APPL PHYS B-LASERS O, V74, P355, DOI 10.1007/s003400200795; Steinke S, 2016, NATURE, V530, P190, DOI 10.1038/nature16525; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267	4	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					165	166		10.1038/530165a	http://dx.doi.org/10.1038/530165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863976				2022-12-28	WOS:000369916700025
J	Li, H; O'Donoghue, AJ; van der Linden, WA; Xie, SC; Yoo, E; Foe, IT; Tilley, L; Craik, CS; da Fonseca, PCA; Bogyo, M				Li, Hao; O'Donoghue, Anthony J.; van der Linden, Wouter A.; Xie, Stanley C.; Yoo, Euna; Foe, Ian T.; Tilley, Leann; Craik, Charles S.; da Fonseca, Paula C. A.; Bogyo, Matthew			Structure- and function-based design of Plasmodium-selective proteasome inhibitors	NATURE			English	Article							HUMAN 20S PROTEASOME; ARTEMISININ RESISTANCE; ELECTRON-MICROSCOPY; FALCIPARUM MALARIA; IDENTIFICATION; VISUALIZATION; MECHANISM; PARASITE; SPECIFICITY; VALIDATION	The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation(1). Compounds that target the proteasome are potentially valuable tools for the treatment of pathogens that depend on proteasome function for survival and replication. In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle(2-5). Most compounds that have been tested against the parasite also inhibit the mammalian proteasome, resulting in toxicity that precludes their use as therapeutic agents(2,6). Therefore, better definition of the substrate specificity and structural properties of the Plasmodium proteasome could enable the development of compounds with sufficient selectivity to allow their use as anti-malarial agents. To accomplish this goal, here we use a substrate profiling method to uncover differences in the specificities of the human and P. falciparum proteasome. We design inhibitors based on amino-acid preferences specific to the parasite proteasome, and find that they preferentially inhibit the beta 2-subunit. We determine the structure of the P. falciparum 20S proteasome bound to the inhibitor using cryoelectron microscopy and single-particle analysis, to a resolution of 3.6 angstrom. These data reveal the unusually open P. falciparum beta 2 active site and provide valuable information about active-site architecture that can be used to further refine inhibitor design. Furthermore, consistent with the recent finding that the proteasome is important for stress pathways associated with resistance of artemisinin family anti-malarials(7,8), we observe growth inhibition synergism with low doses of this beta 2-selective inhibitor in artemisinin-sensitive and -resistant parasites. Finally, we demonstrate that a parasite-selective inhibitor could be used to attenuate parasite growth in vivo without appreciable toxicity to the host. Thus, the Plasmodium proteasome is a chemically tractable target that could be exploited by nextgeneration anti-malarial agents.	[Li, Hao; van der Linden, Wouter A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Li, Hao; Yoo, Euna; Foe, Ian T.; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [O'Donoghue, Anthony J.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Xie, Stanley C.; Tilley, Leann] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic 3010, Australia; [da Fonseca, Paula C. A.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Li, Hao] Agcy Sci Technol & Res, Inst Biomed Sci, Mol Engn Lab, Singapore 138673, Singapore; [O'Donoghue, Anthony J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; University of Melbourne; MRC Laboratory Molecular Biology; Agency for Science Technology & Research (A*STAR); University of California System; University of California San Diego	Bogyo, M (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	pauladf@mrc-lmb.cam.ac.uk; mbogyo@stanford.edu	Tilley, Leann/AAU-5281-2020; Li, Hao/AAS-9804-2020	Li, Hao/0000-0002-6652-4793; da Fonseca, Paula/0000-0001-8656-5747; Bogyo, Matthew/0000-0003-3753-4412; Yoo, Euna/0000-0001-5982-1979; Tilley, Leann/0000-0001-9910-0199; Xie, Stanley/0000-0001-7003-4677	National Institutes of Health [R01AI078947, R01EB05011]; Medical Research Council [MC-UP-1201/5]; Agency for Science, Technology and Research (A*STAR) Singapore; Netherlands Organization for Scientific Research (NWO); Program for Breakthrough Biomedical Research (PBBR); Sandler Foundation; American Heart Association [14POST20280004]; Australian Research Council; Australian National Health and Medical Research Council; MRC [MC_UP_1201/5] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105106, R01AI078947, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104659, P50GM082250] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1201/5] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Program for Breakthrough Biomedical Research (PBBR); Sandler Foundation; American Heart Association(American Heart Association); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was support by National Institutes of Health grants R01AI078947, R01EB05011 to M.B., and by the Medical Research Council grant MC-UP-1201/5 to P.C.A.dF. H.L. was supported by an NSS-PhD scholarshpip from the Agency for Science, Technology and Research (A*STAR) Singapore. W.A.v.d.L. was supported by a Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO). A.J.O. and C.S.C. were supported by the Program for Breakthrough Biomedical Research (PBBR) and the Sandler Foundation. I.T.F. was supported by American Heart Association grant 14POST20280004. We acknowledge support from the Australian Research Council and the Australian National Health and Medical Research Council. We thank K. Chotivanich for providing PL2 and PL7 parasites. We thank E. Yeh's group for help with P. falciparum D10 culture and for use of their equipment. We thank J. Boothroyd for providing the human fibroblast cells. We thank E. Morris and R. Henderson for discussions on image processing, FEI fellows and C. Savva for assisting in the use of the Titan Krios microscope, S. Chen for EM support, and J. Grimmet and T. Darling for computing support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aminake MN, 2012, INT J PARASITOL-DRUG, V2, P1, DOI 10.1016/j.ijpddr.2011.12.001; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Czesny B, 2009, ANTIMICROB AGENTS CH, V53, P4080, DOI 10.1128/AAC.00088-09; da Fonseca PCA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8573; Dogovski C, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002132; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Harshbarger W, 2015, STRUCTURE, V23, P418, DOI 10.1016/j.str.2014.11.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li H, 2014, J AM CHEM SOC, V136, P13562, DOI 10.1021/ja507692y; Li H, 2014, ACS CHEM BIOL, V9, P1869, DOI 10.1021/cb5001263; Li H, 2012, CHEM BIOL, V19, P1535, DOI 10.1016/j.chembiol.2012.09.019; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403; O'Donoghue AJ, 2015, P NATL ACAD SCI USA, V112, P7478, DOI 10.1073/pnas.1507082112; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Verdoes M, 2006, CHEM BIOL, V13, P1217, DOI 10.1016/j.chembiol.2006.09.013; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zhou HJ, 2009, J MED CHEM, V52, P3028, DOI 10.1021/jm801329v	41	203	208	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					233	+		10.1038/nature16936	http://dx.doi.org/10.1038/nature16936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863983	Green Accepted, Green Submitted			2022-12-28	WOS:000369916700042
J	Peyvandi, F; Scully, M; Hovinga, JAK; Cataland, S; Knobl, P; Wu, HF; Artoni, A; Westwood, JP; Taleghani, MM; Jilma, B; Callewaert, F; Ulrichts, H; Duby, C; Tersago, D				Peyvandi, Flora; Scully, Marie; Hovinga, Johanna A. Kremer; Cataland, Spero; Knoebl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Taleghani, Magnus Mansouri; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique		TITAN Investigators	Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADAMTS13 ACTIVITY; MYOCARDIAL-INFARCTION; CARDIAC INVOLVEMENT; MANAGEMENT; RECOVERY; MICROANGIOPATHIES; ANTIBODIES; EXPERIENCE; RITUXIMAB; DIAGNOSIS	BACKGROUND Acquired thrombotic thrombocytopenic purpura (TTP) is caused by aggregation of platelets on ultralarge von Willebrand factor multimers. This microvascular thrombosis causes multiorgan ischemia with potentially life-threatening complications. Daily plasma exchange and immunosuppressive therapies induce remission, but mortality and morbidity due to microthrombosis remain high. METHODS Caplacizumab, an anti-von Willebrand factor humanized single-variable-domain immunoglobulin (Nanobody), inhibits the interaction between ultralarge von Willebrand factor multimers and platelets. In this phase 2, controlled study, we randomly assigned patients with acquired TTP to subcutaneous caplacizumab (10 mg daily) or placebo during plasma exchange and for 30 days afterward. The primary end point was the time to a response, defined as confirmed normalization of the platelet count. Major secondary end points included exacerbations and relapses. RESULTS Seventy-five patients underwent randomization (36 were assigned to receive caplacizumab, and 39 to receive placebo). The time to a response was significantly reduced with caplacizumab as compared with placebo (39% reduction in median time, P = 0.005). Three patients in the caplacizumab group had an exacerbation, as compared with 11 patients in the placebo group. Eight patients in the caplacizumab group had a relapse in the first month after stopping the study drug, of whom 7 had ADAMTS13 activity that remained below 10%, suggesting unresolved autoimmune activity. Bleeding-related adverse events, most of which were mild to moderate in severity, were more common with caplacizumab than with placebo (54% of patients vs. 38%). The frequencies of other adverse events were similar in the two groups. Two patients in the placebo group died, as compared with none in the caplacizumab group. CONCLUSIONS Caplacizumab induced a faster resolution of the acute TTP episode than did placebo. The platelet-protective effect of caplacizumab was maintained during the treatment period. Caplacizumab was associated with an increased tendency toward bleeding, as compared with placebo. (Funded by Ablynx; ClinicalTrials. gov number, NCT01151423.)	[Peyvandi, Flora; Artoni, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Scully, Marie; Westwood, John-Paul] Univ Coll London Hosp, Dept Haematol, London, England; [Scully, Marie] Univ Coll London Hosp, NHS Fdn Trust, Natl Inst Hlth Res Biomed Res Ctr, London, England; [Scully, Marie] UCL, London, England; [Hovinga, Johanna A. Kremer; Taleghani, Magnus Mansouri] Univ Hosp Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer; Taleghani, Magnus Mansouri] Univ Hosp Bern, Inselspital, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Hovinga, Johanna A. Kremer; Taleghani, Magnus Mansouri] Univ Bern, Bern, Switzerland; [Cataland, Spero] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Wu, Haifeng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Knoebl, Paul] Med Univ Vienna, Dept Med, Div Hematol & Hemostasis, Vienna, Austria; [Jilma, Bernd] Med Univ Vienna, Clin Pharmacol, Vienna, Austria; [Callewaert, Filip; Duby, Christian; Tersago, Dominique] Ablynx, Dept Clin Dev, Zwijnaarde, Belgium; [Ulrichts, Hans] Ablynx, Dept Pharmacol, Zwijnaarde, Belgium	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University College London Hospitals NHS Foundation Trust; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Medical University of Vienna; Medical University of Vienna	Callewaert, F (corresponding author), Ablynx, Clin Dev, Technologiepk 21, B-9052 Ghent, Belgium.	filip.callewaert@ablynx.com	Knoebl, Paul/G-2787-2010; Peyvandi, Flora/AAK-7437-2020; Hovinga, Johanna A Kremer/M-3482-2013	Knoebl, Paul/0000-0002-7909-7225; Peyvandi, Flora/0000-0001-7423-9864; Hovinga, Johanna A Kremer/0000-0002-1300-7135; Jilma, Bernd/0000-0001-5652-7977; Angelillo-Scherrer, Anne/0000-0003-2872-4863; Chantepie, Sylvain P/0000-0003-0457-2252; de la Rubia, Javier/0000-0002-8354-768X; Capalbo, Silvana/0000-0002-6247-5007; Arbona, Cristina/0000-0003-3650-1547; Artoni, Andrea/0000-0003-0625-8320	Ablynx; MRC [G0800671] Funding Source: UKRI; British Heart Foundation [PG/15/103/31900, FS/10/013/28073] Funding Source: researchfish; Medical Research Council [G0800671] Funding Source: researchfish	Ablynx(Ablynx); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Ablynx; ClinicalTrials.gov number, NCT01151423.	Benhamou Y, 2015, J THROMB HAEMOST, V13, P293, DOI 10.1111/jth.12790; Bentley MJ, 2015, J THROMB HAEMOST, V13, P1524, DOI 10.1111/jth.12992; Blombery P, 2014, J BLOOD MED, V5, P15, DOI 10.2147/JBM.S46458; Callewaert F, 2012, BLOOD, V120, P3603, DOI 10.1182/blood-2012-04-420943; Chaturvedi S, 2013, AM J HEMATOL, V88, P560, DOI 10.1002/ajh.23455; Deford CC, 2013, BLOOD, V122, P2023, DOI 10.1182/blood-2013-04-496752; Froehlich-Zahnd R, 2012, HAEMATOL-HEMATOL J, V97, P297, DOI 10.3324/haematol.2011.051433; George JN, 2012, AM J HEMATOL, V87, pS88, DOI 10.1002/ajh.23126; George JN, 2009, KIDNEY INT, V75, pS52, DOI 10.1038/ki.2008.622; Han BW, 2015, AM J HEMATOL, V90, P709, DOI 10.1002/ajh.24060; Hawkins BM, 2008, TRANSFUSION, V48, P382, DOI 10.1111/j.1537-2995.2007.01534.x; Hie M, 2014, BLOOD, V124, P204, DOI 10.1182/blood-2014-01-550244; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; Hovinga JAK, 2008, CURR OPIN HEMATOL, V15, P445, DOI 10.1097/MOH.0b013e328309ec62; Hughes C, 2009, J THROMB HAEMOST, V7, P529, DOI 10.1111/j.1538-7836.2009.03285.x; Jin M, 2008, BRIT J HAEMATOL, V141, P651, DOI 10.1111/j.1365-2141.2008.07107.x; Kennedy AS, 2009, TRANSFUSION, V49, P1092, DOI 10.1111/j.1537-2995.2009.02101.x; Lewis QF, 2009, TRANSFUSION, V49, P118, DOI 10.1111/j.1537-2995.2008.01938.x; Nichols L, 2015, THER APHER DIAL, V19, P87, DOI 10.1111/1744-9987.12191; Patschan D, 2006, NEPHROL DIAL TRANSPL, V21, P1549, DOI 10.1093/ndt/gfl127; Peyvandi F, 2008, HAEMATOLOGICA, V93, P232, DOI 10.3324/haematol.11739; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Sarig G, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10160; Sarode R, 1997, AM J HEMATOL, V54, P102, DOI 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Wahla AS, 2008, EUR J HAEMATOL, V81, P311, DOI 10.1111/j.1600-0609.2008.01112.x	27	337	350	7	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					511	522		10.1056/NEJMoa1505533	http://dx.doi.org/10.1056/NEJMoa1505533			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863353	Green Published, Bronze			2022-12-28	WOS:000369755800004
J	Hemkens, LG; Contopoulos-Ioannidis, DG; Ioannidis, JPA				Hemkens, Lars G.; Contopoulos-Ioannidis, Despina G.; Ioannidis, John P. A.			Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DUAL ANTIPLATELET THERAPY; ARTERY-BYPASS SURGERY; PERCUTANEOUS CORONARY INTERVENTION; INTRAAORTIC BALLOON PUMP; ASPIRIN PLUS CLOPIDOGREL; ELEVATION MYOCARDIAL-INFARCTION; ZOTAROLIMUS-ELUTING STENTS; BETA-BLOCKER CONTINUATION; METASTATIC BREAST-CANCER; MITRAL-VALVE REPAIR	Objective To assess differences in estimated treatment effects for mortality between observational studies with routinely collected health data (RCD; that are published before trials are available) and subsequent evidence from randomized controlled trials on the same clinical question. Design Meta-epidemiological survey. Data sources PubMed searched up to November 2014. Methods Eligible RCD studies were published up to 2010 that used propensity scores to address confounding bias and reported comparative effects of interventions for mortality. The analysis included only RCD studies conducted before any trial was published on the same topic. The direction of treatment effects, confidence intervals, and effect sizes (odds ratios) were compared between RCD studies and randomized controlled trials. The relative odds ratio (that is, the summary odds ratio of trial(s) divided by the RCD study estimate) and the summary relative odds ratio were calculated across all pairs of RCD studies and trials. A summary relative odds ratio greater than one indicates that RCD studies gave more favorable mortality results. Results The evaluation included 16 eligible RCD studies, and 36 subsequent published randomized controlled trials investigating the same clinical questions (with 17 275 patients and 835 deaths). Trials were published a median of three years after the corresponding RCD study. For five (31%) of the 16 clinical questions, the direction of treatment effects differed between RCD studies and trials. Confidence intervals in nine (56%) RCD studies did not include the RCT effect estimate. Overall, RCD studies showed significantly more favorable mortality estimates by 31% than subsequent trials (summary relative odds ratio 1.31 (95% confidence interval 1.03 to 1.65; I-2=0%)). Conclusions Studies of routinely collected health data could give different answers from subsequent randomized controlled trials on the same clinical questions, and may substantially overestimate treatment effects. Caution is needed to prevent misguided clinical decision making.	[Hemkens, Lars G.; Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Hemkens, Lars G.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Contopoulos-Ioannidis, Despina G.] Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; University of Basel; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA.	jioannid@stanford.edu	Hemkens, Lars G./AAB-2653-2020; Ioannidis, John P. A./G-9836-2011	Hemkens, Lars G./0000-0002-3444-1432; 	Commonwealth Fund, a private independent foundation based in New York City; Santesuisse, the umbrella association of Swiss social health insurers; Laura and John Arnold Foundation	Commonwealth Fund, a private independent foundation based in New York City; Santesuisse, the umbrella association of Swiss social health insurers; Laura and John Arnold Foundation	This study was supported by the Commonwealth Fund, a private independent foundation based in New York City. The views presented here are those of the authors and not necessarily those of the Commonwealth Fund, its directors, officers, or staff. The Basel Institute for Clinical Epidemiology and Biostatistics received support from Santesuisse, the umbrella association of Swiss social health insurers. The Meta-Research Innovation Center at Stanford is funded by a grant by the Laura and John Arnold Foundation. The work of JPAI is supported by an unrestricted gift from Sue and Bob O'Donnell. The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript or its submission for publication.	Acker MA, 2014, NEW ENGL J MED, V370, P23, DOI 10.1056/NEJMoa1312808; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 1999, EPIDEMIOLOGIC METHOD; Arogundade F A, 2005, Afr J Med Med Sci, V34, P227; Ascione R, 2003, ANN THORAC SURG, V76, P793, DOI 10.1016/S0003-4975(03)00664-7; Badings EA, 2013, EUROINTERVENTION, V9, P54, DOI 10.4244/EIJV9I1A9; Badwe R, 2013, CANC RES S, V73, pS2; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Bradley SM, 2003, ANN THORAC SURG, V76, P783; Butler MJ, 2009, AM HEART J, V157, P899, DOI 10.1016/j.ahj.2009.02.018; Cabell CH, 2005, AM HEART J, V150, P1092, DOI 10.1016/j.ahj.2005.03.057; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Damgaard S, 2009, EUR HEART J, V30, P1005, DOI 10.1093/eurheartj/ehp048; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Fattouch K, 2009, J THORAC CARDIOV SUR, V137, P650, DOI 10.1016/j.jtcvs.2008.11.033; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Fonarow GC, 2008, J AM COLL CARDIOL, V52, P190, DOI 10.1016/j.jacc.2008.03.048; Gao G, 2010, J AM COLL CARDIOL, V56, P1639, DOI 10.1016/j.jacc.2010.03.104; Gasparovic H, 2014, AM J CARDIOL, V113, P1660, DOI 10.1016/j.amjcard.2014.02.024; Gliklich R., 2014, 1314EHC111 AG HEALTH; Gnerlich J, 2007, ANN SURG ONCOL, V14, P2187, DOI 10.1245/s10434-007-9438-0; Guru V, 2006, J THORAC CARDIOV SUR, V131, P1021, DOI 10.1016/j.jtcvs.2005.09.036; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hahn JY, 2010, CIRC J, V74, P2314, DOI 10.1253/circj.CJ-10-0347; Hemkens LG, 2013, CAN MED ASSOC J, V185, pE827, DOI 10.1503/cmaj.130430; Hemkens LG, CMAJ IN PRESS; Hemkens LG, CMAJ OPEN IN PRESS; Hlatky MA, 2013, HEART FAIL CLIN, V9, P29, DOI 10.1016/j.hfc.2012.09.007; Holman WL, 2000, J THORAC CARDIOV SUR, V120, P1112, DOI 10.1067/mtc.2000.110459; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P239, DOI 10.1001/jama.2012.168095; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Jondeau G, 2009, EUR HEART J, V30, P2186, DOI 10.1093/eurheartj/ehp323; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0; Keuter XHA, 2008, J VASC SURG, V47, P395, DOI 10.1016/j.jvs.2007.09.063; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kim DH, 2009, J THORAC CARDIOV SUR, V138, P1377, DOI 10.1016/j.jtcvs.2009.07.027; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Kulik A, 2010, CIRCULATION, V122, P2680, DOI 10.1161/CIRCULATIONAHA.110.978007; Kuss O, 2011, J CLIN EPIDEMIOL, V64, P1076, DOI 10.1016/j.jclinepi.2011.01.005; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Lomivorotov VV, 2012, J CARDIOTHOR VASC AN, V26, P596, DOI 10.1053/j.jvca.2011.09.006; Lonjon G, 2014, ANN SURG, V259, P18, DOI 10.1097/SLA.0000000000000256; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mannacio VA, 2012, HEART, V98, P1710, DOI 10.1136/heartjnl-2012-302449; Masoumi Masoumali, 2008, Asian Cardiovasc Thorac Ann, V16, P16; [MEDLINE / PubMed Search Strategy & Electronic Health Record Information Resources National Library of Medicine], 2015, SEC MEDLINE PUBMED S; Medved I, 2010, COLLEGIUM ANTROPOL, V34, P213; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Moss RR, 2003, CIRCULATION, V108, P90, DOI 10.1161/01.cir.0000089182.44963.bb; Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Ranucci M, 2013, CRIT CARE MED, V41, P2476, DOI 10.1097/CCM.0b013e3182978dfc; Richardson WS, 1995, ACP J CLUB, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12; Rooijens PPGM, 2005, J VASC SURG, V42, P481, DOI 10.1016/j.jvs.2005.05.025; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SAFRAN C, 1991, STAT MED, V10, P559, DOI 10.1002/sim.4780100407; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207; Shavelle DM, 2002, AM HEART J, V143, P488, DOI 10.1067/mhj.2002.120970; Soran A, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S2-03; Sox HC, 2012, ANNU REV PUBL HEALTH, V33, P425, DOI 10.1146/annurev-publhealth-031811-124610; Sterne JAC., 2014, COCHRANE RISK BIAS A; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Wu CT, 2008, ANN THORAC SURG, V86, P1153, DOI 10.1016/j.athoracsur.2008.05.059; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	79	119	120	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2016	352								i493	10.1136/bmj.i493	http://dx.doi.org/10.1136/bmj.i493			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IH	26858277	Green Published, hybrid			2022-12-28	WOS:000370380000002
J	Watts, G				Watts, Geoff			Roderick Norman McIver MacSween Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					530	530		10.1016/S0140-6736(16)00120-3	http://dx.doi.org/10.1016/S0140-6736(16)00120-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26867437	Bronze			2022-12-28	WOS:000369835800019
J	Wadley, P; Howells, B; Zelezny, J; Andrews, C; Hills, V; Campion, RP; Novak, V; Olejnik, K; Maccherozzi, F; Dhesi, SS; Martin, SY; Wagner, T; Wunderlich, J; Freimuth, F; Mokrousov, Y; Kunes, J; Chauhan, JS; Grzybowski, MJ; Rushforth, AW; Edmonds, KW; Gallagher, BL; Jungwirth, T				Wadley, P.; Howells, B.; Zelezny, J.; Andrews, C.; Hills, V.; Campion, R. P.; Novak, V.; Olejnik, K.; Maccherozzi, F.; Dhesi, S. S.; Martin, S. Y.; Wagner, T.; Wunderlich, J.; Freimuth, F.; Mokrousov, Y.; Kunes, J.; Chauhan, J. S.; Grzybowski, M. J.; Rushforth, A. W.; Edmonds, K. W.; Gallagher, B. L.; Jungwirth, T.			Electrical switching of an antiferromagnet	SCIENCE			English	Article							SPIN; MAGNETORESISTANCE; PHASE	Antiferromagnets are hard to control by external magnetic fields because of the alternating directions of magnetic moments on individual atoms and the resulting zero net magnetization. However, relativistic quantum mechanics allows for generating current-induced internal fields whose sign alternates with the periodicity of the antiferromagnetic lattice. Using these fields, which couple strongly to the antiferromagnetic order, we demonstrate room-temperature electrical switching between stable configurations in antiferromagnetic CuMnAs thin-film devices by applied current with magnitudes of order 10(6) ampere per square centimeter. Electrical writing is combined in our solid-state memory with electrical readout and the stored magnetic state is insensitive to and produces no external magnetic field perturbations, which illustrates the unique merits of antiferromagnets for spintronics.	[Wadley, P.; Howells, B.; Andrews, C.; Hills, V.; Campion, R. P.; Chauhan, J. S.; Grzybowski, M. J.; Rushforth, A. W.; Edmonds, K. W.; Gallagher, B. L.; Jungwirth, T.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Zelezny, J.; Novak, V.; Olejnik, K.; Wunderlich, J.; Jungwirth, T.] Acad Sci Czech Republ, Inst Phys, Cukrovarnicka 10, Prague 16200 6, Czech Republic; [Zelezny, J.] Charles Univ Prague, Fac Math & Phys, Ke Karlovu 3, CR-12116 Prague 2, Czech Republic; [Maccherozzi, F.; Dhesi, S. S.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Martin, S. Y.; Wagner, T.; Wunderlich, J.] Hitachi Cambridge Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Wagner, T.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0HE, England; [Freimuth, F.; Mokrousov, Y.] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Freimuth, F.; Mokrousov, Y.] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Freimuth, F.; Mokrousov, Y.] JARA, D-52425 Julich, Germany; [Kunes, J.] Acad Sci Czech Republ, Inst Phys, Na Slovance 2, Prague 18221 8, Czech Republic; [Grzybowski, M. J.] Polish Acad Sci, Inst Phys, Al Lotnikow 32-46, PL-02668 Warsaw, Poland	University of Nottingham; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Charles University Prague; Diamond Light Source; University of Cambridge; University of Cambridge; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Wadley, P (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.	peter.wadley@nottingham.ac.uk	Grzybowski, Michał J/S-2468-2016; Freimuth, Frank/R-9515-2018; Kunes, Jan/B-4484-2008; Novak, Vit/G-6844-2014; Zelezny, Jakub/G-5276-2014; Mokrousov, Yuriy/H-8517-2013; Olejnik, Kamil/I-7085-2012; Jungwirth, Tomas/G-8952-2014; Wadley, Peter/I-8077-2017; Gallagher, Bryan/B-8116-2013	Grzybowski, Michał J/0000-0002-2943-3067; Freimuth, Frank/0000-0001-6193-5991; Kunes, Jan/0000-0001-9682-7640; Novak, Vit/0000-0003-2461-1685; Zelezny, Jakub/0000-0001-9471-0078; Mokrousov, Yuriy/0000-0003-1072-2421; Olejnik, Kamil/0000-0002-1023-0358; Jungwirth, Tomas/0000-0002-9910-1674; Wadley, Peter/0000-0003-4631-9837; Campion, Richard/0000-0001-8990-8987; Gallagher, Bryan/0000-0001-8310-0899	European Union (EU) European Research Council [268066]; Ministry of Education of the Czech Republic [LM2011026]; Grant Agency of the Czech Republic [14-37427]; UK Engineering and Physical Sciences Research Council [EP/K027808/1]; EU [REGPOT-CT-2013-316014, FP7-People-2012-ITN-316657]; HGF Programme [VH-NG 513]; Deutsche Forschungsgemeinschaft [SPP 1568]; RWTH Aachen University; Engineering and Physical Sciences Research Council [1230146, EP/K027808/1] Funding Source: researchfish; EPSRC [EP/K027808/1] Funding Source: UKRI	European Union (EU) European Research Council(European Research Council (ERC)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); HGF Programme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); RWTH Aachen University; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge support from the European Union (EU) European Research Council Advanced (grant 268066); the Ministry of Education of the Czech Republic (grant LM2011026); the Grant Agency of the Czech Republic (grant 14-37427); the UK Engineering and Physical Sciences Research Council (grant EP/K027808/1); the EU 7th Framework Programme (grant REGPOT-CT-2013-316014 and FP7-People-2012-ITN-316657); HGF Programme VH-NG 513 and Deutsche Forschungsgemeinschaft SPP 1568; supercomputing resources at Julich Supercomputing Centre and RWTH Aachen University; and Diamond Light Source for the allocation of beamtime under proposal number SI-12504. We thank C. Nelson for providing the scanning transmission electron microscopy measurement.	Barthem VMTS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3892; Bernevig BA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.033203; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Chernyshov A, 2009, NAT PHYS, V5, P656, DOI 10.1038/NPHYS1362; DAUGHTON JM, 1992, THIN SOLID FILMS, V216, P162, DOI 10.1016/0040-6090(92)90888-I; Endo M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3520514; Fang D, 2011, NAT NANOTECHNOL, V6, P413, DOI [10.1038/NNANO.2011.68, 10.1038/nnano.2011.68]; Fiebig M, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/16/164005; Fina I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5671; Freimuth F, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174423; Gomonay HV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144427; Hills V, 2015, J APPL PHYS, V117, DOI 10.1063/1.4914119; Jungwirth T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035321; Kato YK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176601; Kimel AV, 2004, NATURE, V429, P850, DOI 10.1038/nature02659; Maca F, 2012, J MAGN MAGN MATER, V324, P1606, DOI 10.1016/j.jmmm.2011.12.017; Manchon A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212405; Marti X, 2014, NAT MATER, V13, P367, DOI [10.1038/nmat3861, 10.1038/NMAT3861]; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; Moriyama T, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4931567; Park BG, 2011, NAT MATER, V10, P347, DOI [10.1038/nmat2983, 10.1038/NMAT2983]; Pi UH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502596; Shick AB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.212409; Silov AY, 2004, APPL PHYS LETT, V85, P5929, DOI 10.1063/1.1833565; Suzuki T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579155; Umetsu RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236103; Wadley P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3322; Wang YY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137201; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; YAMAOKA T, 1974, J PHYS SOC JPN, V36, P445, DOI 10.1143/JPSJ.36.445; Zelezny J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157201; Zhang W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.196602	33	826	834	25	556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					587	590		10.1126/science.aab1031	http://dx.doi.org/10.1126/science.aab1031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26841431	Green Accepted, Green Submitted			2022-12-28	WOS:000369291600036
J	Almaddah, N; Ajayi, TO				Almaddah, Nureddin; Ajayi, Tokunbo O.			Cocaine-Induced Coronary-Artery Vasospasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Almaddah, Nureddin; Ajayi, Tokunbo O.] North Shore Med Ctr, Salem, MA USA		Almaddah, N (corresponding author), North Shore Med Ctr, Salem, MA USA.	nalmaddah@partners.org							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					E5	E5		10.1056/NEJMicm1503339	http://dx.doi.org/10.1056/NEJMicm1503339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840152				2022-12-28	WOS:000369319100010
J	Okazaki, K; Hirth, G				Okazaki, Keishi; Hirth, Greg			Dehydration of lawsonite could directly trigger earthquakes in subducting oceanic crust	NATURE			English	Article							HIGH-PRESSURE; ANTIGORITE DEHYDRATION; THERMAL STRUCTURE; HIGH-TEMPERATURE; DEFORMATION; SERPENTINE; STABILITY; KINETICS; RELEASE; CREEP	Intermediate-depth earthquakes in cold subduction zones are observed within the subducting oceanic crust, as well as the mantle(1,2). In contrast, intermediate-depth earthquakes in hot subduction zones predominantly occur just below the Mohorovicic discontinuity(1). These observations have stimulated interest in relationships between blueschist-facies metamorphism and seismicity, particularly through dehydration reactions involving the mineral lawsonite(1,2). Here we conducted deformation experiments on lawsonite, while monitoring acoustic emissions, in a Griggs-type deformation apparatus. The temperature was increased above the thermal stability of lawsonite, while the sample was deforming, to test whether the lawsonite dehydration reaction induces unstable fault slip. In contrast to similar tests on antigorite, unstable fault slip (that is, stick-slip) occurred during dehydration reactions in the lawsonite and acoustic emission signals were continuously observed. Microstructural observations indicate that strain is highly localized along the fault (R-1 and B shears), and that the fault surface develops slickensides (very smooth fault surfaces polished by frictional sliding). The unloading slope during the unstable slip follows the stiffness of the apparatus at all experimental conditions, regardless of the strain rate and temperature ramping rate. A thermomechanical scaling factor(3) for the experiments is within the range estimated for natural subduction zones, indicating the potential for unstable frictional sliding within natural lawsonite layers.	[Okazaki, Keishi; Hirth, Greg] Brown Univ, Dept Earth Environm & Planetary Sci, 324 Brook St,Box 1846, Providence, RI 02906 USA	Brown University	Okazaki, K (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, 324 Brook St,Box 1846, Providence, RI 02906 USA.	keishi_okazaki@brown.edu	Okazaki, Keishi/N-2058-2016	Okazaki, Keishi/0000-0001-9396-392X	US National Science Foundation [EAR-1049582, EAR-1315784]	US National Science Foundation(National Science Foundation (NSF))	We thank A. Schubnel, D. Forsyth, T. Altman and T. Togo for technical advice on the acoustic emissions measurement, B. Proctor for discussion and assistance in the laboratory, J. Boesenberg for technical assistance with the electron probe microanalyser, R. Milliken and K. Robertson for helping with XRD measurements, and H. Marschall and Terry E. Tullis for discussions. This study was supported by the US National Science Foundation (EAR-1049582, EAR-1315784).	Abers GA, 2006, EARTH PLANET SC LETT, V241, P387, DOI 10.1016/j.epsl.2005.11.055; Abers GA, 2013, EARTH PLANET SC LETT, V369, P178, DOI 10.1016/j.epsl.2013.03.022; Chernak LJ, 2011, GEOLOGY, V39, P847, DOI 10.1130/G31919.1; Chernak LJ, 2010, EARTH PLANET SC LETT, V296, P23, DOI 10.1016/j.epsl.2010.04.035; Forneris JF, 2003, EARTH PLANET SC LETT, V214, P187, DOI 10.1016/S0012-82X(03)00305-4; Frost H. J., 1982, DEFORMATION MECHANIS, P49; Gasc J, 2011, PHYS EARTH PLANET IN, V189, P121, DOI 10.1016/j.pepi.2011.08.003; Getsinger AJ, 2014, GEOLOGY, V42, P535, DOI 10.1130/G35327.1; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; Hacker BR, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001707; HADIZADEH J, 1992, J STRUCT GEOL, V14, P57, DOI 10.1016/0191-8141(92)90144-L; Hilairet N, 2007, SCIENCE, V318, P1910, DOI 10.1126/science.1148494; Hirose F, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005274; Jung H, 2009, EARTH PLANET SC LETT, V277, P273, DOI 10.1016/j.epsl.2008.10.019; Katayama I, 2012, NAT GEOSCI, V5, P731, DOI [10.1038/NGEO1559, 10.1038/ngeo1559]; Kelemen PB, 2007, NATURE, V446, P787, DOI 10.1038/nature05717; Kim D, 2013, ISL ARC, V22, P63, DOI 10.1111/iar.12003; Kita S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028239; Marschall HR, 2007, CHEM GEOL, V239, P323, DOI 10.1016/j.chemgeo.2006.08.008; NEWTON RC, 1963, J GEOPHYS RES, V68, P2967, DOI 10.1029/JZ068i010p02967; Okazaki K, 2015, GEOPHYS RES LETT, V42, P1099, DOI 10.1002/2014GL062735; Paterson M.S., 2005, EXPT ROCK DEFORMATIO; Paterson MS, 2000, J STRUCT GEOL, V22, P1341, DOI 10.1016/S0191-8141(00)00042-0; Perrillat JP, 2005, EARTH PLANET SC LETT, V236, P899, DOI 10.1016/j.epsl.2005.06.006; Proctor B, 2015, EARTH PLANET SC LETT, V421, P1, DOI 10.1016/j.epsl.2015.03.040; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Sawai M, 2013, PHYS CHEM MINER, V40, P319, DOI 10.1007/s00269-013-0573-9; SCHMIDT MW, 1994, EARTH PLANET SC LETT, V124, P105, DOI 10.1016/0012-821X(94)00080-8; Scholz C.H., 2002, MECH EARTHQUAKES FAU, P81; Schubnel A, 2013, SCIENCE, V341, P1377, DOI 10.1126/science.1240206; Tsuji Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034461; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; van Keken PE, 2012, SOLID EARTH, V3, P355, DOI 10.5194/se-3-355-2012; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570	34	87	91	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					81	+		10.1038/nature16501	http://dx.doi.org/10.1038/nature16501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842057				2022-12-28	WOS:000369304500036
J	Patzold, M; Andert, T; Hahn, M; Asmar, SW; Barriot, JP; Bird, MK; Hausler, B; Peter, K; Tellmann, S; Grun, E; Weissman, PR; Sierks, H; Jorda, L; Gaskell, R; Preusker, F; Scholten, F				Paetzold, M.; Andert, T.; Hahn, M.; Asmar, S. W.; Barriot, J. -P.; Bird, M. K.; Haeusler, B.; Peter, K.; Tellmann, S.; Gruen, E.; Weissman, P. R.; Sierks, H.; Jorda, L.; Gaskell, R.; Preusker, F.; Scholten, F.			A homogeneous nucleus for comet 67P/Churyumov-Gerasimenko from its gravity field	NATURE			English	Article							MASS; EXPRESS	Cometary nuclei consist mostly of dust and water ice(1). Previous observations have found nuclei to be low-density and highly porous bodies(2-4), but have only moderately constrained the range of allowed densities because of the measurement uncertainties. Here we report the precise mass, bulk density, porosity and internal structure of the nucleus of comet 67P/Churyumov-Gerasimenko on the basis of its gravity field. The mass and gravity field are derived from measured spacecraft velocity perturbations at fly-by distances between 10 and 100 kilometres. The gravitational point mass is GM = 666.2 +/- 0.2 cubic metres per second squared, giving a mass M = (9,982 +/- 3) x 10(9) kilograms. Together with the current estimate of the volume of the nucleus(5), the average bulk density of the nucleus is 533 +/- 6 kilograms per cubic metre. The nucleus appears to be a low-density, highly porous (72-74 per cent) dusty body, similar to that of comet 9P/Tempel 1(2,3). The most likely composition mix has approximately four times more dust than ice by mass and two times more dust than ice by volume. We conclude that the interior of the nucleus is homogeneous and constant in density on a global scale without large voids. The high porosity seems to be an inherent property of the nucleus material.	[Paetzold, M.; Hahn, M.; Bird, M. K.; Peter, K.; Tellmann, S.] Univ Cologne, Rhein Inst Umweltforsch, Abt Planetenforsch, D-50931 Cologne, Germany; [Andert, T.; Haeusler, B.] Univ Bundeswehr Munchen, Inst Raumfahrttech & Weltraumnutzung, D-85577 Neubiberg, Germany; [Asmar, S. W.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Barriot, J. -P.] Univ Polynesie Francaise, Faaa, Tahiti, France; [Gruen, E.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Weissman, P. R.; Gaskell, R.] Planetary Sci Inst, 1700 East Ft Lowell,Suite 106, Tucson, AZ 85719 USA; [Sierks, H.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Jorda, L.] Aix Marseille Univ, Lab Astrophys Marseille, F-13388 Marseille, France; [Preusker, F.; Scholten, F.] Deutsch Zentrum Luft & Raumfahrt DLR Berlin Adler, Inst Planetenforsch, D-12489 Berlin, Germany	University of Cologne; Bundeswehr University Munich; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Max Planck Society; UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; German Aerospace Centre (DLR)	Patzold, M (corresponding author), Univ Cologne, Rhein Inst Umweltforsch, Abt Planetenforsch, D-50931 Cologne, Germany.	martin.paetzold@uni-koeln.de	Jorda, Laurent/AAA-1718-2021; Barriot, Jean-Pierre/AAD-6709-2021	Barriot, Jean-Pierre/0000-0002-2112-9685; JORDA, Laurent/0000-0001-8735-3308	Bundesministerium fur Wirtschaft BMWi, Berlin, via the German Space Agency DLR, Bonn [50QM1401, 50QM1002]; CNES, Paris; NASA/JPL	Bundesministerium fur Wirtschaft BMWi, Berlin, via the German Space Agency DLR, Bonn; CNES, Paris; NASA/JPL(National Aeronautics & Space Administration (NASA))	Rosetta is an ESA mission with contributions from its member states and NASA. The Rosetta RSI experiment is funded by the Bundesministerium fur Wirtschaft BMWi, Berlin, via the German Space Agency DLR, Bonn, under grants 50QM1401 (RIU-PF) and 50QM1002 (UniBw). J.-P.B. is supported by CNES, Paris. Support for the Multimission Radio Science Support Team is provided by NASA/JPL. We thank everyone involved with the Rosetta mission at ESTEC, ESOC, ESAC and JPL. The RSI team expresses deep appreciation for the critical support provided by the Rosetta SGS at ESAC during the planning and in particular by the ESTRACK and DSN ground station networks during the data acquisition periods. We dedicate this work to the late Claudia Alexander, for her support of RSI over many years.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Altwegg K., 2015, SCIENCE, V347; Anderson J. D., 1971, NASA SPEC PUBL, VSP-267, P577; Anderson JD, 1997, SCIENCE, V276, P1236, DOI 10.1126/science.276.5316.1236; Andert TP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041829; [Anonymous], 2004, IERS CONVENTIONS 200; Aster RC, 2005, PARAMETER ESTIMATION; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Chao C. C., 1972, 391350 JET PROP LAB; Ernst Carolyn M., 2007, Icarus, V191, P123, DOI 10.1016/j.icarus.2007.03.037; Greenberg JM, 1998, EARTH MOON PLANETS, V82-3, P313, DOI 10.1023/A:1017086832593; Hausler B, 2006, PLANET SPACE SCI, V54, P1315, DOI 10.1016/j.pss.2006.04.032; Ifadis I., 1986, 38L CHALM U TECHN SC; Kofman W, 2015, SCIENCE, V349, DOI 10.1126/science.aab0639; Massironi M, 2015, NATURE, V526, P402, DOI 10.1038/nature15511; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Patzold M, 2014, ICARUS, V229, P92, DOI 10.1016/j.icarus.2013.10.021; Patzold M, 2011, SCIENCE, V334, P491, DOI 10.1126/science.1209389; Patzold M, 2009, ESA SPEC PUBL, V1291, P217; Patzold M, 2001, ASTRON ASTROPHYS, V375, P651, DOI 10.1051/0004-6361:20010829; Patzold M., 2009, ROSETTA ESAS MISSION, P537; PRESS WH, 1986, NUMERICAL RECIPES FO; Preusker F, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526349; Rotundi A, 2015, SCIENCE, V347, DOI 10.1126/science.aaa3905; Saastamoinen J., 1972, GEOPHYS MONOGR SER, V15, P247, DOI DOI 10.1029/GM015P0247; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Takahashi Y, 2014, ICARUS, V233, P179, DOI 10.1016/j.icarus.2014.02.004; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Yeomans DK, 1997, SCIENCE, V278, P2106, DOI 10.1126/science.278.5346.2106	29	212	215	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					63	+		10.1038/nature16535	http://dx.doi.org/10.1038/nature16535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842054				2022-12-28	WOS:000369304500032
J	Gray, SL; Dublin, S; Yu, O; Walker, R; Anderson, M; Hubbard, RA; Crane, PK; Larson, EB				Gray, Shelly L.; Dublin, Sascha; Yu, Onchee; Walker, Rod; Anderson, Melissa; Hubbard, Rebecca A.; Crane, Paul K.; Larson, Eric B.			Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; HEALTH; ASSOCIATION; MEDICATIONS; CARE	OBJECTIVE To determine whether higher cumulative use of benzodiazepines is associated with a higher risk of dementia or more rapid cognitive decline. DESIGN Prospective population based cohort. SETTING Integrated healthcare delivery system, Seattle, Washington. PARTICIPANTS 3434 participants aged >= 65 without dementia at study entry. There were two rounds of recruitment (1994-96 and 2000-03) followed by continuous enrollment beginning in 2004. MAIN OUTCOMES MEASURES The cognitive abilities screening instrument (CASI) was administered every two years to screen for dementia and was used to examine cognitive trajectory. Incident dementia and Alzheimer's disease were determined with standard diagnostic criteria. Benzodiazepine exposure was defined from computerized pharmacy data and consisted of the total standardized daily doses (TSDDs) dispensed over a 10 year period (a rolling window that moved forward in time during follow-up). The most recent year was excluded because of possible use for prodromal symptoms. Multivariable Cox proportional hazard models were used to examine time varying use of benzodiazepine and dementia risk. Analyses of cognitive trajectory used linear regression models with generalized estimating equations. RESULTS Over a mean follow-up of 7.3 years, 797 participants (23.2%) developed dementia, of whom 637 developed Alzheimer's disease. For dementia, the adjusted hazard ratios associated with cumulative benzodiazepine use compared with non-use were 1.25 (95% confidence interval 1.03 to 1.51) for 1-30 TSDDs; 1.31 (1.00 to 1.71) for 31-120 TSDDs; and 1.07 (0.82 to 1.39) for >= 121 TSDDs. Results were similar for Alzheimer's disease. Higher benzodiazepine use was not associated with more rapid cognitive decline. CONCLUSION The risk of dementia is slightly higher in people with minimal exposure to benzodiazepines but not with the highest level of exposure. These results do not support a causal association between benzodiazepine use and dementia.	[Gray, Shelly L.] Univ Washington, Sch Pharm, Seattle, WA 98195 USA; [Dublin, Sascha; Yu, Onchee; Walker, Rod; Anderson, Melissa; Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Hubbard, Rebecca A.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Crane, Paul K.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Group Health Cooperative; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle	Gray, SL (corresponding author), Univ Washington, Sch Pharm, Seattle, WA 98195 USA.	slgray@u.washington.edu	Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994; Walker, Rod/0000-0002-8464-9805	National Institute on Aging (NIH) [U01AG00678, R03AG042930]; Branta Foundation; NATIONAL INSTITUTE ON AGING [U01AG006781, R03AG042930] Funding Source: NIH RePORTER	National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Branta Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging (NIH Grants U01AG00678 (EBL), R03AG042930 (SD)) and by the Branta Foundation (SD). The sponsors had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or in preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2014, CLIN GUIDELINES IDEN; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Gray SL, 2002, J AM GERIATR SOC, V50, P1012, DOI 10.1046/j.1532-5415.2002.50254.x; Hanlon JT, 2009, J GERONTOL A-BIOL, V64, P492, DOI 10.1093/gerona/gln043; Imfeld P, 2015, DRUG SAFETY, V38, P909, DOI 10.1007/s40264-015-0319-3; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Koyama A, 2013, J AM GERIATR SOC, V61, P258, DOI 10.1111/jgs.12093; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mura T, 2013, EUR NEUROPSYCHOPHARM, V23, P212, DOI 10.1016/j.euroneuro.2012.05.004; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Richard E, 2013, JAMA NEUROL, V70, P383, DOI 10.1001/jamaneurol.2013.603; Semla TP, 2010, GERIATRIC DOSAGE HDB; Skogen JC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0020-5; Spira AP, 2014, CURR OPIN PSYCHIATR, V27, P478, DOI 10.1097/YCO.0000000000000106; Stella F, 2014, CURR OPIN PSYCHIATR, V27, P230, DOI 10.1097/YCO.0000000000000050; Tamim H, 2007, PHARMACOEPIDEM DR S, V16, P250, DOI 10.1002/pds.1360; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Verdoux H, 2005, PSYCHOL MED, V35, P307, DOI 10.1017/S0033291704003897; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	128	132	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								i90	10.1136/bmj.i90	http://dx.doi.org/10.1136/bmj.i90			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2QK	26837813	Green Published, hybrid			2022-12-28	WOS:000369767100002
J	Kaarkuzhali, B; Krishnamurthy, MD				Kaarkuzhali, B.; Krishnamurthy, M. D.			In the Clinic Epilepsy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							QUALITY-STANDARDS-SUBCOMMITTEE; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; SUDDEN UNEXPECTED DEATH; UPDATE MANAGEMENT ISSUES; GUIDELINE DEVELOPMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; NEW-ONSET EPILEPSY; AMERICAN-ACADEMY; PRACTICE PARAMETER; ANTIEPILEPTIC DRUGS	An epileptic seizure is defined by the International League Against Epilepsy (ILAE) as "a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain" (1). In 2014, the ILAE provided an operational (practical) clinical definition of epilepsy as a disease of the brain defined as any of the following conditions: at least 2 unprovoked [or reflex] seizures occurring more than 24 hours apart; 1 unprovoked [or reflex] seizure and a probability of further seizures similar to the general recurrence risk [at least 60%] after 2 unprovoked seizures, occurring over the next 10 years; [and/or] a diagnosis of an epilepsy syndrome (2).										Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Bautista RED, 2015, SEIZURE-EUR J EPILEP, V30, P106, DOI 10.1016/j.seizure.2015.06.006; Benbadis S, 2009, EPILEPSY BEHAV, V15, P15, DOI 10.1016/j.yebeh.2009.02.024; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ERN.11.51, 10.1586/ern.11.51]; Devinsky O, 2005, NEUROLOGY, V65, P980, DOI 10.1212/01.wnl.0000178385.31601.e4; Devinsky O, 2011, NEW ENGL J MED, V365, P1801, DOI 10.1056/NEJMra1010481; Divino V, 2015, EPILEPSY BEHAV, V51, P40, DOI 10.1016/j.yebeh.2015.06.013; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; Gaitatzis A, 2013, CNS DRUGS, V27, P435, DOI 10.1007/s40263-013-0063-0; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Garcia C S, 2012, Epilepsy Res Treat, V2012, P809843, DOI 10.1155/2012/809843; Harden CL, 2009, NEUROLOGY, V73, P142, DOI 10.1212/WNL.0b013e3181a6b325; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Harden CL, 2009, NEUROLOGY, V73, P126, DOI 10.1212/WNL.0b013e3181a6b2f8; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog AG, 2008, SEIZURE-EUR J EPILEP, V17, P101, DOI 10.1016/j.seizure.2007.11.025; Herzog AG, 2014, NEUROLOGY, V83, P345, DOI 10.1212/WNL.0000000000000623; Illingworth JL, 2013, EPILEPSIA, V54, P2036, DOI 10.1111/epi.12340; Jacoby A, 2015, EPILEPSIA, V56, P460, DOI 10.1111/epi.12913; Jehi L, 2015, NEUROLOGY, V85, P208, DOI 10.1212/WNL.0000000000001768; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Krumholz A, 2015, NEUROLOGY, V84, P1705, DOI 10.1212/WNL.0000000000001487; Lamberts RJ, 2015, NEUROLOGY, V85, P212, DOI 10.1212/WNL.0000000000001755; Lim YJ, 2009, EPILEPSY RES, V87, P107, DOI 10.1016/j.eplepsyres.2009.08.014; Lowenstein DH, 2005, CURR OPIN PHARMACOL, V5, P334, DOI 10.1016/j.coph.2005.04.003; Margolis JM, 2014, JAMA NEUROL, V71, P985, DOI 10.1001/jamaneurol.2014.808; Massey CA, 2014, NAT REV NEUROL, V10, P271, DOI 10.1038/nrneurol.2014.64; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; Mohanraj R, 2013, SEIZURE-EUR J EPILEP, V22, P333, DOI 10.1016/j.seizure.2013.02.002; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Morris GL, 2013, NEUROLOGY, V81, P1453, DOI 10.1212/WNL.0b013e3182a393d1; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Naik PA, 2015, EPILEPSY BEHAV, V47, P111, DOI 10.1016/j.yebeh.2015.04.016; Pandey S, 2014, COCHRANE DB SYST REV, V10; Prasad V, 2014, PEDIATRICS, V133, P827, DOI 10.1542/peds.2013-2554; Quigg M, 2014, J NEUROSURG, V121, P232, DOI 10.3171/2014.8.GKS141608; Rissanen I, 2015, EPILEPSY BEHAV, V46, P198, DOI 10.1016/j.yebeh.2015.03.001; Robinson S, 2005, EPILEPSY BEHAV, V7, P345, DOI 10.1016/j.yebeh.2005.06.005; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Shankar R, 2013, SEIZURE-EUR J EPILEP, V22, P812, DOI 10.1016/j.seizure.2013.07.014; Shcherbakova N, 2014, CNS DRUGS, V28, P1047, DOI 10.1007/s40263-014-0191-1; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Smith G, 2009, EPILEPSY BEHAV, V16, P484, DOI 10.1016/j.yebeh.2009.08.028; Sung C, 2014, EPILEPSY RES, V108, P1469, DOI 10.1016/j.eplepsyres.2014.06.016; Sveinsson O, 2014, DRUG AGING, V31, P671, DOI 10.1007/s40266-014-0201-5; Tebo CC, 2014, J NEUROSURG, V120, P1415, DOI 10.3171/2014.1.JNS131694; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; U.S. Food and Drug Administration, 2014, SUIC BEH ID ANT DRUG; Wagner RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129097; Winkler AS, 2010, EPILEPSY BEHAV, V19, P596, DOI 10.1016/j.yebeh.2010.09.023; Witt JA, 2015, SEIZURE-EUR J EPILEP, V26, P65, DOI 10.1016/j.seizure.2015.01.018; Zou XM, 2014, EPILEPSY BEHAV, V31, P129, DOI 10.1016/j.yebeh.2013.11.028	57	7	7	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					ITC17	ITC30		10.7326/AITC201602020	http://dx.doi.org/10.7326/AITC201602020			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26829918				2022-12-28	WOS:000369169400001
J	Dyer, C				Dyer, Clare			BRIEFING Abortion in Northern Ireland: is change on the cards?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						Department of Health Social Services and Public Safety, NO IR TERM PREGN STA; Dyer C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i135; Erwin A., 2015, BELFAST TELEGRA 0619; Gentleman A., 2016, GUARDIAN; McDonald H., 2016, GUARDIAN	5	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2016	352								i629	10.1136/bmj.i629	http://dx.doi.org/10.1136/bmj.i629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QD	26834246				2022-12-28	WOS:000369766400020
J	Lund, DC; Asimow, PD; Farley, KA; Rooney, TO; Seeley, E; Jackson, EW; Durham, ZM				Lund, D. C.; Asimow, P. D.; Farley, K. A.; Rooney, T. O.; Seeley, E.; Jackson, E. W.; Durham, Z. M.			Enhanced East Pacific Rise hydrothermal activity during the last two glacial terminations	SCIENCE			English	Article							CYCLES DRIVE VARIATIONS; SEDIMENTS; BENEATH; FLUXES; PLUME	Mid-ocean ridge magmatism is driven by seafloor spreading and decompression melting of the upper mantle. Melt production is apparently modulated by glacial-interglacial changes in sea level, raising the possibility that magmatic flux acts as a negative feedback on ice-sheet size. The timing of melt variability is poorly constrained, however, precluding a clear link between ridge magmatism and Pleistocene climate transitions. Here we present well-dated sedimentary records from the East Pacific Rise that show evidence of enhanced hydrothermal activity during the last two glacial terminations. We suggest that glacial maxima and lowering of sea level caused anomalous melting in the upper mantle and that the subsequent magmatic anomalies promoted deglaciation through the release of mantle heat and carbon at mid-ocean ridges.	[Lund, D. C.; Seeley, E.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Asimow, P. D.; Farley, K. A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Rooney, T. O.] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Jackson, E. W.; Durham, Z. M.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA	University of Connecticut; California Institute of Technology; Michigan State University; University of Michigan System; University of Michigan	Lund, DC (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	david.lund@uconn.edu	Asimow, Paul D/E-7451-2010; Farley, Kenneth/AAE-7735-2020; Rooney, Tyrone O/B-4594-2010; Jackson, Elliot/W-2178-2019	Asimow, Paul D/0000-0001-6025-8925; Jackson, Elliot/0000-0002-4213-3851; Rooney, Tyrone/0000-0002-8755-7914	University of Michigan; University of Connecticut; Directorate For Geosciences [1558372] Funding Source: National Science Foundation	University of Michigan(University of Michigan System); University of Connecticut; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We dedicate this paper to J. Dymond, whose 1981 treatise on Nazca plate sediments made this work possible. We are also indebted to the Oregon State University Core Repository for carefully preserving the EPR sediment cores since they were collected in the early 1970s. We are grateful to L. Wingate at the University of Michigan and M. Cote at the University of Connecticut for technical support. This work has benefited from discussions with J. Granger, P. Vlahos, B. Fitzgerald, and M. Lyle. Data presented here are available on the National Oceanic and Atmospheric Administration's Paleoclimatology Data website (www.ncdc.noaa.gov/data-access/paleoclimatology-data). Funding was provided by the University of Michigan and the University of Connecticut.	Baker ET, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002424; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Beaulieu SE, 2013, GEOCHEM GEOPHY GEOSY, V14, P4892, DOI 10.1002/2013GC004998; BOSTROM K, 1969, J GEOPHYS RES, V74, P3261, DOI 10.1029/JB074i012p03261; Burley JMA, 2015, EARTH PLANET SC LETT, V426, P246, DOI 10.1016/j.epsl.2015.06.031; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; Cave RR, 2002, GEOCHIM COSMOCHIM AC, V66, P1905, DOI 10.1016/S0016-7037(02)00823-2; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; DYMOND J, 1981, GEOL SOC AM MEM, V154, P133; Emerson S, 2003, TREATISE GEOCHEM, V6, P625, DOI DOI 10.1016/B0-08-043751-6/06112-0; Emile-Geay J, 2009, OCEAN SCI, V5, P203, DOI 10.5194/os-5-203-2009; FRANK M, 1994, PALEOCEANOGRAPHY, V9, P559, DOI 10.1029/94PA01132; German CR, 2002, DEEP-SEA RES PT I, V49, P1921, DOI 10.1016/S0967-0637(02)00086-9; Goff JA, 2015, SCIENCE, V349, DOI 10.1126/science.aab2350; Hofmann M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036078; Huybers P, 2009, EARTH PLANET SC LETT, V286, P479, DOI 10.1016/j.epsl.2009.07.014; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283, DOI 10.1098/rsta.1997.0010; Key K, 2013, NATURE, V495, P500, DOI 10.1038/nature11932; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Lund DC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003693; Maclennan J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000282; Martin P, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000914; Olive JA, 2015, SCIENCE, V350, P310, DOI 10.1126/science.aad0715; Schaller T, 2000, GEOCHIM COSMOCHIM AC, V64, P2243, DOI 10.1016/S0016-7037(99)00443-3; SHIMMIELD GB, 1988, GEOCHIM COSMOCHIM AC, V52, P669, DOI 10.1016/0016-7037(88)90329-8; Smith DK, 2013, EARTH PLANET SC LETT, V371, P6, DOI 10.1016/j.epsl.2013.04.018; Speer K.G., 2003, ENERGY MASS TRANSFER, P287; Tolstoy M, 2015, GEOPHYS RES LETT, V42, P1346, DOI 10.1002/2014GL063015	29	48	51	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					478	482		10.1126/science.aad4296	http://dx.doi.org/10.1126/science.aad4296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823422				2022-12-28	WOS:000368858200030
J	Sender, R; Fuchs, S; Milo, R				Sender, Ron; Fuchs, Shai; Milo, Ron			Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans	CELL			English	Editorial Material							BLOOD-VOLUME; BODY; TRACT	It is often presented as common knowledge that, in the human body, bacteria outnumber human cells by a ratio of at least 10:1. Revisiting the question, we find that the ratio is much closer to 1:1.	[Sender, Ron; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel; [Fuchs, Shai] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Fuchs, Shai] Hosp Sick Children, Dept Pediat Endocrinol & Metab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	Weizmann Institute of Science; Weizmann Institute of Science; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Milo, R (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-7610001 Rehovot, Israel.; Fuchs, S (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.; Fuchs, S (corresponding author), Hosp Sick Children, Dept Pediat Endocrinol & Metab, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	shai.fuchs@sickkids.ca; ron.milo@weizmann.ac.il	Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299				Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; BOER P, 1984, AM J PHYSIOL, V247, pF632, DOI 10.1152/ajprenal.1984.247.4.F632; DAVY KP, 1994, J APPL PHYSIOL, V76, P2059, DOI 10.1152/jappl.1994.76.5.2059; EVE IS, 1966, HEALTH PHYS, V12, P131, DOI 10.1097/00004032-196602000-00002; FELDSCHUH J, 1977, CIRCULATION, V56, P605, DOI 10.1161/01.CIR.56.4.605; ICRP (International Commission on Radiological Protection), 2003, ICRP PUBL, V89, P161; LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292; Pritchard SE, 2014, NEUROGASTROENT MOTIL, V26, P124, DOI 10.1111/nmo.12243; Rosner J., 2014, MICROBE, V9, P47, DOI DOI 10.1128/MICROBE.9.47.2; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sender R, 2016, REVISED ESTIMATES NU; Snyder WS, 1975, REPORT TASK GROUP RE; Tannock G.W., 1995, NORMAL MICROFLORA IN; Wakeman L, 2007, INT J LAB HEMATOL, V29, P279, DOI 10.1111/j.1365-2257.2006.00883.x	15	958	1058	15	183	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					337	340		10.1016/j.cell.2016.01.013	http://dx.doi.org/10.1016/j.cell.2016.01.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824647	Bronze			2022-12-28	WOS:000368906800002
J	Studdert, DM; Bismark, MM; Mello, MM; Singh, H; Spittal, MJ				Studdert, David M.; Bismark, Marie M.; Mello, Michelle M.; Singh, Harnam; Spittal, Matthew J.			Prevalence and Characteristics of Physicians Prone to Malpractice Claims	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL MALPRACTICE; PATIENT COMPLAINTS; RISK; DOCTORS; CARE; EXPERIENCE; INSURANCE; SYSTEM; SURGEONS; PREDICT	BACKGROUND The distribution of malpractice claims among physicians is not well understood. If claim-prone physicians account for a substantial share of all claims, the ability to reliably identify them at an early stage could guide efforts to improve care. METHODS Using data from the National Practitioner Data Bank, we analyzed 66,426 claims paid against 54,099 physicians from 2005 through 2014. We calculated concentrations of claims among physicians. We used multivariable recurrent-event survival analysis to identify characteristics of physicians at high risk for recurrent claims and to quantify risk levels over time. RESULTS Approximately 1% of all physicians accounted for 32% of paid claims. Among physicians with paid claims, 84% incurred only one during the study period ((accounting for 68% of all paid claims), 16% had at least two paid claims ((accounting for 32% of the claims), and 4% had at least three paid claims ((accounting for 12% of the claims). In adjusted analyses, the risk of recurrence increased with the number of previous paid claims. For example, as compared with physicians who had one previous paid claim, the 2160 physicians who had three paid claims had three times the risk of incurring another ((hazard ratio, 3.11; 95% confidence interval [CI], 2.84 to 3.41); this corresponded in absolute terms to a 24% chance ((95% CI, 22 to 26) of another paid claim within 2 years. Risks of recurrence also varied widely according to specialty - for example, the risk among neurosurgeons was four times as great as the risk among psychiatrists. CONCLUSIONS Over a recent 10-year period, a small number of physicians with distinctive characteristics accounted for a disproportionately large number of paid malpractice claims.	[Studdert, David M.; Mello, Michelle M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Studdert, David M.; Mello, Michelle M.] Stanford Law Sch, Stanford, CA USA; [Bismark, Marie M.; Spittal, Matthew J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Singh, Harnam] US Dept HHS, Hlth Resources & Serv Adm, Rockville, MD USA	Stanford University; Stanford University; University of Melbourne; United States Health Resources & Service Administration (HRSA)	Studdert, DM (corresponding author), 117 Encina Commons, Stanford, CA 94305 USA.	studdert@stanford.edu	Studdert, David/AAF-3116-2021; Bismark, Marie/AAO-4830-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270; Spittal, Matthew/0000-0002-2841-1536				Adamson TE, 1997, WESTERN J MED, V166, P37; [Anonymous], 2007, PHYS CHAR DISTR US; [Anonymous], 1987, REP TASK FORC MED LI; Bismark MM, 2013, BMJ QUAL SAF, V22, P532, DOI 10.1136/bmjqs-2012-001691; BOVBJERG RR, 1994, JAMA-J AM MED ASSOC, V272, P1421, DOI 10.1001/jama.272.18.1421; CHARLES SC, 1992, WESTERN J MED, V157, P433; COOIL B, 1991, J AM STAT ASSOC, V86, P285, DOI 10.2307/2290560; Cook RJ, 2007, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-69810-6; Department of Agriculture Economic Research Service, RUR URB COMM AR COD; ELLIS RP, 1990, J RISK INSUR, V57, P66, DOI 10.2307/252925; Ely JW, 1999, J FAM PRACTICE, V48, P23; Frakes M, 2014, DOES MED MALPRACTICE; Gallagher TH, 2013, BMJ QUAL SAF, V22, P521, DOI 10.1136/bmjqs-2013-001880; GIBBONS RD, 1994, J AM STAT ASSOC, V89, P760, DOI 10.2307/2290901; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; HICKSON GB, 1994, JAMA-J AM MED ASSOC, V272, P1583, DOI 10.1001/jama.272.20.1583; Hickson GB, 2007, ACAD MED, V82, P1040, DOI 10.1097/ACM.0b013e31815761ee; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2002, TEX LAW REV, V80, P1595; Morreim H., 2012, OHIO STATE J DISPUTE, V27, P109; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Paterson R., 2012, GOOD DOCTOR WHAT PAT; Phelps CE, 1978, EXPERIENCE RATING ME; Public Citizen, 2007, GREAT MED MALPR HOAX; Pukk-Harenstam K, 2008, QUAL SAF HEALTH CARE, V17, P259, DOI 10.1136/qshc.2007.022897; ROLPH JE, 1991, JAMA-J AM MED ASSOC, V266, P2093, DOI 10.1001/jama.266.15.2093; ROLPH JE, 1981, J RISK INSUR, V48, P247, DOI 10.2307/252739; Rolph John E, 2007, J EMPIR LEGAL STUD, V4, P125, DOI DOI 10.1111/j.1740-1461.2007.00084.x; Royston P, 2011, FLEXIBLE PARAMETRIC; SLOAN FA, 1989, JAMA-J AM MED ASSOC, V262, P3291, DOI 10.1001/jama.262.23.3291; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; TARAGIN MI, 1992, AM J MED, V93, P537, DOI 10.1016/0002-9343(92)90582-V; Unwin E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0413-5; VENEZIAN EC, 1989, J RISK INSUR, V56, P686, DOI 10.2307/253453; Waters TM, 2003, QUAL SAF HEALTH CARE, V12, P330, DOI 10.1136/qhc.12.5.330; Weycker D A, 2000, Health Care Manag Sci, V3, P269, DOI 10.1023/A:1019014028914	39	91	91	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					354	362		10.1056/NEJMsa1506137	http://dx.doi.org/10.1056/NEJMsa1506137			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB8IJ	26816012	Bronze			2022-12-28	WOS:000368760100009
J	Chawes, BL; Bonnelykke, K; Stokholm, J; Vissing, NH; Bjarnadottir, E; Schoos, AMM; Wolsk, HM; Pedersen, TM; Vinding, RK; Thorsteinsdottir, S; Arianto, L; Hallas, HW; Heickendorff, L; Brix, S; Rasmussen, MA; Bisgaard, H				Chawes, Bo L.; Bonnelykke, Klaus; Stokholm, Jakob; Vissing, Nadja H.; Bjarnadottir, Elin; Schoos, Ann-Marie M.; Wolsk, Helene M.; Pedersen, Tine Marie; Vinding, Rebecca K.; Thorsteinsdottir, Sunna; Arianto, Lambang; Hallas, Henrik W.; Heickendorff, Lene; Brix, Susanne; Rasmussen, Morten A.; Bisgaard, Hans			Effect of Vitamin D-3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							25-HYDROXYVITAMIN D; ASTHMA; BRONCHIOLITIS; CHILDREN; BACTERIA; AIRWAYS; ASSAY	IMPORTANCE Observational studies have suggested that increased dietary vitamin D intake during pregnancy may protect against wheezing in the offspring, but the preventive effect of vitamin D supplementation to pregnant women is unknown. OBJECTIVE To determine whether supplementation of vitamin D-3 during the third trimester of pregnancy reduces the risk of persistent wheeze in the offspring. DESIGN, SETTING, AND PARTICIPANTS A double-blind, single-center, randomized clinical trial conducted within the Copenhagen Prospective Studies on Asthma in Childhood 2010 cohort. Enrollment began March 2009 with a goal of 708 participants, but due to delayed ethical approval, only 623 women were recruited at 24 weeks of pregnancy. Follow-up of the children (N = 581) was completed when the youngest child reached age 3 years in March 2014. INTERVENTIONS Vitamin D-3 (2400 IU/d; n = 315) or matching placebo tablets (n = 308) from pregnancy week 24 to 1 week postpartum. All women received 400 IU/d of vitamin D-3 as part of usual pregnancy care. MAIN OUTCOMES AND MEASURES Age at onset of persistent wheeze in the first 3 years of life. Secondary outcomes included number of episodes of troublesome lung symptoms, asthma, respiratory tract infections, and neonatal airway immunology. Adverse events were assessed. RESULTS Of the 581 children, persistent wheeze was diagnosed during the first 3 years of life in 47 children (16%) in the vitamin D-3 group and 57 children (20%) in the control group. Vitamin D-3 supplementation was not associated with the risk of persistent wheeze, but the number of episodes of troublesome lung symptoms was reduced, and the airway immune profile was up-regulated (principal component analysis, P = .04). There was no effect on additional end points. Intrauterine death was observed in 1 fetus (<1%) in the vitamin D-3 group vs 3 fetuses (1%) in the control group and congenital malformations in 17 neonates (5%) in the vitamin D-3 group vs 23 neonates (8%) in the control group. [GRAPHICS] CONCLUSIONS AND RELEVANCE The use of 2800 IU/d of vitamin D-3 during the third trimester of pregnancy compared with 400 IU/d did not result in a statistically significant reduced risk of persistent wheeze in the offspring through age 3 years. However, interpretation of the study is limited by a wide CI that includes a clinically important protective effect.	[Chawes, Bo L.; Bonnelykke, Klaus; Stokholm, Jakob; Vissing, Nadja H.; Bjarnadottir, Elin; Schoos, Ann-Marie M.; Wolsk, Helene M.; Pedersen, Tine Marie; Vinding, Rebecca K.; Thorsteinsdottir, Sunna; Arianto, Lambang; Hallas, Henrik W.; Rasmussen, Morten A.; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Denmark; [Stokholm, Jakob; Bjarnadottir, Elin; Pedersen, Tine Marie; Vinding, Rebecca K.] Naestved Hosp, Dept Pediat, Naestved, Denmark; [Heickendorff, Lene] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Brix, Susanne] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Rasmussen, Morten A.] Univ Copenhagen, Fac Sci, Dept Food Sci, DK-2820 Copenhagen, Denmark	University of Copenhagen; Naestved Hospital; Aarhus University; Technical University of Denmark; University of Copenhagen	Bisgaard, H (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Denmark.	bisgaard@copsac.com	Bisgaard, Hans/N-4761-2016; Arendt, Morten/S-8843-2017; Rasmussen, Morten/AAE-9517-2020; Schoos, Ann-Marie Malby/AAO-7677-2020; Pedersen, Susanne Brix/B-3484-2009	Bisgaard, Hans/0000-0003-4131-7592; Arendt, Morten/0000-0001-7431-5206; Rasmussen, Morten/0000-0001-7431-5206; Schoos, Ann-Marie Malby/0000-0002-5827-0885; Pedersen, Susanne Brix/0000-0001-8951-6705; Bonnelykke, Klaus/0000-0003-2003-1018; Vinding, Rebecca Kofod/0000-0002-7680-3040; Chawes, Bo/0000-0001-6846-6243; Hallas, Henrik Wegener/0000-0001-6998-1087; Stokholm, Jakob/0000-0003-4989-9769	Copenhagen Prospective Study on Asthma in Childhood (COPSAC); Lundbeck Foundation; Danish State Budget; Danish Council for Strategic Research; Danish Council for Independent Research; Capital Region Research Foundation; Lundbeck Foundation [R191-2015-1571] Funding Source: researchfish	Copenhagen Prospective Study on Asthma in Childhood (COPSAC); Lundbeck Foundation(Lundbeckfonden); Danish State Budget; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Capital Region Research Foundation; Lundbeck Foundation(Lundbeckfonden)	The Copenhagen Prospective Study on Asthma in Childhood (COPSAC) is funded by private and public research funds that are all listed on http://www.copsac.com. The Lundbeck Foundation, Danish State Budget, Danish Council for Strategic Research, Danish Council for Independent Research, and the Capital Region Research Foundation have provided core support for COPSAC.	Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Chawes BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099856; Chawes BLK, 2015, J ALLERGY CLIN IMMUN, V135, P1450, DOI 10.1016/j.jaci.2014.11.020; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V125, P1387, DOI 10.1016/j.jaci.2010.01.039; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Folsgaard NV, 2012, AM J RESP CRIT CARE, V185, P275, DOI 10.1164/rccm.201108-1471OC; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollams EM, 2012, CURR OPIN ALLERGY CL, V12, P228, DOI 10.1097/ACI.0b013e3283534a32; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Kho AT, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-47; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Rasmussen MA, 2010, BRIT J CLIN PHARMACO, V69, P379, DOI 10.1111/j.1365-2125.2009.03600.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	36	182	187	7	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					353	361		10.1001/jama.2015.18318	http://dx.doi.org/10.1001/jama.2015.18318			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813208	Bronze			2022-12-28	WOS:000368589500013
J	[Anonymous]				[Anonymous]			A Medicolegal Study of Blood Stains (Reprinted from JAMA, vol 66, pg 277, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1915, INDIA J MED RES, Viii, P205; 1916, JAMA, V66, P277	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					421	421		10.1001/jama.2015.17072	http://dx.doi.org/10.1001/jama.2015.17072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813225				2022-12-28	WOS:000368589500030
J	Masuda, T; Wang, X; Maeda, M; Canver, MC; Sher, F; Funnell, APW; Fisher, C; Suciu, M; Martyn, GE; Norton, LJ; Zhu, C; Kurita, R; Nakamura, Y; Xu, J; Higgs, DR; Crossley, M; Bauer, DE; Orkin, SH; Kharchenko, PV; Maeda, T				Masuda, Takeshi; Wang, Xin; Maeda, Manami; Canver, Matthew C.; Sher, Falak; Funnell, Alister P. W.; Fisher, Chris; Suciu, Maria; Martyn, Gabriella E.; Norton, Laura J.; Zhu, Catherine; Kurita, Ryo; Nakamura, Yukio; Xu, Jian; Higgs, Douglas R.; Crossley, Merlin; Bauer, Daniel E.; Orkin, Stuart H.; Kharchenko, Peter V.; Maeda, Takahiro			Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin	SCIENCE			English	Article							GAMMA-GLOBIN GENE; ERYTHROBLASTS; PROTEINS; MICE	Genes encoding human beta-type globin undergo a developmental switch from embryonic to fetal to adult-type expression. Mutations in the adult form cause inherited hemoglobinopathies or globin disorders, including sickle cell disease and thalassemia. Some experimental results have suggested that these diseases could be treated by induction of fetal-type hemoglobin (HbF). However, the mechanisms that repress HbF in adults remain unclear. We found that the LRF/ZBTB7A transcription factor occupies fetal g-globin genes and maintains the nucleosome density necessary for g-globin gene silencing in adults, and that LRF confers its repressive activity through a NuRD repressor complex independent of the fetal globin repressor BCL11A. Our study may provide additional opportunities for therapeutic targeting in the treatment of hemoglobinopathies.	[Masuda, Takeshi; Maeda, Manami; Zhu, Catherine; Maeda, Takahiro] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA; [Wang, Xin; Kharchenko, Peter V.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA; [Canver, Matthew C.; Sher, Falak; Xu, Jian; Bauer, Daniel E.; Orkin, Stuart H.] Harvard Univ, Sch Med, Div Hematol Oncol, Dept Pediat Oncol,Dana Farber Canc Inst,Boston Ch, Boston, MA 02115 USA; [Funnell, Alister P. W.; Martyn, Gabriella E.; Norton, Laura J.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Fisher, Chris; Suciu, Maria; Higgs, Douglas R.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Mol Haematol Unit, Oxford, England; [Kurita, Ryo; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Xu, Jian] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Dallas, TX 75390 USA; [Orkin, Stuart H.] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of New South Wales Sydney; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; RIKEN; University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Kharchenko, PV (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA.	peter.kharchenko@post.harvard.edu; tmaeda@partners.org	Wang, Xin/A-1130-2012; Nakamura, Yukio/A-5263-2016; Maeda, Takahiro/AAC-4563-2019; Crossley, Merlin/D-7888-2011	Wang, Xin/0000-0002-5122-2418; Nakamura, Yukio/0000-0001-8056-4946; Maeda, Takahiro/0000-0003-4530-6460; Martyn, Gabriella/0000-0001-5024-428X; Norton, Laura/0000-0002-7950-381X; Canver, Matthew/0000-0002-8146-3992; Crossley, Merlin/0000-0003-2057-3642; Higgs, Douglas/0000-0003-3579-8705; Suciu, Maria/0000-0002-3873-8874; Sher, Falak/0000-0002-4429-0084	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Predoctoral National Research Service Award [F30DK103359-01A1]; NIDDK Career Development Award [K08DK093705]; Doris Duke Charitable Foundation Innovations in Clinical Research Award [2013137]; NIH [P01HL032262, P30DK049216, 5K25AG037596, R01 AI084905, R56 DK105001]; Ellison Medical Foundation [AG-NS-0965-12]; American Society of Hematology Bridge Program grant; Medical Research Council [G1000801b, MC_U137961144, MC_U137961145, G1000801j, G1000801] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK093543, F30DK103359, P30DK049216, K08DK093705, R56DK105001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596] Funding Source: NIH RePORTER; Direct For Biological Sciences [1452964] Funding Source: National Science Foundation; MRC [MC_U137961145, G1000801, MC_U137961144] Funding Source: UKRI	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Predoctoral National Research Service Award; NIDDK Career Development Award; Doris Duke Charitable Foundation Innovations in Clinical Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Society of Hematology Bridge Program grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Jarolim, D. Dorfman, and other members of BWH Hematology laboratory for help on HPLC analysis; J. Hughes, J. Eglinton, J. Sharp, C. Babbs, K. di Gleria, D. Chen, and P. Schupp for technical support and assistance; E. Lamar for critical reading of the manuscript; and S-U. Lee, H. Yi, Y. Ishikawa and other members of the Maeda lab for help and advice. Supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Predoctoral National Research Service Award for M.D./Ph.D. Fellowship F30DK103359-01A1 (M.C.C.), NIDDK Career Development Award K08DK093705 and Doris Duke Charitable Foundation Innovations in Clinical Research Award 2013137 (D.E.B.), NIH grants P01HL032262 and P30DK049216 (Center of Excellence in Molecular Hematology) (S.H.O.), NIH grant 5K25AG037596 and Ellison Medical Foundation grant AG-NS-0965-12 (P.V.K.), and NIH grants R01 AI084905 and R56 DK105001 and an American Society of Hematology Bridge Program grant (T. Maeda). All reagents described in this manuscript (mouse models, plasmids) are available to the scientific community upon request. Sequencing data are available at the NCBI Gene Expression Omnibus (GEO accession number GSE74977). T. Masuda, M. Maeda, and T. Maeda are contributors to a patent application filed on behalf of Brigham and Women's Hospital related to therapeutic targeting of LRF/NuRD interaction.	Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Baron MH, 2012, BLOOD, V119, P4828, DOI 10.1182/blood-2012-01-153486; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kingsley PD, 2004, BLOOD, V104, P19, DOI 10.1182/blood-2003-12-4162; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lee SU, 2013, BLOOD, V121, P918, DOI 10.1182/blood-2012-03-418103; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Pleasants S, 2014, NATURE, V515, pS2, DOI 10.1038/515S2a; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	24	189	204	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					285	289		10.1126/science.aad3312	http://dx.doi.org/10.1126/science.aad3312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816381	Green Accepted			2022-12-28	WOS:000368098600043
J	Kamradt-Scott, A; Harman, S; Wenham, C; Smith, F				Kamradt-Scott, Adam; Harman, Sophie; Wenham, Clare; Smith, Frank, III			Civil-military cooperation in Ebola and beyond	LANCET			English	Editorial Material									[Kamradt-Scott, Adam; Smith, Frank, III] Univ Sydney, Dept Govt & Int Relat, Sydney, NSW 2006, Australia; [Harman, Sophie] Queen Mary Univ London, London, England; [Wenham, Clare] London Sch Hyg & Trop Med, London WC1, England	University of Sydney; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine	Kamradt-Scott, A (corresponding author), Univ Sydney, Dept Govt & Int Relat, Sydney, NSW 2006, Australia.	adam.kamradt-scott@sydney.edu.au	Kamradt-Scott, Adam/B-9205-2013	Kamradt-Scott, Adam/0000-0002-4901-4898				[Anonymous], 2015, EB SIT REP 30 DEC 20; [Anonymous], 2015, GUARDIAN; Barrabi T., 2014, INT BUSINESS TIMES; Bristol N, 2006, LANCET, V367, P384, DOI 10.1016/S0140-6736(06)68122-1; Cooper H., 2014, NY TIMES; Gordon Stuart, 2011, Med Confl Surviv, V27, P43; Kamradt-Scott A, 2015, SAVING LIVES CIVIL M; Leone Sierra, 2015, COKORIOKO       0428; Moon S, 2015, LANCET; Searcey Dionne, 2015, NY TIMES; United Nations, 2015, SECR GEN APP HIGH LE; Woods SK, 2015, COMMUNICATION   0211	12	15	15	2	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					104	105		10.1016/S0140-6736(15)01128-9	http://dx.doi.org/10.1016/S0140-6736(15)01128-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8LF	26841981	Bronze			2022-12-28	WOS:000368055500010
J	Young, RJ; Woll, PJ				Young, Robin J.; Woll, Penella J.			Eribulin in soft-tissue sarcoma	LANCET			English	Editorial Material							PHASE-II; MESYLATE; PAZOPANIB		[Young, Robin J.; Woll, Penella J.] Weston Pk Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England	Weston Park Hospital	Young, RJ (corresponding author), Weston Pk Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England.	r.j.young@sheffield.ac.uk		Woll, Penella/0000-0002-1118-0831				Blay JY, 2014, EUR J CANCER, V50, P679, DOI 10.1016/j.ejca.2013.11.011; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734; Dybdal-Hargreaves NF, 2015, CLIN CANCER RES, V21, P2445, DOI 10.1158/1078-0432.CCR-14-3252; Funahashi Y, 2014, CANCER SCI, V105, P1334, DOI 10.1111/cas.12488; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; Schoffski P, 2016, LANCET; Schoffski P, 2011, LANCET ONCOL, V12, P1045, DOI 10.1016/S1470-2045(11)70230-3; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5	10	5	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1594	1596	1629	10.1016/S0140-6736(16)00162-8	http://dx.doi.org/10.1016/S0140-6736(16)00162-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26874886	Green Accepted			2022-12-28	WOS:000374145100005
J	Banerjee, S; Bartesaghi, A; Merk, A; Rao, P; Bulfer, SL; Yan, Y; Green, N; Mroczkowski, B; Neitz, RJ; Wipf, P; Falconieri, V; Deshaies, RJ; Milne, JLS; Huryn, D; Arkin, M; Subramaniam, S				Banerjee, Soojay; Bartesaghi, Alberto; Merk, Alan; Rao, Prashant; Bulfer, Stacie L.; Yan, Yongzhao; Green, Neal; Mroczkowski, Barbara; Neitz, R. Jeffrey; Wipf, Peter; Falconieri, Veronica; Deshaies, Raymond J.; Milne, Jacqueline L. S.; Huryn, Donna; Arkin, Michelle; Subramaniam, Sriram			2.3 angstrom resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition	SCIENCE			English	Article							AAA-ATPASE; DOMAIN; ANALOGS; BINDING; P97/VCP; SYSTEM	p97 is a hexameric AAA+ adenosine triphosphatase (ATPase) that is an attractive target for cancer drug development. We report cryo-electron microscopy (cryo-EM) structures for adenosine diphosphate (ADP)-bound, full-length, hexameric wild-type p97 in the presence and absence of an allosteric inhibitor at resolutions of 2.3 and 2.4 angstroms, respectively. We also report cryo-EM structures (at resolutions of similar to 3.3, 3.2, and 3.3 angstroms, respectively) for three distinct, coexisting functional states of p97 with occupancies of zero, one, or two molecules of adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) per protomer. A large corkscrew-like change in molecular architecture, coupled with upward displacement of the N-terminal domain, is observed only when ATPgS is bound to both the D1 and D2 domains of the protomer. These cryo-EM structures establish the sequence of nucleotide-driven structural changes in p97 at atomic resolution. They also enable elucidation of the binding mode of an allosteric small-molecule inhibitor to p97 and illustrate how inhibitor binding at the interface between the D1 and D2 domains prevents propagation of the conformational changes necessary for p97 function.	[Banerjee, Soojay; Bartesaghi, Alberto; Merk, Alan; Rao, Prashant; Falconieri, Veronica; Milne, Jacqueline L. S.; Subramaniam, Sriram] NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA; [Bulfer, Stacie L.; Neitz, R. Jeffrey; Arkin, Michelle] Univ Calif San Francisco, Sch Pharm, Small Mol Discovery Ctr, Pharmaceut Chem, San Francisco, CA 94143 USA; [Yan, Yongzhao; Wipf, Peter; Huryn, Donna] Univ Pittsburgh, Chem Divers Ctr, Pittsburgh, PA 15260 USA; [Green, Neal] Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Mroczkowski, Barbara] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Deshaies, Raymond J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91107 USA; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91107 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Bldg 37, Bethesda, MD 20892 USA.	ss1@nih.gov	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021; Wipf, Peter/AAG-1771-2021; Deshaies, Raymond/B-8354-2014	arkin, michelle/0000-0002-9366-6770; Wipf, Peter/0000-0001-7693-5863; Subramaniam, Sriram/0000-0003-4231-4115; Huryn, Donna/0000-0001-5542-4968; Deshaies, Raymond/0000-0002-3671-9354	Center for Cancer Research, National Cancer Institute; National Cancer Institute under Chemical Biology Consortium Contract [HHSN261200800001E, 29XS127TO15]; NATIONAL CANCER INSTITUTE [ZIABC010826, ZIABC010412] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute under Chemical Biology Consortium Contract; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by funds from the Center for Cancer Research, National Cancer Institute, and with federal funds from the National Cancer Institute under Chemical Biology Consortium Contract No. HHSN261200800001E Agreement No. 29XS127TO15. R.J.D. is an investigator of the Howard Hughes Medical Institute. This work used the computational resources of the NIH High-Performance Computing Biowulf cluster (http://hpc.nih.gov). We thank K. Moynihan, R. Mueller, and J. Cometa for technical assistance with electron microscopy; F. Ulmer, P. Mooney, and C. Booth for advice and assistance with optimizing K2 detector performance; and M. G. Laporte for contributions to the medicinal chemistry program. The University of Pittsburgh has filed a provisional patent application that covers the inhibitor compound described in this manuscript. R.J.D. is on the Scientific Advisory Board of Cleave Biosciences. The density maps and refined atomic models have been deposited in the Electron Microscopy Data Bank with accession numbers EMD-3295, 3296, 3297, 3298, and 3299, and in the Protein Data Bank with matching accession numbers of PDB-5FTJ, 5FTK, 5FTL, 5FTM, and 5FTN, respectively, for native p97 in the presence and absence of bound inhibitor, and for p97 conformational states I, II, and III observed in the presence of ATP gamma S.	Almeida B, 2015, BBA-MOL BASIS DIS, V1852, P1950, DOI 10.1016/j.bbadis.2015.06.010; Alverez C, 2015, ACS MED CHEM LETT, V6, P1225, DOI 10.1021/acsmedchemlett.5b00364; Anderson D. J., 2015, AM ASS CANC RES ANN; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Barthelme D, 2016, J MOL BIOL, V428, P1861, DOI 10.1016/j.jmb.2015.11.015; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Brown S.J., 2010, PROBE REPORTS NIH MO; Chapman E, 2015, MOLECULES, V20, P3027, DOI 10.3390/molecules20023027; Chia WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050490; Chimenti MS, 2015, J BIOMOL SCREEN, V20, P788, DOI 10.1177/1087057115570550; Chou TF, 2013, CHEMMEDCHEM, V8, P297, DOI 10.1002/cmdc.201200520; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Fang CJ, 2015, CHEMMEDCHEM, V10, P52, DOI 10.1002/cmdc.201402420; Fang L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00016; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kim SJ, 2014, J BIOL CHEM, V289, P12264, DOI 10.1074/jbc.M113.523936; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Noi K, 2013, STRUCTURE, V21, P1992, DOI 10.1016/j.str.2013.08.017; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Polucci P, 2013, J MED CHEM, V56, P437, DOI 10.1021/jm3013213; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tao SS, 2015, ACS CHEM BIOL, V10, P1916, DOI 10.1021/acschembio.5b00367; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Yeung HO, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130142; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	37	225	228	5	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					871	875		10.1126/science.aad7974	http://dx.doi.org/10.1126/science.aad7974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26822609	Green Accepted			2022-12-28	WOS:000370325700047
J	Peters, PJ; Westheimer, E; Cohen, S; Hightow-Weidman, LB; Moss, N; Tsoi, B; Hall, L; Fann, C; Daskalakis, DC; Beagle, S; Patel, P; Radix, A; Foust, E; Kohn, RP; Marmorino, J; Pandori, M; Fu, J; Samandari, T; Gay, CL				Peters, Philip J.; Westheimer, Emily; Cohen, Stephanie; Hightow-Weidman, Lisa B.; Moss, Nicholas; Tsoi, Benjamin; Hall, Laura; Fann, Charles; Daskalakis, Demetre C.; Beagle, Steve; Patel, Pragna; Radix, Asa; Foust, Evelyn; Kohn, Robert P.; Marmorino, Jenni; Pandori, Mark; Fu, Jie; Samandari, Taraz; Gay, Cynthia L.			Screening Yield of HIV Antigen/Antibody Combination and Pooled HIV RNA Testing for Acute HIV Infection in a High-Prevalence Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUAL TRANSMISSION; RATES	IMPORTANCE Although acute HIV infection contributes disproportionately to onward HIV transmission, HIV testing has not routinely included screening for acute HIV infection. OBJECTIVE To evaluate the performance of an HIV antigen/antibody (Ag/Ab) combination assay to detect acute HIV infection compared with pooled HIV RNA testing. DESIGN, SETTING, AND PARTICIPANTS Multisite, prospective, within-individual comparison study conducted between September 2011 and October 2013 in 7 sexually transmitted infection clinics and 5 community-based programs in New York, California, and North Carolina. Participants were 12 years or older and seeking HIV testing, without known HIV infection. EXPOSURES All participants with a negative rapid HIV test result were screened for acute HIV infection with an HIV Ag/Ab combination assay (index test) and pooled human immunodeficiency virus 1(HIV-1) RNA testing. HIV RNA testing was the reference standard, with positive reference standard result defined as detectable HIV-1 RNA on an individual RNA test. MAIN OUTCOMES AND MEASURES Number and proportion with acute HIV infections detected. RESULTS Among 86 836 participants with complete test results (median age, 29 years; 75.0% men; 51.8% men who have sex with men), established HIV infection was diagnosed in 1158 participants (1.33%) and acute HIV infection was diagnosed in 168 participants (0.19%). Acute HIV infection was detected in 134 participants with HIV Ag/Ab combination testing (0.15% [95% CI, 0]3%-0.18%]; sensitivity, 79.8% [95% CI, 72.9%-85.6%]; specificity, 99.9% [95% CI, 99.9%-99.9M; positive predictive value, 59.0% [95% CI, 52.3%-65.5%]) and in 164 participants with pooled HIV RNA testing (0.19% [95% CI, 0.16%-0.22%]; sensitivity, 97.6% [95% CI, 94.0%-99.4%]; specificity, 100% [95% CI, 100%-100%]; positive predictive value, 96.5% [95% CI, 92.5%-98.7%]; sensitivity comparison, P < .001). Overall HIV Ag/Ab combination testing detected 82% of acute HIV infections detectable by pooled HIV RNA testing. Compared with rapid HIV testing alone, HIV Ag/Ab combination testing increased the relative HIV diagnostic yield (both established and acute HIV infections) by 10.4% (95% CI, 8.8%-12.2%) and pooled HIV RNA testing increased the relative HIV diagnostic yield by 12.4% (95% CI, 10.7%-14.3%). CONCLUSIONS AND RELEVANCE In a high-prevalence population, HIV screening using an HIV Ag/Ab combination assay following a negative rapid test detected 82% of acute HIV infections detectable by pooled HIV RNA testing, with a positive predictive value of 59%. Further research is needed to evaluate this strategy in lower-prevalence populations and in persons using preexposure prophylaxis for HIV prevention.	[Peters, Philip J.; Patel, Pragna; Samandari, Taraz] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS E-45, Atlanta, GA 30329 USA; [Westheimer, Emily; Tsoi, Benjamin; Daskalakis, Demetre C.; Fu, Jie] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Cohen, Stephanie; Moss, Nicholas; Fann, Charles; Kohn, Robert P.; Pandori, Mark] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Hightow-Weidman, Lisa B.; Beagle, Steve; Marmorino, Jenni; Gay, Cynthia L.] Univ N Carolina, Chapel Hill, NC USA; [Moss, Nicholas; Pandori, Mark] Alameda Cty Dept Publ Hlth, Oakland, CA USA; [Hall, Laura] ICE Int, Atlanta, GA USA; [Daskalakis, Demetre C.] Mt Sinai Sch Med, New York, NY USA; [Radix, Asa] Callen Lorde Community Hlth Ctr, New York, NY USA; [Foust, Evelyn] North Carolina Dept Publ Hlth, Raleigh, NC USA	Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene; San Francisco Department of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai	Peters, PJ (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS E-45, Atlanta, GA 30329 USA.	pjpeters@cdc.gov	Radix, Asa/X-5189-2019; Gay, Cynthia/AAG-2927-2019; Tsoi, Benjamin/T-2766-2018	Radix, Asa/0000-0001-9611-4181; Radix, Asa/0000-0001-8594-1077; Tsoi, Benjamin/0000-0003-2927-6687; Gay, Cynthia/0000-0002-3620-3059	Centers for Disease Control and Prevention (CDC) [5U01PS001564]; San Francisco Department of Public Health, [5U01PS001564]; New York City Department of Health and Mental Hygiene [5U01PS001561]; University of North Carolina at Chapel Hill [5U01PS001559]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U01PS001561, U01PS001564, U01PS001559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); San Francisco Department of Public Health,; New York City Department of Health and Mental Hygiene; University of North Carolina at Chapel Hill; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a cooperative agreement between the Centers for Disease Control and Prevention (CDC) and the San Francisco Department of Public Health (5U01PS001564), New York City Department of Health and Mental Hygiene (5U01PS001561), and the University of North Carolina at Chapel Hill (5U01PS001559).	Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P489; [Anonymous], 2010, PLOS MED, V7; [Anonymous], 2014, AL DET HIV 1 2 AG AB; [Anonymous], 2009, ARCHITECT HIV AG AB; [Anonymous], 2013, MULT HIV 1 HIV 2 RAP; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Centers for Disease Control and Prevention, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, 2013, CDC FUND HIV TEST US; Centers for Disease Control and Prevention, LAB TEST DIAGN HIV I; De Souza MS, 2015, AIDS, V29, P793, DOI 10.1097/QAD.0000000000000616; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hatano H, LACK DETECTABLE HIV; Hutchinson AB, 2014, 21 C RETR OPP INF MA; Hutchinson AB, 2013, J CLIN VIROL, V58, pE2, DOI 10.1016/j.jcv.2013.10.005; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Linley LAQ, 2015, C RETR OPP INF FEBR; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Masciotra S, 2011, J CLIN VIROL, V52, pS17, DOI 10.1016/j.jcv.2011.09.011; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Quinn TC, 1997, JAMA-J AM MED ASSOC, V278, P58, DOI 10.1001/jama.278.1.58; Ren A, 2008, J MED MICROBIOL, V57, P1228, DOI 10.1099/jmm.0.2008/002386-0; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; US Department of Health and Human Services, COD FED REG PROT HUM; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Westheimer E, 2014, J CLIN VIROL, V61, P623, DOI 10.1016/j.jcv.2014.10.010	34	39	39	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					682	690		10.1001/jama.2016.0286	http://dx.doi.org/10.1001/jama.2016.0286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881371	Green Published, Bronze			2022-12-28	WOS:000370171500014
J	Torjesen, I				Torjesen, Ingrid			PRIMARY CARE The private, online GP will see you now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com							0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2016	352								i823	10.1136/bmj.i823	http://dx.doi.org/10.1136/bmj.i823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JZ	26873876				2022-12-28	WOS:000370384500002
J	Schaeffer, AJ; Nicolle, LE				Schaeffer, Anthony J.; Nicolle, Lindsay E.			Urinary Tract Infections in Older Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC BACTERIAL PROSTATITIS; PELVIC PAIN SYNDROME; LEVOFLOXACIN 750 MG; DOUBLE-BLIND; ASYMPTOMATIC BACTERIURIA; DISEASES-SOCIETY; CIPROFLOXACIN; PYELONEPHRITIS; MANAGEMENT; EPIDEMIOLOGY	A 79-year-old community-dwelling man presents with urinary frequency, dysuria, and fever. Culture reveals extended-spectrum beta-lactamase Escherichia coli. He had a similar infection several months ago, with the same organism isolated, and he had a response to nitrofurantoin treatment. How would you further evaluate and manage this case?	[Schaeffer, Anthony J.] Northwestern Univ, Feinberg Sch Med, 303 E Chicago Ave,Tarry Bldg 16-703, Chicago, IL 60611 USA; [Nicolle, Lindsay E.] Univ Manitoba, Winnipeg, MB, Canada	Northwestern University; Feinberg School of Medicine; University of Manitoba	Schaeffer, AJ (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Chicago Ave,Tarry Bldg 16-703, Chicago, IL 60611 USA.	ajschaeffer@northwestern.edu			Boehringer Ingelheim; Melinta Therapeutics; Quadrant HealthCom; ClearView Healthcare Partners; Navigant Consulting; Hollister; KLJ Associates; Advanstar Communications; Cipla; WebMD	Boehringer Ingelheim(Boehringer Ingelheim); Melinta Therapeutics; Quadrant HealthCom; ClearView Healthcare Partners; Navigant Consulting; Hollister; KLJ Associates; Advanstar Communications; Cipla; WebMD	Dr. Schaeffer reports receiving fees for serving on advisory boards and travel support from Boehringer Ingelheim and Melinta Therapeutics, consulting fees from Quadrant HealthCom, ClearView Healthcare Partners, Navigant Consulting, Hollister, and KLJ Associates, author contribution fees from Advanstar Communications, fees for moderating a webinar from Cipla, and an honorarium and travel expenses from WebMD for video discussion on the treatment of complicated urinary tract infections. No other potential conflict of interest relevant to this article was reported.	Anothaisintawee T, 2011, JAMA-J AM MED ASSOC, V305, P78, DOI 10.1001/jama.2010.1913; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Bundrick W, 2003, UROLOGY, V62, P537, DOI 10.1016/S0090-4295(03)00565-X; Caljouw MAA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-57; den Heijer CDJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060497; Foxman B, 2003, ANN EPIDEMIOL, V13, P144, DOI 10.1016/S1047-2797(02)00272-7; Gardiner BJ, 2014, CLIN INFECT DIS, V58, pE101, DOI 10.1093/cid/cit704; Griebling TL, 2005, J UROLOGY, V173, P1288, DOI 10.1097/01.ju.0000155595.98120.8e; High KP, 2009, J AM GERIATR SOC, V57, P375, DOI 10.1111/j.1532-5415.2009.02175.x; Klimberg IW, 1998, UROLOGY, V51, P610, DOI 10.1016/S0090-4295(97)00708-5; Kudinha T, 2013, CLIN MICROBIOL INFEC, V19, pE173, DOI 10.1111/1469-0691.12123; Lark RL, 2001, DIAGN MICR INFEC DIS, V41, P15, DOI 10.1016/S0732-8893(01)00284-X; LEIBOVICI L, 1993, AGE AGEING, V22, P431, DOI 10.1093/ageing/22.6.431; LIPSKY BA, 1989, ANN INTERN MED, V110, P138, DOI 10.7326/0003-4819-110-2-138; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; May M, 2009, J UROLOGY, V181, P2540, DOI 10.1016/j.juro.2009.01.103; MEARES EM, 1968, INVEST UROL, V5, P492; Mombelli G, 1999, ARCH INTERN MED, V159, P53, DOI 10.1001/archinte.159.1.53; Naber KG, 2009, ANTIMICROB AGENTS CH, V53, P3782, DOI 10.1128/AAC.00837-08; Naber KG, 2008, CURR CLIN UROL, P17, DOI 10.1007/978-1-59745-472-8_2; Nickel JC, 2006, J UROLOGY, V176, P119, DOI 10.1016/S0022-5347(06)00498-8; Nickel JC, 2012, CAMPBELL WALSH UROLO, P327; Nickel JC, 1999, TXB PROSTATITIS; Nicolle LE, 2009, CLIN GERIATR MED, V25, P423, DOI 10.1016/j.cger.2009.04.005; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; NICOLLE LE, 1987, ANN INTERN MED, V106, P682, DOI 10.7326/0003-4819-106-5-682; Nicolle LE, 2001, INFECT CONT HOSP EP, V22, P167, DOI 10.1086/501886; Omli R, 2008, J AM GERIATR SOC, V56, P871, DOI 10.1111/j.1532-5415.2008.01646.x; OUSLANDER JG, 1987, J AM GERIATR SOC, V35, P1063, DOI 10.1111/j.1532-5415.1987.tb04922.x; Paglia M, 2010, CURR MED RES OPIN, V26, P1433, DOI 10.1185/03007991003795030; Perletti G, 2011, MOL MED REP, V4, P1035, DOI 10.3892/mmr.2011.575; Peterson J, 2008, UROLOGY, V71, P17, DOI 10.1016/j.urology.2007.09.002; Rees J, 2015, BJU INT, V116, P509, DOI 10.1111/bju.13101; Rodhe N, 2006, FAM PRACT, V23, P303, DOI 10.1093/fampra/cml007; Rodhe N, 2008, SCAND J INFECT DIS, V40, P804, DOI 10.1080/00365540802195242; Rowe TA, 2014, INFECT DIS CLIN N AM, V28, P75, DOI 10.1016/j.idc.2013.10.004; Saint S, 2006, J AM GERIATR SOC, V54, P1055, DOI 10.1111/j.1532-5415.2006.00785.x; Stone ND, 2012, INFECT CONT HOSP EP, V33, P965, DOI 10.1086/667743; Tal S, 2005, J INFECTION, V50, P296, DOI 10.1016/j.jinf.2004.04.004; Truzzi JCI, 2008, J UROLOGY, V180, P182, DOI 10.1016/j.juro.2008.03.044; Ulleryd P, 1999, BJU INT, V84, P470; Ulleryd P, 2003, INT J ANTIMICROB AG, V22, pS89, DOI 10.1016/S0924-8579(03)00228-0; Ulleryd P, 2003, SCAND J INFECT DIS, V35, P34, DOI 10.1080/0036554021000026988; Ulleryd P, 2001, BJU INT, V88, P15, DOI 10.1046/j.1464-410x.2001.02252.x; van der Starre Willize E, 2011, Curr Infect Dis Rep, V13, P571, DOI 10.1007/s11908-011-0211-y; Wagenlehner FM, 2015, LANCET, V385, P1949, DOI 10.1016/S0140-6736(14)62220-0; Weidner W, 2008, INT J ANTIMICROB AG, V31, pS91, DOI 10.1016/j.ijantimicag.2007.07.044; Weidner W, 2008, CURR CLIN UROL, P31, DOI 10.1007/978-1-59745-472-8_3; Wells WG, 2004, J ANTIMICROB CHEMOTH, V53, P67, DOI 10.1093/jac/dkh208; Zhang ZC, 2012, ASIAN J ANDROL, V14, P870, DOI 10.1038/aja.2012.48	50	50	54	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					562	571		10.1056/NEJMcp1503950	http://dx.doi.org/10.1056/NEJMcp1503950			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863357				2022-12-28	WOS:000369755800009
J	Bachert, C; Mannent, L; Naclerio, RM; Mullol, J; Ferguson, BJ; Gevaert, P; Hellings, P; Jiao, LX; Wang, L; Evans, RR; Pirozzi, G; Graham, NM; Swanson, B; Hamilton, JD; Radin, A; Gandhi, NA; Stahl, N; Yancopoulos, GD; Sutherland, ER				Bachert, Claus; Mannent, Leda; Naclerio, Robert M.; Mullol, Joaquim; Ferguson, Berrylin J.; Gevaert, Philippe; Hellings, Peter; Jiao, Lixia; Wang, Lin; Evans, Robert R.; Pirozzi, Gianluca; Graham, Neil M.; Swanson, Brian; Hamilton, Jennifer D.; Radin, Allen; Gandhi, Namita A.; Stahl, Neil; Yancopoulos, George D.; Sutherland, E. Rand			Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC RHINOSINUSITIS; EOSINOPHIL LEVELS; ASTHMA CONTROL; QUESTIONNAIRE; ENTEROTOXINS; RELIABILITY; EUROPE; ADULTS; IGE	IMPORTANCE Dupilumab has demonstrated efficacy in patients with asthma and atopic dermatitis, which are both type 2 helper T-cell-mediated diseases. OBJECTIVE To assess inhibition of interleukins 4 and 13 with dupilumab in patients with chronic sinusitis and nasal polyposis. DESIGN, SETTING, AND PARTICIPANTS A randomized, double-blind, placebo-controlled parallel-group study conducted at 13 sites in the United States and Europe between August 2013 and August 2014 in 60 adults with chronic sinusitis and nasal polyposis refractory to intranasal corticosteroids with 16 weeks of follow-up. INTERVENTIONS Subcutaneous dupilumab (a 600 mg loading dose followed by 300 mg weekly; n = 30) or placebo (n = 30) plus mometasone furoate nasal spray for 16 weeks. MAIN OUTCOMES AND MEASURES Change in endoscopic nasal polyp score (range, 0-8; higher scores indicate worse status) at 16 weeks (primary end point). Secondary end points included Lund-Mackay computed tomography (CT) score (range, 0-24; higher scores indicate worse status), 22-item SinoNasal Outcome Test score (range, 0-110; higher scores indicating worse quality of life; minimal clinically important difference >= 8.90), sense of smell assessed using the University of Pennsylvania Smell Identification Test (UPSIT) score (range, 0-40; higher scores indicate better status), symptoms, and safety. RESULTS Among the 60 patients who were randomized (mean [SD] age, 48.4 years [9.4 years]; 34 men [56.7%]; 35 with comorbid asthma), 51 completed the study. The least squares (LS) mean change in nasal polyp score was -0.3 (95% CI, -1.0 to 0.4) with placebo and -1.9 (95% CI, -2.5 to -1.2) with dupilumab (LS mean difference, -1.6 [95% CI, -2.4 to -0.7]; P < .001). The LS mean difference between the 2 groups for the Lund-Mackay CT total score was -8.8 (95% CI, -11.1 to -6.6; P < .001). Significant improvements with dupilumab were also observed for the 22-item SinoNasal Outcome Test (LS mean difference between groups, -18.1 [95% CI, -25.6 to -10.6]; P < .001) and sense of smell assessed by UPSIT (LS mean difference, 14.8 [95% CI, 10.9 to 18.7]; P < .001). The most common adverse events were nasopharyngitis (33% in the placebo group vs 47% in the dupilumab group), injection site reactions (7% vs 40%, respectively), and headache (17% vs 20%). CONCLUSIONS AND RELEVANCE Among adults with symptomatic chronic sinusitis and nasal polyposis refractory to intranasal corticosteroids, the addition of subcutaneous dupilumab to mometasone furoate nasal spray compared with mometasone alone reduced endoscopic nasal polyp burden after 16 weeks. Further studies are needed to assess longer treatment duration, larger samples, and direct comparison with other medications.	[Bachert, Claus; Gevaert, Philippe] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, De Pintelaan 185, B-9000 Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Clintec, Stockholm, Sweden; [Mannent, Leda] Sanofi, Res & Dev, Chilly Mazarin, France; [Naclerio, Robert M.] Univ Chicago, Chicago, IL 60637 USA; [Mullol, Joaquim] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Ferguson, Berrylin J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Hellings, Peter] Univ Hosp Leuven, Expt Immunol Lab, Dept Otorhinolaryngol Head & Neck Surg, Leuven, Belgium; [Jiao, Lixia; Wang, Lin; Pirozzi, Gianluca; Swanson, Brian] Sanofi, Res & Dev, Bridgewater, NJ USA; [Evans, Robert R.; Graham, Neil M.; Hamilton, Jennifer D.; Radin, Allen; Gandhi, Namita A.; Stahl, Neil; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Sutherland, E. Rand] Sanofi Res & Dev, Immunol & Inflammat Dev Franchise, Cambridge, MA USA	Ghent University; Ghent University Hospital; Karolinska Institutet; Sanofi-Aventis; Sanofi France; University of Chicago; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; KU Leuven; University Hospital Leuven; Sanofi-Aventis; Regeneron	Bachert, C (corresponding author), Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, De Pintelaan 185, B-9000 Ghent, Belgium.	claus.bachert@ugent.be	Gevaert, Philippe/AAP-1892-2020; Hellings, Peter W/I-4068-2018; Gevaert, Philippe/ABA-4588-2021; Bachert, Claus/J-8825-2012	Gevaert, Philippe/0000-0002-1629-8468; Hellings, Peter W/0000-0001-6898-688X; 	Sanofi; Regeneron Pharmaceuticals Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals Inc.(Regeneron)	The study was funded by Sanofi and Regeneron Pharmaceuticals Inc.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, pe1, DOI DOI 10.1016/J.JACI.2010.07.007; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bhattacharyya N, 1999, LARYNGOSCOPE, V109, P1055, DOI 10.1097/00005537-199907000-00008; Blackwell Debra L, 2014, Vital Health Stat 10, P1; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, pe1, DOI DOI 10.1067/MAI.2002.130051; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Rudmik L, 2015, JAMA-J AM MED ASSOC, V314, P926, DOI 10.1001/jama.2015.7544; Scadding Glenis, 2011, Clin Transl Allergy, V1, P2, DOI 10.1186/2045-7022-1-2; Small CB, 2005, J ALLERGY CLIN IMMUN, V116, P1275, DOI 10.1016/j.jaci.2005.07.027; Vlaminck S, 2014, AM J RHINOL ALLERGY, V28, P260, DOI 10.2500/ajra.2014.28.4024; Wenzel SE, 2015, AM J RESP CRIT CARE, V191; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wynn R, 2004, LARYNGOSCOPE, V114, P811, DOI 10.1097/00005537-200405000-00004	26	488	506	4	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					469	479		10.1001/jama.2015.19330	http://dx.doi.org/10.1001/jama.2015.19330			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836729	Bronze			2022-12-28	WOS:000369049500016
J	Snyder, A				Snyder, Alison			Robert L Spitzer Obituary	LANCET			English	Biographical-Item																		SPITZER R, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					428	428		10.1016/S0140-6736(16)00182-3	http://dx.doi.org/10.1016/S0140-6736(16)00182-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26869562	Bronze			2022-12-28	WOS:000368986800019
J	Boumahdi, S; Blanpain, C				Boumahdi, Soufiane; Blanpain, Cedric			Tracking the origins of tumorigenesis	SCIENCE			English	Editorial Material							NEURAL CREST; MELANOMA; NEVI		[Boumahdi, Soufiane; Blanpain, Cedric] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium.; Blanpain, C (corresponding author), Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021					Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Pavan WJ, 2012, DEV BIOL, V366, P55, DOI 10.1016/j.ydbio.2012.02.038; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628	12	3	3	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					453	454		10.1126/science.aad9670	http://dx.doi.org/10.1126/science.aad9670			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823415				2022-12-28	WOS:000368858200021
J	Horton, R				Horton, Richard			Offline: Health-the Chinese dream	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					212	212		10.1016/S0140-6736(16)00041-6	http://dx.doi.org/10.1016/S0140-6736(16)00041-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26864595	Bronze			2022-12-28	WOS:000368130700013
J	Hemingway, J; Ranson, H; Magill, A; Kolaczinski, J; Fornadel, C; Gimnig, J; Coetzee, M; Simard, F; Roch, DK; Hinzoumbe, CK; Pickett, J; Schellenberg, D; Gething, P; Hoppe, M; Hamon, N				Hemingway, Janet; Ranson, Hilary; Magill, Alan; Kolaczinski, Jan; Fornadel, Christen; Gimnig, John; Coetzee, Maureen; Simard, Frederic; Roch, Dabire K.; Hinzoumbe, Clement Kerah; Pickett, John; Schellenberg, David; Gething, Peter; Hoppe, Mark; Hamon, Nicholas			Averting a malaria disaster: will insecticide resistance derail malaria control?	LANCET			English	Article							ANOPHELES-GAMBIAE; PYRETHROID RESISTANCE; COTE-DIVOIRE; MOSQUITOS; EFFICACY	World Malaria Day 2015 highlighted the progress made in the development of new methods of prevention (vaccines and insecticides) and treatment (single dose drugs) of the disease. However, increasing drug and insecticide resistance threatens the successes made with existing methods. Insecticide resistance has decreased the efficacy of the most commonly used insecticide class of pyrethroids. This decreased efficacy has increased mosquito survival, which is a prelude to rising incidence of malaria and fatalities. Despite intensive research efforts, new insecticides will not reach the market for at least 5 years. Elimination of malaria is not possible without effective mosquito control. Therefore, to combat the threat of resistance, key stakeholders need to rapidly embrace a multifaceted approach including a reduction in the cost of bringing new resistance management methods to market and the streamlining of associated development, policy, and implementation pathways to counter this looming public health catastrophe.	[Hemingway, Janet; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Magill, Alan] Bill & Melinda Gates Fdn, Seattle, WA USA; [Kolaczinski, Jan] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Fornadel, Christen] US Agcy Int Dev, Presidents Malaria Initiat, Washington, DC 20523 USA; [Gimnig, John] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Coetzee, Maureen] Univ Witwatersrand, Fac Hlth Sci, Wits Res Inst Malaria, Johannesburg, South Africa; [Simard, Frederic] Univ Montpellier, Inst Rech Dev, MIVEGEC, F-34059 Montpellier, France; [Roch, Dabire K.] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Hinzoumbe, Clement Kerah] Natl Malaria Control Program, Ndjamena, Chad; [Pickett, John] Rothamsted Res, Harpenden, Herts, England; [Schellenberg, David] Univ Oxford, Oxford, England; [Gething, Peter] London Sch Hyg & Trop Med, London WC1, England; [Hoppe, Mark] Crop Life Int AISBL, Insecticide Resistance Act Comm, Brussels, Belgium; [Hamon, Nicholas] Innovat Vector Control Consortium, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; Bill & Melinda Gates Foundation; United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA; University of Witwatersrand; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre Muraz; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Hemingway, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	Janet.Hemingway@lstmed.ac.uk	Coetzee, Maureen/AAW-4739-2020; Coetzee, Maureen/AAI-1413-2020; Gething, Peter/GQR-1884-2022; Fornadel, Christen/AAF-3555-2020; SIMARD, Frederic/J-9489-2016; Gething, Peter/ABD-2110-2020; Frederic, SIMARD/AFV-5001-2022	Coetzee, Maureen/0000-0003-2019-866X; Gething, Peter/0000-0001-6759-5449; SIMARD, Frederic/0000-0002-2871-5329; Frederic, SIMARD/0000-0002-2871-5329; Ranson, Hilary/0000-0003-2332-8247; Fornadel, Christen/0000-0002-2498-8979; Schellenberg, David/0000-0001-8222-0186; Hemingway, Janet/0000-0002-3200-7173	Medical Research Council [MR/K00669X/1] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; MRC [MR/K00669X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural CDC HHS; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], 2001, ANT DRUG COMB THER; Asidi AN, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-25; BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Lengeler C, 2004, COCHRANE DATABASE SY; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Thomsen EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099822; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, GLOB MAL PROGR 2012	19	230	232	0	82	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1785	1788		10.1016/S0140-6736(15)00417-1	http://dx.doi.org/10.1016/S0140-6736(15)00417-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	26880124	Green Accepted, Green Submitted			2022-12-28	WOS:000374541900031
J	Chen, LH				Chen, Lin H.			Zika Virus Infection in a Massachusetts Resident After Travel to Costa Rica: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Chen, Lin H.] Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA; [Chen, Lin H.] GeoSentinel Surveillance Network, Cambridge, MA USA	Harvard University; Mount Auburn Hospital	Chen, LH (corresponding author), Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA.; Chen, LH (corresponding author), GeoSentinel Surveillance Network, Cambridge, MA USA.		Chen, Lin/ADS-6751-2022	Chen, Lin/0000-0002-5684-8436				Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150; Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005; Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2	5	21	21	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					574	576		10.7326/L16-0075	http://dx.doi.org/10.7326/L16-0075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26864175				2022-12-28	WOS:000374257900030
J	Naylor, AR				Naylor, A. Ross			Age and carotid intervention outcomes	LANCET			English	Editorial Material							ENDARTERECTOMY; STROKE; RISK		[Naylor, A. Ross] Leicester Royal Infirm, Div Cardiovasc Sci, Vasc Res Grp, Leicester LE2 7LX, Leics, England	University of Leicester	Naylor, AR (corresponding author), Leicester Royal Infirm, Div Cardiovasc Sci, Vasc Res Grp, Leicester LE2 7LX, Leics, England.	ross.naylor@uhl-tr.nhs.uk						Aronow HD, 2010, CIRC-CARDIOVASC INTE, V3, P577, DOI 10.1161/CIRCINTERVENTIONS.110.950097; Blackshear JL, 2011, CIRCULATION, V123, P2571, DOI 10.1161/CIRCULATIONAHA.110.008250; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Howard G, 2016, LANCET; Naylor AR, 2012, CARDIOVASC INTER RAD, V35, P225, DOI 10.1007/s00270-011-0282-z; Paraskevas K, 2015, EUR J VASC ENDOVASC; Rantner B, 2013, J VASC SURG, V57, P619, DOI 10.1016/j.jvs.2012.08.107; Roffi M, 2010, LANCET NEUROL, V9, P339, DOI 10.1016/S1474-4422(10)70027-2; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1255	1257		10.1016/S0140-6736(15)00953-8	http://dx.doi.org/10.1016/S0140-6736(15)00953-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	26880126				2022-12-28	WOS:000372697500005
J	Eng, J; Wilson, RF; Subramaniam, RM; Zhang, A; Suarez-Cuervo, C; Turban, S; Choi, MJ; Sherrod, C; Hutfless, S; Iyoha, EE; Bass, EB				Eng, John; Wilson, Renee F.; Subramaniam, Rathan M.; Zhang, Allen; Suarez-Cuervo, Catalina; Turban, Sharon; Choi, Michael J.; Sherrod, Cheryl; Hutfless, Susan; Iyoha, Emmanuel E.; Bass, Eric B.			Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC KIDNEY-DISEASE; LOW-OSMOLAR; ISO-OSMOLAR; RENAL-INSUFFICIENCY; DOUBLE-BLIND; CORONARY-ANGIOGRAPHY; NONIONIC CONTRAST; INDUCED NEPHROTOXICITY; DIABETIC-PATIENTS; IODIXANOL	Background: Iodine contrast media are essential components of many imaging procedures. An important potential side effect is contrast-induced nephropathy (CIN). Purpose: To compare CIN risk for contrast media within and between osmolality classes in patients receiving diagnostic or therapeutic imaging procedures. Data Sources: PubMed, EMBASE, Cochrane Library, Clinical Trials. gov, and Scopus through June 2015. Study Selection: Randomized, controlled trials that reported CIN-related outcomes in patients receiving low-osmolar contrast media (LOCM) or iso-osmolar contrast media for imaging. Data Extraction: Independent study selection and quality assessment by 2 reviewers and dual extraction of study characteristics and results. Data Synthesis: None of the 5 studies that compared types of LOCM reported a statistically significant or clinically important difference among study groups, but the strength of evidence was low. Twenty-five randomized, controlled trials found a slight reduction in CIN risk with the iso-osmolar contrast media agent iodixanol compared with a diverse group of LOCM that just reached statistical significance in a meta-analysis (pooled relative risk, 0.80 [95% CI, 0.65 to 0.99]; P = 0.045). This comparison's strength of evidence was moderate. In a meta regression of randomized, controlled trials of iodixanol, no relationship was found between route of administration and comparative CIN risk. Limitations: Few studies compared LOCM. Procedural details about contrast administration were not uniformly reported. Few studies specified clinical indications or severity of baseline renal impairment. Conclusion: No differences were found in CIN risk among types of LOCM. Iodixanol had a slightly lower risk for CIN than LOCM, but the lower risk did not exceed a criterion for clinical importance.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Eng, J (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21287 USA.	jeng@jhmi.edu	Subramaniam, Rathan M/AAX-2678-2021	Bass, Eric/0000-0001-9106-527X; Subramaniam, Rathan M./0000-0003-3973-4610	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Barrett BJ, 2006, INVEST RADIOL, V41, P815, DOI 10.1097/01.rli.0000242807.01818.24; Becker J, 2013, AM J ROENTGENOL, V200, P822, DOI 10.2214/AJR.12.8871; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Biondi-Zoccai G, 2014, INT J CARDIOL, V172, P375, DOI 10.1016/j.ijcard.2014.01.075; Bolognese L, 2012, AM J CARDIOL, V109, P67, DOI 10.1016/j.amjcard.2011.08.006; CAMPBELL DR, 1990, J CAN ASSOC RADIOL, V41, P133; Carraro M, 1998, EUR RADIOL, V8, P144, DOI 10.1007/s003300050356; Chalmers N, 1999, BRIT J RADIOL, V72, P701, DOI 10.1259/bjr.72.859.10624328; Chuang FR, 2009, RENAL FAILURE, V31, P181, DOI 10.1080/08860220802669636; Davenport MS, 2013, RADIOLOGY, V267, P94, DOI 10.1148/radiol.12121394; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dillman JR, 2012, AM J ROENTGENOL, V198, P392, DOI 10.2214/AJR.11.6993; Dong M, 2012, J NEPHROL, V25, P290, DOI 10.5301/jn.5000067; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eng J, 2016, CONTRACT IN IN PRESS; Feldkamp T, 2006, CLIN NEPHROL, V66, P322; Fountaine H, 1996, ACAD RADIOL, V3, pS475, DOI 10.1016/S1076-6332(05)80362-9; From AM, 2010, CIRC-CARDIOVASC INTE, V3, P351, DOI 10.1161/CIRCINTERVENTIONS.109.917070; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hardiek KJ, 2008, J DIABETES COMPLICAT, V22, P171, DOI 10.1016/j.jdiacomp.2006.11.002; Heinrich MC, 2009, RADIOLOGY, V250, P68, DOI 10.1148/radiol.2501080833; Hernandez F, 2009, REV ESP CARDIOL, V62, P1373, DOI 10.1016/S0300-8932(09)73122-7; Heyman SN, 2005, NEPHROL DIAL TRANSPL, V20, pI6, DOI 10.1093/ndt/gfh1069; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HILL JA, 1993, AM J CARDIOL, V72, P770, DOI 10.1016/0002-9149(93)91061-L; Jakobsen JA, 1996, NEPHRON, V73, P549; JEVNIKAR AM, 1988, NEPHRON, V48, P300, DOI 10.1159/000184947; Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047; Juergens CP, 2009, INTERN MED J, V39, P25, DOI 10.1111/j.1445-5994.2008.01675.x; Kitajima K, 2011, INT J UROL, V18, P686, DOI 10.1111/j.1442-2042.2011.02830.x; KOUTSIKOS D, 1992, RENAL FAILURE, V14, P545, DOI 10.3109/08860229209047664; Kuhn MJ, 2008, AM J ROENTGENOL, V191, P151, DOI 10.2214/AJR.07.3370; Laskey W, 2009, AM HEART J, V158, P822, DOI 10.1016/j.ahj.2009.08.016; Limbruno U, 2014, J CARDIOVASC MED, V15, P587, DOI 10.2459/JCM.0b013e3283638e56; McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073; McCullough PA, 2011, CARDIORENAL MED, V1, P220, DOI 10.1159/000332384; McDonald JS, 2014, RADIOLOGY, V271, P65, DOI 10.1148/radiol.13130775; McDonald JS, 2013, RADIOLOGY, V267, P119, DOI 10.1148/radiol.12121460; McDonald RJ, 2013, RADIOLOGY, V267, P106, DOI 10.1148/radiol.12121823; Mehran R, 2009, JACC-CARDIOVASC INTE, V2, P415, DOI 10.1016/j.jcin.2009.03.007; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newhouse JH, 2013, RADIOLOGY, V267, P4, DOI 10.1148/radiol.13122876; Nguyen SA, 2008, RADIOLOGY, V248, P97, DOI 10.1148/radiol.2481071484; Nie B, 2008, CATHETER CARDIO INTE, V72, P958, DOI 10.1002/ccd.21713; Overview of the National (Nationwide) Inpatient Sample (NIS), 2014, AG HEALTHC RES QUAL; Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x; Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002; Rudnick MR, 2008, AM HEART J, V156, P776, DOI 10.1016/j.ahj.2008.05.023; Semerci T, 2014, ANGIOLOGY, V65, P108, DOI 10.1177/0003319712469094; Serafin Z, 2011, ACTA RADIOL, V52, P422, DOI 10.1258/ar.2011.100501; Sharma SK, 2005, CATHETER CARDIO INTE, V65, P386, DOI 10.1002/ccd.20404; Shin DH, 2011, AM J CARDIOL, V108, P189, DOI 10.1016/j.amjcard.2011.03.019; Solomon RJ, 2007, CIRCULATION, V115, P3189, DOI 10.1161/CIRCULATIONAHA.106.671644; Wessely R, 2009, CIRC-CARDIOVASC INTE, V2, P430, DOI 10.1161/CIRCINTERVENTIONS.109.874933; Zhang BC, 2014, J CARDIOL, V63, P260, DOI 10.1016/j.jjcc.2013.11.021; Zo'o M, 2011, PEDIATR RADIOL, V41, P1393, DOI 10.1007/s00247-011-2164-6	59	80	86	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					417	+		10.7326/M15-1402	http://dx.doi.org/10.7326/M15-1402			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26830055				2022-12-28	WOS:000372207200015
J	Smith, JM				Smith, Jeanette M.			Waiting Room	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					640	641		10.1001/jama.2015.14112	http://dx.doi.org/10.1001/jama.2015.14112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881356				2022-12-28	WOS:000370171500001
J	Davies, B; Hatton, E; Altemose, N; Hussin, JG; Pratto, F; Zhang, G; Hinch, AG; Moralli, D; Biggs, D; Diaz, R; Preece, C; Li, R; Bitoun, E; Brick, K; Green, CM; Amerini-Otero, RDC; Myers, SR; Donnelly, P				Davies, Benjamin; Hatton, Edouard; Altemose, Nicolas; Hussin, Julie G.; Pratto, Florencia; Zhang, Gang; Hinch, Anjali Gupta; Moralli, Daniela; Biggs, Daniel; Diaz, Rebeca; Preece, Chris; Li, Ran; Bitoun, Emmanuelle; Brick, Kevin; Green, Catherine M.; Amerini-Otero, R. Daniel C.; Myers, Simon R.; Donnelly, Peter			Re-engineering the zinc fingers of PRDM9 reverses hybrid sterility in mice	NATURE			English	Article							HISTONE H3 METHYLTRANSFERASE; RECOMBINATION HOT-SPOT; MEIOTIC RECOMBINATION; HOMOLOGY SEARCH; ALIGNMENT; COMPLEX; DRIVE; GENE	The DNA-binding protein PRDM9 directs positioning of the double-strand breaks (DSBs) that initiate meiotic recombination in mice and humans. Prdm9 is the only mammalian speciation gene yet identified and is responsible for sterility phenotypes in male hybrids of certain mouse subspecies. To investigate PRDM9 binding and its role in fertility and meiotic recombination, we humanized the DNA-binding domain of PRDM9 in C57BL/6 mice. This change repositions DSB hotspots and completely restores fertility in male hybrids. Here we show that alteration of one Prdm9 allele impacts the behaviour of DSBs controlled by the other allele at chromosome-wide scales. These effects correlate strongly with the degree to which each PRDM9 variant binds both homologues at the DSB sites it controls. Furthermore, higher genome-wide levels of such ` symmetric' PRDM9 binding associate with increasing fertility measures, and comparisons of individual hotspots suggest binding symmetry plays a downstream role in the recombination process. These findings reveal that subspecies-specific degradation of PRDM9 binding sites by meiotic drive, which steadily increases asymmetric PRDM9 binding, has impacts beyond simply changing hotspot positions, and strongly support a direct involvement in hybrid infertility. Because such meiotic drive occurs across mammals, PRDM9 may play a wider, yet transient, role in the early stages of speciation.	[Davies, Benjamin; Hatton, Edouard; Altemose, Nicolas; Hussin, Julie G.; Zhang, Gang; Hinch, Anjali Gupta; Moralli, Daniela; Biggs, Daniel; Diaz, Rebeca; Preece, Chris; Li, Ran; Bitoun, Emmanuelle; Green, Catherine M.; Myers, Simon R.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Altemose, Nicolas; Li, Ran; Myers, Simon R.; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3LB, England; [Pratto, Florencia; Brick, Kevin; Amerini-Otero, R. Daniel C.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	myers@stats.ox.ac.uk; donnelly@well.ox.ac.uk	Altemose, Nicolas/O-7539-2019; Myers, Simon R/A-6792-2015; Davies, Ben/GYD-9163-2022; Altemose, Nicolas/EIR-2712-2022; Brick, Kevin/N-1156-2019	Altemose, Nicolas/0000-0002-7231-6026; Myers, Simon R/0000-0002-2585-9626; Davies, Ben/0000-0003-3405-507X; Altemose, Nicolas/0000-0002-7231-6026; Brick, Kevin/0000-0002-9596-6400; Donnelly, Peter/0000-0001-9495-3408; Diaz Vazquez, Rebeca/0000-0003-0937-5928; Zhang, Gang/0000-0003-2951-8287; Davies, Benjamin/0000-0003-3623-600X; Pratto, Florencia/0000-0002-9678-8044; Green, Catherine/0000-0002-7068-7106	Wellcome Trust [090532/Z/09/Z, 095552/Z/11/Z, 098387/Z/12/Z]; NIDDK Intramural Research Program; Nuffield Department of Medicine Prize Studentship; Human Frontiers Postdoctoral Program [LT-001017/2013-L]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034, ZICDK071001] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Nuffield Department of Medicine Prize Studentship; Human Frontiers Postdoctoral Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Hortin, S. Chen and R. Davies for technical assistance, the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics for the generation of the sequencing data and R. Esnouf and J. Diprose for assistance with computing facilities. PWD/PhJ mice were a gift from J. Forejt. This work was supported by the Wellcome Trust Core Award Grant 090532/Z/09/Z, Senior Investigator Award 095552/Z/11/Z (to P.D.), Investigator Award 098387/Z/12/Z (to S.R.M.) and the NIDDK Intramural Research Program (R.D.C.O.). E.H. is funded by a Nuffield Department of Medicine Prize Studentship. J.G.H. is an EPAC/Linacre Junior Research Fellow funded by the Human Frontiers Postdoctoral Program (LT-001017/2013-L).	Anderson LK, 1999, GENETICS, V151, P1569; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Baker CL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004916; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bhattacharyya T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004088; Bhattacharyya T, 2013, P NATL ACAD SCI USA, V110, pE468, DOI 10.1073/pnas.1219126110; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Flachs P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095806; Flachs P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003044; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Hinch AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004503; Ishiguro K, 2014, GENE DEV, V28, P594, DOI 10.1101/gad.237313.113; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kono H, 2014, DNA RES, V21, P315, DOI 10.1093/dnares/dst059; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sun F, 2015, CHROMOSOMA; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206	40	115	117	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					171	+		10.1038/nature16931	http://dx.doi.org/10.1038/nature16931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840484	Green Accepted, Green Submitted			2022-12-28	WOS:000369916700029
J	Haering, CH; Gruber, S				Haering, Christian H.; Gruber, Stephan			SnapShot: SMC Protein Complexes Part II	CELL			English	Editorial Material									[Haering, Christian H.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Gruber, Stephan] Max Planck Inst Biochem, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Haering, CH (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.		Gruber, Stephan/AFC-4848-2022	Gruber, Stephan/0000-0002-0150-0395; Haering, Christian/0000-0001-8301-1722				Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Piazza I, 2013, CHROMOSOMA, V122, P175, DOI 10.1007/s00412-013-0405-1	3	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					818	U272		10.1016/j.cell.2016.01.052	http://dx.doi.org/10.1016/j.cell.2016.01.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871638	Bronze			2022-12-28	WOS:000369998300025
J	Yerevanian, A				Yerevanian, Armen			Can I Eat Yet?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yerevanian, Armen] Harbor UCLA Med Ctr, Dept Internal Med, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Yerevanian, A (corresponding author), Harbor UCLA Med Ctr, Dept Internal Med, Torrance, CA 90509 USA.	armenyerevanian@gmail.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					557	557		10.1001/jama.2015.18605	http://dx.doi.org/10.1001/jama.2015.18605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864407				2022-12-28	WOS:000369635200012
J	Lito, P; Solomon, M; Li, LS; Hansen, R; Rosen, N				Lito, Piro; Solomon, Martha; Li, Lian-Sheng; Hansen, Rasmus; Rosen, Neal			Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism	SCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; BLADDER-CARCINOMA ONCOGENE; CELL LUNG-CANCER; STRUCTURAL BASIS; RAS-GTP; ACTIVATION; GENE; SOS; ADENOCARCINOMA; PROTEINS	It is thought that KRAS oncoproteins are constitutively active because their guanosine triphosphatase (GTPase) activity is disabled. Consequently, drugs targeting the inactive or guanosine 5'-diphosphate-bound conformation are not expected to be effective. We describe a mechanism that enables such drugs to inhibit KRAS(G12C) signaling and cancer cell growth. Inhibition requires intact GTPase activity and occurs because drug-bound KRAS(G12C) is insusceptible to nucleotide exchange factors and thus trapped in its inactive state. Indeed, mutants completely lacking GTPase activity and those promoting exchange reduced the potency of the drug. Suppressing nucleotide exchange activity downstream of various tyrosine kinases enhanced KRAS(G12C) inhibition, whereas its potentiation had the opposite effect. These findings reveal that KRAS(G12C) undergoes nucleotide cycling in cancer cells and provide a basis for developing effective therapies to treat KRAS(G12C)-driven cancers.	[Lito, Piro; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Solomon, Martha; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Li, Lian-Sheng; Hansen, Rasmus] Wellspring Biosci, La Jolla, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lito, P; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA.	litop@mskcc.org; rosenn@mskcc.org	Rosen, Neal/ABF-2677-2020	Li, Liansheng/0000-0002-8187-2876	National Institutes of Health [P01CA129243-06, K08CA191082-01A1]; Memorial Sloan Kettering Cancer Center Experimental Therapeutics "Big Bets" program [SKI12103]; LUNGevity Foundation Career Development Award; V Foundation Translational Grant; Scientific Advisory Board of Wellspring Biosciences; NATIONAL CANCER INSTITUTE [R01CA169351, P01CA129243, P30CA008748, K08CA191082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center Experimental Therapeutics "Big Bets" program; LUNGevity Foundation Career Development Award; V Foundation Translational Grant; Scientific Advisory Board of Wellspring Biosciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Sawyers and M. Mroczkowski for reviewing the manuscript. This work has been funded by the National Institutes of Health (P01CA129243-06 to N. R. and P. L.; K08CA191082-01A1 to P. L.), the Memorial Sloan Kettering Cancer Center Experimental Therapeutics "Big Bets" program (SKI12103 to N. R. and P. L.), the LUNGevity Foundation Career Development Award (P. L.) and the V Foundation Translational Grant (P. L.). N. R. is a member of the Scientific Advisory Board of Wellspring Biosciences and has received grant support from this organization. L-S. L. and R.H. are employees of Wellspring Biosciences. ARS853 was obtained from Wellspring Biosciences under a material transfer agreement. L-S. L. is an inventor on a patent held by Araxes Pharma LLC (an affiliate of Wellspring Biosciences) that covers ARS853.	BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Bollag G, 2013, NATURE, V503, P475, DOI 10.1038/nature12835; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hall BE, 2002, P NATL ACAD SCI USA, V99, P12138, DOI 10.1073/pnas.192453199; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; PATEL G, 1992, ONCOGENE, V7, P283; Patricelli M. P., 2016, CANC DISCOV; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	33	369	381	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2016	351	6273					604	608		10.1126/science.aad6204	http://dx.doi.org/10.1126/science.aad6204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC5WO	26841430	Green Accepted			2022-12-28	WOS:000369291600041
J	Riggs, KR; Segal, JB; Shin, EJ; Pollack, CE				Riggs, Kevin R.; Segal, Jodi B.; Shin, Eun Ji; Pollack, Craig Evan			Prevalence and Cost of Office Visits Prior to Colonoscopy for Colon Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ENDOSCOPIES		[Riggs, Kevin R.; Segal, Jodi B.; Pollack, Craig Evan] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 E Monument St, Baltimore, MD 21287 USA; [Shin, Eun Ji] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Riggs, KR (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 E Monument St, Baltimore, MD 21287 USA.	kriggs3@jhmi.edu		Riggs, Kevin/0000-0002-0015-5809	NATIONAL CANCER INSTITUTE [K07CA151910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA151910] Funding Source: Medline; NHLBI NIH HHS [T32HL007180] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen JI, 2014, GASTROENTEROLOGY, V146, P573, DOI 10.1053/j.gastro.2013.12.001; Burt RW, 2013, J NATL COMPR CANC NE, V11, P1538, DOI 10.6004/jnccn.2013.0180; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Liu HS, 2012, JAMA-J AM MED ASSOC, V307, P1178, DOI 10.1001/jama.2012.270; Mahajan RJ, 1997, GASTROINTEST ENDOSC, V46, P21, DOI 10.1016/S0016-5107(97)70204-9; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051	6	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					514	515		10.1001/jama.2015.15278	http://dx.doi.org/10.1001/jama.2015.15278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836736	Bronze			2022-12-28	WOS:000369049500023
J	van Os, J				van Os, Jim			PERSONAL VIEW "Schizophrenia" does not exist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS		[van Os, Jim] Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands	Maastricht University	van Os, J (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.	vanosj@gmail.com	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; 				Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Geekie J, 2009, MAKING SENSE MADNESS; George B, 2013, PSYCHOL MED, V43, P1555, DOI 10.1017/S0033291713000895; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Henderson S, 2014, AUST NZ J PSYCHIAT, V48, P302, DOI 10.1177/0004867414529382; Lasalvia A, 2015, SCHIZOPHR RES, V162, P276, DOI 10.1016/j.schres.2015.01.031; Moncrieff J, 2015, CURR OPIN PSYCHIATR, V28, P264, DOI 10.1097/YCO.0000000000000151; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Van Os J, 2015, NRC HANDELSBLAD	10	54	55	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								i375	10.1136/bmj.i375	http://dx.doi.org/10.1136/bmj.i375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2QK	26837945				2022-12-28	WOS:000369767100005
J	Lewandowsky, S; Bishop, D				Lewandowsky, Stephan; Bishop, Dorothy			Don't let transparency damage science	NATURE			English	Editorial Material							TOBACCO INDUSTRY EFFORTS		[Lewandowsky, Stephan] Univ Bristol, Cognit Psychol, Bristol BS8 1TH, Avon, England; [Bishop, Dorothy] Univ Oxford, Dev Neuropsychol, Oxford OX1 2JD, England	University of Bristol; University of Oxford	Lewandowsky, S (corresponding author), Univ Bristol, Cognit Psychol, Bristol BS8 1TH, Avon, England.; Bishop, D (corresponding author), Univ Oxford, Dev Neuropsychol, Oxford OX1 2JD, England.	stephan.lewandowsky@bristol.ac.uk; dorothy.bishop@psy.ox.ac.uk	Lewandowsky, Stephan/L-4272-2019	Lewandowsky, Stephan/0000-0003-1655-2013; Bishop, Dorothy/0000-0002-2448-4033				Alberts B, 2015, SCIENCE, V348, P1420, DOI 10.1126/science.aab3847; Baba A, 2005, AM J PUBLIC HEALTH, V95, pS20, DOI 10.2105/AJPH.2004.050963; Buckels EE, 2014, PERS INDIV DIFFER, V67, P97, DOI 10.1016/j.paid.2014.01.016; Cataldo JK, 2010, J CLIN EPIDEMIOL, V63, P841, DOI 10.1016/j.jclinepi.2010.01.021; Christakis DA, 2013, JAMA-J AM MED ASSOC, V310, P2499, DOI 10.1001/jama.2013.281337; Landman A, 2009, AM J PUBLIC HEALTH, V99, P45, DOI 10.2105/AJPH.2007.130740; Lewandowsky S., 2013, APS OBSERVER, V26; Morey RD, 2015, ROY SOC OPEN SCI, V2, P15047; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Oreskes N, 2015, ENVIRON SCI TECHNOL, V49, P7527, DOI 10.1021/acs.est.5b02726	10	44	45	2	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					459	461		10.1038/529459a	http://dx.doi.org/10.1038/529459a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB7DD	26819029	Bronze			2022-12-28	WOS:000368673800013
J	Nota, A; Charbonnel, C				Nota, Antonella; Charbonnel, Corinne			The mystery of globular clusters	NATURE			English	Editorial Material							OMEGA-CENTAURI; POPULATIONS		[Nota, Antonella] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Nota, Antonella] European Space Agcy, Baltimore, MD 21218 USA; [Charbonnel, Corinne] Univ Geneva, Observ Geneva, CH-1290 Versoix, Switzerland; [Charbonnel, Corinne] Inst Rech Astrophys & Planetol, Toulouse, France	Space Telescope Science Institute; University of Geneva; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nota, A (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.; Nota, A (corresponding author), European Space Agcy, Baltimore, MD 21218 USA.; Charbonnel, C (corresponding author), Univ Geneva, Observ Geneva, CH-1290 Versoix, Switzerland.; Charbonnel, C (corresponding author), Inst Rech Astrophys & Planetol, Toulouse, France.	nota@stsci.edu; corinne.charbonnel@unige.ch						Bastian N., 2015, PREPRINT; Bedin LR, 2004, ASTROPHYS J, V605, pL125, DOI 10.1086/420847; Gratton RG, 2012, ASTRON ASTROPHYS REV, V20, P1, DOI 10.1007/s00159-012-0050-3; Krause M. G. H., 2015, PREPRINT; Milone AP, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/51; Piotto G, 2005, ASTROPHYS J, V621, P777, DOI 10.1086/427796	8	0	0	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					473	+		10.1038/529473a	http://dx.doi.org/10.1038/529473a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819040				2022-12-28	WOS:000368673800024
J	Weingarten-Gabbay, S; Elias-Kirma, S; Nir, R; Gritsenko, AA; Stern-Ginossar, N; Yakhini, Z; Weinberger, A; Segal, E				Weingarten-Gabbay, Shira; Elias-Kirma, Shani; Nir, Ronit; Gritsenko, Alexey A.; Stern-Ginossar, Noam; Yakhini, Zohar; Weinberger, Adina; Segal, Eran			Systematic discovery of cap-independent translation sequences in human and viral genomes	SCIENCE			English	Article							RIBOSOME ENTRY SITE; 3' UNTRANSLATED REGIONS; MESSENGER-RNA; IN-VIVO; VIRUS-RNA; INITIATION; IRES; IDENTIFICATION; CYCLE; EUKARYOTES	To investigate gene specificity at the level of translation in both the human genome and viruses, we devised a high-throughput bicistronic assay to quantify cap-independent translation. We uncovered thousands of novel cap-independent translation sequences, and we provide insights on the landscape of translational regulation in both humans and viruses. We find extensive translational elements in the 3' untranslated region of human transcripts and the polyprotein region of uncapped RNA viruses. Through the characterization of regulatory elements underlying cap-independent translation activity, we identify potential mechanisms of secondary structure, short sequence motif, and base pairing with the 18S ribosomal RNA (rRNA). Furthermore, we systematically map the 18S rRNA regions for which reverse complementarity enhances translation. Thus, we make available insights into the mechanisms of translational control in humans and viruses.	[Weingarten-Gabbay, Shira; Elias-Kirma, Shani; Nir, Ronit; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Weingarten-Gabbay, Shira; Elias-Kirma, Shani; Nir, Ronit; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Gritsenko, Alexey A.] Delft Univ Technol, Dept Intelligent Syst, Delft Bioinformat Lab, Delft, Netherlands; [Gritsenko, Alexey A.] Platform Green Synthet Biol, Delft, Netherlands; [Gritsenko, Alexey A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Yakhini, Zohar] Technion, Dept Comp Sci, Haifa, Israel; [Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Delft University of Technology; Weizmann Institute of Science; Technion Israel Institute of Technology; Agilent Technologies	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Elias-Kirma, Shani/0000-0002-4859-7120; Segal, Eran/0000-0002-6859-1164; , Noam/0000-0003-3583-5932; Yakhini, Zohar/0000-0002-0420-5412	NIH; European Research Council (ERC); Clore Ph.D. fellowship; Kahn Center for Systems Biology; Azrieli Center for Systems Biology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)); Clore Ph.D. fellowship; Kahn Center for Systems Biology; Azrieli Center for Systems Biology	We gratefully acknowledge N. Rahm and A. Telenti for the lentiviral bicistronic constructs. We are grateful to the Alon lab for the help with tissue culture setting and the Kimchi lab for the help with luciferase assays. We thank M. Levo for fruitful discussions; S. Lubliner for assisting with the design of the library; E. Sharon and Y. Kalma for the help with the high-throughput reporter assay; and Y. Peleg, M. David, M. Selitrennik, H. Sinvani, and T. Danon for help in experimental procedures. S.W.G. is the recipient of the Clore Ph.D. fellowship. This work was supported by grants from the NIH and the European Research Council (ERC) to E. S. and student research grants from the Kahn Center for Systems Biology to S.W.G. and the Azrieli Center for Systems Biology to S.W.G. and S.E.K. Data are deposited in Gene Expression Omnibus (GEO) under accession number GSE74277. Author contributions: S.W.G. concieved the project and devised the experiments, designed the synthetic library, performed experiments, analyzed the data and wrote the manuscript; S.E.K. designed the synthetic library and performed experiments; R.N. performed experiments and provided critical comments on the manuscript; A.A.G performed analyses; N.S.G. performed experiments; Z.Y. contributed to the design and analyses; A.W. contributed to the experimental setting; and E. S. conceived the project, supervised the analyses, and wrote the manuscript.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Ball L. A., 2001, FIELDS VIROLOGY, V1; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2003, J BIOL CHEM, V278, P33793, DOI 10.1074/jbc.M303495200; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Du XF, 2013, CELL, V154, P118, DOI 10.1016/j.cell.2013.05.059; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jakubiec A, 2007, VIRUS RES, V129, P73, DOI 10.1016/j.virusres.2007.07.012; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Kazadi K, 2008, NUCLEIC ACIDS RES, V36, P6918, DOI 10.1093/nar/gkn812; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lozano G, 2015, RNA BIOL, V12, P555, DOI 10.1080/15476286.2015.1025190; Malygin AA, 2013, NUCLEIC ACIDS RES, V41, P8706, DOI 10.1093/nar/gkt632; Matsuda D, 2014, P NATL ACAD SCI USA, V111, P15385, DOI 10.1073/pnas.1413472111; Meng Z, 2010, J CELL BIOCHEM, V110, P531, DOI 10.1002/jcb.22569; Miettinen TP, 2015, NUCLEIC ACIDS RES, V43, P1019, DOI 10.1093/nar/gku1310; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; NICHOLSON R, 1991, J VIROL, V65, P5886, DOI 10.1128/JVI.65.11.5886-5894.1991; Owens GC, 2001, P NATL ACAD SCI USA, V98, P1471, DOI 10.1073/pnas.98.4.1471; Paek KY, 2015, P NATL ACAD SCI USA, V112, P1041, DOI 10.1073/pnas.1416883112; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shatsky IN, 2010, MOL CELLS, V30, P285, DOI 10.1007/s10059-010-0149-1; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Weingarten-Gabbay S, 2014, ONCOGENE, V33, P611, DOI 10.1038/onc.2012.626; Wellensiek BP, 2013, NAT METHODS, V10, P747, DOI 10.1038/nmeth.2522; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	58	173	179	9	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270							aad4939	10.1126/science.aad4939	http://dx.doi.org/10.1126/science.aad4939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816383				2022-12-28	WOS:000368098600031
J	Cleary, JF; Husain, A; Maurer, M				Cleary, James F.; Husain, Asra; Maurer, Martha			Increasing worldwide access to medical opioids	LANCET			English	Editorial Material							CANCER PAIN RELIEF; POLICY		[Cleary, James F.; Husain, Asra; Maurer, Martha] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Pain & Policy Studies Grp, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Cleary, JF (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Pain & Policy Studies Grp, Madison, WI 53792 USA.	jfcleary@wisc.edu						[Anonymous], 1977, WHO TECH REP SER, V615, P1; Berterame S., 2016, LANCET; Blengini C, 2003, EUR J CANCER CARE, V12, P28, DOI 10.1046/j.1365-2354.2003.00325.x; Centers for Disease Control and Prevention, 2012, PRESCR PAINK OV; Cleary J, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt500; Cleary JF, 2010, PALLIATIVE MED, V24, P109, DOI 10.1177/0269216309360103; European Society for Medical Oncology, GLOB OP POL IN; Gilson AM, 2013, PALLIATIVE MED, V27, P105, DOI 10.1177/0269216312461973; Hastie Barbara A, 2014, J Pain Palliat Care Pharmacother, V28, P259, DOI 10.3109/15360288.2014.941132; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Milani B., 2011, WORLD MED SITUATION; World Health Organization, 2011, ENS BAL NAT POL CONT	12	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1597	1599	1644	10.1016/S0140-6736(16)00234-8	http://dx.doi.org/10.1016/S0140-6736(16)00234-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ3ZL	26852263				2022-12-28	WOS:000374145100007
J	Ettema, TJG				Ettema, Thijs J. G.			Mitochondria in the second act	NATURE			English	Editorial Material							EUKARYOTES; EVOLUTION; ORIGIN	A large phylogenomics study reveals that the symbiotic event that led to the emergence of organelles known as mitochondria may have occurred later in the evolution of complex cells than was thought.	[Ettema, Thijs J. G.] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden	Uppsala University	Ettema, TJG (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden.	thijs.ettema@icm.uu.se						CAVALIERSMITH T, 1989, NATURE, V339, P100, DOI 10.1038/339100a0; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Ku C, 2015, P NATL ACAD SCI USA, V112, P10139, DOI 10.1073/pnas.1421385112; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Pittis AA, 2016, NATURE, V531, P101, DOI 10.1038/nature16941; Poole AM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015990; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779	11	18	19	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					39	40		10.1038/nature16876	http://dx.doi.org/10.1038/nature16876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26840482				2022-12-28	WOS:000371211900032
J	Okamura, M; Kondo, M; Kuga, R; Kurashige, Y; Yanai, T; Hayami, S; Praneeth, VKK; Yoshida, M; Yoneda, K; Kawata, S; Masaoka, S				Okamura, Masaya; Kondo, Mio; Kuga, Reiko; Kurashige, Yuki; Yanai, Takeshi; Hayami, Shinya; Praneeth, Vijayendran K. K.; Yoshida, Masaki; Yoneda, Ko; Kawata, Satoshi; Masaoka, Shigeyuki			A pentanuclear iron catalyst designed for water oxidation	NATURE			English	Article							HYDROGEN EVOLUTION; PHOTOSYSTEM-II; COMPLEXES; ELECTROCATALYST; RESOLUTION; ANGSTROM; LIGAND; CYCLE; CORE	Although the oxidation of water is efficiently catalysed by the oxygen-evolving complex in photosystem II (refs 1 and 2), it remains one of the main bottlenecks when aiming for synthetic chemical fuel production powered by sunlight or electricity. Consequently, the development of active and stable water oxidation catalysts is crucial, with heterogeneous systems(3,4) considered more suitable for practical use and their homogeneous counterparts more suitable for targeted, molecular-level design guided by mechanistic understanding(5-19). Research into the mechanism of water oxidation has resulted in a range of synthetic molecular catalysts, yet there remains much interest in systems that use abundant, inexpensive and environmentally benign metals such as iron (the most abundant transition metal in the Earth's crust and found in natural(20,21) and synthetic(22) oxidation catalysts). Water oxidation catalysts based on mononuclear iron complexes have been explored(9,12,16,18), but they often deactivate rapidly and exhibit relatively low activities. Here we report a pentanuclear iron complex that efficiently and robustly catalyses water oxidation with a turnover frequency of 1,900 per second, which is about three orders of magnitude larger than that of other iron-based catalysts. Electrochemical analysis confirms the redox flexibility of the system, characterized by six different oxidation states between Fe-5(II) and Fe-5(III); the Fe-5(III) state is active for oxidizing water. Quantum chemistry calculations indicate that the presence of adjacent active sites facilitates O-O bond formation with a reaction barrier of less than ten kilocalories per mole. Although the need for a high overpotential and the inability to operate in water-rich solutions limit the practicality of the present system, our findings clearly indicate that efficient water oxidation catalysts based on iron complexes can be created by ensuring that the system has redox flexibility and contains adjacent water-activation sites.	[Okamura, Masaya; Kondo, Mio; Kuga, Reiko; Praneeth, Vijayendran K. K.; Yoshida, Masaki; Masaoka, Shigeyuki] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan; [Okamura, Masaya; Kondo, Mio; Kurashige, Yuki; Yanai, Takeshi; Masaoka, Shigeyuki] SOKENDAI Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan; [Kondo, Mio; Masaoka, Shigeyuki] Inst Mol Sci, Res Ctr Integrat Mol Syst, Nishigo Naka 38, Okazaki, Aichi 4448585, Japan; [Kondo, Mio] Japan Sci & Technol Agcy, Adv Catalyt Transformat Program Carbon Utilizat, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan; [Kurashige, Yuki; Yanai, Takeshi] Inst Mol Sci, Dept Theoret & Computat Mol Sci, Nishigo naka 38, Okazaki, Aichi 4448585, Japan; [Kurashige, Yuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hayami, Shinya] Kumamoto Univ, Grad Sch Sci & Technol, Dept Chem, Kurokami 2-39-1, Kumamoto 8608555, Japan; [Yoneda, Ko] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Honjo Machi 1, Saga 8408502, Japan; [Kawata, Satoshi] Fukuoka Univ, Dept Chem, Fac Sci, Jonan Ku 8-19-1, Fukuoka 8140180, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Japan Science & Technology Agency (JST); Kumamoto University; Saga University; Fukuoka University	Masaoka, S (corresponding author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.; Masaoka, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan.; Masaoka, S (corresponding author), Inst Mol Sci, Res Ctr Integrat Mol Syst, Nishigo Naka 38, Okazaki, Aichi 4448585, Japan.	masaoka@ims.ac.jp	Masaoka, Shigeyuki/D-3686-2011; Kurashige, Yuki/M-8888-2016; Hayami, Shinya/Y-3354-2019; Kondo, Mio/I-4532-2015; Yoshida, Masaki/AAV-5617-2020; Hayami, Shinya/E-7019-2014; , PRANEETH/AAN-1633-2021	Masaoka, Shigeyuki/0000-0003-2678-2269; Kurashige, Yuki/0000-0003-4652-8153; Hayami, Shinya/0000-0001-8392-2382; Kondo, Mio/0000-0001-9627-2331; Yoshida, Masaki/0000-0002-4744-2805; Hayami, Shinya/0000-0001-8392-2382; , PRANEETH/0000-0003-1766-8763; Okamura, Masaya/0000-0002-8899-5019	MEXT/JSPS [25708011, 15H05480, 26620160, 15H00889, 25107526, 15H01097, 26104538, 254037, 25288013, 25410030]; JST ACT-C; JST PRESTO; NINS Program for Cross-Disciplinary Study; Morino Foundation for Molecular Science; Grants-in-Aid for Scientific Research [26620160, 25708011, 15K17827] Funding Source: KAKEN	MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST ACT-C(Japan Science & Technology Agency (JST)); JST PRESTO(Japan Science & Technology Agency (JST)); NINS Program for Cross-Disciplinary Study; Morino Foundation for Molecular Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT/JSPS Grants-in-Aid as follows: for Young Scientists A (no. 25708011 (S.M.) and no. 15H05480 (M.K.)), for Challenging Exploratory Research (no. 26620160 (S.M.)), for Scientific Research on Innovative Areas (''AnApple'' (no. 15H00889 (S.M.) and no. 25107526 (S.M.)), for Photosynergetics (no. 15H01097 (T.Y.)), for Soft Molecular Systems (no. 26104538 (Y.K.)), for a JSPS Fellowship (no. 254037 (M.O.)), for Scientific Research B (no. 25288013 (T.Y.)), and for Scientific Research C (no. 25410030 (Y.K.)). This work was also supported by JST ACT-C (M.K.), JST PRESTO (Y.K. and S.M.), the NINS Program for Cross-Disciplinary Study (S.M.) and the Morino Foundation for Molecular Science (Y.K.). The computations were performed using the Research Center for Computational Science, Okazaki, Japan. We also thank S. Furukawa for discussions.	Barnett SM, 2012, NAT CHEM, V4, P498, DOI [10.1038/NCHEM.1350, 10.1038/nchem.1350]; Coggins MK, 2014, J AM CHEM SOC, V136, P5531, DOI 10.1021/ja412822u; Concepcion JJ, 2008, J AM CHEM SOC, V130, P16462, DOI 10.1021/ja8059649; Costas M, 2000, COORDIN CHEM REV, V200, P517, DOI 10.1016/S0010-8545(00)00320-9; Costentin C, 2012, SCIENCE, V338, P90, DOI 10.1126/science.1224581; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Duan LL, 2012, NAT CHEM, V4, P418, DOI [10.1038/NCHEM.1301, 10.1038/nchem.1301]; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Ellis WC, 2010, J AM CHEM SOC, V132, P10990, DOI 10.1021/ja104766z; Fillol JL, 2011, NAT CHEM, V3, P807, DOI [10.1038/nchem.1140, 10.1038/NCHEM.1140]; GERSTEN SW, 1982, J AM CHEM SOC, V104, P4029, DOI 10.1021/ja00378a053; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Hocking RK, 2011, NAT CHEM, V3, P461, DOI [10.1038/NCHEM.1049, 10.1038/nchem.1049]; Hong D, 2013, INORG CHEM, V52, P9522, DOI 10.1021/ic401180r; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kodera M, 2012, J AM CHEM SOC, V134, P13236, DOI 10.1021/ja306089q; Kundu S, 2012, CHEM-EUR J, V18, P2787, DOI 10.1002/chem.201102326; Marinescu SC, 2012, P NATL ACAD SCI USA, V109, P15127, DOI 10.1073/pnas.1213442109; Matheu R, 2015, J AM CHEM SOC, V137, P10786, DOI 10.1021/jacs.5b06541; McCrory CCL, 2012, J AM CHEM SOC, V134, P3164, DOI 10.1021/ja210661k; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vigara L, 2012, CHEM SCI, V3, P2576, DOI 10.1039/c2sc20399e; Wada T, 2000, ANGEW CHEM INT EDIT, V39, P1479, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1479::AID-ANIE1479>3.0.CO;2-4; Wang D, 2013, P NATL ACAD SCI USA, V110, P15579, DOI 10.1073/pnas.1315383110; Yin QS, 2010, SCIENCE, V328, P342, DOI 10.1126/science.1185372; Yoneda K, 2006, ANGEW CHEM INT EDIT, V45, P5459, DOI 10.1002/anie.200602067; Yoshida M, 2010, CHEM-ASIAN J, V5, P2369, DOI 10.1002/asia.201000323; Zong R, 2005, J AM CHEM SOC, V127, P12802, DOI 10.1021/ja054791m	30	298	300	25	518	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					465	468		10.1038/nature16529	http://dx.doi.org/10.1038/nature16529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26863188				2022-12-28	WOS:000370690800032
J	Boyden, SE; Desai, A; Cruse, G; Young, ML; Bolan, HC; Scott, LM; Eisch, AR; Long, RD; Lee, CCR; Satorius, CL; Pakstis, AJ; Olivera, A; Mullikin, JC; Chouery, E; Megarbane, A; Medlej-Hashim, M; Kidd, KK; Kastner, DL; Metcalfe, DD; Komarow, HD				Boyden, Steven E.; Desai, Avanti; Cruse, Glenn; Young, Michael L.; Bolan, Hyejeong C.; Scott, Linda M.; Eisch, A. Robin; Long, R. Daniel; Lee, Chyi-Chia R.; Satorius, Colleen L.; Pakstis, Andrew J.; Olivera, Ana; Mullikin, James C.; Chouery, Eliane; Megarbane, Andre; Medlej-Hashim, Myrna; Kidd, Kenneth K.; Kastner, Daniel L.; Metcalfe, Dean D.; Komarow, Hirsh D.			Vibratory Urticaria Associated with a Missense Variant in ADGRE2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN EMR2; RECEPTOR; LIGATION; CLEAVAGE; CD97	Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum. We identified a previously unknown missense substitution in ADGRE2 (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds. The ADGRE2 receptor undergoes autocatalytic cleavage, producing an extracellular subunit that noncovalently binds a transmembrane subunit. We showed that the variant probably destabilizes an autoinhibitory subunit interaction, sensitizing mast cells to IgE-independent vibration-induced degranulation. (Funded by the National Institutes of Health.)	[Boyden, Steven E.; Satorius, Colleen L.; Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Desai, Avanti; Cruse, Glenn; Bolan, Hyejeong C.; Scott, Linda M.; Eisch, A. Robin; Olivera, Ana; Metcalfe, Dean D.; Komarow, Hirsh D.] NIAID, Mast Cell Biol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lee, Chyi-Chia R.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Young, Michael L.] Frederick Natl Lab Canc Res, Clin Res Directorate, Clin Monitoring Res Program, Leidos Biomed Res, Frederick, MD USA; [Long, R. Daniel] NIAID, Vet Pathol Sect, Rocky Mt Labs, NIH, Hamilton, MT USA; [Pakstis, Andrew J.; Kidd, Kenneth K.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Chouery, Eliane] St Josephs Univ, Med Genet Unit, Beirut, Lebanon; [Medlej-Hashim, Myrna] Lebanese Univ, Dept Life & Earth Sci, Fac Sci 2, Fanar, Lebanon; [Megarbane, Andre] Inst Jerome Lejeune, Paris, France	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University; Saint Joseph University Beirut; Lebanese University	Komarow, HD (corresponding author), NIAID, NIH, Bldg 10,Rm 1C129A1,MSC 1960, Bethesda, MD 20892 USA.	komarowh@mail.nih.gov	Lee, Chyi-Chia Richard/AAO-1149-2020; Chouery, Eliane/AAC-5957-2021; Megarbane, Andre/ABD-5574-2021; Cruse, Glenn/AAZ-1093-2021; Lee, Chyi-Chia/I-1938-2013	Chouery, Eliane/0000-0002-6257-6609; Cruse, Glenn/0000-0002-7511-0082; Lee, Chyi-Chia/0000-0002-5306-7781	National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000965, ZIAAI001091, ZIAAI001206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health.	Abajian M, 2014, IMMUNOL ALLERGY CLIN, V34, P73, DOI 10.1016/j.iac.2013.09.010; Chang GW, 2003, FEBS LETT, V547, P145, DOI 10.1016/S0014-5793(03)00695-1; Chen Tzu-Ying, 2011, Chang Gung Med J, V34, P468; COHEN RW, 1986, J ALLERGY CLIN IMMUN, V77, P802, DOI 10.1016/0091-6749(86)90377-5; EPSTEIN PA, 1981, AM J MED GENET, V9, P307, DOI 10.1002/ajmg.1320090407; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Karpus ON, 2013, J IMMUNOL, V190, P3740, DOI 10.4049/jimmunol.1202192; Kwakkenbos MJ, 2006, FASEB J, V20, P2582, DOI 10.1096/fj.06-6500fje; Kwakkenbos MJ, 2002, J LEUKOCYTE BIOL, V71, P854; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Mathelier-Fusade P, 2001, ANN DERMATOL VENER, V128, P750; Meyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056773; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Scholz N, 2015, CELL REP, V11, P866, DOI 10.1016/j.celrep.2015.04.008; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Yu Y, 2015, EUR J PHARM	24	98	101	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					656	663		10.1056/NEJMoa1500611	http://dx.doi.org/10.1056/NEJMoa1500611			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26841242	Bronze, Green Accepted			2022-12-28	WOS:000370229000011
J	Li, P; Janczewski, WA; Yackle, K; Kam, K; Pagliardini, S; Krasnow, MA; Feldman, JL				Li, Peng; Janczewski, Wiktor A.; Yackle, Kevin; Kam, Kaiwen; Pagliardini, Silvia; Krasnow, Mark A.; Feldman, Jack L.			The peptidergic control circuit for sighing	NATURE			English	Article							NEUROMEDIN-B-RECEPTOR; PREBOTZINGER COMPLEX; RESPIRATORY RHYTHM; EXPRESSING NEURONS; VENTRAL MEDULLA; BOMBESIN; GENERATION; RATS; MICE; VENTILATION	Sighs are long, deep breaths expressing sadness, relief or exhaustion. Sighs also occur spontaneously every few minutes to reinflate alveoli, and sighing increases under hypoxia, stress, and certain psychiatric conditions. Here we use molecular, genetic, and pharmacologic approaches to identify a peptidergic sigh control circuit in murine brain. Small neural subpopulations in a key breathing control centre, the retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG), express bombesin-like neuropeptide genes neuromedin B (Nmb) or gastrin-releasing peptide (Grp). These project to the preBotzinger Complex (preBotC), the respiratory rhythm generator, which expresses NMB and GRP receptors in overlapping subsets of similar to 200 neurons. Introducing either neuropeptide into preBotC or onto preBtC slices, induced sighing or in vitro sigh activity, whereas elimination or inhibition of either receptor reduced basal sighing, and inhibition of both abolished it. Ablating receptor-expressing neurons eliminated basal and hypoxia-induced sighing, but left breathing otherwise intact initially. We propose that these overlapping peptidergic pathways comprise the core of a sigh control circuit that integrates physiological and perhaps emotional input to transform normal breaths into sighs.	[Li, Peng; Yackle, Kevin; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Li, Peng; Yackle, Kevin; Krasnow, Mark A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Janczewski, Wiktor A.; Kam, Kaiwen; Pagliardini, Silvia; Feldman, Jack L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Syst Neurobiol Lab, Los Angeles, CA 90095 USA; [Kam, Kaiwen] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Pagliardini, Silvia] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2E1, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chicago Medical School; Rosalind Franklin University Medical & Science; University of Alberta	Krasnow, MA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.; Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Syst Neurobiol Lab, Los Angeles, CA 90095 USA.	krasnow@stanford.edu; feldman@g.ucla.edu	feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412; Krasnow, Mark/0000-0002-1976-5471; Yackle, Kevin/0000-0003-1870-2759; Pagliardini, Silvia/0000-0002-1482-9173	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959, U01HL099995, R01HL070029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072211] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL70029, HL40959, R01 HL040959, R01 HL070029, U01 HL099995] Funding Source: Medline; NINDS NIH HHS [R01 NS072211, NS72211] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; BENDIXEN HH, 1964, J APPL PHYSIOL, V19, P195, DOI 10.1152/jappl.1964.19.2.195; Caughey J.L., 1943, AM REV TUBERCULOSIS, V48, P382; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Guyenet PG, 2015, NEURON, V87, P946, DOI 10.1016/j.neuron.2015.08.001; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Haladane JS, 1919, J PHYSIOL-LONDON, V52, P433, DOI 10.1113/jphysiol.1919.sp001842; Janczewski W. A., 2012, P SOC NEUR C NEW ORL; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Kam K, 2013, J NEUROSCI, V33, P9235, DOI 10.1523/JNEUROSCI.4143-12.2013; KNOWLTON GC, 1946, AM J PHYSIOL, V147, P100, DOI 10.1152/ajplegacy.1946.147.1.100; Lazarenko RM, 2009, J COMP NEUROL, V517, P69, DOI 10.1002/cne.22136; Lee H, 2003, BEHAV PHARMACOL, V14, P501, DOI 10.1097/00008877-200311000-00002; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Maytung C.K., 1938, J ALLERGY, V10, P50; MCCUTCHEON FH, 1953, J CELL COMPAR PHYSL, V41, P291, DOI 10.1002/jcp.1030410207; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; NIEWOEHNER DE, 1983, PEPTIDES, V4, P277, DOI 10.1016/0196-9781(83)90132-8; Ohki-Hamazaki H, 1999, J NEUROSCI, V19, P948; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; ORBUCH M, 1993, MOL PHARMACOL, V44, P841; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; QIN YF, 1994, CANCER RES, V54, P1035; Ramirez JM, 2014, PROG BRAIN RES, V209, P91, DOI 10.1016/B978-0-444-63274-6.00006-0; REYNOLDS LB, 1962, J APPL PHYSIOL, V17, P683, DOI 10.1152/jappl.1962.17.4.683; Ruangkittisakul A, 2008, J NEUROSCI, V28, P2447, DOI 10.1523/JNEUROSCI.1926-07.2008; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418	34	110	110	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					293	+		10.1038/nature16964	http://dx.doi.org/10.1038/nature16964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26855425	Green Accepted, Green Published			2022-12-28	WOS:000370327100028
J	Schlager, C; Korner, H; Krueger, M; Vidoli, S; Haberl, M; Mielke, D; Brylla, E; Issekutz, T; Cabanas, C; Nelsons, PJ; Ziemssen, T; Rohde, V; Bechmann, I; Lodygin, D; Odoardi, F; Flugel, A				Schlaeger, Christian; Koerner, Henrike; Krueger, Martin; Vidoli, Stefano; Haberl, Michael; Mielke, Dorothee; Brylla, Elke; Issekutz, Thomas; Cabanas, Carlos; Nelsons, Peter J.; Ziemssen, Tjalf; Rohde, Veit; Bechmann, Ingo; Lodygin, Dmitri; Odoardi, Francesca; Fluegel, Alexander			Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CHOROID-PLEXUS; MULTIPLE-SCLEROSIS; CNS LESIONS; REAL-TIME; IN-VIVO; ACTIVATION; MIGRATION; INFLAMMATION	In multiple sclerosis, brain-reactive T cells invade the central nervous system (CNS) and induce a self-destructive inflammatory process. T-cell infiltrates are not only found within the parenchyma and the meninges, but also in the cerebrospinal fluid (CSF) that bathes the entire CNS tissue(1,2). How the T cells reach the CSF, their functionality, and whether they traffic between the CSF and other CNS compartments remains hypothetical(3-6). Here we show that effector T cells enter the CSF from the leptomeninges during Lewis rat experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. While moving through the three-dimensional leptomeningeal network of collagen fibres in a random Brownian walk, T cells were flushed from the surface by the flow of the CSF. The detached cells displayed significantly lower activation levels compared to T cells from the leptomeninges and CNS parenchyma. However, they did not represent a specialized non-pathogenic cellular sub-fraction, as their gene expression profile strongly resembled that of tissue-derived T cells and they fully retained their encephalitogenic potential. T-cell detachment from the leptomeninges was counteracted by integrins VLA-4 and LFA-1 binding to their respective ligands produced by resident macrophages. Chemokine signalling via CCR5/CXCR3 and antigenic stimulation of T cells in contact with the leptomeningeal macrophages enforced their adhesiveness. T cells floating in the CSF were able to reattach to the leptomeninges through steps reminiscent of vascular adhesion in CNS blood vessels, and invade the parenchyma. The molecular/cellular conditions for T-cell reattachment were the same as the requirements for detachment from the leptomeningeal milieu. Our data indicate that the leptomeninges represent a checkpoint at which activated T cells are licensed to enter the CNS parenchyma and non-activated T cells are preferentially released into the CSF, from where they can reach areas of antigen availability and tissue damage.	[Schlaeger, Christian; Koerner, Henrike; Haberl, Michael; Lodygin, Dmitri; Odoardi, Francesca; Fluegel, Alexander] Univ Med Ctr Gottingen, Inst Multiple Sclerosis Res, Inst Neuroimmunol, D-37073 Gottingen, Germany; [Fluegel, Alexander] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Krueger, Martin; Brylla, Elke; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Vidoli, Stefano] Univ Roma La Sapienza, Dept Struct & Geotech Engn, I-00135 Rome, Italy; [Mielke, Dorothee; Rohde, Veit] Univ Med Ctr Gottingen, Dept Neurosurg, D-37075 Gottingen, Germany; [Issekutz, Thomas] Dalhousie Univ, Dept Pediat, Div Immunol, Halifax, NS B3H 4R2, Canada; [Cabanas, Carlos] Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, Madrid 28049, Spain; [Nelsons, Peter J.] Univ Munich, Med Clin & Policlin 4, D-80336 Munich, Germany; [Ziemssen, Tjalf] Univ Hosp, Dept Neurol, D-01307 Dresden, Germany	University of Gottingen; Max Planck Society; Leipzig University; Sapienza University Rome; University of Gottingen; Dalhousie University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Flugel, A (corresponding author), Univ Med Ctr Gottingen, Inst Multiple Sclerosis Res, Inst Neuroimmunol, D-37073 Gottingen, Germany.; Flugel, A (corresponding author), Max Planck Inst Expt Med, D-37075 Gottingen, Germany.	fluegel@med.uni-goettingen.de	Ziemssen, Tjalf/J-2017-2019; Mielke, Dorothee/AAU-6776-2021; CABAÑAS, CARLOS/J-4595-2012	Ziemssen, Tjalf/0000-0001-8799-8202; CABAÑAS, CARLOS/0000-0002-8767-060X; Issekutz, Thomas/0000-0001-5486-9463				Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Alvermann S, 2014, JAMA NEUROL, V71, P905, DOI 10.1001/jamaneurol.2014.395; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Cabeza R, 2014, PLANT PHYSIOL, V164, P400, DOI 10.1104/pp.113.228312; Carnevali L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068316; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; De la Calle JL, 2002, BRAIN RES BULL, V59, P245, DOI 10.1016/S0361-9230(02)00866-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; ISSEKUTZ TB, 1991, J IMMUNOL, V147, P4178; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lodygin D, 2013, NAT MED, V19, P784, DOI 10.1038/nm.3182; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Mues M, 2013, NAT MED, V19, P778, DOI 10.1038/nm.3180; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Siffrin V, 2009, BRAIN, V132, P1247, DOI 10.1093/brain/awn354; Slobodian Ili, 2007, Cerebrospinal Fluid Res, V4, P9, DOI 10.1186/1743-8454-4-9; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975	53	198	202	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					349	+		10.1038/nature16939	http://dx.doi.org/10.1038/nature16939			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26863192				2022-12-28	WOS:000370327100040
J	Siu, AL				Siu, Albert L.		USPSTF	Screening for Autisni Spectrum Disorder in Young Children US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MODIFIED CHECKLIST; EARLY INTERVENTION; PRACTICE PARAMETER; IDENTIFICATION; MANAGEMENT; TODDLERS; TRIAL; RISK	DESCRIPTION New US Preventive Services Task Force (USPSTF) recommendation on screening for autism spectrum disorder (ASD) in young children. METHODS The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of brief, formal screening instruments for ASD administered during routine primary care visits and the benefits and potential harms of early behavioral treatment for young children identified with ASD through screening. POPULATION This recommendation applies to children aged 18 to 30 months who have not been diagnosed with ASD or developmental delay and for whom no concerns of ASD have been raised by parents, other caregivers, or health care professionals. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician. (I statement)										Arunyanart W, 2012, INFANT YOUNG CHILD, V25, P175, DOI 10.1097/IYC.0b013e31825a5a42; Baranek Grace T, 2015, Autism Res Treat, V2015, P386951, DOI 10.1155/2015/386951; Chlebowski C, 2013, PEDIATRICS, V131, pE1121, DOI 10.1542/peds.2012-1525; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Dosreis S, 2006, J DEV BEHAV PEDIATR, V27, pS88, DOI 10.1097/00004703-200604002-00006; Duffee JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0339; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gillis JM, 2009, INFANT YOUNG CHILD, V22, P321, DOI 10.1097/IYC.0b013e3181bc4e21; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; McPheeters ML, 2016, AHRQ PUBLICATION, V13-05185-EF-11; Radecki L, 2011, PEDIATRICS, V128, P14, DOI 10.1542/peds.2010-2180; Recommendations by type: clinical preventive services, REC TYP CLIN PREV SE; Robins DL, 2014, PEDIATRICS, V133, P37, DOI 10.1542/peds.2013-1813; Sallows GO, 2005, AM J MENT RETARD, V110, P417, DOI 10.1352/0895-8017(2005)110[417:IBTFCW]2.0.CO;2; Smith T, 2000, AM J MENT RETARD, V105, P269, DOI 10.1352/0895-8017(2000)105<0269:RTOIEI>2.0.CO;2; Strain PS, 2011, TOP EARLY CHILD SPEC, V31, P133, DOI 10.1177/0271121411408740; UK NSC, UK NSC REC AUT SCREE; Volkmar F, 2014, J AM ACAD CHILD PSY, V53, P237, DOI 10.1016/j.jaac.2013.10.013; Wetherby AM, 2014, PEDIATRICS, V134, P1084, DOI 10.1542/peds.2014-0757; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Zuckerman KE, 2013, PEDIATRICS, V132, P445, DOI 10.1542/peds.2013-0383; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS10, DOI 10.1542/peds.2014-3667C	22	148	150	3	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					691	696		10.1001/jama.2016.0018	http://dx.doi.org/10.1001/jama.2016.0018			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD8JB	26881372	Bronze			2022-12-28	WOS:000370171500015
J	Covington, H; Thornton, J; Hepburn, C				Covington, Howard; Thornton, James; Hepburn, Cameron			Shareholders must vote for climate-change mitigation	NATURE			English	Editorial Material									[Covington, Howard] Alan Turing Inst, London, England; [Thornton, James] ClientEarth, Environm Law Firm, London, England; [Hepburn, Cameron] Univ Oxford, Environm Econ, Oxford OX1 2JD, England	University of Oxford	Covington, H (corresponding author), Alan Turing Inst, London, England.	hcovington@turing.ac.uk		Hepburn, Cameron/0000-0003-0467-7441				Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Dietz S, 2015, ECON J, V125, P574, DOI 10.1111/ecoj.12188; Law Commission, 2014, FID DUT INV INT; Moorhead J, 2014, GLOBAL 500 GREENHOUS; Pal JS, 2016, NAT CLIM CHANGE, V6, P197, DOI [10.1038/NCLIMATE2833, 10.1038/nclimate2833]; The Economist Intelligence Unit, 2015, COST IN REC VAL RISK	6	11	11	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					156	156		10.1038/530156a	http://dx.doi.org/10.1038/530156a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD4TX	26863968	Green Submitted, Bronze			2022-12-28	WOS:000369916700015
J	Jones, DS; Greene, JA				Jones, David S.; Greene, Jeremy A.			Is Dementia in Decline? Historical Trends and Future Trajectories	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Jones, David S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA	Harvard University; Harvard Medical School; Harvard University; Johns Hopkins University; Johns Hopkins University	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							BECK JC, 1982, ANN INTERN MED, V97, P231, DOI 10.7326/0003-4819-97-2-231; Jones DS, 2013, AM J PUBLIC HEALTH, V103, P1207, DOI 10.2105/AJPH.2013.301226; Manton K C, 2005, Adv Gerontol, V16, P30; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002	4	28	30	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					507	509		10.1056/NEJMp1514434	http://dx.doi.org/10.1056/NEJMp1514434			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2ME	26863352				2022-12-28	WOS:000369755800003
J	Wei, PC; Chang, AN; Kao, J; Du, Z; Meyers, RM; Alt, FW; Schwer, B				Wei, Pei-Chi; Chang, Amelia N.; Kao, Jennifer; Du, Zhou; Meyers, Robin M.; Alt, Frederick W.; Schwer, Bjoern			Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells	CELL			English	Article							COMMON FRAGILE SITES; DOUBLE-STRAND BREAKS; GENOME INSTABILITY; SEQUENCING REVEALS; MECHANISMS; REPAIR; TRANSLOCATIONS; AMPLIFICATION; TRANSCRIPTION; DOMAINS	Repair of DNA double-strand breaks (DSBs) by non-homologous end joining is critical for neural development, and brain cells frequently contain somatic genomic variations that might involve DSB intermediates. We now use an unbiased, high-throughput approach to identify genomic regions harboring recurrent DSBs in primary neural stem/progenitor cells (NSPCs). We identify 27 recurrent DSB clusters (RDCs), and remarkably, all occur within gene bodies. Most of these NSPC RDCs were detected only upon mild, aphidicolin-induced replication stress, providing a nucleotide-resolution view of replication-associated genomic fragile sites. The vast majority of RDCs occur in long, transcribed, and late-replicating genes. Moreover, almost 90% of identified RDC-containing genes are involved in synapse function and/or neural cell adhesion, with a substantial fraction also implicated in tumor suppression and/or mental disorders. Our characterization of NSPC RDCs reveals a basis of gene fragility and suggests potential impacts of DNA breaks on neurodevelopment and neural functions.	[Wei, Pei-Chi; Chang, Amelia N.; Kao, Jennifer; Du, Zhou; Meyers, Robin M.; Alt, Frederick W.; Schwer, Bjoern] Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wei, Pei-Chi; Chang, Amelia N.; Kao, Jennifer; Du, Zhou; Meyers, Robin M.; Alt, Frederick W.; Schwer, Bjoern] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wei, Pei-Chi; Chang, Amelia N.; Kao, Jennifer; Du, Zhou; Meyers, Robin M.; Alt, Frederick W.; Schwer, Bjoern] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Schwer, B (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu; bjoern.schwer@childrens.harvard.edu		Wei, Pei-Chi/0000-0002-3309-0511; Meyers, Robin/0000-0002-1802-7231	Porter Anderson Fund from Boston Children's Hospital; Howard Hughes Medical Institute; National Institute on Aging (NIA)/NIH grant [K01AG043630]; National Cancer Center postdoctoral fellowship; NATIONAL INSTITUTE ON AGING [K01AG043630] Funding Source: NIH RePORTER	Porter Anderson Fund from Boston Children's Hospital; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute on Aging (NIA)/NIH grant; National Cancer Center postdoctoral fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. R. Axel, C. Boboila, and members of the F.W.A. laboratory for helpful comments and stimulating discussions; Drs. C. Guo, M. Gostissa, and J. Hu for experimental advice; and Drs. Y. Zhang, L. Shen, and F.-L. Meng for DNA sequencing assistance. This work in the F.W.A. lab was supported by the Porter Anderson Fund from Boston Children's Hospital and the Howard Hughes Medical Institute. B.S. is a Martin D. Abeloff Scholar of The V Foundation for Cancer Research and is supported by National Institute on Aging (NIA)/NIH grant K01AG043630. P.W. is supported by a National Cancer Center postdoctoral fellowship.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Arlt MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002981; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Bosco N, 2010, CANCER GENET CYTOGEN, V202, P47, DOI 10.1016/j.cancergencyto.2010.06.008; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gao G, 2014, CELL MOL LIFE SCI, V71, P4601, DOI 10.1007/s00018-014-1753-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gapud EJ, 2011, CELL CYCLE, V10, P1928, DOI 10.4161/cc.10.12.16011; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Krummel KA, 2002, GENE CHROMOSOME CANC, V34, P154, DOI 10.1002/gcc.10047; Le Tallec B, 2014, CELL MOL LIFE SCI, V71, P4489, DOI 10.1007/s00018-014-1720-2; Le Tallec B, 2013, CELL REP, V4, P420, DOI 10.1016/j.celrep.2013.07.003; Le Tallec B, 2011, NAT STRUCT MOL BIOL, V18, P1421, DOI 10.1038/nsmb.2155; Lee Y, 2002, CANCER RES, V62, P6395; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Savelyeva L, 2014, CELL MOL LIFE SCI, V71, P4561, DOI 10.1007/s00018-014-1723-z; Schwer B., 2016, P NATL ACAD SCI US; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Yan CT, 2006, P NATL ACAD SCI USA, V103, P7378, DOI 10.1073/pnas.0601938103; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	51	162	164	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					644	655		10.1016/j.cell.2015.12.039	http://dx.doi.org/10.1016/j.cell.2015.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871630	Green Accepted, Bronze			2022-12-28	WOS:000369998300011
J	Lindsay, D; D'Souza, S				Lindsay, David; D'Souza, Sunil			CASE REVIEW A limping child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPMENTAL HIP-DYSPLASIA; RISK-FACTORS; CONGENITAL DISLOCATION; DIAGNOSIS; JOINT; NEWBORNS		[Lindsay, David; D'Souza, Sunil] Royal Bolton Hosp, Dept Trauma & Orthopaed, Bolton, England	Royal Bolton Hospital	Lindsay, D (corresponding author), Royal Bolton Hosp, Dept Trauma & Orthopaed, Bolton, England.	david.lindsay3@nhs.net						Agarwal Anil, 2012, J Clin Orthop Trauma, V3, P10, DOI 10.1016/j.jcot.2011.11.001; ARONSSON DD, 1994, PEDIATRICS, V94, P201; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; Bialik V, 1999, PEDIATRICS, V103, P93, DOI 10.1542/peds.103.1.93; Cady RB, 2006, PEDIATR ANN, V35, P92, DOI 10.3928/0090-4481-20060201-09; de Hundt M, 2012, EUR J OBSTET GYN R B, V165, P8, DOI 10.1016/j.ejogrb.2012.06.030; Dezateux C, 2007, LANCET, V369, P1541, DOI 10.1016/S0140-6736(07)60710-7; Donaldson JS, 1997, PEDIATR CLIN N AM, V44, P591, DOI 10.1016/S0031-3955(05)70495-8; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; GRAF R, 1980, ARCH ORTHOP TRAUM SU, V97, P117, DOI 10.1007/BF00450934; GRAF R, 1984, ARCH ORTHOP TRAUM SU, V102, P248, DOI 10.1007/BF00436138; Guille J T, 2000, J Am Acad Orthop Surg, V8, P232; Kruczynski J, 1996, ACTA ORTHOP SCAND S, V268, P1; LAURENSON RD, 1959, J BONE JOINT SURG BR, V41, P702, DOI 10.1302/0301-620X.41B4.702; Lehmann HP, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e57; Loder RT, 2015, J CHILD ORTHOP, V9, P93, DOI 10.1007/s11832-015-0636-1; Loder Randall T, 2011, ISRN Orthop, V2011, P238607, DOI 10.5402/2011/238607; Mace J, 2015, BONE JOINT J, V97B, P265, DOI 10.1302/0301-620X.97B2.34858; Noordin S, 2010, ORTHOP REV, V2, P73, DOI 10.4081/or.2010.e19; Ortiz-Neira CL, 2012, EUR J RADIOL, V81, pE344, DOI 10.1016/j.ejrad.2011.11.003; Panagiotopoulou N, 2012, ACTA ORTHOP BELG, V78, P697; Patel H, 2001, CAN MED ASSOC J, V164, P1669; Public Health England, 2013, NEWB INF PHYS EX SCR; Rhodes AML, 2014, J CHILD ORTHOP, V8, P375, DOI 10.1007/s11832-014-0615-y; Schwend RM, 2014, PEDIATR CLIN N AM, V61, P1095, DOI 10.1016/j.pcl.2014.08.008; Shorter Damon, 2013, Evid Based Child Health, V8, P11, DOI 10.1002/ebch.1891; Solomon L, 2010, APLEYS SYSTEM ORTHOP; Storer SK, 2006, AM FAM PHYSICIAN, V74, P1310; Talbot CL, 2013, ARCH DIS CHILD, V98, P692, DOI 10.1136/archdischild-2013-303647; Tegnander A, 2001, J PEDIATR ORTHOP B, V10, P173; Thomas SRYW, 2015, BONE JOINT J, V97B, P729, DOI 10.1302/0301-620X.97B6.35395; Thomas SR, 2007, J BONE JOINT SURG AM, V89A, P2341, DOI 10.2106/JBJS.F.00857; UK National Screening Committee, 2008, NEWB INF PHYS EX STA; UK National Screening Committee, 2014, PROGR STAT ULTR EX H; VONROSEN S, 1962, J BONE JOINT SURG BR, V44, P284, DOI 10.1302/0301-620X.44B2.284; Williams NS, 2013, BAILEY LOVES SHORT P, V26th, P798; Witt Catherine, 2003, Adv Neonatal Care, V3, P65, DOI 10.1053/adnc.2003.50016; Woolacott NF, 2005, BMJ-BRIT MED J, V330, P1413, DOI 10.1136/bmj.38450.646088.E0	38	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2016	352								i476	10.1136/bmj.i476	http://dx.doi.org/10.1136/bmj.i476			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IR	26861545				2022-12-28	WOS:000370381000002
J	Tubo, NJ; Fife, BT; Pagan, AJ; Kotov, DI; Goldberg, MF; Jenkins, MK				Tubo, Noah J.; Fife, Brian T.; Pagan, Antonio J.; Kotov, Dmitri I.; Goldberg, Michael F.; Jenkins, Marc K.			Most microbe-specific naive CD4(+) T cells produce memory cells during infection	SCIENCE			English	Article							FOLLICULAR HELPER; IMMUNE-RESPONSE; VIRAL-INFECTION; REPERTOIRE; EFFECTOR; DIFFERENTIATION; DIVERSITY; FATES	Infection elicits CD4(+) memory T lymphocytes that participate in protective immunity. Although memory cells are the progeny of naive T cells, it is unclear that all naive cells from a polyclonal repertoire have memory cell potential. Using a single-cell adoptive transfer and spleen biopsy method, we found that in mice, essentially all microbe-specific naive cells produced memory cells during infection. Different clonal memory cell populations had different B cell or macrophage helper compositions that matched effector cell populations generated much earlier in the response. Thus, each microbe-specific naive CD4(+) T cell produces a distinctive ratio of effector cell types early in the immune response that is maintained as some cells in the clonal population become memory cells.	[Tubo, Noah J.] Genzyme Corp, Immune Mediated Dis Therapy Grp, Framingham, MA 01701 USA; [Fife, Brian T.] Univ Minnesota, Sch Med, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Pagan, Antonio J.] MRC Lab Mol Biol, Dept Med, Cambridge, England; [Kotov, Dmitri I.; Goldberg, Michael F.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA	Sanofi-Aventis; Genzyme Corporation; University of Minnesota System; University of Minnesota Twin Cities; MRC Laboratory Molecular Biology; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Pagan, Antonio/AAB-1604-2019; Jenkins, Marc K/G-1063-2012; Fife, Brian/D-2042-2013	Jenkins, Marc K/0000-0001-8009-7655; Fife, Brian/0000-0001-9826-5637; Kotov, Dmitri/0000-0001-7843-1503	NIH [R01 AI039614, R01 AI106791, F32 AI107995]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI107995, R01AI106791, P01AI035296, T32AI007313, R01AI039614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Jameson and D. Masopust for critical discussions and reading the manuscript and J. Walter for help with mouse breeding and screening. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by NIH grants R01 AI039614 (M.K.J.), R01 AI106791 (B.T.F.), and F32 AI107995 (N.J.T.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kim C, 2013, IMMUNITY, V39, P508, DOI 10.1016/j.immuni.2013.08.033; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Martinez RJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00468; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; TASWELL C, 1981, J IMMUNOL, V126, P1614; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014	21	41	42	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					511	514		10.1126/science.aad0483	http://dx.doi.org/10.1126/science.aad0483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823430	Green Accepted			2022-12-28	WOS:000368858200038
J	Cho, A				Cho, Adrian			THE SOCIAL LIFE OF QUARKS	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					217	219		10.1126/science.351.6270.217	http://dx.doi.org/10.1126/science.351.6270.217			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA9AM	26816360				2022-12-28	WOS:000368098600016
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Object lessons William Harvey's demonstration rod	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1933	1933		10.1016/S0140-6736(15)00819-3	http://dx.doi.org/10.1016/S0140-6736(15)00819-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26841739				2022-12-28	WOS:000364763200015
J	Jia, SD; Liu, ZN; Zhang, S; Liu, PX; Zhang, L; Lee, SH; Zhang, J; Signoretti, S; Loda, M; Roberts, TM; Zhao, JJ				Jia, Shidong; Liu, Zhenning; Zhang, Sen; Liu, Pixu; Zhang, Lei; Lee, Sang Hyun; Zhang, Jing; Signoretti, Sabina; Loda, Massimo; Roberts, Thomas M.; Zhao, Jean J.			Essential roles of PI(3)K-p110 beta in cell growth, metabolism and tumorigenesis (vol 454, pg 776, 2008)	NATURE			English	Correction																		Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091	1	7	7	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					278	278		10.1038/nature16543	http://dx.doi.org/10.1038/nature16543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	26814969	Bronze			2022-12-28	WOS:000376007200057
J	Pittis, AA; Gabaldon, T				Pittis, Alexandros A.; Gabaldon, Toni			Late acquisition of mitochondria by a host with chimaeric prokaryotic ancestry	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EUKARYOTIC EVOLUTION; COMMON ANCESTOR; ORIGIN; ORTHOLOGY; GENOME; GENES; TOOL	The origin of eukaryotes stands as a major conundrum in biology(1). Current evidence indicates that the last eukaryotic common ancestor already possessed many eukaryotic hallmarks, including a complex subcellular organization(1-3). In addition, the lack of evolutionary intermediates challenges the elucidation of the relative order of emergence of eukaryotic traits. Mitochondria are ubiquitous organelles derived from an alphaproteobacterial endosymbiont(4). Different hypotheses disagree on whether mitochondria were acquired early or late during eukaryogenesis(5). Similarly, the nature and complexity of the receiving host are debated, with models ranging from a simple prokaryotic host to an already complex proto-eukaryote(1,3,6,7). Most competing scenarios can be roughly grouped into either mito-early, which consider the driving force of eukaryogenesis to be mitochondrial endosymbiosis into a simple host, or mito-late, which postulate that a significant complexity predated mitochondrial endosymbiosis(3). Here we provide evidence for late mitochondrial endosymbiosis. We use phylogenomics to directly test whether proto-mitochondrial proteins were acquired earlier or later than other proteins of the last eukaryotic common ancestor. We find that last eukaryotic common ancestor protein families of alphaproteobacterial ancestry and of mitochondrial localization show the shortest phylogenetic distances to their closest prokaryotic relatives, compared with proteins of different prokaryotic origin or cellular localization. Altogether, our results shed new light on a long-standing question and provide compelling support for the late acquisition of mitochondria into a host that already had a proteome of chimaeric phylogenetic origin. We argue that mitochondrial endosymbiosis was one of the ultimate steps in eukaryogenesis and that it provided the definitive selective advantage to mitochondria-bearing eukaryotes over less complex forms.	[Pittis, Alexandros A.; Gabaldon, Toni] Ctr Genom Regulat CRG, Bioinformat & Genom Programme, Carrer Dr Aiguader 88, Barcelona 08003, Spain; [Pittis, Alexandros A.; Gabaldon, Toni] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain; [Gabaldon, Toni] ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Gabaldon, T (corresponding author), Ctr Genom Regulat CRG, Bioinformat & Genom Programme, Carrer Dr Aiguader 88, Barcelona 08003, Spain.; Gabaldon, T (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain.; Gabaldon, T (corresponding author), ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.	tgabaldon@crg.es	Gabaldón, Toni/A-7336-2008	Gabaldón, Toni/0000-0003-0019-1735; Pittis, Alexandros/0000-0003-4116-9972	Spanish Ministry of Economy and Competitiveness [BIO2012-37161]; European Union [FP7 FP7-PEOPLE-2013-ITN-606786]; European Research Council under the European Union [ERC-2012-StG-310325]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union(European Commission); European Research Council under the European Union(European Research Council (ERC)); ICREA(ICREA)	T.G. group research is funded in part by a grant from the Spanish Ministry of Economy and Competitiveness (BIO2012-37161), a grant from the European Union FP7 FP7-PEOPLE-2013-ITN-606786 and a grant from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC (Grant Agreement number ERC-2012-StG-310325).	Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Do CB, 2008, NAT BIOTECHNOL, V26, P897, DOI 10.1038/nbt1406; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fraley C, 2012, 597 U WASH; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greenacre M., 2007, CORRES ANAL PRACTICE; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Ku C, 2015, P NATL ACAD SCI USA, V112, P10139, DOI 10.1073/pnas.1421385112; Lester L, 2006, BIOESSAYS, V28, P57, DOI 10.1002/bies.20344; Martijn J, 2013, BIOCHEM SOC T, V41, P451, DOI 10.1042/BST20120292; Poole AM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015990; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091	30	133	138	9	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					101	+		10.1038/nature16941	http://dx.doi.org/10.1038/nature16941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26840490	Green Accepted			2022-12-28	WOS:000371211900048
J	Politi, MC; Sonfield, A; Madden, T				Politi, Mary C.; Sonfield, Adam; Madden, Tessa			Addressing Challenges to Implementation of the Contraceptive Coverage Guarantee of the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Politi, Mary C.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,CB 8100, St Louis, MO 63110 USA; [Sonfield, Adam] Alan Guttmacher Inst, 120 Wall St, New York, NY 10005 USA; [Madden, Tessa] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Family Planning, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Politi, MC (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,CB 8100, St Louis, MO 63110 USA.	mpoliti@wustl.edu		Politi, Mary/0000-0001-9103-6495; Madden, Tessa/0000-0001-9455-1943				Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; NationalWomen's Law Center, 2015, STAT BIRTH CONTR COV; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Sonfield A, SOCIAL EC BENEFITS W; Sonfield A, 2015, CONTRACEPTION, V91, P44, DOI 10.1016/j.contraception.2014.09.006; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; United States Department of Labor, 2019, FREQ ASK QUEST	7	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					653	654		10.1001/jama.2016.0204	http://dx.doi.org/10.1001/jama.2016.0204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26832953				2022-12-28	WOS:000370171500007
J	Gil, J; Withers, DJ				Gil, Jesus; Withers, Dominic J.			AGEING Out with the old	NATURE			English	Editorial Material							SENESCENT CELLS; SECRETORY PHENOTYPE; CELLULAR SENESCENCE; TRANSLATION; CLEARANCE; MICE		[Gil, Jesus; Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London W12 0NN, England	Imperial College London	Withers, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Hammersmith Campus, London W12 0NN, England.	d.withers@imperial.ac.uk	Withers, Dominic J/D-7671-2014; Gil, Jesus/C-7739-2012	Withers, Dominic J/0000-0002-8009-7521; Gil, Jesus/0000-0002-4303-6260	Biotechnology and Biological Sciences Research Council [BB/H020527/1, BB/H020527/2] Funding Source: Medline; Medical Research Council [MC_U120097114, MC_U120085810] Funding Source: Medline; Wellcome Trust [098565] Funding Source: Medline; BBSRC [BB/H020527/2] Funding Source: UKRI; MRC [MC_U120097114, MC_U120085810] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	11	11	12	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					164	165		10.1038/nature16875	http://dx.doi.org/10.1038/nature16875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840486	Green Accepted, Green Submitted			2022-12-28	WOS:000369916700024
J	Irvine, DJ				Irvine, Darrell J.			A Receptor for All Occasions	CELL			English	Editorial Material							NOTCH; IMMUNOTHERAPY	Cells communicate with their environment, in part, through cell surface receptors. Engineering receptors that both sense arbitrary inputs and provide outputs orthogonal to endogenous signaling pathways has been a challenge. Now, Lim and colleagues report a system based on synthetic Notch receptors that allows independent control of both inputs and outputs in diverse cell types.	[Irvine, Darrell J.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Harvard Univ, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	djirvine@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9	9	3	3	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					599	600		10.1016/j.cell.2016.01.030	http://dx.doi.org/10.1016/j.cell.2016.01.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871625	Bronze			2022-12-28	WOS:000369998300006
J	Morsut, L; Roybal, KT; Xiong, X; Gordley, RM; Coyle, SM; Thomson, M; Lim, WA				Morsut, Leonardo; Roybal, Kole T.; Xiong, Xin; Gordley, Russell M.; Coyle, Scott M.; Thomson, Matthew; Lim, Wendell A.			Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors	CELL			English	Article							SIGNALING PATHWAY; T-CELLS; ACTIVATION; EXPRESSION; DROSOPHILA; DYNAMICS; BIOLOGY; ORIGIN; DELTA	The Notch protein is one of the most mechanistically direct transmembrane receptors-the intracellular domain contains a transcriptional regulator that is released from the membrane when engagement of the cognate extracellular ligand induces intramembrane proteolysis. We find that chimeric forms of Notch, in which both the extracellular sensor module and the intracellular transcriptional module are replaced with heterologous protein domains, can serve as a general platform for generating novel cell-cell contact signaling pathways. Synthetic Notch (synNotch) pathways can drive user-defined functional responses in diverse mammalian cell types. Because individual synNotch pathways do not share common signaling intermediates, the pathways are functionally orthogonal. Thus, multiple synNotch receptors can be used in the same cell to achieve combinatorial integration of environmental cues, including Boolean response programs, multi-cellular signaling cascades, and self-organized cellular patterns. SynNotch receptors provide extraordinary flexibility in engineering cells with customized sensing/response behaviors to user-specified extracellular cues.	[Morsut, Leonardo; Roybal, Kole T.; Xiong, Xin; Gordley, Russell M.; Coyle, Scott M.; Thomson, Matthew; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Morsut, Leonardo; Roybal, Kole T.; Xiong, Xin; Gordley, Russell M.; Coyle, Scott M.; Thomson, Matthew; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Morsut, Leonardo; Roybal, Kole T.; Xiong, Xin; Gordley, Russell M.; Coyle, Scott M.; Lim, Wendell A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	wendell.lim@ucsf.edu			Jane Coffin Childs Memorial Fund Postdoctoral Fellowship [A121505]; Human Frontiers of Science Program (HFSP); European Molecular Biology Organization (EMBO) Postdoctoral Fellowship; NIH grants [K99 1K99EB021030, PN2 EY016546, P50GM081879, R01 GM055040, R01 CA196277]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA196277] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN1EY016546, PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB021030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM055040] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012194] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund Postdoctoral Fellowship; Human Frontiers of Science Program (HFSP); European Molecular Biology Organization (EMBO) Postdoctoral Fellowship; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank members of the Lim lab for helpful discussions and comments on the manuscript. We thank K. McNally and Joan Garbarino for technical assistance and R. Nicoll for neurons. This work was supported by a Jane Coffin Childs Memorial Fund Postdoctoral Fellowship A121505 (K.T.R.), a Human Frontiers of Science Program (HFSP), a European Molecular Biology Organization (EMBO) Postdoctoral Fellowship (L.M.), NIH grants K99 1K99EB021030 (L.M.), PN2 EY016546, P50GM081879, R01 GM055040, and R01 CA196277, and the Howard Hughes Medical Institute (W.A.L.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kopan R, 2002, J CELL SCI, V115, P1095; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lim W, 2014, CELL SIGNALING; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Matsuda M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002764; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Pratt EB, 2011, ACTA HISTOCHEM, V113, P248, DOI 10.1016/j.acthis.2010.01.006; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Webber MJ, 2015, ANN BIOMED ENG, V43, P641, DOI 10.1007/s10439-014-1104-7; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	32	438	480	15	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					780	791		10.1016/j.cell.2016.01.012	http://dx.doi.org/10.1016/j.cell.2016.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26830878	Bronze, Green Accepted			2022-12-28	WOS:000369998300022
J	Nair, S; Branagan, AR; Liu, J; Boddupalli, CS; Mistry, PK; Dhodapkar, MV				Nair, Shiny; Branagan, Andrew R.; Liu, Jun; Boddupalli, Chandra Sekhar; Mistry, Pramod K.; Dhodapkar, Madhav V.			Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAUCHER-DISEASE; MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; SOMATIC MUTATIONS; SEQUENCES REVEAL; LYSOPHOSPHOLIPIDS; PARAPROTEINS; INDUCTION; SELECTION; PATTERNS	Antigen-driven selection has been implicated in the pathogenesis of monoclonal gammopathies. Patients with Gaucher's disease have an increased risk of monoclonal gammopathies. Here we show that the clonal immunoglobulin in patients with Gaucher's disease and in mouse models of Gaucher's disease-associated gammopathy is reactive against lyso-glucosylceramide (LGL1), which is markedly elevated in these patients and mice. Clonal immunoglobulin in 33% of sporadic human monoclonal gammopathies is also specific for the lysolipids LGL1 and lysophosphatidylcholine (LPC). Substrate reduction ameliorates Gaucher's disease-associated gammopathy in mice. Thus, long-term immune activation by lysolipids may underlie both Gaucher's disease-associated gammopathies and some sporadic monoclonal gammopathies.	[Nair, Shiny; Branagan, Andrew R.; Boddupalli, Chandra Sekhar; Dhodapkar, Madhav V.] Yale Univ, Sch Med, Dept Med, Sect Hematol, New Haven, CT 06510 USA; [Liu, Jun; Mistry, Pramod K.] Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT USA; [Mistry, Pramod K.] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT USA; [Dhodapkar, Madhav V.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Dhodapkar, MV (corresponding author), Yale Univ, Dept Med & Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	madhav.dhodapkar@yale.edu		Branagan, Andrew/0000-0002-3868-9267	National Institutes of Health (NIH) [CA135110, CA106802, CA156689]; NIH [65932]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center of Excellence Grant in Clinical Translational Research from Genzyme; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA135110, R01CA106802, R01CA156689, R35CA197603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center of Excellence Grant in Clinical Translational Research from Genzyme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants (CA135110, CA106802, and CA156689) from the National Institutes of Health (NIH), by a grant (65932) from the NIH and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and by a Center of Excellence Grant in Clinical Translational Research from Genzyme.	ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; BAKKUS MHC, 1992, BLOOD, V80, P2326; BRAUN W, 1989, ELECTROPHORESIS, V10, P249, DOI 10.1002/elps.1150100406; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Grass S, 2011, BLOOD, V118, P635, DOI 10.1182/blood-2011-01-331454; Koduru S, 2012, BLOOD, V119, P2302, DOI 10.1182/blood-2011-08-376236; Landgren O, 2010, BLOOD, V116, P1056, DOI 10.1182/blood-2010-01-262394; Lwin ST, 2015, LEUKEMIA, V29, P507, DOI 10.1038/leu.2014.295; Mistry PK, 2015, JAMA-J AM MED ASSOC, V313, P695, DOI 10.1001/jama.2015.459; Mistry Pramod K., 2013, Critical Reviews in Oncogenesis, V18, P235; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Nair S, 2015, BLOOD, V125, P1256, DOI 10.1182/blood-2014-09-600270; NOOIJ FJM, 1990, J IMMUNOL METHODS, V134, P273, DOI 10.1016/0022-1759(90)90389-D; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pavlova EV, 2015, J PATHOL, V235, P113, DOI 10.1002/path.4452; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Preuss KD, 2015, J CLIN INVEST, V125, P316, DOI 10.1172/JCI76802; Preuss KD, 2009, INT J CANCER, V125, P656, DOI 10.1002/ijc.24427; Sahota SS, 1997, BLOOD, V89, P219, DOI 10.1182/blood.V89.1.219.219_219_226; Sahota SS, 1996, BLOOD, V87, P746, DOI 10.1182/blood.V87.2.746.bloodjournal872746; Sasagawa T, 1999, LIPIDS, V34, P17, DOI 10.1007/s11745-999-332-5; VESCIO RA, 1995, J IMMUNOL, V155, P2487; Zojer N, 2003, BLOOD, V101, P4137, DOI 10.1182/blood-2002-09-2825	24	119	119	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					555	561		10.1056/NEJMoa1508808	http://dx.doi.org/10.1056/NEJMoa1508808			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863356	Green Accepted, Bronze			2022-12-28	WOS:000369755800008
J	Lee, JS; Giesler, DL; Gellad, WF; Fine, MJ				Lee, Jonathan S.; Giesler, Daniel L.; Gellad, Walid F.; Fine, Michael J.			Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BETA-LACTAM MONOTHERAPY; QUALITY-OF-CARE; ELDERLY-PATIENTS; OUTCOMES; MORTALITY; LACTAM/MACROLIDE; AZITHROMYCIN; MANAGEMENT; CONSENSUS; SEVERITY	IMPORTANCE Antibiotic therapy is the cornerstone of medical management for community-acquired pneumonia. OBJECTIVE To assess the associations between 3 key aspects of antibiotic therapy (optimal time to antibiotic initiation, initial antibiotic selection, and criteria for the transition from intravenous to oral therapy) and short-term mortality in adults hospitalized with community-acquired pneumonia. EVIDENCE REVIEW Bibliographic databases of MEDLINE, EMBASE, and the Cochrane Collaboration were searched for studies of adults hospitalized with radiographically confirmed community-acquired pneumonia published from January 1, 1995, until November 5, 2015. FINDINGS Twenty studies (17 observational and 3 randomized trials) met eligibility criteria. Among 8 observational studies identified, the 4 largest (study populations of 2878 to 1 170 022) found that antibiotic initiation within 4 to 8 hours of hospital arrival was associated with relative reductions of 5% to 43% in mortality; the 4 smallest studies (study populations of 451 to 2076) found no associations between the timing of antibiotic initiation and mortality. One cluster randomized trial (n = 1737) demonstrated noninferiority of beta-lactam monotherapy (n = 506) vs beta-lactam plus macrolide combination therapy (n = 566), with an absolute adjusted difference of 2.5%(90% CI, -0.6% to 5.2%) in 90-day mortality favoring beta-lactam monotherapy. A second randomized trial (n = 580) failed to demonstrate noninferiority of beta-lactam monotherapy vs beta-lactam plus macrolide combination therapy, with an absolute difference of 7.6%(1-sided 90% CI upper limit, 13.0%) in attainment of clinical stability on hospital day 7 favoring beta-lactam plus macrolide combination therapy. Six of 8 observational studies (study populations of 1188 to 24 780) found that beta-lactam plus macrolide combination therapy was associated with relative reductions of 26% to 68% in short-term mortality and all 3 observational studies (study populations of 2068 to 24 780) reported that fluoroquinolone monotherapy was associated with relative reductions of 30% to 43% in mortality compared with beta-lactam monotherapy. One randomized trial (n = 302) reported significantly reduced hospital length of stay (absolute difference, 1.9 days; 95% CI, 0.6 to 3.2 days), but no differences in treatment failure when objective clinical criteria were used to decide when to transition patients from intravenous to oral therapy. CONCLUSIONS AND RELEVANCE In adults hospitalized with community-acquired pneumonia, antibiotic therapy consisting of beta-lactam plus macrolide combination therapy or fluoroquinolone monotherapy initiated within 4 to 8 hours of hospital arrival was associated with lower adjusted short-term mortality, supported predominantly by low-quality observational studies. One randomized trial supports the use of objective clinical criteria to guide the transition from intravenous to oral antibiotic therapy.	[Lee, Jonathan S.; Giesler, Daniel L.; Gellad, Walid F.; Fine, Michael J.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Lee, Jonathan S.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Gellad, Walid F.; Fine, Michael J.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Fine, MJ (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 151C Univ Dr,Bldg 30, Pittsburgh, PA 15240 USA.	michael.fine@va.gov						[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Athanassa Z, 2008, DRUGS, V68, P2469, DOI 10.2165/0003495-200868170-00005; Blasi F, 2008, EUR RESPIR J, V32, P902, DOI 10.1183/09031936.00092607; Bratzler DW, 2008, CLIN INFECT DIS, V47, pS193, DOI 10.1086/591404; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Eliakim-Raz Noa, 2012, Cochrane Database Syst Rev, pCD004418, DOI 10.1002/14651858.CD004418.pub4; Ewig S, 2011, J INFECTION, V62, P218, DOI 10.1016/j.jinf.2011.01.009; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Houck Peter M, 2005, Curr Opin Infect Dis, V18, P151, DOI 10.1097/01.qco.0000160905.94684.91; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lee JS, 2014, JAMA INTERN MED, V174, P1806, DOI 10.1001/jamainternmed.2014.4501; Lee JS, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.029; Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Mortensen EM, 2014, JAMA-J AM MED ASSOC, V311, P2199, DOI 10.1001/jama.2014.4304; Nie W, 2014, J ANTIMICROB CHEMOTH, V69, P1441, DOI 10.1093/jac/dku033; Oosterheert JJ, 2006, BMJ-BRIT MED J, V333, P1193, DOI 10.1136/bmj.38993.560984.BE; Paul M, 2007, EUR RESPIR J, V30, P525, DOI 10.1183/09031936.00031007; Pfuntner A, AGENCY HEALTHCARE RE; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Rodrigo C, 2013, THORAX, V68, P493, DOI 10.1136/thoraxjnl-2012-202296; Simonetti A, 2012, CLIN MICROBIOL INFEC, V18, P1149, DOI 10.1111/j.1469-0691.2011.03709.x; Tessmer A, 2009, J ANTIMICROB CHEMOTH, V63, P1025, DOI 10.1093/jac/dkp088; US Centers for Disease Control and Prevention, FASTSTATS LEAD CAUS; Vanderkooi OG, 2005, CLIN INFECT DIS, V40, P1288, DOI 10.1086/429242; Vazquez EG, 2005, EUR J CLIN MICROBIOL, V24, P190, DOI 10.1007/s10096-005-1295-9; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Waterer GW, 2006, CHEST, V130, P11, DOI 10.1378/chest.130.1.11; Yu KT, 2008, ANN EMERG MED, V51, P651, DOI 10.1016/j.annemergmed.2007.10.022	43	87	89	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					593	602		10.1001/jama.2016.0115	http://dx.doi.org/10.1001/jama.2016.0115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864413				2022-12-28	WOS:000369635200018
J	Hofkens, J; Roeffaers, MBJ				Hofkens, Johan; Roeffaers, Maarten B. J.			ELECTROCHEMISTRY Photocatalysts in close-up	NATURE			English	Editorial Material							CATALYSTS; WATER		[Hofkens, Johan] KU Leuven Univ, Dept Chem, B-3001 Heverlee, Belgium; [Roeffaers, Maarten B. J.] KU Leuven Univ, Dept Microbial & Mol Syst, B-3001 Heverlee, Belgium	KU Leuven; KU Leuven	Hofkens, J (corresponding author), KU Leuven Univ, Dept Chem, B-3001 Heverlee, Belgium.	johan.hofkens@chem.kuleuven.be; maarten.roeffaers@biw.kuleuven.be	Roeffaers, Maarten/AAB-8874-2020; Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/AAL-4204-2020; Hofkens, Johan/D-4284-2017	Roeffaers, Maarten/0000-0001-6582-6514; Hofkens, Johan/0000-0002-9101-0567				FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gamelin DR, 2012, NAT CHEM, V4, P965, DOI 10.1038/nchem.1514; Kim TW, 2014, SCIENCE, V343, P990, DOI 10.1126/science.1246913; Plessers E, 2015, ACS CATAL, V5, P6690, DOI 10.1021/acscatal.5b02119; Roeffaers MBJ, 2009, ANGEW CHEM INT EDIT, V48, P9285, DOI 10.1002/anie.200904944; Roeffaers MBJ, 2006, NATURE, V439, P572, DOI 10.1038/nature04502; Sambur JB, 2016, NATURE, V530, P77, DOI 10.1038/nature16534; Tachikawa T, 2011, J AM CHEM SOC, V133, P7197, DOI 10.1021/ja201415j; Zecevic J, 2015, NATURE, V528, P245, DOI 10.1038/nature16173; Zhou XC, 2012, NAT NANOTECHNOL, V7, P237, DOI [10.1038/nnano.2012.18, 10.1038/NNANO.2012.18]	10	13	13	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					36	37		10.1038/530036a	http://dx.doi.org/10.1038/530036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842050				2022-12-28	WOS:000369304500023
J	Pincus, Z				Pincus, Zachary			AGEING A stretch in time	NATURE			English	Editorial Material							CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS		[Pincus, Zachary] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Pincus, Zachary] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Pincus, Z (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.; Pincus, Z (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	zpincus@wustl.edu			NATIONAL INSTITUTE ON AGING [R00AG042487] Funding Source: NIH RePORTER; NIA NIH HHS [R00 AG042487] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gelino S., 2012, J CLIN EXP PATHOL, DOI DOI 10.4172/2161-0681.54-006; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirstein J, 2015, EMBO J, V34, P2334, DOI 10.15252/embj.201591711; Mitnitski A, 2015, BIOGERONTOLOGY; Stroustrup N, 2016, NATURE, V530, P103, DOI 10.1038/nature16550; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002	9	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					37	38		10.1038/nature16873	http://dx.doi.org/10.1038/nature16873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814974				2022-12-28	WOS:000369304500024
J	[Anonymous]				[Anonymous]			WHAT YOUR PATIENT IS THINKING "No small talk please, my baby's just died"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2016	352								i10	10.1136/bmj.i10	http://dx.doi.org/10.1136/bmj.i10			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD4RU	26846441	Bronze, Green Published			2022-12-28	WOS:000369911100001
J	Smith, JM				Smith, Jeanette M.			Symphony in Grey and Green: The Ocean	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		DORMENT R, 1995, JM WHISTLER, P1; SUTHERLAND DE, 2014, WHISTLER LIFE ARTS S, pR1	2	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					442	443		10.1001/jama.2015.14086	http://dx.doi.org/10.1001/jama.2015.14086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836716				2022-12-28	WOS:000369049500001
J	Gao, W; Emaminejad, S; Nyein, HYY; Challa, S; Chen, KV; Peck, A; Fahad, HM; Ota, H; Shiraki, H; Kiriya, D; Lien, DH; Brooks, GA; Davis, RW; Javey, A				Gao, Wei; Emaminejad, Sam; Nyein, Hnin Yin Yin; Challa, Samyuktha; Chen, Kevin; Peck, Austin; Fahad, Hossain M.; Ota, Hiroki; Shiraki, Hiroshi; Kiriya, Daisuke; Lien, Der-Hsien; Brooks, George A.; Davis, Ronald W.; Javey, Ali			Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis	NATURE			English	Article							SWEAT COMPOSITION; SKIN; LACTATE; EXERCISE; ELECTRONICS; POLYMER; DEVICES; DEHYDRATION; BIOSENSORS; PRESSURE	Wearable sensor technologies are essential to the realization of personalized medicine through continuously monitoring an individual's state of health(1-12). Sampling human sweat, which is rich in physiological information(13), could enable non-invasive monitoring. Previously reported sweat-based and other non-invasive biosensors either can only monitor a single analyte at a time or lack on-site signal processing circuitry and sensor calibration mechanisms for accurate analysis of the physiological state(14-18). Given the complexity of sweat secretion, simultaneous and multiplexed screening of target biomarkers is critical and requires full system integration to ensure the accuracy of measurements. Here we present a mechanically flexible and fully integrated (that is, no external analysis is needed) sensor array for multiplexed in situ perspiration analysis, which simultaneously and selectively measures sweat metabolites (such as glucose and lactate) and electrolytes (such as sodium and potassium ions), as well as the skin temperature (to calibrate the response of the sensors). Our work bridges the technological gap between signal transduction, conditioning (amplification and filtering), processing and wireless transmission in wearable biosensors by merging plastic-based sensors that interface with the skin with silicon integrated circuits consolidated on a flexible circuit board for complex signal processing. This application could not have been realized using either of these technologies alone owing to their respective inherent limitations. The wearable system is used to measure the detailed sweat profile of human subjects engaged in prolonged indoor and outdoor physical activities, and to make a real-time assessment of the physiological state of the subjects. This platform enables a wide range of personalized diagnostic and physiological monitoring applications.	[Gao, Wei; Emaminejad, Sam; Nyein, Hnin Yin Yin; Chen, Kevin; Fahad, Hossain M.; Ota, Hiroki; Shiraki, Hiroshi; Kiriya, Daisuke; Lien, Der-Hsien; Javey, Ali] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Gao, Wei; Emaminejad, Sam; Nyein, Hnin Yin Yin; Chen, Kevin; Fahad, Hossain M.; Ota, Hiroki; Shiraki, Hiroshi; Kiriya, Daisuke; Lien, Der-Hsien; Javey, Ali] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA; [Gao, Wei; Emaminejad, Sam; Nyein, Hnin Yin Yin; Chen, Kevin; Fahad, Hossain M.; Ota, Hiroki; Shiraki, Hiroshi; Kiriya, Daisuke; Lien, Der-Hsien; Javey, Ali] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Emaminejad, Sam; Challa, Samyuktha; Davis, Ronald W.] Stanford Genome Technol Ctr, Stanford Sch Med, Palo Alto, CA 94304 USA; [Peck, Austin; Brooks, George A.] Univ Calif Berkeley, Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; University of California System; University of California Berkeley	Javey, A (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.; Javey, A (corresponding author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.; Javey, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	ajavey@eecs.berkeley.edu	Javey, Ali/B-4818-2013; Ota, Hiroki/ACG-9374-2022; Gao, Wei/A-1347-2011; Lien, Der-Hsien/GYD-6547-2022	Javey, Ali/0000-0001-7214-7931; Gao, Wei/0000-0002-8503-4562; Lien, Der-Hsien/0000-0001-6774-2074; Ota, Hiroki/0000-0002-3702-6357; Brooks, George A./0000-0002-1389-1629	Berkeley Sensor and Actuator Center; National Institutes of Health [P01 HG000205]; Office of Science, Office of Basic Energy Sciences, Material Sciences and Engineering Division of the US Department of Energy [DE-AC02-05CH11231]; NSF Nanomanufacturing Systems for mobile Computing and Energy Technologies (NASCENT) Center; Japan Society for the Promotion of Science (JSPS) Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	Berkeley Sensor and Actuator Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, Material Sciences and Engineering Division of the US Department of Energy(United States Department of Energy (DOE)); NSF Nanomanufacturing Systems for mobile Computing and Energy Technologies (NASCENT) Center; Japan Society for the Promotion of Science (JSPS) Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The sensor design, characterization and testing aspects of this work were supported by the Berkeley Sensor and Actuator Center, and National Institutes of Health grant number P01 HG000205. The sensor fabrication was performed in the Electronic Materials (E-MAT) laboratory funded by the Director, Office of Science, Office of Basic Energy Sciences, Material Sciences and Engineering Division of the US Department of Energy under contract number DE-AC02-05CH11231. K.C. acknowledges funding from the NSF Nanomanufacturing Systems for mobile Computing and Energy Technologies (NASCENT) Center. H.O. acknowledges support from a Japan Society for the Promotion of Science (JSPS) Fellowship. We thank J. Bullock, C. M. Sutter-Fella, H. W. W. Nyein, Z. Shahpar, M. Zhou, E. Wu and W. Chen for their help.	Bandodkar AJ, 2015, ANAL CHEM, V87, P394, DOI 10.1021/ac504300n; Bandodkar AJ, 2014, TRENDS BIOTECHNOL, V32, P363, DOI 10.1016/j.tibtech.2014.04.005; Bandodkar AJ, 2014, BIOSENS BIOELECTRON, V54, P603, DOI 10.1016/j.bios.2013.11.039; Barr SI, 1999, CAN J APPL PHYSIOL, V24, P164, DOI 10.1139/h99-014; Bobacka J, 1999, ANAL CHEM, V71, P4932, DOI 10.1021/ac990497z; BOYSEN TC, 1984, J APPL PHYSIOL, V56, P1302, DOI 10.1152/jappl.1984.56.5.1302; Buono MJ, 2010, J PHYSIOL SCI, V60, P103, DOI 10.1007/s12576-009-0073-3; CAGE GW, 1970, J APPL PHYSIOL, V29, P687, DOI 10.1152/jappl.1970.29.5.687; Coyle S, 2010, IEEE T INF TECHNOL B, V14, P364, DOI 10.1109/TITB.2009.2038484; Derbyshire PJ, 2012, J PHYSIOL SCI, V62, P429, DOI 10.1007/s12576-012-0213-z; Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400; Guinovart T, 2014, ANAL CHIM ACTA, V821, P72, DOI 10.1016/j.aca.2014.02.028; Jia WZ, 2013, ANAL CHEM, V85, P6553, DOI 10.1021/ac401573r; Jobst G, 1996, ANAL CHEM, V68, P3173, DOI 10.1021/ac950630x; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kudo H, 2006, BIOSENS BIOELECTRON, V22, P558, DOI 10.1016/j.bios.2006.05.006; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI [10.1038/NPHOTON.2013.242, 10.1038/nphoton.2013.242]; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; McAlpine MC, 2007, NAT MATER, V6, P379, DOI 10.1038/nmat1891; Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013; Morgan RM, 2004, ACTA PHYSIOL SCAND, V182, P37, DOI 10.1111/j.1365-201X.2004.01305.x; NADEL ER, 1971, J APPL PHYSIOL, V31, P80, DOI 10.1152/jappl.1971.31.1.80; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1017/S0958067000020583; Rose DP, 2015, IEEE T BIO-MED ENG, V62, P1457, DOI 10.1109/TBME.2014.2369991; Schazmann B, 2010, ANAL METHODS-UK, V2, P342, DOI 10.1039/b9ay00184k; Sonner Z, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4921039; Speedy D B, 2001, Emerg Med (Fremantle), V13, P17, DOI 10.1046/j.1442-2026.2001.00173.x; Sprigle S, 2001, Adv Skin Wound Care, V14, P133, DOI 10.1097/00129334-200105000-00010; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Talary MS, 2007, J NON-CRYST SOLIDS, V353, P4515, DOI 10.1016/j.jnoncrysol.2007.03.038; Vimieiro-Gomes AC, 2005, BRAZ J MED BIOL RES, V38, P1133, DOI 10.1590/S0100-879X2005000700017; Wang C, 2013, NAT MATER, V12, P899, DOI [10.1038/NMAT3711, 10.1038/nmat3711]; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; Wu WZ, 2014, NATURE, V514, P470, DOI 10.1038/nature13792; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Zhu JW, 2009, ELECTROCHEM COMMUN, V11, P1684, DOI 10.1016/j.elecom.2009.06.025	39	2559	2630	383	4364	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					509	+		10.1038/nature16521	http://dx.doi.org/10.1038/nature16521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819044	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000368673800033
J	Gradinaru, V; Flytzanis, NC				Gradinaru, Viviana; Flytzanis, Nicholas C.			Fluorescent boost for voltage sensors	NATURE			English	Editorial Material							NEURONS		[Gradinaru, Viviana; Flytzanis, Nicholas C.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu						Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Flytzanis NC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5894; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Knopfel T, 2015, CURR OPIN CHEM BIOL, V27, P75, DOI 10.1016/j.cbpa.2015.06.006; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014	9	4	4	0	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					469	470		10.1038/529469a	http://dx.doi.org/10.1038/529469a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819038				2022-12-28	WOS:000368673800021
J	Molyneux, M				Molyneux, Malcolm			Ombudsman's report for 2015	LANCET			English	Editorial Material									[Molyneux, Malcolm] The Lancet, London EC2Y 5AS, England		Molyneux, M (corresponding author), The Lancet, London EC2Y 5AS, England.	ombudsman@lancet.com						Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	1	3	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					210	210		10.1016/S0140-6736(16)00034-9	http://dx.doi.org/10.1016/S0140-6736(16)00034-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26842280				2022-12-28	WOS:000368130700010
J	Luna-Zurita, L; Stirnimann, CU; Glatt, S; Kaynak, BL; Thomas, S; Baudin, F; Samee, MAH; He, D; Small, EM; Mileikovsky, M; Nagy, A; Holloway, AK; Pollard, KS; Muller, CW; Bruneau, BG				Luna-Zurita, Luis; Stirnimann, Christian U.; Glatt, Sebastian; Kaynak, Bogac L.; Thomas, Sean; Baudin, Florence; Samee, Md Abul Hassan; He, Daniel; Small, Eric M.; Mileikovsky, Maria; Nagy, Andras; Holloway, Alisha K.; Pollard, Katherine S.; Mueller, Christoph W.; Bruneau, Benoit G.			Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis	CELL			English	Article							CONGENITAL HEART-DISEASE; GENOME-WIDE ANALYSIS; HOLT-ORAM-SYNDROME; GENE-EXPRESSION; BINDING; TBX5; MUTATIONS; NKX2-5; MOUSE; COOPERATIVITY	Transcription factors (TFs) are thought to function with partners to achieve specificity and precise quantitative outputs. In the developing heart, heterotypic TF interactions, such as between the T-box TF TBX5 and the homeodomain TF NKX2-5, have been proposed as a mechanism for human congenital heart defects. We report extensive and complex interdependent genomic occupancy of TBX5, NKX2-5, and the zinc finger TF GATA4 coordinately controlling cardiac gene expression, differentiation, and morphogenesis. Interdependent binding serves not only to co-regulate gene expression but also to prevent TFs from distributing to ectopic loci and activate lineage-inappropriate genes. We define preferential motif arrangements for TBX5 and NKX2-5 cooperative binding sites, supported at the atomic level by their co-crystal structure bound to DNA, revealing a direct interaction between the two factors and induced DNA bending. Complex interdependent binding mechanisms reveal tightly regulated TF genomic distribution and define a combinatorial logic for heterotypic TF regulation of differentiation.	[Luna-Zurita, Luis; Kaynak, Bogac L.; Thomas, Sean; Samee, Md Abul Hassan; He, Daniel; Holloway, Alisha K.; Pollard, Katherine S.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Luna-Zurita, Luis; Kaynak, Bogac L.; He, Daniel; Bruneau, Benoit G.] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Stirnimann, Christian U.; Glatt, Sebastian; Baudin, Florence; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Baudin, Florence] UJF EMBL CNRS UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Small, Eric M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, 601 Elmwood Ave, Rochester, NY 14642 USA; [Mileikovsky, Maria; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Nagy, Andras] Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Holloway, Alisha K.; Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Stirnimann, Christian U.] ETH, NEXUS Personalized Hlth Technol, CH-8093 Zurich, Switzerland; [Glatt, Sebastian] Jagiellonian Univ Krakow, Max Planck Res Grp, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland	University of California System; University of California San Francisco; The J David Gladstone Institutes; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Rochester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Jagiellonian University	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.; Bruneau, BG (corresponding author), Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA.; Muller, CW (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; Bruneau, BG (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Bruneau, BG (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	cmueller@embl.de; benoit.bruneau@gladstone.ucsf.edu	Glatt, Sebastian/AAS-1230-2020; Zurita, Luis Luna/F-3718-2016; Zurita, Luis Luna/H-2259-2019; Nagy, Andras/G-6465-2013; Müller, Christoph W/I-7420-2012	Glatt, Sebastian/0000-0003-2815-7133; Zurita, Luis Luna/0000-0001-7515-1645; Zurita, Luis Luna/0000-0001-7515-1645; Nagy, Andras/0000-0003-4311-0413; Müller, Christoph W/0000-0003-2176-8337; Baudin, Florence/0000-0003-0816-0861; Stirnimann, Christian/0000-0002-1030-8864; Kaynak, Bogac/0000-0002-6946-9603; Samee, Md Abul Hassan/0000-0002-7472-1156	NIH/NHLBI [P01 HL089707, R01HL114948]; NHLBI Bench to Bassinet Program [U01HL098179/UM1HL098179]; California Institutes for Regenerative Medicine [RN2-00903]; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award; California Institutes for Regenerative Medicine fellowship; Marie Curie Framework Program 7; European Molecular Biology Organization long-term fellowship program; NIH/NCRR grant [C06 RR018928]; BioFulcrum: A Gladstone Institutes Enterprise; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, UM1HL098179, P01HL089707, R01HL114948] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI Bench to Bassinet Program; California Institutes for Regenerative Medicine; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award; California Institutes for Regenerative Medicine fellowship; Marie Curie Framework Program 7; European Molecular Biology Organization long-term fellowship program; NIH/NCRR grant; BioFulcrum: A Gladstone Institutes Enterprise; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Izumo for providing the Nkx2-5<SUP>lacZ/+</SUP> mice. We are grateful to P. Swinton (Gladstone Transgenic Core) for morula injections. We also thank L. Ta and R. Chadwick (Gladstone Genomics Core), A. Williams (Gladstone Bioinformatics Core), C. Miller (Gladstone Histology Core), D. Hawkins (Gladstone Summer Scholars Program), and G. Capitani (Paul Scherrer Institut, Switzerland) for technical support and G. Howard for editorial assistance. This work was funded by NIH/NHLBI P01 HL089707 and R01HL114948 (to B.G.B.), NHLBI Bench to Bassinet Program U01HL098179/UM1HL098179 (to B.G.B. and K.S.P.), the California Institutes for Regenerative Medicine (RN2-00903 (to B.G.B.), and the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award (to B.G.B). L.L.Z. was supported by a California Institutes for Regenerative Medicine fellowship. C.U.S. is grateful for financial support from Marie Curie Framework Program 7 and the European Molecular Biology Organization long-term fellowship program. This work was also supported by an NIH/NCRR grant (C06 RR018928) to the J. David Gladstone Institutes, by BioFulcrum: A Gladstone Institutes Enterprise, and by William H. Younger, Jr. (to B.G.B.).	Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li QY, 1997, NAT GENET, V15, P21; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Nagy A., 2003, MANIPULATING MOUSE E; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pradhan L, 2012, BIOCHEMISTRY-US, V51, P6312, DOI 10.1021/bi300849c; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	45	120	121	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					999	1014		10.1016/j.cell.2016.01.004	http://dx.doi.org/10.1016/j.cell.2016.01.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26875865	Green Accepted, Bronze			2022-12-28	WOS:000370867300022
J	Mitrano, M; Cantaluppi, A; Nicoletti, D; Kaiser, S; Perucchi, A; Lupi, S; Di Pietro, P; Pontiroli, D; Ricco, M; Clark, SR; Jaksch, D; Cavalleri, A				Mitrano, M.; Cantaluppi, A.; Nicoletti, D.; Kaiser, S.; Perucchi, A.; Lupi, S.; Di Pietro, P.; Pontiroli, D.; Ricco, M.; Clark, S. R.; Jaksch, D.; Cavalleri, A.			Possible light-induced superconductivity in K3C60 at high temperature	NATURE			English	Article							OPTICAL-PROPERTIES; DYNAMICS; TRANSPORT; MODEL	The non-equilibrium control of emergent phenomena in solids is an important research frontier, encompassing effects such as the optical enhancement of superconductivity(1). Nonlinear excitation(2,3) of certain phonons in bilayer copper oxides was recently shown to induce superconducting-like optical properties at temperatures far greater than the superconducting transition temperature, T-c (refs 4-6). This effect was accompanied by the disruption of competing charge-density-wave correlations(7,8), which explained some but not all of the experimental results. Here we report a similar phenomenon in a very different compound, K3C60. By exciting metallic K3C60 with mid-infrared optical pulses, we induce a large increase in carrier mobility, accompanied by the opening of a gap in the optical conductivity. These same signatures are observed at equilibrium when cooling metallic K3C60 below T-c (20 kelvin). Although optical techniques alone cannot unequivocally identify non-equilibrium high-temperature superconductivity, we propose this as a possible explanation of our results.	[Mitrano, M.; Cantaluppi, A.; Nicoletti, D.; Kaiser, S.; Clark, S. R.; Cavalleri, A.] Max Planck Inst Struct & Dynam Matter, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Cantaluppi, A.; Nicoletti, D.; Cavalleri, A.] Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Perucchi, A.; Di Pietro, P.] INSTM UdR Trieste ST, Area Sci Pk, I-34012 Trieste, Italy; [Perucchi, A.; Di Pietro, P.] Elettra Sincrotrone Trieste SCpA, Area Sci Pk, I-34012 Trieste, Italy; [Lupi, S.] Univ Roma La Sapienza, CNR IOM, Piazzale A Moro 2, I-00185 Rome, Italy; [Lupi, S.] Univ Roma La Sapienza, Dipartimento Fis, Piazzale A Moro 2, I-00185 Rome, Italy; [Pontiroli, D.; Ricco, M.] Univ Parma, Dipartimento Fis & Sci Terra, Parco Area Sci 7-A, I-43124 Parma, Italy; [Clark, S. R.] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; [Clark, S. R.; Jaksch, D.; Cavalleri, A.] Univ Oxford, Dept Phys, Parks Rd, Oxford OX1 3PU, England; [Jaksch, D.] Natl Univ Singapore, Ctr Quantum Technol, 3 Sci Dr 2, Singapore 117543, Singapore	Max Planck Society; University of Hamburg; Elettra Sincrotrone Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); Sapienza University Rome; Sapienza University Rome; University of Parma; University of Bath; University of Oxford; National University of Singapore	Cavalleri, A (corresponding author), Max Planck Inst Struct & Dynam Matter, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Cavalleri, A (corresponding author), Hamburg Ctr Ultrafast Imaging, Luruper Chaussee 149, D-22761 Hamburg, Germany.	andrea.cavalleri@mpsd.mpg.de	Kaiser, Stefan/B-7788-2008; Mitrano, Matteo/E-6774-2012; Bieridelov, Sam/AAV-3341-2021; Clark, Stephen R/G-5368-2012; Jaksch, Dieter/F-1964-2010; Ricco, Mauro/D-9376-2017; Pontiroli, Daniele/A-4543-2017	Kaiser, Stefan/0000-0001-9862-2788; Mitrano, Matteo/0000-0002-0102-0391; Bieridelov, Sam/0000-0003-0890-949X; Clark, Stephen R/0000-0002-2072-7499; Ricco, Mauro/0000-0002-6879-2687; Pontiroli, Daniele/0000-0002-9990-539X	European Research Council under the European Union [319286]; Deutsche Forschungsgemeinschaft via the excellence cluster 'The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale' [SFB925]; Swiss National Supercomputing Center (CSCS) [s497]	European Research Council under the European Union(European Research Council (ERC)); Deutsche Forschungsgemeinschaft via the excellence cluster 'The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale'(German Research Foundation (DFG)); Swiss National Supercomputing Center (CSCS)	We acknowledge S. Kivelson and A. Georges for discussion. We are also grateful to A. Subedi for sharing microscopic calculations of anharmonic mode coupling. We thank L. Degiorgi for sharing optical data measured on single crystals. Technical support during sample handling was provided by H.-P. Liermann and M. Wendt. We additionally acknowledge support from M. Gaboardi (for SQUID magnetometry) and from J. Harms (for graphics). The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement no. 319286 (QMAC). We acknowledge support from the Deutsche Forschungsgemeinschaft via the excellence cluster 'The Hamburg Centre for Ultrafast Imaging - Structure, Dynamics and Control of Matter at the Atomic Scale' and the priority program SFB925. This work was also supported by the Swiss National Supercomputing Center (CSCS) under the project ID s497.	ANTROPOV VP, 1992, PHYS REV B, V46, P13647, DOI 10.1103/PhysRevB.46.13647; Beard MC, 2001, J APPL PHYS, V90, P5915, DOI 10.1063/1.1416140; Capone M, 2002, SCIENCE, V296, P2364, DOI 10.1126/science.1071122; CHAKRAVARTY S, 1991, SCIENCE, V254, P970, DOI 10.1126/science.254.5034.970; CRUZ CHB, 1988, IEEE J QUANTUM ELECT, V24, P261, DOI 10.1109/3.122; DEGIORGI L, 1994, PHYS REV B, V49, P7012, DOI 10.1103/PhysRevB.49.7012; DEGIORGI L, 1995, MOD PHYS LETT B, V9, P445, DOI 10.1142/S0217984995000413; DEGIORGI L, 1994, NATURE, V369, P541, DOI 10.1038/369541a0; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Forst M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.184514; Forst M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.157002; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gunnarsson O., 2004, ALKALI DOPED FULLERI; Han JE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.167006; Hands ID, 2004, J CHEM PHYS, V120, P6912, DOI 10.1063/1.1683105; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; Hu W, 2014, NAT MATER, V13, P705, DOI [10.1038/nmat3963, 10.1038/NMAT3963]; Hunt CR, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.020505; IWASA Y, 1995, PHYS REV B, V51, P3678, DOI 10.1103/PhysRevB.51.3678; Kaiser S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184516; Kaiser S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03823; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kuzmenko AB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.116804; LAOUINI N, 1995, PHYS REV B, V51, P17446, DOI 10.1103/PhysRevB.51.17446; Lupi S, 2007, J OPT SOC AM B, V24, P959, DOI 10.1364/JOSAB.24.000959; Mankowsky R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.094308; Mankowsky R, 2014, NATURE, V516, P71, DOI 10.1038/nature13875; Nicoletti D., 2015, ARXIV150606758; Orenstein J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.134507; PLASKETT JS, 1963, J CHEM PHYS, V38, P612, DOI 10.1063/1.1733714; SCHLUTER M, 1992, PHYS REV LETT, V68, P526, DOI 10.1103/PhysRevLett.68.526; Singla R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.187401; STEPHENS PW, 1991, NATURE, V351, P632, DOI 10.1038/351632a0; Subedi A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220301; Togo A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134106; VARMA CM, 1991, SCIENCE, V254, P989, DOI 10.1126/science.254.5034.989; XIANG XD, 1992, SCIENCE, V256, P1190, DOI 10.1126/science.256.5060.1190; ZIMMERMANN W, 1991, PHYSICA C, V183, P99, DOI 10.1016/0921-4534(91)90771-P	40	458	462	11	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					461	+		10.1038/nature16522	http://dx.doi.org/10.1038/nature16522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26855424	Green Submitted, Green Accepted			2022-12-28	WOS:000370690800031
J	He, Y; Zeng, MY; Yang, DH; Metro, B; Nunez, G				He, Yuan; Zeng, Melody Y.; Yang, Dahai; Metro, Benny; Nunez, Gabriel			NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux	NATURE			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; PROTEIN-KINASES; CASPASE-11; CYTOKINESIS; MUTATIONS; IMMUNITY; INNATE; FAMILY; TOXINS; CELLS	Inflammasomes are intracellular protein complexes that drive the activation of inflammatory caspases(1). So far, four inflammasomes involving NLRP1, NLRP3, NLRC4 and AIM2 have been described that recruit the common adaptor protein ASC to activate caspase-1, leading to the secretion of mature IL-1 beta and IL-18 proteins(2,3). The NLRP3 inflammasome has been implicated in the pathogenesis of several acquired inflammatory diseases(4,5) as well as cryopyrin-associated periodic fever syndromes (CAPS) caused by inherited NLRP3 mutations(6,7). Potassium efflux is a common step that is essential for NLRP3 inflammasome activation induced by many stimuli(8,9). Despite extensive investigation, the molecular mechanism leading to NLRP3 activation in response to potassium efflux remains unknown. Here we report the identification of NEK7, a member of the family of mammalian NIMA-related kinases (NEK proteins)(10), as an NLRP3-binding protein that acts downstream of potassium efflux to regulate NLRP3 oligomerization and activation. In the absence of NEK7, caspase-1 activation and IL-1 beta release were abrogated in response to signals that activate NLRP3, but not NLRC4 or AIM2 inflammasomes. NLRP3-activating stimuli promoted the NLRP3-NEK7 interaction in a process that was dependent on potassium efflux. NLRP3 associated with the catalytic domain of NEK7, but the catalytic activity of NEK7 was shown to be dispensable for activation of the NLRP3 inflammasome. Activated macrophages formed a high-molecular-mass NLRP3-NEK7 complex, which, along with ASC oligomerization and ASC speck formation, was abrogated in the absence of NEK7. NEK7 was required for macrophages containing the CAPS-associated NLRP3(R258W) activating mutation to activate caspase-1. Mouse chimaeras reconstituted with wild-type, Nek7(-/-) or Nlrp3(-/-) haematopoietic cells showed that NEK7 was required for NLRP3 inflammasome activation in vivo. These studies demonstrate that NEK7 is an essential protein that acts downstream of potassium efflux to mediate NLRP3 inflammasome assembly and activation.	[He, Yuan; Zeng, Melody Y.; Yang, Dahai; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [He, Yuan; Zeng, Melody Y.; Yang, Dahai; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yang, Dahai] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Metro, Benny] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; East China University of Science & Technology; Bar Ilan University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.; Nunez, G (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014		NIH [T32HL007517, T32DK094775, R01AI063331, R01DK091191]; China Scholarship Council [201306740018]; Israel Science Foundation [768/11]; University of Michigan's Cancer Center Support Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R37AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, T32DK094775, R01DK091191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Israel Science Foundation(Israel Science Foundation); University of Michigan's Cancer Center Support Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Munoz-Planillo for potassium efflux assays, S. Varadarajan for plasmid construction, L. Burmeister for animal husbandry, J. Whitfield for ELISA assays, and V. Basrur for mass spectrometry analysis. Y.H. was supported by NIH training grant T32HL007517. M.Y.Z. was supported by NIH training grants T32HL007517 and T32DK094775. D.Y. was supported by the State Scholarship Fund from China Scholarship Council (no. 201306740018). This work was supported by NIH grants R01AI063331 and R01DK091191 to G.N., research funds by the Israel Science Foundation (grant no. 768/11) to B.M., and funds to the Michigan Comprehensive Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shi H., 2015, NATURE IMMUNOL; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	35	594	624	15	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					354	+		10.1038/nature16959	http://dx.doi.org/10.1038/nature16959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26814970	Green Accepted			2022-12-28	WOS:000370327100041
J	Akram, Q; Chinoy, H				Akram, Qasim; Chinoy, Hector			Scalp Necrosis Associated with Giant-Cell Arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Akram, Qasim; Chinoy, Hector] Salford Royal Fdn Trust, Manchester, Lancs, England	Salford Royal NHS Foundation Trust	Akram, Q (corresponding author), Salford Royal Fdn Trust, Manchester, Lancs, England.	qasim.akram.qa@gmail.com	Chinoy, Hector/C-7832-2013	Chinoy, Hector/0000-0001-6492-1288	National Institute for Health Research [CL-2006-06-010] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					E6	E6		10.1056/NEJMicm1505378	http://dx.doi.org/10.1056/NEJMicm1505378			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863373				2022-12-28	WOS:000369755800011
J	Shen, JR				Shen, Jian-Ren			CRYSTALLOGRAPHY Resolution beyond the diffraction limit	NATURE			English	Editorial Material									[Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynthesis Res Ctr, Okayama 7008530, Japan	Okayama University	Shen, JR (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Photosynthesis Res Ctr, Tsushima Naka 3-1-1, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp	Shen, Jian-Ren/B-2558-2011					Ayyer K, 2016, NATURE, V530, P202, DOI 10.1038/nature16949; Bragg WL, 1914, P CAMB PHILOS SOC, V17, P43; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; Elser V, 2008, ACTA CRYSTALLOGR A, V64, P273, DOI 10.1107/S0108767307050684; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Perez J, 1996, ACTA CRYSTALLOGR D, V52, P722, DOI 10.1107/S0907444996002594; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Welberry TR, 2011, ACTA CRYSTALLOGR B, V67, P516, DOI 10.1107/S0108768111037542	10	0	0	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					168	169		10.1038/530168a	http://dx.doi.org/10.1038/530168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863978				2022-12-28	WOS:000369916700027
J	Weissman, IL; Gage, FH				Weissman, Irving L.; Gage, Fred H.			A Mechanism for Somatic Brain Mosaicism	CELL			English	Editorial Material							NEUROGENESIS; GENERATION; DIVERSITY	Double-strand break repair is required for neural development, and brain cells contain somatic genomic variations. Now, Wei et al. demonstrate that neural stem and progenitor cells undergo very frequent DNA breaks in a very restricted set of genes involved in neural cell adhesion and synapse function.	[Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Stanford University; Salk Institute	Gage, FH (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu; gage@salk.edu						Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; TONEGAWA S, 1988, IN VITRO CELL DEV B, V24, P253; Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039; Weissman IL, 2015, P NATL ACAD SCI USA, V112, P8922, DOI 10.1073/pnas.1505464112; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	9	19	19	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					593	595		10.1016/j.cell.2016.01.048	http://dx.doi.org/10.1016/j.cell.2016.01.048			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871622	Bronze			2022-12-28	WOS:000369998300003
J	Callaway, E				Callaway, Ewen			ARCHITECTURE The Crick Institute unpeeled	NATURE			English	Editorial Material																		2015, NATURE, V522, P406; 2015, NATURE, V518, P464	2	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					32	32		10.1038/530032a	http://dx.doi.org/10.1038/530032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842044	Bronze			2022-12-28	WOS:000369304500017
J	Gee, H				Gee, Henry			PHYLOGENY A home for Xenoturbella	NATURE			English	Editorial Material																		Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Rouse GW, 2016, NATURE, V530, P94, DOI 10.1038/nature16545	2	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					43	43		10.1038/530043a	http://dx.doi.org/10.1038/530043a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842053				2022-12-28	WOS:000369304500028
J	Wagner, EF				Wagner, Erwin F.			CANCER Fibroblasts for all seasons	NATURE			English	Editorial Material							COLITIS-ASSOCIATED CANCER; IKK-BETA; TUMORIGENESIS; INFLAMMATION		[Wagner, Erwin F.] Natl Canc Res Ctr CNIO, Dept Canc Cell Biol, E-28029 Madrid, Spain		Wagner, EF (corresponding author), Natl Canc Res Ctr CNIO, Dept Canc Cell Biol, E-28029 Madrid, Spain.	ewagner@cnio.es		Wagner, Erwin F/0000-0001-7872-0196				Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Koliaraki V, 2015, J EXP MED, V212, P2235, DOI 10.1084/jem.20150542; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pallangyo CK, 2015, J EXP MED, V212, P2253, DOI 10.1084/jem.20150576	9	27	27	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					42	43		10.1038/530042a	http://dx.doi.org/10.1038/530042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842052				2022-12-28	WOS:000369304500027
J	Ceccarelli, M; Barthel, FP; Malta, TM; Sabedot, TS; Salama, SR; Murray, BA; Morozova, O; Newton, Y; Radenbaugh, A; Pagnotta, SM; Anjum, S; Wang, JG; Manyam, G; Zoppoli, P; Ling, S; Rao, AA; Grifford, M; Cherniack, AD; Zhang, HL; Poisson, L; Carlotti, CG; Tirapelli, DPD; Rao, A; Mikkelsen, T; Lau, CC; Yung, WKA; Rabadan, R; Huse, J; Brat, DJ; Lehman, NL; Barnholtz-Sloan, JS; Zheng, S; Hess, K; Rao, G; Meyerson, M; Beroukhim, R; Cooper, L; Akbani, R; Wrensch, M; Haussler, D; Aldape, KD; Laird, PW; Gutmann, DH; Noushmehr, H; Iavarone, A; Verhaak, RGW				Ceccarelli, Michele; Barthel, Floris P.; Malta, Tathiane M.; Sabedot, Thais S.; Salama, Sofie R.; Murray, Bradley A.; Morozova, Olena; Newton, Yulia; Radenbaugh, Amie; Pagnotta, Stefano M.; Anjum, Samreen; Wang, Jiguang; Manyam, Ganiraju; Zoppoli, Pietro; Ling, Shiyun; Rao, Arjun A.; Grifford, Mia; Cherniack, Andrew D.; Zhang, Hailei; Poisson, Laila; Carlotti, Carlos Gilberto, Jr.; Tirapelli, Daniela Pretti da Cunha; Rao, Arvind; Mikkelsen, Tom; Lau, Ching C.; Yung, W. K. Alfred; Rabadan, Raul; Huse, Jason; Brat, Daniel J.; Lehman, Norman L.; Barnholtz-Sloan, Jill S.; Zheng, Siyuan; Hess, Kenneth; Rao, Ganesh; Meyerson, Matthew; Beroukhim, Rameen; Cooper, Lee; Akbani, Rehan; Wrensch, Margaret; Haussler, David; Aldape, Kenneth D.; Laird, Peter W.; Gutmann, David H.; Noushmehr, Houtan; Iavarone, Antonio; Verhaak, Roel G. W.		TCGA Res Network	Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma	CELL			English	Article							TERT PROMOTER MUTATIONS; PILOCYTIC ASTROCYTOMA; GENOMIC ANALYSIS; BRAIN-TUMORS; GRADE II; GLIOBLASTOMA; EXPRESSION; CANCER; CELLS; IDH1	Therapy development for adult diffuse glioma is hindered by incomplete knowledge of somatic glioma driving alterations and suboptimal disease classification. We defined the complete set of genes associated with 1,122 diffuse grade II-III-IV gliomas from The Cancer Genome Atlas and used molecular profiles to improve disease classification, identify molecular correlations, and provide insights into the progression from low- to high-grade disease. Whole-genome sequencing data analysis determined that ATRX but not TERT promoter mutations are associated with increased telomere length. Recent advances in glioma classification based on IDH mutation and 1p/19q co-deletion status were recapitulated through analysis of DNA methylation profiles, which identified clinically relevant molecular subsets. A subtype of IDH mutant glioma was associated with DNA demethylation and poor outcome; a group of IDH-wild-type diffuse glioma showed molecular similarity to pilocytic astrocytoma and relatively favorable survival. Understanding of cohesive disease groups may aid improved clinical outcomes.	[Ceccarelli, Michele; Anjum, Samreen] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, POB 5825, Doha, Qatar; [Ceccarelli, Michele; Pagnotta, Stefano M.] Univ Sannio, Dept Sci & Technol, I-82100 Benevento, Italy; [Barthel, Floris P.; Manyam, Ganiraju; Ling, Shiyun; Rao, Arvind; Yung, W. K. Alfred; Zheng, Siyuan; Hess, Kenneth; Rao, Ganesh; Akbani, Rehan; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Dept Bioinformat & Computat Biol,Dept Neurosurg, Dept Genom Med,Dept Biostat,Dept Neurooncol, Houston, TX 77030 USA; [Barthel, Floris P.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Oncol Grad Sch Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Malta, Tathiane M.; Sabedot, Thais S.; Carlotti, Carlos Gilberto, Jr.; Tirapelli, Daniela Pretti da Cunha; Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Dept Genet CISBi NAP, BR-14049900 Ribeirao Preto, SP, Brazil; [Malta, Tathiane M.; Sabedot, Thais S.; Carlotti, Carlos Gilberto, Jr.; Tirapelli, Daniela Pretti da Cunha; Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Integrat Syst Biol CISBi, NAP USP, BR-14049900 Ribeirao Preto, SP, Brazil; [Salama, Sofie R.; Morozova, Olena; Newton, Yulia; Radenbaugh, Amie; Rao, Arjun A.; Grifford, Mia; Haussler, David] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA; [Murray, Bradley A.; Cherniack, Andrew D.; Zhang, Hailei; Meyerson, Matthew; Beroukhim, Rameen] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Murray, Bradley A.; Cherniack, Andrew D.; Zhang, Hailei; Meyerson, Matthew; Beroukhim, Rameen] Harvard Univ, Cambridge, MA 02142 USA; [Pagnotta, Stefano M.] BIOGEM Ist Ric Genetiche G Salvatore, I-83031 Campo Reale, Ariano Irpino, Italy; [Wang, Jiguang; Zoppoli, Pietro; Rabadan, Raul; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Syst Biol & Biomed Informat, Dept Neurol,Dept Pathol,Inst Canc Genet, New York, NY 10032 USA; [Poisson, Laila; Mikkelsen, Tom] Henry Ford Hosp, Detroit, MI 48202 USA; [Lau, Ching C.] Childrens Hosp, Houston, TX 77030 USA; [Lau, Ching C.] Baylor Coll Med, Houston, TX 77030 USA; [Huse, Jason] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Brat, Daniel J.; Cooper, Lee] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Lehman, Norman L.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Meyerson, Matthew; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Wrensch, Margaret] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA; [Aldape, Kenneth D.] Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Laird, Peter W.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Gutmann, David H.] Washington Univ, Sch Med, St Louis, MO 63110 USA	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; University of Sannio; University of Texas System; UTMD Anderson Cancer Center; Vrije Universiteit Amsterdam; Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California Santa Cruz; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Columbia University; Henry Ford Health System; Henry Ford Hospital; Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Emory University; University System of Ohio; Ohio State University; Case Western Reserve University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Van Andel Institute; Washington University (WUSTL)	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Dept Bioinformat & Computat Biol,Dept Neurosurg, Dept Genom Med,Dept Biostat,Dept Neurooncol, Houston, TX 77030 USA.; Noushmehr, H (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Dept Genet CISBi NAP, BR-14049900 Ribeirao Preto, SP, Brazil.; Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol & Biomed Informat, Dept Neurol,Dept Pathol,Inst Canc Genet, New York, NY 10032 USA.	houtan@usp.br; ai2102@columbia.edu; rverhaak@mdanderson.org	Lehman, Norman L/A-7351-2015; Silva, Tiago Chedraoui/AAD-2280-2020; Barthel, Floris P/AHC-3558-2022; Perou, Charles M/H-9934-2014; Marra, Marco A/B-5987-2008; Manyam, Ganiraju/E-9150-2012; Tirapelli, Daniela PC/F-9230-2012; Ostrom, Quinn/F-1820-2018; Ceccarelli, Michele/AGP-1739-2022; Yung, W.K. Alfred/W-5016-2019; Hess, Kenneth/K-6546-2019; Miller, Ryan/B-9365-2008; Jones, Steven J/C-3621-2009; Laird, Peter W/G-8683-2012; Seth, Sahil/I-5809-2019; Zheng, sy/GRS-3136-2022; Manyam, Ganiraju C/B-5890-2014; Carlotti, Carlos G/C-1608-2012; D'Angelo, Fulvio/AAG-9788-2020; Zoppoli, Pietro/J-9954-2018; Cherniack, Andrew D./AAY-8132-2020; Cherniack, Andrew/AAC-5310-2019; Salama, Sofie/K-6412-2019; Chedraoui Silva, Tiago/S-1449-2017; Akbani, Rehan/AAG-1490-2019; Barthel, Floris P/I-4653-2014; N, Houtan/C-9692-2013; Malta, Tathiane/N-1686-2013; Rao, Arjun Arkal/M-6591-2019; Barnholtz-Sloan, Jill/A-4817-2011; Van Den Berg, David J/G-8598-2017; Rabadan, Raul/AAZ-7367-2020; Verhaak, Roel/ABE-7058-2020; Sarraf Sabedot, Thais/J-2349-2016; Mungall, Andrew J./U-7067-2018; Coetzee, Simon/C-1218-2014; Wang, Jiguang/B-2717-2012; Garofano, Luciano/ABI-7602-2022	Barthel, Floris P/0000-0002-7425-4180; Perou, Charles M/0000-0001-9827-2247; Marra, Marco A/0000-0001-7146-7175; Manyam, Ganiraju/0000-0001-6006-8961; Tirapelli, Daniela PC/0000-0002-1886-4988; Ostrom, Quinn/0000-0003-3469-7558; Hess, Kenneth/0000-0003-1377-6070; Miller, Ryan/0000-0002-0096-8762; Jones, Steven J/0000-0003-3394-2208; Laird, Peter W/0000-0001-9117-3641; Seth, Sahil/0000-0003-4579-3959; Carlotti, Carlos G/0000-0002-7055-0564; D'Angelo, Fulvio/0000-0002-4940-4693; Zoppoli, Pietro/0000-0002-7860-9655; Cherniack, Andrew D./0000-0003-0470-0111; Chedraoui Silva, Tiago/0000-0003-1343-6850; Barthel, Floris P/0000-0002-7425-4180; N, Houtan/0000-0003-4051-8114; Malta, Tathiane/0000-0003-1129-5791; Rao, Arjun Arkal/0000-0003-4480-3190; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Van Den Berg, David J/0000-0002-5404-5218; Mungall, Andrew J./0000-0002-0905-2742; Coetzee, Simon/0000-0003-4267-5930; Bowen, Jay/0000-0001-6861-9043; Meyerson, Matthew/0000-0002-9133-8108; Heiman, David/0000-0001-7895-4259; Black, Keith/0000-0002-0546-4934; Iavarone, Antonio/0000-0002-0683-4634; Gutmann, David/0000-0002-3127-5045; Hoadley, Katherine/0000-0002-1216-477X; Vaske, Olena/0000-0002-1677-417X; Park, Peter/0000-0001-9378-960X; Auman, James/0000-0002-9328-8829; Wang, Jiguang/0000-0002-6923-4097; PAGNOTTA, Stefano Maria/0000-0002-8298-9777; Ceccarelli, Michele/0000-0002-4702-6617; Bootwalla, Moiz/0000-0001-6158-7114; Salama, Sofie/0000-0001-6999-7193; Rabadan, Raul/0000-0001-7946-9255; Triche, Tim/0000-0001-5665-946X; Zheng, Siyuan/0000-0002-1031-9424; Mieczkowski, Piotr/0000-0003-2418-0096; Weinstein, John/0000-0001-9401-6908; Garofano, Luciano/0000-0001-8582-0865	NIH [U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003067, U54HG003079, U54HG003273]; Cancer Prevention & Research Institute of Texas (CPRIT) [R140606]; Sao Paulo Research Foundation (FAPESP) [2014/02245-3, 2015/07925-5, 2015/02844-7, 2015/08321-3]; Novartis; Bayer;  [U24CA126543];  [U24CA126544];  [U24CA126546];  [U24CA126551];  [U24CA126554];  [U24CA126561];  [U24CA126563];  [U24CA143731];  [U24CA143843];  [P30CA016672];  [P50 CA127001];  [U54CA193313];  [R01CA179044];  [R01CA185486];  [R01 CA190121];  [P01 CA085878]; NATIONAL CANCER INSTITUTE [P01CA085878, U24CA126561, U24CA143866, U24CA143840, U24CA126546, U54CA193313, U24CA143883, U24CA143835, U24CA126554, R01CA052689, R01CA188743, U24CA143848, R01CA176659, U24CA144025, U24CA143845, U24CA126563, U24CA126544, U24CA143858, P30CA016672, U24CA143799, U24CA126543, F30CA192725, R01CA190121, P30CA008748, P50CA127001, U24CA143882, U24CA126551, P50CA097257, U24CA180951, U24CA143867, R01CA185486, U24CA143843, R01CA179044] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG007990, U54HG003079, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas (CPRIT); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Novartis(Novartis); Bayer(Bayer AG); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grants U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA126544, U24CA126546, U24CA126551, U24CA126554, U24CA126561, U24CA126563, U24CA143731, U24CA143843, P30CA016672, P50 CA127001, U54CA193313, R01CA179044, R01CA185486, R01 CA190121, and P01 CA085878; Cancer Prevention & Research Institute of Texas (CPRIT) R140606; and Sao Paulo Research Foundation (FAPESP) 2014/02245-3, 2015/07925-5, 2015/02844-7, and 2015/08321-3. D.J.W. is a consultant for Zymo Research Corporation. R.B. is a consultant for and received grant funding from Novartis. A.D.C. and M.M. received grant support from Bayer.	Bailey ML, 2014, MOL CANCER THER, V13, P724, DOI 10.1158/1535-7163.MCT-13-0749; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chi AS, 2013, J CLIN ONCOL, V31, pE233, DOI 10.1200/JCO.2012.46.0220; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Kurscheid S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0583-7; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Mur P, 2013, ACTA NEUROPATHOL, V126, P277, DOI 10.1007/s00401-013-1130-9; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olar A, 2015, ACTA NEUROPATHOL, V129, P585, DOI 10.1007/s00401-015-1398-z; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Peters J.-M., 2012, PERSPECT BIOL, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A011130; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P867, DOI 10.1007/s00401-015-1438-8; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612	41	1155	1177	2	188	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					550	563		10.1016/j.cell.2015.12.028	http://dx.doi.org/10.1016/j.cell.2015.12.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824661	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000368906800023
J	Quarta, C; Schneider, R; Tschop, MH				Quarta, Carmelo; Schneider, Robert; Tschoep, Matthias H.			Epigenetic ON/OFF Switches for Obesity	CELL			English	Editorial Material							MICE	Heritable epigenetic mechanisms might contribute to the worldwide increase in the prevalence of obesity. Dalgaard et al. identify an epigenetic molecular switch that controls body weight control. The discovery suggests the existence of mammalian polyphenism in energy metabolism and might have implications for strategies to limit the obesity epidemic.	[Quarta, Carmelo; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany; [Quarta, Carmelo; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, German Diabet Ctr DZD, D-85764 Neuherberg, Germany; [Quarta, Carmelo; Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany; [Schneider, Robert] Helmholtz Zentrum Munchen, Inst Funct Epigenet, D-85764 Neuherberg, Germany; [Schneider, Robert] IGBMC, F-67400 Illkirch Graffenstaden, France	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, German Diabet Ctr DZD, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany.	tschoep@helmholtz-muenchen.de	Quarta, Carmelo/AAC-1629-2020	Quarta, Carmelo/0000-0002-1352-4239; Tschoep, Matthias/0000-0002-4744-371X				Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111; Cleaton MAM, 2014, ANNU REV GENOM HUM G, V15, P93, DOI 10.1146/annurev-genom-091212-153441; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Desai M, 2015, INT J OBESITY, V39, P633, DOI 10.1038/ijo.2015.13; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Donkin I, 2015, CELL METAB; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008	8	16	16	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					341	342		10.1016/j.cell.2016.01.006	http://dx.doi.org/10.1016/j.cell.2016.01.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824648	Bronze			2022-12-28	WOS:000368906800003
J	Smock, RG; Yadid, I; Dym, O; Clarke, J; Tawfik, DS				Smock, Robert G.; Yadid, Itamar; Dym, Orly; Clarke, Jane; Tawfik, Dan S.			De Novo Evolutionary Emergence of a Symmetrical Protein Is Shaped by Folding Constraints	CELL			English	Article							BETA-PROPELLER LECTINS; RECONSTRUCTION; DESIGN; ARCHITECTURE; MUTATIONS; KINETICS; STATE	Molecular evolution has focused on the divergence of molecular functions, yet we know little about how structurally distinct protein folds emerge de novo. We characterized the evolutionary trajectories and selection forces underlying emergence of b-propeller proteins, a globular and symmetric fold group with diverse functions. The identification of short propeller- like motifs (< 50 amino acids) in natural genomes indicated that they expanded via tandem duplications to form extant propellers. We phylogenetically reconstructed 47-residue ancestral motifs that form five-bladed lectin propellers via oligomeric assembly. We demonstrate a functional trajectory of tandemduplications of these motifs leading to monomeric lectins. Foldability, i.e., higher efficiency of folding, was the main parameter leading to improved functionality along the entire evolutionary trajectory. However, folding constraints changed along the trajectory: initially, conflicts between monomer folding and oligomer assembly dominated, whereas subsequently, upon tandem duplication, tradeoffs between monomer stability and foldability took precedence.	[Smock, Robert G.; Dym, Orly; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Yadid, Itamar] Migal Galilee Res Inst, Metab Pathways & Enzyme Evolut Lab, IL-11016 Kiryat Shmona, Israel; [Clarke, Jane] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Weizmann Institute of Science; University of Cambridge	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	dan.tawfik@weizmann.ac.il			Israel Science Foundation [980/14]; Weizmann-UK Joint Research Program; Weizmann Koshland and Dean of Faculty fellowships; EMBO short-term fellowship; MRC [MC_U105485808] Funding Source: UKRI	Israel Science Foundation(Israel Science Foundation); Weizmann-UK Joint Research Program; Weizmann Koshland and Dean of Faculty fellowships; EMBO short-term fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Michael Gurevitz (Tel Aviv University), John Finnerty (Boston University), and Adam Reitzel (Woodshole Oceanographic Institute) for providing N. vectensis cDNA and Joseph Rogers (University of Cambridge) for discussion and assistance. We thank Liam Longo, Ron Milo, and Balaji Santhanam for insightful comments on this manuscript. This work was supported by the Israel Science Foundation grant 980/14 (D.S.T.), the Weizmann-UK Joint Research Program (D.S.T. and J.C.), the Weizmann Koshland and Dean of Faculty fellowships (R.G.S.), and an EMBO short-term fellowship (R.G.S.). J.C. is a Wellcome Trust Fellow (WT 095195).	Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Balaji S, 2015, CURR OPIN STRUC BIOL, V32, P156, DOI 10.1016/j.sbi.2015.05.004; Bar-Rogovsky H, 2015, PROTEIN ENG DES SEL, V28, P507, DOI 10.1093/protein/gzv038; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Broom A, 2015, PROTEIN SCI, V24, P580, DOI 10.1002/pro.2606; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Claren J, 2009, P NATL ACAD SCI USA, V106, P3704, DOI 10.1073/pnas.0810342106; Gillespie B, 2000, P NATL ACAD SCI USA, V97, P12014, DOI 10.1073/pnas.97.22.12014; Hingorani KS, 2014, CURR OPIN STRUC BIOL, V24, P81, DOI 10.1016/j.sbi.2013.11.007; Hocker B, 2014, CURR OPIN STRUC BIOL, V27, P56, DOI 10.1016/j.sbi.2014.04.007; Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074; Larson SM, 2003, J MOL BIOL, V332, P275, DOI 10.1016/S0022-2836(03)00832-5; Lee J, 2011, P NATL ACAD SCI USA, V108, P126, DOI 10.1073/pnas.1015032108; Longo LM, 2014, METHODS MOL BIOL, V1216, P161, DOI 10.1007/978-1-4939-1486-9_8; Longo LM, 2013, STRUCTURE, V21, P2042, DOI 10.1016/j.str.2013.09.003; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Nepomnyachiy S, 2014, P NATL ACAD SCI USA, V111, P11691, DOI 10.1073/pnas.1403395111; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Park K, 2015, NAT STRUCT MOL BIOL, V22, P167, DOI 10.1038/nsmb.2938; Peisajovich SG, 2006, NAT GENET, V38, P168, DOI 10.1038/ng1717; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VELLIEUX FMD, 1989, EMBO J, V8, P2171, DOI 10.1002/j.1460-2075.1989.tb08339.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Voet ARD, 2014, P NATL ACAD SCI USA, V111, P15102, DOI 10.1073/pnas.1412768111; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Yadid I, 2011, PROTEIN ENG DES SEL, V24, P185, DOI 10.1093/protein/gzq053; Yadid I, 2010, P NATL ACAD SCI USA, V107, P7287, DOI 10.1073/pnas.0912616107; Zheng WH, 2013, P NATL ACAD SCI USA, V110, P1680, DOI 10.1073/pnas.1222130110	35	66	68	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					476	486		10.1016/j.cell.2015.12.024	http://dx.doi.org/10.1016/j.cell.2015.12.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26806127	Green Published, hybrid			2022-12-28	WOS:000368906800017
J	Mervis, J				Mervis, Jeffrey			Caltech suspends professor for harassment	SCIENCE			English	News Item																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					216	216		10.1126/science.351.6270.216	http://dx.doi.org/10.1126/science.351.6270.216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816359				2022-12-28	WOS:000368098600015
J	Hofer, TP; Sussman, JB; Hayward, RA				Hofer, Timothy P.; Sussman, Jeremy B.; Hayward, Rodney A.			New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vet Affairs Ctr Clin Management Res, Ctr Innovat, Hlth Serv Res & Dev Serv, Ann Arbor, MI 48109 USA; Univ Michigan, Ann Arbor, MI 48109 USA; [Hofer, Timothy P.; Sussman, Jeremy B.] Vet Affairs Ctr Clin Management Res, Inst Hlth Policy & Innovat, North Campus Res Complex,Bldg 16-328W, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Inst Hlth Policy & Innovat, Natl Clinician Scholars Program, North Campus Res Complex,Bldg 10,Room G016, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hofer, TP (corresponding author), Vet Affairs Ctr Clin Management Res, Inst Hlth Policy & Innovat, North Campus Res Complex,Bldg 16-328W, Ann Arbor, MI 48109 USA.	thofer@umich.edu	Hofer, Timothy Philip/AAC-9238-2022; Sussman, Jeremy/W-3394-2019	Sussman, Jeremy/0000-0002-2158-3618; Hofer, Timothy/0000-0003-0434-8787	NIDDK NIH HHS [P60 DK020572] Funding Source: Medline; HSRD VA [IK2 HX001368] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HSRD VA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beasley D, 2015, REUTERS         0810; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Hayward RA, 2014, CIRC-CARDIOVASC QUAL, V7, P311, DOI 10.1161/CIRCOUTCOMES.114.000876; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Sauser Kori, 2015, Evid Based Med, V20, P162, DOI 10.1136/ebmed-2015-110170; Steenhuysen J, 2014, REUTERS         1121; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894	10	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					683	+		10.7326/M15-2428	http://dx.doi.org/10.7326/M15-2428			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26857151				2022-12-28	WOS:000375878500016
J	Mlakar, J; Korva, M; Tul, N; Popovic, M; Poljsak-Prijatelj, M; Mraz, J; Kolenc, M; Rus, KR; Vipotnik, TV; Vodusek, VF; Vizjak, A; Pizem, J; Petrovec, M; Zupanc, TA				Mlakar, Jernej; Korva, Misa; Tul, Natasa; Popovic, Mara; Poljsak-Prijatelj, Mateja; Mraz, Jerica; Kolenc, Marko; Rus, Katarina Resman; Vipotnik, Tina Vesnaver; Vodusek, Vesna Fabjan; Vizjak, Alenka; Pizem, Joze; Petrovec, Miroslav; Zupanc, Tatjana Avsic			Zika Virus Associated with Microcephaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								A widespread epidemic of Zika virus (ZIKV) infection was reported in 2015 in South and Central America and the Caribbean. A major concern associated with this infection is the apparent increased incidence of microcephaly in fetuses born to mothers infected with ZIKV. In this report, we describe the case of an expectant mother who had a febrile illness with rash at the end of the first trimester of pregnancy while she was living in Brazil. Ultrasonography performed at 29 weeks of gestation revealed microcephaly with calcifications in the fetal brain and placenta. After the mother requested termination of the pregnancy, a fetal autopsy was performed. Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation. ZIKV was found in the fetal brain tissue on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, with consistent findings on electron microscopy. The complete genome of ZIKV was recovered from the fetal brain.	[Mlakar, Jernej; Popovic, Mara; Mraz, Jerica; Vizjak, Alenka; Pizem, Joze] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia; [Korva, Misa; Poljsak-Prijatelj, Mateja; Kolenc, Marko; Rus, Katarina Resman; Petrovec, Miroslav; Zupanc, Tatjana Avsic] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia; [Tul, Natasa; Vodusek, Vesna Fabjan] Univ Med Ctr Ljubljana, Dept Perinatol, Div Gynecol & Obstet, Ljubljana, Slovenia; [Vipotnik, Tina Vesnaver] Univ Med Ctr Ljubljana, Inst Radiol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana; University Medical Centre Ljubljana	Zupanc, TA (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.	tatjana.avsic@mf.uni-ij.si		Korva, Misa/0000-0003-1501-1004				Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5; [Anonymous], 2015, RAP RISK ASS ZIK VIR; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Goldsmith CS, 2013, EMERG INFECT DIS, V19, P886, DOI 10.3201/eid1906.130173; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Macdonald EM, 2015, INT J PEDIAT, V2015, DOI [10.1155/2014/291846, 10.1155/2015/181257]; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729	19	1635	1744	11	867	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					951	958		10.1056/NEJMoa1600651	http://dx.doi.org/10.1056/NEJMoa1600651			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26862926				2022-12-28	WOS:000371660000008
J	Heuckeroth, RO				Heuckeroth, Robert O.			Stem cells make the bowel nervous	NATURE			English	Editorial Material							HIRSCHSPRUNG DISEASE; SYSTEM; DISORDERS	In Hirschsprung disease, the enteric nervous system (ENS) is missing from the distal bowel. It emerges that postnatal transplantation of stem-cell-derived ENS precursors can prevent death in a mouse model of the disease.	[Heuckeroth, Robert O.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Heuckeroth, Robert O.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Heuckeroth, RO (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.; Heuckeroth, RO (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	heuckerothr@email.chop.edu						Avetisyan M, 2015, J CLIN INVEST, V125, P899, DOI 10.1172/JCI76307; Burkardt DD, 2014, CLIN PEDIATR, V53, P71, DOI 10.1177/0009922813500846; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Heuckeroth RO, 2013, PEDIAT NEUROGASTROEN, P271; Kunze WAA, 1999, ANNU REV PHYSIOL, V61, P117, DOI 10.1146/annurev.physiol.61.1.117; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Neunlist M, 2014, J PHYSIOL-LONDON, V592, P2959, DOI 10.1113/jphysiol.2014.272948; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249	11	7	7	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					44	45		10.1038/nature16877	http://dx.doi.org/10.1038/nature16877			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26863191				2022-12-28	WOS:000371211900036
J	Steinke, S; van Tilborg, J; Benedetti, C; Geddes, CGR; Schroeder, CB; Daniels, J; Swanson, KK; Gonsalves, AJ; Nakamura, K; Matlis, NH; Shaw, BH; Esarey, E; Leemans, WP				Steinke, S.; van Tilborg, J.; Benedetti, C.; Geddes, C. G. R.; Schroeder, C. B.; Daniels, J.; Swanson, K. K.; Gonsalves, A. J.; Nakamura, K.; Matlis, N. H.; Shaw, B. H.; Esarey, E.; Leemans, W. P.			Multistage coupling of independent laser-plasma accelerators	NATURE			English	Article							ELECTRON-BEAMS; INTENSITY; PHYSICS; PULSES	Laser-plasma accelerators (LPAs) are capable of accelerating charged particles to very high energies in very compact structures(1). In theory, therefore, they offer advantages over conventional, large-scale particle accelerators. However, the energy gain in a single-stage LPA can be limited by laser diffraction, dephasing, electron-beam loading and laser-energy depletion(1). The problem of laser diffraction can be addressed by using laser-pulse guiding(2) and preformed plasma waveguides to maintain the required laser intensity over distances of many Rayleigh lengths(3); dephasing can be mitigated by longitudinal tailoring of the plasma density(4); and beam loading can be controlled by proper shaping of the electron beam(5). To increase the beam energy further, it is necessary to tackle the problem of the depletion of laser energy, by sequencing the accelerator into stages, each powered by a separate laser pulse(6). Here, we present results from an experiment that demonstrates such staging. Two LPA stages were coupled over a short distance (as is needed to preserve the average acceleration gradient) by a plasma mirror. Stable electron beams from a first LPA were focused to a twenty-micrometre radius-by a discharge capillary-based(7) active plasma lens(8)-into a second LPA, such that the beams interacted with the wakefield excited by a separate laser. Staged acceleration by the wakefield of the second stage is detected via an energy gain of 100 megaelectronvolts for a subset of the electron beam. Changing the arrival time of the electron beam with respect to the second-stage laser pulse allowed us to reconstruct the temporal wakefield structure and to determine the plasma density. Our results indicate that the fundamental limitation to energy gain presented by laser depletion can be overcome by using staged acceleration, suggesting a way of reaching the electron energies required for collider applications(6,9).	[Steinke, S.; van Tilborg, J.; Benedetti, C.; Geddes, C. G. R.; Schroeder, C. B.; Daniels, J.; Swanson, K. K.; Gonsalves, A. J.; Nakamura, K.; Matlis, N. H.; Shaw, B. H.; Esarey, E.; Leemans, W. P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Swanson, K. K.; Shaw, B. H.; Leemans, W. P.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Daniels, J.] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Eindhoven University of Technology	Leemans, WP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	wpleemans@lbl.gov	Steinke, Sven/D-8086-2011	Steinke, Sven/0000-0003-0507-698X; Schroeder, Carl/0000-0002-9610-0166; Gonsalves, Anthony/0000-0002-2567-7582; Nakamura, Kei/0000-0001-9842-7114	US Department of Energy, Office of Science, Office of High Energy Physics [DE-AC02-05CH11231]; US Department of Energy National Nuclear Security Administration, Defense Nuclear Nonproliferation RD [NA22]; National Science Foundation (NSF) [0917687, 0935197, PHY-1415596]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Office of High Energy Physics(United States Department of Energy (DOE)); US Department of Energy National Nuclear Security Administration, Defense Nuclear Nonproliferation RD(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	We thank S. Shiraishi and T. Sokollik for their contributions to the initial construction of the set-up and an early version of the experiment, as well as C. Toth, D. Syversrud, N. Ybarrolaza, M. Kirkpatrick, G. Mannino, T. Sipla, D. Evans, R. Duarte, D. Baum and D. Munson for their contributions. This work was supported by the US Department of Energy, Office of Science, Office of High Energy Physics, under contract no. DE-AC02-05CH11231; by the US Department of Energy National Nuclear Security Administration, Defense Nuclear Nonproliferation R&D (NA22); and by the National Science Foundation (NSF) under contracts 0917687, 0935197, and PHY-1415596. This research used computational resources (Edison, Hopper) of the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231.	Amiranoff F, 1998, PHYS REV LETT, V81, P995, DOI 10.1103/PhysRevLett.81.995; Andreev NE, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/045024; Benedetti C, 2010, AIP CONF PROC, V1299, P250, DOI 10.1063/1.3520323; Benedetti C, 2012, P 11 INT COMP ACC PH; Chen M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3689922; DURFEE CG, 1993, PHYS REV LETT, V71, P2409, DOI 10.1103/PhysRevLett.71.2409; Ellis J, 2001, NATURE, V409, P431, DOI 10.1038/35053224; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Faure J, 2006, NATURE, V444, P737, DOI 10.1038/nature05393; Faure J, 2004, NATURE, V431, P541, DOI 10.1038/nature02963; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; Gonsalves AJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.025002; Gonsalves AJ, 2011, NAT PHYS, V7, P862, DOI [10.1038/nphys2071, 10.1038/NPHYS2071]; Kim HT, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.165002; Leemans WP, 2006, NAT PHYS, V2, P696, DOI 10.1038/nphys418; Leemans WP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.245002; Leemans W, 2009, PHYS TODAY, V62, P44, DOI 10.1063/1.3099645; Liu JS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.035001; Mangles SPD, 2004, PHYS SCRIPTA, VT107, P121, DOI 10.1238/Physica.Topical.107a00121; Nakamura K, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.062801; Nakamura K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2929672; Plateau GR, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3360889; Powers ND, 2014, NAT PHOTONICS, V8, P29, DOI [10.1038/NPHOTON.2013.314, 10.1038/nphoton.2013.314]; Rittershofer W, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3430638; Rowlands-Rees TP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.105005; Schroeder CB, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4849456; Schroeder CB, 2010, PHYS REV SPEC TOP-AC, V13, DOI 10.1103/PhysRevSTAB.13.101301; Shiraishi S, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4810802; Sokollik T, 2010, AIP CONF PROC, V1299, P233, DOI 10.1063/1.3520320; Spence DJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.015401; Thaury C, 2007, NAT PHYS, V3, P424, DOI 10.1038/nphys595; van Tilborg J, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.184802; Vay JL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3663841; Wang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2988	34	185	193	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					190	+		10.1038/nature16525	http://dx.doi.org/10.1038/nature16525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26829223	Green Submitted			2022-12-28	WOS:000369916700032
J	Williamson, P				Williamson, Phil			Scrutinize CO2 removal methods	NATURE			English	Editorial Material							CARBON		[Williamson, Phil] NERC, London, England; [Williamson, Phil] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of East Anglia	Williamson, P (corresponding author), NERC, London, England.	p.williamson@uea.ac.uk						Agee E, 2013, J APPL METEOROL CLIM, V52, P281, DOI 10.1175/JAMC-D-12-0110.1; CBD Secretariat, 2015, UPD CLIM GEOENG REL; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gough C., 2015, SYNTHESISING EXISTIN; Keller DP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4304; N'Yeurt AD, 2012, PROCESS SAF ENVIRON, V90, P467, DOI 10.1016/j.psep.2012.10.008; National Research Council, 2015, CLIM INT CARB DIOX R, DOI [10.17226/18805, DOI 10.17226/18805]; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Smith P., 2016, GLOB CHANGE BIOL; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Taylor L. L., 2015, NATURE CLIM CHANGE; Williamson P, 2012, PROCESS SAF ENVIRON, V90, P475, DOI 10.1016/j.psep.2012.10.007; Wiltshire A, 2015, AVOID	14	165	167	5	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					153	155		10.1038/530153a	http://dx.doi.org/10.1038/530153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863967	Bronze			2022-12-28	WOS:000369916700014
J	Tanksley, AL; Wolfson, RK; Arora, VM				Tanksley, Audrey L.; Wolfson, Rachel K.; Arora, Vineet M.			Changing the "Working While Sick" Culture Promoting Fitness for Duty in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS	Reasons Why Physicians and Advanced Practice Clinicians Work While Sick: A Mixed-Methods Analysis Julia E. Szymczak, PhD; Sarah Smathers, MPH, CIC; Cindy Hoegg, RN, CIC; Sarah Klieger, MPH; Susan E. Coffin, MD, MPH; Julia S. Sammons, MD, MSCE IMPORTANCE When clinicians work with symptoms of infection, they can put patients and colleagues at risk. Little is known about the reasons why attending physicians and advanced practice clinicians (APCs) work while sick. OBJECTIVE To identify a comprehensive understanding of the reasons why attending physicians and APCs work while sick. DESIGN, SETTING, AND PARTICIPANTS We performed a mixed-methods analysis of a cross-sectional, anonymous survey administered from January 15 through March 20, 2014, in a large children's hospital in Philadelphia, Pennsylvania. Data were analyzed from April 1 through June 1, 2014. The survey was administered to 459 attending physicians and 470 APCs, including certified registered nurse practitioners, physician assistants, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives. MAIN OUTCOMES AND MEASURES Self-reported frequency of working while experiencing symptoms of infection, perceived importance of various factors that encourage working while sick, and free-text comments written in response to open-ended questions. RESULTS Of those surveyed, we received responses from 280 attending physicians (61.0%) and 256 APCs (54.5%). Most of the respondents (504 [95.3%]) believed that working while sick put patients at risk. Despite this belief, 446 respondents (83.1%) reported working sick at least 1 time in the past year, and 50(9.3%) reported working while sick at least 5 times. Respondents would work with significant symptoms, including diarrhea (161[30.0%]), fever (86 [16.0%]), and acute onset of significant respiratory symptoms (299 [55.6%]). Physicians were more likely to report working with each of these symptoms than APCs (109[38.9%] vs 51 [19.9%], 61 [21.8%] vs 25 [9.8%], and 168 [60.0%] vs 130 [50.8%], respectively [P < .05]). Reasons deemed important in deciding to work while sick included not wanting to let colleagues down(521[98.7%]), staffing concerns(505[94.9%]), not wanting to let patients down(494[92.5%]), fear of ostracism by colleagues (342[64.0%]), and concern about continuity of care(337[63.8%]). Systematic qualitative analysis of free-text comments from 316 respondents revealed additional reasons why attending physicians and APCs work while sick, including extreme difficulty finding coverage (205 [64.9%]), a strong cultural norm to come to work unless remarkably ill (193 [61.1%]), and ambiguity about what constitutes "too sick to work" (180 [57.0%]). CONCLUSIONS AND RELEVANCE Attending physicians and APCs frequently work while sick despite recognizing that this choice puts patients at risk. The decision to work sick is shaped by systems-level and sociocultural factors. Multimodal interventions are needed to reduce the frequency of this behavior. JAMA Pediatr. 2015;169(9):815-821. doi:10.1001/jamapediatrics.2015.0684	[Tanksley, Audrey L.; Arora, Vineet M.] Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2007 AMB W216, Chicago, IL 60637 USA; [Wolfson, Rachel K.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Arora, VM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2007 AMB W216, Chicago, IL 60637 USA.	varora@uchicago.edu		Arora, Vineet/0000-0002-4745-7599				Accreditation Council for Graduate Medical Education, FREQ ASK QUEST ACGME; [Anonymous], ADV CIRC FITN DUT; Arora VM, 2012, JAMA-J AM MED ASSOC, V308, P2195, DOI 10.1001/jama.2012.14584; Houston S., IM SAFE CHECKLIST PI; Jena AB, 2010, JAMA-J AM MED ASSOC, V304, P1166, DOI 10.1001/jama.2010.1315; Szymczak JE, 2015, JAMA PEDIATR, V169, P815, DOI 10.1001/jamapediatrics.2015.0684	6	8	8	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					603	+		10.1001/jama.2016.0094	http://dx.doi.org/10.1001/jama.2016.0094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864414				2022-12-28	WOS:000369635200019
J	Cavalli, F				Cavalli, Franco			Tackling cancer: time for a global response	LANCET			English	Editorial Material									[Cavalli, Franco] Oncol Inst Southern Switzerland, CH-6500 Bellinzona, Switzerland	Institute of Oncology Research (IOR)	Cavalli, F (corresponding author), Oncol Inst Southern Switzerland, CH-6500 Bellinzona, Switzerland.	franco.cavalli@eoc.ch						Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Bray F, 2015, DIS CONTROL PRIORITI, V3, P23, DOI DOI 10.1596/978-1-4648-0349-9CH2; Cavalli F, 2015, LANCET ONCOL, V16, P133, DOI 10.1016/S1470-2045(15)70012-4; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; European School of Oncology, WORLD ONC FOR; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2; Horton R, 2015, LANCET, V386, P2378, DOI 10.1016/S0140-6736(15)01178-2; Horton S, 2015, CANC DIS CONTROL PRI; Pauli P, 2015, BESTMASTERS, P1; Subbiah V, 2015, JAMA ONCOL, V1, P253, DOI 10.1001/jamaoncol.2014.289; Wagstaff A., 2015, CANC WORLD, V65, P36; WHO, 2011, SCAL ACT NONC DIS MU	14	4	4	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					E13	E14		10.1016/S0140-6736(16)00233-6	http://dx.doi.org/10.1016/S0140-6736(16)00233-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26852262				2022-12-28	WOS:000369835800001
J	Oliver, D				Oliver, David			David Oliver: Doctors need intergenerational solidarity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						BMA, CONS CONTR NEG CONS; Hall LE, 2005, DICT MULTICULTURAL P; Hopkins C, 2016, GUARDIAN; Howker E, 2010, JILLED GENERATION BR; Lawson D, 2016, SUNDAY TIMES; Lintern S, 2016, HLTH SERV J; Spence D., 2016, BMJ; Willetts D., 2010, PINCH BABY BOOMERS T	8	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2016	352								i724	10.1136/bmj.i724	http://dx.doi.org/10.1136/bmj.i724			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3EV	26850455	Bronze, Green Published			2022-12-28	WOS:000369805400007
J	Pillay, S; Meyer, NL; Puschnik, AS; Davulcu, O; Diep, J; Ishikawa, Y; Jae, LT; Wosen, JE; Nagamine, CM; Chapman, MS; Carette, JE				Pillay, S.; Meyer, N. L.; Puschnik, A. S.; Davulcu, O.; Diep, J.; Ishikawa, Y.; Jae, L. T.; Wosen, J. E.; Nagamine, C. M.; Chapman, M. S.; Carette, J. E.			An essential receptor for adeno-associated virus infection	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; ENTRY REQUIRES; GENE-THERAPY; TRANSDUCTION; ENDOCYTOSIS; CORECEPTOR; EXPRESSION; TRANSPORT; RETROMER; VECTORS	Adeno-associated virus (AAV) vectors are currently the leading candidates for virus-based gene therapies because of their broad tissue tropism, non-pathogenic nature and low immunogenicity(1). They have been successfully used in clinical trials to treat hereditary diseases such as haemophilia B (ref. 2), and have been approved for treatment of lipoprotein lipase deficiency in Europe(3). Considerable efforts have been made to engineer AAV variants with novel and biomedically valuable cell tropisms to allow efficacious systemic administration(1,4), yet basic aspects of AAV cellular entry are still poorly understood. In particular, the protein receptor(s) required for AAV entry after cell attachment remains unknown. Here we use an unbiased genetic screen to identify proteins essential for AAV serotype 2 (AAV2) infection in a haploid human cell line. The most significantly enriched gene of the screen encodes a previously uncharacterized type I transmembrane protein, KIAA0319L (denoted hereafter as AAV receptor (AAVR)). We characterize AAVR as a protein capable of rapid endocytosis from the plasma membrane and trafficking to the trans-Golgi network. We show that AAVR directly binds to AAV2 particles, and that anti-AAVR antibodies efficiently block AAV2 infection. Moreover, genetic ablation of AAVR renders a wide range of mammalian cell types highly resistant to AAV2 infection. Notably, AAVR serves as a critical host factor for all tested AAV serotypes. The importance of AAVR for in vivo gene delivery is further highlighted by the robust resistance of Aavr(-/-) (also known as Au040320(-/-) and Kiaa0319l(-/-)) mice to AAV infection. Collectively, our data indicate that AAVR is a universal receptor involved in AAV infection.	[Pillay, S.; Puschnik, A. S.; Diep, J.; Wosen, J. E.; Carette, J. E.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, 299 Campus Dr, Stanford, CA 94305 USA; [Meyer, N. L.; Davulcu, O.; Ishikawa, Y.; Chapman, M. S.] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA; [Ishikawa, Y.] Shriners Hosp Children, 3101 Sam Jackson Pk Rd, Portland, OR 97239 USA; [Jae, L. T.] Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Nagamine, C. M.] Stanford Univ, Dept Comparat Med, Sch Med, 287 Campus Dr, Stanford, CA 94305 USA	Stanford University; Oregon Health & Science University; Netherlands Cancer Institute; Stanford University	Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, 299 Campus Dr, Stanford, CA 94305 USA.; Chapman, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	chapmami@ohsu.edu; carette@stanford.edu	Jae, Lucas/AAH-5342-2020; Jae, Lucas/AAY-3438-2021	Jae, Lucas/0000-0002-3531-1760; Carette, Jan/0000-0002-5187-8070; Chapman, Michael/0000-0001-8525-8585; Puschnik, Andreas/0000-0002-9605-9458; Ishikawa, Yoshihiro/0000-0003-2013-0518	NIH [R01 GM066875, DP2 AI104557, U19 AI109662]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, DP2AI104557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank K. Kirkegaard, M. Kay and T. Brummelkamp for critical reading of the manuscript and valuable advice; T. Lerch, J. Tyner, D. Kabat and H. Nakai for assistance with preliminary experiments; H. P. Bachinger for advice and assistance with surface plasmon resonance experiments; Stanford Shared FACS facility and its staff; X. Ji (Stanford Functional Genomics Facility); Stanford mouse facility; T. Doyle for small animal imaging training; L. Popov for guidance in generating immunofluorescent images; G. Fuchs for technical assistance; and members of the Carette and Chapman laboratories for intellectual discussions and support. The work was funded in part by NIH R01 GM066875 (M.S.C.), DP2 AI104557 (J.E.C.) and U19 AI109662 (J.E.C.). J.E.C. is a David and Lucile Packard Foundation fellow.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhella D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0035; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Ellis BL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-74; Gaudet D, 2012, CURR OPIN LIPIDOL, V23, P310, DOI 10.1097/MOL.0b013e3283555a7e; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; Holster S., 2013, J BIOCH MOL BIOL POS, V2, P45; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	32	238	249	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					108	+		10.1038/nature16465	http://dx.doi.org/10.1038/nature16465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814968	Green Accepted			2022-12-28	WOS:000369304500042
J	Sambur, JB; Chen, TY; Choudhary, E; Chen, GQ; Nissen, EJ; Thomas, EM; Zou, NM; Chen, P				Sambur, Justin B.; Chen, Tai-Yen; Choudhary, Eric; Chen, Guanqun; Nissen, Erin J.; Thomas, Elayne M.; Zou, Ningmu; Chen, Peng			Sub-particle reaction and photocurrent mapping to optimize catalyst-modified photoanodes	NATURE			English	Article							PHOTOELECTROCHEMICAL WATER OXIDATION; OXYGEN-EVOLVING CATALYST; SURFACE-STATES; TIO2; ELECTRODES; PHOTOELECTROLYSIS; ELECTROCATALYSIS; PHOTOCATALYSIS; PARTICLES; HETEROGENEITIES	The splitting of water photoelectrochemically into hydrogen and oxygen represents a promising technology for converting solar energy to fuel(1,2). The main challenge is to ensure that photogenerated holes efficiently oxidize water, which generally requires modification of the photoanode with an oxygen evolution catalyst (OEC) to increase the photocurrent and reduce the onset potential(3). However, because excess OEC material can hinder light absorption and decrease photoanode performance(4), its deposition needs to be carefully controlled-yet it is unclear which semiconductor surface sites give optimal improvement if targeted for OEC deposition, and whether sites catalysing water oxidation also contribute to competing charge-carrier recombination with photogenerated electrons(5). Surface heterogeneity(6) exacerbates these uncertainties, especially for nanostructured photoanodes benefiting from small charge-carrier transport distances(1,7,8). Here we use super-resolution imaging(9-13), operated in a charge-carrier-selective manner and with a spatiotemporal resolution of approximately 30 nanometres and 15 milliseconds, to map both the electron-and hole-driven photoelectrocatalytic activities on single titanium oxide nanorods. We then map, with sub-particle resolution (about 390 nanometres), the photocurrent associated with water oxidation, and find that the most active sites for water oxidation are also the most important sites for charge-carrier recombination. Site-selective deposition of an OEC, guided by the activity maps, improves the overall performance of a given nanorod-even though more improvement in photocurrent efficiency correlates with less reduction in onset potential (and vice versa) at the sub-particle level. Moreover, the optimal catalyst deposition sites for photocurrent enhancement are the lower-activity sites, and for onset potential reduction the optimal sites are the sites with more positive onset potential, contrary to what is obtainable under typical deposition conditions. These findings allow us to suggest an activity-based strategy for rationally engineering catalyst-improved photoelectrodes, which should be widely applicable because our measurements can be performed for many different semiconductor and catalyst materials.	[Sambur, Justin B.; Chen, Tai-Yen; Choudhary, Eric; Chen, Guanqun; Zou, Ningmu; Chen, Peng] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Nissen, Erin J.] Colorado Mesa Univ, Dept Chem, Grand Junction, CO 81501 USA; [Thomas, Elayne M.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Choudhary, Eric] NIST, Ctr Nanosci & Technol, Gaithersburg, MD 20899 USA	Cornell University; University of Michigan System; University of Michigan; National Institute of Standards & Technology (NIST) - USA	Chen, P (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	pc252@cornell.edu	Thomas, Elayne/AAT-8869-2020; Sambur, Justin/Q-2982-2016; Chen, Tai-Yen/AAQ-5887-2021; Zou, Ningmu/R-9151-2017	Thomas, Elayne/0000-0003-0072-4204; Sambur, Justin/0000-0002-8457-4946; Chen, Tai-Yen/0000-0002-2881-3068; Zou, Ningmu/0000-0003-2505-4139; Nissen, Erin/0000-0002-0624-8176	Department of Energy, Office of Science, Basic Energy Science [DE-FG02-10ER16199]; Army Research Office [63767-CH, 65814-CH]; National Science Foundation [CBET-1263736, CHE-1137217]; REU programme [DMR-1063059]; Petroleum Research Foundation [54289-ND7]; NSF MRSEC programme [DMR-1120296]; NSF National Nanotechnology Infrastructure Network [ECCS-15420819]	Department of Energy, Office of Science, Basic Energy Science(United States Department of Energy (DOE)); Army Research Office; National Science Foundation(National Science Foundation (NSF)); REU programme; Petroleum Research Foundation; NSF MRSEC programme(National Science Foundation (NSF)); NSF National Nanotechnology Infrastructure Network	The research is supported by the Department of Energy, Office of Science, Basic Energy Science (grant number DE-FG02-10ER16199), and in part by Army Research Office (grant numbers 63767-CH and 65814-CH), National Science Foundation (grant numbers CBET-1263736 and CHE-1137217 (to J.B.S.), and REU programme DMR-1063059 (to E.J.N. and E.M.T.)), and the Petroleum Research Foundation (grant number 54289-ND7). This work used the Cornell Center for Materials Research Shared Facilities, an NSF MRSEC programme (grant number DMR-1120296), and the Cornell NanoScale Facility, a member of the NSF National Nanotechnology Infrastructure Network (grant number ECCS-15420819). We thank D. Hill of the Cahoon Group at the University of North Carolina at Chapel Hill for the finite-difference frequency-domain simulations presented in Supplementary Fig. 24. We also thank J. McKone, S. Maldonado, B. A. Parkinson, H. D. Abruna and A. J. Nozik for discussions, J. Colson and W. Dichtel for X-ray diffraction measurements, J. Grazul for electron microscopy and H. D. Abruna for electrochemical instrumentation.	Abdi FF, 2012, J PHYS CHEM C, V116, P9398, DOI 10.1021/jp3007552; ABRANTES LM, 1983, J ELECTROANAL CHEM, V150, P593, DOI 10.1016/S0022-0728(83)80238-1; BOLTS JM, 1976, J PHYS CHEM-US, V80, P2641, DOI 10.1021/j100565a004; BUTLER MA, 1977, J APPL PHYS, V48, P1914, DOI 10.1063/1.323948; Buurmans ILC, 2012, NAT CHEM, V4, P873, DOI [10.1038/NCHEM.1478, 10.1038/nchem.1478]; Byers JC, 2014, J AM CHEM SOC, V136, P11252, DOI 10.1021/ja505708y; Cakir S, 2010, CHEM PAP, V64, P386, DOI 10.2478/s11696-010-0007-9; Carroll GM, 2015, ENERG ENVIRON SCI, V8, P577, DOI 10.1039/c4ee02869d; Chen HN, 2014, J PHYS CHEM LETT, V5, P2890, DOI 10.1021/jz5014505; Chen SL, 2004, J PHYS CHEM B, V108, P3262, DOI 10.1021/jp036831j; Chen TY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8445; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; COOPER G, 1982, J ELECTROCHEM SOC, V129, P1973, DOI 10.1149/1.2124334; Dotan H, 2011, ENERG ENVIRON SCI, V4, P958, DOI 10.1039/c0ee00570c; Ebejer N, 2010, ANAL CHEM, V82, P9141, DOI 10.1021/ac102191u; Fabrega C, 2013, J PHYS CHEM C, V117, P20517, DOI 10.1021/jp407167z; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Gamelin DR, 2012, NAT CHEM, V4, P965, DOI 10.1038/nchem.1514; GARTNER WW, 1959, PHYS REV, V116, P84, DOI 10.1103/PhysRev.116.84; Giocondi JL, 2007, TOP CATAL, V44, P529, DOI 10.1007/s11244-006-0101-y; Ida S, 2015, J AM CHEM SOC, V137, P239, DOI 10.1021/ja509970z; Khnayzer RS, 2012, ACS CATAL, V2, P2150, DOI 10.1021/cs3005192; Klahr B, 2012, J AM CHEM SOC, V134, P16693, DOI 10.1021/ja306427f; LASER D, 1979, J ELECTROCHEM SOC, V126, P475, DOI 10.1149/1.2129065; Li RG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2401; Li YX, 2010, J AM CHEM SOC, V132, P3047, DOI 10.1021/ja909408q; Lin FD, 2014, NAT MATER, V13, P81, DOI [10.1038/NMAT3811, 10.1038/nmat3811]; LINDQUIST SE, 1983, J ELECTROCHEM SOC, V130, P351, DOI 10.1149/1.2119710; Liu B, 2013, J AM CHEM SOC, V135, P9995, DOI 10.1021/ja403761s; Liu C, 2014, CHEM MATER, V26, P415, DOI 10.1021/cm4023198; Meier J, 2002, FARADAY DISCUSS, V121, P365, DOI 10.1039/b200014h; MOLLERS F, 1974, J ELECTROCHEM SOC, V121, P1160, DOI 10.1149/1.2402004; Novo C, 2008, NAT NANOTECHNOL, V3, P598, DOI 10.1038/nnano.2008.246; PETER LM, 1990, CHEM REV, V90, P753, DOI 10.1021/cr00103a005; PETER LM, 1984, J ELECTROANAL CHEM, V165, P29, DOI 10.1016/S0022-0728(84)80084-4; PETERSON MW, 1991, J PHYS CHEM-US, V95, P221, DOI 10.1021/j100154a044; Pilli SK, 2013, PHYS CHEM CHEM PHYS, V15, P14723, DOI 10.1039/c3cp52401a; Plessers E, 2015, ACS CATAL, V5, P6690, DOI 10.1021/acscatal.5b02119; REICHMAN J, 1981, APPL PHYS LETT, V38, P251, DOI 10.1063/1.92333; Roeffaers MBJ, 2009, ANGEW CHEM INT EDIT, V48, P9285, DOI 10.1002/anie.200904944; SAGARA T, 1988, J ELECTROCHEM SOC, V135, P363, DOI 10.1149/1.2095616; SALVADOR P, 1992, J PHYS CHEM-US, V96, P10349, DOI 10.1021/j100204a046; SALVADOR P, 1985, J PHYS CHEM-US, V89, P3863, DOI 10.1021/j100264a019; Sambur JB, 2014, ANNU REV PHYS CHEM, V65, P395, DOI 10.1146/annurev-physchem-040513-103729; Shan XN, 2012, NAT NANOTECHNOL, V7, P668, DOI [10.1038/nnano.2012.134, 10.1038/NNANO.2012.134]; Shen H, 2014, J PHYS CHEM C, V118, P26902, DOI 10.1021/jp509507u; Steinmiller EMP, 2009, P NATL ACAD SCI USA, V106, P20633, DOI 10.1073/pnas.0910203106; Surendranath Y, 2012, J AM CHEM SOC, V134, P6326, DOI 10.1021/ja3000084; Surendranath Y, 2009, J AM CHEM SOC, V131, P2615, DOI 10.1021/ja807769r; Sze S. M., 2011, SEMICONDUCTOR DEVICE; Tachikawa T, 2011, J AM CHEM SOC, V133, P7197, DOI 10.1021/ja201415j; TAFALLA D, 1989, SURF SCI, V215, P190, DOI 10.1016/0039-6028(89)90709-7; Tang ML, 2011, J AM CHEM SOC, V133, P13220, DOI 10.1021/ja203215b; Tel-Vered R, 2006, J PHYS CHEM B, V110, P25279, DOI 10.1021/jp064434d; Villarreal TL, 2004, J PHYS CHEM B, V108, P15172, DOI 10.1021/jp049447a; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Wang YM, 2007, SURF SCI, V601, P63, DOI 10.1016/j.susc.2006.09.005; Warren SC, 2013, NAT MATER, V12, P842, DOI [10.1038/NMAT3684, 10.1038/nmat3684]; Warschkow O, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.086102; WILSON RH, 1977, J APPL PHYS, V48, P4292, DOI 10.1063/1.323417; Xiao XY, 2007, J AM CHEM SOC, V129, P9610, DOI 10.1021/ja072344w; Xing J, 2014, CHEM-EUR J, V20, P2138, DOI 10.1002/chem.201303366; Xu W, 2012, J AM CHEM SOC, V134, P3946, DOI 10.1021/ja210010k; Xu WL, 2009, NANO LETT, V9, P3968, DOI 10.1021/nl900988f; Yang JH, 2013, ACCOUNTS CHEM RES, V46, P1900, DOI 10.1021/ar300227e; Ye H, 2011, J PHYS CHEM C, V115, P12464, DOI 10.1021/jp200852c; Zhang Q, 2014, J PHYS CHEM C, V118, P18207, DOI 10.1021/jp505091t; Zhang YW, 2015, P NATL ACAD SCI USA, V112, P8959, DOI 10.1073/pnas.1502005112; Zhong DK, 2011, ENERG ENVIRON SCI, V4, P1759, DOI 10.1039/c1ee01034d; Zhou XC, 2012, NAT NANOTECHNOL, V7, P237, DOI [10.1038/nnano.2012.18, 10.1038/NNANO.2012.18]	70	235	239	27	761	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					77	+		10.1038/nature16534	http://dx.doi.org/10.1038/nature16534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842056	Green Submitted			2022-12-28	WOS:000369304500035
J	Eren, B; Zherebetskyy, D; Patera, LL; Wu, CH; Bluhm, H; Africh, C; Wang, LW; Somorjai, GA; Salmeron, M				Eren, Baran; Zherebetskyy, Danylo; Patera, Laerte L.; Wu, Cheng Hao; Bluhm, Hendrik; Africh, Cristina; Wang, Lin-Wang; Somorjai, Gabor A.; Salmeron, Miquel			Activation of Cu(111) surface by decomposition into nanoclusters driven by CO adsorption	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; METHANOL SYNTHESIS; PHOTOELECTRON-SPECTROSCOPY; AMBIENT CONDITIONS; COPPER SURFACES; CHEMISTRY; SCIENCE; WATER; CATALYSIS; COVERAGE	The (111) surface of copper (Cu), its most compact and lowest energy surface, became unstable when exposed to carbon monoxide (CO) gas. Scanning tunneling microscopy revealed that at room temperature in the pressure range 0.1 to 100 Torr, the surface decomposed into clusters decorated by CO molecules attached to edge atoms. Between 0.2 and a few Torr CO, the clusters became mobile in the scale of minutes. Density functional theory showed that the energy gain from CO binding to low-coordinated Cu atoms and the weakening of binding of Cu to neighboring atoms help drive this process. Particularly for softer metals, the optimal balance of these two effects occurs near reaction conditions. Cluster formation activated the surface for water dissociation, an important step in the water-gas shift reaction.	[Eren, Baran; Zherebetskyy, Danylo; Patera, Laerte L.; Wu, Cheng Hao; Wang, Lin-Wang; Somorjai, Gabor A.; Salmeron, Miquel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Patera, Laerte L.; Africh, Cristina] CNR IOM, Lab TASC, Str Statale 14,Km 163-5, I-34149 Trieste, Italy; [Patera, Laerte L.] Univ Trieste, Dept Phys, Via A Valerio 2, I-34127 Trieste, Italy; [Patera, Laerte L.] Univ Trieste, CENMAT, Via A Valerio 2, I-34127 Trieste, Italy; [Wu, Cheng Hao; Somorjai, Gabor A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bluhm, Hendrik] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Salmeron, Miquel] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Trieste; University of Trieste; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.; Salmeron, M (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	mbsalmeron@lbl.gov	wang, lin/GSE-3040-2022; Wu, Cheng Hao/C-9565-2014; wang, lin/HHM-2225-2022; wang, lili/HDL-7210-2022; Wu, Cheng Hao/AAG-2521-2020; Eren, Baran/A-9644-2013; Africh, Cristina/O-2976-2015; Patera, Laerte/AAR-4188-2020	Wu, Cheng Hao/0000-0002-6515-0988; Wu, Cheng Hao/0000-0002-6515-0988; Africh, Cristina/0000-0002-1922-2557; Patera, Laerte/0000-0002-6214-5681; Eren, Baran/0000-0002-0521-8127	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231, FWP KC3101]	Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering of the U.S. Department of Energy (DOE)	This work was supported by the Office of Basic Energy Sciences (BES), Division of Materials Sciences and Engineering, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231, through the Chemical and Mechanical Properties of Surfaces, Interfaces and Nanostructures program (FWP KC3101). It used resources of the National Energy Research Scientific Computing Center and the Advanced Light Source, which are supported by the Office of Science of the U.S. DOE. The computation used resources from the Oak Ridge Leadership Computing Facility (OLCF), with time allocated by the Innovative and Novel Computational Impact on Theory and Experiment (INCITE) project.	Bartels L, 1999, SURF SCI, V432, pL621, DOI 10.1016/S0039-6028(99)00640-8; Behrens M, 2014, ANGEW CHEM INT EDIT, V53, P12022, DOI 10.1002/anie.201409282; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Besenbacher F, 2012, MRS BULL, V37, P677, DOI 10.1557/mrs.2012.142; Eren B, 2015, J PHYS CHEM C, V119, P14669, DOI 10.1021/jp512831f; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; Herbschleb CT, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891811; KAMBE K, 1955, PHYS REV, V99, P419, DOI 10.1103/PhysRev.99.419; Kittel C, 2021, INTRO SOLID STATE PH; KLIER K, 1982, ADV CATAL, V31, P243, DOI 10.1016/S0360-0564(08)60455-1; Laegsgaard E, 2001, REV SCI INSTRUM, V72, P3537, DOI 10.1063/1.1389497; Lagoute J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136801; Longwitz SR, 2004, J PHYS CHEM B, V108, P14497, DOI 10.1021/jp0492218; Lysenko OV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126102; MCINTYRE BJ, 1993, REV SCI INSTRUM, V64, P687, DOI 10.1063/1.1144198; Mehlhorn M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076101; NEWSOME DS, 1980, CATAL REV, V21, P275, DOI 10.1080/03602458008067535; Olah GA, 2013, ANGEW CHEM INT EDIT, V52, P104, DOI 10.1002/anie.201204995; Osterlund L, 2001, PHYS REV LETT, V86, P460, DOI 10.1103/PhysRevLett.86.460; POENSGEN M, 1992, SURF SCI, V274, P430, DOI 10.1016/0039-6028(92)90848-Z; Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001; Salmeron M, 2013, MRS BULL, V38, P650, DOI 10.1557/mrs.2013.162; Somorjai G. A., 1999, INTRO SURFACE CHEM C; SZANYI J, 1991, CATAL LETT, V10, P383, DOI 10.1007/BF00769173; Tang DC, 2004, J PHYS CHEM B, V108, P13300, DOI 10.1021/jp036580e; Tao F, 2010, SCIENCE, V327, P850, DOI 10.1126/science.1182122; Tao F, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2960569; WALDROP MM, 1986, SCIENCE, V234, P673, DOI 10.1126/science.234.4777.673; Yamamoto S, 2007, J PHYS CHEM C, V111, P7848, DOI 10.1021/jp0731654; Yang HJ, 2013, J PHYS CHEM C, V117, P16429, DOI 10.1021/jp404231t; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240	31	173	174	16	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					475	478		10.1126/science.aad8868	http://dx.doi.org/10.1126/science.aad8868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823421	Green Submitted			2022-12-28	WOS:000368858200029
J	Hu, H; Juvekar, A; Lyssiotis, CA; Lien, EC; Albeck, JG; Oh, D; Varma, G; Hung, YP; Ullas, S; Lauring, J; Seth, P; Lundquist, MR; Tolan, DR; Grant, AK; Needleman, DJ; Asara, JM; Cantley, LC; Wulf, GM				Hu, Hai; Juvekar, Ashish; Lyssiotis, Costas A.; Lien, Evan C.; Albeck, John G.; Oh, Doogie; Varma, Gopal; Hung, Yin Pun; Ullas, Soumya; Lauring, Josh; Seth, Pankaj; Lundquist, Mark R.; Tolan, Dean R.; Grant, Aaron K.; Needleman, Daniel J.; Asara, John M.; Cantley, Lewis C.; Wulf, Gerburg M.			Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton	CELL			English	Article							BREAST-CANCER; F-ACTIN; INHIBITOR; METABOLISM; ACTIVATION; PATHWAY; KINASE; CELLS; RAC; DEHYDROGENASE	The phosphoinositide 3-kinase (PI3K) pathway regulates multiple steps in glucose metabolism and also cytoskeletal functions, such as cell movement and attachment. Here, we show that PI3K directly coordinates glycolysis with cytoskeletal dynamics in an AKT-independent manner. Growth factors or insulin stimulate the PI3K-dependent activation of Rac, leading to disruption of the actin cytoskeleton, release of filamentous actin-bound aldolase A, and an increase in aldolase activity. Consistently, PI3K inhibitors, but not AKT, SGK, or mTOR inhibitors, cause a significant decrease in glycolysis at the step catalyzed by aldolase, while activating PIK3CA mutations have the opposite effect. These results point toward a master regulatory function of PI3K that integrates an epithelial cell's metabolism and its form, shape, and function, coordinating glycolysis with the energy-intensive dynamics of actin remodeling.	[Hu, Hai; Juvekar, Ashish; Wulf, Gerburg M.] Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA; [Hu, Hai; Juvekar, Ashish; Wulf, Gerburg M.] Harvard Univ, Med Sch HMS, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Lundquist, Mark R.; Cantley, Lewis C.] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA; [Lien, Evan C.] BIDMC, Dept Pathol, Boston, MA 02215 USA; [Albeck, John G.] HMS, Dept Cell Biol, Boston, MA 02215 USA; [Oh, Doogie; Needleman, Daniel J.] Harvard Univ, FAS Ctr Syst Biol, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Varma, Gopal; Grant, Aaron K.] BIDMC Boston, Dept Radiol, Boston, MA 02215 USA; [Hung, Yin Pun] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Lauring, Josh] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Seth, Pankaj] BIDMC, Div Interdisciplinary Med, Boston, MA 02215 USA; [Tolan, Dean R.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Asara, John M.] BIDMC, Div Signal Transduct, Boston, MA 02215 USA; [Ullas, Soumya] BIDMC, Longwood Small Anim Imaging Facil, Boston, MA 02215 USA; [Lyssiotis, Costas A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Albeck, John G.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Beth Israel Deaconess Medical Center; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University of California System; University of California Davis	Wulf, GM (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA.; Wulf, GM (corresponding author), Harvard Univ, Med Sch HMS, Boston, MA 02215 USA.	gwulf@bidmc.harvard.edu	Hung, Yin P/AAV-4868-2021; Varma, Gopal/AAD-2012-2022; Wulf, Gerburg/AAS-6713-2021; Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014	Hung, Yin P/0000-0002-8568-1591; Varma, Gopal/0000-0002-7060-1982; Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; Lauring, Josh/0000-0002-4312-704X; Lien, Evan/0000-0001-7866-4761; Tolan, Dean/0000-0002-0598-7241	Breast Cancer Research Foundation (BCRF); Mary Kay Ash Foundation; Men's Initiative of DFHCC; Breast Cancer Alliance; NIH [GM041890, R21 EB014471, R01 CA169470]; NIH NCI [5P01CA120964-05, 5P30CA006516-46]; NSF [DBI-0959721, DMR-0820484]; United States-Israel Binational Science Foundation (BSF) [2009271]; Damon Runyon Cancer Research Foundation; Stand Up to Cancer Dream Team Translational Research Grant [SU2C-AACR-DT0209];  [R01CA152330-0]; NATIONAL CANCER INSTITUTE [P30CA046592, P01CA120964, P30CA006516, R01CA152330, R01CA169470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB014471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	Breast Cancer Research Foundation (BCRF); Mary Kay Ash Foundation; Men's Initiative of DFHCC; Breast Cancer Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Damon Runyon Cancer Research Foundation; Stand Up to Cancer Dream Team Translational Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	L.C.C. and G.M.W. are supported by a Stand Up to Cancer Dream Team Translational Research Grant, (SU2C-AACR-DT0209), by the Breast Cancer Research Foundation (BCRF), the Mary Kay Ash Foundation, the Men's Initiative of DFHCC, and the Breast Cancer Alliance; L.C.C. by NIH grant GM041890; J.M.A. in part by NIH NCI grants 5P01CA120964-05 and 5P30CA006516-46; A.K.G., P.S., and G.V. in part by NIH R21 EB014471 and R01 CA169470; and P.S. in part by R01CA152330-0. D.J.N. is supported in part by NSF DBI-0959721 and DMR-0820484 and the United States-Israel Binational Science Foundation (BSF 2009271); and C.A.L. by a Dale F. Frey award from the Damon Runyon Cancer Research Foundation.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; Barthel A, 1997, ENDOCRINOLOGY, V138, P3559, DOI 10.1210/en.138.8.3559; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; HARRIS SJ, 1987, BIOCHIM BIOPHYS ACTA, V911, P121, DOI 10.1016/0167-4838(87)90279-2; JAGANNATHAN V, 1956, BIOCHEM J, V63, P94, DOI 10.1042/bj0630094; Jijakli H, 2002, INT J MOL MED, V9, P165; Johnson HE, 2015, J CELL BIOL, V208, P443, DOI 10.1083/jcb.201406102; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mayer IA, 2014, J CLIN ONCOL, V32, P1202, DOI 10.1200/JCO.2013.54.0518; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Morris AJ, 1996, PROTEIN ENG, V9, P61, DOI 10.1093/protein/9.1.61; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; SCHAPIRA FANNY, 1966, EUR J CANCER, V2, P131, DOI 10.1016/0014-2964(66)90005-3; SIBLEY JA, 1958, ANN NY ACAD SCI, V75, P339, DOI 10.1111/j.1749-6632.1958.tb36881.x; Varma G., 2015, MAGN RESON MED; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Warburg O.C.W., 1945, BIOCHEM Z, V314, P399; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Wu CYC, 2014, GASTROENTEROLOGY, V147, P1405, DOI 10.1053/j.gastro.2014.08.032; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012	36	214	221	9	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					433	446		10.1016/j.cell.2015.12.042	http://dx.doi.org/10.1016/j.cell.2015.12.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824656	Green Accepted, Bronze			2022-12-28	WOS:000368906800014
J	Mann, RS; Howard, CE				Mann, Richard S.; Howard, Clare E.			The Importance of Timing	CELL			English	Editorial Material							DROSOPHILA; PHOSPHORYLATION; KINASE; GENES; SCUTE	Building a nervous system requires a precise sequence of genetic transitions, mediated in part by the temporal and spatial regulation of transcription factors. Quan et al. add to our understanding of this regulation by describing an evolutionarily conserved post-translational mechanism that rapidly extinguishes proneural protein activity in neural precursors.	[Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, Zuckerman Mind Brain Behav Inst, 630 W 168th St, New York, NY 10027 USA; [Mann, Richard S.] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Syst Biol, New York, NY 10027 USA; [Howard, Clare E.] Columbia Univ, Dept Biochem & Mol Biophys, Zuckerman Mind Brain Behav Inst, Med Scientist Training Program, 630 W 168th St, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Zuckerman Mind Brain Behav Inst, 630 W 168th St, New York, NY 10027 USA.; Mann, RS (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Syst Biol, New York, NY 10027 USA.	rsm10@cumc.columbia.edu			NINDS NIH HHS [NS070644] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070644] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hardwick LJA, 2014, TRENDS GENET, V30, P254, DOI 10.1016/j.tig.2014.04.001; Hartenstein V, 2013, WIRES DEV BIOL, V2, P701, DOI 10.1002/wdev.111; Huang C, 2014, CURR TOP DEV BIOL, V110, P75, DOI 10.1016/B978-0-12-405943-6.00002-6; Kiparaki M, 2015, NUCLEIC ACIDS RES, V43, P2543, DOI 10.1093/nar/gkv083; Quan XJ, 2016, CELL, V164, P460, DOI 10.1016/j.cell.2015.12.048; White NM, 2000, DEVELOPMENT, V127, P1681; Yang MY, 2012, DEVELOPMENT, V139, P325, DOI 10.1242/dev.074260	10	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					347	348		10.1016/j.cell.2016.01.010	http://dx.doi.org/10.1016/j.cell.2016.01.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824651	Bronze			2022-12-28	WOS:000368906800006
J	Roseberry, TK; Lee, AM; Lalive, AL; Wilbrecht, L; Bonci, A; Kreitzer, AC				Roseberry, Thomas K.; Lee, A. Moses; Lalive, Arnaud L.; Wilbrecht, Linda; Bonci, Antonello; Kreitzer, Anatol C.			Cell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia	CELL			English	Article							PEDUNCULOPONTINE TEGMENTAL NUCLEUS; SUPERIOR COLLICULUS; PROJECTION NEURONS; RETICULAR-FORMATION; INDIRECT PATHWAYS; BEHAVIORAL STATE; MOTOR BEHAVIORS; RAT; ACTIVATION; STIMULATION	The basal ganglia (BG) are critical for adaptive motor control, but the circuit principles underlying their pathway-specific modulation of target regions are not well understood. Here, we dissect the mechanisms underlying BG direct and indirect pathway-mediated control of the mesencephalic locomotor region (MLR), a brainstem target of BG that is critical for locomotion. We optogenetically dissect the locomotor function of the three neurochemically distinct cell types within the MLR: glutamatergic, GABAergic, and cholinergic neurons. We find that the glutamatergic subpopulation encodes locomotor state and speed, is necessary and sufficient for locomotion, and is selectively innervated by BG. We further show activation and suppression, respectively, of MLR glutamatergic neurons by direct and indirect pathways, which is required for bidirectional control of locomotion by BG circuits. These findings provide a fundamental understanding of how BG can initiate or suppress a motor program through cell-type-specific regulation of neurons linked to specific actions.	[Roseberry, Thomas K.; Lee, A. Moses; Lalive, Arnaud L.; Kreitzer, Anatol C.] Gladstone Inst, San Francisco, CA 94158 USA; [Roseberry, Thomas K.; Lee, A. Moses; Kreitzer, Anatol C.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA; [Lee, A. Moses; Kreitzer, Anatol C.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Wilbrecht, Linda] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Synapt Plast Sect, Baltimore, MD 21224 USA; [Bonci, Antonello] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Bonci, Antonello] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21287 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Kreitzer, AC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Lee, A Moses/GPP-4361-2022		NIH [NS064984, P01 DA010154, F31 NS092253, 5T32GM007618-38, RR018928]; Swiss National Science Foundation; State of California; NIDA intramural program; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078435, R01NS064984, F31NS092253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of California; NIDA intramural program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Delanie Schulte for assistance with genotyping, histology, and microscopy and the A.C.K. laboratory for comments on the manuscript. This work was funded by NIH R01 NS064984 and P01 DA010154 (to A.C.K.), F31 NS092253 (to T.K.R.), 5T32GM007618-38 (to A.M.L.), RR018928 (to the Gladstone Institutes), a grant from the Swiss National Science Foundation (to A.L.L.), funds from the State of California (to L.W.), and an NIDA intramural program (to A.B.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; BEDFORD TG, 1992, J APPL PHYSIOL, V72, P121, DOI 10.1152/jappl.1992.72.1.121; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Bosch-Bouju C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00163; BRUDZYNSKI SM, 1988, BRAIN RES, V451, P119, DOI 10.1016/0006-8993(88)90755-X; CHEVALIER G, 1984, EXP BRAIN RES, V53, P320; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Ehrich JM, 2014, NEUROPSYCHOPHARMACOL, V39, P3036, DOI 10.1038/npp.2014.157; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Garcia-Rill E, 2001, NEUROSCIENCE, V104, P455, DOI 10.1016/S0306-4522(01)00094-X; GARCIARILL E, 1986, BRAIN RES BULL, V17, P33, DOI 10.1016/0361-9230(86)90158-9; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Giber K, 2015, NAT NEUROSCI, V18, P562, DOI 10.1038/nn.3951; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; Goldberg JH, 2013, TRENDS NEUROSCI, V36, P695, DOI 10.1016/j.tins.2013.09.001; Grace AA, 2010, NEUROTOX RES, V18, P367, DOI 10.1007/s12640-010-9154-6; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee AM, 2014, NEURON, V83, P455, DOI 10.1016/j.neuron.2014.06.031; Mamiya K, 2005, J APPL PHYSIOL, V99, P1127, DOI 10.1152/japplphysiol.00253.2005; Martinez-Gonzalez C, 2014, BRAIN STRUCT FUNCT, V219, P1451, DOI 10.1007/s00429-013-0579-6; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; MITANI A, 1988, BRAIN RES, V451, P397, DOI 10.1016/0006-8993(88)90792-5; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; NOGA BR, 1988, J NEUROSCI, V8, P2074; Norton ABW, 2011, EUR J NEUROSCI, V33, P1885, DOI 10.1111/j.1460-9568.2011.07649.x; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Orlovsky G., 1999, NEURONAL CONTROL LOC; Perkins E, 2014, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00055; REDGRAVE P, 1987, EXP BRAIN RES, V68, P147; Ryczko D, 2013, CURR PHARM DESIGN, V19, P4448, DOI 10.2174/1381612811319240011; RYE DB, 1988, J COMP NEUROL, V269, P315, DOI 10.1002/cne.902690302; SAPER CB, 1979, J COMP NEUROL, V183, P689, DOI 10.1002/cne.901830402; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Shang CP, 2015, SCIENCE, V348, P1472, DOI 10.1126/science.aaa8694; Sherman D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00140; SHIK M. L., 1966, BIOFIZIKA, V11, P879; SHIK M. L., 1966, BLOFIZIKA, V11, P659; SINNAMON HM, 1987, NEUROSCIENCE, V20, P695, DOI 10.1016/0306-4522(87)90120-5; Skinner R D, 1990, Neuroreport, V1, P207, DOI 10.1097/00001756-199011000-00008; Smetana R, 2010, NAT NEUROSCI, V13, P731, DOI 10.1038/nn.2548; Takakusaki K, 1996, J COMP NEUROL, V371, P345, DOI 10.1002/(SICI)1096-9861(19960729)371:3<345::AID-CNE1>3.0.CO;2-2; Thankachan S, 2012, NEUROSCIENCE, V221, P125, DOI 10.1016/j.neuroscience.2012.06.069; Thompson JA, 2013, J NEUROPHYSIOL, V110, P2817, DOI 10.1152/jn.00464.2013; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Whelan PJ, 1996, PROG NEUROBIOL, V49, P481, DOI 10.1016/0301-0082(96)00028-7; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	58	207	208	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					526	537		10.1016/j.cell.2015.12.037	http://dx.doi.org/10.1016/j.cell.2015.12.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824660	Green Accepted, Bronze			2022-12-28	WOS:000368906800021
J	Mazor, KM; Smith, KM; Fisher, KA; Gallagher, TH				Mazor, Kathleen M.; Smith, Kelly M.; Fisher, Kimberly A.; Gallagher, Thomas H.			Speak Up! Addressing the Paradox Plaguing Patient-Centered Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPROVEMENT; EVENTS; SAFETY		[Mazor, Kathleen M.] Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA; [Fisher, Kimberly A.] Univ Massachusetts, Sch Med, Med Ctr, Univ Campus,55 Lake Ave North, Worcester, MA 01655 USA; MedStar Hlth Res Inst, Hyattsville, MD USA; [Gallagher, Thomas H.] Univ Washington, 1959 Northeast Pacific St,Suite BB 1240, Seattle, WA 98195 USA; [Smith, Kelly M.] MedStar Hlth Qual & Safety, 5565 Sterrett Pl,Suite 210, Columbia, MD 21044 USA	University of Massachusetts System; University of Massachusetts Worcester; MedStar Health Research Institute; University of Washington; University of Washington Seattle	Mazor, KM (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	Kathy.Mazor@meyersprimary.org		Smith, Kelly Michelle/0000-0002-9483-5118	AHRQ HHS [R18 HS022757] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS022757] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Davies E, 2005, QUAL SAF HEALTH CARE, V14, P428, DOI 10.1136/qshc.2004.012955; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Gallagher TH, 2015, BMJ QUAL SAF, V24, P352, DOI 10.1136/bmjqs-2015-004337; Mazor KM, 2012, J CLIN ONCOL, V30, P1784, DOI 10.1200/JCO.2011.38.1384; Rainey H, 2015, HEALTH EXPECT, V18, P392, DOI 10.1111/hex.12044; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006	7	21	21	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					618	+		10.7326/M15-2416	http://dx.doi.org/10.7326/M15-2416			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26857030				2022-12-28	WOS:000375744000023
J	Sihvonen, R; Englund, M; Turkiewicz, A; Jarvinen, TLN				Sihvonen, Raine; Englund, Martin; Turkiewicz, Aleksandra; Jarvinen, Teppo L. N.		Finnish Degenerative Meniscal	Mechanical Symptoms and Arthroscopic Partial Meniscectomy in Patients With Degenerative Meniscus Tear A Secondary Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PARTIAL MEDIAL MENISCECTOMY; KNEE OSTEOARTHRITIS; SURGERY; MANAGEMENT; GUIDELINES; TRUE; CARE	Background: Recent evidence shows that arthroscopic partial meniscectomy (APM) offers no benefit over conservative treatment of patients with a degenerative meniscus tear. However, patients who report mechanical symptoms (sensations of knee catching or locking) may benefit from APM. Objective: To assess whether APM improves mechanical symptoms better than sham surgery. Design: Randomized, patient- and outcome assessor-blinded, sham surgery-controlled, multicenter trial. (ClinicalTrials. gov: NCT00549172) Setting: 5 orthopedic clinics in Finland. Patients: Adults (aged 35 to 65 years) with a degenerative medial meniscus tear and no knee osteoarthritis. Intervention: APM or sham surgery. Measurements: Patients' self-report of mechanical symptoms before surgery and at 2, 6, and 12 months after surgery. Results: 70 patients were randomly assigned to APM, and 76 were assigned to sham surgery. Thirty-two patients (46%) in the APM group and 37 (49%) in the sham surgery group reported catching or locking before surgery; the corresponding numbers at any follow-up were 34 (49%) and 33 (43%), with a risk difference of 0.03 (95% CI, -0.06 to 0.12). In the subgroup of 69 patients with preoperative catching or locking, the risk difference was 0.07 (CI, -0.08 to 0.22). Limitation: Analyses were post hoc, and the results are only generalizable to knee catching and occasional locking because few patients reported other types of mechanical symptoms. Conclusion: Resection of a torn meniscus has no added benefit over sham surgery to relieve knee catching or occasional locking. These findings question whether mechanical symptoms are caused by a degenerative meniscus tear and prompt caution in using patients' self-report of these symptoms as an indication for APM.	Hatanpaa Hosp, Tampere, Finland; Univ Tampere, FIN-33101 Tampere, Finland; [Englund, Martin; Turkiewicz, Aleksandra] Lund Univ, Dept Clin Sci Lund, Clin Epidemiol Unit, Orthopaed, Klinikgatan 22, SE-22185 Lund, Sweden; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Helsinki, Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland; [Sihvonen, Raine] Hatanpaan Sairaala, Hatanpaankatu 24, Tampere 33900, Finland	Lund University; Boston University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Jarvinen, TLN (corresponding author), Univ Helsinki, Dept Orthopaed & Traumatol, Toolo Hosp, Topeliuksenkatu 5, FIN-00014 Helsinki, Finland.	aleksandra.turkiewicz@med.lu.se; teppo.jarvinen@helsinki.fi	Englund, Martin/J-7245-2012; Järvinen, Teppo/B-8189-2013	Englund, Martin/0000-0003-3320-2437; Järvinen, Teppo/0000-0003-3713-956X; Turkiewicz, Aleksandra/0000-0003-1460-2275; Paloneva, Juha/0000-0003-3340-9390; Jarvinen, Tero/0000-0002-4027-1759; Sihvonen, Raine/0000-0002-8744-3810	Academy of Finland	Academy of Finland(Academy of Finland)	Academy of Finland.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Buchbinder R, 2016, BRIT J SPORT MED, V50, P1413, DOI 10.1136/bmj.h2212; Buchbinder R, 2013, NEW ENGL J MED, V368, P1740, DOI 10.1056/NEJMe1302696; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; COOPER DE, 1991, CLIN SPORT MED, V10, P529; Cullen KA, 2009, NATL HLTH STAT REPOR, P1; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; JACKSON RW, 1982, J BONE JOINT SURG BR, V64, P481, DOI 10.1302/0301-620X.64B4.6896516; Jarvinen TLN, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2175; Jevsevar DS, 2014, NEW ENGL J MED, V370, P1260, DOI 10.1056/NEJMc1401128; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Krych AJ, 2014, ARTHROSCOPY, V30, P544, DOI 10.1016/j.arthro.2014.02.012; Krych AJ, 2014, NEW ENGL J MED, V370, P1259, DOI 10.1056/NEJMc1401128; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Matsusue Y, 1996, ARTHROSCOPY, V12, P39, DOI 10.1016/S0749-8063(96)90217-0; MCBRIDE GG, 1984, J BONE JOINT SURG AM, V66A, P547, DOI 10.2106/00004623-198466040-00008; Meng QS., 2019, THESIS CHANGCHUN U C; Mezhov V, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4515; National Institute for Health and Care Excellence, 2014, OST CAR MAN, P505; Niu NNN, 2011, ARTHRIT CARE RES, V63, P208, DOI 10.1002/acr.20354; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Sihvonen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002510; Sihvonen RT, 2014, AM AC ORTH SURG 2014; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014	35	75	77	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					449	+		10.7326/M15-0899	http://dx.doi.org/10.7326/M15-0899			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26856620				2022-12-28	WOS:000373625300006
J	Wang, T; Liang, L; Xue, Y; Jia, PF; Chen, W; Zhang, MX; Wang, YC; Li, HJ; Yang, WC				Wang, Tong; Liang, Liang; Xue, Yong; Jia, Peng-Fei; Chen, Wei; Zhang, Meng-Xia; Wang, Ying-Chun; Li, Hong-Ju; Yang, Wei-Cai			A receptor heteromer mediates the male perception of female attractants in plants	NATURE			English	Article							POLLEN-TUBE GUIDANCE; GENE-EXPRESSION; ARABIDOPSIS; KINASE; ACTIVATION; PROTEIN; CELLS; TRANSCRIPTION; REGULATOR; PEPTIDES	Sexual reproduction requires recognition between the male and female gametes. In flowering plants, the immobile sperms are delivered to the ovule-enclosed female gametophyte by guided pollen tube growth. Although the female gametophyte-secreted peptides have been identified to be the chemotactic attractant to the pollen tube(1-3), the male receptor(s) is still unknown. Here we identify a cell-surface receptor heteromer, MDIS1-MIK, on the pollen tube that perceives female attractant LURE1 in Arabidopsis thaliana. MDIS1, MIK1 and MIK2 are plasma-membrane-localized receptor-like kinases with extracellular leucine-rich repeats and an intracellular kinase domain. LURE1 specifically binds the extracellular domains of MDIS1, MIK1 and MIK2, whereas mdis1 and mik1 mik2 mutant pollen tubes respond less sensitively to LURE1. Furthermore, LURE1 triggers dimerization of the receptors and activates the kinase activity of MIK1. Importantly, transformation of AtMDIS1 to the sister species Capsella rubella can partially break down the reproductive isolation barrier. Our findings reveal a new mechanism of the male perception of the female attracting signals.	[Wang, Tong; Liang, Liang; Xue, Yong; Jia, Peng-Fei; Chen, Wei; Zhang, Meng-Xia; Wang, Ying-Chun; Li, Hong-Ju; Yang, Wei-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Wang, Tong; Liang, Liang; Xue, Yong; Chen, Wei; Zhang, Meng-Xia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, HJ; Yang, WC (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China.	hjli@genetics.ac.cn; wcyang@genetics.ac.cn	Yang, Wei-Cai/AAX-7879-2021; Xue, Yong/GLQ-8823-2022; Li, Hong-Ju/AHD-3987-2022	Yang, Wei-Cai/0000-0003-0252-7079; Xue, Yong/0000-0002-7913-4815; 	Ministry of Science and Technology of China [2013CB945103, 2015CB910202]; National Natural Science Foundation of China [31330053, 31221063]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank L. Qu for technique assistance in the pollen tube guidance assay. We thank Y. Guo, Quantum Design Inc. China, and core facilities of public technology service centre of Institute of Microbiology and Institute of Genetics and Developmental Biology (Chinese Academy of Sciences) for the MST measurement. We thank J. Zhou and Q. Xie for sharing seeds. This work was supported by the Ministry of Science and Technology of China grants 2013CB945103 to W.-C. Y. and 2015CB910202 to H.-J.L. and the National Natural Science Foundation of China 31330053 and 31221063 to W.-C.Y.	Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Chang F, 2013, MOL PLANT, V6, P1187, DOI 10.1093/mp/sss103; Chen LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7030; Chen YH, 2007, PLANT CELL, V19, P3563, DOI 10.1105/tpc.107.053967; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Lee JS, 2015, NATURE, V522, P435, DOI 10.1038/nature14561; Li HJ, 2015, PLANT CELL, V27, P2880, DOI 10.1105/tpc.15.00370; Li HJ, 2011, PLANT CELL, V23, P3288, DOI 10.1105/tpc.111.088914; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; MUSCHIETTI J, 1994, PLANT J, V6, P321, DOI 10.1046/j.1365-313X.1994.06030321.x; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	29	143	162	8	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					241	+		10.1038/nature16975	http://dx.doi.org/10.1038/nature16975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26863186				2022-12-28	WOS:000371665100043
J	Caplan, AL; Ray, A				Caplan, Arthur L.; Ray, Amrit			The Ethical Challenges of Compassionate Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCESS		[Caplan, Arthur L.] NYU, Div Med Eth, Langone Med Ctr, 227 E 30th St,Seventh Floor, New York, NY 10016 USA; [Ray, Amrit] Janssen Res & Dev LLC, Titusville, NJ USA	New York University; NYU Langone Medical Center; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Caplan, AL (corresponding author), NYU, Div Med Eth, Langone Med Ctr, 227 E 30th St,Seventh Floor, New York, NY 10016 USA.	arthur.caplan@nyumc.org						Caplan AL., HLTH AFFAIRS FOREFRO, DOI [10.1377/hblog20140827.041027, DOI 10.1377/HBLOG20140827.041027]; Caplan AL, 2015, EXPERT OPIN PHARMACO, V16, P1275, DOI 10.1517/14656566.2015.1046837; Rosenblatt M, 2015, JAMA-J AM MED ASSOC, V313, P2023, DOI 10.1001/jama.2015.4135; Sandel Michael, 2009, JUSTICE WHATS RIGHT; Silverman Ed, 2014, WALL STREET J; Waldstreicher J, 2015, INNOVATING NEW APPRO	6	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					979	980		10.1001/jama.2016.0416	http://dx.doi.org/10.1001/jama.2016.0416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26868205				2022-12-28	WOS:000371540200006
J	Gartlehner, G; Gaynes, BN; Amick, HR; Asher, GN; Morgan, LC; Coker-Schwimmer, E; Forneris, C; Boland, E; Lux, LJ; Gaylord, S; Bann, C; Pierl, CB; Lohr, KN				Gartlehner, Gerald; Gaynes, Bradley N.; Amick, Halle R.; Asher, Gary N.; Morgan, Laura C.; Coker-Schwimmer, Emmanuel; Forneris, Catherine; Boland, Erin; Lux, Linda J.; Gaylord, Susan; Bann, Carla; Pierl, Christiane Barbara; Lohr, Kathleen N.			Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							ST-JOHNS-WORT; RANDOMIZED CONTROLLED-TRIAL; TO-MODERATE DEPRESSION; PRIMARY-CARE PATIENTS; ONCE-DAILY DOSAGE; DOUBLE-BLIND; COGNITIVE THERAPY; TREATING DEPRESSION; 2ND-GENERATION ANTIDEPRESSANTS; PSYCHODYNAMIC PSYCHOTHERAPY	Background: Primary care patients and clinicians may prefer options other than second-generation antidepressants for the treatment of major depressive disorder (MDD). The comparative benefits and harms of antidepressants and alternative treatments are unclear. P urpose: To compare the benefits and harms of second-generation antidepressants and psychological, complementary and alternative medicine (CAM), and exercise treatments as first- and second-step interventions for adults with acute MDD. Data Sources: English-, German-, and Italian-language studies from multiple electronic databases (January 1990 to September 2015); trial registries and gray-literature databases were used to identify unpublished research. Study Selection: Two investigators independently selected comparative randomized trials of at least 6 weeks' duration on health outcomes of adult outpatients; nonrandomized studies were eligible for harms. Data Extraction: Reviewers abstracted data on study design, participants, interventions, and outcomes; rated the risk of bias; and graded the strength of evidence. A senior reviewer confirmed data and ratings. Data Synthesis: 45 trials met inclusion criteria. On the basis of moderate-strength evidence, cognitive behavioral therapy (CBT) and antidepressants led to similar response rates (relative risk [RR], 0.90 [95% CI, 0.76 to 1.07]) and remission rates (RR, 0.98 [CI, 0.73 to 1.32]). In trials, antidepressants had higher risks for adverse events than most other treatment options; no information from nonrandomized studies was available. The evidence was too limited to make firm conclusions about differences in the benefits and harms of antidepressants compared with other treatment options as first-step therapies for acute MDD. For second-step therapies, different switching and augmentation strategies provided similar symptom relief. Limitation: High dropout rates, dosing inequalities, small sample sizes, and poor assessment of adverse events limit confidence in the evidence. Conclusion: Given their similar efficacy, CBT and antidepressants are both viable choices for initial treatment of MDD. Primary Funding Source: Agency for Healthcare Research and Quality.	[Morgan, Laura C.; Boland, Erin; Lux, Linda J.; Bann, Carla; Lohr, Kathleen N.] RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Chapel Hill, NC USA; [Gartlehner, Gerald] Danube Univ, Dr Karl Dorrek Str 30, A-3500 Krems, Austria; [Gaynes, Bradley N.; Forneris, Catherine] Univ N Carolina, Dept Psychiat, 101 Manning Dr,CB 7160, Chapel Hill, NC 27599 USA; [Amick, Halle R.; Coker-Schwimmer, Emmanuel] Univ N Carolina, Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd, Chapel Hill, NC 27599 USA; [Asher, Gary N.] Univ N Carolina, Dept Family Med, 101 Manning Dr,CB 7160, Chapel Hill, NC 27599 USA; [Gaylord, Susan] Univ N Carolina, Dept Phys Med & Rehabil, 101 Manning Dr,CB 7160, Chapel Hill, NC 27599 USA; [Pierl, Christiane Barbara] Danube Univ, Dept Evidence Based Med & Clin Epidemiol, Dr Karl Dorrek Str 30, A-3500 Krems, Austria	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Danube University Krems; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Danube University Krems	Gartlehner, G (corresponding author), Danube Univ, Dr Karl Dorrek Str 30, A-3500 Krems, Austria.	gerald.gartlehner@donau-uni.ac.at	Lux, Linda/GPX-3639-2022; Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Lohr, Kathleen/0000-0002-3825-0713; Bann, Carla/0000-0001-9305-8305	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2010, PRACT GUID TREATM PA, P152; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Barber JP, 2012, J CLIN PSYCHIAT, V73, P66, DOI 10.4088/JCP.11m06831; Bastos AG, 2013, J AFFECT DISORDERS, V151, P1066, DOI 10.1016/j.jad.2013.08.036; Behnke K, 2002, ADV THER, V19, P43, DOI 10.1007/BF02850017; Berkman ND, 2013, 2902007100561 U N CA; Bjerkenstedt L, 2005, EUR ARCH PSY CLIN N, V255, P40, DOI 10.1007/s00406-004-0532-z; Blom MBJ, 2007, PSYCHOTHER PSYCHOSOM, V76, P289, DOI 10.1159/000104705; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Brenner R, 2000, CLIN THER, V22, P411, DOI 10.1016/S0149-2918(00)89010-4; Chen JQ, 2014, NEURAL REGEN RES, V9, P213, DOI 10.4103/1673-5374.125353; Chen JA, 2011, J CLIN PSYCHIAT, V72, P1669, DOI 10.4088/JCP.10m06453; Cochrane Depression Anxiety and Neurosis Group, 2013, CCDAN TOP LIST INT T; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102; David D, 2008, J CLIN PSYCHOL, V64, P728, DOI 10.1002/jclp.20487; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; De Berardis D, 2015, CNS NEUROL DISORD DR; Dekker JJM, 2008, J AFFECT DISORDERS, V109, P183, DOI 10.1016/j.jad.2007.10.015; Department of Veterans Affairs; Department of Defense, 2009, VA DOD CLIN PRACT GU, P199; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Fava M, 2005, J CLIN PSYCHOPHARM, V25, P441, DOI 10.1097/01.jcp.0000178416.60426.29; Fischer A, 2015, LANCET PSYCHIAT, V2, P217, DOI 10.1016/S2215-0366(14)00049-2; Frank E, 2011, PSYCHOL MED, V41, P151, DOI 10.1017/S0033291710000553; Gartlehner G, 2015, AHRQ PUBLICATION; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gastpar M, 2006, PHARMACOPSYCHIATRY, V39, P66, DOI 10.1055/s-2006-931544; Gastpar M, 2005, PHARMACOPSYCHIATRY, V38, P78, DOI 10.1055/s-2005-837807; Gaynes BN, 2011, COMP EFFECTIVENESS R; Gaynes BN, 2008, J GEN INTERN MED, V23, P551, DOI 10.1007/s11606-008-0522-3; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Harrer G, 1999, ARZNEIMITTELFORSCH, V49, P289; Hegerl U, 2010, INT J NEUROPSYCHOPH, V13, P31, DOI 10.1017/S1461145709000224; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoffman BM, 2008, MED SCI SPORT EXER, V40, P1344, DOI 10.1249/MSS.0b013e31816b877c; Huang Y, 2005, INT J CLIN ACUPUNCTU, V14, P7; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jazayeri S, 2008, AUST NZ J PSYCHIAT, V42, P192, DOI 10.1080/00048670701827275; Jorm AF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007142.pub2; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kronstrom K, 2009, DEPRESS ANXIETY, V26, P689, DOI 10.1002/da.20585; Lam RW, 2013, BRIT J PSYCHIAT, V203, P358, DOI 10.1192/bjp.bp.112.125237; Landenberger NA, 2002, PROQUEST INFORM LEAR; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Lenox-Smith AJ, 2008, INT CLIN PSYCHOPHARM, V23, P113, DOI 10.1097/YIC.0b013e3282f424c2; Leykin Y, 2007, J CONSULT CLIN PSYCH, V75, P267, DOI 10.1037/0022-006X.75.2.267; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Menchetti M, 2014, BRIT J PSYCHIAT, V204, P144, DOI 10.1192/bjp.bp.112.122663; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; Mischoulon D, 2014, J CLIN PSYCHIAT, V75, P370, DOI 10.4088/JCP.13m08591; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Moradveisi L, 2013, BRIT J PSYCHIAT, V202, P204, DOI 10.1192/bjp.bp.112.113696; Moreno RA, 2006, REV BRAS PSIQUIATR, V28, P29, DOI 10.1590/S1516-44462006000100007; Murri MB, 2015, BRIT J PSYCHIAT, V207, P235, DOI 10.1192/bjp.bp.114.150516; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Papakostas GI, 2007, NEUROPSYCHOBIOLOGY, V56, P132, DOI 10.1159/000115779; Papakostas GI, 2009, EUR NEUROPSYCHOPHARM, V19, P34, DOI 10.1016/j.euroneuro.2008.08.009; Qu SS, 2013, J PSYCHIATR RES, V47, P726, DOI 10.1016/j.jpsychires.2013.02.004; Raue PJ, 2009, PSYCHIAT SERV, V60, P337, DOI 10.1176/appi.ps.60.3.337; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Rucci P, 2011, DEPRESS ANXIETY, V28, P303, DOI 10.1002/da.20758; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Salminen JK, 2008, PSYCHOTHER PSYCHOSOM, V77, P351, DOI 10.1159/000151388; Sava FA, 2009, J CLIN PSYCHOL, V65, P36, DOI 10.1002/jclp.20550; Schrader E, 2000, INT CLIN PSYCHOPHARM, V15, P61, DOI 10.1097/00004850-200015020-00001; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Shamsaei F, 2008, HONG KONG J PSYCHIAT, V18, P76; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; Song YQ, 2007, J AFFECT DISORDERS, V98, P253, DOI 10.1016/j.jad.2006.07.012; SOTSKY SM, 1991, AM J PSYCHIAT, V148, P997; Spielmans GI, 2011, J NERV MENT DIS, V199, P142, DOI 10.1097/NMD.0b013e31820caefb; Sun H, 2013, J ALTERN COMPLEM MED, V19, P733, DOI 10.1089/acm.2011.0637; Szegedi A, 2005, BMJ-BRIT MED J, V330, P503, DOI 10.1136/bmj.38356.655266.82; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; University of Pittsburgh Epidemiology Data Center, 2010, INV DEPR SYMPT IDS Q; van Gurp G, 2002, CAN FAM PHYSICIAN, V48, P905; Viswanathan M, 2012, ASSESSING RISK BIAS; Weitz ES, 2015, JAMA PSYCHIAT; West SL, 2010, 2902007100561 U N CA; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	89	68	69	2	70	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					331	+		10.7326/M15-1813	http://dx.doi.org/10.7326/M15-1813			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26857743				2022-12-28	WOS:000371220300004
J	Parikh, RB; Kakad, M; Bates, DW				Parikh, Ravi B.; Kakad, Meetali; Bates, David W.			Integrating Predictive Analytics Into High-Value Care The Dawn of Precision Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; RISK		[Parikh, Ravi B.; Kakad, Meetali; Bates, David W.] Brigham & Womens Hosp, Dept Med, 1620 Tremont St, Boston, MA 02120 USA; [Parikh, Ravi B.; Kakad, Meetali; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bates, DW (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	dbates@partners.org	Bates, David/AAE-7283-2019					Amarasingham R, 2014, HEALTH AFFAIR, V33, P1148, DOI 10.1377/hlthaff.2014.0352; Amarasingham R, 2013, BMJ QUAL SAF, V22, P998, DOI 10.1136/bmjqs-2013-001901; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Escobar GJ, 2014, PEDIATRICS, V133, P30, DOI 10.1542/peds.2013-1689; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Hines AL, 2006, CONDITIONS LARGEST N; Madan C. M., 2010, P UBICOMP 2010 12 AC, P291, DOI DOI 10.1145/1864349.1864394.URL; Nelson KM, 2014, JAMA INTERN MED, V174, P1350, DOI 10.1001/jamainternmed.2014.2488; Sniderman AD, 2015, JAMA-J AM MED ASSOC, V314, P25, DOI 10.1001/jama.2015.6177	9	93	94	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					651	652		10.1001/jama.2015.19417	http://dx.doi.org/10.1001/jama.2015.19417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881365				2022-12-28	WOS:000370171500006
J	Roybal, KT; Rupp, LJ; Morsut, L; Walker, WJ; McNally, KA; Park, JS; Lim, WA				Roybal, Kole T.; Rupp, Levi J.; Morsut, Leonardo; Walker, Whitney J.; McNally, Krista A.; Park, Jason S.; Lim, Wendell A.			Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits	CELL			English	Article							CANCER; THERAPIES; TOOLS; ERBB2	T cells can be re-directed to kill cancer cells using chimeric antigen receptors (CARs) or T cell receptors (TCRs). This approach, however, is constrained by the rarity of tumor-specific single antigens. Targeting antigens also found on bystander tissues can cause life-threatening adverse effects. A powerful way to enhance ON-target activity of therapeutic T cells is to engineer them to require combinatorial antigens. Here, we engineer a combinatorially activated T cell circuit in which a synthetic Notch receptor for one antigen induces the expression of a CAR for a second antigen. These dual-receptor AND-gate T cells are only armed and activated in the presence of dual antigen tumor cells. These T cells show precise therapeutic discrimination in vivo-sparing single antigen "bystander'' tumors while efficiently clearing combinatorial antigen "disease'' tumors. This type of precision dual-receptor circuit opens the door to immune recognition of a wider range of tumors.	[Roybal, Kole T.; Rupp, Levi J.; Morsut, Leonardo; Walker, Whitney J.; McNally, Krista A.; Park, Jason S.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Roybal, Kole T.; Rupp, Levi J.; Morsut, Leonardo; Walker, Whitney J.; McNally, Krista A.; Park, Jason S.; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Roybal, Kole T.; Rupp, Levi J.; Morsut, Leonardo; Walker, Whitney J.; McNally, Krista A.; Park, Jason S.; Lim, Wendell A.] Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	wendell.lim@ucsf.edu			Jane Coffin Childs Memorial Fund Postdoctoral Fellowship [A121505]; Human Frontiers of Science Program Postdoctoral Fellowship; NIH [PN2 EY016546, P50GM081879, R01 GM055040, R01 CA196277]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA196277] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB021030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, R01GM055040, P50GM081879] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund Postdoctoral Fellowship; Human Frontiers of Science Program Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Scott Coyle and members of the Lim lab and Arthur Weiss and members of the Weiss lab for helpful discussions and comments on the manuscript. We also thank the Preclinical Therapeutics Core at UCSF for help with in vivo studies and Michael Milone and Carl June (University of Pennsylvania) for the CAR constructs. This work was supported by a Jane Coffin Childs Memorial Fund Postdoctoral Fellowship A121505 (K.T.R.), a Human Frontiers of Science Program Postdoctoral Fellowship (L.M.), and NIH grants PN2 EY016546, P50GM081879, R01 GM055040, and R01 CA196277, and the Howard Hughes Medical Institute (W.A.L.).	Barrett DM, 2014, CURR OPIN PEDIATR, V26, P43, DOI 10.1097/MOP.0000000000000043; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Dotti G, 2014, IMMUNOL REV, V257, P107, DOI 10.1111/imr.12131; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9	18	527	591	12	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					770	779		10.1016/j.cell.2016.01.011	http://dx.doi.org/10.1016/j.cell.2016.01.011			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26830879	Green Accepted, Bronze			2022-12-28	WOS:000369998300021
J	Darcy, AM; Louie, AK; Roberts, LW				Darcy, Alison M.; Louie, Alan K.; Roberts, Laura Weiss			Machine Learning and the Profession of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Darcy, Alison M.; Louie, Alan K.; Roberts, Laura Weiss] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA	Stanford University	Darcy, AM (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA.	adarcy@stanford.edu	Roberts, Laura Weiss/Q-3845-2019	Roberts, Laura Weiss/0000-0003-4270-253X				Aramaki E., 2011, EMNLP 2011; Bedi G, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.30; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Lucas GM, 2014, COMPUT HUM BEHAV, V37, P94, DOI 10.1016/j.chb.2014.04.043; Markoff John, 2015, NY TIMES; Orme Jamie, 2014, GUARDIAN; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	9	198	202	4	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					551	552		10.1001/jama.2015.18421	http://dx.doi.org/10.1001/jama.2015.18421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864406				2022-12-28	WOS:000369635200009
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Jeremy Hunt was wrong to blame the "irresponsible BMA" for his own mistakes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2016	352								i798	10.1136/bmj.i798	http://dx.doi.org/10.1136/bmj.i798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IH	26858263	Bronze, Green Published			2022-12-28	WOS:000370380000015
J	McCaffery, KJ; Jansen, J; Scherer, LD; Thornton, H; Hersch, J; Carter, SM; Barratt, A; Sheridan, S; Moynihan, R; Waller, J; Brodersen, J; Pickles, K; Edwards, A				McCaffery, Kirsten J.; Jansen, Jesse; Scherer, Laura D.; Thornton, Hazel; Hersch, Jolyn; Carter, Stacy M.; Barratt, Alexandra; Sheridan, Stacey; Moynihan, Ray; Waller, Jo; Brodersen, John; Pickles, Kristen; Edwards, Adrian			Walking the tightrope: communicating overdiagnosis in modern healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SHARED DECISION-MAKING; BREAST-CANCER; BACK-PAIN; HARMS; CLINICIAN; PROSTATE; BENEFITS; OVERTREATMENT; TERMINOLOGY; PREFERENCES		[McCaffery, Kirsten J.; Jansen, Jesse; Hersch, Jolyn; Barratt, Alexandra] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Scherer, Laura D.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Thornton, Hazel] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Carter, Stacy M.; Pickles, Kristen] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Sheridan, Stacey] Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC USA; [Moynihan, Ray] Bond Univ, Southport, Qld 4229, Australia; [Waller, Jo] UCL, Epidemiol & Publ Hlth, London WC1E 6BT, England; [Brodersen, John] Univ Copenhagen, Res Unit, DK-1168 Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Sect Gen Practice, Dept Publ Hlth, DK-1168 Copenhagen, Denmark; [Brodersen, John] Primary Hlth Care Res Unit, Aarhus, Zealand Region, Denmark; [Edwards, Adrian] Cardiff Univ, Sch Med, Div Populat Med, Cardiff CF10 3AX, S Glam, Wales	University of Sydney; University of Missouri System; University of Missouri Columbia; University of Leicester; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Bond University; University of London; University College London; University of Copenhagen; University of Copenhagen; Cardiff University	McCaffery, KJ (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	kirsten.mccaffery@sydney.edu.au	Waller, Jo/C-1705-2008; Moynihan, Ray/ABC-3010-2020; Carter, Stacy/A-6544-2011; Pickles, Kristen/AAE-8668-2021; McCaffery, Kirsten/K-7945-2019; Barratt, Alexandra/A-7349-2011; Hersch, Jolyn/H-7153-2013	Waller, Jo/0000-0003-4025-9132; Carter, Stacy/0000-0003-2617-8694; Pickles, Kristen/0000-0002-1621-3217; McCaffery, Kirsten/0000-0003-2696-5006; Barratt, Alexandra/0000-0002-2561-3319; Hersch, Jolyn/0000-0001-5225-6639; Brodersen, John Brandt/0000-0001-9369-3376	National Health and Medical Research Council (NHMRC) [1029241]; NHMRC [1037028]; Cancer Research UK [C7492/A17219]; Cancer Research UK [14134] Funding Source: researchfish	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We have read and understood BMJ policy on declaration of interests and declare KJMcC is supported by a National Health and Medical Research Council (NHMRC) career development fellowship (1029241), JJ is supported by an NHMRC early career fellowship (1037028), and. JW is supported by a career development fellowship from Cancer Research UK (C7492/A17219).	Allegra Carmen J, 2009, NIH Consens State Sci Statements, V26, P1; Arkes HR, 2012, PSYCHOL SCI, V23, P547, DOI 10.1177/0956797612437428; Blacksher E, 2012, HASTINGS CENT REP, V42, P14, DOI 10.1002/hast.26; Buchbinder R, 2008, SPINE, V33, P74, DOI 10.1097/BRS.0b013e31815e39c8; Buchbinder R, 2008, MED J AUSTRALIA, V189, pS29; Centre for Values Ethics and the Law in Medicine, 2015, CANC VAL ETH LAW MED; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Elstad EA, 2015, MED DECIS MAKING, V35, P467, DOI 10.1177/0272989X15569780; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fagerlin A, 2005, MED DECIS MAKING, V25, P614, DOI 10.1177/0272989X05282639; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Gavaruzzi T, 2011, MED DECIS MAKING, V31, P237, DOI 10.1177/0272989X10377116; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Han PKJ, 2013, MED CARE RES REV, V70, p14S, DOI 10.1177/1077558712459361; Heath I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6361; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Hoffman JR, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5702; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P35, DOI 10.5694/mja14.00002; Hoffmann TC, 2014, J GEN INTERN MED, V29, P844, DOI 10.1007/s11606-014-2765-5; Hunt J., 2014, COMMUNICATION; Jorgensen KJ, 2004, BMJ-BRIT MED J, V328, P148, DOI 10.1136/bmj.328.7432.148; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Longman T, 2012, PATIENT EDUC COUNS, V89, P252, DOI 10.1016/j.pec.2012.07.010; McCaffery K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008094; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125165; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Nickel B, 2015, BREAST, V24, P673, DOI 10.1016/j.breast.2015.08.004; Omer ZB, 2013, JAMA INTERN MED, V173, P1830, DOI 10.1001/jamainternmed.2013.8405; Paul C, 2008, HEALTH POLICY, V85, P314, DOI 10.1016/j.healthpol.2007.08.007; Redberg RF, 2013, JAMA INTERN MED, V173, P1769, DOI 10.1001/jamainternmed.2013.9279; Rychetnik L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004682; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Scherer LD, 2013, PEDIATRICS, V131, P839, DOI 10.1542/peds.2012-3070; Schleifer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052552; Schonberg Mara A, 2014, J Clin Trials, V4, P191; Schonberg MA, 2014, JAMA INTERN MED, V174, P417, DOI 10.1001/jamainternmed.2013.13639; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shepherd HL, 2011, PATIENT EDUC COUNS, V84, P379, DOI 10.1016/j.pec.2011.07.022; Sheridan SL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-130; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Waller J, 2015, BRIT J CANCER, V112, P562, DOI 10.1038/bjc.2014.643; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Welch H, 2011, OVERDIAGNOSED MAKING; Wilson AJ, 2012, MED J AUSTRALIA, V197, P324, DOI 10.5694/mja11.11504; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	53	64	65	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2016	352								i348	10.1136/bmj.i348	http://dx.doi.org/10.1136/bmj.i348			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3EV	26850726	Green Published, Green Submitted			2022-12-28	WOS:000369805400002
J	Bachynski, KE				Bachynski, Kathleen E.			Tolerable Risks? Physicians and Youth Tackle Football	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bachynski, Kathleen E.] Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY USA	Columbia University	Bachynski, KE (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY USA.							[Anonymous], 1957, Pa Med J, V60, P627; [Anonymous], 2015, NY TIMES; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Ryan AJ., 1956, JAMA-J AM MED ASSOC, V162, P1160; Walsh J, 1953, WASHINGTON POST	5	23	23	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					405	407		10.1056/NEJMp1513993	http://dx.doi.org/10.1056/NEJMp1513993			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC6GX	26840131				2022-12-28	WOS:000369319100002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Who gains from the media's misrepresentation of science?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Corona G, 2013, ANTIOXID REDOX SIGN, V19, P1676, DOI 10.1089/ars.2012.5142; Emory University; Woodruff Health Sciences Center, 2015, OR LICH SOURC POT AN; Hamill J, 2015, MIRROR          1109; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Palmer William L, 2015, BMJ, V351, ph5774, DOI 10.1136/bmj.h5774; Sheldrick G, 2015, EXPRESS         1021; Spencer B, 2015, DAILY MAIL      1125	7	7	7	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2016	352								i355	10.1136/bmj.i355	http://dx.doi.org/10.1136/bmj.i355			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6CM	26810502	Green Published, Bronze			2022-12-28	WOS:000369307400001
J	Barnett, R				Barnett, Richard			The historian will see you now: introducing Case Histories	LANCET			English	Editorial Material												richard@richardbarnettwriter.com						Kleinert S, 2015, LANCET, V386, P1431, DOI 10.1016/S0140-6736(15)00317-7	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					211	211		10.1016/S0140-6736(16)00038-6	http://dx.doi.org/10.1016/S0140-6736(16)00038-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26842282				2022-12-28	WOS:000368130700011
J	Laurance, J				Laurance, Jeremy			Suniti Solomon Obituary	LANCET			English	Biographical-Item																		SOLOMON S, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1818	1818		10.1016/S0140-6736(15)00772-2	http://dx.doi.org/10.1016/S0140-6736(15)00772-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26843302	Bronze			2022-12-28	WOS:000364194700021
J	Whitty, CJM; Mundel, T; Farrar, J; Heymann, DL; Davies, SC; Walport, MJ				Whitty, Christopher J. M.; Mundel, Trevor; Farrar, Jeremy; Heymann, David L.; Davies, Sally C.; Walport, Mark J.			Providing incentives to share data early in health emergencies: the role of journal editors	LANCET			English	Editorial Material							OUTBREAK		[Whitty, Christopher J. M.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Mundel, Trevor] Bill & Melinda Gates Fdn, Global Hlth Div, Seattle, WA USA; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England; [Heymann, David L.] Publ Hlth England, London, England; [Davies, Sally C.] Dept Hlth, London SE1 6TE, England; [Walport, Mark J.] Govt Off Sci, London, England	University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation; Public Health England	Whitty, CJM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	christopher.whitty@lshtm.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Whitty, Christopher/0000-0002-6076-5027; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Groves T., 2015, THE BMJ BLOGS   0908; Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; World Health Organization, 2015, DEV GLOB NORMS SHAR	7	23	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1797	1798		10.1016/S0140-6736(15)00758-8	http://dx.doi.org/10.1016/S0140-6736(15)00758-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV3VO	26843294	Green Published, hybrid			2022-12-28	WOS:000364194700008
J	Davis, MM; Glimcher, LH				Davis, Mark M.; Glimcher, Laurie H.			William Erwin Paul (1936-2015) Obituary	CELL			English	Biographical-Item									[Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol,Inst Immun Transplantat, Stanford, CA 94304 USA; [Glimcher, Laurie H.] Weill Cornell Med, Off Dean, New York, NY 10065 USA; [Glimcher, Laurie H.] Weill Cornell Med, Dept Med, New York, NY 10065 USA	Howard Hughes Medical Institute; Stanford University; Cornell University; Cornell University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol,Inst Immun Transplantat, Stanford, CA 94304 USA.	mmdavis@stanford.edu; lglimche@med.cornell.edu		Davis, Mark/0000-0001-6868-657X				PAUL WE, PUBLICATION LIST	1	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 22	2015	163	3					529	530		10.1016/j.cell.2015.10.024	http://dx.doi.org/10.1016/j.cell.2015.10.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW2NK	26807452	Bronze			2022-12-28	WOS:000364828900001
J	Kim, KS; Hong, SW; Han, D; Yi, J; Jung, J; Yang, BG; Lee, JY; Lee, MJ; Surh, CD				Kim, Kwang Soon; Hong, Sung-Wook; Han, Daehee; Yi, Jaeu; Jung, Jisun; Yang, Bo-Gie; Lee, Jun Young; Lee, Minji; Surh, Charles D.			Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine	SCIENCE			English	Article							ORAL TOLERANCE; RETINOIC-ACID; DENDRITIC CELLS; REG-CELLS; DIFFERENTIATION; POPULATION; GENERATION; DIVERSITY; ABSENCE; MICE	Dietary antigens are normally rendered nonimmunogenic through a poorly understood "oral tolerance" mechanism that involves immunosuppressive regulatory T (T-reg) cells, especially Treg cells induced from conventional T cells in the periphery (pT(reg) cells). Although orally introducing nominal protein antigens is known to induce such pTreg cells, whether a typical diet induces a population of pT(reg) cells under normal conditions thus far has been unknown. By using germ-free mice raised and bred on an elemental diet devoid of dietary antigens, we demonstrated that under normal conditions, the vast majority of the small intestinal pT(reg) cells are induced by dietary antigens from solid foods. Moreover, these pT(reg) cells have a limited life span, are distinguishable from microbiota-induced pT(reg) cells, and repress underlying strong immunity to ingested protein antigens.	[Kim, Kwang Soon; Hong, Sung-Wook; Han, Daehee; Yi, Jaeu; Jung, Jisun; Yang, Bo-Gie; Lee, Jun Young; Lee, Minji; Surh, Charles D.] Acad Immunol & Microbiol, Inst Basic Sci, Pohang, South Korea; [Kim, Kwang Soon; Hong, Sung-Wook; Han, Daehee; Yi, Jaeu; Jung, Jisun; Yang, Bo-Gie; Lee, Jun Young; Lee, Minji; Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); La Jolla Institute for Immunology	Surh, CD (corresponding author), Acad Immunol & Microbiol, Inst Basic Sci, Pohang, South Korea.; Surh, CD (corresponding author), Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang, South Korea.; Surh, CD (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.	csurh@ibs.re.kr		Yang, Bo-Gie/0000-0002-1538-8488	Institute for Basic Science, Korean Ministry of Science, Information/Communication Technology and Future Planning [IBS-R005-D1]	Institute for Basic Science, Korean Ministry of Science, Information/Communication Technology and Future Planning	We thank A. Macpherson, K. McCoy, and D. Artis for generously providing various strains of germ-free mice to start our colony; T. K. Kim, J. W. Seo, M. O. Lee, H. J. Woo, H. J. Jung, H. J. Ko, J. Kirundi, S. Sakaguchi, and N. Ohkura for technical support; and J. Sprent, S. H. Im, M. H. Jang, D. Rudra, and J. H. Cho for discussions. The data from this study are tabulated in the main paper and in the supplementary materials. This work was supported by project IBS-R005-D1 of the Institute for Basic Science, Korean Ministry of Science, Information/Communication Technology and Future Planning.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Longo G, 2013, LANCET, V382, P1656, DOI 10.1016/S0140-6736(13)60309-8; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; PEREIRA P, 1986, EUR J IMMUNOL, V16, P685, DOI 10.1002/eji.1830160616; PLEASANTS JR, 1986, J NUTR, V116, P1949, DOI 10.1093/jn/116.10.1949; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; WOSTMANN BS, 1991, P SOC EXP BIOL MED, V198, P539	27	295	310	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					858	863		10.1126/science.aac5560	http://dx.doi.org/10.1126/science.aac5560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26822607				2022-12-28	WOS:000370325700044
J	Ayyer, K; Yefanov, OM; Oberthur, D; Roy-Chowdhury, S; Galli, L; Mariani, V; Basu, S; Coe, J; Conrad, CE; Fromme, R; Schaffer, A; Droner, K; James, D; Kupitz, C; Metz, M; Nelson, G; Xavier, PL; Beyerlein, KR; Schmidt, M; Sarrou, I; Spence, JCH; Weierstall, U; White, TA; Yang, JH; Zhao, Y; Liang, MN; Aquila, A; Hunter, MS; Robinson, JS; Koglin, JE; Boutet, S; Fromme, P; Barty, A; Chapman, HN				Ayyer, Kartik; Yefanov, Oleksandr M.; Oberthuer, Dominik; Roy-Chowdhury, Shatabdi; Galli, Lorenzo; Mariani, Valerio; Basu, Shibom; Coe, Jesse; Conrad, Chelsie E.; Fromme, Raimund; Schaffer, Alexander; Droener, Katerina; James, Daniel; Kupitz, Christopher; Metz, Markus; Nelson, Garrett; Xavier, Paulraj Lourdu; Beyerlein, Kenneth R.; Schmidt, Marius; Sarrou, Iosifina; Spence, John C. H.; Weierstall, Uwe; White, Thomas A.; Yang, Jay-How; Zhao, Yun; Liang, Mengning; Aquila, Andrew; Hunter, Mark S.; Robinson, Joseph S.; Koglin, Jason E.; Boutet, Sebastien; Fromme, Petra; Barty, Anton; Chapman, Henry N.			Macromolecular diffractive imaging using imperfect crystals	NATURE			English	Article							X-RAY SCATTERING; DIFFUSE-SCATTERING; PHASE RETRIEVAL; RESOLUTION; CRYSTALLOGRAPHY; RECONSTRUCTION; COMPLEX; OBJECT; MODEL	The three-dimensional structures of macromolecules and their complexes are mainly elucidated by X-ray protein crystallography. A major limitation of this method is access to high-quality crystals, which is necessary to ensure X-ray diffraction extends to sufficiently large scattering angles and hence yields information of sufficiently high resolution with which to solve the crystal structure. The observation that crystals with reduced unit-cell volumes and tighter macromolecular packing often produce higher-resolution Bragg peaks(1,2) suggests that crystallographic resolution for some macromolecules may be limited not by their heterogeneity, but by a deviation of strict positional ordering of the crystalline lattice. Such displacements of molecules from the ideal lattice give rise to a continuous diffraction pattern that is equal to the incoherent sum of diffraction from rigid individual molecular complexes aligned along several discrete crystallographic orientations and that, consequently, contains more information than Bragg peaks alone(3). Although such continuous diffraction patterns have long been observed-and are of interest as a source of information about the dynamics of proteins(4)-they have not been used for structure determination. Here we show for crystals of the integral membrane protein complex photosystem II that lattice disorder increases the information content and the resolution of the diffraction pattern well beyond the 4.5-angstrom limit of measurable Bragg peaks, which allows us to phase(5) the pattern directly. Using the molecular envelope conventionally determined at 4.5 angstroms as a constraint, we obtain a static image of the photosystem II dimer at a resolution of 3.5 angstroms. This result shows that continuous diffraction can be used to overcome what have long been supposed to be the resolution limits of macromolecular crystallography, using a method that exploits commonly encountered imperfect crystals and enables modelfree phasing(6,7).	[Ayyer, Kartik; Yefanov, Oleksandr M.; Galli, Lorenzo; Mariani, Valerio; Droener, Katerina; Xavier, Paulraj Lourdu; Beyerlein, Kenneth R.; White, Thomas A.; Barty, Anton; Chapman, Henry N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Oberthuer, Dominik; Galli, Lorenzo; Metz, Markus; Xavier, Paulraj Lourdu; Chapman, Henry N.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Roy-Chowdhury, Shatabdi; Basu, Shibom; Coe, Jesse; Conrad, Chelsie E.; Fromme, Raimund; Schaffer, Alexander; Droener, Katerina; Kupitz, Christopher; Yang, Jay-How; Fromme, Petra] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Roy-Chowdhury, Shatabdi; Basu, Shibom; Coe, Jesse; Conrad, Chelsie E.; Fromme, Raimund; Schaffer, Alexander; James, Daniel; Nelson, Garrett; Spence, John C. H.; Weierstall, Uwe; Yang, Jay-How; Zhao, Yun; Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [James, Daniel; Nelson, Garrett; Spence, John C. H.; Weierstall, Uwe; Zhao, Yun] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Kupitz, Christopher; Schmidt, Marius] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Sarrou, Iosifina] Fdn Res & Technol, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Greece; [Liang, Mengning; Aquila, Andrew; Hunter, Mark S.; Robinson, Joseph S.; Koglin, Jason E.; Boutet, Sebastien] SLAC, Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22607 Hamburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Chapman, HN (corresponding author), DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany.	henry.chapman@desy.de	Fromme, Raimund/AAG-6578-2019; Sarrou, Iosifina/AAD-5794-2022; Beyerlein, Kenneth/ABB-9823-2020; Schmidt, Marius/A-1537-2014; FRS, Henry N Chapman/G-2153-2010; Basu, Shibom/GLU-3308-2022; Oberthuer, Dominik/AAG-5059-2021; Fromme, Raimund/W-5838-2019; Barty, Anton/K-5137-2014; Fromme, Raimund/C-8885-2012; Xavier, P. Lourdu/T-8283-2017; Ayyer, Kartik/F-9291-2015	Sarrou, Iosifina/0000-0002-6963-5341; Beyerlein, Kenneth/0000-0002-7701-4369; Schmidt, Marius/0000-0002-0962-9468; FRS, Henry N Chapman/0000-0002-4655-1743; Basu, Shibom/0000-0001-6484-8236; Oberthuer, Dominik/0000-0002-0894-9590; Fromme, Raimund/0000-0003-4835-1080; Barty, Anton/0000-0003-4751-2727; Fromme, Raimund/0000-0003-4835-1080; Xavier, P. Lourdu/0000-0001-5132-2999; Ayyer, Kartik/0000-0002-6881-564X; Aquila, Andrew/0000-0003-0358-2774; Yefanov, Oleksandr/0000-0001-8676-0091; White, Thomas/0000-0002-8407-0270; Fromme, Petra/0000-0003-0953-4909	Helmholtz Association; Virtual Institute "Dynamic Pathways in Multidimensional Landscapes"; DFG through the Gottfried Wilhelm Leibniz Program; European Research Council under the European Union's Seventh Framework Programme ERC Synergy Grant [609920]; Marie Curie FP7-PEOPLE-ITN [317079]; BMBF [05E13GU1]; Graduate College at the University of Hamburg [GRK 1355]; International Max Planck Research School UFAST; BioXFEL Science Technology Center [1231306]; US National Institutes of Health (NIH); National Institute of General Medical Sciences [R01 GM095583, U54 GM094599, R01 GM097463]; NIH [P41GM103393, P41RR001209]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, P41GM103393, R01GM095583, R01GM097463] Funding Source: NIH RePORTER	Helmholtz Association(Helmholtz Association); Virtual Institute "Dynamic Pathways in Multidimensional Landscapes"; DFG through the Gottfried Wilhelm Leibniz Program; European Research Council under the European Union's Seventh Framework Programme ERC Synergy Grant; Marie Curie FP7-PEOPLE-ITN; BMBF(Federal Ministry of Education & Research (BMBF)); Graduate College at the University of Hamburg; International Max Planck Research School UFAST; BioXFEL Science Technology Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support of the Helmholtz Association through project-oriented funds and the Virtual Institute "Dynamic Pathways in Multidimensional Landscapes"; the DFG through the Gottfried Wilhelm Leibniz Program; the European Research Council under the European Union's Seventh Framework Programme ERC Synergy Grant 609920 "AXSIS" and Marie Curie FP7-PEOPLE-2011-ITN Grant 317079 "Nanomem"; the BMBF through Project 05E13GU1; the Graduate College "GRK 1355" at the University of Hamburg, the International Max Planck Research School UFAST, the BioXFEL Science Technology Center (award 1231306); and the US National Institutes of Health (NIH), National Institute of General Medical Sciences grants R01 GM095583, U54 GM094599, and R01 GM097463. Parts of the sample injector used at the Linac Coherent Light Source (LCLS) for this research was funded by the NIH, P41GM103393, formerly P41RR001209. Use of the LCLS, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BATES RHT, 1982, OPTIK, V61, P247; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; CASPAR DLD, 1988, NATURE, V332, P659, DOI 10.1038/332659a0; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chapman HN, 2010, NAT PHOTONICS, V4, P833, DOI 10.1038/nphoton.2010.240; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Cowley J. M., 1981, DIFFRACTION PHYSICS, P150; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; DOUCET J, 1987, NATURE, V325, P643, DOI 10.1038/325643a0; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; Elser V, 2008, ACTA CRYSTALLOGR A, V64, P273, DOI 10.1107/S0108767307050684; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; FAURE P, 1994, NAT STRUCT BIOL, V1, P124, DOI 10.1038/nsb0294-124; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Guinier A., 1994, XRAY DIFFRACTION CRY; Hart P, 2012, PROC SPIE, V8504, DOI 10.1117/12.930924; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Liang MN, 2015, J SYNCHROTRON RADIAT, V22, P514, DOI 10.1107/S160057751500449X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Perez J, 1996, ACTA CRYSTALLOGR D, V52, P722, DOI 10.1107/S0907444996002594; Robinson IK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195505; Rupp B., 2009, BIOMOLECULAR CRYSTAL, V10; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Spence JCH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198102; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Urzhumtsev A, 2014, ACTA CRYSTALLOGR D, V70, P2593, DOI 10.1107/S1399004714016289; Wall ME, 1997, P NATL ACAD SCI USA, V94, P6180, DOI 10.1073/pnas.94.12.6180; Wall ME, 2014, STRUCTURE, V22, P182, DOI 10.1016/j.str.2014.01.002; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Welberry TR, 2011, ACTA CRYSTALLOGR B, V67, P516, DOI 10.1107/S0108768111037542; White TA, 2013, ACTA CRYSTALLOGR D, V69, P1231, DOI 10.1107/S0907444913013620; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; WILSON AJC, 1949, ACTA CRYSTALLOGR, V2, P318, DOI 10.1107/S0365110X49000813; Yefanov O, 2015, OPT EXPRESS, V23, P28459, DOI 10.1364/OE.23.028459; Yefanov O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0333	47	92	92	0	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					202	+		10.1038/nature16949	http://dx.doi.org/10.1038/nature16949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863980	Green Accepted, Green Published			2022-12-28	WOS:000369916700035
J	Zhu, YJ; Wienecke, CFR; Nachtrab, G; Chen, XK				Zhu, Yingjie; Wienecke, Carl F. R.; Nachtrab, Gregory; Chen, Xiaoke			A thalamic input to the nucleus accumbens mediates opiate dependence	NATURE			English	Article							SYNAPTIC ADAPTATIONS; REWARD; TRANSMISSION; MOTIVATION; WITHDRAWAL; RECEPTORS; BEHAVIOR; MORPHINE; AMYGDALA; ACTIVATION	Chronic opiate use induces opiate dependence, which is characterized by extremely unpleasant physical and emotional feelings after drug use is terminated. Both the rewarding effects of a drug and the desire to avoid withdrawal symptoms motivate continued drug use(1-3), and the nucleus accumbens is important for orchestrating both processes(4,5). While multiple inputs to the nucleus accumbens regulate reward(6-9), little is known about the nucleus accumbens circuitry underlying withdrawal. Here we identify the paraventricular nucleus of the thalamus as a prominent input to the nucleus accumbens mediating the expression of opiate-withdrawal-induced physical signs and aversive memory. Activity in the paraventricular nucleus of the thalamus to nucleus accumbens pathway is necessary and sufficient to mediate behavioural aversion. Selectively silencing this pathway abolishes aversive symptoms in two different mouse models of opiate withdrawal. Chronic morphine exposure selectively potentiates excitatory transmission between the paraventricular nucleus of the thalamus and D2-receptor-expressing medium spiny neurons via synaptic insertion of GluA2-lacking AMPA receptors. Notably, in vivo optogenetic depotentiation restores normal transmission at these synapses and robustly suppresses morphine withdrawal symptoms. This links morphine-evoked pathway-and cell-type-specific plasticity in the paraventricular nucleus of the thalamus to nucleus accumbens circuit to opiate dependence, and suggests that reprogramming this circuit holds promise for treating opiate addiction.	[Zhu, Yingjie; Wienecke, Carl F. R.; Nachtrab, Gregory; Chen, Xiaoke] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Chen, XK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	xkchen@stanford.edu	Core, Vector/CAF-4832-2022		Whitehall Foundation; Ajinomoto innovation alliance program; Terman Scholarship; Stanford University; National Institute on Drug Abuse [5T32DA035165-02]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA035165] Funding Source: NIH RePORTER	Whitehall Foundation; Ajinomoto innovation alliance program; Terman Scholarship; Stanford University(Stanford University); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. C. Malenka, K. Shen, L. Luo, T. R. Clandinin and members of the Chen laboratory for comments on the manuscript. We thank M. Asaad, J. Charalel and X. Sun for tracing and behaviour experiments. This work was supported by grants from The Whitehall Foundation, the Ajinomoto innovation alliance program, the Terman Scholarship and start-up funding from Stanford University. G.N. is supported by a training grant from the National Institute on Drug Abuse (5T32DA035165-02).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BECHARA A, 1995, BEHAV NEUROSCI, V109, P91, DOI 10.1037/0735-7044.109.1.91; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Browning JR, 2014, DRUG ALCOHOL DEPEN, V134, P387, DOI 10.1016/j.drugalcdep.2013.09.021; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; HARRIS GC, 1994, NATURE, V371, P155, DOI 10.1038/371155a0; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; James MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012980; KOOB GF, 1989, PSYCHOPHARMACOLOGY, V98, P530, DOI 10.1007/BF00441954; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Martin-Fardon R, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00075; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Schwartz N, 2014, SCIENCE, V345, P535, DOI 10.1126/science.1253994; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vanderschuren LJMJ, 1997, PSYCHOPHARMACOLOGY, V131, P115, DOI 10.1007/s002130050273; Vargas-Perez H, 2007, EUR J NEUROSCI, V25, P3713, DOI 10.1111/j.1460-9568.2007.05599.x; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wikler A, 1980, NIDA Res Monogr, V30, P174; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Yasoshima Y, 2007, NEUROSCIENCE, V146, P922, DOI 10.1016/j.neuroscience.2007.02.044	35	214	218	7	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					219	+		10.1038/nature16954	http://dx.doi.org/10.1038/nature16954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840481	Green Accepted			2022-12-28	WOS:000369916700039
J	Dheda, K				Dheda, Keertan			Tuberculosis and Poncet's disease: the many faces of an old enemy	LANCET			English	Editorial Material									[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za						Abdulaziz S, 2012, CLIN RHEUMATOL, V31, P1521, DOI 10.1007/s10067-012-2042-0; Arora S, 2016, LANCET, V387, P617, DOI 10.1016/S0140-6736(16)00157-4; Dheda K, 2015, LANCET; Peter JG, 2015, LANCET IN PRESS; Rueda JC, 2013, CLIN RHEUMATOL, V32, P929, DOI 10.1007/s10067-013-2270-y	5	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					618	618		10.1016/S0140-6736(16)00090-8	http://dx.doi.org/10.1016/S0140-6736(16)00090-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26867451				2022-12-28	WOS:000369835800040
J	de Dieuleveult, M; Yen, KY; Hmitou, I; Depaux, A; Oussouar, FB; Dargham, DB; Jounier, S; Humbertclaude, H; Ibierre, FR; Baulard, C; Farrell, NP; Park, B; Keime, C; Carriere, L; Erlivet, SB; Gut, M; Gut, I; Werner, M; Deleuze, JF; Olaso, R; Aude, JC; Chantalat, S; Pugh, BFR; Gerard, M				de Dieuleveult, Maud; Yen, Kuangyu; Hmitou, Isabelle; Depaux, Arnaud; Oussouar, Faycal B.; Dargham, Daria Bou; Jounier, Sylvie; Humbertclaude, Helene; Ibierre, Florence R.; Baulard, Celine; Farrell, Nina P.; Park, Bongsoo; Keime, Celine; Carriere, Lucie; Erlivet, Soizick B.; Gut, Marta; Gut, Ivo; Werner, Michel; Deleuze, Jean-Francois; Olaso, Robert; Aude, Jean-Christophe; Chantalat, Sophie; Pugh, B. F. Ranklin; Gerard, Matthieu			Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION ELONGATION; CPG ISLANDS; PLURIPOTENCY; BINDING; ESBAF	ATP-dependent chromatin remodellers allow access to DNA for transcription factors and the general transcription machinery, but whether mammalian chromatin remodellers(1-3) target specific nucleosomes to regulate transcription is unclear. Here we present genome-wide remodeller-nucleosome interaction profiles for the chromatin remodellers Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind one or both full nucleosomes that flank micrococcal nuclease (MNase)-defined nucleosome-free promoter regions (NFRs), where they separate divergent transcription. Surprisingly, large CpG-rich NFRs that extend downstream of annotated transcriptional start sites are nevertheless bound by non-nucleosomal or subnucleosomal histone variants (H3.3 and H2A.Z) and marked by H3K4me3 and H3K27ac modifications. RNA polymerase II therefore navigates hundreds of base pairs of altered chromatin in the sense direction before encountering an MNase-resistant nucleosome at the 3' end of the NFR. Transcriptome analysis after remodeller depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. Whereas at active genes individual remodellers have either positive or negative roles via altering nucleosome stability, at polycomb-enriched bivalent genes the same remodellers act in an opposite manner. These findings indicate that remodellers target specific nucleosomes at the edge of NFRs, where they regulate ES cell transcriptional programs.	[de Dieuleveult, Maud; Hmitou, Isabelle; Depaux, Arnaud; Oussouar, Faycal B.; Dargham, Daria Bou; Jounier, Sylvie; Humbertclaude, Helene; Carriere, Lucie; Erlivet, Soizick B.; Werner, Michel; Aude, Jean-Christophe; Gerard, Matthieu] Univ Paris Saclay, Univ Paris Sud, I2BC, IBITECS,CEA,CNRS, F-91198 Gif Sur Yvette, France; [Yen, Kuangyu] Southern Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Dept Dev Biol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China; [Yen, Kuangyu; Farrell, Nina P.; Park, Bongsoo; Pugh, B. F. Ranklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Ibierre, Florence R.; Baulard, Celine; Deleuze, Jean-Francois; Olaso, Robert; Chantalat, Sophie] CEA, Ctr Natl Genotypage, Inst Genom, F-91057 Evry, France; [Keime, Celine] Univ Strasbourg, IGBMC, CNRS, UMR7104,INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Oussouar, Faycal B.] Univ Grenoble Alpes, INSERM, U823, Inst Albert Bonniot Grenoble, F-38700 Grenoble, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	de Dieuleveult, M (corresponding author), Univ Paris Saclay, Univ Paris Sud, I2BC, IBITECS,CEA,CNRS, F-91198 Gif Sur Yvette, France.; Yen, KY (corresponding author), Southern Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Dept Dev Biol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China.; Yen, KY (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	matthieu.gerard@cea.fr; kuangyuyen@smu.edu.cn; bfp2@psu.edu	Olaso, Robert/AAC-4162-2019; Gut, Ivo/ABF-3188-2020; Hmitou, Isabelle/H-8341-2017; Boussouar, Fayçal/E-7542-2019; GERARD, Matthieu/D-2235-2014; Werner, Michel/B-7316-2009	Gut, Ivo/0000-0001-7219-632X; Hmitou, Isabelle/0000-0001-7320-6075; Boussouar, Fayçal/0000-0003-4529-4893; GERARD, Matthieu/0000-0001-8956-0597; de Dieuleveult, Maud/0000-0002-3387-1836; Werner, Michel/0000-0002-2965-5858; KEIME, Celine/0000-0001-7604-3814; AUDE, Jean-Christophe/0000-0002-1755-7417	CEA; Association pour la Recherche sur le Cancer [3164]; Agence Nationale de la Recherche [ANR-05-BLAN-0396]; Fondation pour la Recherche Medicale (FRM); National Institutes of Health [HG004160]; Southern Medical University [B1000465]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160, R56HG004160] Funding Source: NIH RePORTER	CEA(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Medical University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. C. Andrau, S. Ravens, L. Tora and M. de Chaldee for critical reading, J. B. Charbonnier's team for sharing material, A. Krebs, T. Ye, I. Davidson, R. Guerois and F. Ochsenbein for discussions, and A. Martel for computational assistance. This work was supported by the CEA, and by grants from the Association pour la Recherche sur le Cancer (grant 3164), the Agence Nationale de la Recherche (ANR-05-BLAN-0396), the Fondation pour la Recherche Medicale (FRM), the National Institutes of Health (grant HG004160, to B.F.P.) and from Southern Medical University (grant B1000465, to K.Y.).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; Berlivet S, 2010, METHODS MOL BIOL, V650, P85, DOI 10.1007/978-1-60761-769-3_7; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tessarollo L, 2000, METH MOL B, V158, P47; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yildirim O, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004515; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yukawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092689	37	120	122	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					113	+		10.1038/nature16505	http://dx.doi.org/10.1038/nature16505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814966	Green Accepted			2022-12-28	WOS:000369304500043
J	Gibney, E				Gibney, Elizabeth			LOW-COST JOURNALS PIGGYBACK ON ARXIV	NATURE			English	Editorial Material																			0	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					117	118		10.1038/530117a	http://dx.doi.org/10.1038/530117a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26854297				2022-12-28	WOS:000369304500044
J	Syngelaki, A; Nicolaides, KH; Balani, J; Hyer, S; Akolekar, R; Kotecha, R; Pastides, A; Shehata, H				Syngelaki, Argyro; Nicolaides, Kypros H.; Balani, Jyoti; Hyer, Steve; Akolekar, Ranjit; Kotecha, Reena; Pastides, Alice; Shehata, Hassan			Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; MATERNAL OBESITY; DOUBLE-BLIND; OVERWEIGHT; OUTCOMES; INSULIN; HYPERGLYCEMIA; HYPERTENSION	BACKGROUND Obesity is associated with an increased risk of adverse pregnancy outcomes. Lifestyle-intervention studies have not shown improved outcomes. Metformin improves insulin sensitivity and in pregnant patients with gestational diabetes it leads to less weight gain than occurs in those who do not take metformin. METHODS In this double-blind, placebo-controlled trial, we randomly assigned pregnant women without diabetes who had a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of more than 35 to receive metformin, at a dose of 3.0 g per day, or placebo (225 women in each group) from 12 to 18 weeks of gestation until delivery. The BMI was calculated at the time of study entry (12 to 18 weeks of gestation). The primary outcome was a reduction in the median neonatal birth-weight z score by 0.3 SD (equivalent to a 50% reduction, from 20% to 10%, in the incidence of large-for-gestational-age neonates). Secondary outcomes included maternal gestational weight gain and the incidence of gestational diabetes and of preeclampsia, as well as the incidence of adverse neonatal outcomes. Randomization was performed with the use of computer-generated random numbers. The analysis was performed according to the intention-to-treat principle. RESULTS A total of 50 women withdrew consent during the trial, which left 202 women in the metformin group and 198 in the placebo group. There was no significant between-group difference in the median neonatal birth-weight z score (0.05 in the metformin group [interquartile range, -0.71 to 0.92] and 0.17 in the placebo group [interquartile range, -0.62 to 0.89], P = 0.66). The median maternal gestational weight gain was lower in the metformin group than in the placebo group (4.6 kg [interquartile range, 1.3 to 7.2] vs. 6.3 kg [interquartile range, 2.9 to 9.2], P<0.001), as was the incidence of preeclampsia (3.0% vs. 11.3%; odds ratio, 0.24; 95% confidence interval, 0.10 to 0.61; P = 0.001). The incidence of side effects was higher in the metformin group than in the placebo group. There were no significant between-group differences in the incidence of gestational diabetes, large-for-gestational-age neonates, or adverse neonatal outcomes. CONCLUSIONS Among women without diabetes who had a BMI of more than 35, the antenatal administration of metformin reduced maternal weight gain but not neonatal birth weight.	[Syngelaki, Argyro; Nicolaides, Kypros H.; Akolekar, Ranjit; Kotecha, Reena; Pastides, Alice] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England; [Balani, Jyoti; Hyer, Steve] Epsom & St Helier Univ Hosp NHS Trust, Dept Endocrinol, London SM5 1AA, England; [Shehata, Hassan] Epsom & St Helier Univ Hosp NHS Trust, Dept Maternal Med, London SM5 1AA, England; [Akolekar, Ranjit] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Kent, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Medway Maritime Hospital	Shehata, H (corresponding author), Epsom & St Helier Univ Hosp NHS Trust, Dept Maternal Med, London SM5 1AA, England.	hassan.shehata@nhs.net		Syngelaki, Argyro/0000-0001-5856-6072; Nicolaides, Kypros/0000-0003-1266-0711	Fetal Medicine Foundation [2008-005892-83]	Fetal Medicine Foundation	Funded by the Fetal Medicine Foundation; ClinicalTrials.gov number, NCT01273584; EudraCT number, 2008-005892-83.	American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Balani J, 2009, DIABETIC MED, V26, P798, DOI 10.1111/j.1464-5491.2009.02780.x; Barton JR, 2015, AM J PERINAT, V32, P615, DOI 10.1055/s-0034-1386634; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Cassina M, 2014, HUM REPROD UPDATE, V20, P656, DOI 10.1093/humupd/dmu022; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Chiswick C, 2015, LANCET DIABETES ENDO, V3, P778, DOI 10.1016/S2213-8587(15)00219-3; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Fougner KJ, 2008, SCAND J CLIN LAB INV, V68, P771, DOI 10.1080/00365510802254620; Garcia-Patterson A, 2012, J CLIN ENDOCR METAB, V97, P1623, DOI 10.1210/jc.2011-3425; Gavin JR, 1997, DIABETES CARE, V20, P1183; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Johansson S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6572; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oteng-Ntim E, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-47; Poon LCY, 2012, FETAL DIAGN THER, V32, P156, DOI 10.1159/000338655; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Rogozinska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115526; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Salvesen KA, 2007, ULTRASOUND OBST GYN, V29, P433, DOI 10.1002/uog.3965; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Syngelaki A, 2011, FETAL DIAGN THER, V30, P250, DOI 10.1159/000328083; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Vanky E, 2010, J CLIN ENDOCR METAB, V95, pE448, DOI 10.1210/jc.2010-0853; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	33	184	198	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					434	443		10.1056/NEJMoa1509819	http://dx.doi.org/10.1056/NEJMoa1509819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840133	Bronze			2022-12-28	WOS:000369319100006
J	Wallace, E; Smith, SM; Fahey, T; Roland, M				Wallace, Emma; Smith, Susan M.; Fahey, Tom; Roland, Martin			Reducing emergency admissions through community based interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK PREDICTION MODELS; PRIMARY-CARE; HOSPITAL READMISSIONS; GUIDED CARE; HEALTH-CARE; MANAGEMENT; OUTCOMES; QUALITY; IMPACT; ADULTS		[Wallace, Emma; Smith, Susan M.; Fahey, Tom] Royal Coll Surgeons Ireland, Dept Gen Practice, HRB Ctr Primary Care Res, 123 St Stephens Green, Dublin 2, Ireland; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 1TN, England	Health Research Board - Ireland; Royal College of Surgeons - Ireland; University of Cambridge	Wallace, E (corresponding author), Royal Coll Surgeons Ireland, Dept Gen Practice, HRB Ctr Primary Care Res, 123 St Stephens Green, Dublin 2, Ireland.	emmawallace@rcsi.ie	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; wallace, emma/0000-0002-9315-2956; Smith, Susan/0000-0001-6027-2727; Roland, Martin/0000-0002-8533-3060				Abualenain J, 2013, ANN EMERG MED, V61, P638, DOI 10.1016/j.annemergmed.2013.01.016; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Billings J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003352; Blunt I., 2013, FOCUS PREVENTABLE AD; BMA NHS England NHS Employers, 2014, AVOID UNPL ADM ENH S; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Centers for Medicare and Medicaid Services, 2015, ACC CAR ORG 2015 PRO; Centers for Medicare and Medicaid services, 2014, SUMM FIN RUL PROV AC; Chitnis XA, 2013, BMJ SUPPORT PALLIAT, V3, P422, DOI 10.1136/bmjspcare-2012-000424; Deschodt M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-48; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Gao J, 2014, MED CARE, V52, P164, DOI 10.1097/MLR.0000000000000041; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Harrison MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6423; Hastings SN, 2005, ACAD EMERG MED, V12, P978, DOI 10.1197/j.aem.2005.05.032; Huntley AL, 2013, FAM PRACT, V30, P266, DOI 10.1093/fampra/cms081; IS Scotland, 2011, SCOTT PAT RISK READM; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keogh C, 2014, ANN FAM MED, V12, P359, DOI 10.1370/afm.1640; Kiran T, 2010, J EPIDEMIOL COMMUN H, V64, P927, DOI 10.1136/jech.2009.098806; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lewis GH, 2013, IMPACT VIRTUAL WARDS; Louis DZ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005223; Miani C, 2014, HLTH SERVICES DELIVE, V2, P52, DOI [DOI 10.3310/HSDR02520, 10.3310/hsdr02520]; Michalopoulos C, 2014, FINAL REPORT EVALUAT; National Audit Office, 2013, EM ADM HOSP MAN DEM; National Primary Care Research and Development Centre, 2006, EV EV FIN REP; NHS England, 2015, NEXT STEPS RISK STRA; Nuffield Trust Research Group, 2011, PRED RISK HEALTHC OV; O'Cathain A, 2013, HEALTH SERV MANAG RE, V26, P110, DOI 10.1177/0951484814525357; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; Public Health Division, 2001, VICT AMB CAR SENS CO; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Purdy S, 2012, INTERVENTIONS REDUCE; Simmonds RL, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X658278; Sinha SK, 2011, ANN EMERG MED, V57, P672, DOI 10.1016/j.annemergmed.2011.01.021; Stokes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132340; Tian, 2012, DATA BRIEFING EMERGE; Verhaegh KJ, 2014, HEALTH AFFAIR, V33, P1531, DOI 10.1377/hlthaff.2014.0160; Wallace E, 2014, MED CARE, V52, P751, DOI 10.1097/MLR.0000000000000171	43	36	36	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2016	352								h6817	10.1136/bmj.h6817	http://dx.doi.org/10.1136/bmj.h6817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EX	26822070				2022-12-28	WOS:000369313700001
J	Bajwa, R; Kaur, PP; Paluzzi, A				Bajwa, Ramdeep; Kaur, Paven Preet; Paluzzi, Alessandro			CASE REVIEW Headaches and hormones: a potentially lethal combination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PITUITARY APOPLEXY; MANAGEMENT		[Bajwa, Ramdeep] City Hosp Birmingham, Dept Med, Birmingham, W Midlands, England; [Kaur, Paven Preet] Townsville Hosp, Dept Gen Med Surg, Townsville, Qld, Australia; [Paluzzi, Alessandro] Queen Elizabeth Hosp, Dept Neurosurg, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Bajwa, R (corresponding author), Gold Coast Univ Hosp, Dept Emergency Med, Southport, Qld, Australia.	rameybajwa@gmail.com						Ayuk J, 2004, CLIN ENDOCRINOL, V61, P747, DOI 10.1111/j.1365-2265.2004.02162.x; BROUGHAM M, 1950, J NEUROSURG, V7, P421, DOI 10.3171/jns.1950.7.5.0421; GORCZYCA W, 1988, NEUROSURGERY, V22, P1, DOI 10.1227/00006123-198801000-00001; Gruber A, 2006, BRIT J NEUROSURG, V20, P379, DOI 10.1080/02688690601046678; MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190; Nawar Rita N, 2008, J Intensive Care Med, V23, P75, DOI 10.1177/0885066607312992; Ogra S, 2014, J CLIN NEUROSCI, V21, P735, DOI 10.1016/j.jocn.2014.01.005; POON A, 1995, AUST NZ J OPHTHALMOL, V23, P107, DOI 10.1111/j.1442-9071.1995.tb00138.x; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Scheeter J, 1972, AM J PATHOL, V6, P333; Shukla DP, 2013, J NEUROSCI RURAL PRA, V4, P305, DOI 10.4103/0976-3147.118765; Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3; Stamm AC, 2011, OTOLARYNG CLIN N AM, V44, P937, DOI 10.1016/j.otc.2011.06.015; Synder PJ, 2015, UPTODATE; Verrees Meg, 2004, Neurosurg Focus, V16, pE6	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2016	352								h6752	10.1136/bmj.h6752	http://dx.doi.org/10.1136/bmj.h6752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EQ	26812964				2022-12-28	WOS:000369313000001
J	Fisher, ES; Shortell, SM; Savitz, LA				Fisher, Elliott S.; Shortell, Stephen M.; Savitz, Lucy A.			Implementation Science A Potential Catalyst for Delivery System Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Savitz, Lucy A.] Inst Healthcare Leadership, Intermountain Healthcare, Salt Lake City, UT USA	Dartmouth College; University of California System; University of California Berkeley; Intermountain Healthcare; Intermountain Medical Center	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, DHMC, Williamson Bldg,Level 5, Lebanon, NH 03766 USA.	elliott.s.fisher@dartmouth.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS024075] Funding Source: NIH RePORTER; AHRQ HHS [1U19HS024075, U19 HS024075] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bayley KB, 2013, MED CARE, V51, pS80, DOI 10.1097/MLR.0b013e31829b1d48; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Cassel CK, 2015, JAMA-J AM MED ASSOC, V314, P875, DOI 10.1001/jama.2015.9186; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Hubbard T, 2014, EVOLVING LANDSCAPE C; Milstein A, 2012, JAMA-J AM MED ASSOC, V308, P1439, DOI 10.1001/jama.2012.12659; Muhlestein DR, 2016, HLTH AFFAIRS BLOG	7	69	69	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					339	340		10.1001/jama.2015.17949	http://dx.doi.org/10.1001/jama.2015.17949			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813203	Green Accepted			2022-12-28	WOS:000368589500006
J	Vickers, AJ; Van Calster, B; Steyerberg, EW				Vickers, Andrew J.; Van Calster, Ben; Steyerberg, Ewout W.			Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION CURVE ANALYSIS; PROSTATE-CANCER; RISK	Many decisions in medicine involve trade-offs, such as between diagnosing patients with disease versus unnecessary additional testing for those who are healthy. Net benefit is an increasingly reported decision analytic measure that puts benefits and harms on the same scale. This is achieved by specifying an exchange rate, a clinical judgment of the relative value of benefits (such as detecting a cancer) and harms (such as unnecessary biopsy) associated with models, markers, and tests. The exchange rate can be derived by asking simple questions, such as the maximum number of patients a doctor would recommend for biopsy to find one cancer. As the answers to these sorts of questions are subjective, it is possible to plot net benefit for a range of reasonable exchange rates in a "decision curve." For clinical prediction models, the exchange rate is related to the probability threshold to determine whether a patient is classified as being positive or negative for a disease. Net benefit is useful for determining whether basing clinical decisions on a model, marker, or test would do more good than harm. This is in contrast to traditional measures such as sensitivity, specificity, or area under the curve, which are statistical abstractions not directly informative about clinical value. Recent years have seen an increase in practical applications of net benefit analysis to research data. This is a welcome development, since decision analytic techniques are of particular value when the purpose of a model, marker, or test is to help doctors make better clinical decisions.	[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave, New York, NY 10017 USA; [Van Calster, Ben] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Van Calster, Ben; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Memorial Sloan Kettering Cancer Center; KU Leuven; Erasmus University Rotterdam; Erasmus MC	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave, New York, NY 10017 USA.	vickersa@mskcc.org	Van Calster, Ben/F-9150-2010	Van Calster, Ben/0000-0003-1613-7450	Prostate Cancer Foundation; Sidney Kimmel Center for Prostate and Urologic Cancers [P50-CA92629]; National Cancer Institute; NIH/NCI Cancer Center [P30-CA008748, R01 CA179115]; Internal Funds KU Leuven [C24/15/037]; Research Foundation-Flanders [G0B4716N]; U award [AA022802]; FP7 grant [602150]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA179115, P50CA092629] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Sidney Kimmel Center for Prostate and Urologic Cancers; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Internal Funds KU Leuven; Research Foundation-Flanders(FWO); U award; FP7 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by funds from David H Koch provided through the Prostate Cancer Foundation, the Sidney Kimmel Center for Prostate and Urologic Cancers, P50-CA92629 SPORE grant from the National Cancer Institute to H Scher (principal investigator of a programme grant on prostate cancer), the P30-CA008748 NIH/NCI Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center, and R01 CA179115 to AJV. Also supported in part by Internal Funds KU Leuven (grant C24/15/037), Research Foundation-Flanders (grant G0B4716N) to BVC, and U award (AA022802, value of personalized risk information), and by a FP7 grant (602150, CENTER-TBI) to EWS.	Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Liang YY, 2011, J UROLOGY, V185, P104, DOI 10.1016/j.juro.2010.08.088; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2008, MED DECIS MAKING, V28, P146, DOI 10.1177/0272989X07312725; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Van Calster B, 2013, MED DECIS MAKING, V33, P490, DOI 10.1177/0272989X12470757; Vickers A, 2010, J CLIN ONCOL, V28, P2493, DOI 10.1200/JCO.2009.24.1968; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302	14	395	398	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2016	352								i6	10.1136/bmj.i6	http://dx.doi.org/10.1136/bmj.i6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6CM	26810254	hybrid, Green Published			2022-12-28	WOS:000369307400018
J	Bray, GA; Fruhbeck, G; Ryan, DH; Wilding, JPH				Bray, George A.; Fruhbeck, Gema; Ryan, Donna H.; Wilding, John P. H.			Management of obesity	LANCET			English	Review							CARDIOMETABOLIC RISK-FACTORS; BODY-MASS INDEX; PLACEBO-CONTROLLED TRIAL; EASO POSITION STATEMENT; WEIGHT-LOSS; BARIATRIC SURGERY; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; CONTROLLED-RELEASE; METABOLIC SURGERY	A modern approach to obesity acknowledges the multifactorial determinants of weight gain and the health benefits to be derived from weight loss. Foundational to any weight loss effort is lifestyle change, diet, and increased physical activity. The approach should be a high quality diet to which patients will adhere accompanied by an exercise prescription describing frequency, intensity, type, and time with a minimum of 150 min moderate weekly activity. For patients who struggle with weight loss and who would receive health benefit from weight loss, management of medications that are contributing to weight gain and use of approved medications for chronic weight management along with lifestyle changes are appropriate. Medications approved in the USA or European Union are orlistat, naltrexone/bupropion, and liraglutide; in the USA, lorcaserin and phentermine/topiramate are also available. Surgical management (gastric banding, sleeve gastrectomy, and Roux-en Y gastric bypass) can produce remarkable health improvement and reduce mortality for patients with severe obesity.	[Bray, George A.; Ryan, Donna H.] Pennington Biomed Res Ctr LSU, Baton Rouge, LA 70808 USA; [Fruhbeck, Gema] Univ Navarra, Univ Navarra Clin, Dept Endocrinol & Nutr, CIBEROBN,IdiSNA, E-31080 Pamplona, Spain; [Wilding, John P. H.] Univ Liverpool, Dept Med Obes, Liverpool L69 3BX, Merseyside, England	Louisiana State University System; Louisiana State University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra; University of Liverpool	Bray, GA (corresponding author), Pennington Biomed Res Ctr LSU, Baton Rouge, LA 70808 USA.	brayga@pbrc.edu	Wilding, John PH/A-7106-2008; Wilding, John/ABB-6443-2020	Wilding, John PH/0000-0003-2839-8404; Wilding, John/0000-0003-2839-8404; Ryan, Donna/0000-0001-8374-2277	Novo Nordisk; AstraZeneca	Novo Nordisk(Novo Nordisk); AstraZeneca(AstraZeneca)	GAB is a consultant to Herbalife International and Medifast; a member of the Speakers Bureau for Novo Nordisk Pharmaceuticals and Takeda Pharmaceuticals; and receives royalties from Up-to-Date and Handbook of Obesity. GF is a consultant to Novo Nordisk Pharmaceuticals. DHR is a consultant to Novo Nordisk Pharmaceuticals, Takeda Pharmaceuticals, Eisai Pharmaceuticals, Vivus Pharmaceuticals, Janssen Pharmaceuticals, Amgen Pharmaceuticals, Real Appeal, Gila Therapeutics, Tulip Medical, and Scientific Intake; is on the speakers' bureau for Novo Nordisk Pharmaceuticals, Takeda Pharmaceuticals, Eisai Pharmaceuticals, and Vivus Pharmaceuticals; and has equity ownership in Scientific Intake. JPHW received grant funding from Novo Nordisk and AstraZeneca, and is a consultant to Novo Nordisk, Janssen Pharmaceuticals, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, and Pfizer Pharmaceuticals.	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Aronne LJ, 2013, OBESITY, V21, P2163, DOI 10.1002/oby.20584; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Blumenthal SR, 2014, JAMA PSYCHIAT, V71, P889, DOI 10.1001/jamapsychiatry.2014.414; Blundell JE, 2014, OBESITY FACTS, V7, P322, DOI 10.1159/000368783; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2000, ENDOTEXT, P1; Bray GA, 2015, DIABETES CARE, V38, P1997, DOI 10.2337/dci15-0008; Brethauer SA, 2014, SURG OBES RELAT DIS, V10, P952, DOI 10.1016/j.soard.2014.02.014; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Centers for Disease Control and Prevention (CDC), OV OB; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Chang Y, 2012, INT J OBESITY, V36, P1187, DOI 10.1038/ijo.2011.247; Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Finkelstein EA, 2014, PEDIATRICS, V133, P854, DOI 10.1542/peds.2014-0063; Fried M, 2013, OBESITY FACTS, V6, P449, DOI [10.1159/000355480, 10.1007/s11695-013-1079-8]; Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84; Fruhbeck G, 2014, OBESITY FACTS, V7, P408, DOI 10.1159/000370038; Fruhbeck G, 2012, NAT REV ENDOCRINOL, V8, P570, DOI 10.1038/nrendo.2012.165; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Garvey WT, AACE ADV FRAMEWORK N; Giddens Jennifer M, 2014, Innov Clin Neurosci, V11, P66; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gomez-Ambrosi J, 2014, DIABETES CARE, V37, P2813, DOI 10.2337/dc14-0937; Greenway FL, 2015, INT J OBESITY, V39, P1188, DOI 10.1038/ijo.2015.59; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Gudzune KA, 2015, ANN INTERN MED, V162, P501, DOI 10.7326/M14-2238; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Health and Social Care Information Centre, 2015, STAT OB PHYS ACT DIE; Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Huo R, 2015, EUR J CLIN NUTR, V69, P1200, DOI 10.1038/ejcn.2014.243; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Jakicic JM, 2013, DIABETES CARE, V36, P1297, DOI 10.2337/dc12-0712; Janesick AS, 2014, MOL CELL ENDOCRINOL, V398, P31, DOI 10.1016/j.mce.2014.09.002; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Li CY, 2010, PREV MED, V51, P18, DOI 10.1016/j.ypmed.2010.03.016; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Margulis AV, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.008; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Mechanick Jeffrey I, 2013, Endocr Pract, V19, P337, DOI 10.4158/EP12437.GL; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; [National Institute for Health and Clinical Excellence: Guidance National Clinical Guideline Centre (UK)], 2014, GUID OB ID ASS MAN O; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Romero-Corral A, 2008, NAT CLIN PRACT ENDOC, V4, P322, DOI 10.1038/ncpendmet0809; Ross R, 2015, ANN INTERN MED, V162, P325, DOI 10.7326/M14-1189; Ryan D, 2014, OBESITY, V22, pS1, DOI 10.1002/oby.20819; Sacks FM, 2014, JAMA-J AM MED ASSOC, V312, P2531, DOI 10.1001/jama.2014.16658; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schwingshackl L, 2013, NUTR METAB CARDIOVAS, V23, P699, DOI 10.1016/j.numecd.2013.04.008; Scully T, 2014, NATURE, V508, pS50, DOI 10.1038/508S50a; Siervo M, 2015, BRIT J NUTR, V113, P1, DOI 10.1017/S0007114514003341; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Slentz CA, 2009, OBESITY, V17, pS27, DOI 10.1038/oby.2009.385; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Staiano AE, 2013, OBESITY FACTS, V6, P317, DOI 10.1159/000354712; Stegenga H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6608; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; Tack J, 2014, BEST PRACT RES CL GA, V28, P741, DOI 10.1016/j.bpg.2014.07.010; Thomas DM, 2014, OBESITY, V22, P590, DOI 10.1002/oby.20520; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Tsai AG, 2006, OBESITY, V14, P1283; Unick JL, 2015, OBESITY, V23, P1353, DOI 10.1002/oby.21112; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147; Wang Y, 2013, COMP EFFECTIVENESS R, V115; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO regional office for Europe, DAT STAT; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x; Yumuk V, 2014, OBESITY FACTS, V7, P96, DOI 10.1159/000362191	107	464	481	16	231	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1947	1956		10.1016/S0140-6736(16)00271-3	http://dx.doi.org/10.1016/S0140-6736(16)00271-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26868660				2022-12-28	WOS:000375374200039
J	Guidi, L; Chaffron, S; Bittner, L; Eveillard, D; Larhlimi, A; Roux, S; Darzi, Y; Audic, S; Berline, L; Brum, JR; Coelho, LP; Espinoza, JCI; Malviya, S; Sunagawa, S; Dimier, C; Kandels-Lewis, S; Picheral, M; Poulain, J; Searson, S; Stemmann, L; Not, F; Hingamp, P; Speich, S; Follows, M; Karp-Boss, L; Boss, E; Ogata, H; Pesant, S; Weissenbach, J; Wincker, P; Acinas, SG; Bork, P; de Vargas, C; Iudicone, D; Sullivan, MB; Raes, J; Karsenti, E; Bowler, C; Gorsky, G				Guidi, Lionel; Chaffron, Samuel; Bittner, Lucie; Eveillard, Damien; Larhlimi, Abdelhalim; Roux, Simon; Darzi, Youssef; Audic, Stephane; Berline, Leo; Brum, Jennifer R.; Coelho, Luis Pedro; Espinoza, Julio Cesar Ignacio; Malviya, Shruti; Sunagawa, Shinichi; Dimier, Celine; Kandels-Lewis, Stefanie; Picheral, Marc; Poulain, Julie; Searson, Sarah; Stemmann, Lars; Not, Fabrice; Hingamp, Pascal; Speich, Sabrina; Follows, Mick; Karp-Boss, Lee; Boss, Emmanuel; Ogata, Hiroyuki; Pesant, Stephane; Weissenbach, Jean; Wincker, Patrick; Acinas, Silvia G.; Bork, Peer; de Vargas, Colomban; Iudicone, Daniele; Sullivan, Matthew B.; Raes, Jeroen; Karsenti, Eric; Bowler, Chris; Gorsky, Gabriel		Tara Oceans Consortium Coordinator	Plankton networks driving carbon export in the oligotrophic ocean	NATURE			English	Article							PARTICULATE ORGANIC-CARBON; COMMUNITY STRUCTURE; TARA OCEANS; PRINCIPAL COMPONENT; VARIABLE SELECTION; SIZE DISTRIBUTION; DEEP-SEA; PHYTOPLANKTON; ZOOPLANKTON; ECOLOGY	The biological carbon pump is the process by which CO2 is transformed to organic carbon via photosynthesis, exported through sinking particles, and finally sequestered in the deep ocean. While the intensity of the pump correlates with plankton community composition, the underlying ecosystem structure driving the process remains largely uncharacterized. Here we use environmental and metagenomic data gathered during the Tara Oceans expedition to improve our understanding of carbon export in the oligotrophic ocean. We show that specific plankton communities, from the surface and deep chlorophyll maximum, correlate with carbon export at 150 m and highlight unexpected taxa such as Radiolaria and alveolate parasites, as well as Synechococcus and their phages, as lineages most strongly associated with carbon export in the subtropical, nutrient-depleted, oligotrophic ocean. Additionally, we show that the relative abundance of a few bacterial and viral genes can predict a significant fraction of the variability in carbon export in these regions.	[Guidi, Lionel; Berline, Leo; Picheral, Marc; Searson, Sarah; Stemmann, Lars; Gorsky, Gabriel] Univ Paris 06, Sorbonne Univ, LOV, Observ Oceanol,CNRS, F-06230 Villefranche Sur Mer, France; [Guidi, Lionel; Searson, Sarah] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Chaffron, Samuel; Darzi, Youssef; Raes, Jeroen] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Herestr 49, B-3000 Leuven, Belgium; [Chaffron, Samuel; Darzi, Youssef; Raes, Jeroen] VIB, Ctr Biol Dis, Herestr 49, B-3000 Leuven, Belgium; [Chaffron, Samuel; Raes, Jeroen] Vrije Univ Brussel, Dept Appl Biol Sci, Pl Laan 2, B-1050 Brussels, Belgium; [Bittner, Lucie] Univ Paris 06, Sorbonne Univ, CNRS, IBPS,Evolut Paris Seine, F-75005 Paris, France; [Bittner, Lucie; Malviya, Shruti; Karsenti, Eric; Bowler, Chris] PSL Res Univ, Ecole Normale Super, CNRS UMR 8197, IBENS,INSERM U1024, 46 Rue Ulm, F-75005 Paris, France; [Bittner, Lucie; Audic, Stephane; Dimier, Celine; Not, Fabrice; de Vargas, Colomban] Univ Paris 06, Sorbonne Univ, Lab Adaptat & Diversite Milieu Marin, CNRS,Stn Biol Roscoff, F-29680 Roscoff, France; [Eveillard, Damien; Larhlimi, Abdelhalim] Univ Nantes, CNRS, LINA UMR 6241, EMN, F-44322 Nantes, France; [Roux, Simon; Brum, Jennifer R.; Espinoza, Julio Cesar Ignacio; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Coelho, Luis Pedro; Sunagawa, Shinichi; Kandels-Lewis, Stefanie; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Kandels-Lewis, Stefanie; Karsenti, Eric] Directors Res European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Poulain, Julie; Weissenbach, Jean; Wincker, Patrick] CEA Inst Genom, GENOSCOPE, 2 Rue Gaston Cremieux, F-91057 Evry, France; [Hingamp, Pascal] Aix Marseille Univ, CNRS, IGS, UMR 7256, F-13288 Marseille, France; [Speich, Sabrina] Ecole Normale Super, LMD, Dept Geosci, 24 Rue Lhomond, F-75231 Paris 05, France; [Follows, Mick] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Karp-Boss, Lee; Boss, Emmanuel] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Pesant, Stephane] Univ Bremen, PANGAEA, Data Publisher Earth & Environm Sci, D-28359 Bremen, Germany; [Pesant, Stephane] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, CP 5706, Evry, France; [Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, CP 5706, Evry, France; [Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, Pg Maritim Barceloneta 37-49, E-0800 Barcelona, Spain; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Iudicone, Daniele] Stn Zool Anton Dohrn, Villa Comunale, I-80121 Naples, Italy; [Roux, Simon; Brum, Jennifer R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sullivan, Matthew B.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sullivan, Matthew B.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Berline, Leo] Univ Toulon & Var, Aix Marseille Univ, CNRS INSU, IRD,MIO 110, F-13288 Marseille, France; [Malviya, Shruti] CSIR Natl Inst Oceanog, Div Biol Oceanog, Panaji 403004, Goa, India	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Hawaii System; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; IMT Atlantique; Nantes Universite; University of Arizona; European Molecular Biology Laboratory (EMBL); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Ponts ParisTech; Massachusetts Institute of Technology (MIT); University of Maine System; University of Maine Orono; Kyoto University; University of Bremen; University of Bremen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Stazione Zoologica Anton Dohrn di Napoli; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Guidi, L (corresponding author), Univ Paris 06, Sorbonne Univ, LOV, Observ Oceanol,CNRS, F-06230 Villefranche Sur Mer, France.		Bork, Peer/F-1813-2013; Sunagawa, Shinichi/Q-5950-2019; Chaffron, Samuel/B-2300-2012; Berline, Leo/AAJ-5885-2021; Hingamp, Pascal/AAO-1382-2020; stemmann, lars/E-6899-2011; Roux, Simon/ABE-6255-2020; raes, jeroen/D-7835-2018; Chaffron, Samuel/K-1104-2019; Sullivan, Matthew B/H-3256-2011; eveillard, damien/AAQ-2363-2020; Boss, Emmanuel/AAF-2336-2019; stemmann, lars/Q-8458-2019; Bittner, Lucie/ABF-4617-2020; Coelho, Luis Pedro/D-1260-2009; Boss, Emmanuel/C-5765-2009; Speich, Sabrina/L-3780-2014; Berline, Leo/AAM-8802-2021; Bowler, Chris/AAC-6256-2019; Darzi, Youssef/I-8920-2019; Guidi, Lionel/B-3977-2012; Bittner, Lucie/AAD-8921-2019; Acinas, Silvia/F-7462-2016	Bork, Peer/0000-0002-2627-833X; Sunagawa, Shinichi/0000-0003-3065-0314; Chaffron, Samuel/0000-0001-5903-617X; Hingamp, Pascal/0000-0002-7463-2444; Roux, Simon/0000-0002-5831-5895; raes, jeroen/0000-0002-1337-041X; Chaffron, Samuel/0000-0001-5903-617X; Sullivan, Matthew B/0000-0003-4040-9831; eveillard, damien/0000-0002-8162-7360; Boss, Emmanuel/0000-0002-8334-9595; stemmann, lars/0000-0001-8935-4531; Coelho, Luis Pedro/0000-0002-9280-7885; Boss, Emmanuel/0000-0002-8334-9595; Speich, Sabrina/0000-0002-5452-8287; Darzi, Youssef/0000-0001-7655-5764; Guidi, Lionel/0000-0002-6669-5744; Bittner, Lucie/0000-0001-8291-7063; Poulain, Julie/0000-0002-8744-3116; PESANT, Stephane/0000-0002-4936-5209; Jaillon, Olivier/0000-0002-7237-9596; Bowler, Chris/0000-0003-3835-6187; Acinas, Silvia/0000-0002-3439-0428; Berline, Leo/0000-0002-5831-7399; Larhlimi, Abdelhalim/0000-0002-1709-2648; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504; Gorsky, Gabriel/0000-0002-1099-8711	CNRS (Groupement de Recherche) [GDR3280]; European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research - Flanders; Rega Institute; KU Leuven; French Ministry of Research; French Government 'Investissements d'Avenir' programme OCEANOMICS [ANR-11-BTBR-0008]; French Government 'Investissements d'Avenir' programme FRANCE GENOMIQUE [ANR-10-INBS-09-08]; French Government 'Investissements d'Avenir' programme MEMO LIFE [ANR-10-LABX-54]; PSL* Research University [ANR-11-IDEX-0001-02]; ANR [POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA-GIRUS/ANR-09-PCS-GENM-218, ANR-13-ADAP-0010]; European Union [287589]; ERC [294823]; Gordon and Betty Moore Foundation [3790, 2631]; UA Technology and Research Initiative Fund; Water, Environmental, and Energy Solutions Initiative; Italian Flagship Program RITMARE; Spanish Ministry of Science and Innovation [CGL2011-26848/BOS]; TANIT from the Agencia de Gestio d'Ajusts Universitaris i Reserca [CONES 2010-0036]; JSPS KAKENHI [26430184]; FWO, BIO5, Biosphere 2; Agnes b.; Etienne Bourgois; Veolia Environment Foundation; Region Bretagne; Lorient Agglomeration; World Courier, Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation	CNRS (Groupement de Recherche); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research - Flanders(FWO); Rega Institute; KU Leuven(KU Leuven); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Government 'Investissements d'Avenir' programme OCEANOMICS(French National Research Agency (ANR)); French Government 'Investissements d'Avenir' programme FRANCE GENOMIQUE(French National Research Agency (ANR)); French Government 'Investissements d'Avenir' programme MEMO LIFE(French National Research Agency (ANR)); PSL* Research University; ANR(French National Research Agency (ANR)); European Union(European Commission); ERC(European Research Council (ERC)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UA Technology and Research Initiative Fund; Water, Environmental, and Energy Solutions Initiative; Italian Flagship Program RITMARE; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); TANIT from the Agencia de Gestio d'Ajusts Universitaris i Reserca; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FWO, BIO5, Biosphere 2; Agnes b.; Etienne Bourgois; Veolia Environment Foundation; Region Bretagne(Region Bretagne); Lorient Agglomeration; World Courier, Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation	We thank the commitment of the following people and sponsors: CNRS (in particular Groupement de Recherche GDR3280), European Molecular Biology Laboratory (EMBL), Genoscope/CEA, VIB, Stazione Zoologica Anton Dohrn, UNIMIB, Fund for Scientific Research - Flanders, Rega Institute, KU Leuven, The French Ministry of Research, the French Government 'Investissements d'Avenir' programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), MEMO LIFE (ANR-10-LABX-54), PSL* Research University (ANR-11-IDEX-0001-02), ANR (projects POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA-GIRUS/ANR-09-PCS-GENM-218, SAMOSA, ANR-13-ADAP-0010), European Union FP7 (MicroB3/No. 287589, ERC Advanced Grant Award to C.B. (Diatomite: 294823), Gordon and Betty Moore Foundation grant (#3790 and #2631) and the UA Technology and Research Initiative Fund and the Water, Environmental, and Energy Solutions Initiative to M.B.S., the Italian Flagship Program RITMARE to D.I., the Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS to S.G.A., TANIT (CONES 2010-0036) from the Agencia de Gestio d'Ajusts Universitaris i Reserca to S.G.A., JSPS KAKENHI grant number 26430184 to H.O., and FWO, BIO5, Biosphere 2 to M.B.S. We also thank the support and commitment of Agnes b. and Etienne Bourgois, the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the EDF Foundation, FRB, the Prince Albert II de Monaco Foundation, the Tara schooner and its captains and crew. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries who graciously granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled in. This article is contribution number 34 of Tara Oceans.	Agusti S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8608; Aylward FO, 2015, P NATL ACAD SCI USA, V112, P5443, DOI 10.1073/pnas.1502883112; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bork P, 2015, SCIENCE, V348, P873, DOI 10.1126/science.aac5605; BOYD P, 1995, DEEP-SEA RES PT I, V42, P619, DOI 10.1016/0967-0637(95)00017-Z; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Chaffron S, 2014, CONTEXTUAL ENV DATA; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Guidi L, 2008, DEEP-SEA RES PT I, V55, P1364, DOI 10.1016/j.dsr.2008.05.014; Guidi L, 2009, LIMNOL OCEANOGR, V54, P1951, DOI 10.4319/lo.2009.54.6.1951; Henson SA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004099; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Honjo S, 2008, PROG OCEANOGR, V76, P217, DOI 10.1016/j.pocean.2007.11.003; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Kwon EY, 2009, NAT GEOSCI, V2, P630, DOI 10.1038/NGEO612; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Omand MM, 2015, SCIENCE, V348, P222, DOI 10.1126/science.1260062; Picheral M., 2014, VERTICAL PROFILES EN; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; SANCETTA C, 1991, LIMNOL OCEANOGR, V36, P1452, DOI 10.4319/lo.1991.36.7.1452; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Thomas T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003252; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Wymore AS, 2011, NEW PHYTOL, V191, P19, DOI 10.1111/j.1469-8137.2011.03730.x; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	67	386	395	44	552	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					465	+		10.1038/nature16942	http://dx.doi.org/10.1038/nature16942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	26863193	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000374815900039
J	Nishtar, S; Gluckman, P; Armstrong, T				Nishtar, Sania; Gluckman, Peter; Armstrong, Timothy			Ending childhood obesity: a time for action	LANCET			English	Editorial Material							DISEASE; BURDEN; RISK		[Gluckman, Peter] Of Prime Ministers Chief Sci Advisor, Auckland, New Zealand; [Nishtar, Sania] Chak Shahzad, Heartfile, Islamabad 44000, Pakistan; [Armstrong, Timothy] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Nishtar, S (corresponding author), Chak Shahzad, Heartfile, Islamabad 44000, Pakistan.	sania@heartfile.org			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Litwin SE, 2014, J AM COLL CARDIOL, V64, P1588, DOI 10.1016/j.jacc.2014.07.962; Lobstein T, 2006, INT J PEDIATR OBES, V1, P33, DOI 10.1080/17477160600586689; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Pizzi MA, 2013, OCCUP THER HEALTH CA, V27, P99, DOI 10.3109/07380577.2013.784839; UNICEF WHO and World Bank, 2015, LEV TRENDS CHILD MAL; *WHO, 2010, SET REC MARK FOODS N; World Health Organization, 2016, REP COMM END CHILDH; World Health Organization, 1981, INT COD MARK BREAST	9	92	96	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					825	827		10.1016/S0140-6736(16)00140-9	http://dx.doi.org/10.1016/S0140-6736(16)00140-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE9RA	26823046				2022-12-28	WOS:000370974400007
J	Matthies, D; Dalmas, O; Borgnia, MJ; Dominik, PK; Merk, A; Rao, P; Reddy, BG; Islam, S; Bartesaghi, A; Perozo, E; Subramaniam, S				Matthies, Doreen; Dalmas, Olivier; Borgnia, Mario J.; Dominik, Pawel K.; Merk, Alan; Rao, Prashant; Reddy, Bharat G.; Islam, Shahidul; Bartesaghi, Alberto; Perozo, Eduardo; Subramaniam, Sriram			Cryo-EM Structures of the Magnesium Channel CorA Reveal Symmetry Break upon Gating	CELL			English	Article							ACETYLCHOLINE-RECEPTOR; MOLECULAR-MECHANISM; BETA-GALACTOSIDASE; CRYSTAL-STRUCTURE; TRANSPORT; SYSTEM; VISUALIZATION; SELECTIVITY; ACTIVATION; INSIGHTS	CorA, the major Mg2+ uptake system in prokaryotes, is gated by intracellular Mg2+ (K-D similar to 1-2 mM). X-ray crystallographic studies of CorA show similar conformations under Mg2+-bound and Mg2+-free conditions, but EPR spectroscopic studies reveal large Mg2+-driven quaternary conformational changes. Here, we determined cryo-EM structures of CorA in the Mg2+-bound closed conformation and in two open Mg2+-free states at resolutions of 3.8, 7.1, and 7.1 angstrom, respectively. In the absence of bound Mg2+, four of the five subunits are displaced to variable extents (similar to 10-25 angstrom) by hinge-like motions as large as similar to 35 degrees at the stalk helix. The transition between a single 5-fold symmetric closed state and an ensemble of low Mg2+, open, asymmetric conformational states is, thus, the key structural signature of CorA gating. This mechanism is likely to apply to other structurally similar divalent ion channels.	[Matthies, Doreen; Borgnia, Mario J.; Merk, Alan; Rao, Prashant; Bartesaghi, Alberto; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dalmas, Olivier; Dominik, Pawel K.; Reddy, Bharat G.; Islam, Shahidul; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago	Subramaniam, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu; ss1@nih.gov	Islam, Shahidul M./A-9417-2011	Islam, Shahidul M./0000-0001-5769-6844; Matthies, Doreen/0000-0001-9221-4484; Subramaniam, Sriram/0000-0003-4231-4115; Borgnia, Mario/0000-0001-9159-1413	Center for Cancer Research, National Cancer Institute, NIH; NIH [GM088406]; NATIONAL CANCER INSTITUTE [ZIABC010824, ZIABC010278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088406] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from the Center for Cancer Research, National Cancer Institute, NIH, and NIH grant GM088406. We thank Jason Pierson and Lingbo Yu for assistance with data collection; Robert Mueller for technical assistance with electron microscopy; and Soojay Banerjee, Lesley A. Earl, Benoit Roux, and Anthony Kossiakoff for helpful discussions. We also thank Veronica Falconieri for assistance in preparation of the graphical abstract. This work utilized the computational resources of the NIH High-Performance Computing (HPC) Biowulf cluster (http://hpc.nih.gov) and the Gordon cluster at the Extreme Science and Engineering Discovery Environment (XSEDE).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; BROOKS ME, 1983, UROL RES, V11, P187; Catterall WA, 2015, TRENDS BIOCHEM SCI, V40, P526, DOI 10.1016/j.tibs.2015.07.002; Chakrabarti N, 2010, BIOPHYS J, V98, P784, DOI 10.1016/j.bpj.2009.11.009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Cleverley RM, 2015, BBA-BIOMEMBRANES, V1848, P2206, DOI 10.1016/j.bbamem.2015.06.002; Dalmas O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4590; Dalmas O, 2014, P NATL ACAD SCI USA, V111, P3002, DOI 10.1073/pnas.1319054111; Dalmas O, 2010, STRUCTURE, V18, P868, DOI 10.1016/j.str.2010.04.009; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Fromm SA, 2015, J STRUCT BIOL, V189, P87, DOI 10.1016/j.jsb.2014.12.002; Guskov A, 2012, P NATL ACAD SCI USA, V109, P18459, DOI 10.1073/pnas.1210076109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Islam SM, 2013, J PHYS CHEM B, V117, P4740, DOI 10.1021/jp311723a; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuramoto T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001262; Leanza L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00227; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Neale C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004303; Nogales E, 2015, MOL CELL, V58, P677, DOI 10.1016/j.molcel.2015.02.019; Nordin N, 2013, BIOCHEM J, V451, P365, DOI 10.1042/BJ20121745; Palombo I, 2013, BIOCHEMISTRY-US, V52, P4842, DOI 10.1021/bi4007397; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Svidova S, 2011, BBA-BIOMEMBRANES, V1808, P1587, DOI 10.1016/j.bbamem.2010.10.017; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Unwin N, 2013, Q REV BIOPHYS, V46, P283, DOI 10.1017/S0033583513000061; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798	52	84	85	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					747	756		10.1016/j.cell.2015.12.055	http://dx.doi.org/10.1016/j.cell.2015.12.055			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871634	Green Accepted, Bronze			2022-12-28	WOS:000369998300019
J	Sylwestrak, EL; Rajasethupathy, P; Wright, MA; Jaffe, A; Deisseroth, K				Sylwestrak, Emily Lauren; Rajasethupathy, Priyamvada; Wright, Matthew Arnot; Jaffe, Anna; Deisseroth, Karl			Multiplexed Intact-Tissue Transcriptional Analysis at Cellular Resolution	CELL			English	Article							IN-SITU HYBRIDIZATION; MOUSE-BRAIN; NERVOUS-SYSTEM; RNA; MEMORY; EXPRESSION; MICROSCOPY; GENE; HIPPOCAMPUS; FLUORESCENT	In recently developed approaches for high-resolution imaging within intact tissue, molecular characterization over large volumes has been largely restricted to labeling of proteins. But volumetric nucleic acid labeling may represent a far greater scientific and clinical opportunity, enabling detection of not only diverse coding RNA variants but also non-coding RNAs. Moreover, scaling immunohistochemical detection to large tissue volumes has limitations due to high cost, limited renewability/availability, and restricted multiplexing capability of antibody labels. With the goal of versatile, high-content, and scalable molecular phenotyping of intact tissues, we developed a method using carbodiimide-based chemistry to stably retain RNAs in clarified tissue, coupled with amplification tools for multiplexed detection. The resulting technology enables robust measurement of activity-dependent transcriptional signatures, cell-identity markers, and diverse non-coding RNAs in rodent and human tissue volumes. The growing set of validated probes is deposited in an online resource for nucleating related developments from across the scientific community.	[Sylwestrak, Emily Lauren; Rajasethupathy, Priyamvada; Wright, Matthew Arnot; Jaffe, Anna; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wright, Matthew Arnot; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr, Stanford, CA 94305 USA.	deissero@stanford.edu	Sylwestrak, Emily/GSE-3871-2022	Jaffe, Anna/0000-0002-2335-5598; Sylwestrak, Emily/0000-0002-1172-6523	Ellison LSRF fellowship; NIH T32 Fellowship; NIMH; NIDA; U.S. Army Research Laboratory and Defense Advanced Research Projects Agency [W911NF-14-2-0013]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH110144, T32MH019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	Ellison LSRF fellowship; NIH T32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); U.S. Army Research Laboratory and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Niles Pierce and Harry Choi for generously making HCR reagents freely available and for advice during protocol troubleshooting. We thank Michelle Monje for providing human glioblastoma tumor samples and the entire Deisseroth lab for helpful discussions. This work is supported by an Ellison LSRF fellowship (P.R.), NIH T32 Fellowship (M.A.W.), and NIMH, NIDA, and the U.S. Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement Number W911NF-14-2-0013); nothing in this material represents official views or policies of our funders. K.D. is a founder and scientific advisor of ClearLight Diagnostics, a startup exploring improvement of cancer diagnostics using CLARITY-related methods; the authors have disclosed these findings to the Stanford Office of Technology Licensing, and all clones, sequences, protocols and resources are freely distributed and supported (http://clarityresourcecenter.org and http://wiki.claritytechniques.org/index.php/ISH).	Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Choi HMT, 2014, ACS NANO, V8, P4284, DOI 10.1021/nn405717p; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10640; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Renwick N, 2013, J CLIN INVEST, V123, P2694, DOI 10.1172/JCI68760; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Shen G, 2004, NUCLEIC ACIDS RES, V32, P5973, DOI 10.1093/nar/gkh932; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Simard C, 2001, ELECTROPHORESIS, V22, P2679, DOI 10.1002/1522-2683(200108)22:13<2679::AID-ELPS2679>3.0.CO;2-L; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Spalteholz W., 1911, DURCHSICHTIGMACHEN M; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tymianski M, 1997, CELL CALCIUM, V21, P175, DOI 10.1016/S0143-4160(97)90042-7; Wanner AA, 2015, J MICROSC-OXFORD, V259, P137, DOI 10.1111/jmi.12244; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wilkinson D. G., 1999, SITU HYBRIDIZATION P; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	55	91	93	1	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					792	804		10.1016/j.cell.2016.01.038	http://dx.doi.org/10.1016/j.cell.2016.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871636	Green Accepted, Bronze			2022-12-28	WOS:000369998300023
J	Bhatt, SP; Terry, NLJ; Nath, H; Zach, JA; Tschirren, J; Bolding, MS; Stinson, DS; Wilson, CG; Curran-Everett, D; Lynch, DA; Putcha, N; Soler, X; Wise, RA; Washko, GR; Hoffman, EA; Foreman, MG; Dransfield, MT				Bhatt, Surya P.; Terry, Nina L. J.; Nath, Hrudaya; Zach, Jordan A.; Tschirren, Juerg; Bolding, Mark S.; Stinson, Douglas S.; Wilson, Carla G.; Curran-Everett, Douglas; Lynch, David A.; Putcha, Nirupama; Soler, Xavi; Wise, Robert A.; Washko, George R.; Hoffman, Eric A.; Foreman, Marilyn G.; Dransfield, Mark T.		Genetic Epidemiol COPD COPDGene	Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; TRACHEAL COLLAPSE; ACQUIRED TRACHEOBRONCHOMALACIA; MULTIDETECTOR CT; FLOW LIMITATION; COPD; TRACHEOMALACIA; EMPHYSEMA; STANDARDIZATION	IMPORTANCE Central airway collapse greater than 50% of luminal area during exhalation (expiratory central airway collapse [ECAC]) is associated with cigarette smoking and chronic obstructive pulmonary disease (COPD). However, its prevalence and clinical significance are unknown. OBJECTIVE To determine whether ECAC is associated with respiratory morbidity in smokers independent of underlying lung disease. DESIGN, SETTING, AND PARTICIPANTS Analysis of paired inspiratory-expiratory computed tomography images from a large multicenter study (COPDGene) of current and former smokers from 21 clinical centers across the United States. Participants were enrolled from January 2008 to June 2011 and followed up longitudinally until October 2014. Images were initially screened using a quantitative method to detect at least a 30% reduction in minor axis tracheal diameter from inspiration to end-expiration. From this sample of screen-positive scans, cross-sectional area of the trachea was measured manually at 3 predetermined levels (aortic arch, carina, and bronchus intermedius) to confirm ECAC (>50% reduction in cross-sectional area). EXPOSURES Expiratory central airway collapse. MAIN OUTCOMES AND MEASURES The primary outcome was baseline respiratory quality of life (St George's Respiratory Questionnaire [SGRQ] scale 0 to 100; 100 represents worst health status; minimum clinically important difference [MCID], 4 units). Secondary outcomes were baseline measures of dyspnea (modified Medical Research Council [mMRC] scale 0 to 4; 4 represents worse dyspnea; MCID, 0.7 units), baseline 6-minute walk distance (MCID, 30 m), and exacerbation frequency (events per 100 person-years) on longitudinal follow-up. RESULTS The study included 8820 participants with and without COPD (mean age, 59.7 [SD, 6.9] years; 4667 [56.7%] men; 4559 [51.7%] active smokers). The prevalence of ECAC was 5%(443 cases). Patients with ECAC compared with those without ECAC had worse SGRQ scores (30.9 vs 26.5 units; P < .001; absolute difference, 4.4 [95% CI, 2.2-6.6]) and mMRC scale scores (median, 2 [interquartile range [IQR], 0-3]) vs 1 [IQR, 0-3]; P < .001]), but no significant difference in 6-minute walk distance (399 vs 417 m; absolute difference, 18 m [95% CI, 6-30]; P = .30), after adjustment for age, sex, race, body mass index, forced expiratory volume in the first second, pack-years of smoking, and emphysema. On follow-up (median, 4.3 [IQR, 3.2-4.9] years), participants with ECAC had increased frequency of total exacerbations (58 vs 35 events per 100 person-years; incidence rate ratio [IRR], 1.49 [95% CI, 1.29-1.72]; P < .001) and severe exacerbations requiring hospitalization (17 vs 10 events per 100 person-years; IRR, 1.83 [95% CI, 1.51-2.21]; P < .001). CONCLUSIONS AND RELEVANCE In a cross-sectional analysis of current and former smokers, the presence of ECAC was associated with worse respiratory quality of life. Further studies are needed to assess long-term associations with clinical outcomes.	[Bhatt, Surya P.; Dransfield, Mark T.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, THT 422,1720 Second Ave S, Birmingham, AL 35294 USA; [Bhatt, Surya P.; Dransfield, Mark T.] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Bhatt, Surya P.; Terry, Nina L. J.; Nath, Hrudaya; Bolding, Mark S.; Dransfield, Mark T.] Univ Alabama Birmingham, UAB Lung Imaging Core, Birmingham, AL 35294 USA; [Terry, Nina L. J.; Nath, Hrudaya; Bolding, Mark S.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA; [Zach, Jordan A.; Lynch, David A.] Natl Jewish Hlth, Quantitat Imaging Lab, Denver, CO USA; [Tschirren, Juerg] VIDA Diagnost, Coralville, IA USA; [Stinson, Douglas S.; Lynch, David A.] Natl Jewish Hlth, Dept Radiol, Denver, CO USA; [Wilson, Carla G.; Curran-Everett, Douglas] Natl Jewish Hlth, Dept Biostat & Bioinformat, Denver, CO USA; [Putcha, Nirupama; Wise, Robert A.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Soler, Xavi] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92093 USA; [Washko, George R.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Hoffman, Eric A.] Univ Iowa, Carver Coll Med, Dept Radiol & Biomed Engn, Iowa City, IA USA; [Foreman, Marilyn G.] Morehouse Sch Med, Div Pulm & Crit Care Med, Atlanta, GA 30310 USA; [Dransfield, Mark T.] Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Jewish Health; National Jewish Health; National Jewish Health; Johns Hopkins University; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; University of Iowa; Morehouse School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bhatt, SP (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, THT 422,1720 Second Ave S, Birmingham, AL 35294 USA.	spbhatt@uab.edu	Terry, Nina/R-9810-2019	Terry, Nina/0000-0002-2760-9612; Wise, Robert/0000-0002-8353-2349; Curran-Everett, Douglas/0000-0001-5992-4839; Hoffman, Eric/0000-0001-8456-9437; Foreman, Marilyn/0000-0002-9405-7475	NHLBI [R01HL089897, R01HL089856, HL122438]; COPD Foundation; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, KL2TR001419] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089897, U01HL089897, K23HL123594, R01HL122438, U01HL089856, R01HL089856] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018526] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); COPD Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by awards R01HL089897, R01HL089856, and HL122438 from the NHLBI. The COPDGene project is also supported by the COPD Foundation through contributions made to an industry advisory board comprising AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline.	Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Boiselle PM, 2013, COPD, V10, P604, DOI 10.3109/15412555.2013.781149; Boiselle PM, 2009, RADIOLOGY, V252, P255, DOI 10.1148/radiol.2521081958; Bowler RP, 2014, CHEST, V146, P941, DOI 10.1378/chest.13-2946; Carden KA, 2005, CHEST, V127, P984, DOI 10.1378/chest.127.3.984; Collard P, 1996, THORAX, V51, P224, DOI 10.1136/thx.51.2.224; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Ernst A, 2011, CHEST, V140, P1162, DOI 10.1378/chest.10-3051; Ferretti GR, 2008, EUR J RADIOL, V68, P340, DOI 10.1016/j.ejrad.2007.08.029; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hasegawa I, 2003, AM J ROENTGENOL, V181, P1505, DOI 10.2214/ajr.181.6.1811505; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Inoue M, 2009, JPN J RADIOL, V27, P303, DOI 10.1007/s11604-009-0342-3; JOKINEN K, 1977, ANN CLIN RES, V9, P52; JOKINEN K, 1976, ORL J OTO-RHINO-LARY, V38, P178, DOI 10.1159/000275273; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kandaswamy C, 2009, CURR OPIN PULM MED, V15, P113, DOI 10.1097/MCP.0b013e328321832d; Lee KS, 2008, J THORAC IMAG, V23, P121, DOI 10.1097/RTI.0b013e3181653c41; Loring SH, 2007, CHEST, V131, P1118, DOI 10.1378/chest.06-2556; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murgu S, 2013, CLIN CHEST MED, V34, P527, DOI 10.1016/j.ccm.2013.05.003; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; O'Donnell CR, 2014, CLIN RADIOL, V69, P357, DOI 10.1016/j.crad.2013.11.003; O'Donnell CR, 2012, CHEST, V142, P168, DOI 10.1378/chest.11-2361; Ochs RA, 2009, ACAD RADIOL, V16, P46, DOI 10.1016/j.acra.2008.05.020; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Pelley CJ, 2007, RESP CARE, V52, P278; Polkey MI, 2013, AM J RESP CRIT CARE, V187, P382, DOI 10.1164/rccm.201209-1596OC; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Stewart JI, 2012, COPD, V9, P466, DOI 10.3109/15412555.2012.690010; Sverzellati N, 2009, EUR RADIOL, V19, P1669, DOI 10.1007/s00330-009-1306-9; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470	36	48	49	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					498	505		10.1001/jama.2015.19431	http://dx.doi.org/10.1001/jama.2015.19431			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836732	Green Accepted, Bronze			2022-12-28	WOS:000369049500019
J	Lamont, T; Barber, N; de Pury, J; Fulop, N; Garfield-Birkbeck, S; Lilford, R; Mear, L; Raine, R; Fitzpatrick, R				Lamont, Tara; Barber, Nicholas; de Pury, John; Fulop, Naomi; Garfield-Birkbeck, Stephanie; Lilford, Richard; Mear, Liz; Raine, Rosalind; Fitzpatrick, Ray			New approaches to evaluating complex health and care systems	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONS; MODEL; MORTALITY; FRAMEWORK; SERVICES; DESIGN; COHORT; TRIAL		[Lamont, Tara] Univ Southampton, Natl Inst Hlth Res Hlth Serv, Southampton SO16 7NS, Hants, England; [Lamont, Tara] Univ Southampton, Delivery Res Programme, Southampton SO16 7NS, Hants, England; [Barber, Nicholas] Hlth Fdn, London, England; [de Pury, John] Univ UK, London, England; [Fulop, Naomi; Raine, Rosalind] UCL, London WC1E 6BT, England; [Garfield-Birkbeck, Stephanie] Univ Southampton, Southampton SO9 5NH, Hants, England; [Lilford, Richard] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Mear, Liz] North West Coast Acad Hlth Sci Network, Warrington, Cheshire, England; [Fitzpatrick, Ray] Univ Oxford, Oxford OX1 2JD, England	University of Southampton; University of Southampton; University of London; University College London; University of Southampton; University of Warwick; University of Oxford	Lamont, T (corresponding author), Univ Southampton, Natl Inst Hlth Res Hlth Serv, Southampton SO16 7NS, Hants, England.; Lamont, T (corresponding author), Univ Southampton, Delivery Res Programme, Southampton SO16 7NS, Hants, England.	t.lamont@soton.ac.uk		Raine, Rosalind/0000-0003-0904-749X; fitzpatrick, Ray/0000-0003-0607-0563; Fulop, Naomi/0000-0001-5306-6140; Lilford, Richard/0000-0002-0634-984X				Ahmed J, 2012, COLORECTAL DIS, V14, P1045, DOI 10.1111/j.1463-1318.2011.02856.x; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bardsley M, 2013, EVALUATING INTEGRATE; Baxter SK, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-62; Beard E, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0839-2; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d199; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Buxton MJ, 1987, EC APPRAISAL HLTH TE; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Davies A, 2015, EVALUATION COMPLEX H; Dopson S., 2005, KNOWLEDGE ACTION EVI; Drew S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0243-z; Fitzpatrick R, 1994, Qual Health Care, V3, P107; Fulop N, 2005, SOC SCI MED, V60, P119, DOI 10.1016/j.socscimed.2004.04.017; Fulop N, 2015, HLTH SERV J; Girling A, 2010, VALUE HEALTH, V13, P585, DOI 10.1111/j.1524-4733.2010.00726.x; Greenhalgh T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008567; Greenhalgh T, 2009, MILBANK Q, V87, P391, DOI 10.1111/j.1468-0009.2009.00562.x; Grimshaw JM, 2001, MED CARE, V39, pII2; Health and Social Care Information Centre, 2014, 1 HLTH SOC CAR INF C; Hutchings HA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-301; Jagosh J, 2012, MILBANK Q, V90, P311, DOI 10.1111/j.1468-0009.2012.00665.x; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Lewis G, 2013, INT J INTEGR CARE, V13; Lilford RJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4413; Lilford RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000186; Marshall T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-908; May C, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-86; McDaniel RR, 2009, HEALTH CARE MANAGE R, V34, P191, DOI 10.1097/HMR.0b013e31819c8b38; Moore G, 2014, PROCESS EVALUATION C; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; National Institute for Clinical Excellence (NICE), 2014, INTR CAR CAR HLTH WO; National Institute for Health Research, COLL LEAD APPL HLTH; NHS England, AC HLTH SCI NETW; NHS England, 2014, 5 YEAR FORW VIEW; Nolte E, 2014, WHAT IS EVIDENCE EC; Pawson R., 1997, REALISTIC EVALUATION; Peckham S, 2011, COMP STUDY CONSTRUCT; Raine R, HLTH SERV D IN PRESS; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Sheringham JR, 2014, BRIT J CANCER, V111, P1490, DOI 10.1038/bjc.2014.424; Steventon A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4585; Steventon A, 2012, HEALTH SERV RES, V47, P1679, DOI 10.1111/j.1475-6773.2011.01367.x; The Health Foundation, 2015, CONT SUCC QUAL IMPR; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Wardle J, 2016, LANCET, V387, P751, DOI 10.1016/S0140-6736(15)01154-X	50	38	38	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2016	352								i154	10.1136/bmj.i154	http://dx.doi.org/10.1136/bmj.i154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2QD	26830458				2022-12-28	WOS:000369766400001
J	McFadden, A; Mason, F; Baker, J; Begin, F; Dykes, F; Grummer-Strawn, L; Kenney-Muir, N; Whitford, H; Zehner, E; Renfrew, MJ				McFadden, Alison; Mason, Frances; Baker, Jean; Begin, France; Dykes, Fiona; Grummer-Strawn, Laurence; Kenney-Muir, Natalie; Whitford, Heather; Zehner, Elizabeth; Renfrew, Mary J.			Spotlight on infant formula: coordinated global action needed	LANCET			English	Editorial Material									[McFadden, Alison; Kenney-Muir, Natalie; Whitford, Heather; Renfrew, Mary J.] Univ Dundee, Sch Nursing & Hlth Sci, Mother & Infant Res Unit, Dundee, Scotland; [Mason, Frances] Save Children UK, London EC1M 4AR, England; [Baker, Jean] FHI 360, Alive & Thrive Program, Washington, DC USA; [Begin, France] UNICEF, New York, NY USA; [Dykes, Fiona] Univ Cent Lancashire, Maternal & Infant Nutr & Nurture Unit, Preston PR1 2HE, Lancs, England; [Grummer-Strawn, Laurence] WHO, Nutr Hlth & Dev, CH-1211 Geneva, Switzerland; [Zehner, Elizabeth] Helen Keller Int, ARCH Project, Washington, DC USA	University of Dundee; Save the Children; UNICEF; University of Central Lancashire; World Health Organization	Mason, F (corresponding author), Save Children UK, London EC1M 4AR, England.	f.mason@savethechildren.org.uk		Renfrew, Mary/0000-0003-2905-403X; Dykes, Fiona/0000-0002-2728-7967; McFadden, Alison/0000-0002-5164-2025	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Access to Nutrition Foundation, 2016, ACC NUTR IND GLOB IN; [Anonymous], 2013, SUP BAB OV BARR BREA; Euromonitor International, 2013, BAB FOOD CHIN; Euromonitor International, 2013, GLOB PASSP STAT BAB; Hansen K, 2015, BREASTFEED MED, V10, P385, DOI 10.1089/bfm.2015.0113; Lutter CK, 2013, PUBLIC HEALTH NUTR, V16, P1879, DOI 10.1017/S1368980012004235; Mokhiber R, 1987, MULTINATL MONIT, V8, P4; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Piwoz EG, 2015, FOOD NUTR BULL, V36, P373, DOI 10.1177/0379572115602174; Rippeyoung PLF, 2012, AM SOCIOL REV, V77, P244, DOI 10.1177/0003122411435477; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Save the Children, 2015, BREASTF POL MATT ID; Shetty P, 2014, B WORLD HEALTH ORGAN, V92, P234, DOI 10.2471/BLT.14.020414; Small S, 2013, CHIN BAB FORM MARK; Taqi I, 2014, BREASTFEED MED, V9, P355, DOI 10.1089/bfm.2014.0084; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2013, COUNTR IMPL INT COD; World Health Organization, 1981, INT COD MARK BREAST	19	32	32	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					413	415		10.1016/S0140-6736(16)00103-3	http://dx.doi.org/10.1016/S0140-6736(16)00103-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26869552				2022-12-28	WOS:000368986800009
J	Shah, VS; Meyerholz, DK; Tang, XX; Reznikov, L; Abou Alaiwa, M; Ernst, SE; Karp, PH; Wohlford-Lenane, CL; Heilmann, KP; Leidinger, MR; Allen, PD; Zabner, J; McCray, PB; Ostedgaard, LS; Stoltz, DA; Randak, CO; Welsh, MJ				Shah, Viral S.; Meyerholz, David K.; Tang, Xiao Xiao; Reznikov, Leah; Abou Alaiwa, Mahmoud; Ernst, Sarah E.; Karp, Philip H.; Wohlford-Lenane, Christine L.; Heilmann, Kristopher P.; Leidinger, Mariah R.; Allen, Patrick D.; Zabner, Joseph; McCray, Paul B., Jr.; Ostedgaard, Lynda S.; Stoltz, David A.; Randak, Christoph O.; Welsh, Michael J.			Airway acidification initiates host defense abnormalities in cystic fibrosis mice	SCIENCE			English	Article							BICARBONATE SECRETION; BASE SECRETION; SURFACE PH; LIQUID PH; EPITHELIUM; TRANSPORT; MODEL; CHANNEL; DISEASE; CELLS	Cystic fibrosis (CF) is caused by mutations in the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel. In humans and pigs, the loss of CFTR impairs respiratory host defenses, causing airway infection. But CF mice are spared. We found that in all three species, CFTR secreted bicarbonate into airway surface liquid. In humans and pigs lacking CFTR, unchecked H+ secretion by the nongastric H+/K+ adenosine triphosphatase (ATP12A) acidified airway surface liquid, which impaired airway host defenses. In contrast, mouse airways expressed little ATP12A and secreted minimal H+; consequently, airway surface liquid in CF and non-CF mice had similar pH. Inhibiting ATP12A reversed host defense abnormalities in human and pig airways. Conversely, expressing ATP12A in CF mouse airways acidified airway surface liquid, impaired defenses, and increased airway bacteria. These findings help explain why CF mice are protected from infection and nominate ATP12A as a potential therapeutic target for CF.	[Shah, Viral S.; Tang, Xiao Xiao; Reznikov, Leah; Abou Alaiwa, Mahmoud; Ernst, Sarah E.; Karp, Philip H.; Allen, Patrick D.; Zabner, Joseph; Ostedgaard, Lynda S.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Shah, Viral S.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Pappajohn Biomed Inst, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Meyerholz, David K.; Leidinger, Mariah R.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Tang, Xiao Xiao; Ernst, Sarah E.; Karp, Philip H.; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wohlford-Lenane, Christine L.; McCray, Paul B., Jr.; Randak, Christoph O.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Heilmann, Kristopher P.; McCray, Paul B., Jr.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Stoltz, David A.] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Pappajohn Biomed Inst, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Meyerholz, David/J-8131-2019	Reznikov, Leah R./0000-0002-4074-9070; Meyerholz, David/0000-0003-1552-3253; Stoltz, David/0000-0003-0893-9015; Randak, Christoph/0000-0003-3264-4137; Zabner, Joseph/0000-0002-9606-1339; McCray, Paul/0000-0002-4067-577X; Abou Alaiwa, Mahmoud/0000-0003-4525-0217; Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442	NIH [HL091842, HL51670, HL117744, F30HL123239, 5T32GM007337, DK054759, K08HL097071]; Cystic Fibrosis Foundation (University of Iowa Research Development Program) [OSTEDG1410, STOLTZ14XX0]; Roy J. Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, DP2HL117744, P01HL051670, K99HL119560, F30HL123239, K08HL097071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (University of Iowa Research Development Program); Roy J. Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH (grants HL091842, HL51670, HL117744, F30HL123239, 5T32GM007337, DK054759, and K08HL097071), by the Cystic Fibrosis Foundation (University of Iowa Research Development Program, OSTEDG1410, and STOLTZ14XX0), and by the Roy J. Carver Charitable Trust. D.A.S. was funded by the Gilead Sciences Research Scholars Program in Cystic Fibrosis. M.J.W. is an investigator of the Howard Hughes Medical Institute. We thank J. Engelhardt for mice and D. Bouzek, J.-H. Chen, A. Cooney, N. Gansemer, J. Launspach, T. Mayhew, T. Moninger, C. Parker, S. Ramachandran, N. Sawin, P. Sinn, B. Stein, M. Strub, P. Taft, P. Tan, I. Thornell, L. Vargas, and S. Youtsey (Integrated DNA Technologies) for assistance, support, and advice. The CFTR inhibitor GlyH-101 was a generous gift from Cystic Fibrosis Foundation Therapeutics and R. Bridges. M.J.W. holds equity in Exemplar Genetics, which has licensed CF pigs from the University of Iowa.	Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; Abou Alaiwa MH, 2014, J CYST FIBROS, V13, P373, DOI 10.1016/j.jcf.2013.12.006; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Derichs N, 2011, FASEB J, V25, P2325, DOI 10.1096/fj.10-179549; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Grishin AV, 1999, SEMIN NEPHROL, V19, P421; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Laroche-Joubert N, 2002, J BIOL CHEM, V277, P18598, DOI 10.1074/jbc.M201868200; McShane D, 2003, EUR RESPIR J, V21, P37, DOI 10.1183/09031936.03.00027603; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	33	203	209	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					503	507		10.1126/science.aad5589	http://dx.doi.org/10.1126/science.aad5589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823428	Green Accepted			2022-12-28	WOS:000368858200036
J	Uchida, N; Iinuma, T; Nadeau, RM; Burgmann, R; Hino, R				Uchida, Naoki; Iinuma, Takeshi; Nadeau, Robert M.; Buergmann, Roland; Hino, Ryota			Periodic slow slip triggers megathrust zone earthquakes in northeastern Japan	SCIENCE			English	Article							TOHOKU-OKI EARTHQUAKE; SUBDUCTION ZONE; INTERPLATE EARTHQUAKES; FAULT; MICROEARTHQUAKES; RUPTURE; TRENCH; MODEL	Both aseismic and seismic slip accommodate relative motion across partially coupled plate-boundary faults. In northeastern Japan, aseismic slip occurs in the form of decelerating afterslip after large interplate earthquakes and as relatively steady slip on uncoupled areas of the subduction thrust. Here we report on a previously unrecognized quasi-periodic slow-slip behavior that is widespread in the megathrust zone. The repeat intervals of the slow slip range from 1 to 6 years and often coincide with or precede clusters of large [magnitude (M) >= 5] earthquakes, including the 2011 M 9 Tohoku-oki earthquake. These results suggest that inherently periodic slow-slip events result in periodic stress perturbations and modulate the occurrence time of larger earthquakes. The periodicity in the slow-slip rate has the potential to help refine time-dependent earthquake forecasts.	[Uchida, Naoki; Hino, Ryota] Tohoku Univ, Grad Sch Sci, Aoba Ku, 6-6 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan; [Uchida, Naoki; Hino, Ryota] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, 6-6 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan; [Iinuma, Takeshi] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, 468-1 Aramaki Aza Aoba, Sendai, Miyagi 9800845, Japan; [Nadeau, Robert M.] Univ Calif Berkeley, Berkeley Seismol Lab, 211 McCone Hall, Berkeley, CA 94720 USA; [Nadeau, Robert M.] Univ Calif Berkeley, Berkeley Inst Data Sci, 211 McCone Hall, Berkeley, CA 94720 USA; [Buergmann, Roland] Univ Calif Berkeley, Berkeley Seismol Lab, 389 McCone Hall, Berkeley, CA 94720 USA; [Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, 389 McCone Hall, Berkeley, CA 94720 USA; [Iinuma, Takeshi] Japan Agcy Marine Earth Sci Technol, Yokohama, Kanagawa 2360001, Japan	Tohoku University; Tohoku University; Tohoku University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Uchida, N (corresponding author), Tohoku Univ, Grad Sch Sci, Aoba Ku, 6-6 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.; Uchida, N (corresponding author), Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, 6-6 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	naoki.uchida.b6@tohoku.ac.jp	Iinuma, Takeshi/J-6994-2012; Uchida, Naoki/D-6103-2012; Burgmann, Roland/AAE-5138-2022; Nadeau, Robert/G-1884-2017	Iinuma, Takeshi/0000-0003-0386-2055; Uchida, Naoki/0000-0002-4220-9625; Nadeau, Robert/0000-0003-1255-0643; Burgmann, Roland/0000-0002-3560-044X	Japan Society for the Promotion of Science (JSPS) KAKENHI [23740328, 15K05260]; Ministry of Education, Culture, Sports, Science and Technology of Japan under Earthquake and Volcano Hazards Observation and Research Program; Tohoku University; Berkeley Institute for Data Science - Moore-Sloan Data Science Environment Program; U.S. NSF [EAR-1246850]; JSPS KAKENHI [26000002]; Division Of Earth Sciences [1261833] Funding Source: National Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan under Earthquake and Volcano Hazards Observation and Research Program; Tohoku University; Berkeley Institute for Data Science - Moore-Sloan Data Science Environment Program; U.S. NSF(National Science Foundation (NSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Y. Yabe, T. Matsuzawa, W. Nakamura, R. C. Turner, S. Tanaka, C. W. Johnson, W. L. Ellsworth, Y. Ogata, and A. Hasegawa for fruitful discussion. The anonymous reviewers were helpful in greatly improving the manuscript. This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI 23740328 and 15K05260 and the Ministry of Education, Culture, Sports, Science and Technology of Japan, under its Earthquake and Volcano Hazards Observation and Research Program. N.U. acknowledges support by Tohoku University under its Leading Young Researcher Overseas Visit Program. R.M.N. acknowledges support from the Berkeley Institute for Data Science, funded by the Moore-Sloan Data Science Environment Program. R.B. acknowledges support by U.S. NSF award EAR-1246850. R.H. acknowledges support by JSPS KAKENHI 26000002. The repeating earthquakes were selected based on the seismic waveforms from stations of Hokkaido University, Hirosaki University, Tohoku University, and the University of Tokyo. The repeating earthquake catalog is available as supplementary material on Science Online. The Japan Meteorological Agency (JMA) earthquake catalog used in this study is available at www.jma.go.jp, subject to the policies of the JMA. The GEONET F3 GPS solutions used in this study are available at www.gsi.go.jp, subject to the policies of the Geospatial Information Authority of Japan.	Ader T. J., 2013, EARTH PLANET SC LETT, V377-378, P97; Audet P, 2014, NATURE, V510, P389, DOI 10.1038/nature13391; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Heki K, 2003, EARTH PLANET SC LETT, V207, P159, DOI 10.1016/S0012-821X(02)01148-2; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Hino R, 2014, MAR GEOPHYS RES, V35, P181, DOI 10.1007/s11001-013-9208-2; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; Ito Y, 2013, TECTONOPHYSICS, V600, P14, DOI 10.1016/j.tecto.2012.08.022; Jordan TH, 2010, SEISMOL RES LETT, V81, P571, DOI 10.1785/gssrl.81.4.571; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Liu YJ, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50298; Marsan D, 2013, J GEOPHYS RES-SOL EA, V118, P4900, DOI 10.1002/jgrb.50323; Murotani T, 2003, 2003 JAP GEOSC UN CH; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Nadeau RM, 2004, SCIENCE, V303, P220, DOI 10.1126/science.1090353; Ozawa S, 2007, EARTH PLANETS SPACE, V59, P1241, DOI 10.1186/BF03352072; Ozawa S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009120; Pollitz FF, 2013, J GEOPHYS RES-SOL EA, V118, P2445, DOI 10.1002/jgrb.50181; Ruiz S, 2014, SCIENCE, V345, P1165, DOI 10.1126/science.1256074; SAVAGE JC, 1983, J GEOPHYS RES, V88, P4984, DOI 10.1029/JB088iB06p04984; Segall P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052811; Segall P, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007449; Sella GF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000033; Tanaka Y, 2014, GEOPHYS J INT, V196, P760, DOI 10.1093/gji/ggt424; Uchida N, 2004, TECTONOPHYSICS, V385, P1, DOI 10.1016/j.tecto.2004.04.015; Uchida N, 2013, EARTH PLANET SC LETT, V374, P81, DOI 10.1016/j.epsl.2013.05.021; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Yamanaka Y, 2003, EARTH PLANETS SPACE, V55, pE21, DOI 10.1186/BF03352479	29	104	108	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					488	492		10.1126/science.aad3108	http://dx.doi.org/10.1126/science.aad3108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823425	Green Submitted			2022-12-28	WOS:000368858200033
J	Tramacere, I; Del Giovane, C; Filippini, G				Tramacere, Irene; Del Giovane, Cinzia; Filippini, Graziella			Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tramacere, Irene] Fdn IRCCS Ist Neurol Carlo Besta, Neuroepidemiol Unit, I-20133 Milan, Italy; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Italian Cochrane Ctr, Modena, Italy; [Filippini, Graziella] Fdn IRCCS Ist Neurol Carlo Besta, Sci Direct, Via Mangiagalli 3, I-20133 Milan, Italy	IRCCS Istituto Neurologico Besta; Universita di Modena e Reggio Emilia; IRCCS Istituto Neurologico Besta	Filippini, G (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Sci Direct, Via Mangiagalli 3, I-20133 Milan, Italy.	gfilippini@istituto-besta.it	tramacere, irene/B-2876-2013	tramacere, irene/0000-0001-5550-3412; Del Giovane, Cinzia/0000-0002-5028-932X				Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Scolding Neil, 2015, Pract Neurol, V15, P273, DOI 10.1136/practneurol-2015-001139; Tramacere I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011381.pub2	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					409	410		10.1001/jama.2015.18984	http://dx.doi.org/10.1001/jama.2015.18984			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813214				2022-12-28	WOS:000368589500019
J	Zorzela, L				Zorzela, Liliane			PRISMA harms checklist: improving harms reporting in systematic reviews (vol 352, i157, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction													Moher, David/I-3408-2019; Shamseer, Larissa/E-9645-2017; Singh, Sonal/A-4614-2008; Ioannidis, John P. A./G-9836-2011; Vohra, Sunita/F-5755-2016	Moher, David/0000-0003-2434-4206; Shamseer, Larissa/0000-0003-3690-3378; Singh, Sonal/0000-0003-0912-941X; Vohra, Sunita/0000-0002-6210-7933; Clark, Jocalyn/0000-0002-8014-3989; golder, su/0000-0002-8987-5211	Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [PDF-2014-07-041] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))		Zorzela L, 2016, BMJ-BRIT MED J, V352, DOI [10.1136/bmj.i2229, 10.1136/bmj.i157]	1	274	279	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2016	353								i2229	10.1136/bmj.i2229	http://dx.doi.org/10.1136/bmj.i2229			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZF	26830668	Green Published, Bronze			2022-12-28	WOS:000374999100007
J	Choi, GB; Yim, YS; Wong, HL; Kim, S; Kim, H; Kim, SV; Hoeffer, CA; Littman, DR; Huh, JR				Choi, Gloria B.; Yim, Yeong S.; Wong, Helen; Kim, Sangdoo; Kim, Hyunju; Kim, Sangwon V.; Hoeffer, Charles A.; Littman, Dan R.; Huh, Jun R.			The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring	SCIENCE			English	Article							IMMUNE ACTIVATION; ROR-GAMMA; PROINFLAMMATORY IL-17(+); TH17 CELLS; FAMILY; DIFFERENTIATION; HOSPITALIZATION; ABNORMALITIES; INFECTION; PREGNANCY	The SPO11 protein catalyzes the formation of meiotic DNA double strand breaks (DSBs) and is homologous to theAsubunit of an archaeal topoisomerase (topo VI). Topo VI are heterotetrameric enzymes comprising two A and two B subunits; however, no topo VIBinvolved inmeiotic recombination had been identified. We characterized a structural homolog of the archaeal topo VIB subunit [meiotic topoisomerase VIB-like (MTOPVIB)], which is essential for meiotic DSB formation. It forms a complexwith the two Arabidopsis thaliana SPO11 orthologs required for meiotic DSB formation (SPO11-1 and SPO11-2) and is absolutely required for the formation of the SPO11-1/SPO11-2 heterodimer. These findings suggest that the catalytic core complex responsible for meiotic DSB formation in eukaryotes adopts a topo VI-like structure.	[Choi, Gloria B.; Yim, Yeong S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Wong, Helen; Hoeffer, Charles A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Wong, Helen; Hoeffer, Charles A.] Univ Colorado, Dept Integrated Physiol, Inst Behav Genet, Boulder, CO 80303 USA; [Kim, Sangdoo; Kim, Hyunju; Huh, Jun R.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Kim, Sangdoo; Kim, Hyunju; Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA; [Kim, Sangwon V.; Littman, Dan R.; Huh, Jun R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] Howard Hughes Med Inst, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); New York University; University of Colorado System; University of Colorado Boulder; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; New York University; Howard Hughes Medical Institute	Hoeffer, CA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.; Hoeffer, CA (corresponding author), Univ Colorado, Dept Integrated Physiol, Inst Behav Genet, Boulder, CO 80303 USA.; Huh, JR (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA.; Huh, JR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA.; Littman, DR; Huh, JR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.; Littman, DR (corresponding author), Howard Hughes Med Inst, New York, NY 10016 USA.	charles.hoeffer@colorado.edu; dan.littman@med.nyu.edu; jun.huh@umassmed.edu	Yim, Yeong Shin/HCH-4791-2022; Kim, Sangwon V./S-1166-2016	Kim, Sangwon V./0000-0001-8453-7080	Simons Foundation Autism Research Initiative; Simons Foundation; National Research Foundation of Korea [MEST-35B-2011-1-E00012, NRF-2014R1A1A1006089]; Crohn's and Colitis Foundation of America [329388]; Smith Family Foundation; Searle Scholars Program; Alzheimer's Association [MNIRGDP-12-258900]; Brain and Behavior Research Foundation (NARSAD) [21069]; NIH [F31NS083277, R00DK091508, R01NS086933]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK091508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083277, R01NS086933] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; Simons Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Crohn's and Colitis Foundation of America; Smith Family Foundation; Searle Scholars Program; Alzheimer's Association(Alzheimer's Association); Brain and Behavior Research Foundation (NARSAD)(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Kurz, D. Montgomery, and Y. Cai for assistance with experiments and J. Koll for providing the il17ra<SUP>KO</SUP> mouse line, which was originally developed by Amgen. The il17ra<SUP>KO</SUP> line will be available from D.R.L. under a material transfer agreement with Amgen. We also than M. Sellars for critical reading of the manuscript. The data presented in this paper are tabulated in the main text and in the supplementary materials. This work was supported by the Simons Foundation Autism Research Initiative (D.R.L.); the Simons Foundation to the Simons Center for the Social Brain at Massachusetts Institute of Technology (Y.S.Y. and G.B.C.); Robert Buxton (G.B.C.); the National Research Foundation of Korea grants MEST-35B-2011-1-E00012 (S.K.); and NRF-2014R1A1A1006089 (H.K.); the Crohn's and Colitis Foundation of America grant 329388 (S.V.K.); the Smith Family Foundation (J.R.H.); the Searle Scholars Program (J.R.H.); Alzheimer's Association MNIRGDP-12-258900 (C.A.H.); Brain and Behavior Research Foundation (NARSAD) 21069 (C.A.H.); and NIH grants F31NS083277 (H.W.), R00DK091508 (J.R.H.), and R01NS086933 (C.A.H.); and the Howard Hughes Medical Institute (D.R.L.). D.R.L. and J.R.H. are inventors on a patent application filed by Ness York University, related to the studies reported here.	AL-Ayadhi LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-158; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197; Casanova MF, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-67; De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kuchroo VK, 2012, EUR J IMMUNOL, V42, P2211, DOI 10.1002/eji.201242872; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mandal M, 2010, J REPROD IMMUNOL, V87, P97, DOI 10.1016/j.jri.2010.06.156; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Martinez-Garcia EA, 2011, AM J REPROD IMMUNOL, V65, P99, DOI 10.1111/j.1600-0897.2010.00893.x; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakashima A, 2010, AM J REPROD IMMUNOL, V63, P104, DOI 10.1111/j.1600-0897.2009.00771.x; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Schwartzer JJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.16; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Smith SEP, 2012, J NEUROIMMUNE PHARM, V7, P529, DOI 10.1007/s11481-012-9372-1; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Wu HX, 2014, CELL MOL IMMUNOL, V11, P253, DOI 10.1038/cmi.2013.67; Yee N, 2012, J PSYCHIATR RES, V46, P1199, DOI 10.1016/j.jpsychires.2012.05.010; Zhang XP, 2011, PROTEIN CELL, V2, P26, DOI 10.1007/s13238-011-1006-5	44	574	583	11	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2016	351	6276					933	939		10.1126/science.aad0314	http://dx.doi.org/10.1126/science.aad0314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE7MO	26822608	Green Accepted, Green Submitted			2022-12-28	WOS:000370821400032
J	Bilimoria, KY; Chung, JW; Hedges, LV; Dahlke, AR; Love, R; Cohen, ME; Hoyt, DB; Yang, AD; Tarpley, JL; Mellinger, JD; Mahvi, DM; Kelz, RR; Ko, CY; Odell, DD; Stulberg, JJ; Lewis, FR				Bilimoria, Karl Y.; Chung, Jeanette W.; Hedges, Larry V.; Dahlke, Allison R.; Love, Remi; Cohen, Mark E.; Hoyt, David B.; Yang, Anthony D.; Tarpley, John L.; Mellinger, John D.; Mahvi, David M.; Kelz, Rachel R.; Ko, Clifford Y.; Odell, David D.; Stulberg, Jonah J.; Lewis, Frank R.			National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical Training	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATIENT-OUTCOMES; PROGRAM-DIRECTORS; MEDICARE PATIENTS; CLINICAL-TRIALS; REFORM; RESIDENTS; QUALITY; RESTRICTIONS; MORTALITY; CARE	BACKGROUND Concerns persist regarding the effect of current surgical resident duty-hour policies on patient outcomes, resident education, and resident well-being. METHODS We conducted a national, cluster-randomized, pragmatic, noninferiority trial involving 117 general surgery residency programs in the United States (2014-2015 academic year). Programs were randomly assigned to current Accreditation Council for Graduate Medical Education (ACGME) duty-hour policies (standard-policy group) or more flexible policies that waived rules on maximum shift lengths and time off between shifts (flexible-policy group). Outcomes included the 30-day rate of postoperative death or serious complications (primary outcome), other postoperative complications, and resident perceptions and satisfaction regarding their well-being, education, and patient care. RESULTS In an analysis of data from 138,691 patients, flexible, less-restrictive duty-hour policies were not associated with an increased rate of death or serious complications (9.1% in the flexible-policy group and 9.0% in the standard-policy group, P = 0.92; unadjusted odds ratio for the flexible-policy group, 0.96; 92% confidence interval, 0.87 to 1.06; P = 0.44; noninferiority criteria satisfied) or of any secondary postoperative outcomes studied. Among 4330 residents, those in programs assigned to flexible policies did not report significantly greater dissatisfaction with overall education quality (11.0% in the flexible-policy group and 10.7% in the standard-policy group, P = 0.86) or well-being (14.9% and 12.0%, respectively; P = 0.10). Residents under flexible policies were less likely than those under standard policies to perceive negative effects of duty-hour policies on multiple aspects of patient safety, continuity of care, professionalism, and resident education but were more likely to perceive negative effects on personal activities. There were no significant differences between study groups in resident-reported perception of the effect of fatigue on personal or patient safety. Residents in the flexible-policy group were less likely than those in the standard-policy group to report leaving during an operation (7.0% vs. 13.2%, P<0.001) or handing off active patient issues (32.0% vs. 46.3%, P<0.001). CONCLUSIONS As compared with standard duty-hour policies, flexible, less-restrictive duty-hour policies for surgical residents were associated with noninferior patient outcomes and no significant difference in residents' satisfaction with overall well-being and education quality. (FIRST ClinicalTrials.gov number, NCT02050789.)	[Bilimoria, Karl Y.; Chung, Jeanette W.; Dahlke, Allison R.; Love, Remi; Yang, Anthony D.; Mahvi, David M.; Odell, David D.; Stulberg, Jonah J.] Northwestern Univ, Dept Surg, SOQIC, Feinberg Sch Med, 633 N St Clair St,20th Fl, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Chung, Jeanette W.; Dahlke, Allison R.; Love, Remi; Yang, Anthony D.; Mahvi, David M.; Odell, David D.; Stulberg, Jonah J.] Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Chung, Jeanette W.; Dahlke, Allison R.; Love, Remi; Yang, Anthony D.; Mahvi, David M.; Odell, David D.; Stulberg, Jonah J.] Northwestern Univ, Northwestern Med, 633 N St Clair St,20th Fl, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Cohen, Mark E.; Hoyt, David B.; Ko, Clifford Y.] Amer Coll Surg, Chicago, IL USA; [Hedges, Larry V.] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Mellinger, John D.] So Illinois Univ, Dept Surg, Springfield, IL USA; [Tarpley, John L.] Vanderbilt Univ, Dept Surg, Nashville, TN 37240 USA; [Kelz, Rachel R.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelz, Rachel R.] Univ Penn, Ctr Surg & Hlth Econ, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lewis, Frank R.] Amer Board Surg, Philadelphia, PA USA; [Ko, Clifford Y.] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; American College of Surgeons; Northwestern University; Southern Illinois University System; Southern Illinois University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bilimoria, KY (corresponding author), Northwestern Univ, Dept Surg, SOQIC, Feinberg Sch Med, 633 N St Clair St,20th Fl, Chicago, IL 60611 USA.; Bilimoria, KY (corresponding author), Northwestern Univ, Northwestern Med, 633 N St Clair St,20th Fl, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu	Kelz, Rachel/AAF-3162-2019	Mellinger, John/0000-0002-4230-311X; Stulberg, Jonah/0000-0001-9971-8693; Hedges, Larry/0000-0002-7531-0631	American Board of Surgery (ABS); American College of Surgeons (ACS); Accreditation Council for Graduate Medical Education (ACGME)	American Board of Surgery (ABS); American College of Surgeons (ACS); Accreditation Council for Graduate Medical Education (ACGME)	Supported equally by the American Board of Surgery (ABS), the American College of Surgeons (ACS), and the Accreditation Council for Graduate Medical Education (ACGME).	Accreditation Council for Graduate Medical Education, ACGME 2011 DUT HOUR; ACS NSQIP variables and definitions, 2013, ACS NSQIP OP MAN; Ahmed N, 2014, ANN SURG, V259, P1041, DOI 10.1097/SLA.0000000000000595; [Anonymous], RES DUT HOURS LEARN; Antiel RM, 2013, JAMA SURG, V148, P448, DOI 10.1001/jamasurg.2013.1368; Antiel RM, 2011, MAYO CLIN PROC, V86, P185, DOI 10.4065/mcp.2010.0635; Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Barden CB, 2002, J AM COLL SURGEONS, V195, P531, DOI 10.1016/S1072-7515(02)01242-5; Bilimoria KY, 2015, JAMA SURG, V150, P503, DOI 10.1001/jamasurg.2015.0239; Bilimoria KY, 2015, JAMA SURG; Browne JA, 2009, J BONE JOINT SURG AM, V91A, P2079, DOI 10.2106/JBJS.H.01240; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Coverdill JE, 2011, AM J SURG, V201, P16, DOI 10.1016/j.amjsurg.2010.06.015; Coverdill JE, 2006, AM J SURG, V191, P11, DOI 10.1016/j.amjsurg.2005.06.044; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Drolet BC, 2012, NEW ENGL J MED, V366, DOI 10.1056/NEJMp1202848; Drolet BC, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1011413; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Institute of Medicine, 2008, RESIDENT DUTY HOURS; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mattar SG, 2013, ANN SURG, V258, P440, DOI 10.1097/SLA.0b013e3182a191ca; Merkow RP, 2013, ANN SURG, V257, P483, DOI 10.1097/SLA.0b013e318273bf17; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Philibert I, 2013, ANNU REV MED, V64, P467, DOI 10.1146/annurev-med-120711-135717; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Rajaram R, 2016, BMJ QUAL SAF, V25, P962, DOI 10.1136/bmjqs-2015-004794; Rajaram R, 2015, J AM COLL SURGEONS, V221, P748, DOI 10.1016/j.jamcollsurg.2015.06.010; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; StataCorp, 2015, STATA STAT SOFTW REL; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8	41	277	280	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					713	727		10.1056/NEJMoa1515724	http://dx.doi.org/10.1056/NEJMoa1515724			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE6BB	26836220	Bronze			2022-12-28	WOS:000370716600005
J	Baker, DJ; Childs, BG; Durik, M; Wijers, ME; Sieben, CJ; Zhong, J; Saltness, RA; Jeganathan, KB; Verzosa, GC; Pezeshki, A; Khazaie, K; Miller, JD; van Deursen, JM				Baker, Darren J.; Childs, Bennett G.; Durik, Matej; Wijers, Melinde E.; Sieben, Cynthia J.; Zhong, Jian; Saltness, Rachel A.; Jeganathan, Karthik B.; Verzosa, Grace Casaclang; Pezeshki, Abdulmohammad; Khazaie, Khashayarsha; Miller, Jordan D.; van Deursen, Jan M.			Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan	NATURE			English	Article							SENESCENT CELLS; CELLULAR SENESCENCE; BODY-WEIGHT; IN-VIVO; AGE; EXPRESSION; MICE; GROWTH; RESTRICTION; BIOMARKERS	Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective K-ATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.	[Baker, Darren J.; Durik, Matej; Wijers, Melinde E.; Zhong, Jian; Saltness, Rachel A.; Jeganathan, Karthik B.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Childs, Bennett G.; Sieben, Cynthia J.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Verzosa, Grace Casaclang; Miller, Jordan D.] Mayo Clin, Coll Med, Div Cardiovasc Surg, Rochester, MN 55905 USA; [Pezeshki, Abdulmohammad; Khazaie, Khashayarsha] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Baker, DJ (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	baker.darren@mayo.edu	Zhong, Jian/H-8289-2015; zhong, Jian/C-9610-2014; Durik, Matej/C-3917-2013	Zhong, Jian/0000-0001-7157-603X; zhong, Jian/0000-0001-7157-603X; Jeganathan, KARTHIK/0000-0001-5587-1266; Miller, Jordan/0000-0002-9868-4097; Baker, Darren/0000-0001-9006-1939; Sieben, Cynthia/0000-0002-6733-7711; Durik, Matej/0000-0003-1023-919X	National Institutes of Health [AG041122, R01CA96985, HL111121]; Paul F. Glenn Foundation; Ellison Medical Foundation; Noaber Foundation; Children's Research Center; Robert and Arlene Kogod Center on Aging; NATIONAL CANCER INSTITUTE [R01CA166347, R01CA096985, P30CA015083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013925, P01AG041122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Noaber Foundation; Children's Research Center; Robert and Arlene Kogod Center on Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Hamada, J. Rainey, Q. Guo, S. Bornschlegl, M. Li, C. M. Roos, N. Hamada and B. Zhang for assistance, and C. Burd, S. Reyes Ramirez, P. Galardy and D. Katzmann and the members of Program Project Grant AG041122 for discussions. We are grateful to R. Miller and S. Austad for help with the design and interpretation of our lifespan studies. We thank C. Burd and J. Campisi for sharing p16-FLUC and 3MR MEFs, respectively. This work was supported by the National Institutes of Health (J.M.v.D. R01CA96985 and AG041122 project 1) and (J. D. M., HL111121), the Paul F. Glenn Foundation (J.M.v.D. and D.J.B.), the Ellison Medical Foundation (D. J. B.), the Noaber Foundation (J.M.v.D.), the Children's Research Center (D. J. B.) and the Robert and Arlene Kogod Center on Aging (D.J.B.).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169; Buenz EJ, 2009, AM J PATHOL, V175, P668, DOI 10.2353/ajpath.2009.081126; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Ferder LF, 2003, EXP GERONTOL, V38, P237, DOI 10.1016/S0531-5565(02)00264-4; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garelick MG, 2013, CELL CYCLE, V12, P2493, DOI 10.4161/cc.25512; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Richardson A, 2015, J GERONTOL A; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P453, DOI 10.1016/0531-5565(91)90034-J; Stollewerk A, 1996, MICROSC RES TECHNIQ, V35, P294, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;294::AID-JEMT8&gt;3.0.CO;2-N; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Sudhir R, 2011, BIOGERONTOLOGY, V12, P147, DOI 10.1007/s10522-010-9306-3; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Wijshake T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003138; Yuan R, 2012, P NATL ACAD SCI USA, V109, P8224, DOI 10.1073/pnas.1121113109; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	48	1400	1461	14	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					184	+		10.1038/nature16932	http://dx.doi.org/10.1038/nature16932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840489	Green Accepted			2022-12-28	WOS:000369916700031
J	Katoh, S; Beyene, Y; Itaya, T; Hyodo, H; Hyodo, M; Yagi, K; Gouzu, C; WoldeGabriel, G; Hart, WK; Ambrose, SH; Nakaya, H; Bernor, RL; Boisserie, JR; Bibi, F; Saegusa, H; Sasaki, T; Sano, K; Asfaw, B; Suwa, G				Katoh, Shigehiro; Beyene, Yonas; Itaya, Tetsumaru; Hyodo, Hironobu; Hyodo, Masayuki; Yagi, Koshi; Gouzu, Chitaro; WoldeGabriel, Giday; Hart, William K.; Ambrose, Stanley H.; Nakaya, Hideo; Bernor, Raymond L.; Boisserie, Jean-Renaud; Bibi, Faysal; Saegusa, Haruo; Sasaki, Tomohiko; Sano, Katsuhiro; Asfaw, Berhane; Suwa, Gen			New geological and palaeontological age constraint for the gorilla-human lineage split	NATURE			English	Article							MAIN ETHIOPIAN RIFT; LATE MIOCENE; GREAT APE; PLIOPLEISTOCENE TEPHRA; HISTORY; CALIBRATION; EVOLUTION; ORIGINS; SAHARA; RECORD	The palaeobiological record of 12 million to 7 million years ago (Ma) is crucial to the elucidation of African ape and human origins, but few fossil assemblages of this period have been reported from sub-Saharan Africa. Since the 1970s, the Chorora Formation, Ethiopia, has been widely considered to contain similar to 10.5 million year (Myr) old mammalian fossils(1-7). More recently, Chororapithecus abyssinicus, a probable primitive member of the gorilla clade(6), was discovered from the formation. Here we report new field observations and geochemical, magnetostratigraphic and radioisotopic results that securely place the Chorora Formation sediments to between similar to 9 and similar to 7 Ma. The C. abyssinicus fossils are similar to 8.0 Myr old, forming a revised age constraint of the human-gorilla split. Other Chorora fossils range in age from similar to 8.5 to 7 Ma and comprise the first sub-Saharan mammalian assemblage that spans this period. These fossils suggest indigenous African evolution of multiple mammalian lineages/groups between 10 and 7 Ma, including a possible ancestral-descendent relationship between the similar to 9.8 Myr old Nakalipithecus nakayamai(8) and C. abyssinicus. The new chronology and fossils suggest that faunal provinciality between eastern Africa and Eurasia had intensified by similar to 9 Ma, with decreased faunal interchange thereafter(9-12). The Chorora evidence supports the hypothesis of in situ African evolution of the Gorilla-Pan-human clade, and is concordant with the deeper divergence estimates of humans and great apes based on lower mutation rates of similar to 0.5 x 10(-9) per site per year (refs 13-15).	[Katoh, Shigehiro] Hyogo Museum Nat & Human Act, Div Nat Hist, Sanda 6691546, Japan; [Beyene, Yonas] Assoc Conservat Culture Awassa, Addis Ababa, Ethiopia; [Beyene, Yonas; Boisserie, Jean-Renaud] French Minist Foreign Affairs, USR CNRS 3137, CFEE, Addis Ababa, Ethiopia; [Itaya, Tetsumaru; Hyodo, Hironobu] Okayama Univ Sci, Res Inst Nat Sci, Okayama 7000005, Japan; [Hyodo, Masayuki] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan; [Yagi, Koshi; Gouzu, Chitaro] Hiruzen Inst Geol & Chronol, Okayama 7038252, Japan; [WoldeGabriel, Giday] Los Alamos Natl Lab, EES 14, MS D462, Los Alamos, NM 87545 USA; [Hart, William K.] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Ambrose, Stanley H.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Nakaya, Hideo] Kagoshima Univ, Dept Earth & Environm Sci, Kagoshima 8900065, Japan; [Bernor, Raymond L.] Howard Univ, Dept Anat, Washington, DC 20059 USA; [Boisserie, Jean-Renaud] Univ Poitiers, UMR CNRS 7262, Inst Paleoprimatol Paleontol Humaine Evolut & Pa, F-86022 Poitiers, France; [Bibi, Faysal] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, D-10115 Berlin, Germany; [Saegusa, Haruo] Univ Hyogo, Inst Nat & Environm Sci, Sanda 6691546, Japan; [Sasaki, Tomohiko; Sano, Katsuhiro; Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Asfaw, Berhane] Rift Valley Res Serv, Addis Ababa, Ethiopia	Okayama University of Science; Kobe University; United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Ohio; Miami University; University of Illinois System; University of Illinois Urbana-Champaign; Kagoshima University; Howard University; Universite de Poitiers; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Hyogo; University of Tokyo	Suwa, G (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan.	gsuwa@um.u-tokyo.ac.jp	Sano, Katsuhiro/AAE-8937-2021; Bibi, Faysal/AAZ-9917-2021	Bibi, Faysal/0000-0002-9414-5547; Sano, Katsuhiro/0000-0002-0839-8549	Janet and Elliott Banes Professorship; National Science Foundation [EAR-1028789]; Japan Society for the Promotion of Science [21255005, 24000015]	Janet and Elliott Banes Professorship; National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the Authority for Research and Conservation of Cultural Heritage, Ministry of Culture and Tourism of Ethiopia, for permissions and facilitation; we thank the Western Hararge Chiro Zone Culture and Tourism Office and the Mieso Woreda for fieldwork support; we thank all participants in the fieldwork, especially the Gololcha people, who were essential to the success of the project. Neutron irradiation for <SUP>40</SUP>Ar-<SUP>39</SUP>Ar dating was done under the Visiting Researchers Program at the Kyoto University Research Reactor Institute. We thank J. Morton for assistance with major and trace element analyses, and the Janet and Elliott Banes Professorship and National Science Foundation EAR-1028789 for support to W.H. We thank H. Ishiguro for assistance with sampling enamel for the isotope analysis, and M. Nakatsukasa and Y. Kunimatsu for comparative materials. We thank D. Geraads for providing field information about previous geochronological sampling localities. This project was supported primarily by the Japan Society for the Promotion of Science (Kakenhi grant numbers 21255005 and 24000015).	Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; BENEFIT BR, 1986, AM J PHYS ANTHROPOL, V69, P441, DOI 10.1002/ajpa.1330690404; Bernor Raymond L., 2004, Courier Forschungsinstitut Senckenberg, V246, P213; Bernor Raymond L., 2010, P685; Bibi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016688; Boisserie JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103221; Boisserie JR, 2011, BIOL REV, V86, P601, DOI 10.1111/j.1469-185X.2010.00162.x; Boisserie JR, 2005, PALAEOGEOGR PALAEOCL, V221, P153, DOI 10.1016/j.palaeo.2005.02.010; Borchardt G. A., 1971, QUATERNARY RES, V1, P247, DOI [DOI 10.1016/0033-5894(71)90045-7, 10.1016/0033-5894(71)90045-7]; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Cerling T. E., 2003, LOTHAGAM DAWN HUMANI, P584; Chernet T, 1998, J VOLCANOL GEOTH RES, V80, P267, DOI 10.1016/S0377-0273(97)00035-8; Cote SM, 2004, CR PALEVOL, V3, P323, DOI 10.1016/j.crpv.2004.03.006; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Eronen JT, 2009, P NATL ACAD SCI USA, V106, P11867, DOI 10.1073/pnas.0902598106; Feakins SJ, 2013, GEOLOGY, V41, P295, DOI 10.1130/G33845.1; Flynn LJ, 2014, MAMMAL REV, V44, P164, DOI 10.1111/mam.12016; Geraads Denis, 2002, Tertiary Research, V21, P113; Gilbert CC, 2010, J HUM EVOL, V59, P465, DOI 10.1016/j.jhevol.2010.05.005; Godfrey L.R., 2010, CENOZOIC MAMMALS AFR; Hara Y, 2012, GENOME BIOL EVOL, V4, P1133, DOI 10.1093/gbe/evs075; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Hyodo, 2007, J GEOLOGICAL SOC JAP, V113, P492; Hyodo H., 1999, J MINERALOGY PETROLO, V94, P329, DOI DOI 10.2465/GANK0.94.329; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Itaya T., 1991, MINERALOGICAL J, V15, P203; Katoh S, 2000, QUATERNARY SCI REV, V19, P1305, DOI 10.1016/S0277-3791(99)00099-2; Katoh S., 1999, NATURE HUMAN ACTIVIT, V4, P45, DOI DOI 10.24713/NHA.4.0_45; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; KUNZ K, 1975, AFAR DEPRESSION ETHI, P370; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Leakey MG, 2003, LOTHAGAM DAWN HUMANI; Ryu S, 2011, GEOSCI J, V15, P1, DOI 10.1007/s12303-011-0008-x; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Sickenberg O., 1975, AFAR DEPRESSION ETHI, V1, P277; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2015, ANTHROPOL SCI, V123, P19, DOI 10.1537/ase.150206; Tiercelin J. J., 1977, 5 REUN ANN SC TERRE, V449; TIERCELIN JJ, 1979, B SOC GEOL FR, V21, P255; Tipple BJ, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001851; Tsujikawa Hiroshi, 2005, African Study Monographs Supplementary Issue, V32, P1; Uno KT, 2011, P NATL ACAD SCI USA, V108, P6509, DOI 10.1073/pnas.1018435108; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; WoldeGabriel G, 2005, J VOLCANOL GEOTH RES, V147, P81, DOI 10.1016/j.jvolgeores.2005.03.008; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022; Zhang ZS, 2014, NATURE, V513, P401, DOI 10.1038/nature13705	49	32	34	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					215	+		10.1038/nature16510	http://dx.doi.org/10.1038/nature16510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863981				2022-12-28	WOS:000369916700038
J	Arora, S; Prakash, TV; Carey, RA; Hansdak, SG				Arora, Shalabh; Prakash, Turaka Vijay; Carey, Ronald Albert; Hansdak, Samuel George			Poncet's disease: unusual presentation of a common disease	LANCET			English	Editorial Material							TUBERCULOSIS; ARTHRITIS		[Arora, Shalabh; Prakash, Turaka Vijay; Carey, Ronald Albert; Hansdak, Samuel George] Christian Med Coll & Hosp, Dept Internal Med, Vellore 632004, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Arora, S (corresponding author), Christian Med Coll & Hosp, Dept Internal Med, Vellore 632004, Tamil Nadu, India.	dr.shalabharora@gmail.com	Arora, Shalabh/G-9962-2013	Arora, Shalabh/0000-0002-4824-3541; Turaka, Vijay/0000-0002-6964-4934				Kroot EJA, 2007, RHEUMATOLOGY, V46, P484, DOI 10.1093/rheumatology/kel268; Malaviya AN, 2003, BEST PRACT RES CL RH, V17, P319, DOI 10.1016/S1521-6942(02)00126-2; OTTENHOFF THM, 1986, LANCET, V2, P310; Rueda JC, 2013, CLIN RHEUMATOL, V32, P929, DOI 10.1007/s10067-013-2270-y; SOUTHWOOD TR, 1990, BRIT J RHEUMATOL, V29, P491	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					617	618		10.1016/S0140-6736(16)00157-4	http://dx.doi.org/10.1016/S0140-6736(16)00157-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26867450				2022-12-28	WOS:000369835800039
J	Allison, DB; Brown, AW; George, BJ; Kaiser, KA				Allison, David B.; Brown, Andrew W.; George, Brandon J.; Kaiser, Kathryn A.			A tragedy of errors	NATURE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; BASE-LINE		[Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Brown, Andrew W.; George, Brandon J.; Kaiser, Kathryn A.] Univ Alabama Birmingham, Off Energet, Birmingham, AL USA; [Brown, Andrew W.; Kaiser, Kathryn A.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Allison, DB (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA.	dallison@uab.edu	Brown, Andrew W/N-1826-2013; Kaiser, Kathryn Ann/B-5778-2015	Brown, Andrew W/0000-0002-1758-8205; Kaiser, Kathryn Ann/0000-0002-6258-4369	NIDDK NIH HHS [P30 DK056336] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2015, OBESITY, V23, P2522; Bland JM, 2015, AM J CLIN NUTR, V102, P991, DOI 10.3945/ajcn.115.119768; Brown AW, 2015, AM J CLIN NUTR, V102, P241, DOI 10.3945/ajcn.114.105072; Brown AW, 2014, CHILD OBES, V10, P542, DOI 10.1089/chi.2014.0081; George B. J., OBESITY IN PRESS; George Brandon J, 2016, Int J Yoga, V9, P87, DOI 10.4103/0973-6131.171726; George Brandon J, 2015, J Paramed Sci, V6, P153; Hauner H, 2015, OBESITY FACTS, V8, P125, DOI 10.1159/000381481; Li P, 2015, OBESITY FACTS, V8, P127, DOI 10.1159/000381434; Thomas DM, 2015, WORLD J ACUPUNCT-MOX, V25, P66, DOI 10.1016/S1003-5257(15)30019-2	10	120	123	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					27	29		10.1038/530027a	http://dx.doi.org/10.1038/530027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842041	Green Accepted, Bronze			2022-12-28	WOS:000369304500015
J	Lorenzo-Redondo, R; Fryer, HR; Bedford, T; Kim, EY; Archer, J; Pond, SLK; Chung, YS; Penugonda, S; Chipman, JG; Fletcher, CV; Schacker, TW; Malim, MH; Rambaut, A; Haase, AT; McLean, AR; Wolinsky, SM				Lorenzo-Redondo, Ramon; Fryer, Helen R.; Bedford, Trevor; Kim, Eun-Young; Archer, John; Pond, Sergei L. Kosakovsky; Chung, Yoon-Seok; Penugonda, Sudhir; Chipman, Jeffrey G.; Fletcher, Courtney V.; Schacker, Timothy W.; Malim, Michael H.; Rambaut, Andrew; Haase, Ashley T.; McLean, Angela R. .; Wolinsky, Steven M.			Persistent HIV-1 replication maintains the tissue reservoir during therapy	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; IN-VIVO; PERIPHERAL-BLOOD; EVOLUTION; DNA; SEQUENCES; DYNAMICS; ACCURATE	Lymphoid tissue is a key reservoir established by HIV-1 during acute infection. It is a site associated with viral production, storage of viral particles in immune complexes, and viral persistence. Although combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral replication in lymphoid tissue reservoirs. Here we show that virus evolution and trafficking between tissue compartments continues in patients with undetectable levels of virus in their bloodstream. We present a spatial and dynamic model of persistent viral replication and spread that indicates why the development of drug resistance is not a foregone conclusion under conditions in which drug concentrations are insufficient to completely block virus replication. These data provide new insights into the evolutionary and infection dynamics of the virus population within the host, revealing that HIV-1 can continue to replicate and replenish the viral reservoir despite potent antiretroviral therapy.	[Lorenzo-Redondo, Ramon; Kim, Eun-Young; Penugonda, Sudhir; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60011 USA; [Fryer, Helen R.; McLean, Angela R. .] Univ Oxford, Inst Emerging Infect, Dept Zool, Oxford OX1 3PS, England; [Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Archer, John] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal; [Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Chung, Yoon-Seok] Korea Natl Inst Hlth, Div Aids, Ctr Immunol & Pathol, Chungju Si 28159, Chungcheongbuk, South Korea; [Chipman, Jeffrey G.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Fletcher, Courtney V.] Univ Nebraska Med Ctr, Coll Pharm, Antiviral Pharmacol Lab, Omaha, NE 68198 USA; [Schacker, Timothy W.] Univ Minnesota, Div Infect Dis, Minneapolis, MN 55455 USA; [Malim, Michael H.] Kings Coll London, Guys Hosp, Dept Infect Dis, London SE21 7DN, England; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland; [Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Pond, Sergei L. Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA	Northwestern University; Feinberg School of Medicine; University of Oxford; Fred Hutchinson Cancer Center; Universidade do Porto; University of California System; University of California San Diego; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wolinsky, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60011 USA.	s-wolinsky@northwestern.edu	Rambaut, Andrew/B-2481-2009; Pond, Sergei LK/G-9830-2012; Wolinsky, Steven/B-2893-2012; Chung, Yoon-Seok/GQA-3042-2022	Rambaut, Andrew/0000-0003-4337-3707; Pond, Sergei LK/0000-0003-4817-4029; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Kim, Eunyoung/0000-0002-7436-7396; Archer, John/0000-0001-6212-0962; Chung, Yoon-Seok/0000-0003-4562-5533; Chipman, Jeffrey/0000-0002-0759-3705; Malim, Michael/0000-0002-7699-2064; Lorenzo-Redondo, Ramon/0000-0002-5462-9483; Wolinsky, Steven/0000-0002-9625-6697	National Institutes of Health [DA033773, AI1074340, GM110749]; Medical Research Council [G1000196]; Framework Programme for Research and Technological Development [278433-PREDEMICS]; European Research Council [260864]; Oxford Martin School; All Souls College; Royal Society; Wellcome Trust; MRC [G1000196] Funding Source: UKRI; Wellcome Trust [106223/Z/14/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074340, UM1AI106701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Framework Programme for Research and Technological Development; European Research Council(European Research Council (ERC)European Commission); Oxford Martin School; All Souls College; Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. J. Beilman, A. Thorkelson, P. Swantek, K. Mars and K. Kunstman for their technical assistance. We thank E. Domingo and T. Bhattacharya for their constructive and informed review. We are indebted to the patients who participated in this study. This work was supported by the National Institutes of Health (DA033773 to S.M.W., AI1074340 to T.W.S., and GM110749 to S.L.K.P.), the Medical Research Council (G1000196 to M.H.M.), the Framework Programme for Research and Technological Development (278433-PREDEMICS to A.R.) and the European Research Council (260864 to A.R.). The Oxford Martin School supports H.R.F. All Souls College supports A.R.M. where S.M.W. held a Visiting Fellowship. A Newton International Fellowship from the Royal Society supported T.B.A Wellcome Trust Investigator award supported M.H.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003871; Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunthard HF, 1999, J VIROL, V73, P9404; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, GENETICS, V132, P583; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Kim EY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004281; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lemey P, 2006, AIDS REV, V8, P125; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; MCLEAN AR, 1992, AIDS, V6, P71, DOI 10.1097/00002030-199201000-00009; Mugal CF, 2014, MOL BIOL EVOL, V31, P212, DOI 10.1093/molbev/mst192; MURRELL B, 2015, MOL BIOL EVOL; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wagner T. A., 2014, SCIENCE; Wong JK, 1997, J VIROL, V71, P2059, DOI 10.1128/JVI.71.3.2059-2071.1997; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	50	437	440	0	132	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					51	+		10.1038/nature16933	http://dx.doi.org/10.1038/nature16933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814962	Green Submitted, Green Accepted			2022-12-28	WOS:000369304500030
J	Cohen, D				Cohen, Deborah			INVESTIGATION Rivaroxaban: can we trust the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WARFARIN					dcohen@bmj.com						Burger l, 2015, REUTERS; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Cohen D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f837; Cohen D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7090; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; FDA, 2015, DRUG APPR PACK XAR; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Meier B., 2011, NY TIMES; Mundy A, 2009, WALL STREET J; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638	11	25	26	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2016	352								i575	10.1136/bmj.i575	http://dx.doi.org/10.1136/bmj.i575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QN	26843102				2022-12-28	WOS:000369767400004
J	Ray, S				Ray, Sagarika			CASE REVIEW A baby with low Apgar scores at birth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMPLITUDE-INTEGRATED EEG; HYPOXIA-ISCHEMIA; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; CEREBRAL-PALSY; BRAIN-INJURY; TERM; ENCEPHALOPATHY; ASPHYXIA; PATTERNS		[Ray, Sagarika] Shrewsbury & Telford Hosp NHS Trust, Princess Royal Hosp, Telford TF1 6TF, Shrops, England		Ray, S (corresponding author), Shrewsbury & Telford Hosp NHS Trust, Princess Royal Hosp, Telford TF1 6TF, Shrops, England.	sagarika.ray@nhs.net						Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; ARCHER LNJ, 1986, LANCET, V2, P1116; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Carli G, 2004, J PAEDIATR CHILD H, V40, P217, DOI 10.1111/j.1440-1754.2004.00341.x; Clark SL, 2008, AM J OBSTET GYNECOL, V199, pE7, DOI 10.1016/j.ajog.2008.05.010; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051; El Beshlawy Amal, 2004, Pediatr Crit Care Med, V5, P163, DOI 10.1097/01.PCC.0000113261.13338.C3; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; FINER NN, 1981, J PEDIATR-US, V98, P112, DOI 10.1016/S0022-3476(81)80555-0; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Hahn J, 2009, FETAL NEONATAL BRAIN, P187, DOI [10.1017/CBO9780511581281.018, DOI 10.1017/CBO9780511581281.018]; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Jongeling BR, 2002, PEDIATR NEUROL, V26, P37, DOI 10.1016/S0887-8994(01)00354-X; LEVENE ML, 1985, EARLY HUM DEV, V11, P21, DOI 10.1016/0378-3782(85)90115-X; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; National Institute for Health and Care Excellence, 2010, THER HYP INTR TEMP M; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Perlman JM, 1996, PEDIATRICS, V97, P456; Regier DA, 2010, VALUE HEALTH, V13, P695, DOI 10.1111/j.1524-4733.2010.00731.x; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Srinivasan L, 2008, PAEDIAT CHILD HLTH, V18, P183, DOI [10.1016/j.paed.2008.01.003, DOI 10.1016/J.PAED.2008.01.003]; Strohm Brenda, 2011, Pediatrics, V128, pe450, DOI 10.1542/peds.2010-3508; Taylor DL, 2002, PEDIATR RES, V51, P13, DOI 10.1203/00006450-200201000-00005; ter Horst H, 2004, PEDIATR RES, V55, P1026, DOI 10.1203/01.pdr.0000127019.52562.8c; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964	39	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2016	352								i479	10.1136/bmj.i479	http://dx.doi.org/10.1136/bmj.i479			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QN	26843475				2022-12-28	WOS:000369767400003
J	Johansson, J				Johansson, Jorgen			Battling the bureaucracy hydra	SCIENCE			English	Editorial Material									[Johansson, Jorgen] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Umea University	Johansson, J (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	SciCareerEditor@aaas.org		Johansson, Jorgen/0000-0002-0904-497X					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					530	530		10.1126/science.351.6272.530	http://dx.doi.org/10.1126/science.351.6272.530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB9SW	26823432				2022-12-28	WOS:000368858200040
J	Yu, ZL; Tantakitti, F; Yu, T; Palmer, LC; Schatz, GC; Stupp, SI				Yu, Zhilin; Tantakitti, Faifan; Yu, Tao; Palmer, Liam C.; Schatz, George C.; Stupp, Samuel I.			Simultaneous covalent and noncovalent hybrid polymerizations	SCIENCE			English	Article							PEPTIDE-AMPHIPHILE NANOFIBERS; CHAIN-LENGTH DEPENDENCE; NANOSTRUCTURES; POLYMERS; ASSEMBLIES; NANOTUBES; OLIGOMERS	Covalent and supramolecular polymers are two distinct forms of soft matter, composed of long chains of covalently and noncovalently linked structural units, respectively. We report a hybrid system formed by simultaneous covalent and supramolecular polymerizations of monomers. The process yields cylindrical fibers of uniform diameter that contain covalent and supramolecular compartments, a morphology not observed when the two polymers are formed independently. The covalent polymer has a rigid aromatic imine backbone with helicoidal conformation, and its alkylated peptide side chains are structurally identical to the monomer molecules of supramolecular polymers. In the hybrid system, covalent chains grow to higher average molar mass relative to chains formed via the same polymerization in the absence of a supramolecular compartment. The supramolecular compartments can be reversibly removed and re-formed to reconstitute the hybrid structure, suggesting soft materials with novel delivery or repair functions.	[Yu, Zhilin; Yu, Tao; Palmer, Liam C.; Schatz, George C.; Stupp, Samuel I.] Northwestern Univ, Dept Chem, 2220 Campus Dr, Evanston, IL 60208 USA; [Tantakitti, Faifan; Stupp, Samuel I.] Northwestern Univ, Dept Mat & Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA; [Palmer, Liam C.; Stupp, Samuel I.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, 303 East Super St,11th Floor, Chicago, IL 60611 USA; [Schatz, George C.] Northwestern Univ, Dept Chem & Biol Engn, 2220 Campus Dr, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, 2220 Campus Dr, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Biomed Engn, 2220 Campus Dr, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Chem, 2220 Campus Dr, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Mat & Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Simpson Querrey Inst BioNanotechnol, 303 East Super St,11th Floor, Chicago, IL 60611 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Med, 2220 Campus Dr, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Biomed Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Palmer, Liam Charles/E-2975-2010; Schatz, George C./ABF-1341-2020; Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009; Yu, Zhilin/AAO-3550-2021	Palmer, Liam Charles/0000-0003-0804-1168; Yu, Zhilin/0000-0002-7116-3304	NSF [DMR-1508731, CHE-9871268]; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-FG02-00ER45810]; Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - DOE, Office of Science, Basic Energy Sciences [DE-SC0000989]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; E. I. DuPont de Nemours and Co.; Dow Chemical Company; Northwestern University	NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - DOE, Office of Science, Basic Energy Sciences; DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); E. I. DuPont de Nemours and Co.; Dow Chemical Company; Northwestern University	The synthesis and structural characterization of this work was supported by the NSF under award no. DMR-1508731. Experimental work on SAXS was supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under award no. DE-FG02-00ER45810. MD simulations were supported by the Center for Bio-Inspired Energy Science, an Energy Frontier Research Center funded by DOE, Office of Science, Basic Energy Sciences, under award no. DE-SC0000989 (T.Y. and G.C.S.). We thank A. Koltonow for help with AFM measurements and M. Seniw for help with the preparation of graphics. We also acknowledge S. Kewalramani for helpful discussions on the SAXS data. Use of the Advanced Photon Source (APS) was supported by DOE, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. SAXS experiments were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of APS. DND-CAT is supported by E. I. DuPont de Nemours and Co., The Dow Chemical Company, and Northwestern University. We thank the Biological Imaging Facility at Northwestern and the Electron Probe Instrumentation Center facilities of the Northwestern University Atomic and Nanoscale Characterization Experimental Center for the use of TEM. Nuclear magnetic resonance and MS equipment at the Integrated Molecular Structure Education and Research Center was supported by the NSF under grant no. CHE-9871268. We are also grateful to the Peptide Synthesis Core at the Simpson Querrey Institute for BioNanotechnology and Keck Biophysics Facility for instrument use.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Carnall JMA, 2010, SCIENCE, V327, P1502, DOI 10.1126/science.1182767; Cui HG, 2014, J AM CHEM SOC, V136, P12461, DOI 10.1021/ja507051w; Cui H, 2009, NANO LETT, V9, P945, DOI 10.1021/nl802813f; Delclos T, 2008, NANO LETT, V8, P1929, DOI 10.1021/nl080664n; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Godoy-Alcantar C, 2005, J PHYS ORG CHEM, V18, P979, DOI 10.1002/poc.941; Guichard G, 2011, CHEM COMMUN, V47, P5933, DOI 10.1039/c1cc11137j; Guilbaud JB, 2011, CHEM SOC REV, V40, P1200, DOI 10.1039/c0cs00105h; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hirst AR, 2010, NAT CHEM, V2, P1089, DOI [10.1038/nchem.861, 10.1038/NCHEM.861]; Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s; Jiang T, 2014, J AM CHEM SOC, V136, P4300, DOI 10.1021/ja412867z; Jin W, 2005, J AM CHEM SOC, V127, P8284, DOI 10.1021/ja051859p; Lee J, 2014, NAT CHEM, V6, P97, DOI [10.1038/NCHEM.1833, 10.1038/nchem.1833]; Lee OS, 2011, J AM CHEM SOC, V133, P3677, DOI 10.1021/ja110966y; Pizzey CL, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2955745; Prince RB, 1999, J AM CHEM SOC, V121, P3114, DOI 10.1021/ja983995i; Prince RB, 2000, ANGEW CHEM INT EDIT, V39, P228, DOI 10.1002/(SICI)1521-3773(20000103)39:1<228::AID-ANIE228>3.0.CO;2-B; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roe R. J., 2000, METHODS XRAY NEUTRON; Sada K, 2007, CHEM SOC REV, V36, P415, DOI 10.1039/b603555h; Stone MT, 2006, ACCOUNTS CHEM RES, V39, P11, DOI 10.1021/ar0501267; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; STUPP SI, 1993, SCIENCE, V259, P59, DOI 10.1126/science.259.5091.59; Wu DC, 2012, CHEM REV, V112, P3959, DOI 10.1021/cr200440z	27	132	134	6	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					497	502		10.1126/science.aad4091	http://dx.doi.org/10.1126/science.aad4091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823427	Green Submitted			2022-12-28	WOS:000368858200035
J	Bertoia, ML; Rimm, EB; Mukamal, KJ; Hu, FB; Willett, WC; Cassidy, A				Bertoia, Monica L.; Rimm, Eric B.; Mukamal, Kenneth J.; Hu, Frank B.; Willett, Walter C.; Cassidy, Aedin			Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124 086 US men and women followed for up to 24 years	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-FAT DIET; GREEN TEA; BODY-WEIGHT; GLUCOSE-UPTAKE; RISK; SUPPLEMENTATION; CONSUMPTION; OVERWEIGHT; CAFFEINE; GAIN	OBJECTIVE To examine whether dietary intake of specific flavonoid subclasses (including flavonols, flavones, flavanones, flavan-3-ols, anthocyanins, and flavonoid polymers) is associated with weight change over time. DESIGN Three prospective cohort studies. SETTING Health professionals in the United States. PARTICIPANTS 124 086 men and women participating in the Health Professionals Follow-up Study (HPFS), Nurses' Health Study (NHS), and Nurses' Health Study II (NHS II). MAIN OUTCOME MEASURE Self reported change in weight over multiple four year time intervals between 1986 and 2011. RESULTS Increased consumption of most flavonoid subclasses, including flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers, was inversely associated with weight change over four year time intervals, after adjustment for simultaneous changes in other lifestyle factors including other aspects of diet, smoking status, and physical activity. In the pooled results, the greatest magnitude of association was observed for anthocyanins (-0.23 (95% confidence interval -0.30 to -0.15) lbs per additional standard deviation/day, 10 mg), flavonoid polymers (-0.18 (-0.28 to -0.08) lbs per additional SD/day, 138 mg), and flavonols (-0.16 (-0.26 to -0.06) lbs per additional SD/day, 7 mg). After additional adjustment for fiber intake, associations remained significant for anthocyanins, proanthocyanidins, and total flavonoid polymers but were attenuated and no longer statistically significant for other subclasses. CONCLUSIONS Higher intake of foods rich in flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers may contribute to weight maintenance in adulthood and may help to refine dietary recommendations for the prevention of obesity and its potential consequences.	[Bertoia, Monica L.; Rimm, Eric B.; Mukamal, Kenneth J.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA; [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Cassidy, Aedin] Univ E Anglia, Norwich Med Sch, Dept Nutr, Norwich NR4 7TJ, Norfolk, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; University of East Anglia	Bertoia, ML (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.	mbertoia@hsph.harvard.edu	Mukamal, Kenneth/GVR-7978-2022		National Institutes of Health [P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, UM1 CA176726, R01 CA67262, UM1 CA167552, R01 HL35464, UM1 CA186107]; Biotechnology, Biological Sciences Research Council (BBSRC), UK [BB/J004545/1]; Danish Council for Strategic Research (Innovation Fund Denmark) [0603-00488B]; project "Diet and prevention of ischemic heart disease: a translational approach" (DIPI); NATIONAL CANCER INSTITUTE [R01CA049449, UM1CA167552, R01CA067262, P01CA087969, UM1CA176726, UM1CA186107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088521, R01HL035464, R01HL034594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology, Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Danish Council for Strategic Research (Innovation Fund Denmark); project "Diet and prevention of ischemic heart disease: a translational approach" (DIPI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, UM1 CA176726, R01 CA67262, UM1 CA167552, R01 HL35464, and UM1 CA186107 from the National Institutes of Health; the Biotechnology, Biological Sciences Research Council (BBSRC), UK (reference BB/J004545/1); and the project "Diet and prevention of ischemic heart disease: a translational approach" (DIPI, www.dipi.dk), which is supported by the Danish Council for Strategic Research (today, Innovation Fund Denmark) (contract 0603-00488B). AC is a Royal Society Wolfson Research Merit Award holder. The funders played no role in the study design, data collection, analysis and interpretation of data, writing of the manuscript, or the decision to submit the article for publication.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126; Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009; Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001; Bertoia ML, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001878; Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005; Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059; de Kleijn MJJ, 2001, J NUTR, V131, P1826; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058; Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63; Kimmons Joel, 2009, Medscape J Med, V11, P26; Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170; Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784; Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Panico S, 2008, PREV MED, V47, P53, DOI 10.1016/j.ypmed.2008.01.023; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; US Department of Agriculture, 2004, USDA DAT PROANTH CON; US Department of Agriculture, 2007, USDA DAT FLAV CONT S; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142; WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046	39	100	100	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2016	352								i17	10.1136/bmj.i17	http://dx.doi.org/10.1136/bmj.i17			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EX	26823518	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000369313700002
J	Pauluzzi, G; Bailey-Serres, J				Pauluzzi, Germain; Bailey-Serres, Julia			Flexible Ion Barrier	CELL			English	Editorial Material							ARCHITECTURE; SUBERIZATION; ROOTS	The central vasculature of plant roots is protected by a hydrophobic ring of endodermal cells that are enclosed by lamellae of suberin. Barberon et al. demonstrate that endodermal suberization plasticity facilitates ion homeostasis, with antithetical regulation of suberin deposition and degradation by the phytohormones abscisic acid and ethylene.	[Pauluzzi, Germain; Bailey-Serres, Julia] Univ Calif Riverside, Bot & Plant Sci Dept, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bailey-Serres, J (corresponding author), Univ Calif Riverside, Bot & Plant Sci Dept, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	serres@ucr.edu	Bailey-Serres, Julia/A-2470-2010					Andersen TG, 2015, CURR OPIN PLANT BIOL, V28, P9, DOI 10.1016/j.pbi.2015.08.004; Bao Y, 2014, P NATL ACAD SCI USA, V111, P9319, DOI 10.1073/pnas.1400966111; Barberon M, 2016, CELL, V164, P447, DOI 10.1016/j.cell.2015.12.021; Krishnamurthy P, 2009, PLANTA, V230, P119, DOI 10.1007/s00425-009-0930-6; Peret B, 2014, PLANT PHYSIOL, V166, P1713, DOI 10.1104/pp.114.244541; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Shiono K, 2014, PLANT J, V80, P40, DOI 10.1111/tpj.12614; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wachsman G, 2015, NEW PHYTOL, V208, P26, DOI 10.1111/nph.13469	10	2	2	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					345	346		10.1016/j.cell.2016.01.005	http://dx.doi.org/10.1016/j.cell.2016.01.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824650	Bronze			2022-12-28	WOS:000368906800005
J	Quan, XJ; Yuan, LQ; Tiberi, L; Claeys, A; De Geest, N; Yan, JK; van der Kant, R; Xie, WR; Klisch, TJ; Shymkowitz, J; Rousseau, F; Bollen, M; Beullens, M; Zoghbi, HY; Vanderhaeghen, P; Hassan, BA				Quan, Xiao-Jiang; Yuan, Liqun; Tiberi, Luca; Claeys, Annelies; De Geest, Natalie; Yan, Jiekun; van der Kant, Rob; Xie, Wei R.; Klisch, Tiemo J.; Shymkowitz, Joost; Rousseau, Frederic; Bollen, Mathieu; Beullens, Monique; Zoghbi, Huda Y.; Vanderhaeghen, Pierre; Hassan, Bassem A.			Post-translational Control of the Temporal Dynamics of Transcription Factor Activity Regulates Neurogenesis	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; CELL FATE SPECIFICATION; PRONEURAL GENE; DROSOPHILA EYE; EGF RECEPTOR; COMPOUND EYE; FORCE-FIELD; IN-VIVO; PHOSPHORYLATION; EXPRESSION	Neurogenesis is initiated by the transient expression of the highly conserved proneural proteins, bHLH transcriptional regulators. Here, we discover a conserved post-translational switch governing the duration of proneural protein activity that is required for proper neuronal development. Phosphorylation of a single Serine at the same position in Scute and Atonal proneural proteins governs the transition from active to inactive forms by regulating DNA binding. The equivalent Neurogenin2 Threonine also regulates DNA binding and proneural activity in the developing mammalian neocortex. Using genome editing in Drosophila, we show that Atonal outlives its mRNA but is inactivated by phosphorylation. Inhibiting the phosphorylation of the conserved proneural Serine causes quantitative changes in expression dynamics and target gene expression resulting in neuronal number and fate defects. Strikingly, even a subtle change from Serine to Threonine appears to shift the duration of Atonal activity in vivo, resulting in neuronal fate defects.	[Quan, Xiao-Jiang; Yuan, Liqun; Claeys, Annelies; De Geest, Natalie; Yan, Jiekun; Vanderhaeghen, Pierre; Hassan, Bassem A.] VIB, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Quan, Xiao-Jiang; Yuan, Liqun; Claeys, Annelies; De Geest, Natalie; Yan, Jiekun; Vanderhaeghen, Pierre; Hassan, Bassem A.] Katholieke Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium; [Yuan, Liqun; Hassan, Bassem A.] Katholieke Univ Leuven, Sch Grp Biomed, Doctoral Sch Biomed Sci, Program Mol & Dev Genet, B-3000 Louvain, Belgium; [Tiberi, Luca; Vanderhaeghen, Pierre] Univ Libre Bruxelles, Welbio, Inst Interdisciplinary Res IRIBHM, B-1070 Brussels, Belgium; [Tiberi, Luca; Vanderhaeghen, Pierre] ULB Inst Neurosci UNI, B-1070 Brussels, Belgium; [van der Kant, Rob; Shymkowitz, Joost; Rousseau, Frederic] VIB Switch Lab, B-3000 Louvain, Belgium; [van der Kant, Rob; Shymkowitz, Joost; Rousseau, Frederic] Katholieke Univ Leuven, Sch Med, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Xie, Wei R.; Klisch, Tiemo J.; Zoghbi, Huda Y.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Xie, Wei R.; Klisch, Tiemo J.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xie, Wei R.; Klisch, Tiemo J.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Bollen, Mathieu; Beullens, Monique] Katholieke Univ Leuven, Sch Med, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, B-3000 Louvain, Belgium; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Hassan, Bassem A.] Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Universite Libre de Bruxelles; WELBIO; Flanders Institute for Biotechnology (VIB); KU Leuven; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; KU Leuven; Baylor College of Medicine; Howard Hughes Medical Institute; UDICE-French Research Universities; Sorbonne Universite	Hassan, BA (corresponding author), VIB, VIB Ctr Biol Dis, B-3000 Louvain, Belgium.; Hassan, BA (corresponding author), Katholieke Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium.; Hassan, BA (corresponding author), Katholieke Univ Leuven, Sch Grp Biomed, Doctoral Sch Biomed Sci, Program Mol & Dev Genet, B-3000 Louvain, Belgium.; Hassan, BA (corresponding author), Inst Cerveau & Moelle Epiniere ICM, F-75013 Paris, France.	bassem.hassan@icm-institute.org	Hassan, Bassem A/D-5221-2012; Schymkowitz, Joost/K-7764-2016; Schymkowitz, Joost/AAV-3680-2021; Tiberi, Luca/AAQ-4253-2021; Rousseau, Frederic/J-9044-2016	Hassan, Bassem A/0000-0001-9533-4908; Schymkowitz, Joost/0000-0003-2020-0168; Rousseau, Frederic/0000-0002-9189-7399; van der Kant, Rob/0000-0003-3639-9749; Tiberi, Luca/0000-0002-5983-3782; Klisch, Tiemo/0000-0001-8182-384X; Zoghbi, Huda/0000-0002-0700-3349; Vanderhaeghen, Pierre/0000-0001-7899-5720	VIB; WiBrain Interuniversity Attraction Pole network (Belspo); Funds for Scientific Research Flanders (Fonds Wetenschappelijke Onderzoeks; FWO) [G.0543.08, G.0680.10, G.0681.10, G.0503.12]; Flemish Concerted Research Action [GOA 10/18]; China Scholarship Council doctoral fellow; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110390]; University of Leuven; Flanders Institute for Science and Technology (IWT); Federal Office for Scientific Affairs of Belgium (Belspo) [IUAP P7/16]; Boehringer Ingelheim Pharma GmbH and Co. KG; Fond Nationale de Recherche Scientifique (FNRS); Queen Elizabeth Medical Foundation; WELBIO Program of the Walloon Region; Fondation de Spoelbergh; AXA Research Fund; Fondation ULB	VIB; WiBrain Interuniversity Attraction Pole network (Belspo); Funds for Scientific Research Flanders (Fonds Wetenschappelijke Onderzoeks; FWO)(FWO); Flemish Concerted Research Action; China Scholarship Council doctoral fellow(China Scholarship Council); Cancer Prevention and Research Institute of Texas (CPRIT); University of Leuven(KU Leuven); Flanders Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Federal Office for Scientific Affairs of Belgium (Belspo); Boehringer Ingelheim Pharma GmbH and Co. KG(Boehringer Ingelheim); Fond Nationale de Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Queen Elizabeth Medical Foundation; WELBIO Program of the Walloon Region(WELBIO); Fondation de Spoelbergh; AXA Research Fund(AXA Research Fund); Fondation ULB	We are grateful to P. Callaerts, S. Aerts, M. Freeman, H. Bellen, J. Kiger, F. Guillemot, and the Drosophila Stock Center for flies, constructs, and antibodies. We thank F. Velez for technical assistance, members of B.A.H.'s lab for helpful discussions, and D. Schmucker, G. Halder, and P. Verstreken for comments on the manuscript. This work was supported by VIB, the WiBrain Interuniversity Attraction Pole network (Belspo; to B.A.H. and P.V.), the Funds for Scientific Research Flanders (Fonds Wetenschappelijke Onderzoeks; FWO) grants G.0543.08, G.0680.10, G.0681.10, and G.0503.12 (to B.A.H.), and a Flemish Concerted Research Action (GOA 10/18) grant (to M. Bollen and M. Beullens). L.Y. is a China Scholarship Council doctoral fellow. W.R.X. and T.J.K. are supported by a grant from the Cancer Prevention and Research Institute of Texas (CPRIT, RP110390). H.Y.Z. is a Howard Hughes Medical Institute investigator. The Switch Laboratory is supported by VIB, University of Leuven, the Funds for Scientific Research Flanders (Fonds Wetenschappelijke Onderzoeks; FWO), the Flanders Institute for Science and Technology (IWT), and the Federal Office for Scientific Affairs of Belgium (Belspo), IUAP P7/16. R.v.d.K. was supported by Boehringer Ingelheim Pharma GmbH and Co. KG. Work in the P.V.'s lab is funded by the Fond Nationale de Recherche Scientifique (FNRS), the Queen Elizabeth Medical Foundation, the WELBIO Program of the Walloon Region, the Fondation de Spoelbergh, the AXA Research Fund, and Fondation ULB.	Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brown NL, 1998, DEVELOPMENT, V125, P4821; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; Casarosa S, 1999, DEVELOPMENT, V126, P525; Charlton-Perkins M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-20; Choi CM, 2009, SCIENCE, V324, P54, DOI 10.1126/science.1168275; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hansen AS, 2015, ELIFE, V4, DOI 10.7554/eLife.06559; Hassan BA, 2000, GENE DEV, V14, P1852; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; HEBERLEIN U, 1991, DEVELOPMENT, V112, P703; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Korzh V, 2002, TRENDS NEUROSCI, V25, P603, DOI 10.1016/S0166-2236(02)02275-0; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Mao YL, 2009, DEVELOPMENT, V136, P473, DOI 10.1242/dev.026054; MARDON G, 1994, DEVELOPMENT, V120, P3473; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; Nolo R, 2001, GENETICS, V157, P307; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; PINNA LA, 1994, BBA-MOL CELL RES, V1222, P415, DOI 10.1016/0167-4889(94)90050-7; Quan XJ, 2012, CURR TOP DEV BIOL, V98, P259, DOI 10.1016/B978-0-12-386499-4.00010-0; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Sakai D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002566; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang VY, 2002, CURR BIOL, V12, P1611, DOI 10.1016/S0960-9822(02)01144-2; WOLFF T, 1991, DEVELOPMENT, V113, P841; Yang MY, 2012, DEVELOPMENT, V139, P325, DOI 10.1242/dev.074260; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	57	36	36	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					460	475		10.1016/j.cell.2015.12.048	http://dx.doi.org/10.1016/j.cell.2015.12.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824657	Bronze, Green Published			2022-12-28	WOS:000368906800016
J	Beckles, ZL; Edge, JA; Mugglestone, MA; Murphy, MS; Wales, JKH				Beckles, Zosia L.; Edge, Julie A.; Mugglestone, Moira A.; Murphy, M. Stephen; Wales, Jerry K. H.		Guideline Dev Grp	GUIDELINES Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Beckles, Zosia L.; Mugglestone, Moira A.; Murphy, M. Stephen] Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England; [Edge, Julie A.] Oxford Univ Hosp NHS Trust, Oxford Childrens Hosp, Oxford, England; [Wales, Jerry K. H.] Lady Cilento Childrens Hosp, Brisbane, Qld 4101, Australia; [Wales, Jerry K. H.] Univ Queensland, Brisbane, Qld 4101, Australia	Oxford University Hospitals NHS Foundation Trust; University of Queensland	Mugglestone, MA (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England.	mmugglestone@rcog.org.uk	Beckles, Zosia/R-9630-2019	Beckles, Zosia/0000-0003-4352-2266				National Collaborating Centre for Women's and Children's Health, 2015, DIAB TYP 1 TYP 2 CHI; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN DIAB; National Institute for Health and Care Excellence, 2015, DIAB TYP 1 TYP 2 CHI; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB CHILDR YO; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; National Institute for Health and Care Excellence, 2012, GUID MAN; National Institute for Health and Care Excellence, 2015, DIAB FOOT PROBL PREV; National Institute for Health and Care Excellence, 2014, OB ID ASS MAN OV OB; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN, DOI DOI 10.1016/J.ANNEMERGMED.2013.12.004; National Institute for Health and Care Excellence, 2015, DIAB CHILD YOUNG PEO; National Institute for Health and Care Excellence, 2015, TYP 2 DIAB MAN; National Institute for Health and Care Excellence, 2015, MAINT HLTH WEIGHT PR; Royal College of Paediatrics and Child Health, NAT PAED DIAB AUD RE	13	16	17	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2016	352								i139	10.1136/bmj.i139	http://dx.doi.org/10.1136/bmj.i139			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6ET	26819261				2022-12-28	WOS:000369313300001
J	Sharma, T; Guski, LS; Freund, N; Gotzsche, PC				Sharma, Tarang; Guski, Louise Schow; Freund, Nanna; Gotzsche, Peter C.			Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; CONTROLLED-TRIALS; DRUG REGULATION; DEPRESSION; PAROXETINE; VIOLENCE; AKATHISIA; HARMS	OBJECTIVE To study serious harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors. DESIGN Systematic review and meta-analysis. MAIN OUTCOME MEASURES Mortality and suicidality. Secondary outcomes were aggressive behaviour and akathisia. DATA SOURCES Clinical study reports for duloxetine, fluoxetine, paroxetine, sertraline, and venlafaxine obtained from the European and UK drug regulators, and summary trial reports for duloxetine and fluoxetine from Eli Lilly's website. ELIGIBILITY CRITERIA FOR STUDY SELECTION Double blind placebo controlled trials that contained any patient narratives or individual patient listings of harms. DATA EXTRACTION AND ANALYSIS Two researchers extracted data independently; the outcomes were meta-analysed by Peto's exact method (fixed effect model). RESULTS We included 70 trials (64 381 pages of clinical study reports) with 18 526 patients. These trials had limitations in the study design and discrepancies in reporting, which may have led to serious under-reporting of harms. For example, some outcomes appeared only in individual patient listings in appendices, which we had for only 32 trials, and we did not have case report forms for any of the trials. Differences in mortality (all deaths were in adults, odds ratio 1.28, 95% confidence interval 0.40 to 4.06), suicidality (1.21, 0.84 to 1.74), and akathisia (2.04, 0.93 to 4.48) were not significant, whereas patients taking antidepressants displayed more aggressive behaviour (1.93, 1.26 to 2.95). For adults, the odds ratios were 0.81 (0.51 to 1.28) for suicidality, 1.09 (0.55 to 2.14) for aggression, and 2.00 (0.79 to 5.04) for akathisia. The corresponding values for children and adolescents were 2.39 (1.31 to 4.33), 2.79 (1.62 to 4.81), and 2.15 (0.48 to 9.65). In the summary trial reports on Eli Lilly's website, almost all deaths were noted, but all suicidal ideation events were missing, and the information on the remaining outcomes was incomplete. CONCLUSIONS Because of the shortcomings identified and having only partial access to appendices with no access to case report forms, the harms could not be estimated accurately. In adults there was no significant increase in all four outcomes, but in children and adolescents the risk of suicidality and aggression doubled. To elucidate the harms reliably, access to anonymised individual patient data is needed.	[Sharma, Tarang; Guski, Louise Schow; Freund, Nanna; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9,Dept 7811, DK-2100 Copenhagen O, Denmark; [Sharma, Tarang; Guski, Louise Schow; Freund, Nanna; Gotzsche, Peter C.] Univ Copenhagen, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Sharma, T (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9,Dept 7811, DK-2100 Copenhagen O, Denmark.	ts@cochrane.dk	Thastum, Mikael/A-3443-2008; Sharma, Tarang/ABH-6714-2020	Thastum, Mikael/0000-0001-8582-5682; Freund, Nanna/0000-0001-8407-6894; Sharma, Tarang/0000-0001-6916-2604	Laura and John Arnold Foundation	Laura and John Arnold Foundation	This study is part of a PhD (TS) thesis, funded by the Laura and John Arnold Foundation. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	ADLER LA, 1995, BIOL PSYCHIAT, V37, P336, DOI 10.1016/0006-3223(94)00158-Y; [Anonymous], 1995, STRUCT CONT CLIN STU; Baldassano CF, 1996, COMPR PSYCHIAT, V37, P122, DOI 10.1016/S0010-440X(96)90572-6; Bass A., 2008, SIDE EFFECTS PROSECU; Bielefeldt AO, 2015, P 23 COCHR C VIENN A; Bond AJ, 2005, EUR J PHARMACOL, V526, P218, DOI 10.1016/j.ejphar.2005.09.033; Bouvy PF, 2012, PSYCHOPHARMACOLOGY, V222, P499, DOI 10.1007/s00213-012-2668-2; Breggin, 1994, TALKING BACK PROZAC; Breggin P, 2003, INT J RISK SAF MED, V16, P31; Breggin P, 2008, MED MADNESS ROLE PSY; Breggin P. R., 2006, ETHICAL HUMAN PSYCHO, V8, P91, DOI [10.1891/ehpp.8.2.91, DOI 10.1891/EHPP.8.2.91]; Breggin PR, 2002, ETHICAL HUM SCI SERV, V4, P211; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Cox GR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008324.pub2; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Driessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137864; European Medicines Agency, 2014, PUBL ACC CLIN TRIAL; FDA, 2014, ANT US CHILDR AD AD; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Furukawa TA, 2004, BRIT MED J, V329, P626, DOI 10.1136/bmj.329.7466.626-a; Gotzsche PC, 2015, DEADLY PSYCHIAT ORG; Gotzsche PC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2435; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Healy D, 2006, PLOS MED, V3, P1478, DOI 10.1371/journal.pmed.0030372; Healy D, 2006, BRIT MED J, V333, P92, DOI 10.1136/bmj.333.7558.92; Healy David, 2004, LET THEM EAT PROZAC; Koliscak LP, 2009, J AM PHARM ASSOC, V49, pE28, DOI 10.1331/JAPhA.2009.08083; Krakowski M, 2003, J NEUROPSYCH CLIN N, V15, P294, DOI 10.1176/appi.neuropsych.15.3.294; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Laughren TP, 2001, EUR PSYCHIAT, V16, P418, DOI 10.1016/S0924-9338(01)00600-9; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Leucht S, 2013, J AFFECT DISORDERS, V148, P243, DOI 10.1016/j.jad.2012.12.001; Lilly E, 2014, CLIN TRIAL REP CTR S; Lucire Y, 2011, PHARMACOGN PERS MED, V4, P65, DOI 10.2147/PGPM.S17445; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maund E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3510; Miller M, 2014, JAMA INTERN MED, V174, P899, DOI 10.1001/jamainternmed.2014.1053; Molero Y, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001875; Moncrieff J., 2004, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD003012.PUB2; Moore TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015337; Rosenbaum JF, 1998, BIOL PSYCHIAT, V44, P77, DOI 10.1016/S0006-3223(98)00126-7; SSRI stories, 2013, SSRI STOR ANT NIGHTM; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207; United Kingdom Committee on Safety of Medicines CSM, 2004, REP CSM EXP WORK GRO; Vanderburg DG, 2009, J CLIN PSYCHIAT, V70, P674, DOI 10.4088/JCP.07m04004; Walsh MT, 2001, ACTA PSYCHIAT SCAND, V104, P84, DOI 10.1034/j.1600-0447.2001.00357.x; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526	52	169	172	1	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2016	352								i65	10.1136/bmj.i65	http://dx.doi.org/10.1136/bmj.i65			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6ET	26819231	Green Published, hybrid			2022-12-28	WOS:000369313300010
J	Pennisi, E				Pennisi, Elizabeth			Female organs revealed as weapons in sexual arms race	SCIENCE			English	News Item																			0	0	0	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					214	215		10.1126/science.351.6270.214	http://dx.doi.org/10.1126/science.351.6270.214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816357				2022-12-28	WOS:000368098600013
J	Pfeiffer, JK; Virgin, HW				Pfeiffer, Julie K.; Virgin, Herbert W.			Transkingdom control of viral infection and immunity in the mammalian intestine	SCIENCE			English	Review							HUMAN GUT VIROME; MURINE NOROVIRUS INFECTION; ROTAVIRUS INFECTION; INTERFERON-LAMBDA; ENTERIC VIRUS; COMMENSAL MICROBES; GENE ATG16L1; DISEASE; BACTERIA; INFLUENZA	Viruses that infect the intestine include major human pathogens (retroviruses, noroviruses, rotaviruses, astroviruses, picornaviruses, adenoviruses, herpesviruses) that constitute a serious public health problem worldwide. These viral pathogens are members of a large, complex viral community inhabiting the intestine termed "the enteric virome." Enteric viruses have intimate functional and genetic relationships with both the host and other microbial constituents that inhabit the intestine, such as the bacterial microbiota, their associated phages, helminthes, and fungi, which together constitute the microbiome. Emerging data indicate that enteric viruses regulate, and are in turn regulated by, these other microbes through a series of processes termed "transkingdom interactions." This represents a changing paradigm in intestinal immunity to viral infection. Here we review recent advances in the field and propose new ways in which to conceptualize this important area.	[Pfeiffer, Julie K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Pfeiffer, JK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	julie.pfeiffer@utsouthwestern.edu; virgin@wustl.edu		Virgin, Herbert/0000-0001-8580-7628	NIH [R01 AI074668, R21 AI114927]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases Award; Kenneth Rainin Foundation [14H16]; Juvenile Diabetes Research Foundation [2-SRA-2015-305-Q-R];  [U19 AI109725];  [R24 OD019793];  [R01 AI111918];  [R01 DK 101354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114927, R01AI111918, U19AI109725, R01AI074668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD019793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases Award; Kenneth Rainin Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of our laboratories for useful discussions and comments on the manuscript. J.K.P. is supported by NIH grants R01 AI074668 and R21 AI114927 and a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases Award. H.W.V. is supported by U19 AI109725, R24 OD019793, R01 AI111918, R01 DK 101354, Kenneth Rainin Foundation grant no. 14H16, and Juvenile Diabetes Research Foundation grant 2-SRA-2015-305-Q-R.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; DOLOWY WC, 1964, P SOC EXP BIOL MED, V116, P365, DOI 10.3181/00379727-116-29249; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hickman D, 2014, MBIO, V5, DOI 10.1128/mBio.01032-13; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; KATZ M, 1967, AM J PUBLIC HEALTH N, V57, P1837, DOI 10.2105/AJPH.57.10.1837; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Moon C, 2012, CURR OPIN IMMUNOL, V24, P405, DOI 10.1016/j.coi.2012.05.002; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Phan TG, 2012, J GEN VIROL, V93, P1356, DOI 10.1099/vir.0.041731-0; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; SABIN AB, 1956, SCIENCE, V123, P1151, DOI 10.1126/science.123.3209.1151; SCHAFFER J, 1963, P SOC EXP BIOL MED, V112, P561, DOI 10.3181/00379727-112-28105; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037; Underhill DM, 2014, NAT REV IMMUNOL, V14, P405, DOI 10.1038/nri3684; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; WARD RL, 1986, J INFECT DIS, V154, P871, DOI 10.1093/infdis/154.5.871; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilks J, 2015, CELL HOST MICROBE, V18, P456, DOI 10.1016/j.chom.2015.09.005; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	78	156	158	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270							aad5872	10.1126/science.aad5872	http://dx.doi.org/10.1126/science.aad5872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816384	Green Accepted			2022-12-28	WOS:000368098600030
J	Wade, L				Wade, Lizzie			A NATION DIVIDED	SCIENCE			English	Editorial Material																		HUETEPEREZ, 2015, NATURE SCI, P355	1	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					220	223		10.1126/science.351.6270.220	http://dx.doi.org/10.1126/science.351.6270.220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA9AM	26816361				2022-12-28	WOS:000368098600017
J	Kamisawa, T; Wood, LD; Itoi, T; Takaori, K				Kamisawa, Terumi; Wood, Laura D.; Itoi, Takao; Takaori, Kyoichi			Pancreatic cancer	LANCET			English	Review							FINE-NEEDLE-ASPIRATION; PHASE-III TRIAL; INTRAEPITHELIAL NEOPLASIA; INCREASED RISK; AUTOIMMUNE PANCREATITIS; PREOPERATIVE EVALUATION; DIFFERENTIAL-DIAGNOSIS; ADJUVANT CHEMOTHERAPY; CLASSIFICATION-SYSTEM; EARLY MANIFESTATIONS	Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage. There is no standard programme for screening patients at high risk of pancreatic cancer (eg, those with a family history of pancreatic cancer and chronic pancreatitis). Most pancreatic cancers arise from microscopic non-invasive epithelial proliferations within the pancreatic ducts, referred to as pancreatic intraepithelial neoplasias. There are four major driver genes for pancreatic cancer: KRAS, CDKN2A, TP53, and SMAD4. KRAS mutation and alterations in CDKN2A are early events in pancreatic tumorigenesis. Endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration off er high diagnostic ability for pancreatic cancer. Surgical resection is regarded as the only potentially curative treatment, and adjuvant chemotherapy with gemcitabine or S-1, an oral fluoropyrimidine derivative, is given after surgery. FOLFIRINOX (fluorouracil, folinic acid [leucovorin], irinotecan, and oxaliplatin) and gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) are the treatments of choice for patients who are not surgical candidates but have good performance status.	[Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo 1138677, Japan; [Wood, Laura D.] Johns Hopkins Univ, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Takaori, Kyoichi] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan	Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Johns Hopkins University; Tokyo Medical University; Kyoto University	Kamisawa, T (corresponding author), Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	kamisawa@cick.jp	Wood, Laura/ABF-1531-2020					Adsay NV., 2010, PATHOLOGY GENETICS T, P304; Agarwal B, 2004, AM J GASTROENTEROL, V99, P844, DOI 10.1111/j.1572-0241.2004.04177.x; Ahn SS, 2009, EUR RADIOL, V19, P2448, DOI 10.1007/s00330-009-1422-6; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Attam R, 2015, GASTROINTEST ENDOSC, V81, P1260, DOI 10.1016/j.gie.2014.07.036; Balci Numan Cem, 2009, Top Magn Reson Imaging, V20, P43, DOI 10.1097/RMR.0b013e3181b48667; Bang JY, 2013, ENDOSCOPY, V45, P445, DOI 10.1055/s-0032-1326268; Basturk O, 2015, AM J SURG PATHOL, V39, P1730, DOI 10.1097/PAS.0000000000000533; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Bosetti C, 2014, ANN ONCOL, V25, P2065, DOI 10.1093/annonc/mdu276; Brand RE, 2014, CLIN GASTROENTEROL H, V12, P1717, DOI 10.1016/j.cgh.2014.02.038; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Chan A, 2014, CLIN CANCER RES, V20, P5787, DOI 10.1158/1078-0432.CCR-14-0289; Chang KJ, 2005, CANCER, V103, P349, DOI 10.1002/cncr.20771; Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Conrad C, 2013, J SURG ONCOL, V107, P23, DOI 10.1002/jso.23165; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cosci F, 2015, PSYCHOTHER PSYCHOSOM, V84, P22, DOI 10.1159/000367913; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P342, DOI 10.1158/1055-9965.EPI-06-0783; Deeks ED, 2015, DRUGS, V75, P231, DOI 10.1007/s40265-015-0345-6; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Diehl SJ, 1998, RADIOLOGY, V206, P373, DOI 10.1148/radiology.206.2.9457188; Evans DB, 2009, ANN SURG ONCOL, V16, P1736, DOI 10.1245/s10434-009-0416-6; Fan ZH, 2013, EUR J RADIOL, V82, P1385, DOI 10.1016/j.ejrad.2013.04.016; Fattahi R, 2009, J MAGN RESON IMAGING, V29, P350, DOI 10.1002/jmri.21651; Fuccio L, 2013, GASTROINTEST ENDOSC, V78, P596, DOI 10.1016/j.gie.2013.04.162; Fukushima N, 2010, WHO CLASSIFICATION T, P292; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Gattani AM, 1996, CANCER, V78, P57, DOI 10.1002/(SICI)1097-0142(19960701)78:1<57::AID-CNCR10>3.0.CO;2-6; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Gong TT, 2012, GASTROINTEST ENDOSC, V76, P301, DOI 10.1016/j.gie.2012.02.051; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Grahm AL, 1997, DIGESTION, V58, P542, DOI 10.1159/000201499; He J, 2014, WORLD J GASTROENTERO, V20, P2255, DOI 10.3748/wjg.v20.i9.2255; Hruban Ralph H, 2010, Adv Surg, V44, P293; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Huguet F, 2009, J CLIN ONCOL, V27, P2269, DOI 10.1200/JCO.2008.19.7921; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jabbar KS, 2014, J NATL CANC I, V106; Jang JY, 2014, ANN SURG, V259, P656, DOI 10.1097/SLA.0000000000000384; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; KAMISAWA T, 1995, PANCREAS, V11, P345, DOI 10.1097/00006676-199511000-00005; Kamisawa T, 2008, PANCREAS, V37, pE62, DOI 10.1097/MPA.0b013e318175e3a0; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Li JH, 2013, MED HYPOTHESES, V81, P180, DOI 10.1016/j.mehy.2013.05.010; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Lu DSK, 1997, AM J ROENTGENOL, V168, P1439, DOI 10.2214/ajr.168.6.9168704; Lutz ER, 2014, CANCER IMMUNOL RES, V2, P616, DOI 10.1158/2326-6066.CIR-14-0027; Maccioni E, 2010, EUR REV MED PHARMACO, V14, P721; Maeda A, 2008, JPN J CLIN ONCOL, V38, P227, DOI 10.1093/jjco/hym178; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; Meining A, 2012, ENDOSCOPY, V44, P251, DOI 10.1055/s-0031-1291545; Mesleh MG, 2013, J HEPATO-BIL-PAN SCI, V20, P578, DOI 10.1007/s00534-013-0614-2; Mikata R, 2013, J GASTROENTEROL, V48, P866, DOI 10.1007/s00535-012-0684-y; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Nakai Y, 2014, DIGEST DIS SCI, V59, P1578, DOI 10.1007/s10620-013-3019-9; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; Nimura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P230, DOI 10.1007/s00534-011-0466-6; O'Brien DP, 2015, CLIN CANCER RES, V21, P622, DOI 10.1158/1078-0432.CCR-14-0365; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Park HS, 2009, J MAGN RESON IMAGING, V30, P586, DOI 10.1002/jmri.21889; Pelzer U, 2011, EUR J CANCER, V47, P1676, DOI 10.1016/j.ejca.2011.04.011; Philip PA, 2011, J CLIN ONCOL, V29, P4066, DOI 10.1200/JCO.2011.37.2532; Qin SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108762; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Rijkers AP, 2014, EJSO-EUR J SURG ONC, V40, P794, DOI 10.1016/j.ejso.2014.03.016; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; Rustgi AK, 2014, GENE DEV, V28, P1, DOI 10.1101/gad.228452.113; Safi F, 1997, J Gastrointest Surg, V1, P106, DOI 10.1016/S1091-255X(97)80097-2; Sah RP, 2013, NAT REV GASTRO HEPAT, V10, P423, DOI 10.1038/nrgastro.2013.49; Sandrasegaran K, 2013, AM J ROENTGENOL, V201, P1002, DOI 10.2214/AJR.12.10170; Sharma C, 2011, WORLD J GASTROENTERO, V17, P867, DOI 10.3748/wjg.v17.i7.867; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Shin SH, 2015, J AM COLL SURGEONS, V220, P177, DOI 10.1016/j.jamcollsurg.2014.10.014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silverman DT, 2003, EPIDEMIOLOGY, V14, P45, DOI 10.1097/00001648-200301000-00013; Soderlund C, 2006, GASTROINTEST ENDOSC, V63, P986, DOI 10.1016/j.gie.2005.11.052; Solomon S, 2012, CANCER J, V18, P485, DOI 10.1097/PPO.0b013e318278c4a6; Stromnes IM, 2014, CARCINOGENESIS, V35, P1451, DOI 10.1093/carcin/bgu115; Sudo K, 2014, WORLD J GASTROENTERO, V20, P15110, DOI 10.3748/wjg.v20.i41.15110; Takaori K, 2016, PANCREATOLOGY, V16, P14, DOI 10.1016/j.pan.2015.10.013; Takeuchi M, 2008, ACTA RADIOL, V49, P383, DOI 10.1080/02841850801895381; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tang SA, 2011, EUR J RADIOL, V78, P142, DOI 10.1016/j.ejrad.2009.09.026; Tomlinson JS, 2007, ARCH SURG-CHICAGO, V142, P767, DOI 10.1001/archsurg.142.8.767; Tomlinson JS, 2007, ARCH SURG-CHICAGO, V142, P773, DOI DOI 10.1001/ARCHSURG.142.8.767; Van Laethem JL, 2012, ANN ONCOL, V23, P570, DOI 10.1093/annonc/mdr351; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang Z, 2013, WORLD J GASTROENTERO, V19, P4808, DOI 10.3748/wjg.v19.i29.4808; Wood LD, 2012, CANCER J, V18, P492, DOI 10.1097/PPO.0b013e31827459b6; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamaguchi T, 2012, PANCREAS, V41, P1225, DOI 10.1097/MPA.0b013e31825d60fc; Yamaue H, 2015, CANCER SCI, V106, P883, DOI 10.1111/cas.12674; Zamboni G, 2010, WHO CLASSIFICATION T, P300; Zhang YJ, 2012, PANCREATOLOGY, V12, P227, DOI 10.1016/j.pan.2012.03.057	117	916	966	36	508	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					73	85		10.1016/S0140-6736(16)00141-0	http://dx.doi.org/10.1016/S0140-6736(16)00141-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	26830752				2022-12-28	WOS:000378828400030
J	Jensen, CD; Corley, DA; Quinn, VP; Doubeni, CA; Zauber, AG; Lee, JK; Zhao, WK; Marks, AR; Schottinger, JE; Ghai, NR; Lee, AT; Contreras, R; Klabunde, CN; Quesenberry, CP; Levin, TR; Mysliwiec, PA				Jensen, Christopher D.; Corley, Douglas A.; Quinn, Virginia P.; Doubeni, Chyke A.; Zauber, Ann G.; Lee, Jeffrey K.; Zhao, Wei K.; Marks, Amy R.; Schottinger, Joanne E.; Ghai, Nirupa R.; Lee, Alexander T.; Contreras, Richard; Klabunde, Carrie N.; Quesenberry, Charles P.; Levin, Theodore R.; Mysliwiec, Pauline A.			Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							OCCULT-BLOOD-TEST; COLORECTAL-CANCER MORTALITY; RANDOMIZED-CLINICAL-TRIAL; COLLEGE-OF-RADIOLOGY; SERVICES TASK-FORCE; AMERICAN-COLLEGE; ADENOMATOUS POLYPS; QUALITY INDICATORS; JOINT GUIDELINE; COLONOSCOPY	Background: The fecal immunochemical test (FIT) is a common method for colorectal cancer (CRC) screening, yet its acceptability and performance over several rounds of annual testing are largely unknown. Objective: To assess FIT performance characteristics over 4 rounds of annual screening. Design: Retrospective cohort study. Setting: Kaiser Permanente Northern and Southern California. Patients: 323 349 health plan members aged 50 to 70 years on their FIT mailing date in 2007 or 2008 who completed the first round of FIT and were followed for up to 4 screening rounds. Measurements: Screening participation, FIT positivity (>= 20 mu g of hemoglobin/g), positive predictive values for adenoma and CRC, and FIT sensitivity for detecting CRC obtained from Kaiser Permanente electronic databases and cancer registries. Results: Of the patients invited for screening, 48.2% participated in round 1. Of those who remained eligible, 75.3% to 86.1% participated in subsequent rounds. Median follow-up was 4.0 years, and 32% of round 1 participants crossed over to endoscopy over 4 screening rounds-7.0% due to a positive FIT result. The FIT positivity rate (5.0%) and positive predictive values (adenoma, 51.5%; CRC, 3.4%) were highest in round 1. Overall, programmatic FIT screening detected 80.4% of patients with CRC diagnosed within 1 year of testing, including 84.5% in round 1 and 73.4% to 78.0% in subsequent rounds. Limitation: Screening detection, rather than long-term cancer prevention, was evaluated. Conclusion: Annual FIT screening was associated with high sensitivity for CRC, with high adherence to annual follow-up screening among initial participants. The findings indicate that annual programmatic FIT screening is feasible and effective for population-level CRC screening.	Kaiser Permanente No Calif, Oakland, CA USA; [Quinn, Virginia P.; Ghai, Nirupa R.; Contreras, Richard] Kaiser Permanente So Calif, Dept Res & Evaluat, 100 South Los Robles,2nd Floor, Pasadena, CA 91101 USA; [Doubeni, Chyke A.] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, 3400 Spruce St,Gate 2, Philadelphia, PA 19104 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,2063A, New York, NY 10017 USA; [Lee, Jeffrey K.] Univ Calif San Francisco, Div Gastroenterol, 1701 Divisadero St,Suite 120, San Francisco, CA 94115 USA; [Klabunde, Carrie N.] NIH, Off Dis Prevent, 6100 Execut Blvd,Suite 2B03, Rockville, MD 20852 USA; [Schottinger, Joanne E.] Kaiser Permanente So Calif, Permanente Med Grp, 393 East Walnut St, Pasadena, CA 91188 USA; [Lee, Alexander T.] Kaiser Permanente So Calif, Permanente Med Grp, Woodland Hills Med Ctr, 5601 De Soto Ave, Woodland Hills, CA 91365 USA; [Levin, Theodore R.] Kaiser Permanente Med Ctr, 1425 South Main St, Walnut Creek, CA 94596 USA; [Mysliwiec, Pauline A.] Permanente Med Grp Inc, 975 Sereno Dr, Vallejo, CA 94589 USA	Kaiser Permanente; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Permanente Medical Groups	Corley, DA (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	douglas.corley@kp.org			National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA163262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health.	Adamo, 2013, SEER PROGRAM CODING; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; [Anonymous], 2010, CPT 2011 PROF ED; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Corley DA, 2013, CLIN GASTROENTEROL H, V11, P172, DOI 10.1016/j.cgh.2012.09.010; Crotta S, 2012, CLIN GASTROENTEROL H, V10, P633, DOI 10.1016/j.cgh.2012.02.030; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Gordon N, 2006, KAISER PERMANENTE ME; Gupta S, 2013, JAMA INTERN MED, V173, P1725, DOI 10.1001/jamainternmed.2013.9294; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koebnick Corinna, 2012, Perm J, V16, P37; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2011, EPIDEMIOL REV, V33, P101, DOI 10.1093/epirev/mxr007; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 2015, GASTROINTEST ENDOSC, V81, P31, DOI 10.1016/j.gie.2014.07.058; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	33	150	152	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					456	+		10.7326/M15-0983	http://dx.doi.org/10.7326/M15-0983			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26811150	Green Accepted			2022-12-28	WOS:000373625300007
J	Farin, HF; Jordens, I; Mosa, MH; Basak, O; Korving, J; Tauriello, DVF; de Punder, K; Angers, S; Peters, PJ; Maurice, MM; Clevers, H				Farin, Homier F.; Jordens, Ingrid; Mosa, Mohammed H.; Basak, Onur; Korving, Jeroen; Tauriello, Daniele V. F.; de Punder, Karin; Angers, Stephane; Peters, Peter J.; Maurice, Madelon M.; Clevers, Hans			Visualization of a short-range Wnt gradient in the intestinal stem-cell niche	NATURE			English	Article							MORPHOGEN GRADIENT; DROSOPHILA EMBRYOS; STRUCTURAL BASIS; IN-VITRO; WINGLESS; LGR5; EXPRESSION; CRYPT; RECOMBINASE; RECOGNITION	Mammalian Wnt proteins are believed to act as short-range signals(1-4), yet have not been previously visualized in vivo. Selfrenewal, proliferation and differentiation are coordinated along a putative Wnt gradient in the intestinal crypt(5). Wnt3 is produced specifically by Paneth cells(6,7). Here we have generated an epitopetagged, functional Wnt3 knock-in allele. Wnt3 covers basolateral membranes of neighbouring stem cells. In intestinal organoids, Wnt3-transfer involves direct contact between Paneth cells and stem cells. Plasma membrane localization requires surface expression of Frizzled receptors, which in turn is regulated by the transmembrane E3 ligases Rnf43/Znrf3 and their antagonists Lgr4-5/R-spondin. By manipulating Wnt3 secretion and by arresting stem-cell proliferation, we demonstrate that Wnt3 mainly travels away from its source in a cell-bound manner through cell division, and not through diffusion. We conclude that stem-cell membranes constitute a reservoir for Wnt proteins, while Frizzled receptor turnover and ` plasma membrane dilution' through cell division shape the epithelial Wnt3 gradient.	[Farin, Homier F.; Basak, Onur; Korving, Jeroen; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Farin, Homier F.; Basak, Onur; Korving, Jeroen; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Farin, Homier F.; Mosa, Mohammed H.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Farin, Homier F.; Mosa, Mohammed H.] Georg Speyer Haus Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Farin, Homier F.; Mosa, Mohammed H.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Jordens, Ingrid; Tauriello, Daniele V. F.; Maurice, Madelon M.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [de Punder, Karin; Peters, Peter J.] Maastricht Univ, Maastricht Multimodal Mol Imaging Inst, NL-6229 ER Maastricht, Netherlands; [Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Utrecht University; Utrecht University Medical Center; Maastricht University; University of Toronto	Farin, HF; Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.; Farin, HF; Clevers, H (corresponding author), Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands.; Farin, HF (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.; Farin, HF (corresponding author), Georg Speyer Haus Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany.; Farin, HF (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	farin@gsh.uni-frankfurt.de; h.clevers@hubrecht.eu	Tauriello, Daniele/H-4644-2018; Angers, Stephane/E-1432-2014; Farin, Henner/AAC-2574-2021; Basak, Onur/GLV-6113-2022	Tauriello, Daniele/0000-0003-1522-3496; Angers, Stephane/0000-0001-7241-9044; Farin, Henner/0000-0003-1558-5366; Basak, Onur/0000-0002-6864-3403; Jordens, Ingrid/0000-0001-7865-2816; Maurice, Madelon/0000-0001-6885-5361				Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lecourtois M, 2001, DEV BIOL, V235, P467, DOI 10.1006/dbio.2001.0320; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	38	310	318	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					340	+		10.1038/nature16937	http://dx.doi.org/10.1038/nature16937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26863187				2022-12-28	WOS:000370327100038
J	Williams, SL				Williams, Susan L.			GENOMICS From sea to sea	NATURE			English	Editorial Material							SEAGRASSES; ECOSYSTEMS		[Williams, Susan L.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Williams, Susan L.] Univ Calif Davis, Dept Evolut & Ecol, Bodega Bay, CA 94923 USA	University of California System; University of California Davis; University of California System; University of California Davis	Williams, SL (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.; Williams, SL (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Bodega Bay, CA 94923 USA.	slwilliams@ucdavis.edu						Duffy JE, 2015, ECOL LETT, V18, P696, DOI 10.1111/ele.12448; Hemmimga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; RUCKELSHAUS MH, 1995, MAR BIOL, V123, P583, DOI 10.1007/BF00349237; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	7	9	9	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					290	291		10.1038/nature16869	http://dx.doi.org/10.1038/nature16869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26814973				2022-12-28	WOS:000370327100027
J	Patel, M; Orenstein, W				Patel, Manish; Orenstein, Walter			A World Free of Polio - The Final Steps	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patel, Manish] Task Force Global Hlth, Atlanta, GA USA; [Orenstein, Walter] Emory Univ, Atlanta, GA 30322 USA	Emory University	Patel, M (corresponding author), Task Force Global Hlth, Atlanta, GA USA.							Estivariz CF, 2015, LANCET INFECT DIS, V15, P898, DOI 10.1016/S1473-3099(15)00094-8; Patel M, 2015, EXPERT REV VACCINES, V14, P749, DOI 10.1586/14760584.2015.1001750; Thompson KM, 2014, J INFECT DIS, V210, pS475, DOI 10.1093/infdis/jit845; World Health Organization, 2015, M SAGE POL WORK GROU	4	15	17	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					501	503		10.1056/NEJMp1514467	http://dx.doi.org/10.1056/NEJMp1514467			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2ME	26863350				2022-12-28	WOS:000369755800001
J	Porter, ME; Larsson, S; Lee, TH				Porter, Michael E.; Larsson, Stefan; Lee, Thomas H.			Standardizing Patient Outcomes Measurement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Porter, Michael E.] Harvard Univ, Sch Business, Boston, MA 02115 USA; [Larsson, Stefan] Boston Consulting Grp Inc, Boston, MA USA; [Lee, Thomas H.] Press Ganey, Boston, MA USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Consulting Group (BCG); Harvard University; Harvard Medical School	Porter, ME (corresponding author), Harvard Univ, Sch Business, Boston, MA 02115 USA.							Nallamothu BK, 2014, J AM COLL CARDIOL, V63, P722, DOI 10.1016/j.jacc.2013.12.003; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024	2	363	365	2	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					504	506		10.1056/NEJMp1511701	http://dx.doi.org/10.1056/NEJMp1511701			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2ME	26863351				2022-12-28	WOS:000369755800002
J	Cole, TB				Cole, Thomas B.			Moon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					538	539		10.1001/jama.2015.14099	http://dx.doi.org/10.1001/jama.2015.14099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864399				2022-12-28	WOS:000369635200001
J	Fenelon, A; Chen, LH; Baker, SP				Fenelon, Andrew; Chen, Li-Hui; Baker, Susan P.			Major Causes of Injury Death and the Life Expectancy Gap Between the United States and Other High-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MORTALITY		[Fenelon, Andrew; Chen, Li-Hui] Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA; [Baker, Susan P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fenelon, A (corresponding author), Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	afenelon@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Chen L, 2014, MMWR-MORBID MORTAL W, V63, P1095; Ho JY, 2013, HEALTH AFFAIR, V32, P459, DOI 10.1377/hlthaff.2012.0574; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; World Health Organization, WHO MORT DAT	4	17	17	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					609	611		10.1001/jama.2015.15564	http://dx.doi.org/10.1001/jama.2015.15564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864416	Bronze, Green Accepted			2022-12-28	WOS:000369635200021
J	Al-Lamee, R; Davies, J; Malik, IS				Al-Lamee, Rasha; Davies, Justin; Malik, Iqbal S.			What is the role of coronary angioplasty and stenting in stable angina?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPTIMAL MEDICAL THERAPY; DRUG-ELUTING STENTS; ARTERY-DISEASE; CLINICAL-OUTCOMES; INTERVENTION; REVASCULARIZATION; METAANALYSIS; SURVIVAL; PREDICTORS; MANAGEMENT		[Al-Lamee, Rasha; Davies, Justin] Univ London Imperial Coll Sci Technol & Med, NHLI, Int Ctr Circulatory Hlth, London W2 0HS, England; [Malik, Iqbal S.] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London W2 0HS, England	Imperial College London; Imperial College London	Malik, IS (corresponding author), Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London W2 0HS, England.	Iqbal.Malik@imperial.nhs.uk			Volcano Corporation	Volcano Corporation	We have read and understood the BMJ policy on declaration of interests and declare the following interests: JD declares consultancy fees from Volcano Corporation and holds patents pertaining to iFR technology licensed by Volcano Corporation. RAL and ISM declare no competing interests.	[Anonymous], 2014, CORONARY HEART DIS S; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Bangalore S, 2013, AM HEART J, V166, P1027, DOI 10.1016/j.ahj.2013.09.008; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Banon D, 2014, AM J CARDIOL, V113, P1075, DOI 10.1016/j.amjcard.2013.11.070; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Borden WB, 2013, CIRC-CARDIOVASC INTE, V6, P436, DOI 10.1161/CIRCINTERVENTIONS.112.000215; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669; Kureshi F, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5309; Lee MS, 2010, AM J CARDIOL, V105, P1070, DOI 10.1016/j.amjcard.2009.12.007; MASERI A, 1985, AM J CARDIOL, V56, pE30, DOI 10.1016/0002-9149(85)91173-7; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; National Institute for Health and Care Excellence, 2011, MAN STABL ANG; Ozkan O, 2008, INT J CARDIOVAS IMAG, V24, P567, DOI 10.1007/s10554-008-9297-1; PEDERSEN TR, 1994, LANCET, V344, P1383; Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2012, AM HEART J, V164, P243, DOI 10.1016/j.ahj.2012.05.018; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zellweger MJ, 2009, J NUCL CARDIOL, V16, P193, DOI 10.1007/s12350-008-9016-2	31	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2016	352								i205	10.1136/bmj.i205	http://dx.doi.org/10.1136/bmj.i205			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3EV	26850069				2022-12-28	WOS:000369805400001
J	Rush, R				Rush, Raphael			Lost in Translation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rush, Raphael] Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto	Rush, R (corresponding author), Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada.							Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	1	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					407	409		10.1056/NEJMp1511412	http://dx.doi.org/10.1056/NEJMp1511412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840132				2022-12-28	WOS:000369319100003
J	Stroustrup, N; Anthony, WE; Nash, ZM; Gowda, V; Gomez, A; Lopez-Moyado, IF; Apfeld, J; Fontana, W				Stroustrup, Nicholas; Anthony, Winston E.; Nash, Zachary M.; Gowda, Vivek; Gomez, Adam; Lopez-Moyado, Isaac F.; Apfeld, Javier; Fontana, Walter			The temporal scaling of Caenorhabditis elegans ageing	NATURE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; GENETIC-ANALYSIS; C. ELEGANS; DAF-16; TEMPERATURE; MUTANTS; STRESS; DAMAGE	The process of ageing makes death increasingly likely, involving a random aspect that produces a wide distribution of lifespan even in homogeneous populations(1,2). The study of this stochastic behaviour may link molecular mechanisms to the ageing process that determines lifespan. Here, by collecting high-precision mortality statistics from large populations, we observe that interventions as diverse as changes in diet, temperature, exposure to oxidative stress, and disruption of genes including the heat shock factor hsf-1, the hypoxia-inducible factor hif-1, and the insulin/IGF-1 pathway components daf-2, age-1, and daf-16 all alter lifespan distributions by an apparent stretching or shrinking of time. To produce such temporal scaling, each intervention must alter to the same extent throughout adult life all physiological determinants of the risk of death. Organismic ageing in Caenorhabditis elegans therefore appears to involve aspects of physiology that respond in concert to a diverse set of interventions. In this way, temporal scaling identifies a novel state variable, r(t), that governs the risk of death and whose average decay dynamics involves a single effective rate constant of ageing, kr. Interventions that produce temporal scaling influence lifespan exclusively by altering kr. Such interventions, when applied transiently even in early adulthood, temporarily alter kr with an attendant transient increase or decrease in the rate of change in r and a permanent effect on remaining lifespan. The existence of an organismal ageing dynamics that is invariant across genetic and environmental contexts provides the basis for a new, quantitative framework for evaluating the manner and extent to which specific molecular processes contribute to the aspect of ageing that determines lifespan.	[Stroustrup, Nicholas; Anthony, Winston E.; Nash, Zachary M.; Gowda, Vivek; Gomez, Adam; Lopez-Moyado, Isaac F.; Apfeld, Javier; Fontana, Walter] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Nash, Zachary M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Gomez, Adam] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Lopez-Moyado, Isaac F.] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Apfeld, Javier] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Northeastern University	Stroustrup, N; Fontana, W (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	nstroustrup@post.harvard.edu; walter@hms.harvard.edu	Stroustrup, Nicholas/ABG-6402-2020; Stroustrup, Nicholas/K-6412-2017; Stroustrup, Nicholas/S-1425-2019	Stroustrup, Nicholas/0000-0001-9530-7301; Stroustrup, Nicholas/0000-0001-9530-7301; Anthony, Winston E./0000-0001-6165-4700; Lopez-Moyado, Isaac/0000-0002-3720-0722; Apfeld, Javier/0000-0001-9897-5671; Nash, Zachary/0000-0001-7186-4875	US National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; NIH [R01 AG034994]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG034994] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Alcedo for nematode strains, X. Maniere for providing the NEC937 Escherichia coli strain, B. Ward for reading our manuscript, and D. Marks, C. Romero, T. Kolokotrones, D. Yamins, P. F. Stadler, E. Smith, and all members of the Fontana laboratory for discussions and encouragement throughout this project. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by US National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). This work was funded by the NIH through grant R01 AG034994 and by a Glenn Award from the Glenn Foundation for Medical Research.	Aalen OO, 2001, STAT SCI, V16, P1; ATLAN H, 1976, MECH AGEING DEV, V5, P371, DOI 10.1016/0047-6374(76)90035-X; Baeriswyl S, 2010, BIOGERONTOLOGY, V11, P53, DOI 10.1007/s10522-009-9228-0; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Garigan D, 2002, GENETICS, V161, P1101; Gladyshev VN, 2013, TRENDS GENET, V29, P506, DOI 10.1016/j.tig.2013.05.004; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson TE, 2001, J GERONTOL A-BIOL, V56, pB331, DOI 10.1093/gerona/56.8.B331; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P1011, DOI 10.1016/j.mad.2005.03.021; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Medawar P.B., 1951, UNSOLVED PROBLEM BIO; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; R Development Core Team, 2009, R LANG ENV STAT COMP; Rebora P, 2014, R J, V6, P114; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; SHAW RF, 1962, NATURE, V196, P454, DOI 10.1038/196454a0; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Suda H, 2012, MECH AGEING DEV, V133, P600, DOI 10.1016/j.mad.2012.07.007; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wilkinson DS, 2012, METHOD CELL BIOL, V107, P353, DOI 10.1016/B978-0-12-394620-1.00012-6; Wu DQ, 2009, AGING CELL, V8, P666, DOI 10.1111/j.1474-9726.2009.00523.x	35	97	107	2	83	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					103	+		10.1038/nature16550	http://dx.doi.org/10.1038/nature16550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814965	Green Accepted, Green Submitted			2022-12-28	WOS:000369304500041
J	Gill, TM; Pahor, M; Guralnik, JM; McDermott, MM; King, AC; Buford, TW; Strotmeyer, ES; Nelson, ME; Sink, KM; Demons, JL; Kashaf, SS; Walkup, MP; Miller, ME				Gill, Thomas M.; Pahor, Marco; Guralnik, Jack M.; McDermott, Mary M.; King, Abby C.; Buford, Thomas W.; Strotmeyer, Elsa S.; Nelson, Miriam E.; Sink, Kaycee M.; Demons, Jamehl L.; Kashaf, Susan S.; Walkup, Michael P.; Miller, Michael E.		LIFE Study Investigators	Effect of structured physical activity on prevention of serious fall injuries in adults aged 70-89: randomized clinical trial (LIFE Study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLDER-ADULTS; STYLE INTERVENTIONS; HEALTH-EDUCATION; INDEPENDENCE; EXERCISE; ELDERS; RISK; PERFORMANCE; DISABILITY; OUTCOMES	OBJECTIVE To test whether a long term, structured physical activity program compared with a health education program reduces the risk of serious fall injuries among sedentary older people with functional limitations. DESIGN Multicenter, single blinded randomized trial (Lifestyle Interventions and Independence for Elders (LIFE) study). SETTING Eight centers across the United States between February 2010 and December 2013. PARTICIPANTS 1635 sedentary adults aged 70-89 years with functional limitations, defined as a short physical performance battery score <= 9, but who were able to walk 400 m. INTERVENTIONS A permuted block algorithm stratified by field center and sex was used to allocate interventions. Participants were randomized to a structured, moderate intensity physical activity program (n=818) conducted in a center (twice a week) and at home (3-4 times a week) that included aerobic, strength, flexibility, and balance training activities, or to a health education program (n=817) consisting of workshops on topics relevant to older people and upper extremity stretching exercises. MAIN OUTCOME MEASURES Serious fall injuries, defined as a fall that resulted in a clinical, non-vertebral fracture or that led to a hospital admission for another serious injury, was a prespecified secondary outcome in the LIFE Study. Outcomes were assessed every six months for up to 42 months by staff masked to intervention assignment. All participants were included in the analysis. RESULTS Over a median follow-up of 2.6 years, a serious fall injury was experienced by 75 (9.2%) participants in the physical activity group and 84 (10.3%) in the health education group (hazard ratio 0.90, 95% confidence interval 0.66 to 1.23; P=0.52). These results were consistent across several subgroups, including sex. However, in analyses that were not prespecified, sex specific differences were observed for rates of all serious fall injuries (rate ratio 0.54, 95% confidence interval 0.31 to 0.95 in men; 1.07, 0.75 to 1.53 in women; P=0.043 for interaction), fall related fractures (0.47, 0.25 to 0.86 in men; 1.12, 0.77 to 1.64 in women; P=0.017 for interaction), and fall related hospital admissions (0.41, 0.19 to 0.89 in men; 1.10, 0.65 to 1.88 in women; P=0.039 for interaction). CONCLUSIONS In this trial, which was underpowered to detect small, but possibly important reductions in serious fall injuries, a structured physical activity program compared with a health education program did not reduce the risk of serious fall injuries among sedentary older people with functional limitations. These null results were accompanied by suggestive evidence that the physical activity program may reduce the rate of fall related fractures and hospital admissions in men.	[Gill, Thomas M.; Kashaf, Susan S.] Yale Univ, Sch Med, Dept Med, Adler Geriatr Ctr, 874 Howard Ave, New Haven, CT 06510 USA; [Pahor, Marco; Buford, Thomas W.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [King, Abby C.] Stanford Sch Med, Dept Hlth Res, Stanford, CA USA; [King, Abby C.] Stanford Sch Med, Dept Policy & Med, Stanford, CA USA; [Strotmeyer, Elsa S.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Nelson, Miriam E.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Sink, Kaycee M.; Demons, Jamehl L.] Wake Forest Sch Med, Dept Med, Winston Salem, NC USA; [Walkup, Michael P.; Miller, Michael E.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA	Yale University; State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University; Wake Forest University; Wake Forest University	Gill, TM (corresponding author), Yale Univ, Sch Med, Dept Med, Adler Geriatr Ctr, 874 Howard Ave, New Haven, CT 06510 USA.	thomas.gill@yale.edu	Gill, Thomas M./H-7043-2019; Sink, Kaycee/AAY-5920-2020; Buford, Thomas W/B-1111-2011; King, Abby/AAD-5257-2021	Gill, Thomas M./0000-0002-6450-0368; Buford, Thomas W/0000-0002-9541-4358; King, Abby/0000-0002-7949-8811; Kaplan, Robert/0000-0003-4837-5330; Handberg, Eileen/0000-0002-7805-9577; Strotmeyer, Elsa/0000-0002-4093-6036; Sink, Kaycee/0000-0001-9608-3856	National Institutes of Health (NIH) [U01AG22376]; National Institute on Aging; National Heart, Lung, and Blood Institute [U01AG022376]; Intramural Research Program; Claude D Pepper Older Americans Independence Centers at the University of Florida [P30AG028740]; Wake Forest University [P30AG21332]; Tufts University [P30AG031679]; University of Pittsburgh [P30AG024827]; Yale University [P30AG021342, UL1TR000142]; NIH/NCATS CTSA at Stanford University [UL1RR025744]; University of Florida [U54RR025208]; Boston Rehabilitation Outcomes Center [R24HD065688]; National Institute on Aging [K07AG3587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, UL1TR000142, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022376, P30AG021332, P30AG031679, K07AG043587, P30AG024827, P30AG028740, P30AG021342] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; Claude D Pepper Older Americans Independence Centers at the University of Florida; Wake Forest University; Tufts University; University of Pittsburgh(University of Pittsburgh); Yale University; NIH/NCATS CTSA at Stanford University; University of Florida(University of Florida); Boston Rehabilitation Outcomes Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by cooperative agreement U01AG22376 from the National Institutes of Health (NIH) and National Institute on Aging; supplement U01AG022376 from the National Heart, Lung, and Blood Institute; and sponsorship in part from the Intramural Research Program. The research is partially supported by the Claude D Pepper Older Americans Independence Centers at the University of Florida (P30AG028740), Wake Forest University (P30AG21332), Tufts University (P30AG031679), University of Pittsburgh (P30AG024827), and Yale University (P30AG021342), and the NIH/NCATS CTSA at Stanford University (UL1RR025744), University of Florida (U54RR025208) and Yale University (UL1TR000142). Tufts University is also supported by the Boston Rehabilitation Outcomes Center (R24HD065688). LIFE investigators are also partially supported by the following: TMG is the recipient of an academic leadership award (K07AG3587) from the National Institute on Aging.	Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; CDC, 2021, CTR DIS CONTROL PREV; Centers for Disease Control and Prevention, 2015, COST FALLS OLD AD; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P225; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Groessl EJ, 2016, J GERONTOL A; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Marsh AP, 2013, J GERONTOL A-BIOL, V68, P1549, DOI 10.1093/gerona/glt064; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Moye LA, 2010, MULTIPLE ANALYSES IN; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Quach L, 2013, J GERONTOL A-BIOL, V68, P1575, DOI 10.1093/gerona/glt084; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	29	51	53	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2016	352								i245	10.1136/bmj.i245	http://dx.doi.org/10.1136/bmj.i245			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2QN	26842425	Green Published, hybrid			2022-12-28	WOS:000369767400002
J	Hansen, K				Hansen, Keith			Breastfeeding: a smart investment in people and in economies	LANCET			English	Editorial Material									[Hansen, Keith] World Bank, 1818 H St NW, Washington, DC 20433 USA	The World Bank	Hansen, K (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	khansen@worldbank.org						Garschagen M., 2015, WORLD DEV REP 2015 M, P68; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; World Bank, 2006, REP NUTR CENTR DEV S; World Bank Group, 2016, GLOB MON REP 2015 20	6	57	63	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					416	416		10.1016/S0140-6736(16)00012-X	http://dx.doi.org/10.1016/S0140-6736(16)00012-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26869553				2022-12-28	WOS:000368986800010
J	Morris, T				Morris, Thomas			The body politic	LANCET			English	Editorial Material												tom@thomas-morris.uk							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					426	427		10.1016/S0140-6736(16)00181-1	http://dx.doi.org/10.1016/S0140-6736(16)00181-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26869561				2022-12-28	WOS:000368986800018
J	Litonjua, AA; Carey, VJ; Laranjo, N; Harshfield, BJ; McElrath, TF; O'Connor, GT; Sandel, M; Iverson, RE; Lee-Paritz, A; Strunk, RC; Bacharier, LB; Macones, GA; Zeiger, RS; Schatz, M; Hollis, BW; Hornsby, E; Hawrylowicz, C; Wu, AC; Weiss, ST				Litonjua, Augusto A.; Carey, Vincent J.; Laranjo, Nancy; Harshfield, Benjamin J.; McElrath, Thomas F.; O'Connor, George T.; Sandel, Megan; Iverson, Ronald E., Jr.; Lee-Paritz, Aviva; Strunk, Robert C.; Bacharier, Leonard B.; Macones, George A.; Zeiger, Robert S.; Schatz, Michael; Hollis, Bruce W.; Hornsby, Eve; Hawrylowicz, Catherine; Wu, Ann Chen; Weiss, Scott T.			Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years The VDAART Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							1ST 6 YEARS; DENDRITIC CELLS; D DEFICIENCY; LIFE; MANAGEMENT; CHILDHOOD; DIAGNOSIS; CHILDREN; IMPACT	IMPORTANCE Asthma and wheezing begin early in life, and prenatal vitamin D deficiency has been variably associated with these disorders in offspring. OBJECTIVE To determine whether prenatal vitamin D (cholecalciferol) supplementation can prevent asthma or recurrent wheeze in early childhood. DESIGN, SETTING, AND PARTICIPANTS The Vitamin D Antenatal Asthma Reduction Trial was a randomized, double-blind, placebo-controlled trial conducted in 3 centers across the United States. Enrollment began in October 2009 and completed follow-up in January 2015. Eight hundred eighty-one pregnant women between the ages of 18 and 39 years at high risk of having children with asthma were randomized at 10 to 18 weeks' gestation. Five participants were deemed ineligible shortly after randomization and were discontinued. INTERVENTIONS Four hundred forty women were randomized to receive daily 4000 IU vitamin D plus a prenatal vitamin containing 400 IU vitamin D, and 436 women were randomized to receive a placebo plus a prenatal vitamin containing 400 IU vitamin D. MAIN OUTCOMES AND MEASURES Coprimary outcomes of (1) parental report of physician-diagnosed asthma or recurrent wheezing through 3 years of age and (2) third trimester maternal 25-hydroxyvitamin D levels. RESULTS Eight hundred ten infants were born in the study, and 806 were included in the analyses for the 3-year outcomes. Two hundred eighteen children developed asthma or recurrent wheeze: 98 of 405 (24.3%; 95% CI, 18.7%-28.5%) in the 4400-IU group vs 120 of 401 (30.4%, 95% CI, 25.7%-73.1%) in the 400-IU group (hazard ratio, 0.8; 95% CI, 0.6-1.0; P = .051). Of the women in the 4400-IU group whose blood levels were checked, 289 (74.9%) had 25-hydroxyvitamin D levels of 30 ng/mL or higher by the third trimester of pregnancy compared with 133 of 391 (34.0%) in the 400-IU group (difference, 40.9%; 95% CI, 34.2%-47.5%, P < .001). CONCLUSIONS AND RELEVANCE In pregnant women at risk of having a child with asthma, supplementation with 4400 IU/d of vitamin D compared with 400 IU/d significantly increased vitamin D levels in the women. The incidence of asthma and recurrent wheezing in their children at age 3 years was lower by 6.1%, but this did not meet statistical significance; however, the study may have been underpowered. Longer follow-up of the children is ongoing to determine whether the difference is clinically important.	[Litonjua, Augusto A.; Carey, Vincent J.; Laranjo, Nancy; Harshfield, Benjamin J.; Weiss, Scott T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA; [Litonjua, Augusto A.; Carey, Vincent J.; McElrath, Thomas F.; Wu, Ann Chen; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA; [McElrath, Thomas F.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Sandel, Megan] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Iverson, Ronald E., Jr.; Lee-Paritz, Aviva] Boston Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; [Strunk, Robert C.; Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63110 USA; [Strunk, Robert C.; Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Macones, George A.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Zeiger, Robert S.; Schatz, Michael] Kaiser Permanente So Calif, San Diego, CA USA; [Hollis, Bruce W.] Med Univ S Carolina, Dept Pediat, Charleston, SC USA; [Hornsby, Eve; Hawrylowicz, Catherine] Kings Coll London, Sch Med Asthma Allergy & Resp Sci, London WC2R 2LS, England; [Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Wu, Ann Chen] Childrens Hosp Boston, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University; Boston Medical Center; Boston Medical Center; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Kaiser Permanente; Medical University of South Carolina; University of London; King's College London; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Litonjua, AA (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	augusto.litonjua@channing.harvard.edu	Wu, Ann/AAY-4293-2020; Hawrylowicz, Catherine/Q-8483-2017	Wu, Ann/0000-0003-0599-9063; Hawrylowicz, Catherine/0000-0002-2337-7463; Zeiger, Robert/0000-0001-5788-5063; Bacharier, Leonard/0000-0003-0432-2704	NHLBI [U01HL091528]; National Centers for Advancing Translational Sciences (NCATS) [U54TR001012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085993] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL091528] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Centers for Advancing Translational Sciences (NCATS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VDAART was supported by grant U01HL091528 from the NHLBI. Additional support was provided by grant U54TR001012 from the National Centers for Advancing Translational Sciences (NCATS) for participant visits at the Boston Medical Center.	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Braig S, 2014, PEDIAT ALLERG IMM-UK, V25, P781, DOI 10.1111/pai.12280; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dotterud CK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-123; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Edwards CA, 2003, CHEST, V124, P18, DOI 10.1378/chest.124.1.18; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Fay MP, 2010, J STAT SOFTW, V36, P1; Ferreira GB, 2014, J IMMUNOL, V192, P4210, DOI 10.4049/jimmunol.1302350; Gern James E, 2009, BMC Pulm Med, V9, P17, DOI 10.1186/1471-2466-9-17; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miller RG, 2011, SURVIVAL ANAL, V2nd; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Oken E, 2015, INT J EPIDEMIOL, V44, P37, DOI 10.1093/ije/dyu008; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SCHITTNY JC, 2008, FISHMANS PULMONARY D, P91; Stevens CA, 2003, EUR RESPIR J, V21, P1000, DOI 10.1183/09031936.03.00057002; Strachan D, 1996, EUR RESPIR J, V9, pS42; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13&lt;1387::AID-SIM268&gt;3.0.CO;2-R; Venables W., 2013, MODERN APPL STAT S, V53, P86; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yurt M, 2014, AM J PHYSIOL-LUNG C, V307, pL859, DOI 10.1152/ajplung.00032.2014; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	28	256	261	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					362	370		10.1001/jama.2015.18589	http://dx.doi.org/10.1001/jama.2015.18589			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813209	Green Accepted, Bronze			2022-12-28	WOS:000368589500014
J	Subramaniam, RM; Suarez-Cuervo, C; Wilson, RF; Turban, S; Zhang, A; Sherrod, C; Aboagye, J; Eng, J; Choi, MJ; Hutfless, S; Bass, EB				Subramaniam, Rathan M.; Suarez-Cuervo, Catalina; Wilson, Renee F.; Turban, Sharon; Zhang, Allen; Sherrod, Cheryl; Aboagye, Jonathan; Eng, John; Choi, Michael J.; Hutfless, Susan; Bass, Eric B.			Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS CORONARY INTERVENTION; ACUTE KIDNEY INJURY; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE ATORVASTATIN; ELEVATION MYOCARDIAL-INFARCTION; INTRAVENOUS N-ACETYLCYSTEINE; TERM ROSUVASTATIN TREATMENT; MEDIA-INDUCED NEPHROPATHY; SODIUM-BICARBONATE; RENAL-FUNCTION	Background: N-acetylcysteine, sodium bicarbonate, statins, and ascorbic acid have been studied for reducing contrast-induced nephropathy (CIN). Purpose: To evaluate the comparative effectiveness of interventions to reduce CIN in adults receiving contrast media. Data Sources: MEDLINE, EMBASE, Cochrane Library, ClinicalTrials.gov, and Scopus databases through June 2015. Risk of bias and overall strength of evidence (SOE) of studies were assessed. Study Selection: Randomized, controlled trials of N-acetylcysteine, sodium bicarbonate, statins, or ascorbic acid that used intravenous (IV) or intra-arterial contrast media and defined CIN with enough data for meta-analysis. Data Extraction: Two reviewers independently extracted data and assessed study quality. Data Synthesis: Low-dose N-acetylcysteine plus IV saline compared with IV saline (risk ratio [RR], 0.75 [95% CI, 0.63 to 0.89]; low SOE), N-acetylcysteine plus IV saline compared with IV saline in patients receiving low-osmolar contrast media (RR, 0.69 [CI, 0.58 to 0.84]; moderate SOE), and statins plus N-acetylcysteine plus IV saline versus N-acetylcysteine plus IV saline (RR, 0.52 [CI, 0.29 to 0.93]; low SOE) had clinically important and statistically significant benefits. The following 3 comparisons suggested a clinically important difference that was not statistically significant: sodium bicarbonate versus IV saline in patients receiving low-osmolar contrast media (RR, 0.65 [CI, 0.33 to 1.25]; low SOE), statins plus IV saline versus IV saline (RR, 0.68 [CI, 0.39 to 1.20]; low SOE), and ascorbic acid versus IV saline (RR, 0.72 [CI, 0.48 to 1.01]; low SOE). Strength of evidence was generally insufficient for comparisons of the need for renal replacement, cardiac events, and mortality. Limitation: Too few studies were done in patients receiving IV contrast media. Conclusion: The greatest reduction in CIN was seen with N-acetylcysteine plus IV saline in patients receiving LOCM and with statins plus N-acetylcysteine plus IV saline.	Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Evidence Based Practice Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Subramaniam, RM (corresponding author), Johns Hopkins Sch Med, Radiol & Radiol Sci, 601 North Caroline St, Baltimore, MD 21287 USA.	rsubram4@jhmi.edu	Subramaniam, Rathan M/AAX-2678-2021	Subramaniam, Rathan M./0000-0003-3973-4610; Bass, Eric/0000-0001-9106-527X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Abaci O, 2015, AM J CARDIOL, V115, P867, DOI 10.1016/j.amjcard.2015.01.007; Acikel S, 2010, BLOOD COAGUL FIBRIN, V21, P750, DOI 10.1097/MBC.0b013e32834014a4; Agency for Healthcare Research and Quality, 2014, AHRQ PUBL; Albabtain MA, 2013, J INTERV CARDIOL, V26, P90, DOI 10.1111/j.1540-8183.2012.00767.x; Alioglu E, 2013, CARDIOVASC THER, V31, P168, DOI 10.1111/j.1755-5922.2011.00309.x; Allaqaband S, 2002, CATHETER CARDIO INTE, V57, P279, DOI 10.1002/ccd.10323; Amini M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-45; Aslanger E, 2012, CORONARY ARTERY DIS, V23, P265, DOI 10.1097/MCA.0b013e328351aacc; Awal A, 2011, Mymensingh Med J, V20, P264; Azmus Alexandre D, 2005, J Invasive Cardiol, V17, P80; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Baskurt M, 2009, EUR J CLIN INVEST, V39, P793, DOI 10.1111/j.1365-2362.2009.02173.x; Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Beyazal H, 2014, RENAL FAILURE, V36, P351, DOI 10.3109/0886022X.2013.866016; Boccalandro F, 2003, CATHETER CARDIO INTE, V58, P336, DOI 10.1002/ccd.10389; Boscheri A, 2007, CLIN NEPHROL, V68, P279; Boucek P, 2013, DIABETES RES CLIN PR, V101, P303, DOI 10.1016/j.diabres.2013.05.015; Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; Brueck M, 2013, J INVASIVE CARDIOL, V25, P276; Carbonell N, 2007, INT J CARDIOL, V115, P57, DOI 10.1016/j.ijcard.2006.04.023; Carbonell N, 2010, REV ESP CARDIOL, V63, P12, DOI 10.1016/S0300-8932(10)70004-X; Castini D, 2010, CLIN CARDIOL, V33, pE63, DOI 10.1002/clc.20576; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Davenport MS, 2015, AM J ROENTGENOL, V204, P1174, DOI 10.2214/AJR.14.14259; Demir M., 2008, EUR J GEN MED, V5, P222, DOI [10.29333/ejgm/82611, DOI 10.29333/EJGM/82611, DOI 10.29333/ejgm/82611]; Durham JD, 2002, KIDNEY INT, V62, P2202, DOI 10.1046/j.1523-1755.2002.00673.x; Dvorsak B, 2013, THER APHER DIAL, V17, P384, DOI 10.1111/1744-9987.12083; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Erturk M, 2014, CORONARY ARTERY DIS, V25, P111, DOI 10.1097/MCA.0000000000000073; Ferrario F, 2009, NEPHROL DIAL TRANSPL, V24, P3103, DOI 10.1093/ndt/gfp306; Goldenberg I, 2004, EUR HEART J, V25, P212, DOI 10.1016/j.ehj.2003.11.011; Gomes VO, 2012, ARQ BRAS CARDIOL, V99, P1129, DOI 10.1590/S0066-782X2012005000108; Gomes VO, 2005, HEART, V91, P774, DOI 10.1136/hrt.2004.039636; Gueler F, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026609.45827.3D; Gulel O, 2005, J CARDIOVASC PHARM, V46, P464, DOI 10.1097/01.fjc.0000176730.59443.dd; Gunebakmaz O, 2012, CLIN CARDIOL, V35, P250, DOI 10.1002/clc.21013; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Han S, 2013, INT J CARDIOL, V168, P5101, DOI 10.1016/j.ijcard.2013.07.252; Han YL, 2014, J AM COLL CARDIOL, V63, P62, DOI 10.1016/j.jacc.2013.09.017; Heguilen RM, 2013, CLIN EXP NEPHROL, V17, P396, DOI 10.1007/s10157-012-0722-3; Holscher B, 2008, CAN J CARDIOL, V24, P845; Hsu CH, 2007, MIDTAIWAN J MED, V12, P173; Hsu TF, 2012, INTERNAL MED, V51, P2709, DOI 10.2169/internalmedicine.51.7894; Jaffery Z, 2012, CATHETER CARDIO INTE, V79, P921, DOI 10.1002/ccd.23157; Jang JS, 2012, CIRC J, V76, P2255, DOI 10.1253/circj.CJ-12-0096; Jia XW, 2009, AM J CARDIOL, V104, P519, DOI 10.1016/j.amjcard.2009.04.014; Jo SH, 2015, J CARDIOVASC MED, V16, P213, DOI 10.2459/JCM.0000000000000157; Jo SH, 2009, AM HEART J, V157, P576, DOI 10.1016/j.ahj.2008.11.010; Jo SH, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.042; Kama A, 2014, ACAD EMERG MED, V21, P616, DOI 10.1111/acem.12400; Kay J, 2003, JAMA-J AM MED ASSOC, V289, P553, DOI 10.1001/jama.289.5.553; Kaya A, 2013, ACTA CARDIOL, V68, P489, DOI 10.1080/AC.68.5.2994472; Kefer JM, 2003, ACTA CARDIOL, V58, P555, DOI 10.2143/AC.58.6.2005321; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Khalili H., 2006, THERAPY, V3, P773, DOI [10.1586/14750708.3.6.773, DOI 10.1586/14750708.3.6.773]; Kim BJ, 2010, INT J CARDIOL, V138, P239, DOI 10.1016/j.ijcard.2008.08.013; Kimmel M, 2008, NEPHROL DIAL TRANSPL, V23, P1241, DOI 10.1093/ndt/gfm785; Kinbara T, 2010, J CARDIOL, V55, P174, DOI 10.1016/j.jjcc.2009.10.006; Kitajima K, 2011, INT J UROL, V18, P686, DOI 10.1111/j.1442-2042.2011.02830.x; Koc F, 2013, J INVEST MED, V61, P872, DOI [10.2310/JIM.0b013e31828e9cab, 10.231/JIM.0b013e31828e9cab]; Kooiman J, 2014, NEPHROL DIAL TRANSPL, V29, P1029, DOI 10.1093/ndt/gfu025; Kotlyar Eugene, 2005, Heart Lung Circ, V14, P245, DOI 10.1016/j.hlc.2005.06.007; Lee SW, 2011, AM J CARDIOL, V107, P1447, DOI 10.1016/j.amjcard.2011.01.019; Leoncini M, 2014, J AM COLL CARDIOL, V63, P71, DOI 10.1016/j.jacc.2013.04.105; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; Li H, 2014, SCI WORLD J, DOI 10.1155/2014/565367; Li W, 2012, CARDIOLOGY, V122, P195, DOI 10.1159/000339472; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111124; MacNeill BD, 2003, CATHETER CARDIO INTE, V60, P458, DOI 10.1002/ccd.10684; Manari A, 2014, J CARDIOVASC MED, V15, P60, DOI 10.2459/JCM.0b013e3283641bb8; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Masuda M, 2007, AM J CARDIOL, V100, P781, DOI 10.1016/j.amjcard.2007.03.098; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Miner SES, 2004, AM HEART J, V148, P690, DOI 10.1016/j.ahj.2004.05.015; Mohamed WMIW, 2008, INT MED J, V15, P353; Motohiro M, 2011, AM J CARDIOL, V107, P1604, DOI 10.1016/j.amjcard.2011.01.045; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Ochoa Anthony, 2004, J Interv Cardiol, V17, P159, DOI 10.1111/j.1540-8183.2004.09880.x; Oldemeyer JB, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00511-8; Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ahj.2007.05.012; Ozhan H, 2010, ANGIOLOGY, V61, P711, DOI 10.1177/0003319710364216; Patti G, 2011, AM J CARDIOL, V108, P1, DOI 10.1016/j.amjcard.2011.03.001; Poletti PA, 2007, AM J ROENTGENOL, V189, P687, DOI 10.2214/AJR.07.2356; Qiao B, 2015, INT J CLIN EXP MED, V8, P2342; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Ratcliffe JA, 2009, INT J ANGIOL, V18, P193, DOI 10.1055/s-0031-1278353; Reinecke H, 2007, CLIN RES CARDIOL, V96, P130, DOI 10.1007/s00392-007-0473-4; Sadat U, 2013, J AM COLL CARDIOL, V62, P2167, DOI 10.1016/j.jacc.2013.07.065; Sadat U, 2011, ANGIOLOGY, V62, P225, DOI 10.1177/0003319710377078; Sanei H, 2014, ARYA ATHEROSCLER, V10, P252; Seyon RA, 2007, HEART LUNG, V36, P195, DOI 10.1016/j.hrtlng.2006.08.004; Shehata M, 2015, CARDIOVASC THER, V33, P35, DOI 10.1111/1755-5922.12108; Shyu KG, 2002, J AM COLL CARDIOL, V40, P1383, DOI 10.1016/S0735-1097(02)02308-2; Singh N, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000127; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Subramaniam RM, 2015, AHRQ PUBLICATION, V15-EHC023-EF; Subramanian Sujha, 2007, J Med Econ, V10, P119, DOI 10.3111/200710119134; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tanaka A, 2011, INTERNAL MED, V50, P673, DOI 10.2169/internalmedicine.50.4226; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thayssen P, 2014, CIRC-CARDIOVASC INTE, V7, P216, DOI 10.1161/CIRCINTERVENTIONS.113.000653; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Toso A, 2010, AM J CARDIOL, V105, P288, DOI 10.1016/j.amjcard.2009.09.026; Traub SJ, 2013, ANN EMERG MED, V62, P511, DOI 10.1016/j.annemergmed.2013.04.012; Ueda H, 2011, AM J CARDIOL, V107, P1163, DOI 10.1016/j.amjcard.2010.12.012; Vasheghani-Farahani A, 2010, J NEPHROL, V23, P216; Vidt DG, 2006, AM J CARDIOL, V97, P1602, DOI 10.1016/j.amjcard.2005.12.052; Yeganehkhah MR, 2014, SAUDI J KIDNEY DIS T, V25, P1217, DOI 10.4103/1319-2442.144255; Yun KH, 2014, KOREAN CIRC J, V44, P301, DOI 10.4070/kcj.2014.44.5.301; Zhang B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006989; Zhang J, 2015, CHINESE MED J-PEKING, V128, P784, DOI 10.4103/0366-6999.152620; Zhou L, 2012, INTERNAL MED, V51, P531, DOI 10.2169/internalmedicine.51.6260	115	112	118	1	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					406	+		10.7326/M15-1456	http://dx.doi.org/10.7326/M15-1456			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26830221				2022-12-28	WOS:000372207200014
J	Chang, Y; Ryu, S; Choi, Y; Zhang, YY; Cho, J; Kwon, MJ; Hyun, YY; Lee, KB; Kim, H; Jung, HS; Yun, KE; Ahn, J; Rampal, S; Zhao, D; Suh, BS; Chung, EC; Shin, H; Pastor-Barriuso, R; Guallar, E				Chang, Yoosoo; Ryu, Seungho; Choi, Yuni; Zhang, Yiyi; Cho, Juhee; Kwon, Min-Jung; Hyun, Young Youl; Lee, Kyu-Beck; Kim, Hyang; Jung, Hyun-Suk; Yun, Kyung Eun; Ahn, Jiin; Rampal, Sanjay; Zhao, Di; Suh, Byung-Seong; Chung, Eun Cheol; Shin, Hocheol; Pastor-Barriuso, Roberto; Guallar, Eliseo			Metabolically Healthy Obesity and Development of Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; POTENTIAL MECHANISMS; BODY-COMPOSITION; RISK; OVERWEIGHT; FIBROSIS; HUMANS; MODELS; CKD	Background: The risk for chronic kidney disease (CKD) among obese persons without obesity-related metabolic abnormalities, called metabolically healthy obesity, is largely unexplored. Objective: To investigate the risk for incident CKD across categories of body mass index in a large cohort of metabolically healthy men and women. Design: Prospective cohort study. Setting: Kangbuk Samsung Health Study, Kangbuk Samsung Hospital, Seoul, South Korea. Participants: 62 249 metabolically healthy, young and middle-aged men and women without CKD or proteinuria at baseline. Measurements: Metabolic health was defined as a homeostasis model assessment of insulin resistance less than 2.5 and absence of any component of the metabolic syndrome. Underweight, normal weight, overweight, and obesity were defined as a body mass index less than 18.5 kg/m(2), 18.5 to 22.9 kg/m(2), 23 to 24.9 kg/m(2), and 25 kg/m(2) or greater, respectively. The outcome was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m(2). Results: During 369 088 person-years of follow-up, 906 incident CKD cases were identified. The multivariable-adjusted differences in 5-year cumulative incidence of CKD in underweight, overweight, and obese participants compared with normal-weight participants were -4.0 (95% CI, -7.8 to -0.3), 3.5 (CI, 0.9 to 6.1), and 6.7 (CI, 3.0 to 10.4) cases per 1000 persons, respectively. These associations were consistently seen in all clinically relevant subgroups. Limitation: Chronic kidney disease was identified by a single measurement at each visit. Conclusion: Overweight and obesity are associated with an increased incidence of CKD in metabolically healthy young and middle-aged participants. These findings show that metabolically healthy obesity is not a harmless condition and that the obese phenotype, regardless of metabolic abnormalities, can adversely affect renal function. Primary Funding Source: None.	Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Kangbuk Samsung Hosp, Total Healthcare Ctr,Ctr Cohort Studies, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Seoul, South Korea; [Zhang, Yiyi; Zhao, Di; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Room 2-645, Baltimore, MD 21205 USA; Univ Malaya, Julius Ctr, Kuala Lumpur, Malaysia; [Pastor-Barriuso, Roberto] Carlos III Inst Hlth, Natl Ctr Epidemiol, Av Monforte Lemos 5, Madrid 28029, Spain; [Ryu, Seungho] Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Chang, Yoosoo; Ryu, Seungho; Choi, Yuni] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Samsung Main Bldg B2,250 Taepyung Ro 2Ga, Seoul 100742, South Korea; [Chang, Yoosoo; Ryu, Seungho; Cho, Juhee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, 50 Irwon Dong, Seoul 135710, South Korea; [Kwon, Min-Jung] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, 108 Pyung Dong, Seoul 110746, South Korea; [Hyun, Young Youl; Lee, Kyu-Beck; Kim, Hyang] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, 108 Pyung Dong, Seoul 110746, South Korea; [Rampal, Sanjay] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr Clin Epidemiol & Evidence Based Med, Kuala Lumpur 50603, Malaysia; [Suh, Byung-Seong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, 108 Pyung Dong, Seoul 110746, South Korea; [Chung, Eun Cheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, 108 Pyung Dong, Seoul 110746, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, 108 Pyung Dong, Seoul 110746, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Universiti Malaya; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Guallar, E (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Room 2-645, Baltimore, MD 21205 USA.; Ryu, S (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Samsung Main Bldg B2,250 Taepyung Ro 2Ga, Seoul 100742, South Korea.; Ryu, S (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, 50 Irwon Dong, Seoul 135710, South Korea.	sh703.yoo@gmail.com; rpastor@isciii.es; eguallar@jhu.edu	Pastor-Barriuso, Roberto/AAA-6746-2019; Choi, Yuni/I-6298-2012; Cho, Juhee/ABD-2280-2021	Pastor-Barriuso, Roberto/0000-0002-7325-3960; Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646				Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Abdullah A, 2011, PUBLIC HEALTH NUTR, V14, P119, DOI 10.1017/S1368980010001813; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Chang Y, 2014, J AM COLL CARDIOL, V64, P1184, DOI 10.1016/j.jacc.2014.06.1173; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Garland JS, 2014, DIABET METAB SYND OB, V7, P347, DOI 10.2147/DMSO.S46674; Hashimoto Y, 2015, CLIN J AM SOC NEPHRO, V10, P578, DOI 10.2215/CJN.08980914; Hunley Tracy E, 2010, Curr Opin Nephrol Hypertens, V19, P227, DOI 10.1097/MNH.0b013e3283374c09; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalaitzidis RG, 2011, INT UROL NEPHROL, V43, P771, DOI 10.1007/s11255-011-9974-1; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLellan F, 2002, LANCET, V359, P1412, DOI 10.1016/S0140-6736(02)08397-6; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Stefan N, 2014, NEPHROL DIAL TRANSPL; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Zhang YY, 2014, INT J EPIDEMIOL, V43, P1624, DOI 10.1093/ije/dyu126	33	192	196	1	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					305	+		10.7326/M15-1323	http://dx.doi.org/10.7326/M15-1323			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26857595				2022-12-28	WOS:000371220300001
J	Hayes, RP; Xiao, YB; Ding, F; van Erp, PBG; Rajashankar, K; Bailey, S; Wiedenheft, B; Ke, AL				Hayes, Robert P.; Xiao, Yibei; Ding, Fran; van Erp, Paul B. G.; Rajashankar, Kanagalaghatta; Bailey, Scott; Wiedenheft, Blake; Ke, Ailong			Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli	NATURE			English	Article							GUIDED SURVEILLANCE COMPLEX; CRYSTAL-STRUCTURE; DNA RECOGNITION; FOREIGN DNA; VITRO RECONSTITUTION; CRISPR IMMUNITY; DEGRADATION; MECHANISM; DEFENSE; TARGETS	Clustered regularly interspaced short palindromic repeats (CRISPRs) and the cas (CRISPR-associated) operon form an RNA-based adaptive immune system against foreign genetic elements in prokaryotes(1). Type I accounts for 95% of CRISPR systems, and has been used to control gene expression and cell fate(2,3). During CRISPR RNA (crRNA)-guided interference, Cascade (CRISPR-associated complex for antiviral defence) facilitates the crRNA-guided invasion of double-stranded DNA for complementary base-pairing with the target DNA strand while displacing the nontarget strand, forming an R-loop(4,5). Cas3, which has nuclease and helicase activities, is subsequently recruited to degrade two DNA strands(4,6,7). A protospacer adjacent motif (PAM) sequence flanking target DNA is crucial for self versus foreign discrimination(4,8-16). Here we present the 2.45 angstrom crystal structure of Escherichia coli Cascade bound to a foreign double-stranded DNA target. The 5'-ATG PAM is recognized in duplex form, from the minor groove side, by three structural features in the Cascade Cse1 subunit. The promiscuity inherent to minor groove DNA recognition rationalizes the observation that a single Cascade complex can respond to several distinct PAM sequences. Optimal PAM recognition coincides with wedge insertion, initiating directional target DNA strand unwinding to allow segmented base-pairing with crRNA. The non-target strand is guided along a parallel path 25 angstrom apart, and the R-loop structure is further stabilized by locking this strand behind the Cse2 dimer. These observations provide the structural basis for understanding the PAM-dependent directional R-loop formation process(17,18).	[Hayes, Robert P.; Xiao, Yibei; Ding, Fran; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA; [Rajashankar, Kanagalaghatta] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, NE CAT,Adv Photon Source, Argonne, IL 60439 USA; [Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [van Erp, Paul B. G.; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Cornell University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Montana State University System; Montana State University Bozeman	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA.	ak425@cornell.edu	Bailey, Scott/N-7248-2019	Hayes, Robert/0000-0003-4947-4410	National Institutes of Health (NIH) [GM102543, GM086766, GM097330, GM108888, P41 GM103403, S10 RR029205]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086766, R01GM102543, P41GM103403, R01GM097330, R01GM108888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) grants GM102543 and GM086766 to A. K., GM097330 to S. B. and GM108888 to B. W. NE-CAT beamlines were supported by NIH grants P41 GM103403 and S10 RR029205. We thank G. Feigenson and J. Mallon for technical help, and I. Finkelstein, I. Price and A. Dolan for discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	33	104	107	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					499	+		10.1038/nature16995	http://dx.doi.org/10.1038/nature16995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26863189	Green Accepted, Green Submitted			2022-12-28	WOS:000370690800040
J	Bandaria, JN; Qin, PW; Berk, V; Chu, S; Yildiz, A				Bandaria, Jigar N.; Qin, Peiwu; Berk, Veysel; Chu, Steven; Yildiz, Ahmet			Shelterin Protects Chromosome Ends by Compacting Telomeric Chromatin	CELL			English	Article							MAMMALIAN TELOMERES; LENGTH CONTROL; IN-VITRO; TRF2; DNA; BINDING; ATM; CELLS; RECRUITMENT; PROTEINS	Telomeres, repetitive DNA sequences at chromosome ends, are shielded against the DNA damage response (DDR) by the shelterin complex. To understand how shelterin protects telomere ends, we investigated the structural organization of telomeric chromatin in human cells using super-resolution microscopy. We found that telomeres form compact globular structures through a complex network of interactions between shelterin subunits and telomeric DNA, but not by DNA methylation, histone deacetylation, or histone trimethylation at telomeres and subtelomeric regions. Mutations that abrogate shelterin assembly or removal of individual subunits from telomeres cause up to a 10-fold increase in telomere volume. Decompacted telomeres accumulate DDR signals and become more accessible to telomere-associated proteins. Recompaction of telomeric chromatin using an orthogonal method displaces DDR signals from telomeres. These results reveal the chromatin remodeling activity of shelterin and demonstrate that shelterin-mediated compaction of telomeric chromatin provides robust protection of chromosome ends against the DDR machinery.	[Bandaria, Jigar N.; Qin, Peiwu; Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bandaria, Jigar N.; Berk, Veysel; Yildiz, Ahmet] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Berk, Veysel; Chu, Steven] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	yildiz@berkeley.edu			NIH [GM094522]; NSF [MCB-1055017]; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118773, R01GM094522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Collins, A. Dernburg and G. Karpen for critically reading our manuscript, B. Huang for the data analysis software, M. Lei and J. Nandakumar for shelterin plasmids, T. de Lange for HeLa 1.2.11 cells, E. Griffis for advice in transfections, and J. Canty for help with super-resolution imaging. This work has been supported by NIH (GM094522 to A.Y.), NSF (MCB-1055017 to A.Y.), and Ellison Medical Foundation (A.Y.).	Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blasco MA, 2013, HUM GENE THER, V24, pA19; Cacchione S, 1997, FEBS LETT, V400, P37, DOI 10.1016/S0014-5793(96)01318-X; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Frescas D, 2014, MOL CELL BIOL, V34, P1349, DOI 10.1128/MCB.01052-13; Galati A, 2006, J MOL BIOL, V360, P377, DOI 10.1016/j.jmb.2006.04.071; Galati A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034386; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ichikawa Y, 2014, NUCLEIC ACIDS RES, V42, P1541, DOI 10.1093/nar/gkt1006; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kishi S, 2002, J BIOL CHEM, V277, P7420, DOI 10.1074/jbc.M111365200; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lackner DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021407; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pierron G, 1999, CHROMOSOME RES, V7, P581, DOI 10.1023/A:1009253917125; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2010, NUCLEIC ACIDS RES, V38, P2247, DOI 10.1093/nar/gkp1228; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Wu Y, 2007, NAT STRUCT MOL BIOL, V14, P832, DOI 10.1038/nsmb1286; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200	55	103	105	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					735	746		10.1016/j.cell.2016.01.036	http://dx.doi.org/10.1016/j.cell.2016.01.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871633	Green Accepted, Bronze			2022-12-28	WOS:000369998300018
J	Quick, J; Loman, NJ; Duraffour, S; Simpson, JT; Ettore, S; Cowley, L; Bore, JA; Koundouno, R; Dudas, G; Mikhail, A; Ouedraogo, N; Afrough, B; Bah, A; Baum, JHJ; Becker-Ziaja, B; Boettcher, JP; Cabeza-Cabrerizo, M; Camino-Sanchez, A; Carter, LL; Doerrbecker, J; Enkirch, T; Garcia-Dorival, I; Hetzelt, N; Hinzmann, J; Holm, T; Kafetzopoulou, LE; Koropogui, M; Kosgey, A; Kuisma, E; Logue, CH; Mazzarelli, A; Meisel, S; Mertens, M; Michel, J; Ngabo, D; Nitzsche, K; Pallasch, E; Patrono, LV; Portmann, J; Repits, JG; Rickett, NY; Sachse, A; Singethan, K; Vitoriano, I; Emanaberhan, RLY; Zekeng, EG; Racine, T; Bello, A; Sall, AA; Faye, O; Faye, O; Magassouba, N; Williams, CV; Amburgey, V; Winona, L; Davis, E; Gerlach, J; Washington, F; Monteil, V; Jourdain, M; Bererd, M; Camara, A; Somlare, H; Camara, A; Gerard, M; Bado, G; Baillet, B; Delaune, D; Nebie, KY; Diarra, A; Savane, Y; Pallawo, RB; Gutierrez, GJ; Milhano, N; Roger, I; Williams, CJ; Yattara, F; Lewandowski, K; Taylor, J; Rachwal, P; Turner, DJ; Pollakis, G; Hiscox, JA; Matthews, DA; O'Shea, MK; Johnston, AM; Wilson, D; Hutley, E; Smit, E; DiCaro, A; Wolfel, R; Stoecker, K; Fleischmann, E; Gabriel, M; Weller, SA; Koivogui, L; Diallo, B; Keita, S; Rambaut, A; Formenty, P; Gunther, S; Carroll, MW				Quick, Joshua; Loman, Nicholas J.; Duraffour, Sophie; Simpson, Jared T.; Severi, Ettore; Cowley, Lauren; Bore, Joseph Akoi; Koundouno, Raymond; Dudas, Gytis; Mikhail, Amy; Ouedraogo, Nobila; Afrough, Babak; Bah, Amadou; Baum, Jonathan H. J.; Becker-Ziaja, Beate; Boettcher, Jan Peter; Cabeza-Cabrerizo, Mar; Camino-Sanchez, Alvaro; Carter, Lisa L.; Doerrbecker, Juliane; Enkirch, Theresa; Garcia-Dorival, Isabel; Hetzelt, Nicole; Hinzmann, Julia; Holm, Tobias; Kafetzopoulou, Liana Eleni; Koropogui, Michel; Kosgey, Abigael; Kuisma, Eeva; Logue, Christopher H.; Mazzarelli, Antonio; Meisel, Sarah; Mertens, Marc; Michel, Janine; Ngabo, Didier; Nitzsche, Katja; Pallasch, Elisa; Patrono, Livia Victoria; Portmann, Jasmine; Repits, Johanna Gabriella; Rickett, Natasha Y.; Sachse, Andreas; Singethan, Katrin; Vitoriano, Ines; Emanaberhan, Rahel L. Y.; Zekeng, Elsa G.; Racine, Trina; Bello, Alexander; Sall, Amadou Alpha; Faye, Ousmane; Faye, Oumar; Magassouba, N'Faly; Williams, Cecelia V.; Amburgey, Victoria; Winona, Linda; Davis, Emily; Gerlach, Jon; Washington, Frank; Monteil, Vanessa; Jourdain, Marine; Bererd, Marion; Camara, Alimou; Somlare, Hermann; Camara, Abdoulaye; Gerard, Marianne; Bado, Guillaume; Baillet, Bernard; Delaune, Deborah; Nebie, Koumpingnin Yacouba; Diarra, Abdoulaye; Savane, Yacouba; Pallawo, Raymond Bernard; Gutierrez, Giovanna Jaramillo; Milhano, Natacha; Roger, Isabelle; Williams, Christopher J.; Yattara, Facinet; Lewandowski, Kuiama; Taylor, James; Rachwal, Phillip; Turner, Daniel J.; Pollakis, Georgios; Hiscox, Julian A.; Matthews, David A.; O'Shea, Matthew K.; Johnston, Andrew McD; Wilson, Duncan; Hutley, Emma; Smit, Erasmus; DiCaro, Antonino; Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Gabriel, Martin; Weller, Simon A.; Koivogui, Lamine; Diallo, Boubacar; Keita, Sakoba; Rambaut, Andrew; Formenty, Pierre; Guenther, Stephan; Carroll, Miles W.			Real-time, portable genome sequencing for Ebola surveillance	NATURE			English	Article							NANOPORE SEQUENCER; SIERRA-LEONE; VIRUS; OUTBREAK; TRANSMISSION; DNA; EVOLUTION; DYNAMICS	The Ebola virus disease epidemic in West Africa is the largest on record, responsible for over 28,599 cases and more than 11,299 deaths(1). Genome sequencing in viral outbreaks is desirable to characterize the infectious agent and determine its evolutionary rate. Genome sequencing also allows the identification of signatures of host adaptation, identification and monitoring of diagnostic targets, and characterization of responses to vaccines and treatments. The Ebola virus (EBOV) genome substitution rate in the Makona strain has been estimated at between 0.87 x 10(-3) and 1.42 x 10(-3) mutations per site per year. This is equivalent to 16-27 mutations in each genome, meaning that sequences diverge rapidly enough to identify distinct sub-lineages during a prolonged epidemic(2-7). Genome sequencing provides a high-resolution view of pathogen evolution and is increasingly sought after for outbreak surveillance. Sequence data may be used to guide control measures, but only if the results are generated quickly enough to inform interventions(8). Genomic surveillance during the epidemic has been sporadic owing to a lack of local sequencing capacity coupled with practical difficulties transporting samples to remote sequencing facilities(9). To address this problem, here we devise a genomic surveillance system that utilizes a novel nanopore DNA sequencing instrument. In April 2015 this system was transported in standard airline luggage to Guinea and used for real-time genomic surveillance of the ongoing epidemic. We present sequence data and analysis of 142 EBOV samples collected during the period March to October 2015. We were able to generate results less than 24 h after receiving an Ebola-positive sample, with the sequencing process taking as little as 15-60 min. We show that real-time genomic surveillance is possible in resource-limited settings and can be established rapidly to monitor outbreaks.	[Quick, Joshua; Loman, Nicholas J.; Boettcher, Jan Peter; Garcia-Dorival, Isabel] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Duraffour, Sophie; Bore, Joseph Akoi; Koundouno, Raymond; Afrough, Babak; Bah, Amadou; Baum, Jonathan H. J.; Becker-Ziaja, Beate; Boettcher, Jan Peter; Cabeza-Cabrerizo, Mar; Camino-Sanchez, Alvaro; Carter, Lisa L.; Doerrbecker, Juliane; Enkirch, Theresa; Garcia-Dorival, Isabel; Hetzelt, Nicole; Hinzmann, Julia; Holm, Tobias; Kafetzopoulou, Liana Eleni; Koropogui, Michel; Kosgey, Abigael; Kuisma, Eeva; Logue, Christopher H.; Mazzarelli, Antonio; Meisel, Sarah; Mertens, Marc; Michel, Janine; Ngabo, Didier; Nitzsche, Katja; Pallasch, Elisa; Patrono, Livia Victoria; Portmann, Jasmine; Repits, Johanna Gabriella; Rickett, Natasha Y.; Sachse, Andreas; Singethan, Katrin; Vitoriano, Ines; Emanaberhan, Rahel L. Y.; Zekeng, Elsa G.; DiCaro, Antonino; Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Gabriel, Martin; Guenther, Stephan; Carroll, Miles W.] Bernhard Nocht Inst Trop Med, European Mobile Lab Consortium, D-20359 Hamburg, Germany; [Duraffour, Sophie; Baum, Jonathan H. J.; Becker-Ziaja, Beate; Cabeza-Cabrerizo, Mar; Doerrbecker, Juliane; Holm, Tobias; Meisel, Sarah; Nitzsche, Katja; Pallasch, Elisa; Patrono, Livia Victoria; Emanaberhan, Rahel L. Y.; Gabriel, Martin; Guenther, Stephan] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Simpson, Jared T.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Simpson, Jared T.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Severi, Ettore; Milhano, Natacha; Williams, Christopher J.] European Ctr Dis Prevent & Control ECDC, S-17165 Solna, Sweden; [Cowley, Lauren; Mikhail, Amy] Publ Hlth England, Natl Infect Serv, London NW9 5EQ, England; [Dudas, Gytis; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 2FL, Midlothian, Scotland; [Ouedraogo, Nobila] Robert Koch Inst, PAE, German FETP, D-13302 Berlin, Germany; [Afrough, Babak; Kuisma, Eeva; Logue, Christopher H.; Ngabo, Didier; Vitoriano, Ines; Lewandowski, Kuiama; Carroll, Miles W.] Publ Hlth England, Natl Infect Serv, Porton Down SP4 0JG, Wilts, England; [Bah, Amadou] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Boettcher, Jan Peter; Hetzelt, Nicole; Hinzmann, Julia; Michel, Janine; Sachse, Andreas] Robert Koch Inst, D-13302 Berlin, Germany; [Carter, Lisa L.] UCL, London WC1E 6BT, England; [Enkirch, Theresa] Paul Ehrlich Inst, Div Vet Med, D-63225 Langen, Germany; [Garcia-Dorival, Isabel; Rickett, Natasha Y.; Zekeng, Elsa G.; Pollakis, Georgios; Hiscox, Julian A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England; [Kafetzopoulou, Liana Eleni] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, B-3000 Louvain, Belgium; [Koropogui, Michel; Yattara, Facinet; Keita, Sakoba] Minist Hlth Guinea, Conakry, Guinea; [Kosgey, Abigael] Kenya Govt Med Res Ctr, Nairobi 00200, Kenya; [Mazzarelli, Antonio; DiCaro, Antonino] Natl Inst Infect Dis L Spallanzani, I-00149 Rome, Italy; [Mertens, Marc] Friedrich Loeffler Inst, D-17493 Greifswald, Germany; [Portmann, Jasmine] Fed Off Civil Protect, Spiez Lab, CH-3700 Spiez, Switzerland; [Repits, Johanna Gabriella] Janssen Cilag, S-19207 Stockholm, Sweden; [Rickett, Natasha Y.; Zekeng, Elsa G.; Pollakis, Georgios; Hiscox, Julian A.] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool L69 7BE, Merseyside, England; [Singethan, Katrin] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Racine, Trina; Bello, Alexander] Publ Hlth Agcy Canada, Winnipeg, MB R3E 3R2, Canada; [Sall, Amadou Alpha; Faye, Ousmane] Inst Pasteur, Dakar, Senegal; [Magassouba, N'Faly] Lab Fievres Hemorrag Guinee, Conakry, Guinea; [Williams, Cecelia V.; Amburgey, Victoria; Winona, Linda] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Williams, Cecelia V.; Amburgey, Victoria; Winona, Linda; Davis, Emily; Gerlach, Jon; Washington, Frank] Ratoma Ebola Diagnost Ctr, Conakry, Guinea; [Davis, Emily; Gerlach, Jon; Washington, Frank] MRIGlobal, Kansas City, MO 64110 USA; [Monteil, Vanessa; Jourdain, Marine; Bererd, Marion; Camara, Alimou; Somlare, Hermann; Camara, Abdoulaye; Gerard, Marianne; Bado, Guillaume; Baillet, Bernard] Expertise France, Lab Kplan Forecariah Guinee, F-75006 Paris, France; [Delaune, Deborah] Federat Lab HIA Begin, F-94163 St Mande, France; [Delaune, Deborah] Ctr Traitement Soignants, Biol Lab, Conakry, Guinea; [Nebie, Koumpingnin Yacouba; Diarra, Abdoulaye; Savane, Yacouba; Pallawo, Raymond Bernard; Roger, Isabelle; Diallo, Boubacar; Formenty, Pierre] World Hlth Org, Conakry, Guinea; [Gutierrez, Giovanna Jaramillo] London Sch Hyg & Trop Med, London EC1E 7HT, England; [Milhano, Natacha] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Williams, Christopher J.] Publ Hlth Wales, Cardiff CF11 9LJ, S Glam, Wales; [Taylor, James; Rachwal, Phillip; Weller, Simon A.] Dstl Porton Down, Salisbury SP4 0JQ, Wilts, England; [Turner, Daniel J.] Oxford Nanopore Technol, Oxford OX4 4GA, England; [Matthews, David A.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [O'Shea, Matthew K.; Johnston, Andrew McD; Wilson, Duncan] Royal Ctr Def Med, Acad Dept Mil Med, Birmingham B15 2TH, W Midlands, England; [Hutley, Emma] Royal Ctr Def Med, Ctr Def Pathol, Birmingham B15 2TH, W Midlands, England; [Smit, Erasmus] Queen Elizabeth Hosp, Birmingham B12 2TH, W Midlands, England; [Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Koivogui, Lamine] Inst Natl St Publ, Conakry, Guinea; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 2FL, Midlothian, Scotland; [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton SO16 6YD, Hants, England; [Carroll, Miles W.] NIHR Hlth Protect Res, Res Unit Emerging & Zoonot Infect, PHE Porton Down, London, England	University of Birmingham; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; European Centre for Disease Prevention & Control; Public Health England; University of Edinburgh; Robert Koch Institute; Public Health England; University of Basel; Swiss Tropical & Public Health Institute; Robert Koch Institute; University of London; University College London; Paul Ehrlich Institute; University of Liverpool; KU Leuven; Kenya Medical Research Institute; IRCCS Lazzaro Spallanzani; Friedrich Loeffler Institute; Johnson & Johnson; University of Liverpool; Technical University of Munich; Public Health Agency of Canada; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; United States Department of Energy (DOE); Sandia National Laboratories; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Norwegian Institute of Public Health (NIPH); Defence Science & Technology Laboratory; Oxford Nanopore Technologies; University of Bristol; Royal Centre for Defence Medicine; Royal Centre for Defence Medicine; University of Birmingham; Bundeswehr Institute of Microbiology (IMB); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Edinburgh; University of Southampton	Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.	n.j.loman@bham.ac.uk	Loman, Nicholas/Z-1573-2019; Rambaut, Andrew/B-2481-2009; Mazzarelli, Antonio/B-5978-2017; Georgios, Pollakis/Y-2341-2019; Di Caro, Antonino/K-6854-2016; Johnston, Andy/GOK-2428-2022; Monteil, Vanessa/AAN-1904-2021; faye, Ousmane/GMW-6500-2022; Dorival, Isabel Garcia/AAX-5807-2020; Dudas, Gytis/H-5968-2019; Logue, Christopher H/ABH-3469-2020; Wölfel, Roman/AAQ-3977-2021; Faye, Oumar/T-7168-2019	Rambaut, Andrew/0000-0003-4337-3707; Mazzarelli, Antonio/0000-0001-6285-4368; Di Caro, Antonino/0000-0001-6027-3009; Monteil, Vanessa/0000-0002-2652-5695; Dorival, Isabel Garcia/0000-0002-5654-5662; Dudas, Gytis/0000-0002-0227-4158; Wölfel, Roman/0000-0002-8756-7821; Faye, Oumar/0000-0002-3478-1322; CAMARA, Alimou/0000-0002-7122-1885; Pollakis, Georgios/0000-0002-9659-5461; Loman, Nicholas/0000-0002-9843-8988; Enkirch, Theresa/0000-0002-5429-840X; Cowley, Lauren/0000-0003-0835-7971; Hiscox, Julian/0000-0002-6582-0275; Rickett, Natasha/0000-0002-3172-1877; Carroll, Miles/0000-0002-7026-7187; O'Shea, Matthew/0000-0001-6414-8088; Gunther, Stephan/0000-0002-6562-0230; Johnston, Andrew McDonald/0000-0002-0220-0589; Weller, Simon/0000-0001-9286-2991; Ngabo, Didier/0000-0003-1818-1439; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; Ouedraogo, Nobila/0000-0001-6967-9670; Matthews, David/0000-0003-4611-8795; Mikhail, Amy Frances Wahid/0000-0003-3414-2173; Afrough, Babak/0000-0002-6651-1239	European Union [666100]; Directorate-General for International Cooperation and Development [IFS/2011/272-372]; NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC); Medical Research Council; Ontario Institute for Cancer Research through Government of Ontario; UK Ministry of Defence (MOD); EU [278433-PREDEMICS]; ERC [260864]; MRC [MR/J014370/1, MR/L015080/1] Funding Source: UKRI; Medical Research Council [MR/L015080/1, MR/M501621/1, MR/J014370/1] Funding Source: researchfish	European Union(European Commission); Directorate-General for International Cooperation and Development; NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ontario Institute for Cancer Research through Government of Ontario; UK Ministry of Defence (MOD); EU(European Commission); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The EMLab is a technical partner in the WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN), and the Global Outbreak Alert and Response Network (GOARN) and the deployments in West Africa have been coordinated and supported by the GOARN Operational Support Team at WHO/HQ and the African Union. This work was carried out in the context of the project EVIDENT (Ebola virus disease: correlates of protection, determinants of outcome, and clinical management) that received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 666100 and in the context of service contract IFS/2011/272-372 funded by Directorate-General for International Cooperation and Development. J.Q. is funded by the NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC). N.J.L. is funded by a Medical Research Council Special Training Fellowship in Biomedical Informatics (to September 2015) and a Medical Research Council Bioinformatics Fellowship. J.T.S. is supported by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. Dstl support was funded by the UK Ministry of Defence (MOD). Dstl authors thank S. Lonsdale, C. Lonsdale and C. Mayers for supply of RNA, previous assistance, and review of the manuscript. The views expressed in this paper are not necessarily endorsed by the UK MOD. A.R. was supported by EU Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no. 278433-PREDEMICS and ERC Grant agreement no. 260864. We are grateful for the generous support of University of Birmingham alumni for donations in support of the pilot work. The MRC Cloud Infrastructure for Microbial Bioinformatics (CLIMB) cyberinfrastructure was used to conduct bioinformatics analysis. The authors would like to thank B. Oppenheim and C. Wardius for help with logistics and the staff of Alta Biosciences, University of Birmingham and Sigma-Aldrich for generating PCR primers especially rapidly for this project. The authors would like to thank scientists deployed from the Special Pathogens Program from the National Microbiology Laboratory, Public Health Agency of Canada, who worked on EBOV diagnostics in Guinea. We are grateful to I. Goodfellow, M. Cotten and P. Kellam for permission to include sequences from Sierra Leone in this analysis. We thank R. Vipond for assistance with validation experiments. We thank H. Eno and B. Myers for help with proofreading. We are thankful for the generous support of reagents and technical support from Oxford Nanopore. We thank the staff at Oxford Nanopore for technical and logistical support during this project with special thanks to S. Brooking, O. Hartwell, R. Pettett, C. Brown, G. Sanghera and R. Ronan. We thank T. Bedford and R. Neher for developing the Nextstrain website.	Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x; Garrison E., 2012, PREPRINT; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Goodfellow I., 2014, RECENT EVOLUTION PAT; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heger M., 2015, LIBERIAS LIBR GENOME; Herold Keith E., 2009, V504, P441, DOI 10.1007/978-1-60327-569-9_24; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; Smither SJ, 2015, J CLIN MICROBIOL, V53, P3148, DOI 10.1128/JCM.01449-15; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Urban J. M., 2015, PREPRINT; WHO, 2015, EB SIT REP; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	33	747	774	15	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					228	+		10.1038/nature16996	http://dx.doi.org/10.1038/nature16996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26840485	Green Accepted			2022-12-28	WOS:000369916700041
J	Schmelz, J				Schmelz, Joan			Change the system to halt harassment	NATURE			English	Editorial Material									[Schmelz, Joan] Univ Space Res Assoc, Washington, DC USA; [Schmelz, Joan] Arecibo Observ Puerto Rico, Arecibo, PR USA	Universities Space Research Association (USRA)	Schmelz, J (corresponding author), Univ Space Res Assoc, Washington, DC USA.	jschmelz@usra.edu							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					131	131		10.1038/530131a	http://dx.doi.org/10.1038/530131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD4TX	26863946	Bronze			2022-12-28	WOS:000369916700004
J	Nuti, SV; Qin, L; Rumsfeld, JS; Ross, JS; Masoudi, FA; Normand, SLT; Murugiah, K; Bernheim, SM; Suter, LG; Krumholz, HM				Nuti, Sudhakar V.; Qin, Li; Rumsfeld, John S.; Ross, Joseph S.; Masoudi, Frederick A.; Normand, Sharon-Lise T.; Murugiah, Karthik; Bernheim, Susannah M.; Suter, Lisa G.; Krumholz, Harlan M.			Association of Admission to Veterans Affairs Hospitals vs Non-Veterans Affairs Hospitals With Mortality and Readmission Rates Among Older Men Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE-SYSTEM; QUALITY-OF-CARE; 30-DAY MORTALITY; MEDICAL-CENTERS; PERFORMANCE; OUTCOMES; VA; ENROLLEES	IMPORTANCE Little contemporary information is available about comparative performance between Veterans Affairs (VA) and non-VA hospitals, particularly related to mortality and readmission rates, 2 important outcomes of care. OBJECTIVE To assess and compare mortality and readmission rates among men in VA and non-VA hospitals. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analysis involving male Medicare fee-for service beneficiaries aged 65 years or older hospitalized between 2010 and 2013 in VA and non-VA acute care hospitals for acute myocardial infarction (AMI), heart failure (HF), or pneumonia using the Medicare Standard Analytic Files and Enrollment Database together with VA administrative claims data. To avoid confounding geographic effects with health care system effects, we studied VA and non-VA hospitals within the same metropolitan statistical area (MSA). EXPOSURES Hospitalization in a VA or non-VA hospital in MSAs that contained at least 1 VA and non-VA hospital. MAIN OUTCOMES AND MEASURES For each condition, 30-day risk-standardized mortality rates and risk-standardized readmission rates for VA and non-VA hospitals. Mean aggregated within-MSA differences in mortality and readmission rates were also assessed. RESULTS We studied 104 VA and 1513 non-VA hospitals, with each condition-outcome analysis cohort for VA and non-VA hospitals containing at least 7900 patients (men; >= 65 years), in 92 MSAs. Mortality rates were lower in VA hospitals than non-VA hospitals for AMI (13.5% vs 13.7%, P = .02; -0.2 percentage-point difference) and HF (11.4% vs 11.9%, P = .008; -0.5 percentage-point difference), but higher for pneumonia (12.6% vs 12.2%, P = .045; 0.4 percentage-point difference). In contrast, readmission rates were higher in VA hospitals for all 3 conditions (AMI, 17.8% vs 17.2%, 0.6 percentage-point difference; HF, 24.7% vs 23.5%, 1.2 percentage-point difference; pneumonia, 19.4% vs 18.7%, 0.7 percentage-point difference, all P < .001). In within-MSA comparisons, VA hospitals had lower mortality rates for AMI (percentage-point difference, -0.22; 95% CI, -0.40 to -0.04) and HF (-0.63; 95% CI, -0.95 to -0.31), and mortality rates for pneumonia were not significantly different (-0.03; 95% CI, -0.46 to 0.40); however, VA hospitals had higher readmission rates for AMI (0.62; 95% CI, 0.48 to 0.75), HF (0.97; 95% CI, 0.59 to 1.34), or pneumonia (0.66; 95% CI, 0.41 to 0.91). CONCLUSIONS AND RELEVANCE Among older men with AMI, HF, or pneumonia, hospitalization at VA hospitals, compared with hospitalization at non-VA hospitals, was associated with lower 30-day risk-standardized all-cause mortality rates for AMI and HF, and higher 30-day risk-standardized all-cause readmission rates for all 3 conditions, both nationally and within similar geographic areas, although absolute differences between these outcomes at VA and non-VA hospitals were small.	[Nuti, Sudhakar V.; Qin, Li; Ross, Joseph S.; Murugiah, Karthik; Bernheim, Susannah M.; Suter, Lisa G.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Qin, Li; Ross, Joseph S.; Suter, Lisa G.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, Clin Scholars Program,Robert Wood Johnson Fdn, New Haven, CT USA; [Qin, Li; Ross, Joseph S.; Suter, Lisa G.; Krumholz, Harlan M.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT USA; [Qin, Li; Ross, Joseph S.; Suter, Lisa G.; Krumholz, Harlan M.] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT USA; [Rumsfeld, John S.] VA Eastern Colorado Healthcare Syst, Denver, CO USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Masoudi, Frederick A.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Dept Biostat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Suter, Lisa G.] Vet Affairs Med Ctr, West Haven, CT USA	Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, One Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019	Murugiah, Karthik/0000-0001-7932-382X; Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320	National Institute on Aging [K08 AG032886]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [U01 HL105270-05]; VA Connecticut Healthcare System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Connecticut Healthcare System(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Ross is supported by grant K08 AG032886 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. Dr Krumholz is supported by grant U01 HL105270-05 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr Suter is partially supported by the VA Connecticut Healthcare System.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; American Hospital Association, 2014, AHA DAT DIR; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Borrero S, 2006, J GEN INTERN MED, V21, pS54, DOI 10.1111/j.1525-1497.2006.00375.x; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare & Medicaid Services, DEN FIL; Fihn SD, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-44; Gerhardt Geoffrey, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.02.b01; HOLLOWAY JJ, 1990, HEALTH SERV RES, V25, P213; Institute of Medicine (US) Committee on the Future of Rural Health Care, 2005, QUAL COLL FUT RUR HL; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jones LG, 2015, CIRC-HEART FAIL, V8, P17, DOI 10.1161/CIRCHEARTFAILURE.114.001300; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Keyhani S, 2012, CIRC-CARDIOVASC QUAL, V5, P508, DOI 10.1161/CIRCOUTCOMES.111.962936; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Landrum MB, 2004, HEALTH SERV RES, V39, P1773, DOI 10.1111/j.1475-6773.2004.00317.x; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; National Center for Veterans Analysis and Statistics, 2014, UT; Payne SMC, 2005, J AMBUL CARE MANAG, V28, P125, DOI 10.1097/00004479-200504000-00004; QualityNet, MEAS METH REP READM; Rogers William H, 2004, J Ambul Care Manage, V27, P249; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Ross JS, 2010, MED CARE, V48, P652, DOI 10.1097/MLR.0b013e3181dbe35d; Selim AJ, 2006, MED CARE, V44, P359, DOI 10.1097/01.mlr.0000204119.27597.f1; Trivedi AN, 2011, MED CARE, V49, P560, DOI 10.1097/MLR.0b013e31820fb0f6; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; US Census Bureau, 2015, POP EST METR MICR ST; US Department of Labor Office of Workers' Compensation Programs, 2011, GEOGR PRACT COST IND; US Department of Veterans Affairs, VA HOSP HOM H2H IN; US Department of Veterans Affairs, HEART FAIL PROV NETW; Weeks WB, 2002, J RURAL HEALTH, V18, P298, DOI 10.1111/j.1748-0361.2002.tb00890.x; Weeks WB, 2008, MED CARE, V46, P863, DOI 10.1097/MLR.0b013e31817d92e1; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	38	68	70	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					582	592		10.1001/jama.2016.0278	http://dx.doi.org/10.1001/jama.2016.0278			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26864412	Bronze, Green Accepted			2022-12-28	WOS:000369635200017
J	Kim, KT				Kim, Kyung Taec			OPTICAL PHYSICS Ultrashort light pulses shake atoms	NATURE			English	Editorial Material									[Kim, Kyung Taec] Gwangju Inst Sci & Technol, Ctr Relativist Laser Sci, Inst Basic Sci, Gwangju, South Korea; [Kim, Kyung Taec] Gwangju Inst Sci & Technol, Dept Phys & Photon Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Institute for Basic Science - Korea (IBS); Gwangju Institute of Science & Technology (GIST)	Kim, KT (corresponding author), Gwangju Inst Sci & Technol, Ctr Relativist Laser Sci, Inst Basic Sci, Gwangju, South Korea.; Kim, KT (corresponding author), Gwangju Inst Sci & Technol, Dept Phys & Photon Sci, Gwangju, South Korea.	kyungtaec@gist.ac.kr	Kim, Kyung Taec/J-3193-2014	Kim, Kyung Taec/0000-0002-5968-8191				Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Hassan MT, 2016, NATURE, V530, P66, DOI 10.1038/nature16528; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Nisoli M, 1997, OPT LETT, V22, P522, DOI 10.1364/OL.22.000522	5	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					41	42		10.1038/530041a	http://dx.doi.org/10.1038/530041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842051				2022-12-28	WOS:000369304500026
J	Rouse, GW; Wilson, NG; Carvajal, JI; Vrijenhoek, RC				Rouse, Greg W.; Wilson, Nerida G.; Carvajal, Jose I.; Vrijenhoek, Robert C.			New deep-sea species of Xenoturbella and the position of Xenacoelomorpha	NATURE			English	Article							BOCKI PHYLUM XENOTURBELLIDA; MITOCHONDRIAL GENOME; ANIMAL PHYLOGENY; SEQUENCE; DEUTEROSTOME; UNCERTAIN; INDICATE; PROGRAM; SISTER; TREE	The discovery of four new Xenoturbella species from deep waters of the eastern Pacific Ocean is reported here. The genus and two nominal species were described from the west coast of Sweden(1,2), but their taxonomic placement remains unstable(3,4). Limited evidence placed Xenoturbella with molluscs(5,6), but the tissues can be contaminated with prey(7,8). They were then considered deuterostomes(9-13). Further taxon sampling and analysis have grouped Xenoturbella with acoelomorphs (= Xenacoelomorpha) as sister to all other Bilateria (= Nephrozoa)(14,15), or placed Xenacoelomorpha inside Deuterostomia with Ambulacraria (Hemichordata + Echinodermata)(16). Here we describe four new species of Xenoturbella and reassess those hypotheses. A large species (> 20 cm long) was found at cold-water hydrocarbon seeps at 2,890 m depth in Monterey Canyon and at 1,722 m in the Gulf of California (Mexico). A second large species (similar to 10 cm long) also occurred at 1,722 m in the Gulf of California. The third large species (similar to 15 cm long) was found at similar to 3,700 m depth near a newly discovered carbonate-hosted hydrothermal vent in the Gulf of California. Finally, a small species (similar to 2.5 cm long), found near a whale carcass at 631 m depth in Monterey Submarine Canyon (California), resembles the two nominal species from Sweden. Analysis of whole mitochondrial genomes places the three larger species as a sister clade to the smaller Atlantic and Pacific species. Phylogenomic analyses of transcriptomic sequences support placement of Xenacoelomorpha as sister to Nephrozoa or Protostomia.	[Rouse, Greg W.; Wilson, Nerida G.; Carvajal, Jose I.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Wilson, Nerida G.] Western Australian Museum, Locked Bag 49, Welshpool Dc, WA 6986, Australia; [Wilson, Nerida G.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; [Vrijenhoek, Robert C.] Monterey Bay Aquarium & Res Inst, Moss Landing, CA 95039 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Western Australian Museum; University of Western Australia; Monterey Bay Aquarium Research Institute	Rouse, GW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA.	grouse@ucsd.edu	Rouse, Greg W/F-2611-2010; Wilson, Nerida G./AAC-1456-2019; Rouse, Gregory/AAW-1494-2021; Wilson, Nerida/G-8433-2011	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Wilson, Nerida/0000-0002-0784-0200	David and Lucile Packard Foundation via the Monterey Bay Aquarium Research Institute; Scripps Institution of Oceanography; National Science Foundation [DEB1036368]; Direct For Biological Sciences [1036368] Funding Source: National Science Foundation	David and Lucile Packard Foundation via the Monterey Bay Aquarium Research Institute; Scripps Institution of Oceanography(University of California System); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the crew of the R/V Western Flyer and pilots of the ROVs Tiburon and Doc Ricketts for their skill and patience during hunts for these 'purple socks'. We also thank S. Johnson for verifying bivalve sequences obtained from Xenoturbella and L. Lundsten for hunting through many video files for imagery. We acknowledge the Cyberinfrastructure for Phylogenetic Research (CIPRES) Science Gateway<SUP>26</SUP> for computing resources, and thank M. Miller for additional resources, S. Mirarab for discussions on species tree methods and N. Holland for comments on the manuscript. This work was supported by the David and Lucile Packard Foundation via the Monterey Bay Aquarium Research Institute, Scripps Institution of Oceanography and the National Science Foundation Assembling the Tree of Life program (DEB1036368 to G.W.R.).	Barry JP, 1999, VELIGER, V42, P117; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Bourlat SJ, 2008, MOL ECOL RESOUR, V8, P18, DOI 10.1111/j.1471-8286.2007.01959.x; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Church SH, 2015, SYST BIOL, V64, P1048, DOI 10.1093/sysbio/syv055; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Dunn CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-330; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Israelsson O, 1999, P ROY SOC B-BIOL SCI, V266, P835, DOI 10.1098/rspb.1999.0713; Israelsson O, 1997, NATURE, V390, P32, DOI 10.1038/36246; Israelsson O, 2005, DEV GENES EVOL, V215, P358, DOI 10.1007/s00427-005-0485-x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Nakano H, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0018-z; Noren M, 1997, NATURE, V390, P31, DOI 10.1038/36242; Perseke M, 2007, THEOR BIOSCI, V126, P35, DOI 10.1007/s12064-007-0007-7; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; REISINGER ERICH, 1960, ZEITSCHR WISS ZOOL, V164, P188; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Telford MJ, 2015, CURR BIOL, V25, pR876, DOI 10.1016/j.cub.2015.07.060; von Nickisch-Rosenegk M, 2001, MOL BIOL EVOL, V18, P721, DOI 10.1093/oxfordjournals.molbev.a003854; Westblad E., 1949, ARK ZOOL, V1, P11; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112	37	78	81	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					94	+		10.1038/nature16545	http://dx.doi.org/10.1038/nature16545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842060				2022-12-28	WOS:000369304500039
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Technology isn't enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Hunt J., 2015, PATIENT POWER THREAT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2016	352								i620	10.1136/bmj.i620	http://dx.doi.org/10.1136/bmj.i620			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QD	26831338	Bronze, Green Published			2022-12-28	WOS:000369766400016
J	Victora, CG; Bahl, R; Barros, AJD; Franca, GVA; Horton, S; Krasevec, J; Murch, S; Sankar, MJ; Walker, N; Rollins, NC				Victora, Cesar G.; Bahl, Rajiv; Barros, Aluisio J. D.; Franca, Giovanny V. A.; Horton, Susan; Krasevec, Julia; Murch, Simon; Sankar, Mari Jeeva; Walker, Neff; Rollins, Nigel C.		Lancet Breastfeeding Series Grp	Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect	LANCET			English	Article							LARGE RANDOMIZED-TRIAL; BODY-MASS INDEX; BIRTH COHORT; EDUCATIONAL-ATTAINMENT; CHILD-MORTALITY; BLOOD-PRESSURE; UNITED-STATES; HUMAN-MILK; METAANALYSIS; MICROBIOTA	The importance of breastfeeding in low-income and middle-income countries is well recognised, but less consensus exists about its importance in high-income countries. In low-income and middle-income countries, only 37% of children younger than 6 months of age are exclusively breastfed. With few exceptions, breastfeeding duration is shorter in high-income countries than in those that are resource-poor. Our meta-analyses indicate protection against child infections and malocclusion, increases in intelligence, and probable reductions in overweight and diabetes. We did not find associations with allergic disorders such as asthma or with blood pressure or cholesterol, and we noted an increase in tooth decay with longer periods of breastfeeding. For nursing women, breastfeeding gave protection against breast cancer and it improved birth spacing, and it might also protect against ovarian cancer and type 2 diabetes. The scaling up of breastfeeding to a near universal level could prevent 823 000 annual deaths in children younger than 5 years and 20 000 annual deaths from breast cancer. Recent epidemiological and biological findings from during the past decade expand on the known benefits of breastfeeding for women and children, whether they are rich or poor.	[Victora, Cesar G.; Barros, Aluisio J. D.; Franca, Giovanny V. A.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Int Ctr Equ Hlth, BR-96020 Pelotas, RS, Brazil; [Bahl, Rajiv; Rollins, Nigel C.] WHO, Dept Maternal Newborn Child & Adolescent Hlth MCA, CH-1211 Geneva, Switzerland; [Horton, Susan] Univ Waterloo, Dept Econ, Waterloo, ON N2L 3G1, Canada; [Krasevec, Julia] UNICEF, Data & Analyt Sect, Div Data Res & Policy, New York, NY USA; [Murch, Simon] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England; [Sankar, Mari Jeeva] All India Inst Med Sci, WHO Collaborating Ctr Training & Res Newborn Care, New Delhi, India; [Walker, Neff] Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	Universidade Federal de Pelotas; World Health Organization; University of Waterloo; UNICEF; University of Warwick; All India Institute of Medical Sciences (AIIMS) New Delhi; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Victora, CG (corresponding author), Univ Fed Pelotas, Postgrad Programme Epidemiol, Int Ctr Equ Hlth, BR-96020 Pelotas, RS, Brazil.	cvictora@equidade.org	Victora, Cesar G/D-4476-2013; de França, Giovanny Vinícius Araújo/L-7385-2018; Horta, Bernardo/A-7604-2008; Lodge, Caroline J/E-9688-2014; Allen, Katrina/I-4361-2018; de Mola, Christian Loret/C-9534-2012; Sankar, Jeeva/Q-1007-2019; Victora, Cesar Gomes/Y-2455-2019; Barros, Aluisio JD/A-7417-2008; Maia, Fatima S/H-4755-2013	Victora, Cesar G/0000-0002-2465-2180; de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Horta, Bernardo/0000-0001-9843-412X; Allen, Katrina/0000-0002-1921-4493; de Mola, Christian Loret/0000-0002-5264-5914; Sankar, Jeeva/0000-0003-1474-1451; Victora, Cesar Gomes/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Maia, Fatima S/0000-0001-6688-2745; Dharmage, Shyamali/0000-0001-6063-1937; Lodge, Caroline/0000-0002-2342-3888; Horton, Susan/0000-0002-9243-4767	Bill & Melinda Gates Foundation; Wellcome Trust	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission)	This review was supported by a grant from the Bill & Melinda Gates Foundation to WHO. CGV is the recipient of a Wellcome Trust Senior Investigator Award. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the paper.	Al-Sahab B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-20; Almquist-Tangen G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1077; Amitay EL, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1025; [Anonymous], 1984, Pediatrics, V74, P579; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Becker S, 2003, J BIOSOC SCI, V35, P559, DOI 10.1017/S0021932003005996; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Berger-Achituv S, 2005, ISR MED ASSOC J, V7, P515; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bobrow KL, 2013, INT J OBESITY, V37, P712, DOI 10.1038/ijo.2012.76; Bourges D, 2008, MOL IMMUNOL, V45, P3354, DOI 10.1016/j.molimm.2008.04.017; Bowatte G, 2015, ACTA PAEDIATR, V104, P85, DOI 10.1111/apa.13151; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; Dettwyler Katherine A., 1995, BREASTFEEDING, P39, DOI [10.4324/9781315081984-2, DOI 10.4324/9781315081984-2]; Dias CC, 2015, J AFFECT DISORDERS, V171, P142, DOI 10.1016/j.jad.2014.09.022; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Giugliani ERJ, 2015, ACTA PAEDIATR, V104, P20, DOI 10.1111/apa.13160; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326; Gura T, 2014, SCIENCE, V345, P747, DOI 10.1126/science.345.6198.747; Haggkvist AP, 2010, PUBLIC HEALTH NUTR, V13, P2076, DOI 10.1017/S1368980010001771; Hassiotou F, 2014, ADV NUTR, V5, P770, DOI 10.3945/an.114.006924; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Horta B.L., 2013, LONG TERM EFFECTS BR; Horta B. L., 2013, SHORT TERM EFFECTS B; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Horta BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071548; Horwood LJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e9; Ip S, 2007, BREASTFEEDING MATERN; Jelliffe D. B., 1978, HUMAN MILK MODERN WO; JELLIFFE DB, 1978, BRIT MED J, V2, P1573, DOI 10.1136/bmj.2.6151.1573; Jones JR, 2011, PEDIATRICS, V128, P1117, DOI 10.1542/peds.2011-0841; Kohlhuber M, 2008, BRIT J NUTR, V99, P1127, DOI 10.1017/S0007114508864835; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Labbok M., 2008, ACHIEVING EXCLUSIVE; LaTuga MS, 2014, SEMIN REPROD MED, V32, P68, DOI 10.1055/s-0033-1361824; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Martin RM, 2007, ARCH DIS CHILD, V92, P317, DOI 10.1136/adc.2006.105494; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Ministere des Solidarites de la Sante et de la Famille Institut National de la Sante Institut National de la Sante et la Recherche Medicale, 2005, ENQ NAT PER 2003; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Neville CE, 2014, INT J OBESITY, V38, P577, DOI 10.1038/ijo.2013.132; Oakley LL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-88; Onyeaso CO, 2008, ANGLE ORTHOD, V78, P64, DOI 10.2319/021207-66.1; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Paredes PT, 2014, ALLERGY, V69, P463, DOI 10.1111/all.12357; Peres KG, 2015, ACTA PAEDIATR, V104, P54, DOI 10.1111/apa.13103; Peres KG, 2015, AM J ORTHOD DENTOFAC, V147, P492, DOI 10.1016/j.ajodo.2014.12.019; Requejo J, 2014, COUNTDOWN 2015 WRITI; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Richards M, 2002, PUBLIC HEALTH NUTR, V5, P631, DOI 10.1079/PHN2002338; Roberts TJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-254; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Royston P., 2008, MULTIVARIABLE MODEL; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Tham R, 2015, ACTA PAEDIATR, V104, P62, DOI 10.1111/apa.13118; Vahlquist B, 1981, INTRO CONT PATT BREA; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Verier C, 2010, DIABETES CARE, V33, P190, DOI 10.2337/dc09-1459; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO UNICEF, 1989, PROT PROM SUPP BREAS; World Health Organization, 2013, ESS NUTR ACT IMPR MA; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	77	3024	3189	36	582	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					475	490		10.1016/S0140-6736(15)01024-7	http://dx.doi.org/10.1016/S0140-6736(15)01024-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26869575	Green Published, Bronze			2022-12-28	WOS:000368986800036
J	Schuberth, E; Tippmann, M; Steinke, L; Lausberg, S; Steppke, A; Brando, M; Krellner, C; Geibel, C; Yu, R; Si, QM; Steglich, F				Schuberth, Erwin; Tippmann, Marc; Steinke, Lucia; Lausberg, Stefan; Steppke, Alexander; Brando, Manuel; Krellner, Cornelius; Geibel, Christoph; Yu, Rong; Si, Qimiao; Steglich, Frank			Emergence of superconductivity in the canonical heavy-electron metal YbRh2Si2	SCIENCE			English	Article							QUANTUM CRITICALITY; FERMI-SURFACE	The smooth disappearance of antiferromagnetic order in strongly correlated metals commonly furnishes the development of unconventional superconductivity. The canonical heavy-electron compound YbRh2Si2 seems to represent an apparent exception from this quantum critical paradigm in that it is not a superconductor at temperature T >= 10 millikelvin (mK). Here we report magnetic and calorimetric measurements on YbRh2Si2, down to temperatures as low as T approximate to 1 mK. The data reveal the development of nuclear antiferromagnetic order slightly above 2 mK and of heavy-electron superconductivity almost concomitantly with this order. Our results demonstrate that superconductivity in the vicinity of quantum criticality is a general phenomenon.	[Schuberth, Erwin; Tippmann, Marc; Steinke, Lucia] Bayer Akad Wissensch, Walther Meissner Inst Tieftemp Forsch, D-85748 Garching, Germany; [Schuberth, Erwin; Steinke, Lucia; Lausberg, Stefan; Steppke, Alexander; Brando, Manuel; Krellner, Cornelius; Geibel, Christoph; Steglich, Frank] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Tippmann, Marc] Tech Univ Munich, Dept Phys, D-80333 Munich, Germany; [Krellner, Cornelius] Goethe Univ Frankfurt, Inst Phys, D-60438 Frankfurt, Germany; [Yu, Rong] Renmin Univ China, Dept Phys, Beijing 100872, Peoples R China; [Yu, Rong] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Adv Microstruct, Dept Phys & Astron, Shanghai 200240, Peoples R China; [Si, Qimiao] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Steglich, Frank] Zhejiang Univ, Ctr Correlated Matter, Hangzhou 310058, Zhejiang, Peoples R China; [Steglich, Frank] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China	Max Planck Society; Technical University of Munich; University of Munich; Goethe University Frankfurt; Renmin University of China; Shanghai Jiao Tong University; Rice University; Zhejiang University; Chinese Academy of Sciences; Institute of Physics, CAS	Schuberth, E (corresponding author), Bayer Akad Wissensch, Walther Meissner Inst Tieftemp Forsch, D-85748 Garching, Germany.; Schuberth, E; Steglich, F (corresponding author), Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany.; Si, QM (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.; Steglich, F (corresponding author), Zhejiang Univ, Ctr Correlated Matter, Hangzhou 310058, Zhejiang, Peoples R China.; Steglich, F (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	eschuber@ph.tum.de; qmsi@rice.edu; steglich@cpfs.mpg.de	Yu, Rong/H-3355-2016; Brando, Manuel/B-4234-2009; Krellner, Cornelius/A-5389-2009; Tippmann, Marc/AAK-9879-2021	Krellner, Cornelius/0000-0002-0671-7729; Tippmann, Marc/0000-0001-7320-2939	Deutsche Forschungsgemeinschaft Research Unit [960]; NSF [DMR-1309531, 1066293]; Robert A. Welch Foundation [C-1411]; Division Of Materials Research [1309531] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft Research Unit(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank K. Andres, P. Coleman, P. Gegenwart, S. Paschen, and S. Wirth for useful discussions. Part of the work at the Max Planck Institute for Chemical Physics of Solids was supported by the Deutsche Forschungsgemeinschaft Research Unit 960 "Quantum Phase Transitions." Q.S. was supported by NSF grant DMR-1309531 and Robert A. Welch Foundation grant C-1411. E.S., Q.S., and F.S. thank the Institute of Physics, Chinese Academy of Sciences, Beijing, for hospitality. Q.S. and F.S. acknowledge partial support from the NSF under grant 1066293 and the hospitality of the Aspen Center for Physics. We declare no competing financial interests.	ANDRES K, 1975, PHYS REV B, V11, P4364, DOI 10.1103/PhysRevB.11.4364; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Friedemann S, 2010, P NATL ACAD SCI USA, V107, P14547, DOI 10.1073/pnas.1009202107; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Knebel G, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.114709; Knebel G, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114704; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Ronnow HM, 2005, SCIENCE, V308, P389, DOI 10.1126/science.1108317; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Schuberth E, 2013, PHYS STATUS SOLIDI B, V250, P482, DOI 10.1002/pssb.201200786; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Sichelschmidt J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.156401; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892; Steinke L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.077202; Steppke A, 2010, PHYS STATUS SOLIDI B, V247, P737, DOI 10.1002/pssb.200983062; Stockert O, 2011, NAT PHYS, V7, P119, DOI [10.1038/nphys1852, 10.1038/NPHYS1852]; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262	24	58	59	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					485	488		10.1126/science.aaa9733	http://dx.doi.org/10.1126/science.aaa9733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823424	Green Submitted			2022-12-28	WOS:000368858200032
J	Flyak, AI; Shen, XL; Murin, CD; Turner, HL; David, JA; Fusco, ML; Lampley, R; Kose, N; Ilinykh, PA; Kuzmina, N; Branchizio, A; King, H; Brown, L; Bryan, C; Davidson, E; Doranz, BJ; Slaughter, JC; Sapparapu, G; Klages, C; Ksiazek, TG; Saphire, EO; Ward, AB; Bukreyev, A; Crowe, JE				Flyak, Andrew I.; Shen, Xiaoli; Murin, Charles D.; Turner, Hannah L.; David, Joshua A.; Fusco, Marnie L.; Lampley, Rebecca; Kose, Nurgun; Ilinykh, Philipp A.; Kuzmina, Natalia; Branchizio, Andre; King, Hannah; Brown, Leland; Bryan, Christopher; Davidson, Edgar; Doranz, Benjamin J.; Slaughter, James C.; Sapparapu, Gopal; Klages, Curtis; Ksiazek, Thomas G.; Saphire, Erica Ollmann; Ward, Andrew B.; Bukreyev, Alexander; Crowe, James E., Jr.			Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection	CELL			English	Article							NIEMANN-PICK C1; MONOCLONAL-ANTIBODIES; VIRUS GLYCOPROTEIN; HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; POSTEXPOSURE PROTECTION; ZAIRE-EBOLAVIRUS; STRUCTURAL BASIS; MARBURG VIRUS; SYSTEM	Recent studies have suggested that antibody-mediated protection against the Ebolaviruses may be achievable, but little is known about whether or not antibodies can confer cross-reactive protection against viruses belonging to diverse Ebolavirus species, such as Ebola virus (EBOV), Sudan virus (SUDV), and Bundibugyo virus (BDBV). We isolated a large panel of human monoclonal antibodies (mAbs) against BDBV glycoprotein (GP) using peripheral blood B cells from survivors of the 2007 BDBV outbreak in Uganda. We determined that a large proportion of mAbs with potent neutralizing activity against BDBV bind to the glycan cap and recognize diverse epitopes within this major antigenic site. We identified several glycan cap-specific mAbs that neutralized multiple ebolaviruses, including SUDV, and a cross-reactive mAb that completely protected guinea pigs from the lethal challenge with heterologous EBOV. Our results provide a roadmap to develop a single antibody-based treatment effective against multiple Ebolavirus infections.	[Flyak, Andrew I.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Lampley, Rebecca; Kose, Nurgun; Branchizio, Andre; King, Hannah; Brown, Leland; Slaughter, James C.; Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Slaughter, James C.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; [Shen, Xiaoli; Ilinykh, Philipp A.; Kuzmina, Natalia; Ksiazek, Thomas G.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ksiazek, Thomas G.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Klages, Curtis; Ksiazek, Thomas G.; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77550 USA; [Murin, Charles D.; Turner, Hannah L.; David, Joshua A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Murin, Charles D.; Fusco, Marnie L.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Bryan, Christopher; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Bukreyev, A (corresponding author), Galveston Natl Lab, Galveston, TX 77550 USA.	alexander.bukreyev@utmb.edu; alexander.bukreyev@utmb.edu; james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009; Murin, Charles Daniel/ABA-2861-2020; Ward, Andrew/ABD-7728-2021; Kuzmina, Natalia/AAY-8589-2020; Ward, Andrew B/F-9203-2014	Crowe, James/0000-0002-0049-1079; Ward, Andrew/0000-0001-7153-3769; Kuzmina, Natalia/0000-0001-6650-9369; Ward, Andrew B/0000-0001-7153-3769; David, Joshua/0000-0002-4567-9235; Flyak, Andrew/0000-0002-8722-479X; Slaughter, James/0000-0002-8770-980X; Sapparapu, Gopal/0000-0001-9670-1757; Saphire, Erica Ollmann/0000-0002-1206-7451	Defense Threat Reduction Agency [HDTRA1-13-1-0034]; U.S. NIH [U19 AI109711, U19 AI109762]; NIH [HHSN272201400058C, R01 AI067927, P30 CA68485, DK058404]; Burroughs Wellcome Fund; NCRR [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; National Science Foundation Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067927, U19AI109762, U19AI109711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project received support from the Defense Threat Reduction Agency (grant HDTRA1-13-1-0034 to J.E.C. and A.B.), U.S. NIH grant U19 AI109711 (to J.E.C. and A.B.), U19 AI109762 (to E.O.S. and A.B.W.), NIH contract HHSN272201400058C (to B.J.D.), and R01 AI067927 (to E.O.S.). E.O.S. is an Investigator in the Pathogenesis of Infectious Disease of the Burroughs Wellcome Fund. The project was supported by NCRR Grant UL1 RR024975-01 and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank the donors and Cheryl Stewart and Jill Janssen in the Vanderbilt Clinical Trials Center for help in sample acquisition in the United States. We thank Monica Millard and Hannah Kibuuka of the Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda, who provided repository samples from the Long-term Bundibugyo Ebola virus survivors study done in collaboration with U.S. Army Medical Research Institute of Infectious Diseases. We thank Frances Smith-House at Vanderbilt and Kathleen Pommert at Scripps for excellent technical support. L.B. was a summer undergraduate research fellow at the Vanderbilt Vaccine Center, and J.A.D. was a summer undergraduate research fellow at The Scripps Research Institute. We thank Andrew McNeal and Rachel Fong for assistance with epitope mapping. We also thank Dr. Alexander Freiberg (UTMB) for providing the guinea-pig-adapted EBOV strain. Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource, supported by NIH grants P30 CA68485 and DK058404. The EM work was conducted at The Scripps Research Institute electron microscopy facility. C.D.M. is supported by a National Science Foundation Graduate Research Fellowship.	Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; Fusco ML, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005016; Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hernandez H, 2015, J INFECT DIS, V212, pS410, DOI 10.1093/infdis/jiv209; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; MacNeil A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001175; Meyer M, 2015, J CLIN INVEST, V125, P3241, DOI 10.1172/JCI81532; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Ou W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-32; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Warren TK, 2015, MBIO, V6, DOI 10.1128/mBio.02344-14; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008	49	127	132	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					392	405		10.1016/j.cell.2015.12.022	http://dx.doi.org/10.1016/j.cell.2015.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26806128	Bronze, Green Accepted			2022-12-28	WOS:000368906800011
J	McPherson, S; Lucey, MR; Moriarty, KJ				McPherson, Stuart; Lucey, Michael R.; Moriarty, Kieran J.			Decompensated alcohol related liver disease: acute management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPONTANEOUS BACTERIAL PERITONITIS; ACUTE KIDNEY INJURY; SHORT-TERM SURVIVAL; HEPATORENAL-SYNDROME; INTERNATIONAL CLUB; INTENSIVE-CARE; HEPATITIS; CIRRHOSIS; INFECTIONS; MORTALITY		[McPherson, Stuart] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England; [McPherson, Stuart] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lucey, Michael R.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Gastroenterol & Hepatol, Madison, WI USA; [Moriarty, Kieran J.] Royal Bolton Hosp, Dept Gastroenterol, Bolton, England	Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Wisconsin System; University of Wisconsin Madison; Royal Bolton Hospital	McPherson, S (corresponding author), Freeman Rd Hosp, Liver Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	stuart.mcpherson@nuth.nhs.uk	Lucey, Michael/AAR-4571-2020	McPherson, Stuart/0000-0002-5638-2453				Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Angeli P, 2015, GUT, V64, P531, DOI 10.1136/gutjnl-2014-308874; Angeli P, 2013, LIVER INT, V33, P16, DOI 10.1111/j.1478-3231.2012.02807.x; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Bernal W, 2015, LANCET, V386, P1576, DOI 10.1016/S0140-6736(15)00309-8; Boyd Kirsty, 2015, Clin Liver Dis (Hoboken), V6, P15, DOI 10.1002/cld.479; British Society of Gastroenterology, 2009, THORAX           JUN, P1; Cavallin M, 2015, HEPATOLOGY, V62, P567, DOI 10.1002/hep.27709; Chinnock B, 2008, ANN EMERG MED, V52, P268, DOI 10.1016/j.annemergmed.2008.02.016; Cholongitas E, 2008, J GASTROEN HEPATOL, V23, P1223, DOI 10.1111/j.1440-1746.2007.05269.x; Day E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h715; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Ellul MA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4187; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; GINES P, 1987, GASTROENTEROLOGY, V93, P234, DOI 10.1016/0016-5085(87)91007-9; Gines P, 2012, J HEPATOL, V56, pS13, DOI 10.1016/S0168-8278(12)60003-8; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Gluud LL, 2010, HEPATOLOGY, V51, P576, DOI 10.1002/hep.23286; Gordon FD, 2012, CLIN LIVER DIS, V16, P285, DOI 10.1016/j.cld.2012.03.004; Hardy T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-55; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Longacre AV, 2008, HEPATOLOGY, V47, P169, DOI 10.1002/hep.21945; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Maharshi S, 2015, J GASTROEN HEPATOL, V30, P1507, DOI 10.1111/jgh.12999; Masson S, 2014, LIVER INT, V34, P235, DOI 10.1111/liv.12242; Mathurin P, 2015, J HEPATOL, V62, pS38, DOI 10.1016/j.jhep.2015.03.006; Mathurin P, 2013, JAMA-J AM MED ASSOC, V310, P1033, DOI 10.1001/jama.2013.276300; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Mathurin P, 2011, NEW ENGL J MED, V365, P1790, DOI 10.1056/NEJMoa1105703; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; McPhail MJW, 2015, CLIN GASTROENTEROL H, V13, P1353, DOI 10.1016/j.cgh.2014.08.041; McPherson S, 2016, FRONTLINE GASTROENTE, V7, P16, DOI 10.1136/flgastro-2014-100491; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Moriarty KJ, 2010, LIVER; National Condidential Enquiry into Patient Outcome and Death (UK), 2013, MOD SHAL GAS DEV US, P1; National Institute for Health and Care Excellence, ALC US DIS DIAGN CLI; National Institute for Health and Care Excellence, 2012, AC UPP GASTR BLEED C; National Institute for Health and Care Excellence, 2011, ALC US DIS DIAGN ASS; National Institute for Health and Clinical Excellence, 2013, INTR FLUID THER AD H; Nguyen-Khac E, 2011, NEW ENGL J MED, V365, P1781, DOI 10.1056/NEJMoa1101214; O'Leary JG, 2015, CLIN GASTROENTEROL H, V13, P753, DOI 10.1016/j.cgh.2014.07.060; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Park SH, 2014, J HEPATOL, V61, P792, DOI 10.1016/j.jhep.2014.05.014; Piano S, 2015, HEPATOLOGY; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Rambaldi A, 2008, ALIMENT PHARM THER, V27, P1167, DOI 10.1111/j.1365-2036.2008.03685.x; Ratib S, 2015, AM J GASTROENTEROL, V110, P1149, DOI 10.1038/ajg.2015.191; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Rossi RE, 2015, DIGEST LIVER DIS, V47, P819, DOI 10.1016/j.dld.2015.05.021; Runyon BA, 2012, MANAGEMENT ADULT PAT, P1; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Singal AK, 2012, CLIN LIVER DIS, V16, P805, DOI 10.1016/j.cld.2012.08.009; Singh S, 2015, GASTROENTEROLOGY, V149, P958, DOI 10.1053/j.gastro.2015.06.006; Singh V, 2014, AM J GASTROENTEROL, V109, P1417, DOI 10.1038/ajg.2014.154; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Srikureja W, 2005, J HEPATOL, V42, P700, DOI 10.1016/j.jhep.2004.12.022; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Teams AC, 2014, RED AC HOSP ADM IMPR; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Thomson SJ, 2008, ALCOHOL ALCOHOLISM, V43, P416, DOI 10.1093/alcalc/agn020; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; Tripathi D, 2015, GUT, V64, P1680, DOI 10.1136/gutjnl-2015-309262; Volk Michael L, 2014, Clin Liver Dis (Hoboken), V4, P138, DOI 10.1002/cld.420; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	69	19	19	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2016	352								i124	10.1136/bmj.i124	http://dx.doi.org/10.1136/bmj.i124			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EQ	26812946				2022-12-28	WOS:000369313000003
J	Misch, DA				Misch, Donald A.			I Feel Witty, Oh So Witty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPROVISATIONAL THEATER; MEDICINE; SKILLS; HUMOR		[Misch, Donald A.] Univ Colorado, Wardenburg Hlth Serv, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Misch, DA (corresponding author), Univ Colorado, Wardenburg Hlth Serv, Boulder, CO 80309 USA.	donald.misch@colorado.edu						Bennett HJ, 2003, SOUTH MED J, V96, P1257, DOI 10.1097/01.SMJ.0000066657.70073.14; Hoffman A, 2008, MED EDUC, V42, P537, DOI 10.1111/j.1365-2923.2008.03077.x; Johnson K., 1994, TRUTH COMEDY MANUAL; Mora-Ripoll R, 2010, ALTERN THER HEALTH M, V16, P56; Robinson V.M., 1990, HUMOR HLTH PROFESSIO; Shochet R, 2013, EDUC PRIM CARE, V24, P119, DOI 10.1080/14739879.2013.11493466; Stokes TA, 2014, SEMIN PERINATOL, V38, P47, DOI 10.1053/j.semperi.2013.07.008; Watson K, 2011, ACAD MED, V86, P1260, DOI 10.1097/ACM.0b013e31822cf858; Wender RC, 1996, PRIMARY CARE, V23, P141, DOI 10.1016/S0095-4543(05)70267-0	9	6	6	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					345	346		10.1001/jama.2015.16758	http://dx.doi.org/10.1001/jama.2015.16758			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813204				2022-12-28	WOS:000368589500009
J	Prey, S; Voisard, JJ; Delarue, A; Lebbe, G; Taieb, A; Leaute-Labreze, C; Ezzedine, K				Prey, Sorilla; Voisard, Jean-Jacques; Delarue, Alain; Lebbe, Genevieve; Taieb, Alain; Leaute-Labreze, Christine; Ezzedine, Khaled			Safety of Propranolol Therapy for Severe Infantile Hemangioma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Prey, Sorilla; Taieb, Alain; Leaute-Labreze, Christine; Ezzedine, Khaled] CIC P1401, Serv Dermatol, Bordeaux, France; [Prey, Sorilla; Taieb, Alain; Leaute-Labreze, Christine; Ezzedine, Khaled] INSERM, U1035, CHU, Bordeaux, France; [Prey, Sorilla; Taieb, Alain; Leaute-Labreze, Christine; Ezzedine, Khaled] Univ Bordeaux, Bordeaux, France; [Voisard, Jean-Jacques; Delarue, Alain; Lebbe, Genevieve] Lab Pierre Fabre Dermatol, Lavaur, France	CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Prey, S (corresponding author), Hop Enfants Pellegrin, Serv Dermatol Pediat, Pl Amelie Raba Leon, F-33076 Bordeaux, France.; Prey, S (corresponding author), Hop Enfants Pellegrin, Ctr Reference Malad Rares Peau, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	sorilla.prey@chu-bordeaux.fr	Ezzedine, Khaled/F-2716-2017; TAIEB, ALAIN/AAB-1085-2021	Ezzedine, Khaled/0000-0002-5468-4589; 				Agence nationale de securite du medicament et des produits de sante, AUT TEMP UT; BEGAUD B, 1985, THERAPIE, V40, P111; Drolet BA, 2013, PEDIATRICS, V131, P128, DOI 10.1542/peds.2012-1691; Hermans DJJ, 2013, BRIT J DERMATOL, V168, P837, DOI 10.1111/bjd.12189; Leaute-Labreze C, 2015, NEW ENGL J MED, V372, P735, DOI 10.1056/NEJMoa1404710; Leaute-Labreze C, 2011, J EUR ACAD DERMATOL, V25, P1245, DOI 10.1111/j.1468-3083.2011.04102.x	6	39	39	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					413	415		10.1001/jama.2015.13969	http://dx.doi.org/10.1001/jama.2015.13969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813215	Bronze			2022-12-28	WOS:000368589500020
J	Pitulko, VV; Tikhonov, AN; Pavlova, EY; Nikolskiy, PA; Kuper, KE; Polozov, RN				Pitulko, Vladimir V.; Tikhonov, Alexei N.; Pavlova, Elena Y.; Nikolskiy, Pavel A.; Kuper, Konstantin E.; Polozov, Roman N.			Early human presence in the Arctic: Evidence from 45,000-year-old mammoth remains	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; LATE PLEISTOCENE; RUSSIAN-FEDERATION; TAIMYR PENINSULA; NORTHERN EURASIA; PALEOLITHIC SITE; YANA RHS; SIBERIA; CLIMATE; ENVIRONMENT	Archaeological evidence for human dispersal through northern Eurasia before 40,000 years ago is rare. In west Siberia, the northernmost find of that age is located at 57 degrees N. Elsewhere, the earliest presence of humans in the Arctic is commonly thought to be circa 35,000 to 30,000 years before the present. A mammoth kill site in the central Siberian Arctic, dated to 45,000 years before the present, expands the populated area to almost 72 degrees N. The advancement of mammoth hunting probably allowed people to survive and spread widely across northernmost Arctic Siberia.	[Pitulko, Vladimir V.] Russian Acad Sci, Inst Hist Mat Culture, St Petersburg 191186, Russia; [Tikhonov, Alexei N.] Russian Acad Sci, Inst Zool, St Petersburg 191186, Russia; [Pavlova, Elena Y.] Arctic & Antarctic Res Inst, St Petersburg 199397, Russia; [Nikolskiy, Pavel A.] Russian Acad Sci, Inst Geol, Moscow 119017, Russia; [Kuper, Konstantin E.] Russian Acad Sci, Budker Inst Nucl Phys, Siberian Branch, Novosibirsk 630090, Russia; [Polozov, Roman N.] St Petersburg Pediat Med Univ, St Petersburg 194100, Russia	Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Arctic & Antarctic Research Institute; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Budker Institute of Nuclear Physics; Saint Petersburg State Pediatric Medical University	Pitulko, VV (corresponding author), Russian Acad Sci, Inst Hist Mat Culture, 18 Dvortsovaya Naberezhnaya, St Petersburg 191186, Russia.	pitulkov@gmail.com	Nikolskiy, Pavel A/C-5041-2012; Kuper, Konstantin E/Q-9399-2017; Pavlova, Elena/AAA-3291-2019; Pitulko, Vladimir/E-2200-2015; Tikhonov, Alexei/G-7478-2016; Pitulko, Vladimir/N-4009-2019	Pitulko, Vladimir/0000-0001-5672-2756; Tikhonov, Alexei/0000-0002-7227-5797; Kuper, Konstantin/0000-0001-5017-6248; Pavlova, Elena/0000-0002-3010-6290	Russian Foundation of Basic Research [13-06-12044]; Rock Foundation (New York, USA)	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Rock Foundation (New York, USA)	We thank E. Solinder and A. Bystrov (SK weather station), the Taimyr Region administration, and Norilsk Nickel mining company. We are also grateful to P. Ivanov (photography); A. Mashezerskaya (drawings); V. Stegantseva (illustrations); N. Slobodina (translation); and N. Burova, A. Sementsov, and J. van der Plicht (radiocarbon dating). The SK mammoth remains are currently stored at the Zoological Institute, St. Petersburg, Russia. When the study ends, they will be moved to the Taimyr Regional Museum for permanent storage and display (Dudinka, Taimyr Autonomous District, Russia), and they can then be resampled if needed while a bulk sample of the organic deposit from the inside of the SK mammoth stays at the Zoological Institute in St. Petersburg. The Yana site materials and finds from the Bunge-Toll site are stored at the Institute for the History of Material Culture, St. Petersburg, Russia), as a part of the materials collected under the Zhokhov-Yana research project. All collected skeletal elements of the Kastyktakh mammoth are with the Ice Age Museum, Moscow, Russia. This project was supported by the Russian Foundation of Basic Research (grant Nr 13-06-12044 to V.V.P.); publication is supported by the Rock Foundation (New York, USA).	Andreev AA, 2003, BOREAS, V32, P484, DOI 10.1080/03009480310003388; Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Chlachula J, 2003, BOREAS, V32, P506, DOI 10.1080/03009480310003397; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Derevianko A. P., 2004, ARCHAEOL ETHNOL ANTH, V19, P12; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; GOEBEL T, 1995, ANTIQUITY, V69, P349, DOI 10.1017/S0003598X00064747; Haynes G., 1991, MAMMOTHS MASTODONTS; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Kenady SM, 2011, QUATERN INT, V233, P130, DOI 10.1016/j.quaint.2010.04.013; Kienast F, 2011, QUATERNARY SCI REV, V30, P2134, DOI 10.1016/j.quascirev.2010.11.024; Kirillova IV, 2012, QUATERN INT, V276, P269, DOI 10.1016/j.quaint.2011.11.022; Kulik S.F., 1971, SAFARI TRAVELS E CEN; Kumin YV, 2004, EARTH-SCI REV, V68, P133, DOI 10.1016/j.earscirev.2004.04.002; LBOVA L.V, 2000, PALEOLITHIC NW TRANS; LISITSYN N.F, 2000, UPPER PALEOLITHIC CH; Lozhkin AV, 2011, QUATERNARY SCI REV, V30, P2160, DOI 10.1016/j.quascirev.2010.12.022; MacPhee RDE, 2002, J ARCHAEOL SCI, V29, P1017, DOI 10.1006/jasc.2001.0802; Markova AK, 2013, QUATERN INT, V292, P4, DOI 10.1016/j.quaint.2012.11.033; Mol D, 2006, QUATERN INT, V142, P186, DOI 10.1016/j.quaint.2005.03.016; Nikolskiy PA, 2011, QUATERNARY SCI REV, V30, P2309, DOI 10.1016/j.quascirev.2010.10.017; Nikolskiy P, 2013, J ARCHAEOL SCI, V40, P4189, DOI 10.1016/j.jas.2013.05.020; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Pitulko VV, 2012, WORLD ARCHAEOL, V44, P21, DOI 10.1080/00438243.2012.647574; Pitulko V.V., 2013, ZHOKHOV ISLAND SITE; Pitulko V. V., 2011, QUATERNARY ALL ITS V, P146; Pitulko VV, 2015, WORLD ARCHAEOL, V47, P333, DOI 10.1080/00438243.2015.1030508; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Roth L. V., 1988, J ZOOL LOND, V214, P567; Sato T, 2008, QUATERN INT, V179, P101, DOI 10.1016/j.quaint.2007.10.020; Serikov YB, 2014, QUATERN INT, V326, P261, DOI 10.1016/j.quaint.2013.12.026; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Sulerzhitsky L D, 1995, P ZOOL I ACAD SCI US, V263, P163; Sulerzhitsky LD, 1999, AMBIO, V28, P251; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Svendsen JI, 2010, QUATERNARY SCI REV, V29, P3138, DOI 10.1016/j.quascirev.2010.06.043; Vereshchagin N.K., 1974, Polar Record, V17, P3; Vereshchagin N.K., 1999, CRANIUM, V16, P2; Vereshchagin N.K., 1986, P ZOOLOGICAL I USSR, V149, P3	39	81	83	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					260	263		10.1126/science.aad0554	http://dx.doi.org/10.1126/science.aad0554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA9AM	26816376				2022-12-28	WOS:000368098600037
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Object lessons Blood bottles	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					113	113		10.1016/S0140-6736(15)01358-6	http://dx.doi.org/10.1016/S0140-6736(15)01358-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26841985				2022-12-28	WOS:000368055500015
J	Roberts, E; Wessely, S; Chalder, T; Chang, CK; Hotopf, M				Roberts, Emmert; Wessely, Simon; Chalder, Trudie; Chang, Chin-Kuo; Hotopf, Matthew			Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register	LANCET			English	Article							MENTAL-ILLNESS; PRIMARY-CARE; DISORDER; COST; RISK	Background Mortality associated with chronic fatigue syndrome is uncertain. We investigated mortality in individuals diagnosed with chronic fatigue syndrome in secondary and tertiary care using data from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) register. Methods We calculated standardised mortality ratios (SMRs) for all-cause, suicide-specific, and cancer-specific mortality for a 7-year observation period using the number of deaths observed in SLaM records compared with age-specific and sex-specific mortality statistics for England and Wales. Study participants were included if they had had contact with the chronic fatigue service (referral, discharge, or case note entry) and received a diagnosis of chronic fatigue syndrome. Findings We identified 2147 cases of chronic fatigue syndrome from CRIS and 17 deaths from Jan 1, 2007, to Dec 31, 2013. 1533 patients were women of whom 11 died, and 614 were men of whom six died. There was no significant difference in age-standardised and sex-standardised mortality ratios (SMRs) for all-cause mortality (SMR 1.14, 95% CI 0.65-1.85; p=0.67) or cancer-specific mortality (1.39, 0.60-2.73; p=0.45) in patients with chronic fatigue syndrome when compared with the general population in England and Wales. This remained the case when deaths from suicide were removed from the analysis. There was a significant increase in suicide-specific mortality (SMR 6.85, 95% CI 2.22-15.98; p=0.002). Interpretation We did not note increased all-cause mortality in people with chronic fatigue syndrome, but our findings show a substantial increase in mortality from suicide. This highlights the need for clinicians to be aware of the increased risk of completed suicide and to assess suicidality adequately in patients with chronic fatigue syndrome.	[Roberts, Emmert; Wessely, Simon; Chalder, Trudie; Hotopf, Matthew] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, Weston Educ Ctr, London WC2R 2LS, England; [Chang, Chin-Kuo] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, Denmark Hill, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Chang, CK (corresponding author), Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, Denmark Hill, London SE5 8AF, England.; Roberts, E (corresponding author), Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, South London & Maudsley NHS Fdn Trust, London SE5 8AF, England.	emmert.roberts@kcl.ac.uk; chin-kuo.chang@kcl.ac.uk	Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010; Chalder, Trudie/A-5717-2011; Chang, Chin-Kuo/E-4991-2010	Hotopf, Matthew/0000-0002-3980-4466; Chang, Chin-Kuo/0000-0002-8338-7196; Roberts, Emmert/0000-0002-4152-5570; Chalder, Trudie/0000-0003-0775-1045; Wessely, Simon Charles/0000-0002-6743-9929	National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; National Institute for Health Research [ACF-2014-17-009, NF-SI-0515-10102] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.	[Anonymous], 2013, WORKSH NLP MED BIOL; Bongar B., 1991, SUICIDAL PATIENT CLI; Cairns R, 2005, OCCUP MED-OXFORD, V55, P20, DOI 10.1093/occmed/kqi013; Chalder T, 1996, PSYCHOL MED, V26, P791, DOI 10.1017/S0033291700037818; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fischler B, 1997, ACTA PSYCHIAT SCAND, V95, P405, DOI 10.1111/j.1600-0447.1997.tb09653.x; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; Jason Leonard A, 2006, Health Care Women Int, V27, P615, DOI 10.1080/07399330600803766; Jason LA, 2011, J HEALTH PSYCHOL, V16, P445, DOI 10.1177/1359105310383603; McCrone P, 2003, PSYCHOL MED, V33, P253, DOI 10.1017/S0033291702006980; National Institute for Health and Care Excellence, 2007, CHRONIC FATIGUE SYND; Noble M, 2008, ENGLISH INDICES DEPR; Office for National Statistics, 2016, 2011 CENS REL FEM MA; Sabes-Figuera R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-56; Sharpe M, 1997, GEN HOSP PSYCHIAT, V19, P185, DOI 10.1016/S0163-8343(97)80315-5; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Smith WR, 2006, PSYCHOL MED, V36, P1301, DOI 10.1017/S0033291706007975; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Wessely S, 1996, AM J PSYCHIAT, V153, P1050; White PD, 2002, J ROY SOC MED, V95, P440, DOI 10.1258/jrsm.95.9.440; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x; WOOD GC, 1991, PSYCHOL MED, V21, P619, DOI 10.1017/S003329170002225X	26	37	38	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1638	1643		10.1016/S0140-6736(15)01223-4	http://dx.doi.org/10.1016/S0140-6736(15)01223-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26873808	Green Published, hybrid			2022-12-28	WOS:000374145100031
J	Charo, RA				Charo, R. Alta			On the Road (to a Cure?) - Stem-Cell Tourism and Lessons for Gene Editing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, R. Alta] Univ Wisconsin, Dept Med Hist & Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.; Charo, RA (corresponding author), Univ Wisconsin, Dept Med Hist & Bioeth, Sch Med & Publ Hlth, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Araki M, 2016, TRENDS BIOTECHNOL, V34, P86, DOI 10.1016/j.tibtech.2015.12.002; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Reardon S, 2015, NATURE, V527, P146, DOI 10.1038/nature.2015.18737; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002	5	26	26	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					901	903		10.1056/NEJMp1600891	http://dx.doi.org/10.1056/NEJMp1600891			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF9DH	26863030				2022-12-28	WOS:000371660000001
J	Baden, LR; Karita, E; Mutua, G; Bekker, LG; Gray, G; Page-Shipp, L; Walsh, SR; Nyombayire, J; Anzala, O; Roux, S; Laher, F; Innes, C; Seaman, MS; Cohen, YZ; Peter, L; Frahm, N; McElrath, MJ; Hayes, P; Swann, E; Grunenberg, N; Grazia-Pau, M; Weijtens, M; Sadoff, J; Dally, L; Lombardo, A; Gilmour, J; Cox, J; Dolin, R; Fast, P; Barouch, DH; Laufer, DS				Baden, Lindsey R.; Karita, Etienne; Mutua, Gaudensia; Bekker, Linda-Gail; Gray, Glenda; Page-Shipp, Liesl; Walsh, Stephen R.; Nyombayire, Julien; Anzala, Omu; Roux, Surita; Laher, Fatima; Innes, Craig; Seaman, Michael S.; Cohen, Yehuda Z.; Peter, Lauren; Frahm, Nicole; McElrath, M. Juliana; Hayes, Peter; Swann, Edith; Grunenberg, Nicole; Grazia-Pau, Maria; Weijtens, Mo; Sadoff, Jerry; Dally, Len; Lombardo, Angela; Gilmour, Jill; Cox, Josephine; Dolin, Raphael; Fast, Patricia; Barouch, Dan H.; Laufer, Dagna S.		B003-IPCAVD004-HVTN091 Study Grp	Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention	ANNALS OF INTERNAL MEDICINE			English	Article							PHASE-I TRIAL; HEALTHY-ADULTS; IMMUNE-RESPONSES; ENV VACCINE; IPCAVD 001; NYVAC-C; ADENOVIRUS; INFECTION; TYPE-5; STEP	Background: A prophylactic HIV-1 vaccine is a global health priority. Objective: To assess a novel vaccine platform as a prophylactic HIV-1 regimen. Design: Randomized, double-blind, placebo-controlled trial. Both participants and study personnel were blinded to treatment allocation. (ClinicalTrials.gov: NCT01215149) Setting: United States, East Africa, and South Africa. Patients: Healthy adults without HIV infection. Intervention: 2 HIV-1 vaccines (adenovirus serotype 26 with an HIV-1 envelope A insert [Ad26.EnvA] and adenovirus serotype 35 with an HIV-1 envelope A insert [Ad35.Env], both administered at a dose of 5 x 10(10) viral particles) in homologous and heterologous combinations. Measurements: Safety and immunogenicity and the effect of baseline vector immunity. Results: 217 participants received at least 1 vaccination, and 210 (>96%) completed follow-up. No vaccine-associated serious adverse events occurred. All regimens were generally well-tolerated. All regimens elicited humoral and cellular immune responses in nearly all participants. Preexisting Ad26- or Ad35-neutralizing antibody titers had no effect on vaccine safety and little effect on immunogenicity. In both homologous and heterologous regimens, the second vaccination significantly increased EnvA antibody titers (approximately 20-fold from the median enzyme-linked immunosorbent assay titers of 30-300 to 3000). The heterologous regimen of Ad26-Ad35 elicited significantly higher EnvA antibody titers than Ad35-Ad26. T-cell responses were modest and lower in East Africa than in South Africa and the United States. Limitations: Because the 2 envelope inserts were not identical, the boosting responses were complex to interpret. Durability of the immune responses elicited beyond 1 year is unknown. Conclusion: Both vaccines elicited significant immune responses in all populations. Baseline vector immunity did not significantly affect responses. Second vaccinations in all regimens significantly boosted EnvA antibody titers, although vaccine order in the heterologous regimen had a modest effect on the immune response. Primary Funding Source: International AIDS Vaccine Initiative, National Institutes of Health, Ragon Institute, Crucell Holland.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Karita, Etienne; Nyombayire, Julien] Projet San Francisco, KK19Av 57,POB 780, Kigali, Rwanda; Kenya AIDS Vaccine Initiat, Nairobi, Kenya; Univ Nairobi, Nairobi, Kenya; Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Page-Shipp, Liesl; Innes, Craig] Aurum Inst Hlth Res, 2nd Floor,Room 201 Jade Sq, Klerksdorp, South Africa; Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Frahm, Nicole; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,POBox 19024, Seattle, WA 98104 USA; HIV Vaccine Trials Network, Seattle, WA USA; Int AIDS Vaccine Initiat Human Immunol Lab, London, England; [Swann, Edith] NIAID, 5601 Fishers Lane,Room 9C46, Bethesda, MD 20852 USA; [Grazia-Pau, Maria; Sadoff, Jerry] Janssen Pharmaceut Infect Dis & Vaccines, Crucell NV,POB 2048, NL-2301 CA Leiden, Netherlands; [Dally, Len] EMMES Corp, 401 North Washington St,Suite 700, Rockville, MD USA; [Lombardo, Angela; Cox, Josephine; Fast, Patricia; Laufer, Dagna S.] Int AIDS Vaccine Initiat, 125 Broad St,9th Floor, New York, NY 10004 USA; Global BioSolut, Craigieburn, Vic, Australia; [Baden, Lindsey R.; Walsh, Stephen R.] Brigham & Womens Hosp, Div Infect Dis, PBB A4,15 Francis St, Boston, MA 02115 USA; [Mutua, Gaudensia; Anzala, Omu] Univ Nairobi, Inst Clin Res, Kenya AIDS Vaccine Initiat, POB 19676-00202 KNH, Nairobi, Kenya; [Bekker, Linda-Gail; Roux, Surita] Desmond Tutu HIV Ctr, POB 13801, ZA-7705 Cape Town, South Africa; [Seaman, Michael S.; Peter, Lauren; Dolin, Raphael; Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Cohen, Yehuda Z.] Rockefeller Univ, 1230 York Ave,Box 95, New York, NY 10065 USA; [Hayes, Peter; Gilmour, Jill] Chelsea & Westminster Hosp, Int AIDS Vaccine Initiat Human Immunol Lab, 2nd Floor,369 Fulham Rd, London SW10 9NH, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Nairobi; University of Cape Town; University of Witwatersrand; Fred Hutchinson Cancer Center; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johnson & Johnson; Janssen Pharmaceuticals; Emmes Corporation; International AIDS Vaccine Initiative; Harvard University; Brigham & Women's Hospital; University of Nairobi; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rockefeller University; Imperial College London; International AIDS Vaccine Initiative	Baden, LR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, PBB A4,15 Francis St, Boston, MA 02115 USA.	lbaden@partners.org; ldally@emmes.com; dlaufer@iavi.org	Bekker, Linda-Gail/AAZ-8929-2020; Barouch, Dan/Y-3918-2019	Peter, Lauren/0000-0002-2105-7503; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Walsh, Stephen/0000-0002-0817-9370; Cox, Josephine/0000-0003-1301-7373; Cohen, Yehuda/0000-0001-6987-1478	International AIDS Vaccine Initiative; National Institutes of Health; Ragon Institute; Crucell Holland; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069453, UM1AI068618, U19AI066305, UM1AI068614, UM1AI069412] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute; Crucell Holland; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	International AIDS Vaccine Initiative, National Institutes of Health, Ragon Institute, Crucell Holland.	Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Baden LR, 2011, J INFECT DIS, V204, P1541, DOI 10.1093/infdis/jir615; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Creech CB, 2013, HUM VACC IMMUNOTHER, V9, P2548, DOI 10.4161/hv.26038; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Harro C, 2009, CLIN VACCINE IMMUNOL, V16, P1285, DOI 10.1128/CVI.00144-09; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nicholson O, 2010, AIDS RES HUM RETROVI; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067	23	55	58	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					313	+		10.7326/M15-0880	http://dx.doi.org/10.7326/M15-0880			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26833336	Green Accepted			2022-12-28	WOS:000371220300002
J	Forman-Hoffman, V; McClure, E; McKeeman, J; Wood, CT; Middleton, JC; Skinner, AC; Perrin, EM; Viswanathan, M				Forman-Hoffman, Valerie; McClure, Emily; McKeeman, Joni; Wood, Charles T.; Middleton, Jennifer Cook; Skinner, Asheley C.; Perrin, Eliana M.; Viswanathan, Meera			Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SUPPLEMENT NCS-A; PLACEBO-CONTROLLED TRIAL; PRIMARY-CARE; MENTAL-DISORDERS; ANTIDEPRESSANT TREATMENT; PEDIATRIC DEPRESSION; METAANALYSIS; SUICIDE; RISK; TADS	Background: Major depressive disorder (MDD) is common among children and adolescents and is associated with functional impairment and suicide. Purpose: To update the 2009 U.S. Preventive Services Task Force (USPSTF) systematic review on screening for and treatment of MDD in children and adolescents in primary care settings. Data Sources: Several electronic searches (May 2007 to February 2015) and searches of reference lists of published literature. Study Selection: Trials and recent systematic reviews of treatment, test-retest studies of screening, and trials and large cohort studies for harms. Data Extraction: Data were abstracted by 1 investigator and checked by another; 2 investigators independently assessed study quality. Data Synthesis: Limited evidence from 5 studies showed that such tools as the Beck Depression Inventory and Patient Health Questionnaire for Adolescents had reasonable accuracy for identifying MDD among adolescents in primary care settings. Six trials evaluated treatment. Several individual fair-and good-quality studies of fluoxetine, combined fluoxetine and cognitive behavioral therapy, escitalopram, and collaborative care demonstrated benefits of treatment among adolescents, with no associated harms. Limitation: The review included only English-language studies, narrow inclusion criteria focused only on MDD, high thresholds for quality, potential publication bias, limited data on harms, and sparse evidence on long-term outcomes of screening and treatment among children younger than 12 years. Conclusion: No evidence was found of a direct link between screening children and adolescents for MDD in primary care or similar settings and depression or other health-related outcomes. Evidence showed that some screening tools are accurate and some treatments are beneficial among adolescents (but not younger children), with no evidence of associated harms. Primary Funding Source: Agency for Healthcare Research and Quality.	[Forman-Hoffman, Valerie; McClure, Emily; McKeeman, Joni; Wood, Charles T.; Middleton, Jennifer Cook; Skinner, Asheley C.; Perrin, Eliana M.; Viswanathan, Meera] RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Chapel Hill, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Forman-Hoffman, V (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	vhoffman@rti.org	Skinner, Asheley/Q-5793-2016; Wood, Charles/L-2758-2015	Wood, Charles/0000-0002-6884-8265	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; Bang KS, 2012, J ADV NURS, V68, P2646, DOI 10.1111/j.1365-2648.2012.05963.x; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Canals J, 2001, EUR J PSYCHOL ASSESS, V17, P63, DOI 10.1027//1015-5759.17.1.63; Cheung AH, 2008, PEDIATRICS, V121, pE101, DOI 10.1542/peds.2006-3560; Clarke GN, 1999, J AM ACAD CHILD PSY, V38, P272, DOI 10.1097/00004583-199903000-00014; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; Cuijpers P, 2004, J AFFECT DISORDERS, V79, P71, DOI 10.1016/S0165-0327(02)00348-8; Egger HL, 1999, J AM ACAD CHILD PSY, V38, P852, DOI 10.1097/00004583-199907000-00015; Emslie GJ, 2009, J AM ACAD CHILD PSY, V48, P721, DOI 10.1097/CHI.0b013e3181a2b304; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Gledhill J, 2011, SOC PSYCH PSYCH EPID, V46, P993, DOI 10.1007/s00127-010-0271-6; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0; Kaizar EE, 2006, CLIN TRIALS, V3, P73, DOI 10.1191/1740774506cn139oa; Kennard B, 2006, J AM ACAD CHILD PSY, V45, P1404, DOI 10.1097/01.chi.0000242228.75516.21; Kessler RC, 2012, PSYCHOL MED, V42, P1997, DOI 10.1017/S0033291712000025; Kramer T, 2012, CLIN CHILD PSYCHOL P, V17, P482, DOI 10.1177/1359104512442639; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Martin A, 2004, ARCH PEDIAT ADOL MED, V158, P773, DOI 10.1001/archpedi.158.8.773; Merikangas KR, 2011, J AM ACAD CHILD PSY, V50, P32, DOI 10.1016/j.jaac.2010.10.006; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Pagano ME, 2000, PSYCHOL SCHOOLS, V37, P91, DOI 10.1002/(SICI)1520-6807(200003)37:2<91::AID-PITS1>3.0.CO;2-3; Patton GC, 1999, SOC PSYCH PSYCH EPID, V34, P166, DOI 10.1007/s001270050129; Pietsch K, 2011, J AFFECT DISORDERS, V133, P69, DOI 10.1016/j.jad.2011.03.026; Pomerantz EM, 2002, J EDUC PSYCHOL, V94, P396, DOI 10.1037//0022-0663.94.2.396; Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259; Roberts J, 2006, NEPHROL NEWS ISSUES, V20, P47; ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009; Rohde P, 2013, CLIN PSYCHOL SCI, V1, P41, DOI 10.1177/2167702612457599; Sondergard L, 2006, EUR CHILD ADOLES PSY, V15, P232, DOI 10.1007/s00787-006-0527-6; Substance Abuse and Mental Health Services Administration, 2012, NSDUH SER H, VH-45; Substance Abuse and Mental Health Services Administration, 2005, SUIC THOUGHTS YOUTHS; Valuck RJ, 2004, CNS DRUGS, V18, P1119, DOI 10.2165/00023210-200418150-00006; Vitiello B, 2006, J AM ACAD CHILD PSY, V45, P1419, DOI 10.1097/01.chi.0000242229.52646.6e; Wagner KD, 2006, J AM ACAD CHILD PSY, V45, P280, DOI 10.1097/01.chi.0000192250.38400.9e; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wallace AE, 2006, J CHILD ADOL PSYCHOP, V16, P37, DOI 10.1089/cap.2006.16.37; Williams J, 2004, PEDIATRICS, V114, P601, DOI 10.1542/peds.2004-0090; Williams SB, 2009, SCREENING CHILD ADOL; Williams SB, 2009, PEDIATRICS, V123, pE716, DOI 10.1542/peds.2008-2415; Zhou XY, 2015, WORLD PSYCHIATRY, V14, P207, DOI 10.1002/wps.20217; Zuckerbrot RA, 2006, ARCH PEDIAT ADOL MED, V160, P694, DOI 10.1001/archpedi.160.7.694	47	46	47	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					342	+		10.7326/M15-2259	http://dx.doi.org/10.7326/M15-2259			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF3CC	26857836	Green Submitted			2022-12-28	WOS:000371220300005
J	McConnell, KJ				McConnell, K. John			Oregon's Medicaid Coordinated Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McConnell, K. John] Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, Portland, OR 97239 USA; [McConnell, K. John] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	McConnell, KJ (corresponding author), Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, Mail Code MDYCHSE, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	mcconnjo@ohsu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA035640, UG1DA015815] Funding Source: NIH RePORTER; NIDA NIH HHS [R33 DA035640, 1R33DA035640, UG1 DA015815] Funding Source: Medline; NIMH NIH HHS [R01 MH100001, 1R01MH1000001] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], METH 2015 RAT RED CO; [Anonymous], OR MED WAIV AGR; Lewis VA, 2014, HEALTH AFFAIR, V33, P1808, DOI 10.1377/hlthaff.2014.0353; McConnell KJ, 2014, HEALTHCARE, V2, P163, DOI 10.1016/j.hjdsi.2013.11.002; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Oregon Health Authority, 2015, OR HLTH SYST TRANSF; Stecker EC, 2013, NEW ENGL J MED, V368, P982, DOI 10.1056/NEJMp1214141	7	44	44	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2016	315	9					869	870		10.1001/jama.2016.0206	http://dx.doi.org/10.1001/jama.2016.0206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF1DB	26847402	Green Accepted			2022-12-28	WOS:000371077500014
J	Thurston, A				Thurston, Andrew			The Unreasonable Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Thurston, Andrew] Univ Pittsburgh, Med Ctr, Mercy Hosp, Sect Palliat Care & Med Eth, Pittsburgh, PA USA; [Thurston, Andrew] UPMC Palliat & Support Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thurston, A (corresponding author), Univ Pittsburgh, Med Ctr, Mercy Hosp, Sect Palliat Care & Med Eth, Pittsburgh, PA USA.; Thurston, A (corresponding author), UPMC Palliat & Support Inst, Pittsburgh, PA USA.	thurstonal@upmc.edu						Back AL, 2015, JAMA ONCOL, V1, P18, DOI 10.1001/jamaoncol.2014.185; Gogineni K, 2015, JAMA ONCOL, V1, P33, DOI 10.1001/jamaoncol.2014.197	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					657	658		10.1001/jama.2015.17059	http://dx.doi.org/10.1001/jama.2015.17059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881366				2022-12-28	WOS:000370171500009
J	Jin, X; Pokala, N; Bargmann, CI				Jin, Xin; Pokala, Navin; Bargmann, Cornelia I.			Distinct Circuits for the Formation and Retrieval of an Imprinted Olfactory Memory	CELL			English	Article							ELEGANS NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS; C. ELEGANS; PATHOGENIC BACTERIA; AMINE RECEPTORS; TERM-MEMORY; TYRAMINE; BEHAVIOR; HABITUATION; RECOGNITION	Memories formed early in life are particularly stable and influential, representing privileged experiences that shape enduring behaviors. We show that exposing newly hatched C. elegans to pathogenic bacteria results in persistent aversion to those bacterial odors, whereas adult exposure generates only transient aversive memory. Long-lasting imprinted aversion has a critical period in the first larval stage and is specific to the experienced pathogen. Distinct groups of neurons are required during formation (AIB, RIM) and retrieval (AIY, RIA) of the imprinted memory. RIM synthesizes the neuromodulator tyramine, which is required in the L1 stage for learning. AIY memory retrieval neurons sense tyramine via the SER-2 receptor, which is essential for imprinted, but not for adult-learned, aversion. Odor responses in several neurons, most notably RIA, are altered in imprinted animals. These findings provide insight into neuronal substrates of different forms of memory, and lay a foundation for further understanding of early learning.	[Jin, Xin; Pokala, Navin; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst HHMI, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA; [Pokala, Navin] New York Inst Technol, Old Westbury, NY 11568 USA	Howard Hughes Medical Institute; Rockefeller University; New York Institute Technology	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst HHMI, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu	Pokala, Navin/AAH-5719-2019; Jin, Xin/H-7747-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618; Jin, Xin/0000-0003-2344-992X	HHMI international predoctoral fellowship; HHMI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	HHMI international predoctoral fellowship; HHMI(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Yuichi Iino, Takaaki Hirotsu, Villu Maricq, Daniel Colon-Ramos, Mark Alkema, Fred Ausubel, and the Caenorhabditis Genetics Center (CGC) (NIH P40 OD010440) for strains; Kavita Rangan and Alejandro Lopez-Cruz for experimental advice; the Rockefeller bioimaging facility for technical support; Steve Flavell, Meghan Lockard, Shay Stern, and Richard Axel for comments on the manuscript; and Yun Zhang, Michael Hendricks, Andrew Gordus, Sagi Levy, Steve Serene, and members of our laboratory for advice and discussions. X.J. was supported by an HHMI international predoctoral fellowship. C.I.B. is an Investigator of the HHMI. This work was supported by the HHMI.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Gerlach G, 2008, P ROY SOC B-BIOL SCI, V275, P2165, DOI 10.1098/rspb.2008.0647; Gordus A, 2015, CELL, V161, P215, DOI 10.1016/j.cell.2015.02.018; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Harris G, 2014, J NEUROSCI, V34, P9389, DOI 10.1523/JNEUROSCI.0012-14.2014; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Hobert O, 2010, NEUROGENESIS NEMATOD; Kage E, 2005, CURR BIOL, V15, P1554, DOI 10.1016/j.cub.2005.07.057; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Lakhina V, 2015, NEURON, V85, P330, DOI 10.1016/j.neuron.2014.12.029; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lesch BJ, 2009, GENE DEV, V23, P345, DOI 10.1101/gad.1763509; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Meisel JD, 2014, TRENDS IMMUNOL, V35, P465, DOI 10.1016/j.it.2014.08.008; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rankin CH, 2000, J NEUROSCI, V20, P4337; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Remy JJ, 2005, SCIENCE, V309, P787, DOI 10.1126/science.1114209; Rex E, 2005, J NEUROCHEM, V94, P181, DOI 10.1111/j.1471-4159.2005.03180.x; Rose JK, 2003, J NEUROSCI, V23, P9595; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Timbers TA, 2011, BEHAV NEUROSCI, V125, P560, DOI 10.1037/a0024370; Torayama I, 2007, J NEUROSCI, V27, P741, DOI 10.1523/JNEUROSCI.4312-06.2007; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yamazoe-Umemoto A, 2015, NEUROSCI RES, V99, P22, DOI 10.1016/j.neures.2015.05.009; Zaslaver A, 2015, P NATL ACAD SCI USA, V112, P1185, DOI 10.1073/pnas.1423656112; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	50	69	69	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					632	643		10.1016/j.cell.2016.01.007	http://dx.doi.org/10.1016/j.cell.2016.01.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871629	Green Accepted, Bronze			2022-12-28	WOS:000369998300010
J	Tsiairis, CD; Aulehla, A				Tsiairis, Charisios D.; Aulehla, Alexander			Self-Organization of Embryonic Genetic Oscillators into Spatiotemporal Wave Patterns	CELL			English	Article							PRESOMITIC MESODERM CELLS; SOMITE SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; SYNCHRONIZED OSCILLATION; ZEBRAFISH SOMITOGENESIS; DYNAMICS; ADHESION; DICTYOSTELIUM; INITIATION	In vertebrate embryos, somites, the precursor of vertebrae, form from the presomitic mesoderm (PSM), which is composed of cells displaying signaling oscillations. Cellular oscillatory activity leads to periodic wave patterns in the PSM. Here, we address the origin of such complex wave patterns. We employed an in vitro randomization and real-time imaging strategy to probe for the ability of cells to generate order from disorder. We found that, after randomization, PSM cells self-organized into several miniature emergent PSM structures (ePSM). Our results show an ordered macroscopic spatial arrangement of ePSM with evidence of an intrinsic length scale. Furthermore, cells actively synchronize oscillations in a Notch-signaling-dependent manner, re-establishing wave-like patterns of gene activity. We demonstrate that PSM cells self-organize by tuning oscillation dynamics in response to surrounding cells, leading to collective synchronization with an average frequency. These findings reveal emergent properties within an ensemble of coupled genetic oscillators.	[Tsiairis, Charisios D.; Aulehla, Alexander] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Aulehla, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	aulehla@embl.de	Tsiairis, Charisios/A-9145-2018	Aulehla, Alexander/0000-0003-3487-9239	EMBL Imaging, Flow Cytometry Core Facility (FACS); European Research Council [639343]	EMBL Imaging, Flow Cytometry Core Facility (FACS); European Research Council(European Research Council (ERC)European Commission)	We thank Marcus Heisler, Takashi Hiiragi, Francois Spitz, and Aulehla lab members for discussions and comments on the manuscript. This work was supported by EMBL Imaging, Flow Cytometry Core Facility (FACS), and laboratory animal resource core facilities. We thank Bernd Klaus for help in statistical analysis and Alexis Perez Gonzales for FACS analysis. We thank Henning Falk for generation of the graphical abstract. This work received funding from the European Research Council under an ERC starting grant agreement n. 639343 to A.A.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Baker RE, 2009, HFSP J, V3, P1, DOI 10.2976/1.3072371; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; BUCK J, 1966, NATURE, V211, P562, DOI 10.1038/211562a0; Camazine S., 2003, SELF ORG BIOL SYSTEM; Cambray N, 2002, DEVELOPMENT, V129, P4855; Delaune EA, 2012, DEV CELL, V23, P995, DOI 10.1016/j.devcel.2012.09.009; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; HOFER T, 1995, P ROY SOC B-BIOL SCI, V259, P249, DOI 10.1098/rspb.1995.0037; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Maroto M, 2005, INT J DEV BIOL, V49, P309, DOI 10.1387/ijdb.041958mm; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Murray PJ, 2013, DEV BIOL, V373, P407, DOI 10.1016/j.ydbio.2012.10.014; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oginuma M, 2010, DEVELOPMENT, V137, P1515, DOI 10.1242/dev.044545; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; ROSS J, 1988, SCIENCE, V240, P460, DOI 10.1126/science.240.4851.460; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sawai S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r144; Stauber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007996; Tinsley MR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.158301; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Weber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043276; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0	45	74	73	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					656	667		10.1016/j.cell.2016.01.028	http://dx.doi.org/10.1016/j.cell.2016.01.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871631	hybrid, Green Published			2022-12-28	WOS:000369998300012
J	Yadav, AK; Nelson, CT; Hsu, SL; Hong, Z; Clarkson, JD; Schlepuetz, CM; Damodaran, AR; Shafer, P; Arenholz, E; Dedon, LR; Chen, D; Vishwanath, A; Minor, AM; Chen, LQ; Scott, JF; Martin, LW; Ramesh, R				Yadav, A. K.; Nelson, C. T.; Hsu, S. L.; Hong, Z.; Clarkson, J. D.; Schlepueetz, C. M.; Damodaran, A. R.; Shafer, P.; Arenholz, E.; Dedon, L. R.; Chen, D.; Vishwanath, A.; Minor, A. M.; Chen, L. Q.; Scott, J. F.; Martin, L. W.; Ramesh, R.			Observation of polar vortices in oxide superlattices	NATURE			English	Article							FERROELECTRIC DOMAIN-STRUCTURES; PHYSICS; PBTIO3	The complex interplay of spin, charge, orbital and lattice degrees of freedom provides a plethora of exotic phases and physical phenomena(1-5). In recent years, complex spin topologies have emerged as a consequence of the electronic band structure and the interplay between spin and spin-orbit coupling in materials-(6,7). Here we produce complex topologies of electrical polarization-namely, nanometre-scale vortex-antivortex (that is, clockwise-anticlockwise) arrays that are reminiscent of rotational spin topologies(6)-by making use of the competition between charge, orbital and lattice degrees of freedom in superlattices of alternating lead titanate and strontium titanate layers. Atomic-scale mapping of the polar atomic displacements by scanning transmission electron microscopy reveals the presence of long-range ordered vortex-antivortex arrays that exhibit nearly continuous polarization rotation. Phase-field modelling confirms that the vortex array is the low-energy state for a range of superlattice periods. Within this range, the large gradient energy from the vortex structure is counterbalanced by the corresponding large reduction in overall electrostatic energy (which would otherwise arise from polar discontinuities at the lead titanate/strontium titanate interfaces) and the elastic energy associated with epitaxial constraints and domain formation. These observations have implications for the creation of new states of matter (such as dipolar skyrmions, hedgehog states) and associated phenomena in ferroic materials, such as electrically controllable chirality.	[Yadav, A. K.; Nelson, C. T.; Hsu, S. L.; Clarkson, J. D.; Damodaran, A. R.; Dedon, L. R.; Chen, D.; Minor, A. M.; Martin, L. W.; Ramesh, R.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Yadav, A. K.; Vishwanath, A.; Minor, A. M.; Martin, L. W.; Ramesh, R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Nelson, C. T.; Hsu, S. L.; Clarkson, J. D.; Chen, D.; Vishwanath, A.; Ramesh, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Nelson, C. T.; Hsu, S. L.; Minor, A. M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Electron Microscopy, Mol Foundry, Berkeley, CA 94720 USA; [Hong, Z.; Chen, L. Q.] Penn State Univ, Dept Mat Sci & Engn, State Coll, PA 16802 USA; [Schlepueetz, C. M.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Shafer, P.; Arenholz, E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Scott, J. F.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Scott, J. F.] Univ St Andrews, Sch Phys, St Andrews KY16 9ST, Fife, Scotland	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of St Andrews; University of St Andrews	Ramesh, R (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	rramesh@berkeley.edu	Schlepütz, Christian/C-4696-2008; Chen, Deyan/Q-7279-2017; Chen, LongQing/I-7536-2012; Ramesh, Ramamoorthy/ABI-4883-2020; Ryan, Sheena/R-2234-2018; McCoy, Tina/P-3402-2019; Vishwanath, Ashvin/AAO-6878-2020; Martin, Lane W./H-2409-2011; Yadav, Ajay/I-6337-2016	Schlepütz, Christian/0000-0002-0485-2708; Chen, Deyan/0000-0002-8370-6409; Chen, LongQing/0000-0003-3359-3781; Martin, Lane W./0000-0003-1889-2513; Yadav, Ajay/0000-0001-5088-6506; Chen, Deyang/0000-0003-1427-3192	Office of Basic Energy Sciences, US Department of Energy [DE-AC02-05CH11231]; National Science Foundation under the MRSEC program [DMR-1420620]; National Science Foundation [DMR-1210588, DMR-1451219]; US Department of Energy, Office of Science, Office of Basic Energy Science [DE-AC02-06CH11357]; Army Research Office [W911NF-14-1-0104]; Office of Science, Office of Basic Energy Sciences, US Department of Energy [DE-AC02-05CH11231]; US Department of Energy, Office of Basic Energy Sciences [DE-SC0012375]; Engineering and Physical Sciences Research Council [EP/J017825/1] Funding Source: researchfish; Division Of Materials Research [1210588, 1451219] Funding Source: National Science Foundation; EPSRC [EP/J017825/1] Funding Source: UKRI	Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); National Science Foundation under the MRSEC program(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Basic Energy Science(United States Department of Energy (DOE)); Army Research Office; Office of Science, Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	A.K.Y. and R.R. acknowledge support from the Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231), for the synthesis and characterization of superlattices. R.R. and C.T.N. acknowledge support from the Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231), for TEM characterization of superlattices. S.L.H. acknowledges support from the National Science Foundation under the MRSEC program (DMR-1420620). Z.H. acknowledges support from the National Science Foundation (DMR-1210588). J.D.C. acknowledges support from the Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231). C.M.S. acknowledges use of the Advanced Photon Source, which was supported by the US Department of Energy, Office of Science, Office of Basic Energy Science (DE-AC02-06CH11357), for the synchrotron-based reciprocal space map studies of superlattice structures at Sector 33-BM-C beamline. A.R.D. acknowledges support from the Army Research Office (W911NF-14-1-0104). P.S. and E.A. acknowledge support from the Director, Office of Science, Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231), for the synchrotron-based studies of the superlattice structures. L.R.D. acknowledges support from the US Department of Energy, Office of Basic Energy Sciences (DE-SC0012375) for the chemical analysis of the superlattice structures. D.C. acknowledges support from the National Science Foundation under the MRSEC program (DMR-1420620). A.V. and A.M.M. acknowledge support from Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231). L.Q.C. acknowledges support from the National Science Foundation (DMR-1210588). L.W.M. acknowledges support from the National Science Foundation (DMR-1451219). Electron microscopy of superlattice structures was performed at the Molecular Foundry, LBNL, supported by the Office of Science, Office of Basic Energy Sciences, US Department of Energy (DE-AC02-05CH11231). Z.H. thanks J. Britson, F. Xue and J. Wang for help and discussions.	Balke N, 2012, NAT PHYS, V8, P81, DOI 10.1038/nphys2132; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Chakhalian J, 2012, NAT MATER, V11, P92, DOI 10.1038/nmat3225; Chen LQ, 2008, J AM CERAM SOC, V91, P1835, DOI 10.1111/j.1551-2916.2008.02413.x; Chen ZH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875801; Choudhury N, 2011, NATURE, V470, P513, DOI 10.1038/nature09752; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; GLAZER AM, 1978, ACTA CRYSTALLOGR B, V34, P1065, DOI 10.1107/S0567740878004938; Gruverman A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/34/342201; HAUN MJ, 1987, J APPL PHYS, V62, P3331, DOI 10.1063/1.339293; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jia CL, 2011, SCIENCE, V331, P1420, DOI 10.1126/science.1200605; JONES CW, 1989, ACTA CRYSTALLOGR C, V45, P365, DOI 10.1107/S0108270188012077; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kuroiwa Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.217601; Levanyuk AP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.097601; Li YL, 2002, APPL PHYS LETT, V81, P427, DOI 10.1063/1.1492025; Li YL, 2002, ACTA MATER, V50, P395, DOI 10.1016/S1359-6454(01)00360-3; Mannhart J, 2010, SCIENCE, V327, P1607, DOI 10.1126/science.1181862; McQuaid RGP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1413; Millis AJ, 1998, NATURE, V392, P147, DOI 10.1038/32348; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; Ophus C, 2016, ULTRAMICROSCOPY, V162, P1, DOI 10.1016/j.ultramic.2015.12.002; Pitcher MJ, 2015, SCIENCE, V347, P420, DOI 10.1126/science.1262118; POMPE W, 1993, J APPL PHYS, V74, P6012, DOI 10.1063/1.355215; Ponomareva I, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214118; Prosandeev S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094102; Prosandeev S, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/19/193201; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Schulz T, 2012, NAT PHYS, V8, P301, DOI [10.1038/NPHYS2231, 10.1038/nphys2231]; Sheng G, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3442915; Sichuga D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196102; Sichuga D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207603; Tagantsev A. K., 1986, Ferroelectrics, V69, P321, DOI 10.1080/00150198608008205; Tagantsev AK, 2008, FERROELECTRICS, V375, P19, DOI 10.1080/00150190802437746; Tang YL, 2015, SCIENCE, V348, P547, DOI 10.1126/science.1259869; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Wang JJ, 2013, ACTA MATER, V61, P7591, DOI 10.1016/j.actamat.2013.08.055; Yu P, 2012, P NATL ACAD SCI USA, V109, P9710, DOI 10.1073/pnas.1117990109; Zhao HJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174101; Zheng Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075401; Zubko P, 2011, ANNU REV CONDEN MA P, V2, P141, DOI 10.1146/annurev-conmatphys-062910-140445	45	513	525	35	829	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					198	+		10.1038/nature16463	http://dx.doi.org/10.1038/nature16463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26814971	Green Published			2022-12-28	WOS:000369916700034
J	Rajak, S				Rajak, Saul			SPOT DIAGNOSIS Painless, gradually enlarging, subcutaneous lesion of the eyelid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rajak, Saul] Univ Adelaide, S Australian Inst Ophthalmol, Adelaide, SA, Australia	University of Adelaide	Rajak, S (corresponding author), Univ Adelaide, S Australian Inst Ophthalmol, Adelaide, SA, Australia.	saulrajak@hotmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2016	352								i824	10.1136/bmj.i824	http://dx.doi.org/10.1136/bmj.i824			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JN	26864069				2022-12-28	WOS:000370383300014
J	Taylor, S; Campagna, L				Taylor, Scott; Campagna, Leonardo			Avian supergenes	SCIENCE			English	Editorial Material							ALTERNATIVE REPRODUCTIVE STRATEGIES; WHITE-THROATED SPARROW; RUFF		[Taylor, Scott; Campagna, Leonardo] Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY USA; [Taylor, Scott; Campagna, Leonardo] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Cornell University; Cornell University	Taylor, S (corresponding author), Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY USA.	sat235@cornell.edu		Taylor, Scott/0000-0001-9580-9125				Bachtrog D, 2006, CURR BIOL, V16, P1694, DOI 10.1016/j.cub.2006.07.053; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Poelstra JW, 2014, SCIENCE, V344, P1410, DOI 10.1126/science.1253226; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Schwander T, 2014, CURR BIOL, V24, pR288, DOI 10.1016/j.cub.2014.01.056; Thomas JW, 2008, GENETICS, V179, P1455, DOI 10.1534/genetics.108.088229; Throneycroft H.B., 1975, EVOLUTION, V29, P611; Tuttle E. M., 2016, CURR BIOL, DOI [10.1126/j.cub.2015.11.069, DOI 10.1126/J.CUB.2015.11.069]; Tuttle EM, 2003, BEHAV ECOL, V14, P425, DOI 10.1093/beheco/14.3.425; Van Rhijn J.G., 1991, THE RUFF	12	11	12	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					446	447		10.1126/science.aae0389	http://dx.doi.org/10.1126/science.aae0389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823411				2022-12-28	WOS:000368858200017
J	Costa, KM; McManus, JF; Anderson, RF; Ren, H; Sigman, DM; Winckler, G; Fleisher, MQ; Marcantonio, F; Ravelo, AC				Costa, K. M.; McManus, J. F.; Anderson, R. F.; Ren, H.; Sigman, D. M.; Winckler, G.; Fleisher, M. Q.; Marcantonio, F.; Ravelo, A. C.			No iron fertilization in the equatorial Pacific Ocean during the last ice age	NATURE			English	Article							GLACIAL-INTERGLACIAL VARIABILITY; DEEP-SEA; SEDIMENT; TH-230; DUST; DENITRIFICATION; NUTRIENT; PA-231; RATIO; OPAL	The equatorial Pacific Ocean is one of the major high-nutrient, low-chlorophyll regions in the global ocean. In such regions, the consumption of the available macro-nutrients such as nitrate and phosphate is thought to be limited in part by the low abundance of the critical micro-nutrient iron(1). Greater atmospheric dust deposition(2) could have fertilized the equatorial Pacific with iron during the last ice age-the Last Glacial Period (LGP)-but the effect of increased ice-age dust fluxes on primary productivity in the equatorial Pacific remains uncertain(3-6). Here we present meridional transects of dust (derived from the Th-232 proxy), phytoplankton productivity (using opal, Pa-231/Th-230 and excess Ba), and the degree of nitrate consumption (using foraminifera-bound delta N-15) from six cores in the central equatorial Pacific for the Holocene (0-10,000 years ago) and the LGP (17,000-27,000 years ago). We find that, although dust deposition in the central equatorial Pacific was two to three times greater in the LGP than in the Holocene, productivity was the same or lower, and the degree of nitrate consumption was the same. These biogeochemical findings suggest that the relatively greater ice-age dust fluxes were not large enough to provide substantial iron fertilization to the central equatorial Pacific. This may have been because the absolute rate of dust deposition in the LGP (although greater than the Holocene rate) was very low. The lower productivity coupled with unchanged nitrate consumption suggests that the subsurface major nutrient concentrations were lower in the central equatorial Pacific during the LGP. As these nutrients are today dominantly sourced from the Subantarctic Zone of the Southern Ocean, we propose that the central equatorial Pacific data are consistent with more nutrient consumption in the Subantarctic Zone, possibly owing to iron fertilization as a result of higher absolute dust fluxes in this region(7,8). Thus, ice-age iron fertilization in the Subantarctic Zone would have ultimately worked to lower, not raise, equatorial Pacific productivity.	[Costa, K. M.; McManus, J. F.; Anderson, R. F.; Winckler, G.; Fleisher, M. Q.] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; [Costa, K. M.; McManus, J. F.; Anderson, R. F.; Winckler, G.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Ren, H.] Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan; [Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Marcantonio, F.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Ravelo, A. C.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	Columbia University; Columbia University; National Taiwan University; Princeton University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Santa Cruz	Costa, KM (corresponding author), Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA.; Costa, KM (corresponding author), Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA.	kcosta@ldeo.columbia.edu	Sigman, Daniel M/A-2649-2008	Sigman, Daniel M/0000-0002-7923-1973; Anderson, Robert/0000-0002-8472-2494; REN, HAO-JIA/0000-0002-1769-4243; Ravelo, Ana Christina/0000-0003-3929-677X	NSF [AGS 15-02889, OCE-1060947, OCE-1003374, OCE-1159053, OCE-1158886]; Grand Challenges Program of Princeton University; Comer Science and Education Foundation; MOST, Taiwan [103-2116-M-002-032-MY2]; Directorate For Geosciences [1502962, 1502889] Funding Source: National Science Foundation; Division Of Ocean Sciences [1060947] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Grand Challenges Program of Princeton University(Princeton University); Comer Science and Education Foundation; MOST, Taiwan(Ministry of Science and Technology, Taiwan); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank M. Soon at the University of British Columbia for assistance in running the opal analyses and M. A. Weigand and S. Oleynik for assistance with the FB-delta<SUP>15</SUP>N analyses. Funding was provided in part by NSF award AGS 15-02889 (to J.F.McM., G.W. and F.M.), NSF award OCE-1060947 (to D.M.S.) and the Grand Challenges Program of Princeton University (to D.M.S.). This project also benefited from previous support from the NSF (grant numbers OCE-1003374, OCE-1159053, OCE-1158886) and the Comer Science and Education Foundation (to J.F.McM.) and travel funding from MOST, Taiwan (grant number 103-2116-M-002-032-MY2 to H.R.).	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Anderson RF, 2006, EARTH PLANET SC LETT, V242, P406, DOI 10.1016/j.epsl.2005.11.061; Anderson RF, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0054; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Bradtmiller LI, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001282; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Brzezinski MA, 2011, DEEP-SEA RES PT II, V58, P493, DOI 10.1016/j.dsr2.2010.08.005; Chase Z, 2003, DEEP-SEA RES PT II, V50, P739, DOI 10.1016/S0967-0645(02)00593-3; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Conkright M. E., 2002, NUTRIENTS, V4, P1; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; Dubois N, 2011, QUATERNARY SCI REV, V30, P210, DOI 10.1016/j.quascirev.2010.10.012; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; Fleisher MQ, 2003, DEEP-SEA RES PT II, V50, P693, DOI 10.1016/S0967-0645(02)00591-X; Ford HL, 2015, SCIENCE, V347, P255, DOI 10.1126/science.1258437; Francois R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001235; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Gordon RM, 1997, LIMNOL OCEANOGR, V42, P419, DOI 10.4319/lo.1997.42.3.0419; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Hayes CT, 2013, EARTH PLANET SC LETT, V369, P86, DOI 10.1016/j.epsl.2013.03.008; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Hernandez-Sanchez MT, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002111; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Kohfeld KE, 2001, EARTH-SCI REV, V54, P81, DOI 10.1016/S0012-8252(01)00042-3; Kretschmer S, 2011, GEOCHIM COSMOCHIM AC, V75, P6971, DOI 10.1016/j.gca.2011.09.012; Labatut M, 2014, GLOBAL BIOGEOCHEM CY, V28, P1044, DOI 10.1002/2014GB004928; Loubere P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000986; Loubere P, 2000, NATURE, V406, P497, DOI 10.1038/35020041; Loubere P, 2001, GLOBAL PLANET CHANGE, V29, P77, DOI 10.1016/S0921-8181(00)00085-0; Lyle M, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001373; Lyle M, 2014, PALEOCEANOGRAPHY, V29, P747, DOI 10.1002/2014PA002616; Lynch-Stieglitz J, 2015, PALEOCEANOGRAPHY, V30, P423, DOI 10.1002/2014PA002746; Marcantonio F, 2014, GEOPHYS RES LETT, V41, P5547, DOI 10.1002/2014GL060477; Martinez P, 2010, BIOGEOSCIENCES, V7, P1, DOI 10.5194/bg-7-1-2010; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; McGee D, 2007, EARTH PLANET SC LETT, V257, P215, DOI 10.1016/j.epsl.2007.02.033; Mcgee D, 2010, QUATERNARY SCI REV, V29, P2340, DOI 10.1016/j.quascirev.2010.06.009; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Murray RW, 2012, NAT GEOSCI, V5, P270, DOI [10.1038/NGEO1422, 10.1038/ngeo1422]; Owens SA, 2011, MAR CHEM, V127, P31, DOI 10.1016/j.marchem.2011.07.005; Pichat S, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000994; Pichevin LE, 2009, NATURE, V459, P1114, DOI 10.1038/nature08101; Pisias N., 2002, PALEOCEANOGRAPHY, V17, P3; Rafter P. A., 2015, LIMNOL OCEANOGR; Rafter PA, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002367; Rafter PA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003979; Reeves JM, 2013, QUATERNARY SCI REV, V74, P97, DOI 10.1016/j.quascirev.2012.11.027; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Ren HJ, 2012, LIMNOL OCEANOGR, V57, P1011, DOI 10.4319/lo.2012.57.4.1011; Robinson RS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001702; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Schroth AW, 2009, NAT GEOSCI, V2, P337, DOI 10.1038/NGEO501; Sigman DM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035784; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Warnock J, 2007, DEEP-SEA RES PT II, V54, P772, DOI 10.1016/j.dsr2.2007.01.011; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595; Yu EF, 2001, EARTH PLANET SC LETT, V191, P219, DOI 10.1016/S0012-821X(01)00410-1	64	55	59	1	92	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					519	+		10.1038/nature16453	http://dx.doi.org/10.1038/nature16453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819045	Green Published			2022-12-28	WOS:000368673800035
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			From literature to medicine The judgment dilemma	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08903 USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					330	330		10.1016/S0140-6736(16)00116-1	http://dx.doi.org/10.1016/S0140-6736(16)00116-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26842441				2022-12-28	WOS:000368516500017
J	Summerskill, W				Summerskill, William			In appreciation of the peer-review heroes from 2015	LANCET			English	Editorial Material									[Summerskill, William] The Lancet, London EC2Y 5AS, England		Summerskill, W (corresponding author), The Lancet, London EC2Y 5AS, England.								0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					211	211		10.1016/S0140-6736(16)00083-0	http://dx.doi.org/10.1016/S0140-6736(16)00083-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26842281				2022-12-28	WOS:000368130700012
J	Gebauer, F; Hentze, MW				Gebauer, Fatima; Hentze, Matthias W.			IRES unplugged	SCIENCE			English	Editorial Material							TRANSLATION INITIATION; MESSENGER-RNA		[Gebauer, Fatima] Barcelona Inst Sci & Technol, Gene Regulat Stem Cells & Canc Programme, Ctr Genom Regulat, Barcelona 08003, Spain; [Gebauer, Fatima] Univ Pompeu Fabra, Barcelona 08003, Spain; [Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; European Molecular Biology Laboratory (EMBL)	Gebauer, F (corresponding author), Barcelona Inst Sci & Technol, Gene Regulat Stem Cells & Canc Programme, Ctr Genom Regulat, Barcelona 08003, Spain.	hentze@embl.de	Gebauer, Fatima/E-7725-2015; Hentze, Matthias W/V-3980-2017	Gebauer, Fatima/0000-0001-7563-0013; Hentze, Matthias W/0000-0002-4023-7876				Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Shatsky IN, 2014, CRIT REV BIOCHEM MOL, V49, P164, DOI 10.3109/10409238.2014.887051; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010	9	6	6	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					228	228		10.1126/science.aad8540	http://dx.doi.org/10.1126/science.aad8540			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816364	Green Accepted			2022-12-28	WOS:000368098600020
J	Humble, AGR; Sample, CB				Humble, Adam G. R.; Sample, Cliff B.			Morgagni's hernia in a hypoxaemic adult	LANCET			English	Editorial Material									[Humble, Adam G. R.] Univ Alberta, Dept Undergrad Med Educ, Edmonton, AB, Canada; [Sample, Cliff B.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta	Sample, CB (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB T6G 2E1, Canada.	cbsample@me.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					705	705		10.1016/S0140-6736(16)00150-1	http://dx.doi.org/10.1016/S0140-6736(16)00150-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	26831471				2022-12-28	WOS:000381268700030
J	Walls, AC; Tortorici, MA; Bosch, BJ; Frenz, B; Rottier, PJM; DiMaio, F; Rey, FA; Veesler, D				Walls, Alexandra C.; Tortorici, M. Alejandra; Bosch, Berend-Jan; Frenz, Brandon; Rottier, Peter J. M.; DiMaio, Frank; Rey, Felix A.; Veesler, David			Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer	NATURE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; EM STRUCTURE DETERMINATION; PARTICLE CRYO-EM; CRYSTAL-STRUCTURE; MURINE CORONAVIRUS; FUSION PROTEIN; ELECTRON CRYOMICROSCOPY; MEMBRANE-FUSION; HUMAN RECEPTOR; S2 DOMAIN	The tremendous pandemic potential of coronaviruses was demonstrated twice in the past few decades by two global outbreaks of deadly pneumonia. Entry of coronaviruses into cells is mediated by the transmembrane spike glycoprotein S, which forms a trimer carrying receptor-binding and membrane fusion functions(1). S also contains the principal antigenic determinants and is the target of neutralizing antibodies. Here we present the structure of a mouse coronavirus S trimer ectodomain determined at 4.0 resolution by single particle cryo-electron microscopy. It reveals the metastable pre-fusion architecture of S and highlights key interactions stabilizing it. The structure shares a common core with paramyxovirus F proteins(2,3), implicating mechanistic similarities and an evolutionary connection between these viral fusion proteins. The accessibility of the highly conserved fusion peptide at the periphery of the trimer indicates potential vaccinology strategies to elicit broadly neutralizing antibodies against coronaviruses. Finally, comparison with crystal structures of human coronavirus S domains allows rationalization of the molecular basis for species specificity based on the use of spatially contiguous but distinct domains.	[Walls, Alexandra C.; Frenz, Brandon; DiMaio, Frank; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Tortorici, M. Alejandra; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, F-75015 Paris, France; [Tortorici, M. Alejandra; Rey, Felix A.] CNRS UMR 3569 Virol, F-75015 Paris, France; [Bosch, Berend-Jan; Rottier, Peter J. M.] Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands	University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Utrecht University	Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, F-75015 Paris, France.; Rey, FA (corresponding author), CNRS UMR 3569 Virol, F-75015 Paris, France.	felix.rey@pasteur.fr; dveesler@uw.edu	Veesler, David/HCH-3986-2022; Bosch, Berend/ABD-8740-2021; Rey, Felix/B-6497-2012	Walls, Alexandra/0000-0002-9636-8330; Tortorici, M. Alejandra/0000-0002-2260-2577; Rey, Felix/0000-0002-9953-7988	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [T32GM008268]; National Resource for Automated Molecular Microscopy [GM103310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120553, P41GM103310, T32GM008268] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Resource for Automated Molecular Microscopy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award Number T32GM008268 (A.C.W.). Part of this research was facilitated by the National Resource for Automated Molecular Microscopy (award number GM103310), and the Hyak supercomputer system at the University of Washington. We thank W. Bartelink, B. Tummers and B. van der Kooij for assistance in cloning, protein expression and characterization. We are also grateful to B. Baron for assistance with the Thermophoresis experiments.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; DANIEL C, 1993, J VIROL, V67, P1185, DOI 10.1128/JVI.67.3.1185-1194.1993; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Eckert DM, 1998, J MOL BIOL, V284, P859, DOI 10.1006/jmbi.1998.2214; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao J, 2013, J VIROL, V87, P13134, DOI 10.1128/JVI.02433-13; Glaeser RM, 2011, J STRUCT BIOL, V174, P1, DOI 10.1016/j.jsb.2010.12.005; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Lyumkis D, 2013, J STRUCT BIOL, V184, P417, DOI 10.1016/j.jsb.2013.10.009; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Taguchi F, 2002, J VIROL, V76, P950, DOI 10.1128/JVI.76.3.950-958.2002; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; Wang RYR, 2015, NAT METHODS, V12, P335, DOI [10.1038/nmeth.3287, 10.1038/NMETH.3287]; Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zhang H, 2004, J VIROL, V78, P6938, DOI 10.1128/JVI.78.13.6938-6945.2004	53	305	316	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					114	+		10.1038/nature16988	http://dx.doi.org/10.1038/nature16988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26855426	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000371211900051
J	Tuuli, MG; Liu, JX; Stout, MJ; Martin, S; Cahill, AG; Odibo, AO; Colditz, GA; Macones, GA				Tuuli, Methodius G.; Liu, Jingxia; Stout, Molly J.; Martin, Shannon; Cahill, Alison G.; Odibo, Anthony O.; Colditz, Graham A.; Macones, George A.			A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL SITE INFECTION; CHLORHEXIDINE-ALCOHOL; POVIDONE-IODINE; CLINICAL-TRIALS; SECTION; ENDOMETRITIS; PATIENT; REDUCE	BACKGROUND Preoperative skin antisepsis has the potential to decrease the risk of surgical-site infection. However, evidence is limited to guide the choice of antiseptic agent at cesarean delivery, which is the most common major surgical procedure among women in the United States. METHODS In this single-center, randomized, controlled trial, we evaluated whether the use of chlorhexidine-alcohol for preoperative skin antisepsis was superior to the use of iodine-alcohol for the prevention of surgical-site infection after cesarean delivery. We randomly assigned patients undergoing cesarean delivery to skin preparation with either chlorhexidine-alcohol or iodine-alcohol. The primary outcome was superficial or deep surgical-site infection within 30 days after cesarean delivery, on the basis of definitions from the Centers for Disease Control and Prevention. RESULTS From September 2011 through June 2015, a total of 1147 patients were enrolled; 572 patients were assigned to chlorhexidine-alcohol and 575 to iodine-alcohol. In an intention-to-treat analysis, surgical-site infection was diagnosed in 23 patients (4.0%) in the chlorhexidine-alcohol group and in 42 (7.3%) in the iodine-alcohol group (relative risk, 0.55; 95% confidence interval, 0.34 to 0.90; P = 0.02). The rate of superficial surgical-site infection was 3.0% in the chlorhexidine-alcohol group and 4.9% in the iodine-alcohol group (P = 0.10); the rate of deep infection was 1.0% and 2.4%, respectively (P = 0.07). The frequency of adverse skin reactions was similar in the two groups. CONCLUSIONS The use of chlorhexidine-alcohol for preoperative skin antisepsis resulted in a significantly lower risk of surgical-site infection after cesarean delivery than did the use of iodine-alcohol. (Funded by the National Institutes of Health and Washington University School of Medicine in St. Louis; ClinicalTrials.gov number, NCT01472549.)	[Tuuli, Methodius G.; Stout, Molly J.; Martin, Shannon; Cahill, Alison G.; Macones, George A.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 4566 Scott Ave,Campus Box 8064, St Louis, MO 63110 USA; [Liu, Jingxia; Colditz, Graham A.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Odibo, Anthony O.] Univ S Florida, Dept Obstet & Gynecol, Tampa, FL 33620 USA	Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of South Florida	Tuuli, MG (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 4566 Scott Ave,Campus Box 8064, St Louis, MO 63110 USA.	tuulim@wudosis.wustl.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	National Institutes of Health; Washington University School of Medicine in St. Louis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University School of Medicine in St. Louis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the National Institutes of Health and Washington University School of Medicine in St. Louis; ClinicalTrials.gov number, NCT01472549.	Amer-Alshiek J, 2013, J MATERN-FETAL NEO M, V26, P1749, DOI 10.3109/14767058.2013.798291; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Calvert C, 2014, NEW ENGL J MED, V371, P1075, DOI 10.1056/NEJMc1408436; Conroy Kelley, 2012, Rev Obstet Gynecol, V5, P69; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; DeFrances Carol J, 2007, Vital Health Stat 13, P1; Denton GW, 2001, DISINFECTION STERILI, P321; Dixon E, 2012, J AM COLL SURGEONS, V214, P374, DOI 10.1016/j.jamcollsurg.2011.12.006; DUMVILLE JC, 2015, COCHRANE DB SYST REV, V0004; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Horan TC., 2004, HOSP EPIDEMIOL INFEC, P1659; Kunkle CM, 2015, J MATERN-FETAL NEO M, V28, P573, DOI 10.3109/14767058.2014.926884; Lee I, 2010, INFECT CONT HOSP EP, V31, P1219, DOI 10.1086/657134; Lim KS, 2008, ANAESTH INTENS CARE, V36, P502; LORENZ RP, 1988, J REPROD MED, V33, P202; MAGANN EF, 1993, OBSTET GYNECOL, V81, P922; Maiwald M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044277; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mathews TJ, 2015, BIRTHS FINAL DATA 20; Menderes G, 2012, OBSTET GYNECOL, V120, P1037, DOI [10.1097/AOG.0b013e31826f3bd9, http://10.1097/AOG.0b013e31826f3bd9]; Olsen MA, 2010, INFECT CONT HOSP EP, V31, P276, DOI 10.1086/650755; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rauk PN, 2010, AM J INFECT CONTROL, V38, P319, DOI 10.1016/j.ajic.2009.10.004; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Scifres CM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.038; Swenson BR, 2009, INFECT CONT HOSP EP, V30, P964, DOI 10.1086/605926; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Wloch C, 2012, BJOG-INT J OBSTET GY, V119, P1324, DOI 10.1111/j.1471-0528.2012.03452.x	29	133	138	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					647	655		10.1056/NEJMoa1511048	http://dx.doi.org/10.1056/NEJMoa1511048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26844840	Green Accepted, Green Published			2022-12-28	WOS:000370229000010
J	Laiteerapong, N; Cifu, AS				Laiteerapong, Neda; Cifu, Adam S.			Screening for Prediabetes and Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOLLOW-UP		[Laiteerapong, Neda; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu	Laiteerapong, Neda/ABC-5566-2021; Laiteerapong, Neda/AAO-2596-2020	Laiteerapong, Neda/0000-0003-0124-4325; 	NIDDK NIH HHS [K23 DK097283, P30 DK092949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097283, P30DK092949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Centers for Disease Control and Prevention, 2014, 2014 NAT DIAB STAT R; Hoerger TJ, 2015, AM J PREV MED, V48, P419, DOI 10.1016/j.amepre.2014.11.008; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Samuels TA, 2006, AM J MANAG CARE, V12, P717; Selph S, 2015, ANN INTERN MED, V162, P765, DOI 10.7326/M14-2221; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	10	14	16	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					697	698		10.1001/jama.2015.17545	http://dx.doi.org/10.1001/jama.2015.17545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881373	Green Accepted			2022-12-28	WOS:000370171500016
J	Victora, CG; Schuler-Faccini, L; Matijasevich, A; Ribeiro, E; Pessoa, A; Barros, FC				Victora, Cesar Gomes; Schuler-Faccini, Lavinia; Matijasevich, Alicia; Ribeiro, Erlane; Pessoa, Andre; Barros, Fernando Celso			Microcephaly in Brazil: how to interpret reported numbers?	LANCET			English	Editorial Material							GROWTH		[Victora, Cesar Gomes; Barros, Fernando Celso] Univ Fed Pelotas, Programa Pos Grad Epidemiol, BR-96020220 Pelotas, RS, Brazil; [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Programa Pos Grad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Matijasevich, Alicia] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, SP, Brazil; [Ribeiro, Erlane; Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil; [Ribeiro, Erlane; Pessoa, Andre] Univ Estadual Ceara, Fortaleza, Ceara, Brazil; [Barros, Fernando Celso] Univ Catolica Pelotas, Fac Med, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Estadual do Ceara; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, Programa Pos Grad Epidemiol, BR-96020220 Pelotas, RS, Brazil.	cvictora@gmail.com	SCHULER-FACCINI, LAVINIA/C-8309-2013; SCHULER-FACCINI, LAVINIA/K-2927-2016; Victora, Cesar Gomes/Y-2455-2019; Matijasevich, Alicia/C-5576-2009; Victora, Cesar G/D-4476-2013	SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Victora, Cesar Gomes/0000-0002-2465-2180; Matijasevich, Alicia/0000-0003-0060-1589; Victora, Cesar G/0000-0002-2465-2180; Barros, Fernando/0000-0001-5973-1746				[Anonymous], 2016, LIN PREL VIG MICR RE; Brasil Ministerio da Saude, TAB AN DEF CONG NASC; Brasil Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, INF EP 11 SEM EP 04; Brasil Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, 012015 BRAS MIN SAUD; BRASIL. Ministerio de Saude, 2015, PROT VIG RESP OC MIC; Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259; [DATASUS Brasil. Ministerio da Saude], 2016, SIST NAC NASC VIV; Davies H.E., 2011, BMJ, V342, P589; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Giuliani F, 2015, ACTA PAEDIATR, V104, P987, DOI 10.1111/apa.13112; Latin American Network of Congenital Malformations, 2015, MICR ECLAMC BRAS; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Solla J, 2008, POLITICAS SISTEMA SA, P627; Villar J, 2015, AM J OBSTET GYNECOL, V213, P494, DOI 10.1016/j.ajog.2015.07.002; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; WHO, WHO CHILD GROWTH STA; Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882; World Health Organization, 2014, BIRTH DEF SURV MAN P	19	157	166	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					621	624		10.1016/S0140-6736(16)00273-7	http://dx.doi.org/10.1016/S0140-6736(16)00273-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3QH	26864961	hybrid			2022-12-28	WOS:000369837100004
J	Robbiani, DF; Nussenzweig, MC				Robbiani, Davide F.; Nussenzweig, Michel C.			A New Way to Diversify Antibodies by DNA Transposition	CELL			English	Editorial Material							SOMATIC HYPERMUTATION; INSERTIONS; CENTERS; RAG2	While searching for new therapeutics against malaria, Lanzavecchia and colleagues discovered that antibodies can be diversified by DNA sequences encoded outside of antibody genes.	[Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	drobbiani@rockefeller.edu; nussen@rockefeller.edu	Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019	Robbiani, Davide F./0000-0001-7379-3484; 	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R21 AI112602] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112602] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59	10	3	3	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					601	602		10.1016/j.cell.2016.01.031	http://dx.doi.org/10.1016/j.cell.2016.01.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871626	Bronze			2022-12-28	WOS:000369998300007
J	Kaufman, CK; Mosimann, C; Fan, ZP; Yang, S; Thomas, AJ; Ablain, J; Tan, JL; Fogley, RD; van Rooijen, E; Hagedorn, EJ; Ciarlo, C; White, RM; Matos, DA; Puller, AC; Santoriello, C; Liao, EC; Young, RA; Zon, LI				Kaufman, Charles K.; Mosimann, Christian; Fan, Zi Peng; Yang, Song; Thomas, Andrew J.; Ablain, Julien; Tan, Justin L.; Fogley, Rachel D.; van Rooijen, Ellen; Hagedorn, Elliott J.; Ciarlo, Christie; White, Richard M.; Matos, Dominick A.; Puller, Ann-Christin; Santoriello, Cristina; Liao, Eric C.; Young, Richard A.; Zon, Leonard I.			A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation	SCIENCE			English	Article							SUPER-ENHANCERS; TRANSCRIPTION FACTOR; INHIBITORY-ACTIVITY; CELL IDENTITY; GENE; EXPRESSION; SOX10; CHROMATIN; DISEASE; SYSTEM	The "cancerized field" concept posits that cancer-prone cells in a given tissue share an oncogenic mutation, but only discreet clones within the field initiate tumors. Most benign nevi carry oncogenic BRAF(V600E) mutations but rarely become melanoma. The zebrafish crestin gene is expressed embryonically in neural crest progenitors (NCPs) and specifically reexpressed in melanoma. Live imaging of transgenic zebrafish crestin reporters shows that within a cancerized field (BRAF(V600E)-mutant; p53-deficient), a single melanocyte reactivates the NCP state, revealing a fate change at melanoma initiation in this model. NCP transcription factors, including sox10, regulate crestin expression. Forced sox10 overexpression in melanocytes accelerated melanoma formation, which is consistent with activation of NCP genes and super-enhancers leading to melanoma. Our work highlights NCP state reemergence as a key event in melanoma initiation.	[Kaufman, Charles K.; Yang, Song; Thomas, Andrew J.; Ablain, Julien; Tan, Justin L.; Fogley, Rachel D.; van Rooijen, Ellen; Hagedorn, Elliott J.; Ciarlo, Christie; Santoriello, Cristina; Zon, Leonard I.] Childrens Hosp Boston, Howard Hughes Med Inst, Stem Cell Program, Boston, MA 02115 USA; [Kaufman, Charles K.; Yang, Song; Thomas, Andrew J.; Ablain, Julien; Tan, Justin L.; Fogley, Rachel D.; van Rooijen, Ellen; Hagedorn, Elliott J.; Ciarlo, Christie; Santoriello, Cristina; Zon, Leonard I.] Childrens Hosp Boston, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Kaufman, Charles K.; Yang, Song; Ablain, Julien; van Rooijen, Ellen; Hagedorn, Elliott J.; Liao, Eric C.; Zon, Leonard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kaufman, Charles K.; Zon, Leonard I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kaufman, Charles K.; Ablain, Julien; van Rooijen, Ellen; Hagedorn, Elliott J.; Ciarlo, Christie; Liao, Eric C.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Mosimann, Christian] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Fan, Zi Peng; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [White, Richard M.] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY 10075 USA; [Matos, Dominick A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA; [Puller, Ann-Christin] Childrens Canc Ctr Hamburg, Inst Res, D-20246 Hamburg, Germany; [Puller, Ann-Christin] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Santoriello, Cristina; Zon, Leonard I.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Liao, Eric C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Young, Richard A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Zurich; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Cornell University; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Zon, LI (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Stem Cell Program, Boston, MA 02115 USA.; Zon, LI (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA.; Zon, LI (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.; Zon, LI (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Zon, LI (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Zon, LI (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	zon@enders.tch.harvard.edu	, Charles/ABC-8259-2020; Young, Richard A/F-6495-2012; Tan, Justin/AAV-1101-2020	Young, Richard A/0000-0001-8855-8647; Tan, Justin/0000-0003-0268-7363; Kaufman, Charles/0000-0003-3122-1677; Ablain, Julien/0000-0002-4509-3568; Liao, Eric/0000-0001-6385-7448; Mosimann, Christian/0000-0002-0749-2576	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K08 AR061071]; European Molecular Biology Organization; Human Frontier Science Program; Swiss National Science Foundation; Ellison Foundation; V Foundation; Melanoma Research Alliance; Howard Hughes Medical Institute; NIH [HG002668];  [R01 CA103846]; NATIONAL CANCER INSTITUTE [P30CA014051, DP2CA186572, P30CA008748, R01CA103846] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR061071] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ellison Foundation(Lawrence Ellison Foundation); V Foundation; Melanoma Research Alliance; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	C.K.K. and research reported here is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award K08 AR061071. C.M. received support from a European Molecular Biology Organization long-term fellowship, a Human Frontier Science Program long-term fellowship, and a Swiss National Science Foundation advanced postdoctoral fellowship. L.I.Z. is supported by R01 CA103846, the Ellison Foundation, the V Foundation, and the Melanoma Research Alliance and is a Howard Hughes Medical Institute Investigator. R.A.Y. is supported by NIH HG002668. Z.P.F. was supported by NIH HG002668. E.J.H. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation. L.I.Z. is a founder and stock holder of Fate, Inc. and Scholar Rock. R.A.Y. is a founder of Syros Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank the Massachusetts General Hospital DNA Core for providing technical assistance with deep sequencing. We thank J. Ablain for critical review of the manuscript, C. Ceol for the gift of the zebrafish mitfa middle entry clone, and G. Musso for helpful discussions on microarray data and GSEA. All microarray, Chip-seq, and RNA-seq are deposited at Gene Expression Omnibus, ID GSE75356.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bosserhoff AK, 2005, PIGM CELL RES, V18, P411, DOI 10.1111/j.1600-0749.2005.00274.x; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Graf SA, 2014, J INVEST DERMATOL, V134, P2212, DOI 10.1038/jid.2014.128; Grzmil M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000959; Heilmann S, 2015, CANCER RES, V75, P4272, DOI 10.1158/0008-5472.CAN-14-3319; HILDEMANN WH, 1958, IMMUNOLOGY, V1, P46; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Kong YW, 2014, CHEM BIOL, V21, P488, DOI 10.1016/j.chembiol.2014.02.013; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Olesnicky E, 2010, GENESIS, V48, P656, DOI 10.1002/dvg.20673; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ronnstrand L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0648-y; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vogel AM, 1999, MECH DEVELOP, V85, P133, DOI 10.1016/S0925-4773(99)00104-5; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yen J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r113; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	232	235	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272							aad2197	10.1126/science.aad2197	http://dx.doi.org/10.1126/science.aad2197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823433	Green Submitted, Green Accepted			2022-12-28	WOS:000368858200026
J	Pither, J; Fraser, LH; Jentsch, A; Sternberg, M; Zobel, M; Cahill, J; Beierkuhnlein, C; Bartha, S; Bennett, JA; Boldgiv, B; Brown, LR; Cabido, M; Campetella, G; Carlyle, CN; Chelli, S; Csergo, AM; Diaz, S; Enrico, L; Ensing, D; Fidelis, A; Garris, HW; Henry, HAL; Hohn, M; Klironomos, J; Koorem, K; Lawrence-Lodge, R; Manning, P; Mitchell, RJ; Moora, M; Pillar, VD; Stotz, GC; Sugiyama, S; Szentes, S; Tungalag, R; Undrakhbold, S; Wellstein, C; Zupo, T				Pither, Jason; Fraser, Lauchlan H.; Jentsch, Anke; Sternberg, Marcelo; Zobel, Martin; Cahill, James; Beierkuhnlein, Carl; Bartha, Sandor; Bennett, Jonathan A.; Boldgiv, Bazartseren; Brown, Leslie R.; Cabido, Marcelo; Campetella, Giandiego; Carlyle, Cameron N.; Chelli, Stefano; Csergo, Anna Maria; Diaz, Sandra; Enrico, Lucas; Ensing, David; Fidelis, Alessandra; Garris, Heath W.; Henry, Hugh A. L.; Hoehn, Maria; Klironomos, John; Koorem, Kadri; Lawrence-Lodge, Rachael; Manning, Peter; Mitchell, Randall J.; Moora, Mari; Pillar, Valerio D.; Stotz, Gisela C.; Sugiyama, Shu-ichi; Szentes, Szilard; Tungalag, Radnaakhand; Undrakhbold, Sainbileg; Wellstein, Camilla; Zupo, Talita			Response to Comment on "Worldwide evidence of a unimodal relationship between productivity and plant species richness"	SCIENCE			English	Editorial Material									[Pither, Jason; Klironomos, John] Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada; [Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Jentsch, Anke] Univ Bayreuth, Dept Disturbance Ecol, BayCEER, Bayreuth, Germany; [Sternberg, Marcelo] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel; [Zobel, Martin; Bennett, Jonathan A.; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia; [Cahill, James; Bennett, Jonathan A.; Stotz, Gisela C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Beierkuhnlein, Carl] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Dept Biogeog, Bayreuth, Germany; [Bartha, Sandor] Hungarian Acad Sci, Inst Ecol & Bot, Ctr Ecol Res, Vacratot, Hungary; [Bartha, Sandor] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Boldgiv, Bazartseren; Tungalag, Radnaakhand] Natl Univ Mongolia, Ecol Grp, Dept Biol, Ulaanbaatar, Mongolia; [Brown, Leslie R.] Univ S Africa, Dept Environm Sci, Florida, South Africa; [Cabido, Marcelo] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Campetella, Giandiego; Chelli, Stefano] Univ Camerino, Plant Divers & Ecosyst Management Unit, Sch Biosci & Vet Med, I-62032 Camerino, Italy; [Carlyle, Cameron N.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Csergo, Anna Maria] Univ Dublin, Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Diaz, Sandra; Enrico, Lucas] Univ Nacl Cordoba, Natl Sci & Tech Res Council, Inst Multidisciplinario Biol Vegetal, RA-5000 Cordoba, Argentina; [Diaz, Sandra; Enrico, Lucas] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Ensing, David] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Fidelis, Alessandra; Zupo, Talita] UNESP Univ Estadual Paulista, Dept Bot, Rio Claro, SP, Brazil; [Henry, Hugh A. L.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Hoehn, Maria] Corvinus Univ Budapest, Fac Hort Sci, Dept Bot, Budapest, Hungary; [Lawrence-Lodge, Rachael] Univ Otago, Dept Bot, POB 56, Dunedin, New Zealand; [Manning, Peter] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany; [Mitchell, Randall J.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Pillar, Valerio D.] Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil; [Sugiyama, Shu-ichi] Hirosaki Univ, Fac Agr & Life Sci, Aomori, Japan; [Szentes, Szilard] Szent Istvan Univ, Inst Plant Prod, Godollo, Hungary; [Wellstein, Camilla] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy	University of British Columbia; University of Bayreuth; Tel Aviv University; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Alberta; University of Bayreuth; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Western Australia; National University of Mongolia; University of South Africa; National University of Cordoba; University of Camerino; University of Alberta; Trinity College Dublin; National University of Cordoba; National University of Cordoba; Queens University - Canada; Universidade Estadual Paulista; Western University (University of Western Ontario); Corvinus University Budapest; University of Otago; Senckenberg Gesellschaft fur Naturforschung (SGN); University System of Ohio; University of Akron; Universidade Federal do Rio Grande do Sul; Hirosaki University; Hungarian University of Agriculture & Life Sciences; Free University of Bozen-Bolzano	Pither, J (corresponding author), Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada.	jason.pither@ubc.ca	Wellstein, Camilla/C-5042-2012; Bennett, Jonathan/AAH-3191-2021; Beierkuhnlein, Carl/ABF-8797-2021; Moora, Mari/D-1961-2009; Manning, Peter/I-6523-2012; Bennett, Jonathan A/J-5839-2013; Csergo, Anna Maria/AAB-3581-2021; Fidelis, Alessandra/B-9769-2012; Boldgiv, Bazartseren/I-4754-2013; Díaz, Sandra/ABE-7349-2020; Csergő, Anna Mária/J-3446-2013; Diaz, Sandra/Q-9804-2018; Zobel, Martin/H-1336-2015; Brown, Leslie R/N-9762-2015; Beierkuhnlein, Carl/ABF-9693-2021; Henry, Hugh A L/C-3955-2017; Sternberg, Marcelo/AFQ-1615-2022; Pillar, Valerio/B-9872-2008; Mitchell, Randall J/G-6380-2010; Stotz, Gisela/E-2197-2017	Bennett, Jonathan/0000-0001-5617-7524; Moora, Mari/0000-0002-4819-7506; Manning, Peter/0000-0002-7940-2023; Bennett, Jonathan A/0000-0001-5617-7524; Csergo, Anna Maria/0000-0003-3325-2995; Fidelis, Alessandra/0000-0001-9545-2285; Boldgiv, Bazartseren/0000-0003-0015-8142; Díaz, Sandra/0000-0003-0012-4612; Csergő, Anna Mária/0000-0003-3325-2995; Zobel, Martin/0000-0001-7957-6704; Brown, Leslie R/0000-0002-1026-5438; Beierkuhnlein, Carl/0000-0002-6456-4628; Sternberg, Marcelo/0000-0001-8710-4141; Pillar, Valerio/0000-0001-6408-2891; Mitchell, Randall J/0000-0001-7961-3560; Stotz, Gisela/0000-0001-8687-7361; Lawrence Lodge, Rachael/0000-0002-0059-3323; Pither, Jason/0000-0002-7490-6839; Carlyle, Cameron/0000-0003-4753-5945; Ensing, David/0000-0003-2903-1209; Enrico, Lucas/0000-0002-8932-0144; Wellstein, Camilla/0000-0001-6994-274X; Campetella, Giandiego/0000-0001-6126-522X; Koorem, Kadri/0000-0002-3376-9372				Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Fraser LH, 2014, J VEG SCI, V25, P1160, DOI 10.1111/jvs.12167; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Tredennick AT, 2016, SCIENCE, V351, DOI 10.1126/science.aad6236	5	2	3	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272								10.1126/science.aad8019	http://dx.doi.org/10.1126/science.aad8019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823419	Green Accepted, Green Submitted			2022-12-28	WOS:000368858200025
J	Hurley, R				Hurley, Richard			THE BMJ WINTER APPEAL Bringing healthcare to the UK's abused domestic workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2016	352								i502	10.1136/bmj.i502	http://dx.doi.org/10.1136/bmj.i502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6ET	26818739	Green Published, Bronze			2022-12-28	WOS:000369313300005
J	Cole, TB				Cole, Thomas B.			Nkisi Nkondi (Nail Figure) Congolese, Republic of the Congo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					330	+		10.1001/jama.2015.14073	http://dx.doi.org/10.1001/jama.2015.14073			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26813193				2022-12-28	WOS:000368589500001
J	Barnett, R				Barnett, Richard			Case histories Parkinson's disease	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	16	18	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					217	217		10.1016/S0140-6736(16)00049-0	http://dx.doi.org/10.1016/S0140-6736(16)00049-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26842286				2022-12-28	WOS:000368130700016
J	Chen, JY; Miyanishi, M; Wang, SK; Yamazaki, S; Sinha, R; Kao, KS; Seita, J; Sahoo, D; Nakauchi, H; Weissman, IL				Chen, James Y.; Miyanishi, Masanori; Wang, Sean K.; Yamazaki, Satoshi; Sinha, Rahul; Kao, Kevin S.; Seita, Jun; Sahoo, Debashis; Nakauchi, Hiromitsu; Weissman, Irving L.			Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche	NATURE			English	Article							BONE-MARROW; IN-VIVO; DIFFERENTIATION; RECONSTITUTION; PROGENITORS; EXPRESSION	Haematopoietic stem cells (HSCs) are arguably the most extensively characterized tissue stem cells. Since the identification of HSCs by prospective isolation(1), complex multi-parameter flow cytometric isolation of phenotypic subsets has facilitated studies on many aspects of HSC biology, including self-renewal(2-4), differentiation, ageing, niche(5), and diversity(6-8). Here we demonstrate by unbiased multi-step screening, identification of a single gene, homeobox B5 (Hoxb5, also known as Hox-2.1), with expression in the bone marrow that is limited to long-term (LT)-HSCs in mice. Using a mouse single-colour tri-mCherry reporter driven by endogenous Hoxb5 regulation, we show that only the Hoxb5(+) HSCs exhibit long-term reconstitution capacity after transplantation in primary transplant recipients and, notably, in secondary recipients. Only 7-35% of various previously defined immunophenotypic HSCs are LT-HSCs. Finally, by in situ imaging of mouse bone marrow, we show that >94% of LT-HSCs (Hoxb5(+)) are directly attached to VE-cadherin(+) cells, implicating the perivascular space as a near-homogenous location of LT-HSCs.	[Chen, James Y.; Miyanishi, Masanori; Wang, Sean K.; Sinha, Rahul; Kao, Kevin S.; Seita, Jun; Sahoo, Debashis; Nakauchi, Hiromitsu; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Chen, James Y.; Miyanishi, Masanori; Wang, Sean K.; Sinha, Rahul; Kao, Kevin S.; Sahoo, Debashis; Weissman, Irving L.] Stanford Univ, Ludwig Ctr Canc Stem Cell Res & Med, Sch Med, Stanford, CA 94305 USA; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1088639, Japan; [Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Sahoo, Debashis] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92123 USA	Stanford University; Stanford University; University of Tokyo; University of California System; University of California San Diego; University of California System; University of California San Diego	Weissman, IL (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	supamasa@stanford.edu; irv@stanford.edu	Seita, Jun/AAM-1478-2020	Seita, Jun/0000-0002-3008-3615; Wang, Sean K/0000-0003-1557-8510	NCI; NHLBI of the NIH [R01 CA086065, U01 HL099999, R01 HL058770]; Virginia and D. K. Ludwig Fund for Cancer Research; Stanford University Medical Scientist Training Program [T32 GM007365]; NHLBI Ruth L. Kirschstein National Research Service Award [F30-HL122096]; Human Frontier Science Program Long-Term Fellowships; Uehara Memorial Foundation Research Fellowship; Toyobo Biotechnology Foundation Research Fellowship; Kanzawa Medical Research Foundation Overseas study grants; NATIONAL CANCER INSTITUTE [R01CA086065, R00CA151673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, R01HL058770, F30HL122096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16H02661] Funding Source: KAKEN	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Virginia and D. K. Ludwig Fund for Cancer Research; Stanford University Medical Scientist Training Program; NHLBI Ruth L. Kirschstein National Research Service Award; Human Frontier Science Program Long-Term Fellowships; Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); Toyobo Biotechnology Foundation Research Fellowship; Kanzawa Medical Research Foundation Overseas study grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to acknowledge N. Neff and G. Mantalas for advice regarding RNA sequencing; B. Yu and A. Beel for providing critical input on imaging data; H. Nishikii for advice regarding imaging data; S. Karten for help in editing the manuscript; L. Jerabek and T. Storm for laboratory management; A. McCarty and C. Wang for animal care; P. Lovelace and J. Ho for FACS facility management; H. Zeng, Y. Li, and C. Wang for collaboration in generating the mouse model; and Y. Sato for technical assistance in Imaris software analysis. The authors would like to acknowledge ongoing support for this work: NCI and NHLBI of the NIH under award numbers R01 CA086065, U01 HL099999, and R01 HL058770, and by the Virginia and D. K. Ludwig Fund for Cancer Research (I.L.W.); Stanford University Medical Scientist Training Program (T32 GM007365) and NHLBI Ruth L. Kirschstein National Research Service Award (F30-HL122096) (J. Y. C.); and Human Frontier Science Program Long-Term Fellowships, the Uehara Memorial Foundation Research Fellowship, Toyobo Biotechnology Foundation Research Fellowship, and Kanzawa Medical Research Foundation Overseas study grants (M.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fathman JW, 2014, STEM CELL REP, V3, P707, DOI 10.1016/j.stemcr.2014.09.007; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hills D, 2011, BLOOD, V117, P3521, DOI 10.1182/blood-2009-12-253989; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	34	198	208	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					223	+		10.1038/nature16943	http://dx.doi.org/10.1038/nature16943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26863982	Green Accepted, Green Submitted			2022-12-28	WOS:000369916700040
J	Nisi, G; Sisti, A				Nisi, Giuseppe; Sisti, Andrea			Madelung's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nisi, Giuseppe; Sisti, Andrea] Univ Siena, Via Laterina 8, I-53100 Siena, Italy	University of Siena	Sisti, A (corresponding author), Univ Siena, Via Laterina 8, I-53100 Siena, Italy.	asisti6@gmail.com	Sisti, Andrea/AAH-7615-2020	Sisti, Andrea/0000-0002-6634-5613; Nisi, Giuseppe/0000-0002-0357-8487					0	10	11	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					572	572		10.1056/NEJMicm1503861	http://dx.doi.org/10.1056/NEJMicm1503861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863358	Green Published			2022-12-28	WOS:000369755800010
J	Hansen, CH; Schellenberg, JRMA				Hansen, Christian Holm; Schellenberg, Joanna R. M. Armstrong			Modest global achievements in maternal survival: more focus on sub-Saharan Africa is needed	LANCET			English	Editorial Material							MORTALITY; COUNTDOWN		[Hansen, Christian Holm] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Keppel St, London WC1E 7HT, England; [Hansen, Christian Holm] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Schellenberg, Joanna R. M. Armstrong] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Hansen, CH (corresponding author), Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Keppel St, London WC1E 7HT, England.; Hansen, CH (corresponding author), Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania.	christian.hansen@lshtm.ac.uk		Schellenberg, Joanna/0000-0002-0708-3676; Hansen, Christian/0000-0002-5949-0097				Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Alkema L, 2015, BAYESIAN APPROACH GL; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], 2015, MAT NEWB CHILD SURV; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; UN General Assembly, 2015, ARES701; UN General Assembly, 2000, ARES552	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					410	411		10.1016/S0140-6736(16)00099-4	http://dx.doi.org/10.1016/S0140-6736(16)00099-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26869551	Green Accepted			2022-12-28	WOS:000368986800007
J	Ossendrijver, M				Ossendrijver, Mathieu			Ancient Babylonian astronomers calculated Jupiter's position from the area under a time-velocity graph	SCIENCE			English	Article								The idea of computinga body's displacement as an area in time-velocity space is usually traced back to 14th-century Europe. I show that in four ancient Babylonian cuneiform tablets, Jupiter's displacement along the ecliptic is computed as the area of a trapezoidal figure obtained by drawing its daily displacement against time. This interpretation is prompted by a newly discovered tablet on which the same computation is presented in an equivalent arithmetical formulation. The tablets date from 350 to 50 BCE. The trapezoid procedures offer the first evidence for the use of geometrical methods in Babylonian mathematical astronomy, which was thus far viewed as operating exclusively with arithmetical concepts.	[Ossendrijver, Mathieu] Humboldt Univ, Inst Philosophy, Excellence Cluster TOPOI, D-10099 Berlin, Germany	Humboldt University of Berlin	Ossendrijver, M (corresponding author), Humboldt Univ, Inst Philosophy, Excellence Cluster TOPOI, D-10099 Berlin, Germany.	mathieu.ossendrijver@hu-berlin.de		Ossendrijver, Mathieu/0000-0002-9447-034X	Excellence Cluster TOPOI, "The Formation and Transformation of Space and Knowledge in Ancient Cultures" (Deutsche Forschungsgemeinschaft), Berlin [EXC 264]	Excellence Cluster TOPOI, "The Formation and Transformation of Space and Knowledge in Ancient Cultures" (Deutsche Forschungsgemeinschaft), Berlin	The Trustees of the British Museum (London) are thanked for permission to photograph, study, and publish the tablets. Work was supported by the Excellence Cluster TOPOI, "The Formation and Transformation of Space and Knowledge in Ancient Cultures" (Deutsche Forschungsgemeinschaft grant EXC 264), Berlin. Photographs, transliterations, and translations of the relevant parts of the tablets are included in the supplementary materials. The tablets are accessible in the Middle Eastern Department of the British Museum under the registration numbers BM 40054 (text A), BM 36801, BM 41043, BM 34757 (text B), BM 34081+34622+34846+42816+45851+46135 (text C), BM 35915 (text D), and BM 82824+99697+99742 (text E). H. Hunger (Vienna) is acknowledged for providing an unpublished photograph of BM 40054.	Britton JP, 2010, ARCH HIST EXACT SCI, V64, P617, DOI 10.1007/s00407-010-0064-z; Freeth T, 2008, NATURE, V454, P614, DOI 10.1038/nature07130; Friberg, 2000, REV ASSYRIOLOGIE, V94, P97; Friberg J., 1990, REALLEXIKON ASSYRIOL, V7, P561; Friberg J., 2007, MANUSCRIPTS SCHOYEN, P1; Hoyrup Jens., 2002, SOURCES STUDIES HIST; Huber P. J., 1957, Z ASSYRIOLOGIE, V52, P265; Jones Alexander, 1999, ASTRONOMICAL PAPYRI; Neugebauer O., 1955, ASTRONOMICAL CUNEIFO; Neugebauer O., 1935, MATH KEILSCHRIFTTEXT, V1-3; Ossendrijver M., 2012, BABYLONIAN MATH ASTR; Pedersen M., 1974, EARLY PHYS ASTRONOMY; Sylla E., 1982, CAMBRIDGE HIST LATER, P540; Vaiman A. A., 1961, SHUMERO VAVILONSKAYA	14	18	18	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					482	484		10.1126/science.aad8085	http://dx.doi.org/10.1126/science.aad8085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DB9SW	26823423				2022-12-28	WOS:000368858200031
J	Tredennick, AT; Adler, PB; Grace, JB; Harpole, WS; Borer, ET; Seabloom, EW; Anderson, TM; Bakker, JD; Biederman, LA; Brown, CS; Buckley, YM; Chu, CJ; Collins, SL; Crawley, MJ; Fay, PA; Firn, J; Gruner, DS; Hagenah, N; Hautier, Y; Hector, A; Hillebrand, H; Kirkman, K; Knops, JMH; Laungani, R; Lind, EM; MacDougall, AS; McCulley, RL; Mitchell, CE; Moore, JL; Morgan, JW; Orrock, JL; Peri, PL; Prober, SM; Risch, AC; Schutz, M; Speziale, KL; Standish, RJ; Sullivan, LL; Wardle, GM; Williams, RJ; Yang, LH				Tredennick, Andrew T.; Adler, Peter B.; Grace, James B.; Harpole, W. Stanley; Borer, Elizabeth T.; Seabloom, Eric W.; Anderson, T. Michael; Bakker, Jonathan D.; Biederman, Lori A.; Brown, Cynthia S.; Buckley, Yvonne M.; Chu, Chengjin; Collins, Scott L.; Crawley, Michael J.; Fay, Philip A.; Firn, Jennifer; Gruner, Daniel S.; Hagenah, Nicole; Hautier, Yann; Hector, Andy; Hillebrand, Helmut; Kirkman, Kevin; Knops, Johannes M. H.; Laungani, Ramesh; Lind, Eric M.; MacDougall, Andrew S.; McCulley, Rebecca L.; Mitchell, Charles E.; Moore, Joslin L.; Morgan, John W.; Orrock, John L.; Peri, Pablo L.; Prober, Suzanne M.; Risch, Anita C.; Schuetz, Martin; Speziale, Karina L.; Standish, Rachel J.; Sullivan, Lauren L.; Wardle, Glenda M.; Williams, Ryan J.; Yang, Louie H.			Comment on "Worldwide evidence of a unimodal relationship between productivity and plant species richness"	SCIENCE			English	Editorial Material									[Tredennick, Andrew T.; Adler, Peter B.] Utah State Univ, Dept Wildland Resources, 5230 Old Main, Logan, UT 84322 USA; [Tredennick, Andrew T.; Adler, Peter B.] Utah State Univ, Ctr Ecol, 5230 Old Main, Logan, UT 84322 USA; [Grace, James B.] US Geol Survey, Wetland & Aquat Res Ctr, 700 Cajundome Blvd, Lafayette, LA 70506 USA; [Harpole, W. Stanley] UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, Permoserstr 15, D-04318 Leipzig, Germany; [Borer, Elizabeth T.; Lind, Eric M.; Sullivan, Lauren L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Box 7325 Reynolda Stn, Winston Salem, NC 27109 USA; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, 3501 NE 41st St,Box 354115, Seattle, WA 98195 USA; [Biederman, Lori A.] Iowa State Univ, Ecol Evolut & Organismal Biol, 251 Bessey Hall, Ames, IA 50010 USA; [Brown, Cynthia S.] Colorado State Univ, Dept Bioagr Sci & Pest Management, 307 Univ Ave, Ft Collins, CO 80523 USA; [Buckley, Yvonne M.] Univ Dublin, Trinity Coll Dublin, Sch Nat Sci, Zool, Dublin 2, Ireland; [Chu, Chengjin] Sun Yat Sen Univ, Sch Life Sci, Xingang Xi Rd 135, Guangzhou 510275, Guangdong, Peoples R China; [Collins, Scott L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Crawley, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England; [Fay, Philip A.] USDA ARS, Grassland Soil & Water Res Lab, 808 East Blackland Rd, Temple, TX 76502 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci 42, Brisbane, Qld 4001, Australia; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, Plant Sci 4112, College Pk, MD 20742 USA; [Hagenah, Nicole; Kirkman, Kevin] Univ KwaZulu Natal, Sch Life Sci, 1 Carbis Rd, ZA-3201 Pietermaritzburg, South Africa; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Hector, Andy] Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Schleusenstr 1, D-26382 Wihlhemshaven, Germany; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, 211 Manter Hall, Lincoln, NE 68588 USA; [Laungani, Ramesh] Doane Coll, Dept Biol, 1014 Boswell Ave, Crete, NE 68333 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, 50 Stone Rd, Guelph, ON N1G 2W1, Canada; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, N-222D Ag Sci North, Lexington, KY 40546 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Moore, Joslin L.] Monash Univ, Sch Biol Sci, Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia; [Morgan, John W.] La Trobe Univ, Dept Ecol Environm & Evolut, Kingsbury Dr, Bundoora, Vic 3086, Australia; [Orrock, John L.] Univ Wisconsin, Dept Zool, 430 Lincoln Dr, Madison, WI 53706 USA; [Peri, Pablo L.] Southern Patagonia Natl Univ, Dept Forestry Agr & Water, INTA, CONICET, CC 332, RA-9400 Santa Cruz, Patagonia, Argentina; [Prober, Suzanne M.] Commonwealth Sci & Ind Res Org Land & Water, Private Bag 5, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, Community Ecol, Zuercherstr 111, CH-8903 Birmensdorf, Switzerland; [Speziale, Karina L.] UNCO, CONICET, Dept Ecol, INIBIOMA, Quintral 1250, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Standish, Rachel J.] Murdoch Univ, Sch Vet & Life Sci, 90 South St, Murdoch, WA 6150, Australia; [Wardle, Glenda M.] Univ Sydney, Sch Biol Sci, Heydon Laurence Bldg A08, Sydney, NSW 2006, Australia; [Williams, Ryan J.] Iowa State Univ, Agr & Biosyst Engn, Ames, IA USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol & Nematol, One Shields Ave, Davis, CA 95616 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of the Interior; United States Geological Survey; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; University of Washington; University of Washington Seattle; Iowa State University; Colorado State University; Trinity College Dublin; Sun Yat Sen University; University of New Mexico; Imperial College London; United States Department of Agriculture (USDA); Queensland University of Technology (QUT); University System of Maryland; University of Maryland College Park; University of Kwazulu Natal; Utrecht University; University of Oxford; Carl von Ossietzky Universitat Oldenburg; University of Nebraska System; University of Nebraska Lincoln; University of Guelph; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Monash University; La Trobe University; University of Wisconsin System; University of Wisconsin Madison; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Murdoch University; University of Sydney; Iowa State University; University of California System; University of California Davis	Tredennick, AT (corresponding author), Utah State Univ, Dept Wildland Resources, 5230 Old Main, Logan, UT 84322 USA.; Tredennick, AT (corresponding author), Utah State Univ, Ctr Ecol, 5230 Old Main, Logan, UT 84322 USA.	atredenn@gmail.com	Hautier, Yann/I-2526-2019; Buckley, Yvonne/B-1281-2008; Hillebrand, Helmut/I-1717-2014; Standish, Rachel J/B-1028-2011; MacDougall, Andrew S/F-2037-2011; Harpole, William S/C-2814-2013; Kirkman, Kevin P/F-4160-2010; Collins, Scott L/P-7742-2014; Fay, Philip A./I-1853-2012; Moore, Joslin L/C-5270-2009; Moore, Joslin/AAE-3819-2020; Kirkman, Kevin/GNM-5334-2022; Grace, James/B-8472-2009; Wardle, Glenda/D-6533-2016; Hector, Andrew/H-4199-2011; Risch, Anita C./A-9836-2012; Peri, Pablo Luis/ACF-3770-2022; Prober, Suzanne/G-6465-2010; Wardle, Glenda/ABD-9228-2021; Gruner, Daniel Stephen/A-5166-2010; Hautier, Yann/D-5426-2015; Knops, Johannes/AAA-8546-2020; Bakker, Jonathan/I-6960-2013; Chu, Chu/T-6038-2019; Cahill, James/B-6147-2015	Hautier, Yann/0000-0003-4347-7741; Buckley, Yvonne/0000-0001-7599-3201; Hillebrand, Helmut/0000-0001-7449-1613; Harpole, William S/0000-0002-3404-9174; Kirkman, Kevin P/0000-0001-9580-5191; Collins, Scott L/0000-0002-0193-2892; Fay, Philip A./0000-0002-8291-6316; Moore, Joslin L/0000-0001-9809-5092; Moore, Joslin/0000-0001-9809-5092; Kirkman, Kevin/0000-0001-9580-5191; Grace, James/0000-0001-6374-4726; Wardle, Glenda/0000-0003-0189-1899; Hector, Andrew/0000-0002-1309-7716; Risch, Anita C./0000-0003-0531-8336; Prober, Suzanne/0000-0002-6518-239X; Wardle, Glenda/0000-0003-0189-1899; Gruner, Daniel Stephen/0000-0002-3153-4297; Hautier, Yann/0000-0003-4347-7741; Bakker, Jonathan/0000-0002-8973-2771; Seabloom, Eric/0000-0001-6780-9259; Chu, Chengjin/0000-0002-0606-449X; Borer, Elizabeth/0000-0003-2259-5853; CHELLI, Stefano/0000-0001-7184-8242; Lind, Eric/0000-0003-3051-7724; Biederman, Lori/0000-0003-2171-7898; Yang, Louie/0000-0002-9237-5357; Cahill, James/0000-0002-4110-1516; Standish, Rachel/0000-0001-8118-1904; Brown, Cynthia/0000-0001-8486-7119	Direct For Biological Sciences [1400370] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Grace JB, 2012, SCIENCE, V335, DOI 10.1126/science.1214939; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Lefcheck J., 2014, R SQUARED GEN LINEAR; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x	6	11	12	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272								10.1126/science.aad6236	http://dx.doi.org/10.1126/science.aad6236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823418	Green Submitted, Green Published			2022-12-28	WOS:000368858200024
J	Tracey, KJ				Tracey, Kevin J.			Reflexes in Immunity	CELL			English	Editorial Material							T-CELLS; INFLAMMATION		[Tracey, Kevin J.] Hofstra Northwell Sch Med, Feinstein Inst, 350 Community Dr, Manhasset, NY 11030 USA	Northwell Health	Tracey, KJ (corresponding author), Hofstra Northwell Sch Med, Feinstein Inst, 350 Community Dr, Manhasset, NY 11030 USA.	kjtracey@northwell.edu		Tracey, Kevin J/0000-0003-1884-6314	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118182] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Tracey KJ, 2015, SCI AM, V312, P28, DOI 10.1038/scientificamerican0315-28; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	9	40	41	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					343	344		10.1016/j.cell.2016.01.018	http://dx.doi.org/10.1016/j.cell.2016.01.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824649	Bronze			2022-12-28	WOS:000368906800004
J	Tung, MKY; Healy, S				Tung, Matthew K. Y.; Healy, Stewart			Cannon A Waves	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tung, Matthew K. Y.; Healy, Stewart] Monash Hlth, Clayton, Vic, Australia		Tung, MKY (corresponding author), Monash Hlth, Clayton, Vic, Australia.	mattytung@gmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					E4	E4		10.1056/NEJMicm1413235	http://dx.doi.org/10.1056/NEJMicm1413235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816027				2022-12-28	WOS:000368760100012
J	Street, A				Street, Alice			The art of medicine Making people care	LANCET			English	Editorial Material									[Street, Alice] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland	University of Edinburgh	Street, A (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland.	alice.street@ed.ac.uk		Street, Alice/0000-0001-7874-0234				Francis R., 2010, MID STAFFORDSHIRE NH; Honneth Axel., 1995, STRUGGLE RECOGNITION; Kleinman A, 2014, LANCET, V383, P119, DOI 10.1016/S0140-6736(14)60012-X; Street A, 2014, BIOMEDICINE UNSTABLE, DOI DOI 10.1215/9780822376668	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					333	334		10.1016/S0140-6736(16)00119-7	http://dx.doi.org/10.1016/S0140-6736(16)00119-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26842443				2022-12-28	WOS:000368516500018
J	Boseley, S				Boseley, Sarah			Mary Bassett: trailblazer for health in New York City	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					219	219		10.1016/S0140-6736(16)00051-9	http://dx.doi.org/10.1016/S0140-6736(16)00051-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA9LQ	26842288				2022-12-28	WOS:000368130700017
J	Fine, BV				Fine, B. V.			Comment on "Broken translational and rotational symmetry via charge stripe order in underdoped YBa2Cu3O6+y"	SCIENCE			English	Editorial Material								Comin et al. (Reports, 20 March 2015, p. 1335) have interpreted their resonant x-ray scattering experiment as indicating that charge inhomogeneities in the family of high-temperature superconductors YBa2Cu3O6+y (YBCO) have the character of one-dimensional stripes rather than two-dimensional checkerboards. The present Comment shows that one cannot distinguish between stripes and checkerboards on the basis of the above experiment.	[Fine, B. V.] Skolkovo Inst Sci & Technol, Skolkovo 143025, Moscow Region, Russia; [Fine, B. V.] Heidelberg Univ, Inst Theoret Phys, D-69120 Heidelberg, Germany	Skolkovo Institute of Science & Technology; Ruprecht Karls University Heidelberg	Fine, BV (corresponding author), Skolkovo Inst Sci & Technol, 100 Novaya St, Skolkovo 143025, Moscow Region, Russia.	b.fine@skoltech.ru						Christensen NB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.197003; Comin R, 2015, SCIENCE, V347, P1335, DOI 10.1126/science.1258399; Fine BV, 2011, J SUPERCOND NOV MAGN, V24, P1207, DOI 10.1007/s10948-010-1111-3; Fine BV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.060504; Fine BV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.224508; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021	7	13	13	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					235A	+		10.1126/science.aac4454	http://dx.doi.org/10.1126/science.aac4454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816370	Green Submitted			2022-12-28	WOS:000368098600028
J	Zhang, GY; Jin, H; Chen, H; Lu, QJ				Zhang, Guiying; Jin, Hui; Chen, Huan; Lu, Qianjin			Cutaneous nodules with positive autoantibodies: histoid leprosy	LANCET			English	Editorial Material									[Zhang, Guiying; Jin, Hui; Chen, Huan; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha 410011, Hunan, Peoples R China; [Chen, Huan] Hunan Prov Ctr Dis Control & Prevent, Dept Leprosy Prevent & Control, Changsha, Hunan, Peoples R China	Central South University	Lu, QJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha 410011, Hunan, Peoples R China.	qianlu5860@gmail.com						[Anonymous], 2014, Wkly Epidemiol Rec, V89, P389; Mendiratta V, 2011, J INFECT DEV COUNTR, V5, P128, DOI 10.3855/jidc.1190; OHKAWA S, 1985, DERMATOLOGICA, V170, P80, DOI 10.1159/000249504; Sene D, 2008, AUTOIMMUN REV, V7, P272, DOI 10.1016/j.autrev.2007.10.001; Singh I, 2012, CELL IMMUNOL, V278, P63, DOI 10.1016/j.cellimm.2012.06.011	5	5	5	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1915	1916		10.1016/S0140-6736(15)00678-9	http://dx.doi.org/10.1016/S0140-6736(15)00678-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26843313				2022-12-28	WOS:000364194700038
J	Califf, RM; Woodcock, J; Ostroff, S				Califf, Robert M.; Woodcock, Janet; Ostroff, Stephen			A Proactive Response to Prescription Opioid Abuse	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Califf, Robert M.; Woodcock, Janet; Ostroff, Stephen] Food & Drug Adm, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Califf, RM (corresponding author), Food & Drug Adm, Silver Spring, MD USA.				Amgen; Bayer Healthcare; BMEB Services; Bristol-Myers Squibb; Janssen; Medscape/Heart.org; Merck; Novartis; Regado; Roche; Astra-Zeneca; Genentech; GlaxoSmithKline; Heart.org/Daiichi-Sankyo; Kowa; Servier; Bayer Pharma; CV Sight; DSI-Lilly; Gambro; Gilead Sciences; Heart.org/Bayer; Pfizer; Regeneron; Medicines Company; Nile; Parkview; Amylin; Eli Lilly; Schering-Plough Research Institute; Scios	Amgen(Amgen); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); BMEB Services(Pharmatest Services); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medscape/Heart.org; Merck(Merck & Company); Novartis(Novartis); Regado; Roche(Roche Holding); Astra-Zeneca(AstraZeneca); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Heart.org/Daiichi-Sankyo; Kowa; Servier(Servier); Bayer Pharma; CV Sight; DSI-Lilly(Eli Lilly); Gambro; Gilead Sciences(Gilead Sciences); Heart.org/Bayer; Pfizer(Pfizer); Regeneron(Regeneron); Medicines Company; Nile; Parkview; Amylin; Eli Lilly(Eli Lilly); Schering-Plough Research Institute(Merck & Company); Scios	Dr. Califf reports receiving consulting fees from Amgen, Bayer Healthcare, BMEB Services, Bristol-Myers Squibb, Janssen, Medscape/Heart.org, Merck, Novartis, Regado, Roche, Astra-Zeneca, Genentech, GlaxoSmithKline, Heart.org/Daiichi-Sankyo, Kowa, Servier, Bayer Pharma, CV Sight, DSI-Lilly, Gambro, Gilead Sciences, Heart.org/Bayer, Pfizer, Regeneron, the Medicines Company, Nile, and Parkview; receiving grant support from Amylin, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, the Schering-Plough Research Institute, Scios, and Parkview; and holding equity in Nitrox/N30 Pharma and Portola, all prior to March 1, 2015. No other potential conflict of interest relevant to this article was reported.	CDC, 2020, WISQARS WEB BAS INJ; Centers for Disease Control and Prevention, 2014, VIT SIGNS OP PAINK P; Department of Health and Human Services, 2015, HHS TAK STRONG STEPS; Executive Office of the President of the United States, 2011, EP RESP AM PRESCR DR; Federal Register Notice, FED REG NOTICE PROPO; Food and Drug Administration, 2014, FDA APPR NEW HAND HE; Food and Drug Administration, 2015, FDA MOV QUICKL APPR; Food and Drug Administration, RISK EV MIT STRAT RE; Food and Drug Administration, 2015, GUID IND AB OP EV LA; Office of National Drug Control Policy, NAT DRUG CONTR STRAT; Office of the Surgeon General, 2011, NAT PREV STRAT AM PL	11	169	172	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1480	1485		10.1056/NEJMsr1601307	http://dx.doi.org/10.1056/NEJMsr1601307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	26845291	Bronze			2022-12-28	WOS:000374128400013
J	Stone, GW; Gao, RL; Kimura, T; Kereiakes, DJ; Ellis, SG; Onuma, Y; Cheong, WF; Jones-McMeans, J; Su, XL; Zhang, Z; Serruys, PW				Stone, Gregg W.; Gao, Runlin; Kimura, Takeshi; Kereiakes, Dean J.; Ellis, Stephen G.; Onuma, Yoshinobu; Cheong, Wai-Fung; Jones-McMeans, Jennifer; Su, Xiaolu; Zhang, Zhen; Serruys, Patrick W.			1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis	LANCET			English	Article							PACLITAXEL-ELUTING STENTS; VASCULAR SCAFFOLD; MYOCARDIAL-INFARCTION; NETWORK METAANALYSIS; RANDOMIZED-TRIAL; METALLIC STENTS; END-POINTS; FOLLOW-UP; EVEROLIMUS; REVASCULARIZATION	Background Compared with metallic drug-eluting stents, bioresorbable vascular scaffolds (BVS) off er the potential to improve long-term outcomes of percutaneous coronary intervention. Whether or not these devices are as safe and effective as drug-eluting stents within the first year after implantation is unknown. Methods We did a patient-level, pooled meta-analysis of four randomised trials in which 3389 patients with stable coronary artery disease or a stabilised acute coronary syndrome were enrolled at 301 academic and medical centres in North America, Europe, and the Asia-Pacific region. These patients were randomly assigned to the everolimuseluting Absorb BVS (n=2164) or the Xience cobalt-chromium everolimus-eluting stent (CoCr-EES; n=1225). The primary endpoints were the 1-year relative rates of the patient-oriented composite endpoint (all-cause mortality, all myocardial infarction, or all revascularisation) and the device-oriented composite endpoint of target lesion failure (cardiac mortality, target vessel-related myocardial infarction, or ischaemia-driven target lesion revascularisation). All analyses were by intention to treat. The four randomised trials included in our meta-analysis are all registered with ClinicalTrials.gov, numbers NCT01751906, NCT01844284, NCT01923740, and NCT01425281. Findings The summary treatment effect for the 1-year relative rates of the patient-oriented composite endpoint did not differ significantly different between BVS and CoCr-EES (relative risk [RR] 1.09 [0.89-1.34], p=0.38). Similarly, the 1-year relative rates of the device-oriented composite endpoint did not differ between the groups (RR 1.22 [95% CI 0.91-1.64], p=0.17). Target vessel-related myocardial infarction was increased with BVS compared with CoCr-EES (RR 1.45 [95% CI 1.02-2.07], p=0.04), due in part to non-significant increases in peri-procedural myocardial infarction and device thrombosis with BVS (RR 2.09 [0.92-4.75], p=0.08). The relative rates of all-cause and cardiac mortality, all myocardial infarction, ischaemia-driven target lesion revascularisation, and all revascularisation did not differ between BVS and CoCr-EES. Results were similar after multivariable adjustment for baseline imbalances, and were consistent across most subgroups and in sensitivity analysis when two additional randomised trials with less than 1 year of follow-up were included. Interpretation In this meta-analysis, BVS did not lead to different rates of composite patient-oriented and device-oriented adverse events at 1-year follow-up compared with CoCr-EES.	[Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Gao, Runlin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Beijing 100730, Peoples R China; [Kimura, Takeshi] Kyoto Univ Hosp, Kyoto 606, Japan; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Ellis, Stephen G.] Cleveland Clin, Cleveland, OH 44106 USA; [Onuma, Yoshinobu] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Cheong, Wai-Fung; Jones-McMeans, Jennifer; Su, Xiaolu; Zhang, Zhen] Abbott Vasc, Santa Clara, CA USA; [Serruys, Patrick W.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Cardiovasc Hlth, London, England	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Kyoto University; Christ Hospital - Ohio; Cleveland Clinic Foundation; Erasmus University Rotterdam; Erasmus MC; Imperial College London	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Floor, New York, NY 10022 USA.	gs2184@columbia.edu	Onuma, Yoshinobu/AHB-6273-2022	Onuma, Yoshinobu/0000-0001-7702-0649; Zhang, Zhen/0000-0002-0804-8741	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Abbott Vascular.	Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bourantas CV, 2013, AM HEART J, V165, P869, DOI 10.1016/j.ahj.2013.02.015; Brugaletta S, 2012, ATHEROSCLEROSIS, V221, P106, DOI 10.1016/j.atherosclerosis.2011.12.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kereiakes DJ, 2015, AM HEART J, V170, P641, DOI 10.1016/j.ahj.2015.07.013; Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435; Lane JP, 2014, JACC-CARDIOVASC INTE, V7, P688, DOI 10.1016/j.jcin.2013.11.024; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Ong P, 2014, CLIN RES CARDIOL, V103, P11, DOI 10.1007/s00392-013-0615-9; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pocock SJ, 2008, J AM COLL CARDIOL, V51, P23, DOI 10.1016/j.jacc.2007.07.084; Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017; Sabate M, 2015, EUR HEART J; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Serruys PW, 2012, EUR HEART J, V33, P16, DOI 10.1093/eurheartj/ehr384; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Simsek C, 2016, EUROINTERVENTION, V11, P996, DOI 10.4244/EIJY14M10_12; Smits PC, 2015, JACC-CARDIOVASC INTE, V8, P1157, DOI 10.1016/j.jcin.2015.03.028; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Team RC., 2013, R LANG ENV STAT COMP; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WINDECKER S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3859	33	234	241	1	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1277	1289		10.1016/S0140-6736(15)01039-9	http://dx.doi.org/10.1016/S0140-6736(15)01039-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	26825231				2022-12-28	WOS:000372697500026
J	Putman, RK; Hatabu, H; Araki, T; Gudmundsson, G; Gao, W; Nishino, M; Okajima, Y; Dupuis, J; Latourelle, JC; Cho, MH; El-Chemaly, S; Coxson, HO; Celli, BR; Fernandez, IE; Zazueta, OE; Ross, JC; Harmouche, R; Estepar, RSJ; Diaz, AA; Sigurdsson, S; Gudmundsson, EF; Eiriksdottir, G; Aspelund, T; Budoff, MJ; Kinney, GL; Hokanson, JE; Williams, MC; Murchison, JT; MacNee, W; Hoffmann, U; O'Donnell, CJ; Launer, LJ; Harrris, TB; Gudnason, V; Silverman, EK; O'Connor, GT; Washko, GR; Rosas, IO; Hunninghake, GM				Putman, Rachel K.; Hatabu, Hiroto; Araki, Tetsuro; Gudmundsson, Gunnar; Gao, Wei; Nishino, Mizuki; Okajima, Yuka; Dupuis, Josee; Latourelle, Jeanne C.; Cho, Michael H.; El-Chemaly, Souheil; Coxson, Harvey O.; Celli, Bartolome R.; Fernandez, Isis E.; Zazueta, Oscar E.; Ross, James C.; Harmouche, Rola; Estepar, Raul San Jose; Diaz, Alejandro A.; Sigurdsson, Sigurdur; Gudmundsson, Elias F.; Eiriksdottir, Gudny; Aspelund, Thor; Budoff, Matthew J.; Kinney, Gregory L.; Hokanson, John E.; Williams, Michelle C.; Murchison, John T.; MacNee, William; Hoffmann, Udo; O'Donnell, Christopher J.; Launer, Lenore J.; Harrris, Tamara B.; Gudnason, Vilmundur; Silverman, Edwin K.; O'Connor, George T.; Washko, George R.; Rosas, Ivan O.; Hunninghake, Gary M.		ECLIPSE Investigator; COPDGene Investigator	Association Between Interstitial Lung Abnormalities and All-Cause Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MUC5B PROMOTER POLYMORPHISM; SUSCEPTIBILITY; EPIDEMIOLOGY; PREVALENCE; DISEASE	IMPORTANCE Interstitial lung abnormalities have been associated with lower 6-minute walk distance, diffusion capacity for carbon monoxide, and total lung capacity. However, to our knowledge, an association with mortality has not been previously investigated. OBJECTIVE To investigate whether interstitial lung abnormalities are associated with increased mortality. DESIGN, SETTING, AND POPULATION Prospective cohort studies of 2633 participants from the FHS (Framingham Heart Study; computed tomographic [CT] scans obtained September 2008-March 2011), 5320 from the AGES-Reykjavik Study (Age Gene/Environment Susceptibility; recruited January 2002-February 2006), 2068 from the COPDGene Study (Chronic Obstructive Pulmonary Disease; recruited November 2007-April 2010), and 1670 from ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints; between December 2005 -December 2006). EXPOSURES Interstitial lung abnormality status as determined by chest CT evaluation. MAIN OUTCOMES AND MEASURES All-cause mortality over an approximate 3- to 9-year median follow-up time. Cause-of-death information was also examined in the AGES-Reykjavik cohort. RESULTS Interstitial lung abnormalities were present in 177 (7%) of the 2633 participants from FHS, 378 (7%) of 5320 from AGES-Reykjavik, 156 (8%) of 2068 from COPDGene, and in 157 (9%) of 1670 from ECLIPSE. Over median follow-up times of approximately 3 to 9 years, there were more deaths (and a greater absolute rate of mortality) among participants with interstitial lung abnormalities when compared with those who did not have interstitial lung abnormalities in the following cohorts: 7% vs 1% in FHS (6% difference [95% CI, 2% to 10%]), 56% vs 33% in AGES-Reykjavik (23% difference [95% CI, 18% to 28%]), and 11% vs 5% in ECLIPSE (6% difference [95% CI, 1% to 11%]). After adjustment for covariates, interstitial lung abnormalities were associated with a higher risk of death in the FHS (hazard ratio [HR], 2.7 [95% CI, 1]to 6.5]; P = .03), AGES-Reykjavik (HR, 1.3 [95% CI, 1.2 to 1.4]; P < .001), COPDGene (HR, 1.8 [95% CI, 1.1to 2.8]; P = .01), and ECLIPSE (HR, 1.4 [95% CI, 1]to 2.0]; P = .02) cohorts. In the AGES-Reykjavik cohort, the higher rate of mortality could be explained by a higher rate of death due to respiratory disease, specifically pulmonary fibrosis. CONCLUSIONS AND RELEVANCE In 4 separate research cohorts, interstitial lung abnormalities were associated with a greater risk of all-cause mortality. The clinical implications of this association require further investigation.	[Putman, Rachel K.; Cho, Michael H.; El-Chemaly, Souheil; Celli, Bartolome R.; Fernandez, Isis E.; Zazueta, Oscar E.; Harmouche, Rola; Diaz, Alejandro A.; Silverman, Edwin K.; Washko, George R.; Rosas, Ivan O.; Hunninghake, Gary M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Pulm & Crit Care Div, Boston, MA 02115 USA; [Hatabu, Hiroto; Nishino, Mizuki; Okajima, Yuka; Estepar, Raul San Jose] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hatabu, Hiroto; Araki, Tetsuro; Nishino, Mizuki; Washko, George R.; Hunninghake, Gary M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Pulm Funct Imaging, Boston, MA 02115 USA; [Gudmundsson, Gunnar] Univ Iceland, Landspital Univ Hosp, Dept Resp Med & Sleep, Reykjavik, Iceland; [Gao, Wei; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Okajima, Yuka] St Lukes Int Hosp, Dept Radiol, Tokyo, Japan; [Dupuis, Josee; O'Donnell, Christopher J.; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Latourelle, Jeanne C.; O'Connor, George T.] Boston Univ, Dept Med, Ctr Pulm, Boston, MA 02215 USA; [Latourelle, Jeanne C.] Boston Univ, Dept Neurol, Boston, MA 02215 USA; [Cho, Michael H.; Ross, James C.; Silverman, Edwin K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Coxson, Harvey O.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Fernandez, Isis E.] Univ Munich, Univ Hosp Grosshadern, Comprehens Pneumol Ctr, Munich, Germany; [Fernandez, Isis E.] German Ctr Lung Res, Helmholtz Zentrum Munchen, Munich, Germany; [Ross, James C.; Harmouche, Rola; Estepar, Raul San Jose] Brigham & Womens Hosp, Dept Radiol, Surg Planning Lab, 75 Francis St, Boston, MA 02115 USA; [Sigurdsson, Sigurdur; Gudmundsson, Elias F.; Eiriksdottir, Gudny; Aspelund, Thor; Gudnason, Vilmundur] Icelandic Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Budoff, Matthew J.] Harbor UCLA, Los Angeles Biomed Res Inst, Dept Med, Torrance, CA USA; [Kinney, Gregory L.; Hokanson, John E.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Denver, CO USA; [Williams, Michelle C.] Univ Edinburgh, British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Murchison, John T.] Univ Edinburgh, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; [MacNee, William] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Hoffmann, Udo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiac MR PET CT Program, Boston, MA USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Cardiovasc Epidemiol & Human Genom Branch, Bethesda, MD 20892 USA; [Launer, Lenore J.; Harrris, Tamara B.] NIA, Intramural Res Program, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Landspitali National University Hospital; University of Iceland; Boston University; St. Luke's International Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of British Columbia; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Brigham & Women's Hospital; Icelandic Heart Association; University of Iceland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rosas, IO (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Div, 75 Francis St, Boston, MA 02115 USA.	irosas@rics.bwh.harvard.edu	Williams, Michelle C/K-7555-2012; Budoff, Matthew/ABD-5175-2021; Coxson, Harvey O/A-9861-2017; Zazueta, Oscar/GQQ-7506-2022; Kinney, Gregory L/M-4867-2013; Gudnason, Vilmundur/AAE-7126-2019; San Jose Estepar, Raul/AAQ-5657-2020; Kinney, Gregory/ABB-2081-2021; Aspelund, Thor/C-5983-2008; Aspelund, Thor/K-7022-2019	Williams, Michelle C/0000-0003-3556-2428; Budoff, Matthew/0000-0002-9616-1946; Coxson, Harvey O/0000-0001-5750-9711; Kinney, Gregory L/0000-0002-5218-4986; Gudnason, Vilmundur/0000-0001-5696-0084; San Jose Estepar, Raul/0000-0002-3677-1996; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Gudmundsson, Elias Freyr/0000-0002-7661-4872; MacNee, William/0000-0002-3692-1448; Dupuis, Josee/0000-0003-2871-3603; Zazueta, Oscar E/0000-0001-5374-3906; Hoffman, Eric/0000-0001-8456-9437	National Institutes of Health (NIH) [T32 HL007633]; Icelandic Research Fund [141513-051]; Landspitali Scientific Fund [A-2015-030]; National Cancer Institute grant [1K23CA157631]; NIH [K08 HL097029, R01 HL113264, R21 HL119902, K25 HL104085, R01 HL116931, R01 HL116473, K01 HL118714, R01 HL089897, R01 HL089856, N01-AG-1-2100, HHSN27120120022C, P01 HL105339, P01 HL114501, R01 HL107246, R01 HL122464, R01 HL111024]; National Heart, Lung, and Blood Institute's Framingham Heart Study contract [N01-HC-2519.5]; GlaxoSmithKline [NCT00292552, 5C0104960]; National Institute on Aging (NIA) grant [27120120022C]; NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); NIA [27120120022C]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA157631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122464, T32HL007633, P01HL105339, K08HL097029, R21HL119902, R01HL116931, R01HL107246, R01HL111024, K01HL118714, R01HL130974, R01HL116473, R01HL089897, P01HL114501, U01HL089856, R01HL113264, R01HL089856, U01HL089897, K25HL104085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018526] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Icelandic Research Fund; Landspitali Scientific Fund; National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute's Framingham Heart Study contract; GlaxoSmithKline(GlaxoSmithKline); National Institute on Aging (NIA) grant; NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi (the Icelandic Parliament); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Putman is supported by a National Institutes of Health (NIH) grant (T32 HL007633). Dr Gudmundsson is supported by a project grant from the Icelandic Research Fund (141513-051) and from the Landspitali Scientific Fund (A-2015-030). Dr Nishino is supported by a National Cancer Institute grant (1K23CA157631). Dr Cho is supported by 2 NIH grants (K08 HL097029 and R01 HL113264). Dr EI-Chemaly is supported by an NIH grant (R21 HL119902). Dr San Jose Estepar is supported by 3 NIH grants (K25 HL104085, R01 HL116931, and R01 HL116473). Dr Diaz is supported by an NIH grant (K01 HL118714). This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study contract (N01-HC-2519.5). COPDGene is supported by 2 NIH grants (R01 HL089897 and R01 HL089856). The ECLIPSE study was sponsored by GlaxoSmithKline (NCT00292552; GSK code 5C0104960). The AGES (Age, Gene/Environment Susceptibility)-Reykjavik study was supported by a National Institute on Aging (NIA) grant (27120120022C), 2 NIH contracts (N01-AG-1-2100 and HHSN27120120022C), the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Dr Gudnason is supported by an NIA grant (27120120022C) and an Icelandic Research Fund project grant (141513-051). Dr Silverman is supported by 3 NIH grants (R01 HL089856, P01 HL105339, and P01 HL114501). Dr Washko is supported by 3 NIH grants (R01 HL107246, R01 HL116473, and R01 HL122464). Dr Rosas is supported by an NIH grant (P01 HL114501). Dr Hunninghake and this study are supported by 2 NIH grants (P01 HL114501 and R01 HL111024) and a project grant from the Icelandic Research Fund (141513-051).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], GLOB STRAT DIAGN MAN; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Copley SJ, 2009, RADIOLOGY, V251, P566, DOI 10.1148/radiol.2512081242; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P756, DOI 10.1164/rccm.201109-1618OC; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; IWAI K, 1994, AM J RESP CRIT CARE, V150, P670, DOI 10.1164/ajrccm.150.3.8087336; Jin GY, 2013, RADIOLOGY, V268, P563, DOI 10.1148/radiol.13120816; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Putman RK, 2014, AM J RESP CRIT CARE, V189, P770, DOI 10.1164/rccm.201312-2219PP; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ross JC, 2009, LECT NOTES COMPUT SC, V5762, P690, DOI 10.1007/978-3-642-04271-3_84; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sverzellati N, 2011, EUR RESPIR J, V38, P392, DOI 10.1183/09031936.00201809; Tsushima K, 2010, RESP MED, V104, P1712, DOI 10.1016/j.rmed.2010.05.014; Uh Hae-Won, 2009, BMC Proc, V3 Suppl 7, pS123; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Washko GR, 2010, ACAD RADIOL, V17, P48, DOI 10.1016/j.acra.2009.07.016	34	229	232	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					672	681		10.1001/jama.2016.0518	http://dx.doi.org/10.1001/jama.2016.0518			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD8JB	26881370	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000370171500013
J	Baggett, MV; Gonzalez, RG; Bhattacharyya, RP; Mahowald, MA				Baggett, Meridale V.; Gonzalez, R. Gilberto; Bhattacharyya, Roby P.; Mahowald, Michael A.			Case 4-2016: A 58-Year-Old Woman with a Skin Ulcer, Fever, and Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OROPHARYNGEAL TULAREMIA; FRANCISELLA-TULARENSIS; UNITED-STATES; ANTHRAX		[Baggett, Meridale V.; Bhattacharyya, Roby P.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Mahowald, Michael A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Baggett, Meridale V.; Bhattacharyya, Roby P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mahowald, Michael A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Baggett, MV (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA USA.; Baggett, MV (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.		Bhattacharyya, Roby/AAF-7670-2019	Bhattacharyya, Roby/0000-0001-6955-5088	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007061] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, N ENGL J MED, V363, P766; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P963; [Anonymous], 2015, SENT LEV CLIN LAB GU; AYRES JC, 1948, NEW ENGL J MED, V238, P187, DOI 10.1056/NEJM194802052380606; Bustamante B, 2001, CURR OPIN INFECT DIS, V14, P145, DOI 10.1097/00001432-200104000-00006; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Croskerry P, 2009, ADV HEALTH SCI EDUC, V14, P27, DOI 10.1007/s10459-009-9182-2; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; ENDERLIN G, 1994, CLIN INFECT DIS, V19, P42, DOI 10.1093/clinids/19.1.42; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Gozel MG, 2014, JPN J INFECT DIS, V67, P295, DOI 10.7883/yoken.67.295; Kahneman D, 2011, UNIVERSAL MODEL DIAG; Kaya A, 2011, MED SCI MONITOR, V17, pCR376, DOI 10.12659/MSM.881848; Klotz SA, 2011, AM FAM PHYSICIAN, V83, P152; Lewis FMT, 2003, CLIN INFECT DIS, V37, P390, DOI 10.1086/376628; Maurin M, 2011, CLIN INFECT DIS, V53, pE133, DOI 10.1093/cid/cir612; Petersen J, 2007, MANUAL CLIN MICROBIO, P851; Petersen JM, 2004, APPL ENVIRON MICROB, V70, P3733, DOI [10.1128/AEM.70.6.3733-3735.2004, 10.1128/aem.70.6.3733-3735.2004]; Saini Ritu, 2004, J Am Acad Dermatol, V51, pS137, DOI 10.1016/j.jaad.2004.03.036; Semaan R, 2008, INT J INFECT DIS, V12, P472, DOI 10.1016/j.ijid.2008.03.002; Snowden J, 2011, CLIN PEDIATR, V50, P64, DOI 10.1177/0009922810381425; Tancik CA, 2000, CLIN INFECT DIS, V30, P399, DOI 10.1086/313678; Weber IB, 2012, CLIN INFECT DIS, V55, P1283, DOI 10.1093/cid/cis706	23	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					573	581		10.1056/NEJMcpc1508550	http://dx.doi.org/10.1056/NEJMcpc1508550			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2ME	26863359				2022-12-28	WOS:000369755800012
J	Heyer, EE; Moore, MJ				Heyer, Erin E.; Moore, Melissa J.			Redefining the Translational Status of 80S Monosomes	CELL			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA DECAY; ASSOCIATION; RIBOSOMES; IDENTIFICATION; TERMINATION; SYNAPSES; PROTEINS; NMD	Fully assembled ribosomes exist in two populations: polysomes and monosomes. While the former has been studied extensively, to what extent translation occurs on monosomes and its importance for overall translational output remain controversial. Here, we used ribosome profiling to examine the translational status of 80S monosomes in Saccharomyces cerevisiae. We found that the vast majority of 80S monosomes are elongating, not initiating. Further, most mRNAs exhibit some degree of monosome occupancy, with monosomes predominating on nonsense-mediated decay (NMD) targets, upstream open reading frames (uORFs), canonical ORFs shorter than similar to 590 nt, and ORFs for which the total time required to complete elongation is substantially shorter than that required for initiation. Importantly, mRNAs encoding low-abundance regulatory proteins tend to be enriched in the monosome fraction. Our data highlight the importance of monosomes for the translation of highly regulated mRNAs.	[Heyer, Erin E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA; [Heyer, Erin E.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA Therapeut Inst, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu	Heyer, Erin E./AAG-5389-2021	Heyer, Erin E./0000-0003-3426-9350	HHMI	HHMI(Howard Hughes Medical Institute)	We thank John Mattick, Martin Smith, and other Mattick lab members for bioinformatic training and guidance, and we thank Nicholas Ingolia, Christopher Nicchitta, Elisabet Mandon, Hakan Ozadam, and other M.J.M. lab members for helpful discussions and their critical manuscript review. This research was funded by HHMI.	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Chu Q, 2015, CRIT REV BIOCHEM MOL, V50, P134, DOI 10.3109/10409238.2015.1016215; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; Culbertson MR, 2005, RNA, V11, P1333, DOI 10.1261/rna.2113605; FAVAUDON V, 1976, BIOCHEMISTRY-US, V15, P3903, DOI 10.1021/bi00663a001; Fiechter V, 2008, CURR GENET, V53, P107, DOI 10.1007/s00294-007-0169-3; Gao QS, 2005, P NATL ACAD SCI USA, V102, P4258, DOI 10.1073/pnas.0500684102; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Han Y, 2014, CELL RES, V24, P842, DOI 10.1038/cr.2014.74; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Heyer EE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1235; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johansson MJO, 2007, P NATL ACAD SCI USA, V104, P20872, DOI 10.1073/pnas.0709257105; Krishnan K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-159; Landry CR, 2015, CURR OPIN STRUC BIOL, V32, P74, DOI 10.1016/j.sbi.2015.02.017; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Noll H, 2008, BIOESSAYS, V30, P1220, DOI 10.1002/bies.20846; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Potter MD, 2002, J BIOL CHEM, V277, P23314, DOI 10.1074/jbc.M202559200; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Reboll MR, 2014, METHODS MOL BIOL, V1182, P173, DOI 10.1007/978-1-4939-1062-5_14; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Smith JE, 2014, CELL REP, V7, P1858, DOI 10.1016/j.celrep.2014.05.023; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Warner Jonathan R., 2002, Trends in Biochemical Sciences, V27, P376, DOI 10.1016/S0968-0004(02)02126-6; Yu X, 2001, J BIOL CHEM, V276, P33821, DOI 10.1074/jbc.M103772200	49	117	116	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					757	769		10.1016/j.cell.2016.01.003	http://dx.doi.org/10.1016/j.cell.2016.01.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871635	Bronze			2022-12-28	WOS:000369998300020
J	Shu, XD; Pei, DQ				Shu, Xiaodong; Pei, Duanqing			Pluripotency without Proliferation	CELL			English	Editorial Material							CELL; STATE	Mouse embryonic stem cells (mESCs) are capable of unlimited proliferation without losing pluripotency. Scognamiglio et al. now reveal that Myc depletion shifts mESCs into a dormant state reminiscent of embryonic diapause in which pluripotency remains fully preserved, thus decoupling pluripotency from proliferative programs.	[Shu, Xiaodong; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Shu, Xiaodong; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cells & Regenerat Med, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn						Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fenelon JC, 2014, INT J DEV BIOL, V58, P163, DOI 10.1387/ijdb.140074bm; Gonzales KAU, 2015, CELL, V162, P564, DOI 10.1016/j.cell.2015.07.001; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Ma TH, 2009, J BIOL CHEM, V284, P16071, DOI 10.1074/jbc.M109.005041; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Scognamiglio R, 2016, CELL, V164, P668, DOI 10.1016/j.cell.2015.12.033	9	3	4	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					595	597		10.1016/j.cell.2016.01.050	http://dx.doi.org/10.1016/j.cell.2016.01.050			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871623	Bronze			2022-12-28	WOS:000369998300004
J	Yang, XP; Coulombe-Huntington, J; Kang, SL; Sheynkman, GM; Hao, T; Richardson, A; Sun, S; Yang, F; Shen, YA; Murray, RR; Spirohn, K; Begg, BE; Duran-Frigola, M; MacWilliams, A; Pevzner, SJ; Zhong, Q; Trigg, SA; Tam, S; Ghamsari, L; Sahni, N; Yi, S; Rodriguez, MD; Balcha, D; Tan, GH; Costanzo, M; Andrews, B; Boone, C; Zhou, XHJ; Salehi-Ashtiani, K; Charloteaux, B; Chen, AA; Calderwood, MA; Aloy, P; Roth, FP; Hill, DE; Iakoucheva, LM; Xia, Y; Vidal, M				Yang, Xinping; Coulombe-Huntington, Jasmin; Kang, Shuli; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Sun, Song; Yang, Fan; Shen, Yun A.; Murray, Ryan R.; Spirohn, Kerstin; Begg, Bridget E.; Duran-Frigola, Miquel; MacWilliams, Andrew; Pevzner, Samuel J.; Zhong, Quan; Trigg, Shelly A.; Tam, Stanley; Ghamsari, Lila; Sahni, Nidhi; Yi, Song; Rodriguez, Maria D.; Balcha, Dawit; Tan, Guihong; Costanzo, Michael; Andrews, Brenda; Boone, Charles; Zhou, Xianghong J.; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Chen, Alyce A.; Calderwood, Michael A.; Aloy, Patrick; Roth, Frederick P.; Hill, David E.; Iakoucheva, Lilia M.; Xia, Yu; Vidal, Marc			Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing	CELL			English	Article							OPEN READING FRAMES; OSTEOGENESIS IMPERFECTA; SCALE MAP; DISCOVERY; DOMAIN; GENE; TRANSCRIPTOME; ISOFORMS; CLONING; MOTIFS	While alternative splicing is known to diversify the functional characteristics of some genes, the extent to which protein isoforms globally contribute to functional complexity on a proteomic scale remains unknown. To address this systematically, we cloned full-length open reading frames of alternatively spliced transcripts for a large number of human genes and used protein-protein interaction profiling to functionally compare hundreds of protein isoform pairs. The majority of isoform pairs share less than 50% of their interactions. In the global context of interactome network maps, alternative isoforms tend to behave like distinct proteins rather than minor variants of each other. Interaction partners specific to alternative isoforms tend to be expressed in a highly tissue-specific manner and belong to distinct functional modules. Our strategy, applicable to other functional characteristics, reveals a widespread expansion of protein interaction capabilities through alternative splicing and suggests that many alternative "isoforms'' are functionally divergent (i.e., "functional alloforms'').	[Yang, Xinping; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Shen, Yun A.; Spirohn, Kerstin; Begg, Bridget E.; Sahni, Nidhi; Yi, Song; Balcha, Dawit; Charloteaux, Benoit; Chen, Alyce A.; Calderwood, Michael A.; Roth, Frederick P.; Hill, David E.; Vidal, Marc] Dana Farber Canc Inst, Genom Anal Network Perturbat Ctr Excellence Genom, Boston, MA 02215 USA; [Yang, Xinping; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Shen, Yun A.; Murray, Ryan R.; Spirohn, Kerstin; Begg, Bridget E.; MacWilliams, Andrew; Pevzner, Samuel J.; Zhong, Quan; Trigg, Shelly A.; Tam, Stanley; Ghamsari, Lila; Sahni, Nidhi; Yi, Song; Rodriguez, Maria D.; Balcha, Dawit; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Chen, Alyce A.; Calderwood, Michael A.; Roth, Frederick P.; Hill, David E.; Xia, Yu; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Yang, Xinping; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Shen, Yun A.; Murray, Ryan R.; Spirohn, Kerstin; Begg, Bridget E.; MacWilliams, Andrew; Pevzner, Samuel J.; Zhong, Quan; Trigg, Shelly A.; Tam, Stanley; Ghamsari, Lila; Sahni, Nidhi; Yi, Song; Rodriguez, Maria D.; Balcha, Dawit; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Chen, Alyce A.; Calderwood, Michael A.; Roth, Frederick P.; Hill, David E.; Xia, Yu; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Yang, Xinping; Sheynkman, Gloria M.; Hao, Tong; Richardson, Aaron; Shen, Yun A.; Murray, Ryan R.; Spirohn, Kerstin; Begg, Bridget E.; MacWilliams, Andrew; Pevzner, Samuel J.; Zhong, Quan; Trigg, Shelly A.; Tam, Stanley; Ghamsari, Lila; Sahni, Nidhi; Yi, Song; Rodriguez, Maria D.; Balcha, Dawit; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Chen, Alyce A.; Calderwood, Michael A.; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Yang, Xinping] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou 510515, Guangdong, Peoples R China; [Coulombe-Huntington, Jasmin; Xia, Yu] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Kang, Shuli; Iakoucheva, Lilia M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sun, Song; Yang, Fan; Costanzo, Michael; Andrews, Brenda; Boone, Charles; Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Sun, Song; Yang, Fan; Andrews, Brenda; Boone, Charles; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Sun, Song; Yang, Fan; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sun, Song] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Duran-Frigola, Miquel; Aloy, Patrick] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kang, Shuli; Zhou, Xianghong J.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Aloy, Patrick] ICREA, Barcelona 08010, Catalonia, Spain; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Coulombe-Huntington, Jasmin] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Murray, Ryan R.] Univ Helsinki, Biomedicum Helsinki 1, FIN-00290 Helsinki, Finland; [Begg, Bridget E.] MIT, Dept Biol, Cambridge, MA 02139 USA; [MacWilliams, Andrew] Tecan US Inc, Morrisville, NC 27560 USA; [Zhong, Quan] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Trigg, Shelly A.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Tam, Stanley] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ghamsari, Lila] Genocea Biosci Inc, Cambridge, MA 02140 USA; [Rodriguez, Maria D.] Cedars Sinai Med Ctr, Biomed Sci & Translat Med, Los Angeles, CA 90048 USA; [Salehi-Ashtiani, Kourosh] New York Univ Abu Dhabi, Div Sci & Math, Abu Dhabi, U Arab Emirates; [Salehi-Ashtiani, Kourosh] New York Univ Abu Dhabi, Ctr Genom & Syst Biol CGSB, Abu Dhabi, U Arab Emirates; [Charloteaux, Benoit] Univ Liege, Unit Anim Genom, GIGA R, B-4000 Liege, Belgium; [Charloteaux, Benoit] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Southern Medical University - China; McGill University; University of California System; University of California San Diego; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Uppsala University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Boston University; Boston University; University of Southern California; ICREA; Canadian Institute for Advanced Research (CIFAR); Universite de Montreal; University of Helsinki; Massachusetts Institute of Technology (MIT); University System of Ohio; Wright State University Dayton; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Cedars Sinai Medical Center; University of Liege; University of Liege	Vidal, M (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	lilyak@ucsd.edu; brandon.xia@mcgill.ca; marc_vidal@dfci.harvard.edu	Duran-Frigola, Miquel/AAO-3505-2021; Xia, Yu/W-6150-2019; Yang, Xinping/HGA-6104-2022; Aloy, Patrick/AAB-3538-2019; Roth, Frederick P/H-6308-2011; Yi, Song/ABG-6526-2020; zhong, quan/AAE-8893-2021; Yang, Fan/V-6555-2019; Calderwood, Mike/B-2475-2014	Duran-Frigola, Miquel/0000-0002-9906-6936; Xia, Yu/0000-0002-5596-5518; Yi, Song/0000-0003-0047-8103; Yang, Fan/0000-0003-4821-6583; Chen, Alyce/0000-0002-5018-8908; Yang, Xinping/0000-0003-4086-4180; Zhong, Quan/0000-0003-2910-5597; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Calderwood, Mike/0000-0001-6475-1418; Trigg, Shelly/0000-0001-6904-4149; Iakoucheva, Lilia/0000-0002-4542-5219	NHGRI CEGS grant [P50HG004233]; NHGRI grant [U01HG001715]; Ellison Foundation; NCI grant [R33CA132073]; Krembil Foundation (Canada); Canada Excellence Research Chair Award; Ontario Research Fund-Research Excellence Award; E.K. Shriver NICHD grant [R01HD065288]; NIMH grants [R01MH091350, R01MH105524, R21MH104766]; NSF [CCF-1219007]; NSERC grant (Canada) [RGPIN-2014-03892]; Canada Foundation for Innovation grant [JELF-33732]; Canada Research Chairs Program; NIH training grant [T32CA009361]; NSERC fellowship (Canada); NIGMS grant [R01GM105431]; Swedish Research Council International Postdoc Grant; ICREA Funding Source: Custom; Direct For Computer & Info Scie & Enginr [1219007] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065288] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA132073, T32CA009361] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233, R01HG001715, U41HG001715, U01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104766, R01MH105524, R01MH091350] Funding Source: NIH RePORTER	NHGRI CEGS grant; NHGRI grant; Ellison Foundation(Lawrence Ellison Foundation); NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Krembil Foundation (Canada); Canada Excellence Research Chair Award; Ontario Research Fund-Research Excellence Award; E.K. Shriver NICHD grant; NIMH grants; NSF(National Science Foundation (NSF)); NSERC grant (Canada); Canada Foundation for Innovation grant(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC fellowship (Canada); NIGMS grant; Swedish Research Council International Postdoc Grant; ICREA(ICREA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Blencowe for valuable discussions and critical reading of the manuscript. This work was supported by NHGRI CEGS grant P50HG004233 (M.V. and F.P.R.); NHGRI grant U01HG001715 (M.V., D.E.H., and F.P.R.); the Ellison Foundation (M.V.), NCI grant R33CA132073 (M.V.); the Krembil Foundation (Canada) (F.P.R.); a Canada Excellence Research Chair Award (F.P.R.); an Ontario Research Fund-Research Excellence Award (F.P.R.); E.K. Shriver NICHD grant R01HD065288 (L.M.I. and K.S.-A.); NIMH grants R01MH091350 (L.M.I. and T.H.), R01MH105524 (L.M.I.), and R21MH104766 (L.M.I.); NSF grant CCF-1219007, NSERC grant RGPIN-2014-03892 (Canada), Canada Foundation for Innovation grant JELF-33732 and Canada Research Chairs Program (Y.X.); NIH training grant T32CA009361 (G.M.S.); a NSERC fellowship (Canada) (J.C.-H.); NIGMS grant R01GM105431 (X.J.Z.); and a Swedish Research Council International Postdoc Grant (S.S.). M.V. is a FRS-FNRS Chercheur Qualifie Honoraire (Belgium).	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Jones S, 1998, PROTEIN SCI, V7, P233; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mosca R, 2014, NUCLEIC ACIDS RES, V42, pD374, DOI 10.1093/nar/gkt887; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; Raff ML, 2000, HUM GENET, V106, P19, DOI 10.1007/s004390051004; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Salehi-Ashtiani K, 2008, NAT METHODS, V5, P597, DOI 10.1038/nmeth.1224; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229	43	293	300	4	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					805	817		10.1016/j.cell.2016.01.029	http://dx.doi.org/10.1016/j.cell.2016.01.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871637	Green Accepted, Bronze			2022-12-28	WOS:000369998300024
J	Adams, B				Adams, Ben			PATIENT RECORDS Flipping the model for access to patient records	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												benjohnadams26@gmail.com						[Anonymous], 2014, PAT CHOOS OPT OUT CA; [Anonymous], 2014, COMMUNICATION; Hannan A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h266; Haughton Thornley Medical Centres, 2016, DO YOU KNOW MAN OTH; NHS Federation, 2016, KEY STAT NHS; NHS Jobs, WORK NHS; Solon O, 2014, WIRED; West Hampshire Clinical Commissioning Group, 2015, AUD COMM M 7 SEPT	8	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2016	352								i722	10.1136/bmj.i722	http://dx.doi.org/10.1136/bmj.i722			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IR	26860441	Green Published			2022-12-28	WOS:000370381000004
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Why GPs are stressed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bostock N, 2016, GP ONLINE       0130; Campbell D, 2016, GUARDIAN	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2016	352								i693	10.1136/bmj.i693	http://dx.doi.org/10.1136/bmj.i693			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1IH	26856352	Bronze, Green Published			2022-12-28	WOS:000370380000003
J	Washington, AE; Coye, MJ; Boulware, LE				Washington, A. Eugene; Coye, Molly J.; Boulware, L. Ebony			Academic Health Systems' Third Curve Population Health Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Washington, A. Eugene; Boulware, L. Ebony] Duke Univ, Sch Med, Durham, NC USA; [Coye, Molly J.] Network Excellence Hlth Innovat, Cambridge, MA USA	Duke University	Washington, AE (corresponding author), Duke Univ, Sch Med, Hlth Affairs, 40 Duke Med Cir, Durham, NC 27710 USA.; Washington, AE (corresponding author), Duke Univ Hlth Syst, 40 Duke Med Cir, Durham, NC 27710 USA.	eugene.washington@duke.edu		Boulware, Ebony/0000-0002-8650-4212				Fish DR, 2013, LANCET, V381, pE18, DOI 10.1016/S0140-6736(12)60866-6; Fisher ES, 2014, JAMA-J AM MED ASSOC, V312, P2093, DOI 10.1001/jama.2014.13815; Frieden TR, 2015, NEW ENGL J MED, V373, P1748, DOI 10.1056/NEJMsa1511248; Isham GJ, 2015, ROUNDTABLE POPULATIO; Ramsey PG, 2009, JAMA-J AM MED ASSOC, V301, P1475, DOI 10.1001/jama.2009.472; Sprague JB., 2016, PRACTICAL PLAYBOOK P; Washington AE, 2013, JAMA-J AM MED ASSOC, V310, P1929, DOI 10.1001/jama.2013.282012	7	32	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					459	460		10.1001/jama.2015.18550	http://dx.doi.org/10.1001/jama.2015.18550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836726				2022-12-28	WOS:000369049500011
J	Haradhvala, NJ; Polak, P; Stojanov, P; Covington, KR; Shinbrot, E; Hess, JM; Rheinbay, E; Kim, J; Maruvka, YE; Braunstein, LZ; Kamburov, A; Hanawalt, PC; Wheeler, DA; Koren, A; Lawrence, MS; Getz, G				Haradhvala, Nicholas J.; Polak, Paz; Stojanov, Petar; Covington, Kyle R.; Shinbrot, Eve; Hess, Julian M.; Rheinbay, Esther; Kim, Jaegil; Maruvka, Yosef E.; Braunstein, Lior Z.; Kamburov, Atanas; Hanawalt, Philip C.; Wheeler, David A.; Koren, Amnon; Lawrence, Michael S.; Getz, Gad			Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair	CELL			English	Article							SOMATIC MUTATIONS; REPLICATION; SIGNATURES; PATTERNS; LANDSCAPE; ORIGINS; DRIVER; GENES; CELLS	Mutational processes constantly shape the somatic genome, leading to immunity, aging, cancer, and other diseases. When cancer is the outcome, we are afforded a glimpse into these processes by the clonal expansion of the malignant cell. Here, we characterize a less explored layer of the mutational landscape of cancer: mutational asymmetries between the two DNA strands. Analyzing whole-genome sequences of 590 tumors from 14 different cancer types, we reveal widespread asymmetries across mutagenic processes, with transcriptional ("T-class'') asymmetry dominating UV-, smoking-, and liver-cancer-associated mutations and replicative ("R-class'') asymmetry dominating POLE-, APOBEC-, and MSI-associated mutations. We report a striking phenomenon of transcription-coupled damage (TCD) on the non-transcribed DNA strand and provide evidence that APOBEC mutagenesis occurs on the lagging-strand template during DNA replication. As more genomes are sequenced, studying and classifying their asymmetries will illuminate the underlying biological mechanisms of DNA damage and repair.	[Haradhvala, Nicholas J.; Polak, Paz; Rheinbay, Esther; Maruvka, Yosef E.; Kamburov, Atanas; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St, Boston, MA 02114 USA; [Haradhvala, Nicholas J.; Polak, Paz; Rheinbay, Esther; Maruvka, Yosef E.; Kamburov, Atanas; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St, Boston, MA 02114 USA; [Haradhvala, Nicholas J.; Polak, Paz; Hess, Julian M.; Rheinbay, Esther; Kim, Jaegil; Maruvka, Yosef E.; Braunstein, Lior Z.; Kamburov, Atanas; Koren, Amnon; Lawrence, Michael S.; Getz, Gad] Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA; [Polak, Paz; Kamburov, Atanas; Getz, Gad] Harvard Univ, Sch Med, 25 Shattuck St, Boston, MA 02115 USA; [Stojanov, Petar] Carnegie Mellon Univ, Sch Comp Sci, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Covington, Kyle R.; Shinbrot, Eve; Wheeler, David A.] Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA; [Hanawalt, Philip C.] Stanford Univ, Dept Biol, 450 Serra Mall, Stanford, CA 94305 USA; [Koren, Amnon] Cornell Univ, Dept Mol Biol & Genet, 526 Campus Rd, Ithaca, NY 14853 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Carnegie Mellon University; Baylor College of Medicine; Stanford University; Cornell University	Getz, G (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St, Boston, MA 02114 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St, Boston, MA 02114 USA.; Lawrence, MS; Getz, G (corresponding author), Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA.; Getz, G (corresponding author), Harvard Univ, Sch Med, 25 Shattuck St, Boston, MA 02115 USA.	lawrence@broadinstitute.org; gadgetz@broadinstitute.org	Stojanov, Petar/GQI-4462-2022; Wheeler, David A/M-9740-2018; Polak, Paz/AAH-9380-2020; Shinbrot, Eve/V-2784-2019; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Wheeler, David A/0000-0002-9056-6299; Shinbrot, Eve/0000-0002-8879-3150; Maruvka, Yosef/0000-0002-8918-9887; Kamburov, Atanas/0000-0002-0580-0619; Haradhvala, Nicholas/0000-0003-1113-3135	NIH TCGA Genome Data Analysis Center [U24CA143845]; NHGRI Genome Sequencing Center [U54HG003067]; NHGRI [U54HG003273]; G.G.'s startup funds at MGH; NATIONAL CANCER INSTITUTE [R01CA077712, U24CA143845] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003067] Funding Source: NIH RePORTER	NIH TCGA Genome Data Analysis Center; NHGRI Genome Sequencing Center; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); G.G.'s startup funds at MGH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Ashok Bhagwat and Steven Roberts and their collaborators for sharing their unpublished data with us and allowing us to reference them in this work. We thank John Iafrate for valuable insights about the relevance of strand asymmetry in carcinogenesis. G.G. was partially funded by the Paul C. Zamecnik, MD, Chair in Oncology at Massachusetts General Hospital. G. G. and M.S.L. were partially funded by the NIH TCGA Genome Data Analysis Center (U24CA143845). M.S.L. was partially funded by the NHGRI Genome Sequencing Center (U54HG003067). E.S., K.R.C., and D.A.W. were partially funded by NHGRI grant (U54HG003273). N.J.H., P.P., Y.E.M., and A. Kamburov were funded by G.G.'s startup funds at MGH.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bhagwat AS, 2016, P NATL ACAD SCI USA, V113, P2176, DOI 10.1073/pnas.1522325113; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Carreras Puigvert J., 2015, FEBS J; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen CL, 2011, MOL BIOL EVOL, V28, P2327, DOI 10.1093/molbev/msr056; Conticello SG, 2012, ANN NY ACAD SCI, V1267, P79, DOI 10.1111/j.1749-6632.2012.06614.x; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hoopes J., 2016, CELL REPORTS; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Johnson RE, 2015, MOL CELL, V59, P163, DOI 10.1016/j.molcel.2015.05.038; Kane MF, 1997, CANCER RES, V57, P808; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; Kazanov MD, 2015, CELL REP, V13, P1103, DOI 10.1016/j.celrep.2015.09.077; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Koren A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001068; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Middleton FK, 2015, ONCOTARGET, V6, P32396, DOI 10.18632/oncotarget.6136; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Polak P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-187; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Ross KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101093; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Spivak G, 2014, DNA REPAIR, V19, P64, DOI 10.1016/j.dnarep.2014.03.025; Stillman B, 2015, MOL CELL, V59, P139, DOI 10.1016/j.molcel.2015.07.004; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tomasetti C, 2015, STEM CELL RES, V14, P238, DOI 10.1016/j.scr.2015.01.005; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yadlapalli S, 2013, J CELL SCI, V126, P4069, DOI 10.1242/jcs.096024; Yu CH, 2014, MOL CELL, V56, P551, DOI 10.1016/j.molcel.2014.09.017	68	222	224	1	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					538	549		10.1016/j.cell.2015.12.050	http://dx.doi.org/10.1016/j.cell.2015.12.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26806129	Green Accepted, Bronze			2022-12-28	WOS:000368906800022
J	Mostafavi, S; Yoshida, H; Moodley, D; LeBoite, H; Rothamel, K; Raj, T; Ye, CJ; Chevrier, N; Zhang, SY; Feng, T; Lee, M; Casanova, JL; Clark, JD; Hegen, M; Telliez, JB; Hacohen, N; De Jager, PL; Regev, A; Mathis, D; Benoist, C				Mostafavi, Sara; Yoshida, Hideyuki; Moodley, Devapregasan; LeBoite, Hugo; Rothamel, Katherine; Raj, Towfique; Ye, Chun Jimmie; Chevrier, Nicolas; Zhang, Shen-Ying; Feng, Ting; Lee, Mark; Casanova, Jean-Laurent; Clark, James D.; Hegen, Martin; Telliez, Jean-Baptiste; Hacohen, Nir; De Jager, Philip L.; Regev, Aviv; Mathis, Diane; Benoist, Christophe		Immunological Genome Project	Parsing the Interferon Transcriptional Network and Its Disease Associations	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; I INTERFERON; GENE-EXPRESSION; TYK2; ACTIVATION; AUTOIMMUNE; DISCOVERY; RESPONSES; IMMUNITY	Type 1 interferon (IFN) is a key mediator of organismal responses to pathogens, eliciting prototypical "interferon signature genes'' that encode antiviral and inflammatory mediators. For a global view of IFN signatures and regulatory pathways, we performed gene expression and chromatin analyses of the IFN-induced response across a range of immunocyte lineages. These distinguished ISGs by cell-type specificity, kinetics, and sensitivity to tonic IFN and revealed underlying changes in chromatin configuration. We combined 1,398 human and mouse datasets to computationally infer ISG modules and their regulators, validated by genetic analysis in both species. Some ISGs are controlled by Stat1/2 and Irf9 and the ISRE DNA motif, but others appeared dependent on non-canonical factors. This regulatory framework helped to interpret JAK1 blockade pharmacology, different clusters being affected under tonic or IFN-stimulated conditions, and the IFN signatures previously associated with human diseases, revealing unrecognized subtleties in disease footprints, as affected by human ancestry.	[Mostafavi, Sara; Yoshida, Hideyuki; Moodley, Devapregasan; LeBoite, Hugo; Rothamel, Katherine; Feng, Ting; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Mostafavi, Sara] Univ British Columbia, Dept Stat, Vancouver, BC V6H 3N1, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Raj, Towfique; Ye, Chun Jimmie; Lee, Mark; Hacohen, Nir; De Jager, Philip L.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chevrier, Nicolas] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Raj, Towfique; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA; [Raj, Towfique; De Jager, Philip L.] Brigham & Womens Hosp, Dept Psychiat, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA; [Zhang, Shen-Ying; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Clark, James D.; Hegen, Martin; Telliez, Jean-Baptiste] Pfizer Immunosci, Cambridge, MA 02140 USA	Harvard University; Harvard Medical School; University of British Columbia; University of British Columbia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Rockefeller University; Pfizer	Mathis, D; Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Casanova, Jean-Laurent/I-3418-2017; Raj, Towfique/ABD-7620-2021; Ye, Chun/AAK-4868-2021; Zhang, Shen-Ying/I-2685-2017	Ye, Chun/0000-0001-6560-3783; Zhang, Shen-Ying/0000-0002-9449-3672; Clark, James D./0000-0002-4801-0123; Rothamel, Katherine/0000-0001-9896-485X; Lee, Mark/0000-0002-9576-9589; Casanova, Jean-Laurent/0000-0002-7782-4169	NIH [R24-AI072073, RC2-GM093080]; Pfizer, Inc.; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer, Inc.(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank study participants in the ImmVar project for their contribution, Drs. S. Churchman, T. DeFranco, A.-S. Korganow, C. Lowell, D. Price, I. Sanz, and ImmGen members for useful discussions and K. Hattori, A. Ortiz-Lopes, N. Asinovski, A. Rhoads, C. Araeno, M. Thorsen, and K. Waraska for help with mice, cell sorting, and sequencing. This work was supported by NIH R24-AI072073 to the ImmGen consortium, RC2-GM093080 to ImmVar, and a Sponsored Research Agreement from Pfizer, Inc.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; Cohen S, 2014, ARTHRITIS RHEUMATOL, V66, P2924, DOI 10.1002/art.38779; Crow MK, 2015, TRANSL RES, V165, P296, DOI 10.1016/j.trsl.2014.10.005; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Forster S, 2012, IMMUNOL CELL BIOL, V90, P520, DOI 10.1038/icb.2012.12; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lee YH, 2012, INFLAMM RES, V61, P949, DOI 10.1007/s00011-012-0486-y; Mostafavi S, 2010, BIOINFORMATICS, V26, P1759, DOI 10.1093/bioinformatics/btq262; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635; Uddin S, 1998, BRIT J HAEMATOL, V101, P446, DOI 10.1046/j.1365-2141.1998.00731.x; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vogl C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-199; Wang K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000616; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665	43	142	144	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					564	578		10.1016/j.cell.2015.12.032	http://dx.doi.org/10.1016/j.cell.2015.12.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824662	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000368906800024
J	Schwartz, ES				Schwartz, Eben S.			The Spaces Between	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartz, Eben S.] ProHlth Care, Dept Neurosci, Waukesha, WI USA		Schwartz, ES (corresponding author), ProHlth Care, Dept Neurosci, Waukesha, WI USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					308	309		10.1056/NEJMp1510817	http://dx.doi.org/10.1056/NEJMp1510817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816010				2022-12-28	WOS:000368760100004
J	Langlois, EV; Haines, A; Tomson, G; Ghaffar, A				Langlois, Etienne V.; Haines, Andy; Tomson, Goran; Ghaffar, Abdul			Refugees: towards better access to health-care services	LANCET			English	Editorial Material									[Langlois, Etienne V.; Ghaffar, Abdul] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Karolinska Institutet	Langlois, EV (corresponding author), WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland.	langloise@who.int		Haines, Andy/0000-0002-8053-4605; Tomson, Goran/0000-0001-9222-3604	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Arie S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2216; Bozorgmehr K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131483; Burnett A, 2001, BRIT MED J, V322, P606, DOI 10.1136/bmj.322.7286.606; European Union Agency for Fundamental Rights, 2015, COST EXCL HEALTHC CA; Filges T, 2015, IMPACT DET HLTH ASYL; Gornall J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4150; Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4808; International Organization for Migration, 2015, IRR MIGR REF ARR EUR; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Norredam Marie, 2006, Eur J Public Health, V16, P286, DOI 10.1093/eurpub/cki191; Rousseau C, 2013, PAED CHILD HEALT-CAN, V18, P465, DOI 10.1093/pch/18.9.465; United Nations Department of Economic and Social Affairs Population Division, 2016, INT MIGR FLOWS SEL C; WHO Regional Office for Europe, 2010, HLTH SYST CAN ADDR H; World Health Organisation, 2013, RESPONDING INTIMATE	14	76	76	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					319	321		10.1016/S0140-6736(16)00101-X	http://dx.doi.org/10.1016/S0140-6736(16)00101-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26842434	Green Accepted			2022-12-28	WOS:000368516500010
J	Bohannon, J				Bohannon, John			Publishers embrace scheme to end name confusion	SCIENCE			English	News Item																			0	3	3	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					213	213		10.1126/science.351.6270.213	http://dx.doi.org/10.1126/science.351.6270.213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816356				2022-12-28	WOS:000368098600012
J	Polini, M				Polini, Marco			Tuning terahertz lasers via graphene plasmons	SCIENCE			English	Editorial Material							BORON-NITRIDE		[Polini, Marco] Ist Italiano Tecnol, Graphene Labs, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Polini, M (corresponding author), Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy.	marco.polini@iit.it	Polini, Marco/L-3419-2013		Graphene Flagship program [CNECT-ICT-604391]; Fondazione Istituto Italiano di Tecnologia	Graphene Flagship program; Fondazione Istituto Italiano di Tecnologia	Supported by the Graphene Flagship program (contract no. CNECT-ICT-604391) and Fondazione Istituto Italiano di Tecnologia.	Alonso-Gonzalez P, 2014, SCIENCE, V344, P1369, DOI 10.1126/science.1253202; [Anonymous], 2015, NAT NANOTECHNOL, V10; Chakraborty S, 2016, SCIENCE, V351, P246, DOI 10.1126/science.aad2930; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Dai S, 2015, NAT NANOTECHNOL, V10, P682, DOI [10.1038/NNANO.2015.131, 10.1038/nnano.2015.131]; Faist J., 2013, QUANTUM CASCADE LASE; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Freitag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2951; Giuliani G.F., 2005, QUANTUM THEORY ELECT; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Li YL, 2014, NANO LETT, V14, P1573, DOI 10.1021/nl404824w; Rodrigo D, 2015, SCIENCE, V349, P165, DOI 10.1126/science.aab2051; Tredicucci A, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2271692; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]	14	18	19	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					229	230		10.1126/science.aad7995	http://dx.doi.org/10.1126/science.aad7995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816365				2022-12-28	WOS:000368098600021
J	Olsen, JL; Rouze, P; Verhelst, B; Lin, YC; Bayer, T; Collen, J; Dattolo, E; De Paoli, E; Dittami, S; Maumus, F; Michel, G; Kersting, A; Lauritano, C; Lohaus, R; Topel, M; Tonon, T; Vanneste, K; Amirebrahimi, M; Brakel, J; Bostrom, C; Chovatia, M; Grimwood, J; Jenkins, JW; Jueterbock, A; Mraz, A; Stam, WT; Tice, H; Bornberg-Bauer, E; Green, PJ; Pearson, GA; Procaccini, G; Duarte, CM; Schmutz, J; Reusch, TBH; Van de Peer, Y				Olsen, Jeanine L.; Rouze, Pierre; Verhelst, Brain; Lin, Yao-Cheng; Bayer, Till; Collen, Jonas; Dattolo, Emanuela; De Paoli, Emanuele; Dittami, Simon; Maumus, Florian; Michel, Gurvan; Kersting, Anna; Lauritano, Chiara; Lohaus, Rolf; Topel, Mats; Tonon, Thierry; Vanneste, Kevin; Amirebrahimi, Mojgan; Brakel, Janina; Bostrom, Christoffer; Chovatia, Mansi; Grimwood, Jane; Jenkins, Jerry W.; Jueterbock, Alexander; Mraz, Amy; Stam, Wytze T.; Tice, Hope; Bornberg-Bauer, Erich; Green, Pamela J.; Pearson, Gareth A.; Procaccini, Gabriele; Duarte, Carlos M.; Schmutz, Jeremy; Reusch, Thorsten B. H.; Van de Peer, Yves			The genome of the seagrass Zostera marina reveals angiosperm adaptation to the sea	NATURE			English	Article							CHROMOSOME-NUMBERS; NEW-JERSEY; EVOLUTION; ANNOTATION; PROTEIN; ALGORITHMS; RESOURCE; PROGRAM; HISTORY; ORIGIN	Seagrasses colonized the sea(1) on at least three independent occasions to form the basis of one of the most productive and widespread coastal ecosystems on the planet(2). Here we report the genome of Zostera marina (L.), the first, to our knowledge, marine angiosperm to be fully sequenced. This reveals unique insights into the genomic losses and gains involved in achieving the structural and physiological adaptations required for its marine lifestyle, arguably the most severe habitat shift ever accomplished by flowering plants. Key angiosperm innovations that were lost include the entire repertoire of stomatal genes(3), genes involved in the synthesis of terpenoids and ethylene signalling, and genes for ultraviolet protection and phytochromes for far-red sensing. Seagrasses have also regained functions enabling them to adjust to full salinity. Their cell walls contain all of the polysaccharides typical of land plants, but also contain polyanionic, low-methylated pectins and sulfated galactans, a feature shared with the cell walls of all macroalgae(4) and that is important for ion homoeostasis, nutrient uptake and O-2/CO2 exchange through leaf epidermal cells. The Z. marina genome resource will markedly advance a wide range of functional ecological studies from adaptation of marine ecosystems under climate warming(5,6), to unravelling the mechanisms of osmoregulation under high salinities that may further inform our understanding of the evolution of salt tolerance in crop plants(7).	[Olsen, Jeanine L.; Stam, Wytze T.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, POB 11103, NL-9700 CC Groningen, Netherlands; [Rouze, Pierre; Verhelst, Brain; Lin, Yao-Cheng; Lohaus, Rolf; Vanneste, Kevin] VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium; [Rouze, Pierre; Verhelst, Brain; Lin, Yao-Cheng; Lohaus, Rolf; Vanneste, Kevin] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Technol Pk 927, B-9052 Ghent, Belgium; [Bayer, Till; Brakel, Janina; Reusch, Thorsten B. H.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Evolutionary Ecol, Dusternbrooker Weg 20, D-24105 Kiel, Germany; [Collen, Jonas; Dittami, Simon; Michel, Gurvan; Tonon, Thierry] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, Integrat Biol Marine Models, CS 90074, F-29688 Roscoff, France; [Dattolo, Emanuela; Lauritano, Chiara; Procaccini, Gabriele] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [De Paoli, Emanuele] Univ Udine, Dipartimento Sci Agr & Ambientali, Via Sci 206, I-33100 Udine, Italy; [Maumus, Florian] INRA Versailles Grignon, INRA, URGI Res Unit Genom Info UR1164, Route St Cyr, F-78026 Versailles, France; [Kersting, Anna; Bornberg-Bauer, Erich] Univ Munster, Inst Evolut & Biodivers, Hufferstr 1, D-48149 Munster, Germany; [Kersting, Anna] Univ Dusseldorf, Inst Comp Sci, D-40255 Dusseldorf, Germany; [Topel, Mats] Univ Gothenburg, BILS, Dept Biol & Environm Sci, Med Gatan 18A, S-40530 Gothenburg, Sweden; [Amirebrahimi, Mojgan; Chovatia, Mansi; Grimwood, Jane; Jenkins, Jerry W.; Tice, Hope; Schmutz, Jeremy] Joint Genome Inst, Dept Energy, 2800 Mitchell Dr 100, Walnut Creek, CA 94598 USA; [Bostrom, Christoffer] Abo Akad Univ, Fac Sci & Engn, Environm & Marine Biol, Artillerigatan 6, FI-20520 Turku, Finland; [Grimwood, Jane; Jenkins, Jerry W.; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, 601 Genome Way NW, Huntsville, AL 35806 USA; [Jueterbock, Alexander] Nord Univ, Marine Ecol Grp, Postbox 1490, N-8049 Bodo, Norway; [Mraz, Amy] Amplicon Express, 2345 NE Hopkins Ct, Pullman, WA 99163 USA; [Green, Pamela J.] Univ Delaware, Delaware Biotechnol Inst, Dept Plant & Soil Sci, Sch Marine Sci & Policy, 15 Innovat Way, Newark, DE 19711 USA; [Pearson, Gareth A.] Univ Algarve, Ctr Marine Sci CCMAR, Marine Ecol & Evolut, P-8005139 Faro, Portugal; [Duarte, Carlos M.] KAUST, RSRC, Thuwal 239556900, Saudi Arabia; [Reusch, Thorsten B. H.] Univ Kiel, Fac Math & Nat Sci, Christian Albrechts Pl 4, D-24118 Kiel, Germany; [Van de Peer, Yves] Univ Pretoria, Genom Res Inst, Hatfield Campus, ZA-0028 Pretoria, South Africa; [Van de Peer, Yves] Univ Ghent, Bioinformat Inst, B-9000 Ghent, Belgium	University of Groningen; Flanders Institute for Biotechnology (VIB); Ghent University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; UDICE-French Research Universities; Sorbonne Universite; Stazione Zoologica Anton Dohrn di Napoli; University of Udine; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Munster; Heinrich Heine University Dusseldorf; University of Gothenburg; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Abo Akademi University; HudsonAlpha Institute for Biotechnology; Nord University; University of Delaware; Universidade do Algarve; King Abdullah University of Science & Technology; University of Kiel; University of Pretoria; Ghent University	Olsen, JL (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, POB 11103, NL-9700 CC Groningen, Netherlands.; Van de Peer, Y (corresponding author), VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.; Van de Peer, Y (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, Technol Pk 927, B-9052 Ghent, Belgium.; Van de Peer, Y (corresponding author), Univ Pretoria, Genom Res Inst, Hatfield Campus, ZA-0028 Pretoria, South Africa.; Van de Peer, Y (corresponding author), Univ Ghent, Bioinformat Inst, B-9000 Ghent, Belgium.	j.l.olsen@rug.nl; yves.vandepeer@psb.vib-ugent.be	Van de Peer, Yves/D-4388-2009; Reusch, Thorsten B. H./B-9311-2019; Bornberg-Bauer, Erich/A-1563-2013; Maumus, Florian/O-5426-2016; Jenkins, Jerry/ABE-6479-2020; Jueterbock, Alexander/ABH-4869-2020; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Procaccini, Gabriele/A-6618-2010; Reusch, Thorsten B.H./G-4141-2011; Jueterbock, Alexander/Q-8639-2018; Bayer, Till/H-6826-2016; Schmutz, Jeremy/N-3173-2013; Pearson, Gareth/J-3911-2013; Van de Peer, Yves/AAE-7666-2019; Duarte, Carlos M/A-7670-2013; Grimwood, Jane/ABD-5737-2021; Dattolo, Emanuela/ABD-6535-2020; Procaccini, Gabriele/AAA-7040-2019; LIN, Yao-Cheng/B-4394-2008; Tonon, Thierry/A-3214-2009; Lauritano, Chiara/Q-4166-2018	Van de Peer, Yves/0000-0003-4327-3730; Bornberg-Bauer, Erich/0000-0002-1826-3576; Maumus, Florian/0000-0001-7325-0527; Jenkins, Jerry/0000-0002-7943-3997; Jueterbock, Alexander/0000-0002-0659-3172; Procaccini, Gabriele/0000-0002-6179-468X; Jueterbock, Alexander/0000-0002-0659-3172; Bayer, Till/0000-0002-4704-2449; Schmutz, Jeremy/0000-0001-8062-9172; Pearson, Gareth/0000-0002-0768-464X; Van de Peer, Yves/0000-0003-4327-3730; Duarte, Carlos M/0000-0002-1213-1361; Dattolo, Emanuela/0000-0001-6005-5079; Procaccini, Gabriele/0000-0002-6179-468X; LIN, Yao-Cheng/0000-0002-9390-795X; Tonon, Thierry/0000-0002-1454-6018; MICHEL, Gurvan/0000-0002-3009-6205; Reusch, Thorsten B. H./0000-0002-8961-4337; Olsen, Jeanine L./0000-0003-3091-0163; Topel, Mats/0000-0001-7989-696X; Chovatia, Mansi/0000-0001-8175-782X; Lauritano, Chiara/0000-0003-4580-9594; De Paoli, Emanuele/0000-0003-3646-7692				Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Aquino RS, 2005, GLYCOBIOLOGY, V15, P11, DOI 10.1093/glycob/cwh138; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crepet WL, 1998, AM J BOT, V85, P1122, DOI 10.2307/2446345; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DECOCK AWAM, 1980, AQUAT BOT, V9, P201, DOI 10.1016/0304-3770(80)90023-6; Degroeve S, 2005, BIOINFORMATICS, V21, P1332, DOI 10.1093/bioinformatics/bti166; DENHARTOG C, 1987, PLANT SYST EVOL, V156, P55, DOI 10.1007/BF00937201; Doyle James A., 2008, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V64, P59; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Duarte CM, 2009, BIOSCIENCE, V59, P967, DOI 10.1525/bio.2009.59.11.8; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Felsenstein J., 2005, PHYLIP PHYLOGENETIC; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; Fostier J, 2011, BIOINFORMATICS, V27, P749, DOI 10.1093/bioinformatics/btr008; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Furness C. A., 2013, EARLY EVENTS MONOCOT, P1; Gandolfo MA, 1998, AM J BOT, V85, P964, DOI 10.2307/2446363; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Golicz A. A., 2015, J EXP BOT; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green E.P., 2003, WORLD ATLAS SEAGRASS; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Hoede C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091929; Iles WJD, 2015, BOT J LINN SOC, V178, P346, DOI 10.1111/boj.12233; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kuo J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P51; Kuo J, 2001, PLANT SYST EVOL, V226, P155, DOI 10.1007/s006060170063; Lallemand B, 2013, PLANT PHYSIOL, V162, P616, DOI 10.1104/pp.112.213124; Larkum AWD, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P323; Larkum W.D., 2006, SEAGRASSES BIOL ECOL; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macreadie PI, 2014, ECOL INDIC, V38, P279, DOI 10.1016/j.ecolind.2013.11.017; Maumus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094101; Mazzuca S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00038; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nauheimer L, 2012, NEW PHYTOL, V195, P938, DOI 10.1111/j.1469-8137.2012.04220.x; Olsen JL, 2013, MAR ECOL PROG SER, V486, P121, DOI 10.3354/meps10373; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pillitteri Lynn Jo, 2013, Arabidopsis Book, V11, pe0162, DOI 10.1199/tab.0162; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Proost S, 2015, NUCLEIC ACIDS RES, V43, pD974, DOI 10.1093/nar/gku986; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Reusch TBH, 2011, EVOL ECOL, V25, P899, DOI 10.1007/s10682-010-9436-8; Smit AFA., REPEATMODELER OPEN 1; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0353; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yang YM, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5564, 10.1038/ncomms6110]; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716	87	288	301	16	311	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					331	+		10.1038/nature16548	http://dx.doi.org/10.1038/nature16548			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26814964	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000370327100036
J	Claiborne, AB; English, RA; Kahn, JP				Claiborne, Anne B.; English, Rebecca A.; Kahn, Jeffrey P.			Finding an ethical path forward for mitochondrial replacement	SCIENCE			English	Editorial Material							DNA MUTATIONS; DISEASE		[Claiborne, Anne B.; English, Rebecca A.] US Natl Acad Sci, Inst Med, Washington, DC 20001 USA; [Claiborne, Anne B.; English, Rebecca A.] US Natl Acad Engn, Inst Med, Washington, DC 20001 USA; [Claiborne, Anne B.; English, Rebecca A.] US Natl Acad Med, Inst Med, Washington, DC 20001 USA; [Kahn, Jeffrey P.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA	National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; Johns Hopkins University	Claiborne, AB (corresponding author), US Natl Acad Sci, Inst Med, Washington, DC 20001 USA.; Claiborne, AB (corresponding author), US Natl Acad Engn, Inst Med, Washington, DC 20001 USA.; Claiborne, AB (corresponding author), US Natl Acad Med, Inst Med, Washington, DC 20001 USA.	aclaiborne@nas.edu		Kahn, Jeffrey/0000-0003-2493-2016; English, Rebecca/0000-0002-4039-6105	PHS HHS [10002265] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2014, 59 M CELL TISS GEN T, P203; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; International Bioethics Committee, 2015, REP IBC UPD ITS REFL; Isasi R, 2016, SCIENCE, V351, P337, DOI 10.1126/science.aad6778; National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S; National Academy of Medicine, 2015, INT SUMM HUM GEN ED; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0; U.K. Parliament, 2015, LORDS DISC MIT DON; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001	13	15	15	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					668	670		10.1126/science.aaf3091	http://dx.doi.org/10.1126/science.aaf3091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD3GL	26842937				2022-12-28	WOS:000369810000024
J	Hartmann, LC; Lindor, NM				Hartmann, Lynn C.; Lindor, Noralane M.			The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BRCA2 MUTATION CARRIERS; BILATERAL PROPHYLACTIC MASTECTOMY; QUALITY-OF-LIFE; SALPINGO-OOPHORECTOMY; FAMILY-HISTORY; FOLLOW-UP; FALLOPIAN-TUBE; WOMEN; SUSCEPTIBILITY; ASSOCIATION	HEREDITARY BREAST AND OVARIAN CANCER IS A SYNDROME THAT INvolves an increased predisposition to breast cancer, ovarian cancer, or both and an autosomal dominant pattern of transmission. The numbers of breast-cancer diagnoses, the ages of patients at diagnosis, and the occurrence of ovarian cancer in addition to breast cancer vary among families with hereditary breast and ovarian cancer syndrome. The likelihood of detecting an underlying disease-causing mutation is highest in the most severely affected families, especially those with ovarian cancer. Disease-causing mutations in BRCA1 and BRCA2, the genes most often associated with hereditary breast and ovarian cancer syndrome, are identified in only a minority of families with suspected hereditary breast and ovarian cancer syndrome. Risk-reducing mastectomy and risk-reducing salpingo-oophorectomy are options for the primary prevention of breast and ovarian cancers, and they have been shown in multiple studies to have efficacy. However, these procedures, which have profound effects on a woman's body, are associated with complex and emotionally charged decision making. In this review, we address issues related to the care of women in families with hereditary breast and ovarian cancer syndrome who have not had cancer. We discuss risk assessment for breast and ovarian cancers according to the woman's age, the efficacy of risk-reducing surgery, the complications and psychosocial effects of these procedures, alternative strategies for risk management, and the best ways to facilitate individual decision making.	[Hartmann, Lynn C.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Hartmann, LC (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN USA.; Hartmann, LC (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	hartmann.lynn@mayo.edu						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Berg WA, 2014, J CLIN ONCOL, V32, P2193, DOI 10.1200/JCO.2014.56.2975; Brandberg Y, 2008, J CLIN ONCOL, V26, P3943, DOI 10.1200/JCO.2007.13.9568; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; Contant CME, 2002, EUR J SURG ONCOL, V28, P627, DOI 10.1053/ejso.2002.1279; Daly MB, 2015, CANCER PREV RES, V8, P342, DOI 10.1158/1940-6207.CAPR-14-0293; Domchek SM, 2006, LANCET ONCOL, V7, P223, DOI 10.1016/S1470-2045(06)70585-X; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Evans DGR, 2009, J MED GENET, V46, P254, DOI 10.1136/jmg.2008.062232; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; Finch A, 2013, PSYCHO-ONCOLOGY, V22, P212, DOI 10.1002/pon.2041; Finch APM, 2014, J CLIN ONCOL, V32, P1547, DOI 10.1200/JCO.2013.53.2820; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Giuliano AE, 2007, ANN SURG ONCOL, V14, P2425, DOI 10.1245/s10434-007-9447-z; Graeser MK, 2009, J CLIN ONCOL, V27, P5887, DOI 10.1200/JCO.2008.19.9430; Greene MH, 2015, CANCER PREV RES, V8, P339, DOI 10.1158/1940-6207.CAPR-15-0072; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; Heemskerk-Gerritsen BA, 2015, JNCI-J NATL CANCER I, V107, P107; Heemskerk-Gerritsen BAM, 2007, ANN SURG ONCOL, V14, P3335, DOI 10.1245/s10434-007-9449-x; Heiniger L, 2015, FAM CANCER, V14, P105, DOI 10.1007/s10689-014-9759-7; Ingham SL, 2013, J MED GENET, V50, P368, DOI 10.1136/jmedgenet-2013-101607; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Klaren HM, 2003, J NATL CANCER I, V95, P941, DOI 10.1093/jnci/95.13.941; Klitzman R, 2010, AM J MED GENET A, V152A, P52, DOI 10.1002/ajmg.a.33068; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Kuhn E, 2012, CURR OBSTET GYNECOL, V1, P1, DOI 10.1007/s13669-011-0004-1; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee AJ, 2014, BRIT J CANCER, V110, P535, DOI 10.1038/bjc.2013.730; LYNCH HT, 1971, ARCH SURG-CHICAGO, V103, P84; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mingels MJJM, 2014, MODERN PATHOL, V27, P1002, DOI 10.1038/modpathol.2013.212; Moller P, 2013, BREAST CANCER RES TR, V139, P155, DOI 10.1007/s10549-013-2540-z; Moorman PG, 2013, J CLIN ONCOL, V31, P4188, DOI 10.1200/JCO.2013.48.9021; Morrow M, 2009, BRIT J SURG, V96, P1, DOI 10.1002/bjs.6463; National Comprehensive Cancer Network, 2015, NAT COMPR CANC NETW; National Institute for Health and Care Excellence, 2019, FAM BREAST CANC CLAS; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Peled AW, 2014, ANN SURG ONCOL, V21, P37, DOI 10.1245/s10434-013-3230-0; Phillips KA, 2013, J CLIN ONCOL, V31, P3091, DOI 10.1200/JCO.2012.47.8313; Ramus SJ, 2015, J NATL CANC I; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Rebbeck TR, 2005, J CLIN ONCOL, V23, P7804, DOI 10.1200/JCO.2004.00.8151; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Robson ME, 2015, J CLIN ONCOL, V33, P3660, DOI 10.1200/JCO.2015.63.0996; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Singh K, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.026; Skytte AB, 2011, CLIN GENET, V79, P431, DOI 10.1111/j.1399-0004.2010.01604.x; Stan DL, 2013, J WOMENS HEALTH, V22, P825, DOI 10.1089/jwh.2013.4407; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; TOBACMAN JK, 1982, LANCET, V2, P795; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van Dijk S, 2008, J CLIN ONCOL, V26, P2358, DOI 10.1200/JCO.2006.10.5494; Walker JL, 2015, CANCER; Warner E, 2011, J CLIN ONCOL, V29, P1664, DOI 10.1200/JCO.2009.27.0835; ZIEGLER LD, 1991, AM J CLIN ONCOL-CANC, V14, P451, DOI 10.1097/00000421-199110000-00018	75	175	180	0	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					454	468		10.1056/NEJMra1503523	http://dx.doi.org/10.1056/NEJMra1503523			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840135				2022-12-28	WOS:000369319100008
J	Hassan, MT; Luu, TT; Moulet, A; Raskazovskaya, O; Zhokhov, P; Garg, M; Karpowicz, N; Zheltikov, AM; Pervak, V; Krausz, F; Goulielmakis, E				Hassan, M. Th.; Luu, T. T.; Moulet, A.; Raskazovskaya, O.; Zhokhov, P.; Garg, M.; Karpowicz, N.; Zheltikov, A. M.; Pervak, V.; Krausz, F.; Goulielmakis, E.			Optical attosecond pulses and tracking the nonlinear response of bound electrons	NATURE			English	Article							REAL-TIME OBSERVATION; HIGH-HARMONIC-GENERATION; DYNAMICS; GASES; SUSCEPTIBILITIES; SPECTROSCOPY; IONIZATION; SOLIDS; DELAY	The time it takes a bound electron to respond to the electromagnetic force of light sets a fundamental speed limit on the dynamic control of matter and electromagnetic signal processing. Time-integrated measurements of the nonlinear refractive index(1) of matter indicate that the nonlinear response of bound electrons to optical fields is not instantaneous; however, a complete spectral characterization of the nonlinear susceptibility tensors(2)-which is essential to deduce the temporal response of a medium to arbitrary driving forces using spectral measurements-has not yet been achieved. With the establishment of attosecond chronoscopy(3-5), the impulsive response of positive-energy electrons to electromagnetic fields has been explored through ionization of atoms(6) and solids(7) by an extreme-ultraviolet attosecond pulse(8) or by strong near-infrared fields(9-11). However, none of the attosecond studies carried out so far have provided direct access to the nonlinear response of bound electrons. Here we demonstrate that intense optical attosecond pulses synthesized in the visible and nearby spectral ranges allow sub-femtosecond control and metrology of bound-electron dynamics. Vacuum ultraviolet spectra emanating from krypton atoms, exposed to intense waveform-controlled optical attosecond pulses, reveal a finite nonlinear response time of bound electrons of up to 115 attoseconds, which is sensitive to and controllable by the super-octave optical field. Our study could enable new spectroscopies of bound electrons in atomic, molecular or lattice potentials of solids(12), as well as light-based electronics operating on sub-femtosecond timescales and at petahertz rates(13-15).	[Hassan, M. Th.; Luu, T. T.; Moulet, A.; Garg, M.; Karpowicz, N.; Krausz, F.; Goulielmakis, E.] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Raskazovskaya, O.; Pervak, V.; Krausz, F.] Univ Munich, Dept Phys, Coulombwall 1, D-85748 Garching, Germany; [Zhokhov, P.; Zheltikov, A. M.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Zhokhov, P.; Zheltikov, A. M.] Moscow MV Lomonosov State Univ, Dept Phys, Ctr Int Laser, Moscow 119992, Russia	Max Planck Society; University of Munich; Texas A&M University System; Texas A&M University College Station; Lomonosov Moscow State University	Goulielmakis, E (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	elgo@mpq.mpg.de	Garg, Manish/P-7273-2016; Hassan, Mohammed TH/I-5793-2019; Goulielmakis, Eleftherios/AAZ-1052-2020; Goulielmakis, Eleftherios/F-1693-2011; Luu, Tran Trung/HCH-4815-2022	Garg, Manish/0000-0002-1744-7445; Hassan, Mohammed TH/0000-0002-9669-534X; Goulielmakis, Eleftherios/0000-0003-3386-0245; Zheltikov, Aleksei/0000-0002-9138-0576; Luu, Tran Trung/0000-0003-3772-3379	European Research Council [Attoelectronics-258501]; Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics; Max Planck Society; European Research Training Network ATTOFEL; European Research Training Network MEDEA; Russian Foundation for Basic Research [13-02-01465, 13-02-92115, 13-04-40335]; Welch Foundation [A-1801]; Russian Science Foundation [14-12-00772] Funding Source: Russian Science Foundation	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Training Network ATTOFEL; European Research Training Network MEDEA; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Welch Foundation(The Welch Foundation); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by European Research Council grant (Attoelectronics-258501), the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (http://www.munich-photonics. de), the Max Planck Society and the European Research Training Networks ATTOFEL and MEDEA, the Russian Foundation for Basic Research (projects numbers 13-02-01465, 13-02-92115 and 13-04-40335) and the Welch Foundation (grant number A-1801).	Baker S, 2011, NAT PHOTONICS, V5, P665, DOI [10.1038/nphoton.2011.256, 10.1038/NPHOTON.2011.256]; BLOW KJ, 1989, IEEE J QUANTUM ELECT, V25, P2665, DOI 10.1109/3.40655; Boyd R. W., 1992, NONLINEAR OPTICS; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Gauthey FI, 1997, PHYS REV A, V56, P3093, DOI 10.1103/PhysRevA.56.3093; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; Hassan MT, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4758310; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Ivanov M, 2013, CHEM PHYS, V414, P3, DOI 10.1016/j.chemphys.2012.12.021; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; LUNDEEN T, 1983, J CHEM PHYS, V79, P6301, DOI 10.1063/1.445736; Muller HG, 1999, LASER PHYS, V9, P138; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Sansone G, 2011, NAT PHOTONICS, V5, P656, DOI [10.1038/nphoton.2011.167, 10.1038/NPHOTON.2011.167]; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; SHEIKBAHAE M, 1991, IEEE J QUANTUM ELECT, V27, P1296, DOI 10.1109/3.89946; SHELTON DP, 1990, PHYS REV A, V42, P2578, DOI 10.1103/PhysRevA.42.2578; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Weiner A. M., 2009, ULTRAFAST OPTICS; Wirth A, 2011, SCIENCE, V334, P195, DOI 10.1126/science.1210268; Zewail A.H., 1994, FEMTOCHEMISTRY ULTRA, V1; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h	36	262	277	9	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					66	+		10.1038/nature16528	http://dx.doi.org/10.1038/nature16528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842055				2022-12-28	WOS:000369304500033
J	Isanaka, S; Langendorf, C; Berthe, F; Gnegne, S; Li, N; Ousmane, N; Harouna, S; Hassane, H; Schaefer, M; Adehossi, E; Grais, RF				Isanaka, Sheila; Langendorf, Celine; Berthe, Fatou; Gnegne, Smaila; Li, Nan; Ousmane, Nassirou; Harouna, Souley; Hassane, Hamidine; Schaefer, Myrto; Adehossi, Eric; Grais, Rebecca F.			Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALNOURISHED CHILDREN; BACTEREMIA; RESISTANCE; COUNTRIES; MANAGEMENT; DISEASE; KENYA; WORLD	BACKGROUND High-quality evidence supporting a community-based treatment protocol for children with severe acute malnutrition, including routine antibiotic use at admission to a nutritional treatment program, remains limited. In view of the costs and consequences of emerging resistance associated with routine antibiotic use, more evidence is required to support this practice. METHODS In a double-blind, placebo-controlled trial in Niger, we randomly assigned children who were 6 to 59 months of age and had uncomplicated severe acute malnutrition to receive amoxicillin or placebo for 7 days. The primary outcome was nutritional recovery at or before week 8. RESULTS A total of 2412 children underwent randomization, and 2399 children were included in the analysis. Nutritional recovery occurred in 65.9% of children in the amoxicillin group (790 of 1199) and in 62.7% of children in the placebo group (752 of 1200). There was no significant difference in the likelihood of nutritional recovery (risk ratio for amoxicillin vs. placebo, 1.05; 95% confidence interval [CI], 0.99 to 1.12; P = 0.10). In secondary analyses, amoxicillin decreased the risk of transfer to inpatient care by 14% (26.4% in the amoxicillin group vs. 30.7% in the placebo group; risk ratio, 0.86; 95% CI, 0.76 to 0.98; P = 0.02). CONCLUSIONS We found no benefit of routine antibiotic use with respect to nutritional recovery from uncomplicated severe acute malnutrition in Niger. In regions with adequate infrastructure for surveillance and management of complications, health care facilities could consider eliminating the routine use of antibiotics in protocols for the treatment of uncomplicated severe acute malnutrition.	[Isanaka, Sheila; Langendorf, Celine; Berthe, Fatou; Gnegne, Smaila; Grais, Rebecca F.] Epictr, Dept Res, Paris, France; [Schaefer, Myrto] Med Sans Frontieres Operat Ctr Paris, Paris, France; [Isanaka, Sheila] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Isanaka, Sheila; Li, Nan] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ousmane, Nassirou] Minist Hlth, Niamey, Niger; [Harouna, Souley] Forum Sante Niger, Niamey, Niger; [Adehossi, Eric] Natl Hosp, Niamey, Niger; [Hassane, Hamidine] UNICEF, Maradi, Niger	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Grais, RF (corresponding author), 8 Rue St Sabin, F-75011 Paris, France.	rebecca.grais@epicentre.msf.org	Isanaka, Sheila/AAQ-9056-2020	CELINE, LANGENDORF/0000-0002-0811-7540; Gnegne, Smaila/0000-0002-4392-8541; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins sans Frontieres Operational Center Paris	Medecins sans Frontieres Operational Center Paris	Funded by Medecins sans Frontieres Operational Center Paris; ClinicalTrials.gov number, NCT01613547.	Alcoba G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053184; [Anonymous], 2014, ANN MED REP; [Anonymous], 2012, COM ANT SOC FRANC MI; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; FRIEDLAND IR, 1992, ANN TROP PAEDIATR, V12, P433, DOI 10.1080/02724936.1992.11747610; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Hossain MI, 2009, J HEALTH POPUL NUTR, V27, P72; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Laterza L, 2015, EXPERT OPIN PHARMACO, V16, P607, DOI 10.1517/14656566.2015.1007951; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1567; Noorani N, 2005, East Afr Med J, V82, P343; Oshikoya KA, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-50; Page AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068699; Seaton C, 2007, J ANTIMICROB CHEMOTH, V59, P681, DOI 10.1093/jac/dkl561; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; WHO, WHO CHILD GROWTH STA; WHO, 2013, GUID UPD MAN SEV AC; WOLF BHM, 1995, EUR J PEDIATR, V154, P299, DOI 10.1007/s004310050293; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY	29	74	75	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					444	453		10.1056/NEJMoa1507024	http://dx.doi.org/10.1056/NEJMoa1507024			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840134				2022-12-28	WOS:000369319100007
J	Ochodo, E; Garner, P; Sinclair, D				Ochodo, Eleanor; Garner, Paul; Sinclair, David			Achieving universal testing for malaria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RAPID DIAGNOSTIC-TESTS; COMMUNITY CASE-MANAGEMENT; HEALTH FACILITIES; TREATMENT GUIDELINES; ADHERENCE; PATIENT; CONSUMPTION; CLINICIAN; CHILDREN; TRIAL		[Ochodo, Eleanor] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, POB 241, ZA-8000 Cape Town, South Africa; [Garner, Paul; Sinclair, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England	Stellenbosch University; Liverpool School of Tropical Medicine; University of Liverpool	Ochodo, E (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, POB 241, ZA-8000 Cape Town, South Africa.	eleanor.ochodo@gmail.com	Garner, Paul/Y-8385-2019; Garner, Paul/HII-5856-2022	Garner, Paul/0000-0002-0607-6941; Ochodo, Eleanor/0000-0002-7951-3030	Department for International Development (DFID) [201400] Funding Source: researchfish	Department for International Development (DFID)		Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Ansah EK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1019; Ansah EK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-258; Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Chandler CIR, 2012, SOC SCI MED, V74, P1528, DOI 10.1016/j.socscimed.2012.01.025; Chandler CIR, 2011, SOC SCI MED, V72, P937, DOI 10.1016/j.socscimed.2011.01.009; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Cohen J, 2015, AM ECON REV, V105, P609, DOI 10.1257/aer.20130267; Cohen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048296; Coxeter P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010907.pub2; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub4, 10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3]; Ezeoke OP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-368; Fiander M, 2015, COCHRANE DB SYST REV, DOI [10.1097/XEB.0000000000000074, 10.1002/14651858.CD004749.pub3]; Githinji S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054066; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Hasselback L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-295; Kurumop SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076578; Lussiana C., 2015, HLTH POLICY PLAN; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; Modrek S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-69; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Nanyonjo A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1019-5; Odaga J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008998.pub2; Onwujekwe O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133832; Paintain LS, 2014, AM J TROP MED HYG, V91, P461, DOI 10.4269/ajtmh.14-0094; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Ruizendaal E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-229; WHO, 2006, GUID TREATM MAL; WHO, 2015, MAL DIAGN LANDSC UPD; WHO, 2014, MAL RAP DIAGN PERF S; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2015, WORLD MALARIA REPORT; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	41	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2016	352								i107	10.1136/bmj.i107	http://dx.doi.org/10.1136/bmj.i107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD4RU	26846146	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000369911100002
J	Yamauchi, Y; Riel, JM; Ruthig, VA; Ortega, EA; Mitchell, MJ; Ward, MA				Yamauchi, Yasuhiro; Riel, Jonathan M.; Ruthig, Victor A.; Ortega, Egle A.; Mitchell, Michael J.; Ward, Monika A.			Two genes substitute for the mouse Y chromosome for spermatogenesis and reproduction	SCIENCE			English	Article							SEX DETERMINATION; MICE; SRY; REVERSAL; MAMMALS	The mammalian Y chromosome is considered a symbol of maleness, as it encodes a gene driving male sex determination, Sry, as well as a battery of other genes important for male reproduction. We previously demonstrated in the mouse that successful assisted reproduction can be achieved when the Y gene contribution is limited to only two genes, Sry and spermatogonial proliferation factor Eif2s3y. Here, we replaced Sry by transgenic activation of its downstream target Sox9, and Eif2s3y, by transgenic overexpression of its X chromosome-encoded homolog Eif2s3x. The resulting males with no Y chromosome genes produced haploid male gametes and sired offspring after assisted reproduction. Our findings support the existence of functional redundancy between the Y chromosome genes and their homologs encoded on other chromosomes.	[Yamauchi, Yasuhiro; Riel, Jonathan M.; Ruthig, Victor A.; Ortega, Egle A.; Ward, Monika A.] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, 1960 East West Rd, Honolulu, HI 96822 USA; [Mitchell, Michael J.] Aix Marseille Univ, INSERM, GMGF UMR S 910, F-13385 Marseille, France	University of Hawaii System; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ward, MA (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, 1960 East West Rd, Honolulu, HI 96822 USA.	mward@hawaii.edu	Mitchell, Michael/I-3987-2016; Ruthig, Victor A/AAV-1059-2021	Mitchell, Michael/0000-0003-2052-7347; Ruthig, Victor A/0000-0003-1126-6106	NIH [HD072380]; Hawaii Community Foundation [14ADVC-64546]; INSERM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hawaii Community Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH HD072380 and Hawaii Community Foundation 14ADVC-64546 grants to M.A.W. and INSERM core funding to M.J.M.	Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Hughes JF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0667-4; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Riel JM, 2013, J CELL SCI, V126, P803, DOI 10.1242/jcs.114488; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052; Soullier S, 1998, MAMM GENOME, V9, P590, DOI 10.1007/s003359900823; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Warr N, 2012, WIRES DEV BIOL, V1, P559, DOI 10.1002/wdev.42; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544; Yamauchi Y, 2009, BIOL REPROD, V81, P353, DOI 10.1095/biolreprod.109.076307	17	40	48	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					514	516		10.1126/science.aad1795	http://dx.doi.org/10.1126/science.aad1795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823431	Green Accepted			2022-12-28	WOS:000368858200039
J	O'Connor, E; Rossom, RC; Henninger, M; Groom, HC; Burda, BU				O'Connor, Elizabeth; Rossom, Rebecca C.; Henninger, Michelle; Groom, Holly C.; Burda, Brittany U.			Primary Care Screening for and Treatment of Depression in Pregnant and Postpartum Women Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; SEROTONIN-REUPTAKE INHIBITORS; POSTNATAL DEPRESSION; SCALE EPDS; PSYCHOLOGICAL TREATMENTS; PERINATAL DEPRESSION; MATERNAL DEPRESSION; TRANSLATED VERSION; ANTIDEPRESSANT USE	IMPORTANCE Depression is a source of substantial burden for individuals and their families, including women during the pregnant and postpartum period. OBJECTIVE To systematically review the benefits and harms of depression screening and treatment, and accuracy of selected screening instruments, for pregnant and postpartum women. Evidence for depression screening in adults in general is available in the full report. DATA SOURCES MEDLINE, PubMed, PsycINFO, and the Cochrane Collaboration Registry of Controlled Trials through January 20, 2015; references; and government websites. STUDY SELECTION English-language trials of benefits and harms of depression screening, depression treatment in pregnant and postpartum women with screen-detected depression, and diagnostic accuracy studies of depression screening instruments in pregnant and postpartum women. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles and extracted data from fair-and good-quality studies. Random-effects meta-analysis was used to estimate the benefit of cognitive behavioral therapy (CBT) in pregnant and postpartum women. MAIN OUTCOMES AND MEASURES Depression remission, prevalence, symptoms, and related measures of depression recovery or response; sensitivity and specificity of selected screening measures to detect depression; and serious adverse effects of antidepressant treatment. RESULTS Among pregnant and postpartum women 18 years and older, 6 trials (n = 11 869) showed 18% to 59% relative reductions with screening programs, or 2.1% to 9.1% absolute reductions, in the risk of depression at follow-up (3-5 months) after participation in programs involving depression screening, with or without additional treatment components, compared with usual care. Based on 23 studies (n = 5398), a cutoff of 13 on the English-language Edinburgh Postnatal Depression Scale demonstrated sensitivity ranging from 0.67 (95% CI, 0.18-0.96) to 1.00 (95% CI, 0.67-1.00) and specificity consistently 0.87 or higher. Data were sparse for Patient Health Questionnaire instruments. Pooled results for the benefit of CBT for pregnant and postpartum women with screen-detected depression showed an increase in the likelihood of remission (pooled relative risk, 1.34 [95% CI, 1.19-1.50]; No. of studies [K] = 10, I-2 = 7.9%) compared with usual care, with absolute increases ranging from 6.2% to 34.6%. Observational evidence showed that second-generation antidepressant use during pregnancy may be associated with small increases in the risks of potentially serious harms. CONCLUSIONS AND RELEVANCE Direct and indirect evidence suggested that screening pregnant and postpartum women for depression may reduce depressive symptoms in women with depression and reduce the prevalence of depression in a given population. Evidence for pregnant women was sparser but was consistent with the evidence for postpartum women regarding the benefits of screening, the benefits of treatment, and screening instrument accuracy.	[O'Connor, Elizabeth; Henninger, Michelle; Groom, Holly C.; Burda, Brittany U.] Permanente Res Affiliates Evidence Based Practice, Ctr Hlth Res, Portland, OR USA; [Rossom, Rebecca C.] HealthPartners Inst Educ & Res, Kaiser Permanente Res Affiliates Evidence Based P, Bloomington, MN USA	HealthPartners Institute for Education & Research; Kaiser Permanente	O'Connor, E (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, 3800 N Interstate Ave, Portland, OR 97227 USA.	elizabeth.oconnor@kpchr.org	Rossom, Rebecca/R-7103-2019	Groom, Holly/0000-0003-2866-9788; Rossom, Rebecca/0000-0002-9531-914X	Agency for Healthcare Research and Quality (AHRQ) under US Preventive Services Task Force (USPSTF)	Agency for Healthcare Research and Quality (AHRQ) under US Preventive Services Task Force (USPSTF)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the US Preventive Services Task Force (USPSTF).	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Alvarado R, 2015, ARCH WOMEN MENT HLTH, V18, P607, DOI 10.1007/s00737-014-0466-z; Ammerman RT, 2013, BEHAV THER, V44, P359, DOI 10.1016/j.beth.2013.01.002; Andersen JT, 2014, OBSTET GYNECOL, V124, P655, DOI 10.1097/AOG.0000000000000447; [Anonymous], RIS S HUM PROGR DIV; [Anonymous], 2009, AHRQ PUBLICATION; Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Benvenuti P, 1999, J AFFECT DISORDERS, V53, P137, DOI 10.1016/S0165-0327(98)00102-5; Blanco C, 2008, J CLIN PSYCHIAT, V69, P1276, DOI 10.4088/JCP.v69n0810; Bunevicius A, 2009, J PSYCHOSOM OBST GYN, V30, P238, DOI 10.3109/01674820903230708; Bunevicius A, 2009, MED LITH, V45, P544, DOI 10.3390/medicina45070072; Carpiniello B, 1997, J PSYCHOSOM OBST GYN, V18, P280, DOI 10.3109/01674829709080700; Chen HL, 2013, ASIA-PAC PSYCHIAT, V5, pE64, DOI 10.1111/appy.12080; Clarke PJ, 2008, CAN J NURS RES, V40, P112; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooper PJ, 2003, BRIT J PSYCHIAT, V182, P412, DOI 10.1192/bjp.182.5.412; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Felice E, 2006, ARCH WOMEN MENT HLTH, V9, P75, DOI 10.1007/s00737-005-0099-3; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Gjerdingen D, 2009, J AM BOARD FAM MED, V22, P473, DOI 10.3122/jabfm.2009.05.080192; Gjerdingen D, 2009, ANN FAM MED, V7, P63, DOI 10.1370/afm.933; Glavin K, 2010, J CLIN NURS, V19, P3051, DOI 10.1111/j.1365-2702.2010.03332.x; Goodman JH, 2015, ARCH WOMEN MENT HLTH, V18, P493, DOI 10.1007/s00737-014-0483-y; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P813, DOI 10.1192/bjp.154.6.813; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hayes RM, 2013, AM J OBSTET GYNECOL, V208, P326; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Heh SS, 2003, J ADV NURS, V42, P30, DOI 10.1046/j.1365-2648.2003.02576.x; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Hoertel N, 2015, DEPRESS ANXIETY, V32, P129, DOI 10.1002/da.22334; HOLDEN JM, 1989, BRIT MED J, V298, P223, DOI 10.1136/bmj.298.6668.223; Honey KL, 2002, BRIT J CLIN PSYCHOL, V41, P405, DOI 10.1348/014466502760387515; Horowitz JA, 2001, J NURS SCHOLARSHIP, V33, P323, DOI 10.1111/j.1547-5069.2001.00323.x; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Jensen HM, 2013, PSYCHOPHARMACOLOGY, V228, P199, DOI 10.1007/s00213-013-3029-5; Kersten-Alvarez LE, 2012, CHILD PSYCHIAT HUM D, V43, P201, DOI 10.1007/s10578-011-0257-y; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kjaersgaard MIS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072095; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kozinszky Z, 2012, PSYCHOTHER PSYCHOSOM, V81, P98, DOI 10.1159/000330035; Lee DTS, 2001, J AFFECT DISORDERS, V63, P233, DOI 10.1016/S0165-0327(00)00193-2; LeFevre ML, 2014, ANN INTERN MED, V160, P719, DOI 10.7326/M14-0589; Leung SSL, 2011, J PUBLIC HEALTH-UK, V33, P292, DOI 10.1093/pubmed/fdq075; Leverton TJ, 2000, J REPROD INFANT PSYC, V18, P279, DOI 10.1080/713683048; Louik C, 2014, PHARMACOEPIDEM DR S, V23, P1066, DOI 10.1002/pds.3661; Lupattelli A, 2014, J CLIN PSYCHOPHARM, V34, P143, DOI 10.1097/JCP.0000000000000036; MacArthur C, 2002, LANCET, V359, P378, DOI 10.1016/S0140-6736(02)07596-7; Mann R, 2012, CAN MED ASSOC J, V184, pE424, DOI 10.1503/cmaj.111213; McDonagh M, 2013, TREATMENT DEPRESSION; McGregor M, 2014, EARLY INTERV PSYCHIA, V8, P348, DOI 10.1111/eip.12074; Milgrom J, 2005, BRIT J CLIN PSYCHOL, V44, P529, DOI 10.1348/014466505X34200; Milgrom J, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-95; Morrell CJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI [10.3310/hta13300, 10.3310/htal3300]; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Myers E. R., 2013, COMP EFFECTIVENESS R, V106; Niemeyer H, 2013, J CONSULT CLIN PSYCH, V81, P58, DOI 10.1037/a0031152; O'Connor E, 2016, AHRQ PUBLICATION; O'Mahen H, 2013, DEPRESS ANXIETY, V30, P679, DOI 10.1002/da.22050; Palmsten K, 2013, EPIDEMIOLOGY, V24, P682, DOI 10.1097/EDE.0b013e31829e0aaa; Palmsten K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4877; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Polen KND, 2013, BIRTH DEFECTS RES A, V97, P28, DOI 10.1002/bdra.23096; Prendergast J, 2001, AUSTRALAS PSYCHIATRY, V9, P255, DOI DOI 10.1046/J.1440; Segre LS, 2015, J CONSULT CLIN PSYCH, V83, P314, DOI 10.1037/a0038495; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith MV, 2010, GEN HOSP PSYCHIAT, V32, P544, DOI 10.1016/j.genhosppsych.2010.04.011; Sockol LE, 2011, CLIN PSYCHOL REV, V31, P839, DOI 10.1016/j.cpr.2011.03.009; STEIN A, 1991, BRIT J PSYCHIAT, V158, P46, DOI 10.1192/bjp.158.1.46; Tandon SD, 2012, J AFFECT DISORDERS, V136, P155, DOI 10.1016/j.jad.2011.07.014; Teng HW, 2005, COMPR PSYCHIAT, V46, P261, DOI 10.1016/j.comppsych.2004.10.003; Toreki A, 2014, MIDWIFERY, V30, P911, DOI 10.1016/j.midw.2014.02.008; Toreki A, 2013, MIDWIFERY, V29, P308, DOI 10.1016/j.midw.2012.01.011; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; van Wijngaarden B, 2004, J AFFECT DISORDERS, V81, P211, DOI 10.1016/S0165-0327(03)00168-X; Wells G., NEWCASTLE OTTAWA SCA; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Wickberg B, 2005, J REPROD INFANT PSYC, V23, P33, DOI 10.1080/02646830512331330956; Wickberg B, 1996, J AFFECT DISORDERS, V39, P209, DOI 10.1016/0165-0327(96)00034-1; Wiklund I, 2010, ACTA OBSTET GYN SCAN, V89, P1100, DOI 10.3109/00016349.2010.500369; Wisniewski SR, 2009, AM J PSYCHIAT, V166, P599, DOI 10.1176/appi.ajp.2008.08071027; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; Yawn BP, 2012, ANN FAM MED, V10, P320, DOI 10.1370/afm.1418; Yazdy MM, 2014, EPIDEMIOLOGY, V25, P859, DOI 10.1097/EDE.0000000000000157	93	291	293	5	99	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					388	406		10.1001/jama.2015.18948	http://dx.doi.org/10.1001/jama.2015.18948			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB5YI	26813212	Bronze			2022-12-28	WOS:000368589500017
J	Clery, D				Clery, Daniel			Astronomers see ashes of the first stars	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					211	211		10.1126/science.351.6270.211	http://dx.doi.org/10.1126/science.351.6270.211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816354				2022-12-28	WOS:000368098600010
J	Delatte, B; Wang, F; Ngoc, LV; Collignon, E; Bonvin, E; Deplus, R; Calonne, E; Hassabi, B; Putmans, P; Awe, S; Wetzel, C; Kreher, J; Soin, R; Creppe, C; Limbach, PA; Gueydan, C; Kruys, V; Brehm, A; Minakhina, S; Defrance, M; Steward, R; Fuks, F				Delatte, Benjamin; Wang, Fei; Long Vo Ngoc; Collignon, Evelyne; Bonvin, Elise; Deplus, Rachel; Calonne, Emilie; Hassabi, Bouchra; Putmans, Pascale; Awe, Stephan; Wetzel, Collin; Kreher, Judith; Soin, Romuald; Creppe, Catherine; Limbach, Patrick A.; Gueydan, Cyril; Kruys, Veronique; Brehm, Alexander; Minakhina, Svetlana; Defrance, Matthieu; Steward, Ruth; Fuks, Francois			Transcriptome-wide distribution and function of RNA hydroxymethylcytosine	SCIENCE			English	Article							DNA; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DROSOPHILA; REVEALS; CELLS; TET2	Hydroxymethylcytosine, well described in DNA, occurs also in RNA. Here, we show that hydroxymethylcytosine preferentially marks polyadenylated RNAs and is deposited by Tet in Drosophila. We map the transcriptome-wide hydroxymethylation landscape, revealing hydroxymethylcytosine in the transcripts of many genes, notably in coding sequences, and identify consensus sites for hydroxymethylation. We found that RNA hydroxymethylation can favor mRNA translation. Tet and hydroxymethylated RNA are found to be most abundant in the Drosophila brain, and Tet-deficient fruitflies suffer impaired brain development, accompanied by decreased RNA hydroxymethylation. This study highlights the distribution, localization, and function of cytosine hydroxymethylation and identifies central roles for this modification in Drosophila.	[Delatte, Benjamin; Collignon, Evelyne; Bonvin, Elise; Deplus, Rachel; Calonne, Emilie; Hassabi, Bouchra; Putmans, Pascale; Creppe, Catherine; Defrance, Matthieu; Fuks, Francois] Univ Libre Bruxelles, ULB Canc Res Ctr U CRC, Fac Med, Lab Canc Epigenet, Brussels, Belgium; [Wang, Fei; Minakhina, Svetlana; Steward, Ruth] Rutgers State Univ, Dept Mol Biol & Biochem, Canc Inst New Jersey, Waksman Inst, Piscataway, NJ 08855 USA; [Long Vo Ngoc; Soin, Romuald; Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Fac Sci, Lab Mol Biol Gene, Gosselies, Belgium; [Awe, Stephan; Kreher, Judith; Brehm, Alexander] Univ Marburg, Inst Mol Biol & Tumorforsch, Marburg, Germany; [Wetzel, Collin; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Cincinnati, OH USA	Universite Libre de Bruxelles; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Universite Libre de Bruxelles; Philipps University Marburg; University System of Ohio; University of Cincinnati	Fuks, F (corresponding author), Univ Libre Bruxelles, ULB Canc Res Ctr U CRC, Fac Med, Lab Canc Epigenet, Brussels, Belgium.	ffuks@ulb.ac.be	Delatte, Benjamin/AAE-9276-2020; Limbach, Patrick/A-9188-2009; Kruys, Veronique I/N-6613-2018	Limbach, Patrick/0000-0003-1526-4546; Gueydan, Cyril/0000-0003-3097-7667; Delatte, Benjamin/0000-0002-6798-0600; Kruys, Veronique/0000-0002-3144-5403; Vo ngoc, Long/0000-0002-3918-5087; Collignon, Evelyne/0000-0001-7617-5905; Defrance, Matthieu/0000-0002-3090-3142	Belgian Fonds de la Recherche Scientifique (FNRS); FNRS ("Aspirant"); Belgian American Educational Foundation (BAEF) fellowship; Belgian Fund for Research Training in Industry and Agriculture; BAEF fellowship; "l'Oreal" fellowship; WBHealth grant (CanDx) from the Walloon Region; FNRS; Televie; Interuniversity Attraction Poles program [P7/03]; Action de Recherche Concertee (ARC); WB Health program; Belgian Fondation contre le Cancer; Fonds Gaston Ithier; Charles and Johanna Busch graduate fellowship; NIH [RO1 GM089992]; ARC [AV.12/1/]; Brachet Fund; Van Buuren Fund; National Science Foundation [NSF CHE 1212625, 1507357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089992] Funding Source: NIH RePORTER; Division Of Chemistry [1507357] Funding Source: National Science Foundation	Belgian Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS ("Aspirant")(Fonds de la Recherche Scientifique - FNRS); Belgian American Educational Foundation (BAEF) fellowship; Belgian Fund for Research Training in Industry and Agriculture(Fonds de la Recherche Scientifique - FNRS); BAEF fellowship; "l'Oreal" fellowship; WBHealth grant (CanDx) from the Walloon Region; FNRS(Fonds de la Recherche Scientifique - FNRS); Televie; Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Action de Recherche Concertee (ARC); WB Health program; Belgian Fondation contre le Cancer; Fonds Gaston Ithier; Charles and Johanna Busch graduate fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC(Australian Research Council); Brachet Fund; Van Buuren Fund; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. Droogmans for advice, as well as A. Rao and J. Kadonaga for continued support. We also thank Y. N. Jan for providing the antibody to Dpn. R.D., B.H., C.C., and E.B. were supported by the Belgian Fonds de la Recherche Scientifique (FNRS). B.D. was supported by the FNRS ("Aspirant") and a Belgian American Educational Foundation (BAEF) fellowship. L.V.N. was supported by the Belgian Fund for Research Training in Industry and Agriculture and a BAEF fellowship. E.Co. was supported by a "l'Oreal" fellowship, and M.D. was supported by the WBHealth grant (CanDx) from the Walloon Region. F.F. is a ULB Professor. F.F.'s lab was funded by grants from the FNRS and Televie, the Interuniversity Attraction Poles (P7/03) program, the Action de Recherche Concertee (ARC) (AUWB-2010-2015 ULB-No 7), the WB Health program, the Belgian Fondation contre le Cancer, and the Fonds Gaston Ithier. F.W. was supported by a Charles and Johanna Busch graduate fellowship and the work at Rutgers by a NIH grant (RO1 GM089992) to R.S. V.K. was supported by the ARC (AV.12/1/) as well as Brachet and Van Buuren Funds. P.A.L. received financial support from the National Science Foundation (NSF CHE 1212625 and 1507357). The authors declare no conflicts of interest. All sequencing data have been deposited to the Gene Expression Omnibus as series GSE66090.	Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunwell TL, 2013, CELL CYCLE, V12, P3357, DOI 10.4161/cc.26540; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; RACZ I, 1978, PLANTA, V142, P263, DOI 10.1007/BF00385075; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takayama S, 2014, GENOME RES, V24, P821, DOI 10.1101/gr.162412.113; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	15	242	254	5	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					282	285		10.1126/science.aac5253	http://dx.doi.org/10.1126/science.aac5253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816380	Green Submitted			2022-12-28	WOS:000368098600042
J	Sim, I				Sim, Ida			Two Ways of Knowing: Big Data and Evidence-Based Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sim, Ida] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sim, I (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, 1545 Divisadero St,Suite 308, San Francisco, CA 94143 USA.	ida.sim@ucsf.edu						Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Centre for Evidence-Based Medicine, STUD DES; Corley CD, 2011, ADV EXP MED BIOL, V696, P181, DOI 10.1007/978-1-4419-7046-6_18; De Choudhury M, 2013, P 7 INT ASS ADV ART; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Press, 2014, FORBES; Savov V, 2014, THE VERGE       0715; Zhao FH, 2012, ASIAN PAC J CANCER P, V13, P2369, DOI 10.7314/APJCP.2012.13.5.2369	8	36	38	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					562	+		10.7326/M15-2970	http://dx.doi.org/10.7326/M15-2970			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26809201				2022-12-28	WOS:000374257900017
J	West, J; Mehrotra, A				West, Jacob; Mehrotra, Ateev			The Future Ecology of Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICAL-CARE		Harvard Univ, Global Hlth Inst, Boston, MA 02466 USA; [Mehrotra, Ateev] Harvard Univ, Sch Med, 180A Longwood Ave, Boston, MA 02466 USA; [West, Jacob] Harvard Univ, Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, 180A Longwood Ave, Boston, MA 02466 USA.	mehrotra@hcp.med.harvard.edu	West, Jacob/GRJ-8550-2022; Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				[Anonymous], 1961, LIFE, P34; Brooks R., 2014, MAYO CLIN OFFERS REA; Fox S., 2011, PEER TO PEER HEALTHC; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Pearl R, 2014, HEALTH AFFAIR, V33, P251, DOI 10.1377/hlthaff.2013.1005; Pew Research Center, 2015, HLTH FACT SHEET; Semigran HL, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3480; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; Yamamoto DH., 2014, ASSESSMENT FEASIBILI	10	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					560	+		10.7326/M15-1978	http://dx.doi.org/10.7326/M15-1978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26811087				2022-12-28	WOS:000374257900016
J	Qaseem, A; Barry, MJ; Kansagara, D				Qaseem, Amir; Barry, Michael J.; Kansagara, Devan		Amer Coll Phys	Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ST-JOHNS-WORT; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE PATIENTS; ONCE-DAILY DOSAGE; DOUBLE-BLIND; 2ND-GENERATION ANTIDEPRESSANTS; COGNITIVE THERAPY; PSYCHODYNAMIC PSYCHOTHERAPY; BEHAVIORAL ACTIVATION; COMPARATIVE BENEFITS	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the comparative effectiveness of treatment with second-generation antidepressants versus nonpharmacologic treatments for major depressive disorder in adults. Methods: This guideline is based on a systematic review of published, English-language, randomized, controlled trials from 1990 through September 2015 identified using several data-bases and through hand searches of references of relevant studies. Interventions evaluated include psychotherapies, complementary and alternative medicines (including acupuncture, omega-3 fatty acids, S-adenosyl-L-methionine, St. John's wort [Hypericum perforatum]), exercise, and second-generation antidepressants. Evaluated outcomes included response, remission, functional capacity, quality of life, reduction of suicidality or hospitalizations, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with major depressive disorder. This guideline grades the evidence and recommendations using ACP's clinical practice guidelines grading system. Recommendation: ACP recommends that clinicians select between either cognitive behavioral therapy or second-generation antidepressants to treat patients with major depressive disorder after discussing treatment effects, adverse effect profiles, cost, accessibility, and preferences with the patient (Grade: strong recommendation, moderate-quality evidence).	[Qaseem, Amir] Amer Coll Physicians, 190 Independence Mall West, Philadelphia, PA 19106 USA; [Barry, Michael J.] Massachusetts Gen Hosp, 50 Staniford St, Boston, MA 02114 USA; [Kansagara, Devan] Portland VA Med Ctr, Mail Code RD71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA	American College of Physicians; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Barber JP, 2012, J CLIN PSYCHIAT, V73, P66, DOI 10.4088/JCP.11m06831; Bastos AG, 2013, J AFFECT DISORDERS, V151, P1066, DOI 10.1016/j.jad.2013.08.036; Behnke K, 2002, ADV THER, V19, P43, DOI 10.1007/BF02850017; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Bjerkenstedt L, 2005, EUR ARCH PSY CLIN N, V255, P40, DOI 10.1007/s00406-004-0532-z; Blom MBJ, 2007, PSYCHOTHER PSYCHOSOM, V76, P289, DOI 10.1159/000104705; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Brenner R, 2000, CLIN THER, V22, P411, DOI 10.1016/S0149-2918(00)89010-4; Centers for Disease Control and Prevention, 2015, FASTSTATS DEPR; Chen JQ, 2014, NEURAL REGEN RES, V9, P213, DOI 10.4103/1673-5374.125353; David D, 2008, J CLIN PSYCHOL, V64, P728, DOI 10.1002/jclp.20487; Davidson JRT, 2002, JAMA-J AM MED ASSOC, V287, P1807, DOI 10.1001/jama.287.14.1807; Dekker JJM, 2008, J AFFECT DISORDERS, V109, P183, DOI 10.1016/j.jad.2007.10.015; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Fava M, 2005, J CLIN PSYCHOPHARM, V25, P441, DOI 10.1097/01.jcp.0000178416.60426.29; Frank E, 2011, PSYCHOL MED, V41, P151, DOI 10.1017/S0033291710000553; Gartlehner G, 2011, COMP EFFECTIVENESS R, V46; Gartlehner G, 2015, COMP EFFECTIVENESS R, V161; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gartlehner G, 2016, ANN INTERN MED, V164, P331, DOI 10.7326/M15-1813; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gastpar M, 2006, PHARMACOPSYCHIATRY, V39, P66, DOI 10.1055/s-2006-931544; Gastpar M, 2005, PHARMACOPSYCHIATRY, V38, P78, DOI 10.1055/s-2005-837807; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hammerness P, 2003, PSYCHOSOMATICS, V44, P271, DOI 10.1176/appi.psy.44.4.271; Harrer G, 1999, ARZNEIMITTELFORSCH, V49, P289; Hegerl U, 2010, INT J NEUROPSYCHOPH, V13, P31, DOI 10.1017/S1461145709000224; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoffman BM, 2008, MED SCI SPORT EXER, V40, P1344, DOI 10.1249/MSS.0b013e31816b877c; Hong H, 2013, MED DECIS MAKING, V33, P702, DOI 10.1177/0272989X13481110; Huang Y, 2005, INT J CLIN ACUPUNCTU, V14, P7; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Jazayeri S, 2008, AUST NZ J PSYCHIAT, V42, P192, DOI 10.1080/00048670701827275; Jones B, 2011, PHARM STAT, V10, P523, DOI 10.1002/pst.533; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knuppel L, 2004, J CLIN PSYCHIAT, V65, P1470; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam RW, 2013, BRIT J PSYCHIAT, V203, P358, DOI 10.1192/bjp.bp.112.125237; Lenox-Smith AJ, 2008, INT CLIN PSYCHOPHARM, V23, P113, DOI 10.1097/YIC.0b013e3282f424c2; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; Menchetti M, 2014, BRIT J PSYCHIAT, V204, P144, DOI 10.1192/bjp.bp.112.122663; Miller LG, 1998, ARCH INTERN MED, V158, P2200, DOI 10.1001/archinte.158.20.2200; Mills E, 2004, BRIT MED J, V329, P27, DOI 10.1136/bmj.329.7456.27; Mischoulon D, 2014, J CLIN PSYCHIAT, V75, P370, DOI 10.4088/JCP.13m08591; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Moradveisi L, 2013, BRIT J PSYCHIAT, V202, P204, DOI 10.1192/bjp.bp.112.113696; Mueller SC, 2006, EUR J CLIN PHARMACOL, V62, P29, DOI 10.1007/s00228-005-0061-3; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Papakostas GI, 2007, NEUROPSYCHOBIOLOGY, V56, P132, DOI 10.1159/000115779; Qaseem A, 2008, ANN INTERN MED, V149, P725, DOI 10.7326/0003-4819-149-10-200811180-00007; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Qu SS, 2013, J PSYCHIATR RES, V47, P726, DOI 10.1016/j.jpsychires.2013.02.004; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Salminen JK, 2008, PSYCHOTHER PSYCHOSOM, V77, P351, DOI 10.1159/000151388; Schrader E, 2000, INT CLIN PSYCHOPHARM, V15, P61, DOI 10.1097/00004850-200015020-00001; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Sun H, 2013, J ALTERN COMPLEM MED, V19, P733, DOI 10.1089/acm.2011.0637; Szegedi A, 2005, BMJ-BRIT MED J, V330, P503, DOI 10.1136/bmj.38356.655266.82; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; van Gurp G, 2002, CAN FAM PHYSICIAN, V48, P905; Viswanathan M, 2012, ASSESSING RISK BIAS; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Zhang WJ, 2009, J ALTERN COMPLEM MED, V15, P837, DOI 10.1089/acm.2008.0607; Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005	71	131	141	1	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					350	+		10.7326/M15-2570	http://dx.doi.org/10.7326/M15-2570			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26857948				2022-12-28	WOS:000371220300006
J	Rosenbaum, L				Rosenbaum, Lisa			Leaping without Looking - Duty Hours, Autonomy, and the Risks of Research and Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Carome MA, 2015, COMMUNICATION; Hall DV, 2015, COMMUNICATION; Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111; Kraybill A, 2015, AJOB EMPIRICAL  1023; Meyer MN, 2015, COLO TECH L J, V13, P273	5	14	14	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2016	374	8					701	703		10.1056/NEJMp1600233	http://dx.doi.org/10.1056/NEJMp1600233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE6BB	26836311	Bronze			2022-12-28	WOS:000370716600001
J	Valenstein, ML; Roll-Mecak, A				Valenstein, Max L.; Roll-Mecak, Antonina			Graded Control of Microtubule Severing by Tubulin Glutamylation	CELL			English	Article							SPASTIC PARAPLEGIA PROTEIN; ALPHA-TUBULIN; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; MULTISITE PHOSPHORYLATION; AXON REGENERATION; KATANIN; POLYGLUTAMYLATION; DROSOPHILA; BINDING	Microtubule-severing enzymes are critical for the biogenesis and maintenance of complex microtubule arrays in axons, spindles, and cilia where tubulin detyrosination, acetylation, and glutamylation are abundant. These modifications exhibit stereotyped patterns suggesting spatial and temporal control of microtubule functions. Using human-engineered and differentiallymodified microtubuleswefind that glutamylation is themain regulator of the hereditary spastic paraplegia microtubule severing enzyme spastin. Glutamylation acts as a rheostat and tunes microtubule severing as a function of glutamate number added per tubulin. Unexpectedly, glutamylation is a nonlinear biphasic tuner and becomes inhibitory beyond a threshold. Furthermore, the inhibitory effect of localized glutamylationpropagates across neighboring microtubules, modulating severing in trans. Our work provides the first quantitative evidence for a graded response to a tubulin posttranslational modification and a biochemical link between tubulin glutamylation and complex architectures of microtubule arrays such as those in neurons where spastin deficiency causes disease.	[Valenstein, Max L.; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; [Roll-Mecak, Antonina] NHLBI, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA.; Roll-Mecak, A (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.	antonina@mail.nih.gov		Roll-Mecak, Antonina/0000-0003-2621-7307; Valenstein, Max/0000-0001-7616-0148	Searle Scholar award; intramural program of NINDS; intramural program of NHLBI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003165, ZIANS003122, ZIANS003164] Funding Source: NIH RePORTER	Searle Scholar award; intramural program of NINDS; intramural program of NHLBI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C.P. Garnham and I. Yu, National Institute of Neurological Disorders and Stroke (NINDS) for purified TTLL7, A. Syzk (NINDS) for recombinant tubulin, Y. Li of the NINDS Mass Spectrometry facility for MS/MS, D.-Y. Lee and the National Heart, Lung and Blood Institute (NHLBI) Biochemistry facility for access to mass spectrometers, Y. He (NHLBI) for large-scale cultures. A.R.-M. thanks H. Bourne, A. Ferre-D'Amare, E. Giniger, S. Gottesman, and M. Maurizi for helpful discussions. M.L.V. thanks C.C. Valenstein for feedback. This work was supported by a Searle Scholar award to A.R.-M. and the intramural programs of NINDS and NHLBI.	Aiken J, 2014, CURR BIOL, V24, P1295, DOI 10.1016/j.cub.2014.03.078; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Eckert T, 2012, J BIOL CHEM, V287, P26278, DOI 10.1074/jbc.M111.291898; EDDE B, 1992, BIOCHEMISTRY-US, V31, P403, DOI 10.1021/bi00117a014; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Geimer S, 1997, CELL MOTIL CYTOSKEL, V37, P72; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Gouveia SM, 2010, INT REV CEL MOL BIO, V285, P1, DOI 10.1016/S1937-6448(10)85001-4; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Magiera MM, 2013, METHOD CELL BIOL, V115, P247, DOI 10.1016/B978-0-12-407757-7.00016-5; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally KP, 2011, MOL BIOL CELL, V22, P1550, DOI 10.1091/mbc.E10-12-0951; Miller KE, 2015, J CELL BIOL, V209, P211, DOI 10.1083/jcb.201412097; Mukai M, 2009, BIOCHEMISTRY-US, V48, P1084, DOI 10.1021/bi802047y; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; RAYBIN D, 1975, BIOCHEM BIOPH RES CO, V65, P1088, DOI 10.1016/S0006-291X(75)80497-9; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; Redeker V, 2010, METHOD CELL BIOL, V95, P77, DOI 10.1016/S0091-679X(10)95006-1; Regnard C, 1999, J CELL SCI, V112, P4281; Ribbeck K, 2006, CURR BIOL, V16, pR923, DOI 10.1016/j.cub.2006.09.048; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Schneider A, 1998, FEBS LETT, V429, P399, DOI 10.1016/S0014-5793(98)00644-9; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stewart A, 2012, J NEUROSCI, V32, P11631, DOI 10.1523/JNEUROSCI.0729-12.2012; Stone MC, 2012, CELL REP, V2, P1340, DOI 10.1016/j.celrep.2012.09.032; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vemu A, 2014, METHOD ENZYMOL, V540, P149, DOI 10.1016/B978-0-12-397924-7.00009-1; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yu I, 2015, J BIOL CHEM, V290, P17163, DOI 10.1074/jbc.R115.637447; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	77	138	159	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 25	2016	164	5					911	921		10.1016/j.cell.2016.01.019	http://dx.doi.org/10.1016/j.cell.2016.01.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE8DZ	26875866	Green Accepted, Bronze			2022-12-28	WOS:000370867300015
J	Minor, DL				Minor, Daniel L., Jr.			Let It Go and Open Up, an Ensemble of Ion Channel Active States	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CORA; TRANSPORTER; INSIGHTS	Ligand binding usually moves the target protein from an ensemble of inactive states to a well-defined active conformation. Matthies et al. flip this scheme around, finding that, for the magnesium channel CorA, loss of ligand binding induces an ensemble of conformations that turn the channel on.	[Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	daniel.minor@ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080050] Funding Source: Medline; NIDCD NIH HHS [R01 DC007664] Funding Source: Medline; NIMH NIH HHS [R01 MH093603] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Guskov A, 2012, P NATL ACAD SCI USA, V109, P18459, DOI 10.1073/pnas.1210076109; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Matthies D, 2016, CELL, V164, P747, DOI 10.1016/j.cell.2015.12.055; Minor DL, 2007, NEURON, V54, P511, DOI 10.1016/j.neuron.2007.04.026; Neale C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004303; Nogales E, 2015, MOL CELL, V58, P677, DOI 10.1016/j.molcel.2015.02.019; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Payandeh J, 2013, BBA-BIOMEMBRANES, V1828, P2778, DOI 10.1016/j.bbamem.2013.08.002; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Unwin N, 2013, Q REV BIOPHYS, V46, P283, DOI 10.1017/S0033583513000061	11	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					597	598		10.1016/j.cell.2016.01.037	http://dx.doi.org/10.1016/j.cell.2016.01.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871624	Bronze, Green Published			2022-12-28	WOS:000369998300005
J	Marteau, TM				Marteau, Theresa M.			PUBLIC HEALTH Will the UK's new alcohol guidelines change hearts, minds-and livers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCEPTABILITY		[Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge CB2 1TN, England	University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge CB2 1TN, England.	tm388@cam.ac.uk		Marteau, Theresa/0000-0003-3025-1129				Anderson P., 2012, ALCOHOL EUROPEAN UNI; Balance, 2014, NO BAN TV SHOW LINK; [Balance the North East alcohol office Drink Wise Alcohol Focus Scotland Alcohol Concern], 2015, CHILDR REC ALC MARK; Behavioural Expert Group, CMOS REV ALC GUID RE; Branson C, 2012, ACCEPTABLE BEHAV PUB; Department of Health, 2016, UK CHIEF MED OFFICER; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Huang TT, LANCET, V385, P2422; Lovatt M, 2015, ADDICTION, V110, P1912, DOI 10.1111/add.13072; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Pechey R, 2014, SOC SCI MED, V113, P104, DOI 10.1016/j.socscimed.2014.05.010; Royal College of Physicians, 1962, SMOK HLTH REP ROYAL	12	14	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2016	352								i704	10.1136/bmj.i704	http://dx.doi.org/10.1136/bmj.i704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JN	26864473				2022-12-28	WOS:000370383300010
J	Liu, Z; Li, X; Zhang, JT; Cai, YJ; Cheng, TL; Cheng, C; Wang, Y; Zhang, CC; Nie, YH; Chen, ZF; Bian, WJ; Zhang, L; Xiao, JQ; Lu, B; Zhang, YF; Zhang, XD; Sang, X; Wu, JJ; Xu, X; Xiong, ZQ; Zhang, F; Yu, X; Gong, N; Zhou, WH; Sun, Q; Qiu, ZL				Liu, Zhen; Li, Xiao; Zhang, Jun-Tao; Cai, Yi-Jun; Cheng, Tian-Lin; Cheng, Cheng; Wang, Yan; Zhang, Chen-Chen; Nie, Yan-Hong; Chen, Zhi-Fang; Bian, Wen-Jie; Zhang, Ling; Xiao, Jianqiu; Lu, Bin; Zhang, Yue-Fang; Zhang, Xiao-Di; Sang, Xiao; Wu, Jia-Jia; Xu, Xiu; Xiong, Zhi-Qi; Zhang, Feng; Yu, Xiang; Gong, Neng; Zhou, Wen-Hao; Sun, Qiang; Qiu, Zilong			Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2	NATURE			English	Article							MACAQUE MACACA-FASCICULARIS; TRANSCRIPTIONAL REPRESSOR; NONHUMAN-PRIMATES; RHESUS-MONKEYS; GENERATION; CYNOMOLGUS; AMYGDALA; INFANT; DISEASE; ANXIETY	Methyl-CpG binding protein 2 (MeCP2) has crucial roles in transcriptional regulation and microRNA processing(1-4). Mutations in the MECP2 gene are found in 90% of patients with Rett syndrome, a severe developmental disorder with autistic phenotypes(5). Duplications of MECP2-containing genomic segments cause the MECP2 duplication syndrome, which shares core symptoms with autism spectrum disorders(6). Although Mecp2-null mice recapitulate most developmental and behavioural defects seen in patients with Rett syndrome, it has been difficult to identify autism-like behaviours in the mouse model of MeCP2 overexpression(7,8). Here we report that lentivirus-based transgenic cynomolgus monkeys (Macaca fascicularis) expressing human MeCP2 in the brain exhibit autism-like behaviours and show germline transmission of the transgene. Expression of the MECP2 transgene was confirmed by western blotting and immunostaining of brain tissues of transgenic monkeys. Genomic integration sites of the transgenes were characterized by a deep-sequencing-based method. As compared to wild-type monkeys, MECP2 transgenic monkeys exhibited a higher frequency of repetitive circular locomotion and increased stress responses, as measured by the threat-related anxiety and defensive test(9). The transgenic monkeys showed less interaction with wild-type monkeys within the same group, and also a reduced interaction time when paired with other transgenic monkeys in social interaction tests. The cognitive functions of the transgenic monkeys were largely normal in the Wisconsin general test apparatus, although some showed signs of stereotypic cognitive behaviours. Notably, we succeeded in generating five F-1 offspring of MECP2 transgenic monkeys by intracytoplasmic sperm injection with sperm from one F-0 transgenic monkey, showing germline transmission and Mendelian segregation of several MECP2 transgenes in the F-1 progeny. Moreover, F-1 transgenic monkeys also showed reduced social interactions when tested in pairs, as compared to wild-type monkeys of similar age. Together, these results indicate the feasibility and reliability of using genetically engineered non-human primates to study brain disorders.	[Liu, Zhen; Li, Xiao; Zhang, Jun-Tao; Cai, Yi-Jun; Cheng, Tian-Lin; Cheng, Cheng; Wang, Yan; Zhang, Chen-Chen; Nie, Yan-Hong; Chen, Zhi-Fang; Bian, Wen-Jie; Lu, Bin; Zhang, Yue-Fang; Zhang, Xiao-Di; Sang, Xiao; Wu, Jia-Jia; Xiong, Zhi-Qi; Yu, Xiang; Gong, Neng; Sun, Qiang; Qiu, Zilong] Chinese Acad Sci, CAS Key Lab Primate Neurobiol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Shanghai Ins, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Zhang, Ling; Xiao, Jianqiu; Zhang, Feng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Zhang, Ling; Xiao, Jianqiu; Zhang, Feng] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Shanghai 200438, Peoples R China; [Xu, Xiu] Fudan Univ, Childrens Hosp, Dept Child Healthcare, Shanghai 201102, Peoples R China; [Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 201102, Peoples R China	Chinese Academy of Sciences; Fudan University; Fudan University; Fudan University; Fudan University	Sun, Q; Qiu, ZL (corresponding author), Chinese Acad Sci, CAS Key Lab Primate Neurobiol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Shanghai Ins, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	qsun@ion.ac.cn; zqiu@ion.ac.cn	Xiao, Jianqiu/AAB-7860-2021; Zhang, Feng/C-7735-2009; wenhao, zhou/AAA-1505-2020; Bian, Wenjie/ABC-2696-2021	Zhang, Feng/0000-0003-4556-8276; sun, qiang/0000-0002-3359-9465; Xiao, Jianqiu/0000-0002-8896-9187; Bian, Wenjie/0000-0002-0426-1297	CAS Strategic Priority Research Program [XDB02050400]; MoST 973 Program [2011CBA00400]; NSFC [91432111, 91232712, 81527901]; National Key Technology R&D Program of China [2014BAI03B00]; Shanghai City Committee of Science and Technology Project [14140900100]	CAS Strategic Priority Research Program; MoST 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Shanghai City Committee of Science and Technology Project	We thank M.-m. Poo for comments on the manuscript, Y.-Z. Li, Y.-Z. Lu, F. Liu and X. Zhou for maintaining monkey colony, W. Lu, X.-H. Guo and Y.F. Zhou of Fudan Children's Hospital for assistance in mass spectrometry and electroencephalogram, D. Chen and B. Zhang of Novel Bioinformatics for RNA-seq data analysis, and C.-H. Li of Shanghai Geneskies Company for analysis of genomic integration sites. This work was supported by CAS Strategic Priority Research Program (XDB02050400), the MoST 973 Program (2011CBA00400), NSFC grants (91432111, 91232712 and 81527901), National Key Technology R&D Program of China 2014BAI03B00, Shanghai City Committee of Science and Technology Project 14140900100.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bauman MD, 2004, J COGNITIVE NEUROSCI, V16, P1388, DOI 10.1162/0898929042304741; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chan AWS, 2009, METHODS, V49, P78, DOI 10.1016/j.ymeth.2009.05.007; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Drago L, 2000, PRIMATES, V41, P137, DOI 10.1007/BF02557795; Du RQ, 2012, J HUM GENET, V57, P545, DOI 10.1038/jhg.2012.66; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Feng XL, 2011, P NATL ACAD SCI USA, V108, P14312, DOI 10.1073/pnas.1010943108; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Golub MS, 2007, J NUTR, V137, P979, DOI 10.1093/jn/137.4.979; Ha JC, 2011, BEHAV PROCESS, V86, P1, DOI 10.1016/j.beproc.2010.07.010; HARLOW HF, 1959, AM SCI, V47, P458; Higashino A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r58; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Janovitz T, 2013, J VIROL, V87, P8559, DOI 10.1128/JVI.01135-13; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Liu Z, 2016, CELL RES, V26, P139, DOI 10.1038/cr.2015.112; Liu Z, 2014, NEUROSCI BULL, V30, P381, DOI 10.1007/s12264-014-1434-8; Makori N, 2013, J MED PRIMATOL, V42, P147, DOI 10.1111/jmp.12041; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Moran S, 2015, THERIOGENOLOGY, V84, P277, DOI 10.1016/j.theriogenology.2015.03.016; Nakagawa T, 2006, J NEUROSCI METH, V152, P1, DOI 10.1016/j.jneumeth.2005.08.001; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Ramiro LS, 2010, CHILD ABUSE NEGLECT, V34, P842, DOI 10.1016/j.chiabu.2010.02.012; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Rogers J, 2008, GENES BRAIN BEHAV, V7, P463, DOI 10.1111/j.1601-183X.2007.00381.x; Sackett G, 2006, DEV PSYCHOBIOL, V48, P243, DOI 10.1002/dev.20132; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Sun Q, 2008, P NATL ACAD SCI USA, V105, P12956, DOI 10.1073/pnas.0805639105; Suomi SJ, 1997, BRIT MED BULL, V53, P170; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Xiao JQ, 2014, MOL GENET GENOMICS, V289, P755, DOI 10.1007/s00438-014-0850-4; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zheng P, 2001, HUM REPROD, V16, P300, DOI 10.1093/humrep/16.2.300; Zheng P, 2001, MOL REPROD DEV, V58, P348, DOI 10.1002/1098-2795(200103)58:3<348::AID-MRD14>3.0.CO;2-O	44	194	218	10	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					98	+		10.1038/nature16533	http://dx.doi.org/10.1038/nature16533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26808898				2022-12-28	WOS:000369304500040
J	Steffen, M				Steffen, Monika			Universalism, Responsiveness, Sustainability - Regulating the French Health Care System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Steffen, Monika] Univ Grenoble Alps, CNRS, Pacte, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Steffen, M (corresponding author), Univ Grenoble Alps, CNRS, Pacte, Grenoble, France.							[Anonymous], 2014, SIT FIN ORG COMPL AS; [Anonymous], 2000, WORLD HLTH REP 2000; Commission des comptes de la Securite sociale: les comptes de la securite sociale, 2014, RES 2013 PREV 2014 2; Steffen M, 2015, RITSUMEIKAN SOC SCI, V51, P3	4	22	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					401	405		10.1056/NEJMp1504547	http://dx.doi.org/10.1056/NEJMp1504547			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC6GX	26840130				2022-12-28	WOS:000369319100001
J	Piccirillo, JF				Piccirillo, Jay F.			Transcranial Magnetic Stimulation for Chronic Tinnitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Piccirillo, Jay F.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 660 Euclid Ave,CB 8115, St Louis, MO 63110 USA	Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 660 Euclid Ave,CB 8115, St Louis, MO 63110 USA.	piccirilloj@ent.wustl.edu						Folmer RL, 2015, JAMA OTOLARYNGOL, V141, P716, DOI 10.1001/jamaoto.2015.1219; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Meng ZL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007946.pub2; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Pichora-Fuller MK, 2013, COMP EFFECTIVENESS R, V122; Plewnia C, 2003, ANN NEUROL, V53, P263, DOI 10.1002/ana.10468; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Wilson MB, 2015, OTOLARYNG HEAD NECK, V152, P897, DOI 10.1177/0194599815569692	9	2	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					506	507		10.1001/jama.2016.0075	http://dx.doi.org/10.1001/jama.2016.0075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836733				2022-12-28	WOS:000369049500020
J	Zorzela, L; Loke, YK; Ioannidis, JP; Golder, S; Santaguida, P; Altman, DG; Moher, D; Vohra, S				Zorzela, Liliane; Loke, Yoon K.; Ioannidis, John P.; Golder, Su; Santaguida, Pasqualina; Altman, Douglas G.; Moher, David; Vohra, Sunita		Prisma Harms Grp	PRISMA harms checklist: improving harms reporting in systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; RANDOM EFFECTS METAANALYSIS; MYOCARDIAL-INFARCTION; MEDICAL INTERVENTIONS; CLINICAL-TRIALS; ADVERSE EVENTS; DRUG SAFETY; OUTCOMES; BIAS; CHALLENGES	INTRODUCTION For any health intervention, accurate knowledge of both benefits and harms is needed. Systematic reviews often compound poor reporting of harms in primary studies by failing to report harms or doing so inadequately. While the PRISMA statement (Preferred Reporting Items for Systematic reviews and Meta-Analyses) helps systematic review authors ensure complete and transparent reporting, it is focused mainly on efficacy. Thus, a PRISMA harms checklist has been developed to improve harms reporting in systematic reviews, promoting a more balanced assessment of benefits and harms. METHODS A development strategy, endorsed by the EQUATOR Network and existing reporting guidelines (including the PRISMA statement, PRISMA for abstracts, and PRISMA for protocols), was used. After the development of a draft checklist of items, a modified Delphi process was initiated. The Delphi consisted of three rounds of electronic feedback followed by an in-person meeting. RESULTS The PRISMA harms checklist contains four essential reporting elements to be added to the original PRISMA statement to improve harms reporting in reviews. These are reported in the title ("Specifically mention 'harms' or other related terms, or the harm of interest in the review"), synthesis of results ("Specify how zero events were handled, if relevant"), study characteristics ("Define each harm addressed, how it was ascertained (eg, patient report, active search), and over what time period"), and synthesis of results ("Describe any assessment of possible causality"). Additional guidance regarding existing PRISMA items was developed to demonstrate relevance when synthesising information about harms. CONCLUSION The PRISMA harms checklist identifies a minimal set of items to be reported when reviewing adverse events. This guideline extension is intended to improve harms reporting in systematic reviews, whether harms are a primary or secondary outcome.	[Zorzela, Liliane; Vohra, Sunita] Univ Alberta, Fac Med & Dent, Edmonton, AB T6G 2C8, Canada; [Zorzela, Liliane; Vohra, Sunita] Univ Alberta, Integrat Hlth Inst, Edmonton, AB T6G 2C8, Canada; [Loke, Yoon K.] Norwich Med Sch, Norwich, Norfolk, England; [Ioannidis, John P.] Stanford Univ, Sch Humanities & Sci, Sch Med, Stanford, CA 94305 USA; [Golder, Su] Univ York, Dept Hlth Sci, Heslington, England; [Santaguida, Pasqualina] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Altman, Douglas G.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Moher, David] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada	University of Alberta; University of Alberta; University of East Anglia; Stanford University; University of York - UK; McMaster University; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Vohra, S (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB T6G 2C8, Canada.; Vohra, S (corresponding author), Univ Alberta, Integrat Hlth Inst, Edmonton, AB T6G 2C8, Canada.	svohra@ualberta.ca	Moher, David/I-3408-2019; Shamseer, Larissa/E-9645-2017; Singh, Sonal/A-4614-2008; Ioannidis, John P. A./G-9836-2011; Vohra, Sunita/F-5755-2016	Moher, David/0000-0003-2434-4206; Shamseer, Larissa/0000-0003-3690-3378; Singh, Sonal/0000-0003-0912-941X; Vohra, Sunita/0000-0002-6210-7933; Clark, Jocalyn/0000-0002-8014-3989; golder, su/0000-0002-8987-5211	Alberta Innovates, Health Solutions; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [PDF-2014-07-041] Funding Source: researchfish	Alberta Innovates, Health Solutions; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	PRISMA harms was partly funded by Alberta Innovates, Health Solutions. The researchers were fully independent from funders.	Agbabiaka TB, 2009, DRUG SAFETY, V32, P637, DOI 10.2165/00002018-200932080-00003; Albavera-Hernandez C, 2009, CLIN REHABIL, V23, P394, DOI 10.1177/0269215508099860; Anello C, 1996, CLIN RES REGUL AFF, V13, P13, DOI 10.3109/10601339609019625; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Bain ES, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-195; Banach R, 2010, DRUG SAFETY, V33, P73, DOI 10.2165/11317640-000000000-00000; Bangalore S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2234; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Bellis JR, 2014, BRIT J ANAESTH, V113, P23, DOI 10.1093/bja/aeu152; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Chou R, 2007, J CLIN EPIDEMIOL, V60, P18, DOI 10.1016/j.jclinepi.2006.02.021; Cornelius VR, 2009, PHARMACOEPIDEM DR S, V18, P1223, DOI 10.1002/pds.1844; Derry S, 2001, BMC Med Res Methodol, V1, P7, DOI 10.1186/1471-2288-1-7; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Golder S, 2008, J CLIN EPIDEMIOL, V61, P440, DOI 10.1016/j.jclinepi.2007.06.005; Golder Su, 2006, BMC Med Res Methodol, V6, P3, DOI 10.1186/1471-2288-6-3; Golder S, 2013, J CLIN EPIDEMIOL, V66, P253, DOI 10.1016/j.jclinepi.2012.09.013; Golder S, 2012, INT J TECHNOL ASSESS, V28, P133, DOI 10.1017/S0266462312000128; Golder S, 2012, J MED LIBR ASSOC, V100, P130, DOI 10.3163/1536-5050.100.2.012; Golder S, 2010, J CLIN EPIDEMIOL, V63, P1071, DOI 10.1016/j.jclinepi.2010.02.009; Gray JAM, 2001, EVIDENCE BASED HEALT; Hammad TA, 2013, CLIN TRIALS, V10, P389, DOI 10.1177/1740774513479467; Hartley J, 2000, B MED LIBR ASSOC, V88, P332; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hohl CM, 2010, ANN EMERG MED, V56, P105, DOI 10.1016/j.annemergmed.2010.01.030; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Ioannidis JPA, 2013, J CLIN EPIDEMIOL, V66, P903, DOI 10.1016/j.jclinepi.2013.03.002; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jolivot PA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0643-5; Keus F, 2009, AM J GASTROENTEROL, V104, P546, DOI 10.1038/ajg.2008.22; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kotter T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122918; Langendam MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053599; Lathyris D, 2014, PEDIATRICS, V133, pE666, DOI 10.1542/peds.2013-3128; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Loke YK, 2011, THER ADV DRUG SAF, V2, P59, DOI 10.1177/2042098611401129; Loke YK, 2015, CAN MED ASSOC J, V187, P15, DOI 10.1503/cmaj.141344; Loke Yoon Kong, 2011, BMJ, V342, pd1309, DOI 10.1136/bmj.d1309; Loke YK, 2009, DRUG SAFETY, V32, P219, DOI 10.2165/00002018-200932030-00004; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mahoney MR, 2007, LANCET, V369, P171, DOI 10.1016/S0140-6736(07)60086-5; Mattishent K, 2015, DIABETES OBES METAB; McIntosh Heather M, 2004, BMC Med Res Methodol, V4, P19, DOI 10.1186/1471-2288-4-19; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Meyer-Massetti Carla, 2010, J Hosp Med, V5, pE8, DOI 10.1002/jhm.691; Michele TM, 2010, NEW ENGL J MED, V363, P1097, DOI 10.1056/NEJMp1008502; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000035.pub2; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Pilkington K, 2012, COMPLEMENT THER MED, V20, P73, DOI 10.1016/j.ctim.2011.10.002; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Sackett DL, 1997, BRIT MED J, V315, P1636, DOI 10.1136/bmj.315.7123.1636; Saini P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6501; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Shamseer L, 2013, CAN J ANESTH, V60, P337, DOI 10.1007/s12630-013-9895-9; Shuster JJ, 2007, STAT MED, V26, P4375, DOI 10.1002/sim.3060; Shuster JJ, 2010, STAT MED, V29, P1259, DOI 10.1002/sim.3607; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138; Singh S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3215; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Uppsala Monitoring Centre, 2015, WORLD HEALTH ORGANIZ; Yazici Y, 2008, BULL HOSP JT DIS, V66, P143; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	85	274	279	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2016	352								i157	10.1136/bmj.i157	http://dx.doi.org/10.1136/bmj.i157			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD2QD	26830668	Green Published, Bronze			2022-12-28	WOS:000369766400002
J	Phalan, B; Green, RE; Dicks, LV; Dotta, G; Feniuk, C; Lamb, A; Strassburg, BBN; Williams, DR; Ermgassen, EKHJZ; Balmford, A				Phalan, Ben; Green, Rhys E.; Dicks, Lynn V.; Dotta, Graziela; Feniuk, Claire; Lamb, Anthony; Strassburg, Bernardo B. N.; Williams, David R.; Ermgassen, Erasmus K. H. J. Zu; Balmford, Andrew			How can higher-yield farming help to spare nature?	SCIENCE			English	Editorial Material							TROPICAL AGRICULTURAL LANDSCAPES; LAND; DEFORESTATION; POLICY; INTENSIFICATION; CONSERVATION; SERVICES; IMPACT; FOOD		[Phalan, Ben; Green, Rhys E.; Dicks, Lynn V.; Feniuk, Claire; Lamb, Anthony; Williams, David R.; Ermgassen, Erasmus K. H. J. Zu; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England; [Green, Rhys E.] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Dotta, Graziela] PUC RS, Museu Ciencias Tecnol, Ornithol Lab, BR-6681 Porto Alegre, RS, Brazil; [Strassburg, Bernardo B. N.] Int Inst Sustainabil, BR-22460320 Rio De Janeiro, Brazil; [Strassburg, Bernardo B. N.] Pontificia Univ Catolica Rio de Janeiro, Dept Geog & Environm, Rio Conservat & Sustainabil Sci Ctr, BR-22453900 Rio De Janeiro, Brazil	University of Cambridge; Royal Society for Protection of Birds; Pontificia Universidade Catolica Do Rio Grande Do Sul	Phalan, B (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England.	btp22@cam.ac.uk	Dicks, Lynn V./AFH-5289-2022; Phalan, Ben/A-5783-2009	Phalan, Ben/0000-0001-7876-7226; Williams, David/0000-0002-0379-1800; Dicks, Lynn/0000-0002-8304-4468; Balmford, Andrew/0000-0002-0144-3589; zu Ermgassen, Erasmus Klaus Helge Justus/0000-0002-9168-6057	NERC [NE/K015419/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1344055] Funding Source: researchfish; Natural Environment Research Council [NE/K015419/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/J014540/1] Funding Source: Medline	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; [Anonymous], 2005, CONDITIONS AGR GROWT; Balmford A, 2015, DAEDALUS-US, V144, P57, DOI 10.1162/DAED_a_00354; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Byerlee D, 2014, GLOB FOOD SECUR-AGR, V3, P92, DOI 10.1016/j.gfs.2014.04.001; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Clements T, 2015, CONSERV BIOL, V29, P78, DOI 10.1111/cobi.12423; Curtis A., 2008, ACHIEVING NRM OUTCOM; Fagan ME, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034017; Franks JR, 2013, LAND USE POLICY, V30, P847, DOI 10.1016/j.landusepol.2012.06.005; Jackson Rodney M., 2010, P417; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Latawiec AE, 2015, FRONT ECOL ENVIRON, V13, P211, DOI 10.1890/140052; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Shively GE, 2004, ENVIRON DEV ECON, V9, P241, DOI 10.1017/S1355770X03001177	17	157	159	5	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					450	451		10.1126/science.aad0055	http://dx.doi.org/10.1126/science.aad0055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26823413	Green Accepted			2022-12-28	WOS:000368858200019
J	Merrill, AL				Merrill, Andrea L.			Ductal Carcinoma In Situ	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Merrill, Andrea/AAL-7568-2020	Merrill, Andrea/0000-0001-8805-8634					0	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					390	390		10.1056/NEJMclde1512213	http://dx.doi.org/10.1056/NEJMclde1512213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816018				2022-12-28	WOS:000368760100017
J	Phuong, LN; Hanvoravongchai, P; Ryan, J; Oechsli, CG; Chen, L				Le Nhan Phuong; Hanvoravongchai, Piya; Ryan, Jennifer; Oechsli, Christopher G.; Chen, Lincoln			Empowering young leaders for social justice in health	LANCET			English	Editorial Material							EDUCATION		[Le Nhan Phuong] Resources Hlth Equ, Hanoi, Vietnam; [Hanvoravongchai, Piya; Ryan, Jennifer] China Med Board Fdn Bangkok, Bangkok, Thailand; [Oechsli, Christopher G.] Atlantic Philanthropies, New York, NY USA; [Chen, Lincoln] China Med Board, Cambridge, MA 02138 USA		Chen, L (corresponding author), China Med Board, Cambridge, MA 02138 USA.	lchen@cmbfound.org	Hanvoravongchai, Piya/A-1569-2012	Hanvoravongchai, Piya/0000-0003-4256-1271				Acuin J, 2011, LANCET, V377, P534, DOI 10.1016/S0140-6736(10)61426-2; Evans T., 2001, CHALLENGING INEQUITI; Frenk J, 2015, AM J PUBLIC HEALTH, V105, pS109, DOI 10.2105/AJPH.2014.302468; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Sen A, 2002, HEALTH ECON, V11, P659, DOI 10.1002/hec.762; Sen A., 2004, PUBLIC HLTH ETHICS E	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					323	324		10.1016/S0140-6736(16)00104-5	http://dx.doi.org/10.1016/S0140-6736(16)00104-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26842436				2022-12-28	WOS:000368516500012
J	Fugelli, P				Fugelli, Per			Death and planetary health	LANCET			English	Editorial Material									[Fugelli, Per] Univ Oslo, Inst Hlth & Soc, N-0318 Blindern, Norway	University of Oslo	Fugelli, P (corresponding author), Univ Oslo, Inst Hlth & Soc, PB 1130, N-0318 Blindern, Norway.	per.fugelli@medisin.uio.no						LOWN B, 1986, NEW ENGL J MED, V314, P985, DOI 10.1056/NEJM198604103141509	1	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					209	209		10.1016/S0140-6736(16)00037-4	http://dx.doi.org/10.1016/S0140-6736(16)00037-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26842279				2022-12-28	WOS:000368130700009
J	Dukes, C; Hurley, D				Dukes, Catherine; Hurley, Dana			Sampling the Moon's atmosphere	SCIENCE			English	Editorial Material							LUNAR SODIUM; SURFACE		[Dukes, Catherine] Univ Virginia, Lab Astrophys & Surface Phys, Charlottesville, VA 22904 USA; [Hurley, Dana] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	University of Virginia; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Dukes, C (corresponding author), Univ Virginia, Lab Astrophys & Surface Phys, Charlottesville, VA 22904 USA.	cdukes@virginia.edu	Hurley, Dana/F-4488-2015	Hurley, Dana/0000-0003-1052-1494				Colaprete A, 2016, SCIENCE, V351, P249, DOI 10.1126/science.aad2380; Dukes CA, 2011, ICARUS, V212, P463, DOI 10.1016/j.icarus.2011.01.027; Kagitani M, 2010, PLANET SPACE SCI, V58, P1660, DOI 10.1016/j.pss.2010.07.025; Madey TE, 1998, J GEOPHYS RES-PLANET, V103, P5873, DOI 10.1029/98JE00230; Mendillo M, 1999, ICARUS, V137, P13, DOI 10.1006/icar.1998.6042; POTTER AE, 1994, GEOPHYS RES LETT, V21, P2263, DOI 10.1029/94GL01702; Potter AE, 2000, J GEOPHYS RES-PLANET, V105, P15073, DOI 10.1029/1999JE001213; Prettyman TH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002656; Sarantos M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032310; SPRAGUE AL, 1992, ICARUS, V96, P27, DOI 10.1016/0019-1035(92)90004-Q; Yokota S, 2014, J GEOPHYS RES-PLANET, V119, P798, DOI 10.1002/2013JE004529	11	0	0	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					230	231		10.1126/science.aad8245	http://dx.doi.org/10.1126/science.aad8245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816366				2022-12-28	WOS:000368098600022
J	Service, RF				Service, Robert F.			Incandescent lights go green	SCIENCE			English	News Item																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					215	215		10.1126/science.351.6270.215	http://dx.doi.org/10.1126/science.351.6270.215			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816358				2022-12-28	WOS:000368098600014
J	Gunaratnam, Y				Gunaratnam, Yasmin			The art of medicine The time of our lives	LANCET			English	Editorial Material									Univ London Goldsmiths Coll, Dept Sociol, New Cross SE14 6NW, England	University of London; Goldsmiths University London	Gunaratnam, Y (corresponding author), Univ London Goldsmiths Coll, Dept Sociol, New Cross SE14 6NW, England.	y.gunaratnam@gold.ac.uk		Gunaratnam, Yasmin/0000-0002-9025-4981					0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1937	1938		10.1016/S0140-6736(15)00820-X	http://dx.doi.org/10.1016/S0140-6736(15)00820-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26841740	Bronze			2022-12-28	WOS:000364763200017
J	Hofmeyr, GJ				Hofmeyr, G. Justus			Oral misoprostol is as safe as Foley catheter for labour induction ... or is it?	LANCET			English	Editorial Material							TRIAL		[Hofmeyr, G. Justus] Walter Sisulu Univ, PBX9047, ZA-4201 East London, South Africa; [Hofmeyr, G. Justus] Eastern Cape Dept Hlth, PBX9047, ZA-4201 East London, South Africa	Walter Sisulu University	Hofmeyr, GJ (corresponding author), Walter Sisulu Univ, PBX9047, ZA-4201 East London, South Africa.; Hofmeyr, GJ (corresponding author), Eastern Cape Dept Hlth, PBX9047, ZA-4201 East London, South Africa.	justhof@gmail.com						Fawcus S., 2012, Obstetrics and Gynaecology Forum, V22, P9; Hofmeyr GJ, 2001, BRIT J OBSTET GYNAEC, V108, P952, DOI 10.1111/j.1471-0528.2001.00231.x; Hofmeyr GJ, 1998, S AFR MED J, V88, P535; Hofmeyr GJ, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002074.pub2, DOI 10.1002/14651858.CD002074.PUB2]; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; ten Eikelder MLG, 2016, LANCET; Vogel JP, 2014, CLIN OBSTET GYNECOL, V57, P331, DOI 10.1097/GRF.0000000000000031; Weeks A, 2007, INT J GYNECOL OBSTET, V99, pS194, DOI 10.1016/j.ijgo.2007.09.011	8	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1593	1594	1619	10.1016/S0140-6736(15)01042-9	http://dx.doi.org/10.1016/S0140-6736(15)01042-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26850982				2022-12-28	WOS:000374145100004
J	Howard, G; Roubin, GS; Jansen, O; Hendrikse, J; Halliday, A; Fraedrich, G; Eckstein, HH; Calvet, D; Bulbulia, R; Bonati, LH; Becquemin, JP; Algra, A; Brown, MM; Ringleb, PA; Brott, TG; Mas, JL				Howard, George; Roubin, Gary S.; Jansen, Olav; Hendrikse, Jeroen; Halliday, Alison; Fraedrich, Gustav; Eckstein, Hans-Henning; Calvet, David; Bulbulia, Richard; Bonati, Leo H.; Becquemin, Jean-Pierre; Algra, Ale; Brown, Martin M.; Ringleb, Peter A.; Brott, Thomas G.; Mas, Jean-Louis		Carotid Stenting Trialists'	Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials	LANCET			English	Article							WHITE-MATTER; MICROVASCULATURE; PREVENTION; OCCLUSION; EVENTS; SEX	Background Age was reported to be an effect-modifier in four randomised controlled trials comparing carotid artery stenting (CAS) and carotid endarterectomy (CEA), with better CEA outcomes than CAS outcomes noted in the more elderly patients. We aimed to describe the association of age with treatment differences in symptomatic patients and provide age-specific estimates of the risk of stroke and death within narrow (5 year) age groups. Methods In this meta-analysis, we analysed individual patient-level data from four randomised controlled trials within the Carotid Stenosis Trialists' Collaboration (CSTC) involving patients with symptomatic carotid stenosis. We included only trials that randomly assigned patients to CAS or CEA and only patients with symptomatic stenosis. We assessed rates of stroke or death in 5-year age groups in the periprocedural period (between randomisation and 120 days) and ipsilateral stroke during long-term follow-up for patients assigned to CAS or CEA. We also assessed differences between CAS and CEA. All analyses were done on an intention-to-treat basis. Findings Collectively, 4754 patients were randomly assigned to either CEA or CAS treatment in the four studies. 433 events occurred over a median follow-up of 2.7 years. For patients assigned to CAS, the periprocedural hazard ratio (HR) for stroke and death in patients aged 65-69 years compared with patients younger than 60 years was 2.16 (95% CI 1.3-4.13), with HRs of roughly 4.0 for patients aged 70 years or older. We noted no evidence of an increased periprocedural risk by age group in the CEA group (p=0.34). These changes underpinned a CAS-versus CEA periprocedural HR of 1.61 (95% CI 0.90-2.88) for patients aged 65-69 years and an HR of 2.09 (1.32-3.32) for patients aged 70-74 years. Age was not associated with the postprocedural stroke risk either within treatment group (p=0.09 for CAS and 0.83 for CEA), or between treatment groups (p=0.84). Interpretation In these RCTs, CEA was clearly superior to CAS in patients aged 70-74 years and older. The difference in older patients was almost wholly attributable to increasing periprocedural stroke risk in patients treated with CAS. Age had little effect on CEA periprocedural risk or on postprocedural risk after either procedure.	[Howard, George] UAB Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Roubin, Gary S.] Cardiovasc Associates Southeast, Birmingham, AL USA; [Jansen, Olav] UKSH Campus Kiel, Clin Radiol & Neuroradiol, Kiel, Germany; [Hendrikse, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Halliday, Alison] John Radcliffe Hosp, Dept Surg Sci, Oxford OX3 9DU, England; [Fraedrich, Gustav] Med Univ Innsbruck, Dept Vasc Surg, A-6020 Innsbruck, Austria; [Eckstein, Hans-Henning] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc & Endovasc Surg, Vasc Ctr, D-80290 Munich, Germany; [Calvet, David; Mas, Jean-Louis] Univ Paris 05, Dept Neurol, Hop St Anne, DHU Neurovasc Sorbonne Paris Cite,INSERM,U894, Paris, France; [Bulbulia, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bulbulia, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bonati, Leo H.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Bonati, Leo H.] Univ Basel Hosp, Stroke Ctr, CH-4031 Basel, Switzerland; [Bonati, Leo H.; Brown, Martin M.] UCL, Dept Brain Repair & Rehabil, UCL Inst Neurol, London, England; [Becquemin, Jean-Pierre] Univ Paris 12, Dept Vasc Surg, Hop Henri Mondor, Paris, France; [Algra, Ale] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Ringleb, Peter A.] Heidelberg Univ, Dept Neurol, Sch Med, Heidelberg, Germany; [Brott, Thomas G.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	University of Alabama System; University of Alabama Birmingham; University of Kiel; Schleswig Holstein University Hospital; Utrecht University; Utrecht University Medical Center; University of Oxford; Medical University of Innsbruck; Technical University of Munich; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Oxford; University of Basel; University of Basel; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Ruprecht Karls University Heidelberg; Mayo Clinic	Howard, G (corresponding author), UAB Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA.	ghoward@uab.edu	Eckstein, Hans-Henning/AFK-1881-2022; Eckstein, Hans-Henning/AAF-9200-2022; Halliday, Alison/AAA-2230-2022; Bonati, Leo/G-4058-2012; Jansen, Olav/CAF-4179-2022	Halliday, Alison/0000-0001-9828-3579; Bonati, Leo/0000-0003-1163-8133; Brown, Martin M/0000-0002-3273-1356; Howard, George/0000-0002-3068-5720	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Reta Lila Weston Trust for Medical Research; UK Department of Health's National Institute for Health Research Biomedical Research Centres; National Institute of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS); MRC [G0300411] Funding Source: UKRI; Medical Research Council [G0300411] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10339] Funding Source: researchfish; Stroke Association [TSA2008/03] Funding Source: researchfish	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Reta Lila Weston Trust for Medical Research; UK Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); National Institute of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	AH is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. MMB's Chair in Stroke Medicine is supported by the Reta Lila Weston Trust for Medical Research. Part of this work was done at University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. GH is funded by the National Institute of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS).	AKIMA M, 1986, LAB INVEST, V55, P482; Bijuklic K, 2012, J AM COLL CARDIOL, V59, P1383, DOI 10.1016/j.jacc.2011.11.035; Bonati LH, 2011, EUR J VASC ENDOVASC, V41, P153, DOI 10.1016/j.ejvs.2011.01.001; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Bond R, 2005, CEREBROVASC DIS, V20, P69, DOI 10.1159/000086509; Bosiers M, 2007, EUR J VASC ENDOVASC, V33, P135, DOI 10.1016/j.ejvs.2006.09.019; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Doig D, 2016, EUR J VASC ENDOVASC, V51, P327, DOI 10.1016/j.ejvs.2015.08.013; Dumont TM, 2014, J NEUROINTERV SURG, V6, P219, DOI 10.1136/neurintsurg-2013-010721; Ederle J, 2013, LANCET NEUROL, V12, P866, DOI 10.1016/S1474-4422(13)70135-2; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Hobson RW, 2004, J VASC SURG, V40, P1106, DOI 10.1016/j.jvs.2004.10.022; Hoke M, 2012, CIRC-CARDIOVASC INTE, V5, P841, DOI 10.1161/CIRCINTERVENTIONS.112.972430; Howard G, 2011, STROKE, V42, P3369, DOI 10.1161/STROKEAHA.111.625277; Jansen O, 2009, STROKE, V40, P841, DOI 10.1161/STROKEAHA.108.534289; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Mathur A, 1998, CIRCULATION, V97, P1239, DOI 10.1161/01.CIR.97.13.1239; Naggara O, 2011, STROKE, V42, P380, DOI 10.1161/STROKEAHA.110.588772; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Stingele R, 2008, LANCET NEUROL, V7, P216, DOI 10.1016/S1474-4422(08)70024-3; Touze E, 2013, STROKE, V44, P3394, DOI 10.1161/STROKEAHA.113.002756; Voeks JH, 2011, STROKE, V42, P3484, DOI 10.1161/STROKEAHA.111.624155; Wach MM, 2015, J NEUROINTERV SURG, V7, P182, DOI 10.1136/neurintsurg-2013-011052; Wimmer NJ, 2012, STROKE, V43, P3218, DOI 10.1161/STROKEAHA.112.673194	29	118	127	0	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 26	2016	387	10025					1305	1311		10.1016/S0140-6736(15)01309-4	http://dx.doi.org/10.1016/S0140-6736(15)01309-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH3OY	26880122				2022-12-28	WOS:000372697500029
J	Stevenson, AJ; Flores-Vazquez, IM; Allgeyer, RL; Schenkkan, P; Potter, JE				Stevenson, Amanda J.; Flores-Vazquez, Imelda M.; Allgeyer, Richard L.; Schenkkan, Pete; Potter, Joseph E.			Effect of Removal of Planned Parenthood from the Texas Women's Health Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTRACEPTIVE METHODS; IMPACT	BACKGROUND Texas is one of several states that have barred Planned Parenthood affiliates from providing health care services with the use of public funds. After the federal government refused to allow (and courts blocked) the exclusion of Planned Parenthood affiliates from the Texas Medicaid fee-for-service family-planning program, Texas excluded them from a state-funded replacement program, effective January 1, 2013. We assessed rates of contraceptive-method provision, method continuation through the program, and childbirth covered by Medicaid before and after the Planned Parenthood exclusion. METHODS We used all program claims from 2011 through 2014 to examine changes in the number of claims for contraceptives according to method for 2 years before and 2 years after the exclusion. Among women using injectable contraceptives at baseline, we observed rates of contraceptive continuation through the program and of childbirth covered by Medicaid. We used the difference-in-differences method to compare outcomes in counties with Planned Parenthood affiliates with outcomes in those without such affiliates. RESULTS After the Planned Parenthood exclusion, there were estimated reductions in the number of claims from 1042 to 672 (relative reduction, 35.5%) for long-acting, reversible contraceptives and from 6832 to 4708 (relative reduction, 31.1%) for injectable contraceptives (P<0.001 for both comparisons). There was no significant change in the number of claims for short-acting hormonal contraceptive methods during this period. Among women using injectable contraceptives, the percentage of women who returned for a subsequent on-time contraceptive injection decreased from 56.9% among those whose subsequent injections were due before the exclusion to 37.7% among those whose subsequent injections were due after the exclusion in the counties with Planned Parenthood affiliates but increased from 54.9% to 58.5% in the counties without such affiliates (estimated difference in differences in counties with affiliates as compared with those without affiliates, -22.9 percentage points; P<0.001). During this period in counties with Planned Parenthood affiliates, the rate of childbirth covered by Medicaid increased by 1.9 percentage points (a relative increase of 27.1% from baseline) within 18 months after the claim (P = 0.01). CONCLUSIONS The exclusion of Planned Parenthood affiliates from a state-funded replacement for a Medicaid fee-for-service program in Texas was associated with adverse changes in the provision of contraception. For women using injectable contraceptives, there was a reduction in the rate of contraceptive continuation and an increase in the rate of childbirth covered by Medicaid.	[Stevenson, Amanda J.; Potter, Joseph E.] Univ Texas Austin, Populat Res Ctr, 305 East 23rd St,Stop G1800, Austin, TX 78712 USA; [Flores-Vazquez, Imelda M.; Allgeyer, Richard L.] Texas Hlth & Human Serv Commiss, Austin, TX USA; [Schenkkan, Pete] Graves Dougherty Hearon & Moody, Austin, TX USA	University of Texas System; University of Texas Austin	Potter, JE (corresponding author), Univ Texas Austin, Populat Res Ctr, 305 East 23rd St,Stop G1800, Austin, TX 78712 USA.	joe@prc.utexas.edu			NICHD NIH HHS [P2C HD042849, T32 HD007081, R24 HD042849] Funding Source: Medline; PHS HHS [NICHD R24-042849] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042849, P2CHD042849, T32HD007081] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aday L A, 1974, Health Serv Res, V9, P208; [Anonymous], 2009, Obstet Gynecol, V114, P1434, DOI 10.1097/AOG.0b013e3181c6f965; [Anonymous], 2016, MED FAM PLANN EL EXP; Colman S, 2011, J POLICY ANAL MANAG, V30, P775, DOI 10.1002/pam.20603; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Kavanaugh ML, 2015, OBSTET GYNECOL, V126, P917, DOI 10.1097/AOG.0000000000001094; Potter JE, 2014, CONTRACEPTION, V90, P488, DOI 10.1016/j.contraception.2014.06.039; Trussell J, 2011, CONTRACEPTIVE TECHNO, P45; United States Census Bureau, 2015, AM COMM SURV; White K, 2015, AM J PUBLIC HEALTH, V105, P851, DOI 10.2105/AJPH.2014.302515; White K, 2012, NEW ENGL J MED, V367, P1179, DOI 10.1056/NEJMp1207920; Woo CJ, 2015, CONTRACEPTION	14	57	57	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					853	860		10.1056/NEJMsa1511902	http://dx.doi.org/10.1056/NEJMsa1511902			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF2FT	26836435	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000371158400009
J	Wolf, F; Wan, Y; Heip, JC; Gebert, F; Shi, CY; Schmidt, PO				Wolf, Fabian; Wan, Yong; Heip, Jan C.; Gebert, Florian; Shi, Chunyan; Schmidt, Piet O.			Non-destructive state detection for quantum logic spectroscopy of molecular ions	NATURE			English	Article								Precision laser spectroscopy(1) of cold and trapped molecular ions is a powerful tool in fundamental physics-used, for example, in determining fundamental constants(2), testing for their possible variation in the laboratory(3,4), and searching for a possible electric dipole moment of the electron(5). However, the absence of cycling transitions in molecules poses a challenge for direct laser cooling of the ions(6), and for controlling(7-11) and detecting their quantum states. Previously used state-detection techniques based on photodissociation(12) or chemical reactions(13) are destructive and therefore inefficient, restricting the achievable resolution in laser spectroscopy. Here, we experimentally demonstrate non-destructive detection of the quantum state of a single trapped molecular ion through its strong Coulomb coupling to a well controlled, co-trapped atomic ion. An algorithm based on a state-dependent optical dipole force(14) changes the internal state of the atom according to the internal state of the molecule. We show that individual quantum states in the molecular ion can be distinguished by the strength of their coupling to the optical dipole force. We also observe quantum jumps (induced by black-body radiation) between rotational states of a single molecular ion. Using the detuning dependence of the state-detection signal, we implement a variant of quantum logic spectroscopy(15,16) of a molecular resonance. Our state-detection technique is relevant to a wide range of molecular ions, and could be applied to state-controlled quantum chemistry(17) and to spectroscopic investigations of molecules that serve as probes for interstellar clouds(18,19).	[Wolf, Fabian; Wan, Yong; Heip, Jan C.; Gebert, Florian; Shi, Chunyan; Schmidt, Piet O.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Schmidt, Piet O.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany; [Wan, Yong] Natl Inst Stand & Technol, 325 Broadway, Boulder, CO 80305 USA	Physikalisch-Technische Bundesanstalt (PTB); Leibniz University Hannover; National Institute of Standards & Technology (NIST) - USA	Schmidt, PO (corresponding author), Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany.; Schmidt, PO (corresponding author), Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany.	piet.schmidt@quantummetrology.de	Schmidt, Piet/F-6384-2011	Schmidt, Piet/0000-0003-0773-5889; Heip, Jan Christoph/0000-0003-0952-0515; Wolf, Fabian/0000-0003-4092-311X; Wan, Yong/0000-0003-2613-6072; Gebert, Florian/0000-0003-4009-549X	Deutsche Forschungsgemeinschaft through QUEST; State of Lower-Saxony, Hannover, Germany; Braunschweig International Graduate School of Metrology;  [SCHM2678/3-1]	Deutsche Forschungsgemeinschaft through QUEST(German Research Foundation (DFG)); State of Lower-Saxony, Hannover, Germany; Braunschweig International Graduate School of Metrology; 	We acknowledge the support of the Deutsche Forschungsgemeinschaft through QUEST and grant SCHM2678/3-1. This work was financially supported by the State of Lower-Saxony, Hannover, Germany. Y.W. acknowledges support from the Braunschweig International Graduate School of Metrology. We thank E. Tiemann, H. Knockel, O. Dulieu and I.D. Leroux for discussions; M. Drewsen and O. Dulieu for the transition-matrix elements for <SUP>24</SUP>MgH<SUP>+</SUP>; and E. Tiemann, B. Hemmerling, and I.D. Leroux for reading the manuscript.	Aymar M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154025; BALFOUR WJ, 1972, CAN J PHYS, V50, P1082, DOI 10.1139/p72-150; Bergmann K., 1995, COHERENT POPULATION, P367; Brunken S, 2014, NATURE, V516, P219, DOI 10.1038/nature13924; Campbell EK, 2015, NATURE, V523, P322, DOI 10.1038/nature14566; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Ding S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023028; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Gebert F, 2014, OPT EXPRESS, V22, P15388, DOI 10.1364/OE.22.015388; Germann M, 2014, NAT PHYS, V10, P820, DOI [10.1038/NPHYS3085, 10.1038/nphys3085]; Hansen AK, 2014, NATURE, V508, P76, DOI 10.1038/nature12996; Hansson A, 2005, J MOL SPECTROSC, V233, P169, DOI 10.1016/j.jms.2005.06.009; Hemmerling B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023043; Hemmerling B., 2011, APPL PHYS B, V104; Hojbjerre K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055026; Hume DB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.243902; James DFV, 1998, APPL PHYS B-LASERS O, V66, P181, DOI 10.1007/s003400050373; Koelemeij JCJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173002; Leibfried D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023029; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Lien CY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5783; Loh H, 2013, SCIENCE, V342, P1220, DOI 10.1126/science.1243683; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Ozeri R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030403; Ratschbacher L, 2012, NAT PHYS, V8, P649, DOI [10.1038/nphys2373, 10.1038/NPHYS2373]; Rellergert WG, 2013, NATURE, V495, P490, DOI 10.1038/nature11937; Schiller S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032505; Schiller S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023004; Schmidt PO, 2006, AIP CONF PROC, V862, P305, DOI 10.1063/1.2387937; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmidt-Kaler F, 2003, NATURE, V422, P408, DOI 10.1038/nature01494; Schneider T, 2010, NAT PHYS, V6, P275, DOI 10.1038/NPHYS1605; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Vogelius IS, 2006, J PHYS B-AT MOL OPT, V39, pS1259, DOI 10.1088/0953-4075/39/19/S31; Wan Y, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043425; Wan Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4096	38	101	101	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2016	530	7591					457	+		10.1038/nature16513	http://dx.doi.org/10.1038/nature16513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE5RW	26855427	Green Submitted			2022-12-28	WOS:000370690800030
J	Lovchinsky, I; Sushkov, AO; Urbach, E; de Leon, NP; Choi, S; De Greve, K; Evans, R; Gertner, R; Bersin, E; Muller, C; McGuinness, L; Jelezko, F; Walsworth, RL; Park, H; Lukin, MD				Lovchinsky, I.; Sushkov, A. O.; Urbach, E.; de Leon, N. P.; Choi, S.; De Greve, K.; Evans, R.; Gertner, R.; Bersin, E.; Mueller, C.; McGuinness, L.; Jelezko, F.; Walsworth, R. L.; Park, H.; Lukin, M. D.			APPLIED PHYSICS Nuclear magnetic resonance detection and spectroscopy of single proteins using quantum logic	SCIENCE			English	Article							SPIN; NANOSCALE; MICROSCOPY; RESOLUTION; READOUT	Nuclear magnetic resonance spectroscopy is a powerful tool for the structural analysis of organic compounds and biomolecules but typically requires macroscopic sample quantities. We use a sensor, which consists of two quantum bits corresponding to an electronic spin and an ancillary nuclear spin, to demonstrate room temperaturemagnetic resonance detection and spectroscopy of multiple nuclear species within individual ubiquitin proteins attached to the diamond surface. Using quantum logic to improve readout fidelity and a surface-treatment technique to extend the spin coherence time of shallow nitrogen-vacancy centers, we demonstrate magnetic field sensitivity sufficient to detect individual proton spins within 1 second of integration. This gain in sensitivity enables high-confidence detection of individual proteins and allows us to observe spectral features that reveal information about their chemical composition.	[Lovchinsky, I.; Sushkov, A. O.; Urbach, E.; de Leon, N. P.; Choi, S.; De Greve, K.; Evans, R.; Bersin, E.; Walsworth, R. L.; Park, H.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Lovchinsky, I.; Sushkov, A. O.; Urbach, E.; de Leon, N. P.; Choi, S.; De Greve, K.; Evans, R.; Bersin, E.; Walsworth, R. L.; Park, H.; Lukin, M. D.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mueller, C.; McGuinness, L.; Jelezko, F.] Univ Ulm, Inst Quantum Opt, D-89081 Ulm, Germany; [Mueller, C.; McGuinness, L.; Jelezko, F.] Univ Ulm, Ctr Integrated Quantum Sci & Technol IQST, D-89081 Ulm, Germany; [Walsworth, R. L.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Walsworth, R. L.; Park, H.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Park, H.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Sushkov, A. O.] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [de Leon, N. P.] Princeton Univ, Dept Elect Engn, Olden St, Princeton, NJ 08544 USA	Harvard University; Harvard University; Ulm University; Ulm University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Princeton University	Park, H; Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Park, H; Lukin, MD (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Park, H (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Park, H (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	hongkun_park@harvard.edu; lukin@physics.harvard.edu	Sushkov, Alexander/AAJ-1720-2021; Park, Hongkun/R-9842-2019	Park, Hongkun/0000-0001-9576-8829; de Leon, Nathalie/0000-0003-1324-1412; mcguinness, liam/0000-0003-0078-9307; Urbach, Elana/0000-0002-3205-2484; Muller, Christoph/0000-0002-6798-5487; De Greve, Kristiaan/0000-0002-1314-9715	Defense Advanced Research Projects Agency (QuASAR program); NSF; Center for Ultracold Atoms; Army Research Office Multidisciplinary University Research Initiative; National Security Science and Engineering Faculty Fellowship program,; Gordon and Betty Moore Foundation; Air Force Office of Scientific Research National Defense Science and Engineering Graduate Fellowship [32 CFR 168a]; European Research Council; German Academic Exchange Service (DAAD) P.R.I.M.E. Fellowship; Herchel Smith-Harvard Undergraduate Summer Research Program; Direct For Mathematical & Physical Scien [1125846] Funding Source: National Science Foundation; Division Of Physics [1506284] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency (QuASAR program)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Army Research Office Multidisciplinary University Research Initiative(MURI); National Security Science and Engineering Faculty Fellowship program,; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Air Force Office of Scientific Research National Defense Science and Engineering Graduate Fellowship; European Research Council(European Research Council (ERC)European Commission); German Academic Exchange Service (DAAD) P.R.I.M.E. Fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); Herchel Smith-Harvard Undergraduate Summer Research Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. L. Pham, N. Chisholm, G. Kucsko, B. Harada, A. Ajoy, and P. Cappellaro for helpful discussions and experimental help. This work was supported by the Defense Advanced Research Projects Agency (QuASAR program), NSF, the Center for Ultracold Atoms, the Army Research Office Multidisciplinary University Research Initiative, the National Security Science and Engineering Faculty Fellowship program, and the Gordon and Betty Moore Foundation. I.L. was supported by the Air Force Office of Scientific Research National Defense Science and Engineering Graduate Fellowship (32 CFR 168a). Work at Ulm University was supported by the European Research Council. L.M. acknowledges support by a German Academic Exchange Service (DAAD) P.R.I.M.E. Fellowship. E.B. was supported by the Herchel Smith-Harvard Undergraduate Summer Research Program.	Ajoy A, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011001; Cavadini S, 2010, PROG NUCL MAG RES SP, V56, P46, DOI 10.1016/j.pnmrs.2009.08.001; Childress L, 2014, PHYS TODAY, V67, P38, DOI 10.1063/PT.3.2549; Chu Y, 2014, NANO LETT, V14, P1982, DOI 10.1021/nl404836p; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Das T. P., 1958, NUCL QUADRUPOLE RESO; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Kim M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891839; Klar TA, 2014, PHYS SCRIPTA, VT162, DOI 10.1088/0031-8949/2014/T162/014049; Kolkowitz S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137601; London P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.067601; Loretz M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862749; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Romach Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.017601; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600; Shields BJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.136402; Staudacher T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9527; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Sushkov AO, 2014, NANO LETT, V14, P6443, DOI 10.1021/nl502988n; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; ZAX DB, 1985, J CHEM PHYS, V83, P4877, DOI 10.1063/1.449748	29	304	314	10	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					836	841		10.1126/science.aad8022	http://dx.doi.org/10.1126/science.aad8022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26847544				2022-12-28	WOS:000370325700039
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Pity the NHS-Jeremy Hunt has chosen the nuclear option	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2016	352								i909	10.1136/bmj.i909	http://dx.doi.org/10.1136/bmj.i909			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JZ	26873709	Green Published, Bronze			2022-12-28	WOS:000370384500011
J	Hensley, CT; Faubert, B; Yuan, Q; Lev-Cohain, N; Jin, E; Kim, J; Jiang, L; Ko, B; Skelton, R; Loudat, L; Wodzak, M; Klimko, C; McMillan, E; Butt, Y; Ni, M; Oliver, D; Torrealba, J; Malloy, CR; Kernstine, K; Lenkinski, RE; DeBerardinis, RJ				Hensley, Christopher T.; Faubert, Brandon; Yuan, Qing; Lev-Cohain, Naama; Jin, Eunsook; Kim, Jiyeon; Jiang, Lei; Ko, Bookyung; Skelton, Rachael; Loudat, Laurin; Wodzak, Michelle; Klimko, Claire; McMillan, Elizabeth; Butt, Yasmeen; Ni, Min; Oliver, Dwight; Torrealba, Jose; Malloy, Craig R.; Kernstine, Kemp; Lenkinski, Robert E.; DeBerardinis, Ralph J.			Metabolic Heterogeneity in Human Lung Tumors	CELL			English	Article							PYRUVATE-CARBOXYLASE; CANCER; GROWTH; GLYCOLYSIS; PATHWAYS; MRI	Non-small cell lung cancer (NSCLC) is heterogeneous in the genetic and environmental parameters that influence cell metabolism in culture. Here, we assessed the impact of these factors on human NSCLC metabolism in vivo using intraoperative 13 C-glucose infusions in nine NSCLC patients to compare metabolism between tumors and benign lung. While enhanced glycolysis and glucose oxidation were common among these tumors, we observed evidence for oxidation of multiple nutrients in each of them, including lactate as a potential carbon source. Moreover, metabolically heterogeneous regions were identified within and between tumors, and surprisingly, our data suggested potential contributions of non-glucose nutrients in well-perfused tumor areas. Our findings not only demonstrate the heterogeneity in tumor metabolism in vivo but also highlight the strong influence of the microenvironment on this feature.	[Hensley, Christopher T.; Faubert, Brandon; Kim, Jiyeon; Jiang, Lei; Ko, Bookyung; Klimko, Claire; Ni, Min; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Res Inst, Childrens Med Ctr, Dallas, TX 75390 USA; [Yuan, Qing; Malloy, Craig R.; Lenkinski, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Jin, Eunsook; Malloy, Craig R.; Lenkinski, Robert E.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Skelton, Rachael; Loudat, Laurin] Univ Texas SW Med Ctr Dallas, Clin Res Off, Dallas, TX 75390 USA; [McMillan, Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Butt, Yasmeen; Oliver, Dwight; Torrealba, Jose] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Kernstine, Kemp] Univ Texas SW Med Ctr Dallas, Dept Cardiovasc & Thorac Surg, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Lev-Cohain, Naama] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Wodzak, Michelle] Univ Oklahoma, Hlth Sci Ctr, Off Anim Welf Assurance, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	DeBerardinis, RJ (corresponding author), Univ Texas SW Med Ctr Dallas, Res Inst, Childrens Med Ctr, Dallas, TX 75390 USA.	ralph.deberardinis@utsouthwestern.edu	Lev-Cohain, Naama/P-2115-2014	Malloy, Craig/0000-0001-5077-0642; Lenkinski, Robert/0000-0001-7371-5048; Faubert, Brandon/0000-0002-2886-886X	National Institutes of Health [R01 CA157996, CA157996-04S1, P50 CA70907, P41 EB015908, UL1 TR001105]; Welch Foundation [I-1733]; CPRIT [R-1107-02, RP130272]; Canadian Institutes of Health Research [MFE 140911]; V Foundation; NATIONAL CANCER INSTITUTE [R01CA157996, P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); CPRIT; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); V Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John Minna, Joan Schiller, and members of the DeBerardinis lab for helpful discussions. This work was supported by grants from the National Institutes of Health (R01 CA157996 and CA157996-04S1, P50 CA70907, P41 EB015908, and UL1 TR001105), Welch Foundation (I-1733), CPRIT (R-1107-02 and RP130272), Canadian Institutes of Health Research (MFE 140911), and V Foundation. R.J.D. is a member of the advisory boards of Agios Pharmaceuticals and Peloton Therapeutics.	Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Davidson S.M., 2016, CELL METAB; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eilertsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105038; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; Ng CS, 2010, AM J ROENTGENOL, V194, pW134, DOI 10.2214/AJR.09.3116; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Nguyen-Kim TDL, 2015, INVEST RADIOL, V50, P179, DOI 10.1097/RLI.0000000000000124; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V124, P269; Yankeelov TE, 2007, CURR MED IMAGING REV, V3, P91, DOI 10.2174/157340507780619179; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015	32	609	619	13	207	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					681	694		10.1016/j.cell.2015.12.034	http://dx.doi.org/10.1016/j.cell.2015.12.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26853473	Bronze, Green Accepted			2022-12-28	WOS:000369998300014
J	Rai, A; Pathak, D; Thakur, S; Singh, S; Dubey, AK; Mallik, R				Rai, Ashim; Pathak, Divya; Thakur, Shreyasi; Singh, Shampa; Dubey, Alok Kumar; Mallik, Roop			Dynein Clusters into Lipid Microdomains on Phagosomes to Drive Rapid Transport toward Lysosomes	CELL			English	Article							LEISHMANIA-DONOVANI LIPOPHOSPHOGLYCAN; CYTOPLASMIC DYNEIN; MEMBRANE-TRANSPORT; MICROTUBULE MOTORS; KINESIN MOTOR; CHOLESTEROL; MATURATION; ORGANIZATION; RAB7; RILP	Diverse cellular processes are driven by motor proteins that are recruited to and generate force on lipid membranes. Surprisingly little is known about how membranes control the force from motors and how this may impact specific cellular functions. Here, we show that dynein motors physically cluster into microdomains on the membrane of a phagosome as it matures inside cells. Such geometrical reorganization allows many dyneins within a cluster to generate cooperative force on a single microtubule. This results in rapid directed transport of the phagosome toward microtubule minus ends, likely promoting phagolysosome fusion and pathogen degradation. We show that lipophosphoglycan, the major molecule implicated in immune evasion of Leishmania donovani, inhibits phagosome motion by disrupting the clustering and therefore the cooperative force generation of dynein. These findings appear relevant to several pathogens that prevent phagosome-lysosome fusion by targeting lipid microdomains on phagosomes.	[Rai, Ashim; Pathak, Divya; Thakur, Shreyasi; Singh, Shampa; Dubey, Alok Kumar; Mallik, Roop] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Mallik, R (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	roop@tifr.res.in		mallik, roop/0000-0001-6820-6556; , Divya/0000-0001-9944-2308; Dubey, Alok Kumar/0000-0003-0359-4732	Wellcome Trust UK [WT079214MA]; Wellcome Trust Department of Biotechnology Senior Fellowship [IA/S/11/2500255]	Wellcome Trust UK(Wellcome Trust); Wellcome Trust Department of Biotechnology Senior Fellowship(Wellcome Trust DBT India Alliance)	R.M. acknowledges funding through an International Senior Research Fellowship from the Wellcome Trust UK (grant WT079214MA) and a Wellcome Trust Department of Biotechnology Senior Fellowship (grant IA/S/11/2500255). We thank K. Verhey, M. Koonce, T. Hyman, and D. Bhattacharya for sharing reagents. We also thank S.J. Turco and S. Roy for sharing LPG (originally prepared by S.J. Turco). We acknowledge A. Dsouza, R. Jha, and T. Kapoor for help with experiments. We thank A. Chattopadhyay, Arpan Rai, P. Barak, and V. Soppina for comments on the manuscript. We thank S. Mayor for comments and criticism on the manuscript. We acknowledge the mass spectrometry facilities at NCBS and C-CAMP (Bengaluru).	Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Barak P, 2014, METHOD ENZYMOL, V540, P231, DOI 10.1016/B978-0-12-397924-7.00013-3; Barak P, 2013, NAT METHODS, V10, P68, DOI [10.1038/NMETH.2287, 10.1038/nmeth.2287]; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Daitoku H, 2001, INT J MOL MED, V8, P397; Dermine JF, 2005, CELL MICROBIOL, V7, P1263, DOI 10.1111/j.1462-5822.2005.00550.x; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Erickson RP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002032; Ghosh J, 2013, CELL HOST MICROBE, V13, P277, DOI 10.1016/j.chom.2013.02.005; Gotthardt Daniel, 2006, V346, P439; Goyette G, 2012, MOL CELL PROTEOMICS, V11, P1365, DOI 10.1074/mcp.M112.021048; Habermann A, 2001, J CELL SCI, V114, P229; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Huynh KK, 2008, J BIOL CHEM, V283, P35745, DOI 10.1074/jbc.M806232200; Ito J, 2000, J LIPID RES, V41, P894; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mallik R, 2013, TRENDS CELL BIOL, V23, P575, DOI 10.1016/j.tcb.2013.06.003; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Rao MD, 2014, CURR OPIN CELL BIOL, V29, P126, DOI 10.1016/j.ceb.2014.05.007; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Soppina V, 2009, BIOTECHNIQUES, V46, P543, DOI 10.2144/000113124; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; TURCO SJ, 1987, BIOCHEMISTRY-US, V26, P6233, DOI 10.1021/bi00393a042; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	40	119	120	3	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					722	734		10.1016/j.cell.2015.12.054	http://dx.doi.org/10.1016/j.cell.2015.12.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26853472	Green Published, hybrid			2022-12-28	WOS:000369998300017
J	Wang, JR; Andrae, B; Sundstrom, K; Strom, P; Ploner, A; Elfstrom, KM; Arnheim-Dahlstrom, L; Dillner, J; Sparen, P				Wang, Jiangrong; Andrae, Bengt; Sundstrom, Karin; Strom, Peter; Ploner, Alexander; Elfstrom, K. Miriam; Arnheim-Dahlstrom, Lisen; Dillner, Joakim; Sparen, Par			Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNDETERMINED SIGNIFICANCE AGUS; ADENOCARCINOMA IN-SITU; FOLLOW-UP; CLINICAL-SIGNIFICANCE; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; NATURAL-HISTORY; BETHESDA SYSTEM; INTRAEPITHELIAL NEOPLASIA; UTERINE CERVIX	OBJECTIVES To investigate the risks of invasive cervical cancer after detection of atypical glandular cells (AGC) during cervical screening. DESIGN Nationwide population based cohort study. SETTING Cancer and population registries in Sweden. PARTICIPANTS 3 054 328 women living in Sweden at any time between 1 January 1980 and 1 July 2011 who had any record of cervical cytological testing at ages 23-59. Of these, 2 899 968 women had normal cytology results at the first screening record. The first recorded abnormal result was atypical glandular cells (AGC) in 14 625, high grade squamous intraepithelial lesion (HSIL) in 65 633, and low grade squamous intraepithelial lesions (LSIL) in 244 168. MAIN OUTCOME MEASURES Cumulative incidence of invasive cervical cancer over 15.5 years; proportion of invasive cervical cancer within six months of abnormality (prevalence); crude incidence rates for invasive cervical cancer over 0.5-15.5 years of follow-up; incidence rate ratios compared with women with normal cytology, estimated with Poisson regression adjusted for age and stratified by histopathology of cancer; distribution of clinical assessment within six months after the abnormality. RESULTS The prevalence of cervical cancer was 1.4% for women with AGC, which was lower than for women with HSIL (2.5%) but higher than for women with LSIL (0.2%); adenocarcinoma accounted for 73.2% of the prevalent cases associated with AGC. The incidence rate of invasive cervical cancer after AGC was significantly higher than for women with normal results on cytology for up to 15.5 years and higher than HSIL and LSIL for up to 6.5 years. The incidence rate of adenocarcinoma was 61 times higher than for women with normal results on cytology in the first screening round after AGC, and remained nine times higher for up to 15.5 years. Incidence and prevalence of invasive cervical cancer was highest when AGC was found at ages 30-39. Only 54% of women with AGC underwent histology assessment within six months, much less than after HSIL (86%). Among women with histology assessment within six months, the incidence rate of cervical cancer after AGC was significantly higher than that after HSIL for up to 6.5 years. CONCLUSIONS AGC found at cervical screening is associated with a high and persistent risk of cervical cancer for up to 15 years, particularly for cervical adenocarcinoma and women with AGC at age 30-39. Compared with the reduction in risk of cancer seen after HSIL management, management of AGC seems to have been suboptimal in preventing cervical cancer. Research to optimise management is needed, and a more aggressive assessment strategy is warranted.	[Wang, Jiangrong; Andrae, Bengt; Strom, Peter; Ploner, Alexander; Arnheim-Dahlstrom, Lisen; Dillner, Joakim; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Andrae, Bengt] Uppsala Univ Reg Gavleborg, Ctr Res & Dev, SE-80188 Gavle, Sweden; [Sundstrom, Karin; Elfstrom, K. Miriam; Dillner, Joakim] Karolinska Inst, Dept Lab Med, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Wang, JR (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	jiangrong.wang@ki.se	Sundström, Karin/V-5714-2017	Sundström, Karin/0000-0002-6865-0224; Ploner, Alexander/0000-0002-5042-8326; Andrae, Bengt/0000-0003-3046-3447; Strom, Peter/0000-0002-1631-806X; Sparen, Par/0000-0002-5184-8971	Swedish Foundation for Strategic Research; Centre for Research and Development, Uppsala University/Region of Gavleborg; China Scholarship Council	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Centre for Research and Development, Uppsala University/Region of Gavleborg; China Scholarship Council(China Scholarship Council)	This study was funded by Swedish Foundation for Strategic Research, Centre for Research and Development, Uppsala University/Region of Gavleborg, and China Scholarship Council. The study sponsor did not participate in study design, data collection, analysis, interpretation of data, writing of the article, or the decision to submit it for publication.	Adhya AK, 2009, CYTOPATHOLOGY, V20, P375, DOI 10.1111/j.1365-2303.2008.00629.x; Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; [Anonymous], 1989, DIAGN CYTOPATHOL, V5, P331; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Asciutto KC, 2015, ANTICANCER RES, V35, P913; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; BRODER S, 1992, JAMA-J AM MED ASSOC, V267, P1892, DOI 10.1001/jama.267.14.1892; Cheng WF, 2011, BJOG-INT J OBSTET GY, V118, P34, DOI 10.1111/j.1471-0528.2010.02769.x; Chhieng DC, 2001, CANCER CYTOPATHOL, V93, P1; Chhieng DC, 2000, ACTA CYTOL, V44, P557, DOI 10.1159/000328530; Chin AB, 2000, AM J OBSTET GYNECOL, V182, P1278, DOI 10.1067/mob.2000.106537; Costales AB, 2013, GYNECOL ONCOL, V129, P513, DOI 10.1016/j.ygyno.2013.03.015; Dahlstrom LA, 2010, INT J CANCER, V127, P1923, DOI 10.1002/ijc.25408; Eddy GL, 1997, AM J OBSTET GYNECOL, V177, P1188, DOI 10.1016/S0002-9378(97)70039-5; Geier CS, 2001, AM J OBSTET GYNECOL, V184, P64, DOI 10.1067/mob.2001.108995; GOFF BA, 1992, OBSTET GYNECOL, V79, P101; GUSTAFSSON L, 1989, BRIT J CANCER, V60, P132, DOI 10.1038/bjc.1989.236; IARC, 2004, IARC HDB CANC PREV; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Katki Hormuzd A, 2013, J Low Genit Tract Dis, V17, pS50, DOI 10.1097/LGT.0b013e3182854282; Kennedy AW, 2002, GYNECOL ONCOL, V86, P361, DOI 10.1006/gyno.2002.6771; Kennedy AW, 1996, GYNECOL ONCOL, V63, P14, DOI 10.1006/gyno.1996.0270; Kim TJ, 1999, GYNECOL ONCOL, V73, P292, DOI 10.1006/gyno.1999.5360; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; MACGREGOR JE, 1994, BMJ-BRIT MED J, V308, P1407, DOI 10.1136/bmj.308.6941.1407; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Nasuti JF, 2002, DIAGN CYTOPATHOL, V26, P186, DOI 10.1002/dc.10070; Nationellt Kvalitetsregister for Cervixcancerprevention, 2013, FOR LIVM SVER; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Pirog EC, 2014, MODERN PATHOL, V27, P1559, DOI 10.1038/modpathol.2014.55; R Development Core Team, 2009, R LANG ENV STAT COMP; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Schnatz PF, 2006, OBSTET GYNECOL, V107, P701, DOI 10.1097/01.AOG.0000202401.29145.68; Sharpless KE, 2005, OBSTET GYNECOL, V105, P494, DOI 10.1097/01.AOG.0000152350.10875.02; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Ulker V, 2013, EUR J GYNAECOL ONCOL, V34, P457; Verdoodt F, 2016, INT J CANCER, V138, P303, DOI 10.1002/ijc.29424; von Karsa L, 2015, PAPILLOMAVIRUS RES, V1, P22, DOI 10.1016/j.pvr.2015.06.006; Widrich T, 1996, GYNECOL ONCOL, V61, P304, DOI 10.1006/gyno.1996.0147; Working and reference group for cervical cancer prevention, 2010, 63 WORK REF GROUP CE; World Health Organization, 1956, STAT COD HUM TUM WHO; Zhao CQ, 2009, GYNECOL ONCOL, V114, P383, DOI 10.1016/j.ygyno.2009.05.019; Zweizig S, 1997, GYNECOL ONCOL, V65, P314, DOI 10.1006/gyno.1997.4640	45	33	35	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2016	352								i276	10.1136/bmj.i276	http://dx.doi.org/10.1136/bmj.i276			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JT	26869597	Green Published, hybrid			2022-12-28	WOS:000370383900001
J	Sargent, J				Sargent, Jennifer			Rheumatology-a call for papers	LANCET			English	Editorial Material									[Sargent, Jennifer] The Lancet, London EC2Y 5AS, England		Sargent, J (corresponding author), The Lancet, London EC2Y 5AS, England.							Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					519	519		10.1016/S0140-6736(16)00259-2	http://dx.doi.org/10.1016/S0140-6736(16)00259-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26867433				2022-12-28	WOS:000369835800014
J	Lin, CY; Erkek, S; Tong, YA; Yin, LL; Federation, AJ; Zapatka, M; Haldipur, P; Kawauchi, D; Risch, T; Warnatz, HJ; Worst, BC; Ju, BS; Orr, BA; Zeid, R; Polaski, DR; Segura-Wang, M; Waszak, SM; Jones, DTW; Kool, M; Hovestadt, V; Buchhalter, I; Sieber, L; Johann, P; Chavez, L; Groschel, S; Ryzhova, M; Korshunov, A; Chen, WB; Chizhikov, VV; Millen, KJ; Amstislavskiy, V; Lehrach, H; Yaspo, ML; Eils, R; Lichter, P; Korbel, JO; Pfister, SM; Bradner, JE; Northcott, PA				Lin, Charles Y.; Erkek, Serap; Tong, Yiai; Yin, Linlin; Federation, Alexander J.; Zapatka, Marc; Haldipur, Parthiv; Kawauchi, Daisuke; Risch, Thomas; Warnatz, Hans-Joerg; Worst, Barbara C.; Ju, Bensheng; Orr, Brent A.; Zeid, Rhamy; Polaski, Donald R.; Segura-Wang, Maia; Waszak, Sebastian M.; Jones, David T. W.; Kool, Marcel; Hovestadt, Volker; Buchhalter, Ivo; Sieber, Laura; Johann, Pascal; Chavez, Lukas; Groeschel, Stefan; Ryzhova, Marina; Korshunov, Andrey; Chen, Wenbiao; Chizhikov, Victor V.; Millen, Kathleen J.; Amstislavskiy, Vyacheslav; Lehrach, Hans; Yaspo, Marie-Laure; Eils, Roland; Lichter, Peter; Korbel, Jan O.; Pfister, Stefan M.; Bradner, James E.; Northcott, Paul A.			Active medulloblastoma enhancers reveal subgroup-specific cellular origins	NATURE			English	Article							LIBRARY PREPARATION PROTOCOL; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; IDENTITY; EXPRESSION; LANDSCAPE; ONCOGENES; RNA	Medulloblastoma is a highly malignant paediatric brain tumour, often inflicting devastating consequences on the developing child. Genomic studies have revealed four distinct molecular subgroups with divergent biology and clinical behaviour. An understanding of the regulatory circuitry governing the transcriptional landscapes of medulloblastoma subgroups, and how this relates to their respective developmental origins, is lacking. Here, using H3K27ac and BRD4 chromatin immunoprecipitation followed by sequencing (ChIP-seq) coupled with tissue-matched DNA methylation and transcriptome data, we describe the active cis-regulatory landscape across 28 primary medulloblastoma specimens. Analysis of differentially regulated enhancers and super-enhancers reinforced inter-subgroup heterogeneity and revealed novel, clinically relevant insights into medulloblastoma biology. Computational reconstruction of core regulatory circuitry identified a master set of transcription factors, validated by ChIP-seq, that is responsible for subgroup divergence, and implicates candidate cells of origin for Group 4. Our integrated analysis of enhancer elements in a large series of primary tumour samples reveals insights into cis-regulatory architecture, unrecognized dependencies, and cellular origins.	[Lin, Charles Y.; Federation, Alexander J.; Zeid, Rhamy; Polaski, Donald R.; Bradner, James E.] Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA; [Erkek, Serap; Segura-Wang, Maia; Waszak, Sebastian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Erkek, Serap; Kawauchi, Daisuke; Worst, Barbara C.; Jones, David T. W.; Kool, Marcel; Sieber, Laura; Johann, Pascal; Chavez, Lukas; Pfister, Stefan M.; Northcott, Paul A.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Tong, Yiai; Northcott, Paul A.] St Jude Childrens Res Hosp, Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yin, Linlin; Chen, Wenbiao] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Zapatka, Marc; Hovestadt, Volker; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Haldipur, Parthiv; Millen, Kathleen J.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Risch, Thomas; Warnatz, Hans-Joerg; Amstislavskiy, Vyacheslav; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Ju, Bensheng] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA; [Orr, Brent A.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Jones, David T. W.; Kool, Marcel; Lichter, Peter; Pfister, Stefan M.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Buchhalter, Ivo; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Groeschel, Stefan] NCT Heidelberg, Dept Translat Oncol, D-69120 Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Univ Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Chizhikov, Victor V.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Millen, Kathleen J.] Univ Washington, Div Genet, Dept Pediat, Seattle, WA 98195 USA; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol & BioQuant, D-69117 Heidelberg, Germany; [Pfister, Stefan M.] Heidelberg Univ, Dept Pediat, D-69117 Heidelberg, Germany; [Lin, Charles Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); St Jude Children's Research Hospital; Vanderbilt University; Helmholtz Association; German Cancer Research Center (DKFZ); Seattle Children's Hospital; Max Planck Society; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Tennessee System; University of Tennessee Health Science Center; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Baylor College of Medicine	Bradner, JE (corresponding author), Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA.; Northcott, PA (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany.; Pfister, SM (corresponding author), Heidelberg Univ, Dept Pediat, D-69117 Heidelberg, Germany.	s.pfister@dkfz-heidelberg.de; james_bradner@dfci.harvard.edu; paul.northcott@stjude.org	Eils, Roland/B-6121-2009; Chen, Wenbiao/ABG-1276-2020; Northcott, Paul A/N-4022-2018; Ryzhova, Marina/G-4178-2014; Orr, Brent/N-8068-2018; Jones, David T. W./Z-1963-2019; Pfister, Stefan M/F-6860-2013; Jones, David TW/G-9588-2013; Zapatka, Marc/G-9896-2013; Hovestadt, Volker/ABG-2076-2021; Johann, Pascal David/AAT-9368-2021; Haldipur, Parthiv/ABH-8875-2020; Erkek, Serap/AAV-5549-2020; Waszak, Sebastian M./D-7828-2015; Kawauchi, Daisuke/ABE-9133-2021	Eils, Roland/0000-0002-0034-4036; Chen, Wenbiao/0000-0002-0750-8275; Northcott, Paul A/0000-0002-1220-5252; Ryzhova, Marina/0000-0001-7206-6365; Pfister, Stefan M/0000-0002-5447-5322; Jones, David TW/0000-0002-2036-5141; Zapatka, Marc/0000-0001-8287-5967; Hovestadt, Volker/0000-0002-3480-6649; Waszak, Sebastian M./0000-0003-3042-9521; Millen, Kathleen/0000-0001-9978-675X; Chavez, Lukas/0000-0002-8718-8848; Erkek, Serap/0000-0003-4439-5203; HALDIPUR, PARTHIV/0000-0003-2865-8683; Chizhikov, Victor/0000-0003-2338-1267; Orr, Brent/0000-0003-0997-4728; Federation, Alexander/0000-0002-7771-1148; Segura-Wang, Maia/0000-0003-2424-618X; Korshunov, Andrey/0000-0002-5257-3623; Buchhalter, Ivo/0000-0003-0764-5832	Human Frontiers Science Program [LT000432/2014]; SNSF [P2ELP3_155365]; EMBO Long-Term Fellowship [ALTF 755-2014]; US Department of Defense CDMRP [CA120184]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072441, R01NS080390] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); SNSF(Swiss National Science Foundation (SNSF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); US Department of Defense CDMRP(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.E. is a recipient of Human Frontiers Science Program long-term postdoctoral fellowship (LT000432/2014). S.M.W. received funding through a SNSF Early Postdoc Mobility Fellowship (P2ELP3_155365) and an EMBO Long-Term Fellowship (ALTF 755-2014). C.Y.L. is supported by a US Department of Defense CDMRP CA120184 postdoctoral fellowship. P.A.N. is a V Foundation V Scholar in Childhood Cancer Research. We thank Creative Science Studios (http://www.creativesciencestudios.com/) for assistance with artwork. We acknowledge J. Zhang and X. Zhou for their assistance in making this data accessible via the St. Jude PeCan Data Portal (https://pecan.stjude.org/dataset/northcott).	Aruga J, 1998, J NEUROSCI, V18, P284; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Borodina T, 2011, METHOD ENZYMOL, V500, P79, DOI 10.1016/B978-0-12-385118-5.00005-0; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2011, CELL, V145, P25, DOI 10.1016/j.cell.2011.03.019; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Haldipur P, 2012, STEM CELLS DEV, V21, P1059, DOI 10.1089/scd.2011.0206; HALE G, 1988, LANCET, V2, P1394; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milde T, 2012, J NEURO-ONCOL, V110, P335, DOI 10.1007/s11060-012-0978-1; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Skipper M, 2015, NATURE, V518, P313, DOI 10.1038/518313a; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Walter C, 2014, BIOINFORMATICS, V30, P3268, DOI 10.1093/bioinformatics/btu497; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	227	234	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					57	+		10.1038/nature16546	http://dx.doi.org/10.1038/nature16546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26814967	Green Accepted, Green Published			2022-12-28	WOS:000369304500031
J	Watts, G				Watts, Geoff			Charlotte Watts: from pure maths to HIV and gender-based violence	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					425	425		10.1016/S0140-6736(16)00180-X	http://dx.doi.org/10.1016/S0140-6736(16)00180-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC1OX	26869560				2022-12-28	WOS:000368986800017
J	Volkow, ND; Koob, GF; McLellan, AT				Volkow, Nora D.; Koob, George F.; McLellan, A. Thomas			Neurobiologic Advances from the Brain Disease Model of Addiction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUBSTANCE USE; NUCLEUS-ACCUMBENS; COCAINE ADDICTION; SENSATION SEEKING; MENTAL-HEALTH; UNITED-STATES; PRIMARY-CARE; ALCOHOL-USE; DOPAMINE; REWARD		[Volkow, Nora D.] NIDA, 6001 Execut Bldg,Rm 5274, Bethesda, MD 20892 USA; [Koob, George F.] NIAAA, Bethesda, MD USA; [McLellan, A. Thomas] Treatment Res Inst, Philadelphia, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Volkow, ND (corresponding author), NIDA, 6001 Execut Bldg,Rm 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Intramural NIH HHS [Z99 AA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000602] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 2015, VOICE OF AM     1001; [Anonymous], 2011, REP C COMM MENT HLTH; [Anonymous], 2014, EXCESSIVE DRINKING C; Bell J, 2014, BRIT J CLIN PHARMACO, V77, P253, DOI 10.1111/bcp.12051; Bevilacqua L, 2009, CLIN PHARMACOL THER, V85, P359, DOI 10.1038/clpt.2009.6; Britt JP, 2013, CURR OPIN NEUROBIOL, V23, P539, DOI 10.1016/j.conb.2013.01.010; Burnett-Zeigler I, 2012, J ADOLESCENT HEALTH, V50, P559, DOI 10.1016/j.jadohealth.2011.10.005; Busch SH, 2014, AM J MANAG CARE, V20, P76; Castellanos-Ryan N, 2011, ALCOHOL CLIN EXP RES, V35, P140, DOI 10.1111/j.1530-0277.2010.01331.x; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; DeJong W, 2014, J STUD ALCOHOL DRUGS, P108, DOI 10.15288/jsads.2014.s17.108; Demers Catherine H, 2014, Curr Behav Neurosci Rep, V1, P33; Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Department of Justice National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Greenberg MT, 2013, ANNU REV PUBL HEALTH, V34, P253, DOI 10.1146/annurev-publhealth-031811-124619; Hagele C, 2015, PSYCHOPHARMACOLOGY, V232, P331, DOI 10.1007/s00213-014-3662-7; Hyatt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034917; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kaufling J, 2015, J NEUROSCI, V35, P10290, DOI 10.1523/JNEUROSCI.0715-15.2015; Kiluk BD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0420-1; Konova AB, 2012, EUR J NEUROSCI, V36, P2979, DOI 10.1111/j.1460-9568.2012.08211.x; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; Kourrich S, 2015, NAT REV NEUROSCI, V16, P173, DOI 10.1038/nrn3877; Litten RZ, 2015, ALCOHOL CLIN EXP RES, V39, P579, DOI 10.1111/acer.12669; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Muller CA, 2014, EXPERT OPIN PHARMACO, V15, P471, DOI 10.1517/14656566.2014.876008; Nees F, 2012, NEUROPSYCHOPHARMACOL, V37, P986, DOI 10.1038/npp.2011.282; Potenza M, 2015, NATURE, V522, pS62, DOI 10.1038/522S62a; Quinn PD, 2013, DEV PSYCHOPATHOL, V25, P223, DOI 10.1017/S0954579412000284; Saddoris MP, 2015, J NEUROSCI, V35, P11572, DOI 10.1523/JNEUROSCI.2344-15.2015; Sandler I, 2014, ANNU REV CLIN PSYCHO, V10, P243, DOI 10.1146/annurev-clinpsy-050212-185524; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Stanis JJ, 2014, PSYCHOPHARMACOLOGY, V231, P1437, DOI 10.1007/s00213-013-3393-1; Substance Abuse and Mental Health Services Administration, 2013, RES 2013 NAT SURV DR; Sullivan MA, 2013, DRUG ALCOHOL DEPEN, V133, P80, DOI 10.1016/j.drugalcdep.2013.05.030; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Volkow ND, 2014, MOL PSYCHIATR, V19, P1037, DOI 10.1038/mp.2014.58; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Volkow ND, 2015, LANCET PSYCHIAT, V2, P677, DOI 10.1016/S2215-0366(15)00236-9; Volkow ND, 2012, HUM GENET, V131, P773, DOI 10.1007/s00439-012-1173-3; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Williams Timothy, 2015, NY TIMES, pA1; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Zhang Y, 2013, NEUROPHARMACOLOGY, V67, P259, DOI 10.1016/j.neuropharm.2012.10.015	58	787	807	19	175	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					363	371		10.1056/NEJMra1511480	http://dx.doi.org/10.1056/NEJMra1511480			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816013	Green Accepted, Bronze			2022-12-28	WOS:000368760100010
J	Byrd, AL; Segre, JA				Byrd, Allyson L.; Segre, Julia A.			Adapting Koch's postulates	SCIENCE			English	Editorial Material							COLONIZATION RESISTANCE; CLOSTRIDIUM-DIFFICILE; PATHOGENS; DISEASE		[Byrd, Allyson L.; Segre, Julia A.] NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, Bethesda, MD 20892 USA; [Byrd, Allyson L.] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University	Byrd, AL (corresponding author), NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200382] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Break TJ, 2015, INFECT IMMUN, V83, P958, DOI 10.1128/IAI.02604-14; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; EVANS AS, 1976, YALE J BIOL MED, V49, P175; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Koch R., 1890, 10 INT C MED BERL; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; NISSLE A, 1961, Med Welt, V29-30, P1519; Rivers TM, 1937, J BACTERIOL, V33, P1; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	14	112	114	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					224	226		10.1126/science.aad6753	http://dx.doi.org/10.1126/science.aad6753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816362				2022-12-28	WOS:000368098600018
J	Chakraborty, S; Marshall, OP; Folland, TG; Kim, YJ; Grigorenko, AN; Novoselov, KS				Chakraborty, S.; Marshall, O. P.; Folland, T. G.; Kim, Y. -J.; Grigorenko, A. N.; Novoselov, K. S.			Gain modulation by graphene plasmons in aperiodic lattice lasers	SCIENCE			English	Article							QUANTUM CASCADE LASERS; PHOTONIC BAND; ENHANCEMENT; MICROCAVITY; ELECTRONICS; TRANSISTOR; LIGHT	Two-dimensional graphene plasmon-based technologies will enable the development of fast, compact, and inexpensive active photonic elements because, unlike plasmons in other materials, graphene plasmons can be tuned via the doping level. Such tuning is harnessed within terahertz quantum cascade lasers to reversibly alter their emission. This is achieved in two key steps: first, by exciting graphene plasmons within an aperiodic lattice laser and, second, by engineering photon lifetimes, linking graphene's Fermi energy with the round-trip gain. Modal gain and hence laser spectra are highly sensitive to the doping of an integrated, electrically controllable, graphene layer. Demonstration of the integrated graphene plasmon laser principle lays the foundation for a new generation of active, programmable plasmonic metamaterials with major implications across photonics, material sciences, and nanotechnology.	[Chakraborty, S.; Marshall, O. P.; Folland, T. G.] Univ Manchester, Sch Elect & Elect Engn, Manchester M13 9PL, Lancs, England; [Marshall, O. P.; Kim, Y. -J.; Grigorenko, A. N.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Chakraborty, S (corresponding author), Univ Manchester, Sch Elect & Elect Engn, Manchester M13 9PL, Lancs, England.	s.chakraborty@manchester.ac.uk; kostya@manchester.ac.uk	Folland, Thomas/AAE-9601-2019; Kim, Yong-Jin/D-2550-2009; Novoselov, Kostya S/G-9581-2014; Marshall, Owen/C-2080-2017	Folland, Thomas/0000-0002-4665-235X; Novoselov, Kostya S/0000-0003-4972-5371; hai yan, he/0000-0003-0366-6185; Marshall, Owen/0000-0002-4533-7956	EPSRC [EP/G064504/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G064504/1, 1214986] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/NPHOTON.2010.186, 10.1038/nphoton.2010.186]; Chakraborty S, 2005, PHOTONIC NANOSTRUCT, V3, P139, DOI 10.1016/j.photonics.2005.09.011; Chakraborty S, 2012, OPT EXPRESS, V20, pB306, DOI 10.1364/OE.20.00B306; Chakraborty S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753814; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Docherty CJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2235; DOWLING JP, 1994, J APPL PHYS, V75, P1896, DOI 10.1063/1.356336; Eberlein T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.233406; Engel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1911; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Kim JT, 2011, OPT EXPRESS, V19, P24557, DOI 10.1364/OE.19.024557; Li JT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09263; Mahler L, 2004, APPL PHYS LETT, V84, P5446, DOI 10.1063/1.1767957; Marshall OP, 2013, J APPL PHYS, V113, DOI 10.1063/1.4807636; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Pickering T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5972; Polat EO, 2013, NANO LETT, V13, P5851, DOI 10.1021/nl402616t; Tredicucci A, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2271692; Wang XM, 2013, NAT PHOTONICS, V7, P888, DOI 10.1038/nphoton.2013.241; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI [10.1038/NPHOTON.2013.57, 10.1038/nphoton.2013.57]	28	81	85	9	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					246	248		10.1126/science.aad2930	http://dx.doi.org/10.1126/science.aad2930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816373	Green Submitted			2022-12-28	WOS:000368098600033
J	Nelson, BR; Makarewich, CA; Anderson, DM; Winders, BR; Troupes, CD; Wu, FF; Reese, AL; McAnally, JR; Chen, XW; Kavalali, ET; Cannon, SC; Houser, SR; Bassel-Duby, R; Olson, EN				Nelson, Benjamin R.; Makarewich, Catherine A.; Anderson, Douglas M.; Winders, Benjamin R.; Troupes, Constantine D.; Wu, Fenfen; Reese, Austin L.; McAnally, John R.; Chen, Xiongwen; Kavalali, Ege T.; Cannon, Stephen C.; Houser, Steven R.; Bassel-Duby, Rhonda; Olson, Eric N.			A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle	SCIENCE			English	Article							OPEN READING FRAMES; CARDIAC CONTRACTILITY; SKELETAL-MUSCLE; SARCOLIPIN; MICE; PHOSPHOLAMBAN; TRANSPORT	Muscle contraction depends on release of Ca2+ from the sarcoplasmic reticulum (SR) and reuptake by the Ca2+ adenosine triphosphatase SERCA. We discovered a putative muscle-specific long noncoding RNA that encodes a peptide of 34 amino acids and that we named dwarf open reading frame (DWORF). DWORF localizes to the SR membrane, where it enhances SERCA activity by displacing the SERCA inhibitors, phospholamban, sarcolipin, and myoregulin. In mice, overexpression of DWORF in cardiomyocytes increases peak Ca2+ transient amplitude and SR Ca2+ load while reducing the time constant of cytosolic Ca2+ decay during each cycle of contraction-relaxation. Conversely, slow skeletal muscle lacking DWORF exhibits delayed Ca2+ clearance and relaxation and reduced SERCA activity. DWORF is the only endogenous peptide known to activate the SERCA pump by physical interaction and provides a means for enhancing muscle contractility.	[Nelson, Benjamin R.; Makarewich, Catherine A.; Anderson, Douglas M.; Winders, Benjamin R.; McAnally, John R.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nelson, Benjamin R.; Makarewich, Catherine A.; Anderson, Douglas M.; Winders, Benjamin R.; McAnally, John R.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Troupes, Constantine D.; Chen, Xiongwen; Houser, Steven R.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Troupes, Constantine D.; Chen, Xiongwen; Houser, Steven R.] Temple Univ, Sch Med, Dept Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Wu, Fenfen; Cannon, Stephen C.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Reese, Austin L.; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Reese, Austin L.; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Chen, Xiongwen/D-5988-2012; Cannon, Stephen/V-5343-2019	Chen, Xiongwen/0000-0002-3829-5815; Cannon, Stephen/0000-0001-8428-3690; Troupes, Constantine/0000-0002-7000-167X; Reese, Austin/0000-0003-3199-2420	NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401, AR-063182]; Fondation Leducq Networks of Excellence; Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation [1-0025]; National Institute of Arthritis and Musculoskeletal Diseases, NIH, Ruth L. Kirschstein National Research Service Award (NRSA) [F30AR067094]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, R01HL077439, P01HL091799, R01HL130253, U01HL100401, R01HL093039, R01HL088243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063182, F30AR067094, R01AR067294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Networks of Excellence; Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); National Institute of Arthritis and Musculoskeletal Diseases, NIH, Ruth L. Kirschstein National Research Service Award (NRSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Long for advice and expertise, N. Beetz for cDNA, J. Cabrera for graphics, S. Johnson for technical support, and the University of Texas Southwestern Medical Center Live Cell Imaging Core Facility under the direction of K. Luby-Phelps. This work was supported by grants from the NIH (HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401, and AR-063182), Fondation Leducq Networks of Excellence, Cancer Prevention and Research Institute of Texas, and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.). B.R.N. was support by a National Institute of Arthritis and Musculoskeletal Diseases, NIH, Ruth L. Kirschstein National Research Service Award (NRSA) (F30AR067094).	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; DAVIS BA, 1983, J BIOL CHEM, V258, P3587; Dorn GW, 2004, CIRCULATION, V109, P150, DOI 10.1161/01.CIR.0000111581.15521.F5; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guido AN, 2010, ANAT REC, V293, P1722, DOI 10.1002/ar.21224; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nelson BR, 2014, CIRC RES, V114, P18, DOI 10.1161/CIRCRESAHA.113.302716; Nelson BR, 2013, P NATL ACAD SCI USA, V110, P11881, DOI 10.1073/pnas.1310571110; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222	22	452	507	4	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					271	275		10.1126/science.aad4076	http://dx.doi.org/10.1126/science.aad4076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816378	Green Accepted			2022-12-28	WOS:000368098600040
J	Underwood, E				Underwood, Emily			Regulators seek to tame brain training's 'Wild West'	SCIENCE			English	News Item																			0	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					212	213		10.1126/science.351.6270.212	http://dx.doi.org/10.1126/science.351.6270.212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816355				2022-12-28	WOS:000368098600011
J	Garland, SM; Subasinghe, AK; Jayasinghe, YL; Wark, JD; Moscicki, AB; Singer, A; Bosch, X; Cusack, K; Stanley, M				Garland, Suzanne M.; Subasinghe, Asvini K.; Jayasinghe, Yasmin L.; Wark, John D.; Moscicki, Anna-Barbara; Singer, Albert; Bosch, Xavier; Cusack, Karen; Stanley, Margaret			HPV vaccination for victims of childhood sexual abuse	LANCET			English	Editorial Material							CERVICAL-CANCER		[Garland, Suzanne M.; Jayasinghe, Yasmin L.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Garland, Suzanne M.; Subasinghe, Asvini K.; Jayasinghe, Yasmin L.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic 3052, Australia; [Jayasinghe, Yasmin L.] Royal Womens Hosp, Dept Gynaecol, Parkville, Vic 3052, Australia; [Cusack, Karen] Royal Womens Hosp, Corp Council, Parkville, Vic 3052, Australia; [Subasinghe, Asvini K.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Wark, John D.] Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Moscicki, Anna-Barbara] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Singer, Albert] Whittington Hosp, Dept Womens Hlth, London N19 5NF, England; [Bosch, Xavier] Catalan Inst Oncol, Unit Infect & Canc, Barcelona, Spain; [Stanley, Margaret] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Melbourne; Murdoch Children's Research Institute; Royal Melbourne Hospital; University of California System; University of California San Francisco; University of London; University College London; Catalan Institute of Oncology; University of Cambridge	Garland, SM (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	suzanne.garland@thewomens.org.au	Moscicki, Anna-Barbara/AAP-3806-2021	Jayasinghe, Yasmin/0000-0001-5975-9378				Andrews GJ, 2004, CHILD SEXUAL ABUSE C; Barth J, 2013, INT J PUBLIC HEALTH, V58, P469, DOI 10.1007/s00038-012-0426-1; Bergmark K, 2005, J SEX MARITAL THER, V31, P361, DOI 10.1080/00926230591006476; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Coker AL, 2000, J WOMEN HEALTH GEN-B, V9, P1015, DOI 10.1089/15246090050200051; Garland SM, 2015, 30 INT PAP C 2015 LI; Howlader N, 2011, SEER CANC STAT REV 1; International Agency for Research on Cancer, 2004, IARC HDB CANC PREV, V10; Jayasinghe Y, 2015, 30 INT PAP C CLIN PU; Johnson CF, 2004, LANCET, V364, P462, DOI 10.1016/S0140-6736(04)16771-8; Martinez G, 2011, VITAL HLTH STAT, V23, P5; Moore EE, 2011, AUST NZ J OBSTET GYN, V51, P276, DOI 10.1111/j.1479-828X.2010.01260.x; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; WHO, 2014, COMPR CERV CANC CONT; Williams J, 2015, MMWR-MORBID MORTAL W, V64, P1; World Health Organization, 2013, COUNTR HPV VACC NAT; World Health Organization, 1999, WHOHSCPVI991	17	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1919	1920		10.1016/S0140-6736(15)00757-6	http://dx.doi.org/10.1016/S0140-6736(15)00757-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26841735				2022-12-28	WOS:000364763200007
J	Sugahara, F; Pascual-Anaya, J; Oisi, Y; Kuraku, S; Aota, S; Adachi, N; Takagi, W; Hirai, T; Sato, N; Murakami, Y; Kuratani, S				Sugahara, Fumiaki; Pascual-Anaya, Juan; Oisi, Yasuhiro; Kuraku, Shigehiro; Aota, Shin-ichi; Adachi, Noritaka; Takagi, Wataru; Hirai, Tamami; Sato, Noboru; Murakami, Yasunori; Kuratani, Shigeru			Evidence from cyclostomes for complex regionalization of the ancestral vertebrate brain	NATURE			English	Article							PROSOMERIC MODEL; PACIFIC HAGFISH; GROWTH CHANGES; EVOLUTION; GENE; TELENCEPHALON; FOREBRAIN; LAMPREY; STOUTI; ORGANIZATION	The vertebrate brain is highly complex, but its evolutionary origin remains elusive. Because of the absence of certain developmental domains generally marked by the expression of regulatory genes, the embryonic brain of the lamprey, a jawless vertebrate, had been regarded as representing a less complex, ancestral state of the vertebrate brain. Specifically, the absence of a Hedgehog- and Nkx2.1-positive domain in the lamprey subpallium was thought to be similar to mouse mutants in which the suppression of Nkx2-1 leads to a loss of the medial ganglionic eminence1,2. Here we show that the brain of the inshore hagfish (Eptatretus burgeri), another cyclostome group, develops domains equivalent to the medial ganglionic eminence and rhombic lip, resembling the gnathostome brain. Moreover, further investigation of lamprey larvae revealed that these domains are also present, ruling out the possibility of convergent evolution between hagfish and gnathostomes. Thus, brain regionalization as seen in crown gnathostomes is not an evolutionary innovation of this group, but dates back to the latest vertebrate ancestor before the divergence of cyclostomes and gnathostomes more than 500 million years ago.	[Sugahara, Fumiaki; Pascual-Anaya, Juan; Aota, Shin-ichi; Takagi, Wataru; Hirai, Tamami; Kuratani, Shigeru] RIKEN, Evolutionary Morphol Lab, Kobe, Hyogo 6500047, Japan; [Sugahara, Fumiaki] Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan; [Oisi, Yasuhiro] Max Planck Florida Inst Neurosci, Dev & Funct Inhibitory Neural Circuits, Jupiter, FL 33458 USA; [Kuraku, Shigehiro] RIKEN, Ctr Life Sci Technol, Phyloinformat Unit, Kobe, Hyogo 6500047, Japan; [Adachi, Noritaka] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Sato, Noboru] Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata 9508510, Japan; [Murakami, Yasunori] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan	RIKEN; Hyogo College of Medicine; Max Planck Society; RIKEN; University of Chicago; Niigata University; Ehime University	Kuratani, S (corresponding author), RIKEN, Evolutionary Morphol Lab, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Pascual-Anaya, Juan/B-5043-2016; Adachi, Noritaka/C-6747-2017; Sugahara, Fumiaki/ABA-7542-2021; Sugahara, Fumiaki/C-5379-2017; Takagi, Wataru/N-7627-2019; Kuratani, Shigeru/J-4146-2014; Adachi, Noritaka/ABB-6724-2020; Takagi, Wataru/C-5377-2017	Kuraku, Shigehiro/0000-0003-1464-8388; Pascual-Anaya, Juan/0000-0003-3429-9453; Sugahara, Fumiaki/0000-0001-8445-1703; Takagi, Wataru/0000-0002-7882-0223; Kuratani, Shigeru/0000-0001-9717-7221; Adachi, Noritaka/0000-0002-9482-8436; Takagi, Wataru/0000-0002-7882-0223	Centre for Developmental Biology, RIKEN, JSPS KAKENHI [15H02416, 25840133]; Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research [26291065] Funding Source: KAKEN	Centre for Developmental Biology, RIKEN, JSPS KAKENHI; Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank O. Kakitani for hagfish sampling; K. Shirato for shark sampling; S. Shibuya, K. Yamamoto and Y. Yamamoto for maintenance of aquarium tanks; D. Sipp for critical reading of this manuscript; C. Mitgutsch and M. Kawaguchi for discussions; K. G. Ota and I. Sato for technical support; and H. Nagashima for lamprey sampling and discussions. This research was supported by direct budget supplied by Centre for Developmental Biology, RIKEN, JSPS KAKENHI grant numbers 15H02416 and 25840133, and by Hyogo Science and Technology Association.	Adachi N, 2012, EVOL DEV, V14, P257, DOI 10.1111/j.1525-142X.2012.00543.x; [Anonymous], 1906, BERLINER VOLKS ZEITU; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Barreiro-Iglesias A, 2008, BRAIN RES BULL, V75, P42, DOI 10.1016/j.brainresbull.2007.07.020; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Conel JL, 1929, J COMP NEUROL, V47, P343, DOI 10.1002/cne.900470303; Conel JL, 1931, J COMP NEUROL, V52, P365; Dean B., 1899, FESTSCHRIFT ZUM 70TE, P220; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Feiner N, 2014, GENOME BIOL EVOL, V6, P1635, DOI 10.1093/gbe/evu135; Germot A, 2001, MOL BIOL EVOL, V18, P1668, DOI 10.1093/oxfordjournals.molbev.a003955; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Kiecker C, 2012, ANNU REV NEUROSCI, V35, P347, DOI 10.1146/annurev-neuro-062111-150543; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Larsell O, 1967, COMP ANATOMY HISTOLO; Manoli M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00145; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Murakami Y, 2005, DEV BIOL, V280, P249, DOI 10.1016/j.ydbio.2005.02.008; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Noro M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0351-z; Ogasawara M, 2001, GENESIS, V30, P51, DOI 10.1002/gene.1032; Oisi Y, 2015, NEUROMETHODS, V99, P249, DOI 10.1007/978-1-4939-2303-8_12; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Pombal MA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00020; Pombal MA, 2009, BRAIN BEHAV EVOLUT, V74, P7, DOI 10.1159/000229009; Puelles L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00027; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Santagati F, 2003, GENETICS, V165, P235; Stensio E. A., 1927, DOWNTONIAN DEVONI 1; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Sugahara F, 2015, NEUROMETHODS, V99, P263, DOI 10.1007/978-1-4939-2303-8_13; Sugahara F, 2013, CURR OPIN GENET DEV, V23, P475, DOI 10.1016/j.gde.2013.02.008; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; Sussel L, 1999, DEVELOPMENT, V126, P3359; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takechi M, 2013, SEMIN CELL DEV BIOL, V24, P110, DOI 10.1016/j.semcdb.2012.12.010; Takechi M, 2011, J EXP ZOOL PART B, V316B, P526, DOI 10.1002/jez.b.21427; Tank EM, 2009, EVOL DEV, V11, P343, DOI 10.1111/j.1525-142X.2009.00341.x; von Kupffer C., 1900, STUDIEN VERGLEICHEND; Watson C, 2012, MOUSE NERVOUS SYSTEM, P1; WICHT H, 1992, BRAIN BEHAV EVOLUT, V40, P25, DOI 10.1159/000113900; WICHT H, 1994, BRAIN BEHAV EVOLUT, V43, P140, DOI 10.1159/000113631; Wullimann MF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00027; Yamaguchi Y, 2012, GEN COMP ENDOCR, V178, P519, DOI 10.1016/j.ygcen.2012.07.008	47	60	61	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2016	531	7592					97	+		10.1038/nature16518	http://dx.doi.org/10.1038/nature16518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2YW	26878236				2022-12-28	WOS:000371211900047
J	Jiang, FG; Taylor, DW; Chen, JS; Kornfeld, JE; Zhou, KH; Thompson, AJ; Nogales, E; Doudna, JA				Jiang, Fuguo; Taylor, David W.; Chen, Janice S.; Kornfeld, Jack E.; Zhou, Kaihong; Thompson, Aubri J.; Nogales, Eva; Doudna, Jennifer A.			Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage	SCIENCE			English	Article							CAS SYSTEMS; TARGET DNA; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; RNA; ENDONUCLEASE; RECOGNITION; BACTERIA; CASCADE; PROKARYOTES	Bacterial adaptive immunity and genome engineering involving the CRISPR (clustered regularly interspaced short palindromic repeats)-associated (Cas) protein Cas9 begin with RNA-guided DNA unwinding to form an RNA-DNA hybrid and a displaced DNA strand inside the protein. The role of this R-loop structure in positioning each DNA strand for cleavage by the two Cas9 nuclease domains is unknown. We determine molecular structures of the catalytically active Streptococcus pyogenes Cas9 R-loop that show the displaced DNA strand located near the RuvC nuclease domain active site. These protein-DNA interactions, in turn, position the HNH nuclease domain adjacent to the target DNA strand cleavage site in a conformation essential for concerted DNA cutting. Cas9 bends the DNA helix by 30 degrees, providing the structural distortion needed for R-loop formation.	[Jiang, Fuguo; Taylor, David W.; Chen, Janice S.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Taylor, David W.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kornfeld, Jack E.; Zhou, Kaihong; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Thompson, Aubri J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nogales, E; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Nogales, E; Doudna, JA (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Nogales, E; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Nogales, E; Doudna, JA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	enogales@lbl.gov; doudna@berkeley.edu	JIANG, FUGUO/G-6581-2012	JIANG, FUGUO/0000-0003-4469-1803; Chen, Janice/0000-0003-4797-3056; Taylor, David/0000-0002-6198-1194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, P01GM051487] Funding Source: NIH RePORTER; Direct For Biological Sciences [1244557] Funding Source: National Science Foundation; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P01 GM051487, T32 GM066698] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	21	323	357	5	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					867	871		10.1126/science.aad8282	http://dx.doi.org/10.1126/science.aad8282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26841432	Green Accepted			2022-12-28	WOS:000370325700046
J	Dhindsa, RS; Goldstein, DB				Dhindsa, Ryan S.; Goldstein, David B.			SCHIZOPHRENIA From genetics to physiology at last	NATURE			English	Editorial Material									[Dhindsa, Ryan S.; Goldstein, David B.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA	Columbia University	Goldstein, DB (corresponding author), Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA.	rsd2135@cumc.columbia.edu; dg2875@cumc.columbia.edu	Dhindsa, Ryan/W-9678-2019; Goldstein, David/AAY-8125-2020	Dhindsa, Ryan/0000-0002-8965-0813; 				Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036	7	17	18	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					162	163		10.1038/nature16874	http://dx.doi.org/10.1038/nature16874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26814972				2022-12-28	WOS:000369916700022
J	Forejt, J				Forejt, Jiri			GENETICS Asymmetric breaks in DNA cause sterility	NATURE			English	Editorial Material							MEIOTIC RECOMBINATION		[Forejt, Jiri] Acad Sci Czech Republic, Inst Mol Genet, Div BIOCEV, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Forejt, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Div BIOCEV, Videnska 1083, CR-14220 Prague 4, Czech Republic.	jiri.forejt@img.cas.cz	Forejt, Jiri/G-7719-2012; Forejt, Jiri/AAF-5276-2019	Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623				Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bhattacharyya T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004088; Bhattacharyya T, 2013, P NATL ACAD SCI USA, V110, pE468, DOI 10.1073/pnas.1219126110; Buard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085021; Davies B, 2016, NATURE, V530, P171, DOI 10.1038/nature16931; Kono H, 2014, DNA RES, V21, P315, DOI 10.1093/dnares/dst059; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753	10	1	1	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					167	168		10.1038/nature16870	http://dx.doi.org/10.1038/nature16870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD4TX	26840487				2022-12-28	WOS:000369916700026
J	Kadau, H; Schmitt, M; Wenzel, M; Wink, C; Maier, T; Ferrier-Barbut, I; Pfau, T				Kadau, Holger; Schmitt, Matthias; Wenzel, Matthias; Wink, Clarissa; Maier, Thomas; Ferrier-Barbut, Igor; Pfau, Tilman			Observing the Rosensweig instability of a quantum ferrofluid	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; STABILIZATION; HELIUM; GAS	Ferrofluids exhibit unusual hydrodynamic effects owing to the magnetic nature of their constituents. As magnetization increases, a classical ferrofluid undergoes a Rosensweig instability(1) and creates self-organized, ordered surface structures(2) or droplet crystals(3). Quantum ferrofluids such as Bose-Einstein condensates with strong dipolar interactions also display superfluidity(4). The field of dipolar quantum gases is motivated by the search for new phases of matter that break continuous symmetries(5,6). The simultaneous breaking of continuous symmetries such as the phase invariance in a superfluid state and the translational symmetry in a crystal provides the basis for these new states of matter. However, interaction-induced crystallization in a superfluid has not yet been observed. Here we use in situ imaging to directly observe the spontaneous transition from an unstructured superfluid to an ordered arrangement of droplets in an atomic dysprosium Bose-Einstein condensate(7). By using a Feshbach resonance to control the interparticle interactions, we induce a finite-wavelength instability(8) and observe discrete droplets in a triangular structure, the number of which grows as the number of atoms increases. We find that these structured states are surprisingly long-lived and observe hysteretic behaviour, which is typical for a crystallization process and in close analogy to the Rosensweig instability. Our system exhibits both superfluidity and, as we show here, spontaneous translational symmetry breaking. Although our observations do not probe superfluidity in the structured states, if the droplets establish a common phase via weak links, then our system is a very good candidate for a supersolid ground state(9-11).	[Kadau, Holger; Schmitt, Matthias; Wenzel, Matthias; Wink, Clarissa; Maier, Thomas; Ferrier-Barbut, Igor; Pfau, Tilman] Univ Stuttgart, Phys Inst 5, D-70569 Stuttgart, Germany; [Kadau, Holger; Schmitt, Matthias; Wenzel, Matthias; Wink, Clarissa; Maier, Thomas; Ferrier-Barbut, Igor; Pfau, Tilman] Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, D-70569 Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Kadau, H (corresponding author), Univ Stuttgart, Phys Inst 5, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	h.kadau@physik.uni-stuttgart.de; t.pfau@physik.uni-stuttgart.de	Ferrier-Barbut, Igor/J-8759-2016; Pfau, Tilman/G-1774-2011	Ferrier-Barbut, Igor/0000-0002-4707-0474; Pfau, Tilman/0000-0003-3272-3468	German Research Foundation (DFG) [SFB/TRR21]; 'Studienstiftung des deutschen Volkes'	German Research Foundation (DFG)(German Research Foundation (DFG)); 'Studienstiftung des deutschen Volkes'	We thank A. Griesmaier for support at the early stage of the experiment and D. Zajec, D. Peter, H. P. Buchler and L. Santos for discussions. This work is supported by the German Research Foundation (DFG) within SFB/TRR21. H.K. acknowledges support by the 'Studienstiftung des deutschen Volkes'.	ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; COWLEY MD, 1967, J FLUID MECH, V30, P671, DOI 10.1017/S0022112067001697; Goral K, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.051601; HENSHAW DG, 1961, PHYS REV, V121, P1266, DOI 10.1103/PhysRev.121.1266; Kim DY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155301; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Koch T, 2008, NAT PHYS, V4, P218, DOI 10.1038/nphys887; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lahaye T, 2007, NATURE, V448, P672, DOI 10.1038/nature06036; LEE TD, 1957, PHYS REV, V106, P1135, DOI 10.1103/PhysRev.106.1135; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Lima ARP, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.041604; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Maier T, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.060702; Maier T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041029; Maier T, 2014, OPT LETT, V39, P3138, DOI 10.1364/OL.39.003138; Petrov DS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.155302; Ronen S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030406; Rosensweig RE, 1998, FERROHYDRODYNAMICS; Saccani S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175301; Saito H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230403; Santos L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.250403; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; Tang YJ, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.022703; Timonen JVI, 2013, SCIENCE, V341, P253, DOI 10.1126/science.1233775; Wilson RM, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.023614	30	339	341	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					194	+		10.1038/nature16485	http://dx.doi.org/10.1038/nature16485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26829224	Green Submitted			2022-12-28	WOS:000369916700033
J	Greenhalgh, T; Annandale, E; Ashcroft, R; Barlow, J; Black, N; Bleakley, A; Boaden, R; Braithwaite, J; Britten, N; Carnevale, F; Checkland, K; Cheek, J; Clark, A; Cohn, S; Coulehan, J; Crabtree, B; Cummins, S; Davidoff, F; Davies, H; Dingwall, R; Dixon-Woods, M; Elwyn, G; Engebretsen, E; Ferlie, E; Fulop, N; Gabbay, J; Gagnon, MP; Galasinski, D; Garside, R; Gilson, L; Griffiths, P; Hawe, P; Helderman, JK; Hodges, B; Hunter, D; Kearney, M; Kitzinger, C; Kitzinger, J; Kuper, A; Kushner, S; Le May, A; Legare, F; Lingard, L; Locock, L; Maben, J; Macdonald, ME; Mair, F; Mannion, R; Marshall, M; May, C; Mays, N; McKee, L; Miraldo, M; Morgan, D; Morse, J; Nettleton, S; Oliver, S; Pearce, W; Pluye, P; Pope, C; Robert, G; Roberts, C; Rodella, S; Rycroft-Malone, J; Sandelowski, M; Shekelle, P; Stevenson, F; Straus, S; Swinglehurst, D; Thorne, S; Tomson, G; Westert, G; Wilkinson, S; Williams, B; Young, T; Ziebland, S				Greenhalgh, Trisha; Annandale, Ellen; Ashcroft, Richard; Barlow, James; Black, Nick; Bleakley, Alan; Boaden, Ruth; Braithwaite, Jeffrey; Britten, Nicky; Carnevale, Franco; Checkland, Kath; Cheek, Julianne; Clark, Alex; Cohn, Simon; Coulehan, Jack; Crabtree, Benjamin; Cummins, Steven; Davidoff, Frank; Davies, Huw; Dingwall, Robert; Dixon-Woods, Mary; Elwyn, Glyn; Engebretsen, Eivind; Ferlie, Ewan; Fulop, Naomi; Gabbay, John; Gagnon, Marie-Pierre; Galasinski, Dariusz; Garside, Ruth; Gilson, Lucy; Griffiths, Peter; Hawe, Penny; Helderman, Jan-Kees; Hodges, Brian; Hunter, David; Kearney, Margaret; Kitzinger, Celia; Kitzinger, Jenny; Kuper, Ayelet; Kushner, Saville; Le May, Andree; Legare, France; Lingard, Lorelei; Locock, Louise; Maben, Jill; Macdonald, Mary Ellen; Mair, Frances; Mannion, Russell; Marshall, Martin; May, Carl; Mays, Nicholas; McKee, Lorna; Miraldo, Marissa; Morgan, David; Morse, Janice; Nettleton, Sarah; Oliver, Sandy; Pearce, Warrren; Pluye, Pierre; Pope, Catherine; Robert, Glenn; Roberts, Celia; Rodella, Stefania; Rycroft-Malone, Jo; Sandelowski, Margarete; Shekelle, Paul; Stevenson, Fiona; Straus, Sharon; Swinglehurst, Deborah; Thorne, Sally; Tomson, Goran; Westert, Gerd; Wilkinson, Sue; Williams, Brian; Young, Terry; Ziebland, Sue			An open letter to The BMJ editors on qualitative research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL SAFETY CHECKLISTS; HEALTH-CARE; STATISTICS NOTES; MORBIDITY; MORTALITY; MICHIGAN; CHILDREN		[Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Primary Care Hlth Sci, Oxford OX1 2JD, England; [Annandale, Ellen; Nettleton, Sarah] Univ York, Sociol, York YO10 5DD, N Yorkshire, England; [Ashcroft, Richard] Queen Mary Univ London, Bioeth, London, England; [Barlow, James] Univ London Imperial Coll Sci Technol & Med, Sch Business, Technol & Innovat Management Healthcare, London SW7 2AZ, England; [Black, Nick] London Sch Hyg & Trop Med, Hlth Serv Res, London, England; [Bleakley, Alan] Univ Plymouth, Med Educ, Plymouth PL4 8AA, Devon, England; [Boaden, Ruth] Manchester Business Sch, Serv Operat Management, Manchester, Lancs, England; [Braithwaite, Jeffrey] Australian Inst Hlth Innovat, Hlth Syst Res, Sydney, NSW, Australia; [Britten, Nicky] Univ Exeter, Sch Med, Appl Healthcare Res, Exeter EX4 4QJ, Devon, England; [Carnevale, Franco] McGill Univ, Ingram Sch Nursing, Montreal, PQ H3A 2T5, Canada; [Checkland, Kath] Univ Manchester, Ctr Primary Care, Hlth Policy & Primary Care, Manchester M13 9PL, Lancs, England; [Cheek, Julianne] Ostfold Univ Coll, Fac Business Languages & Social Sci, Oslo, Norway; [Clark, Alex] Univ Alberta, Fac Nursing, Edmonton, AB T6G 2M7, Canada; [Cohn, Simon] London Sch Hyg & Trop Med, Anthropol, London, England; [Coulehan, Jack] SUNY Stony Brook, Dept Preventat Med, Stony Brook, NY USA; [Crabtree, Benjamin] Rutgers State Univ, Dept Family Med & Community Hlth, Piscataway, NJ 08855 USA; [Cummins, Steven] London Sch Hyg & Trop Med, Populat Hlth, London, England; [Davidoff, Frank] Inst Healthcare Improvement, Cambridge, MA USA; [Davies, Huw] Univ St Andrews, Healthcare Policy & Management, St Andrews KY16 9AJ, Fife, Scotland; [Dingwall, Robert] Nottingham Trent Univ, Sociol, Nottingham, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Med Sociol, Leicester LE1 7RH, Leics, England; [Elwyn, Glyn] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Engebretsen, Eivind] Univ Oslo, Inst Hlth & Soc, N-0316 Oslo, Norway; [Ferlie, Ewan] Kings Coll London, Publ Serv Management, London WC2R 2LS, England; [Fulop, Naomi] UCL, Healthcare Org & Management, London WC1E 6BT, England; [Gabbay, John] Univ Southampton, Publ Hlth, Southampton SO9 5NH, Hants, England; [Gagnon, Marie-Pierre] Univ Laval, Fac Nursing, Quebec City, PQ, Canada; [Galasinski, Dariusz] Wolverhampton Univ, Discourse & Cultural Studies, Wolverhampton, England; [Garside, Ruth] Univ Exeter, Evidence Synth, Exeter EX4 4QJ, Devon, England; [Gilson, Lucy] Univ Cape Town, Hlth Policy & Syst, ZA-7700 Rondebosch, South Africa; [Griffiths, Peter] Univ Southampton, Hlth Serv Res, Southampton SO9 5NH, Hants, England; [Hawe, Penny] Univ Sydney, Publ Hlth, Sydney, NSW 2006, Australia; [Helderman, Jan-Kees] Radboud Univ Nijmegen, Publ Adm, NL-6525 ED Nijmegen, Netherlands; [Hodges, Brian] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada; [Hunter, David] Univ Durham, Ctr Publ Policy & Hlth, Durham DH1 3HP, England; [Kearney, Margaret] Univ Rochester, Rochester, NY 14627 USA; [Kitzinger, Celia] Univ York, Coma & Disorders Consciousness Res Ctr, York YO10 5DD, N Yorkshire, England; [Kitzinger, Jenny] Cardiff Univ, Coma & Disorders Consciousness Res Ctr, Cardiff CF10 3AX, S Glam, Wales; [Kuper, Ayelet] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Kushner, Saville] Univ Auckland, Publ Educ, Auckland 1, New Zealand; [Le May, Andree] Univ Southampton, Nursing, Southampton SO9 5NH, Hants, England; [Legare, France] Univ Laval, Implementat Shared Decis Making Primary Care, Quebec City, PQ G1K 7P4, Canada; [Lingard, Lorelei] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Locock, Louise] Univ Oxford, Hlth Experiences Res Grp, Appl Res, Oxford OX1 2JD, England; [Maben, Jill] Kings Coll London, Nursing, London WC2R 2LS, England; [Macdonald, Mary Ellen] McGill Univ, Fac Dent, Montreal, PQ H3A 2T5, Canada; [Mair, Frances] Univ Glasgow, Primary Care Res, Glasgow G12 8QQ, Lanark, Scotland; [Mannion, Russell] Univ Birmingham, Hlth Syst, Birmingham B15 2TT, W Midlands, England; [Marshall, Martin] UCL, Healthcare Improvement, London WC1E 6BT, England; [May, Carl] Univ Southampton, Fac Hlth Sci, Healthcare Innovat, Southampton SO9 5NH, Hants, England; [Mays, Nicholas] London Sch Hyg & Trop Med, Hlth Policy, London, England; [McKee, Lorna] Univ Aberdeen, Management, Aberdeen AB9 1FX, Scotland; [Miraldo, Marissa] Univ London Imperial Coll Sci Technol & Med, Hlth Econ, London SW7 2AZ, England; [Morgan, David] Portland State Univ, Dept Sociol, Portland, OR 97207 USA; [Morse, Janice] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA; [Oliver, Sandy] UCL Inst Educ, EPPI Ctr, London, England; [Pearce, Warrren] Univ Nottingham, Inst Sci & Soc, Nottingham NG7 2RD, England; [Pluye, Pierre] McGill Univ, Dept Family Med, Methodol Dev, Montreal, PQ H3A 2T5, Canada; [Pope, Catherine] Univ Southampton, Med Sociol, Southampton SO9 5NH, Hants, England; [Robert, Glenn] Kings Coll London, Healthcare Qual & Innovat, London WC2R 2LS, England; [Roberts, Celia] Kings Coll London, Linguist, London WC2R 2LS, England; [Rodella, Stefania] Reg Agcy Hlth & Social Care, Bologna, Italy; [Rycroft-Malone, Jo] Univ Bangor, Implementat, Bangor, Gwynedd, Wales; [Sandelowski, Margarete] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Shekelle, Paul] RAND Corp, Southern Calif Evidence Based Practice Ctr, Santa Monica, CA 90406 USA; [Stevenson, Fiona] UCL, Med Sociol, London WC1E 6BT, England; [Straus, Sharon] Univ Toronto, Div Med, Toronto, ON M5S 1A1, Canada; [Swinglehurst, Deborah] Queen Mary Univ London, Primary Healthcare, London, England; [Thorne, Sally] Univ British Columbia, Sch Nursing, Vancouver, BC V5Z 1M9, Canada; [Tomson, Goran] Karolinska Inst, Int Hlth Syst Res, Stockholm, Sweden; [Westert, Gerd] Sci Inst Qual Care, Hlth Serv Res & Qual Care, Nijmegen, Netherlands; [Wilkinson, Sue] Univ York, Dept Sociol, York YO10 5DD, N Yorkshire, England; [Williams, Brian] Univ Stirling, Reseach Enhancement, Stirling FK9 4LA, Scotland; [Young, Terry] Brunel Univ, Hlth Partnerships, Uxbridge UB8 3PH, Middx, England; [Ziebland, Sue] Univ Oxford, Hlth Experiences Res Grp, Oxford OX1 2JD, England	University of Oxford; University of York - UK; University of London; Queen Mary University London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Plymouth; University of Manchester; University of Exeter; McGill University; University of Manchester; Ostfold University College; University of Alberta; University of London; London School of Hygiene & Tropical Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; University of London; London School of Hygiene & Tropical Medicine; Institute for Healthcare Improvement; University of St Andrews; Nottingham Trent University; University of Leicester; Dartmouth College; University of Oslo; University of London; King's College London; University of London; University College London; University of Southampton; Laval University; University of Wolverhampton; University of Exeter; University of Cape Town; University of Southampton; University of Sydney; Radboud University Nijmegen; University of Toronto; Durham University; University of Rochester; University of York - UK; Cardiff University; University of Toronto; University of Auckland; University of Southampton; Laval University; Western University (University of Western Ontario); University of Oxford; University of London; King's College London; McGill University; University of Glasgow; University of Birmingham; University of London; University College London; University of Southampton; University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen; Imperial College London; Portland State University; Utah System of Higher Education; University of Utah; University of London; University College London; UCL Institute of Education; University of Nottingham; McGill University; University of Southampton; University of London; King's College London; University of London; King's College London; Bangor University; University of North Carolina; University of North Carolina Chapel Hill; RAND Corporation; University of London; University College London; University of Toronto; University of London; Queen Mary University London; University of British Columbia; Karolinska Institutet; University of York - UK; University of Stirling; Brunel University; University of Oxford	Greenhalgh, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Primary Care Hlth Sci, Oxford OX1 2JD, England.	trish.greenhalgh@phc.ox.ac.uk	Elwyn, G./L-4292-2015; Dingwall, Robert WJ/A-9348-2008; Stevenson, Fiona/AAJ-2727-2021; Griffiths, Peter/D-4016-2009; Gilson, Lucy/R-8846-2019; Gagnon, Marie-Pierre/I-3013-2019; Braithwaite, Jeffrey/AAN-1467-2020; Rather, R A/J-3509-2019; Thorne, Sally/AAF-8599-2019; Williams, Brian/G-5736-2012; Mckee, Martin/E-6673-2018; Greenhalgh, Trisha/B-1825-2015; Boaden, Ruth/L-3443-2016; Thorne, Sally E/R-3389-2016; Miraldo, Marisa/ABF-2584-2020; Williams, Brian/AAS-3714-2021; Pearce, Warren/V-3279-2019; Robert, Glenn/ABD-6477-2021; Cummins, Steven/C-1230-2009; Westert, G.P./H-8115-2014; Engebretsen, Eivind/E-6411-2018; Morgan, David L./B-3546-2008; Elwyn, Glyn/B-4798-2009; Checkland, Kath/G-8442-2014	Dingwall, Robert WJ/0000-0002-1588-3796; Stevenson, Fiona/0000-0003-2139-2309; Griffiths, Peter/0000-0003-2439-2857; Gilson, Lucy/0000-0002-2775-7703; Gagnon, Marie-Pierre/0000-0002-0782-5457; Braithwaite, Jeffrey/0000-0003-0296-4957; Thorne, Sally/0000-0002-1156-9425; Williams, Brian/0000-0003-0000-4354; Mckee, Martin/0000-0002-0121-9683; Greenhalgh, Trisha/0000-0003-2369-8088; Boaden, Ruth/0000-0003-1927-6405; Thorne, Sally E/0000-0002-1156-9425; Miraldo, Marisa/0000-0002-5772-7740; Williams, Brian/0000-0003-0000-4354; Pearce, Warren/0000-0001-6884-3854; Cummins, Steven/0000-0002-3957-4357; Westert, G.P./0000-0003-3744-8207; Engebretsen, Eivind/0000-0001-9455-110X; Ziebland, Sue/0000-0002-6496-4859; Legare, France/0000-0002-2296-6696; Garside, Ruth/0000-0003-1649-4773; Swinglehurst, Deborah/0000-0003-1261-9268; Kitzinger, Celia Clare/0000-0002-7552-7275; May, Carl/0000-0002-0451-2690; Dixon-Woods, Mary/0000-0002-5915-0041; Elwyn, Glyn/0000-0002-0917-6286; Mair, Frances/0000-0001-9780-1135; Barlow, James/0000-0003-4984-0126; Oliver, Sandy/0000-0001-9571-269X; Tomson, Goran/0000-0001-9222-3604; Maben, Jill/0000-0002-6168-0455; Fulop, Naomi/0000-0001-5306-6140; Gastaldo, Denise/0000-0003-3001-7981; Robert, Glenn/0000-0001-8781-6675; Checkland, Kath/0000-0002-9961-5317; ferlie, ewan/0000-0003-2947-5141; Davies, Huw/0000-0002-2653-3695; Mannion, Russell/0000-0002-0680-8049; Crabtree, Benjamin/0000-0003-2292-6835; Pope, Catherine/0000-0002-8935-6702; Galasinski, Dariusz/0000-0003-2247-922X	National Institute for Health Research [10/1008/07, CS-2015-15-004, DRF-2012-05-454, NF-SI-0512-10031, RP-DG-1213-10003, 14/19/19, 13/59/26, NF-SI-0512-10128] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bergs J, 2015, BMJ QUAL SAF, V24, P776, DOI 10.1136/bmjqs-2015-004021; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Dixon-Woods M, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-70; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Hodges BD, 2008, BRIT MED J, V337, pa879, DOI DOI 10.1136/BMJ.A879; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kai J, 1996, BRIT MED J, V313, P983; KEEN J, 1995, BRIT MED J, V311, P444, DOI 10.1136/bmj.311.7002.444; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kuper A, 2008, BMJ-BRIT MED J, V337, pa288, DOI DOI 10.1136/BMJ.A288; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Noyes J, 2010, J RES NURS; Payne D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3660; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Krell R, 2015, JAMA SURG, V150, P208, DOI 10.1001/jamasurg.2014.2873; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1020; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; Saunders B, 2014, QUAL RES; Saunders B, 2015, QUAL RES PSYCHOL, V12, P125, DOI 10.1080/14780887.2014.948697; Seehusen DA, 2006, BMJ-BRIT MED J, V333, P171, DOI 10.1136/bmj.38888.588519.55; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261	33	186	187	3	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2016	352								i563	10.1136/bmj.i563	http://dx.doi.org/10.1136/bmj.i563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JN	26865572	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000370383300001
J	Dhaliwal, MK				Dhaliwal, Muninder K.			My Body, Your Crime The Anatomy of a Medical Note	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dhaliwal, Muninder K.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Dhaliwal, MK (corresponding author), Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA.	mdhaliwal@ucdavis.edu							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					463	464		10.1001/jama.2015.16760	http://dx.doi.org/10.1001/jama.2015.16760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26836727				2022-12-28	WOS:000369049500013
J	Guglietta, PM; Moran, CJ; Ryan, DP; Sagar, P; Huck, AE				Guglietta, Patricia M.; Moran, Christopher J.; Ryan, Daniel P.; Sagar, Pallavi; Huck, Amelia E.			Case 3-2016: A 9-Year-Old Girl with Intermittent Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HELICOBACTER-PYLORI INFECTION; INTESTINAL MALROTATION; CHILDREN; SPLEEN; RECOMMENDATIONS; ESOPHAGITIS; GUIDELINES; NASPGHAN		[Guglietta, Patricia M.; Moran, Christopher J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Ryan, Daniel P.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Sagar, Pallavi] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Huck, Amelia E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guglietta, Patricia M.; Moran, Christopher J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Ryan, Daniel P.] Harvard Univ, Sch Med, Dept Pediat Surg, Boston, MA 02115 USA; [Sagar, Pallavi] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Huck, Amelia E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Guglietta, PM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.				Janssen Scientific; Actavis Labs	Janssen Scientific; Actavis Labs	Dr. Moran reports receiving consulting fees from Janssen Scientific and grant support through his institution from Actavis Labs. No other potential conflict of interest relevant to this article was reported.	Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Chitkara DK, 2005, AM J GASTROENTEROL, V100, P1868, DOI 10.1111/j.1572-0241.2005.41893.x; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Gerik SM, 2005, SOUTH MED J, V98, P295, DOI 10.1097/01.SMJ.0000154772.49481.53; Gupta SK, 2006, DIGEST DIS SCI, V51, P858, DOI 10.1007/s10620-006-9095-3; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Impellizzeri P, 2009, J PEDIATR SURG, V44, pE15, DOI 10.1016/j.jpedsurg.2009.06.029; Kapfer SA, 2004, J AM COLL SURGEONS, V199, P628, DOI 10.1016/j.jamcollsurg.2004.04.024; Khan S, 2008, GASTROENTEROL CLIN N, V37, P333, DOI 10.1016/j.gtc.2008.02.003; Koletzko S, 2011, J PEDIATR GASTR NUTR, V53, P230, DOI 10.1097/MPG.0b013e3182227e90; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Macarthur C, 1999, CAN J GASTROENTEROL, V13, P607, DOI 10.1155/1999/286943; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; Nehra D, 2011, SURGERY, V149, P386, DOI 10.1016/j.surg.2010.07.004; Ridd M, 2009, BRIT J GEN PRACT, V59, P268, DOI 10.3399/bjgp09X420248; Romer T, 2012, JBR-BTR, V95, P61, DOI 10.5334/jbr-btr.75; Tabbers MM, 2014, J PEDIATR GASTR NUTR, V58, P258, DOI 10.1097/MPG.0000000000000266; van Ginkel R, 2003, GASTROENTEROLOGY, V125, P357, DOI 10.1016/S0016-5085(03)00888-6; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Varga I, 2009, MED SCI MONITOR, V15, pRA269; Wacha M, 2002, Surg Endosc, V16, P1242; WOTEKI CE, 1976, AM J CLIN NUTR, V29, P19, DOI 10.1093/ajcn/29.1.19	24	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2016	374	4					373	382		10.1056/NEJMcpc1413305	http://dx.doi.org/10.1056/NEJMcpc1413305			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB8IJ	26816015				2022-12-28	WOS:000368760100013
J	Heikenfeld, J				Heikenfeld, Jason			Technological leap for sweat sensing	NATURE			English	Editorial Material							SENSORS		[Heikenfeld, Jason] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Heikenfeld, J (corresponding author), Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH 45221 USA.	heikenjc@ucmail.uc.edu						Bandodkar AJ, 2014, TRENDS BIOTECHNOL, V32, P363, DOI 10.1016/j.tibtech.2014.04.005; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; Huang X, 2014, SMALL, V10, P3083, DOI 10.1002/smll.201400483; Matzeu G, 2016, ANAL METHODS-UK, V8, P64, DOI 10.1039/c5ay02254a; Rose DP, 2015, IEEE T BIO-MED ENG, V62, P1457, DOI 10.1109/TBME.2014.2369991; Sonner Z, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4921039	6	62	65	6	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					475	476		10.1038/529475a	http://dx.doi.org/10.1038/529475a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819041				2022-12-28	WOS:000368673800026
J	Siu, AL; Bibbins-Domingo, K; Grossman, DC; Baumann, LC; Davidson, KW; Ebell, M; Garcia, FAR; Gillman, M; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Owens, DK; Phillips, WR; Phipps, MG; Pignone, MP				Siu, Albert L.; Bibbins-Domingo, Kirsten; Grossman, David C.; Baumann, Linda Ciofu; Davidson, Karina W.; Ebell, Mark; Garcia, Francisco A. R.; Gillman, Matthew; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Owens, Douglas K.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.		USPSTF	Screening for Depression in Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIORAL THERAPY; POSTPARTUM DEPRESSION; PRIMARY-CARE; PERINATAL DEPRESSION; QUALITY IMPROVEMENT; RANDOMIZED-TRIAL; WOMEN; PHARMACOTHERAPY; OUTCOMES; IMPACT	DESCRIPTION Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depression in adults. METHODS The USPSTF reviewed the evidence on the benefits and harms of screening for depression in adult populations, including older adults and pregnant and postpartum women; the accuracy of depression screening instruments; and the benefits and harms of depression treatment in these populations. POPULATION This recommendation applies to adults 18 years and older. RECOMMENDATION The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation)	[Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI 53706 USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] NYU, New York, NY USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Duke University; Virginia Commonwealth University; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill	Siu, AL (corresponding author), Mt Sinai Sch Med, New York, NY USA.; Siu, AL (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY USA.	albert.siu@mssm.edu	Phillips, William R./V-1065-2017; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Phillips, William R./0000-0003-2802-4349; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, CLIN PREV SERV REC D; [Anonymous], 2015, Obstet Gynecol, V125, P1268, DOI 10.1097/01.AOG.0000465192.34779.dc; [Anonymous], IMPR MENT HLTH ADDR; [Anonymous], 2009, AHRQ PUBLICATION; Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Dalton SO, 2006, CNS DRUGS, V20, P143, DOI 10.2165/00023210-200620020-00005; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; Glavin K, 2010, J CLIN NURS, V19, P3051, DOI 10.1111/j.1365-2702.2010.03332.x; Jarjoura D, 2004, J GEN INTERN MED, V19, P78, DOI 10.1111/j.1525-1497.2004.21249.x; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Kozinszky Z, 2012, PSYCHOTHER PSYCHOSOM, V81, P98, DOI 10.1159/000330035; Leung SSL, 2011, J PUBLIC HEALTH-UK, V33, P292, DOI 10.1093/pubmed/fdq075; McDonagh MS, 2014, OBSTET GYNECOL, V124, P526, DOI 10.1097/AOG.0000000000000410; McGregor M, 2014, EARLY INTERV PSYCHIA, V8, P348, DOI 10.1111/eip.12074; Mitchell J., 2013, ADULT DEPRESSION PRI; Morrell CJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3045; Nimalasuriya K, 2009, J FAM PRACTICE, V58, P535; O'Connor E, 2016, AHRQ PUBLICATION; O'Mahen H, 2013, DEPRESS ANXIETY, V30, P679, DOI 10.1002/da.22050; Pinquart M., 2001, J MENTAL HLTH AGING, V7, P207; Pinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Stone M, MEMORANDUM; Tandon SD, 2012, J AFFECT DISORDERS, V136, P155, DOI 10.1016/j.jad.2011.07.014; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wickberg B, 2005, J REPROD INFANT PSYC, V23, P33, DOI 10.1080/02646830512331330956; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Wilson K., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000561, 10.1002/14651858.CD000561]; Witters D, DEPRESSION COSTS US; Yawn BP, 2012, ANN FAM MED, V10, P320, DOI 10.1370/afm.1418	34	827	839	8	94	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					380	387		10.1001/jama.2015.18392	http://dx.doi.org/10.1001/jama.2015.18392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB5YI	26813211	Bronze			2022-12-28	WOS:000368589500016
J	Snyder, A				Snyder, Alison			Henry Krum Obituary	LANCET			English	Biographical-Item																		KRUM H, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2016	387	10014					120	120		10.1016/S0140-6736(15)01362-8	http://dx.doi.org/10.1016/S0140-6736(15)01362-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LF	26841990	Bronze			2022-12-28	WOS:000368055500018
J	Matono, T; Kato, Y; Yotsu, R; Ohmagari, N				Matono, Takashi; Kato, Yasuyuki; Yotsu, Rie; Ohmagari, Norio			Tungiasis: diagnosis at a glance	LANCET			English	Editorial Material									[Matono, Takashi; Kato, Yasuyuki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Yotsu, Rie] Natl Ctr Global Hlth & Med, Dept Dermatol, Shinjuku Ku, Tokyo 1628655, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Kato, Y (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo 1628655, Japan.	ykato@hosp.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Matono, Takashi/0000-0001-9957-0510					0	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					275	275		10.1016/S0140-6736(15)01239-8	http://dx.doi.org/10.1016/S0140-6736(15)01239-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	26880125				2022-12-28	WOS:000379736100031
J	ten Eikelder, MLG; Rengerink, KO; Jozwiak, M; de Leeuw, JW; de Graaf, IM; van Pampus, MG; Holswilder, M; Oudijk, MA; van Baaren, GJ; Pernet, PJM; Bax, C; van Unnik, GA; Martens, G; Porath, M; van Vliet, H; Rijnders, RJP; Feitsma, AH; Roumen, FJME; van Loon, AJ; Versendaal, H; Weinans, MJN; Woiski, M; van Beek, E; Hermsen, B; Mol, B; Bloemenkamp, KWM				ten Eikelder, Mieke L. G.; Rengerink, Katrien Oude; Jozwiak, Marta; de Leeuw, Jan W.; de Graaf, Irene M.; van Pampus, Marille G.; Holswilder, Marloes; Oudijk, Martijn A.; van Baaren, Gert-Jan; Pernet, Paula J. M.; Bax, Caroline; van Unnik, Gijs A.; Martens, Gratia; Porath, Martina; van Vliet, Huib; Rijnders, Robbert J. P.; Feitsma, A. Hanneke; Roumen, Frans J. M. E.; van Loon, Aren J.; Versendaal, Hans; Weinans, Martin J. N.; Woiski, Mallory; van Beek, Erik; Hermsen, Brenda; Mol, Ben Willem; Bloemenkamp, Kitty W. M.			Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial	LANCET			English	Article								Background Labour is induced in 20-30% of all pregnancies. In women with an unfavourable cervix, both oral misoprostol and Foley catheter are equally effective compared with dinoprostone in establishing vaginal birth, but each has a better safety profile. We did a trial to directly compare oral misoprostol with Foley catheter alone. Methods We did an open-label randomised non-inferiority trial in 29 hospitals in the Netherlands. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section who were scheduled for induction of labour were randomly allocated to cervical ripening with 50 mu g oral misoprostol once every 4 h or to a 30 mL transcervical Foley catheter. The primary outcome was a composite of asphyxia (pH <= 7.05 or 5-min Apgar score <7) or post-partum haemorrhage (>= 1000 mL). The non-inferiority margin was 5%. The trial is registered with the Netherlands Trial Register, NTR3466. Findings Between July, 2012, and October, 2013, we randomly assigned 932 women to oral misoprostol and 927 women to Foley catheter. The composite primary outcome occurred in 113 (12.2%) of 924 participants in the misoprostol group versus 106 (11.5%) of 921 in the Foley catheter group (adjusted relative risk 1.06, 90% CI 0.86-1.31). Caesarean section occurred in 155 (16.8%) women versus 185 (20.1%; relative risk 0.84, 95% CI 0.69-1.02, p=0.067). 27 adverse events were reported in the misoprostol group versus 25 in the Foley catheter group. None were directly related to the study procedure. Interpretation In women with an unfavourable cervix at term, induction of labour with oral misoprostol and Foley catheter has similar safety and effectiveness.	[ten Eikelder, Mieke L. G.; Jozwiak, Marta; Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, Dept Obstet, POB 9600, NL-2300 RC Leiden, Netherlands; [Rengerink, Katrien Oude; de Graaf, Irene M.; Oudijk, Martijn A.; van Baaren, Gert-Jan] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [de Leeuw, Jan W.] Ikazia Hosp, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [van Pampus, Marille G.] Onze Lieve Vrouwen Gasthuis, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Holswilder, Marloes] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9713 AV Groningen, Netherlands; [Pernet, Paula J. M.] Kennemer Gasthuis, Dept Obstet & Gynaecol, Haarlem, Netherlands; [Bax, Caroline] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [van Unnik, Gijs A.] Diaconessenhuis, Dept Obstet & Gynaecol, Leiden, Netherlands; [Martens, Gratia] Zuwe Hofpoort, Dept Obstet & Gynaecol, Woerden, Netherlands; [Porath, Martina] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [van Vliet, Huib] Catharina Hosp, Dept Obstet & Gynaecol, Eindhoven, Netherlands; [Rijnders, Robbert J. P.] Jeroen Bosch Hosp, Dept Obstet & Gynaecol, Shertogenbosch, Netherlands; [Feitsma, A. Hanneke] HAGA Hosp, Dept Obstet & Gynaecol, The Hague, Netherlands; [Roumen, Frans J. M. E.] Atrium Med Ctr, Dept Obstet & Gynaecol, Heerlen, Netherlands; [van Loon, Aren J.] Martini Hosp, Dept Obstet & Gynaecol, Groningen, Netherlands; [Versendaal, Hans] Maasstad Hosp, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Weinans, Martin J. N.] Gelderse Vallei Hosp, Dept Obstet & Gynaecol, Ede, Netherlands; [Woiski, Mallory] Univ Med Ctr Nijmegen, Dept Obstet & Gynaecol, Nijmegen, Netherlands; [van Beek, Erik] St Antonius Hosp, Dept Obstet & Gynaecol, Nieuwegein, Netherlands; [Hermsen, Brenda] St Lucas Andreas Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Mol, Ben Willem] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Mol, Ben Willem] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Bloemenkamp, Kitty W. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp Birth Ctr, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Ikazia Hospital; University of Groningen; Spaarne Hospital; Vrije Universiteit Amsterdam; Maxima Medical Center; Catharina Hospital; Jeroen Bosch Ziekenhuis; Haga Hospital; Atrium Medical Center; Martini Hospital; Maasstad Hospital; Gelderse Vallei Hospital; Radboud University Nijmegen; St. Antonius Hospital Utrecht; Sint Lucas Andreas Hospital; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Utrecht University; Utrecht University Medical Center	ten Eikelder, MLG (corresponding author), Leiden Univ, Med Ctr, Dept Obstet, POB 9600, NL-2300 RC Leiden, Netherlands.	m.teneikelder@gmail.com	Oudijk, Martijn A/C-1520-2019; Woiski, Mallory D/AAN-6632-2021; Woiski, Mallory D/L-4763-2015; Eikelder, Mieke ten/ABE-6061-2020	Oudijk, Martijn A/0000-0001-8672-4365; Woiski, Mallory D/0000-0002-7553-5929; Woiski, Mallory D/0000-0002-7553-5929; van Pampus, Maria/0000-0002-3020-8908	FondsNutsOhra	FondsNutsOhra	FondsNutsOhra.	Alfirevic Z, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD001338.PUB3; Alfirevic Z, 2006, COCHRANE DB SYST REV, V2; Alfirevic Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h217; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X; Gibson KS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.028; HOFMEYR GJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000941; Howard K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-330; Huisman CMA, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/745159; Hussain AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S5; Irion O., 2001, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001997, 10.1002/14651858.CD001997]; Jozwiak M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001233.pub2; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Kelly AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007372.pub3; KJOS SL, 1993, AM J OBSTET GYNECOL, V169, P611, DOI 10.1016/0002-9378(93)90631-R; National Institute for Health and Care Excellence, 2008, IND OF LAB; Perinataal register Nederland, 2015, PER ZORG NED 2013; Rouse DJ, 2013, OBSTET GYNECOL, V122, P193, DOI 10.1097/AOG.0b013e31829c5abd; Sanchez-Ramos L, 2002, OBSTET GYNECOL, V100, P997, DOI 10.1016/S0029-7844(02)02321-9; ten Eikelder MLG, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-67; WHO, 2011, WHO REC IND LAB	22	75	76	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1619	1628		10.1016/S0140-6736(16)00084-2	http://dx.doi.org/10.1016/S0140-6736(16)00084-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	26850983				2022-12-28	WOS:000374145100029
J	Bellinger, DC				Bellinger, David C.			Lead Contamination in Flint - An Abject Failure to Protect Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bellinger, David C.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Bellinger, David C.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA; [Bellinger, David C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bellinger, David C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bellinger, DC (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA USA.; Bellinger, DC (corresponding author), Boston Childrens Hosp, Dept Psychiat, Boston, MA USA.; Bellinger, DC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Bellinger, DC (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.				NICHD NIH HHS [U54 HD090255] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2007, FED REG         1010; European Food Safety Authority, 2010, SCI OP LEAD FOOD, V8, P1570; Hanna-Attisha M, 2016, AM J PUBLIC HEALTH, V106, P283, DOI 10.2105/AJPH.2015.303003; OBERLE MW, 1969, SCIENCE, V165, P991, DOI 10.1126/science.165.3897.991; 2016, ECONOMIST, V418, P23	5	105	106	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1101	1103		10.1056/NEJMp1601013	http://dx.doi.org/10.1056/NEJMp1601013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	26863114	Bronze			2022-12-28	WOS:000372585100001
J	Hou, LP; Heilbronner, U; Degenhardt, F; Adli, M; Akiyama, K; Akula, N; Ardau, R; Arias, B; Backlund, L; Banzato, CEM; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Brichant-Petitjean, C; Bui, ET; Cervantes, P; Chen, GB; Chen, HC; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cousins, DA; Cruceanu, C; Czerski, PM; Dantas, CR; Dayer, A; Etain, B; Falkai, P; Forstner, AJ; Frisen, L; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grof, P; Gruber, O; Hashimoto, R; Hauser, J; Herms, S; Hoffmann, P; Hofmann, A; Jamain, S; Jimenez, E; Kahn, JP; Kassem, L; Kittel-Schneider, S; Kliwicki, S; Konig, B; Kusumi, I; Lackner, N; Laje, G; Landen, M; Lavebratt, C; Leboyer, M; Leckband, SG; Jaramillo, CAL; MacQueen, G; Manchia, M; Martinsson, L; Mattheisen, M; McCarthy, MJ; McElroy, SL; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nothen, MM; Osby, U; Ozaki, N; Perlis, RH; Pfennig, A; Reich-Erkelenz, D; Rouleau, GA; Schofield, PR; Schubert, KO; Schweizer, BW; Seemuller, F; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Smoller, JW; Squassina, A; Stamm, T; Stopkova, P; Tighe, SK; Tortorella, A; Turecki, G; Volkert, J; Witt, S; Wright, A; Young, LT; Zandi, PP; Potash, JB; DePaulo, JR; Bauer, M; Reininghaus, EZ; Novak, T; Aubry, JM; Maj, M; Baune, BT; Mitchell, PB; Vieta, E; Frye, MA; Rybakowski, JK; Kuo, PH; Kato, T; Grigoroiu-Serbanescu, M; Reif, A; Del Zompo, M; Bellivier, F; Schalling, M; Wray, NR; Kelsoe, JR; Alda, M; Rietschel, M; McMahon, FJ; Schulze, TG				Hou, Liping; Heilbronner, Urs; Degenhardt, Franziska; Adli, Mazda; Akiyama, Kazufumi; Akula, Nirmala; Ardau, Raffaella; Arias, Barbara; Backlund, Lena; Banzato, Claudio E. M.; Benabarre, Antoni; Bengesser, Susanne; Bhattacharjee, Abesh Kumar; Biernacka, Joanna M.; Birner, Armin; Brichant-Petitjean, Clara; Bui, Elise T.; Cervantes, Pablo; Chen, Guo-Bo; Chen, Hsi-Chung; Chillotti, Caterina; Cichon, Sven; Clark, Scott R.; Colom, Francesc; Cousins, David A.; Cruceanu, Cristiana; Czerski, Piotr M.; Dantas, Clarissa R.; Dayer, Alexandre; Etain, Bruno; Falkai, Peter; Forstner, Andreas J.; Frisen, Louise; Fullerton, Janice M.; Gard, Sebastien; Garnham, Julie S.; Goes, Fernando S.; Grof, Paul; Gruber, Oliver; Hashimoto, Ryota; Hauser, Joanna; Herms, Stefan; Hoffmann, Per; Hofmann, Andrea; Jamain, Stephane; Jimenez, Esther; Kahn, Jean-Pierre; Kassem, Layla; Kittel-Schneider, Sarah; Kliwicki, Sebastian; Koenig, Barbara; Kusumi, Ichiro; Lackner, Nina; Laje, Gonzalo; Landen, Mikael; Lavebratt, Catharina; Leboyer, Marion; Leckband, Susan G.; Lopez Jaramillo, Carlos A.; MacQueen, Glenda; Manchia, Mirko; Martinsson, Lina; Mattheisen, Manuel; McCarthy, Michael J.; McElroy, Susan L.; Mitjans, Marina; Mondimore, Francis M.; Monteleone, Palmiero; Nievergelt, Caroline M.; Noethen, Markus M.; Oesby, Urban; Ozaki, Norio; Perlis, Roy H.; Pfennig, Andrea; Reich-Erkelenz, Daniela; Rouleau, Guy A.; Schofield, Peter R.; Schubert, K. Oliver; Schweizer, Barbara W.; Seemueller, Florian; Severino, Giovanni; Shekhtman, Tatyana; Shilling, Paul D.; Shimoda, Kazutaka; Simhandl, Christian; Slaney, Claire M.; Smoller, Jordan W.; Squassina, Alessio; Stamm, Thomas; Stopkova, Pavla; Tighe, Sarah K.; Tortorella, Alfonso; Turecki, Gustavo; Volkert, Julia; Witt, Stephanie; Wright, Adam; Young, L. Trevor; Zandi, Peter P.; Potash, James B.; DePaulo, J. Raymond; Bauer, Michael; Reininghaus, Eva Z.; Novak, Tomas; Aubry, Jean-Michel; Maj, Mario; Baune, Bernhard T.; Mitchell, Philip B.; Vieta, Eduard; Frye, Mark A.; Rybakowski, Janusz K.; Kuo, Po-Hsiu; Kato, Tadafumi; Grigoroiu-Serbanescu, Maria; Reif, Andreas; Del Zompo, Maria; Bellivier, Frank; Schalling, Martin; Wray, Naomi R.; Kelsoe, John R.; Alda, Martin; Rietschel, Marcella; McMahon, Francis J.; Schulze, Thomas G.			Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study	LANCET			English	Article							GENOTYPE IMPUTATION; I DISORDER; THERAPY; PHARMACOGENETICS; GADL1	Background Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified. Methods Here, we report the results of a genome-wide association study of lithium response in 2563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen). Data from common single nucleotide polymorphisms (SNPs) were tested for association with categorical and continuous ratings of lithium response. Lithium response was measured using a well established scale (Alda scale). Genotyped SNPs were used to generate data at more than 6 million sites, using standard genomic imputation methods. Traits were regressed against genotype dosage. Results were combined across two batches by meta-analysis. Findings A single locus of four linked SNPs on chromosome 21 met genome-wide significance criteria for association with lithium response (rs79663003, p= 1.37 x 10(-8); rs78015114, p= 1.31 x 10(-8); rs74795342, p= 3.31 x 10(-9); and rs75222709, p= 3.50 x 10(-9)). In an independent, prospective study of 73 patients treated with lithium monotherapy for a period of up to 2 years, carriers of the response-associated alleles had a significantly lower rate of relapse than carriers of the alternate alleles (p= 0.03268, hazard ratio 3.8, 95% CI 1.1-13.0). Interpretation The response-associated region contains two genes for long, non-coding RNAs (lncRNAs), AL157359.3 and AL157359.4. LncRNAs are increasingly appreciated as important regulators of gene expression, particularly in the CNS. Confirmed biomarkers of lithium response would constitute an important step forward in the clinical management of bipolar disorder. Further studies are needed to establish the biological context and potential clinical utility of these findings.	[Hou, Liping; Akula, Nirmala; Bui, Elise T.; Kassem, Layla; Laje, Gonzalo; McMahon, Francis J.; Schulze, Thomas G.] NIMH, Intramural Res Program, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Heilbronner, Urs; Reich-Erkelenz, Daniela; Schulze, Thomas G.] Univ Munich, Inst Psychiat Phen & Genom, Munich, Germany; [Falkai, Peter; Seemueller, Florian] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Heilbronner, Urs; Gruber, Oliver; Schulze, Thomas G.] Univ Gottingen, Univ Med Ctr UMG, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Degenhardt, Franziska; Cichon, Sven; Forstner, Andreas J.; Herms, Stefan; Hoffmann, Per; Hofmann, Andrea; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Degenhardt, Franziska; Cichon, Sven; Forstner, Andreas J.; Herms, Stefan; Hoffmann, Per; Hofmann, Andrea; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, Bonn, Germany; [Adli, Mazda; Stamm, Thomas] Charite, Dept Psychiat & Psychotherapy, Campus Charite Mitte, D-13353 Berlin, Germany; [Adli, Mazda] Fliedner Klin Berlin, Ctr Psychiat Psychotherapy & Psychosomat Med, Berlin, Germany; [Akiyama, Kazufumi] Dokkyo Med Univ, Dept Biol Psychiat & Neurosci, Sch Med, Mibu, Tochigi, Japan; [Ardau, Raffaella; Chillotti, Caterina; Del Zompo, Maria] Hosp Univ Agcy Cagliari, Clin Pharmacol Unit, Cagliari, Italy; [Arias, Barbara; Mitjans, Marina] Univ Barcelona, CIBERSAM, Fac Biol, Dept Biol Anim,Unitat Antropol Dp Biol Anim, Barcelona, Catalonia, Spain; [Arias, Barbara; Mitjans, Marina] Univ Barcelona, CIBERSAM, Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Backlund, Lena; Frisen, Louise; Lavebratt, Catharina; Leckband, Susan G.; Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Frisen, Louise] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Oesby, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Frisen, Louise] Child & Adolescent Psychiat Res Ctr, Stockholm, Sweden; [Banzato, Claudio E. M.; Dantas, Clarissa R.] Univ Campinas Unicamp, Dept Psychiat, Campinas, SP, Brazil; [Benabarre, Antoni; Colom, Francesc; Jimenez, Esther; Vieta, Eduard] Univ Barcelona, IDIBAPS, CIBERSAM, Bipolar Disorder Program,Inst Neurosci,Hosp Clin, Barcelona, Catalonia, Spain; [Bengesser, Susanne; Birner, Armin; Lackner, Nina; Reininghaus, Eva Z.] Med Univ Graz, Dept Psychiat, Neurobiol Background & Anthropometr Bipolar Affec, Graz, Austria; [Shekhtman, Tatyana; Kelsoe, John R.] San Diego Healthcare Syst, Vet Adm, San Diego, CA USA; [Bhattacharjee, Abesh Kumar; Nievergelt, Caroline M.; Shekhtman, Tatyana; Shilling, Paul D.; Kelsoe, John R.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Biernacka, Joanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Biernacka, Joanna M.; Frye, Mark A.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Brichant-Petitjean, Clara; Bellivier, Frank] Univ Paris Diderot Pole Psychiat, INSERM, UMR S 1144, Grp Hosp Lariboisiere F Widal,AP HP, Paris, France; [Cervantes, Pablo] McGill Univ, Ctr Hlth, Neuromodulat Unit, Montreal, PQ, Canada; [Chen, Guo-Bo; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Cichon, Sven; Herms, Stefan; Hoffmann, Per] Univ Basel Hosp, Human Genom Res Grp, Dept Biomed, CH-4031 Basel, Switzerland; [Clark, Scott R.; Schubert, K. Oliver; Baune, Bernhard T.] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia; [Cousins, David A.] Newcastle Univ, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cruceanu, Cristiana; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Psychiat Genet Unit, Poznan, Poland; [Dayer, Alexandre; Aubry, Jean-Michel] Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Mood Disorders Unit, Geneva, Switzerland; [Etain, Bruno; Jamain, Stephane] Hop Henri Mondor, INSERM, U955, Psychiat Translat, F-94010 Creteil, France; [Fullerton, Janice M.; Schofield, Peter R.] Neurosci Res Australia, Mental Illness Res Theme, Sydney, NSW, Australia; [Fullerton, Janice M.; Schofield, Peter R.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Gard, Sebastien] Ctr Hosp Charles Perrens, Pole Psychiat Gen Univ, Bordeaux, France; [Garnham, Julie S.; Slaney, Claire M.; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Goes, Fernando S.; Mondimore, Francis M.; Schweizer, Barbara W.; DePaulo, J. Raymond; Schulze, Thomas G.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Grof, Paul] Mood Disorders Ctr Ottawa, Ottawa, ON, Canada; [Hashimoto, Ryota] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka, Japan; [Kahn, Jean-Pierre] Univ Lorraine, Ctr Psychotherap Nancy Laxou, Serv Psychiat & Psychol Clin, Nancy, France; [Kittel-Schneider, Sarah; Volkert, Julia; Reif, Andreas] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Kliwicki, Sebastian; Rybakowski, Janusz K.] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland; [Koenig, Barbara] Landesklinikum Neunkirchen, Dept Psychiat & Psychotherapeut Med, Neunkirchen, Austria; [Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Landen, Mikael] Gothenburg Univ, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Martinsson, Lina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Leboyer, Marion] Hop Albert Chenevier Henri Mondor, Assistance Publ Hop Paris, Pole Psychiat, Creteil, France; [Leckband, Susan G.] San Diego Healthcare Syst, Dept Pharm, San Diego, CA USA; [McCarthy, Michael J.] San Diego Healthcare Syst, Dept Psychiat, San Diego, CA USA; [Lopez Jaramillo, Carlos A.] Univ Antioquia, Dept Psychiat, Medellin, Colombia; [MacQueen, Glenda] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Manchia, Mirko; Severino, Giovanni; Squassina, Alessio; Del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Manchia, Mirko] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, iPSYCH, Aarhus, Denmark; [McElroy, Susan L.] Univ Cincinnati, Lindner Ctr Hope, Dept Psychiat, Mason, OH USA; [Monteleone, Palmiero] Univ Salerno, Dept Med & Surg, Neurosci Sect, I-84100 Salerno, Italy; [Monteleone, Palmiero; Tortorella, Alfonso; Maj, Mario] Univ Naples SUN, Dept Psychiat, Naples, Italy; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Perlis, Roy H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Perlis, Roy H.; Smoller, Jordan W.] Harvard Univ, Sch Med, Boston, MA USA; [Pfennig, Andrea; Bauer, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, Fac Med, D-01062 Dresden, Germany; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Simhandl, Christian] Bipolar Ctr Wiener Neustadt, Wiener Neustadt, Austria; [Stopkova, Pavla; Novak, Tomas; Alda, Martin] Natl Inst Mental Hlth, Klecany, Czech Republic; [Tighe, Sarah K.; Potash, James B.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Tighe, Sarah K.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Tighe, Sarah K.] Univ Iowa, Coll Publ Hlth, VA Qual Scholars Program, Iowa City VA Hosp, Iowa City, IA USA; [Witt, Stephanie; Rietschel, Marcella; Schulze, Thomas G.] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Wright, Adam; Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Wright, Adam; Mitchell, Philip B.] Black Dog Inst, Sydney, NSW, Australia; [Young, L. Trevor] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Zandi, Peter P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Munich; University of Munich; University of Gottingen; University of Bonn; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dokkyo Medical University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universidade Estadual de Campinas; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Medical University of Graz; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; University of Queensland; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University of Basel; University of Adelaide; Newcastle University - UK; McGill University; Poznan University of Medical Sciences; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Neuroscience Research Australia; University of New South Wales Sydney; Dalhousie University; Johns Hopkins University; University of Ottawa; Osaka University; Universite de Lorraine; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Poznan University of Medical Sciences; Hokkaido University; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Universidad de Antioquia; University of Calgary; University of Cagliari; Dalhousie University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University System of Ohio; University of Cincinnati; University of Salerno; Universita della Campania Vanvitelli; Nagoya University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital; McGill University; Dokkyo Medical University; National Institute of Mental Health - Czech Republic; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of New South Wales Sydney; Black Dog Institute; University of Toronto; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; RIKEN	Schulze, TG (corresponding author), Univ Munich, Med Ctr, IPPG, Munich, Germany.; McMahon, FJ (corresponding author), NIMH, Human Genet Branch, Intramural Res Program, Bethesda, MD 20892 USA.; McMahon, FJ (corresponding author), NIMH, Genet Basis Mood & Anxiety Disorders Sect, Intramural Res Program, Bethesda, MD 20892 USA.	mcmahonf@mail.nih.gov; thomas.schulze@med.uni-muenchen.de	Alda, Martin/F-5812-2010; Landen, Mikael/AAD-7917-2020; Arias, Barbara/U-7560-2017; Vieta, Eduard/I-6330-2013; JIMÉNEZ, ESTHER/D-8037-2018; Herms, Stefan/J-1949-2014; McCarthy, Michael/K-9302-2017; Hou, Liping/G-1648-2011; Mattheisen, Manuel/B-4949-2012; Manchia, Mirko/A-2907-2010; Cousins, David/AAR-3001-2021; Fullerton, Janice/F-8485-2013; Wray, Naomi/C-8639-2015; Jamain, Stéphane/L-1822-2019; Kato, Tadafumi/J-3583-2014; Banzato, Claudio/B-2517-2008; McMahon, Francis J/A-7290-2009; Chen, Hsi-Chung/E-9949-2017; Mitjans, Marina/C-4758-2018; Tortorella, Alfonso Antonio Vincenzo/AAC-4694-2022; Stopkova, Pavla/C-6000-2019; Jaramillo, Carlos López/X-5806-2019; Hashimoto, Ryota/AAE-3200-2019; BELLIVIER, FRANK/H-5197-2012; Schubert, Oliver/AGX-9412-2022; Serbanescu, Maria/D-4306-2011; Novak, Tomas/B-8008-2017; Leboyer, Marion/AAW-3648-2021; Cruceanu, Cristiana/AAK-2885-2021; Falkai, Peter/E-3273-2017; Adli, Mazda/GYV-2083-2022; Hoffmann, Per/A-5149-2010; Hashimoto, Ryota/P-8572-2014; Mattheisen, Manuel/S-3725-2019; Ozaki, Norio/M-8908-2014; Reich-Erkelenz, Daniela/D-9736-2018; Gruber, Oliver/AAY-5563-2020; Grigoroiu-Serbanescu, Maria/R-3689-2019; Heilbronner, Urs/GXF-9880-2022; Etain, Bruno/L-6647-2017; Vieta, Eduard/Y-2919-2019; Jamain, Stéphane/P-3710-2017; Schofield, Peter/C-9669-2011; Chen, Guo-Bo/C-2435-2009	Alda, Martin/0000-0001-9544-3944; Arias, Barbara/0000-0001-9181-2132; Vieta, Eduard/0000-0002-0548-0053; JIMÉNEZ, ESTHER/0000-0001-6929-6207; Herms, Stefan/0000-0002-2786-8200; McCarthy, Michael/0000-0001-6219-4945; Hou, Liping/0000-0003-3972-245X; Mattheisen, Manuel/0000-0002-8442-493X; Manchia, Mirko/0000-0003-4175-6413; Fullerton, Janice/0000-0003-4014-4490; Wray, Naomi/0000-0001-7421-3357; Kato, Tadafumi/0000-0001-7856-3952; McMahon, Francis J/0000-0002-9469-305X; Chen, Hsi-Chung/0000-0003-3191-0093; Mitjans, Marina/0000-0001-5543-7320; Stopkova, Pavla/0000-0003-2712-3652; Hashimoto, Ryota/0000-0002-5941-4238; Serbanescu, Maria/0000-0002-1304-6687; Novak, Tomas/0000-0001-9156-9654; Leboyer, Marion/0000-0001-5473-3697; Cruceanu, Cristiana/0000-0002-7799-5531; Falkai, Peter/0000-0003-2873-8667; Hoffmann, Per/0000-0002-6573-983X; Hashimoto, Ryota/0000-0002-5941-4238; Mattheisen, Manuel/0000-0002-8442-493X; Ozaki, Norio/0000-0002-7360-4898; Reich-Erkelenz, Daniela/0000-0001-7818-539X; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Etain, Bruno/0000-0002-5377-1488; Vieta, Eduard/0000-0002-0548-0053; Jamain, Stéphane/0000-0002-4321-4100; Kuo, Po-Hsiu/0000-0003-0365-3587; Czerski, Piotr M./0000-0003-0745-5916; BELLIVIER, FRANK/0000-0002-3660-6640; Squassina, Alessio/0000-0001-7415-7607; Adli, Mazda/0000-0002-0993-5617; Mitchell, Philip/0000-0002-7954-5235; Turecki, Gustavo/0000-0003-4075-2736; Nothen, Markus/0000-0002-8770-2464; Martinsson, Lina/0000-0002-2938-2773; Colom, Francesc/0000-0002-9516-9030; Seemuller, Florian/0000-0002-3557-1343; Dayer, Alexandre/0000-0002-4490-9780; Reininghaus, Eva/0000-0001-5964-4087; Schofield, Peter/0000-0003-2967-9662; Garnham, Julie/0000-0002-7987-4995; DePaulo, J Raymond/0000-0001-9221-9226; Nievergelt, Caroline/0000-0001-5766-8923; Chen, Guo-Bo/0000-0001-5475-8237; Kittel-Schneider, Sarah/0000-0003-3057-6150; TORTORELLA, Alfonso Antonio Vincenzo/0000-0002-8095-2305; Lopez-Jaramillo, Carlos/0000-0002-1875-1369; Cousins, David/0000-0001-5682-7507; Heilbronner, Urs/0000-0001-7135-762X; Banzato, Claudio/0000-0002-8556-3982	Deutsche Forschungsgemeinschaft; National Institute of Mental Health Intramural Research Program; Deutsche Forschungsgemeinschaft (DFG) [RI 908/7-1, FOR2107, RI 908/11-1, NO 246/10-1]; National Institute of Mental Health [ZIA-MH00284311, NCT00001174]; German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme; German Federal Ministry of Education and Research (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung; BONFOR Programme of the University of Bonn, Germany; Land Steiermark; Swedish Research Council; Swedish Brain Foundation; Karolinska Institutet; Karolinska University Hospital; NIH from National Cancer Institute [P50CA89392]; NIH from National Institute of Drug Abuse [5K02DA021237]; Canadian Institutes of Health Research [64410]; Australian NHMRC Program Grant [1037196]; Centro de Investigacion en Red de Salud Mental (CIBERSAM) IDIBAPS [PI080247, PI1200906, PI12/00018]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement [2014SGR1636, 2014SGR398]; Swiss National Science Foundation [32003B_125469]; Swiss National Science Foundation (NCCR Synapsy); Medical Research Council Clinician Scientist Fellowship Award [MR/L006642/1]; Swedish Research Council [523-2011-3807]; UEFISCDI, Romania [89/2012]; Taiwan Ministry of Science and Technology [MST 99-2314-B-002-140-MY3, 102-2314-B-002-117-MY3]; University of Antioquia; Ministry of Health of the Czech Republic [IGA NT13891]; Reuben Stoltzfus Bipolar Research Fund; James Wah Fund; Project MATCH; Dr-Lisa-Oehler-Foundation (Kassel, Germany); Sardinia Regional Government POR Sardegna FSE Operational Program of the Autonomous Region of Sardinia, European Social Fund; Australian NHMRC Fellowships [613602, 1078901]; Stanley Center for Psychiatric Research at the Broad Institute; Deutsche Forschungsgemeinschaft; National Institute of Mental Health Intramural Research Program; Deutsche Forschungsgemeinschaft (DFG) [RI 908/7-1, FOR2107, RI 908/11-1, NO 246/10-1]; National Institute of Mental Health [ZIA-MH00284311, NCT00001174]; German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme; German Federal Ministry of Education and Research (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung; BONFOR Programme of the University of Bonn, Germany; Land Steiermark; Swedish Research Council; Swedish Brain Foundation; Karolinska Institutet; Karolinska University Hospital; NIH from National Cancer Institute [P50CA89392]; NIH from National Institute of Drug Abuse [5K02DA021237]; Canadian Institutes of Health Research [64410]; Australian NHMRC Program Grant [1037196]; Centro de Investigacion en Red de Salud Mental (CIBERSAM) IDIBAPS [PI080247, PI1200906, PI12/00018]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement [2014SGR1636, 2014SGR398]; Swiss National Science Foundation [32003B_125469]; Swiss National Science Foundation (NCCR Synapsy); Medical Research Council Clinician Scientist Fellowship Award [MR/L006642/1]; Swedish Research Council [523-2011-3807]; UEFISCDI, Romania [89/2012]; Taiwan Ministry of Science and Technology [MST 99-2314-B-002-140-MY3, 102-2314-B-002-117-MY3]; University of Antioquia; Ministry of Health of the Czech Republic [IGA NT13891]; Reuben Stoltzfus Bipolar Research Fund; James Wah Fund; Project MATCH; Dr-Lisa-Oehler-Foundation (Kassel, Germany); Sardinia Regional Government POR Sardegna FSE Operational Program of the Autonomous Region of Sardinia, European Social Fund; Australian NHMRC Fellowships [613602, 1078901]; Stanley Center for Psychiatric Research at the Broad Institute; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059553, R01MH059533, ZIAMH002843, R01MH059535, ZIAMH002810, R01MH059556, Z01MH002810, R01MH059534, R01MH059567, R01MH060068, R01MH059548, R01MH059545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA021237] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/L006642/1] Funding Source: researchfish; MRC [MR/L006642/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; BONFOR Programme of the University of Bonn, Germany; Land Steiermark; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); NIH from National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from National Institute of Drug Abuse; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Centro de Investigacion en Red de Salud Mental (CIBERSAM) IDIBAPS; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (NCCR Synapsy)(Swiss National Science Foundation (SNSF)); Medical Research Council Clinician Scientist Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); UEFISCDI, Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Taiwan Ministry of Science and Technology; University of Antioquia; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Reuben Stoltzfus Bipolar Research Fund; James Wah Fund; Project MATCH; Dr-Lisa-Oehler-Foundation (Kassel, Germany); Sardinia Regional Government POR Sardegna FSE Operational Program of the Autonomous Region of Sardinia, European Social Fund; Australian NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Stanley Center for Psychiatric Research at the Broad Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; BONFOR Programme of the University of Bonn, Germany; Land Steiermark; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); NIH from National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from National Institute of Drug Abuse; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Centro de Investigacion en Red de Salud Mental (CIBERSAM) IDIBAPS; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (NCCR Synapsy)(Swiss National Science Foundation (SNSF)); Medical Research Council Clinician Scientist Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); UEFISCDI, Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Taiwan Ministry of Science and Technology; University of Antioquia; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Reuben Stoltzfus Bipolar Research Fund; James Wah Fund; Project MATCH; Dr-Lisa-Oehler-Foundation (Kassel, Germany); Sardinia Regional Government POR Sardegna FSE Operational Program of the Autonomous Region of Sardinia, European Social Fund; Australian NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Stanley Center for Psychiatric Research at the Broad Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Deutsche Forschungsgemeinschaft, National Institute of Mental Health Intramural Research Program.r We are greatly indebted to all the study participants without whom this research would not have been possible. We thank the members of our Scientific Advisory Board for critical input over the course of the project. This work was in part funded by the Deutsche Forschungsgemeinschaft (DFG; grant no RI 908/7-1; grant FOR2107, RI 908/11-1 to Marcella Rietschel, Michael Bauer, and Thomas G Schulze, NO 246/10-1 to MMN) and the Intramural Research Program of the National Institute of Mental Health (ZIA-MH00284311; NCT00001174). The genotyping was in part funded by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grants awarded to TGS, MR, and MMN). OG, AP, TSt, MB, AR, and TGS received support from the German Federal Ministry of Education and Research (BMBF) within the framework of the BipolLife network. MMN received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. Franziska Degenhardt received support from the BONFOR Programme of the University of Bonn, Germany. EZR received funding from the Land Steiermark as principal investigator. MS received funds from the Swedish Research Council, Swedish Brain Foundation and funds from Karolinska Institutet and Karolinska University Hospital. Some data and biomaterials were collected as part of eleven projects (Study 40) that participated in the National Institute of Mental Health (NIMH) Bipolar Disorder Genetics Initiative. From 2003-07, the principal investigators and co-investigators were: Indiana University, Indianapolis, IN, R01 MH59545 (John Nurnberger, Marvin J Miller, Elizabeth S Bowman, N Leela Rau, P Ryan Moe, Nalini Samavedy, Rif El-Mallakh [University of Louisville], Husseini Manji [Johnson and Johnson], Debra A Glitz [Wayne State University], Eric T Meyer [Oxford University, UK], Carrie Smiley, Tatiana Foroud, Leah Flury, Danielle M Dick [Virginia Commonwealth University], Howard Edenberg); Washington University, St Louis, MO, R01 MH059534 (John Rice, Theodore Reich, Allison Goate, Laura Bierut [K02 DA21237]); Johns Hopkins University, Baltimore, R01 MH59533 (Melvin McInnis, J Raymond DePaulo Jr, Dean F MacKinnon, Francis M Mondimore, James B Potash, Peter P Zandi, Dimitrios Avramopoulos, Jennifer Payne); University of Pennsylvania, PA, R01 MH59553 (Wade Berrettini); University of California at San Francisco, CA, R01 MH60068 (William Byerley, Sophia Vinogradov); University of Iowa, IA, R01 MH059548 (William Coryell, Raymond Crowe); University of Chicago, IL, R01 MH59535 (Elliot Gershon, Judith Badner, Francis McMahon, Chunyu Liu, Alan Sanders, Maria Caserta, Steven Dinwiddie, Tu Nguyen, Donna Harakal); University of California at San Diego, CA, R01 MH59567 (John Kelsoe, Rebecca McKinney); Rush University, IL, R01 MH059556 (William Scheftner, Howard M Kravitz, Diana Marta, Annette Vaughn-Brown, Laurie Bederow); and NIMH Intramural Research Program, Bethesda, 1Z01MH002810-01 (Francis J McMahon, Layla Kassem, PsyD, Sevilla Detera-Wadleigh, Lisa Austin, Dennis L Murphy [Howard University], William B Lawson, Evarista Nwulia, Maria Hipolito). This work was supported by the NIH grants P50CA89392 from the National Cancer Institute and 5K02DA021237 from the National Institute of Drug Abuse. The Canadian part of the study was supported by a grant #64410 from the Canadian Institutes of Health Research to MAl.; r We wish to thank Joanne Petite and Giselle Kraus for assistance with data collection.r Collection and phenotyping of the Australian UNSW sample, by PBM, PRS, JMF, and AW, was funded by an Australian NHMRC Program Grant (No. 1037196). The collection of the Barcelona sample was supported by the Centro de Investigacion en Red de Salud Mental (CIBERSAM) IDIBAPS (grant numbers PI080247, PI1200906, PI12/00018), and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2014SGR1636 and 2014SGR398). J-MA and AD were supported by the Swiss National Science Foundation (grant number 32003B_125469 and NCCR Synapsy). DC was supported by a Medical Research Council Clinician Scientist Fellowship Award (MR/L006642/1). LF was supported by the Swedish Research Council (grant no 523-2011-3807). MG-S was supported by UEFISCDI, Romania, grant no 89/2012. P-HK was funded by the Taiwan Ministry of Science and Technology (grant no MST 99-2314-B-002-140-MY3 and 102-2314-B-002-117-MY3). CALJ was funded by the "Estrategia de Sostenibilidad 2014-2015" program of the University of Antioquia. TN was supported by the Ministry of Health of the Czech Republic (grant no IGA NT13891). JBP was supported by the Reuben Stoltzfus Bipolar Research Fund and with SKT received funding from the James Wah Fund and Project MATCH. TGS and UH received support from the Dr-Lisa-Oehler-Foundation (Kassel, Germany). AS has a postdoctoral fellowship funded by the Sardinia Regional Government POR Sardegna FSE Operational Program of the Autonomous Region of Sardinia, European Social Fund 2007-2013-Axis IV Human Resources, Objective l.3, Line of Activity l.3.1. NRW was funded by Australian NHMRC Fellowships 613602 and 1078901. MMan is now a resident in the psychiatry training program at the Section of Psychiatry, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD. Genotyping for part of the Swedish sample was funded by the Stanley Center for Psychiatric Research at the Broad Institute.	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Bauer MS, 2004, AM J PSYCHIAT, V161, P3, DOI 10.1176/appi.ajp.161.1.3; Birnbaum R, 2014, NEW ENGL J MED, V370, P1855, DOI 10.1056/NEJMc1401817; Can A, 2014, PHARMACOL BIOCHEM BE, V123, P3, DOI 10.1016/j.pbb.2014.02.004; Chen CH, 2014, NEW ENGL J MED, V370, P119, DOI 10.1056/NEJMoa1212444; Consortium on Lithium Genetics, 2014, NEW ENGL J MED, V370, P1857; Cruceanu C, 2015, AM J PSYCHIAT, V172, P94, DOI 10.1176/appi.ajp.2014.14070855; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dilsaver SC, 2011, J AFFECT DISORDERS, V129, P79, DOI 10.1016/j.jad.2010.08.030; Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Duffy A, 2007, CAN J PSYCHIAT, V52, P369, DOI 10.1177/070674370705200606; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Grande I, 2015, LANCET; Grof P, 2002, J CLIN PSYCHIAT, V63, P942, DOI 10.4088/JCP.v63n1013; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kleindienst N, 2005, BIPOLAR DISORD, V7, P404, DOI 10.1111/j.1399-5618.2005.00244.x; Malhotra AK, 2012, ARCH GEN PSYCHIAT, V69, P904, DOI 10.1001/archgenpsychiatry.2012.191; Manchia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065636; McCarthy MJ, 2010, PHARMACOGENOMICS, V11, P1439, DOI [10.2217/pgs.10.127, 10.2217/PGS.10.127]; MENDLEWICZ J, 1978, BRIT J PSYCHIAT, V133, P436, DOI 10.1192/bjp.133.5.436; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rybakowski JK, 2001, BIPOLAR DISORD, V3, P63, DOI 10.1034/j.1399-5618.2001.030203.x; Schulze TG, 2010, NEUROPSYCHOBIOLOGY, V62, P72, DOI 10.1159/000314708; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Tondo L, 2001, ACTA PSYCHIAT SCAND, V104, P163, DOI 10.1034/j.1600-0447.2001.00464.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	33	194	198	3	107	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1085	1093		10.1016/S0140-6736(16)00143-4	http://dx.doi.org/10.1016/S0140-6736(16)00143-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26806518	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000371775000028
J	Galea, S; Annas, GJ				Galea, Sandro; Annas, George J.			Aspirations and Strategies for Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Galea, Sandro] Boston Univ, Sch Publ Hlth, Off Dean, Boston, MA USA; [Annas, George J.] Boston Univ, Sch Publ Hlth, Ctr Hlth Law Eth & Human Rights, 715 Albany St, Boston, MA 02118 USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Hlth Law Eth & Human Rights, 715 Albany St, Boston, MA 02118 USA.	annasgj@bu.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945				American Public Health Association, WHAT IS PUBL HLTH; Frieden TR, 2015, NEW ENGL J MED, V373, P1748, DOI 10.1056/NEJMsa1511248; GLANTZ LH, 1991, AM J PUBLIC HEALTH, V81, P835, DOI 10.2105/AJPH.81.7.835; Mann J.M., 1999, HLTH HUMAN RIGHTS RE; VICKERS G, 1958, NEW ENGL J MED, V258, P589, DOI 10.1056/NEJM195803202581205	5	42	42	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2016	315	7					655	656		10.1001/jama.2016.0198	http://dx.doi.org/10.1001/jama.2016.0198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD8JB	26822847	Bronze			2022-12-28	WOS:000370171500008
J	Hawkes, N				Hawkes, Nigel			HEALTH AND TECHNOLOGY Uber for healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Bancaleiro C., 2015, PUBLICA         1207; Parkinson J., 2016, QUARTZ          0102; Van Grove J., 2016, KRYTYKA POLITYCZNA E	3	2	2	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2016	352								i771	10.1136/bmj.i771	http://dx.doi.org/10.1136/bmj.i771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JZ	26872632				2022-12-28	WOS:000370384500001
J	Bangalore, S; Fakheri, R; Toklu, B; Messerli, FH				Bangalore, Sripal; Fakheri, Robert; Toklu, Bora; Messerli, Franz H.			Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							END-POINT REDUCTION; ANTIHYPERTENSIVE SURVIVAL EVALUATION; CONVERTING-ENZYME-INHIBITORS; RISK HYPERTENSIVE PATIENTS; LIPID-LOWERING TREATMENT; CORONARY-ARTERY-DISEASE; LOSARTAN INTERVENTION; CARDIOVASCULAR MORBIDITY; BLOOD-PRESSURE; SECONDARY PREVENTION	OBJECTIVE To evaluate the outcomes with use of renin angiotensin system (RAS) blockers compared with other antihypertensive agents in people with diabetes. DESIGN Meta-analysis. DATA SOURCES AND STUDY SELECTION PubMed, Embase, and the Cochrane central register of controlled trials databases for randomized trials of RAS blockers versus other antihypertensive agents in people with diabetes mellitus. Outcomes were death, cardiovascular death, myocardial infarction, angina, stroke, heart failure, revascularization, and end stage renal disease. RESULTS The search yielded 19 randomized controlled trials that enrolled 25 414 participants with diabetes for a total of 95 910 patient years of follow-up. When compared with other antihypertensive agents, RAS blockers were associated with a similar risk of death (relative risk 0.99, 95% confidence interval 0.93 to 1.05), cardiovascular death (1.02, 0.83 to 1.24), myocardial infarction (0.87, 0.64 to 1.18), angina pectoris (0.80, 0.58 to 1.11), stroke (1.04, 0.92 to 1.17), heart failure (0.90, 0.76 to 1.07), and revascularization (0.97, 0.77 to 1.22). There was also no difference in the hard renal outcome of end stage renal disease (0.99, 0.78 to 1.28) (power of 94% to show a 23% reduction in end stage renal disease). CONCLUSIONS In people with diabetes, RAS blockers are not superior to other antihypertensive drug classes such as thiazides, calcium channel blockers, and beta blockers at reducing the risk of hard cardiovascular and renal endpoints. These findings support the recommendations of the guidelines of the European Society of Cardiology/European Society of Hypertension and eighth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure to also use other antihypertensive agents in people with diabetes but without kidney disease.	[Bangalore, Sripal; Fakheri, Robert] NYU, Sch Med, New York, NY USA; [Toklu, Bora] Mt Sinai Beth Israel Med Ctr, New York, NY USA; [Messerli, Franz H.] Icahn Sch Med Mt Sinai, Mt Sinai Hlth Med Ctr, New York, NY 10029 USA	New York University; Icahn School of Medicine at Mount Sinai	Bangalore, S (corresponding author), NYU, Sch Med, New York, NY USA.	sripalbangalore@gmail.com	Messerli, Franz/AAR-4783-2021	Bangalore, Sripal/0000-0001-9485-0652; Fakheri, Robert/0000-0003-4900-1955				[Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; Atkins RC, 2005, AM J KIDNEY DIS, V45, P281, DOI 10.1053/j.ajkd.2004.10.019; Baba S, 2001, DIABETES RES CLIN PR, V54, P191, DOI 10.1016/S0168-8227(01)00288-1; Baguet JP, 2009, VASC HEALTH RISK MAN, V5, P175; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Boulanger JM, 2006, STROKE, V37, P335, DOI 10.1161/01.STR.0000199659.31103.d2; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chowdhury EK, 2014, AM J HYPERTENS, V27, P199, DOI 10.1093/ajh/hpt212; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EPSTEIN M, 1992, HYPERTENSION, V19, P403, DOI 10.1161/01.HYP.19.5.403; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fogari R, 2002, AM J HYPERTENS, V15, P316, DOI 10.1016/S0895-7061(01)02340-8; Fukui T, 2003, HYPERTENS RES, V26, P979, DOI 10.1291/hypres.26.979; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gerstein HC, 2000, LANCET, V355, P253; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Holman Rury, 1998, BMJ, V317, P713; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kizer JR, 2005, HYPERTENSION, V45, P46, DOI 10.1161/01.HYP.0000151324.05355.1c; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lindholm LH, 2002, J HYPERTENS, V20, P1879, DOI 10.1097/00004872-200209000-00035; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marre M, 2004, J HYPERTENS, V22, P1613, DOI 10.1097/01.hjh.0000133733.32125.09; Messerli FH, 2003, ANN INTERN MED, V139, P777, DOI 10.7326/0003-4819-139-9-200311040-00012; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Muramatsu T, 2012, HYPERTENSION, V59, P580, DOI 10.1161/HYPERTENSIONAHA.111.184226; Nakao K, 2010, HYPERTENS RES, V33, P600, DOI 10.1038/hr.2010.38; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Ogihara T, 2008, HYPERTENSION, V51, P393, DOI 10.1161/HYPERTENSIONAHA.107.098475; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; PARVING HH, 1983, LANCET, V1, P1175; RITZ E, 1995, AM J HYPERTENS, V8, pS53, DOI 10.1016/0895-7061(95)00189-1; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Schrier RW, 2000, NEW ENGL J MED, V343, P1969, DOI 10.1056/NEJM200012283432614; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Whelton PK, 2005, ARCH INTERN MED, V165, P1401, DOI 10.1001/archinte.165.12.1401; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; WINGARD DL, 1993, DIABETES CARE, V16, P1022, DOI 10.2337/diacare.16.7.1022; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008; Yui Y, 2004, HYPERTENS RES, V27, P449, DOI 10.1291/hypres.27.449; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181	54	94	101	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2016	352								i438	10.1136/bmj.i438	http://dx.doi.org/10.1136/bmj.i438			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1JT	26868137	Green Published, hybrid			2022-12-28	WOS:000370383900002
J	Scognamiglio, R; Cabezas-Wallscheid, N; Thier, MC; Altamura, S; Reyes, A; Prendergast, AM; Baumgartner, D; Carnevalli, LS; Atzberger, A; Haas, S; von Paleske, L; Boroviak, T; Worsdorfer, P; Essers, MAG; Kloz, U; Eisenman, RN; Edenhofer, F; Bertone, P; Huber, W; van der Hoeven, F; Smith, A; Trumpp, A				Scognamiglio, Roberta; Cabezas-Wallscheid, Nina; Thier, Marc Christian; Altamura, Sandro; Reyes, Alejandro; Prendergast, Aine M.; Baumgaertner, Daniel; Carnevalli, Larissa S.; Atzberger, Ann; Haas, Simon; von Paleske, Lisa; Boroviak, Thorsten; Woersdoerfer, Philipp; Essers, Marieke A. G.; Kloz, Ulrich; Eisenman, Robert N.; Edenhofer, Frank; Bertone, Paul; Huber, Wolfgang; van der Hoeven, Franciscus; Smith, Austin; Trumpp, Andreas			Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKEMIA INHIBITORY FACTOR; C-MYC; EMBRYONIC STEM; SELF-RENEWAL; GROUND-STATE; PROTEIN-SYNTHESIS; N-MYC; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION	Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state.	[Scognamiglio, Roberta; Cabezas-Wallscheid, Nina; Thier, Marc Christian; Baumgaertner, Daniel; Carnevalli, Larissa S.; von Paleske, Lisa; Trumpp, Andreas] Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Scognamiglio, Roberta; Cabezas-Wallscheid, Nina; Thier, Marc Christian; Prendergast, Aine M.; Baumgaertner, Daniel; Carnevalli, Larissa S.; Atzberger, Ann; Haas, Simon; von Paleske, Lisa; Essers, Marieke A. G.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Altamura, Sandro] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69120 Heidelberg, Germany; [Reyes, Alejandro; Bertone, Paul; Huber, Wolfgang] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Prendergast, Aine M.; Haas, Simon; Essers, Marieke A. G.] Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, Hematopoiet Stem Cells & Stress Grp, D-69120 Heidelberg, Germany; [Woersdoerfer, Philipp; Bertone, Paul; Smith, Austin] Univ Cambridge, Welcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Boroviak, Thorsten; Bertone, Paul; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Woersdoerfer, Philipp; Edenhofer, Frank] Univ Wurzburg, Inst Anat & Cell Biol, Stem Cell & Regenerat Med Grp, D-97070 Wurzburg, Germany; [Kloz, Ulrich; van der Hoeven, Franciscus] Deutsch Krebsforschungszentrum, Transgen Serv, D-69120 Heidelberg, Germany; [Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Trumpp, Andreas] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Edenhofer, Frank] Leopold Franzens Univ Innsbruck, Dept Genom Stem Cell Biol & Regenerat Med, Inst Mol Biol, A-6020 Innsbruck, Austria	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; University of Cambridge; University of Wurzburg; Helmholtz Association; German Cancer Research Center (DKFZ); Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Innsbruck	Trumpp, A (corresponding author), Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz.de	Bertone, Paul/A-6600-2013; Edenhofer, Frank/ABG-9458-2020; Bertone, Paul/Z-3734-2019; Essers, Marieke A.G./B-7758-2017; Trumpp, Andreas/Z-2141-2019; Reyes, Alejandro/D-8258-2017; Altamura, Sandro/R-1195-2016	Bertone, Paul/0000-0001-5059-4829; Edenhofer, Frank/0000-0002-6489-714X; Bertone, Paul/0000-0001-5059-4829; Essers, Marieke A.G./0000-0003-3117-1809; Trumpp, Andreas/0000-0002-6212-3466; Reyes, Alejandro/0000-0001-8717-6612; Smith, Austin/0000-0002-3029-4682; Huber, Wolfgang/0000-0002-0474-2218; Boroviak, Thorsten Edwin/0000-0001-8703-8949; Carnevalli, Larissa/0000-0001-7432-0195; Worsdorfer, Philipp/0000-0003-3398-3229; Haas, Simon/0000-0001-9227-2051; Altamura, Sandro/0000-0002-6781-1073	Deutsche Forschungsgemeinschaft (DFG) [FOR2033, SFB873]; Dietmar Hopp Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/M004023/1] Funding Source: researchfish; Medical Research Council [G1100526, MC_PC_12009] Funding Source: researchfish; BBSRC [BB/M004023/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA057138] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar Hopp Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Corinna Klein, Katja Mudder, Melanie Neubauer, Adriana Przybylla, and Markus Sohn for technical assistance. We would like to thank Gelo Victoriano De la Cruz and the DKFZ Flow Cytometry Core facility for their assistance and Dr. Kurt Reifenberg, Dr. Michaela Socher, Anja Rathgeb, and all members of the DKFZ Laboratory Animal Core Facility for excellent animal welfare and husbandry. Support by Damir Krunic, Manuela Brom, and the DKFZ Light Microscopy facility is gratefully acknowledged. We thank the microarray unit of the DKFZ Genomics and Proteomics Core Facility for providing the Illumina Whole-Genome Expression analysis and related services. We thank Erika Kruckel for help with all administrative matters and all colleagues of the A.T.'s and HI-STEM laboratories for helpful discussions. The authors would like to thank Dr. Henk Stunnenberg (Nijmegen, NL) for helpful discussions during the initial phase of the project. R.S. was a member of the Hartmut Hoffmann-Berling International Graduate School (HBIGS). This work was supported by the FOR2033 and SFB873 funded by the Deutsche Forschungsgemeinschaft (DFG), the Dietmar Hopp Foundation (all to A.T.), and the Wellcome Trust (to A.S.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang CV, 2015, CANCER CELL, V27, P160, DOI 10.1016/j.ccell.2015.01.004; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Ehninger A, 2014, BLOOD, V123, P3909, DOI 10.1182/blood-2013-10-531038; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hatton KS, 1996, MOL CELL BIOL, V16, P1794; Hondo E, 2005, GENOME BIOL, V6; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Humbert PO, 2000, GENE DEV, V14, P690; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Latil M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1890; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; MANTALENAKIS SJ, 1966, J REPROD FERTIL, V12, P391, DOI 10.1530/jrf.0.0120391; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; NICHOLS J, 1994, EXP CELL RES, V215, P237, DOI 10.1006/excr.1994.1338; Nichols J, 2001, DEVELOPMENT, V128, P2333; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	67	137	140	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 11	2016	164	4					668	680		10.1016/j.cell.2015.12.033	http://dx.doi.org/10.1016/j.cell.2015.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DD5XN	26871632	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000369998300013
J	Sekar, A; Bialas, AR; de Rivera, H; Davis, A; Hammond, TR; Kamitaki, N; Tooley, K; Presumey, J; Baum, M; Van Doren, V; Genovese, G; Rose, SA; Handsaker, RE; Daly, MJ; Carroll, MC; Stevens, B; McCarroll, SA				Sekar, Aswin; Bialas, Allison R.; de Rivera, Heather; Davis, Avery; Hammond, Timothy R.; Kamitaki, Nolan; Tooley, Katherine; Presumey, Jessy; Baum, Matthew; Van Doren, Vanessa; Genovese, Giulio; Rose, Samuel A.; Handsaker, Robert E.; Daly, Mark J.; Carroll, Michael C.; Stevens, Beth; McCarroll, Steven A.		Schizophrenia Working Grp	Schizophrenia risk from complex variation of complement component 4	NATURE			English	Article							CLASSICAL PATHWAY COMPLEMENT; CORTICAL PYRAMIDAL NEURONS; DENDRITIC SPINE DENSITY; ENDOGENOUS RETROVIRUSES; PRENATAL DEVELOPMENT; SYNAPSE ELIMINATION; COMMON VARIANTS; MHC HAPLOTYPES; C4; PROTEIN	Schizophrenia is a heritable brain illness with unknown pathogenic mechanisms. Schizophrenia's strongest genetic association at a population level involves variation in the major histocompatibility complex (MHC) locus, but the genes and molecular mechanisms accounting for this have been challenging to identify. Here we show that this association arises in part from many structurally diverse alleles of the complement component 4 (C4) genes. We found that these alleles generated widely varying levels of C4A and C4B expression in the brain, with each common C4 allele associating with schizophrenia in proportion to its tendency to generate greater expression of C4A. Human C4 protein localized to neuronal synapses, dendrites, axons, and cell bodies. In mice, C4 mediated synapse elimination during postnatal development. These results implicate excessive complement activity in the development of schizophrenia and may help explain the reduced numbers of synapses in the brains of individuals with schizophrenia.	[Sekar, Aswin; de Rivera, Heather; Davis, Avery; Kamitaki, Nolan; Tooley, Katherine; Baum, Matthew; Van Doren, Vanessa; Genovese, Giulio; Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sekar, Aswin; de Rivera, Heather; Davis, Avery; Kamitaki, Nolan; Tooley, Katherine; Baum, Matthew; Genovese, Giulio; Rose, Samuel A.; Handsaker, Robert E.; Daly, Mark J.; Stevens, Beth; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Sekar, Aswin; Baum, Matthew] Harvard Univ, Sch Med, MD PhD Program, Boston, MA 02115 USA; [Bialas, Allison R.; Hammond, Timothy R.; Baum, Matthew; Stevens, Beth] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol,FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Bialas, Allison R.; Presumey, Jessy; Carroll, Michael C.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	McDonald, Colm/C-1430-2009; Melle, Ingrid S/B-4858-2011; Hansen, Thomas Folkmann/O-5965-2014; Hartmann, Annette/AAS-6331-2021; KUČINSKAS, Vaidutis/A-4798-2013; Golimbet, V/E-2328-2016; Milani, Lili/N-1097-2019; McQuillin, Andrew/C-1623-2008; Visscher, Peter/ABB-6151-2020; Handsaker, Bob/AAX-9095-2021; Domenici, Enrico/K-8194-2016; Fanous, Ayman H/O-1263-2017; Webb, Bradley T/B-1459-2009; Meier, Sandra/AAB-1242-2021; Agerbo, Esben/A-2645-2012; Mattingsdal, Morten/Q-9367-2016; Zimprich, Fritz/O-1406-2019; Mattheisen, Manuel/S-3725-2019; Konte, Bettina/AAT-1142-2021; Bergen, Sarah/I-8313-2012; Wu, Jingqin/V-9319-2019; Reichenberg, Abraham/GQB-1227-2022; Lee, Jimmy/ABB-2919-2020; Myin-Germeys, Inez/L-5106-2014; Pantelis, Christos/H-7722-2014; Roffman, Joshua/G-8228-2012; Daly, Mark J/B-2453-2017; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Degenhardt, Franziska/H-4169-2017; Bramon, Elvira/HHC-3809-2022; Hammer, Christian/C-5827-2014; Mattheisen, Manuel/B-4949-2012; Ruderfer, Douglas M/M-5795-2016; Slominsky, Petr/AAO-1852-2020; van Os, Jim/C-2113-2014; Slominsky, Petr A/B-4640-2016; Holmans, Peter/F-4518-2015; Mowry, Bryan/G-5046-2010; Franke, Lude/P-7036-2016; Kelly, Brian/G-7755-2013; Magnusson, Patrik/C-4458-2017; Collier, David/D-1649-2011	McDonald, Colm/0000-0003-1661-5192; Melle, Ingrid S/0000-0002-9783-548X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Golimbet, V/0000-0002-9960-7114; Milani, Lili/0000-0002-5323-3102; McQuillin, Andrew/0000-0003-1567-2240; Visscher, Peter/0000-0002-2143-8760; Handsaker, Bob/0000-0002-3128-3547; Domenici, Enrico/0000-0001-7436-6919; Webb, Bradley T/0000-0002-0576-5366; Agerbo, Esben/0000-0002-2849-524X; Mattingsdal, Morten/0000-0003-4440-0324; Zimprich, Fritz/0000-0002-6998-5480; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Bergen, Sarah/0000-0002-5888-0034; Wu, Jingqin/0000-0002-2052-3875; Lee, Jimmy/0000-0002-7724-7445; Pantelis, Christos/0000-0002-9565-0238; Roffman, Joshua/0000-0003-4073-532X; Daly, Mark J/0000-0002-0949-8752; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Bramon, Elvira/0000-0003-1369-5983; Hammer, Christian/0000-0003-4548-7548; Mattheisen, Manuel/0000-0002-8442-493X; Ruderfer, Douglas M/0000-0002-2365-386X; Slominsky, Petr/0000-0003-3530-0655; Slominsky, Petr A/0000-0003-3530-0655; Holmans, Peter/0000-0003-0870-9412; Mowry, Bryan/0000-0002-4115-5645; Knight, Joanne/0000-0002-7148-1660; Demontis, Ditte/0000-0001-9124-2766; Borglum, Anders/0000-0001-8627-7219; Moran, Jennifer/0000-0002-5664-4716; Julia Cano, Antonio/0000-0001-6064-3620; Bell, Avery Davis/0000-0002-1837-302X; Ehrenreich, Hannelore/0000-0001-8371-5711; Bruggeman, Richard/0000-0002-3238-8471; O'Neill, Francis Anthony/0000-0002-7531-7657; Myin-Germeys, Inez/0000-0002-3731-4930; Suvisaari, Jaana/0000-0001-7167-0990; Legge, Sophie/0000-0001-6617-0289; Pocklington, Andrew/0000-0002-2137-0452; Djurovic, Srdjan/0000-0002-8140-8061; Cairns, Murray/0000-0003-2490-2538; Franke, Lude/0000-0002-5159-8802; Kelly, Brian/0000-0003-4460-1134; Baum, Matthew/0000-0001-6840-8932; Posthuma, Danielle/0000-0001-7582-2365; Buxbaum, Joseph/0000-0001-8898-8313; /0000-0002-8114-7615; Kamitaki, Nolan/0000-0003-0614-0189; Magnusson, Patrik/0000-0002-7315-7899; Sim, Kang/0000-0003-3209-9626; So, Hon-Cheong/0000-0002-7102-833X; Adolfsson, Rolf/0000-0001-9785-8473; Pers, Tune/0000-0003-0207-4831; Nothen, Markus/0000-0002-8770-2464; Jonsson, Erik/0000-0001-8368-6332; Tooley, Katherine/0000-0003-0587-0358; Mors, Ole/0000-0002-5660-0393; Bacanu, Silviu-Alin/0000-0002-4364-1583; Collier, David/0000-0003-4087-1559; marsal, sara/0000-0001-5515-3854; Walters, James/0000-0002-6980-4053; Rose, Samuel/0000-0001-9701-0050; Van Doren, Vanessa/0000-0003-4165-6025; Stogmann, Elisabeth/0000-0003-4688-8482; Papiol, Sergi/0000-0001-9366-8728	Stanley Center for Psychiatric Research;  [R01 HG 006855];  [U01 MH105641];  [R01 MH077139];  [T32 GM007753]; MRC [G0800509, MR/P005748/1, G0901310] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042191, R01MH077139, U01MH105641] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/L010305/1, MR/P005748/1, G0800509, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish	Stanley Center for Psychiatric Research; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to remember the late T. Stanley with appreciation and express their gratitude for his support. We thank S. Hyman, E. Lander, C. Bargmann, and C. Patil for conversations about the project and comments on drafts of the manuscript; M. Webster for expert advice on immunohistochemistry; B. Browning for expert advice on imputation; the Stanley Medical Research Institute Brain Collection and the NHGRI Gene and Tissue Expression (GTEx) Project for access to RNA and tissue samples; C. Emba for assistance with experiments; and C. Usher for contributions to manuscript figures. This work was supported by R01 HG 006855 (to S.A.M.), by the Stanley Center for Psychiatric Research (to S. A. M. and B. S.), by U01 MH105641 (to S. A. M.), by R01 MH077139 (to the PGC), and by T32 GM007753 (to A.S. and M.B.).	Banlaki Z, 2012, GENES IMMUN, V13, P530, DOI 10.1038/gene.2012.29; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Cannon TD, 2002, P NATL ACAD SCI USA, V99, P3228, DOI 10.1073/pnas.052023499; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CARROLL MC, 1984, PHILOS T ROY SOC B, V306, P379, DOI 10.1098/rstb.1984.0098; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; Fischer MB, 1996, J IMMUNOL, V157, P549; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Hakobyan S, 2005, NEUROSCI LETT, V374, P35, DOI 10.1016/j.neulet.2004.10.024; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Illarionova AE, 2007, VIROLOGY, V358, P39, DOI 10.1016/j.virol.2006.06.027; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; ISENMAN DE, 1984, J IMMUNOL, V132, P3019; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; LAW SKA, 1984, EMBO J, V3, P1819, DOI 10.1002/j.1460-2075.1984.tb02052.x; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Mayilyan KR, 2008, WORLD J BIOL PSYCHIA, V9, P225, DOI 10.1080/15622970701227803; Mayilyan KR, 2006, NEUROSCI LETT, V404, P336, DOI 10.1016/j.neulet.2006.06.051; Nakamura A, 2003, J HUM GENET, V48, P575, DOI 10.1007/s10038-003-0081-8; NONAKA M, 1986, J IMMUNOL, V136, P2989; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; RUDDUCK C, 1985, HUM HERED, V35, P223, DOI 10.1159/000153549; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schroers R, 1997, HUM HERED, V47, P279, DOI 10.1159/000154424; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Suntsova M, 2013, P NATL ACAD SCI USA, V110, P19472, DOI 10.1073/pnas.1318172110; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; Yang Y, 2003, J IMMUNOL, V171, P2734, DOI 10.4049/jimmunol.171.5.2734	56	1253	1284	14	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2016	530	7589					177	+		10.1038/nature16549	http://dx.doi.org/10.1038/nature16549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD4TX	26814963	Green Accepted, Green Submitted			2022-12-28	WOS:000369916700030
J	Baude, M; Kunin, WE; Boatman, ND; Conyers, S; Davies, N; Gillespie, MAK; Morton, RD; Smart, SM; Memmott, J				Baude, Mathilde; Kunin, William E.; Boatman, Nigel D.; Conyers, Simon; Davies, Nancy; Gillespie, Mark A. K.; Morton, R. Daniel; Smart, Simon M.; Memmott, Jane			Historical nectar assessment reveals the fall and rise of floral resources in Britain	NATURE			English	Article							GREAT-BRITAIN; PLANTS; POLLINATORS; DECLINES; ENGLAND; CONSERVATION; WALES; COMMUNITIES; NETHERLANDS; DIVERSITY	There is considerable concern over declines in insect pollinator communities and potential impacts on the pollination of crops and wildflowers(1-4). Among the multiple pressures facing pollinators(2-4), decreasing floral resources due to habitat loss and degradation has been suggested as a key contributing factor(2-8). However, a lack of quantitative data has hampered testing for historical changes in floral resources. Here we show that overall floral rewards can be estimated at a national scale by combining vegetation surveys and direct nectar measurements. We find evidence for substantial losses in nectar resources in England and Wales between the 1930s and 1970s; however, total nectar provision in Great Britain as a whole had stabilized by 1978, and increased from 1998 to 2007. These findings concur with trends in pollinator diversity, which declined in the mid-twentieth century(9) but stabilized more recently(10). The diversity of nectar sources declined from 1978 to 1990 and thereafter in some habitats, with four plant species accounting for over 50% of national nectar provision in 2007. Calcareous grassland, broadleaved woodland and neutral grassland are the habitats that produce the greatest amount of nectar per unit area from the most diverse sources, whereas arable land is the poorest with respect to amount of nectar per unit area and diversity of nectar sources. Although agri-environment schemes add resources to arable landscapes, their national contribution is low. Owing to their large area, improved grasslands could add substantially to national nectar provision if they were managed to increase floral resource provision. This national-scale assessment of floral resource provision affords new insights into the links between plant and pollinator declines, and offers considerable opportunities for conservation.	[Baude, Mathilde; Davies, Nancy; Memmott, Jane] Univ Bristol, Sch Biol Sci, Life Sci Bldg, Bristol BS8 1TQ, Avon, England; [Baude, Mathilde; Davies, Nancy; Memmott, Jane] Univ Bristol, Cabot Inst, Bristol BS8 1UJ, Avon, England; [Kunin, William E.; Gillespie, Mark A. K.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Boatman, Nigel D.; Conyers, Simon] Fera Sci Ltd, York Y041 1LZ, N Yorkshire, England; [Morton, R. Daniel; Smart, Simon M.] NERC Ctr Ecol & Hydrol, Lancaster LA1 4AP, England; [Baude, Mathilde] Univ Orleans, Coll Sci & Tech EA LBLGC 1207, F-45067 Orleans, France; [Gillespie, Mark A. K.] Sogn Fjordane Univ Coll, Dept Sci & Engn, N-6851 Sogndal, Norway	University of Bristol; University of Bristol; University of Leeds; Food & Environment Research Agency; UK Centre for Ecology & Hydrology (UKCEH); Universite de Orleans; Western Norway University of Applied Sciences	Baude, M (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg, Bristol BS8 1TQ, Avon, England.	mathilde.baude@univ-orleans.fr	smart, simon M/I-6089-2012	smart, simon/0000-0003-2750-7832	UK Insect Pollinators Initiative (IPI) - Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; Scottish Government; Department of Environment, Food and Rural Affairs (DEFRA); Natural Environment Research Council (NERC) under Living with Environmental Change partnership [BB/H014934/1]; BBSRC [BB/I000119/1, BB/I000577/1, BB/I000437/1, BB/I000364/1] Funding Source: UKRI; NERC [ceh020002] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000577/1, BB/I000437/1, BB/I000119/1, BB/I000364/1] Funding Source: researchfish; Natural Environment Research Council [ceh020002] Funding Source: researchfish	UK Insect Pollinators Initiative (IPI) - Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government; Department of Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council (NERC) under Living with Environmental Change partnership(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the UK Insect Pollinators Initiative (IPI) 'AgriLand: Linking agriculture and land use change to pollinator populations' project, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Scottish Government, Department of Environment, Food and Rural Affairs (DEFRA) and Natural Environment Research Council (NERC) under the auspices of the Living with Environmental Change partnership: grant BB/H014934/1 (http://www.agriland.leeds.ac.uk). Land Cover and Countryside Survey data are owned by NERC - Centre for Ecology & Hydrology (http://www.countrysidesurvey.org.uk).	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; [Anonymous], 2009, COUNTR SURV ENGL RES, P1; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blackstock TH, 1999, GRASS FORAGE SCI, V54, P1, DOI 10.1046/j.1365-2494.1999.00157.x; Boatman ND, 2011, AGR ECOSYST ENVIRON, V143, P8, DOI 10.1016/j.agee.2011.05.003; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carey P. D., 2008, COUNTRYSIDE SURVEY U, P1; Carvalheiro LG, 2008, J APPL ECOL, V45, P1419, DOI 10.1111/j.1365-2664.2008.01518.x; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; Department for Environment Food and Rural Affairs, 2005, ENTR LEV STEW HDB TE, P116; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; FULLER RM, 1987, BIOL CONSERV, V40, P281, DOI 10.1016/0006-3207(87)90121-2; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Kirk GJD, 2010, GLOBAL CHANGE BIOL, V16, P3111, DOI 10.1111/j.1365-2486.2009.02135.x; Kirk W. D. J., 2012, PLANTS BEES GUIDE PL, P1; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Klotz S., 2002, BIOFLOR DATENBANK BI; Morton R. D., 2011, 1107 NERC CTR EC HYD, P112; Natural England, 2015, COUNTR STEW MAN; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Petit S, 2003, J ENVIRON MANAGE, V67, P229, DOI 10.1016/S0301-4797(02)00176-7; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Preston C. D., 2002, NEW ATLAS BRIT IRISH, P910; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raine NE, 2007, ENTOMOL GEN, V30, P191; RATCLIFFE DA, 1984, NEW PHYTOL, V98, P73, DOI 10.1111/j.1469-8137.1984.tb06099.x; Reynolds B, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0114; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Staley JT, 2013, BIOL CONSERV, V167, P97, DOI 10.1016/j.biocon.2013.07.033; Stamp L. D., 1948, LAND BRITAIN ITS USE; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Willmer P., 2011, POLLINATION FLORAL E, P1; Wood C. M., 2012, COUNTRYSIDE SURVEY M, P1	38	214	217	14	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					85	+		10.1038/nature16532	http://dx.doi.org/10.1038/nature16532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26842058	Green Accepted, Green Submitted			2022-12-28	WOS:000369304500037
J	Laidlaw, TM; Boyce, JA				Laidlaw, Tanya M.; Boyce, Joshua A.			Aspirin-Exacerbated Respiratory Disease - New Prime Suspects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEUKOTRIENE C-4 SYNTHASE; PROSTAGLANDIN E-2; INDUCED BRONCHOCONSTRICTION; ASTHMATIC-PATIENTS; INTOLERANT ASTHMA; MONTELUKAST; EXPRESSION; PHENOTYPE; DRIVEN		[Laidlaw, Tanya M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Laidlaw, TM (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.							Berges-Gimeno MP, 2003, J ALLERGY CLIN IMMUN, V111, P180, DOI 10.1067/mai.2003.7; Buchheit KM, 2015, J ALLERGY CLIN IMMUN; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Dahlen B, 1998, AM J RESP CRIT CARE, V157, P1187, DOI 10.1164/ajrccm.157.4.9707089; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; ISRAEL E, 1993, AM REV RESPIR DIS, V148, P1447, DOI 10.1164/ajrccm/148.6_Pt_1.1447; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Liu T, 2015, J IMMUNOL, V195, P3537, DOI 10.4049/jimmunol.1500905; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Petrucci G, 2011, J PHARMACOL EXP THER, V336, P391, DOI 10.1124/jpet.110.174821; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; Robuschi M, 1997, AM J RESP CRIT CARE, V155, P1461, DOI 10.1164/ajrccm.155.4.9105094; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; Safholm J, 2015, J ALLERGY CLIN IMMUN, V136, P1232, DOI 10.1016/j.jaci.2015.04.002; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; Sanak M, 2000, EUR RESPIR J, V16, P44, DOI 10.1034/j.1399-3003.2000.16a08.x; Sestini P, 1996, AM J RESP CRIT CARE, V153, P572, DOI 10.1164/ajrccm.153.2.8564100; Stevenson DD, 2000, ANN ALLERG ASTHMA IM, V85, P477, DOI 10.1016/S1081-1206(10)62575-6; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Van Sambeek R, 2000, J ALLERGY CLIN IMMUN, V106, P72, DOI 10.1067/mai.2000.107603; Woessner KM, 2002, ARTHRITIS RHEUM, V46, P2201, DOI 10.1002/art.10426; Ying S, 2006, J ALLERGY CLIN IMMUN, V117, P312, DOI 10.1016/j.jaci.2005.10.037	30	104	108	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					484	488		10.1056/NEJMcibr1514013	http://dx.doi.org/10.1056/NEJMcibr1514013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26840139				2022-12-28	WOS:000369319100014
J	Enander, J; Andersson, E; Mataix-Cols, D; Lichtenstein, L; Alstrom, K; Andersson, G; Ljotsson, B; Ruck, C				Enander, Jesper; Andersson, Erik; Mataix-Cols, David; Lichtenstein, Linn; Alstroem, Katarina; Andersson, Gerhard; Ljotsson, Brjann; Rueck, Christian			Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY SAMPLE; RATING-SCALE; PREVALENCE; COMPARABILITY; VALIDATION; SYMPTOMS	OBJECTIVES To evaluate the efficacy of therapist guided internet based cognitive behavioural therapy (CBT) programme for body dysmorphic disorder (BDD-NET) compared with online supportive therapy. DESIGN A 12 week single blind parallel group randomised controlled trial. SETTING Academic medical centre. PARTICIPANTS 94 self referred adult outpatients with a diagnosis of body dysmorphic disorder and a modified Yale-Brown obsessive compulsive scale (BDD-YBOCS) score of >= 20. Concurrent psychotropic drug treatment was permitted if the dose had been stable for at least two months before enrolment and remained unchanged during the trial. INTERVENTIONS Participants received either BDD-NET (n=47) or supportive therapy (n=47) delivered via the internet for 12 weeks. MAIN OUTCOME MEASURES The primary outcome was the BDD-YBOCS score after treatment and follow-up (three and six months from baseline) as evaluated by a masked assessor. Responder status was defined as a >= 30% reduction in symptoms on the scale. Secondary outcomes were measures of depression (MADRS-S), global functioning (GAF), clinical global improvement (CGI-I), and quality of life (EQ5D). The six month follow-up time and all outcomes other than BDD-YBOCS and MADRS-S at 3 months were not pre-specified in the registration at clinicaltrials.gov because of an administrative error but were included in the original trial protocol approved by the regional ethics committee before the start of the trial. RESULTS BDD-NET was superior to supportive therapy and was associated with significant improvements in severity of symptoms of body dysmorphic disorder (BDD-YBOCS group difference -7.1 points, 95% confidence interval -9.8 to -4.4), depression (MADRS-S group difference -4.5 points, -7.5 to -1.4), and other secondary measures. At follow-up, 56% of those receiving BDD-NET were classed as responders, compared with 13% receiving supportive therapy. The number needed to treat was 2.34 (1.71 to 4.35). Self reported satisfaction was high. CONCLUSIONS CBT can be delivered safely via the internet to patients with body dysmorphic disorder. BDD-NET has the potential to increase access to evidence based psychiatric care for this mental disorder, in line with NICE priority recommendations. It could be particularly useful in a stepped care approach, in which general practitioner or other mental health professionals can offer treatment to people with mild to moderate symptoms at low risk of suicide.	[Enander, Jesper; Andersson, Erik; Mataix-Cols, David; Rueck, Christian] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Erik; Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Mataix-Cols, David] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Lichtenstein, Linn; Alstroem, Katarina; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; University of London; King's College London; Linkoping University	Enander, J (corresponding author), Karolinska Univ, Huddinge Hosp, M46, SE-14186 Stockholm, Sweden.	jesper.enander@ki.se	Mataix-Cols, David/G-3843-2010; Mataix-Cols, David/AAF-3347-2021; Andersson, Gerhard/J-8529-2012	Mataix-Cols, David/0000-0002-4545-0924; Mataix-Cols, David/0000-0002-4545-0924; Andersson, Gerhard/0000-0003-4753-6745; Ruck, Christian/0000-0002-8742-0168; Enander, Jesper/0000-0002-1897-5549	Stockholm County Council; Karolinska Institutet; Swedish Research Council [K2013-61X-22168-01-3]; Swedish Society of Medicine (Soderstromska Konigska sjukhemmet) [SLS3B4451]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine (Soderstromska Konigska sjukhemmet)	This study was funded through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet, the Swedish Research Council (grant No: K2013-61X-22168-01-3), and the Swedish Society of Medicine (Soderstromska Konigska sjukhemmet, grant No: SLS3B4451).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brohede S, 2015, COMPR PSYCHIAT, V58, P108, DOI 10.1016/j.comppsych.2014.12.014; Brohede S, 2013, PSYCHIAT RES, V210, P647, DOI 10.1016/j.psychres.2013.07.019; Buhlmann U, 2011, J NERV MENT DIS, V199, P268, DOI 10.1097/NMD.0b013e31821245ce; Buhlmann U, 2010, PSYCHIAT RES, V178, P171, DOI 10.1016/j.psychres.2009.05.002; Cavanagh K, 2014, BEHAV COGN PSYCHOTH, V42, P497, DOI 10.1017/S1352465813000568; Coles ME, 2007, BEHAV RES THER, V45, P2232, DOI 10.1016/j.brat.2006.12.009; Crerand CE, 2005, PSYCHOSOMATICS, V46, P549, DOI 10.1176/appi.psy.46.6.549; Department of Health, 2011, NO HEALTH WITHOUT ME; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Enander Jesper, 2014, BMJ Open, V4, pe005923, DOI 10.1136/bmjopen-2014-005923; Enander J, 2012, J OBSESS-COMPULS REL, V1, P325, DOI 10.1016/j.jocrd.2012.07.008; Grant JE, 2001, J CLIN PSYCHIAT, V62, P517, DOI 10.4088/JCP.v62n07a03; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hedman E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1977; Hollis C, 2015, BRIT J PSYCHIAT, V206, P263, DOI 10.1192/bjp.bp.113.142612; Ipser JC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005332.pub2; Kollei I, 2011, PSYCHIAT RES, V189, P153, DOI 10.1016/j.psychres.2011.02.009; Ljotsson B, 2014, BEHAV RES THER, V55, P27, DOI 10.1016/j.brat.2014.01.007; Marques L, 2011, J PSYCHOSOM RES, V70, P286, DOI 10.1016/j.jpsychores.2010.10.002; Mataix-Cols D, 2015, J AM ACAD CHILD PSY, V54, P895, DOI 10.1016/j.jaac.2015.08.011; National Institute for Health and Care Excellence, 2005, OBS COMP DIS COR INT; Otto MW, 2001, AM J PSYCHIAT, V158, P2061, DOI 10.1176/appi.ajp.158.12.2061; Phillips KA, 2013, PSYCHOL MED, V43, P1109, DOI 10.1017/S0033291712001730; Phillips KA, 2006, AM J PSYCHIAT, V163, P1280, DOI 10.1176/appi.ajp.163.7.1280; Phillips KA, 2005, COMPR PSYCHIAT, V46, P254, DOI 10.1016/j.comppsych.2004.10.004; Phillips KA, 1997, PSYCHOPHARMACOL BULL, V33, P17; Phillips KA, 2014, J OBSESS-COMPULS REL, V3, P205, DOI 10.1016/j.jocrd.2014.04.004; Rief W, 2006, PSYCHOL MED, V36, P877, DOI 10.1017/S0033291706007264; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Sarwer DB, 2012, AESTHET SURG J, V32, P999, DOI 10.1177/1090820X12462715; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Veale D, 2014, PSYCHOTHER PSYCHOSOM, V83, P341, DOI 10.1159/000360740; Wilhelm S, 2014, BEHAV THER, V45, P314, DOI 10.1016/j.beth.2013.12.007; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	43	56	58	3	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2016	352								i241	10.1136/bmj.i241	http://dx.doi.org/10.1136/bmj.i241			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2QK	26837684	hybrid, Green Published			2022-12-28	WOS:000369767100003
J	Chaurasia, A				Chaurasia, Anurag			India needs home-grown GM food to stop starvation	NATURE			English	Editorial Material									[Chaurasia, Anurag] Natl Bur Agr Important Microorganisms, Kushmaur, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agriculturally Important Microorganisms	Chaurasia, A (corresponding author), Natl Bur Agr Important Microorganisms, Kushmaur, India.	govtofindia.icar@gmail.com		Chaurasia, Anurag/0000-0003-4622-0642					0	0	0	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					439	439		10.1038/529439a	http://dx.doi.org/10.1038/529439a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26819009	hybrid			2022-12-28	WOS:000368673800004
J	Dadi, S; Chhangawala, S; Whitlock, BM; Franklin, RA; Luo, CT; Oh, SA; Toure, A; Pritykin, Y; Huse, M; Leslie, CS; Li, MO				Dadi, Saida; Chhangawala, Sagar; Whitlock, Benjamin M.; Franklin, Ruth A.; Luo, Chong T.; Oh, Soyoung A.; Toure, Ahmed; Pritykin, Yuri; Huse, Morgan; Leslie, Christina S.; Li, Ming O.			Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells	CELL			English	Article							NATURAL-KILLER-CELL; PROSTATE-CANCER; ADAPTIVE IMMUNITY; CUTTING EDGE; IFN-GAMMA; INFLAMMATION; EXPRESSION; DIFFERENTIATION; SURVEILLANCE; DISTINCT	Malignancy can be suppressed by the immune system in a process termed immunosurveillance. However, to what extent immunosurveillance occurs in spontaneous cancers and the composition of participating cell types remains obscure. Here, we show that cell transformation triggers a tissue-resident lymphocyte response in oncogene-induced murine cancer models. Non-circulating cytotoxic lymphocytes, derived from innate, T cell receptor (TCR)alpha beta, and TCR gamma delta lineages, expand in early tumors. Characterized by high expression of NK1.1, CD49a, and CD103, these cells share a gene-expression signature distinct from those of conventional NK cells, T cells, and invariant NKT cells. Generation of these lymphocytes is dependent on the cytokine IL-15, but not the transcription factor Nfil3 that is required for the differentiation of tumor-infiltrating NK cells, and IL-15 deficiency, but not Nfil3 deficiency, results in accelerated tumor growth. These findings reveal a tumor-elicited immunosurveillance mechanism that engages unconventional type-1-like innate lymphoid cells and type 1 innate-like T cells.	[Dadi, Saida; Whitlock, Benjamin M.; Franklin, Ruth A.; Luo, Chong T.; Oh, Soyoung A.; Toure, Ahmed; Huse, Morgan; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Chhangawala, Sagar; Whitlock, Benjamin M.; Pritykin, Yuri; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Chhangawala, Sagar] Cornell Univ, Weill Cornell Grad Sch Med Sci, Physiol Biophys & Syst Biol Grad Program, New York, NY 10065 USA; [Whitlock, Benjamin M.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Biochem & Struct Biol Cell & Dev Biol & Mol Biol, New York, NY 10065 USA; [Franklin, Ruth A.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10065 USA; [Luo, Chong T.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org	Franklin, Ruth/AFK-5723-2022; Pritykin, Yuri/ACA-0558-2022; Franklin, Ruth/AAG-4161-2022	Dadi-Mehmetaj, Saida/0000-0002-2215-5324; Chhangawala, Sagar/0000-0001-9626-1034; li, ming/0000-0002-1383-0535; Pritykin, Yury/0000-0001-6589-981X; Luo, Chong/0000-0002-3477-5969	Ludwig Center for Cancer Immunology; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Ludwig Center for Cancer Immunology; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Rothman for providing the Nfil3<SUP>-/-</SUP> mouse strain, Y. Tagaya and T. Waldmann for providing the IL-15 Transgenic mouse strain, and N. Cheung for the IL-15/IL-15R alpha complex. We also thank the M. Li lab for insightful discussions. MSKCC has filed a provisional patent application with the U.S. Patent and Trademark Office towards methods and compositions for cancer immunotherapy targeting innate lymphoid cells and innate-like T cells. S.D. and M.O.L. are listed as inventors on this patent application. This work was supported by the Ludwig Center for Cancer Immunology (M.O.L.) and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gillgrass AE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1264-3; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stevenaert F, 2003, J LEUKOCYTE BIOL, V73, P731, DOI 10.1189/jlb.0902443; Street SEA, 2007, CANCER RES, V67, P5454, DOI 10.1158/0008-5472.CAN-06-4084; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	62	198	206	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					365	377		10.1016/j.cell.2016.01.002	http://dx.doi.org/10.1016/j.cell.2016.01.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26806130	Green Accepted, Bronze			2022-12-28	WOS:000368906800009
J	Sieber, MH; Thomsen, MB; Spradling, AC				Sieber, Matthew H.; Thomsen, Michael B.; Spradling, Allan C.			Electron Transport Chain Remodeling by GSK3 during Oogenesis Connects Nutrient State to Reproduction	CELL			English	Article							OOCYTE DEVELOPMENTAL COMPETENCE; GLYCOGEN-SYNTHASE KINASE-3; DROSOPHILA-MELANOGASTER; MITOCHONDRIAL RESPIRATION; TRANSCRIPTION FACTOR; LIPID-METABOLISM; BALBIANI BODY; MOUSE OOCYTES; PI3 KINASE; IN-VITRO	Reproduction is heavily influenced by nutrition and metabolic state. Many common reproductive disorders in humans are associated with diabetes and metabolic syndrome. We characterized the metabolic mechanisms that support oogenesis and found that mitochondria in mature Drosophila oocytes enter a low-activity state of respiratory quiescence by remodeling the electron transport chain (ETC). This shift in mitochondrial function leads to extensive glycogen accumulation late in oogenesis and is required for the developmental competence of the oocyte. Decreased insulin signaling initiates ETC remodeling and mitochondrial respiratory quiescence through glycogen synthase kinase 3 (GSK3). Intriguingly, we observed similar ETC remodeling and glycogen uptake in maturing Xenopus oocytes, suggesting that these processes are evolutionarily conserved aspects of oocyte development. Our studies reveal an important link between metabolism and oocyte maturation.	[Sieber, Matthew H.; Spradling, Allan C.] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Thomsen, Michael B.] Johns Hopkins Univ, Dept Biol, 3400 North Charles St, Baltimore, MD 21218 USA; [Spradling, Allan C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Carnegie Institution for Science; Johns Hopkins University; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.; Spradling, AC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	spradling@ciwemb.edu			HHMI; Carnegie Institution for Science; Jane Coffin Childs Research Fund	HHMI(Howard Hughes Medical Institute); Carnegie Institution for Science; Jane Coffin Childs Research Fund	We thank Joseph G. Gall, Zehra Nizami, and Gaelle Talhouarne for training and assistance in conducting the experiments using Xenopus laevis. We are very grateful to Dianne Williams for her assistance in testing and troubleshooting a number of the antibodies used for western blot analysis in this paper. We also thank the University of Utah GC/MS core facility and James Cox for his assistance in analyzing GC/MS samples. We are grateful to Joseph Tran, Erik Duboue, Lei Lei, Rebecca Obniski, and Vicki Losick for helpful discussion and comments during the preparation of this manuscript. A.C.S. is supported by HHMI and the Carnegie Institution for Science, and M.H.S. is funded by the Jane Coffin Childs Research Fund.	Acevedo N, 2007, BIOL REPROD, V77, P872, DOI 10.1095/biolreprod.107.060152; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Barri PN, 2014, REPROD BIOMED ONLINE, V28, P99, DOI 10.1016/j.rbmo.2013.08.012; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bass BP, 2009, CELL DEATH DIFFER, V16, P1362, DOI 10.1038/cdd.2009.79; Ben-Shlomo I, 2014, REPROD BIOMED ONLINE, V28, P669, DOI 10.1016/j.rbmo.2014.02.011; BROWN GC, 1992, BIOCHEM J, V284, P1; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Buszczak M, 2002, GENETICS, V160, P1511; Campbell K, 2006, DEV BIOL, V298, P225, DOI 10.1016/j.ydbio.2006.06.032; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deady LD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004989; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Dunning KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087327; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; GUTZEIT HO, 1994, EUR J CELL BIOL, V63, P52; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; HEINEMAN FW, 1990, ANNU REV PHYSIOL, V52, P523; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hsu HJ, 2011, DEV BIOL, V350, P290, DOI 10.1016/j.ydbio.2010.11.032; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; LOVETT JA, 1977, DEV BIOL, V61, P70, DOI 10.1016/0012-1606(77)90342-6; MAGNUSSON C, 1986, HUM REPROD, V1, P183, DOI 10.1093/oxfordjournals.humrep.a136377; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MELARIKER LM, 1985, ANNU REV PHYSIOL, V47, P645; MERMOD JJ, 1977, DEV BIOL, V57, P393, DOI 10.1016/0012-1606(77)90224-X; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Neufeld Thomas P, 2003, J Biol, V2, P18, DOI 10.1186/1475-4924-2-18; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; PERRIMON N, 1984, DEV BIOL, V105, P404, DOI 10.1016/0012-1606(84)90297-5; Raikhel A. S., 2005, COMPREHENSIVE MOL IN, V3, P432; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanz A, 2010, J BIOENERG BIOMEMBR, V42, P135, DOI 10.1007/s10863-010-9281-z; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019; Sieber MH, 2012, CELL METAB, V15, P122, DOI 10.1016/j.cmet.2011.11.011; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Simon A, 2012, J ASSIST REPROD GEN, V29, P1227, DOI 10.1007/s10815-012-9861-4; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Sun JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00415; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Takeo S, 2012, P NATL ACAD SCI USA, V109, P6382, DOI 10.1073/pnas.1120367109; Tania M, 2010, CURR ONCOL, V17, P6; Tanno M, 2014, J BIOL CHEM, V289, P29285, DOI 10.1074/jbc.M114.563924; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Zheng P, 2001, MOL REPROD DEV, V58, P348, DOI 10.1002/1098-2795(200103)58:3<348::AID-MRD14>3.0.CO;2-O	66	69	71	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					420	432		10.1016/j.cell.2015.12.020	http://dx.doi.org/10.1016/j.cell.2015.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26824655	Green Accepted, Bronze			2022-12-28	WOS:000368906800013
J	Davies, SC; Akksilp, S; Takemi, K; Matsoso, P; Da Silva, JB				Davies, Sally C.; Akksilp, Somsak; Takemi, Keizo; Matsoso, Precious; Da Silva Junior, Jarbas Barbosa			The future leadership of WHO	LANCET			English	Editorial Material									[Davies, Sally C.] Dept Hlth, London SW1A 2NS, England; [Akksilp, Somsak] Thai Minist Publ Hlth, Nonthaburi, Thailand; [Takemi, Keizo] Natl Diet Japan, House Councillors, Tokyo, Japan; [Matsoso, Precious] Natl Dept Hlth, Pretoria, South Africa; [Da Silva Junior, Jarbas Barbosa] Natl Hlth Surveillance Agcy ANVISA, Brasilia, DF, Brazil	Ministry of Public Health - Thailand	Davies, SC (corresponding author), Dept Hlth, London SW1A 2NS, England.	sally.davies@dh.gsi.gov.uk						[Anonymous], 2015, 1 ADV GROUP REF WHOS; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; WHO, 2015, REP EB INT ASS PAN; WHO, 2014, FOLL UP REP WORK GRO; WHO, 2015, NEP EARTHQ 2015; World Health Organization, 2015, WHO SECR RESP REP EB	7	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					321	323		10.1016/S0140-6736(16)00105-7	http://dx.doi.org/10.1016/S0140-6736(16)00105-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26842435				2022-12-28	WOS:000368516500011
J	Snyder, A				Snyder, Alison			Alisha Lee Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2016	387	10015					222	222		10.1016/S0140-6736(16)00053-2	http://dx.doi.org/10.1016/S0140-6736(16)00053-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA9LQ	26842290	Bronze			2022-12-28	WOS:000368130700019
J	Comin, R; Sutarto, R; Neto, EHD; Chauviere, L; Liang, R; Hardy, WN; Bonn, DA; He, F; Sawatzky, GA; Damascelli, A				Comin, R.; Sutarto, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; He, F.; Sawatzky, G. A.; Damascelli, A.			Response to Comment on "Broken translational and rotational symmetry via charge stripe order in underdoped YBa2Cu3O6+y"	SCIENCE			English	Editorial Material								Fine questions our interpretation of unidirectional stripes over a bidirectional checkerboard and illustrates his criticism by simulating a momentum space structure consistent with our data and corresponding to a checkerboard-looking real space density. Here, we use a local rotational-symmetry analysis to demonstrate that the simulated image is actually composed of locally unidirectional modulations of the charge density, consistent with our original conclusions.	[Comin, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Comin, R.; Neto, E. H. da Silva; Chauviere, L.; Liang, R.; Hardy, W. N.; Bonn, D. A.; Sawatzky, G. A.; Damascelli, A.] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [Sutarto, R.; He, F.] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Neto, E. H. da Silva] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON M5G 1Z8, Canada; [Neto, E. H. da Silva] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	University of British Columbia; University of British Columbia; University of Saskatchewan; Canadian Institute for Advanced Research (CIFAR); Max Planck Society	Comin, R (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	r.comin@utoronto.ca; damascelli@physics.ubc.ca	Hardy, Walter Newbold/AAN-7827-2020; He, Feizhou/G-8493-2015; damascelli, andrea/P-6329-2014; Comin, Riccardo/H-7731-2016	He, Feizhou/0000-0002-3125-1406; damascelli, andrea/0000-0001-9895-2226; Comin, Riccardo/0000-0002-1069-9973				Comin R, 2015, SCIENCE, V347, P1335, DOI 10.1126/science.1258399; Del Maestro A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024520; Fine BV, 2016, SCIENCE, V351, p235A, DOI 10.1126/science.aac4454; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Hamidian M. H., 2015, RXIV150707865	6	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					235B	+		10.1126/science.aac4778	http://dx.doi.org/10.1126/science.aac4778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26816371	Green Submitted			2022-12-28	WOS:000368098600029
J	Shiode, J				Shiode, Josh			My adviser's best advice	SCIENCE			English	Editorial Material									[Shiode, Josh] AAAS, Washington, DC 20005 USA		Shiode, J (corresponding author), AAAS, Washington, DC 20005 USA.								0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					310	310		10.1126/science.351.6270.310	http://dx.doi.org/10.1126/science.351.6270.310			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA9AM	26816382				2022-12-28	WOS:000368098600044
